PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huh, JR; Leung, MWL; Huang, PX; Ryan, DA; Krout, MR; Malapaka, RRV; Chow, J; Manel, N; Ciofani, M; Kim, SV; Cuesta, A; Santori, FR; Lafaille, JJ; Xu, HE; Gin, DY; Rastinejad, F; Littman, DR				Huh, Jun R.; Leung, Monica W. L.; Huang, Pengxiang; Ryan, Daniel A.; Krout, Michael R.; Malapaka, Raghu R. V.; Chow, Jonathan; Manel, Nicolas; Ciofani, Maria; Kim, Sangwon V.; Cuesta, Adolfo; Santori, Fabio R.; Lafaille, Juan J.; Xu, H. Eric; Gin, David Y.; Rastinejad, Fraydoon; Littman, Dan R.			Digoxin and its derivatives suppress T(H)17 cell differentiation by antagonizing ROR gamma t activity	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CARDIAC-GLYCOSIDES; THERAPEUTIC APPLICATIONS; AUTOIMMUNE INFLAMMATION; SODIUM/POTASSIUM-ATPASE; LIGAND-BINDING; BETA; IL-23; ALPHA; POPULATIONS	CD4(+) T helper lymphocytes that express interleukin-17 (T(H)17 cells) have critical roles in mouse models of autoimmunity, and there is mounting evidence that they also influence inflammatory processes in humans. Genome-wide association studies in humans have linked genes involved in T(H)17 cell differentiation and function with susceptibility to Crohn's disease, rheumatoid arthritis and psoriasis(1-3). Thus, the pathway towards differentiation of T(H)17 cells and, perhaps, of related innate lymphoid cells with similar effector functions(4,5), is an attractive target for therapeutic applications. Mouse and human T(H)17 cells are distinguished by expression of the retinoic acid receptor-related orphan nuclear receptor ROR gamma t, which is required for induction of IL-17 transcription and for the manifestation of T(H)17-dependent autoimmune disease in mice(6). By performing a chemical screen with an insect cell-based reporter system, we identified the cardiac glycoside digoxin as a specific inhibitor of ROR gamma t transcriptional activity. Digoxin inhibited murine T(H)17 cell differentiation without affecting differentiation of other T cell lineages and was effective in delaying the onset and reducing the severity of autoimmune disease in mice. At high concentrations, digoxin is toxic for human cells, but non-toxic synthetic derivatives 20,22-dihydrodigoxin-21,23-diol and digoxin-21-salicylidene specifically inhibited induction of IL-17 in human CD4(+) T cells. Using these small-molecule compounds, we demonstrate that ROR gamma t is important for the maintenance of IL-17 expression in mouse and human effector T cells. These data indicate that derivatives of digoxin can be used as chemical templates for the development of ROR gamma t-targeted therapeutic agents that attenuate inflammatory lymphocyte function and autoimmune disease.	[Huh, Jun R.; Leung, Monica W. L.; Chow, Jonathan; Manel, Nicolas; Ciofani, Maria; Kim, Sangwon V.; Cuesta, Adolfo; Santori, Fabio R.; Lafaille, Juan J.; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Huang, Pengxiang; Rastinejad, Fraydoon] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA; [Ryan, Daniel A.; Krout, Michael R.; Gin, David Y.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Malapaka, Raghu R. V.; Xu, H. Eric] Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Chow, Jonathan; Cuesta, Adolfo; Littman, Dan R.] NYU, Howard Hughes Med Inst, Sch Med, New York, NY 10016 USA	New York University; Sanford Burnham Prebys Medical Discovery Institute; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA.	Dan.Littman@med.nyu.edu	Malapaka, Raghu/B-6185-2012; Xu, H. Eric/ABD-7487-2021; Santori, Fabio/GRF-1002-2022; Manel, Nicolas/E-2128-2011; Kim, Sangwon V./S-1166-2016	Manel, Nicolas/0000-0002-1481-4430; Chow, Jonathan/0000-0002-4321-2420; Xu, H. Eric/0000-0002-6829-8144; Santori, Fabio/0000-0002-0220-8935; Ciofani, Maria/0000-0001-6472-5260; Kim, Sangwon V./0000-0001-8453-7080; Krout, Michael/0000-0002-0539-6986	Jane Coffin Childs Memorial Funds; Howard Hughes Medical Institute; National Institutes of Health [F32GM0860552, RO1GM058833, RO1GM067659, 2RO1GM55217, RO1AI080885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058833, R01GM067659, R01GM055217] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Funds; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Shamu at ICCB-Longwood for screening small-compound libraries. We also thank the New York Cord Blood Center for providing samples, the Developmental Studies Hybridoma Bank for beta-tubulin antibody, the NYU Cancer Institute Genomics Facility for expert assistance with microarray experiments, V. Kuchroo and M. Oukka for the IL-23R GFP reporter mice, T. Iwaki, C. Thummel and R. Dasgupta for plasmids, M. Garabedian for R1881 and plasmids, D. Mangelsdorf for dafachronic acid and plasmids, G. Diehl and M. Sellars for reading the manuscript, M. Menager and J. Johnson for sharing peripheral blood mononuclear cells, and members of the D. R. L. laboratory for their suggestions. Supported by the Jane Coffin Childs Memorial Funds (J. R. H.), the Howard Hughes Medical Institute (D. R. L.) and National Institutes of Health grants F32GM0860552 (M. R. K.), RO1GM058833 (D.Y.G.), RO1GM067659 (D.Y.G), 2RO1GM55217 (F. R.) and RO1AI080885 (D.R.L.).	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Johansson S, 2001, ANTI-CANCER DRUG, V12, P475, DOI 10.1097/00001813-200106000-00009; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; ROBERTSON LW, 1986, APPL ENVIRON MICROB, V51, P1300, DOI 10.1128/AEM.51.6.1300-1303.1986; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stehlin C, 2001, EMBO J, V20, P5822, DOI 10.1093/emboj/20.21.5822; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zavareh RB, 2008, CANCER RES, V68, P6688, DOI 10.1158/0008-5472.CAN-07-6833; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	30	395	429	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					486	490		10.1038/nature09978	http://dx.doi.org/10.1038/nature09978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21441909	Green Accepted			2022-12-01	WOS:000289949600037
J	Oh, JS; Susor, A; Conti, M				Oh, Jeong Su; Susor, Andrej; Conti, Marco			Protein Tyrosine Kinase Wee1B Is Essential for Metaphase II Exit in Mouse Oocytes	SCIENCE			English	Article							ACTIVATION; EGG; PHOSPHORYLATION; RESUMPTION; ARREST; CDC20	Waves of cyclin synthesis and degradation regulate the activity of Cdc2 protein kinase during the cell cycle. Cdc2 inactivation by Wee1B-mediated phosphorylation is necessary for arrest of the oocyte at G2-prophase, but it is unclear whether this regulation functions later during the metaphase-to-anaphase transition. We show that reactivation of a Wee1B pathway triggers the decrease in Cdc2 activity during egg activation. When Wee1B is down-regulated, oocytes fail to form a pronucleus in response to Ca2+ signals. Calcium-calmodulin-dependent kinase II (CaMKII) activates Wee1B, and CaMKII-driven exit from metaphase II is inhibited by Wee1B down-regulation, demonstrating that exit from metaphase requires not only a proteolytic degradation of cyclin B but also the inhibitory phosphorylation of Cdc2 by Wee1B.	[Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conti, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA.	contim@obgyn.ucsf.edu			NIH [GM080527-05, HD052909]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. J. Han for Wee1B plasmids, K. T. Jones for cyclin B plasmids, and T. Lorca for the CaMKII plasmid. This work was supported by NIH grants GM080527-05 and HD052909. J.O. designed, performed, and analyzed most of the experiments in this study. A. S. performed immunostaining. M.C. conceived the project and supervised the study. J.O. and M.C. wrote the manuscript.	BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; D'Angiolella V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000247; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Hutchins JRA, 2003, MOL BIOL CELL, V14, P4003, DOI 10.1091/mbc.E03-02-0061; Jones KT, 2005, REPRODUCTION, V130, P813, DOI 10.1530/rep.1.00710; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Madgwick S, 2005, J CELL SCI, V118, P3849, DOI 10.1242/jcs.02506; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Sveiczer A, 1999, J CELL SCI, V112, P1085; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yin S, 2007, CELL CYCLE, V6, P2990, DOI 10.4161/cc.6.23.4993	15	75	88	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					462	465		10.1126/science.1199211	http://dx.doi.org/10.1126/science.1199211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21454751	Green Accepted			2022-12-01	WOS:000289784900042
J	Uytterhoeven, V; Kuenen, S; Kasprowicz, J; Miskiewicz, K; Verstreken, P				Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik			Loss of Skywalker Reveals Synaptic Endosomes as Sorting Stations for Synaptic Vesicle Proteins	CELL			English	Article							FROG NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER RELEASE; BULK ENDOCYTOSIS; RAB PROTEINS; MEMBRANE; TRANSMITTER; EXOCYTOSIS; TRANSPORT; MACHINERY; ELEGANS	Exchange of proteins at sorting endosomes is not only critical to numerous signaling pathways but also to receptor-mediated signaling and to pathogen entry into cells; however, how this process is regulated in synaptic vesicle cycling remains unexplored. In this work, we present evidence that loss of function of a single neuronally expressed GTPase activating protein (GAP), Skywalker (Sky) facilitates endosomal trafficking of synaptic vesicles at Drosophila neuromuscular junction boutons, chiefly by controlling Rab35 GTPase activity. Analyses of genetic interactions with the ESCRT machinery as well as chimeric ubiquitinated synaptic vesicle proteins indicate that endosomal trafficking facilitates the replacement of dysfunctional synaptic vesicle components. Consequently, sky mutants harbor a larger readily releasable pool of synaptic vesicles and show a dramatic increase in basal neurotransmitter release. Thus, the trafficking of vesicles via endosomes uncovered using sky mutants provides an elegant mechanism by which neurons may regulate synaptic vesicle rejuvenation and neurotransmitter release.	[Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik] Katholieke Univ Leuven, Ctr Human Genet, Program Mol & Dev Genet, Program Cognit & Mol Neurosci,Lab Neuronal Commun, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Verstreken, P (corresponding author), VIB, Dept Mol & Dev Genet, Herestr 49, B-3000 Louvain, Belgium.	patrik.verstreken@med.kuleuven.be	Uytterhoeven, Valerie/ABB-6274-2021; Verstreken, Patrik/AAC-7591-2022	Verstreken, Patrik/0000-0002-5073-5393	Marie Curie Excellence grant [MEXT-CT-2006-042267]; ERC [260678]; FWO [G074709, G094011]; Research Fund; Flemish Government; Francqui Foundation; VIB; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	Marie Curie Excellence grant(European Commission); ERC(European Research Council (ERC)European Commission); FWO(FWO); Research Fund; Flemish Government(European Commission); Francqui Foundation; VIB; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	We thank H. Bellen for reagents and access to screen mutants and A. Di Antonio, M. Scott, K. Suyama, M. Gonzalez-Gaitan, G. Davis, Harvard University, the Bloomington and Harvard Drosophila stock centers, and the Developmental Studies Hybridoma bank for reagents. We thank S. Munck (LiMoNe), P. Baatsen (EM-facility of the CME, VIB-KULeuven), V. Morais, W. Annaert, B. Hassan and members of the Verstreken lab for help and comments. Support was provided by a Marie Curie Excellence grant (MEXT-CT-2006-042267); and ERC Starting Grant (260678), FWO grants G074709 and G094011; the Research Fund KU Leuven; a Methusalem grant of the Flemish Government; the Francqui Foundation; VIB and an Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen), fellowship to VU.	Akbergenova Y, 2009, MOL CELL NEUROSCI, V40, P199, DOI 10.1016/j.mcn.2008.10.005; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Clayton EL, 2008, NEUROCHEM INT, V53, P51, DOI 10.1016/j.neuint.2008.06.002; Clayton EL, 2009, J NEUROSCI METH, V185, P76, DOI 10.1016/j.jneumeth.2009.09.016; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HOOPMANN P, 2010, P NATL ACAD SCI US; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Opazo F, 2010, TRAFFIC, V11, P800, DOI 10.1111/j.1600-0854.2010.01058.x; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Rosenmund C, 1997, J NEUROSCI METH, V76, P1, DOI 10.1016/S0165-0270(97)00061-7; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Vijayakrishnan N, 2009, J CELL SCI, V122, P114, DOI 10.1242/jcs.036673; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yao CK, 2009, CELL, V138, P947, DOI 10.1016/j.cell.2009.06.033; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	49	137	144	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					117	132		10.1016/j.cell.2011.02.039	http://dx.doi.org/10.1016/j.cell.2011.02.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458671	Bronze			2022-12-01	WOS:000289053900014
J	Zettl, M; Adrain, C; Strisovsky, K; Lastun, V; Freeman, M				Zettl, Markus; Adrain, Colin; Strisovsky, Kvido; Lastun, Viorica; Freeman, Matthew			Rhomboid Family Pseudoproteases Use the ER Quality Control Machinery to Regulate Intercellular Signaling	CELL			English	Article							INTRAMEMBRANE PROTEOLYSIS; SUBSTRATE-SPECIFICITY; DROSOPHILA RHOMBOID-1; SLEEP; PROTEASES; PATHWAY; IDENTIFICATION; ACTIVATION; PEPTIDASE; RESIDUES	Intramembrane proteolysis governs many cellular control processes, but little is known about how intramembrane proteases are regulated. iRhoms are a conserved subfamily of proteins related to rhomboid intramembrane serine proteases that lack key catalytic residues. We have used a combination of genetics and cell biology to determine that these "pseudoproteases'' inhibit rhomboid-dependent signaling by the epidermal growth factor receptor pathway in Drosophila, thereby regulating sleep. iRhoms prevent the cleavage of potential rhomboid substrates by promoting their destabilization by endoplasmic reticulum (ER)-associated degradation; this mechanism has been conserved in mammalian cells. The exploitation of the intrinsic quality control machinery of the ER represents a new mode of regulation of intercellular signaling. Inactive cognates of enzymes are common, but their functions are mostly unclear; our data indicate that pseudoenzymes can readily evolve into regulatory proteins, suggesting that this may be a significant evolutionary mechanism.	[Zettl, Markus; Adrain, Colin; Strisovsky, Kvido; Lastun, Viorica; Freeman, Matthew] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	mf1@mrc-lmb.cam.ac.uk	Strisovsky, Kvido/H-6284-2014; Adrain, Colin/I-6259-2013	Strisovsky, Kvido/0000-0003-3677-0907; Adrain, Colin/0000-0001-7597-4393; Freeman, Matthew/0000-0003-0410-5451	Austrian FWF; Austrian Academy of Science; International Human Frontier Science Program Organization; EMBO Long-Term Fellowship; Marie Curie Intraeuropean Fellowship; MRC [MC_U105178780] Funding Source: UKRI; Medical Research Council [MC_U105178780] Funding Source: researchfish	Austrian FWF(Austrian Science Fund (FWF)); Austrian Academy of Science; International Human Frontier Science Program Organization(Human Frontier Science Program); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Intraeuropean Fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Yonka Christova, Marius Lemberg, Marc de la Roche, Amita Sehgal, Sean Munro, Don Ryoo, and Simon Bullock for reagents, discussion, and unpublished data. M.Z. was supported by an Erwin-Schrodinger fellowship from the Austrian FWF and an APART fellowship from the Austrian Academy of Science. C. A. was supported by a long-term fellowship from The International Human Frontier Science Program Organization and was the recipient of an EMBO Long-Term Fellowship. K. S. acknowledges support from Marie Curie Intraeuropean Fellowship and an EMBO Long-Term Fellowship.	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Bartlett GJ, 2003, J MOL BIOL, V331, P829, DOI 10.1016/S0022-2836(03)00734-4; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cirelli C, 2008, ANN NY ACAD SCI, V1129, P323, DOI 10.1196/annals.1417.017; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sakai J, 2001, CURR OPIN LIPIDOL, V12, P261, DOI 10.1097/00041433-200106000-00004; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wasserman JD, 2000, GENE DEV, V14, P1651; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Yan ZW, 2008, MOL CANCER THER, V7, P1355, DOI 10.1158/1535-7163.MCT-08-0104; Yogev S, 2008, EMBO J, V27, P1219, DOI 10.1038/emboj.2008.58; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	42	123	133	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					79	91		10.1016/j.cell.2011.02.047	http://dx.doi.org/10.1016/j.cell.2011.02.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21439629	Green Published, hybrid			2022-12-01	WOS:000289053900011
J	Baker, M				Baker, Monya			A LIVING SYSTEM ON A CHIP	NATURE			English	Editorial Material																		Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Imura Y, 2010, ANAL CHEM, V82, P9983, DOI 10.1021/ac100806x; Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sonntag F, 2010, J BIOTECHNOL, V148, P70, DOI 10.1016/j.jbiotec.2010.02.001; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Sung JH, 2011, LAB CHIP, V11, P389, DOI [10.1039/c0lc00273a, 10.1039/c01c00273a]; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a	10	153	165	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					661	665		10.1038/471661a	http://dx.doi.org/10.1038/471661a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455183	Bronze			2022-12-01	WOS:000288951200047
J	Fowler, CD; Lu, Q; Johnson, PM; Marks, MJ; Kenny, PJ				Fowler, Christie D.; Lu, Qun; Johnson, Paul M.; Marks, Michael J.; Kenny, Paul J.			Habenular alpha 5 nicotinic receptor subunit signalling controls nicotine intake	NATURE			English	Article							INTRACRANIAL SELF-STIMULATION; BRAIN REWARD SYSTEMS; LUNG-CANCER; INTERPEDUNCULAR NUCLEUS; ACETYLCHOLINE-RECEPTORS; SUSCEPTIBILITY LOCUS; RISK; ASSOCIATION; RATS; ACTIVATION	Genetic variation in CHRN alpha 5, the gene encoding the alpha 5 nicotinic acetylcholine receptor subunit, increases vulnerability to tobacco addiction and lung cancer, but the underlying mechanisms are unknown. Here we report markedly increased nicotine intake in mice with a null mutation in Chrn alpha 5. This effect was 'rescued' in knockout mice by re-expressing alpha 5 subunits in the medial habenula (MHb), and recapitulated in rats through alpha 5 subunit knockdown in MHb. Remarkably, alpha 5 subunit knockdown in MHb did not alter the rewarding effects of nicotine but abolished the inhibitory effects of higher nicotine doses on brain reward systems. The MHb extends projections almost exclusively to the interpeduncular nucleus (IPN). We found diminished IPN activation in response to nicotine in alpha 5 knockout mice. Further, disruption of IPN signalling increased nicotine intake in rats. Our findings indicate that nicotine activates the habenulo-interpeduncular pathway through alpha 5-containing nAChRs, triggering an inhibitory motivational signal that acts to limit nicotine intake.	[Fowler, Christie D.; Lu, Qun; Johnson, Paul M.; Kenny, Paul J.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA; [Marks, Michael J.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Boulder	Kenny, PJ (corresponding author), Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA.	pjkenny@scripps.edu	Fowler, Christie D/A-1754-2015	Fowler, Christie/0000-0003-2864-2163	National Institute on Drug Abuse [DA020686, DA026693, P30DA015663]; Florida Department of Health [07KN-06]; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026693, P30DA015663, R01DA020686] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Florida Department of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse (DA020686 to P.J.K.; DA026693 to C.D.F.; P30DA015663 to M.J.M.) and The James and Esther King Biomedical Research Program, Florida Department of Health (07KN-06 to P.J.K.).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; DONOVICK PJ, 1970, J COMP PHYSIOL PSYCH, V71, P376, DOI 10.1037/h0029114; Gavrilov Yu V, 2008, Neurosci Behav Physiol, V38, P189, DOI 10.1007/s11055-008-0028-9; Girod R, 2000, NEUROPHARMACOLOGY, V39, P2715, DOI 10.1016/S0028-3908(00)00145-3; Glick SD, 2006, EUR J PHARMACOL, V537, P94, DOI 10.1016/j.ejphar.2006.03.045; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; HENNINGFIELD JE, 1983, PHARMACOL BIOCHEM BE, V19, P989, DOI 10.1016/0091-3057(83)90405-7; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hussain RJ, 2008, NEUROSCI LETT, V440, P270, DOI 10.1016/j.neulet.2008.06.001; HUSTONLYONS D, 1992, PHARMACOL BIOCHEM BE, V41, P755, DOI 10.1016/0091-3057(92)90223-3; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Jackson KJ, 2010, J PHARMACOL EXP THER, V334, P137, DOI 10.1124/jpet.110.165738; Kenny PJ, 2007, TRENDS PHARMACOL SCI, V28, P135, DOI 10.1016/j.tips.2007.01.008; Kenny PJ, 2009, NEUROPSYCHOPHARMACOL, V34, P266, DOI 10.1038/npp.2008.58; Kenny PJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1203, DOI 10.1038/sj.npp.1300905; KORNETSKY C, 1979, ARCH GEN PSYCHIAT, V36, P289; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Laviolette SR, 2002, J NEUROSCI, V22, P8653; Le Foll B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000230; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lecourtier L, 2004, EUR J NEUROSCI, V19, P2551, DOI 10.1111/j.0953-816X.2004.03356.x; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; LONDON ED, 1988, J NEUROSCI, V8, P3920; Lynch WJ, 1999, EXP CLIN PSYCHOPHARM, V7, P198, DOI 10.1037/1064-1297.7.3.198; Lynch WJ, 2001, EXP CLIN PSYCHOPHARM, V9, P131, DOI 10.1037//1064-1297.9.2.131; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Qin C, 2009, NEUROSCIENCE, V161, P827, DOI 10.1016/j.neuroscience.2009.03.085; Rauhut AS, 2008, PHARMACOL BIOCHEM BE, V90, P598, DOI 10.1016/j.pbb.2008.05.002; RISNER ME, 1983, J PHARMACOL EXP THER, V224, P319; RUSSELL MAH, 1975, BRIT MED J, V2, P414, DOI 10.1136/bmj.2.5968.414; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; SCHAEFER GJ, 1986, NEUROPHARMACOLOGY, V25, P125, DOI 10.1016/0028-3908(86)90033-X; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Shoaib M, 2002, NEUROPHARMACOLOGY, V42, P530, DOI 10.1016/S0028-3908(01)00194-0; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Wang YF, 2010, CARCINOGENESIS, V31, P234, DOI 10.1093/carcin/bgp287	56	442	446	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					597	601		10.1038/nature09797	http://dx.doi.org/10.1038/nature09797			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21278726	Green Accepted, Green Submitted			2022-12-01	WOS:000288951200034
J	Arnaud-Haond, S; Arrieta, JM; Duarte, CM				Arnaud-Haond, Sophie; Arrieta, Jesus M.; Duarte, Carlos M.			Marine Biodiversity and Gene Patents	SCIENCE			English	Editorial Material							DISTRIBUTIONS; RESOURCES; LAW		[Arnaud-Haond, Sophie] Ifremer French Res Inst Explorat Sea, Ctr Brest, Dept DEEP LEP, F-29280 Plouzane, France; [Arrieta, Jesus M.; Duarte, Carlos M.] CSIC UIB, Dept Global Change Resarch, Mediterranean Inst Adv Studies, IMEDEA, Esporles 07190, Mallorca, Spain; [Duarte, Carlos M.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia	Ifremer; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; University of Western Australia	Arnaud-Haond, S (corresponding author), Ifremer French Res Inst Explorat Sea, Ctr Brest, Dept DEEP LEP, F-29280 Plouzane, France.	sophie.arnaud@ifremer.fr	Arnaud-Haond, Sophie/B-2479-2008; Duarte, Carlos M/A-7670-2013; Arrieta, Jesus M/B-1226-2008; Duarte Quesada, Carlos Manuel/ABD-6208-2021	Arnaud-Haond, Sophie/0000-0001-5814-8452; Duarte, Carlos M/0000-0002-1213-1361; Arrieta, Jesus M/0000-0002-0190-6950; 				[Anonymous], 2007, REP WORK UN OP END I; Arico S., 2005, REP WORK UN OP END I; Arico S., 2005, BIOPROSPECTING GENET; Arrieta JM, 2010, P NATL ACAD SCI USA, V107, P18318, DOI 10.1073/pnas.0911897107; Bermudez Jorge, 2010, Open AIDS J, V4, P37, DOI 10.2174/1874613601004020037; Blaustein RJ, 2010, BIOSCIENCE, V60, P408, DOI 10.1525/bio.2010.60.6.3; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1352, DOI 10.1038/nbt1106-1352; Clark J., 2000, PATENT POOLS SOLUTIO; Douglas-Westwood Limited, 2005, MAR FOR SER, V1; Dragulescu A, 2001, PHYSICA A, V299, P213, DOI 10.1016/S0378-4371(01)00298-9; Francisco M., 2010, BIOTECHNIQUES, V28, P300; FRANCISCO M, 2010, NAT BIOTECHNOL, V28, P300; GARRISON C, 2007, KESTUDIES, V1, P1, DOI DOI 10.1038/NRD2487; GROSSMAN GM, 1994, J ECON PERSPECT, V8, P23, DOI 10.1257/jep.8.1.23; Hu MB, 2006, EUR PHYS J B, V53, P273, DOI 10.1140/epjb/e2006-00365-8; Leary D, 2009, MAR POLICY, V33, P183, DOI 10.1016/j.marpol.2008.05.010; Martinez SI, 2010, CURR OPIN ENV SUST, V2, P27, DOI 10.1016/j.cosust.2010.03.004; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ossorio PN, 2007, J LAW MED ETHICS, V35, P425, DOI 10.1111/j.1748-720X.2007.00165.x; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; ZEWERS K, 2007, LOYOLA U CHICAGO INT, V5, P151	22	50	50	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1521	1522		10.1126/science.1200783	http://dx.doi.org/10.1126/science.1200783			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436424				2022-12-01	WOS:000288754500027
J	Fine, DR				Fine, David R.			Personal View We need a simple test for prosopagnosia	BRITISH MEDICAL JOURNAL			English	Editorial Material									Southampton Univ Hosp NHS Trust, Southampton, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust	Fine, DR (corresponding author), Southampton Univ Hosp NHS Trust, Southampton, Hants, England.	davidrfine@gmail.com		Fine, David/0000-0001-8041-3275					0	6	6	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1736	10.1136/bmj.d1736	http://dx.doi.org/10.1136/bmj.d1736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742MJ	21429993				2022-12-01	WOS:000288948000030
J	Yanovski, SZ; Yanovski, JA				Yanovski, Susan Z.; Yanovski, Jack A.			Obesity Prevalence in the United States - Up, Down, or Sideways?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADULTS		[Yanovski, Susan Z.] NIDDKD, Off Obes Res, Bethesda, MD 20892 USA; [Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Obes, Program Dev Endocrinol & Genet, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yanovski, SZ (corresponding author), NIDDKD, Off Obes Res, Bethesda, MD 20892 USA.			Yanovski, Jack/0000-0001-8542-1637	Intramural NIH HHS [Z99 HD999999, ZIA HD000641-16] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P951; EATON DK, 2007, OBES REV, V8, P307; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012	4	114	121	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					987	989		10.1056/NEJMp1009229	http://dx.doi.org/10.1056/NEJMp1009229			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735SX	21410367	Bronze, Green Accepted			2022-12-01	WOS:000288439000002
J	Simsek, D; Furda, A; Gao, Y; Artus, J; Brunet, E; Hadjantonakis, AK; Van Houten, B; Shuman, S; McKinnon, PJ; Jasin, M				Simsek, Deniz; Furda, Amy; Gao, Yankun; Artus, Jerome; Brunet, Erika; Hadjantonakis, Anna-Katerina; Van Houten, Bennett; Shuman, Stewart; McKinnon, Peter J.; Jasin, Maria			Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair	NATURE			English	Article							STRAND BREAK REPAIR; EMBRYONIC LETHALITY; GENE ENCODES; XRCC1; NUCLEAR; PROTEINS; BINDING; ALPHA; CELLS; CYCLE	Mammalian cells have three ATP-dependent DNA ligases, which are required for DNA replication and repair(1). Homologues of ligase I (Lig1) and ligase IV (Lig4) are ubiquitous in Eukarya, whereas ligase III (Lig3), which has nuclear and mitochondrial forms, appears to be restricted to vertebrates. Lig3 is implicated in various DNA repair pathways with its partner protein Xrcc1 (ref. 1). Deletion of Lig3 results in early embryonic lethality in mice, as well as apparent cellular lethality(2), which has precluded definitive characterization of Lig3 function. Here we used pre-emptive complementation to determine the viability requirement for Lig3 in mammalian cells and its requirement in DNA repair. Various forms of Lig3 were introduced stably into mouse embryonic stem (mES) cells containing a conditional allele of Lig3 that could be deleted with Cre recombinase. With this approach, we find that the mitochondrial, but not nuclear, Lig3 is required for cellular viability. Although the catalytic function of Lig3 is required, the zinc finger (ZnF) and BRCA1 carboxy (C)-terminal-related (BRCT) domains of Lig3 are not. Remarkably, the viability requirement for Lig3 can be circumvented by targeting Lig1 to the mitochondria or expressing Chlorella virus DNA ligase, the minimal eukaryal nick-sealing enzyme(3), or Escherichia coli LigA, an NAD(+)-dependent ligase(1). Lig3-null cells are not sensitive to several DNA-damaging agents that sensitize Xrcc1-deficient cells(4-6). Our results establish a role for Lig3 in mitochondria, but distinguish it from its interacting protein Xrcc1.	[Simsek, Deniz; Artus, Jerome; Brunet, Erika; Hadjantonakis, Anna-Katerina; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Simsek, Deniz; Hadjantonakis, Anna-Katerina; Shuman, Stewart; Jasin, Maria] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Furda, Amy; Van Houten, Bennett] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Furda, Amy; Van Houten, Bennett] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Gao, Yankun; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Brunet, Erika] Museum Natl Hist Nat, F-75005 Paris, France; [Brunet, Erika] CNRS, UMR7196, F-75005 Paris, France; [Brunet, Erika] INSERM, U565, F-75005 Paris, France; [Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Weill Cornell Medical College Qatar; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Memorial Sloan Kettering Cancer Center	Jasin, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA.	m-jasin@ski.mskcc.org	Van Houten, Bennett/K-2284-2019; BRUNET, ERIKA/H-9297-2017; BRUNET, ERIKA/K-7154-2016	BRUNET, ERIKA/0000-0002-1726-4673; BRUNET, ERIKA/0000-0002-1726-4673; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Artus, Jerome/0000-0003-3423-8634	PA CURE; National Institutes of Health [ES019566, NS37956, CA21765, GM54668]; NATIONAL CANCER INSTITUTE [P30CA021765, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037956, R01NS037956] Funding Source: NIH RePORTER	PA CURE; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Caldecott for the gift of the Lig3 expression vector, and M. Sanz for initial assistance with the SCE analysis. We also thank the members of Jasin laboratory, especially Y. Akamatsu, J. LaRocque, E. Kass and F. Vanoli, for discussions. This work was supported by PA CURE (to B.V.H.) and by National Institutes of Health grants ES019566 (to B.V.H.), NS37956 and CA21765 (to P.J.M.), and GM54668 (to M.J.).	BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Chen X, 2009, DNA REPAIR, V8, P961, DOI 10.1016/j.dnarep.2009.06.002; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Willer M, 1999, CURR BIOL, V9, P1085, DOI 10.1016/S0960-9822(99)80477-1	26	165	167	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					245	U139		10.1038/nature09794	http://dx.doi.org/10.1038/nature09794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390132	Green Accepted			2022-12-01	WOS:000288170200043
J	Fan, J; Crooks, C; Creissen, G; Hill, L; Fairhurst, S; Doerner, P; Lamb, C				Fan, Jun; Crooks, Casey; Creissen, Gary; Hill, Lionel; Fairhurst, Shirley; Doerner, Peter; Lamb, Chris			Pseudomonas sax Genes Overcome Aliphatic Isothiocyanate-Mediated Non-Host Resistance in Arabidopsis	SCIENCE			English	Article							PV. TOMATO DC3000; GENOME SEQUENCE; PLANT DEFENSE; PATHOGENS; ACCUMULATION; METABOLITES; THALIANA; INSIGHTS; FAMILY	Most plant-microbe interactions do not result in disease; natural products restrict non-host pathogens. We found that sulforaphane (4-methylsulfinylbutyl isothiocyanate), a natural product derived from aliphatic glucosinolates, inhibits growth in Arabidopsis of non-host Pseudomonas bacteria in planta. Multiple sax genes (saxCAB/F/D/G) were identified in Pseudomonas species virulent on Arabidopsis. These sax genes are required to overwhelm isothiocyanate-based defenses and facilitate a disease outcome, especially in the young leaves critical for plant survival. Introduction of saxCAB genes into non-host strains enabled them to overcome these Arabidopsis defenses. Our study shows that aliphatic isothiocyanates, previously shown to limit damage by herbivores, are also crucial, robust, and developmentally regulated defenses that underpin non-host resistance in the Arabidopsis-Pseudomonas pathosystem.	[Fan, Jun; Crooks, Casey; Creissen, Gary; Hill, Lionel; Fairhurst, Shirley; Lamb, Chris] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Crooks, Casey] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Doerner, Peter] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Doerner, Peter] INRA, CNRS, CEA, Physiol Cellulaire Vegetale Lab, F-38000 Grenoble, France; [Doerner, Peter] Univ Grenoble 1, F-38000 Grenoble, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; United States Department of Agriculture (USDA); United States Forest Service; University of Edinburgh; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fan, J (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	jun.fan@bbsrc.ac.uk; peter.doerner@ed.ac.uk	Creissen, Gary P/C-7481-2009	Creissen, Gary P/0000-0003-4992-8056; Doerner, Peter/0000-0001-7218-8469; Fan, Jun/0000-0003-0591-0372	UK Biotechnology and Biological Sciences Research Council	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Haas, C. Zipfel, K. Sohn, and D. J. Kliebenstein for providing the pME vectors, bacterial strains, and Arabidopsis myb mutants used in this study; B. Lee and S. Kopriva for help with the glucosinolate assay; and C. Zipfel, C. Dean, A. Maule, and V. Vitart for critical reading of earlier versions of the manuscript. Supported by a grant from the UK Biotechnology and Biological Sciences Research Council (C.L.). J.F., C.C., G.C., L.H., S.F., and P.D. dedicate this paper to the memory of Chris Lamb.	Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Beekwilder J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002068; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Hipskind JD, 2000, MOL PLANT MICROBE IN, V13, P551, DOI 10.1094/MPMI.2000.13.5.551; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Sandrock RW, 2001, PHYSIOL MOL PLANT P, V58, P159, DOI 10.1006/pmpp.2001.0324; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2	26	135	136	7	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1185	1188		10.1126/science.1199707	http://dx.doi.org/10.1126/science.1199707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385714				2022-12-01	WOS:000287971200040
J	Bhutta, MF; Williamson, IG; Sudhoff, HH				Bhutta, Mahmood F.; Williamson, Ian G.; Sudhoff, Holger H.			Easily Missed? Cholesteatoma	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC OTITIS-MEDIA; MIDDLE-EAR CHOLESTEATOMA; PREDICTORS; MANAGEMENT; PALSY					m.bhutta@doctors.org.uk	Sudhoff, Holger/AAV-9741-2020	Sudhoff, Holger/0000-0002-9274-5645; Bhutta, Mahmood/0000-0002-4688-1670				BAIN J, 1988, BRIT MED J, V296, P1617, DOI 10.1136/bmj.296.6637.1617; Browning GG., 2008, SCOTT BROWNS OTORHIN, P3396; Ikeda M, 2006, ACTA OTO-LARYNGOL, V126, P95, DOI 10.1080/00016480500265950; Jung JY, 2002, ORL-J OTO-RHIN-LARYN, V64, P95, DOI 10.1159/000057787; Kemppainen HO, 1999, ACTA OTO-LARYNGOL, V119, P568; Lemmerling MM, 2008, EUR J RADIOL, V66, P363, DOI 10.1016/j.ejrad.2008.01.020; MILROY CM, 1989, J CLIN PATHOL, V42, P460, DOI 10.1136/jcp.42.5.460; NUNEZ DA, 1990, J LARYNGOL OTOL, V104, P468, DOI 10.1017/S0022215100112903; Olszewska E, 2004, EUR ARCH OTO-RHINO-L, V261, P6, DOI 10.1007/s00405-003-0623-x; Omran A, 2006, LARYNGOSCOPE, V116, P619, DOI 10.1097/01.mlg.0000208367.03963.ca; OREILLY BJ, 1991, J LARYNGOL OTOL, V105, P990, DOI 10.1017/S0022215100118031; ROSENFELD RM, 1992, ARCH OTOLARYNGOL, V118, P384; Sheahan P, 2001, J LARYNGOL OTOL, V115, P962; Siddiq MA, 2007, J LARYNGOL OTOL, V121, P114, DOI 10.1017/S0022215106003227; Smith JA, 2006, OTOLARYNG CLIN N AM, V39, P1237, DOI 10.1016/j.otc.2006.09.001; Syed I, 2008, BRIT J HOSP MED, V69, pM34, DOI 10.12968/hmed.2008.69.Sup3.28764; Vercruysse JP, 2009, B-ENT, V5, P233; WETMORE RF, 1987, INT J PEDIATR OTORHI, V14, P101, DOI 10.1016/0165-5876(87)90020-6	18	21	21	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2011	342								d1088	10.1136/bmj.d1088	http://dx.doi.org/10.1136/bmj.d1088			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732EQ	21372073				2022-12-01	WOS:000288168200003
J	Chiefari, E; Tanyolac, S; Paonessa, F; Pullinger, CR; Capula, C; Iiritano, S; Mazza, T; Forlin, M; Fusco, A; Durlach, V; Durlach, A; Malloy, MJ; Kane, JP; Heiner, SW; Filocamo, M; Foti, DP; Goldfine, ID; Brunetti, A				Chiefari, Eusebio; Tanyolac, Sinan; Paonessa, Francesco; Pullinger, Clive R.; Capula, Carmelo; Iiritano, Stefania; Mazza, Tommaso; Forlin, Michele; Fusco, Alfredo; Durlach, Vincent; Durlach, Anne; Malloy, Mary J.; Kane, John P.; Heiner, Steven W.; Filocamo, Mirella; Foti, Daniela P.; Goldfine, Ira D.; Brunetti, Antonio			Functional Variants of the HMGA1 Gene and Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context High-mobility group A1 (HMGA1) protein is a key regulator of insulin receptor (INSR) gene expression. We previously identified a functional HMGA1 gene variant in 2 insulin-resistant patients with decreased INSR expression and type 2 diabetes mellitus (DM). Objective To examine the association of HMGA1 gene variants with type 2 DM. Design, Settings, and Participants Case-control study that analyzed the HMGA1 gene in patients with type 2 DM and controls from 3 populations of white European ancestry. Italian patients with type 2 DM(n=3278) and 2 groups of controls (n=3328) were attending the University of Catanzaro outpatient clinics and other health care sites in Calabria, Italy, during 2003-2009; US patients with type 2 DM (n=970) were recruited in Northern California clinics between 1994 and 2005 and controls (n=958) were senior athletes without DM collected in 2004 and 2009; and French patients with type 2 DM (n=354) and healthy controls (n=50) were enrolled at the University of Reims in 1992. Genomic DNA was either directly sequenced or analyzed for specific HMGA1 mutations. Messenger RNA and protein expression for HMGA1 and INSR were measured in both peripheral lymphomonocytes and cultured Epstein-Barr virus-transformed lymphoblasts from patients with type 2 DM and controls. Main Outcome Measures The frequency of HMGA1 gene variants among cases and controls. Odds ratios (ORs) for type 2 DM were estimated by logistic regression analysis. Results The most frequent functional HMGA1 variant, IVS5-13insC, was present in 7% to 8% of patients with type 2 DM in all 3 populations. The prevalence of IVS5-13insC variant was higher among patients with type 2 DM than among controls in the Italian population (7.23% vs 0.43% in one control group; OR, 15.77 [95% confidence interval {CI}, 8.57-29.03]; P<.001 and 7.23% vs 3.32% in the other control group; OR, 2.03 [95% CI, 1.51-3.43]; P<.001). In the US population, the prevalence of IVS5-13insC variant was 7.7% among patients with type 2 DM vs 4.7% among controls (OR, 1.64 [95% CI, 1.05-2.57]; P=.03). In the French population, the prevalence of IVS5-13insC variant was 7.6% among patients with type 2 DM and 0% among controls (P=.046). In the Italian population, 3 other functional variants were observed. When all 4 variants were analyzed, HMGA1 defects were present in 9.8% of Italian patients with type 2 DM and 0.6% of controls. In addition to the IVS5 C-insertion, the c. 310G>T (p.E104X) variant was found in 14 patients and no controls (Bonferroni-adjusted P=.01); the c.*82G>A variant (rs2780219) was found in 46 patients and 5 controls (Bonferroni-adjusted P<.001); the c.*369del variant was found in 24 patients and no controls (Bonferroni-adjusted P<.001). In circulating monocytes and Epstein-Barr virus-transformed lymphoblasts from patients with type 2 DM and the IVS5-13insC variant, the messenger RNA levels and protein content of both HMGA1 and the INSR were decreased by 40% to 50%, and these defects were corrected by transfection with HMGA1 complementary DNA. Conclusions Compared with healthy controls, the presence of functional HMGA1 gene variants in individuals of white European ancestry was associated with type 2 DM. JAMA. 2011;305(9):903-912 www.jama.com	[Chiefari, Eusebio; Paonessa, Francesco; Capula, Carmelo; Iiritano, Stefania; Foti, Daniela P.; Brunetti, Antonio] Univ Catanzaro Magna Graecia, Dipartimento Med Sperimentale & Clin G Salvatore, Catanzaro, Italy; [Brunetti, Antonio] Univ Catanzaro Magna Graecia, Cattedra Endocrinol, Catanzaro, Italy; [Tanyolac, Sinan; Malloy, Mary J.; Goldfine, Ira D.] Univ Calif San Francisco, Sch Nursing, Dept Med, San Francisco, CA 94143 USA; [Kane, John P.] Univ Calif San Francisco, Sch Nursing, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Tanyolac, Sinan; Goldfine, Ira D.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Pullinger, Clive R.; Malloy, Mary J.; Kane, John P.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Mazza, Tommaso; Forlin, Michele] Microsoft Res Univ Trento, Ctr Computat & Syst Biol, Trento, Italy; [Fusco, Alfredo] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Durlach, Vincent] Ctr Hosp Univ, Hop Robert Debre, Reims, France; [Durlach, Anne] Ctr Hosp Univ, Hop Maison Blanche, Lab Pol Bouin, Reims, France; [Heiner, Steven W.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Filocamo, Mirella] Ist Giannina Gaslini, Lab Diagnosi Prepostnatale Malattie Metab, I-16148 Genoa, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Microsoft; University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne; Brigham Young University; University of Genoa; IRCCS Istituto Giannina Gaslini	Brunetti, A (corresponding author), Univ Catanzaro Magna Graecia, Viale Europa, I-88100 Germaneto Catanzaro, Italy.	brunetti@unicz.it	Foti, Daniela P/K-8038-2016; Chiefari, Eusebio/Y-2558-2019; Mazza, Tommaso/I-4531-2019; Tanyolac, Sinan/AAP-5966-2021; Mazza, Tommaso/H-6414-2016; Brunetti, Antonio/K-7756-2016; Filocamo, Mirella/AAG-3948-2021	Chiefari, Eusebio/0000-0001-5329-3124; Mazza, Tommaso/0000-0003-0434-8533; Mazza, Tommaso/0000-0003-0434-8533; Filocamo, Mirella/0000-0001-5505-8507; Fusco, Alfredo/0000-0003-3332-5197; Paonessa, Francesco/0000-0002-4729-0928; Foti, Daniela/0000-0002-9536-5736	Telethon-Italy [GGP04245]; MIUR Italy [2004062059-002]; National Institutes of Health [RO1DK056933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056933] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); MIUR Italy(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Brunetti received research funding from Telethon-Italy (grant GGP04245) and from MIUR Italy (protocol 2004062059-002). Dr Goldfine received research funding from National Institutes of Health grant RO1DK056933.	Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Borrmann L, 2001, ONCOGENE, V20, P4537, DOI 10.1038/sj.onc.1204577; Brunetti A, 1996, J CLIN INVEST, V97, P258, DOI 10.1172/JCI118400; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groop L, 2008, CURR DIABETES REP, V8, P192, DOI 10.1007/s11892-008-0033-y; HARRIS M, 1979, DIABETES, V28, P1039; HOLLENBECK C, 1987, J CLIN ENDOCR METAB, V64, P1169, DOI 10.1210/jcem-64-6-1169; International Diabetes Federation, IDF DIAB ATL; Krolewski AS, 2005, JOSLINS DIABETES MEL; Lakka TA, 2004, DIABETES, V53, P1603, DOI 10.2337/diabetes.53.6.1603; Liu J, 2003, MOL REPROD DEV, V66, P81, DOI 10.1002/mrd.10323; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; O'Rahilly S, 2007, BIOCHEM SOC T, V35, P33, DOI 10.1042/BST0350033; OLEFSKY JM, 1977, DIABETES, V26, P680, DOI 10.2337/diab.26.7.680; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Roth J, 1975, Recent Prog Horm Res, V31, P95; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Smith RJ, 2010, J CLIN ENDOCR METAB, V95, P1566, DOI 10.1210/jc.2009-1966; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Tan K, 2007, DIABETES, V56, P714, DOI 10.2337/db06-0921; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; Unger RH, 2008, JAMA-J AM MED ASSOC, V299, P1185, DOI 10.1001/jama.299.10.1185; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171	43	69	71	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					903	912		10.1001/jama.2011.207	http://dx.doi.org/10.1001/jama.2011.207			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364139	Bronze			2022-12-01	WOS:000287854700023
J	Anderson, SH; Kelly, D; Ladley, JJ; Molloy, S; Terry, J				Anderson, Sandra H.; Kelly, Dave; Ladley, Jenny J.; Molloy, Sue; Terry, Jon			Cascading Effects of Bird Functional Extinction Reduce Pollination and Plant Density	SCIENCE			English	Article							POLLEN LIMITATION; DISPERSAL; CONSEQUENCES	Reductions in bird numbers could hamper ecosystem services such as pollination, but experimental proof is lacking. We show that functional extinction of bird pollinators has reduced pollination, seed production, and plant density in the shrub Rhabdothamnus solandri (Gesneriaceae) on the North Island ("mainland") of New Zealand but not on three nearby island bird sanctuaries where birds remain abundant. Pollen limitation of fruit set is strong [pollen limitation index (PLI) = 0.69] and significant on the mainland but small (PLI = 0.15) and nonsignificant on islands. Seed production per flower on the mainland is reduced 84%. Mainland sites have similar adult densities, but 55% fewer juvenile plants per adult, than island sites. Seed addition experiments near adult R. solandri plants on the mainland found strong seed limitation 5 years after sowing for R. solandri but not for two other co-occurring woody species. This demonstrates a terrestrial trophic cascade.	[Kelly, Dave; Ladley, Jenny J.; Molloy, Sue; Terry, Jon] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Anderson, Sandra H.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand	University of Canterbury; University of Auckland	Kelly, D (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand.	dave.kelly@canterbury.ac.nz	Kelly, Dave/A-6129-2013	Kelly, Dave/0000-0002-9469-2161; Anderson, Sandra/0000-0002-6164-7380	Foundation for Research, Science and Technology [CO9X0004, CO9X0503]	Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	W. Ji helped frequently with field work. Funding was provided by contracts (CO9X0004 and CO9X0503) from the Public Good Science Fund under the Foundation for Research, Science and Technology's Sustaining and Restoring Biodiversity program.	Allan H.H., 1961, FLORA NZ, V1; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Beever R. E., 1983, AUCKLAND BOT SOC NEW, V38, P24; Bell B.D., 1991, P195; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; CLOUT MN, 1989, NEW ZEAL J ECOL, V12, P27; DIAMOND JM, 1984, NEW ZEAL J ECOL, V7, P37; Driskell A, 2007, AUST J ZOOL, V55, P73, DOI 10.1071/ZO07007; Heather B.D., 1996, FIELD GUIDE BIRDS NZ; Higgins P.J., 2001, HDB AUSTR NZ ANTARCT, V5; Innes J, 2010, NEW ZEAL J ECOL, V34, P86; JANZEN DH, 1974, NAT HIST, V83, P48; Kelly D, 2006, ECOL STUD-ANAL SYNTH, V186, P227; Kelly D, 2004, NEW ZEAL J BOT, V42, P89, DOI 10.1080/0028825X.2004.9512892; Kelly D, 2010, NEW ZEAL J ECOL, V34, P66; King CM., 2005, HDB NZ MAMMALS; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; Norton DA, 2009, SCIENCE, V325, P569, DOI 10.1126/science.1172978; Petrie D., 1902, T P R SOC NZ, V35, P321; Robertson AW, 1999, CONSERV BIOL, V13, P499, DOI 10.1046/j.1523-1739.1999.97471.x; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sharam GJ, 2009, SCIENCE, V325, P51, DOI 10.1126/science.1173805; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; Traveset A, 2005, CONSERV BIOL, V19, P421, DOI 10.1111/j.1523-1739.2005.00019.x; [No title captured]	26	191	198	4	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1068	1071		10.1126/science.1199092	http://dx.doi.org/10.1126/science.1199092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21292938				2022-12-01	WOS:000287699000064
J	Godfray, HCJ; Pretty, J; Thomas, SM; Warham, EJ; Beddington, JR				Godfray, H. C. J.; Pretty, J.; Thomas, S. M.; Warham, E. J.; Beddington, J. R.			Linking Policy on Climate and Food	SCIENCE			English	Editorial Material									[Thomas, S. M.; Warham, E. J.; Beddington, J. R.] Foresight, Govt Off Sci, London, England; [Godfray, H. C. J.] Univ Oxford, Oxford Martin Sch, Dept Zool, Oxford OX1 3PS, England; [Godfray, H. C. J.] Univ Oxford, Oxford Martin Sch, Inst Biodivers, Oxford OX1 3PS, England; [Pretty, J.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Oxford; University of Oxford; University of Essex	Thomas, SM (corresponding author), Foresight, Govt Off Sci, London, England.	sandy.thomas@bis.gsi.gov.uk	Pretty, Jules/D-4071-2012	Pretty, Jules/0000-0002-3897-6581				[Anonymous], JOINT STAT GLOB FOOD; [Anonymous], 5 NATL COMMUNICATION; [Anonymous], KYOTO PROTOCOL; [Anonymous], FAOSTAT; Batjes N. H., 1999, 401200031 DUTCH NAT; Bellarby J., 2008, COOL FARMING CLIMATE; Evans L., 1998, FEEDING 10 BILLION P; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Government Office of Science, 2011, FOR MIGR GLOB ENV CH; REDD+, REDD; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497	11	100	104	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1013	1014		10.1126/science.1202899	http://dx.doi.org/10.1126/science.1202899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726DM	21273449				2022-12-01	WOS:000287699000036
J	Takemoto, T; Uchikawa, M; Yoshida, M; Bell, DM; Lovell-Badge, R; Papaioannou, VE; Kondoh, H				Takemoto, Tatsuya; Uchikawa, Masanori; Yoshida, Megumi; Bell, Donald M.; Lovell-Badge, Robin; Papaioannou, Virginia E.; Kondoh, Hisato			Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells	NATURE			English	Article							MOUSE EMBRYO; PARAXIAL MESODERM; PRESOMITIC MESODERM; NERVOUS-SYSTEM; EXPRESSION; GENE; WNT; TBX6; GASTRULATION; ELEMENTS	The classical view of neural plate development held that it arises from the ectoderm, after its separation from the mesodermal and endodermal lineages. However, recent cell-lineage-tracing experiments indicate that the caudal neural plate and paraxial mesoderm are generated from common bipotential axial stem cells originating from the caudal lateral epiblast(1,2). Tbx6 null mutant mouse embryos which produce ectopic neural tubes at the expense of paraxial mesoderm(3) must provide a clue to the regulatory mechanism underlying this neural versus mesodermal fate choice. Here we demonstrate that Tbx6-dependent regulation of Sox2 determines the fate of axial stem cells. In wild-type embryos, enhancer N1 of the neural primordial gene Sox2 is activated in the caudal lateral epiblast, and the cells staying in the superficial layer sustain N1 activity and activate Sox2 expression in the neural plate(4-6). In contrast, the cells destined to become mesoderm activate Tbx6 and turn off enhancer N1 before migrating into the paraxial mesoderm compartment. In Tbx6 mutant embryos, however, enhancer N1 activity persists in the paraxial mesoderm compartment, eliciting ectopic Sox2 activation and transforming the paraxial mesoderm into neural tubes. An enhancer-N1-specific deletion mutation introduced into Tbx6 mutant embryos prevented this Sox2 activation in the mesodermal compartment and subsequent development of ectopic neural tubes, indicating that Tbx6 regulates Sox2 via enhancer N1. Tbx6-dependent repression of Wnt3a in the paraxial mesodermal compartment is implicated in this regulatory process. Paraxial mesoderm-specific misexpression of a Sox2 transgene in wild-type embryos resulted in ectopic neural tube development. Thus, Tbx6 represses Sox2 by inactivating enhancer N1 to inhibit neural development, and this is an essential step for the specification of paraxial mesoderm from the axial stem cells.	[Takemoto, Tatsuya; Uchikawa, Masanori; Yoshida, Megumi; Kondoh, Hisato] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Bell, Donald M.; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Papaioannou, Virginia E.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Osaka University; MRC National Institute for Medical Research; Columbia University	Kondoh, H (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	kondohh@fbs.osaka-u.ac.jp		Bell, Donald/0000-0002-3788-1580; Lovell-Badge, Robin/0000-0001-9364-4179; Papaioannou, Virginia/0000-0001-7558-8601	MEXT Japan; NIH; MRC; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056248] Funding Source: NIH RePORTER	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the members of Kondoh laboratory for discussions. This study was supported by Grants-in-Aid for Scientific Research from MEXT Japan to T.T. and H.K., an NIH grant to V.E.P., and MRC funding to R.L.-B.	Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1; Behringer R., 2003, MANIPULATING MOUSE E; Bouillet P, 1996, MECH DEVELOP, V58, P141, DOI 10.1016/S0925-4773(96)00569-2; Brown JM, 2000, CURR BIOL, V10, P869, DOI 10.1016/S0960-9822(00)00601-1; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Conlon FL, 2001, DEVELOPMENT, V128, P3749; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Delfino-Machin M, 2005, DEVELOPMENT, V132, P4273, DOI 10.1242/dev.02009; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dosch R, 1997, DEVELOPMENT, V124, P2325; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; KAMACHI Y, 1993, MOL CELL BIOL, V13, P5206, DOI 10.1128/MCB.13.9.5206; Kamachi Y, 2009, P JPN ACAD B-PHYS, V85, P55, DOI 10.2183/pjab.85.55; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; Kimura-Yoshida C, 2005, DEV CELL, V9, P639, DOI 10.1016/j.devcel.2005.09.011; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; NISWANDER L, 1992, DEVELOPMENT, V114, P755; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SASAKI H, 1993, DEVELOPMENT, V118, P47; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takemoto T, 2006, DEVELOPMENT, V133, P297, DOI 10.1242/dev.02196; Tonegawa A, 1998, DEV BIOL, V202, P172, DOI 10.1006/dbio.1998.8895; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Xu PX, 1999, DEVELOPMENT, V126, P383; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamaguchi Terry P., 2008, V468, P287, DOI 10.1007/978-1-59745-249-6_23; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144	43	174	175	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					394	398		10.1038/nature09729	http://dx.doi.org/10.1038/nature09729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331042	Green Accepted			2022-12-01	WOS:000287409100042
J	Dermitzakis, ET				Dermitzakis, Emmanouil T.			Genome Literacy	SCIENCE			English	Editorial Material									Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	University of Geneva	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.		Dermitzakis, Emmanouil/B-7687-2013					DERMITZAKIS ET, GENOME LITERACY	1	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					689	690		10.1126/science.1203237	http://dx.doi.org/10.1126/science.1203237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310993	Green Published			2022-12-01	WOS:000287205700039
J	Lin, DY; Boyle, MP; Dollar, P; Lee, H; Lein, ES; Perona, P; Anderson, DJ				Lin, Dayu; Boyle, Maureen P.; Dollar, Piotr; Lee, Hyosang; Lein, E. S.; Perona, Pietro; Anderson, David J.			Functional identification of an aggression locus in the mouse hypothalamus	NATURE			English	Article							BRAIN-STIMULATION; FEMALE RATS; ANTERIOR HYPOTHALAMUS; VENTROMEDIAL NUCLEUS; VIOLENT AGGRESSION; AGONISTIC BEHAVIOR; RECEPTOR BLOCKADE; LORDOSIS REFLEX; NEURAL ACTIVITY; C-FOS	Electrical stimulation of certain hypothalamic regions in cats and rodents can elicit attack behaviour, but the exact location of relevant cells within these regions, their requirement for naturally occurring aggression and their relationship to mating circuits have not been clear. Genetic methods for neural circuit manipulation in mice provide a potentially powerful approach to this problem, but brain-stimulation-evoked aggression has never been demonstrated in this species. Here we show that optogenetic, but not electrical, stimulation of neurons in the ventromedial hypothalamus, ventrolateral subdivision (VMHvl) causes male mice to attack both females and inanimate objects, as well as males. Pharmacogenetic silencing of VMHvl reversibly inhibits inter-male aggression. Immediate early gene analysis and single unit recordings from VMHvl during social interactions reveal overlapping but distinct neuronal subpopulations involved in fighting and mating. Neurons activated during attack are inhibited during mating, suggesting a potential neural substrate for competition between these opponent social behaviours.	[Lin, Dayu; Lee, Hyosang; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Lin, Dayu; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Boyle, Maureen P.; Lein, E. S.] Allen Inst Brain Sci, Seattle, WA 98103 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Allen Institute for Brain Science	Lin, DY (corresponding author), CALTECH, Div Biol 216 76, 1201 E Calif Blvd, Pasadena, CA 91125 USA.	dayu.lin@nyumc.org; wuwei@caltech.edu		Lin, Dayu/0000-0003-2006-0791; , Hyosang/0000-0002-3200-8678	Weston-Havens Foundation; Jane Coffin Childs Foundation	Weston-Havens Foundation; Jane Coffin Childs Foundation	We thank S. Ciocchi, S. Lin, Y. Ben-Shaul and A. Wang for advice on electrode and microdrive design; M. Gerfen and M. Vondrus for microdrive fabrication; M. P. Walsh, T. D. Heitzman and V. Rush for electronics support; A. Steele, R. Robbins, S. Ossorio, K. Gunapala, A. Paul, D. Oh, C. Kim and J. Nishiguchi for behaviour annotation and video scoring; H. Kim for technical assistance; W. E. Haubensak for teaching fibre-optic implant methods; J. T. Henderson for advice on stereotactic surgery; M. Kruk for advice on electrical stimulation experiments; K. Deisseroth for the Cre-dependent ChR2-EYFP AAV construct. M. Kruk, R. Mooney and R. Simerly for comments on the manuscripts; G. Mosconi for lab management and G. Mancuso for administrative support. This work was supported in part by the Weston-Havens Foundation and Jane Coffin Childs Foundation. D. J. A. is an Investigator of the Howard Hughes Medical Institute.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.psych.39.1.43; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bragin A, 2000, J NEUROSCI METH, V98, P77, DOI 10.1016/S0165-0270(00)00193-X; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Delville Y, 2000, BRAIN BEHAV EVOLUT, V55, P53, DOI 10.1159/000006642; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guzowski JF, 2001, CURR OPIN NEUROBIOL, V11, P579, DOI 10.1016/S0959-4388(00)00252-X; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Halasz J, 2008, BIOL PSYCHIAT, V63, P271, DOI 10.1016/j.biopsych.2007.04.022; Halasz J, 2009, EUR J PHARMACOL, V611, P35, DOI 10.1016/j.ejphar.2009.03.050; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hess W. R., 1943, HELVETICA PHYSIOL ET PHARMACOL ACTA, V1, P33; Hess WR, 1928, PHYSIOLOGIE, V42, P554; Hrabovszky E, 2005, NEUROSCIENCE, V133, P657, DOI 10.1016/j.neuroscience.2005.03.042; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; KRUK MR, 1991, NEUROSCI BIOBEHAV R, V15, P527, DOI 10.1016/S0149-7634(05)80144-7; KRUK MR, 1984, PROG BRAIN RES, V61, P303; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; LAMMERS JHCM, 1988, BRAIN RES, V449, P311, DOI 10.1016/0006-8993(88)91046-3; LAMMERS JHCM, 1988, BRAIN RES, V449, P294, DOI 10.1016/0006-8993(88)91045-1; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lonstein JS, 2002, NEUROSCI BIOBEHAV R, V26, P869, DOI 10.1016/S0149-7634(02)00087-8; Mongeau R, 2003, J NEUROSCI, V23, P3855; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; OLIVIER B, 1974, BRAIN RES, V65, P521, DOI 10.1016/0006-8993(74)90241-8; OLIVIER B, 1977, AGGRESSIVE BEHAV, V3, P47, DOI 10.1002/1098-2337(1977)3:1<47::AID-AB2480030105>3.0.CO;2-H; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; ROELING TAP, 1994, NEUROSCIENCE, V59, P1001, DOI 10.1016/0306-4522(94)90302-6; Siegel A, 1999, NEUROSCI BIOBEHAV R, V23, P359, DOI 10.1016/S0149-7634(98)00040-2; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Slimko EM, 2002, J NEUROSCI, V22, P7373; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Tinbergen N., 1951, STUDY INSTINCT; VANDERPOEL AM, 1983, PHYSIOL BEHAV, V31, P259, DOI 10.1016/0031-9384(83)90130-0; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041	47	528	537	5	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					221	+		10.1038/nature09736	http://dx.doi.org/10.1038/nature09736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307935	Green Accepted			2022-12-01	WOS:000287144200036
J	Capotosti, F; Guernier, S; Lammers, F; Waridel, P; Cai, Y; Jin, JJ; Conaway, JW; Conaway, RC; Herr, W				Capotosti, Francesca; Guernier, Sophie; Lammers, Fabienne; Waridel, Patrice; Cai, Yong; Jin, Jingji; Conaway, Joan W.; Conaway, Ronald C.; Herr, Winship			O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1	CELL			English	Article							N-ACETYLGLUCOSAMINE; COACTIVATOR HCF-1; TERMINAL SUBUNIT; PROTEINS; NUCLEAR; GLYCOSYLATION; COMPLEX; FAMILY; DOMAIN; VP16	The human epigenetic cell-cycle regulator HCF-1 undergoes an unusual proteolytic maturation process resulting in stably associated HCF-1(N) and HCF-1(C) subunits that regulate different aspects of the cell cycle. Proteolysis occurs at six centrally located HCF-1(PRO)-repeat sequences and is important for activation of HCF-1(C)-subunit functions in M phase progression. We show here that the HCF-1(PRO) repeat is recognized by O-linked beta-N-acetylglucosamine transferase (OGT), which both O-GlcNAcylates the HCF-1(N) subunit and directly cleaves the HCF-1(PRO) repeat. Replacement of the HCF-1(PRO) repeats by a heterologous proteolytic cleavage signal promotes HCF-1 proteolysis but fails to activate HCF-1(C)-subunit M phase functions. These results reveal an unexpected role of OGT in HCF-1 proteolytic maturation and an unforeseen nexus between OGT-directed O-GlcNAcylation and proteolytic maturation in HCF-1 cell-cycle regulation.	[Waridel, Patrice; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Prot Anal Facil, CH-1015 Lausanne, Switzerland; [Cai, Yong; Jin, Jingji; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Lausanne; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Prot Anal Facil, CH-1015 Lausanne, Switzerland.	winship.herr@unil.ch	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546; Conaway, Joan/0000-0002-2786-0663	Stowers Institute for Medical Research; Greater Kansas City Community Foundation; Swiss National Science Foundation; Oncosuisse; University of Lausanne	Stowers Institute for Medical Research; Greater Kansas City Community Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; University of Lausanne	We thank T. M. Kristie and J.A. Hanover for the HCF-1nc and the bacterial OGT expression vectors, respectively; M. Boutros and A. Wilson for the HCF-1<INF>Delta PROrep2</INF> construct; R. S. Haltiwanger for the alpha-OGT antibody; E. Julien and D.J. Aufiero for the N13 and C18 antibodies; S. S. Taylor for the Flp-In-HeLa cells; M. Quadroni for advice with the mass spectrometry analysis; L. Capponi, P. L'Hote, and M. McLaird for technical support; and J.H. Reina for art design. We thank N. Hernandez, J. Michaud, and S. H. Verhelst for critical reading of the manuscript; and V. Zoete, O. Michielin, N. Hernandez, J. Muller, P. Schneider, and K. Struhl for discussion. This study was supported by the Stowers Institute for Medical Research and the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation to J. W. C. and R. C. C. and by the Swiss National Science Foundation, Oncosuisse, and the University of Lausanne to W.H.	Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cai Y, 2006, METHODS, V40, P312, DOI 10.1016/j.ymeth.2006.06.023; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gani OABSM, 2010, NAT PROD REP, V27, P489, DOI 10.1039/b923848b; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Luciano RL, 2002, P NATL ACAD SCI USA, V99, P13403, DOI 10.1073/pnas.202200399; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mazars R, 2010, J BIOL CHEM, V285, P13364, DOI 10.1074/jbc.M109.072579; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Nalivaeva NN, 2001, PROTEOMICS, V1, P735, DOI 10.1002/1615-9861(200106)1:6<735::AID-PROT735>3.0.CO;2-8; STARR CM, 1990, J BIOL CHEM, V265, P6868; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Vogel JL, 2000, P NATL ACAD SCI USA, V97, P9425, DOI 10.1073/pnas.160266697; Vogel JL, 2006, P NATL ACAD SCI USA, V103, P6817, DOI 10.1073/pnas.0602109103; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	46	164	164	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					376	388		10.1016/j.cell.2010.12.030	http://dx.doi.org/10.1016/j.cell.2010.12.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295698	Bronze			2022-12-01	WOS:000286973100010
J	Kitagawa, D; Vakonakis, I; Olieric, N; Hilbert, M; Keller, D; Olieric, V; Bortfeld, M; Erat, MC; Fluckiger, I; Gonczy, P; Steinmetz, MO				Kitagawa, Daiju; Vakonakis, Ioannis; Olieric, Natacha; Hilbert, Manuel; Keller, Debora; Olieric, Vincent; Bortfeld, Miriam; Erat, Michele C.; Flueckiger, Isabelle; Goenczy, Pierre; Steinmetz, Michel O.			Structural Basis of the 9-Fold Symmetry of Centrioles	CELL			English	Article							CENTROSOME DUPLICATION; BASAL BODY; C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN SPD-2; HUMAN-CELLS; SAS-6; PROCENTRIOLE; CYCLE; MECHANISMS	The centriole, and the related basal body, is an ancient organelle characterized by a universal 9-fold radial symmetry and is critical for generating cilia, flagella, and centrosomes. The mechanisms directing centriole formation are incompletely understood and represent a fundamental open question in biology. Here, we demonstrate that the centriolar protein SAS-6 forms rod-shaped homodimers that interact through their N-terminal domains to form oligomers. We establish that such oligomerization is essential for centriole formation in C. elegans and human cells. We further generate a structural model of the related protein Bld12p from C. reinhardtii, in which nine homodimers assemble into a ring from which nine coiled-coil rods radiate outward. Moreover, we demonstrate that recombinant Bld12p self-assembles into structures akin to the central hub of the cartwheel, which serves as a scaffold for centriole formation. Overall, our findings establish a structural basis for the universal 9-fold symmetry of centrioles.	[Kitagawa, Daiju; Keller, Debora; Flueckiger, Isabelle; Goenczy, Pierre] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland; [Vakonakis, Ioannis; Hilbert, Manuel; Olieric, Vincent] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Olieric, Natacha; Hilbert, Manuel; Bortfeld, Miriam; Steinmetz, Michel O.] Paul Scherrer Inst, Biomol Res, CH-5232 Villigen, Switzerland; [Vakonakis, Ioannis; Erat, Michele C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Oxford	Gonczy, P (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland.	pierre.gonczy@epfl.ch	Olieric, Vincent/D-1078-2011; Steinmetz, Michel O/AAA-3349-2022	Olieric, Vincent/0000-0002-0533-7222; Steinmetz, Michel O/0000-0001-6157-3687; Olieric, Natacha/0000-0002-6273-390X; Keller, Debora/0000-0002-5284-3195; Gonczy, Pierre/0000-0002-6305-6883	JSPS; EMBO [ALTF-667-2007]; Wellcome Trust; FP7 Marie Curie Fellowship; Oncosuisse [OCS KLS 02024-02-2007]; ERC [AdG 233335]; Swiss National Foundation [CRSII3_125463]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); FP7 Marie Curie Fellowship; Oncosuisse; ERC(European Research Council (ERC)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF))	We are grateful to Fritz Winkler (PSI) for help with the modeling and critical reading of the manuscript; to Vesna Oliveri, Ursula Sauder, and Gianni Morson (ZMB, University of Basel) for excellent support and access to the electron microscope; to Meitian Wang, Andrea Prota, and Daniel Frey (PSI) for help with crystallization and X-ray data collection; to Davide Demuras and Graham Knott (BioEM core facility, EPFL), as well as Petr Leiman (EPFL), for help with EM analysis; to Christine Wandrey (EPFL) for AUC analysis; to Coralie Busso (EPFL) for help in generating the C. elegans transgenic lines; to Diego Chiappe and Marc Moniatte (Proteomic core facility, EPFL) for mass spectrometry; and to Katayoun Afshar, Virginie Hachet, and Joachim Lingner for helpful comments on the manuscript. D. K. held postdoctoral fellowships from the JSPS and EMBO (ALTF-667-2007). I. V. was partly supported by the Wellcome Trust Career Development Fellowship program. M. C. E. was supported by a FP7 Marie Curie Fellowship. This work was supported also by grants to P. G. from Oncosuisse (OCS KLS 02024-02-2007) and from the ERC (AdG 233335) as well as by grants from the Swiss National Foundation to P. G. and M. S. (Sinergia CRSII3_125463). We are also indebted to Clemens Schulze-Briese (PSI) for generous support.	Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Bach M, 2007, FEBS J, V274, P783, DOI 10.1111/j.1742-4658.2006.05623.x; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; CAVALIER.T, 1974, J CELL SCI, V16, P529; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9; GAVIN RH, 1984, J CELL SCI, V66, P147; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marshall WF, 2000, CURR TOP DEV BIOL, V49, P187; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Yabe T, 2007, DEV BIOL, V312, P44, DOI 10.1016/j.ydbio.2007.08.054	38	247	252	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					364	375		10.1016/j.cell.2011.01.008	http://dx.doi.org/10.1016/j.cell.2011.01.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21277013	hybrid, Green Published, Green Accepted			2022-12-01	WOS:000286973100009
J	Sugg, R				Sugg, Richard			The art of medicine Prescientific death rites, vampires, and the human soul	LANCET			English	Editorial Material									Univ Durham, Dept English Studies, Durham DH1 3LZ, England	Durham University	Sugg, R (corresponding author), Univ Durham, Dept English Studies, Durham DH1 3LZ, England.	richard.sugg@durham.ac.uk						Barley N., 1997, DANCING GRAVE ENCOUN; BLUM R, 1970, DANGEROUS HOUR LORE; DUBOULAY J, 1982, MAN, V17, P219, DOI 10.2307/2801810; Merridale C., 2000, NIGHT STONE DEATH ME; Sugg R., 2011, MUMMIES CANNIBALS VA; Warner EA, 2000, FOLKLORE, V111, P67, DOI 10.1080/001558700360898; WARNER EA, 2000, FOLKLORE, V111, P255	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					712	713		10.1016/S0140-6736(11)60259-6	http://dx.doi.org/10.1016/S0140-6736(11)60259-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	729JQ	21374901				2022-12-01	WOS:000287946000014
J	Guaita, A; Jones, M				Guaita, Antonio; Jones, Marc			A "Prosthetic" Approach for Individuals With Dementia?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COGNITIVE REHABILITATION; ALZHEIMERS-DISEASE; SYMPTOMS; MANAGEMENT		[Guaita, Antonio] Golgi Cenci Fdn, I-20081 Abbiategrasso, MI, Italy; [Jones, Marc] Moyra Jones Resources Ltd, New Westminster, BC, Canada		Guaita, A (corresponding author), Golgi Cenci Fdn, Piazza Golgi 11, I-20081 Abbiategrasso, MI, Italy.	a.guaita@golgiredaelli.it	Guaita, Antonio/Q-1787-2019	Guaita, Antonio/0000-0003-3954-5932				Clare L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003260; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Colombo M, 2007, ARCH GERONTOL GERIAT, V44, P113, DOI 10.1016/j.archger.2007.01.017; Friedrich MJ, 2009, JAMA-J AM MED ASSOC, V301, P2430, DOI 10.1001/jama.2009.809; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Herrmann N, 2008, CAN MED ASSOC J, V179, P1279, DOI 10.1503/cmaj.070804; Jones M, 1999, GENTLECARE CHANGING; Rodda J, 2009, INT PSYCHOGERIATR, V21, P813, DOI 10.1017/S1041610209990354; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Trumble WR, 2007, OXFORD ENGLISH DICT	10	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					402	403		10.1001/jama.2011.28	http://dx.doi.org/10.1001/jama.2011.28			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266688				2022-12-01	WOS:000286595200026
J	Liu, Y; Jiang, YA; Si, YX; Kim, JY; Chen, ZF; Rao, Y				Liu, Yan; Jiang, Yun'ai; Si, Yunxia; Kim, Ji-Young; Chen, Zhou-Feng; Rao, Yi			Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice	NATURE			English	Article							PARA-CHLOROPHENYLALANINE; COPULATORY-BEHAVIOR; SEROTONIN; LACKING; INNATE; RATS	Although the question of to whom a male directs his mating attempts(1,2) is a critical one in social interactions, little is known about the molecular and cellular mechanisms controlling mammalian sexual preference. Here we report that the neurotransmitter 5-hydroxytryptamine (5-HT) is required for male sexual preference. Wild-type male mice preferred females over males, but males lacking central serotonergic neurons lost sexual preference although they were not generally defective in olfaction or in pheromone sensing. A role for 5-HT was demonstrated by the phenotype of mice lacking tryptophan hydroxylase 2 (Tph2), which is required for the first step of 5-HT synthesis in the brain. Thirty-five minutes after the injection of the intermediate 5-hydroxytryptophan (5-HTP), which circumvented Tph2 to restore 5-HT to the wildtype level, adult Tph2 knockout mice also preferred females over males. These results indicate that 5-HT and serotonergic neurons in the adult brain regulate mammalian sexual preference.	[Liu, Yan; Jiang, Yun'ai; Si, Yunxia; Rao, Yi] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Yan] Chinese Acad Med Sci, Grad Sch, Beijing 100730, Peoples R China; [Liu, Yan] Peking Union Med Coll, Beijing 100730, Peoples R China; [Jiang, Yun'ai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Beijing 100864, Peoples R China; [Jiang, Yun'ai] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Rao, Yi] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Peking University	Rao, Y (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	yrao@pku.edu.cn		Rao, Yi/0000-0002-0405-5426	Ministry of Science and Technology [2010CB833901]; Beijing Municipal Commission on Science and Technology; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Beijing Municipal Commission on Science and Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to E. S. Deneris for ePet1-Cre mice; to R. Johnson for Lmx1b<SUP>fl</SUP> mice; to M. Luo for discussions; to Z. Yan and Y. Lu for the operant conditioning apparatus; to X. Wang and Y. Wan for help with HPLC; to J. Lang and J. Yin for mouse breeding and genotyping; to P. Ding, P. Wang, H. Lu and X. Wang for technical assistance; to L. Zhao, Z. Qiu and H. Jing for animal caring; and to the Ministry of Science and Technology (973 program 2010CB833901) and Beijing Municipal Commission on Science and Technology for grant support (to Y.R.), and the NIH for grant support (to Z.-F.C.).	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Blanchard DC, 2003, BEHAV NEUROSCI, V117, P360, DOI 10.1037/0735-7044.117.2.360; Burwash MD, 1998, J CHEM ECOL, V24, P49, DOI 10.1023/A:1022384728170; Dailly E, 2006, J NEUROSCI METH, V150, P111, DOI 10.1016/j.jneumeth.2005.06.008; ERWIN J, 1976, ARCH SEX BEHAV, V5, P9, DOI 10.1007/BF01542236; FERGUSON J, 1970, SCIENCE, V168, P499, DOI 10.1126/science.168.3930.499; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferkin MH, 2005, PHYSIOL BEHAV, V85, P489, DOI 10.1016/j.physbeh.2005.05.014; GAWIENOWSKI AM, 1971, PHYSIOL BEHAV, V7, P551, DOI 10.1016/0031-9384(71)90108-9; Guo ZS, 2007, CHEM SENSES, V32, P463, DOI 10.1093/chemse/bjm015; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kinnunen LH, 2004, BRAIN RES, V1024, P251, DOI 10.1016/j.brainres.2004.07.070; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; MALMNAS CO, 1971, NATURE, V232, P398, DOI 10.1038/232398a0; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; PRICE EO, 1991, J ANIM SCI, V69, P1019; SALIS PJ, 1971, NATURE, V232, P400, DOI 10.1038/232400a0; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Sommer V., 2006, HOMOSEXUAL BEHAV ANI; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wainberg ML, 2006, J CLIN PSYCHIAT, V67, P1968, DOI 10.4088/JCP.v67n1218; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	30	99	106	7	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					95	U125		10.1038/nature09822	http://dx.doi.org/10.1038/nature09822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21441904	Green Accepted			2022-12-01	WOS:000289199400044
J	Morris, MC; Tangney, CC				Morris, Martha Clare; Tangney, Christine C.			A Potential Design Flaw of Randomized Trials of Vitamin Supplements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COGNITIVE FUNCTION; ALZHEIMER-DISEASE; CARDIOVASCULAR-DISEASE; ACID SUPPLEMENTATION; DIETARY-INTAKE; RISK; ANTIOXIDANT; WOMEN		[Morris, Martha Clare] Rush Univ, Med Ctr, Sect Nutr & Nutr Epidemiol, Dept Internal Med, Oak Pk, IL 60304 USA; [Tangney, Christine C.] Rush Univ, Med Ctr, Dept Clin Nutr, Oak Pk, IL 60304 USA	Rush University; Rush University	Morris, MC (corresponding author), Rush Univ, Med Ctr, Sect Nutr & Nutr Epidemiol, Dept Internal Med, Rush Oak Pk Profess Off Bldg,610 S Maple,Ste 4700, Oak Pk, IL 60304 USA.	martha_c_morris@rush.edu			NIA NIH HHS [R01 AG021972] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021972] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Kang JH, 2009, CIRCULATION, V119, P2772, DOI 10.1161/CIRCULATIONAHA.108.816900; Kang JH, 2008, AM J CLIN NUTR, V88, P1602, DOI 10.3945/ajcn.2008.26404; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Luchsinger JA, 2003, ARCH NEUROL-CHICAGO, V60, P203, DOI 10.1001/archneur.60.2.203; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86	10	79	82	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1348	1349		10.1001/jama.2011.383	http://dx.doi.org/10.1001/jama.2011.383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467288	Green Accepted			2022-12-01	WOS:000289162400025
J	Gomez, P; Buckling, A				Gomez, Pedro; Buckling, Angus			Bacteria-Phage Antagonistic Coevolution in Soil	SCIENCE			English	Article							LOCAL ADAPTATION; POPULATION; EVOLUTION; DYNAMICS; COST	Bacteria and their viruses (phages) undergo rapid coevolution in test tubes, but the relevance to natural environments is unclear. By using a "mark-recapture" approach, we showed rapid coevolution of bacteria and phages in a soil community. Unlike coevolution in vitro, which is characterized by increases in infectivity and resistance through time (arms race dynamics), coevolution in soil resulted in hosts more resistant to their contemporary than past and future parasites (fluctuating selection dynamics). Fluctuating selection dynamics, which can potentially continue indefinitely, can be explained by fitness costs constraining the evolution of high levels of resistance in soil. These results suggest that rapid coevolution between bacteria and phage is likely to play a key role in structuring natural microbial communities.	[Gomez, Pedro; Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Gomez, Pedro] CSIC, CEBAS, Murcia 30100, Espinardo, Spain; [Buckling, Angus] Univ Exeter, Penryn TR10 9EZ, England	University of Oxford; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Exeter	Gomez, P (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	pedro.gomezlopez@zoo.ox.ac.uk	López, Pedro Gómez/M-4712-2019; Gómez López, Pedro/H-2230-2012	López, Pedro Gómez/0000-0003-2830-4105; Gómez López, Pedro/0000-0003-2830-4105; Buckling, Angus/0000-0003-1170-4604	Ministerio de Ciencia e Innovacion (MICINN, Spain)	Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank T. Bell and A. Hall for comments on the manuscript. The work was supported by the European Research Council. P. G. was supported from Ministerio de Ciencia e Innovacion (MICINN, Spain) by National Mobility Program of Human Resources "Jose Castillejo." Partial 16S ribosomal RNA sequences have been assigned to the European Nucleotide Archive, European Molecular Biology Laboratory-European Bioinformatics Institute, under accession numbers FR746065 to FR746094.	Adams MH., 1959, N Y, V74, P164; Agrawal A, 2002, EVOL ECOL RES, V4, P79; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Gandon S, 2008, J EVOLUTION BIOL, V21, P1861, DOI 10.1111/j.1420-9101.2008.01598.x; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; PARKER MA, 1985, EVOLUTION, V39, P713, DOI 10.1111/j.1558-5646.1985.tb00414.x; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Thompson J.N., 2005, INTERSPEC INTERACT; Thrall PH, 2002, EVOLUTION, V56, P1340; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173	27	290	294	7	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					106	109		10.1126/science.1198767	http://dx.doi.org/10.1126/science.1198767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454789				2022-12-01	WOS:000289000000048
J	Pappu, S; Gunnell, Y; Akhilesh, K; Braucher, R; Taieb, M; Demory, F; Thouveny, N				Pappu, Shanti; Gunnell, Yanni; Akhilesh, Kumar; Braucher, Regis; Taieb, Maurice; Demory, Francois; Thouveny, Nicolas			Early Pleistocene Presence of Acheulian Hominins in South India	SCIENCE			English	Article							ATTIRAMPAKKAM; EXCAVATIONS; ARTIFACTS; BURIAL; SITE; AGE	South Asia is rich in Lower Paleolithic Acheulian sites. These have been attributed to the Middle Pleistocene on the basis of a small number of dates, with a few older but disputed age estimates. Here, we report new ages from the excavated site of Attirampakkam, where paleomagnetic measurements and direct Al-26/Be-10 burial dating of stone artifacts now position the earliest Acheulian levels as no younger than 1.07 million years ago (Ma), with a pooled average age of 1.51 +/- 0.07 Ma. These results reveal that, during the Early Pleistocene, India was already occupied by hominins fully conversant with an Acheulian technology including handaxes and cleavers among other artifacts. This implies that a spread of bifacial technologies across Asia occurred earlier than previously accepted.	[Pappu, Shanti; Akhilesh, Kumar] Sharma Ctr Heritage Educ, Madras 600004, Tamil Nadu, India; [Gunnell, Yanni] Univ Lyon 2, Dept Geog, CNRS UMR 5600, F-69676 Bron, France; [Braucher, Regis; Taieb, Maurice; Demory, Francois; Thouveny, Nicolas] CEREGE, F-13545 Aix En Provence 04, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Universite Jean Moulin Lyon 3; Universite Lyon 2; UDICE-French Research Universities; Aix-Marseille Universite	Pappu, S (corresponding author), Sharma Ctr Heritage Educ, 28 I Main Rd, Madras 600004, Tamil Nadu, India.	pappu.shanti@gmail.com	, Braucher/Q-5971-2017; DEMORY, FRANCOIS/AAC-6641-2019	, Braucher/0000-0002-4637-4302; Demory, Francois/0000-0002-7526-9886; Pappu, Shanti/0000-0003-4786-4968; THOUVENY, Nicolas/0000-0001-6601-856X	Homi Bhabha Fellowships Council; Leakey Foundation; Earthwatch Institute; Sharma Centre for Heritage Education; Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru; Archaeological Survey of India, Delhi and Chennai Circle; Department of Archaeology, State Government of Tamil Nadu; Institut Universitaire de France; Institut National des Sciences de l'Univers/CNRS; French Ministry of Research; Institut de Recherche pour le Developpement; Commissariat a l'Energie Atomique	Homi Bhabha Fellowships Council; Leakey Foundation; Earthwatch Institute; Sharma Centre for Heritage Education; Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru; Archaeological Survey of India, Delhi and Chennai Circle; Department of Archaeology, State Government of Tamil Nadu; Institut Universitaire de France; Institut National des Sciences de l'Univers/CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut de Recherche pour le Developpement; Commissariat a l'Energie Atomique(French Atomic Energy Commission)	Excavations at Attirampakkam were funded by the Homi Bhabha Fellowships Council, the Leakey Foundation, the Earthwatch Institute, and the Sharma Centre for Heritage Education. Ongoing studies are being funded by the Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru, (Geosphere Biosphere Program). We thank Uday Raj, S. Ravindranath, C. B. S. Dutt, P. G. Diwakar, and R. Ramesh. We also thank the Archaeological Survey of India, Delhi and Chennai Circle, and the Department of Archaeology, State Government of Tamil Nadu, for licenses to excavate and support; the Institut Universitaire de France for field and analytical costs; M. Arnold and G. Aumaitre for assistance with <SUP>10</SUP>Be and <SUP>26</SUP>Al measurements; and the ASTER (Accelerateur pour les Sciences de la Terre, Environnement, Risques) national facility (CEREGE, Aix-en-Provence), which is supported by the Institut National des Sciences de l'Univers/CNRS, the French Ministry of Research, the Institut de Recherche pour le Developpement, and the Commissariat a l'Energie Atomique. All three reviewers contributed valuable comments.	Acharyya SK, 2003, CURR SCI INDIA, V84, P127; ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Chauhan PR, 2010, QUATERN INT, V223, P248, DOI 10.1016/j.quaint.2010.01.021; de la Torre I, 2008, J ANTHROPOL ARCHAEOL, V27, P244, DOI 10.1016/j.jaa.2007.12.001; DENNELL RW, 1988, CURR ANTHROPOL, V29, P495, DOI 10.1086/203666; DENNELL RW, 2004, BAR INT SERIES, V1265; DENNELL RW, 2009, PALAEOLITHIC SETTLEM; Gaillard C, 2010, QUATERN INT, V223, P234, DOI 10.1016/j.quaint.2009.08.021; Gibbon RJ, 2009, J HUM EVOL, V56, P152, DOI 10.1016/j.jhevol.2008.09.006; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; Gunnell Y, 2006, CURR SCI INDIA, V91, P114; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Kailath AJ, 2000, RADIAT MEAS, V32, P371, DOI 10.1016/S1350-4487(99)00282-6; MISHRA S, 1995, CURR ANTHROPOL, V36, P847, DOI 10.1086/204442; MISHRA S, 1992, CURR ANTHROPOL, V33, P325, DOI 10.1086/204074; Paddayya K, 2002, CURR SCI INDIA, V83, P641; Pappu S, 2003, CURR ANTHROPOL, V44, P591, DOI 10.1086/377652; Pappu S., 2004, MAN ENV, VXXIX, P1; PAPPU S, 2001, BRIT ARCHAOLOGICAL R, V1003; Pappu S., 2006, AXE AGE ACHEULIAN TO, P155; Patnaik R, 2009, J HUM EVOL, V56, P114, DOI 10.1016/j.jhevol.2008.08.023; Petraglia MD, 2007, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/1-4020-5562-5_1; RENDELL H, 1985, CURR ANTHROPOL, V26, P393, DOI 10.1086/203287; Sangode S.J., 2007, GONDAWANA MAGZINE, V10, P111; Shen GJ, 2009, NATURE, V458, P198, DOI 10.1038/nature07741; Westgate JA, 1998, QUATERNARY RES, V50, P107, DOI 10.1006/qres.1998.1974	29	127	131	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1596	1599		10.1126/science.1200183	http://dx.doi.org/10.1126/science.1200183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436450				2022-12-01	WOS:000288754500053
J	Sato, T; Katagiri, K; Gohbara, A; Inoue, K; Ogonuki, N; Ogura, A; Kubota, Y; Ogawa, T				Sato, Takuya; Katagiri, Kumiko; Gohbara, Ayako; Inoue, Kimiko; Ogonuki, Narumi; Ogura, Atsuo; Kubota, Yoshinobu; Ogawa, Takehiko			In vitro production of functional sperm in cultured neonatal mouse testes	NATURE			English	Article							RAT SPERMATOGENIC CELLS; TRANSMEIOTIC DIFFERENTIATION; ORGAN-CULTURE; GERM-CELLS; PROTEIN; NUCLEI; MARKER	Spermatogenesis is one of the most complex and longest processes of sequential cell proliferation and differentiation in the body, taking more than a month from spermatogonial stem cells, through meiosis, to sperm formation(1,2). The whole process, therefore, has never been reproduced in vitro in mammals(3-5), nor in any other species with a very few exceptions in some particular types of fish(6,7). Here we show that neonatal mouse testes which contain only gonocytes or primitive spermatogonia as germ cells can produce spermatids and sperm in vitro with serum-free culture media. Spermatogenesis was maintained over 2 months in tissue fragments positioned at the gas-liquid interphase. The obtained spermatids and sperm resulted in healthy and reproductively competent offspring through microinsemination. In addition, neonatal testis tissues were cryopreserved and, after thawing, showed complete spermatogenesis in vitro. Our organ culture method could be applicable through further refinements to a variety of mammalian species, which will serve as a platform for future clinical application as well as mechanistic understanding of spermatogenesis.	[Sato, Takuya; Katagiri, Kumiko; Gohbara, Ayako; Kubota, Yoshinobu; Ogawa, Takehiko] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan; [Inoue, Kimiko; Ogonuki, Narumi; Ogura, Atsuo] RIKEN, Bioresource Ctr, Ibaraki 3050074, Japan; [Ogawa, Takehiko] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; RIKEN; Yokohama City University	Ogawa, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan.	ogawa@med.yokohama-cu.ac.jp	Sato, Takuya/F-8251-2017; Jeong, Wonjun/AAM-5937-2020; Ogura, Atsuo/J-3916-2014; Sato, Takuya/X-9143-2019	Sato, Takuya/0000-0002-6198-2234; Ogura, Atsuo/0000-0003-0447-1988; Sato, Takuya/0000-0002-6198-2234	Ministry of Education, Culture, Sports, Science, and Technology, Japan [20116005, 21592080]; Yokohama Foundation for Advancement of Medical Science; Yokohama City University, Japan [S2116]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Foundation for Advancement of Medical Science; Yokohama City University, Japan	We thank S. Yoshida and G. Yoshizaki for comments and pre-submission review. We thank A. Tanaka and Y. W. Zheng for their technical help in flow cytometric analysis. T.O. is grateful to his mentor R. L. Brinster for his advice on devising the experimental strategies and for his encouragements. We would like to thank A. Steinberger and the late E. Steinberger whose work in the study of in vitro spermatogenesis became the ground work for our present study. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, "Regulatory Mechanism of Gamete Stem Cells'' (#20116005); a Grant-in-Aid for Scientific Research (C) (#21592080) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant from the Yokohama Foundation for Advancement of Medical Science; and a grant for Research and Development Project II (No.S2116) of Yokohama City University, Japan (to T.O.).	Champy C., 1920, Archives de Zoologie Experimentale Paris, V60; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; GOETZ P, 1984, J CELL SCI, V65, P249; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Goldsborough M.D, 1998, FOCUS, V20, P8; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Ogonuki N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011062; Ogura A, 1999, HUM REPROD, V14, P1294, DOI 10.1093/humrep/14.5.1294; Parks JE, 2003, THERIOGENOLOGY, V59, P73, DOI 10.1016/S0093-691X(02)01275-X; PRICE PJ, 1998, Patent No. 9830679; Price PJ, 1998, Patent No. [PCT/US98/00467, 9800467]; RASSOULZADEGAN M, 1993, CELL, V75, P997, DOI 10.1016/0092-8674(93)90543-Y; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Sakai N, 2002, DEVELOPMENT, V129, P3359; SHARPE RM, 2006, SERTOLI CELL BIOL, P199; Staub C, 2000, EXP CELL RES, V260, P85, DOI 10.1006/excr.2000.4998; Staub C, 2001, J ANDROL, V22, P911; STEINBERGER A, 1964, EXP CELL RES, V36, P19, DOI 10.1016/0014-4827(64)90156-9; Steinberger A., 1967, J REPROD FERTIL S, V2, P117; Tanaka H, 1999, J BIOL CHEM, V274, P17049, DOI 10.1074/jbc.274.24.17049; TRES LL, 1983, P NATL ACAD SCI-BIOL, V80, P3377, DOI 10.1073/pnas.80.11.3377; TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0; Ventela S, 2000, TISSUE CELL, V32, P501, DOI [10.1016/S0040-8166(00)80006-3, 10.1054/tice.2000.0140]; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5	28	452	481	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					504	+		10.1038/nature09850	http://dx.doi.org/10.1038/nature09850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430778				2022-12-01	WOS:000288702200060
J	Woodcock, J; Griffin, JP; Behrman, RE				Woodcock, Janet; Griffin, Joseph P.; Behrman, Rachel E.			Development of Novel Combination Therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Griffin, Joseph P.; Behrman, Rachel E.] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							AD L, 2010, SCIENCE, V328, P137; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; *FOOD DRUG ADM, 2010, GUID IND CH IN PRESS; *FOOD DRUG ADM, 2010, GUID IND CO IN PRESS	4	198	202	3	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					985	987		10.1056/NEJMp1101548	http://dx.doi.org/10.1056/NEJMp1101548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21323535				2022-12-01	WOS:000288439000001
J	Zhang, HB; Zhou, XH; McQuade, T; Li, JH; Chan, FKM; Zhang, JK				Zhang, Haibing; Zhou, Xiaohui; McQuade, Thomas; Li, Jinghe; Chan, Francis Ka-Ming; Zhang, Jianke			Functional complementation between FADD and RIP1 in embryos and lymphocytes	NATURE			English	Article							RECEPTOR-INTERACTING PROTEIN; DEATH DOMAIN PROTEIN; CELL-DEATH; KINASE RIP; PROGRAMMED NECROSIS; FAS; APOPTOSIS; REGULATOR; FAS/APO1	FADD is a common adaptor shared by several death receptors for signalling apoptosis through recruitment and activation of caspase 8 (refs 1-3). Death receptors are essential for immune homeostasis, but dispensable during embryogenesis. Surprisingly, Fadd(-/-) mice die in utero(4,5) and conditional deletion of FADD leads to impaired lymphocyte proliferation(6,7). How FADD regulates embryogenesis and lymphocyte responses has been a long-standing enigma. FADD could directly bind to RIP1 (also known as RIPK1), a serine/threonine kinase that mediates both necrosis and NF-kappa B activation. Here we show that Fadd(-/-) embryos contain raised levels of RIP1 and exhibit massive necrosis. To investigate a potential in vivo functional interaction between RIP1 and FADD, null alleles of RIP1 were crossed into Fadd(-/-) mice. Notably, RIP1 deficiency allowed normal embryogenesis of Fadd(-/-) mice. Conversely, the developmental defect of Rip1(-/-) lymphocytes was partially corrected by FADD deletion. Furthermore, RIP1 deficiency fully restored normal proliferation in Fadd(-/-) T cells but not in Fadd(-/-) B cells. Fadd(-/-)Rip1(-/-) double-knockout T cells are resistant to death induced by Fas or TNF-alpha and show reduced NF-kappa B activity. Therefore, our data demonstrate an unexpected cell-type-specific interplay between FADD and RIP1, which is critical for the regulation of apoptosis and necrosis during embryogenesis and lymphocyte function.	[Zhang, Haibing; Zhou, Xiaohui; Li, Jinghe; Zhang, Jianke] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [McQuade, Thomas; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	Jefferson University; University of Massachusetts System; University of Massachusetts Worcester	Zhang, JK (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	francis.chan@umassmed.edu; jzhang@mail.jci.tju.edu	Chan, Francis/ABB-1895-2021; Chan, Francis Ka-Ming/E-9647-2014	Chan, Francis Ka-Ming/0000-0002-4803-8353; Zhang, Jianke/0000-0002-5822-2226; Zhang, Haibing/0000-0002-8814-7378	NIH [CA95454, AI083915, AI076788, AI083497, AI017672]; W. W. Smith Charitable Trust grant; TJU Enhancement grant; CONCERN Foundation; NATIONAL CANCER INSTITUTE [R01CA095454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI076788, R01AI017672, R21AI083915, R37AI017672, R01AI083497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust grant; TJU Enhancement grant; CONCERN Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Kelliher for providing Rip1<SUP>-/-</SUP> mice, S. Rosenberg, S. Waggoner, R. Welsh, V. Vanguri and Y. Liu for advice and technical assistance, X. Lin for discussions and suggestions, C. E. Calkins and K. Reinersmann for critical reading of the manuscript, and Z. Zhong for help with histology analysis. This study was supported in part by NIH grants CA95454, AI083915 and AI076788 awarded to J.Z. and AI083497 awarded to F. K.-M. C.; a W. W. Smith Charitable Trust grant, a TJU Enhancement grant, and a CONCERN Foundation grant awarded to J.Z. F. K.-M. C. is a member of the UMass DERC (DK32520) and is also supported in part by an NIH grant (AI017672).	BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Rosenberg S, 2011, J IMMUNOL, V186, P203, DOI 10.4049/jimmunol.1000648; Shen HM, 2004, MOL CELL BIOL, V24, P5914, DOI 10.1128/MCB.24.13.5914-5922.2004; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	23	333	335	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					373	+		10.1038/nature09878	http://dx.doi.org/10.1038/nature09878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368761	Green Accepted			2022-12-01	WOS:000288444000044
J	Gore, A; Li, Z; Fung, HL; Young, JE; Agarwal, S; Antosiewicz-Bourget, J; Canto, I; Giorgetti, A; Israel, MA; Kiskinis, E; Lee, JH; Loh, YH; Manos, PD; Montserrat, N; Panopoulos, AD; Ruiz, S; Wilbert, ML; Yu, JY; Kirkness, EF; Belmonte, JCI; Rossi, DJ; Thomson, JA; Eggan, K; Daley, GQ; Goldstein, LSB; Zhang, K				Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Young, Jessica E.; Agarwal, Suneet; Antosiewicz-Bourget, Jessica; Canto, Isabel; Giorgetti, Alessandra; Israel, Mason A.; Kiskinis, Evangelos; Lee, Je-Hyuk; Loh, Yuin-Han; Manos, Philip D.; Montserrat, Nuria; Panopoulos, Athanasia D.; Ruiz, Sergio; Wilbert, Melissa L.; Yu, Junying; Kirkness, Ewen F.; Izpisua Belmonte, Juan Carlos; Rossi, Derrick J.; Thomson, James A.; Eggan, Kevin; Daley, George Q.; Goldstein, Lawrence S. B.; Zhang, Kun			Somatic coding mutations in human induced pluripotent stem cells	NATURE			English	Article							FIBROBLASTS; GENERATION; EFFICIENT; VARIANTS	Defined transcription factors can induce epigenetic reprogramming of adult mammalian cells into induced pluripotent stem cells. Although DNA factors are integrated during some reprogramming methods, it is unknown whether the genome remains unchanged at the single nucleotide level. Here we show that 22 human induced pluripotent stem (hiPS) cell lines reprogrammed using five different methods each contained an average of five protein-coding point mutations in the regions sampled (an estimated six protein-coding point mutations per exome). The majority of these mutations were non-synonymous, nonsense or splice variants, and were enriched in genes mutated or having causative effects in cancers. At least half of these reprogramming-associated mutations pre-existed in fibroblast progenitors at low frequencies, whereas the rest occurred during or after reprogramming. Thus, hiPS cells acquire genetic modifications in addition to epigenetic modifications. Extensive genetic screening should become a standard procedure to ensure hiPS cell safety before clinical use.	[Young, Jessica E.; Canto, Isabel; Israel, Mason A.; Wilbert, Melissa L.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Young, Jessica E.; Canto, Isabel; Israel, Mason A.; Wilbert, Melissa L.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Inst Genom Med, Dept Bioengn, La Jolla, CA 92093 USA; [Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Agarwal, Suneet; Loh, Yuin-Han; Manos, Philip D.; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; Manos, Philip D.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Antosiewicz-Bourget, Jessica; Yu, Junying; Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53705 USA; [Giorgetti, Alessandra; Montserrat, Nuria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med, Barcelona 08003, Spain; [Kiskinis, Evangelos; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lee, Je-Hyuk] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02135 USA; [Panopoulos, Athanasia D.; Ruiz, Sergio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Kirkness, Ewen F.] J Craig Venter Inst, Rockville, MD 20850 USA; [Rossi, Derrick J.] Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Wisconsin System; University of Wisconsin Madison; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Salk Institute; J. Craig Venter Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu; kzhang@bioeng.ucsd.edu	Eggan, Kevin/P-7119-2018; Giorgetti, Alessandra/D-3784-2016; Montserrat, Nuria/F-3136-2016; Giorgetti, Alessandra/AAB-5870-2019; Loh, Yuin-Han/E-1096-2014; Ruiz, Sergio/G-1561-2016; Zhang, Kun/ABE-6349-2020	Giorgetti, Alessandra/0000-0002-2747-6514; Montserrat, Nuria/0000-0002-1603-1755; Giorgetti, Alessandra/0000-0001-5803-3567; Loh, Yuin-Han/0000-0002-4715-6454; Ruiz, Sergio/0000-0002-0177-6965; Zhang, Kun/0000-0002-7596-5224; Panopoulos, Athanasia/0000-0002-9610-2604; Israel, Mason/0000-0003-0867-0626	NIH [R01 HL094963]; UCSD; California Institute for Regenerative Medicine [TG2-01154]; CIRM [RC1-00116]; Focht-Powell Fellowship; National Institute of General Medical Sciences [T32 GM008666]; A*Star Institute of Medical Biology; Singapore Stem Cell Consortium; MICINN; Sanofi-Aventis; G. Harold and Leila Y. Mathers Foundation; Cellex Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150, R01HL094963, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine); Focht-Powell Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); A*Star Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Sanofi-Aventis(Sanofi-Aventis); G. Harold and Leila Y. Mathers Foundation; Cellex Foundation(Foundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. M. Akey, G. M. Church, S. Ding, J. B. Li and J. Shendure for discussions and suggestions, S. Vassallo for assistance with DNA shearing, and G. L. Boulting and S. Ratansirintrawoot for assistance with hiPS cell culture. This study is supported by NIH R01 HL094963 and a UCSD new faculty start-up fund (to K.Z.), a training grant from the California Institute for Regenerative Medicine (TG2-01154) and a CIRM grant (RC1-00116) (to L.S.B.G.). L.S.B.G. is an Investigator of the Howard Hughes Medical Institute. A. Gore is supported by the Focht-Powell Fellowship and a CIRM predoctoral fellowship. M.L.W. is supported by an institutional training grant from the National Institute of General Medical Sciences (T32 GM008666). Y.-H.L. is supported by the A*Star Institute of Medical Biology and the Singapore Stem Cell Consortium. Work in the laboratory of J.C.I.B. was supported by grants from MICINN, Sanofi-Aventis, the G. Harold and Leila Y. Mathers Foundation and the Cellex Foundation. G.Q.D. is an investigator of the Howard Hughes Medical Institute and supported by grants from the NIH.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	41	914	966	3	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					63	U76		10.1038/nature09805	http://dx.doi.org/10.1038/nature09805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368825	Green Accepted, Green Submitted			2022-12-01	WOS:000287924100034
J	Ostera, GR; Gostin, LO				Ostera, Graciela R.; Gostin, Lawrence O.			Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Ostera, Graciela R.] Georgetown Univ, Dept Microbiol & Immunol, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Alsop Z, 2007, LANCET, V370, P925, DOI 10.1016/S0140-6736(07)61428-7; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Enserink M, 2010, SCIENCE, V330, P1460, DOI 10.1126/science.330.6010.1460; Enserink M, 2010, SCIENCE, V330, P1030, DOI 10.1126/science.330.6007.1030; Fang J, 2010, NATURE, V466, P432, DOI 10.1038/466432a; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Marshall JM, 2010, NAT BIOTECHNOL, V28, P896, DOI 10.1038/nbt0910-896; Secretariat of the Convention on Biological Diversity, CART PROT BIOS CONV; Taylor SM, 2010, JAMA-J AM MED ASSOC, V304, P2048, DOI 10.1001/jama.2010.1578; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3	10	19	21	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					930	931		10.1001/jama.2011.246	http://dx.doi.org/10.1001/jama.2011.246			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364141	Green Published			2022-12-01	WOS:000287854700026
J	Clase, CM; Gao, P; Tobe, SW; McQueen, MJ; Grosshennig, A; Teo, KK; Yusuf, S; Mann, JFE				Clase, Catherine M.; Gao, Peggy; Tobe, Sheldon W.; McQueen, Matthew J.; Grosshennig, Anja; Teo, Koon K.; Yusuf, Salim; Mann, Johannes F. E.		ONTARGET Investigators; TRANSCEND Investigators	Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; GENERAL-POPULATION; ADVERSE OUTCOMES; ALL-CAUSE; MORTALITY; EVENTS; MICROALBUMINURIA; CLASSIFICATION; INDIVIDUALS	Background: Glomerular filtration rate and albuminuria are risk factors for cardiovascular disease and markers of renal function. Objective: To examine the contribution of estimated glomerular filtration rate (eGFR) and urinary albumin-creatinine ratio beyond that of traditional cardiovascular risk factors to classification of patient risk for cardiovascular and renal outcomes. Design: Prospective cohort study that pooled all patients of ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease). Patients: 27 620 patients older than 55 years with documented cardiovascular disease, who were followed for a mean of 4.6 years. Measurements: Baseline eGFR, urinary albumin-creatinine ratio, and cardiovascular risk factors. Outcomes were all-cause mortality; a composite of cardiovascular death, myocardial infarction, stroke, and hospitalization for heart failure; long-term dialysis; and a composite of long-term dialysis and doubling of serum creatinine level. Results: Lower eGFRs and higher urinary albumin-creatinine ratios were associated with the primary cardiovascular composite outcome (for example, an adjusted hazard ratio of 2.53 [95% CI, 1.61 to 3.99] for an eGFR <30 mL/min per 1.73 m(2) and a very high urinary albumin-creatinine ratio). However, adding information about eGFR and urinary albumin-creatinine ratio to the risk reclassification analyses led to no meaningful decrease in the proportion of patients assigned to the intermediate-risk category (31% without vs. 32% with renal information). In contrast, eGFR and urinary albumin-creatinine ratio were strongly associated with risk for long-term dialysis and greatly improved both model calibration and risk stratification capacity when added to traditional cardiovascular risk factors (65% assigned to intermediate-risk categories without renal information vs. 18% with renal information). Limitation: Creatinine levels were not standardized. Conclusion: In patients with high vascular risk, eGFR and urinary albumin-creatinine ratio add little to traditional cardiovascular risk factors for stratifying cardiovascular risk but greatly improve risk stratification for renal outcomes.	McMaster Univ, Hamilton, ON, Canada; Populat Hlth Res Inst, Hamilton, ON, Canada; Univ Toronto, Toronto, ON, Canada; Schwabing Gen Hosp, Munich, Germany; KfH Kidney Ctr, Munich, Germany; Univ Erlangen Nurnberg, Erlangen, Germany	McMaster University; Population Health Research Institute; University of Toronto; University of Erlangen Nuremberg	Clase, CM (corresponding author), St Josephs Healthcare Hamilton, 50 Charlton Ave E, Hamilton, ON L8P 4A6, Canada.	clase@mcmaster.ca	Mann, Johannes/AAI-8803-2020	Teo, Koon/0000-0002-3731-0956; Clase, Catherine/0000-0002-4538-5958	Boehringer Ingelheim; Population Health Research Institute; European Commission [241544]	Boehringer Ingelheim(Boehringer Ingelheim); Population Health Research Institute; European Commission(European CommissionEuropean Commission Joint Research Centre)	Grant Support: By Boehringer Ingelheim, the Population Health Research Institute, and the European Commission (grant 241544, SysKid; Dr. Mann). Dr. Clase is supported by the clinical work of her colleagues.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Brantsma AH, 2008, J AM SOC NEPHROL, V19, P1785, DOI 10.1681/ASN.2007101065; *CAN ORG REPL REG, 2010, ANN REP 2008 CAN I H, P18853; Foster MC, 2007, ARCH INTERN MED, V167, P1386, DOI 10.1001/archinte.167.13.1386; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tonelli M, 2006, BMJ-BRIT MED J, V332, P1426, DOI 10.1136/bmj.38814.566019.2F; Vlek ALM, 2008, J INTERN MED, V264, P351, DOI 10.1111/j.1365-2796.2008.01970.x; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Warram JH, 1996, J AM SOC NEPHROL, V7, pA0606; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8	25	61	64	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					310	318		10.7326/0003-4819-154-5-201103010-00005	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357908				2022-12-01	WOS:000287799900003
J	Ascunce, MS; Yang, CC; Oakey, J; Calcaterra, L; Wu, WJ; Shih, CJ; Goudet, J; Ross, KG; Shoemaker, D				Ascunce, Marina S.; Yang, Chin-Cheng; Oakey, Jane; Calcaterra, Luis; Wu, Wen-Jer; Shih, Cheng-Jen; Goudet, Jerome; Ross, Kenneth G.; Shoemaker, DeWayne			Global Invasion History of the Fire Ant Solenopsis invicta	SCIENCE			English	Article							POPULATION-GENETICS; UNITED-STATES; HYMENOPTERA; FORMICIDAE; TRANSPORT; PATHWAYS; ROUTES; TRADE	The fire ant Solenopsis invicta is a significant pest that was inadvertently introduced into the southern United States almost a century ago and more recently into California and other regions of the world. An assessment of genetic variation at a diverse set of molecular markers in 2144 fire ant colonies from 75 geographic sites worldwide revealed that at least nine separate introductions of S. invicta have occurred into newly invaded areas and that the main southern U.S. population is probably the source of all but one of these introductions. The sole exception involves a putative serial invasion from the southern United States to California to Taiwan. These results illustrate in stark fashion a severe negative consequence of an increasingly massive and interconnected global trade and travel system.	[Ascunce, Marina S.; Yang, Chin-Cheng; Shoemaker, DeWayne] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Ascunce, Marina S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Yang, Chin-Cheng; Wu, Wen-Jer; Shih, Cheng-Jen] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan; [Oakey, Jane] Biosecur Queensland, Brisbane, Qld, Australia; [Calcaterra, Luis] USDA ARS S Amer Biol Control Lab, Buenos Aires, DF, Argentina; [Goudet, Jerome] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Ross, Kenneth G.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; National Taiwan University; Queensland Department of Agriculture & Fisheries; University of Lausanne; University System of Georgia; University of Georgia	Shoemaker, D (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, 1600-1700 SW 23rd Dr, Gainesville, FL USA.	dewayne.shoemaker@ars.usda.gov	Ascunce, Marina/AAW-2139-2020; Calcaterra, Luis/AAM-7370-2020; Goudet, Jerome/A-9730-2012	Goudet, Jerome/0000-0002-5318-7601; Shoemaker, DeWayne/0000-0003-3659-8393; Ascunce, Marina/0000-0002-5239-3585	National Research Initiative of the USDA National Institute of Food and Agriculture [2006-35302-16561, 58-6615-7-137]; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan [98AS-9.1.2-BQ-B1(1)]; National Science Council Executive Yuan, Taiwan [NSC97-2917-I-002-103]	National Research Initiative of the USDA National Institute of Food and Agriculture; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan; National Science Council Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	We thank numerous individuals responsible for fire ant collections (see table S1) and the University of Florida Interdisciplinary Center for Biotechnology Research and Genetics Institute Fisher Bioinformatics Cluster for technical and computer support. We are grateful to S. Porter and D. Gotzek for reviewing an earlier draft of the manuscript. This work was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture (grant no. 2006-35302-16561: Agreement No. 58-6615-7-137); the Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan [grant no. 98AS-9.1.2-BQ-B1(1)]; and the National Science Council Executive Yuan, Taiwan (grant no. NSC97-2917-I-002-103). Sequence data have been deposited in GenBank (accession nos. HM231195-96, HM231200, and HM241155-65).	Caldera EJ, 2008, BIOL INVASIONS, V10, P1457, DOI 10.1007/s10530-008-9219-0; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Henshaw MT, 2005, AUST J ENTOMOL, V44, P37, DOI 10.1111/j.1440-6055.2005.00421.x; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lard CF, 2006, EC IMPACT IMPORTED F; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; MARKIN G P, 1971, Journal of the Georgia Entomological Society, V6, P145; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Perrings C, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P1; Sax DF, 2005, SPECIES INVASIONS IN; Shoemaker DD, 2006, ANN ENTOMOL SOC AM, V99, P1213, DOI 10.1603/0013-8746(2006)99[1213:PGOTIF]2.0.CO;2; Tschinkel W. R., 2006, FIRE ANTS; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Yang CC, 2008, INSECT SOC, V55, P54, DOI 10.1007/s00040-007-0969-y	21	302	337	15	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1066	1068		10.1126/science.1198734	http://dx.doi.org/10.1126/science.1198734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350177				2022-12-01	WOS:000287699000063
J	Gratton, E				Gratton, Enrico			Deeper Tissue Imaging with Total Detection	SCIENCE			English	Editorial Material							FLUORESCENCE MICROSCOPY		Univ Calif Irvine, Irvine, CA 92679 USA	University of California System; University of California Irvine	Gratton, E (corresponding author), Univ Calif Irvine, Irvine, CA 92679 USA.	egratton22@yahoo.com						Combs CA, 2011, J MICROSC-OXFORD, V241, P153, DOI 10.1111/j.1365-2818.2010.03411.x; Combs CA, 2007, J MICROSC-OXFORD, V228, P330, DOI 10.1111/j.1365-2818.2007.01851.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; FISHKIN JB, 1993, J OPT SOC AM A, V10, P127, DOI 10.1364/JOSAA.10.000127; Zimmerley M, 2009, APPL OPTICS, V48, pD79, DOI 10.1364/AO.48.000D79	5	19	22	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1016	1017		10.1126/science.1201542	http://dx.doi.org/10.1126/science.1201542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350154	Green Published			2022-12-01	WOS:000287699000038
J	Cook-Deegan, R				Cook-Deegan, Robert			Gene Patents: The Shadow of Uncertainty	SCIENCE			English	Editorial Material									Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.			Cook-Deegan, Robert/0000-0002-8251-4237	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003391] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					873	874		10.1126/science.1203458	http://dx.doi.org/10.1126/science.1203458			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330530				2022-12-01	WOS:000287455100043
J	Mathews, DJH; Graff, GD; Saha, K; Winickoff, DE				Mathews, Debra J. H.; Graff, Gregory D.; Saha, Krishanu; Winickoff, David E.			Access to Stem Cells and Data: Persons, Property Rights, and Scientific Progress	SCIENCE			English	Editorial Material								Many fields have struggled to develop strategies, policies, or structures to optimally manage data, materials, and intellectual property rights (IPRs). There is growing recognition that the field of stem cell science, in part because of its complex IPRs landscape and the importance of cell line collections, may require collective action to facilitate basic and translational research. Access to pluripotent stem cell lines and the information associated with them is critical to the progress of stem cell science, but simple notions of access are substantially complicated by shifting boundaries between what is considered information versus material, person versus artifact, and private property versus the public domain.	[Mathews, Debra J. H.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Saha, Krishanu] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Winickoff, David E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Johns Hopkins University; Colorado State University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley	Mathews, DJH (corresponding author), Johns Hopkins Berman Inst Bioeth, Deering Hall 208,1809 Ashland Ave, Baltimore, MD 21205 USA.	dmathews@jhu.edu	Saha, Krishanu/J-3980-2014	Saha, Krishanu/0000-0003-2837-0858; Graff, Gregory/0000-0002-9140-0901; Mathews, Debra/0000-0002-4897-7617				[Anonymous], 2009, NATURE, V461, P145, DOI 10.1038/461145a; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Field D, 2009, SCIENCE, V326, P234, DOI 10.1126/science.1180598; Fullerton SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000361; Kohane IS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000809; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; Skloot Rebecca, 2010, IMMORTAL LIFE H LACK; Stacey G, 2006, REGEN MED, V1, P139, DOI 10.2217/17460751.1.1.139; The Hinxton Group, 2011, POL PRACT GOV DAT MA; Winickoff, 2009, YALE J HLTH POLICY L, V9, P52	12	21	22	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					725	727		10.1126/science.1201382	http://dx.doi.org/10.1126/science.1201382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311015				2022-12-01	WOS:000287205700058
J	Hess, M; Sczyrba, A; Egan, R; Kim, TW; Chokhawala, H; Schroth, G; Luo, SJ; Clark, DS; Chen, F; Zhang, T; Mackie, RI; Pennacchio, LA; Tringe, SG; Visel, A; Woyke, T; Wang, Z; Rubin, EM				Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Kim, Tae-Wan; Chokhawala, Harshal; Schroth, Gary; Luo, Shujun; Clark, Douglas S.; Chen, Feng; Zhang, Tao; Mackie, Roderick I.; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.			Metagenomic Discovery of Biomass-Degrading Genes and Genomes from Cow Rumen	SCIENCE			English	Article							IONIC LIQUIDS; PAN-GENOME; ONE-CELL; SWITCHGRASS; CELLULOSE; BACTERIAL; BIOFUELS; TIME	The paucity of enzymes that efficiently deconstruct plant polysaccharides represents a major bottleneck for industrial-scale conversion of cellulosic biomass into biofuels. Cow rumen microbes specialize in degradation of cellulosic plant material, but most members of this complex community resist cultivation. To characterize biomass-degrading genes and genomes, we sequenced and analyzed 268 gigabases of metagenomic DNA from microbes adherent to plant fiber incubated in cow rumen. From these data, we identified 27,755 putative carbohydrate-active genes and expressed 90 candidate proteins, of which 57% were enzymatically active against cellulosic substrates. We also assembled 15 uncultured microbial genomes, which were validated by complementary methods including single-cell genome sequencing. These data sets provide a substantially expanded catalog of genes and genomes participating in the deconstruction of cellulosic biomass.	[Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Chen, Feng; Zhang, Tao; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Chen, Feng; Zhang, Tao; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Kim, Tae-Wan; Chokhawala, Harshal; Clark, Douglas S.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Schroth, Gary; Luo, Shujun] Illumina Inc, Hayward, CA 94545 USA; [Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Dept Anim Sci, Urbana, IL 61801 USA; [Mackie, Roderick I.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Illumina; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rubin, EM (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov	Hess, Matthias/B-1783-2012; Wang, Zhong/J-3244-2019; Visel, Axel/A-9398-2009; Wang, Zhong/E-7897-2011; Hess, Matthias/R-3006-2017	Wang, Zhong/0000-0002-6307-0458; Visel, Axel/0000-0002-4130-7784; Hess, Matthias/0000-0003-0321-0380; Pennacchio, Len/0000-0002-8748-3732; Sczyrba, Alexander/0000-0002-4405-3847	Office of Science of the U.S. Department of Energy [DE-AC02-05CH112]; U.S. Department of Energy [DE-AC02-05CH11231]; Energy Biosciences Institute at the University of California, Berkeley	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute at the University of California, Berkeley	We thank J. Bristow, P. Hugenholtz, F. Warnecke, and K. Mavrommatis for critical discussions and reading the manuscript. We acknowledge technical support by the JGI production team, L. M. Sczyrba, M. Harmon-Smith, J. Froula, J. Martin, C. Wright, A. Lipzen, J. Zhao, S. Malfatti and Stefan Bauer. We thank P. D'Haeseleer for sequences extracted from the CAZy database, Jonas Lovaas Gjerstad for the picture of the fistulated cow, T. Shinkei, T. Yannarell, J. Kim and staff at the Dairy Farm, Department of Animal Sciences for assistance with the maintenance of the fistulated cows, nylon bag experiments and lab procedures carried out at the University of Illinois. The work conducted by the U.S. Department of Energy Joint Genome Institute was supported in part by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH112 and U.S. Department of Energy under contract DE-AC02-05CH11231 (cow rumen metagenomics data analysis and informatics). Supported by a research grant from the Energy Biosciences Institute at the University of California, Berkeley (M.H.). Data are available at the NCBI Short Read Archive under accession number SRA023560 and GenBank accession numbers HQ706005-HQ706094. Complete data can also be accessed through the Web site of the DOE Joint Genome Institute (www.jgi.doe.gov).	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blanch HW, 2008, ACS CHEM BIOL, V3, P17, DOI 10.1021/cb700267s; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MEYER JHF, 1986, APPL ENVIRON MICROB, V51, P622, DOI 10.1128/AEM.51.3.622-629.1986; Parrish DJ, 2009, METHODS MOL BIOL, V581, P27, DOI 10.1007/978-1-60761-214-8_2; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sanderson K, 2006, NATURE, V444, P673, DOI 10.1038/444673a; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; Wang FC, 2009, MICROBIOL RES, V164, P650, DOI 10.1016/j.micres.2008.12.002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Weimer PJ, 1996, J DAIRY SCI, V79, P1496, DOI 10.3168/jds.S0022-0302(96)76509-8; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhao H, 2010, BIOTECHNOL PROGR, V26, P127, DOI 10.1002/btpr.331; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	30	846	941	24	544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					463	467		10.1126/science.1200387	http://dx.doi.org/10.1126/science.1200387			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273488				2022-12-01	WOS:000286635900054
J	Khunti, K; Walker, N; Satter, N; Davies, M				Khunti, Kamlesh; Walker, Nicola; Satter, Naveed; Davies, Melanie			Unanswered questions over NHS health checks	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Khunti, Kamlesh; Walker, Nicola] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Satter, Naveed] BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Davies, Melanie] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester; University of Glasgow; University of Leicester	Khunti, K (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099; Davies, Melanie/0000-0002-9987-9371					0	16	16	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								c6312	10.1136/bmj.c6312	http://dx.doi.org/10.1136/bmj.c6312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270080	Green Accepted			2022-12-01	WOS:000286887800016
J	Alavez, S; Vantipalli, MC; Zucker, DJS; Klang, IM; Lithgow, GJ				Alavez, Silvestre; Vantipalli, Maithili C.; Zucker, David J. S.; Klang, Ida M.; Lithgow, Gordon J.			Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan	NATURE			English	Article							CAENORHABDITIS-ELEGANS; DISEASE; STRESS; DAF-16; PROTEOSTASIS; INHIBITION; ALZHEIMER; LONGEVITY; SELECTION	Genetic studies indicate that protein homeostasis is a major contributor to metazoan longevity(1). Collapse of protein homeostasis results in protein misfolding cascades and the accumulation of insoluble protein fibrils and aggregates, such as amyloids(2). A group of small molecules, traditionally used in histopathology to stain amyloid in tissues, bind protein fibrils and slow aggregationin vitro and in cell culture(3,4). We proposed that treating animals with such compounds would promote protein homeostasis in vivo and increase longevity. Here we show that exposure of adult Caenorhabditis elegans to the amyloid-binding dye Thioflavin T (ThT) resulted in a profoundly extended lifespan and slowed ageing. ThT also suppressed pathological features of mutant metastable proteins and human beta-amyloid-associated toxicity. These beneficial effects of ThT depend on the protein homeostasis network regulator heat shock factor 1 (HSF-1), the stress resistance and longevity transcription factor SKN-1, molecular chaperones, autophagy and proteosomal functions. Our results demonstrate that pharmacological maintenance of the protein homeostatic network has a profound impact on ageing rates, prompting the development of novel therapeutic interventions against ageing and age-related diseases.	[Alavez, Silvestre; Vantipalli, Maithili C.; Zucker, David J. S.; Klang, Ida M.; Lithgow, Gordon J.] Buck Inst Res Aging, Novato, CA 94945 USA; [Zucker, David J. S.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA 94901 USA; [Klang, Ida M.] Karolinska Inst, Ctr Biosci, Novum, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Buck Institute for Research on Aging; Karolinska Institutet	Lithgow, GJ (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	salavez@buckinstitute.org; glithgow@buckinstitute.org	Alavez, Silvestre/AAM-4894-2021	Alavez, Silvestre/0000-0002-9220-0696; Zucker, David/0000-0001-7476-8299	National Institutes of Health (NIH) National Center for Research Resources; Larry L. Hillblom Foundation; NIH [UL1024917, 1R01AG029631-01A1, AG21069, AG22868, AG029631-01A1, ES016655]; Larry L. Hillblom Foundation [UL1 RR024917]; Longevity Consortium [U19AGO231222]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RL1ES016655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021069, R01AG029631, R01AG022868] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Larry L. Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; Longevity Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. A. Gerencser for expert assistance with the confocal microscopy; A. M. Cuervo, M. S. Gill, M. Lucanic, J. Campisi, S. Melov, V. Lunyak and P. Kapahi for suggestions on the manuscript, members of the G.J.L. and P. Kapahi laboratories for helpful discussion and members of the Paper Polishing Club. Nematode strains were provided by the Ceanorhabditis Genetics Center, funded by the National Institutes of Health (NIH) National Center for Research Resources. CF2189 was a gift from C. Kenyon's laboratory. This work was supported by grants from the Larry L. Hillblom Foundation and the NIH (UL1024917, supporting the Interdisciplinary Research Consortium on Geroscience and 1R01AG029631-01A1). G.J.L. is supported by the NIH AG21069, AG22868, AG029631-01A1, ES016655, the Larry L. Hillblom Foundation and UL1 RR024917. S.A. was supported by the U19AGO231222 from the Longevity Consortium.	ANDERSON P, 1984, P NATL ACAD SCI-BIOL, V81, P4470, DOI 10.1073/pnas.81.14.4470; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Rodriguez-Rodriguez C, 2009, J AM CHEM SOC, V131, P1436, DOI 10.1021/ja806062g; Temussi PA, 2003, EMBO J, V22, P355, DOI 10.1093/emboj/cdg044; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; ZENGEL JM, 1980, CELL MOTIL CYTOSKEL, V1, P73, DOI 10.1002/cm.970010107	26	274	284	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					226	229		10.1038/nature09873	http://dx.doi.org/10.1038/nature09873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451522	Green Accepted			2022-12-01	WOS:000289469100044
J	Manson, JE; Mayne, ST; Clinton, SK				Manson, JoAnn E.; Mayne, Susan T.; Clinton, Steven K.			Vitamin D and Prevention of Cancer - Ready for Prime Time?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Manson, JoAnn E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Mayne, Susan T.] Yale Univ, Sch Publ Hlth, Dept Epidemiol & Publ Hlth, New Haven, CT USA; [Mayne, Susan T.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Clinton, Steven K.] Ohio State Univ, Div Med Oncol, Columbus, OH 43210 USA; [Manson, JoAnn E.; Mayne, Susan T.; Clinton, Steven K.] Comm Dietary Reference Intakes Vitamin D & Calciu, Inst Med, Washington, DC USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Yale University; University System of Ohio; Ohio State University	Manson, JE (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.							Byers T, 2010, AM J EPIDEMIOL, V172, P1, DOI 10.1093/aje/kwq112; Chung M, 2009, AHRQ PUBLICATION; Helzlsouer KJ, 2010, AM J EPIDEMIOL, V172, P4, DOI 10.1093/aje/kwq119; Institute of Medicine, 2011, DIETARY REFERENCE IN; International Agency for Research on Cancer, 2008, VIT D CANC REP IARC	5	112	119	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1385	1387		10.1056/NEJMp1102022	http://dx.doi.org/10.1056/NEJMp1102022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21428761				2022-12-01	WOS:000289467200001
J	Zhou, Z; Feng, HQ; Zhou, BR; Ghirlando, R; Hu, KF; Zwolak, A; Jenkins, LMM; Xiao, H; Tjandra, N; Wu, C; Bai, YW				Zhou, Zheng; Feng, Hanqiao; Zhou, Bing-Rui; Ghirlando, Rodolfo; Hu, Kaifeng; Zwolak, Adam; Jenkins, Lisa M. Miller; Xiao, Hua; Tjandra, Nico; Wu, Carl; Bai, Yawen			Structural basis for recognition of centromere histone variant CenH3 by the chaperone Scm3	NATURE			English	Article							FISSION YEAST SCM3; SACCHAROMYCES-CEREVISIAE; SEDIMENTATION-VELOCITY; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN; NMR; NUCLEOSOMES; CHROMATIN; HJURP; CSE4	The centromere is a unique chromosomal locus that ensures accurate segregation of chromosomes during cell division by directing the assembly of a multiprotein complex, the kinetochore(1). The centromere is marked by a conserved variant of conventional histone H3 termed CenH3 or CENP-A (ref. 2). A conserved motif of CenH3, the CATD, defined by loop 1 and helix 2 of the histone fold, is necessary and sufficient for specifying centromere functions of CenH3 (refs 3, 4). The structural basis of this specification is of particular interest. Yeast Scm3 and human HJURP are conserved non-histone proteins that interact physically with the (CenH3-H4) 2 heterotetramer and are required for the deposition of CenH3 at centromeres in vivo(5-13). Here we have elucidated the structural basis for recognition of budding yeast (Saccharomyces cerevisiae) CenH3 (called Cse4) by Scm3. We solved the structure of the Cse4-binding domain (CBD) of Scm3 in complex with Cse4 and H4 in a single chain model. An alpha-helix and an irregular loop at the conserved amino terminus and a shorter alpha-helix at the carboxy terminus of Scm3(CBD) wraps around the Cse4-H4 dimer. Four Cse4-specific residues in the N-terminal region of helix 2 are sufficient for specific recognition by conserved and functionally important residues in the N-terminal helix of Scm3 through formation of a hydrophobic cluster. Scm3(CBD) induces major conformational changes and sterically occludes DNA-binding sites in the structure of Cse4 and H4. These findings have implications for the assembly and architecture of the centromeric nucleosome.	[Zhou, Zheng; Feng, Hanqiao; Zhou, Bing-Rui; Xiao, Hua; Wu, Carl; Bai, Yawen] NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA; [Ghirlando, Rodolfo] NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; [Hu, Kaifeng] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Zwolak, Adam; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Jenkins, Lisa M. Miller] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bai, YW (corresponding author), NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA.	yawen@helix.nih.gov	Jenkins, Lisa/AAI-2490-2021; Zhou, Bing-Rui/D-4766-2009; Ghirlando, Rodolfo/A-8880-2009	Zhou, Bing-Rui/0000-0002-5375-7977	NCI; NIDDK; NHLBI; NATIONAL CANCER INSTITUTE [ZIABC010808, ZIABC005263] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064, ZIAHL001048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Ying, K. Varney, J. F. Ellena and J. Gruschus for help collecting NMR spectra, A. Bax for discussion, C. Klee and M. Lichten for comments on the manuscript, and D. Cleveland for plasmids of human CENP-A and H4 histones. This work is supported by the intramural research programs of NCI, NIDDK and NHLBI.	Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; COTTAREL G, 1989, MOL CELL BIOL, V9, P3342, DOI 10.1128/MCB.9.8.3342; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Wood CM, 2005, ACTA CRYSTALLOGR F, V61, P541, DOI 10.1107/S1744309105013813; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	39	98	101	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					234	237		10.1038/nature09854	http://dx.doi.org/10.1038/nature09854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21412236	Green Accepted			2022-12-01	WOS:000289469100046
J	Loewenberg, S				Loewenberg, Samuel			Profile Mitch Besser-helping mothers with HIV become mentors	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1145	1145		10.1016/S0140-6736(11)60452-2	http://dx.doi.org/10.1016/S0140-6736(11)60452-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21459200				2022-12-01	WOS:000289539300015
J	Lazzaro, BP; Rolff, J				Lazzaro, Brian P.; Rolff, Jens			Danger, Microbes, and Homeostasis	SCIENCE			English	Editorial Material							INNATE IMMUNE-SYSTEM; ANTIMICROBIAL PEPTIDE; BACTERIAL-INFECTION; HOST-DEFENSE; DROSOPHILA; SELF; PATTERNS; INSECTS; GENES; SENSE		[Lazzaro, Brian P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Rolff, Jens] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Cornell University; University of Sheffield	Lazzaro, BP (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	jor@sheffield.ac.uk	hongbo, yi/G-9615-2011	Rolff, Jens/0000-0002-1529-5409				Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Gambaryan S, 2010, J BIOL CHEM, V285, P18352, DOI 10.1074/jbc.M109.077602; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; OTTI O, UNPUB; Ragan Emily J., 2009, P34; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vilcinskas A, 2010, VIRULENCE, V1, P206, DOI 10.4161/viru.1.3.12072; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	20	43	48	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					43	44		10.1126/science.1200486	http://dx.doi.org/10.1126/science.1200486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454776				2022-12-01	WOS:000289000000030
J	Moszynski, P				Moszynski, Peter			RESPIRATORY DISEASES Tuberculosis: a clear and present danger	BRITISH MEDICAL JOURNAL			English	Editorial Material												globewisecom@hotmail.com						LAWN SD, 2011, LANCET          0317; Moszynski P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1937; *PUBL HLTH ACT SUP, 2010, LOND TB SERV REV HLT; STOP TB Partnership, GLOB PLAN STOP TB 20	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 1	2011	342								d2089	10.1136/bmj.d2089	http://dx.doi.org/10.1136/bmj.d2089			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WJ	21459967				2022-12-01	WOS:000289201700007
J	Greving, JP; Visseren, FLJ; de Wit, GA; Algra, A				Greving, J. P.; Visseren, F. L. J.; de Wit, G. A.; Algra, A.			Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; LONG-TERM SURVIVAL; CARDIOVASCULAR-DISEASE; LOWERING MEDICATIONS; DRUG-TREATMENT; RISK; STROKE; METAANALYSIS	Objective To assess the cost-effectiveness of low dose statins for primary prevention of vascular disease, incorporating current prices, non-adherence (reduced clinical efficacy while maintaining healthcare costs), and the results of the recently published JUPITER trial. Design Cost-effectiveness analysis using a Markov model. Sensitivity analyses and Monte Carlo simulation evaluated the robustness of the results. Setting Primary care in The Netherlands. Participants Hypothetical populations of men and women aged 45 to 75 years without a history of vascular disease at different levels of risk for vascular disease (myocardial infarction and stroke) over 10 years. Interventions Low dose statin treatment daily versus no treatment for 10 years. Main outcome measures Number of fatal and nonfatal vascular events prevented, quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness ratios over 10 years. Results Over a 10-year period, statin treatment cost (sic)35 000 (30 pound 000, $49 000) per QALY gained for men aged 55 years with a 10-year vascular risk of 10%. The incremental cost-effectiveness ratio improved as risk for vascular disease increased. The cost per QALY ranged from approximately (sic)5000 to (sic)125 000 when the 10-year vascular risk for men aged 55 years was varied from 25% to 5%. The incremental cost-effectiveness ratio slightly decreased with age after the level of vascular risk was specified. Results were sensitive to the costs of statin treatment, statin effectiveness, non-adherence, disutility of taking medication daily, and the time horizon of the model. Conclusions In daily practice, statin treatment seemed not to be cost-effective for primary prevention in populations at low risk of vascular disease, despite low costs of generic drug pills. Adherence to statin treatment needs to be improved to enhance the cost-effectiveness of the use of statins for primary prevention.	[Greving, J. P.; de Wit, G. A.; Algra, A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Visseren, F. L. J.] Univ Med Ctr Utrecht, Dept Vasc Med, NL-3584 CX Utrecht, Netherlands; [de Wit, G. A.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Algra, A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosc, Dept Neurol & Neurosurg, Utrecht Stroke Ctr, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Greving, JP (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands.	J.P.Greving@umcutrecht.nl	Visseren, Frank LJ/I-4855-2013	Visseren, Frank/0000-0003-3951-5223; de Wit, G. Ardine/0000-0002-1375-7657	Netherlands Organisation for Health Research and Development (ZonMW) [6120.0019]; Merck; Catharijne foundation Utrecht; AstraZeneca	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Merck(Merck & Company); Catharijne foundation Utrecht; AstraZeneca(AstraZeneca)	This study was supported by an unconditional grant from the Netherlands Organisation for Health Research and Development (ZonMW, project number 6120.0019). The funding source had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit an article for publication.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that: the submitted work was supported only by ZonMW; JPG, GAdW, and AA have no relationships with companies that might have an interest in the submitted work in the previous three years; the department of FLV has received research grants from Merck, the Netherlands Organisation for Health research and Development and from the Catharijne foundation Utrecht and speaker fees from Merck and AstraZeneca; none of the authors has non-financial interests that may be relevant to the submitted work.	*AM HEART ASS, 2008, HEART DIS STROK STAT; Augustovski FA, 1998, J GEN INTERN MED, V13, P824, DOI 10.1046/j.1525-1497.1998.00246.x; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bates TR, 2009, EXPERT OPIN PHARMACO, V10, P2973, DOI 10.1517/14656560903376186; Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Buskens E, 2004, RADIOLOGY, V233, P101, DOI 10.1148/radiol.2331030863; Christie Bryan, 2006, BMJ, V333, P988, DOI 10.1136/bmj.39024.405602.DB; DEBOER MJ, 1995, AM J CARDIOL, V76, P830, DOI 10.1016/S0002-9149(99)80238-0; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Dutch Health Care Insurance Board, 2009, DRUG COSTS; Dutch Healthcare Authority, 2009, RAT VAR PROF VAR LAB; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; Grover SA, 2003, ARCH INTERN MED, V163, P333, DOI 10.1001/archinte.163.3.333; Helin-Salmivaara A, 2008, CLIN THER, V30, P2228, DOI 10.1016/j.clinthera.2008.12.003; Hiatt JG, 1999, AM J MANAG CARE, V5, P437; Huse DM, 1998, AM J CARDIOL, V82, P1357, DOI 10.1016/S0002-9149(98)00641-9; JAGERGEURTS MH, 2006, CARDIOVASCULAR DIS N; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Johannesson M, 2001, EUR HEART J, V22, P919, DOI 10.1053/euhj.2000.2484; Koek HL, 2007, NETH J MED, V65, P434; Koek HL, 2006, AM J CARDIOL, V98, P993, DOI 10.1016/j.amjcard.2006.05.016; Lampe FC, 2000, EUR HEART J, V21, P1052, DOI 10.1053/euhj.1999.1866; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; NAGLIE IG, 1992, MED DECIS MAKING, V12, P239, DOI 10.1177/0272989X9201200401; OOSTENBRINK JB, 2004, GUIDELINE COSTING RE; Perreault S, 2009, AM J MED, V122, P647, DOI 10.1016/j.amjmed.2009.01.032; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Post PN, 2001, STROKE, V32, P1425, DOI 10.1161/01.STR.32.6.1425; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Statistics Netherlands, 2002, LIF DUTCH POP AG SEX; Stolk E, 2007, P PLEN M EUROQOL GRO, V153, P65; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	45	75	75	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2011	342								d1672	10.1136/bmj.d1672	http://dx.doi.org/10.1136/bmj.d1672			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WF	21450800	hybrid			2022-12-01	WOS:000289201200002
J	Cisneros, JC; Abdala, F; Rubidge, BS; Dentzien-Dias, PC; Bueno, AD				Cisneros, Juan Carlos; Abdala, Fernando; Rubidge, Bruce S.; Dentzien-Dias, Paula Camboim; Bueno, Ana de Oliveira			Dental Occlusion in a 260-Million-Year-Old Therapsid with Saber Canines from the Permian of Brazil	SCIENCE			English	Article							EVOLUTION; ORIGIN	Anomodonts, a group of herbivorous therapsid "mammal-like reptiles," were the most abundant tetrapods of the Permian. We present a basal anomodont from South America, a new taxon that has transversally expanded palatal teeth and long saber canines. The function of the saber teeth is unknown, but probable uses include deterring attack from predators and intraspecific display or combat. The complex palatal teeth were used to process high-fiber food and represent early evidence of dental occlusion in a therapsid. This discovery provides new insight into the evolution of heterogeneous dentition in therapsids and broadens our understanding of ecological interactions at the end of the Paleozoic.	[Cisneros, Juan Carlos] Univ Fed Piaui, Ctr Ciencias Nat, BR-64049550 Teresina, Piaui, Brazil; [Cisneros, Juan Carlos; Bueno, Ana de Oliveira] Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil; [Abdala, Fernando; Rubidge, Bruce S.] Univ Witwatersrand, Bernard Price Inst Palaeontol Res, ZA-2050 Johannesburg, Johannesburg, South Africa; [Dentzien-Dias, Paula Camboim] Univ Fed Piaui, Picos, Piaui, Brazil	Universidade Federal do Piaui; Universidade Federal do Rio Grande do Sul; University of Witwatersrand; Universidade Federal do Piaui	Cisneros, JC (corresponding author), Univ Fed Piaui, Ctr Ciencias Nat, BR-64049550 Teresina, Piaui, Brazil.		Abdala, Fernando/I-8054-2019; Rubidge, Bruce/AAE-7021-2019; Dentzien-Dias, Paula/AAZ-3945-2020	Rubidge, Bruce/0000-0003-2477-1873; Cisneros, Juan Carlos/0000-0001-6159-1981	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478914/2006-77]; Department of Science and Technology; National Research Foundation; Palaeontological Scientific Trust	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Department of Science and Technology(Department of Science & Technology (India)); National Research Foundation; Palaeontological Scientific Trust	We thank A. E. Figueiredo, M. A. Franca, T. P. Melo, and W. Velasques-Alves for field support. V. Abdala, K. Angielczyk, L. Backwell, P. Backwell, M. Jennions, T. Kemp, and R. Reisz, are acknowledged for discussion and valuable comments. J.C.C., P. C. D. D., and A.O.B. were funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); F. A. and B. S. R. were funded by the Department of Science and Technology, National Research Foundation, and Palaeontological Scientific Trust. Fieldwork was funded by a CNPq grant (478914/2006-77) awarded to C. L. Schultz.	Angielczyk KD, 2004, PALEOBIOLOGY, V30, P268, DOI 10.1666/0094-8373(2004)030<0268:PEFAIO>2.0.CO;2; BARGHUSEN H R, 1975, Paleobiology, V1, P295; Caro Tim, 2005, pXIII; Cisneros Juan Carlos, 2005, Revista Brasileira de Paleontologia, V8, P13; Darwin C., 1871, P423; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Geist V., 1998, DEER WORLD THEIR EVO; Ivakhnenko M.F., 2005, Paleontological Journal, V39, pS393; Ivakhnenko M, 2008, PALEONTOL J+, V42, P859, DOI 10.1134/S0031030108090013; Kemp TS, 2006, J EVOLUTION BIOL, V19, P1231, DOI 10.1111/j.1420-9101.2005.01076.x; KING GM, 1981, PHILOS T R SOC B, V291, P244; Liu J, 2010, P ROY SOC B-BIOL SCI, V277, P285, DOI 10.1098/rspb.2009.0883; Liu J, 2009, ACTA PALAEONTOL POL, V54, P393, DOI 10.4202/app.2008.0071; Modesto S, 1999, P ROY SOC B-BIOL SCI, V266, P331, DOI 10.1098/rspb.1999.0642; Modesto S. P., 2000, AGE DINOSAURS RUSSIA; MODESTO SP, 1995, PALAEONTOLOGY, V38, P213; Ogg G.J., 2008, CONCISE GEOLOGIC TIM; POOLE DFG, 1956, Q J MICROSC SCI, V97, P303; Reisz RR, 2006, J EXP ZOOL PART B, V306B, P261, DOI 10.1002/jez.b.21115; Rose K. D., 2006, BEGINNING AGE MAMMAL; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Rybczynski N, 2001, NATURE, V411, P684, DOI 10.1038/35079567; Sues H.-D., 2000, EVOLUTION HERBIVORY, P9; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189	26	38	39	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1603	1605		10.1126/science.1200305	http://dx.doi.org/10.1126/science.1200305			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436452				2022-12-01	WOS:000288754500055
J	Brower, V				Brower, Vicki			BIOMARKERS Portents of malignancy	NATURE			English	Editorial Material																		Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Gustafson AM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000251; Lam S, 2006, CANCER EPIDEM BIOMAR, V15, P1526, DOI 10.1158/1055-9965.EPI-06-0128; Paz-Elizur T, 2006, CANCER RES, V66, P11683, DOI 10.1158/0008-5472.CAN-06-2294; Qui J., 2008, J CLIN ONCOL, V26, P5060; Zhang XL, 2010, PHYSIOL GENOMICS, V41, P1, DOI 10.1152/physiolgenomics.00167.2009	6	33	33	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S19	S21		10.1038/471S19a	http://dx.doi.org/10.1038/471S19a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430715	Bronze			2022-12-01	WOS:000288702200016
J	Meek, SJ; O'Brien, RV; Llaveria, J; Schrock, RR; Hoveyda, AH				Meek, Simon J.; O'Brien, Robert V.; Llaveria, Josep; Schrock, Richard R.; Hoveyda, Amir H.			Catalytic Z-selective olefin cross-metathesis for natural product synthesis	NATURE			English	Article							RING-CLOSING METATHESIS; EFFICIENT; COMPLEXES; PLASMALOGEN; MOLYBDENUM; KRN7000	Alkenes are found in many biologically active molecules, and there are a large number of chemical transformations in which alkenes act as the reactants or products (or both) of the reaction. Many alkenes exist as either the E or the higher-energy Z stereoisomer. Catalytic procedures for the stereoselective formation of alkenes are valuable, yet methods enabling the synthesis of 1,2-disubstituted Z alkenes are scarce. Here we report catalytic Z-selective cross-metathesis reactions of terminal enol ethers, which have not been reported previously, and of allylic amides, used until now only in E-selective processes. The corresponding disubstituted alkenes are formed in up to >98% Z selectivity and 97% yield. These transformations, promoted by catalysts that contain the highly abundant and inexpensive metal molybdenum, are amenable to gram-scale operations. Use of reduced pressure is introduced as a simple and effective strategy for achieving high stereoselectivity. The utility of this method is demonstrated by its use in syntheses of an anti-oxidant plasmalogen phospholipid, found in electrically active tissues and implicated in Alzheimer's disease, and the potent immunostimulant KRN7000.	[Meek, Simon J.; O'Brien, Robert V.; Llaveria, Josep; Hoveyda, Amir H.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Cros, Josep Llaveria/W-1021-2019	Cros, Josep Llaveria/0000-0003-2260-3657	US National Institutes of Health, Institute of General Medical Sciences [GM-59426]; National Science Foundation [CHE-0715138]; US National Science Foundation [DBI-0619576]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER; Division Of Chemistry [1111074] Funding Source: National Science Foundation	US National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (GM-59426 to A.H.H. and R.R.S.) and the National Science Foundation (CHE-0715138 to A.H.H.). R.V.O. and J.L. were LaMattina and Spanish government Visiting Scholar Fellows, respectively. We thank S. Castillon, S. J. Malcolmson and M. Yu for discussions. Mass spectrometry facilities at Boston College are supported by the US National Science Foundation (DBI-0619576).	Alexander JB, 1998, J AM CHEM SOC, V120, P4041, DOI 10.1021/ja974353i; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; CHATTERJEE AK, 2003, HDB METATHESIS, V2, P246, DOI DOI 10.1002/9783527619481.CH20; CROWE WE, 1995, J AM CHEM SOC, V117, P5162, DOI 10.1021/ja00123a023; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Hansen EC, 2004, ORG LETT, V6, P2035, DOI 10.1021/ol049378i; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Hoveyda AH, 2010, ANGEW CHEM INT EDIT, V49, P34, DOI 10.1002/anie.200904491; Ibrahem I, 2009, J AM CHEM SOC, V131, P3844, DOI 10.1021/ja900097n; Jiang AJ, 2009, J AM CHEM SOC, V131, P16630, DOI 10.1021/ja908098t; Kim SJ, 2004, SHAPING BUSINESS STRATEGY IN A NETWORKED WORLD, VOLS 1 AND 2, PROCEEDINGS, P847, DOI 10.1055/s-2004-822315; La DS, 2001, J AM CHEM SOC, V123, P7767, DOI 10.1021/ja010684q; Lankalapalli RS, 2009, ORG LETT, V11, P2784, DOI 10.1021/ol9009078; Lee YJ, 2009, J AM CHEM SOC, V131, P10652, DOI 10.1021/ja904098h; Lee Y, 2009, J AM CHEM SOC, V131, P18234, DOI 10.1021/ja9089928; Llaveria J, 2009, ORG LETT, V11, P205, DOI 10.1021/ol802379b; Malcolmson SJ, 2008, NATURE, V456, P933, DOI 10.1038/nature07594; Meek SJ, 2009, J AM CHEM SOC, V131, P16407, DOI 10.1021/ja907805f; Michieletti M, 2008, J ORG CHEM, V73, P9192, DOI 10.1021/jo8019994; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Negishi EI, 2008, ACCOUNTS CHEM RES, V41, P1474, DOI 10.1021/ar800038e; Nicolaou K. C., 1997, LIEBIGS ANN CHEM, P1283; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4490, DOI 10.1002/anie.200500369; Prunet J., 2010, METATHESIS NATURAL P, P287; Qin DH, 1999, J AM CHEM SOC, V121, P662, DOI 10.1021/ja982837o; SCHRADER TO, 2003, HDB METATHESIS, V2, P205; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Solans-Monfort X, 2005, J AM CHEM SOC, V127, P14015, DOI 10.1021/ja053528i; Trappeniers M, 2008, CHEMMEDCHEM, V3, P1061, DOI 10.1002/cmdc.200800021	30	284	304	4	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					461	466		10.1038/nature09957	http://dx.doi.org/10.1038/nature09957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430774	Green Accepted			2022-12-01	WOS:000288702200052
J	Vacic, V; McCarthy, S; Malhotra, D; Murray, F; Chou, HH; Peoples, A; Makarov, V; Yoon, S; Bhandari, A; Corominas, R; Iakoucheva, LM; Krastoshevsky, O; Krause, V; Larach-Walters, V; Welsh, DK; Craig, D; Kelsoe, JR; Gershon, ES; Leal, SM; Aquila, MD; Morris, DW; Gill, M; Corvin, A; Insel, PA; McClellan, J; King, MC; Karayiorgou, M; Levy, DL; DeLisi, LE; Sebat, J				Vacic, Vladimir; McCarthy, Shane; Malhotra, Dheeraj; Murray, Fiona; Chou, Hsun-Hua; Peoples, Aine; Makarov, Vladimir; Yoon, Seungtai; Bhandari, Abhishek; Corominas, Roser; Iakoucheva, Lilia M.; Krastoshevsky, Olga; Krause, Verena; Larach-Walters, Veronica; Welsh, David K.; Craig, David; Kelsoe, John R.; Gershon, Elliot S.; Leal, Suzanne M.; Aquila, Marie Dell; Morris, Derek W.; Gill, Michael; Corvin, Aiden; Insel, Paul A.; McClellan, Jon; King, Mary-Claire; Karayiorgou, Maria; Levy, Deborah L.; DeLisi, Lynn E.; Sebat, Jonathan			Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia	NATURE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; MICRODELETIONS; 7Q	Rare copy number variants (CNVs) have a prominent role in the aetiology of schizophrenia and other neuropsychiatric disorders(1). Substantial risk for schizophrenia is conferred by large (>500-kilobase) CNVs at several loci, including microdeletions at 1q21.1 (ref. 2), 3q29 (ref. 3), 15q13.3 (ref. 2) and 22q11.2 (ref. 4) and microduplication at 16p11.2 (ref. 5). However, these CNVs collectively account for a small fraction (2-4%) of cases, and the relevant genes and neurobiological mechanisms are not well understood. Here we performed a large two-stage genome-wide scan of rare CNVs and report the significant association of copy number gains at chromosome 7q36.3 with schizophrenia. Microduplications with variable breakpoints occurred within a 362-kilobase region and were detected in 29 of 8,290 (0.35%) patients versus 2 of 7,431 (0.03%) controls in the combined sample. All duplications overlapped or were located within 89 kilobases upstream of the vasoactive intestinal peptide receptor gene VIPR2. VIPR2 transcription and cyclic-AMP signalling were significantly increased in cultured lymphocytes from patients with microduplications of 7q36.3. These findings implicate altered vasoactive intestinal peptide signalling in the pathogenesis of schizophrenia and indicate the VPAC2 receptor as a potential target for the development of new antipsychotic drugs.	[Vacic, Vladimir; McCarthy, Shane; Malhotra, Dheeraj; Bhandari, Abhishek; Sebat, Jonathan] Cold Spring Harbor Lab, Stanley Inst Cognit Genom, Cold Spring Harbor, NY 12824 USA; [Vacic, Vladimir] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Malhotra, Dheeraj; Chou, Hsun-Hua; Bhandari, Abhishek; Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA USA; [Malhotra, Dheeraj; Chou, Hsun-Hua; Bhandari, Abhishek; Corominas, Roser; Iakoucheva, Lilia M.; Welsh, David K.; Kelsoe, John R.; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA USA; [Murray, Fiona; Aquila, Marie Dell; Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA USA; [Murray, Fiona; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA USA; [Peoples, Aine; Morris, Derek W.; Gill, Michael; Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin 2, Ireland; [Peoples, Aine; Morris, Derek W.; Gill, Michael; Corvin, Aiden] Trinity Coll Dublin, Dept Psychiat, Dublin 2, Ireland; [Makarov, Vladimir; Yoon, Seungtai] Mt Sinai Sch Med, Seaver Autism Ctr, New York, NY 10029 USA; [Makarov, Vladimir; Yoon, Seungtai] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Krastoshevsky, Olga; Krause, Verena; Levy, Deborah L.] McLean Hosp, Belmont, MA 02478 USA; [Larach-Walters, Veronica] Univ Andres Bello, Fac Med, Santiago, Chile; [Welsh, David K.; Kelsoe, John R.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Welsh, David K.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA USA; [Craig, David] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; [Kelsoe, John R.; Sebat, Jonathan] Univ Calif San Diego, Inst Genom Med, La Jolla, CA USA; [Gershon, Elliot S.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77025 USA; [Aquila, Marie Dell] Univ Calif San Diego, Div Med Genet, La Jolla, CA USA; [McClellan, Jon] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [DeLisi, Lynn E.] Boston VA Healthcare Syst, Dept Psychiat, Brockton, MA 02301 USA; [DeLisi, Lynn E.] Harvard Univ, Sch Med, Brockton, MA 02301 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA USA	Cold Spring Harbor Laboratory; Columbia University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Trinity College Dublin; Trinity College Dublin; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; McLean Hospital; Universidad Andres Bello; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Translational Genomics Research Institute; University of California System; University of California San Diego; University of Chicago; Baylor College of Medicine; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; Harvard University; University of California System; University of California San Diego	Sebat, J (corresponding author), Cold Spring Harbor Lab, Stanley Inst Cognit Genom, Cold Spring Harbor, NY 12824 USA.	jsebat@ucsd.edu	Craig, David Wesley/K-6961-2019; Morris, Derek/AAW-8343-2021; Welsh, David K/G-2277-2011; Corominas, Roser/H-4163-2016	Craig, David Wesley/0000-0003-2040-1955; Morris, Derek/0000-0002-3413-570X; Corominas, Roser/0000-0001-8888-5402; Gill, Michael/0000-0003-0206-5337; Sebat, Jonathan/0000-0002-9087-526X; Walters, James/0000-0002-6980-4053; Vacic, Vladimir/0000-0001-6571-2293; King, Mary-Claire/0000-0001-9426-1743; Iakoucheva, Lilia/0000-0002-4542-5219; Corvin, Aiden/0000-0001-6717-4089; Murray, Fiona/0000-0002-5572-4810	Beyster family foundation; NIH [MH076431, HG04222, MH071523, MH083989, GM66232, HL091061, MH082945, MH061399, MH044245]; NARSAD; Wellcome Trust [072894/Z/03/Z]; Science Foundation Ireland [08INIB1916]; Sidney R. Baer, Jr Foundation; Essel Foundation; Veterans Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091061] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061399, R01MH076431, R01MH091350, R01MH082945, R01MH044245, R01MH083989, R01MH071523] Funding Source: NIH RePORTER	Beyster family foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Sidney R. Baer, Jr Foundation; Essel Foundation; Veterans Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a gift from Ted and Vada Stanley to the Cold Spring Harbor Laboratory, a gift to J.S. from the Beyster family foundation, NIH grants to J.S. (MH076431, HG04222), D.L.L. (MH071523), M.-C.K. (MH083989), P.A.I. (GM66232), F.M. (HL091061), D.K.W. (MH082945), M.K. (MH061399), L.E.D. (MH044245), grants to J.S., D.K.W., D.L.L. and M.-C.K from NARSAD, grants to A.C., M.G., D.M. from the Wellcome Trust (072894/Z/03/Z) and Science Foundation Ireland (08INIB1916), a career development award to D.K.W. by the Veterans Administration, and grants to D.L.L. from the Sidney R. Baer, Jr Foundation and Essel Foundation. We wish to thank the Genetic Association Information Network (GAIN), Molecular Genetics of Schizophrenia (MGS) and the Bipolar Genome Study (BiGS) for providing data for this study (investigators listed in the Supplementary Note). We wish to thank B. Trask, R. Malinow and J. Gleeson for discussions.	Bartsch O, 2007, CYTOGENET GENOME RES, V119, P158, DOI 10.1159/000109634; Braun MM, 2010, NAT REV DRUG DISCOV, V9, P519, DOI 10.1038/nrd3160; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Chu A, 2010, MOL PHARMACOL, V77, P95, DOI 10.1124/mol.109.060137; FAHRENKRUG J, 1993, PHARMACOL TOXICOL, V72, P354, DOI 10.1111/j.1600-0773.1993.tb01344.x; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Morava E, 2003, CLIN DYSMORPHOL, V12, P123, DOI 10.1097/01.mcd.0000059768.40218.9b; Moreno D, 2000, PEPTIDES, V21, P1543, DOI 10.1016/S0196-9781(00)00309-0; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; SHEWARD WJ, 1995, NEUROSCIENCE, V67, P409, DOI 10.1016/0306-4522(95)00048-N; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Turetsky BI, 2009, AM J PSYCHIAT, V166, P226, DOI 10.1176/appi.ajp.2008.07071210; Tyson C, 2005, AM J MED GENET A, V139A, P173, DOI 10.1002/ajmg.a.31015; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WASCHEK JA, 1995, DEV NEUROSCI-BASEL, V17, P1, DOI 10.1159/000111268; Wu Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-72; Yang K, 2009, HIPPOCAMPUS, V19, P779, DOI 10.1002/hipo.20559; Zaben M, 2009, STEM CELLS, V27, P2539, DOI 10.1002/stem.184; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144	30	238	250	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					499	503		10.1038/nature09884	http://dx.doi.org/10.1038/nature09884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21346763	Green Accepted, Green Submitted			2022-12-01	WOS:000288702200059
J	White, RM; Cech, J; Ratanasirintrawoot, S; Lin, CY; Rahl, PB; Burke, CJ; Langdon, E; Tomlinson, ML; Mosher, J; Kaufman, C; Chen, F; Long, HK; Kramer, M; Datta, S; Neuberg, D; Granter, S; Young, RA; Morrison, S; Wheeler, GN; Zon, LI				White, Richard Mark; Cech, Jennifer; Ratanasirintrawoot, Sutheera; Lin, Charles Y.; Rahl, Peter B.; Burke, Christopher J.; Langdon, Erin; Tomlinson, Matthew L.; Mosher, Jack; Kaufman, Charles; Chen, Frank; Long, Hannah K.; Kramer, Martin; Datta, Sumon; Neuberg, Donna; Granter, Scott; Young, Richard A.; Morrison, Sean; Wheeler, Grant N.; Zon, Leonard I.			DHODH modulates transcriptional elongation in the neural crest and melanoma	NATURE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; ZEBRAFISH; LEFLUNOMIDE; EXPRESSION; INHIBITOR; DISCOVERY; KINASE; CELLS; GENE	Melanoma is a tumour of transformed melanocytes, which are originally derived from the embryonic neural crest. It is unknown to what extent the programs that regulate neural crest development interact with mutations in the BRAF oncogene, which is the most commonly mutated gene in human melanoma(1). We have used zebrafish embryos to identify the initiating transcriptional events that occur on activation of human BRAF(V600E) (which encodes an amino acid substitution mutant of BRAF) in the neural crest lineage. Zebrafish embryos that are transgenic for mitfa:BRAF(V600E) and lack p53 (also known as tp53) have a gene signature that is enriched for markers of multipotent neural crest cells, and neural crest progenitors from these embryos fail to terminally differentiate. To determine whether these early transcriptional events are important for melanoma pathogenesis, we performed a chemical genetic screen to identify small-molecule suppressors of the neural crest lineage, which were then tested for their effects on melanoma. One class of compound, inhibitors of dihydroorotate dehydrogenase (DHODH), for example leflunomide, led to an almost complete abrogation of neural crest development in zebrafish and to a reduction in the self-renewal of mammalian neural crest stem cells. Leflunomide exerts these effects by inhibiting the transcriptional elongation of genes that are required for neural crest development and melanoma growth. When used alone or in combination with a specific inhibitor of the BRAF(V600E) oncogene, DHODH inhibition led to a marked decrease in melanoma growth both in vitro and in mouse xenograft studies. Taken together, these studies highlight developmental pathways in neural crest cells that have a direct bearing on melanoma formation.	[White, Richard Mark; Cech, Jennifer; Ratanasirintrawoot, Sutheera; Burke, Christopher J.; Langdon, Erin; Kaufman, Charles; Datta, Sumon; Zon, Leonard I.] Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [White, Richard Mark; Kaufman, Charles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Lin, Charles Y.; Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Tomlinson, Matthew L.; Wheeler, Grant N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Mosher, Jack; Morrison, Sean] Univ Michigan, Howard Hughes Med Inst, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Chen, Frank] Harvard Univ, Cambridge, MA 02138 USA; [Long, Hannah K.] Univ Cambridge, Cambridge CB2 1TN, England; [Kramer, Martin] Genzyme Corp, Cambridge, MA 02142 USA; [Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Granter, Scott] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of East Anglia; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Harvard University; University of Cambridge; Sanofi-Aventis; Genzyme Corporation; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Zon, LI (corresponding author), Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Long, Hannah/A-6301-2013; Long, Hannah/X-9731-2019; Wheeler, Grant N/D-3023-2009; Young, Richard A/F-6495-2012; , Charles/ABC-8259-2020; Morrison, Sean/ABD-5326-2021	Long, Hannah/0000-0002-5694-0398; Long, Hannah/0000-0002-5694-0398; Wheeler, Grant N/0000-0002-4335-8577; Young, Richard A/0000-0001-8855-8647; Burke, Christopher/0000-0001-7609-1146; Ratanasirintrawoot, Sutheera/0000-0002-0641-5106; Morrison, Sean/0000-0003-1587-8329; Kaufman, Charles/0000-0003-3122-1677	Howard Hughes Medical Institute; National Cancer Institute (National Institutes of Health); American Society for Clinical Oncology; National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health); Biotechnology and Biological Sciences Research Council/Pfizer; NATIONAL CANCER INSTITUTE [R01CA103846, T32CA009172] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055368] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society for Clinical Oncology; National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Biotechnology and Biological Sciences Research Council/Pfizer(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank G. Bollag and P. Lin for supplying PLX4720. The melanoma xenografts were performed with the assistance of T. Venezia-Bowman. In situ hybridization probes for crestin were supplied by P. Henion. We thank S. Lacadie, C. Ceol, Y. Houvras, T. Bowman, X. Bai and R. Field for discussions and/or comments on the manuscript. This work was supported by the Howard Hughes Medical Institute and the National Cancer Institute (National Institutes of Health) (L.I.Z.), Aid for Cancer Research, the American Society for Clinical Oncology and the National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health) (R.M.W.). M.L.T. was a Biotechnology and Biological Sciences Research Council/Pfizer Industrial CASE award recipient.	AOKI T, 1982, J BIOL CHEM, V257, P432; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Hong SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002029; Kaplan M J, 2001, Curr Opin Investig Drugs, V2, P222; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nguyen CT, 2010, DEV BIOL, V341, P167, DOI 10.1016/j.ydbio.2010.02.020; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rubinstein AL, 2000, GENESIS, V26, P86, DOI 10.1002/(SICI)1526-968X(200001)26:1<86::AID-GENE11>3.0.CO;2-Q; Schiff MH, 2000, DRUGS TODAY, V36, P383, DOI 10.1358/dot.2000.36.6.584259; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967	26	326	338	8	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					518	522		10.1038/nature09882	http://dx.doi.org/10.1038/nature09882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430780	Green Accepted, Green Submitted			2022-12-01	WOS:000288702200063
J	Fogle, KJ; Parson, KG; Dahm, NA; Holmes, TC				Fogle, Keri J.; Parson, Kelly G.; Dahm, Nicole A.; Holmes, Todd C.			CRYPTOCHROME Is a Blue-Light Sensor That Regulates Neuronal Firing Rate	SCIENCE			English	Article							DROSOPHILA CRYPTOCHROME; CIRCADIAN CLOCK; PDF CELLS; PHOTORECEPTOR; SLEEP; AROUSAL	Light-responsive neural activity in central brain neurons is generally conveyed through opsin-based signaling from external photoreceptors. Large lateral ventral arousal neurons (lLNvs) in Drosophila melanogaster increase action potential firing within seconds in response to light in the absence of all opsin-based photoreceptors. Light-evoked changes in membrane resting potential occur in about 100 milliseconds. The light response is selective for blue wavelengths corresponding to the spectral sensitivity of CRYPTOCHROME (CRY). cry-null lines are light-unresponsive, but restored CRY expression in the lLNv rescues responsiveness. Furthermore, expression of CRY in neurons that are normally unresponsive to light confers responsiveness. The CRY-mediated light response requires a flavin redox-based mechanism and depends on potassium channel conductance, but is independent of the classical circadian CRY-TIMELESS interaction.	[Fogle, Keri J.; Parson, Kelly G.; Dahm, Nicole A.; Holmes, Todd C.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Holmes, TC (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	tholmes@uci.edu		Holmes, Todd/0000-0001-8152-8832	NIH [NS046750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107405, R01GM102965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank P. Hardin (anti-CRY), D. O'Dowd (gh146GAL4), J. Hall (cry<SUP>01</SUP> and cry<SUP>02</SUP>), S. Reppert (UAS-dpCRY1 and UAS-dpCRY2), P. Emery (UAS-cry<SUP>m</SUP>), and the Bloomington Stock Center for reagents; S. Vasu, M. Digman, and A. Starr for helpful discussion and technical advice; B. Horne for helpful comments on the manuscript and technical assistance; and S. DeGroot and D. Mumford for technical assistance. This work was funded by NIH grant NS046750 to T. C. H. The authors have no competing financial interests.	Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park D, 2006, J NEUROPHYSIOL, V95, P3955, DOI 10.1152/jn.00117.2006; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	23	137	140	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1409	1413		10.1126/science.1199702	http://dx.doi.org/10.1126/science.1199702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21385718	Green Accepted			2022-12-01	WOS:000288504000033
J	Welch, HG; Sharp, SM; Gottlieb, DJ; Skinner, JS; Wennberg, JE				Welch, H. Gilbert; Sharp, Sandra M.; Gottlieb, Dan J.; Skinner, Jonathan S.; Wennberg, John E.			Geographic Variation in Diagnosis Frequency and Risk of Death Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUSTMENT	Context Because diagnosis is typically thought of as purely a patient attribute, it is considered a critical factor in risk-adjustment policies designed to reward efficient and high-quality care. Objective To determine the association between frequency of diagnoses for chronic conditions in geographic areas and case-fatality rate among Medicare beneficiaries. Design, Setting, and Participants Cross-sectional analysis of the mean number of 9 serious chronic conditions (cancer, chronic obstructive pulmonary disease, coronary artery disease, congestive heart failure, peripheral artery disease, severe liver disease, diabetes with end-organ disease, chronic renal failure, and dementia) diagnosed in 306 hospital referral regions (HRRs) in the United States; HRRs were divided into quintiles of diagnosis frequency. Participants were 5 153 877 fee-for-service Medicare beneficiaries in 2007. Main Outcome Measures Age/sex/race-adjusted case-fatality rates. Results Diagnosis frequency ranged across HRRs from 0.58 chronic conditions in Grand Junction, Colorado, to 1.23 in Miami, Florida (mean, 0.90 [95% confidence interval {CI}, 0.89-0.91]; median, 0.87 [interquartile range, 0.80-0.96]). The number of conditions diagnosed was related to risk of death: among patients diagnosed with 0, 1, 2, and 3 conditions the case-fatality rate was 16, 45, 93, and 154 per 1000, respectively. As regional diagnosis frequency increased, however, the case fatality associated with a chronic condition became progressively less. Among patients diagnosed with 1 condition, the case-fatality rate decreased in a stepwise fashion across quintiles of diagnosis frequency, from 51 per 1000 in the lowest quintile to 38 per 1000 in the highest quintile (relative rate, 0.74 [95% CI, 0.72-0.76]). For patients diagnosed with 3 conditions, the corresponding case-fatality rates were 168 and 137 per 1000 (relative rate, 0.81 [95% CI, 0.79-0.84]). Conclusion Among fee-for-service Medicare beneficiaries, there is an inverse relationship between the regional frequency of diagnoses and the case-fatality rate for chronic conditions. JAMA. 2011;305(11):1113-1118 www.jama.com	[Welch, H. Gilbert; Sharp, Sandra M.; Gottlieb, Dan J.; Skinner, Jonathan S.; Wennberg, John E.] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Welch, H. Gilbert] Dept Vet Affairs Med Ctr, White River Jct, VT USA; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Welch, HG (corresponding author), Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy,Ste 202, Lebanon, NH 03766 USA.	h.gilbert.welch@dartmouth.edu			National Institute on Aging [PO1-AG19783]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by grant PO1-AG19783 from the National Institute on Aging.	Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; IEZZONI LI, 1994, HEALTH SERV RES, V29, P435; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; MedPAC (Medicare Payment Advisory Commission), 2011, REG VAR MED SERV US; MORREIM EH, 1991, ARCH INTERN MED, V151, P443, DOI 10.1001/archinte.151.3.443; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Pine M, 2009, MED DECIS MAKING, V29, P69, DOI 10.1177/0272989X08323297; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Welch WP, 1995, HEALTH AFFAIR, V14, P104, DOI 10.1377/hlthaff.14.4.104	10	111	112	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1113	1118		10.1001/jama.2011.307	http://dx.doi.org/10.1001/jama.2011.307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734ZF	21406648	Green Accepted, Bronze			2022-12-01	WOS:000288381900023
J	Butler, CD				Butler, Colin D.			A stormy future for population health in southeast Asia?	LANCET			English	Editorial Material							CLIMATE-CHANGE		Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	Butler, CD (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 0200, Australia.	colin.butler@anu.edu.au	Butler, Colin D./H-2267-2019	Butler, Colin D./0000-0002-2942-5294				Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Bryant L, 2009, B WORLD HEALTH ORGAN, V87, P852, DOI 10.2471/BLT.08.062562; Butler C. D., 2010, SCN News, P18; Butler CD, 2010, POSTGRAD MED J, V86, P230, DOI 10.1136/pgmj.2009.082727; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Dear K, 2005, ARCH ENVIRON OCCUP H, V60, P205, DOI 10.3200/AEOH.60.4.205-212; Hull TH, 2009, B INDONES ECON STUD, V45, P61, DOI 10.1080/00074910902836197; Owen NA, 2010, ENERG POLICY, V38, P4743, DOI 10.1016/j.enpol.2010.02.026; Pan CJ, 2010, ANN GEOPHYS-GERMANY, V28, P11, DOI 10.5194/angeo-28-11-2010; Pasricha SR, 2010, J PAEDIATR CHILD H, V46, P497, DOI 10.1111/j.1440-1754.2010.01839.x; Reuveny R, 2007, POLIT GEOGR, V26, P656, DOI 10.1016/j.polgeo.2007.05.001; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775	12	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					885	886		10.1016/S0140-6736(10)62140-X	http://dx.doi.org/10.1016/S0140-6736(10)62140-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	21269679				2022-12-01	WOS:000288628800009
J	Gao, YK; Katyal, S; Lee, YS; Zhao, JF; Rehg, JE; Russell, HR; McKinnon, PJ				Gao, Yankun; Katyal, Sachin; Lee, Youngsoo; Zhao, Jingfeng; Rehg, Jerold E.; Russell, Helen R.; McKinnon, Peter J.			DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair	NATURE			English	Article							BASE EXCISION-REPAIR; STRAND BREAK REPAIR; MITOCHONDRIAL-DNA; MOUSE CELLS; DISEASE; XRCC1; DAMAGE; INACTIVATION; POLYMERASE; EXPRESSION	DNA replication and repair in mammalian cells involves three distinct DNA ligases: ligase I (Lig1), ligase III (Lig3) and ligase IV (Lig4)(1). Lig3 is considered a key ligase during base excision repair because its stability depends upon its nuclear binding partner Xrcc1, a critical factor for this DNA repair pathway(2,3). Lig3 is also present in the mitochondria, where its role in mitochondrial DNA (mtDNA) maintenance is independent of Xrcc1 (ref. 4). However, the biological role of Lig3 is unclear as inactivation of murine Lig3 results in early embryonic lethality(5). Here we report that Lig3 is essential for mtDNA integrity but dispensable for nuclear DNA repair. Inactivation of Lig3 in the mouse nervous system resulted in mtDNA loss leading to profound mitochondrial dysfunction, disruption of cellular homeostasis and incapacitating ataxia. Similarly, inactivation of Lig3 in cardiac muscle resulted in mitochondrial dysfunction and defective heart-pump function leading to heart failure. However, Lig3 inactivation did not result in nuclear DNA repair deficiency, indicating essential DNA repair functions of Xrcc1 can occur in the absence of Lig3. Instead, we found that Lig1 was critical for DNA repair, but acted in a cooperative manner with Lig3. Additionally, Lig3 deficiency did not recapitulate the hallmark features of neural Xrcc1 inactivation such as DNA damage-induced cerebellar interneuron loss(6), further underscoring functional separation of these DNA repair factors. Therefore, our data reveal that the critical biological role of Lig3 is to maintain mtDNA integrity and not Xrcc1-dependent DNA repair.	[Gao, Yankun; Katyal, Sachin; Lee, Youngsoo; Zhao, Jingfeng; Russell, Helen R.; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	McKinnon, PJ (corresponding author), St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA.	peter.mckinnon@stjude.org	Rehg, Jerold E/N-8111-2018	Katyal, Sachin/0000-0002-7790-4054; Lee, Youngsoo/0000-0003-4773-6464	National Institutes of Health [NS-37956, CA-21765]; Cancer Center [P30 CA21765]; American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Hartwell Center for biotechnology support, the Transgenic Core Facility for blastocyst injections and the Animal Resources Center for animal husbandry. We also acknowledge the Light Microscopy Core, the Electron Microscopy Core and C. Calabrese and the Animal Imaging Core for magnetic resonance imaging and echocardiography analysis. P.J.M. is supported by the National Institutes of Health (NS-37956, CA-21765), a Cancer Center Support Grant (P30 CA21765) and the American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital. S.K. is a Neoma Boadway AP Endowed Fellow.	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bentley DJ, 2002, J CELL SCI, V115, P1551; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; LJUNGQUIST S, 1994, MUTAT RES, V314, P177, DOI 10.1016/0921-8777(94)90081-7; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Nakai A, 2000, DEV BRAIN RES, V121, P67, DOI 10.1016/S0165-3806(00)00025-0; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08; Sleeth KM, 2004, BIOCHEMISTRY-US, V43, P12924, DOI 10.1021/bi0492612; TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089	30	134	135	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					240	U134		10.1038/nature09773	http://dx.doi.org/10.1038/nature09773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390131	Green Accepted			2022-12-01	WOS:000288170200042
J	Perrings, C; Duraiappah, A; Larigauderie, A; Mooney, H				Perrings, Charles; Duraiappah, Anantha; Larigauderie, Anne; Mooney, Harold			The Biodiversity and Ecosystem Services Science-Policy Interface	SCIENCE			English	Editorial Material							GLOBAL BIODIVERSITY		[Perrings, Charles] Arizona State Univ, Sch Life Sci, IPBES Proc, ICSU, Tempe, AZ 85287 USA; [Duraiappah, Anantha] United Nations Univ, IHDP, D-53113 Bonn, Germany; [Larigauderie, Anne] Museum Natl Hist Nat, DIVERSITAS, F-75231 Paris, France; [Mooney, Harold] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Arizona State University; Arizona State University-Tempe; Museum National d'Histoire Naturelle (MNHN); Stanford University	Perrings, C (corresponding author), Arizona State Univ, Sch Life Sci, IPBES Proc, ICSU, Tempe, AZ 85287 USA.	charles.perrings@asu.edu			Division Of Behavioral and Cognitive Sci [1134890] Funding Source: National Science Foundation	Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Andrefouet S, 2008, GEO BIODIVERSITY OBS; [Anonymous], 2010, EC ECOSYSTEMS BIODIV; Bolin B, 2007, HISTORY OF THE SCIENCE AND POLITICS OF CLIMATE CHANGE: THE ROLE OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P1, DOI 10.1017/CBO9780511721731; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; *CBD, 2010, C PART 10 CBD DOC, P10; Convention on Biological Diversity, 2010, GLOB BIOD OUTL; Heywood V. H., 1995, GLOBAL BIODIVERSITY; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; *MILL EC ASS, 2005, MILL EC ASS LIV OUR; Pachauri RK, 2007, CLIMATE CHANGE 2007; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Reid WV, 2010, SCIENCE, V330, P916, DOI 10.1126/science.1196263; Reid WV, 2009, SCIENCE, V325, P245, DOI 10.1126/science.1178591; Shapiro H. T., 2010, CLIMATE CHANGE ASSES; *UN GEN ASS, GEN ASS UN RES 64 SE; UNEP, 2010, GREEN EC DRIV GREEN; Van Kersberen K, 2004, COMP EUROPEAN POLITI, V2, P142, DOI DOI 10.1057/PALGRAVE.CEP.6110033; BUSAN OUTCOME; STRATEGIC PLAN INCLU	23	212	230	2	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1139	1140		10.1126/science.1202400	http://dx.doi.org/10.1126/science.1202400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729SN	21330488				2022-12-01	WOS:000287971200024
J	Suzuki, A; Stern, SA; Bozdagi, O; Huntley, GW; Walker, RH; Magistretti, PJ; Alberini, CM				Suzuki, Akinobu; Stern, Sarah A.; Bozdagi, Ozlem; Huntley, George W.; Walker, Ruth H.; Magistretti, Pierre J.; Alberini, Cristina M.			Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation	CELL			English	Article							ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY GENE; D-SERINE; RAT HIPPOCAMPUS; GLYCOGEN; GLUCOSE; POTENTIATION; PLASTICITY; ACTIN; CONSOLIDATION	We report that, in the rat hippocampus, learning leads to a significant increase in extracellular lactate levels that derive from glycogen, an energy reserve selectively localized in astrocytes. Astrocytic glycogen breakdown and lactate release are essential for long-term but not short-term memory formation, and for the maintenance of long-term potentiation (LTP) of synaptic strength elicited in vivo. Disrupting the expression of the astrocytic lactate transporters monocarboxylate transporter 4 (MCT4) or MCT1 causes amnesia, which, like LTP impairment, is rescued by L-lactate but not equicaloric glucose. Disrupting the expression of the neuronal lactate transporter MCT2 also leads to amnesia that is unaffected by either L-lactate or glucose, suggesting that lactate import into neurons is necessary for long-term memory. Glycogenolysis and astrocytic lactate transporters are also critical for the induction of molecular changes required for memory formation, including the induction of phospho-CREB, Arc, and phospho-cofilin. We conclude that astrocyte-neuron lactate transport is required for long-term memory formation.	[Magistretti, Pierre J.] Univ Lausanne CHUV, Lab Neuroenerget & Cellular Dynam, Brain Mind Inst, EPFL, Lausanne, Switzerland; [Magistretti, Pierre J.] Univ Lausanne CHUV, Ctr Psychiat Neurosci, Lausanne, Switzerland; [Suzuki, Akinobu; Stern, Sarah A.; Bozdagi, Ozlem; Huntley, George W.; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Bozdagi, Ozlem; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Walker, Ruth H.] James J Peters VAMC, Dept Neurol, Bronx, NY 10468 USA; [Walker, Ruth H.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Magistretti, PJ (corresponding author), Univ Lausanne CHUV, Lab Neuroenerget & Cellular Dynam, Brain Mind Inst, EPFL, Lausanne, Switzerland.	pierre.magistretti@epfl.ch; cristina.alberini@mssm.edu	Stern, Sarah/AAV-6019-2021	Stern, Sarah/0000-0002-3033-8251; Huntley, George W./0000-0003-3645-6192; Magistretti, Pierre Julius/0000-0002-6678-320X	Department of Veterans Affairs;  [R01-MH065635];  [R01-MH074736];  [T32-MH087004]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065635, T32MH087004, R01MH074736] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants R01-MH065635 and R01-MH074736 to C. M. A., Department of Veterans Affairs Merit Award to R. H. W. and T32-MH087004 to S. A. S. We thank Rick Koch, Dhananjay Bambah-Mukku, Dillon Chen, Gabriella Pollonini, and Virginia Gao for technical support; and Reginald Miller and the Center for Comparative Medicine and Surgery facility at Mount Sinai School of Medicine for technical support. P.J.M. is the recipient of the Asterion Chair at Ecole Polytechnique Federale de Lausanne (EPFL).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Clarke Donald D., 1994, P645; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P1895, DOI 10.1038/jcbfm.2010.151; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fray AE, 1996, J PHYSIOL-LONDON, V496, P49, DOI 10.1113/jphysiol.1996.sp021664; Ghosh A, 2005, J BIOL CHEM, V280, P11114, DOI 10.1074/jbc.M410894200; Gibbs ME, 2007, J NEUROSCI RES, V85, P3326, DOI 10.1002/jnr.21307; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hamprecht B., 2005, NEUROGLIA, V2, P202, DOI [10.1093/acprof:oso/9780195152227.003.0015, DOI 10.1093/ACPROF:OSO/9780195152227.003.0015]; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jahanshahi M, 2008, SINGAP MED J, V49, P388; Jahanshahi M., 2008, AM J ANIM VET SCI, V3, P28; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kettenmann H, 2005, NEUROGLIA, DOI Oxford University Press; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Leutgeb JK, 2005, NEUROSCIENCE, V131, P601, DOI 10.1016/j.neuroscience.2004.12.002; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MAGISTRETTI PJ, 1988, NEUROSCIENCE, V24, P367, DOI 10.1016/0306-4522(88)90338-7; MAGISTRETTI PJ, 2008, FUNDAMENTAL NEUROSCI, P271; Mantzur L, 2009, NEUROBIOL LEARN MEM, V91, P85, DOI 10.1016/j.nlm.2008.09.001; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKenna M.C., 2006, BASIC NEUROCHEMISTRY, P531; McNay Ewan C, 2002, Behav Cogn Neurosci Rev, V1, P264, DOI 10.1177/1534582302238337; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Rex A, 2009, PHYSIOL BEHAV, V98, P467, DOI 10.1016/j.physbeh.2009.07.015; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SOTELO C, 1968, J CELL BIOL, V36, P151, DOI 10.1083/jcb.36.1.151; Swanson RA, 1992, CAN J PHYSIOL PHARM, V70, P138; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Urrila AS, 2004, J SLEEP RES, V13, P111, DOI 10.1111/j.1365-2869.2004.00401.x; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Waagepetersen HS, 2000, NEUROCHEM INT, V36, P435, DOI 10.1016/S0197-0186(99)00146-1; Walls AB, 2008, J NEUROCHEM, V105, P1462, DOI 10.1111/j.1471-4159.2008.05250.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008	64	931	963	14	133	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					810	823		10.1016/j.cell.2011.02.018	http://dx.doi.org/10.1016/j.cell.2011.02.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376239	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000288007100018
J	Li, B; Piriz, J; Mirrione, M; Chung, CH; Proulx, CD; Schulz, D; Henn, F; Malinow, R				Li, Bo; Piriz, Joaquin; Mirrione, Martine; Chung, ChiHye; Proulx, Christophe D.; Schulz, Daniela; Henn, Fritz; Malinow, Roberto			Synaptic potentiation onto habenula neurons in the learned helplessness model of depression	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; DORSAL RAPHE NUCLEUS; LATERAL HABENULA; ANIMAL-MODEL; TRYPTOPHAN DEPLETION; RESPONSES; BEHAVIOR; STRESS; RAT; STIMULATION	The cellular basis of depressive disorders is poorly understood(1). Recent studies in monkeys indicate that neurons in the lateral habenula (LHb), a nucleus that mediates communication between forebrain and midbrain structures, can increase their activity when an animal fails to receive an expected positive reward or receives a stimulus that predicts aversive conditions (that is, disappointment or anticipation of a negative outcome)(2-4). LHb neurons project to, and modulate, dopamine-rich regions, such as the ventral tegmental area (VTA)(2,5), that control reward-seeking behaviour(6) and participate in depressive disorders(7). Here we show that in two learned helplessness models of depression, excitatory synapses onto LHb neurons projecting to the VTA are potentiated. Synaptic potentiation correlates with an animal's helplessness behaviour and is due to an enhanced presynaptic release probability. Depleting transmitter release by repeated electrical stimulation of LHb afferents, using a protocol that can be effective for patients who are depressed(8,9), markedly suppresses synaptic drive onto VTA-projecting LHb neurons in brain slices and can significantly reduce learned helplessness behaviour in rats. Our results indicate that increased presynaptic action onto LHb neurons contributes to the rodent learned helplessness model of depression.	[Li, Bo; Piriz, Joaquin; Chung, ChiHye; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Neurosci, La Jolla, CA 92093 USA; [Li, Bo; Piriz, Joaquin; Chung, ChiHye; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Biol Sci, La Jolla, CA 92093 USA; [Li, Bo; Mirrione, Martine; Henn, Fritz] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Mirrione, Martine; Schulz, Daniela; Henn, Fritz] Brookhaven Natl Lab, Upton, NY 11973 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Li, B (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Neurosci, 9500 Gilman Dr 0634, La Jolla, CA 92093 USA.	bli@cshl.edu; rmalinow@ucsd.edu	Schulz, Daniela/H-5625-2011	Chung, ChiHye/0000-0002-3104-2399; Li, Bo/0000-0002-0154-3088; Piriz, Joaquin/0000-0002-4588-6568; Proulx, Christophe/0000-0001-6484-9677	Dana Foundation; National Institute of Mental Health, National Institutes of Health [1R01MH091903-01]; Shiley-Marcos Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049159, R01MH091119, R01MH091903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	Dana Foundation; National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Shiley-Marcos Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Deisseroth for help and suggestions, A. Gifford and A. Biegon for sharing equipment and laboratory space, and members of the Malinow Lab and Li Lab for discussions. This study was supported by the Dana Foundation (B. L.), the Biobehavioral Research Awards for Innovative New Scientists (BRAINS) from the National Institute of Mental Health, National Institutes of Health (1R01MH091903-01) (B. L.) and the Shiley-Marcos Endowment (R.M.).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Roiser JP, 2009, BIOL PSYCHIAT, V66, P441, DOI 10.1016/j.biopsych.2009.05.002; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schulz D, 2010, NEUROBIOL LEARN MEM, V93, P291, DOI 10.1016/j.nlm.2009.11.003; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Winter C, 2011, BEHAV BRAIN RES, V216, P463, DOI 10.1016/j.bbr.2010.07.034; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	34	397	419	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					535	U125		10.1038/nature09742	http://dx.doi.org/10.1038/nature09742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350486	Green Accepted			2022-12-01	WOS:000287652900042
J	Solit, DB; Rosen, N				Solit, David B.; Rosen, Neal			Resistance to BRAF Inhibition in Melanomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RAF; PATHWAY; CRAF		[Solit, David B.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.		Rosen, Neal/ABF-2677-2020; Solit, David B./AAC-5309-2019					Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758	8	184	190	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					772	774		10.1056/NEJMcibr1013704	http://dx.doi.org/10.1056/NEJMcibr1013704			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345109				2022-12-01	WOS:000287652500016
J	Tutu, D				Tutu, Desmond			A Celebration of the Genome, Part II - My Genome	SCIENCE			English	Editorial Material																			0	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					689	689		10.1126/science.1203150	http://dx.doi.org/10.1126/science.1203150			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310994				2022-12-01	WOS:000287205700038
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Definitely not acceptable: drug company sues journal over review	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2011	342								d602	10.1136/bmj.d602	http://dx.doi.org/10.1136/bmj.d602			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PR	21285186				2022-12-01	WOS:000287138000009
J	Heuser, RG; Osborne, M; Hall, J				Heuser, Rose G.; Osborne, Molly L.; Hall, Jesse			Update in Pulmonary and Critical Care Medicine: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE; RISK	This Update summarizes studies published in 2010 that the authors consider highly relevant to the practice of pulmonary and critical care medicine. Topics include anticholinergic therapy in asthma, identification of patients with chronic obstructive pulmonary disease who are at risk for exacerbations, pulmonary vasodilator therapy in idiopathic pulmonary fibrosis, tuberculosis testing, tyrosine kinase inhibitors in non-small cell lung cancer, early palliative care and cancer survival, outcomes of critical illness, sedatives and neuromuscular blockade in critically ill patients, interventions and monitoring in patients with shock, and management of acute hypoxemic respiratory failure.	Oregon Hlth & Sci Univ, Dept Med, Pulm & Crit Care, Portland, OR 97239 USA; Univ Chicago Hosp & Clin, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	Oregon Health & Science University; University of Chicago; University of Illinois System	Osborne, M (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Pulm & Crit Care, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.							Au DH, 2009, J GEN INTERN MED, V24, P457, DOI 10.1007/s11606-009-0907-y; Collard HR, 2007, CHEST, V131, P897, DOI 10.1378/chest.06-2101; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					614	621		10.7326/0003-4819-154-9-201105030-00339	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00339			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21464338				2022-12-01	WOS:000290112300014
J	Sahay, A; Scobie, KN; Hill, AS; O'Carroll, CM; Kheirbek, MA; Burghardt, NS; Fenton, AA; Dranovsky, A; Hen, R				Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Fenton, Andre A.; Dranovsky, Alex; Hen, Rene			Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation	NATURE			English	Article							DENTATE GYRUS; SYNAPTIC PLASTICITY; FLUOXETINE; MATURATION; NEURONS; BRAIN; DEPRESSION; DISORDER; MODELS; MEMORY	Adult hippocampal neurogenesis is a unique form of neural circuit plasticity that results in the generation of new neurons in the dentate gyrus throughout life(1,2). Neurons that arise in adults (adult-born neurons) show heightened synaptic plasticity during their maturation(3) and can account for up to ten per cent of the entire granule cell population(4). Moreover, levels of adult hippocampal neurogenesis are increased by interventions that are associated with beneficial effects on cognition and mood, such as learning(5), environmental enrichment(6), exercise(6) and chronic treatment with antidepressants(7-10). Together, these properties of adult neurogenesis indicate that this process could be harnessed to improve hippocampal functions. However, despite a substantial number of studies demonstrating that adult-born neurons are necessary for mediating specific cognitive functions(11), as well as some of the behavioural effects of antidepressants(8-10,12,13), it is unknown whether an increase in adult hippocampal neurogenesis is sufficient to improve cognition and mood. Here we show that inducible genetic expansion of the population of adult-born neurons through enhancing their survival improves performance in a specific cognitive task in which two similar contexts need to be distinguished. Mice with increased adult hippocampal neurogenesis show normal object recognition, spatial learning, contextual fear conditioning and extinction learning but are more efficient in differentiating between overlapping contextual representations, which is indicative of enhanced pattern separation. Furthermore, stimulation of adult hippocampal neurogenesis, when combined with an intervention such as voluntary exercise, produces a robust increase in exploratory behaviour. However, increasing adult hippocampal neurogenesis alone does not produce a behavioural response like that induced by anxiolytic agents or antidepressants. Together, our findings suggest that strategies that are designed to increase adult hippocampal neurogenesis specifically, by targeting the cell death of adult-born neurons or by other mechanisms, may have therapeutic potential for reversing impairments in pattern separation and dentate gyrus dysfunction such as those seen during normal ageing(14,15).	[Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Fenton, Andre A.] SUNY, Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; [Fenton, Andre A.] SUNY, Downstate Med Ctr, Dept Pharmacol & Neurol, Brooklyn, NY 11203 USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; Columbia University	Sahay, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	as2619@columbia.edu; rh95@columbia.edu	Kheirbek, Mazen A/J-3656-2015; Sahay, Amar/J-3696-2014; Dranovsky, Alex/P-4357-2018	Kheirbek, Mazen A/0000-0001-9157-7363; Dranovsky, Alex/0000-0001-7896-3243; Fenton, Andre/0000-0002-5063-1156	National Institute of Mental Health [1K99MH86615-01]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Sackler Institute of Columbia University; Ruth L. Kirschstein National Research Service Award [F31]; New York Stem Cell Initiative (NYSTEM); National Institutes of Health [R01 MH068542]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH086615, R01MH091844, R01MH068542, K08MH079088] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Sackler Institute of Columbia University; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Initiative (NYSTEM); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Gordon, S. Fusi, C. Kellendonk, H. Scharfman and members of the Hen laboratory for comments on the manuscript and discussions about the project. We thank E. Pavlopoulos for consultation on spatial learning, and M. Drew and C. A. Denny for input on the novel object recognition test. A. S. was supported by a 2009 National Institute of Mental Health Grant (1K99MH86615-01), 2006 and 2008 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards, and a 2008 Sackler Institute of Columbia University Award. K.N.S. was supported by a Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31). R. H. was supported by grants from NARSAD, the New York Stem Cell Initiative (NYSTEM) and the National Institutes of Health (R01 MH068542).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Lever C, 2006, REV NEUROSCIENCE, V17, P111; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TRONEL S, 2010, HIPPOCAMPUS     1103, DOI DOI 10.1002/HIPO.20895; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; YASSA M, 2010, HIPPOCAMPUS     0520, DOI DOI 10.1002/HIPO.20808; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	36	1022	1054	8	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					466	U539		10.1038/nature09817	http://dx.doi.org/10.1038/nature09817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21460835	Green Accepted, Green Submitted			2022-12-01	WOS:000289949600033
J	Rappaport, B; Mellon, RD; Simone, A; Woodcock, J				Rappaport, Bob; Mellon, R. Daniel; Simone, Arthur; Woodcock, Janet			Defining Safe Use of Anesthesia in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COHORT		[Rappaport, Bob; Mellon, R. Daniel; Simone, Arthur] US FDA, Off New Drugs, Div Anesthesia & Analgesia Prod, Silver Spring, MD 20993 USA; [Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Rappaport, B (corresponding author), US FDA, Off New Drugs, Div Anesthesia & Analgesia Prod, Silver Spring, MD 20993 USA.							Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; JR SW, 2007, TOXICOL SCI, V98, P145; PAULE MG, 2011, NEUROTOXICOL TE 0115; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d	5	152	155	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1387	1390		10.1056/NEJMp1102155	http://dx.doi.org/10.1056/NEJMp1102155			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749LD	21388302	Bronze			2022-12-01	WOS:000289467200002
J	Wang, KC; Yang, YW; Liu, B; Sanyal, A; Corces-Zimmerman, R; Chen, Y; Lajoie, BR; Protacio, A; Flynn, RA; Gupta, RA; Wysocka, J; Lei, M; Dekker, J; Helms, JA; Chang, HY				Wang, Kevin C.; Yang, Yul W.; Liu, Bo; Sanyal, Amartya; Corces-Zimmerman, Ryan; Chen, Yong; Lajoie, Bryan R.; Protacio, Angeline; Flynn, Ryan A.; Gupta, Rajnish A.; Wysocka, Joanna; Lei, Ming; Dekker, Job; Helms, Jill A.; Chang, Howard Y.			A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression	NATURE			English	Article							ANATOMIC DEMARCATION; HISTONE H3; TRANSCRIPTION; ELEMENTS; METHYLATION; DIVERSITY; GENOME; 5C	The genome is extensively transcribed into long intergenic noncoding RNAs (lincRNAs), many of which are implicated in gene silencing(1,2). Potential roles of lincRNAs in gene activation are much less understood(3-5). Development and homeostasis require coordinate regulation of neighbouring genes through a process termed locus control(6). Some locus control elements and enhancers transcribe lincRNAs(7-10), hinting at possible roles in long-range control. In vertebrates, 39 Hox genes, encoding homeodomain transcription factors critical for positional identity, are clustered in four chromosomal loci; the Hox genes are expressed in nested anterior-posterior and proximal-distal patterns colinear with their genomic position from 3' to 5' of the cluster(11). Here we identify HOTTIP, a lincRNA transcribed from the 5' tip of the HOXA locus that coordinates the activation of several 5' HOXA genes in vivo. Chromosomal looping brings HOTTIP into close proximity to its target genes. HOTTIP RNA binds the adaptor protein WDR5 directly and targets WDR5/MLL complexes across HOXA, driving histone H3 lysine 4 trimethylation and gene transcription. Induced proximity is necessary and sufficient for HOTTIP RNA activation of its target genes. Thus, by serving as key intermediates that transmit information from higher order chromosomal looping into chromatin modifications, lincRNAs may organize chromatin domains to coordinate long-range gene activation.	[Wang, Kevin C.; Yang, Yul W.; Corces-Zimmerman, Ryan; Protacio, Angeline; Flynn, Ryan A.; Gupta, Rajnish A.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA; [Wang, Kevin C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Liu, Bo; Helms, Jill A.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Sanyal, Amartya; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Gene Funct & Express, Worcester, MA 01605 USA; [Chen, Yong; Lei, Ming] Univ Michigan, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Stanford University	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu	Chen, Yong/AAF-9915-2020; Jha, Rajneesh/L-5606-2017; Corces, M. Ryan/ABG-6947-2020; SANYAL, AMARTYA/D-7240-2015	Chen, Yong/0000-0001-5857-6086; Corces, M. Ryan/0000-0001-7465-7652; SANYAL, AMARTYA/0000-0002-2109-4478; Wang, Kevin/0000-0002-5305-6791; Flynn, Ryan/0000-0001-5013-0442; Helms, Jill/0000-0002-0463-396X	California Institute for Regenerative Medicine; National Institutes of Health [HG003143]; Scleroderma Research Foundation; Dermatology Foundation; W. M. Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; Dermatology Foundation; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Tabin for chick Hox gene probes, M. Scott and members of our labs for input, and M. Lin for use of the confocal microscope and imaging expertise. Supported by grants from the California Institute for Regenerative Medicine (H.Y.C., J.W.), the National Institutes of Health (HG003143 to J.D.), and the Scleroderma Research Foundation (H.Y.C.). K.C.W. is a recipient of a Dermatology Foundation Career Development Award. J.D. is a recipient of the W. M. Keck Foundation Distinguished Young Scholar Award. H.Y.C. and M.L. are Early Career Scientists of the Howard Hughes Medical Institute.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chang HY, 2009, SCIENCE, V326, P1206, DOI 10.1126/science.1175686; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Harpavat S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-2; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Michlewski G, 2010, RNA, V16, P1673, DOI 10.1261/rna.2136010; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P724, DOI 10.1016/j.bbrc.2007.03.200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	45	1457	1536	3	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					120	U158		10.1038/nature09819	http://dx.doi.org/10.1038/nature09819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21423168	Green Accepted			2022-12-01	WOS:000289199400049
J	Edlich, F; Banerjee, S; Suzuki, M; Cleland, MM; Arnoult, D; Wang, CX; Neutzner, A; Tjandra, N; Youle, RJ				Edlich, Frank; Banerjee, Soojay; Suzuki, Motoshi; Cleland, Megan M.; Arnoult, Damien; Wang, Chunxin; Neutzner, Albert; Tjandra, Nico; Youle, Richard J.			Bcl-x(L) Retrotranslocates Bax from the Mitochondria into the Cytosol	CELL			English	Article							PROSURVIVAL BCL-2 PROTEINS; CELL-DEATH; MEMBRANE PERMEABILIZATION; CYTOCHROME-C; APOPTOTIC FUNCTION; BH3-ONLY PROTEINS; PROAPOPTOTIC BAX; DISULFIDE BONDS; BH3 DOMAINS; FAMILY	The Bcl-2 family member Bax translocates from the cytosol to mitochondria, where it oligomerizes and permeabilizes the mitochondrial outer membrane to promote apoptosis. Bax activity is counteracted by prosurvival Bcl-2 proteins, but how they inhibit Bax remains controversial because they neither colocalize nor form stable complexes with Bax. We constrained Bax in its native cytosolic conformation within cells using intramolecular disulfide tethers. Bax tethers disrupt interaction with Bcl-x(L) in detergents and cell-free MOMP activity but unexpectedly induce Bax accumulation on mitochondria. Fluorescence loss in photobleaching (FLIP) reveals constant retrotranslocation of WT Bax, but not tethered Bax, from the mitochondria into the cytoplasm of healthy cells. Bax retrotranslocation depends on prosurvival Bcl-2 family proteins, and inhibition of retrotranslocation correlates with Bax accumulation on the mitochondria. We propose that Bcl-x(L) inhibits and maintains Bax in the cytosol by constant retrotranslocation of mitochondrial Bax.	[Edlich, Frank; Banerjee, Soojay; Cleland, Megan M.; Wang, Chunxin; Youle, Richard J.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Suzuki, Motoshi; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Neutzner, Albert] Univ Spital Basel, Augenklin, CH-4031 Basel, Switzerland; [Arnoult, Damien] Hop Paul Brousse, INSERM, U1014, F-94807 Villejuif, France	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Basel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Youle, RJ (corresponding author), NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	youle@helix.nih.gov	Arnoult, Damien/R-2032-2018; Neutzner, Albert/ABC-4368-2020; Wang, Chunxin/B-9312-2016	Wang, Chunxin/0000-0001-6015-6806; Neutzner, Albert/0000-0001-9254-5558; Suzuki, Motoshi/0000-0002-4346-7677; Harwig, Megan/0000-0003-2140-5739	Leopoldina, National Academy of Sciences, Germany; La Ligue contre le Cancer; NHLBI; NINDS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002859] Funding Source: NIH RePORTER	Leopoldina, National Academy of Sciences, Germany; La Ligue contre le Cancer(Ligue nationale contre le cancer); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. D. W. Andrews and Dr. J.-C. Martinou for helpful discussions and comments. We also thank Dr. D. R. Green for the Omi-mCherry construct. This work is supported by the Leopoldina, National Academy of Sciences, Germany (F. E.); La Ligue contre le Cancer (D. A.); the NHLBI (M. S. and N.T.); and the NINDS intramural programs.	Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Locker JK, 1999, J CELL BIOL, V144, P267, DOI 10.1083/jcb.144.2.267; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schouten A, 2002, J BIOL CHEM, V277, P19339, DOI 10.1074/jbc.M201245200; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang GQ, 2001, J BIOL CHEM, V276, P3610, DOI 10.1074/jbc.M006222200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	41	414	433	4	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					104	116		10.1016/j.cell.2011.02.034	http://dx.doi.org/10.1016/j.cell.2011.02.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458670	Green Accepted, Bronze			2022-12-01	WOS:000289053900013
J	Haber, DA; Gray, NS; Baselga, J				Haber, Daniel A.; Gray, Nathanael S.; Baselga, Jose			The Evolving War on Cancer	CELL			English	Article							CELL LUNG-CANCER; KINASE INHIBITORS; MUTATIONS; EGFR; GEFITINIB; IMATINIB; GENE; IDENTIFICATION; CHROMOSOME; RESISTANCE	Building on years of basic scientific discovery, recent advances in the fields of cancer genetics and medicinal chemistry are now converging to revolutionize the treatment of cancer. Starting with serendipitous observations in rare subsets of cancer, a paradigm shift in clinical research is poised to ensure that new molecular insights are rapidly applied to shape emerging cancer therapies. Could this mark a turning point in the "War on Cancer''?	[Haber, Daniel A.; Baselga, Jose] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Baselga J, 2010, SAN ANT BREAST CANC, pS3; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Cosimo S, 2010, ASCO M, V28, P3008; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Furman RR, 2010, ASCO MEET ABSTR, V28, P3032; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leaf C., 2004, FORTUNE MAGAZIN 0322; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Marsden BD, 2008, CURR OPIN CHEM BIOL, V12, P40, DOI 10.1016/j.cbpa.2008.01.042; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NOWELL PC, 1960, SCIENCE, V132, P1497; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; ODAY S, 2010, ASCO M, V28, P4; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	39	163	170	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					19	24		10.1016/j.cell.2011.03.026	http://dx.doi.org/10.1016/j.cell.2011.03.026			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458664	Bronze			2022-12-01	WOS:000289053900005
J	Lachke, SA; Alkuraya, FS; Kneeland, SC; Ohn, T; Aboukhalil, A; Howell, GR; Saadi, I; Cavallesco, R; Yue, YZ; Tsai, ACH; Nair, KS; Cosma, MI; Smith, RS; Hodges, E; AlFadhli, SM; Al-Hajeri, A; Shamseldin, HE; Behbehani, A; Hannon, GJ; Bulyk, ML; Drack, AV; Anderson, PJ; John, SWM; Maas, RL				Lachke, Salil A.; Alkuraya, Fowzan S.; Kneeland, Stephen C.; Ohn, Takbum; Aboukhalil, Anton; Howell, Gareth R.; Saadi, Irfan; Cavallesco, Resy; Yue, Yingzi; Tsai, Anne C-H.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; Hodges, Emily; AlFadhli, Suad M.; Al-Hajeri, Amal; Shamseldin, Hanan E.; Behbehani, AbdulMutalib; Hannon, Gregory J.; Bulyk, Martha L.; Drack, Arlene V.; Anderson, Paul J.; John, Simon W. M.; Maas, Richard L.			Mutations in the RNA Granule Component TDRD7 Cause Cataract and Glaucoma	SCIENCE			English	Article							CYTOPLASMIC PROCESSING BODIES; MAMMALIAN STRESS GRANULES; EUKARYOTIC MESSENGER-RNAS; MALE GERM-CELLS; P-BODIES; CHROMATOID BODY; TRANSLATION; PROTEINS; DECAY; LOCALIZATION	The precise transcriptional regulation of gene expression is essential for vertebrate development, but the role of posttranscriptional regulatory mechanisms is less clear. Cytoplasmic RNA granules (RGs) function in the posttranscriptional control of gene expression, but the extent of RG involvement in organogenesis is unknown. We describe two human cases of pediatric cataract with loss-of-function mutations in TDRD7 and demonstrate that Tdrd7 nullizygosity in mouse causes cataracts, as well as glaucoma and an arrest in spermatogenesis. TDRD7 is a Tudor domain RNA binding protein that is expressed in lens fiber cells in distinct TDRD7-RGs that interact with STAU1-ribonucleoproteins (RNPs). TDRD7 coimmunoprecipitates with specific lens messenger RNAs (mRNAs) and is required for the posttranscriptional control of mRNAs that are critical to normal lens development and to RG function. These findings demonstrate a role for RGs in vertebrate organogenesis.	[Kneeland, Stephen C.; Howell, Gareth R.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; John, Simon W. M.] Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Kneeland, Stephen C.; Howell, Gareth R.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Lachke, Salil A.; Alkuraya, Fowzan S.; Aboukhalil, Anton; Saadi, Irfan; Cavallesco, Resy; Yue, Yingzi; Bulyk, Martha L.; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Massachusetts Inst Technol Div Hlth Sci &, Boston, MA 02115 USA; [Alkuraya, Fowzan S.; Shamseldin, Hanan E.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia; [Ohn, Takbum; Anderson, Paul J.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Aboukhalil, Anton] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Tsai, Anne C-H.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Cosma, Mihai I.] Maine Med Ctr, Dept Med, Portland, ME 04102 USA; [Hodges, Emily; Hannon, Gregory J.] Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hodges, Emily; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [AlFadhli, Suad M.; Al-Hajeri, Amal] Kuwait Univ, Fac Allied Hlth Sci, Kuwait 13060, Kuwait; [Behbehani, AbdulMutalib] Kuwait Univ, Fac Med, Dept Surg, Alsafat 13110, Kuwait; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Drack, Arlene V.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [John, Simon W. M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Jackson Laboratory; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; King Faisal Specialist Hospital & Research Center; Alfaisal University; King Saud University; King Saud University; King Khalid University Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Maine Medical Center; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Kuwait University; Kuwait University; Harvard University; Brigham & Women's Hospital; University of Iowa; Tufts University	John, SWM (corresponding author), Howard Hughes Med Inst, 600 Main St, Bar Harbor, ME 04609 USA.	simon.john@jax.org; maas@genetics.med.harvard.edu	Alkuraya, Fowzan S./A-1542-2009; Saadi, Irfan/I-5989-2019; Hannon, Gregory/AAB-3568-2019	Alkuraya, Fowzan S./0000-0003-4158-341X; Saadi, Irfan/0000-0002-6250-6651; Lachke, Salil/0000-0001-8845-010X; Hodges, Emily/0000-0001-6513-610X; Drack, Arlene/0000-0002-8195-8426	Barbara and Joseph Cohen Foundation; Peace by Pieces Fund; Dubai Harvard Foundation for Medical Research; Kuwait University [YM01/09]; Foundation Fighting Blindness; American Heart Association;  [R01 EY10123];  [R01 HD060050];  [P01 GM061354];  [KACST 08-MED497-20];  [R01 EY11721]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060050] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010123, R01EY011721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	Barbara and Joseph Cohen Foundation; Peace by Pieces Fund; Dubai Harvard Foundation for Medical Research; Kuwait University; Foundation Fighting Blindness(European Commission); American Heart Association(American Heart Association); ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 EY10123, R01 HD060050, P01 GM061354, KACST 08-MED497-20, R01 EY11721, The Barbara and Joseph Cohen Foundation, The Peace by Pieces Fund, and the Dubai Harvard Foundation for Medical Research. S.M.A. is supported by a grant from Kuwait University (YM01/09). A.V.D. was supported by a Marjorie Carr Adams Career Development Award from the Foundation Fighting Blindness. A.A. is supported by an American Heart Association Predoctoral Fellowship. S.W.M.J. and G.J.H. are Investigators of the Howard Hughes Medical Institute. We thank C. Cepko for advice on the chick experiments, L. Reinholdt for assistance in assessing male sterility, A. Bell for technical assistance, J. Reddan and V. Reddy for their gifts of lens cell lines, and the patients and their families for participating in this research. All microarray data are deposited in the Gene Expression Omnibus database (www.ncbi.nih.gov/geo), and the accession number for the SuperSeries for all data files is GSE25812.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Alkuraya FS, 2010, GENET MED, V12, P236, DOI 10.1097/GIM.0b013e3181ceb95d; Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-13; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fu L, 2003, BIOCHEM BIOPH RES CO, V302, P710, DOI 10.1016/S0006-291X(03)00257-2; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Haque MSR, 1999, MOL VIS, V5, pU1; Harpavat S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-2; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008	37	132	138	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1571	1576		10.1126/science.1195970	http://dx.doi.org/10.1126/science.1195970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436445	Green Accepted			2022-12-01	WOS:000288754500046
J	Chen, P; Lin, JJ; Lu, CS; Ong, CT; Hsieh, PF; Yang, CC; Tai, CT; Wu, SL; Lu, CH; Hsu, YC; Yu, HY; Ro, LS; Lu, CT; Chu, CC; Tsai, JJ; Su, YH; Lan, SH; Sung, SF; Lin, SY; Chuang, HP; Huang, LC; Chen, YJ; Tsai, PJ; Liao, HT; Lin, YH; Chen, CH; Chung, WH; Hung, SI; Wu, JY; Chang, CF; Chen, L; Chen, YT; Shen, CY				Chen, Pei; Lin, Juei-Jueng; Lu, Chin-Song; Ong, Cheung-Ter; Hsieh, Peiyuan F.; Yang, Chih-Chao; Tai, Chih-Ta; Wu, Shey-Lin; Lu, Cheng-Hsien; Hsu, Yung-Chu; Yu, Hsiang-Yu; Ro, Long-Sun; Lu, Chung-Ta; Chu, Chun-Che; Tsai, Jing-Jane; Su, Yu-Hsiang; Lan, Sheng-Hsing; Sung, Sheng-Feng; Lin, Shu-Yi; Chuang, Hui-Ping; Huang, Li-Chen; Chen, Ying-Ju; Tsai, Pei-Joung; Liao, Hung-Ting; Lin, Yu-Hsuan; Chen, Chien-Hsiun; Chung, Wen-Hung; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chang, Chi-Feng; Chen, Luke; Chen, Yuan-Tsong; Shen, Chen-Yang		Taiwan SJS Consortium	Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEVENS-JOHNSON-SYNDROME; ADVERSE DRUG-REACTIONS; EPIDERMAL NECROLYSIS; ASSOCIATION; ALLELE; POPULATION; MARKER; DEATH	BACKGROUND Carbamazepine, an anticonvulsant and a mood-stabilizing drug, is the main cause of the Stevens-Johnson syndrome (SJS) and its related disease, toxic epidermal necrolysis (TEN), in Southeast Asian countries. Carbamazepine-induced SJS-TEN is strongly associated with the HLA B* 1502 allele. We sought to prevent carbamazepine- induced SJS-TEN by using HLA-B*1502 screening to prospectively identify subjects at genetic risk for the condition. METHODS From 23 hospitals in Taiwan, we recruited 4877 candidate subjects who had not taken carbamazepine. We genotyped DNA purified from the subjects' peripheral blood to determine whether they carried the HLA-B*1502 allele. Those testing positive for HLA-B*1502 (7.7% of the total) were advised not to take carbamazepine and were given an alternative medication or advised to continue taking their prestudy medication; those testing negative (92.3%) were advised to take carbamazepine. We interviewed the subjects by telephone once a week for 2 months to monitor them for symptoms. We used the estimated historical incidence of SJS-TEN as a control. RESULTS Mild, transient rash developed in 4.3% of subjects; more widespread rash developed in 0.1% of subjects, who were hospitalized. SJS-TEN did not develop in any of the HLA-B*1502-negative subjects receiving carbamazepine. In contrast, the estimated historical incidence of carbamazepine-induced SJS-TEN (0.23%) would translate into approximately 10 cases among study subjects (P<0.001). CONCLUSIONS The identification of subjects carrying the HLA-B* 1502 allele and the avoidance of carbamazepine therapy in these subjects was strongly associated with a decrease in the incidence of carbamazepine-induced SJS-TEN.	[Chen, Pei; Wu, Shey-Lin; Chuang, Hui-Ping; Huang, Li-Chen; Chen, Ying-Ju; Tsai, Pei-Joung; Liao, Hung-Ting; Lin, Yu-Hsuan; Chen, Chien-Hsiun; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chen, Yuan-Tsong; Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lin, Juei-Jueng] Chu Shang Show Chwan Hosp, Nantou, Taiwan; [Lu, Chin-Song; Ro, Long-Sun; Chu, Chun-Che] Chang Gung Mem Hosp Linkou, Dept Neurol, Kweishan, Taiwan; [Chung, Wen-Hung] Chang Gung Mem Hosp Linkou, Dept Dermatol, Kweishan, Taiwan; Chang Gung Univ, Coll Med, Kweishan, Taiwan; [Ong, Cheung-Ter; Hsu, Yung-Chu; Su, Yu-Hsiang; Sung, Sheng-Feng] Chia Yi Christian Hosp, Chiayi, Taiwan; [Hsieh, Peiyuan F.] Taichung Vet Gen Hosp, Taichung, Taiwan; [Hsieh, Peiyuan F.] Natl Chi Nan Univ, Nantou, Taiwan; [Yang, Chih-Chao] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Tai, Chih-Ta; Lan, Sheng-Hsing] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Tai, Chih-Ta; Lan, Sheng-Hsing] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Wu, Shey-Lin] Changhua Christian Hosp, Changhua, Taiwan; [Lu, Cheng-Hsien] Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Yu, Hsiang-Yu] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Yu, Hsiang-Yu] Natl Yang Ming Univ, Taipei 112, Taiwan; [Shen, Chen-Yang] China Med Univ, Coll Publ Hlth, Taichung, Taiwan; [Lu, Chung-Ta] China Med Univ, China Med Univ Hosp, Taichung, Taiwan; [Tsai, Jing-Jane] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taichung Veterans General Hospital; National Chi Nan University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Changhua Christian Hospital; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Duke University	Chen, P (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd, Taipei 115, Taiwan.	chen0010@ibms.sinica.edu.tw; bmcys@ibms.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Hung, Shuen-Iu/ABB-2139-2021; Shen, CY/F-6271-2010; Chen, Chien Hsiun/Q-3826-2018	Hung, Shuen-Iu/0000-0001-6531-5538; Chen, Pei-Jer/0000-0001-8316-3785; Huang, Ying-Zu/0000-0002-8666-4013; Yang, Chih-Chao/0000-0002-0352-3144; Yu, Hsiang-Yu/0000-0002-8183-1863	National Science Council of Taiwan; Taiwan Drug Relief Foundation; National Science Council, Taiwan; Academy-Industry Collaboration Program [NSC95-3112- B-001-023, NSC97-3112-B-001-007]; Taiwan Drug Relief Foundation [TDRF9707, TDRF9809]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Drug Relief Foundation; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academy-Industry Collaboration Program; Taiwan Drug Relief Foundation	Funded by the National Science Council of Taiwan and the Taiwan Drug Relief Foundation; Supported by grants from the National Research Program for Genomic Medicine, National Science Council, Taiwan (for the National Clinical Core and the National Genotyping Core) and from the Academy-Industry Collaboration Program (NSC95-3112- B-001-023 and NSC97-3112-B-001-007); and the Taiwan Drug Relief Foundation (TDRF9707 and TDRF9809).	Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Flockhart DA, 2009, CLIN PHARMACOL THER, V86, P109, DOI 10.1038/clpt.2009.39; Fritsch P O, 2000, Am J Clin Dermatol, V1, P349, DOI 10.2165/00128071-200001060-00003; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; Hung Shuen-Iu, 2005, Per Med, V2, P225, DOI 10.2217/17410541.2.3.225; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; JC R, 1994, NEW ENGL J MED, V331, P1272; Lim KS, 2008, NEUROL ASIA, V13, P15; Locharernkul C, 2009, EPILEPSIA, V50, P971, DOI 10.1111/j.1528-1167.2009.02138_2.x; Lonjou C, 2006, PHARMACOGENOMICS J, V6, P265, DOI 10.1038/sj.tpj.6500356; Man CBL, 2008, EPILEPSIA, V49, P941; Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mehta TY, 2009, INDIAN J DERMATOL VE, V75, P579, DOI 10.4103/0378-6323.57718; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Tassaneeyakul W, 2010, EPILEPSIA, V51, P926, DOI 10.1111/j.1528-1167.2010.02533.x; WEI CY, 2010, TAIW ACGA 2010 INT C; Yang CWO, 2007, J ALLERGY CLIN IMMUN, V120, P870, DOI 10.1016/j.jaci.2007.06.017	19	472	505	0	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1126	1133		10.1056/NEJMoa1009717	http://dx.doi.org/10.1056/NEJMoa1009717			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428768				2022-12-01	WOS:000288701100007
J	Sporn, MB				Sporn, Michael B.			PERSPECTIVE The big C - for Chemoprevention	NATURE			English	Editorial Material							TRIAL		Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA	Dartmouth College	Sporn, MB (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA.	michael.b.sporn@dartmouth.edu						Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Issa JPJ, 2011, CANCER PREV RES, V4, P6, DOI 10.1158/1940-6207.CAPR-10-0348; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; LaCroix AZ, 2010, JNCI-J NATL CANCER I, V102, P1706, DOI 10.1093/jnci/djq415; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Schmidt C, 2010, J NATL CANCER I, V102, P1690, DOI 10.1093/jnci/djq477; Sporn MB, 2006, NAT CLIN PRACT ONCOL, V3, P364, DOI 10.1038/ncponc0536; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047	10	31	32	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S10	S11		10.1038/471S10a	http://dx.doi.org/10.1038/471S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430710				2022-12-01	WOS:000288702200011
J	Behravesh, CB; Mody, RK; Jungk, J; Gaul, L; Redd, JT; Chen, S; Cosgrove, S; Hedican, E; Sweat, D; Chavez-Hauser, L; Snow, SL; Hanson, H; Nguyen, TA; Sodha, SV; Boore, AL; Russo, E; Mikoleit, M; Theobald, L; Gerner-Smidt, P; Hoekstra, RM; Angulo, FJ; Swerdlow, DL; Tauxe, RV; Griffin, PM; Williams, IT				Behravesh, Casey Barton; Mody, Rajal K.; Jungk, Jessica; Gaul, Linda; Redd, John T.; Chen, Sanny; Cosgrove, Shaun; Hedican, Erin; Sweat, David; Chavez-Hauser, Lina; Snow, Sandra L.; Hanson, Heather; Nguyen, Thai-An; Sodha, Samir V.; Boore, Amy L.; Russo, Elizabeth; Mikoleit, Matthew; Theobald, Lisa; Gerner-Smidt, Peter; Hoekstra, Robert M.; Angulo, Frederick J.; Swerdlow, David L.; Tauxe, Robert V.; Griffin, Patricia M.; Williams, Ian T.		Salmonella Saintpaul Outbreak Inve	2008 Outbreak of Salmonella Saintpaul Infections Associated with Raw Produce	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; FRESH PRODUCE; TOMATOES; ILLNESS; BURDEN	BACKGROUND Raw produce is an increasingly recognized vehicle for salmonellosis. We investigated a nationwide outbreak that occurred in the United States in 2008. METHODS We defined a case as diarrhea in a person with laboratory-confirmed infection with the outbreak strain of Salmonella enterica serotype Saintpaul. Epidemiologic, trace-back, and environmental studies were conducted. RESULTS Among the 1500 case subjects, 21% were hospitalized, and 2 died. In three case-control studies of cases not linked to restaurant clusters, illness was significantly associated with eating raw tomatoes (matched odds ratio, 5.6; 95% confidence interval [CI], 1.6 to 30.3); eating at a Mexican-style restaurant (matched odds ratio, 4.6; 95% CI, 2.1 to 8) and eating pico de gallo salsa (matched odds ratio, 4.0; 95% CI, 1.5 to 17.8), corn tortillas (matched odds ratio, 2.3; 95% CI, 1.2 to 5.0), or salsa (matched odds ratio, 2.1; 95% CI, 1.1 to 3.9); and having a raw jalape no pepper in the household (matched odds ratio, 2.9; 95% CI, 1.2 to 7.6). In nine analyses of clusters associated with restaurants or events, jalapeno peppers were implicated in all three clusters with implicated ingredients, and jalapeno or serrano peppers were an ingredient in an implicated item in the other three clusters. Raw tomatoes were an ingredient in an implicated item in three clusters. The outbreak strain was identified in jalapeno peppers collected in Texas and in agricultural water and serrano peppers on a Mexican farm. Tomato tracebacks did not converge on a source. CONCLUSIONS Although an epidemiologic association with raw tomatoes was identified early in this investigation, subsequent epidemiologic and microbiologic evidence implicated jalape o and serrano peppers. This outbreak highlights the importance of preventing raw-produce contamination.	[Behravesh, Casey Barton; Mody, Rajal K.; Nguyen, Thai-An; Sodha, Samir V.; Boore, Amy L.; Russo, Elizabeth; Mikoleit, Matthew; Theobald, Lisa; Gerner-Smidt, Peter; Hoekstra, Robert M.; Angulo, Frederick J.; Swerdlow, David L.; Tauxe, Robert V.; Griffin, Patricia M.; Williams, Ian T.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Mody, Rajal K.; Chen, Sanny; Boore, Amy L.; Russo, Elizabeth] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Jungk, Jessica] New Mexico Dept Hlth, Santa Fe, NM USA; [Gaul, Linda] Texas Dept State Hlth Serv, Austin, TX USA; [Chen, Sanny] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Redd, John T.] Indian Hlth Serv, Albuquerque, NM USA; [Cosgrove, Shaun] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Hedican, Erin] Minnesota Dept Hlth, St Paul, MN USA; [Sweat, David] N Carolina Div Publ Hlth, Raleigh, NC USA; [Chavez-Hauser, Lina] Missouri Dept Hlth & Senior Serv, Jefferson, AR USA; [Snow, Sandra L.] Arkansas Dept Hlth, Little Rock, AR 72205 USA; [Hanson, Heather] New York City Dept Hlth & Mental Hyg, New York, NY USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; New Mexico Department of Health; Texas Department of State Health Services; Arizona Department of Health Services; Colorado Department of Public Health & Environment; Minnesota Department of Health (MHD); New York City Department of Health & Mental Hygiene	Behravesh, CB (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd NE,MS A-38, Atlanta, GA 30333 USA.	cbartonbehravesh@cdc.gov	BARTON BEHRAVESH, Casey/HDL-8040-2022; alzahrani, saud hamed/C-2014-2012; Jungk, Jessica/A-9958-2015	BARTON BEHRAVESH, Casey/0000-0003-2270-5573; Jungk, Jessica/0000-0001-7087-7623; Biggerstaff, Matthew/0000-0001-5108-8311; Mikoleit, Matthew/0000-0002-4582-6733; Shanahan, Lisa/0000-0001-5048-9615; Ayers, Tracy/0000-0003-4140-3263; Hoekstra, Robert Michael/0000-0002-0340-8015				*C FOOD PROT, 2006, COUNC 3 ISS RES 3 00; *CDCP, 2008, SAL SURV ANN SUMM 20; Gallegos-Robles MA, 2008, J FOOD PROTECT, V71, P2217, DOI 10.4315/0362-028X-71.11.2217; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; Gutierrez-Cogco E, 2000, SALUD PUBLICA MEXICO, V42, P490; Hedberg CW, 1999, EPIDEMIOL INFECT, V122, P385, DOI 10.1017/S0950268899002393; Kirkland E, 2009, J FOOD PROTECT, V72, P1692, DOI 10.4315/0362-028X-72.8.1692; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Ma L, 2010, J FOOD PROTECT, V73, P434, DOI 10.4315/0362-028X-73.3.434; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; *WHO COLL CTR REF, 2007, ANT FORM SALM SER; 2010, MMWR MORB MORTAL WKL, V59, P418	16	108	112	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					918	927		10.1056/NEJMoa1005741	http://dx.doi.org/10.1056/NEJMoa1005741			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21345092				2022-12-01	WOS:000288170300008
J	Larschan, E; Bishop, EP; Kharchenko, PV; Core, LJ; Lis, JT; Park, PJ; Kuroda, MI				Larschan, Erica; Bishop, Eric P.; Kharchenko, Peter V.; Core, Leighton J.; Lis, John T.; Park, Peter J.; Kuroda, Mitzi I.			X chromosome dosage compensation via enhanced transcriptional elongation in Drosophila	NATURE			English	Article							MSL COMPLEX; H4-K16 ACETYLATION; ANALYSIS REVEALS; RNA-POLYMERASE; GENES; GENOME; MELANOGASTER; INITIATION; YEAST; MOF	The evolution of sex chromosomes has resulted innumerous species in which females inherit two X chromosomes but males have a single X, thus requiring dosage compensation. MSL (Male-specific lethal) complex increases transcription on the single X chromosome of Drosophila males to equalize expression of X-linked genes between the sexes(1). The biochemical mechanisms used for dosage compensation must function over a wide dynamic range of transcription levels and differential expression patterns. It has been proposed(2) that the MSL complex regulates transcriptional elongation to control dosage compensation, a model subsequently supported by mapping of the MSL complex and MSL-dependent histone 4 lysine 16 acetylation to the bodies of X-linked genes in males, with a bias towards 39 ends(3-7). However, experimental analysis of MSL function at the mechanistic level has been challenging owing to the small magnitude of the chromosome-wide effect and the lack of an in vitro system for biochemical analysis. Here we use global run-on sequencing (GRO-seq) 8 to examine the specific effect of the MSL complex on RNA Polymerase II (RNAP II) on a genome-wide level. Results indicate that the MSL complex enhances transcription by facilitating the progression of RNAP II across the bodies of active X-linked genes. Improving transcriptional output downstream of typical gene-specific controls may explain how dosage compensation can be imposed on the diverse set of genes along an entire chromosome.	[Larschan, Erica; Kuroda, Mitzi I.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Larschan, Erica; Kuroda, Mitzi I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Larschan, Erica] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Bishop, Eric P.; Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Bishop, Eric P.; Kharchenko, Peter V.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Bishop, Eric P.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Core, Leighton J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Boston University; Cornell University	Kuroda, MI (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	peter_park@harvard.edu; mkuroda@genetics.med.harvard.edu		Park, Peter/0000-0001-9378-960X	NIH [GM45744, GM082798, HG4845]; Medical Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045744, R01GM082798, R01GM045744] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. M. Winston, S. Buratowski, A. Alekseyenko, M. Gelbart, C. Wang and A. Gortchakov for comments on the manuscript, and are grateful to N. Gehlenborg for graphic design expertise. This work was supported by the following NIH grants: GM45744 (M.I.K.), GM082798 (P.J.P.) and HG4845 (J.T.L.). E.L. was supported by a Charles A. King Trust fellowship from the Medical Foundation.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; BELOTE JM, 1980, GENETICS, V96, P165; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Oh K, 2003, GENE DEV, V17, P1334, DOI 10.1101/gad.1082003; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	28	136	135	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					115	U139		10.1038/nature09757	http://dx.doi.org/10.1038/nature09757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368835	Green Accepted			2022-12-01	WOS:000287924100045
J	Spence, D				Spence, Des			From The Frontline Bad medicine: gynaecological examinations	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS					destwo@yahoo.co.uk						Chernesky MA, 2005, SEX TRANSM DIS, V32, P729, DOI 10.1097/01.olq.0000190057.61633.8d; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Fang JY, 2008, J PEDIATR ADOL GYNEC, V21, P355, DOI 10.1016/j.jpag.2008.03.010; Padilla LA, 2005, INT J GYNECOL OBSTET, V88, P84, DOI 10.1016/j.ijgo.2004.09.015; Simms I, 2003, SEX TRANSM INFECT, V79, P491, DOI 10.1136/sti.79.6.491	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2011	342								d1342	10.1136/bmj.d1342	http://dx.doi.org/10.1136/bmj.d1342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EO	21367841				2022-12-01	WOS:000288167900003
J	Lander, ES				Lander, Eric S.			GENOME-SEQUENCING ANNIVERSARY A Celebration of the Genome, Part IV	SCIENCE			English	Editorial Material									[Lander, Eric S.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Lander, Eric S.] MIT, Cambridge, MA 02139 USA; [Lander, Eric S.] Council Advisors Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02138 USA.								0	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1024	1024		10.1126/science.1204037	http://dx.doi.org/10.1126/science.1204037			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350161				2022-12-01	WOS:000287699000044
J	Ressler, KJ; Mercer, KB; Bradley, B; Jovanovic, T; Mahan, A; Kerley, K; Norrholm, SD; Kilaru, V; Smith, AK; Myers, AJ; Ramirez, M; Engel, A; Hammack, SE; Toufexis, D; Braas, KM; Binder, EB; May, V				Ressler, Kerry J.; Mercer, Kristina B.; Bradley, Bekh; Jovanovic, Tanja; Mahan, Amy; Kerley, Kimberly; Norrholm, Seth D.; Kilaru, Varun; Smith, Alicia K.; Myers, Amanda J.; Ramirez, Manuel; Engel, Anzhelika; Hammack, Sayamwong E.; Toufexis, Donna; Braas, Karen M.; Binder, Elisabeth B.; May, Victor			Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor	NATURE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION; BRAIN-DEVELOPMENT; STRIA TERMINALIS; GENE-EXPRESSION; FEAR INHIBITION; BED NUCLEUS; AMYGDALA; PTSD	Pituitary adenylate cyclase-activating polypeptide (PACAP) is known to broadly regulate the cellular stress response. In contrast, it is unclear if the PACAP-PAC1 receptor pathway has a role in human psychological stress responses, such as post-traumatic stress disorder (PTSD). Here we find, in heavily traumatized subjects, a sex-specific association of PACAP blood levels with fear physiology, PTSD diagnosis and symptoms in females. We examined 44 single nucleotide polymorphisms (SNPs) spanning the PACAP (encoded by ADCYAP1) and PAC1 (encoded by ADCYAP1R1) genes, demonstrating a sex-specific association with PTSD. A single SNP in a putative oestrogen response element within ADCYAP1R1, rs2267735, predicts PTSD diagnosis and symptoms in females only. This SNP also associates with fear discrimination and with ADCYAP1R1 messenger RNA expression in human brain. Methylation of ADCYAP1R1 in peripheral blood is also associated with PTSD. Complementing these human data, ADCYAP1R1 mRNA is induced with fear conditioning or oestrogen replacement in rodent models. These data suggest that perturbations in the PACAP-PAC1 pathway are involved in abnormal stress responses underlying PTSD. These sex-specific effects may occur via oestrogen regulation of ADCYAP1R1. PACAP levels and ADCYAP1R1 SNPs may serve as useful biomarkers to further our mechanistic understanding of PTSD.	[Ressler, Kerry J.; Mercer, Kristina B.; Kerley, Kimberly] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ressler, Kerry J.; Bradley, Bekh; Jovanovic, Tanja; Norrholm, Seth D.; Kilaru, Varun; Smith, Alicia K.; Binder, Elisabeth B.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Bradley, Bekh; Norrholm, Seth D.] Atlanta VA Med Ctr, Atlanta, GA 30033 USA; [Ressler, Kerry J.; Mahan, Amy; Toufexis, Donna] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Myers, Amanda J.; Ramirez, Manuel; Engel, Anzhelika] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Hammack, Sayamwong E.; Toufexis, Donna] Univ Vermont, Dept Psychol, Burlington, VT 05401 USA; [Braas, Karen M.; May, Victor] Univ Vermont, Coll Med, Dept Anat & Neurobiol, Burlington, VT 05401 USA; [Braas, Karen M.; May, Victor] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05401 USA; [Binder, Elisabeth B.] Max Planck Inst Psychiat, D-80804 Munich, Germany	Howard Hughes Medical Institute; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of Miami; University of Vermont; University of Vermont; University of Vermont; Max Planck Society	Ressler, KJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	kressle@emory.edu	Smith, Alicia/W-6809-2019; Binder, Elisabeth B/K-8905-2014; Norrholm, Seth/AAC-2464-2022; Ressler, Kerry J/N-8741-2018; Bradley, Bekh/H-8399-2012; Myers, Amanda J/B-1796-2010	Smith, Alicia/0000-0002-8537-5156; Ressler, Kerry J/0000-0002-5158-1103; Myers, Amanda J/0000-0002-3100-9396	NIH [MH071537, DA019624, HD27468]; Emory and Grady Memorial Hospital General Clinical Research Center; NIH National Centers for Research Resources [M01RR00039, P20RR16435]; American Foundation for Suicide Prevention; Burroughs Wellcome Fund; National Institute on Aging [AG034504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027468] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435, M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH071537, R01MH071537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory and Grady Memorial Hospital General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Centers for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Foundation for Suicide Prevention; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was primarily supported by NIH grant MH071537 (K.J.R.), as well as DA019624 (K.J.R.) and HD27468 (V. M.). Support was also received from Emory and Grady Memorial Hospital General Clinical Research Center, NIH National Centers for Research Resources (M01RR00039 and P20RR16435), the American Foundation for Suicide Prevention (B. B.) and the Burroughs Wellcome Fund (K.J.R.). RNA samples were run using the Oncogenomics Core Facility at University of Miami. A.J.M. is supported by The National Institute on Aging (AG034504). We thank J.F. Cubells, Y. Tang and K. Conneely for discussions. We thank the Grady Trauma Project, including C. F. Gillespie, A. Schwartz, A. Wingo, D. A. Gutman and T. Weiss for medical support; A. Graham, A. Brown, J. Phifer, D. Crain, A. Kamkwalala, J. Poole, D. Cross, N. Fani and A. Smith for clinical research support; and K. Schutz, E. Reiser and C. Fitzgerald for molecular/genetics technical support. Methylation chip assays were performed by the Emory University Biomarkers Service Center.	Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Bangasser DA, 2010, MOL PSYCHIATR, V15, P896, DOI 10.1038/mp.2010.66; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dejda A, 2008, J MOL NEUROSCI, V36, P26, DOI 10.1007/s12031-008-9087-1; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Ghzili H, 2008, FRONT NEUROENDOCRIN, V29, P128, DOI 10.1016/j.yfrne.2007.10.001; Gillespie CF, 2009, GEN HOSP PSYCHIAT, V31, P505, DOI 10.1016/j.genhosppsych.2009.05.003; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Girard BA, 2006, J NEUROCHEM, V99, P499, DOI 10.1111/j.1471-4159.2006.04112.x; Grillon C, 1998, AM J PSYCHIAT, V155, P812; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Hashimoto H, 2006, ANN NY ACAD SCI, V1070, P75, DOI 10.1196/annals.1317.038; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; LEDOUX JE, 1993, ANN NY ACAD SCI, V702, P149, DOI 10.1111/j.1749-6632.1993.tb17246.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCEWEN BS, 1992, HORM RES, V37, P1, DOI 10.1159/000182393; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Shansky RM, 2010, CEREB CORTEX, V20, P2560, DOI 10.1093/cercor/bhq003; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Walker DL, 1997, J NEUROSCI, V17, P9375; Walker DL, 2002, PSYCHOPHARMACOLOGY, V159, P304, DOI 10.1007/s002130100913; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	41	534	545	9	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					492	497		10.1038/nature09856	http://dx.doi.org/10.1038/nature09856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350482	Green Accepted			2022-12-01	WOS:000287652900033
J	Hellal, F; Hurtado, A; Ruschel, J; Flynn, KC; Laskowski, CJ; Umlauf, M; Kapitein, LC; Strikis, D; Lemmon, V; Bixby, J; Hoogenraad, CC; Bradke, F				Hellal, Farida; Hurtado, Andres; Ruschel, Joerg; Flynn, Kevin C.; Laskowski, Claudia J.; Umlauf, Martina; Kapitein, Lukas C.; Strikis, Dinara; Lemmon, Vance; Bixby, John; Hoogenraad, Casper C.; Bradke, Frank			Microtubule Stabilization Reduces Scarring and Causes Axon Regeneration After Spinal Cord Injury	SCIENCE			English	Article							TGF-BETA; FUNCTIONAL RECOVERY; GROWTH; PROLIFERATION; INHIBITION; ELEVATION; CAMP; CNS	Hypertrophic scarring and poor intrinsic axon growth capacity constitute major obstacles for spinal cord repair. These processes are tightly regulated by microtubule dynamics. Here, moderate microtubule stabilization decreased scar formation after spinal cord injury in rodents through various cellular mechanisms, including dampening of transforming growth factor-beta signaling. It prevented accumulation of chondroitin sulfate proteoglycans and rendered the lesion site permissive for axon regeneration of growth-competent sensory neurons. Microtubule stabilization also promoted growth of central nervous system axons of the Raphe-spinal tract and led to functional improvement. Thus, microtubule stabilization reduces fibrotic scarring and enhances the capacity of axons to grow.	[Hellal, Farida; Ruschel, Joerg; Flynn, Kevin C.; Laskowski, Claudia J.; Umlauf, Martina; Bradke, Frank] Max Planck Inst Neurobiol, Axonal Growth & Regenerat Grp, D-82152 Martinsried, Germany; [Hurtado, Andres] Johns Hopkins Univ, Hugo W Moser Res Inst Kennedy Krieger, Int Ctr Spinal Cord Injury, Dept Neurol, Baltimore, MD 21205 USA; [Kapitein, Lukas C.; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Kapitein, Lukas C.; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Strikis, Dinara; Lemmon, Vance; Bixby, John] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	Max Planck Society; Johns Hopkins University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; University of Miami	Bradke, F (corresponding author), Max Planck Inst Neurobiol, Axonal Growth & Regenerat Grp, Klopferspitz 18, D-82152 Martinsried, Germany.	fbradke@neuro.mpg.de	Hoogenraad, Casper/B-8866-2011; Hellal, Farida/E-8533-2013; Hellal, Farida/D-1834-2015; Hellal, Farida/AHC-2588-2022; Lemmon, Vance/A-7410-2010; Kapitein, Lukas C/J-4776-2016	Hoogenraad, Casper/0000-0002-2666-0758; Hellal, Farida/0000-0002-9344-1846; Hellal, Farida/0000-0002-9344-1846; Lemmon, Vance/0000-0003-3550-7576; Kapitein, Lukas C/0000-0001-9418-6739; Ruschel, Joerg/0000-0002-4782-9786; Bixby, John/0000-0003-1633-5318; Bradke, Frank/0000-0002-0345-3772	Max-Planck-Society; Deutsche Forschungsgemeinschaft; International Foundation for Paraplegia; Human Frontier Science Program; NIH; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMW)-TOP; European Science Foundation; NWO-VICI; Marie Curie Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Foundation for Paraplegia; Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMW)-TOP(Netherlands Organization for Health Research and Development); European Science Foundation(European Science Foundation (ESF)European Commission); NWO-VICI(Netherlands Organization for Scientific Research (NWO)); Marie Curie Fellowship(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Hill for the SMAD2-PAGFP plasmid; A. Ullrich for the HaCaT cells; Ariad Pharmaceuticals for FKBP/FRB plasmids and Rapalog; G. Morfini for technical advice; K. Dornmair, M. Hubener, R. Klein, D. Neukirchen, M. Stiess, S. Tahirovic, and H. Wekerle for critically reading the manuscript; and V. Ha, T. Irl, D. F. Wendell, and R. Zenke for technical assistance. This work was supported by the Max-Planck-Society, Deutsche Forschungsgemeinschaft, International Foundation for Paraplegia, and Human Frontier Science Program (F.B.); NIH (J.B.); Netherlands Organization for Scientific Research (NWO)-Veni (L.C.K.); Netherlands Organization for Health Research and Development (ZonMW)-TOP, European Science Foundation Young Investigator Award, and NWO-VICI (C.C.H.); and a Marie Curie Fellowship (K.C.F.). The Max-Planck-Society has filed a patent on the use of Taxol after spinal cord injury.	Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Dergham P, 2002, J NEUROSCI, V22, P6570; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Hurtado A, 2008, BRAIN, V131, P2596, DOI 10.1093/brain/awn206; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kapitein LC, 2010, BIOPHYS J, V99, P2143, DOI 10.1016/j.bpj.2010.07.055; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; MOSES HL, 1987, J CELL PHYSIOL, P1, DOI 10.1002/jcp.1041330403; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017	28	415	429	8	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					928	931		10.1126/science.1201148	http://dx.doi.org/10.1126/science.1201148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21273450	Green Accepted, Green Published			2022-12-01	WOS:000287455100062
J	Lim, C; Lee, J; Choi, C; Kilman, VL; Kim, J; Park, SM; Jang, SK; Allada, R; Choe, J				Lim, Chunghun; Lee, Jongbin; Choi, Changtaek; Kilman, Valerie L.; Kim, Juwon; Park, Sung Mi; Jang, Sung Key; Allada, Ravi; Choe, Joonho			The novel gene twenty-four defines a critical translational step in the Drosophila clock	NATURE			English	Article							MESSENGER-RNA TRANSLATION; CIRCADIAN-RHYTHMS; BINDING-PROTEIN; PERIOD PROTEIN; MOLECULAR OSCILLATIONS; EXPRESSION; NEURONS; SYSTEM; ABLATION; ORANGE	Daily oscillations of gene expression underlie circadian behaviours in multicellular organisms(1). While attention has been focused on transcriptional and post-translational mechanisms(1-3), other post-transcriptional modes have been less clearly delineated. Here we report mutants of a novel Drosophila gene twenty-four (tyf) that show weak behavioural rhythms. Weak rhythms are accompanied by marked reductions in the levels of the clock protein Period (PER) as well as more modest effects on Timeless (TIM). Nonetheless, PER induction in pacemaker neurons can rescue tyf mutant rhythms. TYF associates with a 5'-cap-binding complex, poly(A)-binding protein (PABP), as well as per and tim transcripts. Furthermore, TYF activates reporter expression when tethered to reporter messenger RNA even in vitro. Taken together, these data indicate that TYF potently activates PER translation in pacemaker neurons to sustain robust rhythms, revealing a new and important role for translational control in the Drosophila circadian clock.	[Lim, Chunghun; Kilman, Valerie L.; Allada, Ravi] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Lee, Jongbin; Choi, Changtaek; Kim, Juwon; Choe, Joonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Sung Mi; Jang, Sung Key] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	Northwestern University; Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH)	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu; jchoe@kaist.ac.kr	Lim, Chunghun/AAB-1253-2020; Choe, Joonho/F-3066-2011; Jang, Sung K/P-1230-2017	Lim, Chunghun/0000-0001-8473-9272; Lee, Jongbin/0000-0002-5868-7437	Ministry of Education, Science and Technology, the Republic of Korea; National Institutes of Health [R01NS059042, R01NS052903, R01MH067870]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059042, R01NS052903] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Edery, J. Hall, H. Keshishian, M. Rosbash, F. Rouyer, A. Sehgal, the Bloomington Drosophila stock center, Harvard Exelixis Drosophila stock collection, KAIST GenExel Drosophila library and the National Institute of Genetics for Drosophila strains; P. Hardin, E. Izaurralde, A. Nakamura, M. Rosbash and N. Sonenberg for antibodies; J. Lykke-Andersen for plasmids; K. E. Duncan for suggestions on in vitro translation assays. This work was supported by grants from the Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, the Republic of Korea (J.C.) and from the National Institutes of Health (R01NS059042, R01NS052903, R01MH067870; R.A.)	Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Castagnetti S, 2000, DEVELOPMENT, V127, P1063; Cheng YZ, 1998, MOL CELL BIOL, V18, P6505, DOI 10.1128/MCB.18.11.6505; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Keryer-Bibens C, 2008, BIOL CELL, V100, P125, DOI 10.1042/BC20070067; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Lim C, 2007, MOL CELL BIOL, V27, P4876, DOI 10.1128/MCB.02155-06; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Monzo K, 2006, P NATL ACAD SCI USA, V103, P18160, DOI 10.1073/pnas.0606508103; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roy G, 2004, MOL CELL BIOL, V24, P1143, DOI 10.1128/MCB.24.3.1143-1154.2004; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sofola O, 2008, J NEUROSCI, V28, P10200, DOI 10.1523/JNEUROSCI.2786-08.2008; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Suri V, 2000, J NEUROSCI, V20, P7547; Thoma Christian, 2004, Methods Mol Biol, V257, P171, DOI 10.1385/1-59259-750-5:171; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	51	63	64	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					399	U152		10.1038/nature09728	http://dx.doi.org/10.1038/nature09728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331043	Green Accepted			2022-12-01	WOS:000287409100043
J	Bock, C; Kiskinis, E; Verstappen, G; Gu, HC; Boulting, G; Smith, ZD; Ziller, M; Croft, GF; Amoroso, MW; Oakley, DH; Gnirke, A; Eggan, K; Meissner, A				Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Gu, Hongcang; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.; Gnirke, Andreas; Eggan, Kevin; Meissner, Alexander			Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines	CELL			English	Article							EMBRYONIC STEM-CELLS; METHYLATION; DIFFERENTIATION; DERIVATION; MOUSE; BIOINFORMATICS; GENERATION; BIOLOGY	The developmental potential of human pluripotent stem cells suggests that they can produce disease-relevant cell types for biomedical research. However, substantial variation has been reported among pluripotent cell lines, which could affect their utility and clinical safety. Such cell-line-specific differences must be better understood before one can confidently use embryonic stem (ES) or induced pluripotent stem (iPS) cells in translational research. Toward this goal we have established genome-wide reference maps of DNA methylation and gene expression for 20 previously derived human ES lines and 12 human iPS cell lines, and we have measured the in vitro differentiation propensity of these cell lines. This resource enabled us to assess the epigenetic and transcriptional similarity of ES and iPS cells and to predict the differentiation efficiency of individual cell lines. The combination of assays yields a scorecard for quick and comprehensive characterization of pluripotent cell lines.	[Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Eggan, Kevin; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bock, Christoph; Verstappen, Griet; Gu, Hongcang; Smith, Zachary D.; Ziller, Michael; Gnirke, Andreas; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Eggan, Kevin; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Kiskinis, Evangelos; Boulting, Gabriella; Eggan, Kevin] Howard Hughes Med Inst, Chevy Chase, MD USA; [Boulting, Gabriella] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Pathol, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Neurol, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Neurosci, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, CSCI, New York, NY 10032 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; Howard Hughes Medical Institute; Harvard University; Columbia University; Columbia University; Columbia University; Columbia University	Eggan, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu; alexander_meissner@harvard.edu	Eggan, Kevin/P-7119-2018; Oakley, Derek/ABA-4689-2020; Bock, Christoph/AAE-7618-2019	Oakley, Derek/0000-0002-6998-9510; Bock, Christoph/0000-0001-6091-3088; Mathis, Mackenzie/0000-0001-7368-4456; Boulting, Gabriella/0000-0003-2012-1259; Croft, Gist/0000-0002-9721-0148; Gu, Hongcang/0000-0002-1439-7606	Alexander von Humboldt Foundation; NIH Roadmap Initiative on Epigenomics [U01ES017155]; Massachusetts Life Science Center (MLSC); Pew Charitable Trusts; Harvard Research Computing team; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042191] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NIH Roadmap Initiative on Epigenomics; Massachusetts Life Science Center (MLSC); Pew Charitable Trusts; Harvard Research Computing team; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Christopher Henderson and Hynek Wichterle (Columbia University Motor Neuron Center, Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research) for sharing fibroblast and iPS cell lines prior to publication and for many helpful discussions. We would also like to thank Tarjei Mikkelsen, Eleni Tomazou, Chad Cowan, Leon Plastek, and Tim Ahfeldt for their involvement in early pilot experiments; Patrick Boyle for technical assistance; the Harvard Research Computing team for support and computation time on the Odyssey cluster; and the members of the Eggan and Meissner labs for their comments on the manuscript. Furthermore, we acknowledge the members of the Broad Institute's Genome Sequencing Platform, Genetic Analysis Platform, and Epigenomics Initiative, including Ido Amit, Fontina Kelley, Kathleen Tibbetts, Tim Fennell, Supriya Gupta, Andrew Crenshaw, Charles Epstein, and Brad Bernstein. C. B. is supported by a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation. E. K. is a fellow of the European Molecular Biology Organization. K. E. is an assistant investigator of the Stowers Medical Institute, a Howard Hughes Medical Institute early career scientist, and fellow of the MacArthur Foundation. The described work was funded by the NIH Roadmap Initiative on Epigenomics (U01ES017155), the Massachusetts Life Science Center (MLSC), and the Pew Charitable Trusts. A patent has been filed for the scorecard described in the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bock C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r14; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hastie T., 2001, ELEMENTS STAT LEARNI; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nistri A, 2006, J PHYSIOL-LONDON, V572, P323, DOI 10.1113/jphysiol.2005.100610; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tukey J.W., 1977, EXPLORATORY DATA ANA, P61, DOI 10.1007/978-0-387-32833-1_136; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	46	690	731	2	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					439	452		10.1016/j.cell.2010.12.032	http://dx.doi.org/10.1016/j.cell.2010.12.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295703	Bronze, Green Accepted			2022-12-01	WOS:000286973100015
J	Michard, E; Lima, PT; Borges, F; Silva, AC; Portes, MT; Carvalho, JE; Gilliham, M; Liu, LH; Obermeyer, G; Feijo, JA				Michard, Erwan; Lima, Pedro T.; Borges, Filipe; Silva, Ana Catarina; Portes, Maria Teresa; Carvalho, Joao E.; Gilliham, Matthew; Liu, Lai-Hua; Obermeyer, Gerhard; Feijo, Jose A.			Glutamate Receptor-Like Genes Form Ca2+ Channels in Pollen Tubes and Are Regulated by Pistil D-Serine	SCIENCE			English	Article							D-AMINO ACIDS; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; CALCIUM-CHANNELS; ROOT HAIRS; GROWTH; PLANTS; REVEALS; GLR3.3; CELLS	Elevations in cytosolic free calcium concentration ([Ca2+](cyt)) constitute a fundamental signal transduction mechanism in eukaryotic cells, but the molecular identity of Ca2+ channels initiating this signal in plants is still under debate. Here, we show by pharmacology and loss-of-function mutants that in tobacco and Arabidopsis, glutamate receptor-like channels (GLRs) facilitate Ca2+ influx across the plasma membrane, modulate apical [Ca2+] cyt gradient, and consequently affect pollen tube growth and morphogenesis. Additionally, wild-type pollen tubes grown in pistils of knock-out mutants for serine-racemase (SR1) displayed growth defects consistent with a decrease in GLR activity. Our findings reveal a novel plant signaling mechanism between male gametophyte and pistil tissue similar to amino acid-mediated communication commonly observed in animal nervous systems.	[Michard, Erwan; Lima, Pedro T.; Borges, Filipe; Silva, Ana Catarina; Portes, Maria Teresa; Carvalho, Joao E.; Feijo, Jose A.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Gilliham, Matthew] Univ Adelaide, Waite Res Inst, Glen Osmond, SA 5064, Australia; [Gilliham, Matthew] Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA 5064, Australia; [Liu, Lai-Hua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Beijing 100193, Peoples R China; [Obermeyer, Gerhard] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1749016 Lisbon, Portugal	Instituto Gulbenkian de Ciencia; University of Adelaide; University of Adelaide; China Agricultural University; Salzburg University; Universidade de Lisboa	Feijo, JA (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	jfeijo@fc.ul.pt	Gilliham, Matthew/C-1998-2013; Obermeyer, Gerhard/M-5942-2019; Feijo, Jose A./ADM-0262-2022; Obermeyer, Gerhard/G-4061-2013; Carvalho, João E/AAQ-1456-2020; Gilliham, Matthew/Y-4403-2019; Portes, Maria Teresa/AAC-1353-2019; michard, erwan/GXH-1685-2022	Gilliham, Matthew/0000-0003-0666-3078; Obermeyer, Gerhard/0000-0001-8102-6322; Feijo, Jose A./0000-0002-1100-5478; Obermeyer, Gerhard/0000-0001-8102-6322; Carvalho, João E/0000-0002-7770-4351; Gilliham, Matthew/0000-0003-0666-3078; Portes, Maria Teresa/0000-0001-5668-0605; Michard, Erwan/0000-0001-7997-3822; Borges, Filipe/0000-0002-7388-2118	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD 21056/2004]; European Molecular Biology Organization [ASTF 193-2007]; Agropolis fellowships; Centro de Biologia do Desenvolvimento [FCT U664]; FCT [BIA-BCM/108044/2008, QUI/64339/2006]; Austrian Science Fund [P21298]; China National Science Foundation [30771288]; Austrian Science Fund (FWF) [P 21298] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Agropolis fellowships; Centro de Biologia do Desenvolvimento; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); China National Science Foundation(National Natural Science Foundation of China (NSFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	E. M. acknowledges Fundacao para a Ciencia e a Tecnologia (SFRH/BPD 21056/2004), European Molecular Biology Organization (ASTF 193-2007), and Agropolis fellowships. We thank M. Watahiki (University of Hokkaido) for the YC3.1 construct and M. Iwano (Nara Institute of Science and Technology, Japan) for the YC3.6C Arabidopsis line. glr1.2-1 and glr3.7-1 insertion lines were originally characterized by P. Walch-Liu, X. Q. Qu, and Y. Y. Gong in L.-H. L.'s laboratory, in collaboration with M. Tester (University of Adelaide) and B. Forde (University of Lancaster). We thank N. Moreno and P. Almada for imaging support, A. Sommer for protoplast preparation, C. E. Tadokoro for immunofluorescence advice, J. Becker for helpful discussions on the genetic design of the experiments, P. Dias for help in oscillation analysis, and J. B. Thibaud (Institut National de la Recherche Agronomique-Supagro, Montpellier) for other institutional support to E. M. J.A.F.' s laboratory is supported by the Centro de Biologia do Desenvolvimento (FCT U664) and FCT grants BIA-BCM/108044/2008 and QUI/64339/2006. G.O.'s laboratory is supported by Austrian Science Fund grant P21298. L.-H. L. was supported by China National Science Foundation grant 30771288.	Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; BOAVIDA LC, 2011, PLANT PHYSL; Bruckner H, 2003, AMINO ACIDS, V24, P43, DOI 10.1007/s00726-002-0322-8; Davenport R, 2002, ANN BOT-LONDON, V90, P549, DOI 10.1093/aob/mcf228; Demidchik V, 2004, PLANTA, V219, P167, DOI 10.1007/s00425-004-1207-8; Dennison KL, 2000, PLANT PHYSIOL, V124, P1511, DOI 10.1104/pp.124.4.1511; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dubos C, 2003, PLANT J, V35, P800, DOI 10.1046/j.1365-313X.2003.01849.x; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Feijo Jose A., 2010, Journal of Biology (London), V9, P18, DOI 10.1186/jbiol233; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Fujitani Y, 2006, PHYTOCHEMISTRY, V67, P668, DOI 10.1016/j.phytochem.2006.01.003; Iwano M, 2009, PLANT PHYSIOL, V150, P1322, DOI 10.1104/pp.109.139329; MALHO R, 1995, PLANT CELL, V7, P1173, DOI 10.1105/tpc.7.8.1173; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Meyerhoff O, 2005, PLANTA, V222, P418, DOI 10.1007/s00425-005-1551-3; Michard E, 2008, SEX PLANT REPROD, V21, P169, DOI 10.1007/s00497-008-0076-x; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; Miedema H, 2008, NEW PHYTOL, V179, P378, DOI 10.1111/j.1469-8137.2008.02465.x; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Moreno N., 2007, Rhythms in plants: phenomenology, mechanisms, and adaptive significance, P39, DOI 10.1007/978-3-540-68071-0_2; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Prado AM, 2008, MOL PLANT, V1, P703, DOI 10.1093/mp/ssn034; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Qu HY, 2007, NEW PHYTOL, V174, P524, DOI 10.1111/j.1469-8137.2007.02069.x; ROBINSON T, 1976, LIFE SCI, V19, P1097, DOI 10.1016/0024-3205(76)90244-7; Roy SJ, 2008, PLANT CELL ENVIRON, V31, P861, DOI 10.1111/j.1365-3040.2008.01801.x; Shang ZL, 2005, PLANT CELL PHYSIOL, V46, P598, DOI 10.1093/pcp/pci063; Stephens NR, 2008, PLANT PHYSIOL, V146, P529, DOI 10.1104/pp.107.108134; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wu JY, 2010, PLANT J, V63, P1042, DOI 10.1111/j.1365-313X.2010.04301.x	35	279	300	7	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					434	437		10.1126/science.1201101	http://dx.doi.org/10.1126/science.1201101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21415319				2022-12-01	WOS:000289784900034
J	Savage, N				Savage, Neil			EARLY DETECTION Spotting the first signs	NATURE			English	Editorial Material																		Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Wax A, 2011, GASTROENTEROLOGY, V141, P443, DOI 10.1053/j.gastro.2011.06.020; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007	4	26	27	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S14	S15		10.1038/471S14a	http://dx.doi.org/10.1038/471S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430712				2022-12-01	WOS:000288702200013
J	Wirgin, I; Roy, NK; Loftus, M; Chambers, RC; Franks, DG; Hahn, ME				Wirgin, Isaac; Roy, Nirmal K.; Loftus, Matthew; Chambers, R. Christopher; Franks, Diana G.; Hahn, Mark E.			Mechanistic Basis of Resistance to PCBs in Atlantic Tomcod from the Hudson River	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; FISH FUNDULUS-HETEROCLITUS; DIOXIN SENSITIVITY; MICROGADUS-TOMCOD; INDUCTION; CYTOCHROME-P4501A; POPULATIONS; KILLIFISH; AHR2	The mechanistic basis of resistance of vertebrate populations to contaminants, including Atlantic tomcod from the Hudson River (HR) to polychlorinated biphenyls (PCBs), is unknown. HR tomcod exhibited variants in the aryl hydrocarbon receptor 2 (AHR2) that were nearly absent elsewhere. In ligand-binding assays, AHR2-1 protein (common in the HR) was impaired as compared to widespread AHR2-2 in binding TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) and in driving expression in reporter gene assays in AHR-deficient cells treated with TCDD or PCB126. We identified a six-base deletion in AHR2 as the basis of resistance and suggest that the HR population has undergone rapid evolution, probably due to contaminant exposure. This mechanistic basis of resistance in a vertebrate population provides evidence of evolutionary change due to selective pressure at a single locus.	[Wirgin, Isaac; Roy, Nirmal K.; Loftus, Matthew] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Franks, Diana G.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Chambers, R. Christopher] NOAA, Howard Marine Sci Lab, NE Fisheries Sci Ctr, Fisheries Serv, Highlands, NJ 07732 USA	New York University; Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA	Wirgin, I (corresponding author), NYU, Dept Environm Med, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	Isaac.wirgin@nyumc.org	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082	Hudson River Foundation; Northeast Fisheries Science Center;  [R01ES015447];  [P42ES007381];  [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES015447, P42ES007381, P42ES010344] Funding Source: NIH RePORTER	Hudson River Foundation; Northeast Fisheries Science Center; ; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge support of R01ES015447, P42ES007381, ES00260, the Hudson River Foundation, and the Northeast Fisheries Science Center. We thank M. Mattson, K. Sullivan, D. Danila, S. Courtenay, C. Burnett, L. Upchurch, P. Roy, S. Karchner, and A. Nadas for assistance. Accession nos. FJ215751 to FJ215756.	Able KW., 1998, 1 YEAR LIFE ESTUARIN; Fernandez MP, 2004, ENVIRON SCI TECHNOL, V38, P976, DOI 10.1021/es034177f; Hahn ME, 2004, PHARMACOGENETICS, V14, P131, DOI 10.1097/00008571-200402000-00007; Hahn ME, 1997, P NATL ACAD SCI USA, V94, P13743, DOI 10.1073/pnas.94.25.13743; Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Ma Q, 2001, CURR DRUG METAB, V2, P149, DOI 10.2174/1389200013338603; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Nacci D, 2005, MECH PCB DIOXIN RESI; Nacci DE, 2010, ESTUAR COAST, V33, P853, DOI 10.1007/s12237-009-9257-6; POLAND A, 1994, MOL PHARMACOL, V46, P915; Powell WH, 2000, TOXICOL SCI, V57, P229, DOI 10.1093/toxsci/57.2.229; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; van Straalen N. M., 2000, DEMOGRAPHY ECOTOXICO, P147; Van Veld Peter A., 2008, P597, DOI 10.1201/9780203647295.ch13; WIRGIN I, 2004, MUTAT RES, V55, P1897; WIRGIN II, 1992, MAR ENVIRON RES, V34, P103, DOI 10.1016/0141-1136(92)90091-Y; Wirgin I, 2006, AM FISH S S, V51, P331; Yuan ZP, 2006, AQUAT TOXICOL, V76, P306, DOI 10.1016/j.aquatox.2005.10.006; Yuan ZP, 2006, ENVIRON HEALTH PERSP, V114, P77, DOI 10.1289/ehp.8255	21	146	152	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1322	1325		10.1126/science.1197296	http://dx.doi.org/10.1126/science.1197296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21330491	Green Accepted			2022-12-01	WOS:000288215200046
J	Nabel, GJ; Wei, CJ; Ledgerwood, JE				Nabel, Gary J.; Wei, Chih-Jen; Ledgerwood, Julie E.			Vaccinate for the next H2N2 pandemic now	NATURE			English	Editorial Material							INFLUENZA-VIRUSES		[Nabel, Gary J.; Wei, Chih-Jen; Ledgerwood, Julie E.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Nabel, GJ (corresponding author), NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wei, Chih/GVT-5734-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005047] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen GL, 2010, J VIROL, V84, P7695, DOI 10.1128/JVI.00511-10; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Kaverin NV, 2000, ARCH VIROL, V145, P1059, DOI 10.1007/s007050070109; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Stohr K, 2010, NATURE, V465, P161, DOI 10.1038/465161a; Webster Robert G., 1997, Journal of Infectious Diseases, V176, pS14, DOI 10.1086/514168; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	10	53	55	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					157	158		10.1038/471157a	http://dx.doi.org/10.1038/471157a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FK	21390107				2022-12-01	WOS:000288170200013
J	Pasqualucci, L; Dominguez-Sola, D; Chiarenza, A; Fabbri, G; Grunn, A; Trifonov, V; Kasper, LH; Lerach, S; Tang, HY; Ma, J; Rossi, D; Chadburn, A; Murty, VV; Mullighan, CG; Gaidano, G; Rabadan, R; Brindle, PK; Dalla-Favera, R				Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Trifonov, Vladimir; Kasper, Lawryn H.; Lerach, Stephanie; Tang, Hongyan; Ma, Jing; Rossi, Davide; Chadburn, Amy; Murty, Vundavalli V.; Mullighan, Charles G.; Gaidano, Gianluca; Rabadan, Raul; Brindle, Paul K.; Dalla-Favera, Riccardo			Inactivating mutations of acetyltransferase genes in B-cell lymphoma	NATURE			English	Article							CREB-BINDING-PROTEIN; ACUTE MYELOID-LEUKEMIA; CYCLE ARREST; CBP; P300; P53; TRANSCRIPTION; COACTIVATOR; ACETYLATION; HEMATOPOIESIS	B-cell non-Hodgkin's lymphoma comprises biologically and clinically distinct diseases the pathogenesis of which is associated with genetic lesions affecting oncogenes and tumour-suppressor genes. We report here that the two most common types-follicular lymphoma and diffuse large B-cell lymphoma-harbour frequent structural alterations inactivating CREBBP and, more rarely, EP300, two highly related histone and non-histone acetyltransferases (HATs) that act as transcriptional co-activators in multiple signalling pathways. Overall, about 39% of diffuse large B-cell lymphoma and 41% of follicular lymphoma cases display genomic deletions and/or somatic mutations that remove or inactivate the HAT coding domain of these two genes. These lesions usually affect one allele, suggesting that reduction in HAT dosage is important for lymphomagenesis. We demonstrate specific defects in acetylation-mediated inactivation of the BCL6 oncoprotein and activation of the p53 tumour suppressor. These results identify CREBBP/EP300 mutations as a major pathogenetic mechanism shared by common forms of B-cell non-Hodgkin's lymphoma, with direct implications for the use of drugs targeting acetylation/deacetylation mechanisms.	[Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Tang, Hongyan; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Tang, Hongyan; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Pasqualucci, Laura; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Kasper, Lawryn H.; Lerach, Stephanie; Brindle, Paul K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Clin & Expt Med, I-28100 Novara, Italy; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, IRCAD, I-28100 Novara, Italy; [Chadburn, Amy] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Northwestern University; Feinberg School of Medicine; St Jude Children's Research Hospital; Columbia University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	lp171@columbia.edu; rd10@columbia.edu	Kasper, Lawryn/GWV-5700-2022; Rabadan, Raul/AAZ-7367-2020; Mullighan, Charles/H-3253-2011; Chiarenza, Annalisa/AAC-2013-2019; Gaidano, Gianluca/AAW-2773-2021	Mullighan, Charles/0000-0002-1871-1850; Chiarenza, Annalisa/0000-0002-8759-4854; Gaidano, Gianluca/0000-0002-4681-0151; Dominguez-Sola, David/0000-0001-9569-8402; Rabadan, Raul/0000-0001-7946-9255; Brindle, Paul/0000-0001-7172-8478	NIH [PO1-CA092625, RO1-CA37295, DE018183]; Leukemia and Lymphoma Society; Cancer Center (CORE) [P30 CA021765]; American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; Northeast Biodefence Center [U54-AI057158]; National Library of Medicine [1R01LM010140-01]; AIRC [10007]; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA092625, R37CA037295, R01CA037295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018183] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Center (CORE); American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Northeast Biodefence Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Q. Shen and the Molecular Pathology Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University for histology service; W. Gu for discussions and reagents; Y. Tang, M. Li and D. Chao for suggestions; V. Bardwell for the Bcl6 reporter construct; and R. S. K. Chaganti for sharing unpublished information. Whole-exome capture and sequencing were conducted at Roche NimbleGen and 454 Life Sciences. Automated DNA sequencing was performed at Genewiz Inc. This work was supported by NIH grants PO1-CA092625 and RO1-CA37295 (to R.D.-F.), a Specialized Center of Research grant from the Leukemia and Lymphoma Society (to R.D.-F.), NIH grant DE018183, a Cancer Center (CORE) support grant P30 CA021765, and the American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital (to P.K.B.), the Northeast Biodefence Center (U54-AI057158) and the National Library of Medicine(1R01LM010140-01) (to R.R.), and the AIRC Special Program Molecular Clinical Oncology-5 per mille (contract number 10007, Milan) (to G.G.). A. Chiarenza is on leave from the Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy. L.P. is on leave from the University of Perugia Medical School, Perugia, Italy.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bieber T, 2001, BIOTECHNIQUES, V30, P74, DOI 10.2144/01301st03; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Downing JR, 2009, NEW ENGL J MED, V361, P1111, DOI 10.1056/NEJMe0906090; Garbati MR, 2010, CANCER LETT, V291, P237, DOI 10.1016/j.canlet.2009.10.018; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Huynh KD, 2000, GENE DEV, V14, P1810; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kung AL, 2000, GENE DEV, V14, P272; Kuninger D, 2007, J BIOTECHNOL, V131, P253, DOI 10.1016/j.jbiotec.2007.07.498; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oike Y, 1999, BLOOD, V93, P2771; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Roelfsema Jeroen H., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000415; Rowley JD, 1997, BLOOD, V90, P535; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Shigeno K, 2004, CANCER LETT, V213, P11, DOI 10.1016/S0304-3835(03)00442-7; Sobulo OM, 1997, P NATL ACAD SCI USA, V94, P8732, DOI 10.1073/pnas.94.16.8732; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; Swerdlow SH, 2016, WHO CLASSIFICATION T, V4th; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Ward R, 2005, J MED GENET, V42, P514, DOI 10.1136/jmg.2004.025080; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	49	630	657	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					189	U75		10.1038/nature09730	http://dx.doi.org/10.1038/nature09730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390126	Green Published, Green Accepted			2022-12-01	WOS:000288170200031
J	Nuesch, E; Dieppe, P; Reichenbach, S; Williams, S; Iff, S; Juni, P				Nueesch, Eveline; Dieppe, Paul; Reichenbach, Stephan; Williams, Susan; Iff, Samuel; Jueni, Peter			All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; MULTIPLE IMPUTATION; REPLACEMENT SURGERY; ASSOCIATION; PAIN; PREVALENCE; DISABILITY; INFLAMMATION; REQUIREMENT	Objective To examine all cause and disease specific mortality in patients with osteoarthritis of the knee or hip. Design Population based cohort study. Setting General practices in the southwest of England. Participants 1163 patients aged 35 years or over with symptoms and radiological confirmation of osteoarthritis of the knee or hip. Main outcome measures Age and sex standardised mortality ratios and multivariable hazard ratios of death after a median of 14 years' follow-up. Results Patients with osteoarthritis had excess all cause mortality compared with the general population (standardised mortality ratio 1.55, 95% confidence interval 1.41 to 1.70). Excess mortality was observed for all disease specific causes of death but was particularly pronounced for cardiovascular (standardised mortality ratio 1.71, 1.49 to 1.98) and dementia associated mortality (1.99, 1.22 to 3.25). Mortality increased with increasing age (P for trend <0.001), male sex (adjusted hazard ratio 1.59, 1.30 to 1.96), self reported history of diabetes (1.95, 1.31 to 2.90), cancer (2.28, 1.50 to 3.47), cardiovascular disease (1.38, 1.12 to 1.71), and walking disability (1.48, 1.17 to 1.86). However, little evidence existed for increased mortality associated with previous joint replacement, obesity, depression, chronic inflammatory disease, eye disease, or presence of pain at baseline. The more severe the walking disability, the higher was the risk of death (P for trend <0.001). Conclusion Patients with osteoarthritis are at higher risk of death compared with the general population. History of diabetes, cancer, or cardiovascular disease and the presence of walking disability are major risk factors. Management of patients with osteoarthritis and walking disability should focus on effective treatment of cardiovascular risk factors and comorbidities, as well as on increasing physical activity.	[Nueesch, Eveline; Reichenbach, Stephan; Iff, Samuel; Jueni, Peter] Univ Bern, ISPM, CH-3012 Bern, Switzerland; [Nueesch, Eveline; Iff, Samuel; Jueni, Peter] Univ Hosp Bern, CTU Bern, CH-3010 Bern, Switzerland; [Dieppe, Paul] Univ Exeter, Peninsula Med Sch, Inst Clin Educ, Exeter EX4 4QJ, Devon, England; [Dieppe, Paul] Univ Plymouth, Peninsula Med Sch, Inst Clin Educ, Plymouth PL4 8AA, Devon, England; [Reichenbach, Stephan] Univ Hosp Bern, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland; [Williams, Susan] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Bern; University of Bern; University Hospital of Bern; University of Exeter; University of Plymouth; University of Bern; University Hospital of Bern; University of Bristol	Juni, P (corresponding author), Univ Bern, ISPM, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016; Iff, Samuel/AAJ-4998-2020; Hug, Balthasar L./G-1568-2010	Juni, Peter/0000-0002-5985-0670; Iff, Samuel/0000-0002-4441-5465; Reichenbach, Stephan/0000-0001-8098-6567	Department of Health; South and West NHS Research and Development Directorate; Swiss National Science Foundation [3233-066377, 3200-066378]; Arthritis Research UK	Department of Health; South and West NHS Research and Development Directorate; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Arthritis Research UK(Versus Arthritis)	The Somerset and Avon Survey of Health was originally funded by the Department of Health and the South and West NHS Research and Development Directorate. This work was funded by the Swiss National Science Foundation (grant numbers 3233-066377 and 3200-066378) and by Arthritis Research UK. The funding bodies had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Bellocco R, 2010, EUR J EPIDEMIOL, V25, P777, DOI 10.1007/s10654-010-9497-6; CERHAN JR, 1995, AM J EPIDEMIOL, V141, P225, DOI 10.1093/oxfordjournals.aje.a117424; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Cisternas MG, 2009, ARTHRIT RHEUM-ARTHR, V61, P1694, DOI 10.1002/art.24897; Couzin-Frankel J, 2010, SCIENCE, V330, P1621, DOI 10.1126/science.330.6011.1621; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Frankel S, 1999, LANCET, V353, P1304, DOI 10.1016/S0140-6736(98)06451-4; Fransen M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004376.PUB2; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Haara MM, 2004, J BONE JOINT SURG AM, V86A, P1452, DOI 10.2106/00004623-200407000-00013; Haara MM, 2003, ANN RHEUM DIS, V62, P151, DOI 10.1136/ard.62.2.151; Hernandez-Molina G, 2008, ARTHRIT RHEUM-ARTHR, V59, P1221, DOI 10.1002/art.24010; Hochber MC, 2008, CLIN EXP RHEUMATOL, V26, pS120; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P366, DOI 10.5271/sjweh.2914; Jenkinson CM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3170; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Juni P, 2010, OSTEOARTHR CARTILAGE, V18, P640, DOI 10.1016/j.joca.2009.12.010; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Juni P, 2003, RHEUMATOLOGY, V42, P516, DOI 10.1093/rheumatology/keg196; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kumar N, 2007, J RHEUMATOL, V34, P1695; Landi F, 2010, J CLIN EPIDEMIOL, V63, P752, DOI 10.1016/j.jclinepi.2009.09.007; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lawrence RC, 1990, HLTH STATUS WELL BEI, P136; MCALINDON TE, 1992, BRIT J RHEUMATOL, V31, P189; MONSON RR, 1976, J CHRON DIS, V29, P459, DOI 10.1016/0021-9681(76)90086-2; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Myasoedova Elena, 2010, Curr Rheumatol Rep, V12, P379, DOI 10.1007/s11926-010-0117-y; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Reichenbach S, 2011, ANN RHEUM DIS, V70, P293, DOI 10.1136/ard.2010.132985; Robertsson O, 2007, J BONE JOINT SURG BR, V89B, P599, DOI 10.1302/0301-620X.89B5.18355; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Snow MH, 2005, CURR OPIN RHEUMATOL, V17, P234; Stannus O, 2010, OSTEOARTHR CARTILAGE, V18, P1441, DOI 10.1016/j.joca.2010.08.016; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Wagner P, 2011, EUR J CANC      0110; Watson DJ, 2003, J RHEUMATOL, V30, P1196; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	45	423	429	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d1165	10.1136/bmj.d1165	http://dx.doi.org/10.1136/bmj.d1165			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385807	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-01	WOS:000288446800005
J	Pape, KA; Taylor, JJ; Maul, RW; Gearhart, PJ; Jenkins, MK				Pape, Kathryn A.; Taylor, Justin J.; Maul, Robert W.; Gearhart, Patricia J.; Jenkins, Marc K.			Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response	SCIENCE			English	Article							INDUCED CYTIDINE DEAMINASE; SUBSETS; RECOMBINATION; HYPERMUTATION; EXPRESSION; ANTIGENS; AID	Memory B cells formed in response to microbial antigens provide immunity to later infections; however, the inability to detect rare endogenous antigen-specific cells limits current understanding of this process. Using an antigen-based technique to enrich these cells, we found that immunization with a model protein generated B memory cells that expressed isotype-switched immunoglobulins (swIg) or retained IgM. The more numerous IgM(+) cells were longer lived than the swIg(+) cells. However, swIg(+) memory cells dominated the secondary response because of the capacity to become activated in the presence of neutralizing serum immunoglobulin. Thus, we propose that memory relies on swIg(+) cells until they disappear and serum immunoglobulin falls to a low level, in which case memory resides with durable IgM(+) reserves.	[Pape, Kathryn A.; Taylor, Justin J.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; [Maul, Robert W.; Gearhart, Patricia J.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Maul, Robert W./Y-6818-2019; Jenkins, Marc K/G-1063-2012; Gearhart, Patricia/Y-7227-2019	Jenkins, Marc K/0000-0001-8009-7655; Maul, Robert/0000-0002-6958-8514	NIH [R01 AI036914, R37 AI027998, F32 AI091033, T32 CA009138]; NIH, National Institute on Aging; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI091033, R37AI027998, R01AI039614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000732] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Walter and R. Speier for expert technical assistance and all members of the Jenkins lab for helpful discussions. This work was supported by grants from the NIH (R01 AI036914 and R37 AI027998 to M.K.J., F32 AI091033 and T32 CA009138 to J.T.), and the Intramural Research Program of the NIH, National Institute on Aging (R.W.M. and P.J.G.).	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Bell J, 2003, J EXP MED, V197, P1233, DOI 10.1084/jem.20020270; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Freund J, 1937, P SOC EXP BIOL MED, V37, P509; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; Le TVL, 2008, J IMMUNOL, V181, P6027, DOI 10.4049/jimmunol.181.9.6027; Liu JY, 1999, J BIOL CHEM, V274, P16945, DOI 10.1074/jbc.274.24.16945; Mackay F, 2006, SEMIN IMMUNOL, V18, P261, DOI 10.1016/j.smim.2006.07.003; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Newman J, 2003, J IMMUNOL METHODS, V272, P177, DOI 10.1016/S0022-1759(02)00499-4; Ravetch JV, 1997, CURR OPIN IMMUNOL, V9, P121, DOI 10.1016/S0952-7915(97)80168-9; Ridderstad A, 1998, J IMMUNOL, V160, P4688; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	26	370	377	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1203	1207		10.1126/science.1201730	http://dx.doi.org/10.1126/science.1201730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21310965	Green Accepted			2022-12-01	WOS:000287971200045
J	van Breugel, M; Hirono, M; Andreeva, A; Yanagisawa, H; Yamaguchi, S; Nakazawa, Y; Morgner, N; Petrovich, M; Ebong, IO; Robinson, CV; Johnson, CM; Veprintsev, D; Zuber, B				van Breugel, Mark; Hirono, Masafumi; Andreeva, Antonina; Yanagisawa, Haru-aki; Yamaguchi, Shoko; Nakazawa, Yuki; Morgner, Nina; Petrovich, Miriana; Ebong, Ima-Obong; Robinson, Carol V.; Johnson, Christopher M.; Veprintsev, Dmitry; Zuber, Benoit			Structures of SAS-6 Suggest Its Organization in Centrioles	SCIENCE			English	Article							CRYSTAL-STRUCTURE; BASAL BODY; CENTROSOME DUPLICATION; 9-FOLD SYMMETRY; PROTEIN; PROCENTRIOLE; CARTWHEEL; CHLAMYDOMONAS; BIOGENESIS; MECHANISMS	Centrioles are cylindrical, ninefold symmetrical structures with peripheral triplet microtubules strictly required to template cilia and flagella. The highly conserved protein SAS-6 constitutes the center of the cartwheel assembly that scaffolds centrioles early in their biogenesis. We determined the x-ray structure of the amino-terminal domain of SAS-6 from zebrafish, and we show that recombinant SAS-6 self-associates in vitro into assemblies that resemble cartwheel centers. Point mutations are consistent with the notion that centriole formation in vivo depends on the interactions that define the self-assemblies observed here. Thus, these interactions are probably essential to the structural organization of cartwheel centers.	[van Breugel, Mark; Andreeva, Antonina; Petrovich, Miriana; Johnson, Christopher M.; Veprintsev, Dmitry; Zuber, Benoit] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Hirono, Masafumi; Yanagisawa, Haru-aki; Yamaguchi, Shoko; Nakazawa, Yuki] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan; [Morgner, Nina; Ebong, Ima-Obong; Robinson, Carol V.] Univ Oxford, Chem Res Lab, Oxford, England	MRC Laboratory Molecular Biology; University of Tokyo; University of Oxford	van Breugel, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	vanbreug@mrc-lmb.cam.ac.uk	HIRONO, MASAFUMI/G-4948-2014; Morgner, Nina/O-7021-2018; Zuber, Benoît/U-1952-2019; Morgner, Nina/I-7975-2012; Hirono, Masafumi/G-5140-2013; Veprintsev, Dmitry B/H-2228-2012	HIRONO, MASAFUMI/0000-0002-2497-4227; Morgner, Nina/0000-0002-1872-490X; Zuber, Benoît/0000-0001-7725-5579; Hirono, Masafumi/0000-0002-2497-4227; Veprintsev, Dmitry B/0000-0002-3583-5409; Andreeva, Antonina/0000-0002-0450-0091; Yanagisawa, Haruaki/0000-0003-0313-2343; robinson, carol/0000-0001-7829-5505	MRC; Ministry of Education, Culture, Science and Technology of Japan [21370088]; European Molecular Biology Organization; MRC [MC_U105184294, MC_U105192716] Funding Source: UKRI; Medical Research Council [MC_U105184294, MC_U105192716] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23657046] Funding Source: KAKEN	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The structure factors and coordinates of D. rerio N-SAS-6<SUP>1-156</SUP> and D. rerio N-SAS-6<SUP>1-179</SUP> F131D have been deposited at the Protein Data Bank Europe under wwPDB ID codes 2y3v and 2y3w. We gratefully acknowledge P. Evans (MRC-LMB, Cambridge, UK) for his modeling of SAS-6 ring assemblies and our beamline support team, M. Nanao at ID29 and H. Belrhali at BM14UK at the European Synchrotron Radiation Facility (Grenoble, France). We thank L. Rey (MRC-LMB) for the kind gift of U2OS cells and S. Munro (MRC-LMB) for the kind gift of a construct expressing the red fluorescent protein (RFP)-tagged C-terminal PACT domain of pericentrin. This work was supported by a MRC Career Development Fellowship (to M.v.B.); Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Science and Technology of Japan (21370088) (to M.H.); and a European Molecular Biology Organization long-term fellowship (to B.Z.). Material will be provided to academic and not-for-profit research organizations under the MRC's standard academic Material Transfer Agreement. The UltraSpin software will be provided by MRC under an academic license.	ALLEN RD, 1969, J CELL BIOL, V40, P716, DOI 10.1083/jcb.40.3.716; ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; CAVALIER.T, 1974, J CELL SCI, V16, P529; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Gillingham AK, 2000, EMBO REP, V1, P524; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Jerka-Dziadosz M, 2010, CYTOSKELETON, V67, P161, DOI 10.1002/cm.20433; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Yabe T, 2007, DEV BIOL, V312, P44, DOI 10.1016/j.ydbio.2007.08.054	34	219	223	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1196	1199		10.1126/science.1199325	http://dx.doi.org/10.1126/science.1199325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21273447				2022-12-01	WOS:000287971200043
J	Ruan, YJ				Ruan, Yijun			Presenting the Human Genome: Now in 3D!	SCIENCE			English	Editorial Material									Genome Inst Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ruan, YJ (corresponding author), Genome Inst Singapore, Singapore, Singapore.								0	1	3	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1025	1026		10.1126/science.1203602	http://dx.doi.org/10.1126/science.1203602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350163				2022-12-01	WOS:000287699000047
J	Lipska, KJ; Ross, JS				Lipska, Kasia J.; Ross, Joseph S.			Switching From Rosiglitazone Thinking Outside the Class	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TYPE-2 DIABETES-MELLITUS		[Lipska, Kasia J.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06520 USA	Yale University; Yale University	Lipska, KJ (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, 333 Cedar St,SHM IE-60, New Haven, CT 06520 USA.	kasia.lipska@yale.edu		Ross, Joseph/0000-0002-9218-3320	NIA NIH HHS [K08 AG032886] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Cohen A, 2010, DIABETES CARE, V33, P823, DOI 10.2337/dc09-1834; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; Erdmann E, 2010, J DIABETES, V2, P212, DOI 10.1111/j.1753-0407.2010.00082.x; McEvoy B, 2010, PIOGLITAZONE ROSIGLI; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; US Department of Health and Human Services Food and Drug Administration, 2008, GUID IND DIAB MELL E; WILSON D, ACTOS ADS JUMP AVAND	10	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					820	821		10.1001/jama.2011.193	http://dx.doi.org/10.1001/jama.2011.193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21304068				2022-12-01	WOS:000287594300026
J	Williams, SE; Beronja, S; Pasolli, HA; Fuchs, E				Williams, Scott E.; Beronja, Slobodan; Pasolli, H. Amalia; Fuchs, Elaine			Asymmetric cell divisions promote Notch-dependent epidermal differentiation	NATURE			English	Article							REGULATES SPINDLE ORIENTATION; STEM-CELLS; PLANAR DIVISIONS; DROSOPHILA; PROTEIN; NUMA; LGN; POLARITY; FATE; PINS	Stem and progenitor cells use asymmetric cell divisions to balance proliferation and differentiation. Evidence from invertebrates shows that this process is regulated by proteins asymmetrically distributed at the cell cortex during mitosis: Par3-Par6-aPKC, which confer polarity, and G alpha(i)-LGN/AGS3-NuMA-dynein/dynactin, which govern spindle positioning. Here we focus on developing mouse skin, where progenitor cells execute a switch from symmetric to predominantly asymmetric divisions concomitant with stratification. Using in vivo skin-specific lentiviral RNA interference, we investigate spindle orientation regulation and provide direct evidence that LGN (also called Gpsm2), NuMA and dynactin (Dctn1) are involved. In compromising asymmetric cell divisions, we uncover profound defects in stratification, differentiation and barrier formation, and implicate Notch signalling as an important effector. Our study demonstrates the efficacy of applying RNA interference in vivo to mammalian systems, and the ease of uncovering complex genetic interactions, here to gain insights into how changes in spindle orientation are coupled to establishing proper tissue architecture during skin development.	[Williams, Scott E.; Beronja, Slobodan; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Williams, Scott/0000-0001-9975-7334; Beronja, Slobodan/0000-0002-6769-9261; Pasolli, Hilda Amalia/0000-0003-3899-3530	National Institutes of Health [R01AR27883]; American Cancer Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883, R01AR050452, R01AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank N. Stokes, L. Polak and D. Oristian for their assistance in the mouse facility; S. Lanier and T. Gettys for providing AGS3 and G alpha<INF>i</INF> antibodies; N. Gaiano and C. Cepko for constructs; D. Melton and T. Honjo for mice; S. Chai for Numb constructs; E. Ezhkova for sharing microarray data; and J. Knoblich for sharing unpublished results and reagents. We are grateful to M. Schober, D. Devenport, E. Ezratty, C. Luxenburg and members of the Fuchs laboratory for discussions and critical reading of the manuscript. We thank S. Mazel and the RU Flow Cytometry Resource Center for assistance with cell sorting, A. North and the RU Bioimaging Resource Center for assistance with image acquisition and the Comparative Biology Center (AAALAC accredited) for veterinary care of our mice. S.E.W. was supported by an American Cancer Society postdoctoral fellowship and S.B. was a Human Frontier Science Program postdoctoral fellow. E.F. is an investigator in the Howard Hughes Medical Institute. Work in the Fuchs laboratory was supported by a grant from the National Institutes of Health (E.F. R01AR27883).	Adams RJ, 1996, J NEUROSCI, V16, P7610; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	49	310	316	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					353	358		10.1038/nature09793	http://dx.doi.org/10.1038/nature09793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331036	Green Accepted			2022-12-01	WOS:000287409100033
J	Ding, ZH; Wu, CJ; Chu, GC; Xiao, YH; Ho, D; Zhang, JF; Perry, SR; Labrot, ES; Wu, XQ; Lis, R; Hoshida, Y; Hiller, D; Hu, BL; Jiang, S; Zheng, HW; Stegh, AH; Scott, KL; Signoretti, S; Bardeesy, N; Wang, YA; Hill, DE; Golub, TR; Stampfer, MJ; Wong, WH; Loda, M; Mucci, L; Chin, L; DePinho, RA				Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Zhang, Jingfang; Perry, Samuel R.; Labrot, Emma S.; Wu, Xiaoqiu; Lis, Rosina; Hoshida, Yujin; Hiller, David; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Signoretti, Sabina; Bardeesy, Nabeel; Wang, Y. Alan; Hill, David E.; Golub, Todd R.; Stampfer, Meir J.; Wong, Wing H.; Loda, Massimo; Mucci, Lorelei; Chin, Lynda; DePinho, Ronald A.			SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression	NATURE			English	Article							TGF-BETA; EXPRESSION; PTEN; SMAD4; INACTIVATION; OSTEOPONTIN; PROMOTER; ROLES; MODEL; LEADS	Effective clinical management of prostate cancer (PCA) has been challenged by significant intratumoural heterogeneity on the genomic and pathological levels and limited understanding of the genetic elements governing disease progression(1). Here, we exploited the experimental merits of the mouse to test the hypothesis that pathways constraining progression might be activated in indolent Pten-null mouse prostate tumours and that inactivation of such progression barriers in mice would engender a metastasis-prone condition. Comparative transcriptomic and canonical pathway analyses, followed by biochemical confirmation, of normal prostate epithelium versus poorly progressive Pten-null prostate cancers revealed robust activation of the TGF beta/BMP-SMAD4 signalling axis. The functional relevance of SMAD4 was further supported by emergence of invasive, metastatic and lethal prostate cancers with 100% penetrance upon genetic deletion of Smad4 in the Pten-null mouse prostate. Pathological and molecular analysis as well as transcriptomic knowledge-based pathway profiling of emerging tumours identified cell proliferation and invasion as two cardinal tumour biological features in the metastatic Smad4/Pten-null PCA model. Follow-on pathological and functional assessment confirmed cyclin D1 and SPP1 as key mediators of these biological processes, which together with PTEN and SMAD4, form a four-gene signature that is prognostic of prostate-specific antigen (PSA) biochemical recurrence and lethal metastasis in human PCA. This model-informed progression analysis, together with genetic, functional and translational studies, establishes SMAD4 as a key regulator of PCA progression in mice and humans.	[Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Perry, Samuel R.; Labrot, Emma S.; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Perry, Samuel R.; Labrot, Emma S.; Wu, Xiaoqiu; Lis, Rosina; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Wang, Y. Alan; Loda, Massimo; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Ho, Dennis; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Hill, David E.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Ho, Dennis; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Chu, Gerald C.; Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zhang, Jingfang] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Wu, Xiaoqiu; Lis, Rosina; Loda, Massimo] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Hoshida, Yujin; Golub, Todd R.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Hoshida, Yujin; Golub, Todd R.] Harvard Univ, Cambridge, MA 02142 USA; [Hiller, David; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Signoretti, Sabina] Dana Farber Harvard Canc Ctr, Renal Canc Program, Boston, MA 02115 USA; [Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA; [Hill, David E.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Chin, Lynda] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Stampfer, Meir J.; Mucci, Lorelei] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Stampfer, Meir J.; Mucci, Lorelei] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu; ron_depinho@dfci.harvard.edu	Hill, David E/B-6617-2011; Hoshida, Yujin/R-7513-2019	Zheng, Hongwu/0000-0002-5823-4913; DePinho, Ronald/0000-0002-5625-577X	Damon Runyon Cancer Research Foundation; National Science Foundation; Helen Hay Whitney Foundation; Multiple Myeloma Research Foundation; Belfer Institute for Applied Cancer Science (NCI) [U01-CA84313]; DF/HCC SPORE in Prostate Cancer [P50 CA090381-08]; National Cancer Institute [RO1CA131945, P50 CA90381, RO1 5R01CA136578, R01CA141298]; Linda and Arthur Gelb Center for Translational Research; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA131945, R01CA141298, P50CA090381, R01CA136578, U01CA084313] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; Multiple Myeloma Research Foundation; Belfer Institute for Applied Cancer Science (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DF/HCC SPORE in Prostate Cancer; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Linda and Arthur Gelb Center for Translational Research; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to the late W. Gerald for providing the primary gene expression data and clinical outcome files<SUP>13</SUP>. We thank S. Zhou for excellent mouse husbandry and care, B. Xiong and G. Tonon for bioinformatic assistance, and S. Jia, J. M. Stommel, J. Paik, M. Kim and A. C. Kimmelman for helpful discussion. We thank M. Vidal, the Ellison Foundation and DFCI ISR for support of ORF cloning efforts, R. Maser for MSCV-puro-v5 gateway vector, W. Hahn for shRNA constructs. We thank the DF/HCC Specialized Histopathology Core and the DF/HCC Tissue Microarray and Imaging core for the TMA IHC staining; the DFCI/BWH Center for Molecular Oncologic Pathology (CMOP) for the quantification of the IHC. Z.D was supported by the Damon Runyon Cancer Research Foundation. D. H. was supported by a graduate fellowship from the National Science Foundation. H.Z. was supported by the Helen Hay Whitney Foundation. Y.A.W. was supported by the Multiple Myeloma Research Foundation. This work is supported by the Belfer Institute for Applied Cancer Science, NCI U01-CA84313 (L. C. and R. A. D.), DF/HCC SPORE in Prostate Cancer P50 CA090381-08 (Z.D.), the National Cancer Institute (M. L. RO1CA131945 and P50 CA90381, L. M. RO1 5R01CA136578, M. S. R01CA141298), and the Linda and Arthur Gelb Center for Translational Research (M. L.). R. A. D. was supported by an American Cancer Society Research Professorship and L. M. was supported by the Prostate Cancer Foundation.	Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hullinger TG, 2001, EXP CELL RES, V262, P69, DOI 10.1006/excr.2000.5074; Jeet V, 2010, CANCER METAST REV, V29, P123, DOI 10.1007/s10555-010-9212-9; JEMAL A, 2010, CA CANC J CLIN; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Marino S, 2000, GENE DEV, V14, P994; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Packer L, 2006, CARCINOGENESIS, V27, P1778, DOI 10.1093/carcin/bgl016; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Rubin MA, 2008, MODERN PATHOL, V21, pS44, DOI 10.1038/modpathol.2008.11; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Shi XM, 2001, J BIOL CHEM, V276, P850, DOI 10.1074/jbc.M005955200; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Walsh PC, 2007, NEW ENGL J MED, V357, P2696, DOI 10.1056/NEJMcp0706784; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang YZ, 2001, CANCER RES, V61, P6064; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zeng L, 2004, HUM PATHOL, V35, P290, DOI 10.1016/j.humpath.2003.11.001; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	33	371	387	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					269	+		10.1038/nature09677	http://dx.doi.org/10.1038/nature09677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21289624	Green Accepted			2022-12-01	WOS:000287144200046
J	Shapiro, ND; Rauniyar, V; Hamilton, GL; Wu, J; Toste, FD				Shapiro, Nathan D.; Rauniyar, Vivek; Hamilton, Gregory L.; Wu, Jeffrey; Toste, F. Dean			Asymmetric additions to dienes catalysed by a dithiophosphoric acid	NATURE			English	Article							O,O-DIETHYLDITHIOPHOSPHORIC ACID; PHOSPHORIC-ACID; HYDROAMINATION; ALKENES	Chiral Bronsted acids (proton donors) have been shown to facilitate a broad range of asymmetric chemical transformations under catalytic conditions without requiring additional toxic or expensive metals(1-8). Although the catalysts developed thus far are remarkably effective at activating polarized functional groups, it is not clear whether organic Bronsted acids can be used to catalyse highly enantioselective transformations of unactivated carbon-carbon multiple bonds. This deficiency persists despite the fact that racemic acid-catalysed 'Markovnikov' additions to alkenes are well known chemical transformations. Here we show that chiral dithiophosphoric acids can catalyse the intramolecular hydroamination and hydroarylation of dienes and allenes to generate heterocyclic products in exceptional yield and enantiomeric excess. We present a mechanistic hypothesis that involves the addition of the acid catalyst to the diene, followed by nucleophilic displacement of the resulting dithiophosphate intermediate; we also report mass spectroscopic and deuterium labelling studies in support of the proposed mechanism. The catalysts and concepts revealed in this study should prove applicable to other asymmetric functionalizations of unsaturated systems.	[Shapiro, Nathan D.; Rauniyar, Vivek; Hamilton, Gregory L.; Wu, Jeffrey; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019	Toste, F. Dean/0000-0001-8018-2198	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NIHGMS [R01 GM074774]; Natural Sciences and Engineering Research Council of Canada (NSERC); Bristol-Myers/Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074774] Funding Source: NIH RePORTER	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bristol-Myers/Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Benitez and E. Tkatchouk (Goddard Group, California Institute of Technology) for performing DFT calculations, to U. Anderson and T. Iavarone of the QB3/Chemistry Mass Spectrometry Facility, and to A. DiPasquale of the X-ray Crystallography Facility. We acknowledge funding from the Director, Office of Science of the US Department of Energy (contract no. DE-AC02-05CH11231) and from NIHGMS (R01 GM074774). V. R. is grateful for a Natural Sciences and Engineering Research Council of Canada (NSERC) postdoctoral fellowship. G. L. H. is grateful for a Bristol-Myers/Squibb graduate fellowship.	Ackermann L, 2008, SYNLETT, P995, DOI 10.1055/s-2008-1072505; Aillaud I, 2007, DALTON T, P5105, DOI 10.1039/b711126f; Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Borrmann T, 1996, LIEBIGS ANN, P1593; Cheng XC, 2008, BIOORGAN MED CHEM, V16, P7932, DOI 10.1016/j.bmc.2008.07.073; Cheon CH, 2008, J AM CHEM SOC, V130, P9246, DOI 10.1021/ja8041542; Garcia-Garcia P, 2009, ANGEW CHEM INT EDIT, V48, P4363, DOI 10.1002/anie.200901768; Hatano M, 2008, J AM CHEM SOC, V130, P16858, DOI 10.1021/ja806875c; HOUK KN, 1983, J MOL STRUC-THEOCHEM, V12, P197, DOI 10.1016/0166-1280(83)85020-9; Hultzsch KC, 2005, ORG BIOMOL CHEM, V3, P1819, DOI 10.1039/b418521h; Hultzsch KC, 2005, ADV SYNTH CATAL, V347, P367, DOI 10.1002/adsc.200404261; KABACHNIK MI, 1960, TETRAHEDRON, V9, P10, DOI 10.1016/0040-4020(60)80048-8; Leavitt CM, 2008, INORG CHEM, V47, P3056, DOI 10.1021/ic7020897; Li ZG, 2006, ORG LETT, V8, P4175, DOI 10.1021/ol0610035; Liu C, 2007, ORG LETT, V9, P1935, DOI 10.1021/ol070483c; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; MASTRYUKOVA TA, 1971, ZH OBSHCH KHIM+, V41, P1938; MEBAH JMN, 1992, PHOSPHORUS SULFUR, V73, P49, DOI 10.1080/10426509208034430; MUELLER WH, 1966, J ORG CHEM, V31, P1894, DOI 10.1021/jo01344a051; Mutel V., 2005, European patent, Patent No. [1,299 383, 1299383]; Nakashima D, 2006, J AM CHEM SOC, V128, P9626, DOI 10.1021/ja062508t; NORMAN GR, 1952, J AM CHEM SOC, V74, P161, DOI 10.1021/ja01121a040; OBUSHAK ND, 1987, ZH OBSHCH KHIM+, V57, P1078; Pousse G, 2009, TETRAHEDRON, V65, P10617, DOI 10.1016/j.tet.2009.10.068; Roesky PW, 2003, ANGEW CHEM INT EDIT, V42, P2708, DOI 10.1002/anie.200301637; Rosenfeld DC, 2006, ORG LETT, V8, P4179, DOI 10.1021/ol061174+; Schlummer B, 2002, ORG LETT, V4, P1471, DOI 10.1021/ol025659j; Terada M, 2008, CHEM COMMUN, P4097, DOI 10.1039/b807577h; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533	30	150	150	2	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					245	+		10.1038/nature09723	http://dx.doi.org/10.1038/nature09723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	718RQ	21307938	Green Accepted, Green Submitted			2022-12-01	WOS:000287144200041
J	Xian, Y; Holloway, RG; Noyes, K; Shah, MN; Friedman, B				Xian, Ying; Holloway, Robert G.; Noyes, Katia; Shah, Manish N.; Friedman, Bruce			Racial Differences in Mortality Among Patients With Acute Ischemic Stroke An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							COMORBIDITY ADJUSTMENT; TREATMENT INTENSITY; HOSPITAL MORTALITY; CARE; END; DISPARITIES; POPULATION; ADMISSION; SURVIVAL; OUTCOMES	Background: Black patients are commonly believed to have higher stroke mortality. However, several recent studies have reported better survival in black patients with stroke. Objective: To examine racial differences in stroke mortality and explore potential reasons for these differences. Design: Observational cohort study. Setting: 164 hospitals in New York. Participants: 5319 black and 18 340 white patients aged 18 years or older who were hospitalized with acute ischemic stroke between January 2005 and December 2006. Measurements: Influence of race on mortality, examined by using propensity score analysis. Secondary outcomes were selected aspects of end-of-life treatment, use of tissue plasminogen activator, hospital spending, and length of stay. Patients were followed for mortality for 1 year after admission. Results: Overall in-hospital mortality was lower for black patients than for white patients (5.0% vs. 7.4%; P < 0.001), as was all-cause mortality at 30 days (6.1% vs. 11.4%; P < 0.001) and 1 year (16.5% vs. 24.4%; P < 0.001). After propensity score adjustment, black race was independently associated with lower inhospital mortality (odds ratio [OR], 0.77 [95% CI, 0.61 to 0.98]) and all-cause mortality up to 1 year (OR, 0.86 [CI, 0.77 to 0.96]). The adjusted hazard ratio was 0.87 (CI, 0.79 to 0.96). After adjustment for the probability of dying in the hospital, black patients with stroke were more likely to receive life-sustaining interventions (OR, 1.22 [CI, 1.09 to 1.38]) but less likely to be discharged to hospice (OR, 0.25 [CI, 0.14 to 0.46]). Limitations: The study used hospital administrative data that lacked a stroke severity measure. The study design precluded determination of causality. Conclusion: Among patients with acute ischemic stroke, black patients had lower mortality than white patients. This could be the result of differences in receipt of life-sustaining interventions and end-of-life care.	[Holloway, Robert G.] Univ Rochester, Dept Neurol, Sch Med & Dent, Rochester, NY 14642 USA; Duke Clin Res Inst, Durham, NC USA	University of Rochester; Duke University	Holloway, RG (corresponding author), Univ Rochester, Dept Neurol, Sch Med & Dent, 601 Elmwood Ave,Box 673, Rochester, NY 14642 USA.	Robert_Holloway@URMC.Rochester.edu	Xian, Ying/O-1956-2019	Xian, Ying/0000-0002-1237-1162; Shah, Manish/0000-0001-6331-1074	American Heart Association [0815772D]; National Center for Research Resources; National Institutes of Health (NIH) and the NIH Roadmap for Medical Research [1 UL1 RR024160-01]; Paul B. Beeson Career Development Award [NIA 1K23AG028942]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028942] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH) and the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul B. Beeson Career Development Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By an American Heart Association Founders Affiliate Predoctoral Fellowship Award (0815772D) (Dr. Xian); the National Center for Research Resources, a component of the National Institutes of Health (NIH) and the NIH Roadmap for Medical Research (1 UL1 RR024160-01) (Drs. Holloway and Noyes); and a Paul B. Beeson Career Development Award (NIA 1K23AG028942) (Dr. Shah).	Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Dupreez AE, 2008, J PALLIAT MED, V11, P1249, DOI 10.1089/jpm.2008.0124; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ellis C, 2009, ETHNIC DIS, V19, P161; Epstein RM, 2010, HEALTH AFFAIR, V29, P1489, DOI 10.1377/hlthaff.2009.0888; Feng WW, 2009, STROKE, V40, P3096, DOI 10.1161/STROKEAHA.109.554535; Gillum RF, 1996, NEW ENGL J MED, V335, P1597, DOI 10.1056/NEJM199611213352110; Gillum RF, 1999, STROKE, V30, P1711, DOI 10.1161/01.STR.30.8.1711; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Gorelick PB, 1998, STROKE, V29, P2656, DOI 10.1161/01.STR.29.12.2656; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Holloway RG, 2007, JAMA-J AM MED ASSOC, V298, P802, DOI 10.1001/jama.298.7.802; Holloway RG, 2010, J PALLIAT MED, V13, P407, DOI 10.1089/jpm.2009.0278; Iezzoni LI, 1996, MED DECIS MAKING, V16, P348, DOI 10.1177/0272989X9601600405; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Johnston SC, 2001, STROKE, V32, P1061, DOI 10.1161/01.STR.32.5.1061; Jones MR, 2000, STROKE, V31, P563, DOI 10.1161/01.STR.31.3.563; Kelly A, 2008, STROKE, V39, P3367, DOI 10.1161/STROKEAHA.108.518738; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; Kleindorfer D, 2006, STROKE, V37, P2473, DOI 10.1161/01.STR.0000242766.65550.92; KUHLEMEIER KV, 1994, STROKE, V25, P2126, DOI 10.1161/01.STR.25.11.2126; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Loggers ET, 2009, J CLIN ONCOL, V27, P5559, DOI 10.1200/JCO.2009.22.4733; OBRIEN LA, 1995, JAMA-J AM MED ASSOC, V274, P1775, DOI 10.1001/jama.274.22.1775; Pathak EB, 2009, NEUROEPIDEMIOLOGY, V32, P302, DOI 10.1159/000208795; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Polsky D, 2007, MED CARE, V45, P1083, DOI 10.1097/MLR.0b013e3180ca960e; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; Schwamm LH, 2010, CIRCULATION, V121, P1492, DOI 10.1161/CIRCULATIONAHA.109.881490; Stukenborg GJ, 2007, CIRCULATION, V116, P2960, DOI 10.1161/CIRCULATIONAHA.107.712323; Tuhrim Stanley, 2008, J Stroke Cerebrovasc Dis, V17, P226, DOI 10.1016/j.jstrokecerebrovasdis.2008.02.003; Volpp KG, 2007, HEALTH SERV RES, V42, P1613, DOI 10.1111/j.1475-6773.2006.00688.x; Wolfe CDA, 2005, BMJ-BRIT MED J, V331, P431, DOI 10.1136/bmj.38510.458218.8F; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zhu HF, 2008, NEUROLOGY, V71, P283, DOI 10.1212/01.wnl.0000318278.41347.94	45	42	42	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					152	+		10.7326/0003-4819-154-3-201102010-00004	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	713HY	21282694	Green Accepted			2022-12-01	WOS:000286729200002
J	Healey, F; Darowski, A; Lamont, T; Panesar, S; Poulton, S; Treml, J; Wiese, M				Healey, Frances; Darowski, Adam; Lamont, Tara; Panesar, Sukhmeet; Poulton, Susan; Treml, Jonathan; Wiese, Martin			Safety Alerts Essential care after an inpatient fall: summary of a safety report from the National Patient Safety Agency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITALS		[Healey, Frances; Lamont, Tara; Panesar, Sukhmeet] Natl Patient Safety Agcy, London W1T 5HD, England; [Darowski, Adam] John Radcliffe Hosp, Oxford OX3 9DU, England; [Poulton, Susan] Queen Alexandra Hosp, Portsmouth PO6 3LY, Hants, England; [Treml, Jonathan] Queen Elizabeth Hosp, Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2WB, W Midlands, England; [Wiese, Martin] Leicester Royal Infirm, Leicester LE1 5WW, Leics, England	University of Oxford; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Birmingham; University of Leicester	Healey, F (corresponding author), Natl Patient Safety Agcy, London W1T 5HD, England.							British Orthopaedic Association British Geriatric Society, 2007, BLUE BOOK GUID TREAT; National Institute for Health and Clinical Excellence, 2007, 56 NAT I HLTH CLIN E; National Patient Safety Agency, 2010, SLIPS TRIPS FALLS DA; National Patient Safety Agency, 2010, NPSA2011RRR001; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Patient Safety First, 2009, GUID RED HARM FALLS; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Wiese MF, 2003, BMJ-BRIT MED J, V327, P782, DOI 10.1136/bmj.327.7418.782; Youde J, 2009, INJURY, V40, P1226, DOI 10.1016/j.injury.2009.06.167	9	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2011	342								d329	10.1136/bmj.d329	http://dx.doi.org/10.1136/bmj.d329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715MR	21278215				2022-12-01	WOS:000286889100002
J	Bendesky, A; Tsunozaki, M; Rockman, MV; Kruglyak, L; Bargmann, CI				Bendesky, Andres; Tsunozaki, Makoto; Rockman, Matthew V.; Kruglyak, Leonid; Bargmann, Cornelia I.			Catecholamine receptor polymorphisms affect decision-making in C. elegans	NATURE			English	Article							QUANTITATIVE TRAIT LOCUS; CARBON-DIOXIDE AVOIDANCE; DEPENDENT PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; PHEROMONE ATTRACTION; NATURAL VARIATION; SOCIAL-BEHAVIOR; OCTOPAMINE; TYRAMINE; NEURONS	Innate behaviours are flexible: they change rapidly in response to transient environmental conditions, and are modified slowly by changes in the genome. A classical flexible behaviour is the exploration-exploitation decision, which describes the time at which foraging animals choose to abandon a depleting food supply. We have used quantitative genetic analysis to examine the decision to leave a food patch in Caenorhabditis elegans. Here we show that patch-leaving is a multigenic trait regulated in part by naturally occurring non-coding polymorphisms in tyra-3 (tyramine receptor 3), which encodes a G-protein-coupled catecholamine receptor related to vertebrate adrenergic receptors. tyra-3 acts in sensory neurons that detect environmental cues, suggesting that the internal catecholamines detected by tyra-3 regulate responses to external conditions. These results indicate that genetic variation and environmental cues converge on common circuits to regulate behaviour, and suggest that catecholamines have an ancient role in regulating behavioural decisions.	[Bendesky, Andres; Tsunozaki, Makoto; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; [Rockman, Matthew V.] New York Univ, Dept Biol, New York, NY 10003 USA; [Rockman, Matthew V.] New York Univ, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Rockefeller University; New York University; New York University; Howard Hughes Medical Institute; Princeton University; Princeton University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@rockefeller.edu		Bendesky, Andres/0000-0002-4220-3653; Bargmann, Cornelia/0000-0002-8484-0618	Secretaria de Educacion Publica of Mexico; Rockefeller University; HHMI; NIH [GM089972]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089972] Funding Source: NIH RePORTER	Secretaria de Educacion Publica of Mexico; Rockefeller University; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Shingai for strains, and P. McGrath and members of the C. I. B. laboratory for discussions. A. B. was supported by the Secretaria de Educacion Publica of Mexico and by The Rockefeller University. C. I. B. and L. K. are Investigators of the Howard Hughes Medical Institute. This work was supported by HHMI and by NIH grant GM089972.	Ahringer J., 2006, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.47.1; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Barrett HC, 2000, TRENDS COGN SCI, V4, P251, DOI 10.1016/S1364-6613(00)01495-9; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Edwards AC, 2009, GENETICS, V182, P889, DOI 10.1534/genetics.109.101691; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gerke J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001144; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Harvey SC, 2009, J EXP ZOOL PART B, V312B, P224, DOI 10.1002/jez.b.21287; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Legare ME, 2000, GENOME RES, V10, P42; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Mello C, 1995, METHOD CELL BIOL, V48, P451; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stephens D.W., 2007, FORAGING BEHAV ECOLO; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Thomson MJ, 2006, GENETICS, V172, P2501, DOI 10.1534/genetics.105.050500; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	56	131	132	2	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					313	U207		10.1038/nature09821	http://dx.doi.org/10.1038/nature09821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21412235	Green Submitted, Green Accepted			2022-12-01	WOS:000289724600032
J	Brennan, DF; Dar, AC; Hertz, NT; Chao, WCH; Burlingame, AL; Shokat, KM; Barford, D				Brennan, Damian F.; Dar, Arvin C.; Hertz, Nicholas T.; Chao, William C. H.; Burlingame, Alma L.; Shokat, Kevan M.; Barford, David			A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK	NATURE			English	Article							KINASE SUPPRESSOR; GENE ENCODES; WEB SERVER; PROTEIN; ACTIVATION; INHIBITOR; MECHANISM; DOMAIN; SCAFFOLDS; PATHWAY	In metazoans, the Ras-Raf-MEK (mitogen-activated protein-kinase kinase)-ERK (extracellular signal-regulated kinase) signalling pathway relays extracellular stimuli to elicit changes in cellular function and gene expression. Aberrant activation of this pathway through oncogenic mutations is responsible for a large proportion of human cancer. Kinase suppressor of Ras (KSR)(1-3) functions as an essential scaffolding protein to coordinate the assembly of Raf-MEK-ERK complexes(4,5). Here we integrate structural and biochemical studies to understand how KSR promotes stimulatory Raf phosphorylation of MEK (refs 6, 7). We show, from the crystal structure of the kinase domain of human KSR2 (KSR2(KD)) in complex with rabbit MEK1, that interactions between KSR2(KD) and MEK1 are mediated by their respective activation segments and C-lobe alpha G helices. Analogous to BRAF (refs 8, 9), KSR2 self-associates through a side-to-side interface involving Arg 718, a residue identified in a genetic screen as a suppressor of Ras signalling(1-3). ATP is bound to the KSR2(KD) catalytic site, and we demonstrate KSR2 kinase activity towards MEK1 by in vitro assays and chemical genetics. In the KSR2(KD)-MEK1 complex, the activation segments of both kinases are mutually constrained, and KSR2 adopts an inactive conformation. BRAF allosterically stimulates the kinase activity of KSR2, which is dependent on formation of a side-to-side KSR2-BRAF heterodimer. Furthermore, KSR2-BRAF heterodimerization results in an increase of BRAF-induced MEK phosphorylation via the KSR2-mediated relay of a signal from BRAF to release the activation segment of MEK for phosphorylation. We propose that KSR interacts with a regulatory Raf molecule in cis to induce a conformational switch of MEK, facilitating MEK's phosphorylation by a separate catalytic Raf molecule in trans.	[Brennan, Damian F.; Chao, William C. H.; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Dar, Arvin C.; Hertz, Nicholas T.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; [Dar, Arvin C.; Hertz, Nicholas T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA; [Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94107 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	shokat@cmp.ucsf.edu; david.barford@ic.ac.uk		Hertz, Nicholas/0000-0002-6527-6898	Cancer Research UK; ICR; HHMI; NIH [NCRR RR015804, NCRR RR001614]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); ICR; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Cancer Research UK grant to D. B., ICR studentships to D. F. B. and W. C. H. C. and HHMI grant to K. M. S. We thank staff at the ESRF for help with data collection and K. Wood and V. Good for help with protein production and Z. Zhang for assistance with cloning. Mass spectrometry was made possible by NIH grants NCRR RR015804 and NCRR RR001614. The MEK1/p50<SUP>Cdc37</SUP> baculovirus was a gift from C. Vaughan. We thank Cell Signaling Technologies for help with phosphospecific MEK antibodies.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bankston D, 2002, ORG PROCESS RES DEV, V6, P777, DOI 10.1021/op020205n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Statsuk AV, 2008, J AM CHEM SOC, V130, P17568, DOI 10.1021/ja807066f; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	39	184	188	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					366	U134		10.1038/nature09860	http://dx.doi.org/10.1038/nature09860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21441910				2022-12-01	WOS:000289724600043
J	Garcia, NVD; Karayannis, T; Fishell, G				Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord			Neuronal activity is required for the development of specific cortical interneuron subtypes	NATURE			English	Article							ELECTRICAL-ACTIVITY; IN-VIVO; GANGLIONIC EMINENCE; APOPTOTIC CELLS; CEREBRAL-CORTEX; MIGRATION; NETWORKS; MOUSE; PROJECTIONS; ENGULFMENT	Electrical activity has been shown to regulate development in a variety of species and in various structures(1), including the retina(2-4), spinal cord(5,6) and cortex(5). Within the mammalian cortex specifically, the development of dendrites and commissural axons in pyramidal cells is activity-dependent(7,8). However, little is known about the developmental role of activity in the other major cortical population of neurons, the GABA-producing interneurons. These neurons are morphologically and functionally heterogeneous and efforts over the past decade have focused on determining the mechanisms that contribute to this diversity(9-11). It was recently discovered that 30% of all cortical interneurons arise from a relatively novel source within the ventral telencephalon, the caudal ganglionic eminence (CGE)(11,12). Owing to their late birth date, these interneurons populate the cortex only after the majority of other interneurons and pyramidal cells are already in place and have started to functionally integrate. Here we demonstrate in mice that for CGE-derived reelin (Re)-positive and calretinin (Cr)-positive (but not vasoactive intestinal peptide (VIP)-positive) interneurons(12,13), activity is essential before postnatal day 3 for correct migration, and that after postnatal day 3, glutamate-mediated activity controls the development of their axons and dendrites. Furthermore, we show that the engulfment and cell motility 1 gene (Elmo1)(14), a target of the transcription factor distal-less homeobox 1 (Dlx1)(15), is selectively expressed in Re+ and Cr+ interneurons and is both necessary and sufficient for activity-dependent interneuron migration. Our findings reveal a selective requirement for activity in shaping the cortical integration of specific neuronal subtypes.	[Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord] NYU, Langone Med Ctr, Smilow Neurosci Program, Dept Cell Biol, New York, NY 10016 USA; [Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord] NYU, Langone Med Ctr, Dept Neural Sci, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Fishell, G (corresponding author), NYU, Langone Med Ctr, Smilow Neurosci Program, Dept Cell Biol, 550 1St Ave, New York, NY 10016 USA.	fisheg01@nyumc.org	Karayannis, Theofanis/GRR-3982-2022; Karayannis, Theofanis/O-5194-2014	Karayannis, Theofanis/0000-0002-3267-6254; Fishell, Gordon/0000-0002-9640-9278	Patterson Trust; National Institutes of Health, National Institute of Mental Health [5RO1MH068469-08, 2R01MH071679-09]; National Institute of Neurological Disorders and Stroke [5R01NS039007-1]; New York Stem Cell Science State [NGSG-130]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032993, R01NS039007] Funding Source: NIH RePORTER	Patterson Trust; National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); New York Stem Cell Science State; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to R. Batista-Brito, E. Chiappe, R. Cossart, J. Dasen, J. Kaltschmidt, S. Lee, J. Hjerling Leffler, M. Long, D. Pisapia and B. Rudy for comments on the manuscript. We thank L. Yin for technical assistance. We are indebted to K. Ravichandran for providing the ELMO1 constructs. N.V.D.G. and T. K. are both supported by grants from The Patterson Trust. Research in the Fishell laboratory is supported by the National Institutes of Health, National Institute of Mental Health (5RO1MH068469-08 and 2R01MH071679-09), National Institute of Neurological Disorders and Stroke (5R01NS039007-1), New York Stem Cell Science State (NGSG-130) and the Simons Foundation.	Allene C, 2010, J PHYSIOL-LONDON, V588, P83, DOI 10.1113/jphysiol.2009.178798; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Manent JB, 2006, J NEUROSCI, V26, P5901, DOI 10.1523/JNEUROSCI.1033-06.2006; McCabe AK, 2006, J PHYSIOL-LONDON, V577, P155, DOI 10.1113/jphysiol.2006.117523; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stenman J, 2003, J NEUROSCI, V23, P167; STONE TW, 1993, PHARMACOL REV, V45, P309; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7	34	171	172	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					351	U116		10.1038/nature09865	http://dx.doi.org/10.1038/nature09865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460837	Green Accepted			2022-12-01	WOS:000289724600040
J	Yu, XJ; Liang, MF; Zhang, SY; Liu, Y; Li, JD; Sun, YL; Zhang, LH; Zhang, QF; Popov, VL; Li, C; Qu, J; Li, Q; Zhang, YP; Hai, R; Wu, W; Wang, Q; Zhan, FX; Wang, XJ; Kan, B; Wang, SW; Wan, KL; Jing, HQ; Lu, JX; Yin, WW; Zhou, H; Guan, XH; Liu, JF; Bi, ZQ; Liu, GH; Ren, J; Wang, H; Zhao, Z; Song, JD; He, JR; Wan, T; Zhang, JS; Fu, XP; Sun, LN; Dong, XP; Feng, ZJ; Yang, WZ; Hong, T; Zhang, Y; Walker, DH; Wang, Y; Li, DX				Yu, Xue-Jie; Liang, Mi-Fang; Zhang, Shou-Yin; Liu, Yan; Li, Jian-Dong; Sun, Yu-Lan; Zhang, Lihong; Zhang, Quan-Fu; Popov, Vsevolod L.; Li, Chuan; Qu, Jing; Li, Qun; Zhang, Yan-Ping; Hai, Rong; Wu, Wei; Wang, Qin; Zhan, Fa-Xian; Wang, Xian-Jun; Kan, Biao; Wang, Shi-Wen; Wan, Kang-Lin; Jing, Huai-Qi; Lu, Jin-Xin; Yin, Wen-Wu; Zhou, Hang; Guan, Xu-Hua; Liu, Jia-Fa; Bi, Zhen-Qiang; Liu, Guo-Hua; Ren, Jun; Wang, Hua; Zhao, Zhuo; Song, Jing-Dong; He, Jin-Rong; Wan, Tao; Zhang, Jing-Shan; Fu, Xiu-Ping; Sun, Li-Na; Dong, Xiao-Ping; Feng, Zi-Jian; Yang, Wei-Zhong; Hong, Tao; Zhang, Yu; Walker, David H.; Wang, Yu; Li, De-Xin			Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS	BACKGROUND Heightened surveillance of acute febrile illness in China since 2009 has led to the identification of a severe fever with thrombocytopenia syndrome (SFTS) with an unknown cause. Infection with Anaplasma phagocytophilum has been suggested as a cause, but the pathogen has not been detected in most patients on laboratory testing. METHODS We obtained blood samples from patients with the case definition of SFTS in six provinces in China. The blood samples were used to isolate the causal pathogen by inoculation of cell culture and for detection of viral RNA on polymerase-chain-reaction assay. The pathogen was characterized on electron microscopy and nucleic acid sequencing. We used enzyme-linked immunosorbent assay, indirect immunofluorescence assay, and neutralization testing to analyze the level of virus-specific antibody in patients' serum samples. RESULTS We isolated a novel virus, designated SFTS bunyavirus, from patients who presented with fever, thrombocytopenia, leukocytopenia, and multiorgan dysfunction. RNA sequence analysis revealed that the virus was a newly identified member of the genus phlebovirus in the Bunyaviridae family. Electron-microscopical examination revealed virions with the morphologic characteristics of a bunyavirus. The presence of the virus was confirmed in 171 patients with SFTS from six provinces by detection of viral RNA, specific antibodies to the virus in blood, or both. Serologic assays showed a virus-specific immune response in all 35 pairs of serum samples collected from patients during the acute and convalescent phases of the illness. CONCLUSIONS A novel phlebovirus was identified in patients with a life-threatening illness associated with fever and thrombocytopenia in China.	[Liang, Mi-Fang; Li, Jian-Dong; Sun, Yu-Lan; Zhang, Quan-Fu; Li, Chuan; Qu, Jing; Zhang, Yan-Ping; Wu, Wei; Wang, Qin; Wang, Shi-Wen; Song, Jing-Dong; Wan, Tao; Sun, Li-Na; Hong, Tao; Li, De-Xin] Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing 102206, Peoples R China; [Yu, Xue-Jie; Li, Qun; Yin, Wen-Wu; Zhou, Hang; Dong, Xiao-Ping; Feng, Zi-Jian; Yang, Wei-Zhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Chinese CDC, Beijing 102206, Peoples R China; [Zhang, Shou-Yin; Hai, Rong; Kan, Biao; Wan, Kang-Lin; Jing, Huai-Qi; Lu, Jin-Xin; He, Jin-Rong; Zhang, Jing-Shan; Fu, Xiu-Ping] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China; [Wang, Xian-Jun; Bi, Zhen-Qiang] Shandong Prov CDC, Jinan, Shandong, Peoples R China; [Zhan, Fa-Xian; Guan, Xu-Hua; Liu, Jia-Fa] Hubei Prov CDC, Wuhan, Hubei, Peoples R China; [Liu, Guo-Hua] Henan Prov CDC, Zhengzhou, Henan, Peoples R China; [Liu, Yan; Ren, Jun] Anhui Prov CDC, Hefei, Anhui, Peoples R China; [Wang, Hua] Jiangshu Prov CDC, Nanjing, Jiangshu, Peoples R China; [Zhao, Zhuo] Liaoning Prov CDC, Shenyang, Liaoning, Peoples R China; [Zhang, Yu] Hubei Prov Dept Hlth, Wuhan, Hubei, Peoples R China; [Yu, Xue-Jie; Liu, Yan; Zhang, Lihong; Popov, Vsevolod L.; Walker, David H.] Univ Texas Galveston, Med Branch, Dept Pathol, Galveston, TX 77550 USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Texas System; University of Texas Medical Branch Galveston	Li, DX (corresponding author), Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing 102206, Peoples R China.	wangyu@chinacdc.cn; lidx@chinacdc.cn	Yu, Xuejie/AAP-9246-2021; Wang, Tao/B-1331-2016		Ministry of Science and Technology [2008ZX10004-001, 2009ZX10004]; Ministry of Health; National Institute of Allergy and Infectious Diseases [U54 AI057156]; Chinese Center for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chinese Center for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by China Mega-Project for Infectious Diseases grants (2008ZX10004-001 and 2009ZX10004) from the Ministry of Science and Technology and the Ministry of Health, by a Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases grant (U54 AI057156) from the National Institute of Allergy and Infectious Diseases, and by a grant from the Chinese Recruitment Program of Global Experts in the Chinese Center for Disease Control and Prevention (to Dr. Yu).	Depaquit J, 2010, EUROSURVEILLANCE, V15, P40; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Li CA, 2010, VACCINE, V28, P4294, DOI 10.1016/j.vaccine.2010.04.025; Nichol S. T., 2005, VIRUS TAXONOMY, P695; Peters CJ, 1999, ANNU REV MED, V50, P531, DOI 10.1146/annurev.med.50.1.531; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Tenquist JD, 2001, J ROY SOC NEW ZEAL, V31, P481, DOI 10.1080/03014223.2001.9517666; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; 2010, NATL GUIDELINE PREVE	14	967	1210	4	184	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1523	1532		10.1056/NEJMoa1010095	http://dx.doi.org/10.1056/NEJMoa1010095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21410387	Green Accepted			2022-12-01	WOS:000289722700009
J	Autier, P; Dore, JF; Breitbart, E; Greinert, R; Pasterk, M; Boniol, M				Autier, Philippe; Dore, Jean Francois; Breitbart, Eckhard; Greinert, Ruediger; Pasterk, Markus; Boniol, Mathieu			The indoor tanning industry's double game	LANCET			English	Editorial Material									[Autier, Philippe; Pasterk, Markus; Boniol, Mathieu] Int Prevent Res Inst, F-69006 Lyon, France; [Dore, Jean Francois] INSERM, U590, F-69008 Lyon, France; [Breitbart, Eckhard; Greinert, Ruediger] Elbekliniken Klinikum Buxtehude, EUROSKIN, Buxtehude, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm)	Autier, P (corresponding author), Int Prevent Res Inst, F-69006 Lyon, France.	philippe.autier@i-pri.org	Autier, Philippe/A-4402-2014; Ferris, Laura/I-7689-2012; Boniol, Mathieu/F-9623-2011; Pasterk, Markus/A-6588-2011	Autier, Philippe/0000-0003-1538-5321; Boniol, Mathieu/0000-0003-1052-5604; Pasterk, Markus/0000-0002-6127-3323				El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; *EUROSKIN, 2008, PROP COD PRACT ART T; *FTC, 2010, FTC CONS AL; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; Greenman J, 2010, J AM ACAD DERMATOL, V62, P685; Greinert R, 2001, EUR J CANCER PREV, V10, P157, DOI 10.1097/00008469-200104000-00007; *INT AG RES CANC, 2008, IARC WORK GROUP REP, V5; International Agency for Research on Cancer, 2006, IARC WORK GROUP REP, V1; Levine JA, 2005, J AM ACAD DERMATOL, V53, P1038, DOI 10.1016/j.jaad.2005.07.066; *PROS, 2010, NEWSL; *PROS, 2009, JOINT ACT SUNB 2008; *US FDA, 2010, FDA CONS HLTH INF IN; IS SUNLIGHT GOOD YOU; VITAMIN D IS ESSENTI	14	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1299	1301		10.1016/S0140-6736(10)61966-6	http://dx.doi.org/10.1016/S0140-6736(10)61966-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21324519				2022-12-01	WOS:000289962900009
J	Volkow, ND; McLellan, TA; Cotto, JH; Karithanom, M; Weiss, SRB				Volkow, Nora D.; McLellan, Thomas A.; Cotto, Jessica H.; Karithanom, Meena; Weiss, Susan R. B.			Characteristics of Opioid Prescriptions in 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ADOLESCENTS; DEPENDENCE; ADULTS; ABUSE		[Volkow, Nora D.; Cotto, Jessica H.; Karithanom, Meena; Weiss, Susan R. B.] NIDA, NIH, Bethesda, MD 20892 USA; [McLellan, Thomas A.] Univ Penn, Sch Med, Ctr Subst Abuse Solut, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Pennsylvania	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], CDCS ISS BRIEF UN DR; [Anonymous], VECT ON NAT VONA; Fortuna RJ, 2010, PEDIATRICS, V126, P1108, DOI 10.1542/peds.2010-0791; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Zacny J, 2003, DRUG ALCOHOL DEPEN, V69, P215, DOI 10.1016/S0376-8716(03)00003-6	6	549	552	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1299	1301		10.1001/jama.2011.401	http://dx.doi.org/10.1001/jama.2011.401			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467282	Bronze, Green Accepted			2022-12-01	WOS:000289162400016
J	Volkow, ND; McLellan, TA				Volkow, Nora D.; McLellan, Thomas A.			Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN		[Volkow, Nora D.] NIDA, NIH, Bethesda, MD 20892 USA; [McLellan, Thomas A.] Univ Penn, Sch Med, Ctr Subst Abuse Solut, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Pennsylvania	Volkow, ND (corresponding author), NIDA, NIH, 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		*AM MED ASS, 2011, ASS TREAT PAIN PAT S; Centers for Disease Control and Prevention, 2010, UN DRUG POIS US; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Halperin EC, 2010, ACAD MED, V85, P203, DOI 10.1097/ACM.0b013e3181c88506; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; JOHNSTON LD, NIH PUBLICATION, V1; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P401; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; *SAMHSA, TRENDS EM DEP VIS IN; *SAMHSA DRUG ALC S, 2008, SUBST AB TREATM ADM	10	160	162	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1346	1347		10.1001/jama.2011.369	http://dx.doi.org/10.1001/jama.2011.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745JT	21467287				2022-12-01	WOS:000289162400024
J	Eliason, EJ; Clark, TD; Hague, MJ; Hanson, LM; Gallagher, ZS; Jeffries, KM; Gale, MK; Patterson, DA; Hinch, SG; Farrell, AP				Eliason, Erika J.; Clark, Timothy D.; Hague, Merran J.; Hanson, Linda M.; Gallagher, Zoe S.; Jeffries, Ken M.; Gale, Marika K.; Patterson, David A.; Hinch, Scott G.; Farrell, Anthony P.			Differences in Thermal Tolerance Among Sockeye Salmon Populations	SCIENCE			English	Article							CLIMATE-CHANGE; FRASER-RIVER; TEMPERATURE; MIGRATION; PACIFIC; PERFORMANCE; PHYSIOLOGY; WATER	Climate change-induced increases in summer water temperature have been associated with elevated mortality of adult sockeye salmon ( Oncorhynchus nerka) during river migration. We show that cardiorespiratory physiology varies at the population level among Fraser River sockeye salmon and relates to historical environmental conditions encountered while migrating. Fish from populations with more challenging migratory environments have greater aerobic scope, larger hearts, and better coronary supply. Furthermore, thermal optima for aerobic, cardiac, and heart rate scopes are consistent with the historic river temperature ranges for each population. This study suggests that physiological adaptation occurs at a very local scale, with population-specific thermal limits being set by physiological limitations in aerobic performance, possibly due to cardiac collapse at high temperatures.	[Eliason, Erika J.; Clark, Timothy D.; Gallagher, Zoe S.; Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Clark, Timothy D.; Hanson, Linda M.; Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada; [Clark, Timothy D.; Jeffries, Ken M.; Gale, Marika K.; Hinch, Scott G.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada; [Hague, Merran J.; Patterson, David A.] Simon Fraser Univ, Fisheries & Oceans Canada, Sci Branch, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Fisheries & Oceans Canada; Simon Fraser University	Eliason, EJ (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	eliason@zoology.ubc.ca	Clark, Timothy Darren/K-7129-2012	Clark, Timothy Darren/0000-0001-8738-3347; Eliason, Erika/0000-0002-0120-7498	Natural Sciences and Engineering Research Council of Canada (NSERC); Pacific Salmon Forum grants; Killam Postdoctoral Fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Pacific Salmon Forum grants; Killam Postdoctoral Fellowship	We thank C. Whitney for assistance with the beta-adrenoceptors experiment and field assistance; A. Lotto, G. Cox, E. Sandblom, A. Collins, M. Drenner, C. Wilson, D. Roscoe, M. Donaldson, J. Burt, E. Martins, S. Pieperhoff, L. Thompson, J. Hills, V. Ives, S. Tang, B. Smith, M. Hamer, D. Eliason, G. Eliason, and P. Parsons for field assistance; S. Ballesta and S. Lague for assistance with the b-adrenoceptors experiment; D. Guo for assistance with heart dissection; S. Cooke for valuable discussions; S. Latham for scale analysis; K. Miller, N. Ginther, C. Wallace, and J. Candy for DNA analysis; and the Department of Fisheries and Oceans (DFO) Environmental Watch Program and the DFO Cultus Lake Salmon Research Laboratory. This research was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants to A. P. F. and S. G. H.; an NSERC Strategic grant to S. G. H. and A. P. F.; Pacific Salmon Forum grants to E. J. E., A. P. F., and S. G. H.; NSERC postgraduate scholarships to E. J. E., K. M. J., and M. K. G.; and a Killam Postdoctoral Fellowship to T. D. C.	Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Brander KM, 2003, ICES MARINE SCI S, V219, P261; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Endler J.A., 1986, Monographs in Population Biology, pviii; English KK, 2005, T AM FISH SOC, V134, P1342, DOI 10.1577/T04-119.1; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Farrell AP, 2009, J EXP BIOL, V212, P3771, DOI 10.1242/jeb.023671; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Hanson LM, 2007, J FISH BIOL, V71, P926, DOI 10.1111/j.1095-8649.2007.01533.x; Hinch SG, 2000, CAN J FISH AQUAT SCI, V57, P2470, DOI 10.1139/cjfas-57-12-2470; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; Hyatt K.D., 2003, CANADIAN WATER RESOU, V28, P689, DOI DOI 10.4296/CWRJ2804689; KEEN JE, 1993, J EXP BIOL, V181, P27; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; Mathes MT, 2010, CAN J FISH AQUAT SCI, V67, P70, DOI 10.1139/F09-158; Munday PL, 2008, CORAL REEFS, V27, P927, DOI 10.1007/s00338-008-0393-4; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shiels HA, 1997, J EXP BIOL, V200, P1607; Steinhausen MF, 2008, J EXP BIOL, V211, P3915, DOI 10.1242/jeb.019281; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Wang T, 2007, SCIENCE, V315, P49, DOI 10.1126/science.1137359	28	598	619	6	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					109	112		10.1126/science.1199158	http://dx.doi.org/10.1126/science.1199158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454790				2022-12-01	WOS:000289000000049
J	Standfuss, J; Edwards, PC; D'Antona, A; Fransen, M; Xie, GF; Oprian, DD; Schertler, GFX				Standfuss, Jorg; Edwards, Patricia C.; D'Antona, Aaron; Fransen, Maikel; Xie, Guifu; Oprian, Daniel D.; Schertler, Gebhard F.X.			The structural basis of agonist-induced activation in constitutively active rhodopsin	NATURE			English	Article							CRYSTAL-STRUCTURE; OPSIN; BINDING; INTERMEDIATE; COUNTERION; MECHANISM; MOVEMENT; REVEALS; FAMILY; ROD	G-protein-coupled receptors (GPCRs) comprise the largest family of membrane proteins in the human genome and mediate cellular responses to an extensive array of hormones, neurotransmitters and sensory stimuli. Although some crystal structures have been determined for GPCRs, most are for modified forms, showing little basal activity, and are bound to inverse agonists or antagonists. Consequently, these structures correspond to receptors in their inactive states. The visual pigment rhodopsin is the only GPCR for which structures exist that are thought to be in the active state(1),(2). However, these structures are for the apoprotein, or opsin, form that does not contain the agonist all-trans retinal. Here we present a crystal structure at a resolution of 3 angstrom for the constitutively active rhodopsin mutant Glu 113 Gln(3-5) in complex with a peptide derived from the carboxy terminus of the alpha-subunit of the G protein transducin. The protein is in an active conformation that retains retinal in the binding pocket after photoactivation. Comparison with the structure of ground-state rhodopsin(6) suggests how translocation of the retinal beta-ionone ring leads to a rotation of transmembrane helix 6, which is the critical conformational change on activation(7). A key feature of this conformational change is a reorganization of water-mediated hydrogen-bond networks between the retinal-binding pocket and three of the most conserved GPCR sequence motifs. We thus show how an agonist ligand can activate its GPCR.	[Standfuss, Jorg; Fransen, Maikel; Schertler, Gebhard F.X.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Standfuss, Jorg; Edwards, Patricia C.; Schertler, Gebhard F.X.] MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [D'Antona, Aaron; Xie, Guifu; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [D'Antona, Aaron; Xie, Guifu; Oprian, Daniel D.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; MRC Laboratory Molecular Biology; Brandeis University; Brandeis University	Standfuss, J (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.		Standfuss, Joerg/G-5126-2011; Schertler, Gebhard/M-9512-2014	Schertler, Gebhard F.X./0000-0002-5846-6810	Medical Research Council [MC_U105178937, MC_U105197215] Funding Source: Medline; NEI NIH HHS [EY007965, R01 EY007965] Funding Source: Medline; NINDS NIH HHS [T32 NS007292] Funding Source: Medline; MRC [MC_U105197215, MC_U105178937] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Standfuss J, 2008, J MOL BIOL, V380, P145, DOI 10.1016/j.jmb.2008.04.055; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	30	367	372	4	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					656	660		10.1038/nature09795	http://dx.doi.org/10.1038/nature09795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21389983	Green Accepted			2022-12-01	WOS:000288951200049
J	Drucker, DJ; Goldfine, AB				Drucker, Daniel J.; Goldfine, Allison B.			Cardiovascular safety and diabetes drug development	LANCET			English	Editorial Material							EXENATIDE TWICE; OPEN-LABEL; TYPE-2; LIRAGLUTIDE; THERAPIES; OUTCOMES; WEIGHT; RISK		[Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Goldfine, Allison B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Drucker, DJ (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada.	d.drucker@utoronto.ca	Drucker, Daniel J/A-4092-2010	Goldfine, Allison/0000-0002-0345-1048				Ban K, 2009, J AM SOC HYPERTENS, V3, P245, DOI 10.1016/j.jash.2009.04.001; Best JH, 2009, DIABETIC MED, V26, P722, DOI 10.1111/j.1464-5491.2009.02752.x; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Chatterjee DJ, 2009, J CLIN PHARMACOL, V49, P1353, DOI 10.1177/0091270009339189; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Orexigen, 2011, FDA ISS COMPL RESP N; US Department of Health and Human Services Food and Drug Administration, 2008, GUID IND DIAB MELL E	14	30	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					977	979		10.1016/S0140-6736(10)62299-4	http://dx.doi.org/10.1016/S0140-6736(10)62299-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21316097				2022-12-01	WOS:000288775800009
J	Lishko, PV; Botchkina, IL; Kirichok, Y				Lishko, Polina V.; Botchkina, Inna L.; Kirichok, Yuriy			Progesterone activates the principal Ca2+ channel of human sperm	NATURE			English	Article							HUMAN SPERMATOZOA; STEROID-HORMONES; CALCIUM INFLUX; HYPERACTIVATED MOTILITY; MAMMALIAN SPERMATOZOA; NONGENOMIC ACTIONS; ACROSOME REACTION; CATSPER CHANNELS; MALE-FERTILITY; MOUSE SPERM	Steroid hormone progesterone released by cumulus cells surrounding the egg is a potent stimulator of human spermatozoa. It attracts spermatozoa towards the egg and helps them penetrate the egg's protective vestments(1). Progesterone induces Ca2+ influx into spermatozoa(1-3) and triggers multiple Ca2+-dependent physiological responses essential for successful fertilization, such as sperm hyperactivation, acrosome reaction and chemotaxis towards the egg(4-8). As an ovarian hormone, progesterone acts by regulating gene expression through a well-characterized progesterone nuclear receptor(9). However, the effect of progesterone upon transcriptionally silent spermatozoa remains unexplained and is believed to be mediated by a specialized, non-genomic membrane progesterone receptor(5,10). The identity of this non-genomic progesterone receptor and the mechanism by which it causes Ca2+ entry remain fundamental unresolved questions in human reproduction. Here we elucidate the mechanism of the non-genomic action of progesterone on human spermatozoa by identifying the Ca2+ channel activated by progesterone. By applying the patch-clamp technique to mature human spermatozoa, we found that nanomolar concentrations of progesterone dramatically potentiate CatSper, a pH-dependent Ca2+ channel of the sperm flagellum. We demonstrate that human CatSper is synergistically activated by elevation of intracellular pH and extracellular progesterone. Interestingly, human CatSper can be further potentiated by prostaglandins, but apparently through a binding site other than that of progesterone. Because our experimental conditions did not support second messenger signalling, CatSper or a directly associated protein serves as the elusive non-genomic progesterone receptor of sperm. Given that the CatSper-associated progesterone receptor is sperm specific and structurally different from the genomic progesterone receptor, it represents a promising target for the development of a new class of non-hormonal contraceptives.	[Lishko, Polina V.; Botchkina, Inna L.; Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kirichok, Y (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2140,Genentech Hall Room N272F,600, San Francisco, CA 94158 USA.	yuriy.kirichok@ucsf.edu	Lishko, Polina/L-1191-2017; Lishko, Polina/GQH-9569-2022		UCSF	UCSF	This work was funded by the UCSF Program for Breakthrough Biomedical Research.	AITKEN RJ, 1986, J REPROD FERTIL, V77, P451; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Neri-Vidaurri PD, 2006, BIOCHEM BIOPH RES CO, V343, P105, DOI 10.1016/j.bbrc.2006.02.095; Olsona SD, 2010, B MATH BIOL, V72, P1925, DOI 10.1007/s11538-010-9516-5; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2010, PHYSIOLOGY, V25, P165, DOI 10.1152/physiol.00049.2009; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Revelli A, 1998, ENDOCR REV, V19, P3, DOI 10.1210/er.19.1.3; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Schaefer M, 1998, P NATL ACAD SCI USA, V95, P3008, DOI 10.1073/pnas.95.6.3008; Shimizu Y, 1998, MOL HUM REPROD, V4, P555, DOI 10.1093/molehr/4.6.555; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; UHLER ML, 1992, FERTIL STERIL, V58, P1191; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039	30	421	447	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					387	+		10.1038/nature09767	http://dx.doi.org/10.1038/nature09767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412339				2022-12-01	WOS:000288444000047
J	Zhang, HM; Landmann, F; Zahreddine, H; Rodriguez, D; Koch, M; Labouesse, M				Zhang, Huimin; Landmann, Frederic; Zahreddine, Hala; Rodriguez, David; Koch, Marc; Labouesse, Michel			A tension-induced mechanotransduction pathway promotes epithelial morphogenesis	NATURE			English	Article							CYTOPLASMIC INTERMEDIATE-FILAMENT; CAENORHABDITIS-ELEGANS CUTICLE; MUSCLE DEVELOPMENT; C.-ELEGANS; IN-VIVO; GENE; ELONGATION; EMBRYO; MUTATIONS; EPIDERMIS	Mechanotransduction refers to the transformation of physical forces into chemical signals. It generally involves stretch-sensitive channels or conformational change of cytoskeleton-associated proteins(1). Mechanotransduction is crucial for the physiology of several organs and for cell migration(2,3). The extent to which mechanical inputs contribute to development, and how they do this, remains poorly defined. Here we show that a mechanotransduction pathway operates between the body-wall muscles of Caenorhabditis elegans and the epidermis. This pathway involves, in addition to a Rac GTPase, three signalling proteins found at the hemidesmosome: p21-activated kinase (PAK-1), the adaptor GIT-1 and its partner PIX-1. The phosphorylation of intermediate filaments is one output of this pathway. Tension exerted by adjacent muscles or externally exerted mechanical pressure maintains GIT-1 at hemidesmosomes and stimulates PAK-1 activity through PIX-1 and Rac. This pathway promotes the maturation of a hemidesmosome into a junction that can resist mechanical stress and contributes to coordinating the morphogenesis of epidermal and muscle tissues. Our findings suggest that the C. elegans hemidesmosome is not only an attachment structure, but also a mechanosensor that responds to tension by triggering signalling processes. We suggest that similar pathways could promote epithelial morphogenesis or wound healing in other organisms in which epithelial cells adhere to tension-generating contractile cells.	[Zhang, Huimin; Landmann, Frederic; Zahreddine, Hala; Rodriguez, David; Labouesse, Michel] Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,INSERM,UMR7104,U964, F-67400 Illkirch Graffenstaden, France; [Koch, Marc] Univ Strasbourg, Imaging Ctr, IGBMC, CNRS,INSERM,UMR7104,U964, F-67400 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Labouesse, M (corresponding author), Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,INSERM,UMR7104,U964, 1 Rue Laurent Fries,BP 10142, F-67400 Illkirch Graffenstaden, France.	lmichel@igbmc.fr		Zahreddine Fahs, Hala/0000-0003-0720-2484; Koch, Marc/0000-0002-2678-235X; Zhang, Huimin/0000-0002-2167-9644	ANR; ARC; EU; CNRS; INSERM	ANR(French National Research Agency (ANR)); ARC(Australian Research Council); EU(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We are grateful to H.-J. Cheng, the CGC and NBP-Japan, L. Lim, J. Nance, C. Gally and L. Broday for reagents, as well as M. Argentini for technical advice. We thank J. Ahringer for a discussion, and O. Pourquie, J.-L. Bessereau, S. Jarriault and members of the Labouesse laboratory (C. Gally, I. Kolotueva, N. Osmani and S. Quintin) for critical reading of the manuscript. This work was supported by grants from the ANR, ARC and EU (STREP-FP6 programme) (M. L.) and by institutional funds from the CNRS and INSERM.	Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRENNER S, 1974, GENETICS, V77, P71; Chen WN, 1996, J BIOL CHEM, V271, P26362, DOI 10.1074/jbc.271.42.26362; CHISHOLM AD, 2005, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.7.1; Costa M, 1997, DEV BIOL, V184, P373, DOI 10.1006/dbio.1997.8530; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Gally C, 2009, DEVELOPMENT, V136, P3109, DOI 10.1242/dev.039412; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; Hapiak V, 2003, DEV BIOL, V263, P330, DOI 10.1016/j.ydbio.2003.08.001; HODGKIN J, 1983, GENETICS, V103, P43; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Karabinos A, 2003, J MOL BIOL, V333, P307, DOI 10.1016/j.jmb.2003.08.041; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; Orr AW, 2008, CIRC RES, V103, P671, DOI 10.1161/CIRCRESAHA.108.182097; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; SCHNABEL R, 1995, DEVELOPMENT, V121, P2219; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Zahreddine H, 2010, CURR BIOL, V20, P322, DOI 10.1016/j.cub.2009.12.061; Zhang HM, 2010, DEV DYNAM, V239, P1465, DOI 10.1002/dvdy.22255; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	41	184	205	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					99	U120		10.1038/nature09765	http://dx.doi.org/10.1038/nature09765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368832				2022-12-01	WOS:000287924100042
J	Black, B; Cleveland, DW				Black, Ben E.; Cleveland, Don W.			Epigenetic Centromere Propagation and the Nature of CENP-A Nucleosomes	CELL			English	Article							E3 UBIQUITIN LIGASE; FISSION YEAST SCM3; HISTONE H3 VARIANT; CHROMATIN REQUIRES; MAINTENANCE; DOMAIN; CSE4; ORGANIZATION; REPLICATION; RECOGNITION	Centromeres direct chromosome inheritance, but in multicellular organisms their positions on chromosomes are primarily specified epigenetically rather than by a DNA sequence. The major candidate for the epigenetic mark is chromatin assembled with the histone H3 variant CENP-A. Recent studies offer conflicting evidence for the structure of CENP-A-containing chromatin, including the histone composition and handedness of the DNA wrapped around the histones. We present a model for the assembly and deposition of centromeric nucleosomes that couples these processes to the cell cycle. This model reconciles divergent data for CENP-A-containing nucleosomes and provides a basis for how centromere identity is stably inherited.	[Black, Ben E.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of Pennsylvania; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Black, B (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	blackbe@mail.med.upenn.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	National Institutes of Health [GM82989, GM74150]; Burroughs Wellcome Fund; Rita Allen Foundation; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082989, R01GM074150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Rita Allen Foundation; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank members of their laboratories for many discussions of centromere inheritance and anonymous reviewers for helpful comments. This work was supported by grants from the National Institutes of Health to B. E. B. (GM82989) and D. W. C. (GM74150). B. E. B. is also supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund and a Rita Allen Foundation Scholar Award. D. W. C. receives salary support from the Ludwig Institute for Cancer Research.	Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; Dimitriadis EK, 2010, P NATL ACAD SCI USA, V107, P20317, DOI 10.1073/pnas.1009563107; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; duSart D, 1997, NAT GENET, V16, P144; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kingston IJ, 2011, J BIOL CHEM, V286, P4021, DOI 10.1074/jbc.M110.189340; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lavelle C, 2009, CELL, V139, P1216, DOI 10.1016/j.cell.2009.12.014; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Maggert KA, 2001, GENETICS, V158, P1615; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106	53	237	239	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					471	479		10.1016/j.cell.2011.02.002	http://dx.doi.org/10.1016/j.cell.2011.02.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335232	Bronze, Green Accepted			2022-12-01	WOS:000287473100004
J	Fujiwara, H; Ferreira, M; Donati, G; Marciano, DK; Linton, JM; Sato, Y; Hartner, A; Sekiguchi, K; Reichardt, LF; Watt, FM				Fujiwara, Hironobu; Ferreira, Manuela; Donati, Giacomo; Marciano, Denise K.; Linton, James M.; Sato, Yuya; Hartner, Andrea; Sekiguchi, Kiyotoshi; Reichardt, Louis F.; Watt, Fiona M.			The Basement Membrane of Hair Follicle Stem Cells Is a Muscle Cell Niche	CELL			English	Article							ARRECTOR PILI MUSCLE; BETA-CATENIN; INTEGRIN ALPHA-8-BETA-1; MOUSE EPIDERMIS; DIFFERENTIATED PHENOTYPE; KIDNEY MORPHOGENESIS; PROTEIN NEPHRONECTIN; MAMMALIAN EPIDERMIS; ADULT EPIDERMIS; SKIN	The hair follicle bulge in the epidermis associates with the arrector pili muscle (APM) that is responsible for piloerection ("goosebumps''). We show that stem cells in the bulge deposit nephronectin into the underlying basement membrane, thus regulating the adhesion of mesenchymal cells expressing the nephronectin receptor, alpha 8 beta 1 integrin, to the bulge. Nephronectin induces alpha 8 integrin-positive mesenchymal cells to upregulate smooth muscle markers. In nephronectin knockout mice, fewer arrector pili muscles form in the skin, and they attach to the follicle above the bulge, where there is compensatory upregulation of the nephronectin family member EGFL6. Deletion of alpha 8 integrin also abolishes selective APM anchorage to the bulge. Nephronectin is a Wnt target; epidermal beta-catenin activation upregulates epidermal nephronectin and dermal alpha 8 integrin expression. Thus, bulge stem cells, via nephronectin expression, create a smooth muscle cell niche and act as tendon cells for the APM. Our results reveal a functional role for basement membrane heterogeneity in tissue patterning.	[Fujiwara, Hironobu; Ferreira, Manuela; Donati, Giacomo; Watt, Fiona M.] Li Ka Shing Ctr, Cancer Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Marciano, Denise K.] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94158 USA; [Reichardt, Louis F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Linton, James M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Sato, Yuya; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Hartner, Andrea] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany	Cancer Research UK; CRUK Cambridge Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Osaka University; University of Erlangen Nuremberg	Watt, FM (corresponding author), Li Ka Shing Ctr, Cancer Res UK Cambridge Res Inst, Robinson Way, Cambridge CB2 0RE, England.	fiona.watt@cancer.org.uk	Fujiwara, Hironobu/A-5971-2016; Ferreira, Manuela/AAF-5299-2020; Watt, Fiona/AHB-0226-2022; Ferreira, Manuela/I-7904-2018	Fujiwara, Hironobu/0000-0003-0883-3384; Ferreira, Manuela/0000-0001-9498-8061; Watt, Fiona/0000-0001-9151-5154; Ferreira, Manuela/0000-0001-9498-8061; Marciano, Denise/0000-0003-0612-4664; Ferreira, Manuela/0000-0002-0075-2400; DONATI, Giacomo/0000-0002-0370-8288	Cancer Research UK; University of Cambridge and Hutchison Whampoa Ltd.; NIH [NS19090]; Uehara Memorial Foundation; EU; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); University of Cambridge and Hutchison Whampoa Ltd.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); EU(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Vladimir Botchkarev for K14-Noggin skin and Takako Sasaki for Fibulin-1 antibody. We gratefully acknowledge the technical assistance of the core resources of the CRUK Cambridge Research Institute. We thank the entire Watt lab for valuable reagents, suggestions, and advice. This work was funded by Cancer Research UK and supported by the University of Cambridge and Hutchison Whampoa Ltd. We also gratefully acknowledge financial support from the NIH (NS19090 to L. F. R.), from the Uehara Memorial Foundation (H. F.), and from EU FP7 (Optistem).	AKIYAMA M, 1995, J INVEST DERMATOL, V105, P844, DOI 10.1111/1523-1747.ep12326649; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Baker CM, 2010, DEV BIOL, V343, P40, DOI 10.1016/j.ydbio.2010.04.005; Barcaui CB, 2002, BRIT J DERMATOL, V146, P657, DOI 10.1046/j.1365-2133.2002.04541.x; Bolcato-Bellemin AL, 2003, DEV BIOL, V260, P376, DOI 10.1016/S0012-1606(03)00254-9; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Christiano AM, 2004, CELL, V118, P530, DOI 10.1016/j.cell.2004.08.024; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/10001-000, DOI 10.1037/10001-000]; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; HALL PA, 1989, DEVELOPMENT, V106, P619; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kuroda K, 2004, J CUTAN PATHOL, V31, P241, DOI 10.1111/j.0303-6987.2003.00166.x; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Niemann C, 2002, DEVELOPMENT, V129, P95; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; Poblet E, 2004, J AM ACAD DERMATOL, V51, P217, DOI 10.1016/j.jaad.2004.01.054; RODRIGO FG, 1975, BRIT J DERMATOL, V93, P631, DOI 10.1111/j.1365-2133.1975.tb05112.x; Sato Y, 2009, J BIOL CHEM, V284, P14524, DOI 10.1074/jbc.M900200200; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Sharov AA, 2009, AM J PATHOL, V175, P1303, DOI 10.2353/ajpath.2009.090163; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2008, COLD SH Q B, V73, P503, DOI 10.1101/sqb.2008.73.011; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Zargham R, 2007, ATHEROSCLEROSIS, V195, P303, DOI 10.1016/j.atherosclerosis.2007.01.005; Zargham R, 2006, CARDIOVASC RES, V71, P170, DOI 10.1016/j.cardiores.2006.03.003	54	213	222	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					577	589		10.1016/j.cell.2011.01.014	http://dx.doi.org/10.1016/j.cell.2011.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335239	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000287473100012
J	Mair, W; Morantte, I; Rodrigues, APC; Manning, G; Montminy, M; Shaw, RJ; Dillin, A				Mair, William; Morantte, Ianessa; Rodrigues, Ana P. C.; Manning, Gerard; Montminy, Marc; Shaw, Reuben J.; Dillin, Andrew			Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; C-ELEGANS; INSULIN-RESISTANCE; COACTIVATOR CRTC2; GENE-REGULATION; ER STRESS; PATHWAY; KINASE; TORC2	Activating AMPK or inactivating calcineurin slows ageing in Caenorhabditis elegans(1,2) and both have been implicated as therapeutic targets for age-related pathology in mammals(3-5). However, the direct targets that mediate their effects on longevity remain unclear. In mammals, CREB-regulated transcriptional coactivators (CRTCs)(6) are a family of cofactors involved in diverse physiological processes including energy homeostasis(7-9), cancer(10) and endoplasmic reticulum stress(11). Here we show that both AMPK and calcineurin modulate longevity exclusively through post-translational modification of CRTC-1, the sole C. elegans CRTC. We demonstrate that CRTC-1 is a direct AMPK target, and interacts with the CREB homologue-1 (CRH-1) transcription factor in vivo. The pro-longevity effects of activating AMPK or deactivating calcineurin decrease CRTC-1 and CRH-1 activity and induce transcriptional responses similar to those of CRH-1 null worms. Downregulation of crtc-1 increases lifespan in a crh-1-dependent manner and directly reducing crh-1 expression increases longevity, substantiating a role for CRTCs and CREB in ageing. Together, these findings indicate a novel role for CRTCs and CREB in determining lifespan downstream of AMPK and calcineurin, and illustrate the molecular mechanisms by which an evolutionarily conserved pathway responds to low energy to increase longevity.	[Mair, William; Morantte, Ianessa; Shaw, Reuben J.; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Mair, William; Morantte, Ianessa; Montminy, Marc; Shaw, Reuben J.; Dillin, Andrew] Salk Inst Biol Studies, Glenn Fdn Med Res, La Jolla, CA 92037 USA; [Rodrigues, Ana P. C.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu; dillin@salk.edu	Rodrigues, Ana/B-7446-2011; Manning, Gerard/C-8308-2009	Grant, Ana/0000-0002-5439-9331; Manning, Gerard/0000-0002-5087-9151; Mair, William/0000-0002-0661-1342	George E. Hewitt Foundation for Medical Research; American Federation for Aging Research; Glenn Foundation for Medical Research; National Institutes of Health (NIH) [R01 DK080425, P01 CA120964, R01 HG004164, AG031097, CA14195, R01 DK070696, AG027463]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA014195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070696, R01DK080425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463, P01AG031097] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; American Federation for Aging Research; Glenn Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	W.M. is funded by the George E. Hewitt Foundation for Medical Research, the American Federation for Aging Research and the Glenn Foundation for Medical Research. R.J.S. is funded by National Institutes of Health (NIH) R01 DK080425 and P01 CA120964. A.P.C.R. and G.M. are funded by NIH R01 HG004164, AG031097 and CA14195. A.D. is supported by NIH R01 DK070696 and AG027463. We thank the Caenorhabditis Genetics Center, the National Bioresource Project for the Nematode and Mark Alkema for providing worm strains. We are grateful to M. Raices and M. D'Angelo for critical analysis of the manuscript, DAPI images and the NUP-160::GFP construct. We also thank members of the A.D. laboratory and M. Hansen for comments on the manuscript and discussion and K. Butler for technical assistance in the early stages of this project.	*AFF, 2004, GENECHIP EXPR AN; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Dwivedi M, 2009, AUTOPHAGY, V5, P604, DOI 10.4161/auto.5.5.8157; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hope IA., 1999, C ELEGANS PRACTICAL; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Komiya T, 2010, ONCOGENE, V29, P1672, DOI 10.1038/onc.2009.453; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; MAIR W, 2009, WORM BREED GAZ, V18, P33; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535	41	263	278	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					404	U179		10.1038/nature09706	http://dx.doi.org/10.1038/nature09706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331044	Green Accepted			2022-12-01	WOS:000287409100044
J	Sun, JR; Singh, V; Kajino-Sakamoto, R; Aballay, A				Sun, Jingru; Singh, Varsha; Kajino-Sakamoto, Rie; Aballay, Alejandro			Neuronal GPCR Controls Innate Immunity by Regulating Noncanonical Unfolded Protein Response Genes	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TOLL-LIKE RECEPTOR; CAENORHABDITIS-ELEGANS; ACTIVATION; DISEASE	The unfolded protein response (UPR), which is activated when unfolded or misfolded proteins accumulate in the endoplasmic reticulum, has been implicated in the normal physiology of immune defense and in several human diseases, including diabetes, cancer, neurodegenerative disease, and inflammatory disease. In this study, we found that the nervous system controlled the activity of a noncanonical UPR pathway required for innate immunity in Caenorhabditis elegans. OCTR-1, a putative octopamine G protein-coupled catecholamine receptor (GPCR, G protein-coupled receptor), functioned in sensory neurons designated ASH and ASI to actively suppress innate immune responses by down-regulating the expression of noncanonical UPR genes pqn/abu in nonneuronal tissues. Our findings suggest a molecular mechanism by which the nervous system may sense inflammatory responses and respond by controlling stress-response pathways at the organismal level.	[Sun, Jingru; Singh, Varsha; Kajino-Sakamoto, Rie; Aballay, Alejandro] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27705 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27705 USA.	a.aballay@duke.edu			Dana Foundation; NIH [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977, R37GM070977] Funding Source: NIH RePORTER	Dana Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center (Univ. of Minnesota) for strains used in this study, R. Komuniecki (Univ. of Toledo) for providing FY745 and FY746, and D. Ron for providing the abu-1 transgenic strain. A.A. is funded by the Dana Foundation and the NIH (grant GM070977).	Aballay A, 2009, CELL CYCLE, V8, P966, DOI 10.4161/cc.8.7.8074; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007	18	161	180	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					729	732		10.1126/science.1203411	http://dx.doi.org/10.1126/science.1203411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21474712	Green Accepted			2022-12-01	WOS:000290265800046
J	Paul, P; van den Hoorn, T; Jongsma, MLM; Bakker, MJ; Hengeveld, R; Janssen, L; Cresswell, P; Egan, DA; van Ham, M; ten Brinke, A; Ovaa, H; Beijersbergen, RL; Kuijl, C; Neefjes, J				Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Cresswell, Peter; Egan, David A.; van Ham, Marieke; ten Brinke, Anja; Ovaa, Huib; Beijersbergen, Roderick L.; Kuijl, Coenraad; Neefjes, Jacques			A Genome-wide Multidimensional RNAi Screen Reveals Pathways Controlling MHC Class II Antigen Presentation	CELL			English	Article							HLA-DR MOLECULES; DENDRITIC CELLS; MYOSIN 1E; TRANSPORT; PROTEIN; EXPRESSION; MEMBRANE; INHIBITION; MATURATION; COMPLEXES	MHC class II molecules (MHC-II) present peptides to T helper cells to facilitate immune responses and are strongly linked to autoimmune diseases. To unravel processes controlling MHC-II antigen presentation, we performed a genome-wide flow cytometry-based RNAi screen detecting MHC-II expression and peptide loading followed by additional high-throughput assays. All data sets were integrated to answer two fundamental questions: what regulates tissue-specific MHC-II transcription, and what controls MHC-II transport in dendritic cells? MHC-II transcription was controlled by nine regulators acting in feedback networks with higher-order control by signaling pathways, including TGF beta. MHC-II transport was controlled by the GTPase ARL14/ARF7, which recruits the motor myosin 1E via an effector protein ARF7EP. This complex controls movement of MHC-II vesicles along the actin cytoskeleton in human dendritic cells (DCs). These genome-wide systems analyses have thus identified factors and pathways controlling MHC-II transcription and transport, defining targets for manipulation of MHC-II antigen presentation in infection and autoimmunity.	[Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Ovaa, Huib; Kuijl, Coenraad; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Ovaa, Huib; Kuijl, Coenraad; Neefjes, Jacques] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Egan, David A.; Beijersbergen, Roderick L.] Netherlands Canc Inst, Robot & Screening Ctr, NL-1066 CX Amsterdam, Netherlands; [Cresswell, Peter] Yale Univ, Howard Hughes Med Inst, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [van Ham, Marieke; ten Brinke, Anja] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Howard Hughes Medical Institute; Yale University; University of Amsterdam; Academic Medical Center Amsterdam	Kuijl, C (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	kuijl.coenraad@gene.com; j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017; Yang, Chen/G-1379-2010; ovaa, huib/M-2334-2016	Neefjes, Jacques J.C./0000-0001-6763-2211; ovaa, huib/0000-0002-0068-054X; Janssen, Lennert/0000-0001-9705-0204; Paul, Petra/0000-0003-1187-7994; ten Brinke, Anja/0000-0002-0135-7496; Kuijl, Coen/0000-0003-4378-1428; Beijersbergen, Roderick/0000-0003-0116-4130	NWO ALW and CW; Dutch Cancer Society; Centre for Biomedical Genetics (CBG); EEC MC RTN; ERC; Organon/Merck	NWO ALW and CW; Dutch Cancer Society(KWF Kankerbestrijding); Centre for Biomedical Genetics (CBG); EEC MC RTN; ERC(European Research Council (ERC)European Commission); Organon/Merck(Merck & Company)	We thank the NKI Central Microarray and Protein Production Facility and the NKI Robotics and Screening Center, as well as A. Pfauth and F. van Diepen for help with the flow cytometry; L. Oomen and L. Brocks for support with the confocal microscope; D. Logan (Broad Institute, Cambridge, MA) for support in operating CellProfiler; P. van Veelen for mass spec analyses; I. Lee (Network Biotechnology Lab, Seoul, Korea) and E. Marcotte (University of Texas, Austin, TX) for access to the Humannet v. 1 software; and Y. Souwer for samples of human primary B cells. This work was supported by grants from NWO ALW and CW, the Dutch Cancer Society, the Centre for Biomedical Genetics (CBG), EEC MC RTN, and an ERC program grant. The NKI Robotics and Screening Center is supported by Organon/Merck.	Agrawal S, 2004, NAT BIOTECHNOL, V22, P1533, DOI 10.1038/nbt1042; Anderson HA, 1998, J IMMUNOL, V160, P4850; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Breton G, 2009, J CLIN IMMUNOL, V29, P637, DOI 10.1007/s10875-009-9313-9; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; Chaplin D D, 1988, Year Immunol, V3, P179; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Derrien V, 2002, J CELL SCI, V115, P2867; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dong YS, 2001, J IMMUNOL, V167, P311, DOI 10.4049/jimmunol.167.1.311; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Imai A, 2007, EUR J IMMUNOL, V37, P1730, DOI 10.1002/eji.200636392; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; Kuipers HF, 2005, HUM IMMUNOL, V66, P653, DOI 10.1016/j.humimm.2005.04.004; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Schietroma C, 2007, J BIOL CHEM, V282, P29504, DOI 10.1074/jbc.M705825200; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Souwer Y, 2009, J IMMUNOL, V182, P7473, DOI 10.4049/jimmunol.0802831; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; ten Brinke A, 2007, VACCINE, V25, P7145, DOI 10.1016/j.vaccine.2007.07.031; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Voong LN, 2008, J BIOL CHEM, V283, P9031, DOI 10.1074/jbc.M706487200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	58	97	102	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					268	283		10.1016/j.cell.2011.03.023	http://dx.doi.org/10.1016/j.cell.2011.03.023			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21458045	Bronze			2022-12-01	WOS:000289549900015
J	Ghosh, S; Larson, SD; Hefzi, H; Marnoy, Z; Cutforth, T; Dokka, K; Baldwin, KK				Ghosh, Sulagna; Larson, Stephen D.; Hefzi, Hooman; Marnoy, Zachary; Cutforth, Tyler; Dokka, Kartheek; Baldwin, Kristin K.			Sensory maps in the olfactory cortex defined by long-range viral tracing of single neurons	NATURE			English	Article							ODOR REPRESENTATIONS; MONOMERIC RED; MITRAL CELLS; BULB; NUCLEUS; PROJECTIONS; ORGANIZATION; INFORMATION; RECEPTORS; CIRCUITRY	Sensory information may be represented in the brain by stereotyped mapping of axonal inputs or by patterning that varies between individuals. In olfaction, a stereotyped map is evident in the first sensory processing centre, the olfactory bulb (OB), where different odours elicit activity in unique combinatorial patterns of spatially invariant glomeruli(1,2). Activation of each glomerulus is relayed to higher cortical processing centres by a set of similar to 20-50 'homotypic' mitral and tufted (MT) neurons(3). In the cortex, target neurons integrate information from multiple glomeruli to detect distinct features of chemically diverse odours(4-6). How this is accomplished remains unclear, perhaps because the cortical mapping of glomerular information by individual MT neurons has not been described. Here we use new viral tracing and three-dimensional brain reconstruction methods to compare the cortical projections of defined sets of MT neurons. We show that the gross-scale organization of the OB is preserved in the patterns of axonal projections to one processing centre yet reordered in another, suggesting that distinct coding strategies may operate in different targets. However, at the level of individual neurons neither glomerular order nor stereotypy is preserved in either region. Rather, homotypic MT neurons from the same glomerulus innervate broad regions that differ between individuals. Strikingly, even in the same animal, MT neurons exhibit extensive diversity in wiring; axons of homotypic MT pairs diverge from each other, emit primary branches at distinct locations and 70-90% of branches of homotypic and heterotypic pairs are non-overlapping. This pronounced reorganization of sensory maps in the cortex offers an anatomic substrate for expanded combinatorial integration of information from spatially distinct glomeruli and predicts an unanticipated role for diversification of otherwise similar output neurons.	[Ghosh, Sulagna; Hefzi, Hooman; Marnoy, Zachary; Dokka, Kartheek; Baldwin, Kristin K.] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Larson, Stephen D.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Program Neurosci, La Jolla, CA 92037 USA; [Cutforth, Tyler] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California Santa Cruz	Baldwin, KK (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	kbaldwin@scripps.edu		Baldwin, Kristin/0000-0002-6137-030X	Pew Scholars Award; California Institute of Regenerative Medicine; Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation; Dorris Neuroscience Center	Pew Scholars Award; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation; Dorris Neuroscience Center	We wish to thank G. Patrick for the gift of pSin2gene virus and S. Djakovic for help with viral production. We thank O. Kwon and K. Spencer for assistance with imaging. We thank A. Maximov and J. Hazen for critical reading of the manuscript. We thank T. Cutforth for generating and R. Axel for supporting the generation of the ORT mouse strain, which was a gift. We thank the NCMIR, the Waitt Foundation and M. Ellisman for providing access to state-of-the-art imaging equipment and image processing tools. We thank the Baldwin and Cline lab members for providing laboratory support and advice. This work was supported by a Pew Scholars Award (K.K.B.) and support from the California Institute of Regenerative Medicine, the Whitehall Foundation, the O'Keefe Foundation, the Shapiro Family Foundation and the Dorris Neuroscience Center.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Brunjes PC, 2010, J COMP NEUROL, V518, P1603, DOI 10.1002/cne.22293; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; Khan AG, 2010, WIRES SYST BIOL MED, V2, P603, DOI 10.1002/wsbm.85; Kikuta S, 2010, P NATL ACAD SCI USA, V107, P12363, DOI 10.1073/pnas.1003999107; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; SCOTT JW, 1985, J COMP NEUROL, V242, P415, DOI 10.1002/cne.902420309; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012	33	182	187	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					217	220		10.1038/nature09945	http://dx.doi.org/10.1038/nature09945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451523				2022-12-01	WOS:000289469100042
J	Schrijvers, EMC; Koudstaal, PJ; Hofman, A; Breteler, MMB				Schrijvers, Elisabeth M. C.; Koudstaal, Peter J.; Hofman, Albert; Breteler, Monique M. B.			Plasma Clusterin and the Risk of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; APOLIPOPROTEIN-J; MENTAL STATE; DIAGNOSIS; DEMENTIA; CLU	Context Variants in the clusterin gene are associated with the risk of Alzheimer disease (AD) and clusterin levels have been found to be increased in brain and cerebrospinal fluid of patients with AD. Plasma clusterin was reported to be associated with brain atrophy, baseline disease severity, and rapid clinical progression in patients with AD. Objective To evaluate the potential of plasma clusterin as a biomarker of the presence, severity, and risk of AD. Design, Setting, and Participants A case-cohort study nested within the Rotterdam Study, a prospective population-based cohort study conducted in Rotterdam, the Netherlands. Plasma levels of clusterin were measured at baseline (1997-1999) in 60 individuals with prevalent AD, a random subcohort of 926 participants, and an additional 156 participants diagnosed with AD during follow-up until January 1, 2007 (mean [SD], 7.2 [2.3] years). Main Outcome Measures Prevalent AD, severity of AD measured by the Mini-Mental State Examination (MMSE) score, and the risk of developing AD during follow-up. Results The likelihood of prevalent AD increased with increasing plasma levels of clusterin (odds ratio [OR] per SD increase of plasma clusterin level, 1.63; 95% confidence interval [CI], 1.21-2.20; adjusted for age, sex, education level, apolipoprotein E status, diabetes, smoking, coronary heart disease, and hypertension). Among patients with AD, higher clusterin levels were associated with more severe disease (adjusted difference in MMSE score per SD increase in clusterin levels, -1.36; 95% CI, -2.70 to -0.02; P=.047). Plasma clusterin levels were not related to the risk of incident AD during total follow-up (adjusted HR, 1.00; 95% CI, 0.85-1.17; P for trend=.77) or within 3 years of baseline (adjusted HR, 1.09; 95% CI, 0.84-1.42; P for trend=.65). Conclusion Plasma clusterin levels were significantly associated with baseline prevalence and severity of AD, but not with incidence of AD. JAMA. 2011;305(13):1322-1326 www.jama.com	[Schrijvers, Elisabeth M. C.; Hofman, Albert; Breteler, Monique M. B.] Univ Med Ctr, Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Schrijvers, Elisabeth M. C.; Koudstaal, Peter J.] Univ Med Ctr, Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Breteler, Monique M. B.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Breteler, MMB (corresponding author), Univ Med Ctr, Erasmus MC, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.breteler@erasmusmc.nl	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305	Erasmus MC University Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science; Ministry of Health, Welfare, and Sports; European Commission; Municipality of Rotterdam; Alzheimer's Association [IIRG-06-27261]; Pfizer	Erasmus MC University Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Alzheimer's Association(Alzheimer's Association); Pfizer(Pfizer)	The Rotterdam Study is supported by the Erasmus MC University Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture, and Science; the Ministry of Health, Welfare, and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. This study was financially supported by grant IIRG-06-27261 from the Alzheimer's Association and by an unrestricted research grant from Pfizer (Dr Breteler).	American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A, V3; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Ott A, 1998, AM J EPIDEMIOL, V147, P574; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sihlbom C, 2008, NEUROCHEM RES, V33, P1332, DOI 10.1007/s11064-008-9588-x; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	22	158	167	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1322	1326		10.1001/jama.2011.381	http://dx.doi.org/10.1001/jama.2011.381			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467285	Bronze			2022-12-01	WOS:000289162400021
J	Gott, M; Ingleton, C; Bennett, MI; Gardiner, C				Gott, Merryn; Ingleton, Christine; Bennett, Michael I.; Gardiner, Clare			Transitions to palliative care in acute hospitals in England: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE CARE; HEART-FAILURE; CANCER; END; SPOTLIGHT; PEOPLE	Objective To explore how transitions to a palliative care approach are perceived to be managed in acute hospital settings in England. Design Qualitative study. Setting Secondary or primary care settings in two contrasting areas of England. Participants 58 health professionals involved in the provision of palliative care in secondary or primary care. Results Participants identified that a structured transition to a palliative care approach of the type advocated in UK policy guidance is seldom evident in acute hospital settings. In particular they reported that prognosis is not routinely discussed with inpatients. Achieving consensus among the clinical team about transition to palliative care was seen as fundamental to the transition being effected; however, this was thought to be insufficiently achieved in practice. Secondary care professionals reported that discussions about adopting a palliative care approach to patient management were not often held with patients; primary care professionals confirmed that patients were often discharged from hospital with "false hope" of cure because this information had not been conveyed. Key barriers to ensuring a smooth transition to palliative care included the difficulty of "standing back" in an acute hospital situation, professional hierarchies that limited the ability of junior medical and nursing staff to input into decisions on care, and poor communication. Conclusion Significant barriers to implementing a policy of structured transitions to palliative care in acute hospitals were identified by health professionals in both primary and secondary care. These need to be addressed if current UK policy on management of palliative care in acute hospitals is to be established.	[Gott, Merryn] Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand; [Ingleton, Christine] Univ Sheffield, No Gen Hosp, Sch Nursing & Midwifery, Sheffield S10 2TN, S Yorkshire, England; [Bennett, Michael I.] Univ Lancaster, Sch Hlth & Med, Int Observ End Life Care, Lancaster LA1 4YW, England; [Gardiner, Clare] Univ Sheffield, St Lukes Hosp, Sch Nursing & Midwifery, Sheffield S10 2TN, S Yorkshire, England	University of Auckland; Northern General Hospital; University of Sheffield; Lancaster University; University of Sheffield	Gott, M (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand.	m.gott@auckland.ac.nz	Harding, Richard/G-9729-2012; Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349; Gott, Merryn/0000-0003-4399-962X; Gardiner, Clare/0000-0003-1785-7054	National Institute of Health Research; National Institute for Health Research [08/1809/233] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the National Institute of Health Research under the Service Delivery and Organisation programme. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Department of Health. All authors declare independence from the study funders.	Barclay S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4862; Barnes S, 2006, HEALTH SOC CARE COMM, V14, P482, DOI 10.1111/j.1365-2524.2006.00636.x; Bell D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3231; Bennett MI, 2010, PALLIATIVE MED, V24, P456, DOI 10.1177/0269216310366064; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Burt R. S., 2005, BROKERAGE CLOSURE IN; Department of Health, 2008, END LIF CAR STRAT EN; Department of Health, 2010, ROUT SUCC END LIF CA; Doug M, 2009, ARCH DIS CHILD; General Medical Council, 2010, TREATM CAR END LIF G; Gold Standards Framework, 2010, GSF AC HOSP; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gott M, 2009, PALLIATIVE MED, V23, P642, DOI 10.1177/0269216309106790; Gott M, 2007, PALLIATIVE MED, V21, P95, DOI 10.1177/0269216307076348; Grande G, 2009, PALLIATIVE MED, V23, P187, DOI 10.1177/0269216309102697; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Morgan D.L., 1997, FOCUS GROUPS QUALITA, V16; Murray SA, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.491238.94; National Audit Office, 2008, END LIF CAR; O'Leary N, 2009, EUR J HEART FAIL, V11, P406, DOI 10.1093/eurjhf/hfp007; Schofield P, 2006, PALLIATIVE MED, V20, P397, DOI 10.1191/0269216306pm1156oa; Selman L, 2007, HEART, V93, P963, DOI 10.1136/hrt.2006.106518; Seymour J, 2011, LIVING AGEING DYING; The Gold Standards Framework, 2010, GSF PROGN IND GUID; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x	25	91	91	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2011	342								d1773	10.1136/bmj.d1773	http://dx.doi.org/10.1136/bmj.d1773			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WE	21447572	hybrid, Green Submitted, Green Published			2022-12-01	WOS:000289200800004
J	Kendall, T; Tyrer, P; Whittington, C; Taylor, C				Kendall, Tim; Tyrer, Peter; Whittington, Craig; Taylor, Clare		Guideline Dev Grp	Guidelines Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDERS; ALCOHOL					tim2.kendall@virgin.net	Whittington, Craig/B-1380-2008	Whittington, Craig/0000-0002-1950-0334				[Anonymous], 2007, CLIN GUID NAT I HLTH; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Cerullo MA, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-29; Gregg L, 2007, CLIN PSYCHOL REV, V27, P494, DOI 10.1016/j.cpr.2006.09.004; Jackson CT, 2007, PSYCHIAT SERV, V58, P270, DOI 10.1176/appi.ps.58.2.270; Kavanagh DJ, 2004, SCHIZOPHR RES, V66, P115, DOI 10.1016/S0920-9964(03)00130-0; Loubser I., 2009, J PSYCHIAT INTENSIVE, V5, P33, DOI [https://doi.org/10.1017/S1742646408001386, DOI 10.1017/S1742646408001386]; McCreadie RG, 2002, BRIT J PSYCHIAT, V181, P321, DOI 10.1192/bjp.181.4.321; Moolchan ET, 2001, J ADDICT DIS, V20, P55, DOI 10.1300/J069v20n02_05; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2011, CLIN GUID NAT I HLTH; National Institute for Health and Clinical Excellence, 2009, CLIN GUID NAT I HLTH; National Institute for Health and Clinical Excellence, 2006, CLIN GUID NAT I HLTH; Noordsy DL, 2003, SUBSTANCE MISUSE PSY, P159; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Ries RK, 2004, PSYCHIAT SERV, V55, P445, DOI 10.1176/appi.ps.55.4.445; Tracy K, 2007, AM J DRUG ALCOHOL AB, V33, P253, DOI 10.1080/00952990601174931; Urichuk L, 2008, CURR DRUG METAB, V9, P410, DOI 10.2174/138920008784746373	18	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2011	342								d1351	10.1136/bmj.d1351	http://dx.doi.org/10.1136/bmj.d1351			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21430003				2022-12-01	WOS:000288948000003
J	Tan, T; Shaw, EJ; Siddiqui, F; Kandaswamy, P; Barry, PW; Baker, M				Tan, T.; Shaw, E. J.; Siddiqui, F.; Kandaswamy, P.; Barry, P. W.; Baker, M.		Guideline Dev Grp	Guidelines Inpatient management of diabetic foot problems: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material												pwb1@leicester.ac.uk						Diabetes UK, 2009, PUTT FEET 1 COMM SPE; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V114; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V119; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V73; *NAT I HLTH CLIN E, 2004, CLIN GUID NAT I HLTH, V10; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157	6	19	25	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1280	10.1136/bmj.d1280	http://dx.doi.org/10.1136/bmj.d1280			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21430002				2022-12-01	WOS:000288948000014
J	Greaves, SJ; Rose, RA; Oliver, TAA; Glowacki, DR; Ashfold, MNR; Harvey, JN; Clark, IP; Greetham, GM; Parker, AW; Towrie, M; Orr-Ewing, AJ				Greaves, Stuart J.; Rose, Rebecca A.; Oliver, Thomas A. A.; Glowacki, David R.; Ashfold, Michael N. R.; Harvey, Jeremy N.; Clark, Ian P.; Greetham, Gregory M.; Parker, Anthony W.; Towrie, Michael; Orr-Ewing, Andrew J.			Vibrationally Quantum-State-Specific Reaction Dynamics of H Atom Abstraction by CN Radical in Solution	SCIENCE			English	Article							ROOM-TEMPERATURE LIQUIDS; BIMOLECULAR REACTIONS; HCN; RELAXATION; SPECTROSCOPY; COMPLEXES	Solvent collisions can often mask initial disposition of energy to the products of solution-phase chemical reactions. Here, we show with transient infrared absorption spectra obtained with picosecond time resolution that the nascent HCN products of reaction of CN radicals with cyclohexane in chlorinated organic solvents exhibit preferential excitation of one quantum of the C-H stretching mode and up to two quanta of the bending mode. On time scales of approximately 100 to 300 picoseconds, the HCN products undergo relaxation to the vibrational ground state by coupling to the solvent bath. Comparison with reactions of CN radicals with alkanes in the gas phase, known to produce HCN with greater C-H stretch and bending mode excitation (up to two and approximately six quanta, respectively), indicates partial damping of the nascent product vibrational motion by the solvent. The transient infrared spectra therefore probe solvent-induced modifications to the reaction free energy surface and chemical dynamics.	[Greaves, Stuart J.; Rose, Rebecca A.; Oliver, Thomas A. A.; Glowacki, David R.; Ashfold, Michael N. R.; Harvey, Jeremy N.; Orr-Ewing, Andrew J.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Clark, Ian P.; Greetham, Gregory M.; Parker, Anthony W.; Towrie, Michael] Rutherford Appleton Lab, Cent Laser Facil, Harwell Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	University of Bristol; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Orr-Ewing, AJ (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	a.orr-ewing@bris.ac.uk	Parker, Anthony W./G-5445-2011; Oliver, Tom/A-6432-2012; Greaves, Stuart/D-9213-2011; Harvey, Jeremy N/E-8848-2010; Harvey, Jeremy/AAC-6433-2019	Parker, Anthony W./0000-0003-3094-9762; Greaves, Stuart/0000-0002-5238-7150; Harvey, Jeremy N/0000-0002-1728-1596; Harvey, Jeremy/0000-0002-1728-1596; Towrie, Mike/0000-0002-1305-701X; Oliver, Tom/0000-0003-3979-7857; ashfold, michael/0000-0001-5762-7048; Orr-Ewing, Andrew/0000-0001-5551-9609; Clark, Ian/0000-0002-0105-4743	Science and Technology Facilities Council (STFC); UK Biotechnology and Biological Sciences Research Council (STFC) [ST/501784]; Engineering and Physical Sciences Research Council [EP/G00224X]; Leverhulme Trust; Royal Society; Wolfson Foundation; Engineering and Physical Sciences Research Council [EP/G00224X/1] Funding Source: researchfish; EPSRC [EP/G00224X/1] Funding Source: UKRI	Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); UK Biotechnology and Biological Sciences Research Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Wolfson Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Measurements were made at the Central Laser Facility, Rutherford Appleton Laboratory, with financial support for the ULTRA laser complex from the Science and Technology Facilities Council (STFC) and UK Biotechnology and Biological Sciences Research Council (STFC Facility Grant ST/501784). Funding for the Bristol group was provided by the Engineering and Physical Sciences Research Council Programme Grant EP/G00224X. We thank the Leverhulme Trust for an Early Career Research Fellowship (S.J.G.) and the Royal Society and the Wolfson Foundation for a Research Merit Award (A.J.O.E.).	Althorpe SC, 2003, ANNU REV PHYS CHEM, V54, P493, DOI 10.1146/annurev.physchem.54.011002.103750; Bethardy GA, 1996, J CHEM PHYS, V105, P4533, DOI 10.1063/1.472537; BETHARDY GA, 1995, J CHEM PHYS, V102, P7966, DOI 10.1063/1.468995; BOTSCHWINA P, 1983, CHEM PHYS, V81, P73, DOI 10.1016/0301-0104(83)85303-8; Bragg AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233005; Cahoon JF, 2008, SCIENCE, V319, P1820, DOI 10.1126/science.1154041; COPELAND LR, 1992, J CHEM PHYS, V96, P5817, DOI 10.1063/1.462681; Crowther AC, 2008, J PHYS CHEM A, V112, P12081, DOI 10.1021/jp8064079; Crowther AC, 2009, J PHYS CHEM A, V113, P3758, DOI 10.1021/jp8084099; Elles CG, 2006, ANNU REV PHYS CHEM, V57, P273, DOI 10.1146/annurev.physchem.57.032905.104538; Greaves SJ, 2010, PHYS CHEM CHEM PHYS, V12, P9129, DOI 10.1039/c001233e; Greetham GM, 2010, APPL SPECTROSC, V64, P1311, DOI 10.1366/000370210793561673; HERZBERG G, 1945, MOL SPECTRA MOL STRU, pR2; Huang C, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2968547; Levine R. D., 2005, MOL REACTION DYNAMIC, DOI [10.1017/CBO9780511614125, DOI 10.1017/CBO9780511614125]; Linstrom P. J., NIST STANDARD REFERE; Mohammed OF, 2005, SCIENCE, V310, P83, DOI 10.1126/science.1117756; MORRIS VR, 1994, CHEM PHYS LETT, V220, P448, DOI 10.1016/0009-2614(94)00212-6; Moskun AC, 2006, SCIENCE, V311, P1907, DOI 10.1126/science.1123738; Moskun AC, 2003, J CHEM PHYS, V119, P4500, DOI 10.1063/1.1591726; OWRUTSKY JC, 1994, ANNU REV PHYS CHEM, V45, P519, DOI 10.1146/annurev.physchem.45.1.519; POLANYI JC, 1972, ACCOUNTS CHEM RES, V5, P161, DOI 10.1021/ar50053a001; RAFTERY D, 1994, J CHEM PHYS, V101, P8572, DOI 10.1063/1.468052; RAFTERY D, 1993, CHEM PHYS LETT, V201, P513, DOI 10.1016/0009-2614(93)85110-A; Sheps L, 2006, J PHYS CHEM A, V110, P3087, DOI 10.1021/jp0543835; Voth GA, 1996, J PHYS CHEM-US, V100, P13034, DOI 10.1021/jp960317e; Yang XM, 2007, ANNU REV PHYS CHEM, V58, P433, DOI 10.1146/annurev.physchem.58.032806.104632	27	72	73	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1423	1426		10.1126/science.1197796	http://dx.doi.org/10.1126/science.1197796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21292937	Green Submitted			2022-12-01	WOS:000288504000037
J	Zakar, T; Mesiano, S				Zakar, Tamas; Mesiano, Sam			How Does Progesterone Relax the Uterus in Pregnancy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zakar, Tamas] John Hunter Hosp, Dept Obstet & Gynaecol, Newcastle, NSW, Australia; [Zakar, Tamas] Univ Newcastle, Mothers & Babies Res Ctr, Newcastle, NSW 2308, Australia; [Mesiano, Sam] Case Western Reserve Univ, Dept Reprod Biol, Cleveland, OH 44106 USA	John Hunter Hospital; University of Newcastle; Case Western Reserve University	Zakar, T (corresponding author), John Hunter Hosp, Dept Obstet & Gynaecol, Newcastle, NSW, Australia.		Zakar, Tamas/G-7507-2013	Zakar, Tamas/0000-0002-1690-1159				Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107	2	49	51	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					972	973		10.1056/NEJMcibr1100071	http://dx.doi.org/10.1056/NEJMcibr1100071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388317	Green Published			2022-12-01	WOS:000288170300017
J	Cortazar, D; Kunz, C; Selfridge, J; Lettieri, T; Saito, Y; MacDougall, E; Wirz, A; Schuermann, D; Jacobs, AL; Siegrist, F; Steinacher, R; Jiricny, J; Bird, A; Schar, P				Cortazar, Daniel; Kunz, Christophe; Selfridge, Jim; Lettieri, Teresa; Saito, Yusuke; MacDougall, Eilidh; Wirz, Annika; Schuermann, David; Jacobs, Angelika L.; Siegrist, Fredy; Steinacher, Roland; Jiricny, Josef; Bird, Adrian; Schaer, Primo			Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability	NATURE			English	Article							THYMINE-DNA GLYCOSYLASE; BASE-EXCISION; STEM-CELLS; METHYLATION; PROMOTER; REPAIR; GENE; 5-METHYLCYTOSINE; MLL; DEMETHYLATION	Thymine DNA glycosylase (TDG) is a member of the uracil DNA glycosylase (UDG) superfamily of DNA repair enzymes. Owing to its ability to excise thymine when mispaired with guanine, it was proposed to act against the mutability of 5-methylcytosine (5-mC) deamination in mammalian DNA(1). However, TDG was also found to interact with transcription factors(2,3), histone acetyltransferases(4) and de novo DNA methyltransferases(5,6), and it has been associated with DNA demethylation in gene promoters following activation of transcription(7-9), altogether implicating an engagement in gene regulation rather than DNA repair. Here we use a mouse genetic approach to determine the biological function of this multifaceted DNA repair enzyme. We find that, unlike other DNA glycosylases, TDG is essential for embryonic development, and that this phenotype is associated with epigenetic aberrations affecting the expression of developmental genes. Fibroblasts derived from Tdg null embryos (mouse embryonic fibroblasts, MEFs) show impaired gene regulation, coincident with imbalanced histone modification and CpG methylation at promoters of affected genes. TDG associates with the promoters of such genes both in fibroblasts and in embryonic stem cells (ESCs), but epigenetic aberrations only appear upon cell lineage commitment. We show that TDG contributes to the maintenance of active and bivalent chromatin throughout cell differentiation, facilitating a proper assembly of chromatin-modifying complexes and initiating base excision repair to counter aberrant de novo methylation. We thus conclude that TDG-dependent DNA repair has evolved to provide epigenetic stability in lineage committed cells.	[Cortazar, Daniel; Kunz, Christophe; Saito, Yusuke; Wirz, Annika; Schuermann, David; Jacobs, Angelika L.; Steinacher, Roland; Schaer, Primo] Univ Basel, Inst Biochem & Genet, Dept Biomed, CH-4048 Basel, Switzerland; [Selfridge, Jim; MacDougall, Eilidh; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Lettieri, Teresa; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Siegrist, Fredy] F Hoffmann La Roche Ltd, Global Preclin Safety, Pharmaceut Res, CH-4058 Basel, Switzerland	University of Basel; University of Edinburgh; University of Zurich; Roche Holding	Schar, P (corresponding author), Univ Basel, Inst Biochem & Genet, Dept Biomed, CH-4048 Basel, Switzerland.	primo.schaer@unibas.ch	Siegrist, Fredy/A-8230-2013; Schär, Primo/G-5967-2012; Schuermann, David/AAC-4075-2019	Schär, Primo/0000-0003-1843-6147; Schuermann, David/0000-0003-2904-1378; SELFRIDGE, JIM/0000-0003-2473-4386; Kunz, Christophe/0000-0002-0511-3915; Lettieri, Teresa/0000-0002-3363-9666; Bird, Adrian/0000-0002-8600-0372	Swiss National Science Foundation [3100A0-108436, 3100A0-122574/]; Association For International Cancer Research [01-330]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Association For International Cancer Research	We thank D. Klewe-Nebenius for preparations of mouse primary fibroblast, and F. Mohn and D. Schubeler for discussions and assistance in the setup and evaluation of the ChIP experiments. The work was supported by project grants from the Swiss National Science Foundation (3100A0-108436; 3100A0-122574/) and the Association For International Cancer Research (01-330).	Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cheng YY, 2007, BRIT J CANCER, V97, P895, DOI 10.1038/sj.bjc.6603968; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Gallais R, 2007, MOL ENDOCRINOL, V21, P2085, DOI 10.1210/me.2006-0490; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zhu B, 2001, P NATL ACAD SCI USA, V98, P5031, DOI 10.1073/pnas.091097298	29	274	283	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					419	U210		10.1038/nature09672	http://dx.doi.org/10.1038/nature09672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21278727				2022-12-01	WOS:000287409100047
J	Matsuoka, RL; Nguyen-Ba-Charvet, KT; Parray, A; Badea, TC; Chedotal, A; Kolodkin, AL				Matsuoka, Ryota L.; Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Badea, Tudor C.; Chedotal, Alain; Kolodkin, Alex L.			Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina	NATURE			English	Article							GANGLION-CELLS; PLEXIN-A4; RESPONSES; REQUIREMENT; EXPRESSION; DSCAM	In the vertebrate retina, establishment of precise synaptic connections among distinct retinal neuron cell types is critical for processing visual information and for accurate visual perception. Retinal ganglion cells (RGCs), amacrine cells and bipolar cells establish stereotypic neurite arborization patterns to form functional neural circuits in the inner plexiform layer (IPL)(1-3), a laminar region that is conventionally divided into five major parallel sublaminae(1,2). However, the molecular mechanisms governing distinct retinal subtype targeting to specific sublaminae within the IPL remain to be elucidated. Here we show that the transmembrane semaphorin Sema6A signals through its receptor PlexinA4 (PlexA4) to control lamina-specific neuronal stratification in the mouse retina. Expression analyses demonstrate that Sema6A and PlexA4 proteins are expressed in a complementary fashion in the developing retina: Sema6A in most ON sublaminae and PlexA4 in OFF sublaminae of the IPL. Mice with null mutations in PlexA4 or Sema6A exhibit severe defects in stereotypic lamina-specific neurite arborization of tyrosine hydroxylase (TH)-expressing dopaminergic amacrine cells, intrinsically photosensitive RGCs (ipRGCs) and calbindin-positive cells in the IPL. Sema6A and PlexA4 genetically interact in vivo for the regulation of dopaminergic amacrine cell laminar targeting. Therefore, neuronal targeting to subdivisions of the IPL in the mammalian retina is directed by repulsive transmembrane guidance cues present on neuronal processes.	[Matsuoka, Ryota L.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Badea, Tudor C.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Matsuoka, Ryota L.; Badea, Tudor C.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] INSERM, UMR S968, Inst Vis, F-75012 Paris, France; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] Univ Paris 06, UMR S968, Inst Vis, F-75012 Paris, France; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] CNRS, UMR 7210, Inst Vis, F-75012 Paris, France	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Chedotal, Alain/F-2750-2017; Matsuoka, Ryota L./K-5439-2019; Nguyen-Ba-Charvet, Kim/J-3507-2017; Badea, Tudor Constantin/B-1654-2018	Chedotal, Alain/0000-0001-7577-3794; Matsuoka, Ryota L./0000-0001-6214-2889; Nguyen-Ba-Charvet, Kim/0000-0001-5398-0872; Badea, Tudor Constantin/0000-0003-3086-6713	Nakajima Foundation; Fondation pour la Recherche Medicale (FRM); Fondation Retina France; Paris School of Neuroscience (ENP);  [R01 NS35165]; NATIONAL EYE INSTITUTE [ZIAEY000504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165, R37NS035165] Funding Source: NIH RePORTER	Nakajima Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Retina France; Paris School of Neuroscience (ENP); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K.-W. Yau for the C-terminal melanopsin antibody, F. Suto for the PlexA4 antibody, B. Howell for the Dab-1 antibody, Y. Yoshida for the PlexA1<SUP>-/-</SUP> eyes, P. Mombaerts for the PlexB1<SUP>-/-</SUP> and PlexB3<SUP>-/-</SUP> mice (unpublished), C. Gu for the PlexD1<SUP>-/flox</SUP>; nestin cre (unpublished) eyes and M. Tessier-Lavigne for the PlexA4<SUP>-/-</SUP> mice. We also thank J. Nathans, S. Hattar, K. Mandai and M. Riccomagno for comments on the manuscript and discussions, and members of the Kolodkin laboratory for assistance. This work was supported by R01 NS35165 to A. L. K., a predoctoral fellowship from the Nakajima Foundation to R. L. M., the Fondation pour la Recherche Medicale (Programme equipe FRM) to A. C., the Fondation Retina France to K. T. N.-B.-C., and a PhD fellowship from the Paris School of Neuroscience (ENP) to A. P. A. L. K. is an investigator of the Howard Hughes Medical Institute.	Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; de Winter F, 2004, INVEST OPHTH VIS SCI, V45, P4554, DOI 10.1167/iovs.04-0173; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105	30	149	149	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					259	+		10.1038/nature09675	http://dx.doi.org/10.1038/nature09675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21270798	Green Accepted			2022-12-01	WOS:000287144200044
J	Jones, CE; Naidoo, S; De Beer, C; Esser, M; Kampmann, B; Hesseling, AC				Jones, Christine E.; Naidoo, Shalena; De Beer, Corena; Esser, Monika; Kampmann, Beate; Hesseling, Anneke C.			Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; PLACENTAL MALARIA; MEASLES-VIRUS; PERTUSSIS ANTIBODIES; CHILD-MORTALITY; IMMUNIZATION; PREVALENCE; MORBIDITY; AVIDITY; SERUM	Context Altered immune responses might contribute to the high morbidity and mortality observed in human immunodeficiency virus (HIV)-exposed uninfected infants. Objective To study the association of maternal HIV infection with maternal-and infant-specific antibody levels to Haemophilus influenzae type b (Hib), pneumococcus, Bordetella pertussis antigens, tetanus toxoid, and hepatitis B surface antigen. Design, Setting, and Participants A community-based cohort study in Khayelitsha, Western Cape Province, South Africa, between March 3, 2009, and April 28, 2010, of 109 HIV-infected and uninfected women and their infants. Serum samples from 104 women and 100 infants were collected at birth and samples from 93 infants were collected at 16 weeks. Main Outcome Measure Level of specific antibody in mother-infant pairs at delivery and in infants at 16 weeks, determined by enzyme-linked immunosorbent assays. Results At birth, HIV-exposed uninfected infants (n=46) had lower levels of specific antibodies than unexposed infants (n=54) did to Hib (0.37 [interquartile range {IQR}, 0.22-0.67] mg/L vs 1.02 [IQR, 0.34-3.79] mg/L; P<.001), pertussis (16.07 [IQR, 8.87-30.43] Food and Drug Administration [FDA] U/mL vs 36.11 [IQR, 20.41-76.28] FDA U/mL; P<.001), pneumococcus (17.24 [IQR, 11.33-40.25] mg/L vs 31.97 [IQR, 18.58-61.80] mg/L; P=.02), and tetanus (0.08 [IQR, 0.03-0.39] IU/mL vs 0.24 [IQR, 0.08-0.92] IU/mL; P=.006). Compared with HIV-uninfected women (n=58), HIV-infected women (n=46) had lower specific antibody levels to Hib (0.67 [IQR, 0.16-1.54] mg/L vs 1.34 [IQR, 0.15-4.82] mg/L; P=.009) and pneumococcus (33.47 [IQR, 4.03-69.43] mg/L vs 50.84 [IQR, 7.40-118.00] mg/L; P=.03); however, no differences were observed for antipertussis or antitetanus antibodies. HIV-exposed uninfected infants (n=38) compared with HIV-unexposed infants (n=55) had robust antibody responses following vaccination, with higher antibody responses to pertussis (270.1 [IQR, 84.4-355.0] FDA U/mL vs 91.7 [IQR, 27.9-168.4] FDA U/mL; P=.006) and pneumoccocus (47.32 [IQR, 32.56-77.80] mg/L vs 14.77 [IQR, 11.06-41.08] mg/L; P=.001). Conclusion Among South African infants, antenatal HIV exposure was associated with lower specific antibody responses in exposed uninfected infants compared with unexposed infants at birth, but with robust responses following routine vaccination. JAMA. 2011; 305(6): 576-584	[Jones, Christine E.; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Acad Dept Pediat, London W2 1PG, England; [Jones, Christine E.; Kampmann, Beate] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Kampmann, Beate] Med Res Council UK Gambia, Fajara, Gambia; [Naidoo, Shalena; De Beer, Corena; Esser, Monika] Univ Stellenbosch, Dept Pathol, Cape Town, South Africa; [De Beer, Corena; Esser, Monika] Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Hesseling, Anneke C.] Univ Stellenbosch, Dept Pediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa	Imperial College London; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; University of Cape Town; Tygerberg Hospital; Stellenbosch University	Jones, CE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Acad Dept Pediat, St Marys Campus,Norfolk Pl, London W2 1PG, England.	christine.jones@imperial.ac.uk	Jones, Chrissie/GXG-4400-2022	Jones, Christine/0000-0003-1523-2368	European Society for Pediatric Infectious Diseases; Thrasher Research Foundation; Wellcome Trust; National Institute for Health Research, England; Elizabeth Glaser Pediatric AIDS Foundation; Medical Research Council [MC_UP_A900_1115, MC_UP_A900_1122] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_UP_A900_1115] Funding Source: UKRI	European Society for Pediatric Infectious Diseases; Thrasher Research Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research, England(National Institute for Health Research (NIHR)); Elizabeth Glaser Pediatric AIDS Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Society for Pediatric Infectious Diseases (Dr Jones), the Thrasher Research Foundation (Dr Jones), the Wellcome Trust (Dr Kampmann), National Institute for Health Research, England (Dr Kampmann), and Elizabeth Glaser Pediatric AIDS Foundation (Dr Hesseling).	AGBARAKWE AE, 1995, J CLIN PATHOL, V48, P206, DOI 10.1136/jcp.48.3.206; ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1283; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1050; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; DUCLOS P, 2009, J AM COLL CARDIOL, V9, pS2; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; ENGLUND JA, 1995, PEDIATRICS, V96, P580; Farquhar C, 2005, JAIDS-J ACQ IMM DEF, V40, P494, DOI 10.1097/01.qai.0000168179.68781.95; Healy CM, 2006, CURR OPIN INFECT DIS, V19, P271, DOI 10.1097/01.qco.0000224822.65599.5b; Healy CM, 2004, J INFECT DIS, V190, P335, DOI 10.1086/421033; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Joint United Nations Programme on HIV/AIDS, 2011, GLOB REP UNAIDS REP; KNUF M, 2008, J PEDIAT, V152, pE1; KNUF M, 2008, J PEDIAT, V152, P660; Knuf M, 2008, J PEDIATR-US, V152, P655, DOI 10.1016/j.jpeds.2007.09.034; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kurikka S, 1996, PEDIATR INFECT DIS J, V15, P530, DOI 10.1097/00006454-199606000-00011; Madhi SA, 2005, VACCINE, V23, P5517, DOI 10.1016/j.vaccine.2005.07.038; Madhi SA, 2005, PEDIATR INFECT DIS J, V24, P410, DOI 10.1097/01.inf.0000160942.84169.14; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; MUSHER DM, 1990, J INFECT DIS, V161, P728, DOI 10.1093/infdis/161.4.728; Nair N, 2009, J INFECT DIS, V200, P1031, DOI 10.1086/605648; Ned RM, 2008, J INFECT DIS, V198, P1609, DOI 10.1086/593066; Nuttall JJ, 2008, INT J INFECT DIS, V12, pE99, DOI 10.1016/j.ijid.2008.06.014; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; SARVAS H, 1992, J INFECT DIS, V165, P977, DOI 10.1093/infdis/165.5.977; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Scott S, 2007, CLIN INFECT DIS, V45, P1417, DOI 10.1086/522989; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; *U CAP TOWN CTR IN, COMPR TB HIV SERV PR; *U CAP TOWN CTR IN, PROV HIV TB CAR PRIM; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P198	43	170	172	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					576	584		10.1001/jama.2011.100	http://dx.doi.org/10.1001/jama.2011.100			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304083				2022-12-01	WOS:000287080500022
J	Edgeworth, JA; Farmer, M; Sicilia, A; Tavares, P; Beck, J; Campbell, T; Lowe, J; Mead, S; Rudge, P; Collinge, J; Jackson, GS				Edgeworth, Julie Ann; Farmer, Michael; Sicilia, Anita; Tavares, Paul; Beck, Jonathan; Campbell, Tracy; Lowe, Jessica; Mead, Simon; Rudge, Peter; Collinge, John; Jackson, Graham S.			Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay	LANCET			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; PROTEIN; TRANSFUSION; COMPONENTS; DIAGNOSIS; PATIENT	Background Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegenerative disorder originating from exposure to bovine-spongiform-encephalopathy-like prions. Prion infections are associated with long and clinically silent incubations. The number of asymptomatic individuals with vCJD prion infection is unknown, posing risk to others via blood transfusion, blood products, organ or tissue grafts, and contaminated medical instruments. We aimed to establish the sensitivity and specificity of a blood-based assay for detection of vCJD prion infection. Methods We developed a solid-state binding matrix to capture and concentrate disease-associated prion proteins and coupled this method to direct immunodetection of surface-bound material. Quantitative assay sensitivity was assessed with a serial dilution series of 10(-7) to 10(-10) of vCJD prion-infected brain homogenate into whole human blood, with a baseline control of normal human brain homogenate in whole blood (10(-6)). To establish the sensitivity and specificity of the assay for detection of endogenous vCJD, we analysed a masked panel of 190 whole blood samples from 21 patients with vCJD, 27 with sporadic CJD, 42 with other neurological diseases, and 100 normal controls. Samples were masked and numbered by individuals independent of the assay and analysis. Each sample was tested twice in independent assay runs; only samples that were reactive in both runs were scored as positive overall. Findings We were able to distinguish a 10(-10) dilution of exogenous vCJD prion-infected brain from a 10(-6) dilution of normal brain (mean chemiluminescent signal, 1.3x10(5) [SD 1.1x10(4)] for vCJD vs 9.9x10(4)[4.5x10(3)] for normal brain; p<0.0001)-an assay sensitivity that was orders of magnitude higher than any previously reported. 15 samples in the masked panel were scored as positive. All 15 samples were from patients with vCJD, showing an assay sensitivity for vCJD of 71.4% (95% CI 47.8-88.7) and a specificity of 100% (95% Cis between 97.8% and 100%). Interpretation These initial studies provide a prototype blood test for diagnosis of vCJD in symptomatic individuals, which could allow development of large-scale screening tests for asymptomatic vCJD prion infection.	[Edgeworth, Julie Ann; Farmer, Michael; Sicilia, Anita; Tavares, Paul; Beck, Jonathan; Campbell, Tracy; Lowe, Jessica; Mead, Simon; Collinge, John; Jackson, Graham S.] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London WC1N 3BG, England; [Mead, Simon; Rudge, Peter; Collinge, John] Natl Hosp Neurol & Neurosurg, Natl Prion Clin, London WC1N 3BG, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Collinge, J (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk; g.s.jackson@prion.ucl.ac.uk	Mead, Simon/E-9414-2011	Mead, Simon/0000-0002-4326-1468; Jackson, Graham/0000-0002-3125-2011	UK Medical Research Council; Department of Health (England); University College London Hospital NHS Foundation Trust; Department of Health's NIHR Biomedical Research Centres; Medical Research Council [MC_U123160657, MC_U123170362] Funding Source: researchfish; MRC [MC_U123160657, MC_U123170362] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); University College London Hospital NHS Foundation Trust; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and families affected by prion and other neurodegenerative diseases for their kind and generous support of these studies; our neurological and other clinical colleagues across the UK for referring patients, particularly colleagues at the National CJD Surveillance Centre in Edinburgh with whom we coordinate patient referral and research under a national protocol; present and past staff of the National Prion Clinic and Dementia Research Centre at the National Hospital for Neurology and Neurosurgery and of the MRC Prion Unit for many years of work collecting, documenting, and curating our sample collections (in particular, we thank Andrew Thompson, Ana Lukic, Chris Carswell, Michelle Gorham, Liz Ford, Imogen Eastwood, Steve Wroe, Daffyd Thomas, Angus Kennedy, Tom Webb, Dune Siddique, Suvankar Pal, Gary Adamson, James Uphill, Mark Poulter, Huda Al-Doujaily, Sabeena Chaudary, Gosala Gopalakrishnan, Nick Fox, Jason Warren, Martin Rossor, Jonathan Rohrer, Natalie Ryan, Colin Mahoney, and Suzie Barker); Paul Bassett of the UCL Biomedical Research Unit for statistical advice and analysis; Ray Young for preparation of the figures; and Jonathan Wadsworth for his critical reading of the report and assistance with preparing the panel of masked samples. This research was funded by the UK Medical Research Council. The Department of Health (England) funds the National Prion Monitoring Cohort study. Some of the work was undertaken at University College London Hospital NHS Foundation Trust, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.	BARCIKOWSKA M, 1995, HISTOPATHOLOGY, V26, P445; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Duncan RE, 2005, J MED ETHICS, V31, P625, DOI 10.1136/jme.2005.011965; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; Ghani AC, 2002, CR BIOL, V325, P37, DOI 10.1016/S1631-0691(02)01389-6; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, LANCET, V368, P2226, DOI 10.1016/S0140-6736(06)69897-8; Health Protection Analytical Team Department of Health, 2008, 1006 SEAC DEP HLTH H; Hewitt PE, 2006, VOX SANG, V91, P348, DOI 10.1111/j.1423-0410.2006.00837.x; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Minor PD, 2004, VOX SANG, V86, P164, DOI 10.1111/j.0042-9007.2004.00411.x; National Prion Clinic, 2009, NATL PRION CLIN; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Spongiform Encephalopathy Advisory Committee, 2010, 1042 SEAC; Spongiform Encephalopathy Advisory Committee, 2008, 1002 SEAC; Tattum MH, 2010, TRANSFUSION, V50, P2619, DOI 10.1111/j.1537-2995.2010.02731.x; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wadsworth JDF, 2007, GUT, V56, P90, DOI 10.1136/gut.2006.091637; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	41	131	135	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					487	493		10.1016/S0140-6736(10)62308-2	http://dx.doi.org/10.1016/S0140-6736(10)62308-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21295339				2022-12-01	WOS:000287381800029
J	deMenocal, PB				deMenocal, Peter B.			Climate and Human Evolution	SCIENCE			English	Editorial Material							EAST-AFRICA; PLIOPLEISTOCENE; ECOSYSTEMS; NEOGENE; PERIOD; MA		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	deMenocal, PB (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	peter@ldeo.columbia.edu	demenocal, peter/B-1386-2013	demenocal, peter/0000-0002-7191-717X				Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobe Rene, 2009, P173, DOI 10.1007/978-1-4020-9980-9_15; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; DARWIN C, 2003, ORIGIN SPECIES MEANS, pCH3; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kingston JD, 2007, J HUM EVOL, V53, P487, DOI 10.1016/j.jhevol.2006.12.007; Lourens LJ, 1996, PALEOCEANOGRAPHY, V11, P391, DOI 10.1029/96PA01125; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; National Research Council, 2010, UND CLIM INFL HUM EV; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	23	158	162	5	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					540	542		10.1126/science.1190683	http://dx.doi.org/10.1126/science.1190683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292958				2022-12-01	WOS:000286933600032
J	Garfield, AS; Cowley, M; Smith, FM; Moorwood, K; Stewart-Cox, JE; Gilroy, K; Baker, S; Xia, J; Dalley, JW; Hurst, LD; Wilkinson, LS; Isles, AR; Ward, A				Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Gilroy, Kerry; Baker, Sian; Xia, Jing; Dalley, Jeffrey W.; Hurst, Laurence D.; Wilkinson, Lawrence S.; Isles, Anthony R.; Ward, Andrew			Distinct physiological and behavioural functions for parental alleles of imprinted Grb10	NATURE			English	Article							GENE-EXPRESSION; MOUSE; ACETYLCHOLINE; METHYLATION; DISRUPTION; DOMINANCE; GROWTH; MODEL; LEADS; MICE	Imprinted genes, defined by their preferential expression of a single parental allele, represent a subset of the mammalian genome and often have key roles in embryonic development(1), but also postnatal functions including energy homeostasis(2) and behaviour(3,4). When the two parental alleles are unequally represented within a social group (when there is sex bias in dispersal and/or variance in reproductive success)(5,6), imprinted genes may evolve to modulate social behaviour, although so far no such instance is known. Predominantly expressed from the maternal allele during embryogenesis, Grb10 encodes an intracellular adaptor protein that can interact with several receptor tyrosine kinases and downstream signalling molecules(7). Here we demonstrate that within the brain Grb10 is expressed from the paternal allele from fetal life into adulthood and that ablation of this expression engenders increased social dominance specifically among other aspects of social behaviour, a finding supported by the observed increase in allogrooming by paternal Grb10-deficient animals. Grb10 is, therefore, the first example of an imprinted gene that regulates social behaviour. It is also currently alone in exhibiting imprinted expression from each of the parental alleles in a tissue-specific manner, as loss of the peripherally expressed maternal allele leads to significant fetal and placental overgrowth. Thus Grb10 is, so far, a unique imprinted gene, able to influence distinct physiological processes, fetal growth and adult behaviour, owing to actions of the two parental alleles in different tissues.	[Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Hurst, Laurence D.; Ward, Andrew] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Hurst, Laurence D.; Ward, Andrew] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Garfield, Alastair S.; Gilroy, Kerry; Baker, Sian; Wilkinson, Lawrence S.; Isles, Anthony R.] Cardiff Univ, Sch Med, Neurosci & Mental Hlth Res Inst, MRC,Ctr Neuropsychiat Genet & Genom,Behav Genet G, Cardiff CF14 4XN, S Glam, Wales; [Garfield, Alastair S.; Gilroy, Kerry; Baker, Sian; Wilkinson, Lawrence S.; Isles, Anthony R.] Cardiff Univ, Sch Psychol, Neurosci & Mental Hlth Res Inst, MRC,Ctr Neuropsychiat Genet & Genom,Behav Genet G, Cardiff CF14 4XN, S Glam, Wales; [Xia, Jing; Dalley, Jeffrey W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Xia, Jing; Dalley, Jeffrey W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Dalley, Jeffrey W.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England	University of Bath; University of Bath; Cardiff University; Cardiff University; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ward, A (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	bssaw@bath.ac.uk	Cowley, Mike/B-9425-2013; Hurst, Laurence/F-9215-2010	Dalley, Jeffrey/0000-0002-2282-3660; Cowley, Michael/0000-0001-8564-4224; Ward, Andrew/0000-0001-8311-5695; Hurst, Laurence/0000-0002-1002-1054; Garfield, Alastair/0000-0002-9628-6140; Isles, Anthony/0000-0002-7587-5712; Moorwood, Kim/0000-0003-0943-6161	Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust; Medical Research Council [G0001354B, G1000183B, G0001354, G0801418B, G0300415] Funding Source: researchfish; MRC [G0300415] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Wonnacott for reagents, the University of Bath Biological Services Unit and S. Routley for technical assistance, I. Jones and P. Mitchell for advice and C. Tickle for comments on the manuscript. We acknowledge funding of the work from the Biotechnology and Biological Sciences Research Council, Medical Research Council, Wellcome Trust and external benefactors.	Ainscough JFX, 1997, DEVELOPMENT, V124, P3621; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Behringer R., 2003, MANIPULATING MOUSE E; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Haig D, 2000, ANN NY ACAD SCI, V907, P149, DOI 10.1111/j.1749-6632.2000.tb06621.x; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Isles AR, 2006, PHILOS T R SOC B, V361, P2229, DOI 10.1098/rstb.2006.1942; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; Kaplan JR, 2002, NEUROPSYCHOPHARMACOL, V26, P431, DOI 10.1016/S0893-133X(01)00344-X; Keverne B, 2009, BIOESSAYS, V31, P1318, DOI 10.1002/bies.200900074; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Monk D, 2009, HUM MOL GENET, V18, P3066, DOI 10.1093/hmg/ddp248; MORALES MA, 1995, P NATL ACAD SCI USA, V92, P11819, DOI 10.1073/pnas.92.25.11819; Nevison CM, 2003, P ROY SOC B-BIOL SCI, V270, P1957, DOI 10.1098/rspb.2003.2452; Plagge A, 2005, MOL CELL BIOL, V25, P3019, DOI 10.1128/MCB.25.8.3019-3026.2005; Przydzial MJ, 2010, BEHAV BRAIN RES, V206, P313, DOI 10.1016/j.bbr.2009.09.017; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rousseau SJ, 2005, NEUROPHARMACOLOGY, V49, P59, DOI 10.1016/j.neuropharm.2005.01.030; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Sarna JR, 2000, BEHAV BRAIN RES, V108, P39, DOI 10.1016/S0166-4328(99)00137-0; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Ubeda F, 2010, EVOLUTION, V64, P2587, DOI 10.1111/j.1558-5646.2010.01015.x; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Yamasaki-Ishizaki Y, 2007, MOL CELL BIOL, V27, P732, DOI 10.1128/MCB.01329-06	36	141	144	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					534	U101		10.1038/nature09651	http://dx.doi.org/10.1038/nature09651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270893	Green Accepted			2022-12-01	WOS:000286596500033
J	Amato, S; Liu, XX; Zheng, B; Cantley, L; Rakic, P; Man, HY				Amato, Stephen; Liu, Xiuxin; Zheng, Bin; Cantley, Lewis; Rakic, Pasko; Man, Heng-Ye			AMP-Activated Protein Kinase Regulates Neuronal Polarization by Interfering with PI 3-Kinase Localization	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; BRAIN-DEVELOPMENT; AXONAL-TRANSPORT; POLARITY; TRANSLOCATION; KINESIN-1; MIGRATION; CULTURE; GROWTH; ENERGY	Axon-dendrite polarization is crucial for neural network wiring and information processing in the brain. Polarization begins with the transformation of a single neurite into an axon and its subsequent rapid extension, which requires coordination of cellular energy status to allow for transport of building materials to support axon growth. We found that activation of the energy-sensing adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway suppressed axon initiation and neuronal polarization. Phosphorylation of the kinesin light chain of the Kif5 motor protein by AMPK disrupted the association of the motor with phosphatidylinositol 3-kinase (PI3K), preventing PI3K targeting to the axonal tip and inhibiting polarization and axon growth.	[Amato, Stephen; Man, Heng-Ye] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Liu, Xiuxin; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Liu, Xiuxin; Rakic, Pasko] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Zheng, Bin; Cantley, Lewis] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Zheng, Bin; Cantley, Lewis] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Boston University; Yale University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Man, HY (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	hman@bu.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Zheng, Bin/0000-0002-0998-7177	Kavli Institute; NAAR/Autism Speaks fellowship;  [MH07907];  [GM56203];  [GM41890];  [K99CA133245]; NATIONAL CANCER INSTITUTE [K99CA133245, R00CA133245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041890, R01GM056203, R01GM041890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER	Kavli Institute; NAAR/Autism Speaks fellowship; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. R. Luo for providing EGFP-PH, K. Hasimoto-Torii for GFP virus, and J. Asara for assistance with mass spectrometry. This research was supported by MH07907 (H.-Y.M), GM56203 and GM41890 (L. C. C.), K99CA133245 (B.Z.), the Kavli Institute (P. R.), and a NAAR/Autism Speaks fellowship (X.L.).	Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jareb M, 1997, J NEUROSCI, V17, P8955; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Katagiri H, 1996, J BIOL CHEM, V271, P16987, DOI 10.1074/jbc.271.29.16987; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; NAKATA T, 2007, SCI STKE, pPE6; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Tabata H, 2003, J NEUROSCI, V23, P9996; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010	29	102	104	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					247	251		10.1126/science.1201678	http://dx.doi.org/10.1126/science.1201678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21436401	Green Accepted			2022-12-01	WOS:000289251100055
J	Kivimaki, M; Batty, GD; Hamer, M; Ferrie, JE; Vahtera, J; Virtanen, M; Marmot, MG; Singh-Manoux, A; Shipley, MJ				Kivimaeki, Mika; Batty, G. David; Hamer, Mark; Ferrie, Jane E.; Vahtera, Jussi; Virtanen, Marianna; Marmot, Michael G.; Singh-Manoux, Archana; Shipley, Martin J.			Using Additional Information on Working Hours to Predict Coronary Heart Disease	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; JAPANESE WORKERS; OVERTIME WORK; RISK-FACTOR; PREVENTION; STATEMENT; CURVE; SCORE; AREA	Background: Long working hours are associated with increased risk for coronary heart disease (CHD). Adding information on long hours to traditional risk factors for CHD may help to improve risk prediction for this condition. Objective: To examine whether information on long working hours improves the ability of the Framingham risk model to predict CHD in a low-risk, employed population. Design: Cohort study with baseline medical examination performed between 1991 and 1993 and prospective follow-up for incident CHD performed until 2004. Setting: Civil service departments in London (the Whitehall II study). Participants: 7095 adults (2109 women and 4986 men) aged 39 to 62 years working full-time without CHD at baseline. Measurements: Working hours and the Framingham risk score were measured at baseline. Coronary death and nonfatal myocardial infarction were ascertained from medical screenings every 5 years, hospital data, and registry linkage. Results: 192 participants had incident CHD during a median 12.3-year follow-up. After adjustment for their Framingham risk score, participants working 11 hours or more per day had a 1.67-fold (95% CI, 1.10-to 2.55-fold) increased risk for CHD compared with participants working 7 to 8 hours per day. Adding working hours to the Framingham risk score led to a net reclassification improvement of 4.7% (P = 0.034) due to better identification of persons who later developed CHD (sensitivity gain). Limitation: The findings may not be generalizable to populations with a larger proportion of high-risk persons and were not validated in an independent cohort. Conclusion: Information on working hours may improve risk prediction of CHD on the basis of the Framingham risk score in low-risk, working populations.	[Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Turku, FI-20520 Turku, Finland; Turku Univ Hosp, FI-20520 Turku, Finland; Finnish Inst Occupat Hlth, FI-00250 Helsinki, Finland; Univ Helsinki, FI-00250 Helsinki, Finland; INSERM, F-75654 Paris 13, France	University of London; University College London; University of Turku; University of Turku; Finnish Institute of Occupational Health; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Singh-Manoux, Archana/F-6804-2013; Vahtera, Jussi/J-3271-2013; Marmot, M G/Y-3920-2019; Kivimaki, Mika/B-3607-2012; Batty, GD/Y-4401-2018; Hamer, Mark/AAJ-6814-2021; Hamer, Mark/C-1602-2008; Ferrie, Jane/AAZ-2009-2020	Singh-Manoux, Archana/0000-0002-1244-5037; Marmot, M G/0000-0002-2431-6419; Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753; Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Vahtera, Jussi/0000-0002-6036-061X	Medical Research Council; British Heart Foundation; Bupa Foundation; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health; Wellcome Trust; Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; Academy of Finland; NEW OSH ERA; European Science Foundation; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G8802774, G19/35, G0902037] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Bupa Foundation; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome Trust); Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; Academy of Finland(Academy of Finland); NEW OSH ERA; European Science Foundation(European Science Foundation (ESF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Medical Research Council; British Heart Foundation; Bupa Foundation; and the National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health.r By the Medical Research Council; British Heart Foundation; Wellcome Trust; Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health; Academy of Finland; NEW OSH ERA Research Programme; and European Science Foundation. Drs. Kivimaki and Vahtera are supported by the Academy of Finland, Dr. Batty is a Wellcome Trust Fellow, Dr. Ferrie is supported by the Medical Research Council, Dr. Marmot is a Medical Research Council professor, Dr. Singh-Manoux is supported by a European Young Investigator Award from the European Science Foundation, and Mr. Shipley is supported by the British Heart Foundation.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; ARMITAGE P, 1977, STAT METHODS MED RES; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P1; BUELL P, 1960, J Chronic Dis, V11, P615, DOI 10.1016/0021-9681(60)90060-6; Caruso CC, 2004, DHHS NIOSH PUBLICATI, DOI 10.26616/NIOSHPUB2004143; Cook NR, 2010, CURR CARDIOVASC RISK, V4, P112, DOI 10.1007/s12170-010-0084-x; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; FALGER PRJ, 1992, J PSYCHOSOM RES, V36, P777, DOI 10.1016/0022-3999(92)90136-P; Fukuoka Y, 2005, INT J CARDIOL, V100, P29, DOI 10.1016/j.ijcard.2004.04.003; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Holtermann A, 2010, HEART, V96, P1638, DOI 10.1136/hrt.2010.197145; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; LIU L, 2009, SAS GLOB FOR 2009 WA; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; Mannan H, 2010, J EVAL CLIN PRACT, V16, P756, DOI 10.1111/j.1365-2753.2009.01190.x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; *ORG EC COOP DEV, 2004, OECD EMPL OUTL REC L; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Rose G.A., 1982, CARDIOVASCULAR SURVE; *SAS I, JACKKN BOOTSTR AN; SHAFER JL, 1997, ANAL INCOMPLETE MULT; Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Tarumi K, 2003, IND HEALTH, V41, P101, DOI 10.2486/indhealth.41.101; THEORELL T, 1972, J CHRON DIS, V25, P139, DOI 10.1016/0021-9681(72)90170-1; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Uchiyama S, 2005, J OCCUP HEALTH, V47, P102, DOI 10.1539/joh.47.102; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	43	61	62	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							457	10.7326/0003-4819-154-7-201104050-00003	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464347	Green Accepted			2022-12-01	WOS:000289078700002
J	Lammens, K; Bemeleit, DJ; Mockel, C; Clausing, E; Schele, A; Hartung, S; Schiller, CB; Lucas, M; Angermuller, C; Soding, J; Strasser, K; Hopfner, KP				Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter			The Mre11:Rad50 Structure Shows an ATP-Dependent Molecular Clamp in DNA Double-Strand Break Repair	CELL			English	Article							MRE11 COMPLEX; ESCHERICHIA-COLI; DAMAGE RESPONSE; PROTEIN COMPLEX; KINASE-ACTIVITY; RECOMBINATION; CHROMOSOME; RAD50; SBCCD; MECHANISMS	The MR (Mre11 nuclease and Rad50 ABC ATPase) complex is an evolutionarily conserved sensor for DNA double-strand breaks, highly genotoxic lesions linked to cancer development. MR can recognize and process DNA ends even if they are blocked and mis-folded. To reveal its mechanism, we determined the crystal structure of the catalytic head of Thermotoga maritima MR and analyzed ATP-dependent conformational changes. MR adopts an open form with a central Mre11 nuclease dimer and two peripheral Rad50 molecules, a form suited for sensing obstructed breaks. The Mre11 C-terminal helix-loophelix domain binds Rad50 and attaches flexibly to the nuclease domain, enabling large conformational changes. ATP binding to the two Rad50 subunits induces a rotation of the Mre11 helix-loop-helix and Rad50 coiled-coil domains, creating a clamp conformation with increased DNA-binding activity. The results suggest that MR is an ATP-controlled transient molecular clamp at DNA double-strand breaks.	[Lammens, Katja; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, CIPSM, D-81377 Munich, Germany; [Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Hopfner, Karl-Peter] Univ Munich, Munich Ctr Adv Photon, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, CIPSM, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Söding, Johannes/A-3341-2013; Hopfner, Karl-Peter/B-6864-2014; Lucas, Maria/G-9788-2012	Söding, Johannes/0000-0001-9642-8244; Hopfner, Karl-Peter/0000-0002-4528-8357; Lucas, Maria/0000-0002-7854-4249; Strasser, Katja/0000-0003-3533-5516	German Research Council [SFBs 684, 646, TR5]; German Excellence Initiative (CIPSM); European Commission; NIH [U19AI83025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	German Research Council(German Research Foundation (DFG)); German Excellence Initiative (CIPSM); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank John Petrini for his gift of an alpha-Mre11 antibody. We thank Britta Coordes for help with the yeast work and members of the Hopfner lab, especially Matthew Bennett, Gregor Witte, and Alfred Lammens, for discussions. We thank the staffs of the Swiss Light Source (Villingen), European Synchrotron Radiation Facility (Grenoble), German Electron Synchrotron (Hamburg), and Advanced Light Source (Berkeley) for technical support. We thank the Max-Planck-Crystallization Facility (Martinsried) for crystallization trials. This work was funded by grants from the German Research Council (SFBs 684, 646, and TR5), the German Excellence Initiative (CIPSM), European Commission (IP DNA repair), and NIH U19AI83025.	Bentchikou E, 2007, J BACTERIOL, V189, P4784, DOI 10.1128/JB.00452-07; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chamankhah M, 1999, NUCLEIC ACIDS RES, V27, P2072, DOI 10.1093/nar/27.10.2072; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Mascarenhas J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-20; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/s0079-6603(08)60611-x; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Zahradka K, 2009, J BACTERIOL, V191, P1677, DOI 10.1128/JB.01877-07; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	47	157	160	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					54	66		10.1016/j.cell.2011.02.038	http://dx.doi.org/10.1016/j.cell.2011.02.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458667	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-01	WOS:000289053900009
J	Tsaytler, P; Harding, HP; Ron, D; Bertolotti, A				Tsaytler, Pavel; Harding, Heather P.; Ron, David; Bertolotti, Anne			Selective Inhibition of a Regulatory Subunit of Protein Phosphatase 1 Restores Proteostasis	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; STRESS; DEPHOSPHORYLATION; EIF2-ALPHA; GUANABENZ; DEATH	Many biological processes are regulated through the selective dephosphorylation of proteins. Protein serine-threonine phosphatases are assembled from catalytic subunits bound to diverse regulatory subunits that provide substrate specificity and subcellular localization. We describe a small molecule, guanabenz, that bound to a regulatory subunit of protein phosphatase 1, PPP1R15A/GADD34, selectively disrupting the stress-induced dephosphorylation of the a subunit of translation initiation factor 2 (eIF2 alpha). Without affecting the related PPP1R15B-phosphatase complex and constitutive protein synthesis, guanabenz prolonged eIF2 alpha phosphorylation in human stressed cells, adjusting the protein production rates to levels manageable by available chaperones. This favored protein folding and thereby rescued cells from protein misfolding stress. Thus, regulatory subunits of phosphatases are drug targets, a property used here to restore proteostasis in stressed cells.	[Tsaytler, Pavel; Bertolotti, Anne] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Harding, Heather P.; Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; University of Cambridge	Bertolotti, A (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	aberto@mrc-lmb.cam.ac.uk		Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974	UK Medical Research Council; MRC [MC_U105185860] Funding Source: UKRI; Medical Research Council [MC_U105185860, G0600717B] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Merritt and C. Wallace for biotinylated guanabenz, J. Hastie for purified recombinant PP1c, anonymous reviewers for suggestions, and M. Goedert for advice on the manuscript. Supported by the UK Medical Research Council. D. R. is a Wellcome Trust Principal Research Fellow. A. B. is a co-inventor on patent WO/2008/041133.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431	15	374	392	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					91	94		10.1126/science.1201396	http://dx.doi.org/10.1126/science.1201396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21385720				2022-12-01	WOS:000289000000044
J	Deltcheva, E; Chylinski, K; Sharma, CM; Gonzales, K; Chao, YJ; Pirzada, ZA; Eckert, MR; Vogel, J; Charpentier, E				Deltcheva, Elitza; Chylinski, Krzysztof; Sharma, Cynthia M.; Gonzales, Karine; Chao, Yanjie; Pirzada, Zaid A.; Eckert, Maria R.; Vogel, Joerg; Charpentier, Emmanuelle			CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III	NATURE			English	Article							PROVIDES ACQUIRED-RESISTANCE; IMMUNE-SYSTEM; BACTERIA; REPEATS; GENE; ENDORIBONUCLEASE; MECHANISMS; VIRULENCE; PHAGES; DNA	CRISPR/Cas systems constitute a widespread class of immunity systems that protect bacteria and archaea against phages and plasmids, and commonly use repeat/spacer-derived short crRNAs to silence foreign nucleic acids in a sequence-specific manner. Although the maturation of crRNAs represents a key event in CRISPR activation, the responsible endoribonucleases (CasE, Cas6, Csy4) are missing in many CRISPR/Cas subtypes. Here, differential RNA sequencing of the human pathogen Streptococcus pyogenes uncovered tracrRNA, a trans-encoded small RNA with 24-nucleotide complementarity to the repeat regions of crRNA precursor transcripts. We show that tracrRNA directs the maturation of crRNAs by the activities of the widely conserved endogenous RNase III and the CRISPR-associated Csn1 protein; all these components are essential to protect S. pyogenes against prophage-derived DNA. Our study reveals a novel pathway of small guide RNA maturation and the first example of a host factor (RNase III) required for bacterial RNA-mediated immunity against invaders.	[Deltcheva, Elitza; Chylinski, Krzysztof; Charpentier, Emmanuelle] Umea Univ, Dept Mol Biol, UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Deltcheva, Elitza; Chylinski, Krzysztof; Gonzales, Karine; Pirzada, Zaid A.; Eckert, Maria R.; Charpentier, Emmanuelle] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Sharma, Cynthia M.; Chao, Yanjie; Vogel, Joerg] Univ Wurzburg, ZINF Res Ctr Infect Dis, D-97080 Wurzburg, Germany; [Chao, Yanjie; Vogel, Joerg] Univ Wurzburg, RNA Biol Grp, Inst Mol Infect Biol, D-97080 Wurzburg, Germany	Umea University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Wurzburg; University of Wurzburg	Charpentier, E (corresponding author), Umea Univ, Dept Mol Biol, UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.	emmanuelle.charpentier@mims.umu.se	Chao, Yanjie/J-1931-2014; Sharma, Cynthia/D-2869-2013; Vogel, Jörg/D-5574-2011	Chao, Yanjie/0000-0002-5735-7954; Vogel, Jörg/0000-0003-2220-1404; Kohrer, Karine Anne/0000-0001-6713-2540; Chylinski, Krzysztof/0000-0001-7029-8090; Sharma, Cynthia Mira/0000-0002-2321-9705	European Community [BACRNAs-018618]; Austrian Science Fund (FWF) [P17238-B09, W1207-B09]; Austrian Agency for Research Promotion (FFG) [812138-SCK/KUG]; Theodor Korner Fonds; Umea University; Swedish Research Council; IMPRS-IDI; German Research Council (DFG) [SPP1258, Vo875/4]; German Ministry of Education and Research (BMBF) [01GS0806/JV-BMBF-01, 0315836]	European Community(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Agency for Research Promotion (FFG); Theodor Korner Fonds; Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission); IMPRS-IDI; German Research Council (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank D. Veit for technical help. This work was funded by the European Community (FP6, BACRNAs-018618; E.C.), the Austrian Science Fund (FWF, P17238-B09 (E.C.) and W1207-B09 (E.C., K.C.)), the Austrian Agency for Research Promotion (FFG, 812138-SCK/KUG; E.C.), the Theodor Korner Fonds (E.C.), Umea University (E.C.), the Swedish Research Council (E.C.), IMPRS-IDI (Y.C.), the German Research Council (DFG Priority Program "Sensory and Regulatory RNAs in Prokaryotes'' SPP1258, Vo875/4; J.V.), and the German Ministry of Education and Research (BMBF, 01GS0806/JV-BMBF-01 and 0315836; J.V.).	Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Drider D, 2004, J MOL MICROB BIOTECH, V8, P195, DOI 10.1159/000086700; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fischetti VA, 2007, TRENDS MICROBIOL, V15, P297, DOI 10.1016/j.tim.2007.05.003; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Koonin Eugene V, 2009, F1000 Biol Rep, V1, P95; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1111/j.1574-6976.1999.tb00405.x; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Siller M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-188; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; van der Oost J, 2009, CELL, V139, P863, DOI 10.1016/j.cell.2009.11.018; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Vogel J, 2004, CURR BIOL, V14, P2271, DOI 10.1016/j.cub.2004.12.003; Vojtek I, 2008, J INFECT DIS, V197, P225, DOI 10.1086/524687; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	66	1480	1957	36	792	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					602	+		10.1038/nature09886	http://dx.doi.org/10.1038/nature09886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455174	Green Accepted			2022-12-01	WOS:000288951200035
J	Buchen, L				Buchen, Lizzie			MISSING THE MARK	NATURE			English	News Item							DIAGNOSTIC MARKERS; BIOMARKERS; READY											Berg AO, 2009, GENET MED, V11, P66, DOI 10.1097/GIM.0b013e3181928f56; Coates RJ, 2008, CLIN CANCER RES, V14, P7575, DOI 10.1158/1078-0432.CCR-08-2296; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Greene MH, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-2232; Mai PL, 2011, CANCER PREV RES, V4, P303, DOI 10.1158/1940-6207.CAPR-11-0053; McIntosh M, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-0623; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mor G., 2009, P AM ASS CANC RES AA; Mor G, 2008, CLIN CANCER RES, V14, P7577, DOI 10.1158/1078-0432.CCR-08-2621; Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	13	56	56	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					428	432		10.1038/471428a	http://dx.doi.org/10.1038/471428a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430749	Bronze			2022-12-01	WOS:000288702200030
J	Dillner, L				Dillner, Luisa			Long term conditions How services for long term conditions could be reborn	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Department of Health, 2011, FUNCT GP COMM CONS W	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2011	342								d1730	10.1136/bmj.d1730	http://dx.doi.org/10.1136/bmj.d1730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MF	21427039				2022-12-01	WOS:000288947500008
J	Pe'er, D; Hacohen, N				Pe'er, Dana; Hacohen, Nir			Principles and Strategies for Developing Network Models in Cancer	CELL			English	Article							TRANSCRIPTIONAL NETWORK; IDENTIFICATION; INHIBITION; GENE; MAP; ACTIVATION; REGULATORS; DYNAMICS; GENOME; MODULE	The flood of genome-wide data generated by high-throughput technologies currently provides biologists with an unprecedented opportunity: to manipulate, query, and reconstruct functional molecular networks of cells. Here, we outline three underlying principles and six strategies to infer network models from genomic data. Then, using cancer as an example, we describe experimental and computational approaches to infer "differential" networks that can identify genes and processes driving disease phenotypes. In conclusion, we discuss how a network-level understanding of cancer can be used to predict drug response and guide therapeutics.	[Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Pe'er, Dana] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	dpeer@biology.columbia.edu	Califano, Andrea/F-7239-2012	Pe'er, Dana/0000-0002-9259-8817	NIH [DP2-OD002414-01, DP2 OD002230]; NIAID [U54 AI057159]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414, DP2OD002230] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Arnon Arazi, Andrea Califano, William Hahn, Andreja Jovic, Oren Litvin, Neal Rosen, Sagi Shapira, and Cathy Wu for valuable comments. The authors would like to thank Oren Litvin for help with the illustrations. This research was supported by the NIH Director's New Innovator Award Program through grant numbers DP2-OD002414-01 (D.P.) and DP2 OD002230 (N.H.), as well as NIAID U54 AI057159 (N.H.). D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Litvin O, 2009, P NATL ACAD SCI USA, V106, P6441, DOI 10.1073/pnas.0810208106; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sachs K, 2009, J COMPUT BIOL, V16, P201, DOI 10.1089/cmb.2008.07TT; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	48	132	133	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					864	873		10.1016/j.cell.2011.03.001	http://dx.doi.org/10.1016/j.cell.2011.03.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414479	Bronze, Green Accepted			2022-12-01	WOS:000288543500006
J	Turtle, EP; Perry, JE; Hayes, AG; Lorenz, RD; Barnes, JW; McEwen, AS; West, RA; Del Genio, AD; Barbara, JM; Lunine, JI; Schaller, EL; Ray, TL; Lopes, RMC; Stofan, ER				Turtle, E. P.; Perry, J. E.; Hayes, A. G.; Lorenz, R. D.; Barnes, J. W.; McEwen, A. S.; West, R. A.; Del Genio, A. D.; Barbara, J. M.; Lunine, J. I.; Schaller, E. L.; Ray, T. L.; Lopes, R. M. C.; Stofan, E. R.			Rapid and Extensive Surface Changes Near Titan's Equator: Evidence of April Showers	SCIENCE			English	Article							REFLECTANCE; CONSTRAINTS; ATMOSPHERE; STORMS; RAIN; WET; DRY	Although there is evidence that liquids have flowed on the surface at Titan's equator in the past, to date, liquids have only been confirmed on the surface at polar latitudes, and the vast expanses of dunes that dominate Titan's equatorial regions require a predominantly arid climate. We report the detection by Cassini's Imaging Science Subsystem of a large low-latitude cloud system early in Titan's northern spring and extensive surface changes (spanning more than 500,000 square kilometers) in the wake of this storm. The changes are most consistent with widespread methane rainfall reaching the surface, which suggests that the dry channels observed at Titan's low latitudes are carved by seasonal precipitation.	[Turtle, E. P.; Lorenz, R. D.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Perry, J. E.; McEwen, A. S.; Schaller, E. L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Hayes, A. G.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Barnes, J. W.] Univ Idaho, Dept Phys, Moscow, ID 83844 USA; [West, R. A.; Ray, T. L.; Lopes, R. M. C.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Del Genio, A. D.; Barbara, J. M.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Lunine, J. I.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Stofan, E. R.] Proxemy Res, Rectortown, VA 20140 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; California Institute of Technology; Idaho; University of Idaho; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Rome Tor Vergata	Turtle, EP (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	elizabeth.turtle@jhuapl.edu	Del Genio, Anthony/D-4663-2012; Barnes, Jason W/B-1284-2009; Lorenz, Ralph D/B-8759-2016; Turtle, Elizabeth/K-8673-2012; Lopes, Rosaly M.C./D-1608-2016; Hayes, Alexander G/P-2024-2014	Del Genio, Anthony/0000-0001-7450-1359; Barnes, Jason W/0000-0002-7755-3530; Lorenz, Ralph D/0000-0001-8528-4644; Turtle, Elizabeth/0000-0003-1423-5751; Lopes, Rosaly M.C./0000-0002-7928-3167; Hayes, Alexander G/0000-0001-6397-2630; Schaller, Emily/0000-0001-8967-5423; Lunine, Jonathan/0000-0003-2279-4131; Barbara, John/0000-0002-2190-4290	Cassini-Huygens mission; NASA; ESA; ASI; Hubble Postdoctoral Fellowship	Cassini-Huygens mission; NASA(National Aeronautics & Space Administration (NASA)); ESA(European Space Agency); ASI(Agenzia Spaziale Italiana (ASI)); Hubble Postdoctoral Fellowship	We are grateful to all who developed and operate the Cassini-Huygens mission and to two very helpful anonymous reviewers. Research was supported by the Cassini-Huygens mission, a cooperative project of NASA, ESA, and ASI, managed by JPL, a division of the California Institute of Technology, under a contract with NASA. Supported by a Hubble Postdoctoral Fellowship (E.L.S.).	Almeida MP, 2008, P NATL ACAD SCI USA, V105, P6222, DOI 10.1073/pnas.0800202105; Brown ME, 2009, ASTROPHYS J LETT, V706, pL110, DOI 10.1088/0004-637X/706/1/L110; Clark RN, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003369; Collins GC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024551; Griffith CA, 2009, ASTROPHYS J LETT, V702, pL105, DOI 10.1088/0004-637X/702/2/L105; Griffith CA, 2008, ASTROPHYS J LETT, V687, pL41, DOI 10.1086/593117; Hayes A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033409; Hayes AG, 2011, ICARUS, V211, P655, DOI 10.1016/j.icarus.2010.08.017; Jaumann R, 2008, ICARUS, V197, P526, DOI 10.1016/j.icarus.2008.06.002; Karkoschka E, 2009, ICARUS, V199, P442, DOI 10.1016/j.icarus.2008.09.020; Lopes RMC, 2010, ICARUS, V205, P540, DOI 10.1016/j.icarus.2009.08.010; Lorenz RD, 2008, PLANET SPACE SCI, V56, P1132, DOI 10.1016/j.pss.2008.02.009; Lorenz RD, 2006, METEORIT PLANET SCI, V41, P1705, DOI 10.1111/j.1945-5100.2006.tb00446.x; Lorenz RD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036850; Lorenz RD, 1995, J GEOPHYS RES-PLANET, V100, P26377, DOI 10.1029/95JE02708; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Lorenz RD, 1996, PLANET SPACE SCI, V44, P1021, DOI 10.1016/0032-0633(95)00139-5; Mitchell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003017; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Schaller EL, 2009, NATURE, V460, P873, DOI 10.1038/nature08193; Schaller EL, 2006, ICARUS, V182, P224, DOI 10.1016/j.icarus.2005.12.021; Self S., 1997, GEOPH MONOG SERIES, P381; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2025, DOI 10.1016/j.pss.2007.04.014; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2015, DOI 10.1016/j.pss.2007.04.015; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tokano T, 2006, NATURE, V442, P432, DOI 10.1038/nature04948; Tokano T, 2010, AEOLIAN RES, V2, P113, DOI 10.1016/j.aeolia.2010.04.003; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; Turtle EP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046266; Turtle EP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036186; TWOMEY SA, 1986, APPL OPTICS, V25, P431, DOI 10.1364/AO.25.000431; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; Zhang H, 2006, APPL OPTICS, V45, P8753, DOI 10.1364/AO.45.008753	34	147	149	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1414	1417		10.1126/science.1201063	http://dx.doi.org/10.1126/science.1201063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415347				2022-12-01	WOS:000288504000034
J	Burden, SJ				Burden, Steven J.			SnapShot: Neuromuscular Junction	CELL			English	Editorial Material							MUSCLE; DOK-7; MUSK		[Burden, Steven J.] New York Univ Med Sch, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University				Burden, Steven/0000-0002-3550-6891				Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Farrugia ME, 2010, CURR OPIN NEUROL, V23, P489, DOI 10.1097/WCO.0b013e32833cc968; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711	10	36	36	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					826	827		10.1016/j.cell.2011.02.037	http://dx.doi.org/10.1016/j.cell.2011.02.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376240	Bronze			2022-12-01	WOS:000288007100022
J	Sinnott, M; Shaban, RZ				Sinnott, Michael; Shaban, Ramon Z.			Personal View Can we have a culture of patient safety without one of staff safety?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinnott, Michael; Shaban, Ramon Z.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Sinnott, Michael] Univ Queensland, Brisbane, Qld, Australia; [Shaban, Ramon Z.] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia	University of Queensland; Griffith University; Menzies Health Institute Queensland	Sinnott, M (corresponding author), Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	michael_sinnott@health.qld.gov.au	Sinnott, Michael/D-1155-2012	Sinnott, Michael/0000-0002-2338-3126; Shaban, Ramon/0000-0002-5203-0557				Occupational Safety and Health Administration, 2008, OCC SAF HLTH STAND; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; SINNOTT M, 2010, PERIOPERAT NURS CLIN, V5, P59; *SOC THOR SURG, 2009, HIST PAT SAF PAT SAF; Tseng D, 2005, INFECT DIS HEALTH, V10, P89, DOI 10.1071/HI05089	5	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2011	342								c6171	10.1136/bmj.c6171	http://dx.doi.org/10.1136/bmj.c6171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EU	21378073	Green Published			2022-12-01	WOS:000288168600001
J	Lister, R; Pelizzola, M; Kida, YS; Hawkins, RD; Nery, JR; Hon, G; Antosiewicz-Bourget, J; O'Malley, R; Castanon, R; Klugman, S; Downes, M; Yu, R; Stewart, R; Ren, B; Thomson, JA; Evans, RM; Ecker, JR				Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R.			Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells	NATURE			English	Article							DNA METHYLATION; DIFFERENTIATION; GENES; MICE	Induced pluripotent stem cells (iPSCs) offer immense potential for regenerative medicine and studies of disease and development. Somatic cell reprogramming involves epigenomic reconfiguration, conferring iPSCs with characteristics similar to embryonic stem (ES) cells. However, it remains unknown how complete the reestablishment of ES-cell-like DNA methylation patterns is throughout the genome. Here we report the first whole-genome profiles of DNA methylation at single-base resolution in five human iPSC lines, along with methylomes of ES cells, somatic cells, and differentiated iPSCs and ES cells. iPSCs show significant reprogramming variability, including somatic memory and aberrant reprogramming of DNA methylation. iPSCs share megabase-scale differentially methylated regions proximal to centromeres and telomeres that display incomplete reprogramming of non-CG methylation, and differences in CG methylation and histone modifications. Lastly, differentiation of iPSCs into trophoblast cells revealed that errors in reprogramming CG methylation are transmitted at a high frequency, providing an iPSC reprogramming signature that is maintained after differentiation.	[Lister, Ryan; Pelizzola, Mattia; Nery, Joseph R.; O'Malley, Ronan; Castanon, Rosa; Ecker, Joseph R.] Salk Inst Biol Studies, Genome Anal Lab, La Jolla, CA 92037 USA; [Kida, Yasuyuki S.; Downes, Michael; Yu, Ruth; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hawkins, R. David; Hon, Gary; Klugman, Sarit; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Ludwig Institute for Cancer Research; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genome Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	kida, yasuyuki S/J-1718-2018; Nery, Joseph/AAE-8422-2019; Ecker, Joseph R/B-9144-2008; Evans, Ronald/AAF-4001-2019; Lister, Ryan/B-5168-2012	kida, yasuyuki S/0000-0002-9972-293X; Nery, Joseph/0000-0003-0153-5659; Ecker, Joseph R/0000-0001-5799-5895; Evans, Ronald/0000-0002-9986-5965; Lister, Ryan/0000-0001-6637-7239; Pelizzola, Mattia/0000-0001-6672-9636	California Institute; Catharina Foundation; American Cancer Society; Japan Society for the Promotion of Science; Mary K. Chapman Foundation; National Science Foundation (NSF) [NSF 0726408]; National Institutes of Health (NIH) [U01 ES017166, U01 1U01ES017166-01, DK062434]; California Institute for Regenerative Medicine [RB2-01530]; Morgridge Institute for Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	California Institute; Catharina Foundation; American Cancer Society(American Cancer Society); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mary K. Chapman Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Morgridge Institute for Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Zhang and G. Schroth for assistance with MethylC-Seq library sequencing. R.L. is supported by a California Institute for Regenerative Medicine Training Grant. M.P. is supported by a Catharina Foundation postdoctoral fellowship. R.D.H. is supported by an American Cancer Society Postdoctoral Fellowship. Y.K. is supported by the Japan Society for the Promotion of Science. This work was supported by grants from the following: Mary K. Chapman Foundation, the National Science Foundation (NSF) (NSF 0726408), the National Institutes of Health (NIH) (U01 ES017166, U01 1U01ES017166-01, DK062434), the California Institute for Regenerative Medicine (RB2-01530), the Morgridge Institute for Research and the Howard Hughes Medical Institute. We thank the NIH Roadmap Reference Epigenome Consortium (http://www.roadmapepigenomics.org/). This study was carried out as part of the NIH Roadmap Epigenomics Program.	Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; O'Malley RC, 2007, NAT PROTOC, V2, P2910, DOI 10.1038/nprot.2007.425; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yilmaz Gokhan, 2010, Exp Transl Stroke Med, V2, P11, DOI 10.1186/2040-7378-2-11; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	37	1111	1168	2	319	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					68	U84		10.1038/nature09798	http://dx.doi.org/10.1038/nature09798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21289626	Green Accepted, Green Published			2022-12-01	WOS:000287924100035
J	Donnelly, P				Donnelly, Peter			Making Sense of the Data	SCIENCE			English	Editorial Material									Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.			Donnelly, Peter/0000-0001-9495-3408					0	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1024	1025		10.1126/science.1204089	http://dx.doi.org/10.1126/science.1204089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350160				2022-12-01	WOS:000287699000045
J	Kasturi, SP; Skountzou, I; Albrecht, RA; Koutsonanos, D; Hua, T; Nakaya, HI; Ravindran, R; Stewart, S; Alam, M; Kwissa, M; Villinger, F; Murthy, N; Steel, J; Jacob, J; Hogan, RJ; Garcia-Sastre, A; Compans, R; Pulendran, B				Kasturi, Sudhir Pai; Skountzou, Ioanna; Albrecht, Randy A.; Koutsonanos, Dimitrios; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Stewart, Shelley; Alam, Munir; Kwissa, Marcin; Villinger, Francois; Murthy, Niren; Steel, John; Jacob, Joshy; Hogan, Robert J.; Garcia-Sastre, Adolfo; Compans, Richard; Pulendran, Bali			Programming the magnitude and persistence of antibody responses with innate immunity	NATURE			English	Article							MEMORY B-CELLS; YELLOW-FEVER VACCINE; DERMAL DENDRITIC CELLS; TOLL-LIKE RECEPTORS; GERMINAL CENTER; IN-VIVO; T-CELLS; LANGERHANS CELLS; EXPRESSION; ANTIGEN	Many successful vaccines induce persistent antibody responses that can last a lifetime. The mechanisms by which they do so remain unclear, but emerging evidence indicates that they activate dendritic cells via Toll-like receptors (TLRs)(1,2). For example, the yellow fever vaccine YF-17D, one of the most successful empiric vaccines ever developed(3), activates dendritic cells via multiple TLRs to stimulate proinflammatory cytokines(4,5). Triggering specific combinations of TLRs in dendritic cells can induce synergistic production of cytokines(6), which results in enhanced T-cell responses, but its impact on antibody responses remain unknown. Learning the critical parameters of innate immunity that program such antibody responses remains a major challenge in vaccinology. Here we demonstrate that immunization of mice with synthetic nanoparticles containing antigens plus ligands that signal through TLR4 and TLR7 induces synergistic increases in antigen-specific, neutralizing antibodies compared to immunization with nanoparticles containing antigens plus a single TLR ligand. Consistent with this there was enhanced persistence of germinal centres and of plasma-cell responses, which persisted in the lymph nodes for >1.5 years. Surprisingly, there was no enhancement of the early short-lived plasma-cell response relative to that observed with single TLR ligands. Molecular profiling of activated B cells, isolated 7 days after immunization, indicated that there was early programming towards B-cell memory. Antibody responses were dependent on direct triggering of both TLRs on B cells and dendritic cells, as well as on T-cell help. Immunization protected completely against lethal avian and swine influenza virus strains in mice, and induced robust immunity against pandemic H1N1 influenza in rhesus macaques.	[Kasturi, Sudhir Pai; Skountzou, Ioanna; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Kwissa, Marcin; Villinger, Francois; Jacob, Joshy; Compans, Richard; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Kasturi, Sudhir Pai; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Kwissa, Marcin; Villinger, Francois; Jacob, Joshy; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Skountzou, Ioanna; Koutsonanos, Dimitrios; Jacob, Joshy; Compans, Richard] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Albrecht, Randy A.; Steel, John; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Stewart, Shelley; Alam, Munir] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Villinger, Francois; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Murthy, Niren] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Hogan, Robert J.] Univ Georgia, Dept Anat & Radiol, Coll Vet Med, Athens, GA 30602 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA	Emory University; Emory University; Emory University; Icahn School of Medicine at Mount Sinai; Duke University; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; University of Georgia; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.	bpulend@emory.edu	Skountzou, Ioanna/A-4454-2010; Compans, Richard W/I-4087-2013; Albrecht, Randy A./H-5119-2019; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder/AAF-1738-2020; Alam, S. Munir/AAC-6711-2019; Nakaya, Helder I/A-1397-2010	Skountzou, Ioanna/0000-0002-6429-244X; Compans, Richard W/0000-0003-2360-335X; Albrecht, Randy A./0000-0003-4008-503X; Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Pulendran, Bali/0000-0001-6517-4333	National Institutes of Health [U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025, U19AI090023, HHSN266200700010C, U54AI57158, U01AI070469]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048638, U19AI090023, N01AI050025, U54AI057158, R01AI048638, U54AI057157, U01AI070469, R56AI048638, U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Ahmed and B. Rouse for discussion and comments on the manuscript. We thank B. Norris for assistance with FACS analysis, and H. Oluoch for assistance with cryostat sectioning. The work in the laboratory of B. P. was supported by grants U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025 and U19AI090023 from the National Institutes of Health and a grant from the Bill & Melinda Gates Foundation. Work in A.G.-S. laboratories was partly funded by grants HHSN266200700010C, U54AI57158) and U01AI070469 from the National Institutes of Health.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Airoldi I, 2004, CLIN CANCER RES, V10, P144, DOI 10.1158/1078-0432.CCR-1026-3; Airoldi I, 2000, J IMMUNOL, V165, P6880, DOI 10.4049/jimmunol.165.12.6880; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Badr G, 2010, CELL IMMUNOL, V263, P31, DOI 10.1016/j.cellimm.2010.02.012; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Chen GL, 2009, CURR TOP MICROBIOL, V333, P109, DOI 10.1007/978-3-540-92165-3_5; Chin AID, 1999, MOL CELL BIOL, V19, P6665; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; den Haan JMM, 2007, J IMMUNOL, V178, P5429, DOI 10.4049/jimmunol.178.9.5429; Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kano G, 2008, LEUKEMIA LYMPHOMA, V49, P965, DOI 10.1080/10428190801993462; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010; Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nera KP, 2006, SCAND J IMMUNOL, V64, P190, DOI 10.1111/j.1365-3083.2006.01809.x; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sah HK, 1997, J PHARM SCI, V86, P1315, DOI 10.1021/js960363q; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Tovey MG, 2008, BIOL CHEM, V389, P541, DOI 10.1515/BC.2008.051; van Essen D, 2000, J IMMUNOL, V165, P3640; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Young JAT, 2002, SCI AM, V286, P48, DOI 10.1038/scientificamerican0302-48; Zhou G, 2005, EXP MOL PATHOL, V78, P25, DOI 10.1016/j.yexmp.2004.08.008; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	56	684	713	5	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					543	U136		10.1038/nature09737	http://dx.doi.org/10.1038/nature09737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350488	Green Accepted			2022-12-01	WOS:000287652900044
J	Al-Gazali, L				Al-Gazali, Lihadh			Human Genome Sequencing: Celebrating 10 years	SCIENCE			English	Editorial Material									United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates	United Arab Emirates University	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates.								0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					873	873		10.1126/science.1203266	http://dx.doi.org/10.1126/science.1203266			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330531				2022-12-01	WOS:000287455100042
J	Lesburgueres, E; Gobbo, OL; Alaux-Cantin, S; Hambucken, A; Trifilieff, P; Bontempi, B				Lesburgueres, Edith; Gobbo, Oliviero L.; Alaux-Cantin, Stephanie; Hambucken, Anne; Trifilieff, Pierre; Bontempi, Bruno			Early Tagging of Cortical Networks Is Required for the Formation of Enduring Associative Memory	SCIENCE			English	Article							LONG-TERM-MEMORY; TRANSMITTED FOOD PREFERENCES; ORBITOFRONTAL CORTEX; SYNAPTIC PLASTICITY; REMOTE MEMORY; CONSOLIDATION; HIPPOCAMPUS; ACTIVATION; CASCADE; STORAGE	Although formation and stabilization of long-lasting associative memories are thought to require time-dependent coordinated hippocampal-cortical interactions, the underlying mechanisms remain unclear. Here, we present evidence that neurons in the rat cortex must undergo a "tagging process" upon encoding to ensure the progressive hippocampal-driven rewiring of cortical networks that support remote memory storage. This process was AMPA-and N-methyl-D-aspartate receptor-dependent, information-specific, and capable of modulating remote memory persistence by affecting the temporal dynamics of hippocampal-cortical interactions. Post-learning reinforcement of the tagging process via time-limited epigenetic modifications resulted in improved remote memory retrieval. Thus, early tagging of cortical networks is a crucial neurobiological process for remote memory formation whose functional properties fit the requirements imposed by the extended time scale of systems-level memory consolidation.	[Bontempi, Bruno] Univ Bordeaux 1, CNRS, UMR 5293, Inst Malad Neurodegenerat, F-33405 Talence, France; Univ Bordeaux 2, CNRS, UMR 5293, Inst Malad Neurodegenerat, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bontempi, B (corresponding author), Univ Bordeaux 1, CNRS, UMR 5293, Inst Malad Neurodegenerat, Ave Fac, F-33405 Talence, France.	bruno.bontempi@u-bordeaux2.fr	Gobbo, Oliviero L/R-1763-2016; Gobbo, Oliviero/S-2043-2019; Trifilieff, Pierre/ABB-4317-2020	Gobbo, Oliviero L/0000-0003-4629-9485; Gobbo, Oliviero/0000-0003-4629-9485; Trifilieff, Pierre/0000-0002-7893-9697	CNRS, Fondation Simone et Cino del Duca; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche (ANR) [09-MNPS-005-01]	CNRS, Fondation Simone et Cino del Duca(Centre National de la Recherche Scientifique (CNRS)); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	We thank T. Durkin for comments on earlier drafts of the manuscript and T. Maviel, L. Restivo, M. Ammassari-Teule, C. Saugier, L. Decorte, and A. Faugere for their experimental contribution or technical advice. This work was supported by the CNRS, Fondation Simone et Cino del Duca (B.B. and O.L.G.), Federation pour la Recherche sur le Cerveau (B.B.), and the Agence Nationale de la Recherche (ANR grant 09-MNPS-005-01 to B.B.).	Alvarez P, 2001, LEARN MEMORY, V8, P79, DOI 10.1101/lm.38201; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Galef BG, 2003, LEARN BEHAV, V31, P160; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Smith CA, 2010, BEHAV BRAIN RES, V208, P243, DOI 10.1016/j.bbr.2009.12.001; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2	28	215	217	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					924	928		10.1126/science.1196164	http://dx.doi.org/10.1126/science.1196164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330548				2022-12-01	WOS:000287455100061
J	Green, ED; Guyer, MS				Green, Eric D.; Guyer, Mark S.		Natl Human Genome Res Inst	Charting a course for genomic medicine from base pairs to bedside	NATURE			English	Article							ABL TYROSINE KINASE; AMERICAN SOCIETY; MYELOID-LEUKEMIA; WIDE ASSOCIATION; GENE-MUTATIONS; DISEASE; INFORMATION; AUTOPHAGY; CARE; RISK	There has been much progress in genomics in the ten years since a draft sequence of the human genome was published. Opportunities for understanding health and disease are now unprecedented, as advances in genomics are harnessed to obtain robust foundational knowledge about the structure and function of the human genome and about the genetic contributions to human health and disease. Here we articulate a 2011 vision for the future of genomics research and describe the path towards an era of genomic medicine.	[Green, Eric D.; Guyer, Mark S.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Green, ED (corresponding author), NHGRI, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA.	egreen@nhgri.nih.gov						Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Berg K, 2005, AM J HUM GENET, V77, P519; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P2028, DOI 10.1074/mcp.M800264-MCP200; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Brufsky A, 2010, AM J CLIN ONCOL-CANC, V33, P186, DOI 10.1097/COC.0b013e318191bfb0; Buntin MB, 2010, HEALTH AFFAIR, V29, P1214, DOI 10.1377/hlthaff.2010.0503; Burke W, 2010, PUBLIC HEALTH GENOM, V13, P215, DOI 10.1159/000279623; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caskey CT, 2010, ANNU REV MED, V61, P1, DOI 10.1146/annurev-med-011209-132719; Chan JNY, 2010, TRENDS PHARMACOL SCI, V31, P82, DOI 10.1016/j.tips.2009.11.002; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Contreras JL, 2010, SCIENCE, V329, P393, DOI 10.1126/science.1189253; Couzin-Frankel J, 2010, SCIENCE, V328, P558, DOI 10.1126/science.328.5978.558; D'Hulst C, 2009, J MED GENET, V46, P577, DOI 10.1136/jmg.2008.064667; Del Fiol Guilherme, 2006, AMIA Annu Symp Proc, P904; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; DULBECCO R, 1986, SCIENCE, V231, P1055, DOI 10.1126/science.3945817; Ewing SWF, 2009, ADDICT BIOL, V14, P356, DOI 10.1111/j.1369-1600.2009.00149.x; Feinberg AP, 2010, NAT BIOTECHNOL, V28, P1049, DOI 10.1038/nbt1010-1049; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Frueh FW, 2008, PHARMACOTHERAPY, V28, P992, DOI 10.1592/phco.28.8.992; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Grasemann H, 2010, EXPERT OPIN EMERG DR, V15, P653, DOI 10.1517/14728214.2010.517746; Gulcher JR, 2000, NEW ENGL J MED, V342, P1827, DOI 10.1056/NEJM200006153422411; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hiraki S, 2010, OBSTET GYN CLIN N AM, V37, P11, DOI 10.1016/j.ogc.2010.01.002; Hudson KL, 2008, NEW ENGL J MED, V358, P2661, DOI 10.1056/NEJMp0803964; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jain KK, 2007, CLIN CHEM, V53, P2002, DOI 10.1373/clinchem.2007.090795; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kohane IS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000809; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy PA, 2010, J DEV BEHAV PEDIATR, V31, P622, DOI 10.1097/DBP.0b013e3181eedf01; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Loukides G, 2010, P NATL ACAD SCI USA, V107, P7898, DOI 10.1073/pnas.0911686107; Ludman EJ, 2010, J EMPIR RES HUM RES, V5, P9, DOI 10.1525/jer.2010.5.3.9; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; McBride CM, 2010, AM J PREV MED, V38, P556, DOI 10.1016/j.amepre.2010.01.027; McGuire AL, 2008, NAT REV GENET, V9, P152, DOI 10.1038/nrg2302; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Oita I, 2010, ANAL BIOANAL CHEM, V398, P239, DOI 10.1007/s00216-010-3857-7; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; *PAN ANT GUID AD A, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramos E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-29; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Shiwaku K, 2003, INT J OBESITY, V27, P1028, DOI 10.1038/sj.ijo.0802375; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Smushkin G, 2010, CURR OPIN CLIN NUTR, V13, P471, DOI 10.1097/MCO.0b013e32833a558d; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Stover PJ, 2010, CURR OPIN LIPIDOL, V21, P136, DOI 10.1097/MOL.0b013e3283377395; Stuart D, 2009, CURR OPIN CELL BIOL, V21, P304, DOI 10.1016/j.ceb.2009.02.001; Thorisson GA, 2003, NUCLEIC ACIDS RES, V31, P124, DOI 10.1093/nar/gkg052; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	103	617	633	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					204	213		10.1038/nature09764	http://dx.doi.org/10.1038/nature09764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307933	Bronze			2022-12-01	WOS:000287144200034
J	Hansen, CJ; Bourke, M; Bridges, NT; Byrne, S; Colon, C; Diniega, S; Dundas, C; Herkenhoff, K; McEwen, A; Mellon, M; Portyankina, G; Thomas, N				Hansen, C. J.; Bourke, M.; Bridges, N. T.; Byrne, S.; Colon, C.; Diniega, S.; Dundas, C.; Herkenhoff, K.; McEwen, A.; Mellon, M.; Portyankina, G.; Thomas, N.			Seasonal Erosion and Restoration of Mars' Northern Polar Dunes	SCIENCE			English	Article							SUBLIMATION-DRIVEN ACTIVITY; HIRISE OBSERVATIONS; DEPOSITS	Despite radically different environmental conditions, terrestrial and martian dunes bear a strong resemblance, indicating that the basic processes of saltation and grainfall (sand avalanching down the dune slipface) operate on both worlds. Here, we show that martian dunes are subject to an additional modification process not found on Earth: springtime sublimation of Mars' CO2 seasonal polar caps. Numerous dunes in Mars' north polar region have experienced morphological changes within a Mars year, detected in images acquired by the High-Resolution Imaging Science Experiment on the Mars Reconnaissance Orbiter. Dunes show new alcoves, gullies, and dune apron extension. This is followed by remobilization of the fresh deposits by the wind, forming ripples and erasing gullies. The widespread nature of these rapid changes, and the pristine appearance of most dunes in the area, implicates active sand transport in the vast polar erg in Mars' current climate.	[Hansen, C. J.; Bourke, M.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Bourke, M.] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Bridges, N. T.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Byrne, S.; Dundas, C.; McEwen, A.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Colon, C.] Rutgers State Univ, Dept Earth & Environm Sci, Newark, NJ 07102 USA; [Diniega, S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Herkenhoff, K.] US Geol Survey, Flagstaff, AZ 86001 USA; [Mellon, M.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80309 USA; [Portyankina, G.; Thomas, N.] Univ Bern, Space Res & Planetol Div, CH-0132 Bern, Switzerland	University of Oxford; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; Rutgers State University Newark; Rutgers State University New Brunswick; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Boulder; University of Bern	Hansen, CJ (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.	cjhansen@psi.edu	Bourke, Mary/I-4387-2012; Bridges, Nathan T/D-6341-2016; Byrne, Shane/B-8104-2012; Mellon, Michael/C-3456-2016	Bourke, Mary/0000-0002-0424-0322; Dundas, Colin/0000-0003-2343-7224	Jet Propulsion Laboratory, California Institute of Technology; NASA	Jet Propulsion Laboratory, California Institute of Technology; NASA(National Aeronautics & Space Administration (NASA))	This work was partially supported by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Aharonson O., 2004, 35 LUN PLAN SCI C 15; Balme M, 2008, GEOMORPHOLOGY, V101, P703, DOI 10.1016/j.geomorph.2008.03.011; Bourke MC, 2008, GEOMORPHOLOGY, V94, P247, DOI 10.1016/j.geomorph.2007.05.012; Bourke M. C., 2009, P LUNAR PLANET SCI C, V40, P1748; CUTTS JA, 1973, J GEOPHYS RES, V78, P4139, DOI 10.1029/JB078i020p04139; Diniega S, 2010, GEOLOGY, V38, P1047, DOI 10.1130/G31287.1; Dundas C. M., 2009, GEOPHYS RES LETT, V37; Gardin E, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003515; Hansen C., 2010, P LUNAR PLANET SCI C, V41, P1533; Hansen CJ, 2010, ICARUS, V205, P283, DOI 10.1016/j.icarus.2009.07.021; Hansen C. J., 2008, B AM ASTRON SOC, V40, P409; Hayward RK, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002943; Kereszturi A, 2010, ICARUS, V207, P149, DOI 10.1016/j.icarus.2009.10.012; Kereszturi A, 2009, ICARUS, V201, P492, DOI 10.1016/j.icarus.2009.01.014; Kieffer H. H., 2000, LUNAR PLANETARY I CO, P1057; Kieffer HH, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002816; Malin M. C., 2005, NASA JPL PLANETARY P; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Matsuo K, 2009, ICARUS, V202, P90, DOI 10.1016/j.icarus.2009.02.023; MCCAULEY JF, 1972, ICARUS, V17, P289, DOI 10.1016/0019-1035(72)90003-6; McEwen AS, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2005JE002605; Mellon MT, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003417; Mohlmann D, 2010, ICARUS, V207, P654, DOI 10.1016/j.icarus.2010.01.002; Piqueux S, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002007; Piqueux S, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003009; Portyankina G, 2010, ICARUS, V205, P311, DOI 10.1016/j.icarus.2009.08.029; Putzig N., 2010, P LUNAR PLANET SCI C, V41, P1533; Schatz V, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002514; Silvestro S., 2010, 2 INT DUN C LPI CONT, V1552, P65; Thomas N, 2010, ICARUS, V205, P296, DOI 10.1016/j.icarus.2009.05.030; TSOAR H, 1979, J GEOPHYS RES, V84, P8167, DOI 10.1029/JB084iB14p08167; WARD AW, 1983, ICARUS, V55, P420, DOI 10.1016/0019-1035(83)90112-4	32	116	117	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					575	578		10.1126/science.1197636	http://dx.doi.org/10.1126/science.1197636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292976				2022-12-01	WOS:000286933600051
J	Tuite, AR; Tien, J; Eisenberg, M; Earn, DJD; Ma, JL; Fisman, DN				Tuite, Ashleigh R.; Tien, Joseph; Eisenberg, Marisa; Earn, David J. D.; Ma, Junling; Fisman, David N.			Cholera Epidemic in Haiti, 2010: Using a Transmission Model to Explain Spatial Spread of Disease and Identify Optimal Control Interventions	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTIOUS-DISEASE; UNITED-STATES; INFLUENZA; DYNAMICS; TIME	Background: Haiti is in the midst of a cholera epidemic. Surveillance data for formulating models of the epidemic are limited, but such models can aid understanding of epidemic processes and help define control strategies. Objective: To predict, by using a mathematical model, the sequence and timing of regional cholera epidemics in Haiti and explore the potential effects of disease-control strategies. Design: Compartmental mathematical model allowing person-to-person and waterborne transmission of cholera. Within-and between-region epidemic spread was modeled, with the latter dependent on population sizes and distance between regional centroids (a "gravity" model). Setting: Haiti, 2010 to 2011. Data Sources: Haitian hospitalization data, 2009 census data, literature-derived parameter values, and model calibration. Measurements: Dates of epidemic onset and hospitalizations. Results: The plausible range for cholera's basic reproductive number (R-o, defined as the number of secondary cases per primary case in a susceptible population without intervention) was 2.06 to 2.78. The order and timing of regional cholera outbreaks predicted by the gravity model were closely correlated with empirical observations. Analysis of changes in disease dynamics over time suggests that public health interventions have substantially affected this epidemic. A limited vaccine supply provided late in the epidemic was projected to have a modest effect. Limitations: Assumptions were simplified, which was necessary for modeling. Projections are based on the initial dynamics of the epidemic, which may change. Conclusion: Despite limited surveillance data from the cholera epidemic in Haiti, a model simulating between-region disease transmission according to population and distance closely reproduces reported disease patterns. This model is a tool that planners, policy-makers, and medical personnel seeking to manage the epidemic could use immediately.	[Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; Ohio State Univ, Columbus, OH 43210 USA; McMaster Univ, Hamilton, ON, Canada; Univ Victoria, Victoria, BC, Canada	University of Toronto; University System of Ohio; Ohio State University; McMaster University; University of Victoria	Fisman, DN (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St,Room 678, Toronto, ON M5T 3M7, Canada.	david.fisman@utoronto.ca	Ma, Junling/I-7349-2012	Ma, Junling/0000-0002-0197-2317; Earn, David/0000-0002-7562-1341	Institute of Population and Public Health of the Canadian Institutes of Health Research [22228]; National Science Foundation [0635561]; Natural Sciences and Engineering Research Council of Canada; James S. McDonnell Foundation	Institute of Population and Public Health of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); James S. McDonnell Foundation	Ms. Tuite and Dr. Fisman are supported by a grant from the Institute of Population and Public Health of the Canadian Institutes of Health Research (PH2-#22228). Dr. Eisenberg is supported by the National Science Foundation (agreement 0635561). Dr. Earn receives support from the Natural Sciences and Engineering Research Council of Canada and the James S. McDonnell Foundation.	Albert M. John, 1997, World Health Statistics Quarterly, V50, P111; ANDERSON RM, 1991, CMAJ; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1586; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1473; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; BHARTI N, 2008, NEW ENGL J MED, V3; BROWNSTEIN JS, 2008, MMWR-MORBID MORTAL W, V5, pE151; CAMPBELLMCINTYRE R, 1979, LANCET, V1, P311; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1411; CHIN CS, 2011, WKLY EPIDEMIOL REC, V364, P33; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Crepey P, 2007, AM J EPIDEMIOL, V166, P1244, DOI 10.1093/aje/kwm266; Eggo RM, 2011, J R SOC INTERFACE, V8, P233, DOI 10.1098/rsif.2010.0216; Graves PM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000974.pub2; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Guthmann JP, 1995, J TROP MED HYG, V98, P419; HOOD MA, 1981, APPL ENVIRON MICROB, V41, P559, DOI 10.1128/AEM.41.2.559-560.1981; Institut Haitien de Statistique et d'Informatique, 2009, POP TOT POP 18 ANS P; *INT MON FUND, 2009, HAIT ENH IN HEAV IND; IVERS LC, 2010, J R SOC INTERFACE, V376, P2048; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; JOHANNESSON M, 1994, MED DECIS MAKING, V14, P188, DOI 10.1177/0272989X9401400212; KEELING MJ, 2009, PLOS MED, P233; KNOX R, 2010, DOCTORS URGE CHOLERA; *MIN SANT PUBL POP, 2010, DOC HAIT CHOL EP; Misch A, 1991, World Watch, V4, P37; Mishra S, 2011, J EPIDEMIOL COMMUN H, V65, P87, DOI 10.1136/jech.2009.097113; Moghadas S, 2009, CAN MED ASSOC J, V181, P171, DOI 10.1503/cmaj.090885; NEILAN RLM, 2010, J R SOC INTERFACE, V72, P2004; PASCUAL M, 2006, CMAJ, V3, pE280; *PUBL HLTH AG CAN, 2006, CAN IMM GUID, P158; RABBANI GH, 1999, LANCET, V17, P1; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Sontag Deborah, 2010, NY TIMES, pA1; TAUXE RV, 1998, BACTERIAL INFECT HUM, P223; TIEN JH, 2010, PLOS MED; Tien JH, 2010, B MATH BIOL, V72, P1506, DOI 10.1007/s11538-010-9507-6; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; 2008, WKLY EPIDEMIOL REC, V83, P269; 2007, WKLY EPIDEMIOL REC, V82, P273	41	171	174	1	71	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					593	601		10.7326/0003-4819-154-9-201105030-00334	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00334			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21383314				2022-12-01	WOS:000290112300003
J	Murakoshi, H; Wang, H; Yasuda, R				Murakoshi, Hideji; Wang, Hong; Yasuda, Ryohei			Local, persistent activation of Rho GTPases during plasticity of single dendritic spines	NATURE			English	Article							LONG-TERM POTENTIATION; KINASE; PROTEINS; DYNAMICS; ACTIN; CULTURES; BINDING	The Rho family of GTPases have important roles in the morphogenesis of the dendritic spines(1-3) of neurons in the brain and synaptic plasticity(4-9) by modulating the organization of the actin cytoskeleton(10). Here we used two-photon fluorescence lifetime imaging microscopy(11-13) to monitor the activity of two Rho GTPases-RhoA and Cdc42-in single dendritic spines undergoing structural plasticity associated with long-term potentiation in CA1 pyramidal neurons in cultured slices of rat hippocampus. When long-term volume increase was induced in a single spine using two-photon glutamate uncaging(14,15), RhoA and Cdc42 were rapidly activated in the stimulated spine. These activities decayed over about five minutes, and were then followed by a phase of persistent activation lasting more than half an hour. Although active RhoA and Cdc42 were similarly mobile, their activity patterns were different. RhoA activation diffused out of the stimulated spine and spread over about 5 mm along the dendrite. In contrast, Cdc42 activation was restricted to the stimulated spine, and exhibited a steep gradient at the spine necks. Inhibition of the Rho-Rock pathway preferentially inhibited the initial spine growth, whereas the inhibition of the Cdc42-Pak pathway blocked the maintenance of sustained structural plasticity. RhoA and Cdc42 activation depended on Ca2+/calmodulin-dependent kinase (CaMKII). Thus, RhoA and Cdc42 relay transient CaMKII activation(13) to synapse-specific, long-term signalling required for spine structural plasticity.	[Murakoshi, Hideji; Wang, Hong; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yasuda, Ryohei] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Murakoshi, Hideji/W-9266-2018; Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297	Howard Hughes Medical Institute; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute of Drug Abuse; Alzheimer's Association; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Alzheimer's Association(Alzheimer's Association); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Hahn, G. Bokock, A. Aplin, S. Soderling, M. Matsuda and Y. Hayashi for plasmids and reagents, S.-J. Lee for CaMKII activation data, S. Soderling, S. Raghavachari, L. van Aelst, Y. Hayashi, H. Kasai and M. Ehlers for discussion, and H. Hedrick and M. Patterson for comments on the manuscript. We also thank A. Wan for preparing cultured slices and D. Kloetzer for laboratory management. This study was funded by the Howard Hughes Medical Institute, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute of Drug Abuse, the Alzheimer's Association and the Japan Society for the Promotion of Science (H.M.).	Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, pCH8, DOI DOI 10.1007/978-0-387-46312-4; Lee S. J., 2010, CAMKII RAS OPEN NEUR, V3, P117; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McAllister A K, 2000, Sci STKE, V2000, ppl1, DOI 10.1126/stke.2000.51.pl1; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nikolic M, 2008, MOL NEUROBIOL, V37, P187, DOI 10.1007/s12035-008-8032-1; O'Brien JA, 2006, NAT PROTOC, V1, P977, DOI 10.1038/nprot.2006.145; O'Kane EM, 2003, J NEUROCHEM, V87, P1309, DOI 10.1046/j.1471-4159.2003.02102.x; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wilde C, 2000, J BIOL CHEM, V275, P16478, DOI 10.1074/jbc.M910362199; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao J, 2002, BIOCHEM BIOPH RES CO, V297, P653, DOI 10.1016/S0006-291X(02)02257-X	40	379	387	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					100	U132		10.1038/nature09823	http://dx.doi.org/10.1038/nature09823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21423166	Green Accepted			2022-12-01	WOS:000289199400045
J	Adams, KN; Takaki, K; Connolly, LE; Wiedenhoft, H; Winglee, K; Humbert, O; Edelstein, PH; Cosma, CL; Ramakrishnan, L				Adams, Kristin N.; Takaki, Kevin; Connolly, Lynn E.; Wiedenhoft, Heather; Winglee, Kathryn; Humbert, Olivier; Edelstein, Paul H.; Cosma, Christine L.; Ramakrishnan, Lalita			Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism	CELL			English	Article							ANTITUBERCULOSIS DRUGS; ANTIBIOTIC-RESISTANCE; MARINUM INFECTION; INITIAL TREATMENT; TUBERCULOSIS; PUMP; EXPRESSION; STRESS; GENES; SUSCEPTIBILITY	Treatment of tuberculosis, a complex granulomatous disease, requires long-term multidrug therapy to overcome tolerance, an epigenetic drug resistance that is widely attributed to nonreplicating bacterial subpopulations. Here, we deploy Mycobacterium marinum-infected zebrafish larvae for in vivo characterization of antitubercular drug activity and tolerance. We describe the existence of multidrug-tolerant organisms that arise within days of infection, are enriched in the replicating intracellular population, and are amplified and disseminated by the tuberculous granuloma. Bacterial efflux pumps that are required for intracellular growth mediate this macrophage-induced tolerance. This tolerant population also develops when Mycobacterium tuberculosis infects cultured macrophages, suggesting that it contributes to the burden of drug tolerance in human tuberculosis. Efflux pump inhibitors like verapamil reduce this tolerance. Thus, the addition of this currently approved drug or more specific efflux pump inhibitors to standard antitubercular therapy should shorten the duration of curative treatment.	[Adams, Kristin N.; Takaki, Kevin; Wiedenhoft, Heather; Winglee, Kathryn; Humbert, Olivier; Cosma, Christine L.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Connolly, Lynn E.; Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Edelstein, Paul H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@uw.edu	Edelstein, Paul/I-5527-2019	Edelstein, Paul/0000-0002-4069-5279; Winglee, Kathryn/0000-0002-3623-0700; Takaki, Kevin/0000-0002-4790-4598; Ramakrishnan, Lalita/0000-0003-0692-5533	Gates Foundation; University of Washington; Burroughs Wellcome Foundation; NIH [RO1 AI036396, RO1 AI54503, U54AI057141, T32 AI55396, K08 AI076620, 5R21 AI073328-02, 5R21 AI078189-02]; Levinson Emerging Scholars Program; Mary Gates Endowment Grant; Washington NASA; Pfizer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396, R21AI078189, K08AI076620, R01AI054503, U54AI057141, R21AI073328, R01AI036396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099901] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); University of Washington(University of Washington); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Levinson Emerging Scholars Program; Mary Gates Endowment Grant; Washington NASA; Pfizer(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. R. Sherman for the gift of pBP10, advice, and the use of the BSL-3 facilities at Seattle BioMed; the members of his laboratory, especially R. Liao and J. Pang, for help in using the BSL-3 facilities; M. Nixon for advice in analyzing the unstable plasmid data; W. R. Bishai and G. Lamichhane for providing the Mtb Rv1258c mutants through the Tuberculosis Animal Research and Gene Evaluation Taskforce (NIH/NIAID N01 AI30036); E. Nuermberger and P. Donald for sharing knowledge and insights about TB drugs; B. Cormack and M. Troll for discussion; J. M. Davis and C. T. Yang for technical advice; J. Ray and H. Volkman for figure design and preparation; and S. Phillips and T. Pecor for technical assistance. This work was supported by a Gates Foundation TB drug accelerator grant; a University of Washington Royalty Research Fund Grant; a Burroughs Wellcome Foundation Pathogenesis of Infectious Diseases award; NIH grants RO1 AI036396, RO1 AI54503, and U54AI057141 to L. R.; NIH grant T32 AI55396 to K.N.A.; a Levinson Emerging Scholars Program Grant, a Mary Gates Endowment Grant, and a Washington NASA Space Grant to K. W.; a Pfizer Fellowship in Infectious Diseases and NIH grant K08 AI076620 to L. E. C.; and NIH grants 5R21 AI073328-02 and 5R21 AI078189-02 to P. H. E. L. R. is a recipient of the NIH Director's Pioneer Award and a consultant for Sanofi Aventis.	Akira M, 2000, J COMPUT ASSIST TOMO, V24, P426, DOI 10.1097/00004728-200005000-00014; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Aubry A, 2002, ARCH INTERN MED, V162, P1746, DOI 10.1001/archinte.162.15.1746; BARKER J, 1995, ANTIMICROB AGENTS CH, V39, P2684, DOI 10.1128/AAC.39.12.2684; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; BOBROWITZ ID, 1980, AM REV RESPIR DIS, V121, P735; Canetti G., 1955, TUBERCLE BACILLUS PU; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Cosma C. L., 2006, CURRENT PROTOCOLS MI, DOI 10.1002/; Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Dannenberg AM, 2003, TUBERCULOSIS, V83, P251, DOI 10.1016/S1472-9792(03)00048-9; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Decostere A, 2004, VET MICROBIOL, V99, P159, DOI 10.1016/j.vetmic.2003.07.011; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Duits LA, 2001, BIOCHEM BIOPH RES CO, V280, P522, DOI 10.1006/bbrc.2000.4157; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Grange, 2009, TUBERCULOSIS COMPREH, P608, DOI [10.1016/B978-1-4160-3988-4.00059-7, DOI 10.1016/B978-1-4160-3988-4.00059-7]; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Ibrahim M, 2009, AM J RESP CRIT CARE, V180, P553, DOI 10.1164/rccm.200807-1152OC; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nguyen L, 2006, TRENDS MICROBIOL, V14, P304, DOI 10.1016/j.tim.2006.05.005; Paramasivan CN, 2005, ANTIMICROB AGENTS CH, V49, P627, DOI 10.1128/AAC.49.2.627-631.2005; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rich AR, 1946, PATHOGENESIS TUBERCU; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; ROOK GAW, 1987, EUR J RESPIR DIS, V71, P286; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Viveiros M, 2002, ANTIMICROB AGENTS CH, V46, P2804, DOI 10.1128/AAC.46.9.2804-2810.2002; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Zahner D, 2010, ANTIMICROB AGENTS CH, V54, P3516, DOI 10.1128/AAC.01756-09	58	360	369	5	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					39	53		10.1016/j.cell.2011.02.022	http://dx.doi.org/10.1016/j.cell.2011.02.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21376383	Green Accepted, Bronze			2022-12-01	WOS:000289053900008
J	Tokunaga, F; Nakagawa, T; Nakahara, M; Saeki, Y; Taniguchi, M; Sakata, S; Tanaka, K; Nakano, H; Iwai, K				Tokunaga, Fuminori; Nakagawa, Tomoko; Nakahara, Masaki; Saeki, Yasushi; Taniguchi, Masami; Sakata, Shin-ichi; Tanaka, Keiji; Nakano, Hiroyasu; Iwai, Kazuhiro			SHARPIN is a component of the NF-kappa B-activating linear ubiquitin chain assembly complex	NATURE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; INCONTINENTIA PIGMENTI; IMMUNE-DEFICIENCY; SIGNALING PATHWAY; MUTATIONS; NEMO; PROTEIN; LIGASE; IDENTIFICATION; ALPHA	Cpdm (chronic proliferative dermatitis) mice develop chronic dermatitis and an immunodeficiency with increased serum IgM(1-3), symptoms that resemble those of patients with X-linked hyper-IgM syndrome and hypohydrotic ectodermal dysplasia (XHM-ED), which is caused by mutations in NEMO (NF-kappa B essential modulator; also known as IKBKG)(4-6). Spontaneous null mutations in the Sharpin (SHANK-associated RH domain interacting protein in postsynaptic density)(7) gene are responsible for the cpdm phenotype in mice(8). SHARPIN shows significant similarity to HOIL-1L (also known as RBCK1)(8,9), a component of linear ubiquitin chain assembly complex (LUBAC), which induces NF-kappa B activation through conjugation of linear polyubiquitin chains to NEMO10-13. Here, we identify SHARPIN as an additional component of LUBAC. SHARPIN-containing complexes can linearly ubiquitinate NEMO and activated NF-kappa B. Thus, we re-define LUBAC as a complex containing SHARPIN, HOIL-1L, and HOIP (also known as RNF31). Deletion of SHARPIN drastically reduced the amount of LUBAC, which resulted in attenuated TNF-alpha- and CD40-mediated activation of NF-kappa B in mouse embryonic fibroblasts (MEFs) or B cells from cpdm mice. Considering the pleomorphic phenotype of cpdm mice, these results confirm the predicted role of LUBAC-mediated linear polyubiquitination in NF-kappa B activation induced by various stimuli, and strongly suggest the involvement of LUBAC-induced NF-kappa B activation in various disorders.	[Tokunaga, Fuminori; Nakagawa, Tomoko; Nakahara, Masaki; Taniguchi, Masami; Sakata, Shin-ichi; Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Suita, Osaka 5650871, Japan; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Suita, Osaka 5650871, Japan	Osaka University; Tokyo Metropolitan Institute of Medical Science; Juntendo University; Osaka University	Iwai, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kiwai@cellbio.med.osaka-u.ac.jp	Saeki, Yasushi/AAR-8198-2021; IWAI, KAZUHIRO/GSN-7385-2022	Saeki, Yasushi/0000-0002-9202-5453; Tokunaga, Fuminori/0000-0003-3626-9119; Nakano, Hiroyasu/0000-0003-4843-1427; Iwai, Kazuhiro/0000-0001-5620-5951	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23659404, 22117006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura, S. Sugano, P. Rennert and J. Browning for reagents; O. Takeuchi for comments; and K. Kamei and K. Fukunaga for technical assistance. This work was partly supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (F.T. and K.I.).	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HogenEsch H, 1999, J IMMUNOL, V162, P3890; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jain A, 2004, J CLIN INVEST, V114, P1593, DOI 10.1172/JCI21345; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Piao JH, 2007, J IMMUNOL, V178, P2272, DOI 10.4049/jimmunol.178.4.2272; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Torres HIG, 1995, PATHOBIOLOGY, V63, P341; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	26	459	478	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					633	U113		10.1038/nature09815	http://dx.doi.org/10.1038/nature09815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455180				2022-12-01	WOS:000288951200042
J	Malik, FI; Hartman, JJ; Elias, KA; Morgan, BP; Rodriguez, H; Brejc, K; Anderson, RL; Sueoka, SH; Lee, KH; Finer, JT; Sakowicz, R; Baliga, R; Cox, DR; Garard, M; Godinez, G; Kawas, R; Kraynack, E; Lenzi, D; Lu, PP; Muci, A; Niu, CR; Qian, XP; Pierce, DW; Pokrovskii, M; Suehiro, I; Sylvester, S; Tochimoto, T; Valdez, C; Wang, WY; Katori, T; Kass, DA; Shen, YT; Vatner, SF; Morgans, DJ				Malik, Fady I.; Hartman, James J.; Elias, Kathleen A.; Morgan, Bradley P.; Rodriguez, Hector; Brejc, Katjusa; Anderson, Robert L.; Sueoka, Sandra H.; Lee, Kenneth H.; Finer, Jeffrey T.; Sakowicz, Roman; Baliga, Ramesh; Cox, David R.; Garard, Marc; Godinez, Guillermo; Kawas, Raja; Kraynack, Erica; Lenzi, David; Lu, Pu Ping; Muci, Alexander; Niu, Congrong; Qian, Xiangping; Pierce, Daniel W.; Pokrovskii, Maria; Suehiro, Ion; Sylvester, Sheila; Tochimoto, Todd; Valdez, Corey; Wang, Wenyue; Katori, Tatsuo; Kass, David A.; Shen, You-Tang; Vatner, Stephen F.; Morgans, David J.			Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure	SCIENCE			English	Article							CONSCIOUS DOGS; SUBFRAGMENT-1; ACTOMYOSIN; MECHANISM; ATPASE; MOTOR; 1ST	Decreased cardiac contractility is a central feature of systolic heart failure. Existing drugs increase cardiac contractility indirectly through signaling cascades but are limited by their mechanism-related adverse effects. To avoid these limitations, we previously developed omecamtiv mecarbil, a small-molecule, direct activator of cardiac myosin. Here, we show that it binds to the myosin catalytic domain and operates by an allosteric mechanism to increase the transition rate of myosin into the strongly actin-bound force-generating state. Paradoxically, it inhibits adenosine 5'-triphosphate turnover in the absence of actin, which suggests that it stabilizes an actin-bound conformation of myosin. In animal models, omecamtiv mecarbil increases cardiac function by increasing the duration of ejection without changing the rates of contraction. Cardiac myosin activation may provide a new therapeutic approach for systolic heart failure.	[Malik, Fady I.; Hartman, James J.; Elias, Kathleen A.; Morgan, Bradley P.; Rodriguez, Hector; Brejc, Katjusa; Anderson, Robert L.; Sueoka, Sandra H.; Lee, Kenneth H.; Finer, Jeffrey T.; Sakowicz, Roman; Baliga, Ramesh; Cox, David R.; Garard, Marc; Godinez, Guillermo; Kawas, Raja; Kraynack, Erica; Lenzi, David; Lu, Pu Ping; Muci, Alexander; Niu, Congrong; Qian, Xiangping; Pierce, Daniel W.; Pokrovskii, Maria; Suehiro, Ion; Sylvester, Sheila; Tochimoto, Todd; Valdez, Corey; Wang, Wenyue; Morgans, David J.] Cytokinetics Inc, Preclin Res & Dev, San Francisco, CA 94080 USA; [Katori, Tatsuo; Kass, David A.] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Shen, You-Tang; Vatner, Stephen F.] CV Dynam, N Brunswick, NJ 08902 USA; [Vatner, Stephen F.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Vatner, Stephen F.] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Shen, You-Tang] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shen, You-Tang] Univ Penn, Sch Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; University of Pennsylvania	Malik, FI (corresponding author), Cytokinetics Inc, Preclin Res & Dev, San Francisco, CA 94080 USA.	fmalik@cytokinetics.com		Brejc, Katjusa/0000-0002-4562-6109	Cytokinetics; NIH [1-R43-HL-66647-1]; Cytokinetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106511, R43HL066647] Funding Source: NIH RePORTER	Cytokinetics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytokinetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Chabala, C. Homcy, T. A. Pollard, J. H. Sabry, R. J. Solaro, J. A. Spudich, J. R. Teerlink, and R. D. Vale for their advice over the course of this work; A. Franklin and S. Hollenbach for their contributions to the conduct of some of these studies; and M. Rowley and J. Goldstein for assistance in preparing the manuscript. Y.-T.S., D. A. K., and S. F. V. are members of the Scientific Advisory Board and received research support, compensation, and stock options (D. A. K. and S. F. V.) from Cytokinetics. Cytokinetics holds a patent on omecamtiv mecarbil (U. S. Patent no. 7,507,735); Amgen is a licensee of this patent. Support provided by Small Business Innovation Research grant, NIH (1-R43-HL-66647-1) and Cytokinetics, Inc.	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Banfor PN, 2008, AM J PHYSIOL-HEART C, V294, pH238, DOI 10.1152/ajpheart.01181.2007; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CLEEMANN L, 1991, J PHYSIOL-LONDON, V432, P283, DOI 10.1113/jphysiol.1991.sp018385; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; KOMAMURA K, 1992, J CLIN INVEST, V89, P1825, DOI 10.1172/JCI115787; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; Morgan BP, 2010, ACS MED CHEM LETT, V1, P472, DOI 10.1021/ml100138q; Petersen John W, 2008, Crit Care Med, V36, pS106, DOI 10.1097/01.CCM.0000296273.72952.39; Pollard TD, 2008, CELL BIOL, V2nd, P705; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Shen YT, 2010, CIRC-HEART FAIL, V3, P522, DOI 10.1161/CIRCHEARTFAILURE.109.930321; Shen YT, 1999, AM J PHYSIOL-HEART C, V277, pH388, DOI 10.1152/ajpheart.1999.277.1.H388; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; Suzuki T, 2009, CIRC-HEART FAIL, V2, P334, DOI 10.1161/CIRCHEARTFAILURE.108.802298; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	24	362	373	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1439	1443		10.1126/science.1200113	http://dx.doi.org/10.1126/science.1200113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415352	Green Accepted			2022-12-01	WOS:000288504000042
J	Chiolo, I; Minoda, A; Colmenares, SU; Polyzos, A; Costes, SV; Karpen, GH				Chiolo, Irene; Minoda, Aki; Colmenares, Serafin U.; Polyzos, Aris; Costes, Sylvain V.; Karpen, Gary H.			Double-Strand Breaks in Heterochromatin Move Outside of a Dynamic HP1a Domain to Complete Recombinational Repair	CELL			English	Article							DNA-DAMAGE; PROTEIN-1; GENE; STABILITY; TELOMERES; MEIOSIS; FAMILY; YEAST; SUMO; RPA	Double-strand breaks (DSBs) in heterochromatic repetitive DNAs pose significant threats to genome integrity, but information about how such lesions are processed and repaired is sparse. We observe dramatic expansion and dynamic protrusions of the heterochromatin domain in response to ionizing radiation (IR) in Drosophila cells. We also find that heterochromatic DSBs are repaired by homologous recombination (HR) but with striking differences from euchromatin. Proteins involved in early HR events (resection) are rapidly recruited to DSBs within heterochromatin. In contrast, Rad51, which mediates strand invasion, only associates with DSBs that relocalize outside of the domain. Heterochromatin expansion and relocalization of foci require checkpoint and resection proteins. Finally, the Smc5/6 complex is enriched in heterochromatin and is required to exclude Rad51 from the domain and prevent abnormal recombination. We propose that the spatial and temporal control of DSB repair in heterochromatin safeguards genome stability by preventing aberrant exchanges between repeats.	[Chiolo, Irene; Minoda, Aki; Colmenares, Serafin U.; Polyzos, Aris; Costes, Sylvain V.; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chiolo, I (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA.	iechiolo@lbl.gov; karpen@fruitfly.org	Minoda, Aki/D-5335-2017; Minoda, Aki/Q-4454-2019; Costes, Sylvain V/D-2522-2013	Minoda, Aki/0000-0002-2927-5791; Minoda, Aki/0000-0002-2927-5791; Costes, Sylvain V/0000-0002-8542-2389; Chiolo, Irene/0000-0002-3080-550X	FIRC; Unesco; Ruth Kirchstein NIH [1F32GM086111]; U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086111, R01GM086613] Funding Source: NIH RePORTER	FIRC(Fondazione AIRC per la ricerca sul cancro); Unesco; Ruth Kirchstein NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by postdoctoral fellowships from FIRC and Unesco to I. C., by Ruth Kirchstein NIH Postdoctoral Fellowship to S. U. C. (1F32GM086111), and by the Low Dose Radiation Research Program U.S. Department of Energy (DOE) (DE-AC02-05CH11231) to S. V. C. and G. H. K. We are grateful to P.-O. Mari for assistance with the NIR experiments and to S. Elgin, J. Kadonaga, B. Mellone, and D. Rio for reagents. We thank H. V. Le, R. Kunitake, and C. Pham for their help; A. Dernburg, E. Dunleavy, J. Swenson, and W. Zhang for comments on the manuscript; S. Langley for advice on ChIP-array data analysis; C-Y. Chen for software development; and the Karpen lab for sharing reagents and helpful discussions.	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; COSTES SV, 2009, MUTAT RES, V704, P78; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Digilio FA, 1996, DEV BIOL, V178, P90, DOI 10.1006/dbio.1996.0200; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Dronamraju R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000473; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; KELLUM R, 1995, J CELL SCI, V108, P1407; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kusano K, 1999, GENETICS, V151, P1027; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Royou A, 2010, CELL, V140, P235, DOI 10.1016/j.cell.2009.12.043; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Shin DM, 2011, GERONTOLOGY, V57, P76, DOI 10.1159/000281882; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Soutoglou Evi, 2008, J Natl Cancer Inst Monogr, P16, DOI 10.1093/jncimonographs/lgn017; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Westphal T, 2002, GENETICS, V160, P609; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	368	373	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					732	744		10.1016/j.cell.2011.02.012	http://dx.doi.org/10.1016/j.cell.2011.02.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21353298	Green Accepted, Bronze			2022-12-01	WOS:000288007100012
J	Marimuthu, MPA; Jolivet, S; Ravi, M; Pereira, L; Davda, JN; Cromer, L; Wang, LL; Nogue, F; Chan, SWL; Siddiqi, I; Mercier, R				Marimuthu, Mohan P. A.; Jolivet, Sylvie; Ravi, Maruthachalam; Pereira, Lucie; Davda, Jayeshkumar N.; Cromer, Laurence; Wang, Lili; Nogue, Fabien; Chan, Simon W. L.; Siddiqi, Imran; Mercier, Raphael			Synthetic Clonal Reproduction Through Seeds	SCIENCE			English	Article									[Ravi, Maruthachalam; Wang, Lili; Chan, Simon W. L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Marimuthu, Mohan P. A.; Davda, Jayeshkumar N.; Siddiqi, Imran] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Jolivet, Sylvie; Pereira, Lucie; Cromer, Laurence; Nogue, Fabien; Mercier, Raphael] INRA, UMR1318, Inst Jean Pierre Bourgin, F-78026 Versailles, France	University of California System; University of California Davis; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chan, SWL (corresponding author), Univ Calif Davis, Dept Plant Biol, 1 Shields Ave, Davis, CA 95616 USA.	srchan@ucdavis.edu; imran@ccmb.res.in; raphael.mercier@versailles.inra.fr	cromer, Laurence/I-4814-2014; wang, lili/HDL-7210-2022; mercier, Raphael/L-1497-2016	mercier, Raphael/0000-0001-6508-6608; Nogue, Fabien/0000-0003-0619-4638; Maruthachalam, Ravi/0000-0003-0036-3330	Agence Nationale de la Recherche [ANR-09-EBIO-011]; INRA GAP Department; NSF [IOS-1026094]; March of Dimes; CSIR; Department of Biotechnology	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA GAP Department; NSF(National Science Foundation (NSF)); March of Dimes(March of Dimes); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	We thank D. Singh for fluorescent in situ hybridization analysis; E. Gugan and N. Shukla for technical assistance; and L. Comai, O. Loudet, J. P. Vielle-Calzada, W. Lucas, and V. Sundaresan for comments on the manuscript. This research was funded by Agence Nationale de la Recherche (ANR-09-EBIO-011 to R.M.), INRA GAP Department (R.M.), NSF (IOS-1026094 to S.W. L.C.), the Basil O'Connor Starter Scholar Program from the March of Dimes (S.W.L.C.), a targeted allocation grant from CSIR (I.S.), and a Centre of Excellence grant from Department of Biotechnology (I. S.). Two provisional patent applications based on the work have been filed jointly by INRA and UC Davis (USA 61/418,792) and jointly by CSIR and UC Davis (India 619/DEL/2010).	d'Erfurth I, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000124; Dilkes BP, 2008, PLOS BIOL, V6, P2707, DOI 10.1371/journal.pbio.0060308; Pichot C, 2001, NATURE, V412, P39, DOI 10.1038/35083687; Ravi M, 2008, NATURE, V451, P1121, DOI 10.1038/nature06557; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Spillane C, 2004, NAT BIOTECHNOL, V22, P687, DOI 10.1038/nbt976	6	91	103	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					876	876		10.1126/science.1199682	http://dx.doi.org/10.1126/science.1199682			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330535				2022-12-01	WOS:000287455100046
J	Choi, M; Scholl, UI; Yue, P; Bjorklund, P; Zhao, BX; Nelson-Williams, C; Ji, WZ; Cho, YS; Patel, A; Men, CJ; Lolis, E; Wisgerhof, MV; Geller, DS; Mane, S; Hellman, P; Westin, G; Akerstrom, G; Wang, WH; Carling, T; Lifton, RP				Choi, Murim; Scholl, Ute I.; Yue, Peng; Bjoerklund, Peyman; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Cho, Yoonsang; Patel, Aniruddh; Men, Clara J.; Lolis, Elias; Wisgerhof, Max V.; Geller, David S.; Mane, Shrikant; Hellman, Per; Westin, Gunnar; Akerstrom, Goran; Wang, Wenhui; Carling, Tobias; Lifton, Richard P.			K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension	SCIENCE			English	Article							REMEDIABLE ALDOSTERONISM; ADRENOCORTICAL-CELLS; COLORECTAL CANCERS; GLOMERULOSA CELLS; POTASSIUM CHANNEL; MOLECULAR-BASIS; HUMAN BREAST; SELECTIVITY; IDENTIFICATION; CONDUCTION	Endocrine tumors such as aldosterone-producing adrenal adenomas (APAs), a cause of severe hypertension, feature constitutive hormone production and unrestrained cell proliferation; the mechanisms linking these events are unknown. We identify two recurrent somatic mutations in and near the selectivity filter of the potassium (K+) channel KCNJ5 that are present in 8 of 22 human APAs studied. Both produce increased sodium (Na+) conductance and cell depolarization, which in adrenal glomerulosa cells produces calcium (Ca2+) entry, the signal for aldosterone production and cell proliferation. Similarly, we identify an inherited KCNJ5 mutation that produces increased Na+ conductance in a Mendelian form of severe aldosteronism and massive bilateral adrenal hyperplasia. These findings explain pathogenesis in a subset of patients with severe hypertension and implicate loss of K+ channel selectivity in constitutive cell proliferation and hormone production.	[Choi, Murim; Scholl, Ute I.; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Patel, Aniruddh; Men, Clara J.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Choi, Murim; Scholl, Ute I.; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Patel, Aniruddh; Men, Clara J.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; [Yue, Peng; Wang, Wenhui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Bjoerklund, Peyman; Carling, Tobias] Yale Univ, Sch Med, Yale Endocrine Neoplasia Lab, Dept Surg, New Haven, CT 06510 USA; [Bjoerklund, Peyman; Carling, Tobias] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Bjoerklund, Peyman; Hellman, Per; Westin, Gunnar; Akerstrom, Goran] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Cho, Yoonsang; Lolis, Elias] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Wisgerhof, Max V.] Henry Ford Hosp, Div Endocrinol, Detroit, MI 48202 USA; [Geller, David S.] Yale Univ, Sch Med, Nephrol Sect, West Haven, CT 06516 USA; [Geller, David S.] Vet Affairs Med Ctr, Dept Med, West Haven, CT 06516 USA; [Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, West Haven, CT 06516 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; New York Medical College; Yale University; Yale University; Uppsala University; Yale University; Henry Ford Health System; Henry Ford Hospital; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Björklund, Peyman/A-1509-2014; Bjørklund, Geir/B-7319-2014; Hellman, Per/AAL-9817-2021; Choi, Murim/AAP-9120-2021	Björklund, Peyman/0000-0002-9398-4496; Bjørklund, Geir/0000-0003-2632-3935; Hellman, Per/0000-0002-5322-5073; Lolis, Elias/0000-0002-7902-7868; Scholl, Ute/0000-0002-0309-8045; Zhao, Bixiao/0000-0002-1775-1690; Choi, Murim/0000-0002-9195-1455; Patel, Aniruddh/0000-0001-7871-9638	National Institutes of Health (NIH) [DK54983]; Yale Center for Human Genetics and Genomics; Yale NIH O'Brien Center for Kidney Research; Yale NIH; Swedish Cancer Society; Swedish Research Council; Lions Cancer Fund, Uppsala; Fondation Leducq Transatlantic Network in Hypertension; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, R01DK054983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Center for Human Genetics and Genomics; Yale NIH O'Brien Center for Kidney Research; Yale NIH; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Fund, Uppsala; Fondation Leducq Transatlantic Network in Hypertension(Leducq Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients whose participation made this study possible and the staff of the Yale West Campus Genomics Center and the Endocrine Surgical Laboratory, Clinical Research Centre, University Hospital, Uppsala. Supported in part by the Fondation Leducq Transatlantic Network in Hypertension, National Institutes of Health (NIH) grant DK54983, the Yale Center for Human Genetics and Genomics, Yale NIH O'Brien Center for Kidney Research, and the Yale NIH Clinical Translational Science Award, and by the Swedish Cancer Society, the Swedish Research Council, and the Lions Cancer Fund, Uppsala. U.I.S. is a fellow of the Deutsche Forschungsgemeinschaft; B.Z. is an investigator of the Yale Medical Scientist Training Program; T.C. is a Doris Duke-Damon Runyon Clinical Investigator; R.P.L. is a paid scientific advisor to Merck and is an investigator of the Howard Hughes Medical Institute.	Calvo-Romero JM, 2000, POSTGRAD MED J, V76, P160, DOI 10.1136/pmj.76.893.160; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Czirjak G, 2002, MOL ENDOCRINOL, V16, P621, DOI 10.1210/me.16.3.621; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; Geller DS, 2008, J CLIN ENDOCR METAB, V93, P3117, DOI 10.1210/jc.2008-0594; Ghose RP, 1999, ANN INTERN MED, V131, P105, DOI 10.7326/0003-4819-131-2-199907200-00005; Gregerson KA, 2001, ENDOCRINOLOGY, V142, P2820, DOI 10.1210/en.142.7.2820; HAJNOCZKY G, 1992, ENDOCRINOLOGY, V130, P1637, DOI 10.1210/en.130.3.1637; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUMAR V, 2009, ROBBINS COTRAN PATHO, pCH24; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pawlikowski M, 2001, Endocr Regul, V35, P139; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tanabe A, 1998, J ENDOCRINOL INVEST, V21, P668, DOI 10.1007/BF03350796; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	25	667	697	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					768	772		10.1126/science.1198785	http://dx.doi.org/10.1126/science.1198785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311022	Green Accepted, Green Published			2022-12-01	WOS:000287205700070
J	Schadt, E				Schadt, Eric			First Steps on a Long Road	SCIENCE			English	Editorial Material									Pacific Biosci Calif, Menlo Pk, CA USA		Schadt, E (corresponding author), Pacific Biosci Calif, Menlo Pk, CA USA.								0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					691	691		10.1126/science.1203235	http://dx.doi.org/10.1126/science.1203235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310999	Bronze			2022-12-01	WOS:000287205700044
J	Powell, T				Powell, Tia			Life Imitates Work	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bioethics@montefiore.org							0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					542	543		10.1001/jama.2011.98	http://dx.doi.org/10.1001/jama.2011.98			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304072				2022-12-01	WOS:000287080500002
J	Diep, CQ; Ma, DD; Deo, RC; Holm, TM; Naylor, RW; Arora, N; Wingert, RA; Bollig, F; Djordjevic, G; Lichman, B; Zhu, H; Ikenaga, T; Ono, F; Englert, C; Cowan, CA; Hukriede, NA; Handin, RI; Davidson, AJ				Diep, Cuong Q.; Ma, Dongdong; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Arora, Natasha; Wingert, Rebecca A.; Bollig, Frank; Djordjevic, Gordana; Lichman, Benjamin; Zhu, Hao; Ikenaga, Takanori; Ono, Fumihito; Englert, Christoph; Cowan, Chad A.; Hukriede, Neil A.; Handin, Robert I.; Davidson, Alan J.			Identification of adult nephron progenitors capable of kidney regeneration in zebrafish	NATURE			English	Article							TRANSGENIC ZEBRAFISH; GENES; MORPHOGENESIS; PRONEPHROS; REPORTER	Loss of kidney function underlies many renal diseases(1). Mammals can partly repair their nephrons (the functional units of the kidney), but cannot form new ones(2,3). By contrast, fish add nephrons throughout their lifespan and regenerate nephrons de novo after injury(4,5), providing a model for understanding how mammalian renal regeneration may be therapeutically activated. Here we trace the source of new nephrons in the adult zebrafish to small cellular aggregates containing nephron progenitors. Transplantation of single aggregates comprising 10-30 cells is sufficient to engraft adults and generate multiple nephrons. Serial transplantation experiments to test self-renewal revealed that nephron progenitors are long-lived and possess significant replicative potential, consistent with stem-cell activity. Transplantation of mixed nephron progenitors tagged with either green or red fluorescent proteins yielded some mosaic nephrons, indicating that multiple nephron progenitors contribute to a single nephron. Consistent with this, live imaging of nephron formation in transparent larvae showed that nephrogenic aggregates form by the coalescence of multiple cells and then differentiate into nephrons. Taken together, these data demonstrate that the zebrafish kidney probably contains self-renewing nephron stem/progenitor cells. The identification of these cells paves the way to isolating or engineering the equivalent cells in mammals and developing novel renal regenerative therapies.	[Diep, Cuong Q.; Ma, Dongdong; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Wingert, Rebecca A.; Cowan, Chad A.; Handin, Robert I.; Davidson, Alan J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ma, Dongdong; Handin, Robert I.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Wingert, Rebecca A.; Cowan, Chad A.; Handin, Robert I.; Davidson, Alan J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bollig, Frank; Englert, Christoph] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Zhu, Hao] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ikenaga, Takanori; Ono, Fumihito] NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Englert, Christoph] Friedrich Schiller Univ, D-07743 Jena, Germany; [Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hukriede, Neil A.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA; [Diep, Cuong Q.; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Arora, Natasha; Wingert, Rebecca A.; Djordjevic, Gordana; Lichman, Benjamin; Cowan, Chad A.; Davidson, Alan J.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Friedrich Schiller University of Jena; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital	Davidson, AJ (corresponding author), Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1142, New Zealand.	a.davidson@auckland.ac.nz	Zhu, Hao/L-5114-2013; Wingert, Rebecca A/ABE-2786-2020; Ma, Diane/AAR-6749-2021; Wilson, Matthew H/K-3193-2013	Zhu, Hao/0000-0002-8417-9698; Wingert, Rebecca A/0000-0003-3133-7549; ono, fumihito/0000-0001-7532-5262; Naylor, Richard/0000-0003-2901-7677; Ikenaga, Takanori/0000-0002-7321-9703; Lichman, Benjamin/0000-0002-0033-1120; Englert, Christoph/0000-0002-5931-3189; Ma, Diane/0000-0001-7125-9587	Harvard Stem Cell Institute; American Society of Nephrology; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P50DK074030]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030, R01DK069403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000437] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; American Society of Nephrology; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank E. C. Liao for help with suturing, and R. Ethier and L. Gyr for zebrafish care. A.J.D. was supported by the Harvard Stem Cell Institute, the American Society of Nephrology and the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (P50DK074030).	Augusto J, 1996, DIS AQUAT ORGAN, V26, P49, DOI 10.3354/dao026049; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; Hall C, 2009, J LEUKOCYTE BIOL, V85, P751, DOI 10.1189/jlb.0708405; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Reimschuessel R, 2001, ILAR J, V42, P285; Swanhart LM, 2010, INT J DEV BIOL, V54, P731, DOI 10.1387/ijdb.092969ls; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Westerfield M., 1993, GUIDE LAB USE ZEBRAF; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF1040, DOI 10.1152/ajprenal.00394.2010	23	200	208	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					95	U108		10.1038/nature09669	http://dx.doi.org/10.1038/nature09669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21270795	Green Accepted			2022-12-01	WOS:000286886400041
J	Mills, RE; Walter, K; Stewart, C; Handsaker, RE; Chen, K; Alkan, C; Abyzov, A; Yoon, SC; Ye, K; Cheetham, RK; Chinwalla, A; Conrad, DF; Fu, YT; Grubert, F; Hajirasouliha, I; Hormozdiari, F; Iakoucheva, LM; Iqbal, Z; Kang, SL; Kidd, JM; Konkel, MK; Korn, J; Khurana, E; Kural, D; Lam, HYK; Leng, J; Li, RQ; Li, YR; Lin, CY; Luo, RB; Mu, XJ; Nemesh, J; Peckham, HE; Rausch, T; Scally, A; Shi, XH; Stromberg, MP; Stutz, AM; Urban, AE; Walker, JA; Wu, JT; Zhang, YJ; Zhang, ZDD; Batzer, MA; Ding, L; Marth, GT; McVean, G; Sebat, J; Snyder, M; Wang, J; Ye, K; Eichler, EE; Gerstein, MB; Hurles, ME; Lee, C; McCarroll, SA; Korbel, JO				Mills, Ryan E.; Walter, Klaudia; Stewart, Chip; Handsaker, Robert E.; Chen, Ken; Alkan, Can; Abyzov, Alexej; Yoon, Seungtai Chris; Ye, Kai; Cheetham, R. Keira; Chinwalla, Asif; Conrad, Donald F.; Fu, Yutao; Grubert, Fabian; Hajirasouliha, Iman; Hormozdiari, Fereydoun; Iakoucheva, Lilia M.; Iqbal, Zamin; Kang, Shuli; Kidd, Jeffrey M.; Konkel, Miriam K.; Korn, Joshua; Khurana, Ekta; Kural, Deniz; Lam, Hugo Y. K.; Leng, Jing; Li, Ruiqiang; Li, Yingrui; Lin, Chang-Yun; Luo, Ruibang; Mu, Xinmeng Jasmine; Nemesh, James; Peckham, Heather E.; Rausch, Tobias; Scally, Aylwyn; Shi, Xinghua; Stromberg, Michael P.; Stuetz, Adrian M.; Urban, Alexander Eckehart; Walker, Jerilyn A.; Wu, Jiantao; Zhang, Yujun; Zhang, Zhengdong D.; Batzer, Mark A.; Ding, Li; Marth, Gabor T.; McVean, Gil; Sebat, Jonathan; Snyder, Michael; Wang, Jun; Ye, Kenny; Eichler, Evan E.; Gerstein, Mark B.; Hurles, Matthew E.; Lee, Charles; McCarroll, Steven A.; Korbel, Jan O.		1000 Genomes Project	Mapping copy number variation by population-scale genome sequencing	NATURE			English	Article							STRUCTURAL VARIATION; SEGMENTAL DUPLICATIONS; SHORT-READ; REARRANGEMENTS; COMMON; POLYMORPHISM; INSERTIONS; DELETIONS; SNPS	Genomic structural variants (SVs) are abundant in humans, differing from other forms of variation in extent, origin and functional impact. Despite progress in SV characterization, the nucleotide resolution architecture of most SVs remains unknown. We constructed a map of unbalanced SVs (that is, copy number variants) based on whole genome DNA sequencing data from 185 human genomes, integrating evidence from complementary SV discovery approaches with extensive experimental validations. Our map encompassed 22,025 deletions and 6,000 additional SVs, including insertions and tandem duplications. Most SVs (53%) were mapped to nucleotide resolution, which facilitated analysing their origin and functional impact. We examined numerous whole and partial gene deletions with a genotyping approach and observed a depletion of gene disruptions amongst high frequency deletions. Furthermore, we observed differences in the size spectra of SVs originating from distinct formation mechanisms, and constructed a map of SV hotspots formed by common mechanisms. Our analytical framework and SV map serves as a resource for sequencing-based association studies.	[Rausch, Tobias; Stuetz, Adrian M.; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany; [Mills, Ryan E.; Shi, Xinghua; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mills, Ryan E.; Shi, Xinghua; Lee, Charles] Harvard Univ, Sch Med, Boston, MA USA; [Walter, Klaudia; Conrad, Donald F.; Scally, Aylwyn; Zhang, Yujun; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Stewart, Chip; Kural, Deniz; Stromberg, Michael P.; Wu, Jiantao; Marth, Gabor T.] Boston Coll, Dept Biol, Boston, MA USA; [Handsaker, Robert E.; Korn, Joshua; Nemesh, James; McCarroll, Steven A.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Handsaker, Robert E.; Korn, Joshua; Nemesh, James; McCarroll, Steven A.] MIT, Cambridge, MA 02139 USA; [Chen, Ken; Chinwalla, Asif; Ding, Li] Washington Univ, Genome Ctr, St Louis, MO USA; [Alkan, Can; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Alkan, Can; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Abyzov, Alexej; Khurana, Ekta; Leng, Jing; Mu, Xinmeng Jasmine; Zhang, Zhengdong D.; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Yoon, Seungtai Chris] Mt Sinai Sch Med, Seaver Autism Ctr, New York, NY USA; [Yoon, Seungtai Chris] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Ye, Kai] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Ye, Kai] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Cheetham, R. Keira] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Fu, Yutao; Peckham, Heather E.] Life Technol, Beverly, MA USA; [Grubert, Fabian; Lam, Hugo Y. K.; Urban, Alexander Eckehart; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Hajirasouliha, Iman; Hormozdiari, Fereydoun] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Iakoucheva, Lilia M.; Kang, Shuli; Sebat, Jonathan] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, Dept Psychiat, La Jolla, CA 92093 USA; [Iqbal, Zamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Konkel, Miriam K.; Walker, Jerilyn A.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Khurana, Ekta; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Li, Ruiqiang; Li, Yingrui; Luo, Ruibang; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Lin, Chang-Yun; Ye, Kenny] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Ding, Li] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [McVean, Gil] Univ Oxford, Dept Stat, Oxford OX3 7BN, England; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Urban, Alexander Eckehart] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	European Molecular Biology Laboratory (EMBL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Wellcome Trust Sanger Institute; Boston College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Illumina; Thermo Fisher Scientific; Stanford University; Simon Fraser University; University of California System; University of California San Diego; University of Oxford; Wellcome Centre for Human Genetics; Louisiana State University System; Louisiana State University; Yale University; Beijing Genomics Institute (BGI); Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); University of Oxford; University of Copenhagen; Yale University; Harvard University; Harvard Medical School; Stanford University	Korbel, JO (corresponding author), European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany.	jan.korbel@embl.de	Handsaker, Bob/AAX-9095-2021; Ye, Kenny/U-2341-2019; Khurana, Ekta/C-4933-2013; Wang, Jun/A-7261-2013; Abyzov, Alexej/AAT-4615-2020; Myers, Simon R/A-6792-2015; Alkan, Can/D-2982-2009; Li, Yingrui/K-1064-2015; Dahl, Andreas/E-3783-2017; Cooper, David N/H-4384-2011; Sahinalp, Suleyman Cenk/X-7843-2018; Mu, Xinmeng/P-2562-2016; Ye, Kai/GSD-9856-2022; Chen, Ken/AAU-1432-2021; Abyzov, Alexej/M-4284-2013; Browning, Brian L/A-1178-2010; Rosenstiel, Philip/A-5137-2009; Maestrini, Elena/K-7508-2012; Rausch, Tobias/H-6511-2019; Fang, Xiaodong/K-6743-2018; Ye, Kenny/GSM-7731-2022; Chen, Wei/AAX-5994-2020; Chen, Ken/A-1074-2009; Korbel, Jan O/G-6470-2012; Ye, Kai/B-3640-2012; Mills, Ryan E/F-4225-2010; Wilson, Richard K./AAF-4139-2019; Tumian, Afidalina/J-4404-2014; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Handsaker, Bob/0000-0002-3128-3547; Ye, Kenny/0000-0002-1466-855X; Myers, Simon R/0000-0002-2585-9626; Alkan, Can/0000-0002-5443-0706; Dahl, Andreas/0000-0002-2668-8371; Cooper, David N/0000-0002-8943-8484; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Mu, Xinmeng/0000-0002-8079-0828; Ye, Kai/0000-0002-2851-6741; Chen, Ken/0000-0003-4013-5279; Browning, Brian L/0000-0001-6454-6633; Rosenstiel, Philip/0000-0002-9692-8828; Maestrini, Elena/0000-0001-5924-3179; Rausch, Tobias/0000-0001-5773-5620; Fang, Xiaodong/0000-0001-7061-3337; Chen, Wei/0000-0001-7196-8703; Korbel, Jan O/0000-0002-2798-3794; Mills, Ryan E/0000-0003-3425-6998; Wilson, Richard K./0000-0002-1992-1358; Hinrichs, Angie/0000-0002-1697-1130; Tumian, Afidalina/0000-0003-2763-6677; Palotie, Aarno/0000-0002-2527-5874; Zalunin, Vadim/0000-0002-7722-1958; Eberle, Michael/0000-0001-8965-1253; Cibulskis, Kristian/0000-0003-1343-1582; Iqbal, Zamin/0000-0001-8466-7547; Haraksingh, Rajini/0000-0002-6644-8874; Wang, Jun/0000-0002-8540-8931; Radhakrishnan, Rajesh/0000-0001-7170-699X; Balasubramanian, Shankar/0000-0002-0281-5815; Swerdlow, Harold/0000-0002-9510-160X; Keenan, Stephen/0000-0002-9141-7690; Walter, Klaudia/0000-0003-4448-0301; Leinonen, Rasko/0000-0002-2639-7187; Snyder, Michael/0000-0003-0784-7987; Kulesha, Eugene/0000-0002-4285-6232; Wang, Jun/0000-0002-2113-5874; Clark, Andrew/0000-0001-7159-8511; Chinwalla, Asif/0000-0001-7831-3996; Abyzov, Alexej/0000-0001-5405-6729; Kidd, Jeffrey/0000-0002-9631-1465; Bustamante, Carlos D./0000-0002-4187-7920; Stone, Eric/0000-0002-2725-4209; Sebat, Jonathan/0000-0002-9087-526X; MCLELLAN, MICHAEL/0000-0002-2703-8784; Luo, Ruibang/0000-0001-9711-6533; Lin, Chang-Yun/0000-0001-7599-1214; Keinan, Alon/0000-0002-9760-1122; Sherry, Stephen/0000-0002-7982-076X; Keane, Thomas/0000-0001-7532-6898; Kural, Deniz/0000-0002-8085-0771; Herrero, Javier/0000-0001-7313-717X; Schaffner, Stephen/0000-0001-6699-3568; Iakoucheva, Lilia/0000-0002-4542-5219; MacArthur, Daniel/0000-0002-5771-2290; McLaren, William/0000-0001-6218-1116; Stuetz, Adrian/0000-0001-7650-3470; Borodina, Tatiana/0000-0002-6978-016X; Clarke, Laura/0000-0002-5989-6898; Hormozdiari, Fereydoun/0000-0003-2703-9274	National Institutes of Health [RO1 GM59290, R01 HG004719, RC2 HG005552, P01 HG004120, U01 HG005209, P41 HG004221, RO1 GM081533, UO1 HG005209]; German Research Foundation (Deutsche Forschungsgemeinschaft); National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531, 30221004]; Chinese 863 program [2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Danish Natural Science Research Council; Medical Research Council [G1000758, G0701805, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, P41HG004221, U01HG005209, U54HG003273, RC2HG005552, R01HG004719, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081533, R01GM059290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022707] Funding Source: NIH RePORTER; MRC [G0701805] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to acknowledge C. Hardy, R. Smith, A. De Witte and S. Giles for their assistance with validation. M.A.B.'s group was supported by a grant from the National Institutes of Health (RO1 GM59290) and G.T.M.'s group by grants R01 HG004719 and RC2 HG005552, also from the NIH. J.O.K.'s group was supported by an Emmy Noether Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft). J.W.'s group was supported by the National Basic Research Program of China (973 program no. 2011CB809200), the National Natural Science Foundation of China (30725008; 30890032; 30811130531; 30221004), the Chinese 863 program (2006AA02Z177; 2006AA02Z334; 2006AA02A302; 2009AA022707), the Shenzhen Municipal Government of China (grants JC200903190767A; JC200903190772A; ZYC200903240076A; CXB200903110066A; ZYC200903240077A; ZYC200903240076A and ZYC200903240080A) and the Ole Romer grant from the Danish Natural Science Research Council. E.E.E.'s group was supported by grants P01 HG004120 and U01 HG005209 from the National Institutes of Health. C.L.'s group was supported by grants from the National Institutes of Health: P41 HG004221, RO1 GM081533 and UO1 HG005209 and X. S. was supported by a T32 fellowship award from the NIH. We thank the Genome Structural Variation Consortium (http://www.sanger.ac.uk/humgen/cnv/42mio/) and the International HapMap Consortium for making available microarray data. The authors acknowledge the individuals participating in the 1000 Genomes Project by providing samples, including the Yoruba people of Ibadan, Nigeria, the community at Beijing Normal University, the people of Tokyo, Japan, and the people of the Utah CEPH community. Furthermore, we thank R. Durbin and L. Steinmetz for comments on the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee S, 2008, BIOINFORMATICS, V24, pI59, DOI 10.1093/bioinformatics/btn176; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/nmeth.1374, 10.1038/NMETH.1374]; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	44	771	824	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					59	65		10.1038/nature09708	http://dx.doi.org/10.1038/nature09708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293372	Green Published, Green Submitted, Green Accepted			2022-12-01	WOS:000286886400033
J	Weisfeldt, ML; Everson-Stewart, S; Sitlani, C; Rea, T; Aufderheide, TP; Atkins, DL; Bigham, B; Brooks, SC; Foerster, C; Gray, R; Ornato, JP; Powell, J; Kudenchuk, PJ; Morrison, LJ				Weisfeldt, Myron L.; Everson-Stewart, Siobhan; Sitlani, Colleen; Rea, Thomas; Aufderheide, Tom P.; Atkins, Dianne L.; Bigham, Blair; Brooks, Steven C.; Foerster, Christopher; Gray, Randal; Ornato, Joseph P.; Powell, Judy; Kudenchuk, Peter J.; Morrison, Laurie J.		Resuscitation Outcomes Consortium	Ventricular Tachyarrhythmias after Cardiac Arrest in Public versus at Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; ACCESS DEFIBRILLATION; CARDIOPULMONARY-RESUSCITATION; OUTCOMES; SURVIVAL; CPR; COMPRESSION; POPULATION; LOCATIONS	BACKGROUND The incidence of ventricular fibrillation or pulseless ventricular tachycardia as the first recorded rhythm after out-of-hospital cardiac arrest has unexpectedly declined. The success of bystander-deployed automated external defibrillators (AEDs) in public settings suggests that this may be the more common initial rhythm when out-of-hospital cardiac arrest occurs in public. We conducted a study to determine whether the location of the arrest, the type of arrhythmia, and the probability of survival are associated. METHODS Between 2005 and 2007, we conducted a prospective cohort study of out-of-hospital cardiac arrest in adults in 10 North American communities. We assessed the frequencies of ventricular fibrillation or pulseless ventricular tachycardia and of survival to hospital discharge for arrests at home as compared with arrests in public. RESULTS Of 12,930 evaluated out-of-hospital cardiac arrests, 2042 occurred in public and 9564 at home. For cardiac arrests at home, the incidence of ventricular fibrillation or pulseless ventricular tachycardia was 25% when the arrest was witnessed by emergency-medical-services (EMS) personnel, 35% when it was witnessed by a bystander, and 36% when a bystander applied an AED. For cardiac arrests in public, the corresponding rates were 38%, 60%, and 79%. The adjusted odds ratio for initial ventricular fibrillation or pulseless ventricular tachycardia in public versus at home was 2.28 (95% confidence interval [CI], 1.96 to 2.66; P<0.001) for bystander-witnessed arrests and 4.48 (95% CI, 2.23 to 8.97; P<0.001) for arrests in which bystanders applied AEDs. The rate of survival to hospital discharge was 34% for arrests in public settings with AEDs applied by bystanders versus 12% for arrests at home (adjusted odds ratio, 2.49; 95% CI, 1.03 to 5.99; P=0.04). CONCLUSIONS Regardless of whether out-of-hospital cardiac arrests are witnessed by EMS personnel or bystanders and whether AEDs are applied by bystanders, the proportion of arrests with initial ventricular fibrillation or pulseless ventricular tachycardia is much greater in public settings than at home. The incremental value of resuscitation strategies, such as the ready availability of an AED, may be related to the place where the arrest occurs.	[Weisfeldt, Myron L.] Johns Hopkins Univ, Baltimore, MD 21287 USA; [Everson-Stewart, Siobhan; Sitlani, Colleen; Rea, Thomas; Powell, Judy; Kudenchuk, Peter J.] Univ Washington, Seattle, WA 98195 USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Atkins, Dianne L.] Univ Iowa, Iowa City, IA USA; [Bigham, Blair; Brooks, Steven C.; Foerster, Christopher; Morrison, Laurie J.] Univ Toronto, Toronto, ON, Canada; [Gray, Randal] Univ Alabama, Birmingham, AL USA; [Ornato, Joseph P.] Virginia Commonwealth Univ, Richmond, VA USA	Johns Hopkins University; University of Washington; University of Washington Seattle; Medical College of Wisconsin; University of Iowa; University of Toronto; University of Alabama System; University of Alabama Birmingham; Virginia Commonwealth University	Weisfeldt, ML (corresponding author), Johns Hopkins Univ, 1830 E Monument St,Suite 9026, Baltimore, MD 21287 USA.	mlw5@jhmi.edu	Brooks, Steven/ABC-8078-2021; Atkins, Dianne/AFM-2981-2022; Morrison, Laurie Jean/A-6325-2012; Brooks, Steven/N-4317-2015	Morrison, Laurie Jean/0000-0001-8369-9774; Brooks, Steven/0000-0002-4592-4974; Brown, Siobhan/0000-0002-4774-3122	National Heart, Lung, and Blood Institute [5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, HL077865]; National Institute of Neurological Disorders and Stroke; U.S. Army Medical Research & Materiel Command; Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health; Defence Research and Development Canada; American Heart Association; Heart and Stroke Foundation of Canada; Philips and Physio-Control; Medtronic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077887, U01HL077867, U01HL077885, U01HL077872, U01HL077881, U01HL077866, U01HL077865, U01HL077873, U01HL077871, U01HL077863, U01HL077908] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Army Medical Research & Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Defence Research and Development Canada; American Heart Association(American Heart Association); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Philips and Physio-Control; Medtronic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by cooperative agreements with 10 regional clinical centers and one data coordinating center (5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, and HL077865) from the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, the U.S. Army Medical Research & Materiel Command, the Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, the American Heart Association, and the Heart and Stroke Foundation of Canada.; Dr. Atkins reports receiving support from the American Heart Association as the editor of the CPR Guidelines and having testified as an expert witness on pediatric defibrillation; Dr. Aufderheide, serving as a consultant for the Medtronic Foundation and Jolife; Dr. Ornato, being employed as the American editor of the journal Resuscitation; Dr. Rea, using AEDs supplied by Philips and Physio-Control and receiving funding on behalf of his institution, the University of Washington, from Philips and Physio-Control and the Medtronic Foundation; and Dr. Weisfeldt, receiving royalties both for himself and on behalf of his institution, the Johns Hopkins University School of Medicine, from a patent for a pacemaker. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2010, CIRCULATION, V121, pe46; Atkins DL, 2009, CIRCULATION, V120, P461, DOI 10.1161/CIRCULATIONAHA.109.883488; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Becker L, 2008, RESUSCITATION, V79, P22, DOI 10.1016/j.resuscitation.2008.06.019; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Ewy GA, 2007, CIRCULATION, V116, P2525, DOI 10.1161/CIRCULATIONAHA.107.711820; Folke F, 2010, CIRCULATION, V122, P623, DOI 10.1161/CIRCULATIONAHA.109.924423; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Investigators TPADT., 2004, NEW ENGL J MED, V351, P637, DOI [10.1056/NEJMoa040566, DOI 10.1056/NEJMOA040566]; Iwami T, 2006, RESUSCITATION, V69, P221, DOI 10.1016/j.resuscitation.2005.08.018; MacDonald RD, 2001, ANN EMERG MED, V38, P262, DOI 10.1067/mem.2001.117953; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; NICHOL G, 2008, JAMA-J AM MED ASSOC, V300, P1763; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; Stolzenberg Brett T, 2002, Prehosp Emerg Care, V6, P65, DOI 10.1080/10903120290938814; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Weisfeldt ML, 2010, NEW ENGL J MED, V363, P481, DOI 10.1056/NEJMe1006306; Weisfeldt ML, 2010, J AM COLL CARDIOL, V55, P1712, DOI 10.1016/j.jacc.2009.11.077	26	217	228	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					313	321		10.1056/NEJMoa1010663	http://dx.doi.org/10.1056/NEJMoa1010663			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268723	Green Accepted, Green Published			2022-12-01	WOS:000286592600006
J	Hingorani, AD; Hemingway, H				Hingorani, Aroon D; Hemingway, Harry			How should we balance individual and population benefits of statins for preventing cardiovascular disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hingorani, Aroon D] UCL, Dept Epidemiol & Publ Hlth, Clin Epidemiol Grp, London, England; [Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England	University of London; University College London; University of London; University College London	Hingorani, AD (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England.	a.hingorani@ucl.ac.uk	Hemingway, Harry/C-1219-2009	Hemingway, Harry/0000-0003-2279-0624; Hingorani, Aroon/0000-0001-8365-0081	British Heart Foundation [FS05/125] Funding Source: Medline; Department of Health [RP-PG-0407-10314] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Department of Health			0	12	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								c6244	10.1136/bmj.c6244	http://dx.doi.org/10.1136/bmj.c6244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270079				2022-12-01	WOS:000286887800015
J	Wu, H; D'Alessio, AC; Ito, S; Xia, K; Wang, ZB; Cui, KR; Zhao, KJ; Sun, YE; Zhang, Y				Wu, Hao; D'Alessio, Ana C.; Ito, Shinsuke; Xia, Kai; Wang, Zhibin; Cui, Kairong; Zhao, Keji; Sun, Yi Eve; Zhang, Yi			Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells	NATURE			English	Article							DNA METHYLATION; HISTONE H3; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; POLYCOMB; GENOME; GENES; COMPLEX; BINDING; PROTEIN	Epigenetic modification of the mammalian genome by DNA methylation (5-methylcytosine) has a profound impact on chromatin structure, gene expression and maintenance of cellular identity(1). The recent demonstration that members of the Ten-eleven translocation (Tet) family of proteins can convert 5-methylcytosine to 5-hydroxymethylcytosine raised the possibility that Tet proteins are capable of establishing a distinct epigenetic state(2,3). We have recently demonstrated that Tet1 is specifically expressed in murine embryonic stem (ES) cells and is required for ES cell maintenance(2). Using chromatin immunoprecipitation coupled with high-throughput DNA sequencing, here we show in mouse ES cells that Tet1 is preferentially bound to CpG-rich sequences at promoters of both transcriptionally active and Polycomb-repressed genes. Despite an increase in levels of DNA methylation at many Tet1-binding sites, Tet1 depletion does not lead to downregulation of all the Tet1 targets. Interestingly, although Tet1-mediated promoter hypomethylation is required for maintaining the expression of a group of transcriptionally active genes, it is also involved in repression of Polycomb-targeted developmental regulators. Tet1 contributes to silencing of this group of genes by facilitating recruitment of PRC2 to CpG-rich gene promoters. Thus, our study not only establishes a role for Tet1 in modulating DNA methylation levels at CpG-rich promoters, but also reveals a dual function of Tet1 in promoting transcription of pluripotency factors as well as participating in the repression of Polycomb-targeted developmental regulators.	[D'Alessio, Ana C.; Ito, Shinsuke; Xia, Kai; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wu, Hao; Sun, Yi Eve] Univ Calif Los Angeles, David Geffen Sch Med, IDDRC Semel Inst Neurosci & Human Behav, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Hao; Sun, Yi Eve] Univ Calif Los Angeles, David Geffen Sch Med, IDDRC Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Wang, Zhibin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Lab Human Environm Epigenomes, Baltimore, MD 21025 USA; [Cui, Kairong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Xia, Kai/B-7214-2014; Wu, Hao/G-4145-2013	Wu, Hao/0000-0002-1256-6891; Wu, Hao/0000-0003-4395-6929; Zhang, Yi/0000-0002-2789-0811; Xia, Kai/0000-0003-1326-0891	NIH [GM68804, R56MH082068]; Division of Intramural Research of National Heart, Lung and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH082068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of National Heart, Lung and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Abraham and I. Chepelev for Illumina sequencing and data transfer; J. He and A. T. Nguyen for FACS sorting; O. Taranova for discussion; S. Wu for critical reading of the manuscript. This work was supported by NIH grants GM68804 (to Y.Z.), R56MH082068 (to Y.E.S.) and support from the Division of Intramural Research Program of National Heart, Lung and Blood Institute, NIH (K.Z.). S. I. is a research fellow of the Japan Society for the Promotion of Science. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pelizzola M, 2008, GENOME RES, V18, P1652, DOI 10.1101/gr.080721.108; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	488	507	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					389	U578		10.1038/nature09934	http://dx.doi.org/10.1038/nature09934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21451524	Green Published, Green Accepted			2022-12-01	WOS:000290722400052
J	Bivona, TG; Hieronymus, H; Parker, J; Chang, K; Taron, M; Rosell, R; Moonsamy, P; Dahlman, K; Miller, VA; Costa, C; Hannon, G; Sawyers, CL				Bivona, Trever G.; Hieronymus, Haley; Parker, Joel; Chang, Kenneth; Taron, Miquel; Rosell, Rafael; Moonsamy, Philicia; Dahlman, Kimberly; Miller, Vincent A.; Costa, Carlota; Hannon, Gregory; Sawyers, Charles L.			FAS and NF-kappa B signalling modulate dependence of lung cancers on mutant EGFR	NATURE			English	Article							ACQUIRED-RESISTANCE; MET AMPLIFICATION; ERLOTINIB; MUTATIONS; KINASE; CELLS; ADENOCARCINOMA; INHIBITION; GEFITINIB; APOPTOSIS	Human lung adenocarcinomas with activating mutations in EGFR (epidermal growth factor receptor) often respond to treatment with EGFR tyrosine kinase inhibitors (TKIs), but the magnitude of tumour regression is variable and transient(1,2). This heterogeneity in treatment response could result from genetic modifiers that regulate the degree to which tumour cells are dependent on mutant EGFR. Through a pooled RNA interference screen, we show that knockdown of FAS and several components of the NF-kappa B pathway specifically enhanced cell death induced by the EGFR TKI erlotinib in EGFR-mutant lung cancer cells. Activation of NF-kappa B through overexpression of c-FLIP or IKK (also known as CFLAR and IKBKB, respectively), or silencing of I kappa B (also known as NFKBIA), rescued EGFR-mutant lung cancer cells from EGFR TKI treatment. Genetic or pharmacologic inhibition of NF-kappa B enhanced erlotinib-induced apoptosis in erlotinib-sensitive and erlotinib-resistant EGFR-mutant lung cancer models. Increased expression of the NF-kappa B inhibitor I kappa B predicted for improved response and survival in EGFR-mutant lung cancer patients treated with EGFR TKI. These data identify NF-kappa B as a potential companion drug target, together with EGFR, in EGFR-mutant lung cancers and provide insight into the mechanisms by which tumour cells escape from oncogene dependence.	[Bivona, Trever G.; Hieronymus, Haley; Moonsamy, Philicia; Dahlman, Kimberly; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Parker, Joel] Express Anal Inc, Durham, NC 27713 USA; [Chang, Kenneth; Hannon, Gregory] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Taron, Miquel; Rosell, Rafael; Costa, Carlota] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona 08916, Spain; [Taron, Miquel; Rosell, Rafael; Costa, Carlota] USP Dexeus Univ Inst, Barcelona 08028, Spain; [Hannon, Gregory; Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA.	sawyersc@mskcc.org	Sawyers, Charles/G-5327-2016; Parker, Joel/AAG-1108-2019; Hannon, Gregory/AAB-3568-2019		Charles A. Dana Foundation; ASCO YIA; Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	Charles A. Dana Foundation; ASCO YIA; Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Pao, H. Varmus and members of the MSKCC Lung Cancer Oncogenome group for intellectual support. We thank J. Javier Sanchez for analysing human lung cancer gene expression data. We thank J. Wongvipat and E. Philips for technical assistance and W. Polkinghorn and members of the Sawyers Laboratory for critique of the manuscript. T.G.B. is supported by the MSKCC Clinical Scholars Fellowship funded by the Charles A. Dana Foundation, an ASCO YIA, and the Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer Research Grant. C.L.S. and G.H. are Investigators of the Howard Hughes Medical Institute.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Green DR, 2010, NATURE, V465, P433, DOI 10.1038/465433a; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Miller VA, 2008, J CLIN ONCOL, V26, P1472, DOI 10.1200/JCO.2007.13.0062; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220	23	312	329	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					523	526		10.1038/nature09870	http://dx.doi.org/10.1038/nature09870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430781	Green Accepted, Green Published			2022-12-01	WOS:000288702200064
J	Gravitz, L				Gravitz, Lauren			CHEMOPREVENTION First line of defence	NATURE			English	Editorial Material							CANCER PREVENTION; CELLS											Bode AM, 2009, NAT REV CANCER, V9, P508, DOI 10.1038/nrc2646; Gerner EW, 2009, CLIN CANCER RES, V15, P758, DOI 10.1158/1078-0432.CCR-08-2235; Lippman SM, 2009, CANCER RES, V69, P5269, DOI 10.1158/0008-5472.CAN-09-1750; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871	6	29	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S5	S7		10.1038/471S5a	http://dx.doi.org/10.1038/471S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430719				2022-12-01	WOS:000288702200009
J	Negre, N; Brown, CD; Ma, LJ; Bristow, CA; Miller, SW; Wagner, U; Kheradpour, P; Eaton, ML; Loriaux, P; Sealfon, R; Li, ZR; Ishii, H; Spokony, RF; Chen, J; Hwang, L; Cheng, C; Auburn, RP; Davis, MB; Domanus, M; Shah, PK; Morrison, CA; Zieba, J; Suchy, S; Senderowicz, L; Victorsen, A; Bild, NA; Grundstad, AJ; Hanley, D; MacAlpine, DM; Mannervik, M; Venken, K; Bellen, H; White, R; Gerstein, M; Russell, S; Grossman, RL; Ren, B; Posakony, JW; Kellis, M; White, KP				Negre, Nicolas; Brown, Christopher D.; Ma, Lijia; Bristow, Christopher Aaron; Miller, Steven W.; Wagner, Ulrich; Kheradpour, Pouya; Eaton, Matthew L.; Loriaux, Paul; Sealfon, Rachel; Li, Zirong; Ishii, Haruhiko; Spokony, Rebecca F.; Chen, Jia; Hwang, Lindsay; Cheng, Chao; Auburn, Richard P.; Davis, Melissa B.; Domanus, Marc; Shah, Parantu K.; Morrison, Carolyn A.; Zieba, Jennifer; Suchy, Sarah; Senderowicz, Lionel; Victorsen, Alec; Bild, Nicholas A.; Grundstad, A. Jason; Hanley, David; MacAlpine, David M.; Mannervik, Mattias; Venken, Koen; Bellen, Hugo; White, Robert; Gerstein, Mark; Russell, Steven; Grossman, Robert L.; Ren, Bing; Posakony, James W.; Kellis, Manolis; White, Kevin P.			A cis-regulatory map of the Drosophila genome	NATURE			English	Article							TRANSCRIPTION FACTOR; ENHANCERS; MELANOGASTER; EXPRESSION; BLASTODERM; PROTEINS	Systematic annotation of gene regulatory elements is a major challenge in genome science. Direct mapping of chromatin modification marks and transcriptional factor binding sites genome-wide(1,2) has successfully identified specific subtypes of regulatory elements(3). In Drosophila several pioneering studies have provided genome-wide identification of Polycomb response elements(4), chromatin states(5), transcription factor binding sites(6-9), RNA polymerase II regulation(8) and insulator elements(10); however, comprehensive annotation of the regulatory genome remains a significant challenge. Here we describe results from the modENCODE cis-regulatory annotation project. We produced a map of the Drosophila melanogaster regulatory genome on the basis of more than 300 chromatin immunoprecipitation data sets for eight chromatin features, five histone deacetylases and thirty-eight site-specific transcription factors at different stages of development. Using these data we inferred more than 20,000 candidate regulatory elements and validated a subset of predictions for promoters, enhancers and insulators in vivo. We identified also nearly 2,000 genomic regions of dense transcription factor binding associated with chromatin activity and accessibility. We discovered hundreds of new transcription factor co-binding relationships and defined a transcription factor network with over 800 potential regulatory relationships.	[Negre, Nicolas; Brown, Christopher D.; Ma, Lijia; Spokony, Rebecca F.; Davis, Melissa B.; Domanus, Marc; Morrison, Carolyn A.; Zieba, Jennifer; Suchy, Sarah; Senderowicz, Lionel; Victorsen, Alec; Bild, Nicholas A.; Grundstad, A. Jason; Grossman, Robert L.; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA; [Bristow, Christopher Aaron; Kheradpour, Pouya; Sealfon, Rachel; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Miller, Steven W.; Ishii, Haruhiko; Posakony, James W.] Univ Calif San Diego, Div Biol Sci CDB, La Jolla, CA 92093 USA; [Wagner, Ulrich; Li, Zirong; Hwang, Lindsay; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Eaton, Matthew L.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Loriaux, Paul] Univ Calif San Diego, Signaling Syst Lab, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Chen, Jia; Hanley, David; Grossman, Robert L.] Univ Illinois, Natl Ctr Data Min, Chicago, IL 60607 USA; [Cheng, Chao; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Cheng, Chao; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Cheng, Chao] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Auburn, Richard P.; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Auburn, Richard P.; Russell, Steven] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England; [Shah, Parantu K.] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Mannervik, Mattias] Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, Arrhenius Labs E3, S-10691 Stockholm, Sweden; [Venken, Koen; Bellen, Hugo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [White, Robert] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Grossman, Robert L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ren, Bing] Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Moores Canc Ctr, La Jolla, CA 92093 USA	University of Chicago; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Duke University; University of California System; University of California San Diego; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University; Yale University; Yale University; University of Cambridge; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Stockholm University; Baylor College of Medicine; University of Cambridge; University of Chicago	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, 900 E 57th St, Chicago, IL 60637 USA.	kpwhite@uchicago.edu	Russell, Steve/A-4072-2011; White, Rob A H/G-4835-2012; Eaton, Matthew/C-4408-2011; Zieba, Jennifer/ABE-1077-2020; Venken, Koen/B-9909-2013; Kellis, Manolis/ABE-7385-2020; Spokony, Rebecca/AAD-3014-2020; Grossman, Robert/B-1865-2009	Russell, Steve/0000-0003-0546-3031; Zieba, Jennifer/0000-0003-1650-1830; Venken, Koen/0000-0003-0741-4698; Kellis, Manolis/0000-0001-7113-9630; Bellen, Hugo/0000-0001-5992-5989; Davis, Melissa/0000-0002-6124-6923; Negre, Nicolas/0000-0001-9727-3416; Mannervik, Mattias/0000-0003-4999-9655; Miller, Steven/0000-0001-7610-6336; Brown, Christopher/0000-0002-3785-5008; Ishii, Haruhiko/0000-0002-1593-096X; Grossman, Robert/0000-0003-3741-5739	National Human Genome Research Institute [U01HG004264]; Chicago Biomedical Consortium; Chicago Community Trust; Lilly-Life Sciences Research Foundation; NIH NRSA; Isaac Newton Trust; Department of Energy; NHGRI [U01 HG004279]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004279, RC2HG005639, U01HG004264, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074364, P50GM081892] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Chicago Biomedical Consortium; Chicago Community Trust; Lilly-Life Sciences Research Foundation; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Isaac Newton Trust; Department of Energy(United States Department of Energy (DOE)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U01HG004264 from the National Human Genome Research Institute to K.P.W. and also funded by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Human Genome Research Institute (NHGRI) or the National Institutes of Health (NIH). C.D.B. is supported by a Lilly-Life Sciences Research Foundation fellowship. C.A.B. is supported by a NIH NRSA postdoctoral fellowship. R.P.A. is in part supported by an Isaac Newton Trust award to R.W.P.L. was supported by a grant from the Department of Energy Computational Sciences Graduate Fellowship (DOE CSGF). M.E.L. and D.M.M. work was supported by NHGRI grant U01 HG004279. We thank the Functional Genomics Facility at the University of Chicago and the High-Throughput Genome Analysis Core at Argonne National Laboratory for processing of microarrays and of Illumina sequence. We thank T.-R. Li, J.D. Lambert, S. Rifkin, T. Herreman, C. Mason, L. Sun and Z. Gauhar for producing the developmental expression microarray data. We also thank the many members of the Drosophila community who contributed to this work by providing reagents. A complete list of community participants is included in the Supplementary Methods.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Haecker A, 2007, PLOS BIOL, V5, P1298, DOI 10.1371/journal.pbio.0050145; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531; Zraly CB, 2003, DEV BIOL, V253, P291, DOI 10.1016/S0012-1606(02)00011-8	27	370	378	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					527	531		10.1038/nature09990	http://dx.doi.org/10.1038/nature09990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430782	Green Submitted, Green Accepted			2022-12-01	WOS:000288702200065
J	Mateen, FJ; Brook, RD				Mateen, Farrah J.; Brook, Robert D.			Air Pollution as an Emerging Global Risk Factor for Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASES		[Mateen, Farrah J.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; [Mateen, Farrah J.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21287 USA; [Brook, Robert D.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins University; University of Michigan System; University of Michigan	Mateen, FJ (corresponding author), Johns Hopkins Univ, Dept Neurol, 600 N Wolfe St,Pathol Bldg,Room 627, Baltimore, MD 21287 USA.	fmateen@jhsph.edu		Mateen, Farrah/0000-0002-4293-8115				[Anonymous], 2009, REUTERS         0217; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; LOGAN WPD, 1953, LANCET, V264, P336; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Oudin A, 2010, NEUROEPIDEMIOLOGY, V34, P131, DOI 10.1159/000274807; *WHO, 2008, 310 WHO; Zhou PP, 2005, CLIMATE CHANGE AFRIC, P140	10	57	60	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1240	1241		10.1001/jama.2011.352	http://dx.doi.org/10.1001/jama.2011.352			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427378				2022-12-01	WOS:000288652100022
J	Nurse, P; Hayles, J				Nurse, Paul; Hayles, Jacqueline			The Cell in an Era of Systems Biology	CELL			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; PROTEIN INTERACTION NETWORK; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; GLOBAL ANALYSIS; BUDDING YEAST; SIZE CONTROL; GENOME; CYCLE	The increasing use of high-throughput technologies and computational modeling is revealing new levels of biological function and organization. How are these features of systems biology influencing our view of the cell?	[Nurse, Paul; Hayles, Jacqueline] Cancer Res UK, London Res Inst, London WC2A 3LY, England; [Nurse, Paul] Rockefeller Univ, New York, NY 10021 USA	Cancer Research UK; Rockefeller University	Nurse, P (corresponding author), Cancer Res UK, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	janet.bonner@royalsociety.org			Wellcome Trust [093917] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bray D., 2009, WETWARE COMPUTER EVE; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DICKSON RC, 1975, SCIENCE, V187, P27, DOI 10.1126/science.1088926; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Monod, 1972, CHANCE NECESSITY ESS; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; OHKI M, 1975, NATURE, V253, P654, DOI 10.1038/253654a0; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SAUNDERS PT, 1976, J THEOR BIOL, V63, P375, DOI 10.1016/0022-5193(76)90040-0; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sioud M, 2011, METHODS MOL BIOL, V703, P173, DOI 10.1007/978-1-59745-248-9_12; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Towers M, 2009, INT J DEV BIOL, V53, P805, DOI 10.1387/ijdb.072499mt; TYSON JJ, 1983, J THEOR BIOL, V104, P617, DOI 10.1016/0022-5193(83)90250-3; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	54	52	56	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					850	854		10.1016/j.cell.2011.02.045	http://dx.doi.org/10.1016/j.cell.2011.02.045			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414476	Bronze			2022-12-01	WOS:000288543500003
J	Steidl, C; Shah, SP; Woolcock, BW; Rui, LX; Kawahara, M; Farinha, P; Johnson, NA; Zhao, YJ; Telenius, A; Ben Neriah, S; McPherson, A; Meissner, B; Okoye, UC; Diepstra, A; van den Berg, A; Sun, M; Leung, G; Jones, SJ; Connors, JM; Huntsman, DG; Savage, KJ; Rimsza, LM; Horsman, DE; Staudt, LM; Steidl, U; Marra, MA; Gascoyne, RD				Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Rui, Lixin; Kawahara, Masahiro; Farinha, Pedro; Johnson, Nathalie A.; Zhao, Yongjun; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Okoye, Ujunwa C.; Diepstra, Arjan; van den Berg, Anke; Sun, Mark; Leung, Gillian; Jones, Steven J.; Connors, Joseph M.; Huntsman, David G.; Savage, Kerry J.; Rimsza, Lisa M.; Horsman, Douglas E.; Staudt, Louis M.; Steidl, Ulrich; Marra, Marco A.; Gascoyne, Randy D.			MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers	NATURE			English	Article							B-CELL LYMPHOMA; POOR PATIENT SURVIVAL; REED-STERNBERG CELLS; HODGKIN LYMPHOMA; PROTEIN EXPRESSION; LINE; JAK2; TRANSLOCATION; ABERRATIONS; RESOLUTION	Chromosomal translocations are critically involved in the molecular pathogenesis of B-cell lymphomas, and highly recurrent and specific rearrangements have defined distinct molecular subtypes linked to unique clinicopathological features(1,2). In contrast, several well-characterized lymphoma entities still lack disease-defining translocation events. To identify novel fusion transcripts resulting from translocations, we investigated two Hodgkin lymphoma cell lines by whole-transcriptome paired-end sequencing (RNA-seq). Here we show a highly expressed gene fusion involving the major histocompatibility complex (MHC) class II transactivator CIITA (MHC2TA) in KM-H2 cells. In a subsequent evaluation of 263 B-cell lymphomas, we also demonstrate that genomic CIITA breaks are highly recurrent in primary mediastinal B-cell lymphoma (38%) and classical Hodgkin lymphoma (cHL) (15%). Furthermore, we find that CIITA is a promiscuous partner of various in-frame gene fusions, and we report that CIITA gene alterations impact survival in primary mediastinal B-cell lymphoma (PMBCL). As functional consequences of CIITA gene fusions, we identify downregulation of surface HLA class II expression and overexpression of ligands of the receptor molecule programmed cell death 1 (CD274/PDL1 and CD273/PDL2). These receptor-ligand interactions have been shown to impact anti-tumour immune responses in several cancers(3), whereas decreased MHC class II expression has been linked to reduced tumour cell immunogenicity(4). Thus, our findings suggest that recurrent rearrangements of CIITA may represent a novel genetic mechanism underlying tumour-microenvironment interactions across a spectrum of lymphoid cancers.	[Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Farinha, Pedro; Johnson, Nathalie A.; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Sun, Mark; Leung, Gillian; Huntsman, David G.; Horsman, Douglas E.; Gascoyne, Randy D.] Ctr Lymphoid Cancers, Dept Pathol & Lab Med, Vancouver, BC V5Z 4E6, Canada; [Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Farinha, Pedro; Johnson, Nathalie A.; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Sun, Mark; Leung, Gillian; Huntsman, David G.; Horsman, Douglas E.; Gascoyne, Randy D.] Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Rui, Lixin; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Kawahara, Masahiro; Okoye, Ujunwa C.; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Kawahara, Masahiro; Okoye, Ujunwa C.; Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Zhao, Yongjun; Jones, Steven J.; Marra, Marco A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Diepstra, Arjan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 AB Groningen, Netherlands; [Connors, Joseph M.; Savage, Kerry J.] BC Canc Agcy Ctr Lymphoid Canc, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; British Columbia Cancer Agency; University of Groningen; University of Arizona; University of British Columbia	Gascoyne, RD (corresponding author), Ctr Lymphoid Cancers, Dept Pathol & Lab Med, Vancouver, BC V5Z 4E6, Canada.	rgascoyn@bccancer.bc.ca	rui, li/GYR-3791-2022; Connors, Joseph/AAF-5284-2019; li, rui/GSD-4367-2022; Marra, Marco A/B-5987-2008; van den Berg, Anke/H-1718-2011; Gascoyne, Randy D/A-6009-2013; Savage, Kerry/HCH-5539-2022; Jones, Steven J/C-3621-2009; Staudt, Louis/AAC-5324-2019; Huntsman, David/ABE-6082-2020	Connors, Joseph/0000-0002-1361-7531; Marra, Marco A/0000-0001-7146-7175; van den Berg, Anke/0000-0002-8894-2638; Gascoyne, Randy D/0000-0002-2610-5690; Jones, Steven J/0000-0003-3394-2208; Farinha, Pedro/0000-0001-9364-9391; Okoye-Okafor, Ujunwa/0000-0001-8824-1666; Diepstra, Arjan/0000-0001-9239-1050	Cancer Research Society; Michael Smith Foundation for Health Research; Lymphoma Research Foundation; Canadian Breast Cancer Foundation; Canadian Institutes of Health Research [178536]; Terry Fox Foundation [019001]; Genome Canada/Genome BC; National Institutes of Health/National Cancer Institute [R00CA131503]; Leukemia Research Foundation; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [ZIABC011008, R00CA131503, ZIABC011006] Funding Source: NIH RePORTER	Cancer Research Society; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Lymphoma Research Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Genome Canada/Genome BC(Genome Canada); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by a postdoctoral fellowship of the Cancer Research Society (Steven E. Drabin Fellowship) to C. S., the Michael Smith Foundation for Health Research to C. S. and S. P. S., the Lymphoma Research Foundation to C. S. and the Canadian Breast Cancer Foundation to S. P. S. Operational funds were available through the Canadian Institutes of Health Research, grant number 178536 to R. D. G. R. D. G., J.M.C., M. A. M. and D. E. H. are also supported by the Terry Fox Foundation ( number 019001). This work was in part supported by an infrastructure grant of Genome Canada/Genome BC. U. S. is the recipient of a Howard Temin Award of the National Institutes of Health/National Cancer Institute (R00CA131503), a new investigator award of the Leukemia Research Foundation, and is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research of the Albert Einstein College of Medicine. We thank G. Simkin, C. Polumbo and T. Vogler for technical support. L. R. is the recipient of a CJ Martin Fellowship from the National Health and Medical Research Council of Australia.	Amini RM, 2002, LEUKEMIA LYMPHOMA, V43, P2179, DOI 10.1080/1042819021000032917; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Chin KC, 1997, J IMMUNOL, V159, P2789; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Diepstra A, 2007, J CLIN ONCOL, V25, P3101, DOI 10.1200/JCO.2006.10.0917; Dyer MJS, 2003, INT J HEMATOL, V77, P315, DOI 10.1007/BF02982637; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lennon AM, 1997, IMMUNOGENETICS, V45, P266, DOI 10.1007/s002510050202; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lestou VS, 2003, BRIT J HAEMATOL, V122, P745, DOI 10.1046/j.1365-2141.2003.04502.x; Martin-Subero JI, 2006, CANCER RES, V66, P10332, DOI 10.1158/0008-5472.CAN-06-1992; Martinez-Ramirez A, 2004, LEUKEMIA, V18, P348, DOI 10.1038/sj.leu.2403230; Masternak K, 2000, GENE DEV, V14, P1156; Melzner I, 2006, INT J CANCER, V118, P1941, DOI 10.1002/ijc.21485; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Roberts RA, 2006, BLOOD, V108, P311, DOI 10.1182/blood-2005-11-4742; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Sambade C, 2006, INT J CANCER, V118, P555, DOI 10.1002/ijc.21417; Savage KJ, 2006, ANN ONCOL, V17, P123, DOI 10.1093/annonc/mdj030; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Shah SP, 2006, BIOINFORMATICS, V22, pE431, DOI 10.1093/bioinformatics/btl238; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Shustik J, 2010, HAEMATOL-HEMATOL J, V95, P96, DOI 10.3324/haematol.2009.007203; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Yamamoto R, 2008, BLOOD, V111, P3220, DOI 10.1182/blood-2007-05-085159; Zhou H, 1997, J IMMUNOL, V158, P4741	41	408	425	5	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					377	+		10.1038/nature09754	http://dx.doi.org/10.1038/nature09754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368758	Green Accepted			2022-12-01	WOS:000288444000045
J	Mirza, DM; Hashim, MJ; Sheikh, A				Mirza, Deen M.; Hashim, Muhammad Jawad; Sheikh, Aziz			10-Minute Consultation Malaria	BRITISH MEDICAL JOURNAL			English	Editorial Material												deenmirza@doctors.org.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Hashim, Muhammad Jawad/0000-0002-9280-9709				Chiodini P, 2007, GUIDELINES MALARIA P	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2011	342								d1149	10.1136/bmj.d1149	http://dx.doi.org/10.1136/bmj.d1149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FA	21406530	Green Submitted			2022-12-01	WOS:000288698100016
J	Feng, D; Liu, T; Sun, Z; Bugge, A; Mullican, SE; Alenghat, T; Liu, XS; Lazar, MA				Feng, Dan; Liu, Tao; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Liu, X. Shirley; Lazar, Mitchell A.			A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism	SCIENCE			English	Article							RECEPTOR COREPRESSOR; TRANSCRIPTION; LIVER; CLOCK; MICE; TISSUE	Disruption of the circadian clock exacerbates metabolic diseases, including obesity and diabetes. We show that histone deacetylase 3 ( HDAC3) recruitment to the genome displays a circadian rhythm in mouse liver. Histone acetylation is inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent. Although amounts of HDAC3 are constant, its genomic recruitment in liver corresponds to the expression pattern of the circadian nuclear receptor Rev-erb alpha. Rev-erb alpha colocalizes with HDAC3 near genes regulating lipid metabolism, and deletion of HDAC3 or Rev-erb alpha in mouse liver causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by Rev-erb alpha directs a circadian rhythm of histone acetylation and gene expression required for normal hepatic lipid homeostasis.	[Feng, Dan; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA; [Feng, Dan; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab IDOM, Philadelphia, PA 19104 USA; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Tao; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Feng, Dan/F-7205-2013; Liu, Tao/G-3585-2010; Lazar, Mitchell A/AAF-3738-2019; Sun, Zheng/C-1146-2012; Liu, Tao/AAO-6310-2021	Liu, Tao/0000-0002-8818-8313; Sun, Zheng/0000-0002-6858-0633; Liu, Tao/0000-0002-8818-8313; Feng, Dan/0000-0001-5926-8894; Liu, Tao/0000-0003-0446-9001; Bugge, Anne/0000-0001-5885-4541	NIH [DK19525, DK49210, DK45586, DK43806, RC1DK08623, HG4069]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, R37DK043806, R01DK043806, P30DK019525, RC1DK086239, R01DK045586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ChIP-seq and microarray data have been deposited in the Gene Expression Omnibus (GSE25937 and GSE26345) database. We thank B. Vennstrom for providing Rev-erba KO mice; M. Brown, D. Steger, and members of the Lazar lab for helpful discussions; D. Zhuo for technical assistance; the Penn IDOM Metabolism Resource (J. Millar) for help with de novo lipogenesis experiments; the Functional Genomics Core (J. Schug and K. Kaestner) and the Viral Vector Core (J. Johnston) of the Penn Diabetes Endocrinology Research Center (NIH DK19525) for deep sequencing and virus preparation; the Morphology Core (J. Katz and G. Swain) (NIH DK49210) for tissue preparation and staining; and the Penn Bioinformatics Core (J. Tobias) and Microarray Core (D. Baldwin) for gene expression analysis. Supported by the Cox Institute, NIH DK45586, DK43806, and RC1DK08623 (to M. A. L.) and NIH HG4069 (to X. S. L.).	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Chomez P, 2000, DEVELOPMENT, V127, P1489; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Sookoian S, 2007, WORLD J GASTROENTERO, V13, P4242, DOI 10.3748/wjg.v13.i31.4242; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zamir I, 1996, MOL CELL BIOL, V16, P5458	30	474	489	5	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1315	1319		10.1126/science.1198125	http://dx.doi.org/10.1126/science.1198125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393543	Green Accepted			2022-12-01	WOS:000288215200044
J	Briggman, KL; Helmstaedter, M; Denk, W				Briggman, Kevin L.; Helmstaedter, Moritz; Denk, Winfried			Wiring specificity in the direction-selectivity circuit of the retina	NATURE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RABBIT RETINA; ACETYLCHOLINE-RECEPTORS; DENDRITIC STRUCTURE; CALCIUM SIGNALS; IMAGE MOTION; MECHANISMS; GABA; CONNECTIONS	The proper connectivity between neurons is essential for the implementation of the algorithms used in neural computations, such as the detection of directed motion by the retina. The analysis of neuronal connectivity is possible with electron microscopy, but technological limitations have impeded the acquisition of high-resolution data on a large enough scale. Here we show, using serial block-face electron microscopy and two-photon calcium imaging, that the dendrites of mouse starburst amacrine cells make highly specific synapses with direction-selective ganglion cells depending on the ganglion cell's preferred direction. Our findings indicate that a structural (wiring) asymmetry contributes to the computation of direction selectivity. The nature of this asymmetry supports some models of direction selectivity and rules out others. It also puts constraints on the developmental mechanisms behind the formation of synaptic connections. Our study demonstrates how otherwise intractable neurobiological questions can be addressed by combining functional imaging with the analysis of neuronal connectivity using large-scale electron microscopy.	[Briggman, Kevin L.; Helmstaedter, Moritz; Denk, Winfried] Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Max Planck Society	Briggman, KL (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany.	briggman@mpimf-heidelberg.mpg.de	denk, winfried/I-6627-2012					BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BRIGGMAN KL, J NEUROPHYS IN PRESS; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Chiao CC, 2002, J NEUROSCI, V22, P10509; Dacheux RF, 2003, J COMP NEUROL, V456, P267, DOI 10.1002/cne.10521; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dmitrieva NA, 2003, J COMP NEUROL, V456, P167, DOI 10.1002/cne.10520; Dmitrieva NA, 2007, J HISTOCHEM CYTOCHEM, V55, P461, DOI 10.1369/jhc.6A7116.2006; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Fahmy A., 1967, P ELECTRON MICROSCOP, P148; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; GLAUERT AM, 1998, PRACTICAL METHODS EL, V21; Granstedt AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006923; Grzywacz NM, 1997, VISUAL NEUROSCI, V14, P39, DOI 10.1017/S0952523800008749; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; He SG, 1999, J NEUROSCI, V19, P8049; Karnovsky M.J., 1971, P 11 M AM SOC CELL B, P146; Keeley PW, 2007, J COMP NEUROL, V505, P539, DOI 10.1002/cne.21518; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Mumm JS, 2005, PROG BRAIN RES, V147, P155, DOI 10.1016/S0079-6123(04)47012-5; Oesch NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012447; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Schlichtenbrede FC, 2009, INVEST OPHTH VIS SCI, V50, P5880, DOI 10.1167/iovs.08-3078; SELIGMAN AM, 1966, J CELL BIOL, V30, P424, DOI 10.1083/jcb.30.2.424; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; WALTON J, 1979, J HISTOCHEM CYTOCHEM, V27, P1337, DOI 10.1177/27.10.512319; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Yamada ES, 2003, J COMP NEUROL, V461, P76, DOI 10.1002/cne.10672; YANG G, 1994, J NEUROSCI, V14, P5267; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	55	535	540	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					183	U67		10.1038/nature09818	http://dx.doi.org/10.1038/nature09818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390125				2022-12-01	WOS:000288170200030
J	Brown, RE				Brown, Raeford E., Jr.			A Door Closes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rbrow1@email.uky.edu	Brown, Raeford/I-1211-2019	Brown, Raeford/0000-0002-2295-2657					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					977	978		10.1001/jama.2011.254	http://dx.doi.org/10.1001/jama.2011.254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386070				2022-12-01	WOS:000288129600001
J	Pan, J; Sasaki, M; Kniewel, R; Murakami, H; Blitzblau, HG; Tischfield, SE; Zhu, X; Neale, MJ; Jasin, M; Socci, ND; Hochwagen, A; Keeney, S				Pan, Jing; Sasaki, Mariko; Kniewel, Ryan; Murakami, Hajime; Blitzblau, Hannah G.; Tischfield, Sam E.; Zhu, Xuan; Neale, Matthew J.; Jasin, Maria; Socci, Nicholas D.; Hochwagen, Andreas; Keeney, Scott			A Hierarchical Combination of Factors Shapes the Genome-wide Topography of Yeast Meiotic Recombination Initiation	CELL			English	Article							DOUBLE-STRAND BREAKS; TRANSCRIPTION FACTOR; CHROMATIN-STRUCTURE; GENE CONVERSION; GLOBAL ANALYSIS; CHROMOSOME-III; DNA REVEALS; IN-VIVO; SITES; CROSSOVERS	The nonrandom distribution of meiotic recombination influences patterns of inheritance and genome evolution, but chromosomal features governing this distribution are poorly understood. Formation of the DNA double-strand breaks (DSBs) that initiate recombination results in the accumulation of Spo11 protein covalently bound to small DNA fragments. By sequencing these fragments, we uncover a genome-wide DSB map of unprecedented resolution and sensitivity. We use this map to explore how DSB distribution is influenced by large-scale chromosome structures, chromatin, transcription factors, and local sequence composition. Our analysis offers mechanistic insight into DSB formation and early processing steps, supporting the view that the recombination terrain is molded by combinatorial and hierarchical interaction of factors that work on widely different size scales. This map illuminates the occurrence of DSBs in repetitive DNA elements, repair of which can lead to chromosomal rearrangements. We also discuss implications for evolutionary dynamics of recombination hot spots.	[Pan, Jing; Sasaki, Mariko; Kniewel, Ryan; Murakami, Hajime; Tischfield, Sam E.; Zhu, Xuan; Neale, Matthew J.; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Sasaki, Mariko; Kniewel, Ryan; Zhu, Xuan] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Blitzblau, Hannah G.; Hochwagen, Andreas] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tischfield, Sam E.] Cornell Univ, Triinst Training Program Computat Biol & Med, New York, NY 10065 USA; [Neale, Matthew J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Cornell University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Cornell University; University of Sussex	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Murakami, Hajime/AAX-9411-2021; Keeney, Scott/GVR-8515-2022; Sasaki, Mariko/K-6217-2017; Sasaki, Mariko/AAF-3414-2019; Sasaki, Mariko/AAT-6090-2020	Kniewel, Ryan/0000-0003-3462-6450; Murakami, Hajime/0000-0002-7022-6887; Sasaki, Mariko/0000-0003-4208-1251; Keeney, Scott/0000-0002-1283-6417; Hochwagen, Andreas/0000-0002-6184-443X; Neale, Matthew/0000-0002-6453-1877	NIH [GM58673, HD53855, T32 GM008539]; Royal Society; MRC; HFSP; Leukemia and Lymphoma Society; Medical Research Council [G0800005] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539, R01GM058673] Funding Source: NIH RePORTER; MRC [G0800005] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Viale (MSKCC Genomics Core Laboratory) for sequencing; S. Shuman and J. Nandakumar (MSKCC) for generous gifts of RNA ligase; and M. Lichten (NCI), I. Whitehouse (MSKCC), and G. Smith (Fred Hutchinson Cancer Research Center) for comments on the manuscript. This work was supported in part by NIH grants GM58673 (S. K.) and HD53855 (S. K. and M. J.). M. J. N. is supported by a Royal Society University Research Fellowship, an MRC New Investigator Grant, and an HFSP Career Development Award. J. P. was supported by a Leukemia and Lymphoma Society Fellowship. R. K. was supported by NIH training grant T32 GM008539. S. K. is an Investigator of the Howard Hughes Medical Institute.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barton AB, 2008, GENETICS, V179, P1221, DOI 10.1534/genetics.107.083493; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 1999, MOL CELL BIOL, V19, P4832; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Gabriel A, 2006, PLOS GENET, V2, P2026, DOI 10.1371/journal.pgen.0020212; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOROWITZ H, 1984, MOL CELL BIOL, V4, P2509, DOI 10.1128/MCB.4.11.2509; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Murakami H, 2009, MOL CELL BIOL, V29, P3500, DOI 10.1128/MCB.00088-09; Neale MJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-104; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Schlecht U, 2008, MOL BIOL CELL, V19, P2193, DOI 10.1091/mbc.E07-12-1242; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Xu F, 1996, GENETICS, V143, P1115	50	348	350	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					719	731		10.1016/j.cell.2011.02.009	http://dx.doi.org/10.1016/j.cell.2011.02.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376234	Green Accepted, Bronze			2022-12-01	WOS:000288007100011
J	Pilling, S; Yesufu-Udechuku, A; Taylor, C; Drummond, C				Pilling, Stephen; Yesufu-Udechuku, Amina; Taylor, Clare; Drummond, Colin		Guideline Dev Grp	Diagnosis, assessment, and management of harmful drinking and alcohol dependence: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material												s.pilling@ucl.ac.uk	Drummond, Colin/O-9141-2019	Drummond, Colin/0000-0001-9379-5452; Mavranezouli, Ifigeneia/0000-0001-9095-3566	National Institute for Health Research [RP-PG-0609-10162] Funding Source: researchfish; MRC [G0701681, G0701818] Funding Source: UKRI; Medical Research Council [G0701681, G0701818] Funding Source: Medline; Department of Health [RP-PG-0609-10162] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Babor T., 2001, ALCOHOL USE DISORDER; *DEP HLTH, 2006, MOD CAR ALC MIS; Drummond C, 1990, BR J ADDICT, V85, P357; Drummond DC, 2005, ALCOHOL NEEDS ASSESS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuller E., 2008, DRUG USE SMOKING DRI; *N W PUBL HLTH OBS, 2010, N W PUBL HLTH OBS LO; *NAT I HLTH CLIN E, 2009, GUID MAN NAT I HLTH; *NAT I HLTH CLIN E, 2005, CLIN GUID, V31; *NAT I HLTH CLIN E, 2005, CLIN GUID, V26; National Institute for Health and Care Excellence (NICE), 2011, ALCOHOL USE DISORDER; National Institute for Health and Clinical Excellence, 2009, CLIN GUID; National Institute for Health and Clinical Excellence, 2011, CLIN GUID; National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV; National Institute for Health and Clinical Excellence, 2010, CLIN GUID, V94; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; Stockwell T, 1979, BR J ADDICT ALCOHOL, V74, P78	17	24	25	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d700	10.1136/bmj.d700	http://dx.doi.org/10.1136/bmj.d700			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345905				2022-12-01	WOS:000287920100006
J	Horsfall, LJ; Rait, G; Walters, K; Swallow, DM; Pereira, SP; Nazareth, I; Petersen, I				Horsfall, Laura J.; Rait, Greta; Walters, Kate; Swallow, Dallas M.; Pereira, Stephen P.; Nazareth, Irwin; Petersen, Irene			Serum Bilirubin and Risk of Respiratory Disease and Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEME OXYGENASE-1; POLYMORPHISMS; ASSOCIATION; POPULATION; PROMOTER; UGT1A1; GENOME; GENES	Context Serum total bilirubin levels in healthy patients reflect genetic and environmental factors that could influence the risk of developing respiratory disease. Objective To examine the relationship between bilirubin levels and respiratory disease. Design, Setting, and Participants Cohort study among 504 206 adults from a UK primary care research database (the Health Improvement Network) with serum bilirubin levels recorded but no evidence of hepatobiliary or hemolytic disease. Data were recorded between January 1988 and December 2008. Main Outcome Measures Incidence of chronic obstructive pulmonary disease (COPD), lung cancer, and all-cause mortality. Results Median bilirubin levels were 0.64 mg/dL (interquartile range, 0.47-0.88 mg/dL) in men and 0.53 mg/dL (interquartile range, 0.41-0.70 mg/dL) in women. There were 1341 cases of lung cancer, 5863 cases of COPD, and 23 103 deaths, with incidence rates of 2.5, 11.9, and 42.5 per 10 000 person-years, respectively. The incidence of lung cancer per 10 000 person-years in men was 5.0 (95% confidence interval [CI], 4.2-6.0) in the first decile category of bilirubin compared with 3.0 (95% CI, 2.3-3.8) in the fifth decile. The corresponding incidences for COPD in men were 19.5 (95% CI, 17.7-21.4) and 14.4 (95% CI, 12.7-16.2). The mortality rates per 10 000 person-years in men were 51.3 (95% CI, 48.5-54.2) in the first decile category compared with 38.1 (95% CI, 35.5-40.8) in the fifth decile. The associations were similar for women. After adjusting for other important health indicators, regression estimates for incidence rate of lung cancer per 0.1-mg/dL increase in bilirubin level were an 8% decrease (95% CI, 5%-11%) for men and an 11% decrease (95% CI, 7%-14%) for women. The regression estimate for COPD in men per 0.1-mg/dL increase in bilirubin level was a 6% decrease (95% CI, 5%-7%) and for mortality in men was a 3% decrease (95% CI, 2%-3%) after accounting for other health indicators. The results for COPD and mortality in women were very similar. Conclusion Among patients with normal-range bilirubin levels in primary care practices, relatively higher levels of bilirubin were associated with a lower risk of respiratory disease and all-cause mortality. JAMA. 2011;305(7):691-697 www.jama.com	[Horsfall, Laura J.; Rait, Greta; Walters, Kate; Nazareth, Irwin; Petersen, Irene] UCL, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Horsfall, Laura J.; Swallow, Dallas M.] UCL, Res Dept Genet Evolut & Environm, London NW3 2PF, England; [Pereira, Stephen P.] UCL, Inst Hepatol, London NW3 2PF, England; [Rait, Greta; Nazareth, Irwin] MRC, Gen Practice Res Framework, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Horsfall, LJ (corresponding author), UCL, Royal Free Hosp, Res Dept Primary Care & Populat Hlth, Rowland Hill St, London NW3 2PF, England.	laura.horsfall@ucl.ac.uk	Petersen, Irene/C-5702-2009; Petersen, Irene/I-2751-2012; Pereira, Stephen P/C-5639-2009	Petersen, Irene/0000-0002-0037-7524; Pereira, Stephen P/0000-0003-0821-1809; Nazareth, Irwin/0000-0003-2146-9628; Walters, Kate/0000-0003-2173-2430; Rait, Greta/0000-0002-7216-7294	National Institute for Health Research School for Primary Care Research; UK Medical Research Council [G0601726, G0900701]; MRC [MC_U122797165, G0900701, G0601726] Funding Source: UKRI; Medical Research Council [MC_U122797165, G0601726, G0900701] Funding Source: researchfish	National Institute for Health Research School for Primary Care Research; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Ms Horsfall completed this work as part of her post at the University College London Department of Primary Care and Population Health with additional funding from the National Institute for Health Research School for Primary Care Research. Dr Petersen received funding through grants G0601726 and G0900701 from the UK Medical Research Council.	Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Booth N, 1994, Health Libr Rev, V11, P177; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Bourke Alison, 2004, Inform Prim Care, V12, P171; Campbell M.J., 2009, STAT SQUARE ONE; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Hong AL, 2007, DRUG METAB DISPOS, V35, P1254, DOI 10.1124/dmd.106.014183; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lin JP, 2010, CLIN CHEM, V56, P1535, DOI 10.1373/clinchem.2010.151043; Lin R, 2009, HUM MUTAT, V30, P609, DOI 10.1002/humu.20895; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Office for National Statistics, 2005, CENS 2001 GEN REP EN; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Temme EHM, 2001, CANCER CAUSE CONTROL, V12, P887, DOI 10.1023/A:1013794407325; Thanassoulis G, 2009, JAMA-J AM MED ASSOC, V301, P2386, DOI 10.1001/jama.2009.812; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; WILDING P, 1972, CLIN CHIM ACTA, V41, P375, DOI 10.1016/0009-8981(72)90534-7; Zucker SD, 2004, HEPATOLOGY, V40, P827, DOI [10.1002/hep.20407, 10.1002/hep.1840400412]	31	142	150	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					691	697		10.1001/jama.2011.124	http://dx.doi.org/10.1001/jama.2011.124			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325185	Bronze			2022-12-01	WOS:000287361100020
J	Schreiber, A; Stengel, F; Zhang, ZG; Enchev, RI; Kong, EH; Morris, EP; Robinson, CV; da Fonseca, PCA; Barford, D				Schreiber, Anne; Stengel, Florian; Zhang, Ziguo; Enchev, Radoslav I.; Kong, Eric H.; Morris, Edward P.; Robinson, Carol V.; da Fonseca, Paula C. A.; Barford, David			Structural basis for the subunit assembly of the anaphase-promoting complex	NATURE			English	Article							CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; SACCHAROMYCES-CEREVISIAE; PROTEIN; COMPLEX/CYCLOSOME; EXPRESSION; INSIGHTS; CYCLIN; VISUALIZATION; PURIFICATION	The anaphase-promoting complex or cyclosome (APC/C) is an unusually large E3 ubiquitin ligase responsible for regulating defined cell cycle transitions. Information on how its 13 constituent proteins are assembled, and how they interact with co-activators, substrates and regulatory proteins is limited. Here, we describe a recombinant expression system that allows the reconstitution of holo APC/C and its sub-complexes that, when combined with electron microscopy, mass spectrometry and docking of crystallographic and homology-derived coordinates, provides a precise definition of the organization and structure of all essential APC/C subunits, resulting in a pseudo-atomic model for 70% of the APC/C. A lattice-like appearance of the APC/C is generated by multiple repeat motifs of most APC/C subunits. Three conserved tetratricopeptide repeat (TPR) subunits (Cdc16, Cdc23 and Cdc27) share related superhelical homo-dimeric architectures that assemble to generate a quasi-symmetrical structure. Our structure explains how this TPR sub-complex, together with additional scaffolding subunits (Apc1, Apc4 and Apc5), coordinate the juxtaposition of the catalytic and substrate recognition module (Apc2, Apc11 and Apc10 (also known as Doc1)), and TPR-phosphorylation sites, relative to co-activator, regulatory proteins and substrates.	[Schreiber, Anne; Zhang, Ziguo; Enchev, Radoslav I.; Kong, Eric H.; Morris, Edward P.; da Fonseca, Paula C. A.; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Stengel, Florian; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Morris, Edward/0000-0003-3544-0041; Zhang, Ziguo/0000-0002-7268-9631; Schreiber, Anne/0000-0001-6766-2808; robinson, carol/0000-0001-7829-5505; da Fonseca, Paula/0000-0001-8656-5747; Stengel, Florian/0000-0003-1447-4509	Cancer Research UK; EU [HEALTH-F4-2008-201648]	Cancer Research UK(Cancer Research UK); EU(European Commission)	This work was funded by a Cancer Research UK grant to D. B. and EU FP7 PROSPECTS (Proteomics Specification in Space and Time) Grant HEALTH-F4-2008-201648 to C. V. R. We thank F. Beuron for help with electron microscopy and Jing Yang for help with insect cell expression.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Han D, 2009, J BIOL CHEM, V284, P15137, DOI 10.1074/jbc.M804887200; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P195, DOI 10.1016/S0968-0004(97)01058-X; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Mckay AR, 2006, J AM CHEM SOC, V128, P11433, DOI 10.1021/ja061468q; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfleger CM, 2000, GENE DEV, V14, P655; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; SIKORSKI RS, 1993, MOL CELL BIOL, V13, P1212, DOI 10.1128/MCB.13.2.1212; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045	56	134	141	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					227	+		10.1038/nature09756	http://dx.doi.org/10.1038/nature09756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307936				2022-12-01	WOS:000287144200037
J	Arria, AM; O'Brien, MC				Arria, Amelia M.; O'Brien, Mary Claire			The "High" Risk of Energy Drinks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLLEGE-STUDENTS; CAFFEINE INTAKE; ADOLESCENTS; CONSUMPTION		[Arria, Amelia M.] Univ Maryland, Sch Publ Hlth, Dept Family Sci, Ctr Young Adult Hlth & Dev, College Pk, MD 20742 USA; [Arria, Amelia M.] Treatment Res Inst, Philadelphia, PA USA; [O'Brien, Mary Claire] Wake Forest Univ, Sch Med, Dept Emergency Med, Winston Salem, NC 27109 USA	University System of Maryland; University of Maryland College Park; Wake Forest University	Arria, AM (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Family Sci, Ctr Young Adult Hlth & Dev, 1142 Sch Publ Hlth Bldg, College Pk, MD 20742 USA.	aarria@umd.edu		Arria, Amelia/0000-0002-6360-9265	NIAAA NIH HHS [R01AA14007, R01 AA014007, R01 AA014007-06A1] Funding Source: Medline; NIDA NIH HHS [R01 DA014845-08, R01 DA014845-07, R01DA14845, R01 DA014845] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014845] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ARRIA AM, COMMUNICATION; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P1; Arria AM, 2010, J ADDICT MED, V4, P74, DOI 10.1097/ADM.0b013e3181aa8dd4; Ferreira SE, 2006, ALCOHOL CLIN EXP RES, V30, P598, DOI 10.1111/j.1530-0277.2006.00070.x; Greenwood DC, 2010, EUR J EPIDEMIOL, V25, P275, DOI 10.1007/s10654-010-9443-7; Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003; O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x; Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Savoca MR, 2005, AM J HYPERTENS, V18, P116, DOI 10.1016/j.amjhyper.2004.08.011	10	121	131	1	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					600	601		10.1001/jama.2011.109	http://dx.doi.org/10.1001/jama.2011.109			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	717XI	21266673	Green Accepted			2022-12-01	WOS:000287080500025
J	Sasaki, T; Matsuki, N; Ikegaya, Y				Sasaki, Takuya; Matsuki, Norio; Ikegaya, Yuji			Action-Potential Modulation During Axonal Conduction	SCIENCE			English	Article							HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; ASTROCYTES; RECEPTORS	Once initiated near the soma, an action potential (AP) is thought to propagate autoregeneratively and distribute uniformly over axonal arbors. We challenge this classic view by showing that APs are subject to waveform modulation while they travel down axons. Using fluorescent patch-clamp pipettes, we recorded APs from axon branches of hippocampal CA3 pyramidal neurons ex vivo. The waveforms of axonal APs increased in width in response to the local application of glutamate and an adenosine A(1) receptor antagonist to the axon shafts, but not to other unrelated axon branches. Uncaging of calcium in periaxonal astrocytes caused AP broadening through ionotropic glutamate receptor activation. The broadened APs triggered larger calcium elevations in presynaptic boutons and facilitated synaptic transmission to postsynaptic neurons. This local AP modification may enable axonal computation through the geometry of axon wiring.	[Sasaki, Takuya; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo 1130033, Japan; [Ikegaya, Yuji] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo 1130033, Japan.	ikegaya@mol.f.u-tokyo.ac.jp	Sasaki, Takuya/J-3283-2015	Ikegaya, Yuji/0000-0003-2260-8191	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22115003, 22650080, 22680025]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Science Research (nos. 22115003, 22650080, and 22680025) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. T.S. collected experimental data and carried out the data analysis. Y.I. conceived the project and carried out the data analysis. T.S. and Y.I. wrote the manuscript. N.M. supervised the project and provided feedback on the manuscript.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Ishikawa D, 2010, NEURAL NETWORKS, V23, P669, DOI 10.1016/j.neunet.2010.02.004; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Schicker K W, 2008, Curr Mol Pharmacol, V1, P106; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999	15	148	151	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					599	601		10.1126/science.1197598	http://dx.doi.org/10.1126/science.1197598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292979				2022-12-01	WOS:000286933600058
J	Wang, W; Barnaby, JY; Tada, Y; Li, H; Tor, M; Caldelari, D; Lee, DU; Fu, XD; Dong, XN				Wang, Wei; Barnaby, Jinyoung Yang; Tada, Yasuomi; Li, Hairi; Toer, Mahmut; Caldelari, Daniela; Lee, Dae-un; Fu, Xiang-Dong; Dong, Xinnian			Timing of plant immune responses by a central circadian regulator	NATURE			English	Article							DOWNY MILDEW RESISTANCE; PERONOSPORA-PARASITICA; CELL-DEATH; ARABIDOPSIS; RHYTHMS; GENES; TRANSCRIPTION; EXPRESSION; MUTANT; BAK1	The principal immune mechanism against biotrophic pathogens in plants is the resistance (R)-gene-mediated defence(1). It was proposed to share components with the broad-spectrum basal defence machinery(2). However, the underlying molecular mechanism is largely unknown. Here we report the identification of novel genes involved in R-gene-mediated resistance against downy mildew in Arabidopsis and their regulatory control by the circadian regulator, CIRCADIAN CLOCK-ASSOCIATED 1 (CCA1). Numerical clustering based on phenotypes of these gene mutants revealed that programmed cell death (PCD) is the major contributor to resistance. Mutants compromised in the R-gene-mediated PCD were also defective in basal resistance, establishing an interconnection between these two distinct defence mechanisms. Surprisingly, we found that these new defence genes are under circadian control by CCA1, allowing plants to 'anticipate' infection at dawn when the pathogen normally disperses the spores and time immune responses according to the perception of different pathogenic signals upon infection. Temporal control of the defence genes by CCA1 differentiates their involvement in basal and R-gene-mediated defence. Our study has revealed a key functional link between the circadian clock and plant immunity.	[Wang, Wei; Barnaby, Jinyoung Yang; Tada, Yasuomi; Caldelari, Daniela; Lee, Dae-un; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Toer, Mahmut] Univ Worcester, NPARU, Henwick Grove WR2 6AJ, Worcester, England	Duke University; University of California System; University of California San Diego; University of Worcester	Dong, XN (corresponding author), Duke Univ, Dept Biol, POB 90338, Durham, NC 27708 USA.	xdong@duke.edu	Wang, Wei/I-5230-2015; Tor, Mahmut/AAU-4624-2020; Tada, Yasuomi/M-5041-2014; Tor, Mahmut/AAF-6449-2020; Wang, Wei/F-7425-2013	Wang, Wei/0000-0002-3780-5158; Tor, Mahmut/0000-0002-4416-5048; Tada, Yasuomi/0000-0001-9900-069X; Barnaby, Jinyoung/0000-0001-6507-9985; LEE, DAEUN/0000-0002-8517-7010	NSF [MCB-0519898, HG004659]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Brady for performing mixed model ANOVA of the data and advice on data analyses; J. Li for sharing the protocol for elf18 treatment, E. Tobin for providing the CCA1<INF>OE</INF> transgenic line, R. McClung for CCA1:LUC, LHY:LUC, ztl-4 lines. H. Lu for helpful discussion of the work, F. Ausubel, P. Benfey, S. Brady, J. Siedow and R. Mohan for critiquing the manuscript. This work was supported by a grant from NSF (MCB-0519898) to X.D. and a grant (HG004659) to X.-D.F.	Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Donofrio NM, 2001, MOL PLANT MICROBE IN, V14, P439, DOI 10.1094/MPMI.2001.14.4.439; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; McDowell JM, 2000, PLANT J, V22, P523, DOI 10.1046/j.1365-313x.2000.00771.x; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Roden LC, 2009, PLANT CELL, V21, P2546, DOI 10.1105/tpc.109.069922; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Slusarenko AJ, 2003, MOL PLANT PATHOL, V4, P159, DOI 10.1046/j.1364-3703.2003.00166.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tor M, 2002, PLANT CELL, V14, P993, DOI 10.1105/tpc.001123; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353	27	307	326	9	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					110	U126		10.1038/nature09766	http://dx.doi.org/10.1038/nature09766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293378	Green Accepted			2022-12-01	WOS:000286886400044
J	Piovia-Scott, J; Spiller, DA; Schoener, TW				Piovia-Scott, Jonah; Spiller, David A.; Schoener, Thomas W.			Effects of Experimental Seaweed Deposition on Lizard and Ant Predation in an Island Food Web	SCIENCE			English	Article							RECENT CLIMATE-CHANGE; SPECIES INTERACTIONS; TROPHIC CASCADES; RESPONSES; SUBSIDIES; PREY; COMMUNITY; EVOLUTION; INVASION; IMPACTS	The effect of environmental change on ecosystems is mediated by species interactions. Environmental change may remove or add species and shift life-history events, altering which species interact at a given time. However, environmental change may also reconfigure multispecies interactions when both species composition and phenology remain intact. In a Caribbean island system, a major manifestation of environmental change is seaweed deposition, which has been linked to eutrophication, overfishing, and hurricanes. Here, we show in a whole-island field experiment that without seaweed two predators-lizards and ants-had a substantially greater-than-additive effect on herbivory. When seaweed was added to mimic deposition by hurricanes, no interactive predator effect occurred. Thus environmental change can substantially restructure food-web interactions, complicating efforts to predict anthropogenic changes in ecosystem processes.	[Piovia-Scott, Jonah] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Piovia-Scott, J (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	jpioviascott@ucdavis.edu	Piovia-Scott, Jonah/W-9308-2019		NSF; University of California Davis Center for Population Biology	NSF(National Science Foundation (NSF)); University of California Davis Center for Population Biology(University of California System)	We thank L. H. Yang, J. J. Stachowicz, M. L. Stanton, and three anonymous reviewers for comments on the manuscript; A. N. Wright and S. S. Porter for help in the field; L. Wong for help in the lab; and the Bahamas Ministry of Agriculture and Marine Resources for permission to conduct this research. This project was supported by grants from NSF and the University of California Davis Center for Population Biology to the authors.	Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Blomquist HL, 1943, AM J BOT, V30, P28, DOI 10.2307/2437389; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Nakano S, 1999, ECOLOGY, V80, P2435; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piovia-Scott J, 2011, J ECOL, V99, P327, DOI 10.1111/j.1365-2745.2010.01728.x; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.1890/0012-9658(2002)083[1860:RWEEOR]2.0.CO;2; Schoener TW, 1999, AM NAT, V153, P347, DOI 10.1086/303177; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SPILLER DA, 1994, ECOLOGY, V75, P182, DOI 10.2307/1939393; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Takimoto G, 2009, AM NAT, V173, P200, DOI 10.1086/595759; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x	28	35	35	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					461	463		10.1126/science.1200282	http://dx.doi.org/10.1126/science.1200282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273487				2022-12-01	WOS:000286635900053
J	Shirey, PD; Lamberti, GA				Shirey, Patrick D.; Lamberti, Gary A.			Regulate trade in rare plants	NATURE			English	Editorial Material									[Shirey, Patrick D.; Lamberti, Gary A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Shirey, PD (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	pshirey@nd.edu	Shirey, Patrick/A-3017-2010	Shirey, Patrick/0000-0001-5933-5022				BARLOW C, 2009, GAIA TURMOIL CLIMATE, pCH10; Ellstrand NC, 2010, BIOSCIENCE, V60, P384, DOI 10.1525/bio.2010.60.5.8; Goble DD, 1999, ENVIRON SCI POLICY, V2, P43, DOI DOI 10.1016/S1462-9011(98)00041-0; Marris E, 2009, NATURE, V459, P906, DOI 10.1038/459906a; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; READ M, 1989, Oryx, V23, P127; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Shirey PD, 2010, CONSERV LETT, V3, P45, DOI 10.1111/j.1755-263X.2009.00083.x	10	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					465	467		10.1038/469465a	http://dx.doi.org/10.1038/469465a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	711MU	21270870				2022-12-01	WOS:000286596500009
J	Graham, WJ; Varghese, B				Graham, Wendy J.; Varghese, Beena			Quality, quality, quality: gaps in the continuum of care	LANCET			English	Editorial Material							HEALTH		[Graham, Wendy J.] Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Varghese, Beena] Publ Hlth Fdn India, New Delhi, India	University of Aberdeen; Public Health Foundation of India	Graham, WJ (corresponding author), Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland.	w.graham@abdn.ac.uk		Graham, Wendy/0000-0003-1473-5342				Bell JS., 2003, TRENDS DELIVERY CARE; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Godlee F, 2009, BMJ-BRIT MED J, V339, pb4346, DOI DOI 10.1136/bmj.b4346; Institute of Medicine, 2001, CROSS QUAL CHASM; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Neal S, 2010, WHITE RIBBON ALLIANC; Nehru, 1962, GLIMPSES WORLD HIST; Pan American Health Organization/WHO, 2003, MON RED MAT MORB MOR; The Earth Institute Columbia University, 2010, BARR GAPS AFF MHEALT; United Nations, 2010, GLOB STRAT WOM CHILD; United Nations Population Fund, 2009, CONC ASS JAN SUR YOJ; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WHO, 2010, WOR HEALT REP, P1; WHO, 2008, FACTSH SKILL ATT; COUNTDOWN 2015 MATER; 2010, PARTNERSHIP MATERNAL	16	56	56	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					E5	E6		10.1016/S0140-6736(10)62267-2	http://dx.doi.org/10.1016/S0140-6736(10)62267-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	21474173				2022-12-01	WOS:000299317700001
J	Suter, DM; Molina, N; Gatfield, D; Schneider, K; Schibler, U; Naef, F				Suter, David M.; Molina, Nacho; Gatfield, David; Schneider, Kim; Schibler, Ueli; Naef, Felix			Mammalian Genes Are Transcribed with Widely Different Bursting Kinetics	SCIENCE			English	Article							EXPRESSION; CELLS; TIME	In prokaryotes and eukaryotes, most genes appear to be transcribed during short periods called transcriptional bursts, interspersed by silent intervals. We describe how such bursts generate gene-specific temporal patterns of messenger RNA (mRNA) synthesis in mammalian cells. To monitor transcription at high temporal resolution, we established various gene trap cell lines and transgenic cell lines expressing a short-lived luciferase protein from an unstable mRNA, and recorded bioluminescence in real time in single cells. Mathematical modeling identified gene-specific on-and off-switching rates in transcriptional activity and mean numbers of mRNAs produced during the bursts. Transcriptional kinetics were markedly altered by cis-regulatory DNA elements. Our analysis demonstrated that bursting kinetics are highly gene-specific, reflecting refractory periods during which genes stay inactive for a certain time before switching on again.	[Suter, David M.; Gatfield, David; Schneider, Kim; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Suter, David M.; Gatfield, David; Schneider, Kim; Schibler, Ueli] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; [Molina, Nacho; Naef, Felix] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Molina, Nacho; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Gatfield, David] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Lausanne	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch; felix.naef@epfl.ch	Gatfield, David/C-2354-2011; Suter, David/S-9210-2019; Molina, Nacho/F-2244-2010; Naef, Felix/C-9527-2011	Gatfield, David/0000-0001-5114-2824; Suter, David/0000-0001-5644-4899; Molina, Nacho/0000-0003-0233-3055; Naef, Felix/0000-0001-9786-3037	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1, 3100A0-113617, 31-130714]; NCCR; European Research Council [ERC-2009-AdG 20090506]; State of Geneva; Louis Jeantet Foundation of Medicine; Ecole Polytechnique Federale de Lausanne (EPFL)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; Ecole Polytechnique Federale de Lausanne (EPFL)	We thank A. Liani and Y.-A. Poget for building a bioluminescence reader, C. Bauer and J. Bosset for help with time-lapse imaging, P. Salmon and D. Trono for providing lentiviral constructs, A. Oates for critical reading of the manuscript, and N. Roggli for the artwork. The computations were performed at Vital-IT (www.vital-it.ch). The U.S.'s laboratory was supported by the Swiss National Science Foundation (SNF 31-113565, SNF 31-128656/1, and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC-2009-AdG 20090506), the State of Geneva, and the Louis Jeantet Foundation of Medicine. F. N.'s laboratory was supported by the Swiss National Science Foundation (SNF grants 3100A0-113617 and 31-130714) and the Ecole Polytechnique Federale de Lausanne (EPFL).	Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Octavio LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000673; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	24	569	581	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					472	474		10.1126/science.1198817	http://dx.doi.org/10.1126/science.1198817			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21415320				2022-12-01	WOS:000289784900045
J	Xu, GZ; Lo, YC; Li, QB; Napolitano, G; Wu, XF; Jiang, XL; Dreano, M; Karin, M; Wu, H				Xu, Guozhou; Lo, Yu-Chih; Li, Qiubai; Napolitano, Gennaro; Wu, Xuefeng; Jiang, Xuliang; Dreano, Michel; Karin, Michael; Wu, Hao			Crystal structure of inhibitor of kappa B kinase beta	NATURE			English	Article							UBIQUITIN-LIKE DOMAIN; PROTEIN-KINASE; CATALYTIC SUBUNIT; IKK-BETA; DOCKING INTERACTIONS; COMPLEX; PHOSPHORYLATION; ACTIVATION; ALPHA; BINDING	Inhibitor of kappa B (I kappa B) kinase (IKK) phosphorylates I kappa B proteins, leading to their degradation and the liberation of nuclear factor kappa B for gene transcription. Here we report the crystal structure of IKK beta in complex with an inhibitor, at a resolution of 3.6 angstrom. The structure reveals a trimodular architecture comprising the kinase domain, a ubiquitin-like domain (ULD) and an elongated, alpha-helical scaffold/dimerization domain (SDD). Unexpectedly, the predicted leucine zipper and helix-loop-helix motifs do not form these structures but are part of the SDD. The ULD and SDD mediate a critical interaction with I kappa B alpha that restricts substrate specificity, and the ULD is also required for catalytic activity. The SDD mediates IKK beta dimerization, but dimerization per se is not important for maintaining IKK beta activity and instead is required for IKK beta activation. Other IKK family members, IKK alpha, TBK1 and IKK-i, may have a similar trimodular architecture and function.	[Xu, Guozhou; Lo, Yu-Chih; Li, Qiubai; Wu, Hao] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Napolitano, Gennaro; Wu, Xuefeng; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Jiang, Xuliang] EMD Serono Res Inst, Billerica, MA 01821 USA; [Dreano, Michel] Merck Serono, CH-1211 Geneva, Switzerland	Cornell University; University of California System; University of California San Diego; Merck KGaA; EMD Serono Inc.	Wu, H (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA.	haowu@med.cornell.edu	Wu, Xuefeng/F-5003-2011; Napolitano, Gennaro/O-5377-2016	Napolitano, Gennaro/0000-0002-8615-4654	National Institutes of Health; American Heart Association; Cancer Research Institute; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872, R01AI079260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cancer Research Institute; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Rajashankar and N. Sukumar for data collection at the NE-CAT of APS, B. Schwer for help with the kinase assay, P. Gaillard for help with the chemistry and G. Ahlsen, L. Shapiro and B. Honig for the ultracentrifugation experiments. This work was supported by the National Institutes of Health (H. W. and M. K.), the American Heart Association (G. X. and Y.-C.L.) and the Cancer Research Institute (Y.-C.L.). M. K. is an American Cancer Society Research Professor.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARROGA CF, 1995, P NATL ACAD SCI USA, V92, P7637, DOI 10.1073/pnas.92.17.7637; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; DeLano W.L., 2002, PYMOL MOL VIEWER; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; HACKER H, 2006, SCI STKE, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaul JD, 2008, BIOCHEM BIOPH RES CO, V374, P592, DOI 10.1016/j.bbrc.2008.07.082; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Tang ED, 2003, J BIOL CHEM, V278, P49661; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu RM, 1996, P NATL ACAD SCI USA, V93, P6308, DOI 10.1073/pnas.93.13.6308; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	50	140	144	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					325	U222		10.1038/nature09853	http://dx.doi.org/10.1038/nature09853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21423167	Green Accepted			2022-12-01	WOS:000289724600034
J	Buiting, HM; Rurup, ML; Wijsbek, H; van Zuylen, L; den Hartogh, G				Buiting, Hilde M.; Rurup, Mette L.; Wijsbek, Henri; van Zuylen, Lia; den Hartogh, Govert			Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To examine health professionals' experiences of and attitudes towards the provision of chemotherapy to patients with end stage cancer. Design Purposive, qualitative design based on in-depth interviews. Setting Oncology departments at university hospitals and general hospitals in the Netherlands. Participants 14 physicians and 13 nurses who cared for patients with metastatic cancer. Results Physicians and nurses reported trying to inform patients fully about their poor prognosis and treatment options. They would carefully consider the (side) effects of chemotherapy and sometimes doubted whether further treatment would contribute to patients' quality of life. Both groups considered the patients' wellbeing to be important, and physicians seemed inclined to try to preserve this by offering further chemotherapy, often followed by the patient. Nurses were more often inclined to express their doubts about further treatment, preferring to allow patients to make the best use of the time that is left. When confronted with a treatment dilemma and a patient's wish for treatment, physicians preferred to make compromises, such as by "trying out one dose." Discussing death or dying with patients while at the same time administering chemotherapy was considered contradictory as this could diminish the patients' hope. Conclusions The trend to greater use of chemotherapy at the end of life could be explained by patients' and physicians' mutually reinforcing attitudes of "not giving up" and by physicians' broad interpretation of patients' quality of life, in which taking away patients' hope by withholding treatment is considered harmful. To rebalance the ratio of quantity of life to quality of life, input from other health professionals, notably nurses, may be necessary.	[Buiting, Hilde M.; Rurup, Mette L.; Wijsbek, Henri; den Hartogh, Govert] Univ Amsterdam, Dept Philosophy, Oude Turfmarkt 141-147, NL-1012 GC Amsterdam, Netherlands; [van Zuylen, Lia] Univ Med Ctr, Erasmus MC, Dept Med Oncol, POB 2040, NL-3000 CA Rotterdam, Netherlands	University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Buiting, HM (corresponding author), Univ Amsterdam, Dept Philosophy, Oude Turfmarkt 141-147, NL-1012 GC Amsterdam, Netherlands.	h.m.buiting@uva.nl			ZonMw, the Netherlands Organization for Health Research and Development [70-71300-98-048]	ZonMw, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study was supported by a grant from ZonMw, the Netherlands Organization for Health Research and Development ( grant No 70-71300-98-048). The study sponsor had no role in the study design; collection, analysis, and interpretation of the data; or in the writing of the article and decision to submit the article for publication.	Ablin RJ, 2010, ARCH INTERN MED, V170, P1397, DOI 10.1001/archinternmed.2010.290; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA; Braga S, 2007, PSYCHO-ONCOL, V16, P863, DOI 10.1002/pon.1140; Breier-Mackie S, 2001, NURS ETHICS, V8, P510, DOI 10.1191/096973301682553805; Buiting HM, 2008, EUR J PUBLIC HEALTH, V18, P681, DOI 10.1093/eurpub/ckn084; de Kort SJ, 2010, HEALTH CARE ANAL, V18, P164, DOI 10.1007/s10728-009-0121-4; Dreyer A, 2009, J MED ETHICS, V35, P672, DOI 10.1136/jme.2009.030668; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fishman J, 2010, ARCH INTERN MED, V170, P515, DOI 10.1001/archinternmed.2010.11; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Grant L, 2010, BMJ-BRIT MED J, V341, pc4859; Kirk P, 2004, BMJ-BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; LANTOS JD, 1989, AM J MED, V87, P81; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Punt CJA, 1998, CANCER-AM CANCER SOC, V83, P679, DOI 10.1002/(SICI)1097-0142(19980815)83:4<679::AID-CNCR8>3.0.CO;2-F; Ritchie J, 2007, QUALITATIVE RES PRAC; SCHNEIDERMAN LJ, 1993, ARCH INTERN MED, V153, P437, DOI 10.1001/archinte.153.4.437; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Spencer L, 2007, QUALITATIVE RES PRAC; STEWARD WP, 1995, ANN ONCOL, V6, P49; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; van Leeunven AF, 2004, J PAIN SYMPTOM MANAG, V28, P351, DOI 10.1016/j.jpainsymman.2004.01.005; Vos T, 2009, THESIS U AMSTERDAM; Zanchetta Margareth S, 2006, Clin J Oncol Nurs, V10, P803, DOI 10.1188/06.CJON.803-807	28	70	70	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2011	342								d1933	10.1136/bmj.d1933	http://dx.doi.org/10.1136/bmj.d1933			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44GZ	21464103	Green Published			2022-12-01	WOS:000209738800001
J	Rizzini, L; Favory, JJ; Cloix, C; Faggionato, D; O'Hara, A; Kaiserli, E; Baumeister, R; Schafer, E; Nagy, F; Jenkins, GI; Ulm, R				Rizzini, Luca; Favory, Jean-Jacques; Cloix, Catherine; Faggionato, Davide; O'Hara, Andrew; Kaiserli, Eirini; Baumeister, Ralf; Schaefer, Eberhard; Nagy, Ferenc; Jenkins, Gareth I.; Ulm, Roman			Perception of UV-B by the Arabidopsis UVR8 Protein	SCIENCE			English	Article							CHROMOSOME CONDENSATION; SIGNAL-TRANSDUCTION; RADIATION; LIGHT; PHOTOMORPHOGENESIS; COMPLEMENTATION; TRANSCRIPTION; ACCUMULATION; PROTECTION; REGULATOR	To optimize their growth and survival, plants perceive and respond to ultraviolet-B ( UV-B) radiation. However, neither the molecular identity of the UV-B photoreceptor nor the photoperception mechanism is known. Here we show that dimers of the UVR8 protein perceive UV-B, probably by a tryptophan-based mechanism. Absorption of UV-B induces instant monomerization of the photoreceptor and interaction with COP1, the central regulator of light signaling. Thereby this signaling cascade controlled by UVR8 mediates UV-B photomorphogenic responses securing plant acclimation and thus promotes survival in sunlight.	[Rizzini, Luca; Favory, Jean-Jacques; Faggionato, Davide; Baumeister, Ralf; Schaefer, Eberhard; Ulm, Roman] Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Cloix, Catherine; O'Hara, Andrew; Kaiserli, Eirini; Jenkins, Gareth I.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Faggionato, Davide; Baumeister, Ralf] Univ Freiburg, Fac Med, ZBMZ, D-79104 Freiburg, Germany; [Baumeister, Ralf; Schaefer, Eberhard; Ulm, Roman] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Nagy, Ferenc] Biol Res Ctr, Inst Plant Biol, H-6726 Szeged, Hungary; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Ulm, Roman] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva 4, Switzerland	University of Freiburg; University of Glasgow; University of Freiburg; University of Freiburg; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Edinburgh; University of Geneva	Ulm, R (corresponding author), Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany.	roman.ulm@unige.ch	Nagy, Ferenc/D-3532-2015; Jenkins, Gareth I/B-4785-2010; Rizzini, Luca/AAV-4799-2020	Nagy, Ferenc/0000-0002-6157-9269; Rizzini, Luca/0000-0001-6950-0167; KAISERLI, EIRINI/0000-0003-1517-4591; Faggionato, Davide/0000-0003-1999-4706; Cloix, Catherine/0000-0001-5666-7558; Faggionato, Davide/0000-0003-0877-5479	UK Biotechnology and Biological Sciences Research Council; Leverhulme Trust; Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund [OTKA-81399]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Deutsche Forschungsgemeinschaft [UL341/1-1];  [Sonderforschungsbereich (SFB) 592];  [SFB 746]; BBSRC [BB/F014961/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F014961/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund; Excellence Initiative of the German Federal and State Governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L.-O. Essen, J. Paszkowski, and T. Kunkel for helpful comments and advice, and P. King for editing the manuscript. This research was supported by grants from the UK Biotechnology and Biological Sciences Research Council and the Leverhulme Trust to G. I. J.; the Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund (OTKA-81399) to F.N.; the Sonderforschungsbereich (SFB) 592 to R. B.; the Excellence Initiative of the German Federal and State Governments (EXC 294) and the SFB 746 to R. B., E. S., and R. U.; and the Emmy Noether Programme of the Deutsche Forschungsgemeinschaft (grant UL341/1-1) to R. U.	Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1147, DOI 10.1111/j.1751-1097.2009.00579.x; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; FLEISCHMANN M, 1991, MOL GEN GENET, V227, P417, DOI 10.1007/BF00273932; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Frohnmeyer H, 2003, PLANT PHYSIOL, V133, P1420, DOI 10.1104/pp.103.030049; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Paul ND, 2003, TRENDS ECOL EVOL, V18, P48, DOI 10.1016/S0169-5347(02)00014-9; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Tong HY, 2008, P NATL ACAD SCI USA, V105, P21039, DOI 10.1073/pnas.0809942106; Ulm R, 2005, CURR OPIN PLANT BIOL, V8, P477, DOI 10.1016/j.pbi.2005.07.004; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Wargent JJ, 2009, NEW PHYTOL, V183, P315, DOI 10.1111/j.1469-8137.2009.02855.x; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007	24	730	798	22	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					103	106		10.1126/science.1200660	http://dx.doi.org/10.1126/science.1200660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454788				2022-12-01	WOS:000289000000047
J	Sleeman, JP; Thiery, JP				Sleeman, Jonathan P.; Thiery, Jean Paul			SnapShot: The Epithelial-Mesenchymal Transition	CELL			English	Editorial Material							PROGRESSION; CANCER		[Thiery, Jean Paul] Biopolis ASTAR, IMCB, Singapore 138673, Singapore; [Thiery, Jean Paul] Biopolis ASTAR, Expt Therapeut Ctr, Singapore 138673, Singapore; [Thiery, Jean Paul] Canc Sci Inst, Singapore 117456, Singapore; [Sleeman, Jonathan P.] Heidelberg Univ, Med Fac Mannheim, D-68167 Mannheim, Germany; [Sleeman, Jonathan P.] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Sleeman, JP (corresponding author), Biopolis ASTAR, IMCB, Singapore 138673, Singapore.		Sleeman, Jonathan P/H-2515-2013; Thiery, Jean Paul/M-9387-2019; Thiery, Jean Paul/H-1550-2011	Sleeman, Jonathan P/0000-0003-1718-7687; Thiery, Jean Paul/0000-0003-0478-5020				Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	10	96	101	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1							162.e1	10.1016/j.cell.2011.03.029	http://dx.doi.org/10.1016/j.cell.2011.03.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458675	Bronze			2022-12-01	WOS:000289053900020
J	Gaston, MA; Zhang, LW; Green-Church, KB; Krzycki, JA				Gaston, Marsha A.; Zhang, Liwen; Green-Church, Kari B.; Krzycki, Joseph A.			The complete biosynthesis of the genetically encoded amino acid pyrrolysine from lysine	NATURE			English	Article							TRANSFER-RNA SYNTHETASE; M METHYL TRANSFER; METHANOSARCINA-BARKERI; CORRINOID PROTEIN; METHYLTRANSFERASES; CODE; RECONSTITUTION; UAG; EXPANSION; ANALOGS	Pyrrolysine, the twenty-second amino acid found to be encoded in the natural genetic code(1-4), is necessary for all of the known pathways by which methane is formed from methylamines(5,6). Pyrrolysine comprises a methylated pyrroline carboxylate in amide linkage to the e-amino group of L-lysine(2,7,8). In certain Archaea, three methyltransferases initiate methanogenesis from the various methylamines(9-11), and these enzymes are encoded by genes with an in-frame amber codon(12,13) that is translated as pyrrolysine(2,7,8). Escherichia coli that has been transformed with the pylTSBCD genes from methanogenic Archaea can incorporate endogenously biosynthesized pyrrolysine into proteins(14). The decoding of UAG as pyrrolysine requires pylT(1,6), which produces tRNA(Pyl) (also called tRNA(CUA)), and pylS(1), which encodes a pyrrolysyl-tRNA synthetase(4,15,16). The pylB, pylC and pylD genes(1) are each required for tRNA-independent pyrrolysine synthesis(14). Pyrrolysine is the last remaining genetically encoded amino acid with an unknown biosynthetic pathway. Here we provide genetic and mass spectrometric evidence for a pylBCD-dependent pathway in which pyrrolysine arises from two lysines. We show that a newly uncovered UAG-encoded amino acid, desmethylpyrrolysine, is made from lysine and exogenous D-ornithine in a pylC-dependent process followed by a pylD-dependent process, but it is not further converted to pyrrolysine. These results indicate that the radical S-adenosyl-L-methionine (SAM) protein PylB mediates a lysine mutase reaction that produces 3-methylornithine, which is then ligated to a second molecule of lysine by PylC before oxidation by PylD results in pyrrolysine. The discovery of lysine as the sole precursor to pyrrolysine will further inform discussions of the evolution of the genetic code and amino acid biosynthetic pathways. Furthermore, intermediates of the pathway may provide new avenues by which the pyl system can be exploited to produce recombinant proteins with useful modified residues.	[Gaston, Marsha A.; Krzycki, Joseph A.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Zhang, Liwen; Green-Church, Kari B.] Ohio State Univ, Mass Spectrometry & Prote Facil, CCIC, Columbus, OH 43210 USA; [Krzycki, Joseph A.] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	krzycki.1@osu.edu	Zhang, Liwen/P-1111-2016; Green, Kari B/H-3541-2011		National Institutes of Health; US Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health to K.B.G.-C. and by grants from the US Department of Energy and the National Institutes of Health to J.A.K. The authors are grateful to D. Longstaff for preparing the tagged mtmB1 version of pDLBAD.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Atkins JF, 2002, SCIENCE, V296, P1409, DOI 10.1126/science.1073339; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Fekner T, 2009, ANGEW CHEM INT EDIT, V48, P1633, DOI 10.1002/anie.200805420; Ferguson DJ, 1997, J BACTERIOL, V179, P846, DOI 10.1128/jb.179.3.846-852.1997; Ferguson DJ, 2000, J BIOL CHEM, V275, P29053, DOI 10.1074/jbc.M910218199; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Hao B, 2004, CHEM BIOL, V11, P1317, DOI 10.1016/j.chembiol.2004.07.011; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Krzycki JA, 2004, CURR OPIN CHEM BIOL, V8, P484, DOI 10.1016/j.cbpa.2004.08.012; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; Li WT, 2009, J MOL BIOL, V385, P1156, DOI 10.1016/j.jmb.2008.11.032; Longstaff DG, 2007, P NATL ACAD SCI USA, V104, P1021, DOI 10.1073/pnas.0610294104; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; Namy O, 2007, FEBS LETT, V581, P5282, DOI 10.1016/j.febslet.2007.10.022; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Rother M, 2010, ARCHAEA, V2010, DOI 10.1155/2010/453642; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004	30	81	91	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					647	U131		10.1038/nature09918	http://dx.doi.org/10.1038/nature09918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455182	Green Accepted			2022-12-01	WOS:000288951200045
J	Hocking, MD; Reynolds, JD				Hocking, Morgan D.; Reynolds, John D.			Impacts of Salmon on Riparian Plant Diversity	SCIENCE			English	Article							PACIFIC SALMON; MYCORRHIZAL FUNGI; FRESH-WATER; NITROGEN; NUTRIENT; FORESTS; PRODUCTIVITY; ECOSYSTEMS; ABUNDANCE; DYNAMICS	The study of natural gradients in nutrient subsidies between ecosystems allows for predictions of how changes in one system can affect biodiversity in another. We performed a large-scale empirical test of the role of Pacific salmon (Oncorhynchus spp.) in structuring riparian plant communities. A comparison of 50 watersheds in the remote Great Bear Rainforest of British Columbia's central coast in Canada shows that salmon influence nutrient loading to plants, shifting plant communities toward nutrient-rich species, which in turn decreases plant diversity. These effects are mediated by interactions between salmon density and the physical characteristics of watersheds. Predicting how salmon affect terrestrial ecosystems is central to conservation plans that aim to better integrate ecosystem values into resource management.	[Hocking, Morgan D.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Hocking, MD (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	mhocking@sfu.ca	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	Simon Fraser University (SFU); Natural Science and Engineering Research Council of Canada (NSERC); B.C. Leading Edge Endowment Fund; Pacific Salmon Foundation; B.C. Pacific Salmon Forum; Mountain Equipment Co-op	Simon Fraser University (SFU); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); B.C. Leading Edge Endowment Fund; Pacific Salmon Foundation; B.C. Pacific Salmon Forum; Mountain Equipment Co-op	Supported by the Tom Buell Endowment Fund at Simon Fraser University (SFU), a Natural Science and Engineering Research Council of Canada (NSERC) postdoctoral fellowship (M. D. H.), NSERC Discovery and Accelerator grants (J.D.R.), the B.C. Leading Edge Endowment Fund, the Pacific Salmon Foundation, the B.C. Pacific Salmon Forum, and Mountain Equipment Co-op. We thank C. Aries for plant surveys; D. Braun, A. Cooper, E. Darling, N. Dulvy, R. Field, J. Harding, J. Linton, M. Stubbs, W. Palen, J. Verspoor, and the Earth<INF>2</INF>Ocean Research Group at SFU for discussions and analytical support; A. Albright, J. Barlow, J. Beaudin, J. Gordon-Walker, I. Jansma, E. Nelson, M. Spoljaric, J. Wilson, and the Raincoast Conservation Foundation for field support; R. Carpenter, M. Reid, and others at the Heiltsuk Integrated Resource Management Department; L. Jorgenson from Qqs Projects Society in Bella Bella; and the Heiltsuk Nation for research partnerships in their traditional territory.	ALABACK PB, 1982, ECOLOGY, V63, P1932, DOI 10.2307/1940131; Bartz KK, 2005, ECOSYSTEMS, V8, P529, DOI 10.1007/s10021-005-0064-z; Bilby RE, 1996, CAN J FISH AQUAT SCI, V53, P164, DOI 10.1139/cjfas-53-1-164; Bilby RE, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:PEOTUO>2.0.CO;2; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Darimont CT, 2010, CONSERV LETT, V3, P379, DOI 10.1111/j.1755-263X.2010.00145.x; Darimont Chris T., 2008, BMC Ecology, V8, P14, DOI 10.1186/1472-6785-8-14; DFO, 2005, FISH OC CAN; Diez JM, 2007, ECOLOGY, V88, P3144, DOI 10.1890/07-0047.1; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Helfield JM, 2002, OECOLOGIA, V133, P573, DOI 10.1007/s00442-002-1070-x; Hobbie EA, 2008, ECOSYSTEMS, V11, P815, DOI 10.1007/s10021-008-9159-7; Hocking MD, 2009, OIKOS, V118, P1307, DOI 10.1111/j.1600-0706.2009.17302.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; Klinka K., 1989, INDICATOR PLANTS COA; Kranabetter JM, 2010, ECOSYSTEMS, V13, P108, DOI 10.1007/s10021-009-9304-y; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; Moore JW, 2007, ECOLOGY, V88, P1278, DOI 10.1890/06-0782; Moore JW, 2004, CAN J FISH AQUAT SCI, V61, P1582, DOI 10.1139/F04-103; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Pinay G, 2003, ECOSYSTEMS, V6, P336, DOI 10.1007/s10021-002-0169-6; POJAR J, 1987, FOREST ECOL MANAG, V22, P119, DOI 10.1016/0378-1127(87)90100-9; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Price MHH, 2008, CAN J FISH AQUAT SCI, V65, P2712, DOI 10.1139/F08-174; Reimchen TE, 2000, CAN J ZOOL, V78, P448, DOI 10.1139/cjz-78-3-448; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Tiegs SD, 2008, ECOL APPL, V18, P4, DOI 10.1890/07-0655.1; Verspoor JJ, 2010, ECOSYSTEMS, V13, P1020, DOI 10.1007/s10021-010-9371-0; Wilkinson CE, 2005, OIKOS, V108, P85, DOI 10.1111/j.0030-1299.2005.13277.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuur Alain F., 2009, P1	35	134	139	4	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1609	1612		10.1126/science.1201079	http://dx.doi.org/10.1126/science.1201079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21442794				2022-12-01	WOS:000288754500057
J	Chabner, BA				Chabner, Bruce A.			Early Accelerated Approval for Highly Targeted Cancer Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INHIBITION		Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Chabner, BA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.							Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Kwak EL, 2011, NEW ENGL J MED, V364, P588; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; McClellan M, 2011, NAT REV DRUG DISCOV, V10, P79, DOI 10.1038/nrd3360; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Sequist, 2008, J CLIN ONCOL, V26, P3472, DOI 10.1200/JCO.2008.18.4747; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494	7	64	65	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1087	1089		10.1056/NEJMp1100548	http://dx.doi.org/10.1056/NEJMp1100548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FY	21428763				2022-12-01	WOS:000288701100002
J	Brown, NJ; Newell, CA; Stanley, S; Chen, JE; Perrin, AJ; Kajala, K; Hibberd, JM				Brown, Naomi J.; Newell, Christine A.; Stanley, Susan; Chen, Jit E.; Perrin, Abigail J.; Kajala, Kaisa; Hibberd, Julian M.			Independent and Parallel Recruitment of Preexisting Mechanisms Underlying C-4 Photosynthesis	SCIENCE			English	Article							GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYLASE; MAIZE; FLAVERIA; PLANT; MESOPHYLL; EVOLUTION; PROMOTER; RICE; GRASSES	C-4 photosynthesis allows increased photosynthetic efficiency because carbon dioxide (CO2) is concentrated around the key enzyme RuBisCO. Leaves of C-4 plants exhibit modified biochemistry, cell biology, and leaf development, but despite this complexity, C-4 photosynthesis has evolved independently in at least 45 lineages of plants. We found that two independent lineages of C-4 plant, whose last common ancestor predates the divergence of monocotyledons and dicotyledons about 180 million years ago, show conserved mechanisms controlling the expression of genes important for release of CO2 around RuBisCO in bundle sheath (BS) cells. Orthologous genes from monocotyledonous and dicotyledonous C-3 species also contained conserved regulatory elements that conferred BS specificity when placed into C-4 species. We conclude that these conserved functional genetic elements likely facilitated the repeated evolution of C-4 photosynthesis.	[Brown, Naomi J.; Newell, Christine A.; Stanley, Susan; Chen, Jit E.; Perrin, Abigail J.; Kajala, Kaisa; Hibberd, Julian M.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Hibberd, JM (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	julian.hibberd@plantsci.cam.ac.uk	Kajala, Kaisa/E-8345-2011	Kajala, Kaisa/0000-0001-6483-7473; Chen, Jit Ern/0000-0003-4779-7275; Perrin, Abigail/0000-0001-6682-4297	Leverhulme Trust; BBSRC; BBSRC [BB/I002243/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I002243/1, P19982] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Leverhulme Trust and BBSRC for funding; C. Weil for B73; and M. Patel, J. Berry, S. Brockington, and D. Bradley for advice. N.J.B., J. E. C., and K. K. generated constructs; N.J.B., S. S., J. E. C., and A. J. P. performed microprojectile bombardment; C.A.N. and N.J.B. generated and analyzed stable transformants; N.J.B. and S. S. performed hybridization in situ; and N.J.B. and J. M. H. designed the experiments, analyzed the data, and wrote the paper. The complete study was supervised by J. M. H. All authors discussed the results and commented on the manuscript.	Akyildiz M, 2007, PLANT CELL, V19, P3391, DOI 10.1105/tpc.107.053322; BANSAL KC, 1992, P NATL ACAD SCI USA, V89, P3654, DOI 10.1073/pnas.89.8.3654; BOWES G, 1971, BIOCHEM BIOPH RES CO, V45, P716, DOI 10.1016/0006-291X(71)90475-X; Brown NJ, 2010, PLANT J, V61, P122, DOI 10.1111/j.1365-313X.2009.04040.x; Brown NJ, 2005, TRENDS PLANT SCI, V10, P215, DOI 10.1016/j.tplants.2005.03.003; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hibberd JM, 2002, NATURE, V415, P451, DOI 10.1038/415451a; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Majeran W, 2009, TRENDS PLANT SCI, V14, P100, DOI 10.1016/j.tplants.2008.11.006; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; MATSUOKA M, 1991, MOL GEN GENET, V228, P143, DOI 10.1007/BF00282459; Nomura M, 2005, PLANT CELL PHYSIOL, V46, P754, DOI 10.1093/pcp/pci078; Nomura M, 2000, PLANT MOL BIOL, V44, P99, DOI 10.1023/A:1006461812053; Patel M, 2006, J BIOL CHEM, V281, P25485, DOI 10.1074/jbc.M604162200; PRENDERGAST HDV, 1987, AUST J PLANT PHYSIOL, V14, P403, DOI 10.1071/PP9870403; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; Sinha NR, 1996, AM J BOT, V83, P1458, DOI 10.2307/2446101; Stockhaus J, 1997, PLANT CELL, V9, P479; Voznesenskaya EV, 2001, NATURE, V414, P543, DOI 10.1038/35107073; Westhoff P, 2004, ANN BOT-LONDON, V93, P13, DOI 10.1093/aob/mch003	25	96	97	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1436	1439		10.1126/science.1201248	http://dx.doi.org/10.1126/science.1201248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415351				2022-12-01	WOS:000288504000041
J	Janssens, ACJW; Ioannidis, JPA; van Duijn, CM; Little, J; Khoury, MJ				Janssens, A. Cecile J. W.; Ioannidis, John P. A.; van Duijn, Cornelia M.; Little, Julian; Khoury, Muin J.		GRIPS Grp	Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER; EPIDEMIOLOGY; ASSOCIATION; MARKER; CURVE		[Janssens, A. Cecile J. W.; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA	Erasmus University Rotterdam; Erasmus MC; University of Ioannina; University of Ottawa; Centers for Disease Control & Prevention - USA	Janssens, ACJW (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.janssens@erasmusmc.nl	janssens, cecile c/L-1075-2015; Little, Julian/AAR-6117-2020; Ioannidis, John P. A./G-9836-2011	Little, Julian/0000-0001-5026-5531; Janssens, A Cecile/0000-0002-6153-4976; Van Duijn, Cornelia/0000-0002-2374-9204; Dolan, Siobhan/0000-0001-8890-8045	Centers for Disease Control and Prevention; Erasmus University Medical Center; Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research; Tufts Clinical and Translational Science Institute; National Institutes of Health, National Center for Research Resources [UL1 RR025752]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Erasmus University Medical Center; Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Tufts Clinical and Translational Science Institute; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Centers for Disease Control and Prevention sponsored the workshop on behalf of the Human Genome Epidemiology Network. Dr. Janssens is supported by grants from Erasmus University Medical Center, the Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative, and the VIDI grant of the Netherlands Organisation for Scientific Research. Dr. Ioannidis is supported by Tufts Clinical and Translational Science Institute, which is supported by the National Institutes of Health, National Center for Research Resources (UL1 RR025752). Dr. Little holds a Canada Research Chair in Human Genome Epidemiology. The funding sources had no role in the study design, data collection, analysis, preparation of the manuscript, or decision to submit the manuscript for publication.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janssens ACJW, 2010, CIRC-CARDIOVASC GENE, V3, P3, DOI 10.1161/CIRCGENETICS.110.938092; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Kyzas PA, 2007, JNCI-J NATL CANCER I, V99, P236, DOI 10.1093/jnci/djk032; Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136, 10.1136/bmj.b2700]; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Vandenbrouke JP, 2009, J CLIN EPIDEMIOL, V62, P594, DOI 10.1016/j.jclinepi.2008.12.003; von Elm E, 2004, BMJ-BRIT MED J, V329, P868, DOI 10.1136/bmj.329.7471.868; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	24	16	16	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					421	+		10.7326/0003-4819-154-6-201103150-00008	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21403077				2022-12-01	WOS:000288370000006
J	Yazawa, M; Hsueh, B; Jia, XL; Pasca, AM; Bernstein, JA; Hallmayer, J; Dolmetsch, RE				Yazawa, Masayuki; Hsueh, Brian; Jia, Xiaolin; Pasca, Anca M.; Bernstein, Jonathan A.; Hallmayer, Joachim; Dolmetsch, Ricardo E.			Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome	NATURE			English	Article							GATING MECHANISMS; SYNDROME MUTATION; SUDDEN-DEATH; CHANNELS; CARDIOMYOCYTES; ROSCOVITINE; ARRHYTHMIA; INHIBITOR; MYOCYTES	Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia(1,2). LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors(1,3). A missense mutation in the L-type calcium channel Ca(V)1.2 leads to LQTS in patients with Timothy syndrome(4,5). To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca2+) imaging studies of these cells revealed irregular contraction, excess Ca2+ influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of Ca(V)1.2 (refs 6-8), restored the electrical and Ca2+ signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.	[Yazawa, Masayuki; Hsueh, Brian; Jia, Xiaolin; Pasca, Anca M.; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Bernstein, Jonathan A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu		Jia, Xiaolin/0000-0002-2172-4716	Japan Society for the Promotion for Science; American Heart Association Western States; National Institutes of Health; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087898, DP1MH099904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	Japan Society for the Promotion for Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association Western States(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Timothy and the Timothy syndrome patients who participated in this study; U. Francke for discussion and for providing karyotyping expertise; A. Cherry and D. Bangs for fibroblast isolation; K. C. Chan for iPSC cultures; O. Shcheglovitov for help with electrophysiological recordings; and A. Olson for help with the confocal microscope. Funding was provided by grants from the Japan Society for the Promotion for Science and the American Heart Association Western States to M.Y., and a National Institutes of Health Director's Pioneer Award, a grant from the Simons Foundation to R.E.D and gifts from L. Miller, B. and F. Horowitz and M. McCaffery.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Keating MT, 1996, MEDICINE, V75, P1, DOI 10.1097/00005792-199601000-00001; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Paakkari I, 2002, TOXICOL LETT, V127, P279, DOI 10.1016/S0378-4274(01)00510-0; REUTER H, 1984, ANNU REV PHYSIOL, V46, P473; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Thiel WH, 2008, CIRCULATION, V118, P2225, DOI 10.1161/CIRCULATIONAHA.108.788067; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Yarotskyy V, 2007, BRIT J PHARMACOL, V152, P386, DOI 10.1038/sj.bjp.0707414; Yarotskyy V, 2010, J BIOL CHEM, V285, P43, DOI 10.1074/jbc.M109.076448; Yarotskyy V, 2009, J PHYSIOL-LONDON, V587, P551, DOI 10.1113/jphysiol.2008.161737; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	27	474	489	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					230	U120		10.1038/nature09855	http://dx.doi.org/10.1038/nature09855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21307850	Green Accepted			2022-12-01	WOS:000288170200040
J	Struck, TH; Paul, C; Hill, N; Hartmann, S; Hosel, C; Kube, M; Lieb, B; Meyer, A; Tiedemann, R; Purschke, G; Bleidorn, C				Struck, Torsten H.; Paul, Christiane; Hill, Natascha; Hartmann, Stefanie; Hoesel, Christoph; Kube, Michael; Lieb, Bernhard; Meyer, Achim; Tiedemann, Ralph; Purschke, Guenter; Bleidorn, Christoph			Phylogenomic analyses unravel annelid evolution	NATURE			English	Article							POLYCHAETES ANNELIDA; CHARACTER LOSS; LOPHOTROCHOZOA; POSITION; MYZOSTOMIDA; RECONSTRUCTION; SEGMENTATION; CLITELLATA; ACCURACY; MODELS	Annelida, the ringed worms, is a highly diverse animal phylum that includes more than 15,000 described species and constitutes the dominant benthic macrofauna from the intertidal zone down to the deep sea. A robust annelid phylogeny would shape our understanding of animal body-plan evolution and shed light on the bilaterian ground pattern. Traditionally, Annelida has been split into two major groups: Clitellata (earthworms and leeches) and polychaetes (bristle worms), but recent evidence suggests that other taxa that were once considered to be separate phyla (Sipuncula, Echiura and Siboglinidae (also known as Pogonophora)) should be included in Annelida(1-4). However, the deep-level evolutionary relationships of Annelida are still poorly understood, and a robust reconstruction of annelid evolutionary history is needed. Here we show that phylogenomic analyses of 34 annelid taxa, using 47,953 amino acid positions, recovered a well-supported phylogeny with strong support for major splits. Our results recover chaetopterids, myzostomids and sipunculids in the basal part of the tree, although the position of Myzostomida remains uncertain owing to its long branch. The remaining taxa are split into two clades: Errantia (which includes the model annelid Platynereis), and Sedentaria (which includes Clitellata). Ancestral character trait reconstructions indicate that these clades show adaptation to either an errant or a sedentary lifestyle, with alteration of accompanying morphological traits such as peristaltic movement, parapodia and sensory perception. Finally, life history characters in Annelida seem to be phylogenetically informative.	[Struck, Torsten H.; Hoesel, Christoph; Purschke, Guenter] Univ Osnabruck, Biol Chem FB05, AG Zool, D-49069 Osnabruck, Germany; [Paul, Christiane; Tiedemann, Ralph; Bleidorn, Christoph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, D-14476 Potsdam, Germany; [Hill, Natascha; Hartmann, Stefanie] Univ Potsdam, Inst Biochem & Biol, Unit Bioinformat, D-14476 Potsdam, Germany; [Kube, Michael] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Lieb, Bernhard; Meyer, Achim] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; [Bleidorn, Christoph] Univ Leipzig, Inst Biol Mol Evolut & Systemat Anim 2, D-04103 Leipzig, Germany	University Osnabruck; University of Potsdam; University of Potsdam; Max Planck Society; Johannes Gutenberg University of Mainz; Leipzig University	Struck, TH (corresponding author), Univ Osnabruck, Biol Chem FB05, AG Zool, Barbarastr 11, D-49069 Osnabruck, Germany.	struck@biologie.uni-osnabrueck.de; bleidorn@uni-leipzig.de	Lieb, Bernhard/AFT-2157-2022; Hartmann, Stefanie/H-4413-2011; Purschke, Guenter/AAU-9660-2021; Meyer, Achim/AAE-9061-2021	Purschke, Guenter/0000-0002-2572-3390; Tiedemann, Ralph/0000-0002-2604-6336; Meyer, Achim/0000-0002-4345-274X; Bleidorn, Christoph/0000-0001-7295-6616	marine biological stations in Bamfield; Helgoland; List and Roscoff for collection of annelids; Deutsche Forschungsgemeinschaft [DFG-STR 683/5-2, DFG-Pu-84/5-1, DFG-TI-349/4-1, DFG Li 998/3-1, DFG-HA 5744/1-1, DFG-BL-787/2-1]	marine biological stations in Bamfield; Helgoland; List and Roscoff for collection of annelids; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to I. Ebersberger, S. Strauss and A. von Haeseler for the processing of our raw EST libraries. We also thank M. Aguado for species identification of Typosyllis pigmentata, as well as K. M. Halanych and P. A. Ramey-Balci for suggestions. T.H.S. and C.B. acknowledge support from the marine biological stations in Bamfield, Helgoland, List and Roscoff for collection of annelids. This work was funded by the priority programme 'Deep Metazoan Phylogeny' of the Deutsche Forschungsgemeinschaft by grants DFG-STR 683/5-2 (T.H.S.), DFG-Pu-84/5-1 (G.P. and T.H.S.), DFG-TI-349/4-1 (R.T.), DFG Li 998/3-1 (B.L.), DFG-HA 5744/1-1 (S.H.) and DFG-BL-787/2-1 (C.B.).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; [Anonymous], 1967, MONOGRAPH POLYCHAE 1; [Anonymous], 2010, NCBI DBEST EXPR SEQ; [Anonymous], 2010, RIBOSOMAL PROTEIN GE; [Anonymous], 2010, EUK ORTH GROUPS 100; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bleidorn C, 2007, J ZOOL SYST EVOL RES, V45, P299, DOI 10.1111/j.1439-0469.2007.00425.x; Bleidorn C, 2007, MOL BIOL EVOL, V24, P1690, DOI 10.1093/molbev/msm086; Bleidorn C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-150; Bleidorn C, 2009, MOL PHYLOGENET EVOL, V52, P57, DOI 10.1016/j.ympev.2009.03.022; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Dordel J, 2010, J ZOOL SYST EVOL RES, V48, P197, DOI 10.1111/j.1439-0469.2010.00567.x; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eeckhaut I, 2003, J MORPHOL, V258, P269, DOI 10.1002/jmor.10160; Eibye-Jacobsen D, 2004, LETHAIA, V37, P317, DOI 10.1080/00241160410002027; Erseus C, 2005, HYDROBIOLOGIA, V535, P357, DOI 10.1007/s10750-004-4426-x; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Fauvel P., 1923, Faune de France Paris, V5, P1; FAUVEL PIERRE, 1927, FAUNE DE FRANCE, V16, P1; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hartmann-Schru┬der, 1996, ANNELIDA BORSTENW 58; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Helmkampf M, 2008, P ROY SOC B-BIOL SCI, V275, P1927, DOI 10.1098/rspb.2008.0372; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Maddison WP, 2018, MESQUITE MODULAR SYS; McHugh D, 2005, HYDROBIOLOGIA, V535, P309, DOI 10.1007/s10750-004-4414-1; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Pattengale ND, 2009, LECT NOTES COMPUT SC, V5541, P184, DOI 10.1007/978-3-642-02008-7_13; Purschke G, 2000, J ZOOL SYST EVOL RES, V38, P165, DOI 10.1046/j.1439-0469.2000.383146.x; Purschke G, 2006, ARTHROPOD STRUCT DEV, V35, P211, DOI 10.1016/j.asd.2006.07.005; Quatrefages A. de, 1866, HIST NATURELLE ANNEL, V1; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rambaut A., 2014, TRACER V1 6; Rivera AS, 2009, DEV GENES EVOL, V219, P37, DOI 10.1007/s00427-008-0264-6; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rouse GW, 1999, BIOL J LINN SOC, V66, P411, DOI 10.1006/bijl.1998.0278; Shain DH, 2009, ANNELIDS IN MODERN BIOLOGY, P1, DOI 10.1002/9780470455203; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-22; Struck TH, 2008, MOL PHYLOGENET EVOL, V48, P628, DOI 10.1016/j.ympev.2008.05.015; Struck TH, 2008, MOL BIOL EVOL, V25, P728, DOI 10.1093/molbev/msn019; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2006, INTEGR COMP BIOL, V46, P558, DOI 10.1093/icb/icj055; Suschenko D, 2009, ZOOMORPHOLOGY, V128, P75, DOI 10.1007/s00435-008-0075-3; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8; Westheide W, 1997, J NAT HIST, V31, P1, DOI 10.1080/00222939700770011; Westheide W., 1996, SPEZIELLE ZOOLOGIE E; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	55	320	338	6	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					95	U113		10.1038/nature09864	http://dx.doi.org/10.1038/nature09864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368831				2022-12-01	WOS:000287924100041
J	Gohler, B; Hamelbeck, V; Markus, TZ; Kettner, M; Hanne, GF; Vager, Z; Naaman, R; Zacharias, H				Goehler, B.; Hamelbeck, V.; Markus, T. Z.; Kettner, M.; Hanne, G. F.; Vager, Z.; Naaman, R.; Zacharias, H.			Spin Selectivity in Electron Transmission Through Self-Assembled Monolayers of Double-Stranded DNA	SCIENCE			English	Article							LOW-ENERGY ELECTRONS; SCATTERING; POLARIZATION; FILMS; GOLD; SPINTRONICS; METALS	In electron-transfer processes, spin effects normally are seen either in magnetic materials or in systems containing heavy atoms that facilitate spin-orbit coupling. We report spin-selective transmission of electrons through self-assembled monolayers of double-stranded DNA on gold. By directly measuring the spin of the transmitted electrons with a Mott polarimeter, we found spin polarizations exceeding 60% at room temperature. The spin-polarized photoelectrons were observed even when the photoelectrons were generated with unpolarized light. The observed spin selectivity at room temperature was extremely high as compared with other known spin filters. The spin filtration efficiency depended on the length of the DNA in the monolayer and its organization.	[Markus, T. Z.; Naaman, R.] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Goehler, B.; Hamelbeck, V.; Kettner, M.; Hanne, G. F.; Zacharias, H.] Univ Munster, Inst Phys, D-48149 Munster, Germany; [Vager, Z.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel	Weizmann Institute of Science; University of Munster; Weizmann Institute of Science	Naaman, R (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	ron.naaman@weizmann.ac.il	Markus, Tal Z/C-8905-2011	Zacharias, Helmut/0000-0001-9807-1103	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	T.Z.M. and R.N. acknowledge the partial support from the Israel Science Foundation.	Aqua T, 2003, LANGMUIR, V19, P10573, DOI 10.1021/la035116y; Awschalom DD, 2007, NAT PHYS, V3, P153, DOI 10.1038/nphys551; Brede J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047204; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; Cacho C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066601; Drouhin HJ, 1997, PHYS REV B, V56, P14886, DOI 10.1103/PhysRevB.56.14886; GELLRICH A, 1991, PHYS REV A, V43, P204, DOI 10.1103/PhysRevA.43.204; GETZLAFF M, 1993, SOLID STATE COMMUN, V87, P467, DOI 10.1016/0038-1098(93)90799-S; Grobli C., 1995, PHYS REV B, V51, P2945; LASSAILLY Y, 1994, PHYS REV B, V50, P13054, DOI 10.1103/PhysRevB.50.13054; Levy N, 2010, SCIENCE, V329, P544, DOI 10.1126/science.1191700; Markus TZ, 2009, J AM CHEM SOC, V131, P89, DOI 10.1021/ja804177j; MARUYAMA T, 1991, PHYS REV LETT, V66, P2376, DOI 10.1103/PhysRevLett.66.2376; MAYER S, 1995, PHYS REV LETT, V74, P4803, DOI 10.1103/PhysRevLett.74.4803; Mott NF, 1932, P R SOC LOND A-CONTA, V135, P429, DOI 10.1098/rspa.1932.0044; Mott NF, 1929, P R SOC LOND A-CONTA, V124, P425, DOI 10.1098/rspa.1929.0127; Naaman R, 2010, MRS BULL, V35, P429, DOI 10.1557/mrs2010.580; Oberli D, 1998, PHYS REV LETT, V81, P4228, DOI 10.1103/PhysRevLett.81.4228; PAPPAS DP, 1991, PHYS REV LETT, V66, P504, DOI 10.1103/PhysRevLett.66.504; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Qi XL, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3293411; Ray K, 1999, SCIENCE, V283, P814, DOI 10.1126/science.283.5403.814; Ray SG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036101; Ron H, 1998, LANGMUIR, V14, P1116, DOI 10.1021/la970785v; SCHONHENSE G, 1993, ANN PHYS-LEIPZIG, V2, P465, DOI 10.1002/andp.19935050504; Skourtis SS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238103; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yeganeh S, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3167404	29	444	450	24	337	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					894	897		10.1126/science.1199339	http://dx.doi.org/10.1126/science.1199339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330541				2022-12-01	WOS:000287455100052
J	Li, QX; Kannan, A; DeMayo, FJ; Lydon, JP; Cooke, PS; Yamagishi, H; Srivastava, D; Bagchi, MK; Bagchi, IC				Li, Quanxi; Kannan, Athilakshmi; DeMayo, Francesco J.; Lydon, John P.; Cooke, Paul S.; Yamagishi, Hiroyuki; Srivastava, Deepak; Bagchi, Milan K.; Bagchi, Indrani C.			The Antiproliferative Action of Progesterone in Uterine Epithelium Is Mediated by Hand2	SCIENCE			English	Article							GROWTH-FACTOR; MOUSE UTERUS; IMPLANTATION; INHIBITION; RECEPTOR; PROLIFERATION; CANCER	During pregnancy, progesterone inhibits the growth-promoting actions of estrogen in the uterus. However, the mechanism for this is not clear. The attenuation of estrogen-mediated proliferation of the uterine epithelium by progesterone is a prerequisite for successful implantation. Our study reveals that progesterone-induced expression of the basic helix-loop-helix transcription factor Hand2 in the uterine stroma suppresses the production of several fibroblast growth factors (FGFs) that act as paracrine mediators of mitogenic effects of estrogen on the epithelium. In mouse uteri lacking Hand2, continued induction of these FGFs in the stroma maintains epithelial proliferation and stimulates estrogen-induced pathways, resulting in impaired implantation. Thus, Hand2 is a critical regulator of the uterine stromal-epithelial communication that directs proper steroid regulation conducive for the establishment of pregnancy.	[Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61820 USA; [DeMayo, Francesco J.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yamagishi, Hiroyuki] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Li, Quanxi; Kannan, Athilakshmi; Cooke, Paul S.; Bagchi, Indrani C.] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; Keio University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Illinois System; University of Illinois Urbana-Champaign	Bagchi, MK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61820 USA.	mbagchi@life.illinois.edu; ibagchi@illinois.edu	Yamagishi, Hiroyuki/A-6345-2017; DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Cooke, Paul/0000-0002-9370-4896	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [U54HD055787]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Laws for genotyping and Y. Li for immunohistochemistry. This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, through U54HD055787 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. The Gene Expression Omnibus (GEO) microarray accession number is GSE25881.	Bagchi IC, 2005, SEMIN REPROD MED, V23, P38, DOI 10.1055/s-2005-864032; Bagchi IC, 2003, FRONT BIOSCI-LANDMRK, V8, pS852, DOI 10.2741/1148; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FINN CA, 1974, J REPROD FERTIL, V39, P195, DOI 10.1530/jrf.0.0390195; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; MARTIN L, 1973, J ENDOCRINOL, V57, P549, DOI 10.1677/joe.0.0570549; Pan HY, 2006, P NATL ACAD SCI USA, V103, P14021, DOI 10.1073/pnas.0601271103; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; SURVEYOR GA, 1995, ENDOCRINOLOGY, V136, P3639, DOI 10.1210/en.136.8.3639	18	241	255	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					912	916		10.1126/science.1197454	http://dx.doi.org/10.1126/science.1197454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330545	Green Accepted			2022-12-01	WOS:000287455100058
J	Janes, H; Pepe, MS; Bossuyt, PM; Barlow, WE				Janes, Holly; Pepe, Margaret S.; Bossuyt, Patrick M.; Barlow, William E.			Measuring the Performance of Markers for Guiding Treatment Decisions	ANNALS OF INTERNAL MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; VALIDATION; CANCER; PREDICTIVENESS; CHEMOTHERAPY	Treatment selection markers, sometimes called predictive markers, are factors that help clinicians select therapies that maximize good outcomes and minimize adverse outcomes for patients. Existing statistical methods for evaluating a treatment selection marker include assessing its prognostic value, evaluating treatment effects in patients with a restricted range of marker values, and testing for a statistical interaction between marker value and treatment. These methods are inadequate, because they give misleading measures of performance that do not answer key clinical questions about how the marker might help patients choose treatment, how treatment decisions should be made on the basis of a continuous marker measurement, what effect using the marker to select treatment would have on the population, or what proportion of patients would have treatment changes on the basis of marker measurement. Marker-by-treatment predictiveness curves are proposed as a more useful aid to answering these clinically relevant questions, because they illustrate treatment effects as a function of marker value, outcomes when using or not using the marker to select treatment, and the proportion of patients for whom treatment recommendations change after marker measurement. Randomized therapeutic clinical trials, in which entry criteria and treatment regimens are not restricted by the marker, are also proposed as the basis for constructing the curves and evaluating and comparing markers.	[Janes, Holly] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Fred Hutchinson Cancer Center; University of Amsterdam; Academic Medical Center Amsterdam	Janes, H (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M2 C200, Seattle, WA 98109 USA.	hjanes@fhcrc.org	Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128	National Institutes of Health [R01CA152089]; NATIONAL CANCER INSTITUTE [R01CA152089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the National Institutes of Health (grant R01CA152089).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; [Anonymous], 2021, J NATL COMPR CANC NE; Buyse M, 2007, EJC SUPPL, V5, P89, DOI 10.1016/S1359-6349(07)70028-9; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798; Freidlin B, 2005, CLIN CANCER RES, V11, P7872, DOI 10.1158/1078-0432.CCR-05-0605; Huang Y, 2007, BIOMETRICS, V63, P1181, DOI 10.1111/j.1541-0420.2007.00814.x; Lazar AA, 2010, J CLIN ONCOL, V28, P4539, DOI 10.1200/JCO.2009.27.9182; Oratz R, 2007, J ONCOL PRACT, V3, P182, DOI 10.1200/JOP.0742001; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Pepe MS, 2004, STAT EVALUATION MED; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Simon R, 2008, J STAT PLAN INFER, V138, P308, DOI 10.1016/j.jspi.2007.06.010; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Song XY, 2004, ACTA CRYSTALLOGR E, V60, pO1919, DOI 10.1107/S1600536804024250; Stern RH, 2008, J CLIN HYPERTENS, V10, P485, DOI 10.1111/j.1751-7176.2008.07814.x; Vickers AJ, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-14; Zhou X., 2002, STAT METHODS DIAGNOS, DOI [10.1002/9780470317082, DOI 10.1002/9780470906514]	25	100	100	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					253	W80		10.7326/0003-4819-154-4-201102150-00006	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320940	Green Accepted			2022-12-01	WOS:000287310000017
J	Clark, AL; Johnson, MJ; Squire, I				Clark, Andrew L.; Johnson, Miriam J.; Squire, Iain			Uncertainties Page Does home oxygen benefit people with chronic heart failure?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXERCISE CAPACITY; BREATHLESSNESS; THERAPY; DYSPNEA					a.l.clark@hull.ac.uk		Johnson, Miriam/0000-0001-6204-9158	National Institute for Health Research [06/80/01] Funding Source: researchfish; Department of Health [06/80/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Booth S, 2004, RESP MED, V98, P66, DOI 10.1016/j.rmed.2003.08.008; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; CLARK A, 1994, BRIT HEART J, V71, P528; Cranston JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001744.pub2; Cranston JM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004769.pub2; Currow DC, 2009, PALLIATIVE MED, V23, P309, DOI 10.1177/0269216309104058; Mak S, 2001, CHEST, V120, P467, DOI 10.1378/chest.120.2.467; MOORE DP, 1992, LANCET, V339, P850, DOI 10.1016/0140-6736(92)90288-E; Oldenburg O, 2007, EUR J HEART FAIL, V9, P251, DOI 10.1016/j.ejheart.2006.08.003; RUBIN SA, 1982, CIRCULATION, V66, P143, DOI 10.1161/01.CIR.66.1.143; Russell SD, 1999, AM J CARDIOL, V84, P1412, DOI 10.1016/S0002-9149(99)00587-1; Sasayama S, 2009, CIRC J, V73, P1255, DOI 10.1253/circj.CJ-08-1210; Scottish Intercollegiate Guidelines Network, 2003, 73 SCOTT INT GUID NE; THOMAS M, 1965, BRIT HEART J, V27, P401; Toyama T, 2009, CIRC J, V73, P299, DOI 10.1253/circj.CJ-07-0297	16	15	15	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2011	342								d234	10.1136/bmj.d234	http://dx.doi.org/10.1136/bmj.d234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PX	21296836				2022-12-01	WOS:000287138600005
J	Schmajuk, G; Trivedi, AN; Solomon, DH; Yelin, E; Trupin, L; Chakravarty, EF; Yazdany, J				Schmajuk, Gabriela; Trivedi, Amal N.; Solomon, Daniel H.; Yelin, Edward; Trupin, Laura; Chakravarty, Eliza F.; Yazdany, Jinoos			Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; HEALTH PLANS; DISPARITIES; OUTCOMES; DATABASE; COST; BENEFICIARIES; NEIGHBORHOOD; MEDICATIONS; AMERICAN	Context In 2005, the Healthcare Effectiveness Data and Information Set (HEDIS) introduced a quality measure to assess the receipt of disease-modifying antirheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA). Objective To identify sociodemographic, community, and health plan factors associated with DMARD receipt among Medicare managed care enrollees. Design, Setting, and Participants We analyzed individual-level HEDIS data for 93 143 patients who were at least 65 years old with at least 2 diagnoses of RA within a measurement year (during 2005-2008). Logistic regression models with generalized estimating equations were used to determine factors associated with DMARD receipt and logistic regression was used to adjust health plan performance for case mix. Main Outcome Measures Receipt or nonreceipt of DMARD. Results The mean age of patients was 74 years; 75% were women and 82% were white. Overall performance on the HEDIS measure for RA was 59% in 2005, increasing to 67% in 2008 (P for trend <.001). The largest difference in performance was based on age: patients aged 85 years and older had a 30 percentage point lower rate of DMARD receipt (95% confidence interval [CI], -29 to -32 points; P<.001), compared with patients 65 to 69 years of age, even after adjusting for other factors. Lower percentage point rates were also found for patients who were men (-3 points; 95% CI, -5 to -2 points; P<.001), of black race (-4 points; 95% CI, -6 to -2 points; P<.001), with low personal income (-6 points; 95% CI, -8 to -5 points; P<.001), with the lowest zip code-based socioeconomic status (-4 points; 95% CI, -6 to 2 points; P<.001), or enrolled in for-profit health plans (-4 points; 95% CI, -7 to 0 points; P<.001); and in the Middle Atlantic region (-7 points; 95% CI, -13 to -2 points; P<.001) and South Atlantic regions (-11 points; 95% CI, -20 to -3 points; P<.001) as compared with the Pacific region. Performance varied widely by health plan, ranging from 16% to 87%. Conclusions Among Medicare managed care enrollees carrying a diagnosis of RA between 2005 and 2008, 63% received a DMARD. Receipt of DMARDs varied based on demographic factors, socioeconomic status, geographic location, and health plan. JAMA. 2011;305(5):480-486 www.jama.com	[Schmajuk, Gabriela; Chakravarty, Eliza F.] Stanford Univ, Dept Med, Div Rheumatol, Stanford, CA 94304 USA; [Trivedi, Amal N.] Brown Univ, Dept Community Hlth & Med, Providence, RI 02912 USA; [Solomon, Daniel H.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Yelin, Edward; Trupin, Laura; Yazdany, Jinoos] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA USA	Stanford University; Brown University; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Schmajuk, G (corresponding author), Stanford Univ, Dept Med, Div Rheumatol, 1000 Welch Rd,Ste 203, Stanford, CA 94304 USA.	schmajuk@gmail.com			Merck; Pzifer (Pzifer Foundation); American College of Rheumatology/Research and Education Foundation; National Center for Research Resources [5-M01-RR-00079]; Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health [R01-AR-44804]; State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1-R01-HS-013893, P60-AR-053308, K24-AR-AR055989, R01-AR-056215]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013893] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR055989, K23AR060259, R01AR056476, R01AR056215, P60AR053308, R01AR044804] Funding Source: NIH RePORTER	Merck(Merck & Company); Pzifer (Pzifer Foundation); American College of Rheumatology/Research and Education Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Trivedi reports receipt of compensation from Merck (for editing a chapter of the Merck Manual) and from the Pzifer (for receiving a Health Policy Scholars Award from the Pzifer Foundation). Other authors reported no potential conflicts.; Funding was provided by the American College of Rheumatology/Research and Education Foundation Physician-Scientist Development Award; National Center for Research Resources (5-M01-RR-00079); Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health (R01-AR-44804); State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality; and National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant numbers: 1-R01-HS-013893, P60-AR-053308, K24-AR-AR055989, and R01-AR-056215).	Agency for Healthcare Research and Quality, RHEUM ARTHR PERC MEM; [Anonymous], 2001, INTERSTUDY COMPETITI; [Anonymous], 2008, AHRQ PUBL, V08-0034 (1-4), P1; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Baker LC, 2010, INT J QUAL HEALTH C, V22, P210, DOI 10.1093/intqhc/mzq011; Best A E, 1999, J Med Syst, V23, P175, DOI 10.1023/A:1020515419714; Brown AF, 2007, AM J PUBLIC HEALTH, V97, P926, DOI 10.2105/AJPH.2005.069443; Bruce B, 2007, J RHEUMATOL, V34, P1475; Brunner HI, 2006, ARTHRIT RHEUM-ARTHR, V55, P378, DOI 10.1002/art.21991; Edwards CJ, 2005, RHEUMATOLOGY, V44, pI2; GABRIEL SE, 1994, ARTHRITIS RHEUM, V37, P821, DOI 10.1002/art.1780370607; Gleason PP, 2009, J MANAGE CARE PHARM, V15, P648, DOI 10.18553/jmcp.2009.15.8.648; Grijalva CG, 2008, RHEUMATOLOGY, V47, P1061, DOI 10.1093/rheumatology/ken193; Groessl EJ, 2006, PHARMACOECONOMICS, V24, P109, DOI 10.2165/00019053-200624020-00002; Health Care Financing Administration, MED HE DIS DAT AUD M; Iren UT, 2005, J RHEUMATOL, V32, P602; Keenan PS, 2010, MED CARE, V48, P260, DOI 10.1097/MLR.0b013e3181ca410a; Khanna R, 2007, CLIN THER, V29, P2456, DOI 10.1016/j.clinthera.2007.11.009; Koroukian SM, 2010, HEALTH SERV RES, V45, P265, DOI 10.1111/j.1475-6773.2009.01051.x; Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328; Lacaille D, 2005, ARTHRIT RHEUM-ARTHR, V53, P241, DOI 10.1002/art.21077; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Pincus T, 1999, ANN INTERN MED, V131, P768, DOI 10.7326/0003-4819-131-10-199911160-00009; Pisetsky DS, 2001, JAMA-J AM MED ASSOC, V286, P2787, DOI 10.1001/jama.286.22.2787; Polinski JM, 2009, ARTHRIT RHEUM-ARTHR, V61, P745, DOI 10.1002/art.24560; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Schneider EC, 2005, AM J MED, V118, P1392, DOI 10.1016/j.amjmed.2005.05.032; Sequist TD, 2006, HEALTH SERV RES, V41, P1451, DOI 10.1111/j.1475-6773.2006.00549; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Strand V, 2008, AM J MANAG CARE, V14, P239; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Trupin L, 2008, J RHEUMATOL, V35, P1782; Tutuncu Z, 2006, ANN RHEUM DIS, V65, P1226, DOI 10.1136/ard.2005.051144; Widdifield J, 2011, ARTHRIT CARE RES, V63, P53, DOI 10.1002/acr.20304; Zaslavsky AM, 2005, INT J QUAL HEALTH C, V17, P67, DOI 10.1093/intqhc/mzi005; Ziegler S, 2010, ANN RHEUM DIS, V69, P1803, DOI 10.1136/ard.2009.122101; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	39	100	101	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					480	486		10.1001/jama.2011.67	http://dx.doi.org/10.1001/jama.2011.67			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714LI	21285425	Green Accepted, Bronze			2022-12-01	WOS:000286810700021
J	Lin, JZ; Lai, SM; Jia, R; Xu, AB; Zhang, LM; Lu, J; Ye, KQ				Lin, Jinzhong; Lai, Shaomei; Jia, Ru; Xu, Anbi; Zhang, Liman; Lu, Jing; Ye, Keqiong			Structural basis for site-specific ribose methylation by box C/D RNA protein complexes	NATURE			English	Article							CRYSTAL-STRUCTURE; SOLUBLE-RNA; CORE; 2'-O-METHYLATION; REQUIREMENT; RNPS	Box C/D RNA protein complexes (RNPs) direct site-specific 2'-O-methylation of RNA and ribosome assembly(1-4). The guide RNA in C/D RNP forms base pairs with complementary substrates and selects the modification site using a molecular ruler(5-7). Despite many studies of C/D RNP structure(8-25), the fundamental questions of how C/D RNAs assemble into RNPs and how they guide modification remain unresolved. Here we report the crystal structure of an entire catalytically active archaeal C/D RNP consisting of a bipartite C/D RNA associated with two substrates and two copies each of Nop5, L7Ae and fibrillarin at 3.15-angstrom resolution. The substrate pairs with the second through the eleventh nucleotide of the 12-nucleotide guide, and the resultant duplex is bracketed in a channel with flexible ends. The methyltransferase fibrillarin binds to an undistorted A-form structure of the guide-substrate duplex and specifically loads the target ribose into the active site. Because interaction with the RNA duplex alone does not determine the site specificity, fibrillarin is further positioned by non-specific and specific protein interactions. Compared with the structure of the inactive C/D RNP, extensive domain movements are induced by substrate loading. Our results reveal the organization of a monomeric C/D RNP and the mechanism underlying its site-specific methylation activity.	[Lin, Jinzhong; Lai, Shaomei; Jia, Ru; Xu, Anbi; Zhang, Liman; Lu, Jing; Ye, Keqiong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Liman; Lu, Jing] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Zhang, Liman; Lu, Jing] Peking Union Med Coll, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ye, KQ (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526	Chinese Ministry of Science and Technology [2008AA022310]; Beijing Municipal Government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government	We are grateful to the staff at the Shanghai Synchrotron Radiation Facility beamline BL17U for assistance in data collection and to B. Zhu for help with the methylation assay. This research was supported by the Chinese Ministry of Science and Technology (863 grant 2008AA022310) and the Beijing Municipal Government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; Appel CD, 2007, RNA, V13, P899, DOI 10.1261/rna.517307; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Chen CL, 2007, J MOL BIOL, V369, P771, DOI 10.1016/j.jmb.2007.03.052; DeLano WL., 2002, PYMOL USERS MANUAL D; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hardin JW, 2006, NUCLEIC ACIDS RES, V34, P5039, DOI 10.1093/nar/gkl644; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Omer AD, 2006, RNA, V12, P1708, DOI 10.1261/rna.31506; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rashid R, 2003, J MOL BIOL, V333, P295, DOI 10.1016/j.jmb.2003.08.012; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Tran E, 2005, RNA, V11, P285, DOI 10.1261/rna.7223405; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106	37	90	94	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					559	U140		10.1038/nature09688	http://dx.doi.org/10.1038/nature09688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270896				2022-12-01	WOS:000286596500038
J	Arora, N; Chertow, GM				Arora, Neiha; Chertow, Glenn M.			Update in Nephrology: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chertow, Glenn M.] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94034 USA	Stanford University	Chertow, GM (corresponding author), Stanford Univ, Sch Med, Div Nephrol, 780 Welch Rd,Suite 106, Palo Alto, CA 94034 USA.	gchertow@stanford.edu		Chertow, Glenn/0000-0002-7599-0534					0	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					824	829		10.7326/0003-4819-154-12-201106210-00342	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00342			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21464341				2022-12-01	WOS:000291800500018
J	Armstrong, J				Armstrong, Joanne			Unintended Consequences - The Cost of Preventing Preterm Births after FDA Approval of a Branded Version of 17OHP	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Aetna, Womens Hlth Div, Sugar Land, TX USA		Armstrong, J (corresponding author), Aetna, Womens Hlth Div, Sugar Land, TX USA.							Behrman R.E, 2006, PRETERM BIRTH CAUSES; *FOOD DRUG ADM, 2002, FOOD DRUG ADM COMPL; Petrini JR, 2005, OBSTET GYNECOL, V105, P267, DOI 10.1097/01.AOG.0000150560.24297.4f; PJ MEIS, 2003, NEW ENGL J MED, V348, P2379; 2011, MAKENA WHOLESALE ACQ	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1689	1691		10.1056/NEJMp1102796	http://dx.doi.org/10.1056/NEJMp1102796			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21410391				2022-12-01	WOS:000290219800003
J	Root, CM; Ko, KI; Jafari, A; Wang, JW				Root, Cory M.; Ko, Kang I.; Jafari, Amir; Wang, Jing W.			Presynaptic Facilitation by Neuropeptide Signaling Mediates Odor-Driven Food Search	CELL			English	Article							ANTENNAL LOBE; PHOSPHOINOSITIDE 3-KINASE; GENE-EXPRESSION; SOCIAL-BEHAVIOR; GAIN-CONTROL; Y-LIKE; CIRCUIT; NEURONS; INHIBITION; RECEPTOR	Internal physiological states influence behavioral decisions. We have investigated the underlying cellular and molecular mechanisms at the first olfactory synapse for starvation modulation of food-search behavior in Drosophila. We found that a local signal by short neuropeptide F (sNPF) and a global metabolic cue by insulin are integrated at specific odorant receptor neurons (ORNs) to modulate olfactory sensitivity. Results from two-photon calcium imaging show that starvation increases presynaptic activity via intraglomerular sNPF signaling. Expression of sNPF and its receptor (sNPFR1) in Or42b neurons is necessary for starvation-induced food-search behavior. Presynaptic facilitation in Or42b neurons is sufficient to mimic starvation-like behavior in fed flies. Furthermore, starvation elevates the transcription level of sNPFR1 but not that of sNPF, and insulin signaling suppresses sNPFR1 expression. Thus, starvation increases expression of sNPFR1 to change the odor map, resulting in more robust food-search behavior.	[Root, Cory M.; Ko, Kang I.; Jafari, Amir; Wang, Jing W.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JW (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	jw800@ucsd.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802	National Institute of Deafness and other Communication Disorders [R01DC009597, R21DC010458, 1F31DC009511]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC009511, R01DC009597, R21DC010458] Funding Source: NIH RePORTER	National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank R. Axel, M. Gallio, A. Gelperin, S. Kim, and M. Ramaswami for comments on the manuscript. We thank D. Green for assistance with the fly tracking software, E. Troemel for assistance with quantitative RT-PCR, and Jun Hee Lee for helpful discussion of insulin signaling. This work was supported by research grants from the National Institute of Deafness and other Communication Disorders to J.W.W. (R01DC009597, R21DC010458) and fellowship to C. M. R. (1F31DC009511). C. M. R. and J.W.W. designed experiments, analyzed data, and wrote the manuscript. C. M. R, K. I. K., and A.J. carried out experiments.	ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrg862, 10.1038/nrn902]; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Destexhe A, 2004, NATURE, V431, P789, DOI 10.1038/nature03011; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Distler PG, 1997, J COMP NEUROL, V383, P529, DOI 10.1002/(SICI)1096-9861(19970714)383:4&lt;529::AID-CNE9&gt;3.0.CO;2-4; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; GELPERIN A, 1971, ANNU REV ENTOMOL, V16, P365, DOI 10.1146/annurev.en.16.010171.002053; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1, DOI 10.1023/A:1022598900246; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mathieu M, 2002, DEV BRAIN RES, V139, P255, DOI 10.1016/S0165-3806(02)00577-1; Mayer CM, 2009, MOL CELL ENDOCRINOL, V307, P99, DOI 10.1016/j.mce.2009.02.031; Mousley A, 2006, J NEUROSCI, V26, P7707, DOI 10.1523/JNEUROSCI.1977-06.2006; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	51	312	315	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					133	144		10.1016/j.cell.2011.02.008	http://dx.doi.org/10.1016/j.cell.2011.02.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458672	Bronze, Green Accepted			2022-12-01	WOS:000289053900015
J	Ceol, CJ; Houvras, Y; Jane-Valbuena, J; Bilodeau, S; Orlando, DA; Battisti, V; Fritsch, L; Lin, WM; Hollmann, TJ; Ferre, F; Bourque, C; Burke, CJ; Turner, L; Uong, A; Johnson, LA; Beroukhim, R; Mermel, CH; Loda, M; Ait-Si-Ali, S; Garraway, LA; Young, RA; Zon, LI				Ceol, Craig J.; Houvras, Yariv; Jane-Valbuena, Judit; Bilodeau, Steve; Orlando, David A.; Battisti, Valentine; Fritsch, Lauriane; Lin, William M.; Hollmann, Travis J.; Ferre, Fabrizio; Bourque, Caitlin; Burke, Christopher J.; Turner, Laura; Uong, Audrey; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Loda, Massimo; Ait-Si-Ali, Slimane; Garraway, Levi A.; Young, Richard A.; Zon, Leonard I.			The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset	NATURE			English	Article							MALIGNANT-MELANOMA; BRAF MUTATIONS; HUMAN CANCER; GENES; NEVI; SENESCENCE; EXPRESSION; REPRESSION; LYSINE-9; CELLS	The most common mutation in human melanoma, BRAF(V600E), activates the serine/threonine kinase BRAF and causes excessive activity in the mitogen-activated protein kinase pathway(1,2). BRAF(V600E) mutations are also present in benign melanocytic naevi(3), highlighting the importance of additional genetic alterations in the genesis of malignant tumours. Such changes include recurrent copy number variations that result in the amplification of oncogenes(4,5). For certain amplifications, the large number of genes in the interval has precluded an understanding of the cooperating oncogenic events. Here we have used a zebrafish melanoma model to test genes in a recurrently amplified region of chromosome 1 for the ability to cooperate with BRAF(V600E) and accelerate melanoma. SETDB1, an enzyme that methylates histone H3 on lysine 9 (H3K9), was found to accelerate melanoma formation significantly in zebrafish. Chromatin immunoprecipitation coupled with massively parallel DNA sequencing and gene expression analyses uncovered genes, including HOX genes, that are transcriptionally dysregulated in response to increased levels of SETDB1. Our studies establish SETDB1 as an oncogene in melanoma and underscore the role of chromatin factors in regulating tumorigenesis.	[Ceol, Craig J.; Houvras, Yariv; Bourque, Caitlin; Burke, Christopher J.; Turner, Laura; Uong, Audrey; Zon, Leonard I.] Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Houvras, Yariv] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Harvard Univ, Dept Med Oncol, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Harvard Univ, Ctr Canc Genome Discovery, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Bilodeau, Steve; Orlando, David A.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Battisti, Valentine; Fritsch, Lauriane; Ait-Si-Ali, Slimane] Univ Paris Diderot, Epigenet & Destin Cellulaire UMR7216, CNRS, F-75013 Paris, France; [Hollmann, Travis J.; Loda, Massimo] Harvard Univ, Ctr Mol Oncol Pathol, Brigham & Womens Hosp, Dana Farber Canc Inst,Med Sch, Boston, MA 02115 USA; [Ferre, Fabrizio] Univ Roma La Sapienza, A Rossi Fanelli Biochem Sci Dept, I-00185 Rome, Italy	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Sapienza University Rome	Zon, LI (corresponding author), Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Mermel, Craig/AAZ-7322-2020; Young, Richard A/F-6495-2012	Mermel, Craig/0000-0002-0816-3395; Young, Richard A/0000-0001-8855-8647; Burke, Christopher/0000-0001-7609-1146; FERRE', FABRIZIO/0000-0003-2768-5305; Houvras, Yariv/0000-0003-0751-3215; Bilodeau, Steve/0000-0002-9799-3832	Damon Runyon Cancer Research Foundation [DRG-1855-05]; Charles A. King Trust Foundation; American Society of Clinical Oncology; Canadian Institutes of Health Research; National Institutes of Health [K99AR056899-02, K08DK075432-04, CA146455, HG002668, CA103846, DK055381]; NATIONAL CANCER INSTITUTE [R01CA146445, R01CA103846] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR056899, K99AR056899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK075432, R01DK053298, R01DK055381, R37DK055381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Charles A. King Trust Foundation; American Society of Clinical Oncology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Harrington, R. White and Y. Zhou for discussions; C. Lawrence, I. Adatto and L.-K. Zhang for expert fish care; G. Frampton for bioinformatics assistance; and K. Kwan, C.-B. Chien, and J. Boehm for reagents. This work was supported by grants from the Damon Runyon Cancer Research Foundation (C.J.C., DRG-1855-05), the Charles A. King Trust Foundation (C.J.C.), a Young Investigator Award from the American Society of Clinical Oncology (Y.H.), the Canadian Institutes of Health Research (S.B.) and the National Institutes of Health (C.J.C., K99AR056899-02; Y.H., K08DK075432-04; R.A.Y., CA146455, HG002668; and L.I.Z., CA103846 and DK055381).	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nisolle M, 1999, HUM REPROD, V14, P2844, DOI 10.1093/humrep/14.11.2844; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Santoriello C, 2009, DIS MODEL MECH, V2, P56, DOI 10.1242/dmm.001016; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007	23	381	390	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					513	+		10.1038/nature09806	http://dx.doi.org/10.1038/nature09806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430779	Green Submitted, Green Accepted			2022-12-01	WOS:000288702200062
J	O'Callaghan, T				O'Callaghan, Tiffany			The prevention agenda INTRODUCTION	NATURE			English	Editorial Material																		Boyle P, 2008, WORLD CANC REPORT; Niederdeppe J, 2010, J COMMUN, V60, P230, DOI 10.1111/j.1460-2466.2009.01474.x	2	22	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S2	S4		10.1038/471S2a	http://dx.doi.org/10.1038/471S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430716	Bronze			2022-12-01	WOS:000288702200008
J	Cao, Y; Jin, XS; Huang, H; Derebe, MG; Levin, EJ; Kabaleeswaran, V; Pan, YP; Punta, M; Love, J; Weng, J; Quick, M; Ye, S; Kloss, B; Bruni, R; Martinez-Hackert, E; Hendrickson, WA; Rost, B; Javitch, JA; Rajashankar, KR; Jiang, YX; Zhou, M				Cao, Yu; Jin, Xiangshu; Huang, Hua; Derebe, Mehabaw Getahun; Levin, Elena J.; Kabaleeswaran, Venkataraman; Pan, Yaping; Punta, Marco; Love, James; Weng, Jun; Quick, Matthias; Ye, Sheng; Kloss, Brian; Bruni, Renato; Martinez-Hackert, Erik; Hendrickson, Wayne A.; Rost, Burkhard; Javitch, Jonathan A.; Rajashankar, Kanagalaghatta R.; Jiang, Youxing; Zhou, Ming			Crystal structure of a potassium ion transporter, TrkH	NATURE			English	Article							K+-UPTAKE SYSTEM; ESCHERICHIA-COLI; CATION-TRANSPORT; GLYCINE RESIDUES; LIGHT-SCATTERING; HIGH-AFFINITY; KTRAB SYSTEM; PROTEIN TRKA; CHANNEL; SELECTIVITY	The TrkH/TrkG/KtrB proteins mediate K+ uptake in bacteria and probably evolved from simple K+ channels by multiple gene duplications or fusions. Here we present the crystal structure of a TrkH from Vibrio parahaemolyticus. TrkH is a homodimer, and each protomer contains an ion permeation pathway. A selectivity filter, similar in architecture to those of K+ channels but significantly shorter, is lined by backbone and side-chain oxygen atoms. Functional studies showed that TrkH is selective for permeation of K+ and Rb+ over smaller ions such as Na+ or Li+. Immediately intracellular to the selectivity filter are an intramembrane loop and an arginine residue, both highly conserved, which constrict the permeation pathway. Substituting the arginine with an alanine significantly increases the rate of K+ flux. These results reveal the molecular basis of K+ selectivity and suggest a novel gating mechanism for this large and important family of membrane transport proteins.	[Cao, Yu; Huang, Hua; Levin, Elena J.; Kabaleeswaran, Venkataraman; Pan, Yaping; Weng, Jun; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Jin, Xiangshu] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Derebe, Mehabaw Getahun; Ye, Sheng; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Derebe, Mehabaw Getahun; Ye, Sheng; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Punta, Marco; Love, James; Kloss, Brian; Bruni, Renato; Rost, Burkhard] New York Struct Biol Ctr, NewYork Consortium Membrane Prot Struct, New York, NY 10027 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, NE CAT, Adv Photon Source, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Technical University of Munich; Technical University of Munich; Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu	Punta, Marco/ABH-4698-2020; Rost, Burkhard/A-1908-2016; Cao, Yu/GNP-6653-2022	Punta, Marco/0000-0002-0050-0676; Rost, Burkhard/0000-0003-0179-8424; Cao, Yu/0000-0003-1409-2068; Bruni, Renato/0000-0002-2312-0254; Javitch, Jonathan/0000-0001-7395-2967; Martinez-Hackert, Erik/0000-0002-6182-7023; Kloss, Brian/0000-0003-0130-8739; Jin, Xiangshu/0000-0002-6551-8850	U.S. National Institutes of Health [HL086392, DK088057, GM05026-sub0007]; American Heart Association [0630148N]; National Institute of General Medical Sciences [GM05026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Data for this study were measured at beamlines X4A, X4C, X25 and X29 of the National Synchrotron Light Source and the NE-CAT 24ID-C and E at the Advanced Photon Source. This work was supported by the U.S. National Institutes of Health (grants HL086392, DK088057 and GM05026-sub0007 to M. Z.) and the American Heart Association (0630148N to M. Z.). M. Z is a Pew Scholar in Biomedical Sciences. The New York Consortium on Membrane Protein Structure central facility is supported by grant GM05026 to W. A. H. aspart of the Protein Structure Initiative (PSI-2) established by the National Institute of General Medical Sciences. We thank B. Honig for support, K. Jung for providing E. coli LB650, and J. Morais-Cabral, S.-Y. Lee, H. R. Guy, C. L. Slayman and E. P. Bakker for discussions and comments on the manuscript. M. Z. is grateful to R. MacKinnon for advice and support throughout the project.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Alkhuder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008966; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; BOSSEMEYER D, 1989, J BIOL CHEM, V264, P16403; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2000, BIOPHYS J, V78, P188, DOI 10.1016/S0006-3495(00)76584-2; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Durell SR, 1999, BIOPHYS J, V77, P789, DOI 10.1016/S0006-3495(99)76932-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hille B., 2001, ION CHANNELS EXCITAB; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kato N, 2007, CHANNELS, V1, P161, DOI 10.4161/chan.4374; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; KROLL RG, 1981, BIOCHEM J, V198, P691, DOI 10.1042/bj1980691; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLACK RH, 1980, J BIOL CHEM, V255, P3824; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; SCHULTZ SG, 1963, J GEN PHYSIOL, V47, P329, DOI 10.1085/jgp.47.2.329; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Zeng GF, 2004, J BIOL CHEM, V279, P3003, DOI 10.1074/jbc.M309760200; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	100	105	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					336	+		10.1038/nature09731	http://dx.doi.org/10.1038/nature09731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21317882	Green Accepted			2022-12-01	WOS:000288444000036
J	Schlegelmilch, K; Mohseni, M; Kirak, O; Pruszak, J; Rodriguez, JR; Zhou, DW; Kreger, BT; Vasioukhin, V; Avruch, J; Brummelkamp, TR; Camargo, FD				Schlegelmilch, Karin; Mohseni, Morvarid; Kirak, Oktay; Pruszak, Jan; Rodriguez, J. Renato; Zhou, Dawang; Kreger, Bridget T.; Vasioukhin, Valera; Avruch, Joseph; Brummelkamp, Thijn R.; Camargo, Fernando D.			Yap1 Acts Downstream of alpha-Catenin to Control Epidermal Proliferation	CELL			English	Article							ORGAN SIZE CONTROL; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; PROMOTES APOPTOSIS; SIGNALING PATHWAY; HIPPO PATHWAY; PROGENITOR CELLS; TEAD/TEF FAMILY; PROTEIN-KINASE; GROWTH-CONTROL	During development and regeneration, proliferation of tissue-specific stem cells is tightly controlled to produce organs of a predetermined size. The molecular determinants of this process remain poorly understood. Here, we investigate the function of Yap1, the transcriptional effector of the Hippo signaling pathway, in skin biology. Using gain- and loss-of-function studies, we show that Yap1 is a critical modulator of epidermal stem cell proliferation and tissue expansion. Yap1 mediates this effect through interaction with TEAD transcription factors. Additionally, our studies reveal that alpha-catenin, a molecule previously implicated in tumor suppression and cell density sensing in the skin, is an upstream negative regulator of Yap1. alpha-catenin controls Yap1 activity and phosphorylation by modulating its interaction with 14-3-3 and the PP2A phosphatase. Together, these data identify Yap1 as a determinant of the proliferative capacity of epidermal stem cells and as an important effector of a "crowd control" molecular circuitry in mammalian skin.	[Schlegelmilch, Karin; Mohseni, Morvarid; Camargo, Fernando D.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Schlegelmilch, Karin; Mohseni, Morvarid; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Schlegelmilch, Karin; Mohseni, Morvarid; Pruszak, Jan; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schlegelmilch, Karin] FU Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Kirak, Oktay; Pruszak, Jan; Rodriguez, J. Renato; Brummelkamp, Thijn R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Zhou, Dawang; Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol & Cellular Biol, Boston, MA 02114 USA; [Kreger, Bridget T.; Vasioukhin, Valera] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Free University of Berlin; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Fred Hutchinson Cancer Center	Camargo, FD (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	fernando.camargo@childrens.harvard.edu	Kirak, Oktay/H-6347-2013; Pruszak, Jan/G-6972-2015	Kirak, Oktay/0000-0002-6524-4685; Pruszak, Jan/0000-0003-4297-4009; Zhou, Dawang/0000-0002-9053-5249; Schlegelmilch, Karin/0000-0003-3173-0914; Vasioukhin, Valeri/0000-0002-6730-0281	Stand Up to Cancer-AACR initiative, NIH [R01 CA131426]; Whitehead Institute; NATIONAL CANCER INSTITUTE [R01CA131426] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Shrestha and S. Zaghlul for their technical assistance; L. Zon and A. von Giese and members of the Camargo lab for critical discussion; and members of the Gregory laboratory for advice on mass spectrometry experiments. This work was supported by grants from the Stand Up to Cancer-AACR initiative, NIH grant R01 CA131426, and funds from the Whitehead Institute Fellows Program. F. D. C. is a V Foundation Scholar and Pew Scholar in the Biomedical Sciences.	Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hariharan IK, 2006, CURR BIOL, V16, pR1037, DOI 10.1016/j.cub.2006.11.012; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Herron BJ, 2005, NAT GENET, V37, P1210, DOI 10.1038/ng1652; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Tinkle CL, 2008, P NATL ACAD SCI USA, V105, P15405, DOI 10.1073/pnas.0807374105; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	58	745	776	0	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					782	795		10.1016/j.cell.2011.02.031	http://dx.doi.org/10.1016/j.cell.2011.02.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376238	Green Accepted, Bronze			2022-12-01	WOS:000288007100016
J	Manceau, M; Domingues, VS; Mallarino, R; Hoekstra, HE				Manceau, Marie; Domingues, Vera S.; Mallarino, Ricardo; Hoekstra, Hopi E.			The Developmental Role of Agouti in Color Pattern Evolution	SCIENCE			English	Article							SIGNAL PROTEIN; COAT COLOR; MOUSE COAT; PIGMENTATION; MELANOCYTES; MUTATIONS; GENETICS; STRIPES; GENES; LOCUS	Animal color patterns can affect fitness in the wild; however, little is known about the mechanisms that control their formation and subsequent evolution. We took advantage of two locally camouflaged populations of Peromyscus mice to show that the negative regulator of adult pigmentation, Agouti, also plays a key developmental role in color pattern evolution. Genetic and functional analyses showed that ventral-specific embryonic expression of Agouti establishes a prepattern by delaying the terminal differentiation of ventral melanocytes. Moreover, a skin-specific increase in both the level and spatial domain of Agouti expression prevents melanocyte maturation in a regionalized manner, resulting in a novel and adaptive color pattern. Thus, natural selection favors late-acting, tissue-specific changes in embryonic Agouti expression to produce large changes in adult color pattern.	[Manceau, Marie; Domingues, Vera S.; Mallarino, Ricardo; Hoekstra, Hopi E.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Manceau, Marie; Domingues, Vera S.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hoekstra, HE (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	hoekstra@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769	Portuguese Foundation for Science and Technology; NSF [DEB-0919190]; Direct For Biological Sciences [0919190] Funding Source: National Science Foundation	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Kanadia, C. Punzo, E. McGlinn, J. Gros, A. Abzhanov, and C. Tabin for technical assistance; G. Barsh for helpful discussions; V. Hearing for antibodies to Trp1/Trp2; and C. Desplan, C. Tabin, A. Abzhanov, C. Linnen, and J. Gros for comments on the manuscript. In situ hybridizations on sections and in utero injections were conducted in the Abzhanov and Tabin/Cepko laboratories, respectively. Supported by the Portuguese Foundation for Science and Technology (V.S.D.) and by NSF grant DEB-0919190 (H.E.H.).	[Anonymous], 1940, ADAPTIVE COLORATION; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Botchkareva NV, 2003, J INVEST DERM SYMP P, V8, P76, DOI 10.1046/j.1523-1747.2003.12176.x; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen YR, 1996, GENETICS, V144, P265; Hirobe T, 1998, EUR J CELL BIOL, V75, P184, DOI 10.1016/S0171-9335(98)80060-5; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Kopp A, 2009, EVOLUTION, V63, P2771, DOI 10.1111/j.1558-5646.2009.00761.x; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Parichy DM, 2003, CURR BIOL, V13, pR947, DOI 10.1016/S0960-9822(03)00880-7; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x	24	150	155	0	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1062	1065		10.1126/science.1200684	http://dx.doi.org/10.1126/science.1200684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350176	Green Submitted			2022-12-01	WOS:000287699000062
J	Sahin, E; Colla, S; Liesa, M; Moslehi, J; Muller, FL; Guo, MR; Cooper, M; Kotton, D; Fabian, AJ; Walkey, C; Maser, RS; Tonon, G; Foerster, F; Xiong, R; Wang, YA; Shukla, SA; Jaskelioff, M; Martin, ES; Heffernan, TP; Protopopov, A; Ivanova, E; Mahoney, JE; Kost-Alimova, M; Perry, SR; Bronson, R; Liao, RL; Mulligan, R; Shirihai, OS; Chin, L; DePinho, RA				Sahin, Erguen; Colla, Simona; Liesa, Marc; Moslehi, Javid; Mueller, Florian L.; Guo, Mira; Cooper, Marcus; Kotton, Darrell; Fabian, Attila J.; Walkey, Carl; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Xiong, Robert; Wang, Y. Alan; Shukla, Sachet A.; Jaskelioff, Mariela; Martin, Eric S.; Heffernan, Timothy P.; Protopopov, Alexei; Ivanova, Elena; Mahoney, John E.; Kost-Alimova, Maria; Perry, Samuel R.; Bronson, Roderick; Liao, Ronglih; Mulligan, Richard; Shirihai, Orian S.; Chin, Lynda; DePinho, Ronald A.			Telomere dysfunction induces metabolic and mitochondrial compromise	NATURE			English	Article							HEART-FAILURE; STEM-CELLS; DAMAGE; LEADS; PGC-1-ALPHA; MICE; COACTIVATORS; HOMEOSTASIS; BIOGENESIS; CARCINOMA	Telomere dysfunction activates p53-mediated cellular growth arrest, senescence and apoptosis to drive progressive atrophy and functional decline in high-turnover tissues. The broader adverse impact of telomere dysfunction across many tissues including more quiescent systems prompted transcriptomic network analyses to identify common mechanisms operative in haematopoietic stem cells, heart and liver. These unbiased studies revealed profound repression of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta (PGC-1 alpha and PGC-1 beta, also known as Ppargc1a and Ppargc1b, respectively) and the downstream network in mice null for either telomerase reverse transcriptase (Tert) or telomerase RNA component (Terc) genes. Consistent with PGCs as master regulators of mitochondrial physiology and metabolism, telomere dysfunction is associated with impaired mitochondrial biogenesis and function, decreased gluconeogenesis, cardiomyopathy, and increased reactive oxygen species. In the setting of telomere dysfunction, enforced Tert or PGC-1a expression or germline deletion of p53 (also known as Trp53) substantially restores PGC network expression, mitochondrial respiration, cardiac function and gluconeogenesis. We demonstrate that telomere dysfunction activates p53 which in turn binds and represses PGC-1 alpha and PGC-1 beta promoters, thereby forging a direct link between telomere and mitochondrial biology. We propose that this telomere-p53-PGC axis contributes to organ and metabolic failure and to diminishing organismal fitness in the setting of telomere dysfunction.	[Sahin, Erguen; Colla, Simona; Mueller, Florian L.; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Xiong, Robert; Wang, Y. Alan; Shukla, Sachet A.; Jaskelioff, Mariela; Martin, Eric S.; Heffernan, Timothy P.; Protopopov, Alexei; Ivanova, Elena; Mahoney, John E.; Kost-Alimova, Maria; Perry, Samuel R.; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Sahin, Erguen; Colla, Simona; Moslehi, Javid; Mueller, Florian L.; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Jaskelioff, Mariela; Martin, Eric S.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liesa, Marc; Kotton, Darrell; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Moslehi, Javid; Liao, Ronglih; DePinho, Ronald A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Guo, Mira] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Cooper, Marcus] Univ Massachusetts, Div Cardiovasc Med, Worcester, MA 01605 USA; [Fabian, Attila J.; Mulligan, Richard; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Walkey, Carl] Univ Melbourne, St Vincents Hosp, St Vincents Inst, Victoria 3065, Australia; [Walkey, Carl] Univ Melbourne, St Vincents Hosp, Dept Med, Victoria 3065, Australia; [Bronson, Roderick] Harvard Univ, Sch Med, Rodent Histopathol Lab, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Maser, Richard/B-2970-2012; Liesa, Marc/K-8590-2019; Walkley, Carl/AAO-6021-2020; Tonon, Giovanni/J-9804-2018	Liesa, Marc/0000-0002-5909-8570; Walkley, Carl/0000-0002-4784-9031; Tonon, Giovanni/0000-0003-2973-5038; Colla, Simona/0000-0001-6583-8910; Muller, Florian/0000-0001-7568-2948; DePinho, Ronald/0000-0002-5625-577X; Ivanova, Elena/0000-0002-5069-4974; Shirihai, Orian/0000-0002-9502-2661; Mahoney, John (Jed)/0000-0001-9414-9110; Kotton, Darrell/0000-0002-9604-8476	Deutsche Forschungsgemeinschaft; NIH National Cancer Institute; Robert A. and Renee E. Belfer Foundation; Ellison Foundation; American Cancer Society; Fundacion Ramon Areces; NATIONAL CANCER INSTITUTE [R01CA084628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, R01DK056690, P30DK046200, R01DK089185, P30DK079638, R01DK035914, R01DK063356] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert A. and Renee E. Belfer Foundation; Ellison Foundation(Lawrence Ellison Foundation); American Cancer Society(American Cancer Society); Fundacion Ramon Areces; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Bianchi, J. Moriarty, K. Marmon and E. Thompson for excellent mouse husbandry and care. We are grateful to B. Spiegelman, P. Puigserver, J. E. Dominy and J. L. Estall for providing Ad-PGC-1 alpha and Ad-GFP virus and helpful comments on the manuscript. We thank G. I. Evan for the p53-ER construct. We appreciate input, critical comments and helpful discussions from many DePinho/Chin lab members, in particular A.-J. Chen, C. Khoo, R. Carrasco, A. Kimmelman, S. Quayle, D. Liu and R. Wiedemeyer. We acknowledge the services of the Mouse Metabolism Cores at Yale (NIH/NIDDK U24 DK-59635) and at Baylor College of Medicine (BCM) and the BCM Diabetes & Endocrinology Research Center (DERC) grant (P30 DK079638). E.S. was supported by the Deutsche Forschungsgemeinschaft and this work and R.A.D. are supported by R01 and U01 grants from the NIH National Cancer Institute and the Robert A. and Renee E. Belfer Foundation. R.A.D. was supported by an Ellison Foundation for Medical Research Senior Scholar and an American Cancer Society Research Professor award. M.L. is a recipient of a postdoctoral fellowship from Fundacion Ramon Areces.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Arnold AS, 2011, GERONTOLOGY, V57, P37, DOI 10.1159/000281883; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Farazi PA, 2003, CANCER RES, V63, P5021; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Miyagawa K, 2010, HYPERTENSION, V55, P738, DOI 10.1161/HYPERTENSIONAHA.109.141903; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	45	880	901	4	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					359	365		10.1038/nature09787	http://dx.doi.org/10.1038/nature09787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21307849	Green Accepted			2022-12-01	WOS:000287409100034
J	Stefan, CJ; Manford, AG; Baird, D; Yamada-Hanff, J; Mao, YX; Emr, SD				Stefan, Christopher J.; Manford, Andrew G.; Baird, Daniel; Yamada-Hanff, Jason; Mao, Yuxin; Emr, Scott D.			Osh Proteins Regulate Phosphoinositide Metabolism at ER-Plasma Membrane Contact Sites	CELL			English	Article							OXYSTEROL-BINDING-PROTEIN; SAC1 LIPID PHOSPHATASE; ENDOPLASMIC-RETICULUM; YEAST SAC1; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; GOLGI-COMPLEX; TRANSPORT; REQUIRES; 4-KINASE; MUTANTS	Sac1 phosphoinositide (PI) phosphatases are essential regulators of PI-signaling networks. Yeast Sac1, an integral endoplasmic reticulum (ER) membrane protein, controls PI4P levels at the ER, Golgi, and plasma membrane (PM). Whether Sac1 can act in trans and turn over PI4P at the Golgi and PM from the ER remains a paradox. We find that Sac1-mediated PI4P metabolism requires the oxysterol-binding homology (Osh) proteins. The PH domain-containing family member, Osh3, localizes to PM/ER membrane contact sites dependent upon PM PI4P levels. We reconstitute Osh protein-stimulated Sac1 PI phosphatase activity in vitro. We also show that the ER membrane VAP proteins, Scs2/Scs22, control PM PI4P levels and Sac1 activity in vitro. We propose that Osh3 functions at ER/PM contact sites as both a sensor of PM PI4P and an activator of the ER Sac1 phosphatase. Our findings further suggest that the conserved Osh proteins control PI metabolism at additional membrane contact sites.	[Stefan, Christopher J.; Manford, Andrew G.; Baird, Daniel; Yamada-Hanff, Jason; Mao, Yuxin; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Emr, SD (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	sde26@cornell.edu		Manford, Andrew/0000-0003-4472-9509; Mao, Yuxin/0000-0002-5064-1397; Stefan, Christopher/0000-0002-4118-5721	Weill Institute for Cell and Molecular Biology	Weill Institute for Cell and Molecular Biology	We thank C. Beh for strains and plasmids. We are grateful to S. Weys for technical assistance. We thank members of the S. D. E. laboratory, C. McMaster, and S. Henry for discussions, and A. Bretscher, C. Fromme, and D. Teis for comments on the manuscript. This work was supported by funds from the Weill Institute for Cell and Molecular Biology (S.D.E.).	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kagiwada S, 2007, BIOCHEM BIOPH RES CO, V364, P870, DOI 10.1016/j.bbrc.2007.10.079; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Konrad G, 2002, J BIOL CHEM, V277, P10547, DOI 10.1074/jbc.M200090200; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Liu Y, 2008, MOL BIOL CELL, V19, P3080, DOI 10.1091/mbc.E07-12-1290; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Nemoto Y, 2000, J BIOL CHEM, V275, P34293, DOI 10.1074/jbc.M003923200; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wei HC, 2003, CURR BIOL, V13, P1882, DOI 10.1016/j.cub.2003.09.056	35	326	336	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					389	401		10.1016/j.cell.2010.12.034	http://dx.doi.org/10.1016/j.cell.2010.12.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295699	Bronze			2022-12-01	WOS:000286973100011
J	Ogawa, T; Akahane, M; Koike, S; Tanabe, S; Mizoguchi, T; Imamura, T				Ogawa, Toshio; Akahane, Manabu; Koike, Soichi; Tanabe, Seizan; Mizoguchi, Tatsuhiro; Imamura, Tomoaki			Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; EUROPEAN-RESUSCITATION-COUNCIL; SUDDEN CARDIAC-ARREST; BASIC LIFE-SUPPORT; HEALTH-PROFESSIONALS; STROKE-FOUNDATION; TASK-FORCE; STATEMENT; GUIDELINES; ATTITUDES	ABSTRACT Objective To compare the effectiveness of cardiopulmonary resuscitation (CPR) with chest compression only and conventional CPR on outcomes after cardiopulmonary arrest out of hospital. Design Nationwide population based observational study. Setting A nationwide emergency medical service system in Japan. Population All consecutive patients with out of hospital cardiopulmonary arrest, January 2005 to December 2007 in Japan, witnessed at the moment of collapse. Lay people attempted chest compression only CPR (n=20 707) or conventional CPR (mouth to mouth ventilation and chest compression) (n=19 328), and patients were transferred to hospital by ambulance. Main outcome measures Factors associated with better outcomes (assessed with chi superset of 2 superset of, multiple logistic regression analysis, odds ratios and their 95% confidence intervals): one month survival and neurologically favourable one month survival rates defined as category one (good cerebral performance) or two (moderate cerebral disability) of the cerebral performance categories. Results Conventional CPR was associated with better outcomes than chest compression only CPR, for both one month survival (adjusted odds ratio 1.17, 95% confidence interval 1.06 to 1.29) and neurologically favourable one month survival (1.17, 1.01 to 1.35). Neurologically favourable one month survival decreased with increasing age and with delays of up to 10 minutes in starting CPR for both conventional and chest compression only CPR. The benefit of conventional CPR over chest compression only CPR was significantly greater in younger people in non-cardiac cases (P=0.025) and with a delay in start of CPR after the event was witnessed in non-cardiac cases (P=0.015) and all cases combined (P=0.037). Conclusions Conventional CPR is associated with better outcomes than chest compression only CPR for selected patients with out of hospital cardiopulmonary arrest, such as those with arrests of non-cardiac origin and younger people, and people in whom there was delay in the start of CPR.	[Ogawa, Toshio; Akahane, Manabu; Imamura, Tomoaki] Nara Med Univ, Sch Med, Dept Publ Hlth Hlth Management & Policy, Kashihara 6348521, Nara, Japan; [Koike, Soichi] Univ Tokyo Hosp, Dept Planning Information & Management, Bunkyo Ku, Tokyo 1920364, Japan; [Tanabe, Seizan; Mizoguchi, Tatsuhiro] Emergency Life Saving Technique Acad Of Tokyo, Fdn Ambulance Serv Dev, Tokyo 1920364, Japan; Fire & Disaster Management Agcy, Ambulance Serv Planning Off, Chiyoda Ku, Tokyo 1008927, Japan	Nara Medical University; University of Tokyo	Ogawa, T (corresponding author), Nara Med Univ, Sch Med, Dept Publ Hlth Hlth Management & Policy, 840 Shijo Cho, Kashihara 6348521, Nara, Japan.	ogawat@naramed-u.ac.jp	Akahane, Manabu/GYD-5539-2022					[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Arrich J, 2009, RESUSCITATION, V80, P876, DOI 10.1016/j.resuscitation.2009.04.045; Bohm K, 2007, CIRCULATION, V116, P2908, DOI 10.1161/CIRCULATIONAHA.107.710194; Caves ND, 2006, RESUSCITATION, V68, P93, DOI 10.1016/j.resuscitation.2005.05.014; Chamberlain D, 2005, RESUSCITATION, V67, P157, DOI 10.1016/j.resuscitation.2005.05.011; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Holmberg M, 1999, AM J CARDIOL, V83, p88D; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; LOCKE CJ, 1995, ARCH INTERN MED, V155, P938, DOI 10.1001/archinte.155.9.938; *MIN ED CULT SPORT, 2006, SPORTS SCI TECHNOL J; Nagao K, 2007, LANCET, V369, P920; Olasveengen TM, 2008, ACTA ANAESTH SCAND, V52, P914, DOI 10.1111/j.1399-6576.2008.01723.x; Ong MEH, 2008, RESUSCITATION, V78, P119, DOI 10.1016/j.resuscitation.2008.03.012; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Sayre MR, 2009, PREHOSP EMERG CARE, V13, P469, DOI 10.1080/10903120903144965; Steen PA, 2007, CIRCULATION, V116, P2514, DOI 10.1161/CIRCULATIONAHA.107.739086; Taniguchi T, 2007, RESUSCITATION, V75, P82, DOI 10.1016/j.resuscitation.2007.02.019; Vukmir RB, 2004, EMERG MED J, V21, P370, DOI 10.1136/emj.2003.008383	23	85	93	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2011	342								c7106	10.1136/bmj.c7106	http://dx.doi.org/10.1136/bmj.c7106			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715MM	21273279	hybrid, Green Submitted			2022-12-01	WOS:000286888600014
J	Chen, CF; Park, CH; Boudouris, BW; Horng, J; Geng, BS; Girit, C; Zettl, A; Crommie, MF; Segalman, RA; Louie, SG; Wang, F				Chen, Chi-Fan; Park, Cheol-Hwan; Boudouris, Bryan W.; Horng, Jason; Geng, Baisong; Girit, Caglar; Zettl, Alex; Crommie, Michael F.; Segalman, Rachel A.; Louie, Steven G.; Wang, Feng			Controlling inelastic light scattering quantum pathways in graphene	NATURE			English	Article							GEL GATE DIELECTRICS; CARBON NANOTUBES; RAMAN-SPECTROSCOPY; TRANSISTORS; ELECTRONS	Inelastic light scattering spectroscopy has, since its first discovery(1,2), been an indispensable tool in physical science for probing elementary excitations, such as phonons(3), magnons(4) and plasmons(5) in both bulk and nanoscale materials. In the quantum mechanical picture of inelastic light scattering, incident photons first excite a set of intermediate electronic states, which then generate crystal elementary excitations and radiate energy-shifted photons(6). The intermediate electronic excitations therefore have a crucial role as quantum pathways in inelastic light scattering, and this is exemplified by resonant Raman scattering(6) and Raman interference(7,8). The ability to control these excitation pathways can open up new opportunities to probe, manipulate and utilize inelastic light scattering. Here we achieve excitation pathway control in graphene with electrostatic doping. Our study reveals quantum interference between different Raman pathways in graphene: when some of the pathways are blocked, the one-phonon Raman intensity does not diminish, as commonly expected, but increases dramatically. This discovery sheds new light on the understanding of resonance Raman scattering in graphene. In addition, we demonstrate hot-electron luminescence9 in graphene as the Fermi energy approaches half the laser excitation energy. This hot luminescence, which is another form of inelastic light scattering, results from excited-state relaxation channels that become available only in heavily doped graphene.	[Chen, Chi-Fan; Park, Cheol-Hwan; Horng, Jason; Geng, Baisong; Girit, Caglar; Zettl, Alex; Crommie, Michael F.; Louie, Steven G.; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Boudouris, Bryan W.; Segalman, Rachel A.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Boudouris, Bryan W.; Zettl, Alex; Crommie, Michael F.; Segalman, Rachel A.; Louie, Steven G.; Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	fengwang76@berkeley.edu	5.4, ALS Beamline/I-2863-2014; Girit, Çağlar/D-4845-2014; 1.4, ALS Beamline/I-1886-2014; Girit, Çağlar/AFT-1507-2022; Zettl, Alex K/O-4925-2016; Park, Cheol-Hwan/A-1543-2009; wang, Feng/I-5727-2015	Girit, Çağlar/0000-0001-8953-9261; Girit, Çağlar/0000-0001-8953-9261; Zettl, Alex K/0000-0001-6330-136X; Park, Cheol-Hwan/0000-0003-1584-6896; wang, Feng/0000-0001-8369-6194; Segalman, Rachel/0000-0002-4292-5103	US Department of Energy, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Office of Basic Energy Sciences [DE-AC02-05CH11231, DE-AC03-76SF0098]; ONR MURI [N00014-09-1-1066]; National Science Council; National Tsing Hua University, Taiwan [NSC98-2811-M-007-008, NSC98-2120-M-007-004]	US Department of Energy, Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); ONR MURI(MURIOffice of Naval Research); National Science Council(Ministry of Science and Technology, Taiwan); National Tsing Hua University, Taiwan	This work was supported by the US Department of Energy, Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231 (C.-F.C. and F.W.), by the Office of Basic Energy Sciences under contract nos DE-AC02-05CH11231 (B.W.B. and R.A.S.), DE-AC03-76SF0098 (Materials Science Division) (C.G., A.Z.) and DE-AC02-05CH11231 (Advanced Light Source), and by ONR MURI award N00014-09-1-1066 (J.H., C.-H.P., S.G.L., M.F.C.). C.-F.C. also acknowledges fellowship support from the National Science Council and National Tsing Hua University, Taiwan, under awards NSC98-2811-M-007-008 and NSC98-2120-M-007-004.	Basko DM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165413; Basko DM, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/095011; CARDONA M, 1982, LIGHT SCATTERING SOL, V1; Cho JH, 2008, NAT MATER, V7, P900, DOI 10.1038/nmat2291; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Devereaux TP, 2007, REV MOD PHYS, V79, P175, DOI 10.1103/RevModPhys.79.175; Dresselhaus MS, 2010, NANO LETT, V10, P751, DOI 10.1021/nl904286r; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; ELSAESSER T, 1991, PHYS REV LETT, V66, P1757, DOI 10.1103/PhysRevLett.66.1757; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; GONI AR, 1991, PHYS REV LETT, V67, P3298, DOI 10.1103/PhysRevLett.67.3298; Ilani S, 2006, NAT PHYS, V2, P687, DOI 10.1038/nphys412; Kashuba O, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.241404; Kim BJ, 2010, NANO LETT, V10, P3464, DOI 10.1021/nl101559n; Landsberg G, 1928, NATURWISSENSCHAFTEN, V16, P557; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; LUI CH, 2010, ULTRAFAST PHOTOLUMIN; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; RALSTON JM, 1970, PHYS REV LETT, V25, P814, DOI 10.1103/PhysRevLett.25.814; Raman CV, 1928, NATURE, V121, P619, DOI 10.1038/121619b0; Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187; STOEHR RJ, 2010, FLUORESCENCE LASER C; Wang CJ, 2001, SCIENCE, V291, P2390, DOI 10.1126/science.291.5512.2390; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105	30	446	456	6	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					617	620		10.1038/nature09866	http://dx.doi.org/10.1038/nature09866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21412234				2022-12-01	WOS:000288951200038
J	Brower, V				Brower, Vicki			EPIGENETICS Unravelling the cancer code	NATURE			English	Editorial Material							METHYLATION; CARCINOMA; GENE											Brait M, 2009, CANCER EPIDEM BIOMAR, V18, P2984, DOI 10.1158/1055-9965.EPI-08-1245; Christensen BC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001043; Frank B., 2010, CANC GENETICS, V127, P2822; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Slattery ML, 2011, CANCER EPIDEM BIOMAR, V20, P57, DOI 10.1158/1055-9965.EPI-10-0843	7	48	49	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S12	S13		10.1038/471S12a	http://dx.doi.org/10.1038/471S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430711	Bronze			2022-12-01	WOS:000288702200012
J	Woods, RJ; Barrick, JE; Cooper, TF; Shrestha, U; Kauth, MR; Lenski, RE				Woods, Robert J.; Barrick, Jeffrey E.; Cooper, Tim F.; Shrestha, Utpala; Kauth, Mark R.; Lenski, Richard E.			Second-Order Selection for Evolvability in a Large Escherichia coli Population	SCIENCE			English	Article							TERM EXPERIMENTAL EVOLUTION; ASEXUAL POPULATIONS; CLONAL INTERFERENCE; BENEFICIAL MUTATIONS; ADAPTATION; GENERATIONS; EPISTASIS; VIRUS	In theory, competition between asexual lineages can lead to second-order selection for greater evolutionary potential. To test this hypothesis, we revived a frozen population of Escherichia coli from a long-term evolution experiment and compared the fitness and ultimate fates of four genetically distinct clones. Surprisingly, two clones with beneficial mutations that would eventually take over the population had significantly lower competitive fitness than two clones with mutations that later went extinct. By replaying evolution many times from these clones, we showed that the eventual winners likely prevailed because they had greater potential for further adaptation. Genetic interactions that reduce the benefit of certain regulatory mutations in the eventual losers appear to explain, at least in part, why they were outcompeted.	[Woods, Robert J.; Lenski, Richard E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Barrick, Jeffrey E.; Kauth, Mark R.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Cooper, Tim F.; Shrestha, Utpala] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Michigan State University; Michigan State University; University of Houston System; University of Houston	Barrick, JE (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	jbarrick@cm.utexas.edu; lenski@msu.edu	Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Woods, Robert/0000-0002-0679-9998; Cooper, Timothy/0000-0001-5038-9366; Lenski, Richard/0000-0002-1064-8375	NSF [DEB1019989]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]; NIH [K99GM087550]; McDonnell Foundation [220020174]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087550, K99GM087550] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NSF (DEB1019989 to R. E. L.), Defense Advanced Research Projects Agency (HR0011-09-1-0055 to R. E. L. and T. F. C), the NIH (K99GM087550 to J.E.B.), and the McDonnell Foundation (220020174 to T. F. C). We thank N. Hajela for laboratory assistance, staff at the Michigan State University (MSU) Research Technology Support Facility for assistance with genome sequencing, and the MSU High-Performance Computing Cluster for computational support. Genome sequencing data have been deposited in the NCBI Short Read Archive (SRA024331).	Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2010, MOL BIOL EVOL, V27, P1338, DOI 10.1093/molbev/msq024; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; Colegrave N, 2008, HEREDITY, V100, P464, DOI 10.1038/sj.hdy.6801095; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Crozat E, 2005, GENETICS, V169, P523, DOI 10.1534/genetics.104.035717; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Elena SF, 1997, EVOLUTION, V51, P1058, DOI 10.1111/j.1558-5646.1997.tb03953.x; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; McBride RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-231; Park SC, 2007, P NATL ACAD SCI USA, V104, P18135, DOI 10.1073/pnas.0705778104; Philippe N, 2007, BIOESSAYS, V29, P846, DOI 10.1002/bies.20629; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Rozen DE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001715; Sniegowski PD, 2010, PHILOS T R SOC B, V365, P1255, DOI 10.1098/rstb.2009.0290; Stanek MT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-302; Tenaillon O, 1999, GENETICS, V152, P485; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200	30	221	225	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1433	1436		10.1126/science.1198914	http://dx.doi.org/10.1126/science.1198914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415350	Green Submitted, Green Accepted			2022-12-01	WOS:000288504000040
J	Wickliffe, KE; Lorenz, S; Wemmer, DE; Kuriyan, J; Rape, M				Wickliffe, Katherine E.; Lorenz, Sonja; Wemmer, David E.; Kuriyan, John; Rape, Michael			The Mechanism of Linkage-Specific Ubiquitin Chain Elongation by a Single-Subunit E2	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; DEGRADATION; INSIGHTS; REVEALS; POLYUBIQUITINATION; PERFORMANCE; ACTIVATION; TARGETS; ENZYMES	Ubiquitin chains of different topologies trigger distinct functional consequences, including protein degradation and reorganization of complexes. The assembly of most ubiquitin chains is promoted by E2s, yet how these enzymes achieve linkage specificity is poorly understood. We have discovered that the K11-specific Ube2S orients the donor ubiquitin through an essential noncovalent interaction that occurs in addition to the thioester bond at the E2 active site. The E2-donor ubiquitin complex transiently recognizes the acceptor ubiquitin, primarily through electrostatic interactions. The recognition of the acceptor ubiquitin surface around Lys11, but not around other lysines, generates a catalytically competent active site, which is composed of residues of both Ube2S and ubiquitin. Our studies suggest that monomeric E2s promote linkage-specific ubiquitin chain formation through substrate-assisted catalysis.	[Wickliffe, Katherine E.; Lorenz, Sonja; Wemmer, David E.; Kuriyan, John; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Lorenz, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	slorenz@berkeley.edu; mrape@berkeley.edu	Lorenz, Sonja/AAL-4499-2020	Lorenz, Sonja/0000-0002-9639-2381; Rape, Michael/0000-0003-4849-6343	NIH [GM 68933, GM68933, RR15756, GM83064]; NSF [BBS 0119304, BBS 8720134]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083064, P41GM068933] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003088] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. J. Meyer for Ub-L-cycA; A. Williamson for golden extracts; members of the Rape and Kuriyan labs, J. Winger, S. Kassube, and J. Kirsch for discussions; J. Schaletzky for reading the manuscript and suggestions; J. Pelton for help with NMR experiments; D. King and T. Iavarone for mass spectrometry; and the staff at beamline 12.3.1 at LBNL for technical support. NMR instrumentation and operation were supported by NIH-GM 68933, NIH GM68933, NSF BBS 0119304 and NIH RR15756, and NSF BBS 8720134. S. L. is a fellow of The Leukemia & Lymphoma Society. M. R. is a Pew fellow and is supported by NIH GM83064 and an NIH New Innovator Award.	Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	30	212	215	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					769	781		10.1016/j.cell.2011.01.035	http://dx.doi.org/10.1016/j.cell.2011.01.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376237	Green Accepted, Bronze			2022-12-01	WOS:000288007100015
J	Sare, J				Sare, Jeremy			Medicine and the Media How the media helped ban mephedrone	BRITISH MEDICAL JOURNAL			English	Editorial Material												jeremysare@btinternet.com							0	4	4	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2011	342								d1138	10.1136/bmj.d1138	http://dx.doi.org/10.1136/bmj.d1138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729BE	21349891				2022-12-01	WOS:000287920900004
J	Breen, DP; Rowe, JB; Barker, RA				Breen, David P.; Rowe, James B.; Barker, Roger A.			Practice Rational Imaging Role of brain imaging in early parkinsonism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOPAMINE TRANSPORTERS; DISEASE; DIAGNOSIS; MOVEMENT; SPECT; DEMENTIA; MRI					davebreen@excite.co.uk	rowe, james B/C-3661-2013; Tick, Beata/ABA-1728-2020	rowe, james B/0000-0001-7216-8679; Barker, Roger Alistair/0000-0001-8843-7730	Medical Research Council [MC_U105597119] Funding Source: Medline; Wellcome Trust [088324] Funding Source: Medline; MRC [MC_U105597119] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, DIAGN PHARM MAN PARK, V113; Bohnen NI, 1999, NEUROLOGY, V52, P541, DOI 10.1212/WNL.52.3.541; Booij J, 1998, J NUCL MED, V39, P1879; Brooks DJ, 2008, NAT CLIN PRACT NEURO, V4, P267, DOI 10.1038/ncpneuro0773; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Kagi G, 2010, J NEUROL NEUROSUR PS, V81, P5, DOI 10.1136/jnnp.2008.157370; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; Oba H, 2005, NEUROLOGY, V64, P2050, DOI 10.1212/01.WNL.0000165960.04422.D0; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Rowe JB, 2008, BRAIN, V131, P2094, DOI 10.1093/brain/awn112; Seibyl JP, 1997, J NUCL MED, V38, P1453; Spiegel J, 2007, J NEURAL TRANSM, V114, P331, DOI 10.1007/s00702-006-0518-2; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Vlaar AMM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-27; Yekhlef F, 2003, J NEURAL TRANSM, V110, P151, DOI 10.1007/s00702-002-0785-5	21	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2011	342								d638	10.1136/bmj.d638	http://dx.doi.org/10.1136/bmj.d638			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729AZ	21345904				2022-12-01	WOS:000287920100018
J	Deutsch, GB; Zielonka, EM; Coutandin, D; Weber, TA; Schafer, B; Hannewald, J; Luh, LM; Durst, FG; Ibrahim, M; Hoffmann, J; Niesen, FH; Senturk, A; Kunkel, H; Brutschy, B; Schleiff, E; Knapp, S; Acker-Palmer, A; Grez, M; McKeon, F; Dotsch, V				Deutsch, Gregor B.; Zielonka, Elisabeth M.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Hannewald, Jens; Luh, Laura M.; Durst, Florian G.; Ibrahim, Mohamed; Hoffmann, Jan; Niesen, Frank H.; Sentuerk, Aycan; Kunkel, Hana; Brutschy, Bernd; Schleiff, Enrico; Knapp, Stefan; Acker-Palmer, Amparo; Grez, Manuel; McKeon, Frank; Doetsch, Volker			DNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63 alpha from Dimer to Tetramer	CELL			English	Article							P53 TUMOR-SUPPRESSOR; STRUCTURAL EVOLUTION; MASS-SPECTROMETRY; MUTANT P53; GERM-LINE; P63; PROTEIN; DOMAIN; HOMOLOG; P73	TAp63 alpha, a homolog of the p53 tumor suppressor, is a quality control factor in the female germline. Remarkably, already undamaged oocytes express high levels of the protein, suggesting that TAp63 alpha's activity is under tight control of an inhibitory mechanism. Biochemical studies have proposed that inhibition requires the C-terminal transactivation inhibitory domain. However, the structural mechanism of TAp63 alpha inhibition remains unknown. Here, we show that TAp63 alpha is kept in an inactive dimeric state. We reveal that relief of inhibition leads to tetramer formation with similar to 20-fold higher DNA affinity. In vivo, phosphorylation-triggered tetramerization of TAp63 alpha is not reversible by dephosphorylation. Furthermore, we show that a helix in the oligomerization domain of p63 is crucial for tetramer stabilization and competes with the transactivation domain for the same binding site. Our results demonstrate how TAp63 alpha is inhibited by complex domain-domain interactions that provide the basis for regulating quality control in oocytes.	[Deutsch, Gregor B.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Luh, Laura M.; Durst, Florian G.; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Deutsch, Gregor B.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Luh, Laura M.; Durst, Florian G.; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Zielonka, Elisabeth M.; McKeon, Frank] Univ Strasbourg, ISIS, F-67000 Strasbourg, France; [Zielonka, Elisabeth M.; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Hannewald, Jens] Merck KGaA, MS DTB C Prot Purificat, D-64293 Darmstadt, Germany; [Ibrahim, Mohamed; Schleiff, Enrico] Goethe Univ Frankfurt, Inst Mol & Cell Biol Plants, D-60438 Frankfurt, Germany; [Hoffmann, Jan; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany; [Niesen, Frank H.; Knapp, Stefan] Univ Oxford, Nuffield Dept Med, Oxford OX3 7DQ, England; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Struct Genom Consortium, Oxford OX3 7DQ, England; [McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Goethe University Frankfurt; Goethe University Frankfurt; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Merck KGaA; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of Oxford; University of Oxford; Harvard University; Harvard Medical School	Dotsch, V (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany.	vdoetsch@em.uni-frankfurt.de	Doetsch, Volker/D-5697-2011; Knapp, Stefan/AAG-2347-2019; Ibrahim, Mohamed/AAH-8007-2019; Coutandin, Daniel/O-8449-2016; Schleiff, Enrico/C-5105-2017	Knapp, Stefan/0000-0001-5995-6494; Coutandin, Daniel/0000-0003-4537-1393; Schleiff, Enrico/0000-0002-0518-3489; Dotsch, Volker/0000-0001-5720-212X	DFG [DO 545/2-1]; EU [LSHB-CT-019067]; Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); ANR; ERC; Boehringer Ingelheim Fonds PhD Fellowship; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	DFG(German Research Foundation (DFG)); EU(European Commission); Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	The research was funded by the DFG (DO 545/2-1), EU-Grant EPISTEM (LSHB-CT-019067), the Centre for Biomolecular Magnetic Resonance (BMRZ), and the Cluster of Excellence Frankfurt (Macromolecular Complexes). F. M. acknowledges support by ANR and ERC. D. C. was supported by a Boehringer Ingelheim Fonds PhD Fellowship. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. J. Hannewald is an employee of Merck KGaA, Darmstadt.	Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Burge S, 2009, P NATL ACAD SCI USA, V106, P3142, DOI 10.1073/pnas.0900383106; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Coutandin D, 2009, CELL DEATH DIFFER, V16, P1582, DOI 10.1038/cdd.2009.139; Coutandin D, 2010, P NATL ACAD SCI USA, V107, P15318, DOI 10.1073/pnas.1001069107; Davison TS, 2001, J MOL BIOL, V307, P605, DOI 10.1006/jmbi.2001.4450; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hoffmann J, 2009, RAPID COMMUN MASS SP, V23, P2176, DOI 10.1002/rcm.4129; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; Senoo M, 1998, BIOCHEM BIOPH RES CO, V248, P603, DOI 10.1006/bbrc.1998.9013; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Straub WE, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.1; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Ying HQ, 2005, MOL CELL BIOL, V25, P6154, DOI 10.1128/MCB.25.14.6154-6164.2005	44	96	100	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					566	576		10.1016/j.cell.2011.01.013	http://dx.doi.org/10.1016/j.cell.2011.01.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335238	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000287473100011
J	Huang, WD; Ghisletti, S; Saijo, KR; Gandhi, M; Aouadi, M; Tesz, GJ; Zhang, DX; Yao, J; Czech, MP; Goode, BL; Rosenfeld, MG; Glass, CK				Huang, Wendy; Ghisletti, Serena; Saijo, Kaoru; Gandhi, Meghal; Aouadi, Myriam; Tesz, Greg J.; Zhang, Dawn X.; Yao, Joyee; Czech, Michael P.; Goode, Bruce L.; Rosenfeld, Michael G.; Glass, Christopher K.			Coronin 2A mediates actin-dependent de-repression of inflammatory response genes	NATURE			English	Article							PPAR-GAMMA; NUCLEAR; RECEPTOR; PATHWAYS; TRANSREPRESSION; INTEGRATION; ACTIVATION; CHECKPOINT; EXPRESSION; ROLES	Toll-like receptors (TLRs) function as initiators of inflammation through their ability to sense pathogen-associated molecular patterns and products of tissue damage(1,2). Transcriptional activation of many TLR-responsive genes requires an initial de-repression step in which nuclear receptor co-repressor (NCoR) complexes are actively removed from the promoters of target genes to relieve basal repression(3,4). Ligand-dependent SUMOylation of liver X receptors (LXRs) has been found to suppress TLR4-induced transcription potently by preventing the NCoR clearance step(5-7), but the underlying mechanisms remain enigmatic. Here we provide evidence that coronin 2A (CORO2A), a component of the NCoR complex of previously unknown function(8,9), mediates TLR-induced NCoR turnover by a mechanism involving interaction with oligomeric nuclear actin. SUMOylated LXRs block NCoR turnover by binding to a conserved SUMO2/SUMO3-interaction motif in CORO2A and preventing actin recruitment. Intriguingly, the LXR transrepression pathway can itself be inactivated by inflammatory signals that induce calcium/calmodulin-dependent protein kinase II gamma (CaMKII gamma)-dependent phosphorylation of LXRs, leading to their deSUMOylation by the SUMO protease SENP3 and release from CORO2A. These findings uncover a CORO2A-actin-dependent mechanism for the de-repression of inflammatory response genes that can be differentially regulated by phosphorylation and by nuclear receptor signalling pathways that control immunity and homeostasis.	[Huang, Wendy; Ghisletti, Serena; Saijo, Kaoru; Zhang, Dawn X.; Yao, Joyee; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Huang, Wendy; Zhang, Dawn X.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Gandhi, Meghal; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA; [Aouadi, Myriam; Tesz, Greg J.; Czech, Michael P.] Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Czech, Michael P.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Brandeis University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Ghisletti, Serena/AAO-6437-2021; Huang, Wendy Jia Men/AAF-2030-2021; Glass, Christopher/AAI-3933-2021	Huang, Wendy Jia Men/0000-0001-7425-8280; Glass, Christopher/0000-0003-4344-3592; Ghisletti, Serena/0000-0002-7087-5553	NRSA [1F31DK083913]; National Institutes of Health [CA52599, DK074868, HC088093, DK085853]; Leducq Foundation Transatlantic Network; NATIONAL CANCER INSTITUTE [R01CA052599, R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445, P50HL056989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R37DK039949, F31DK083913, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation Transatlantic Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Amano for preparation of GeRP delivery spheres. We thank L. Bautista for assistance with preparation of the manuscript. W.H. was supported by NRSA 1F31DK083913. These studies were supported by National Institutes of Health grants CA52599, DK074868, HC088093 and DK085853 and a Leducq Foundation Transatlantic Network Grant. M.G.R. is an investigator of the Howard Hughes Medical Institute.	Amarzguioui M, 2006, CLIN CANCER RES, V12, P4055, DOI 10.1158/1078-0432.CCR-05-2482; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blaschke F, 2006, CIRC RES, V99, pE88, DOI 10.1161/01.RES.0000252878.34269.06; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gandhi M, 2010, J BIOL CHEM, V285, P34899, DOI 10.1074/jbc.M110.171496; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Gonsior SM, 1999, J CELL SCI, V112, P797; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120	30	119	126	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					414	U25		10.1038/nature09703	http://dx.doi.org/10.1038/nature09703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331046	Green Accepted			2022-12-01	WOS:000287409100046
J	Pogach, L; Aron, DC				Pogach, Leonard; Aron, David C.			Sudden Acceleration of Diabetes Quality Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MELLITUS		[Aron, David C.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Educ Off 14W, Cleveland, OH 44106 USA; [Pogach, Leonard] Vet Affairs New Jersey Healthcare Syst, E Orange, NJ USA; [Pogach, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ USA; [Aron, David C.] Case Western Reserve Univ, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Case Western Reserve University	Aron, DC (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Educ Off 14W, 10701 E Blvd, Cleveland, OH 44106 USA.	david.aron@va.gov						Kerr EA, 2008, ASSESSING QUALITY CA; [Anonymous], 2010, AL FORC MINN COMM SN; Aron D, 2009, JAMA-J AM MED ASSOC, V301, P210, DOI 10.1001/jama.2008.930; Bridges to Excellence (BTE), 2010, BRIDG EXC BTE; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DeBord M, 2010, NY TIMES        0205; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Pogach L, 2007, JAMA-J AM MED ASSOC, V297, P520, DOI 10.1001/jama.297.5.520	8	32	33	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					709	710		10.1001/jama.2011.153	http://dx.doi.org/10.1001/jama.2011.153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325188				2022-12-01	WOS:000287361100023
J	Martyn, C				Martyn, Christopher			Out of Hours Lactation wars	BRITISH MEDICAL JOURNAL			English	Editorial Material												cmartyn@bmj.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2011	342								d835	10.1136/bmj.d835	http://dx.doi.org/10.1136/bmj.d835			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307115				2022-12-01	WOS:000287402900008
J	Weatherall, DJ				Weatherall, David J.			Systems Biology and Red Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weatherall, David J.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Weatherall, David J.] John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Weatherall, DJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.							Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; HORGAN J, 1996, END SCI LIMITS KNOWL; Ntaios G, 2007, ANN HEMATOL, V86, P487, DOI 10.1007/s00277-007-0302-x; WEATHERALL DJ, 2001, THALASSAEMIA SYNDROM, P345	5	14	14	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					376	377		10.1056/NEJMcibr1012683	http://dx.doi.org/10.1056/NEJMcibr1012683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268732				2022-12-01	WOS:000286592600016
J	Schrag, SJ				Schrag, Stephanie J.		Global Grp B Streptococcal Vaccine	Group B streptococcal vaccine for resource-poor countries	LANCET			English	Editorial Material							CONJUGATE VACCINE; DISEASE; MORTALITY; INFANTS		[Schrag, Stephanie J.; Global Grp B Streptococcal Vaccine] Ctr Dis Control & Prevent CDC, Div Bacterial Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Schrag, SJ (corresponding author), Ctr Dis Control & Prevent CDC, Div Bacterial Dis, Atlanta, GA 30333 USA.	sschrag@cdc.gov						Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; DEVANI, 2010, VACC NEON INF DES VA; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Hillier S, 2009, INFECT DIS SOC AM, P186; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Lee CH, 2009, VACCINE, V27, P726, DOI 10.1016/j.vaccine.2008.11.065; Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Moore MR, 2003, LANCET INFECT DIS, V3, P201, DOI 10.1016/S1473-3099(03)00577-2; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Saleem S, 2010, OBSTET GYNECOL, V115, P1225, DOI 10.1097/AOG.0b013e3181e00ff0	14	12	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					11	12		10.1016/S0140-6736(10)61932-0	http://dx.doi.org/10.1016/S0140-6736(10)61932-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791IU	21377722				2022-12-01	WOS:000292659700008
J	Beaglehole, R; Bonita, R; Horton, R; Adams, C; Alleyne, G; Asaria, P; Baugh, V; Bekedam, H; Billo, N; Casswell, S; Cecchini, M; Colagiuri, R; Colagiuri, S; Collins, T; Ebrahim, S; Engelgau, M; Galea, G; Gaziano, T; Geneau, R; Haines, A; Hospedales, J; Jha, P; Keeling, A; Leeder, S; Lincoln, P; McKee, M; Mackay, J; Magnusson, R; Moodie, R; Mwatsama, M; Nishtar, S; Norrving, B; Patterson, D; Piot, P; Ralston, J; Rani, M; Reddy, KS; Sassi, F; Sheron, N; Stuckler, D; Suh, I; Torode, J; Varghese, C; Watt, J				Beaglehole, Robert; Bonita, Ruth; Horton, Richard; Adams, Cary; Alleyne, George; Asaria, Perviz; Baugh, Vanessa; Bekedam, Henk; Billo, Nils; Casswell, Sally; Cecchini, Michele; Colagiuri, Ruth; Colagiuri, Stephen; Collins, Tea; Ebrahim, Shah; Engelgau, Michael; Galea, Gauden; Gaziano, Thomas; Geneau, Robert; Haines, Andy; Hospedales, James; Jha, Prabhat; Keeling, Ann; Leeder, Stephen; Lincoln, Paul; McKee, Martin; Mackay, Judith; Magnusson, Roger; Moodie, Rob; Mwatsama, Modi; Nishtar, Sonia; Norrving, Bo; Patterson, David; Piot, Peter; Ralston, Johanna; Rani, Manju; Reddy, K. Srinath; Sassi, Franco; Sheron, Nick; Stuckler, David; Suh, Il; Torode, Julie; Varghese, Cherian; Watt, Judith		Lancet NCD Action Grp; NCD Alliance	Priority actions for the non-communicable disease crisis	LANCET			English	Article							PREVENTING CHRONIC DISEASES; MIDDLE-INCOME COUNTRIES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEALTH-BENEFITS; CLIMATE-CHANGE; GLOBAL BURDEN; RISK-FACTORS; ALCOHOL; SMOKING	The UN High-Level Meeting on Non-Communicable Diseases (NCDs) in September, 2011, is an unprecedented opportunity to create a sustained global movement against premature death and preventable morbidity and disability from NCDs, mainly heart disease, stroke, cancer, diabetes, and chronic respiratory disease. The increasing global crisis in NCDs is a barrier to development goals including poverty reduction, health equity, economic stability, and human security. The Lancet NCD Action Group and the NCD Alliance propose five overarching priority actions for the response to the crisis leadership, prevention, treatment, international cooperation, and monitoring and accountability and the delivery of five priority interventions tobacco control, salt reduction, improved diets and physical activity, reduction in hazardous alcohol intake, and essential drugs and technologies. The priority interventions were chosen for their health effects, cost-effectiveness, low costs of implementation, and political and financial feasibility. The most urgent and immediate priority is tobacco control. We propose as a goal for 2040, a world essentially free from tobacco where less than 5% of people use tobacco. Implementation of the priority interventions, at an estimated global commitment of about US$9 billion per year, will bring enormous benefits to social and economic development and to the health sector. If widely adopted, these interventions will achieve the global goal of reducing NCD death rates by 2% per year, averting tens of millions of premature deaths in this decade.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Horton, Richard] The Lancet, London, England; [Adams, Cary; Torode, Julie] NCD Alliance Union Int Canc Control, Geneva, Switzerland; [Alleyne, George; Hospedales, James] Pan Amer Hlth Org, Washington, DC USA; [Asaria, Perviz] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Baugh, Vanessa] Commonwealth Secretariat, London, England; [Bekedam, Henk; Rani, Manju; Varghese, Cherian] WHO Western Pacific Reg Off, Manila, Philippines; [Billo, Nils] NCD Alliance Int Union Against TB & Lung Dis, Paris, France; [Casswell, Sally] Massey Univ, Auckland, New Zealand; [Cecchini, Michele; Sassi, Franco] Org Econ Cooperat & Dev, Hlth Div, Paris, France; [Collins, Tea] NCD Alliance, Geneva, Switzerland; [Ebrahim, Shah] S Asia Network Chron Dis, New Delhi, India; [Engelgau, Michael] World Bank, Washington, DC 20433 USA; [Galea, Gauden] WHO European Reg Off, Copenhagen, Denmark; [Gaziano, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Geneau, Robert] Univ Ottawa, Ottawa, ON, Canada; [Haines, Andy; McKee, Martin; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Jha, Prabhat] Ctr Global Hlth Res, Toronto, ON, Canada; [Colagiuri, Ruth; Colagiuri, Stephen; Keeling, Ann] NCD Alliance Int Diabet Federat, Brussels, Belgium; [Leeder, Stephen; Magnusson, Roger] Univ Sydney, Sydney, NSW 2006, Australia; [Lincoln, Paul; Mwatsama, Modi] Natl Heart Forum, London, England; [Mackay, Judith] World Lung Fdn, Hong Kong, Hong Kong, Peoples R China; [Moodie, Rob] Univ Melbourne, Melbourne, Vic, Australia; [Nishtar, Sonia] HeartFile, Islamabad, Pakistan; [Norrving, Bo] World Stroke Org, Geneva, Switzerland; [Patterson, David] Int Dev Law Org, Rome, Italy; [Ralston, Johanna] NCD Alliance World Heart Federat, Geneva, Switzerland; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Sheron, Nick] Univ Southampton, Southampton, Hants, England; [Stuckler, David] Harvard Univ, Boston, MA USA; [Suh, Il] Yonsei Univ, Coll Med, Seoul, South Korea	University of Auckland; Pan American Health Organization; Imperial College London; WHO Western Pacific Regional Office; Massey University; Organisation for Economic Co-operation & Development (OECD); The World Bank; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Ottawa; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Melbourne; Public Health Foundation of India; University of Southampton; Harvard University; Yonsei University; Yonsei University Health System	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz	Stuckler, David/H-2261-2012; Galea, Gauden/AAV-4335-2021; McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	Galea, Gauden/0000-0002-2257-6014; McKee, Marc D/0000-0001-8349-965X; Reddy, K Srinath/0000-0003-3416-3548; Stuckler, David/0000-0002-1288-8401; Sheron, Nick/0000-0002-6156-8367; Billo, Nils Eric/0000-0002-5735-5107; McKee, Martin/0000-0002-0121-9683; Geneau, Robert/0000-0001-6180-2515; Haines, Andy/0000-0002-8053-4605; Sheron, Nick/0000-0001-5232-8292; Norrving, Bo/0000-0002-8024-5096; Casswell, Sally/0000-0002-2211-7096; Sassi, Franco/0000-0001-9773-2117; Suh, Il/0000-0002-9689-7849; Asaria, Perviz/0000-0002-9037-0894; Colagiuri, Stephen/0000-0002-2398-4781; Moodie, Alan/0000-0002-8425-7975	Wellcome Trust; Family Health International; 19 Inter-American Development Bank; Bayer; Allergan; Syngis; Servier; 22 Photothera; Boehringer-Ingelheim; Pfizer; Wiley; Sanofi-Aventis; Varian Medical Systems; Roche; Boehringer Ingelheim; Novartis; Slender; 23 Merck; Eli Lilly; Heng Rui; Irmet; National Heart Forum	Wellcome Trust(Wellcome TrustEuropean Commission); Family Health International; 19 Inter-American Development Bank; Bayer(Bayer AG); Allergan(AbbVieAllergan); Syngis; Servier(Servier); 22 Photothera; Boehringer-Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Wiley; Sanofi-Aventis(Sanofi-Aventis); Varian Medical Systems; Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Slender; 23 Merck; Eli Lilly(Eli Lilly); Heng Rui; Irmet; National Heart Forum	PA has received grants from Wellcome Trust Clinical PhD Fellowship. SE has received grants from the Wellcome Trust, and royalties from 18 McGraw Hill for editing a book. RI-I is the editor of The Lancet. TG has received consultancy payments from Family Health International and 19 Inter-American Development Bank; and payment for lectures, including lectures on speakers bureaus, from Network for Continuing Medical 20 Education. BN has received consultancy payments from Bayer, payment for lectures including service on speakers bureaus from Allergan, and 21 royalties for a book published by Karolinska University Press. BN's institute has received money for consultancy from Syngis, Servier, Bayer, 22 Photothera, and Boehringer-Ingelheim. JT has received or has grants pending from Corporate Partners, Pfizer, Wiley, Sanofi-Aventis, Varian Medical Systems, Roche, Boehringer Ingelheim, Novartis, Slender, 23 Merck, Eli Lilly, Heng Rui, and Irmet. The other authors declare that they have no conflicts of interest.; We thank the National Heart Forum for providing financial, technical, and administrative support for the production of this report. The authors alone are responsible for the views expressed in this report and they do not necessarily represent the decisions, policy, or views of WHO, the World Bank, the OECD, or those of the member countries of these organisations.	Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], 2008, ACT PLAN GLOB STRAT; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2010, LANCET, V376, P1619, DOI 10.1016/S0140-6736(10)61929-0; Beaglehole R, 2009, LANCET, V373, P2173, DOI 10.1016/S0140-6736(09)61168-5; Bhutta Z, 2011, LANCET, V377, P969, DOI 10.1016/S0140-6736(11)60169-4; Callaway M, 2007, J PAIN SYMPTOM MANAG, V33, P509, DOI 10.1016/j.jpainsymman.2007.02.003; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Casswell S, 2011, ADDICTION, V106, P1087, DOI 10.1111/j.1360-0443.2011.03361.x; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; ENGELAU MM, CAPITALIZING DEMOGRA; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; FIDLER DP, 2008, REVOLUTION GLOBAL HL; Freeman B, 2010, TOB CONTROL, V19, pE1, DOI 10.1136/tc.2009.032847; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; GLUCKMAN P, 2006, WHY OUR WORLD NO LON; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; HOSPEDALES CJ, PAN AM J PU IN PRESS; Institute of Medicine, 2010, PROM CARD HLTH DEV W; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jha P, 1999, CURBING EPIDEMIC GOV; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Knai C, 2010, LANCET, V376, P75, DOI 10.1016/S0140-6736(09)62063-8; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lindholm LH, 2007, LANCET, V370, P720, DOI 10.1016/S0140-6736(07)61356-7; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Magnusson RS, 2009, PUBLIC HEALTH, V123, P265, DOI 10.1016/j.puhe.2008.12.023; Mahal A., 2010, HLTH NUTR POPUL SER; MALONE R, 2010, BOTTOM LINE PUBLIC H; New Zealand Government, GOV RESP REP MAOR AF; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Piot Peter, 2010, BMJ, V341, pc4865, DOI 10.1136/bmj.c4865; Rayner G, 2006, HEALTH PROMOT INT, V21, P67, DOI 10.1093/heapro/dal053; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; *RGI CGHR, 2009, CAUS DEATH IND 2001; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; SRIDHAR D, 2011, GETTING POLITICS RIG; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Stuckler D, 2010, POLITICAL EC UNIVERS; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UN, 2010, PREV CONTR NONC DIS; *UN, 2008, COMPR FRAM ACT HIGH; *UN FRAM CONV CLIM, 2009, C PART 15 SESS COP A; Verkaik-Kloosterman J, 2010, BRIT J NUTR, V104, P1712, DOI 10.1017/S0007114510002722; WHO, 2010, WOR HEALT REP, P1; *WHO, 2004, TOB POV VIC CYCL; WHO, 2008, COMM SOC DET HLTH; World Economic Forum, 2011, GLOB RISKS 2011; World Health Organization, 2007, PREVENTION CARDIOVAS; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 2005, PREVENTING CHRONIC D; World health organization, RISK FACT EST 2004; World Health Organization, 2009, MORT BURD DIS EST WH, P2009; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization (WHO), STEPWISE APPR SURV S; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Younger M, 2008, AM J PREV MED, V35, P517, DOI 10.1016/j.amepre.2008.08.017; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; 2011, LANCET, V377, P783	84	1091	1129	8	359	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1438	1447		10.1016/S0140-6736(11)60393-0	http://dx.doi.org/10.1016/S0140-6736(11)60393-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21474174				2022-12-01	WOS:000289963000033
J	Mozaffarian, D; Shi, PL; Morris, JS; Spiegelman, D; Grandjean, P; Siscovick, DS; Willett, WC; Rimm, EB				Mozaffarian, Dariush; Shi, Peilin; Morris, J. Steven; Spiegelman, Donna; Grandjean, Philippe; Siscovick, David S.; Willett, Walter C.; Rimm, Eric B.			Mercury Exposure and Risk of Cardiovascular Disease in Two U.S. Cohorts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; FOOD FREQUENCY QUESTIONNAIRE; POLYUNSATURATED FATTY-ACIDS; MYOCARDIAL-INFARCTION; FISH INTAKE; SELENIUM INTAKE; SERUM SELENIUM; DIETARY-INTAKE; WHOLE-BLOOD; WOMEN	BACKGROUND Exposure to methylmercury from fish consumption has been linked to a potentially increased risk of cardiovascular disease, but evidence from prior studies is equivocal. Beneficial effects of the ingestion of fish and selenium may also modify such effects. METHODS Among subjects from two U. S. cohorts (a total of 51,529 men and 121,700 women) whose toenail clippings had been stored, we prospectively identified incident cases of cardiovascular disease (coronary heart disease and stroke) in 3427 participants and matched them to risk-set-sampled controls according to age, sex, race, and smoking status. Toenail mercury and selenium concentrations were assessed with the use of neutron-activation analysis. Other demographic characteristics, cardiovascular risk factors, fish consumption, and lifestyle habits were assessed by means of validated questionnaires. Associations between mercury exposure and incident cardiovascular disease were evaluated with the use of conditional logistic regression. RESULTS Median toenail mercury concentrations were 0.23 mu g per gram (interdecile range, 0.06 to 0.94) in the case participants and 0.25 mu g per gram (interdecile range, 0.07 to 0.97) in the controls. In multivariate analyses, participants with higher mercury exposures did not have a higher risk of cardiovascular disease. For comparisons of the fifth quintile of mercury exposure with the first quintile, the relative risks were as follows: coronary heart disease, 0.85 (95% confidence interval [CI], 0.69 to 1.04; P = 0.10 for trend); stroke, 0.84 (95% CI, 0.62 to 1.14; P = 0.27 for trend); and total cardiovascular disease, 0.85 (95% CI, 0.72 to 1.01; P = 0.06 for trend). Findings were similar in analyses of participants with low selenium concentrations or low overall fish consumption and in several additional sensitivity analyses. CONCLUSIONS We found no evidence of any clinically relevant adverse effects of mercury exposure on coronary heart disease, stroke, or total cardiovascular disease in U. S. adults at the exposure levels seen in this study.	[Mozaffarian, Dariush] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush; Willett, Walter C.; Rimm, Eric B.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Mozaffarian, Dariush; Shi, Peilin; Spiegelman, Donna; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mozaffarian, Dariush; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Grandjean, Philippe] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Morris, J. Steven] Univ Missouri, Columbia, MO 65211 USA; [Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Missouri System; University of Missouri Columbia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008; Grandjean, Philippe/I-2962-2014	Grandjean, Philippe/0000-0003-4046-9658	National Institute of Environmental Health Sciences [R01-ES014433, ES013692]; National Heart, Lung, and Blood Institute [HL34594, HL088521, HL35464]; National Cancer Institute [CA87969, CA55075]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA055075, P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464, R01HL034594, R01HL088521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013692, R01ES014433] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by grants from the National Institute of Environmental Health Sciences (R01-ES014433 and ES013692), the National Heart, Lung, and Blood Institute (HL34594, HL088521, and HL35464), and the National Cancer Institute (CA87969 and CA55075).; Funded by the National Institutes of Health.	Ahlqwist M, 1999, ACTA ODONTOL SCAND, V57, P168; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 2010, JOINT FAO WHO EXP CO; Bleys J, 2009, AM J EPIDEMIOL, V169, P996, DOI 10.1093/aje/kwn414; Chan HM, 2004, NUTR REV, V62, P68, DOI 10.1301/nr.2004.janr.68-72; Choi AL, 2009, ENVIRON HEALTH PERSP, V117, P367, DOI 10.1289/ehp.11608; *EPA, 1997, MERC STUD REP C; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fillion Myriam, 2006, Environ Health, V5, P29, DOI 10.1186/1476-069X-5-29; GARLAND M, 1993, CANCER EPIDEM BIOMAR, V2, P493; Ghilarducci Teresa, 2004, WHAT YOU NEED KNOW E; Groth E, 2010, ENVIRON RES, V110, P226, DOI 10.1016/j.envres.2009.12.006; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hallgren CG, 2001, BRIT J NUTR, V86, P397, DOI 10.1079/BJN2001415; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Joshi A, 2003, J PUBLIC HEALTH DENT, V63, P52, DOI 10.1111/j.1752-7325.2003.tb03474.x; Konig A, 2005, AM J PREV MED, V29, P335, DOI 10.1016/j.amepre.2005.07.001; Lim S, 2010, NEUROTOXICOLOGY, V31, P10, DOI 10.1016/j.neuro.2009.10.001; Longnecker MP, 1996, EPIDEMIOLOGY, V7, P384, DOI 10.1097/00001648-199607000-00008; LONGNECKER MP, 1993, AM J CLIN NUTR, V57, P408, DOI 10.1093/ajcn/57.3.408; MacIntosh DL, 1997, CANCER EPIDEM BIOMAR, V6, P1043; Mason MM, 1998, J RADIOANAL NUCL CH, V236, P29, DOI 10.1007/BF02386313; McDowell MA, 2004, ENVIRON HEALTH PERSP, V112, P1165, DOI 10.1289/ehp.7046; Morton J, 2004, BIOMARKERS, V9, P47, DOI 10.1080/13547500410001670312; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2009, INT J ENV RES PUB HE, V6, P1894, DOI 10.3390/ijerph6061894; Ohno T, 2007, ENVIRON RES, V103, P191, DOI 10.1016/j.envres.2006.06.009; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schafer J. L., 1997, ANAL INCOMPLETE MULT, DOI [10.1201/9781439821862, DOI 10.1201/]; Suzuki T, 1989, Sangyo Igaku, V31, P235; VARO P, 1988, AM J CLIN NUTR, V48, P324, DOI 10.1093/ajcn/48.2.324; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; Walker A E, 1981, Stroke, V12, pI13; Wennberg M, 2007, BRIT J NUTR, V98, P1038, DOI 10.1017/S0007114507756519; Yaginuma-Sakurai K, 2010, NEUROTOXICOL TERATOL, V32, P240, DOI 10.1016/j.ntt.2009.08.009; Yorifuji T, 2010, ENVIRON RES, V110, P40, DOI 10.1016/j.envres.2009.10.011; Yoshizawa K, 2002, NEW ENGL J MED, V347, P1755, DOI 10.1056/NEJMoa021437; [No title captured]	43	130	132	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1116	1125		10.1056/NEJMoa1006876	http://dx.doi.org/10.1056/NEJMoa1006876			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428767	Green Accepted, Green Published			2022-12-01	WOS:000288701100006
J	Hughes, JM				Hughes, James M.			Preserving the Lifesaving Power of Antimicrobial Agents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTIOUS-DISEASES SOCIETY; AMERICA		[Hughes, James M.] Infect Dis Soc Amer, Arlington, VA USA; [Hughes, James M.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Hughes, James M.] Emory Univ, Hubert Dept Global Hlth, Sch Med, Atlanta, GA 30322 USA; [Hughes, James M.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Rollins School Public Health	Hughes, JM (corresponding author), Emory Univ, Dept Med, 1462 Clifton Rd,Ste 446 Mailstop 1370-004-1AD, Atlanta, GA 30322 USA.	jmhughe@emory.edu						Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Garcia MS, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI 10.1001/jama.2010.757; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891	7	71	72	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1027	1028		10.1001/jama.2011.279	http://dx.doi.org/10.1001/jama.2011.279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21343545				2022-12-01	WOS:000288129600022
J	Shema, R; Haramati, S; Ron, S; Hazvi, S; Chen, A; Sacktor, TC; Dudai, Y				Shema, Reut; Haramati, Sharon; Ron, Shiri; Hazvi, Shoshi; Chen, Alon; Sacktor, Todd Charlton; Dudai, Yadin			Enhancement of Consolidated Long-Term Memory by Overexpression of Protein Kinase M zeta in the Neocortex	SCIENCE			English	Article							PKM-ZETA; FACILITATION; MAINTENANCE; POTENTIATION; STORAGE; CORTEX; LTP	Memories are more easily disrupted than improved. Many agents can impair memories during encoding and consolidation. In contrast, the armamentarium of potential memory enhancers is so far rather modest. Moreover, the effect of the latter appears to be limited to enhancing new memories during encoding and the initial period of cellular consolidation, which can last from a few minutes to hours after learning. Here, we report that overexpression in the rat neocortex of the protein kinase C isozyme protein kinase M zeta (PKM zeta) enhances long-term memory, whereas a dominant negative PKM zeta disrupts memory, even long after memory has been formed.	[Shema, Reut; Haramati, Sharon; Ron, Shiri; Hazvi, Shoshi; Chen, Alon; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Pharmacol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA	Weizmann Institute of Science; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	yadin.dudai@weizmann.ac.il		Haramati, Sharon/0000-0002-7496-5214; Chen, Alon/0000-0003-3625-8233	Israel-U.S. Binational Science Foundation; Nella and Leon Benoziyo Center for Neurologica Diseases; NIH [R01 MH53576, MH57068]; Israeli Academy of Sciences and Humanities; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057068, R01MH057068, R01MH053576] Funding Source: NIH RePORTER	Israel-U.S. Binational Science Foundation(US-Israel Binational Science Foundation); Nella and Leon Benoziyo Center for Neurologica Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Academy of Sciences and Humanities; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The support of the Israel-U.S. Binational Science Foundation (Y.D and T.C.S), the Nella and Leon Benoziyo Center for Neurologica Diseases (Y.D.), and of NIH R01 MH53576 and MH57068 (T.C.S.) is gratefully acknowledged. R.S. is supported by the Adams Fellowship program of the Israeli Academy of Sciences and Humanities. We thank R. Eilam for providing invaluable assistance in histochemistry.	[Anonymous], 1983, CANADIAN PSYCHOL; Aydin A, 1997, ANIM LEARN BEHAV, V25, P108, DOI 10.3758/BF03199029; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y., 2002, MEMORY KEYWORDS CONC; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GIURGEA C, 1973, Conditional Reflex, V8, P108; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; STERNBERG DB, 1985, BEHAV NEURAL BIOL, V44, P447, DOI 10.1016/S0163-1047(85)90856-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935	24	139	151	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1207	1210		10.1126/science.1200215	http://dx.doi.org/10.1126/science.1200215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385716				2022-12-01	WOS:000287971200046
J	Inuzuka, H; Shaik, S; Onoyama, I; Gao, DM; Tseng, A; Maser, RS; Zhai, B; Wan, LX; Gutierrez, A; Lau, AW; Xiao, YH; Christie, AL; Aster, J; Settleman, J; Gygi, SP; Kung, AL; Look, T; Nakayama, KI; DePinho, RA; Wei, WY				Inuzuka, Hiroyuki; Shaik, Shavali; Onoyama, Ichiro; Gao, Daming; Tseng, Alan; Maser, Richard S.; Zhai, Bo; Wan, Lixin; Gutierrez, Alejandro; Lau, Alan W.; Xiao, Yonghong; Christie, Amanda L.; Aster, Jon; Settleman, Jeffrey; Gygi, Steven P.; Kung, Andrew L.; Look, Thomas; Nakayama, Keiichi I.; DePinho, Ronald A.; Wei, Wenyi			SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction	NATURE			English	Article							FBW7 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; PHOSPHORYLATION; DEGRADATION; DIFFERENTIATION; COMPLEX; CANCERS; PROTEIN	The effective use of targeted therapy is highly dependent on the identification of responder patient populations. Loss of FBW7, which encodes a tumour-suppressor protein, is frequently found in various types of human cancer, including breast cancer, colon cancer(1) and T-cell acute lymphoblastic leukaemia (T-ALL)(2). In line with these genomic data, engineered deletion of Fbw7 in mouse T cells results in T-ALL(3-5), validating FBW7 as a T-ALL tumour suppressor. Determining the precise molecular mechanisms by which FBW7 exerts antitumour activity is an area of intensive investigation. These mechanisms are thought to relate in part to FBW7-mediated destruction of key proteins relevant to cancer, including Jun(6), Myc(7), cyclin E-8 and notch 1 (ref. 9), all of which have oncoprotein activity and are overexpressed in various human cancers, including leukaemia. In addition to accelerating cell growth(10), overexpression of Jun, Myc or notch 1 can also induce programmed cell death(11). Thus, considerable uncertainty surrounds how FBW7-deficient cells evade cell death in the setting of upregulated Jun, Myc and/or notch 1. Here we show that the E3 ubiquitin ligase SCFFBW7 (a SKP1-cullin-1-F-box complex that contains FBW7 as the F-box protein) governs cellular apoptosis by targeting MCL1, a pro-survival BCL2 family member, for ubiquitylation and destruction in a manner that depends on phosphorylation by glycogen synthase kinase 3. Human T-ALL cell lines showed a close relationship between FBW7 loss and MCL1 overexpression. Correspondingly, T-ALL cell lines with defective FBW7 are particularly sensitive to the multi-kinase inhibitor sorafenib but resistant to the BCL2 antagonist ABT-737. On the genetic level, FBW7 reconstitution or MCL1 depletion restores sensitivity to ABT-737, establishing MCL1 as a therapeutically relevant bypass survival mechanism that enables FBW7-deficient cells to evade apoptosis. Therefore, our work provides insight into the molecular mechanism of direct tumour suppression by FBW7 and has implications for the targeted treatment of patients with FBW7-deficient T-ALL.	[Inuzuka, Hiroyuki; Shaik, Shavali; Gao, Daming; Tseng, Alan; Wan, Lixin; Lau, Alan W.; Wei, Wenyi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Onoyama, Ichiro; Nakayama, Keiichi I.] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Maser, Richard S.; Xiao, Yonghong; DePinho, Ronald A.] Harvard Univ, Belfer Inst Appl Canc Sci, Dana Farber Canc Inst, Dept Med Oncol,Sch Med, Boston, MA 02115 USA; [Maser, Richard S.] Jackson Lab, Bar Harbor, ME 04609 USA; [Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gutierrez, Alejandro; Christie, Amanda L.; Kung, Andrew L.; Look, Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Christie, Amanda L.; Kung, Andrew L.] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Aster, Jon] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Settleman, Jeffrey] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc,Dept Med, Boston, MA 02129 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Jackson Laboratory; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wei, WY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Wan, Lixin/F-2124-2011; Maser, Richard/B-2970-2012; Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022	Kung, Andrew L/0000-0002-9091-488X; Gutierrez, Alejandro/0000-0002-0249-9007; DePinho, Ronald/0000-0002-5625-577X; Gao, Daming/0000-0003-4374-1055	Emerald Foundation; Leukemia and Lymphoma Society; National Institutes of Health [GM089763]; Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089763] Funding Source: NIH RePORTER	Emerald Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lawler, C. Schorl, Q. Zhang and S. Glueck for critical reading of the manuscript, J. DeCaprio, M.-C. Hung, M. A. Kelliher, W. Harper and W. Hahn for providing reagents, L. Cantley and A. Toker for suggestions, I. Wertz and V. Dixit for sharing unpublished data, and members of the Wei and DePinho labs for useful discussions. W.W. is a Kimmel Scholar and V Scholar. This work was supported in part by the Emerald Foundation New Investigator award (W.W.), the Leukemia and Lymphoma Society Special Fellow award (W.W.) and a grant from the National Institutes of Health (W.W.; GM089763). R.A.D. is an American Cancer Society Research Professor and is supported by the Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science.	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Panka DJ, 2008, J BIOL CHEM, V283, P726, DOI 10.1074/jbc.M705343200; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Sanchez I, 2001, NEURON, V29, P563, DOI 10.1016/S0896-6273(01)00232-X; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	29	480	498	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					104	U128		10.1038/nature09732	http://dx.doi.org/10.1038/nature09732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368833	Green Accepted			2022-12-01	WOS:000287924100043
J	Robert, T; Vanoli, F; Chiolo, I; Shubassi, G; Bernstein, KA; Rothstein, R; Botrugno, OA; Parazzoli, D; Oldani, A; Minucci, S; Foiani, M				Robert, Thomas; Vanoli, Fabio; Chiolo, Irene; Shubassi, Ghadeer; Bernstein, Kara A.; Rothstein, Rodney; Botrugno, Oronza A.; Parazzoli, Dario; Oldani, Amanda; Minucci, Saverio; Foiani, Marco			HDACs link the DNA damage response, processing of double-strand breaks and autophagy	NATURE			English	Article							VALPROIC ACID; END RESECTION; CHECKPOINT; ACETYLATION; ACTIVATION; YEAST; SAE2; HELICASE; SGS1; SRS2	Protein acetylation is mediated by histone acetyltransferases (HATs) and deacetylases (HDACs), which influence chromatin dynamics, protein turnover and the DNA damage response. ATM and ATR mediate DNA damage checkpoints by sensing double-strand breaks and single-strand-DNA-RFA nucleofilaments, respectively. However, it is unclear how acetylation modulates the DNA damage response. Here we show that HDAC inhibition/ablation specifically counteracts yeast Mec1 (orthologue of human ATR) activation, double-strand-break processing and single-strand-DNA-RFA nucleofilament formation. Moreover, the recombination protein Sae2 (human CtIP) is acetylated and degraded after HDAC inhibition. Two HDACs, Hda1 and Rpd3, and one HAT, Gcn5, have key roles in these processes. We also find that HDAC inhibition triggers Sae2 degradation by promoting autophagy that affects the DNA damage sensitivity of hda1 and rpd3 mutants. Rapamycin, which stimulates autophagy by inhibiting Tor, also causes Sae2 degradation. We propose that Rpd3, Hda1 and Gcn5 control chromosome stability by coordinating the ATR checkpoint and double-strand-break processing with autophagy.	[Robert, Thomas; Vanoli, Fabio; Chiolo, Irene; Shubassi, Ghadeer; Foiani, Marco] Fdn IFOM, I-20139 Milan, Italy; [Chiolo, Irene] LBNL, Dept Genome Biol, Berkeley, CA 94710 USA; [Bernstein, Kara A.; Rothstein, Rodney] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA; [Botrugno, Oronza A.; Minucci, Saverio] European Inst Oncol, I-20139 Milan, Italy; [Parazzoli, Dario; Oldani, Amanda] Cogentech, I-20139 Milan, Italy; [Minucci, Saverio; Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Columbia University; IRCCS European Institute of Oncology (IEO); University of Milan	Foiani, M (corresponding author), Fdn IFOM, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	saverio.minucci@ifom-ieo-campus.it; marco.foiani@ifom-ieo-campus.it	Minucci, Saverio/J-9669-2012; Botrugno, Oronza Antonietta/P-2065-2017; Foiani, Marco/M-8234-2014; Bernstein, Kara A/S-4943-2016; Bernstein, Kara/AAK-9958-2021	Botrugno, Oronza Antonietta/0000-0002-2568-9815; Foiani, Marco/0000-0003-4795-834X; Bernstein, Kara A/0000-0003-2247-6459; Bernstein, Kara/0000-0003-2247-6459; Chiolo, Irene/0000-0002-3080-550X; Rothstein, Rodney/0000-0002-4107-9654; Robert, Thomas/0000-0002-2458-7454	Italian Association for Cancer Research; Telethon; European Community (GENICA); Italian Ministry of Health; FRM; EMBO; HFSP; FIRC;  [GM50237];  [GM67055];  [GM088413]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050237, R00GM088413, R01GM067055, R01GM050237, K99GM088413] Funding Source: NIH RePORTER	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); European Community (GENICA)(European Commission); Italian Ministry of Health(Ministry of Health, Italy); FRM(Fondation pour la Recherche Medicale); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); FIRC(Fondazione AIRC per la ricerca sul cancro); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Piatti, M. P. Longhese, M. Grunstein, J. K. Tyler, A. Pellicioli, M. Costanzo, R. Brost, M. Vogelauer, D. Klionsky, T. Roberts and C. Bertoli for reagents and technical suggestions, J. Barlow for DNA damage foci analysis, A. Sartori and S. Ferrari for communicating unpublished results, C. Lucca, D. Branzei, R. Bermejo and the members of our laboratories for comments. Work in M. F. laboratory was supported by grants from the Italian Association for Cancer Research and partially from Telethon, European Community (GENICA) and the Italian Ministry of Health. T. R. was supported by fellowships from FRM and EMBO and I.C. was supported by a short fellowship from HFSP and from FIRC. This work was also supported by GM50237 (to R.R.), GM67055 (to R.R.) and GM088413 (to K.B.).	Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Fu J, 2010, NEURO-ONCOLOGY, V12, P328, DOI 10.1093/neuonc/nop005; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Neecke H, 1999, EMBO J, V18, P4485, DOI 10.1093/emboj/18.16.4485; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Robert T, 2006, EMBO J, V25, P2837, DOI 10.1038/sj.emboj.7601158; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shintani T, 2008, METHOD ENZYMOL, V451, P43, DOI 10.1016/S0076-6879(08)03204-7; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	47	300	311	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					74	79		10.1038/nature09803	http://dx.doi.org/10.1038/nature09803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368826	Green Accepted			2022-12-01	WOS:000287924100036
J	Kamiya, D; Banno, S; Sasai, N; Ohgushi, M; Inomata, H; Watanabe, K; Kawada, M; Yakura, R; Kiyonari, H; Nakao, K; Jakt, LM; Nishikawa, S; Sasai, Y				Kamiya, Daisuke; Banno, Satoe; Sasai, Noriaki; Ohgushi, Masatoshi; Inomata, Hidehiko; Watanabe, Kiichi; Kawada, Masako; Yakura, Rieko; Kiyonari, Hiroshi; Nakao, Kazuki; Jakt, Lars Martin; Nishikawa, Shin-ichi; Sasai, Yoshiki			Intrinsic transition of embryonic stem-cell differentiation into neural progenitors	NATURE			English	Article							ZINC-FINGER PROTEIN; IN-VITRO; DIRECTED DIFFERENTIATION; NERVOUS-SYSTEM; MOTOR-NEURONS; MOUSE EMBRYO; ES CELLS; INDUCTION; EXPRESSION; SIGNALS	The neural fate is generally considered to be the intrinsic direction of embryonic stem (ES) cell differentiation. However, little is known about the intracellular mechanism that leads undifferentiated cells to adopt the neural fate in the absence of extrinsic inductive signals. Here we show that the zinc-finger nuclear protein Zfp521 is essential and sufficient for driving the intrinsic neural differentiation of mouse ES cells. In the absence of the neural differentiation inhibitor BMP4, strong Zfp521 expression is intrinsically induced in differentiating ES cells. Forced expression of Zfp521 enables the neural conversion of ES cells even in the presence of BMP4. Conversely, in differentiation culture, Zfp521-depleted ES cells do not undergo neural conversion but tend to halt at the epiblast state. Zfp521 directly activates early neural genes by working with the co-activator p300. Thus, the transition of ES cell differentiation from the epiblast state into neuroectodermal progenitors specifically depends on the cell-intrinsic expression and activator function of Zfp521.	[Kamiya, Daisuke; Banno, Satoe; Sasai, Noriaki; Ohgushi, Masatoshi; Inomata, Hidehiko; Watanabe, Kiichi; Kawada, Masako; Yakura, Rieko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Kamiya, Daisuke; Sasai, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Med Embryol, Kyoto 6068501, Japan; [Kiyonari, Hiroshi; Nakao, Kazuki] RIKEN Ctr Dev Biol, Lab Anim Resource & Genet Engn, Kobe, Hyogo 6500047, Japan; [Jakt, Lars Martin; Nishikawa, Shin-ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Res, Kobe, Hyogo 6500047, Japan	RIKEN; Kyoto University; RIKEN; RIKEN	Sasai, Y (corresponding author), RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Watanabe, Kiichi/ABA-4854-2020; Kiyonari, Hiroshi/N-7936-2015; Inomata, Hidehiko/N-7390-2015	Sasai, Noriaki/0000-0003-0360-1138; Jakt, Lars Martin/0000-0002-3787-8138; zhong wei, he gui/0000-0002-3066-3564	MEXT; Kobe Cluster Project; Leading Project	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project	We are grateful to H. Niwa for comments; M. Okada for advice on the GeneChip study; Y. Toyooka-Kamiya for constant encouragement and technical advice; H. Akimaru for advice on the shRNA knockdown study; and members of the Sasai laboratory for discussion and advice. This work was supported by grants-in-aid from MEXT, the Kobe Cluster Project and the Leading Project (Y.S.).	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Behringer R., 2003, MANIPULATING MOUSE E; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Brunelli S, 2003, GENESIS, V36, P12, DOI 10.1002/gene.10193; Chan HM, 2001, J CELL SCI, V114, P2363; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; JAKT LM, 2003, GENOME INFORM, V14, P276; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002; Zwart R, 1996, MECH DEVELOP, V54, P185, DOI 10.1016/0925-4773(95)00472-6	38	159	168	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					503	U92		10.1038/nature09726	http://dx.doi.org/10.1038/nature09726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326203				2022-12-01	WOS:000287652900035
J	Olson, MV				Olson, Maynard V.			What Does a "Normal" Human Genome Look Like?	SCIENCE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Olson, MV (corresponding author), Univ Washington, Seattle, WA 98195 USA.								0	5	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					872	872		10.1126/science.1203236	http://dx.doi.org/10.1126/science.1203236			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330527				2022-12-01	WOS:000287455100040
J	Harismendy, O; Notani, D; Song, XY; Rahim, NG; Tanasa, B; Heintzman, N; Ren, B; Fu, XD; Topol, EJ; Rosenfeld, MG; Frazer, KA				Harismendy, Olivier; Notani, Dimple; Song, Xiaoyuan; Rahim, Nazli G.; Tanasa, Bogdan; Heintzman, Nathaniel; Ren, Bing; Fu, Xiang-Dong; Topol, Eric J.; Rosenfeld, Michael G.; Frazer, Kelly A.			9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response	NATURE			English	Article							GENOME-WIDE ASSOCIATION; NEGATIVE REGULATOR; RAPID EVOLUTION; NONCODING RNA; PROTEIN CTCF; LOCUS; SUSCEPTIBILITY; SEQUENCE; PROJECT; ANRIL	Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in the 9p21 gene desert associated with coronary artery disease (CAD)(1-4) and type 2 diabetes(5-7). Despite evidence for a role of the associated interval in neighbouring gene regulation(8-10), the biological underpinnings of these genetic associations with CAD or type 2 diabetes have not yet been explained. Here we identify 33 enhancers in 9p21; the interval is the second densest gene desert for predicted enhancers and six times denser than the whole genome (P < 6.55 x 10(-33)). The CAD risk alleles of SNPs rs10811656 and rs10757278 are located in one of these enhancers and disrupt a binding site for STAT1. Lymphoblastoid cell lines homozygous for the CAD risk haplotype show no binding of STAT1, and in lymphoblastoid cell lines homozygous for the CAD non-risk haplotype, binding of STAT1 inhibits CDKN2BAS (also known as CDKN2B-AS1) expression, which is reversed by short interfering RNA knockdown of STAT1. Using a new, open-ended approach to detect long-distance interactions, we find that in human vascular endothelial cells the enhancer interval containing the CAD locus physically interacts with the CDKN2A/B locus, the MTAP gene and an interval downstream of IFNA21. In human vascular endothelial cells, interferon-c activation strongly affects the structure of the chromatin and the transcriptional regulation in the 9p21 locus, including STAT1-binding, long-range enhancer interactions and altered expression of neighbouring genes. Our findings establish a link between CAD genetic susceptibility and the response to inflammatory signalling in a vascular cell type and thus demonstrate the utility of genome-wide association study findings in directing studies to novel genomic loci and biological processes important for disease aetiology.	[Rahim, Nazli G.; Topol, Eric J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Sch Med, Radys Childrens Hosp, La Jolla, CA 92093 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Notani, Dimple; Song, Xiaoyuan; Tanasa, Bogdan; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Heintzman, Nathaniel; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Fu, Xiang-Dong] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Scripps Research Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Topol, EJ (corresponding author), Scripps Res Inst, Scripps Translat Sci Inst, 3344 N Torrey Pines Court, La Jolla, CA 92037 USA.	etopol@scripps.edu; mrosenfeld@ucsd.edu; kafrazer@ucsd.edu	Harismendy, Olivier/AAM-2072-2021; , songxy/P-1094-2014; Stefanadis, Christodoulos/ABH-2232-2020	Harismendy, Olivier/0000-0002-8098-9888; , songxy/0000-0002-9011-5033; Notani, Dimple/0000-0002-9460-8070; Topol, Eric/0000-0002-1478-4729; Stefanadis, Christodoulos/0000-0001-5974-6454; Frazer, Kelly/0000-0002-6060-8902	National Center for Research Resources [1U54RR025204, 1UL1RR025774, 1UL1RR031980-01]; National Institutes of Health [HL065445, DK39949, DK018477, DK074868, L65445, CA97134, DK74686, NS34934, 1R21CA152613-01]; Department of Defence [BC075019]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA097134, R21CA152613] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774, UL1RR031980] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442, R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039949, R01DK018477, P01DK074868, R01DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025204] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank X. Wang, K. Trevarthen and M. Nakano for experimental assistance. We thank the Scripps Genomic Medicine Clinical team for sample collection. This work was partially supported by National Center for Research Resources grants 1U54RR025204, 1UL1RR025774 and 1UL1RR031980-01 and National Institutes of Health grants HL065445, DK39949, DK018477, DK074868, L65445, CA97134, DK74686, NS34934 and 1R21CA152613-01, the Department of Defence grant BC075019 and the Prostate Cancer Foundation. M. G. R. is an Investigator with the Howard Hughes Medical Institute.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hindorff LA, CATALOG PUBLISHED GE; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Najjar I, 2005, J VIROL, V79, P4936, DOI 10.1128/JVI.79.8.4936-4943.2005; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Tousoulis D, 2008, TRENDS MOL MED, V14, P441, DOI 10.1016/j.molmed.2008.08.004; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng M, 2007, BIOMETRICS, V63, P787, DOI 10.1111/j.1541-0420.2007.00768.x	45	453	475	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					264	+		10.1038/nature09753	http://dx.doi.org/10.1038/nature09753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307941	Green Accepted			2022-12-01	WOS:000287144200045
J	O'Neill, JS; van Ooijen, G; Dixon, LE; Troein, C; Corellou, F; Bouget, FY; Reddy, AB; Millar, AJ				O'Neill, John S.; van Ooijen, Gerben; Dixon, Laura E.; Troein, Carl; Corellou, Florence; Bouget, Francois-Yves; Reddy, Akhilesh B.; Millar, Andrew J.			Circadian rhythms persist without transcription in a eukaryote	NATURE			English	Article							CLOCK; PHOSPHORYLATION; OSTREOCOCCUS; SYSTEM; PLANTS	Circadian rhythms are ubiquitous in eukaryotes, and coordinate numerous aspects of behaviour, physiology and metabolism, from sleep/wake cycles in mammals to growth and photosynthesis in plants(1,2). This daily timekeeping is thought to be driven by transcriptional-translational feedback loops, whereby rhythmic expression of 'clock' gene products regulates the expression of associated genes in approximately 24-hour cycles. The specific transcriptional components differ between phylogenetic kingdoms(3). The unicellular pico-eukaryotic alga Ostreococcus tauri possesses a naturally minimized clock, which includes many features that are shared with plants, such as a central negative feedback loop that involves the morning-expressed CCA1 and evening-expressed TOC1 genes(4). Given that recent observations in animals and plants have revealed prominent post-translational contributions to time-keeping(5), a reappraisal of the transcriptional contribution to oscillator function is overdue. Here we show that non-transcriptional mechanisms are sufficient to sustain circadian timekeeping in the eukaryotic lineage, although they normally function in conjunction with transcriptional components. We identify oxidation of peroxiredoxin proteins as a transcription-independent rhythmic biomarker, which is also rhythmic in mammals(6). Moreover we show that pharmacological modulators of the mammalian clock mechanism have the same effects on rhythms in Ostreococcus. Post-translational mechanisms, and at least one rhythmic marker, seem to be better conserved than transcriptional clock regulators. It is plausible that the oldest oscillator components are non-transcriptional in nature, as in cyanobacteria(7), and are conserved across kingdoms.	[O'Neill, John S.; Reddy, Akhilesh B.] Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Inst Metab Sci,Dept Clin Neurosci, Cambridge CB2 0QQ, England; [O'Neill, John S.; van Ooijen, Gerben; Dixon, Laura E.; Millar, Andrew J.] Ctr Syst Biol Edinburgh, Edinburgh EH9 3JD, Midlothian, Scotland; [Troein, Carl; Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Corellou, Florence; Bouget, Francois-Yves] Univ Paris 06, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, F-66651 Banyuls Sur Mer, France; [Corellou, Florence; Bouget, Francois-Yves] CNRS, UMR7621, Lab Observ Oceanog Microbienne, Observ Oceanol, F-66651 Banyuls Sur Mer, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Reddy, AB (corresponding author), Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Inst Metab Sci,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	areddy@cantab.net; Andrew.Millar@ed.ac.uk	Millar, Andrew J/G-2423-2012; van Ooijen, Gerben/E-9371-2013; Corellou, Florence/E-1378-2011	Millar, Andrew J/0000-0003-1756-3654; van Ooijen, Gerben/0000-0001-7967-0637; O'Neill, John Stuart/0000-0003-2204-6096; Corellou, Florence/0000-0001-8026-2120	BBSRC; EPSRC [D019621]; BBSRC/ANR [F005466]; HFSP; Wellcome Trust [083643/Z/07/Z]; MRC Centre for Obesity and Related metabolic Disorders (MRC CORD); BBSRC [BB/D019621/1, BB/F005466/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005466/1, BB/D019621/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC/ANR(French National Research Agency (ANR)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HFSP(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Obesity and Related metabolic Disorders (MRC CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CSBE is a Centre for Integrative Systems Biology funded by BBSRC and EPSRC award D019621. C.T. is supported by a BBSRC/ANR joint project F005466 awarded to F.-Y.B. and A.J.M. and by the HFSP. A.B.R. is supported by the Wellcome Trust (083643/Z/07/Z) and the MRC Centre for Obesity and Related metabolic Disorders (MRC CORD).	Baier M, 1997, PLANT J, V12, P179, DOI 10.1046/j.1365-313X.1997.12010179.x; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Edwards KD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.81; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Khalsa SBS, 1996, AM J PHYSIOL-CELL PH, V271, pC1646, DOI 10.1152/ajpcell.1996.271.5.C1646; KONOPKA RJ, 1979, FED PROC, V38, P2602; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Merrow M, 2006, GENE DEV, V20, P2629, DOI 10.1101/gad.1479706; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; MORSE DS, 1990, TRENDS BIOCHEM SCI, V15, P262, DOI 10.1016/0968-0004(90)90050-L; Moulager M, 2007, PLANT PHYSIOL, V144, P1360, DOI 10.1104/pp.107.096149; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Roenneberg T, 2005, NAT REV MOL CELL BIO, V6, P965, DOI 10.1038/nrm1766; Ueda HR, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100105; WOOLUM JC, 1991, J BIOL RHYTHM, V6, P129, DOI 10.1177/074873049100600203	29	361	370	2	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					554	558		10.1038/nature09654	http://dx.doi.org/10.1038/nature09654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270895	Green Accepted			2022-12-01	WOS:000286596500037
J	Peca, J; Feliciano, C; Ting, JT; Wang, WT; Wells, MF; Venkatraman, TN; Lascola, CD; Fu, ZY; Feng, GP				Peca, Joao; Feliciano, Catia; Ting, Jonathan T.; Wang, Wenting; Wells, Michael F.; Venkatraman, Talaignair N.; Lascola, Christopher D.; Fu, Zhanyan; Feng, Guoping			Shank3 mutant mice display autistic-like behaviours and striatal dysfunction	NATURE			English	Article							22Q13 DELETION SYNDROME; SPECTRUM DISORDERS; SYNAPTIC-TRANSMISSION; MUTATIONS; PROTEIN; BRAIN; GENE; NEUROLIGINS; SAPAPS; FAMILY	Autismspectrum disorders (ASDs) comprise a range of disorders that share a core of neurobehavioural deficits characterized by widespread abnormalities in social interactions, deficits in communication as well as restricted interests and repetitive behaviours. The neurological basis and circuitry mechanisms underlying these abnormal behaviours are poorly understood. SHANK3 is a postsynaptic protein, whose disruption at the genetic level is thought to be responsible for the development of 22q13 deletion syndrome (Phelan-McDermid syndrome) and other non-syndromic ASDs. Here we show that mice with Shank3 gene deletions exhibit self-injurious repetitive grooming and deficits in social interaction. Cellular, electrophysiological and biochemical analyses uncovered defects at striatal synapses and cortico-striatal circuits in Shank3 mutant mice. Our findings demonstrate a critical role for SHANK3 in the normal development of neuronal connectivity and establish causality between a disruption in the Shank3 gene and the genesis of autistic-like behaviours in mice.	[Peca, Joao; Feliciano, Catia; Ting, Jonathan T.; Wang, Wenting; Wells, Michael F.; Lascola, Christopher D.; Fu, Zhanyan; Feng, Guoping] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Peca, Joao] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Biomed & Expt Biol, Coimbra, Portugal; [Feliciano, Catia] Gulbenkian Inst Sci, Gulbenkian PhD Programme Biomed, P-2781901 Oeiras, Portugal; [Venkatraman, Talaignair N.; Lascola, Christopher D.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Venkatraman, Talaignair N.; Lascola, Christopher D.] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; [Fu, Zhanyan] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Fu, Zhanyan; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Feng, Guoping] Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA 02142 USA	Duke University; Universidade de Coimbra; Duke University; Duke University; Duke University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Feng, GP (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	fengg@mit.edu	Peça, João/K-7900-2013; Feng, Guoping/Y-2827-2019; Lascola, Christopher D/B-9126-2017	Peça, João/0000-0003-4989-2129; Lascola, Christopher D/0000-0002-8031-782X; Wells, Michael/0000-0002-1367-2565; Ting, Jonathan/0000-0001-8266-0392; Wang, Wenting/0000-0002-8344-0102; Feliciano, Catia/0000-0001-7545-6924	NIMH/NIH [R01MH081201]; Hartwell Foundation; Simons Foundation Autism Research Initiative (SFARI); NARSAD; NIH [F32MH084460, R03MH085224]; Portuguese Foundation for Science and Technology [SFRH/BD/15231/2004, SFRH/BD/15855/2005]; "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal); "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal); NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH084460, R01MH081201, R03MH085224] Funding Source: NIH RePORTER	NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hartwell Foundation; Simons Foundation Autism Research Initiative (SFARI); NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal); "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Duarte, S. Chaterjee and A. Oliveira-Maia for discussions; L. Kruger and Q. Liu for technical assistance; A. Hadiono for assistance in behavioural annotation; D. Bredt for the PSD-93 antibody; T. Boeckers for the anti-SHANK3 antibody; S. Miller and P. Christopher for advice and assistance with electron microscopy techniques; J. Crawley for the demonstration of social behaviour tests; N. Calakos and Y. Wan for advice on electrophysiology studies; A. Graybiel for critical comments of the manuscript; D. Wang and the other members of the G. F. laboratory for their support. We thank The Poitras Center for Affective Disorders Research. This work was funded by a grant from NIMH/NIH (R01MH081201), a Hartwell Individual Biomedical Research Award from The Hartwell Foundation, and a Simons Foundation Autism Research Initiative (SFARI) grant Award to G. F.; a NARSAD Young Investigator Award and NIH Ruth L. Kirschstein National Research Service Award (F32MH084460) to J. T. T.; a NIH (R03MH085224) grant to Z.F.; and doctoral fellowships from the Portuguese Foundation for Science and Technology to J. P. (SFRH/BD/15231/2004) and C. F. (SFRH/BD/15855/2005). C. F. would like to acknowledge the support from the "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal) and J. P. the "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; HORWITZ B, 1988, ARCH NEUROL-CHICAGO, V45, P749, DOI 10.1001/archneur.1988.00520310055018; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; MALENKA RC, 1988, J NEUROSCI, V8, P3750; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prasad C, 2000, CLIN GENET, V57, P103, DOI 10.1034/j.1399-0004.2000.570203.x; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Yin HH, 2006, J NEUROSCI, V26, P11811, DOI 10.1523/JNEUROSCI.3196-06.2006; Zoghbi HY, 2010, NEURON, V68, P165, DOI 10.1016/j.neuron.2010.10.015; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	42	901	944	5	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					437	U534		10.1038/nature09965	http://dx.doi.org/10.1038/nature09965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21423165	Green Submitted, Green Accepted			2022-12-01	WOS:000289949600027
J	Lu, FR; Li, S; Jiang, Y; Jiang, J; Fan, H; Lu, GF; Deng, D; Dang, SY; Zhang, X; Wang, JW; Yan, NE				Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng			Structure and mechanism of the uracil transporter UraA	NATURE			English	Article							SIGNATURE MOTIF; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE RECOGNITION; XANTHINE PERMEASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLECULAR-BASIS; FAMILY; CLONING; PROTEINS	The nucleobase/ascorbate transporter (NAT) proteins, also known as nucleobase/cation symporter 2 (NCS2) proteins, are responsible for the uptake of nucleobases in all kingdoms of life and for the transport of vitamin C in mammals(1,2). Despite functional characterization of the NAT family members in bacteria, fungi and mammals, detailed structural information remains unavailable. Here we report the crystal structure of a representative NAT protein, the Escherichia coli uracil/H+ symporter UraA, in complex with uracil at a resolution of 2.8 angstrom. UraA has a novel structural fold, with 14 transmembrane segments (TMs) divided into two inverted repeats. A pair of antiparallel beta-strands is located between TM3 and TM10 and has an important role in structural organization and substrate recognition. The structure is spatially arranged into a core domain and a gate domain. Uracil, located at the interface between the two domains, is coordinated mainly by residues from the core domain. Structural analysis suggests that alternating access of the substrate may be achieved through conformational changes of the gate domain.	[Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Dang, Shangyu/0000-0001-9141-1865; Lu, Feiran/0000-0002-1757-2895	Ministry of Science and Technology [2009CB918802, 2011CB910501]; Tsinghua University; National Natural Science Foundation of China [91017011]; Yuyuan Foundation; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yuyuan Foundation; Li Foundation	We thank N. Shimizu at the Spring-8 beamline BL41XU, and J. He and S. Huang at the Shanghai Synchrotron Radiation Facility for on-site assistance. We thank Y. Shi and Y. Yan for critical discussions. This work was supported by funds from the Ministry of Science and Technology (grant numbers 2009CB918802 and 2011CB910501), Tsinghua University 985 Phase II funds and Project 91017011 supported by the National Natural Science Foundation of China. N.Y. acknowledges support from the Yuyuan Foundation and the Li Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; DeLano W.L., 2002, PYMOL MOL VIEWER; DIALLINAS G, 1989, GENETICS, V122, P341; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	35	140	141	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					243	246		10.1038/nature09885	http://dx.doi.org/10.1038/nature09885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21423164				2022-12-01	WOS:000289469100048
J	Xiao, B; Sanders, MJ; Underwood, E; Heath, R; Mayer, FV; Carmena, D; Jing, C; Walker, PA; Eccleston, JF; Haire, LF; Saiu, P; Howell, SA; Aasland, R; Martin, SR; Carling, D; Gamblin, SJ				Xiao, Bing; Sanders, Matthew J.; Underwood, Elizabeth; Heath, Richard; Mayer, Faith V.; Carmena, David; Jing, Chun; Walker, Philip A.; Eccleston, John F.; Haire, Lesley F.; Saiu, Peter; Howell, Steven A.; Aasland, Rein; Martin, Stephen R.; Carling, David; Gamblin, Steven J.			Structure of mammalian AMPK and its regulation by ADP	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; LKB1-AMPK PATHWAY; SKELETAL-MUSCLE; PHOSPHORYLATION; BINDING	The heterotrimeric AMP-activated protein kinase (AMPK) has a key role in regulating cellular energy metabolism; in response to a fall in intracellular ATP levels it activates energy-producing pathways and inhibits energy-consuming processes(1). AMPK has been implicated in a number of diseases related to energy metabolism including type 2 diabetes, obesity and, most recently, cancer(2-6). AMPK is converted from an inactive form to a catalytically competent form by phosphorylation of the activation loop within the kinase domain(7): AMP binding to the c-regulatory domain promotes phosphorylation by the upstream kinase(8), protects the enzyme against dephosphorylation, as well as causing allosteric activation(9). Here we show that ADP binding to just one of the two exchangeable AXP (AMP/ADP/ATP) binding sites on the regulatory domain protects the enzyme from dephosphorylation, although it does not lead to allosteric activation. Our studies show that active mammalian AMPK displays significantly tighter binding to ADP than to MgATP, explaining how the enzyme is regulated under physiological conditions where the concentration of Mg-ATP is higher than that of ADP and much higher than that of AMP. We have determined the crystal structure of an active AMPK complex. The structure shows how the activation loop of the kinase domain is stabilized by the regulatory domain and how the kinase linker region interacts with the regulatory nucleotide-binding site that mediates protection against dephosphorylation. From our biochemical and structural data we develop a model for how the energy status of a cell regulates AMPK activity.	[Sanders, Matthew J.; Mayer, Faith V.; Carmena, David; Carling, David] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; [Xiao, Bing; Underwood, Elizabeth; Heath, Richard; Jing, Chun; Walker, Philip A.; Eccleston, John F.; Haire, Lesley F.; Saiu, Peter; Howell, Steven A.; Aasland, Rein; Martin, Stephen R.; Gamblin, Steven J.] Natl Inst Med Res, MRC, London NW7 1AA, England	Imperial College London; MRC National Institute for Medical Research	Carling, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Hammersmith Hosp Campus,DuCane Rd, London W12 0NN, England.	david.carling@csc.mrc.ac.uk; sgambli@nimr.mrc.ac.uk	Carling, David/F-1943-2014; Sanders, Matthew J/B-4077-2009; Carmena, David/S-4049-2019	Carling, David/0000-0002-2316-1830; Carmena, David/0000-0002-4015-8553; Gamblin, Steve/0000-0001-5331-639X; Sanders, Matthew James/0000-0001-6185-6337	MRC; Medical Research Council [MC_U120027537, MC_U117584222] Funding Source: researchfish; MRC [MC_U117584222] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Webb for gift of coumarin nucleotides, J. Skehel for comments on the manuscript and S. Smerdon for discussion and assistance. Work in both laboratories is supported by the MRC and we gratefully acknowledge Diamond Light Source for synchrotron access.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; Hellsten Y, 1999, J PHYSIOL-LONDON, V520, P909, DOI 10.1111/j.1469-7793.1999.00909.x; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; Littler DR, 2010, ACTA CRYSTALLOGR F, V66, P143, DOI 10.1107/S1744309109052543; McConell GK, 2005, J PHYSIOL-LONDON, V568, P665, DOI 10.1113/jphysiol.2005.089839; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Otwinowski Z., 1993, P CCP4 STUDY WEEKEND, P556; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	30	621	658	4	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					230	233		10.1038/nature09932	http://dx.doi.org/10.1038/nature09932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21399626	Green Accepted			2022-12-01	WOS:000289469100045
J	Persha, L; Agrawal, A; Chhatre, A				Persha, Lauren; Agrawal, Arun; Chhatre, Ashwini			Social and Ecological Synergy: Local Rulemaking, Forest Livelihoods, and Biodiversity Conservation	SCIENCE			English	Article							HUMAN-MODIFIED WORLD; DECENTRALIZATION; GOVERNANCE; POVERTY; MANAGEMENT	Causal pathways to achieve social and ecological benefits from forests are unclear, because there are few systematic multicountry empirical analyses that identify important factors and their complex relationships with social and ecological outcomes. This study examines biodiversity conservation and forest-based livelihood outcomes using a data set on 84 sites from six countries in East Africa and South Asia. We find both positive and negative relationships, leading to joint wins, losses, and trade-offs depending on specific contextual factors; participation in forest governance institutions by local forest users is strongly associated with jointly positive outcomes for forests in our study.	[Persha, Lauren; Agrawal, Arun] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Chhatre, Ashwini] Univ Illinois, Dept Geog, Urbana, IL 61801 USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign	Persha, L (corresponding author), Univ Michigan, Sch Nat Resources & Environm, 440 Church St, Ann Arbor, MI 48109 USA.	lpersha@umich.edu	Agrawal, Arun/A-4257-2009	Agrawal, Arun/0000-0001-6796-2958; Chhatre, Ashwini/0000-0002-5374-7867; Persha, Lauren/0000-0002-4956-0442	Ford Foundation; MacArthur Foundation; National Science Foundation [BCS-0703073, CNH-0709545]; University of Michigan	Ford Foundation; MacArthur Foundation; National Science Foundation(National Science Foundation (NSF)); University of Michigan(University of Michigan System)	We thank E. Ostrom, T. Hayes, two anonymous reviewers, and members of the Development, Sustainable Livelihoods and Conservation (DESULICO) group for comments on an earlier draft of this paper, and R. Kornak and J. England for assistance with data cleaning. We gratefully acknowledge the many researchers affiliated with IFRI as Collaborating Research Centers for their data contributions and ongoing involvement with the IFRI network. This work was funded by the Ford Foundation, the MacArthur Foundation, National Science Foundation grants BCS-0703073 and CNH-0709545, and a University of Michigan OVPR/Rackham grant for an Annual Institute on Joint Outcomes related to Sustainability.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Agrawal A, 2001, POLIT SOC, V29, P485, DOI 10.1177/0032329201029004002; Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; Andersson KP, 2006, WORLD DEV, V34, P576, DOI 10.1016/j.worlddev.2005.08.009; BARROW E, 2009, CUTOMARY PRACTICES F; Belcher B, 2005, WORLD DEV, V33, P1435, DOI 10.1016/j.worlddev.2004.10.007; Belcher BM, 2005, INT FOREST REV, V7, P82, DOI 10.1505/ifor.2005.7.2.82; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Gardner TA, 2010, BIOL CONSERV, V143, P2293, DOI 10.1016/j.biocon.2010.05.017; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Larson AM, 2008, ANNU REV ENV RESOUR, V33, P213, DOI 10.1146/annurev.environ.33.020607.095522; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Putz FE, 2001, CONSERV BIOL, V15, P7, DOI 10.1046/j.1523-1739.2001.00018.x; Ribot JC, 2006, WORLD DEV, V34, P1864, DOI 10.1016/j.worlddev.2005.11.020; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Wollenberg E, 2007, INT FOREST REV, V9, P670, DOI 10.1505/ifor.9.2.670; Wunder S, 2001, WORLD DEV, V29, P1817, DOI 10.1016/S0305-750X(01)00070-5	20	363	370	6	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1606	1608		10.1126/science.1199343	http://dx.doi.org/10.1126/science.1199343			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436453				2022-12-01	WOS:000288754500056
J	Toien, O; Blake, J; Edgar, DM; Grahn, DA; Heller, HC; Barnes, BM				Toien, Oivind; Blake, John; Edgar, Dale M.; Grahn, Dennis A.; Heller, H. Craig; Barnes, Brian M.			Hibernation in Black Bears: Independence of Metabolic Suppression from Body Temperature	SCIENCE			English	Article							DAILY TORPOR; ARCTIC HIBERNATOR; GROUND-SQUIRRELS; URSUS-AMERICANUS; CNS REGULATION; MARMOTA; MAMMALS; MUSCLE; PHYSIOLOGY; REDUCTION	Black bears hibernate for 5 to 7 months a year and, during this time, do not eat, drink, urinate, or defecate. We measured metabolic rate and body temperature in hibernating black bears and found that they suppress metabolism to 25% of basal rates while regulating body temperature from 30 degrees to 36 degrees C, in multiday cycles. Heart rates were reduced from 55 to as few as 9 beats per minute, with profound sinus arrhythmia. After returning to normal body temperature and emerging from dens, bears maintained a reduced metabolic rate for up to 3 weeks. The pronounced reduction and delayed recovery of metabolic rate in hibernating bears suggest that the majority of metabolic suppression during hibernation is independent of lowered body temperature.	[Toien, Oivind; Blake, John; Barnes, Brian M.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Edgar, Dale M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Grahn, Dennis A.; Heller, H. Craig] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Alaska System; University of Alaska Fairbanks; Stanford University; Stanford University	Toien, O (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	otoien@alaska.edu; bmbarnes@alaska.edu	Heller, H. Craig/C-9785-2011	Heller, H Craig/0000-0003-4479-5880; Toien, Oivind/0000-0001-5967-2483	U.S. Army Medical Research and Materiel Command [05178001]; NSF [9819540, 0076039, 0732755]; NIH [HD-00973]; American Heart Association [0020626Z]; Fulbright Program	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fulbright Program	This work was supported by U.S. Army Medical Research and Materiel Command grant 05178001; NSF grants 9819540, 0076039, and 0732755; NIH HD-00973; and gift funds to Stanford University, American Heart Association #0020626Z, and the Fulbright Program. We thank the Alaska Department of Fish and Game for providing bears, D. Ritter for technical assistance, and J. Kenagy and J. Duman for comments.	AZIZI F, 1979, AM J PHYSIOL, V237, pE224, DOI 10.1152/ajpendo.1979.237.3.E224; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; Donahue SW, 2003, J EXP BIOL, V206, P4233, DOI 10.1242/jeb.00671; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; FLORANT GL, 1977, AM J PHYSIOL, V232, pR203, DOI 10.1152/ajpregu.1977.232.5.R203; Folk Jr G. E., 1980, BEARS THEIR BIOL MAN, P43; Folk Jr G. E., 1967, MAMMAL HIBERNAT, VIII, P75; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; GEISER F, 1988, J COMP PHYSIOL B, V158, P25, DOI 10.1007/BF00692726; Harlow HJ, 2004, J MAMMAL, V85, P414, DOI 10.1644/1545-1542(2004)085<0414:BSTOHB>2.0.CO;2; Harlow HJ, 2001, NATURE, V409, P997, DOI 10.1038/35059165; HAYSSEN V, 1985, COMP BIOCHEM PHYS A, V81, P741, DOI 10.1016/0300-9629(85)90904-1; HELDMAIER G, 1992, J COMP PHYSIOL B, V162, P696, DOI 10.1007/BF00301619; HELLER HC, 1974, AM J PHYSIOL, V227, P583, DOI 10.1152/ajplegacy.1974.227.3.583; Hissa R, 1997, ANN ZOOL FENN, V34, P267; Hock R. J., 1951, AAAS, V2, P310; Hume ID, 2002, J COMP PHYSIOL B, V172, P197, DOI 10.1007/s00360-001-0240-1; Lee TN, 2009, ETHOL ECOL EVOL, V21, P403, DOI 10.1080/08927014.2009.9522495; Lyman C. P., 1982, HIBERNATION TORPOR M; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Nelson OL, 2010, J COMP PHYSIOL B, V180, P465, DOI 10.1007/s00360-009-0421-x; Rausch RL., 1961, Z SAUGETIERKD, V26, P1; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; SNAPP BD, 1981, PHYSIOL ZOOL, V54, P297, DOI 10.1086/physzool.54.3.30159944; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; WATTS P, 1988, ACTA PHYSIOL SCAND, V134, P149, DOI 10.1111/j.1748-1716.1988.tb08471.x	29	240	246	3	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					906	909		10.1126/science.1199435	http://dx.doi.org/10.1126/science.1199435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330544				2022-12-01	WOS:000287455100056
J	Chamot-Rooke, J; Mikaty, G; Malosse, C; Soyer, M; Dumont, A; Gault, J; Imhaus, AF; Martin, P; Trellet, M; Clary, G; Chafey, P; Camoin, L; Nilges, M; Nassif, X; Dumenil, G				Chamot-Rooke, Julia; Mikaty, Guillain; Malosse, Christian; Soyer, Magali; Dumont, Audrey; Gault, Joseph; Imhaus, Anne-Flore; Martin, Patricia; Trellet, Mikael; Clary, Guilhem; Chafey, Philippe; Camoin, Luc; Nilges, Michael; Nassif, Xavier; Dumenil, Guillaume			Posttranslational Modification of Pili upon Cell Contact Triggers N. meningitidis Dissemination	SCIENCE			English	Article							NEISSERIA-MENINGITIDIS; IV PILI; EPITHELIAL-CELLS; GONORRHOEAE; PHOSPHOETHANOLAMINE; PHOSPHOCHOLINE; GENE	The Gram-negative bacterium Neisseria meningitidis asymptomatically colonizes the throat of 10 to 30% of the human population, but throat colonization can also act as the port of entry to the blood (septicemia) and then the brain (meningitis). Colonization is mediated by filamentous organelles referred to as type IV pili, which allow the formation of bacterial aggregates associated with host cells. We found that proliferation of N. meningitidis in contact with host cells increased the transcription of a bacterial gene encoding a transferase that adds phosphoglycerol onto type IV pili. This unusual posttranslational modification specifically released type IV pili-dependent contacts between bacteria. In turn, this regulated detachment process allowed propagation of the bacterium to new colonization sites and also migration across the epithelium, a prerequisite for dissemination and invasive disease.	[Mikaty, Guillain; Soyer, Magali; Dumont, Audrey; Imhaus, Anne-Flore; Martin, Patricia; Clary, Guilhem; Chafey, Philippe; Camoin, Luc; Nassif, Xavier; Dumenil, Guillaume] Univ Paris 05, Fac Med Paris Descartes, F-75006 Paris, France; [Chamot-Rooke, Julia; Malosse, Christian; Gault, Joseph] Ecole Polytech, Lab Mecanismes React, F-91128 Palaiseau, France; [Chamot-Rooke, Julia; Malosse, Christian; Gault, Joseph] CNRS, UMR7651, F-91128 Palaiseau, France; [Mikaty, Guillain; Martin, Patricia; Nassif, Xavier] INSERM, U1002, F-75015 Paris, France; [Soyer, Magali; Dumont, Audrey; Imhaus, Anne-Flore; Dumenil, Guillaume] Paris Cardiovasc Res Ctr, INSERM, U970, F-75015 Paris, France; [Trellet, Mikael; Nilges, Michael] Inst Pasteur, Unite Rech Associee CNRS 2185, Unite Bioinformat Struct, F-75015 Paris, France; [Clary, Guilhem; Chafey, Philippe; Camoin, Luc] CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France; [Clary, Guilhem; Chafey, Philippe; Camoin, Luc] INSERM, U1016, F-75014 Paris, France; [Nassif, Xavier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Dumenil, G (corresponding author), Univ Paris 05, Fac Med Paris Descartes, F-75006 Paris, France.	guillaume.dumenil@inserm.fr	Nilges, Michael/E-4803-2011; Gault, Joseph/C-9623-2013; Dumenil, Guillaume/F-7567-2015; Dumenil, Guillaume/N-3377-2019; Trellet, Mikael/A-9370-2017; Camoin, Luc/AAB-3856-2019; Chamot-Rooke, Julia/F-3644-2014	Nilges, Michael/0000-0002-1451-8092; Gault, Joseph/0000-0001-7686-2983; Dumenil, Guillaume/0000-0001-9174-9110; Dumenil, Guillaume/0000-0001-9174-9110; Trellet, Mikael/0000-0001-6337-581X; Camoin, Luc/0000-0002-1230-4787; Chamot-Rooke, Julia/0000-0002-9427-543X	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche; Agence Nationale de la Recherche [PCV08_319010, FRM INE20100118195]	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Authors thank M.-C. Prevost, S. Guadagnini, D. Lankar, J.-L. Beretti, M. Dupuis, G. Guilbaud for help with experiments and A.-M. Lennon, E. Camerer, S. Silva, and K. Melican for critical reading of the manuscript. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche (including Avenir program), and Agence Nationale de la Recherche grants PCV08_319010 and FRM INE20100118195.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Deghmane AE, 2000, EMBO J, V19, P1068, DOI 10.1093/emboj/19.5.1068; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Ilver D, 1998, INFECT IMMUN, V66, P469, DOI 10.1128/IAI.66.2.469-473.1998; Jamet A, 2009, MICROBIOL-SGM, V155, P2288, DOI 10.1099/mic.0.027755-0; MARCEAU M, 1995, MOL MICROBIOL, V17, P855, DOI 10.1111/j.1365-2958.1995.mmi_17050855.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Morelle S, 2003, J BACTERIOL, V185, P2618, DOI 10.1128/JB.185.8.2618-2627.2003; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Rusniok C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r110; Stimson E, 1996, BIOCHEM J, V316, P29, DOI 10.1042/bj3160029; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Warren MJ, 2003, INFECT IMMUN, V71, P6892, DOI 10.1128/IAI.71.12.6892-6898.2003	16	136	141	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					778	782		10.1126/science.1200729	http://dx.doi.org/10.1126/science.1200729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311024				2022-12-01	WOS:000287205700073
J	Tamura, K; Nomura, N; Seki, R; Yonei-Tamura, S; Yokoyama, H				Tamura, Koji; Nomura, Naoki; Seki, Ryohei; Yonei-Tamura, Sayuri; Yokoyama, Hitoshi			Embryological Evidence Identifies Wing Digits in Birds as Digits 1, 2, and 3	SCIENCE			English	Article							PENTADACTYL GROUND-STATE; CHICK LIMB-BUD; SONIC-HEDGEHOG; VERTEBRATE LIMB; POLARIZING ACTIVITY; GENE-EXPRESSION; AVIAN HAND; HOX GENES; EVOLUTION; ZPA	The identities of the digits of the avian forelimb are disputed. Whereas paleontological findings support the position that the digits correspond to digits one, two, and three, embryological evidence points to digit two, three, and four identities. By using transplantation and cell-labeling experiments, we found that the posteriormost digit in the wing does not correspond to digit four in the hindlimb; its progenitor segregates early from the zone of polarizing activity, placing it in the domain of digit three specification. We suggest that an avian-specific shift uncouples the digit anlagen from the molecular mechanisms that pattern them, resulting in the imposition of digit one, two, and three identities on the second, third, and fourth anlagens.	[Tamura, Koji; Nomura, Naoki; Seki, Ryohei; Yonei-Tamura, Sayuri; Yokoyama, Hitoshi] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Tamura, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	tam@m.tohoku.ac.jp	Yokoyama, Hitoshi/F-5161-2015	Yokoyama, Hitoshi/0000-0003-4821-9506; Seki-Omura, Ryohei/0000-0002-3314-9237	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.)	We thank S. Kuratani for valuable discussions and comments on this study; R. Ladher, J. Fallon, H. Yajima, T. Suzuki, and D. Sipp for critical reading of this manuscript; and Y. Wakamatsu for supplying quail eggs. H.Y. was supported by Grant-in-Aid for Scientific Research on Innovative Areas. This work was supported by the Global Center of Excellence Program (J03) and grants from Japan Society for the Promotion of Science; the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Toray Science Foundation.	Amano T, 2005, DEV DYNAM, V233, P326, DOI 10.1002/dvdy.20390; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cohn MJ, 2002, BIOESSAYS, V24, P460, DOI 10.1002/bies.10088; Galis F, 2005, J EXP ZOOL PART B, V304B, P198, DOI 10.1002/jez.b.21042; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hinchliffe J. R., 1977, VERTEBRATE LIMB SOMI, P293; HINCHLIFFE JR, 1985, J EMBRYOL EXP MORPH, V86, P169; HONIG LS, 1985, J EMBRYOL EXP MORPH, V87, P163; Larsson HCE, 2010, J EXP ZOOL PART B, V314B, P571, DOI 10.1002/jez.b.21362; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROWE DA, 1982, J EMBRYOL EXP MORPH, V68, P1; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; SUMMERBELL D, 1975, J EMBRYOL EXP MORPH, V33, P621; Summerbell D., 1977, VERTEBRATE LIMB SOMI, P41; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Uejima A, 2010, DEV GROWTH DIFFER, V52, P223, DOI 10.1111/j.1440-169X.2009.01161.x; Vargas AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003325; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P206, DOI 10.1002/jez.b.21051; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; WILSON DJ, 1987, DEVELOPMENT, V99, P99; Wolpert L., 2006, PRINCIPLES DEV, V3rd; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	29	46	49	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					753	757		10.1126/science.1198229	http://dx.doi.org/10.1126/science.1198229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311019				2022-12-01	WOS:000287205700066
J	Schooler, SS; Salau, B; Julien, MH; Ives, AR				Schooler, Shon S.; Salau, Buck; Julien, Mic H.; Ives, Anthony R.			Alternative stable states explain unpredictable biological control of Salvinia molesta in Kakadu	NATURE			English	Article							REGIME SHIFTS; ECOSYSTEMS; RESTORATION; ECOLOGY; COMMUNITIES; THRESHOLDS; TRANSIENTS; NITROGEN; GROWTH; FIELD	Suppression of the invasive plant Salvinia molesta by the salvinia weevil is an iconic example of successful biological control. However, in the billabongs (oxbow lakes) of Kakadu National Park, Australia, control is fitful and incomplete. By fitting a process-based nonlinear model to thirteen-year data sets from four billabongs, here we show that incomplete control can be explained by alternative stable states(1-4)-one state in which salvinia is suppressed and the other in which salvinia escapes weevil control. The shifts between states are associated with annual flooding events. In some years, high water flow reduces weevil populations, allowing the shift from a controlled to an uncontrolled state; in other years, benign conditions for weevils promote the return shift to the controlled state. In most described ecological examples, transitions between alternative stable states are relatively rare, facilitated by slow-moving environmental changes, such as accumulated nutrient loading or climate change(5,6). The billabongs of Kakadu give a different manifestation of alternative stable states that generate complex and seemingly unpredictable dynamics. Because shifts between alternative stable states are stochastic, they present a potential management strategy to maximize effective biological control: when the domain of attraction to the state of salvinia control is approached, augmentation of the weevil population or reduction of the salvinia biomass may allow the lower state to trap the system.	[Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Schooler, Shon S.; Julien, Mic H.] CSIRO Ecosyst Sci, Long Pocket Labs, Indooroopilly, Qld 4068, Australia; [Salau, Buck] Dept Environm Water Heritage & Arts, Jabiru, NT 0886, Australia	University of Wisconsin System; University of Wisconsin Madison; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ives, AR (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	arives@wisc.edu	Julien, Mic/B-6619-2009; Ives, Anthony/A-5698-2008; Schooler, Shon/C-1860-2008; Schooler, Shon/AAE-9369-2019	Ives, Anthony/0000-0001-9375-9523; 	Australian Department of Agriculture, Fisheries and Forestry; CSIRO; United States National Science Foundation through the North Temperate Lakes Long Term Ecological Research Network	Australian Department of Agriculture, Fisheries and Forestry(Australian GovernmentDepartment of Agriculture and Water Resources); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); United States National Science Foundation through the North Temperate Lakes Long Term Ecological Research Network	We thank S. Winderlich (Kakadu National Park) for facilitating data processing, and S. Cruickshank and G. Willis of the Northern Territory Department of Natural Resources, Environment, the Arts and Sport for providing gauging station data. M. Storrs, C. Murakami, F. Hunter, M. Hattand F. Baird provided field assistance. A. Bourne assisted with data interpretation, and P. Milewski provided value insight into the mathematical analyses. S.S.S. received funding from the Australian Department of Agriculture, Fisheries and Forestry and A.R.I. received funding from a CSIRO McMaster's Fellowship and United States National Science Foundation funds through the North Temperate Lakes Long Term Ecological Research Network and individual grants. S. R. Carpenter, Y. Buckley, and R. van Klinken provided comments on earlier versions of this manuscript.	Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; FINLAYSON CM, 1984, AQUAT BOT, V18, P257, DOI 10.1016/0304-3770(84)90067-6; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Harvey A.C., 1989, FORECASTING STRUCTUR; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Julien MH, 2009, BIOLOGICAL CONTROL OF TROPICAL WEEDS USING ARTHROPODS, P378, DOI 10.1017/CBO9780511576348.019; KNOWLTON N, 1992, AM ZOOL, V32, P674; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; ROOM PM, 1986, J APPL ECOL, V23, P1013, DOI 10.2307/2403952; ROOM PM, 1986, AQUAT BOT, V24, P213, DOI 10.1016/0304-3770(86)90058-6; ROOM PM, 1990, TRENDS ECOL EVOL, V5, P74, DOI 10.1016/0169-5347(90)90234-5; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schmitz OJ, 2006, ECOSYSTEMS, V9, P659, DOI 10.1007/s10021-006-0006-4; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Storrs MJ, 1996, NO LANDSCAPES OCCASI, V1; Strogatz S. H, 1994, NONLINEAR DYNAMICS C, V1st; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0	28	61	63	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					86	89		10.1038/nature09735	http://dx.doi.org/10.1038/nature09735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293376				2022-12-01	WOS:000286886400039
J	Spiegel, D				Spiegel, David			Mind Matters in Cancer Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METASTATIC BREAST-CANCER; TRIAL		Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Spiegel, D (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd,Off 2325, Stanford, CA 94305 USA.	dspiegel@stanford.edu		Spiegel, David/0000-0002-9476-9173	NATIONAL CANCER INSTITUTE [R01CA118567] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P30AT005886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG018784] Funding Source: NIH RePORTER; NCCIH NIH HHS [1 P30 AT00 5886] Funding Source: Medline; NCI NIH HHS [1 R01 CA118567] Funding Source: Medline; NIA NIH HHS [P01 AG18784] Funding Source: Medline; NIMH NIH HHS [R01 MH47226] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen BL, 2008, CANCER-AM CANCER SOC, V113, P3450, DOI 10.1002/cncr.23969; Giese-Davis J, 2011, J CLIN ONCOL, V29, P413, DOI 10.1200/JCO.2010.28.4455; Goodwin PJ, 2001, NEW ENGL J MED, V345, P1719, DOI 10.1056/NEJMoa011871; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; SPIEGEL D, 1989, LANCET, V2, P888; Spiegel D, 2007, CANCER-AM CANCER SOC, V110, P1130, DOI 10.1002/cncr.22890; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	10	44	44	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					502	503		10.1001/jama.2011.69	http://dx.doi.org/10.1001/jama.2011.69			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285429	Green Accepted			2022-12-01	WOS:000286810700025
J	Cao, Y; Jin, XS; Levin, EJ; Huang, H; Zong, YN; Quick, M; Weng, J; Pan, YP; Love, J; Punta, M; Rost, B; Hendrickson, WA; Javitch, JA; Rajashankar, KR; Zhou, M				Cao, Yu; Jin, Xiangshu; Levin, Elena J.; Huang, Hua; Zong, Yinong; Quick, Matthias; Weng, Jun; Pan, Yaping; Love, James; Punta, Marco; Rost, Burkhard; Hendrickson, Wayne A.; Javitch, Jonathan A.; Rajashankar, Kanagalaghatta R.; Zhou, Ming			Crystal structure of a phosphorylation-coupled saccharide transporter	NATURE			English	Article							COLI MANNITOL PERMEASE; BACTERIAL PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; MEMBRANE TOPOLOGY; CARBOHYDRATE TRANSPORTERS; CHITIN DISACCHARIDE; SUBSTRATE-BINDING; PHOSPHOENOLPYRUVATE; PROTEIN; N,N'-DIACETYLCHITOBIOSE	Saccharides have a central role in the nutrition of all living organisms. Whereas several saccharide uptake systems are shared between the different phylogenetic kingdoms, the phosphoenolpyruvate-dependent phosphotransferase system exists almost exclusively in bacteria. This multi-component system includes an integral membrane protein EIIC that transports saccharides and assists in their phosphorylation. Here we present the crystal structure of an EIIC from Bacillus cereus that transports diacetylchitobiose. The EIIC is a homodimer, with an expansive interface formed between the amino-terminal halves of the two protomers. The carboxy-terminal half of each protomer has a large binding pocket that contains a diacetylchitobiose, which is occluded from both sides of the membrane with its site of phosphorylation near the conserved His 250 and Glu 334 residues. The structure shows the architecture of this important class of transporters, identifies the determinants of substrate binding and phosphorylation, and provides a framework for understanding the mechanism of sugar translocation.	[Cao, Yu; Levin, Elena J.; Huang, Hua; Weng, Jun; Pan, Yaping; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Jin, Xiangshu] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Zong, Yinong] Sanford Burnham Inst, La Jolla, CA 92037 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Love, James; Punta, Marco; Rost, Burkhard; Hendrickson, Wayne A.] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, NE CAT, Adv Photon Source, Argonne, IL 60439 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Sanford Burnham Prebys Medical Discovery Institute; Columbia University; Columbia University; New York State Psychiatry Institute; Technical University of Munich; Technical University of Munich; Columbia University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu	Rost, Burkhard/A-1908-2016; Punta, Marco/ABH-4698-2020; Cao, Yu/GNP-6653-2022	Rost, Burkhard/0000-0003-0179-8424; Punta, Marco/0000-0002-0050-0676; Cao, Yu/0000-0003-1409-2068; Jin, Xiangshu/0000-0002-6551-8850; Javitch, Jonathan/0000-0001-7395-2967	US National Institutes of Health [DK088057, GM098878, GM05026-sub0007, T32HL087745];  [GM05026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087745, R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Data for this study were measured at beamlines X4A, X4C, X25 and X29 of the National Synchrotron Light Source and the NE-CAT 24ID-C and E at the Advanced Photon Source. This work was supported by the US National Institutes of Health (DK088057, GM098878 and GM05026-sub0007 to M.Z., and T32HL087745 to E.J.L.). M.Z. is a Pew Scholar in Biomedical Sciences. The NYCOMPS central facility was supported by GM05026 to W.A.H. as part of the Protein Structure Initiative (PSI-2) established by the National Institute of General Medical Sciences. The authors would like to thank B. Honig for support and M. Saier, B. Erni, R. Kaback and D.-N. Wang for comments on the manuscript and helpful discussions. M.Z. is grateful to R. MacKinnon for advice and encouragement.	Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BUHR A, 1993, J BIOL CHEM, V268, P11599; Chen Q, 1998, BIOCHEMISTRY-US, V37, P8714, DOI 10.1021/bi9731652; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNI B, 1986, BIOCHEMISTRY-US, V25, P305, DOI 10.1021/bi00350a004; Keyhani NO, 2000, J BIOL CHEM, V275, P33084, DOI 10.1074/jbc.M001043200; Keyhani NO, 1997, P NATL ACAD SCI USA, V94, P14367, DOI 10.1073/pnas.94.26.14367; KHANDEKAR SS, 1989, J CELL BIOCHEM, V39, P207, DOI 10.1002/jcb.240390212; Koning RI, 1999, J MOL BIOL, V287, P845, DOI 10.1006/jmbi.1999.2650; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; Lemieux MJ, 2004, CURR OPIN STRUC BIOL, V14, P405, DOI 10.1016/j.sbi.2004.06.003; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Nguyen TX, 2006, J MOL MICROB BIOTECH, V11, P345, DOI 10.1159/000095636; Opacic M, 2010, J BIOL CHEM, V285, P25324, DOI 10.1074/jbc.M110.122523; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAS HH, 1987, BIOCHEMISTRY-US, V26, P6689, DOI 10.1021/bi00395a019; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; REPHAELI AW, 1980, J BACTERIOL, V141, P658, DOI 10.1128/JB.141.2.658-663.1980; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; SaraceniRichards CA, 1997, J BACTERIOL, V179, P1135, DOI 10.1128/jb.179.4.1135-1142.1997; SaraceniRichards CA, 1997, J BACTERIOL, V179, P5171, DOI 10.1128/jb.179.16.5171-5177.1997; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; SUGIYAMA JE, 1991, P NATL ACAD SCI USA, V88, P9603, DOI 10.1073/pnas.88.21.9603; van Montfort BA, 2002, J BIOL CHEM, V277, P14717, DOI 10.1074/jbc.M201533200; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WENG QP, 1992, J BIOL CHEM, V267, P19529; WENG QP, 1993, BIOCHEMISTRY-US, V32, P11211, DOI 10.1021/bi00092a034; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Yagur-Kroll S, 2005, J BIOL CHEM, V280, P19306, DOI 10.1074/jbc.M410896200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020	50	67	67	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					50	U58		10.1038/nature09939	http://dx.doi.org/10.1038/nature09939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471968	Green Accepted			2022-12-01	WOS:000290218300028
J	Montpetit, B; Thomsen, ND; Helmke, KJ; Seeliger, MA; Berger, JM; Weis, K				Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten			A conserved mechanism of DEAD-box ATPase activation by nucleoporins and InsP(6) in mRNA export	NATURE			English	Article							PROTEIN DBP5; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HELICASE; COMPLEX; DOMAIN; EIF4A; CRYSTALLOGRAPHY; REVEALS; NUP214	Superfamily 1 and superfamily 2 RNA helicases are ubiquitous messenger-RNA-protein complex (mRNP) remodelling enzymes that have critical roles in all aspects of RNA metabolism(1,2). The superfamily 2 DEAD-box ATPase Dbp5 (human DDX19) functions in mRNA export and is thought to remodel mRNPs at the nuclear pore complex (NPC)(3-8). Dbp5 is localized to the NPC via an interaction with Nup159 (NUP214 in vertebrates)(3-5,8,9) and is locally activated there by Gle1 together with the small-molecule inositol hexakisphosphate (InsP(6))(10,11). Local activation of Dbp5 at the NPC by Gle1 is essential for mRNA export in vivo(10,12); however, the mechanistic role of Dbp5 in mRNP export is poorly understood and it is not known how Gle1(InsP6) and Nup159 regulate the activity of Dbp5. Here we report, from yeast, structures of Dbp5 in complex with Gle1(InsP6), Nup159/Gle1(InsP6) and RNA. These structures reveal that InsP6 functions as a small-molecule tether for the Gle1-Dbp5 interaction. Surprisingly, the Gle1(InsP6)-Dbp5 complex is structurally similar to another DEAD-box ATPase complex essential for translation initiation, eIF4G-eIF4A, and we demonstrate that Gle1(InsP6) and eIF4G both activate their DEAD-box partner by stimulating RNA release. Furthermore, Gle1(InsP6) relieves Dbp5 autoregulation and cooperates with Nup159 in stabilizing an open Dbp5 intermediate that precludes RNA binding. These findings explain how Gle1(InsP6), Nup159 and Dbp5 collaborate in mRNA export and provide a general mechanism for DEAD-box ATPase regulation by Gle1/eIF4G-like activators.	[Montpetit, Ben; Helmke, Kara J.; Weis, Karsten] Univ Calif Berkeley, Div Cell & Dev Biol, Berkeley, CA 94720 USA; [Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Thomsen, Nathan D.; Seeliger, Markus A.; Berger, James M.] Univ Calif Berkeley, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Weis, K (corresponding author), Univ Calif Berkeley, Div Cell & Dev Biol, Berkeley, CA 94720 USA.	jmberger@berkeley.edu; kweis@berkeley.edu	Seeliger, Markus A/D-6409-2013; Weis, Karsten/F-5719-2011; Montpetit, Ben/L-6456-2019	Weis, Karsten/0000-0001-7224-925X; Montpetit, Ben/0000-0002-8317-983X; Seeliger, Markus/0000-0003-0990-1756	G Harold and Leila Y Mathers foundation; NIH [R01GM58065, RC1GM91533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232, RC1GM091533, R01GM058065, R00GM080097] Funding Source: NIH RePORTER	G Harold and Leila Y Mathers foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kirsch, J. Thorner, M. Welch, D. Wemmer, B. Krantz, J. Zorn and all J.M.B. and K.W. laboratory members for discussions and advice. We also thank J. Kuriyan, M. Welch and S. Marqusee for access to equipment and workspace; J. Tanamachi, G. Meigs and J. Holton at ALS beamline 8.3.1; and N. Echols for assistance with programs from the Yale Morph Server. Research was supported by the G Harold and Leila Y Mathers foundation (J.M.B.) and the NIH (K.W., R01GM58065 and RC1GM91533).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dossani ZY, 2009, P NATL ACAD SCI USA, V106, P16251, DOI 10.1073/pnas.0902251106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan JS, 2009, J MOL BIOL, V388, P1, DOI 10.1016/j.jmb.2009.03.004; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032	40	178	184	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					238	242		10.1038/nature09862	http://dx.doi.org/10.1038/nature09862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21441902	Green Accepted			2022-12-01	WOS:000289469100047
J	Wochner, A; Attwater, J; Coulson, A; Holliger, P				Wochner, Aniela; Attwater, James; Coulson, Alan; Holliger, Philipp			Ribozyme-Catalyzed Transcription of an Active Ribozyme	SCIENCE			English	Article							RNA-POLYMERASE RIBOZYME; MOLECULAR EVOLUTION; POLYMERIZATION; EXTENSION; SELECTION; SEQUENCES; LIGANDS	A critical event in the origin of life is thought to have been the emergence of an RNA molecule capable of replicating a primordial RNA "genome." Here we describe the evolution and engineering of an RNA polymerase ribozyme capable of synthesizing RNAs of up to 95 nucleotides in length. To overcome its sequence dependence, we recombined traits evolved separately in different ribozyme lineages. This yielded a more general polymerase ribozyme that was able to synthesize a wider spectrum of RNA sequences, as we demonstrate by the accurate synthesis of an enzymatically active RNA, a hammerhead endonuclease ribozyme. This recapitulates a central aspect of an RNA-based genetic system: the RNA-catalyzed synthesis of an active ribozyme from an RNA template.	[Wochner, Aniela; Attwater, James; Coulson, Alan; Holliger, Philipp] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Holliger, P (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ph1@mrc-lmb.cam.ac.uk	daehun, lee/H-2435-2013	Attwater, James/0000-0002-7244-9910	Medical Research Council (MRC) [MC_US_A024_0014]; Medical Research Council [MC_U105178804] Funding Source: researchfish; MRC [MC_U105178804] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to M. Daly for assistance with FACS and to our colleagues V. B. Pinheiro, C. Cozens, A. Taylor, and J. Sutherland for helpful discussions. This work was supported by the Medical Research Council (MRC) program grant MC_US_A024_0014.	Attwater J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1076; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GESTELAND R, 2005, RNA WORLD NATURE MOD; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joyce GF, 2007, SCIENCE, V315, P1507, DOI 10.1126/science.1140736; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; McCall MJ, 2000, MOL BIOTECHNOL, V14, P5, DOI 10.1385/MB:14:1:5; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Shechner DM, 2009, SCIENCE, V326, P1271, DOI 10.1126/science.1174676; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Wang QS, 2011, RNA, V17, P469, DOI 10.1261/rna.2495011; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	235	247	5	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					209	212		10.1126/science.1200752	http://dx.doi.org/10.1126/science.1200752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474753				2022-12-01	WOS:000289251100043
J	Premsrirut, PK; Dow, LE; Kim, SY; Camiolo, M; Malone, CD; Miething, C; Scuoppo, C; Zuber, J; Dickins, RA; Kogan, SC; Shroyer, KR; Sordella, R; Hannon, GJ; Lowe, SW				Premsrirut, Prem K.; Dow, Lukas E.; Kim, Sang Yong; Camiolo, Matthew; Malone, Colin D.; Miething, Cornelius; Scuoppo, Claudio; Zuber, Johannes; Dickins, Ross A.; Kogan, Scott C.; Shroyer, Kenneth R.; Sordella, Raffaella; Hannon, Gregory J.; Lowe, Scott W.			A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference	CELL			English	Article							TRANSGENIC MICE; STEM-CELLS; MOUSE; EXPRESSION; DIFFERENTIATION; APC; DISRUPTION; ACTIVATION; RAS	RNA interference is a powerful tool for studying gene function, however, the reproducible generation of RNAi transgenic mice remains a significant limitation. By combining optimized fluorescence-coupled miR30-based shRNAs with high efficiency ES cell targeting, we developed a fast, scalable pipeline for the production of shRNA transgenic mice. Using this system, we generated eight tet-regulated shRNA transgenic lines targeting Firefly and Renilla luciferases, Oct4 and tumor suppressors p53, p16(INK4a), p19(ARF) and APC and demonstrate potent gene silencing and GFP-tracked knockdown in a broad range of tissues in vivo. Further, using an shRNA targeting APC, we illustrate how this approach can identify predicted phenotypes and also unknown functions for a well-studied gene. In addition, through regulated gene silencing we validate APC/Wnt and p19(ARF) as potential therapeutic targets in T cell acute lymphoblastic leukemia/lymphoma and lung adenocarcinoma, respectively. This system provides a cost-effective and scalable platform for the production of RNAi transgenic mice targeting any mammalian gene.	[Premsrirut, Prem K.; Dow, Lukas E.; Kim, Sang Yong; Camiolo, Matthew; Malone, Colin D.; Miething, Cornelius; Scuoppo, Claudio; Zuber, Johannes; Dickins, Ross A.; Sordella, Raffaella; Hannon, Gregory J.; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Malone, Colin D.; Scuoppo, Claudio] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Hannon, Gregory J.; Lowe, Scott W.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Premsrirut, Prem K.; Camiolo, Matthew] SUNY Stony Brook, Med Ctr, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Shroyer, Kenneth R.] SUNY Stony Brook, Med Ctr, Dept Pathol, Stony Brook, NY 11794 USA; [Dickins, Ross A.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3052, Australia; [Kogan, Scott C.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Kogan, Scott C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Walter & Eliza Hall Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Zuber, Johannes/E-7517-2011; Hannon, Gregory/AAB-3568-2019; Dickins, Ross A/K-2852-2012; Miething, Cornelius/F-9498-2014	Zuber, Johannes/0000-0001-8810-6835; Dickins, Ross A/0000-0003-4112-5304; Miething, Cornelius/0000-0003-4699-3805; Dow, Lukas/0000-0001-7048-1418; Kogan, Scott/0000-0002-2395-8479; Kim, Sang Yong/0000-0001-7326-7505	National Cancer Institute; National Health & Medical Research Council of Australia; Deutsche Forschungsgemeinschaft; AACR-Astellas USA Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, R01GM062534] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); AACR-Astellas USA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Beard and R. Jaenisch (Whitehead Institute) for pBS31 flp-in and pCAGs-FLPe-Puro vectors, ColA1 3' probe and KH2 ES cells; X. Guo, Y. Park, and P.W.J. Russell for discussions and assistance in procedures; and E. McGlinn and C. Tabin (Harvard Medical School) for advice with the skeletal preparations of embryos. Thanks to L. Bianco, J. Coblentz, E. Earl, and the Cold Spring Harbor Laboratory animal house staff. We gratefully acknowledge Janelle Simon, Danielle Grace, and Jacqueline Cappellani for technical assistance, and members of the Lowe laboratory for advice and discussions. This study was supported by a Mouse Models of Human Cancer Consortium grant, a program project grant from the National Cancer Institute, and philanthropic support from the Don Monti Research Foundation. P. K. P is MSTP Fellow of Stony Brook University, L. E. D. is supported by a National Health & Medical Research Council of Australia overseas Biomedical Training Fellowship, C. M. was supported by a fellowship from the Deutsche Forschungsgemeinschaft and a AACR-Astellas USA Foundation Fellowship in Basic Cancer Research, J.Z. is the Andrew Seligson Memorial Fellow, R. A. D is a VESKI Fellow, and G. J. H and S. W. L. are Howard Hughes Medical Institute investigators. P. K. P, G. J. H, and S. W. L. are founders on the scientific advisory board of Mirimus, Inc., a company that has licensed technology related to this work.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kado M, 2008, BIOCHEM BIOPH RES CO, V377, P413, DOI 10.1016/j.bbrc.2008.09.160; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Miclea RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-26; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Yang Y, 2005, LEUKEMIA RES, V29, P47, DOI 10.1016/j.leukres.2004.05.004; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	43	222	231	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					145	158		10.1016/j.cell.2011.03.012	http://dx.doi.org/10.1016/j.cell.2011.03.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458673	Green Accepted, Bronze			2022-12-01	WOS:000289053900016
J	Choe, HW; Kim, YJ; Park, JH; Morizumi, T; Pai, EF; Krauss, N; Hofmann, KP; Scheerer, P; Ernst, OP				Choe, Hui-Woog; Kim, Yong Ju; Park, Jung Hee; Morizumi, Takefumi; Pai, Emil F.; Krauss, Norbert; Hofmann, Klaus Peter; Scheerer, Patrick; Ernst, Oliver P.			Crystal structure of metarhodopsin II	NATURE			English	Article							HELIX MOVEMENT; RHODOPSIN; ACTIVATION; TRANSDUCIN; LIGAND; DISPLACEMENT; CONFORMATION; SPECTROSCOPY; OPSIN; LIGHT	G-protein-coupled receptors (GPCRs) are seven transmembrane helix (TM) proteins that transduce signals into living cells by binding extracellular ligands and coupling to intracellular heterotrimeric Gproteins (G alpha beta gamma)(1). The photoreceptor rhodopsin couples to transducin and bears its ligand 11-cis-retinal covalently bound via a protonated Schiff base to the opsin apoprotein(2). Absorption of a photon causes retinal cis/trans isomerization and generates the agonist all-trans-retinal in situ. After early photoproducts, the active G-protein-binding intermediate metarhodopsin II (Meta II) is formed, in which the retinal Schiff base is still intact but deprotonated. Dissociation of the proton from the Schiff base breaks a major constraint in the protein and enables further activating steps, including an outward tilt of TM6 and formation of a large cytoplasmic crevice for uptake of the interacting C terminus of the G alpha subunit(3-5). Owing to Schiff base hydrolysis, Meta II is short-lived and notoriously difficult to crystallize. We therefore soaked opsin crystals with all-trans-retinal to form Meta II, presuming that the crystal's high concentration of opsin in an active conformation (Ops*)(6,7) may facilitate all-trans-retinal uptake and Schiff base formation. Here we present the 3.0 angstrom and 2.85 angstrom crystal structures, respectively, of Meta II alone or in complex with an 11-amino-acid C-terminal fragment derived from G alpha (G alpha CT2). G alpha CT2 binds in a large crevice at the cytoplasmic side, akin to the binding of a similar G alpha-derived peptide to Ops* (ref. 7). In the Meta II structures, the electron density from the retinal ligand seamlessly continues into the Lys 296 side chain, reflecting proper formation of the Schiff base linkage. The retinal is in a relaxed conformation and almost undistorted compared with pure crystalline all-trans-retinal. By comparison with early photoproducts we propose how retinal translocation and rotation induce the gross conformational changes characteristic for Meta II. The structures can now serve as models for the large GPCR family.	[Choe, Hui-Woog; Kim, Yong Ju; Park, Jung Hee; Morizumi, Takefumi; Hofmann, Klaus Peter; Scheerer, Patrick; Ernst, Oliver P.] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju 561756, South Korea; [Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jeonbuk National University; University of Toronto; University of Toronto; University of Toronto; University of London; Queen Mary University London; Humboldt University of Berlin	Choe, HW (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charite Pl 1, D-10117 Berlin, Germany.	hwchoe@jbnu.ac.kr; klaus_peter.hofmann@charite.de; oliver.ernst@utoronto.ca	Pai, Emil/R-8908-2019; Morizumi, Takefumi/AAA-2063-2021; Pai, Emil F/D-2526-2013	Pai, Emil/0000-0002-1162-7242; Morizumi, Takefumi/0000-0002-2785-209X; Scheerer, Patrick/0000-0001-5028-2075; Krauss, Norbert/0000-0002-7128-4632	DFG [Sfb449, Sfb740]; ERC; Canada Research Chairs Program; Ministry of Education, Science and Technology [2010-0002738]; CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Canada Research Chairs Program(Canada Research Chairs); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	We thank J. Engelmann, C. Koch and B. Bauer for technical assistance, and F. Siebert and W. Hubbell for critically reading the manuscript. We are grateful to the European Synchrotron Radiation Facility (ESRF, Grenoble), D. von Stetten and A. Royant of the ID29S-Cryobench (ESRF, Grenoble) and U. Muller and the scientific staff of the BESSY-MX/Helmholtz Zentrum Berlin fur Materialien und Energie at beamlines BL 14.1 and BL 14.2, where the data were collected, for continuous support. This work was supported by the DFG Sfb449 (to O.P.E.), Sfb740 (to O.P.E. and K.P.H.) and an Advanced Investigator ERC grant (to K.P.H.) and by the Canada Research Chairs Program (to E.F.P.). H.-W.C. gratefully acknowledges the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0002738) and CBNU funds for overseas research 2009. Y.J.K. thanks the Leibniz Graduate School of Molecular Biophysics, Berlin, for a scholarship.	Ahuja S, 2009, J AM CHEM SOC, V131, P15160, DOI 10.1021/ja9034768; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe HW, 2011, NEUROPHARMACOLOGY, V60, P52, DOI 10.1016/j.neuropharm.2010.07.018; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ernst OP, 2000, METHOD ENZYMOL, V315, P471; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fujimoto Y, 2001, CHEM-EUR J, V7, P4198, DOI 10.1002/1521-3765(20011001)7:19<4198::AID-CHEM4198>3.0.CO;2-X; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knierim B, 2008, J BIOL CHEM, V283, P4967, DOI 10.1074/jbc.M703059200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Salgado GFJ, 2006, J AM CHEM SOC, V128, P11067, DOI 10.1021/ja058738+; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Siebert F, 1995, ISRAEL J CHEM, V35, P309; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948	43	517	522	4	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					651	U137		10.1038/nature09789	http://dx.doi.org/10.1038/nature09789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21389988				2022-12-01	WOS:000288951200046
J	Deweerdt, S				Deweerdt, Sarah			FOOD The omnivore's labyrinth	NATURE			English	Editorial Material							CANCER INCIDENCE; RISK											ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; Lampe JW, 2009, AM J CLIN NUTR, V89, pS1553, DOI 10.3945/ajcn.2009.26736D; Maskarinec G, 2004, ETHNIC DIS, V14, P431; Navarro SL, 2009, CANCER PREV RES, V2, P345, DOI 10.1158/1940-6207.CAPR-08-0178; Wu AH, 2008, BRIT J CANCER, V98, P9, DOI 10.1038/sj.bjc.6604145; ZHANG Y, 1994, P NATL ACAD SCI USA, V12; ZHANG Y, 1992, P NATL ACAD SCI USA, V15, P2399	10	18	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S22	S24		10.1038/471S22a	http://dx.doi.org/10.1038/471S22a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430718				2022-12-01	WOS:000288702200018
J	Curry, LA; Spatz, E; Cherlin, E; Thompson, JW; Berg, D; Ting, HH; Decker, C; Krumholz, HM; Bradley, EH				Curry, Leslie A.; Spatz, Erica; Cherlin, Emily; Thompson, Jennifer W.; Berg, David; Ting, Henry H.; Decker, Carole; Krumholz, Harlan M.; Bradley, Elizabeth H.			What Distinguishes Top-Performing Hospitals in Acute Myocardial Infarction Mortality Rates? A Qualitative Study	ANNALS OF INTERNAL MEDICINE			English	Article							ELDERLY-PATIENTS; OF-CARE; UNITED-STATES; OUTCOMES; CONSEQUENCES; ALLIANCE; FAILURE; IMPROVE; CULTURE; PROJECT	Background: Mortality rates for patients with acute myocardial infarction (AMI) vary substantially across hospitals, even when adjusted for patient severity; however, little is known about hospital factors that may influence this variation. Objective: To identify factors that may be related to better performance in AMI care, as measured by risk-standardized mortality rates. Design: Qualitative study that used site visits and in-depth interviews. Setting: Eleven U.S. hospitals that ranked in either the top or the bottom 5% in risk-standardized mortality rates for 2 recent years of data from the Centers for Medicare & Medicaid Services (2005 to 2006 and 2006 to 2007), with diversity among hospitals in key characteristics. Participants: 158 members of hospital staff, all of whom were involved with AMI care at the 11 hospitals. Measurements: Site visits and in-depth interviews conducted with hospital staff during 2009. A multidisciplinary team performed analyses by using the constant comparative method. Results: Hospitals in the high-performing and low-performing groups differed substantially in the domains of organizational values and goals, senior management involvement, broad staff presence and expertise in AMI care, communication and coordination among groups, and problem solving and learning. Participants described diverse protocols or processes for AMI care (such as rapid response teams, clinical guidelines, use of hospitalists, and medication reconciliation); however, these did not systematically differentiate high-performing from low-performing hospitals. Limitation: The qualitative design informed the generation of hypotheses, and statistical associations could not be assessed. Conclusion: High-performing hospitals were characterized by an organizational culture that supported efforts to improve AMI care across the hospital. Evidence-based protocols and processes, although important, may not be sufficient for achieving high hospital performance in care for patients with AMI.			Curry, LA (corresponding author), 60 Coll St,Box 208034, New Haven, CT 06520 USA.	leslie.curry@yale.edu	curry, leslie/AAA-6100-2022; , Harlan/AAI-2875-2020	curry, leslie/0000-0002-3419-4654; 	Agency for Healthcare Research and Quality [R01-HS-016929]; United Health Foundation; Commonwealth Fund [20090565]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS016929] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [U01FD004585] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); United Health Foundation; Commonwealth Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Grant Support: By the Agency for Healthcare Research and Quality (R01-HS-016929), United Health Foundation, and the Commonwealth Fund (20090565).	Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Bradley Elizabeth H, 2007, Crit Pathw Cardiol, V6, P91, DOI 10.1097/HPC.0b013e31812da7bc; Bradley EH, 2010, AM J CARDIOL, V106, P1108, DOI 10.1016/j.amjcard.2010.06.014; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Bradley EH, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-25; CLARITAS N, 2009, POPULATION FACTS 200; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Glaser B. G., 1978, THEORETICAL SENSITIV; GORDON GG, 1992, J MANAGE STUD, V29, P783, DOI 10.1111/j.1467-6486.1992.tb00689.x; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; Inui TS, 1996, ANN INTERN MED, V125, P770, DOI 10.7326/0003-4819-125-9-199611010-00012; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Lincoln Y.S., 1986, NATURALISTIC INQUIRY, V1986, P73, DOI 10.1002/ev.1427; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Marsh DR, 2004, BMJ-BRIT MED J, V329, P1177, DOI 10.1136/bmj.329.7475.1177; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Miles M., 2019, QUALITATIVE DATA ANA, V4th; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd ed.; Popescu I, 2009, CIRC-CARDIOVASC QUAL, V2, P221, DOI 10.1161/CIRCOUTCOMES.108.813790; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; SPEAR SJ, 1999, HARVARD BUS REV, P96; Sternin J, 2000, HARVARD BUS REV, V78, P14; Sudman S., 1996, THINKING ANSWERS APP, V1; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; van Dyck C, 2005, J APPL PSYCHOL, V90, P1228, DOI 10.1037/0021-9010.90.6.1228	39	225	225	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					384	+		10.7326/0003-4819-154-6-201103150-00003	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734WA	21403074	Green Accepted			2022-12-01	WOS:000288370000002
J	Fuller, J; Wright, A				Fuller, John; Wright, Andrew			A Patient's Journey Adult atopic eczema	BRITISH MEDICAL JOURNAL			English	Editorial Material												somersettalk@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 14	2011	342								d644	10.1136/bmj.d644	http://dx.doi.org/10.1136/bmj.d644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739EZ	21402667				2022-12-01	WOS:000288697700004
J	Carter, AP; Cho, C; Jin, L; Vale, RD				Carter, Andrew P.; Cho, Carol; Jin, Lan; Vale, Ronald D.			Crystal Structure of the Dynein Motor Domain	SCIENCE			English	Article							MICROTUBULE-BINDING DOMAIN; ENERGY TRANSDUCTION; COILED-COIL; MECHANISMS; ATPASE; PROCESSIVITY; HYDROLYSIS; RESOLUTION; REVEALS; MOTIONS	Dyneins are microtubule-based motor proteins that power ciliary beating, transport intracellular cargos, and help to construct the mitotic spindle. Evolved from ring-shaped hexameric AAA-family adenosine triphosphatases (ATPases), dynein's large size and complexity have posed challenges for understanding its structure and mechanism. Here, we present a 6 angstrom crystal structure of a functional dimer of two similar to 300-kilodalton motor domains of yeast cytoplasmic dynein. The structure reveals an unusual asymmetric arrangement of ATPase domains in the ring-shaped motor domain, the manner in which the mechanical element interacts with the ATPase ring, and an unexpected interaction between two coiled coils that create a base for the microtubule binding domain. The arrangement of these elements provides clues as to how adenosine triphosphate-driven conformational changes might be transmitted across the motor domain.	[Carter, Andrew P.; Cho, Carol; Jin, Lan; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Carter, Andrew P.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Howard Hughes Medical Institute; University of California System; University of California San Francisco; MRC Laboratory Molecular Biology	Carter, AP (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	cartera@mrc-lmb.cam.ac.uk; vale@cmp.ucsf.edu		Carter, Andrew/0000-0001-7292-5430; Cho, Carol/0000-0003-4070-6561	NIH; Jane Coffin Child Foundation; Lymphoma and Leukemia Foundation; American Heart Association; Genentech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097312] Funding Source: NIH RePORTER; MRC [MC_UP_A025_1011] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1011] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Child Foundation; Lymphoma and Leukemia Foundation; American Heart Association(American Heart Association); Genentech(Roche HoldingGenentech); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank N. Zhang (UCSF), J. Holton (Advanced Light Source), H. Schmidt (MRC), E. Gleave (MRC), and M. Sirajuddin (UCSF) for their assistance and helpful discussions. This work was supported by the NIH (R.D.V.), Jane Coffin Child Foundation (A.P.C.), Lymphoma and Leukemia Foundation (A.P.C.), American Heart Association (C.C.), and Genentech Graduate Student Fellowship (C.C.). The PDB accession number for this dynein dimer structure is 3QMZ.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Bushnell DA, 2001, STRUCTURE, V9, pR11, DOI 10.1016/S0969-2126(00)00554-2; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Neuwald AF, 1999, GENOME RES, V9, P27; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Serohijos AWR, 2006, P NATL ACAD SCI USA, V103, P18540, DOI 10.1073/pnas.0602867103; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X	37	173	175	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1159	1165		10.1126/science.1202393	http://dx.doi.org/10.1126/science.1202393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21330489	Green Accepted			2022-12-01	WOS:000287971200033
J	Wertz, IE; Kusam, S; Lam, C; Okamoto, T; Sandoval, W; Anderson, DJ; Helgason, E; Ernst, JA; Eby, M; Liu, JF; Belmont, LD; Kaminker, JS; O'Rourke, KM; Pujara, K; Kohli, PB; Johnson, AR; Chiu, ML; Lill, JR; Jackson, PK; Fairbrother, WJ; Seshagiri, S; Ludlam, MJC; Leong, KG; Dueber, EC; Maecker, H; Huang, DCS; Dixit, VM				Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Okamoto, Toru; Sandoval, Wendy; Anderson, Daniel J.; Helgason, Elizabeth; Ernst, James A.; Eby, Mike; Liu, Jinfeng; Belmont, Lisa D.; Kaminker, Josh S.; O'Rourke, Karen M.; Pujara, Kanan; Kohli, Pawan Bir; Johnson, Adam R.; Chiu, Mark L.; Lill, Jennie R.; Jackson, Peter K.; Fairbrother, Wayne J.; Seshagiri, Somasekar; Ludlam, Mary J. C.; Leong, Kevin G.; Dueber, Erin C.; Maecker, Heather; Huang, David C. S.; Dixit, Vishva M.			Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7	NATURE			English	Article							UBIQUITIN LIGASE; MITOTIC EXIT; CANCER; CELLS; APOPTOSIS; RESISTANCE; CATALYZES; PROTEINS; DIVISION	Microtubules have pivotal roles in fundamental cellular processes and are targets of antitubulin chemotherapeutics(1). Microtubule-targeted agents such as Taxol and vincristine are prescribed widely for various malignancies, including ovarian and breast adenocarcinomas, non-small-cell lung cancer, leukaemias and lymphomas(1). These agents arrest cells in mitosis and subsequently induce cell death through poorly defined mechanisms(2). The strategies that resistant tumour cells use to evade death induced by antitubulin agents are also unclear(2). Here we show that the pro-survival protein MCL1 (ref. 3) is a crucial regulator of apoptosis triggered by antitubulin chemotherapeutics. During mitotic arrest, MCL1 protein levels decline markedly, through a post-translational mechanism, potentiating cell death. Phosphorylation of MCL1 directs its interaction with the tumour-suppressor protein FBW7, which is the substrate-binding component of a ubiquitin ligase complex. The polyubiquitylation of MCL1 then targets it for proteasomal degradation. The degradation of MCL1 was blocked in patient-derived tumour cells that lacked FBW7 or had loss-of-function mutations in FBW7, conferring resistance to antitubulin agents and promoting chemotherapeutic-induced polyploidy. Additionally, primary tumour samples were enriched for FBW7 inactivation and elevated MCL1 levels, underscoring the prominent roles of these proteins in oncogenesis. Our findings suggest that profiling the FBW7 and MCL1 status of tumours, in terms of protein levels, messenger RNA levels and genetic status, could be useful to predict the response of patients to antitubulin chemotherapeutics.	[Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Helgason, Elizabeth; Ernst, James A.; Fairbrother, Wayne J.; Dueber, Erin C.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Okamoto, Toru; Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Sandoval, Wendy; Ernst, James A.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Anderson, Daniel J.; Eby, Mike; Belmont, Lisa D.; Jackson, Peter K.; Ludlam, Mary J. C.; Leong, Kevin G.; Maecker, Heather] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Liu, Jinfeng; Kaminker, Josh S.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [O'Rourke, Karen M.; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Pujara, Kanan; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kohli, Pawan Bir; Johnson, Adam R.] Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA; [Chiu, Mark L.] Abbott Labs, Dept Biol Struct, Abbott Pk, IL 60064 USA; [Huang, David C. S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Roche Holding; Genentech; Walter & Eliza Hall Institute; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Abbott Laboratories; University of Melbourne	Wertz, IE (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	ingrid@gene.com	dixit, vishva m/A-4496-2012; Huang, David C. S./C-7586-2013; chiu, mark/AAK-2756-2021	dixit, vishva m/0000-0001-6983-0326; Huang, David C. S./0000-0002-3101-4873; Liu, Jinfeng/0000-0002-0343-8222; Jackson, Peter/0000-0002-1742-2539; Seshagiri, Somasekar/0000-0003-4272-6443; Chiu, Mark/0000-0001-6300-404X; Anderson, Daniel/0000-0002-3249-2439; Helgason, Elizabeth/0000-0002-0397-9125; Maecker, Heather/0000-0002-5378-1141	National Health and Medical Research Council [461221, 361646]; Leukemia and Lymphoma Society [SCOR 7413]; National Institutes of Health [CA043540, CA80188]; Australian Cancer Research Foundation; Australian Research Council; NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Cancer Research Foundation; Australian Research Council(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Ekert for FDM cell lines, J. Stinson for sequencing assistance, S. Johnson and C. Santos for assistance with obtaining patient samples, P. Haverty for bioinformatics analysis, C. Grimaldi for cloning assistance, J. Dynek for TaqMan advice, D. French for tumour analysis, C. Quan and J. Tom for peptide synthesis, I. Zilberleyb and the Baculovirus Expression Group for cloning and protein production, S. Charuvu for generating MCL1 point mutants, A. Bruce for graphics assistance, the Genentech Cancer Genome Project Team, Z. Modrusan, R. Soriano and the microarray lab for ovarian tumour data sets, K. Newton for editorial assistance, W. Wei for sharing unpublished results, and A. Eldridge, D. Kirkpatrick, D. Vucic, E. Varfolomeev, T. Goncharov, A. Cochran, O. Huang, A. Huang, Y. Pereg, A. Loktev, D. Phillips, J. Wu, M. van Delft, D. Eaton, E. Shaulian, T. Hunter, S. Cory, J. Adams, A. Strasser, R. Deshaies and G. Evan for discussions. Work in the Huang laboratory is supported by the National Health and Medical Research Council (program grant #461221, IRIISS grant #361646 and a fellowship to D.C.S.H.), the Leukemia and Lymphoma Society (SCOR 7413), the National Institutes of Health (grants CA043540 and CA80188), the Australian Cancer Research Foundation, and an Australian Research Council Australian Postdoctoral fellowship to T.O. We apologize to our colleagues whose primary work could not be cited owing to space constraints.	Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Finkin S, 2008, ONCOGENE, V27, P4411, DOI 10.1038/onc.2008.77; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Mesquita B, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-101; Ozalp SS, 2002, EUR J GYNAECOL ONCOL, V23, P337; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	20	593	618	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					110	114		10.1038/nature09779	http://dx.doi.org/10.1038/nature09779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368834				2022-12-01	WOS:000287924100044
J	Kuepper, R; van Os, J; Lieb, R; Wittchen, HU; Hofler, M; Henquet, C				Kuepper, Rebecca; van Os, Jim; Lieb, Roselind; Wittchen, Hans-Ulrich; Hoefler, Michael; Henquet, Cecile			Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; EARLY DEVELOPMENTAL-STAGES; BEHAVIORAL SENSITIZATION; GENERAL-POPULATION; CROSS-SENSITIZATION; SWEDISH CONSCRIPTS; USE DISORDERS; SCHIZOPHRENIA; PSYCHOPATHOLOGY; RELIABILITY	Objective To determine whether use of cannabis in adolescence increases the risk for psychotic outcomes by affecting the incidence and persistence of subclinical expression of psychosis in the general population (that is, expression of psychosis below the level required for a clinical diagnosis). Design Analysis of data from a prospective population based cohort study in Germany (early developmental stages of psychopathology study). Setting Population based cohort study in Germany. Participants 1923 individuals from the general population, aged 14-24 at baseline. Main outcome measure Incidence and persistence of subthreshold psychotic symptoms after use of cannabis in adolescence. Cannabis use and psychotic symptoms were assessed at three time points (baseline, T2 (3.5 years), T3 (8.4 years)) over a 10 year follow-up period with the Munich version of the composite international diagnostic interview (M-CIDI). Results In individuals who had no reported lifetime psychotic symptoms and no reported lifetime cannabis use at baseline, incident cannabis use over the period from baseline to T2 increased the risk of later incident psychotic symptoms over the period from T2 to T3 (adjusted odds ratio 1.9, 95% confidence interval 1.1 to 3.1; P=0.021). Furthermore, continued use of cannabis increased the risk of persistent psychotic symptoms over the period from T2 to T3 (2.2, 1.2 to 4.2; P=0.016). The incidence rate of psychotic symptoms over the period from baseline to T2 was 31% (152) in exposed individuals versus 20% (284) in non-exposed individuals; over the period from T2 to T3 these rates were 14% (108) and 8% (49), respectively. Conclusion Cannabis use is a risk factor for the development of incident psychotic symptoms. Continued cannabis use might increase the risk for psychotic disorder by impacting on the persistence of symptoms.	[Kuepper, Rebecca; van Os, Jim; Henquet, Cecile] Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol,EURON, S Limburg Mental Hlth Res & Teaching Network, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England; [Lieb, Roselind] Univ Basel, Dept Psychol, Div Epidemiol & Hlth Psychol, CH-4003 Basel, Switzerland; [Lieb, Roselind; Wittchen, Hans-Ulrich] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wittchen, Hans-Ulrich; Hoefler, Michael] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany	Maastricht University; University of London; King's College London; University of Basel; Max Planck Society; Technische Universitat Dresden	van Os, J (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol,EURON, S Limburg Mental Hlth Res & Teaching Network, POB 616, NL-6200 MD Maastricht, Netherlands.	j.vanos@sp.unimaas.nl	Wittchen, Hans-Ulrich/A-8507-2014; Wittchen, Hans-Ulrich/ABA-8901-2020; van Os, Jim/I-9496-2012; van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Hofler, Michael/A-8153-2014	Wittchen, Hans-Ulrich/0000-0002-6311-7711; van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Hofler, Michael/0000-0001-7646-8265	German Ministry of Research, Education and Technology [01EB9405/6, 01EB9901/6]; Deutsche Forschungsgemeinschaft (DFG); NIH [RO1DA016977-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016977] Funding Source: NIH RePORTER	German Ministry of Research, Education and Technology; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The EDSP study is funded by grants of the German Ministry of Research, Education and Technology (01EB9405/6 and 01EB9901/6) and the Deutsche Forschungsgemeinschaft (DFG), and this paper is part of NIH grant RO1DA016977-01, PL.	ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Arseneault L, 2004, BRIT J PSYCHIAT, V184, P110, DOI 10.1192/bjp.184.2.110; Cadoni C, 2001, PSYCHOPHARMACOLOGY, V158, P259, DOI 10.1007/s002130100875; Cadoni C, 2008, J NEUROCHEM, V106, P1586, DOI 10.1111/j.1471-4159.2008.05503.x; Collip D, 2008, SCHIZOPHRENIA BULL, V34, P220, DOI 10.1093/schbul/sbm163; COTTLER LB, 1991, DRUG ALCOHOL DEPEN, V29, P17, DOI 10.1016/0376-8716(91)90018-T; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Degenhardt L, 2006, CAN J PSYCHIAT, V51, P556, DOI 10.1177/070674370605100903; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Ferdinand RF, 2005, ADDICTION, V100, P612, DOI 10.1111/j.1360-0443.2005.01070.x; Fisher HL, 2009, SCHIZOPHR B     1007; Grech A, 2005, EUR PSYCHIAT, V20, P349, DOI 10.1016/j.eurpsy.2004.09.013; *GROUP INV, 2010, ARCH GEN PSYCHI 1004; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Howes OD, 2004, INT J NEUROPSYCHOPH, V7, pS7, DOI 10.1017/S1461145704004122; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; Keshavan M, 2008, SCHIZOPHR RES, V103, P114, DOI 10.1016/j.schres.2008.03.006; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Lieb R, 2000, EUR ADDICT RES, V6, P170, DOI 10.1159/000052043; McGrath J, 2010, ARCH GEN PSYCHIAT, V67, P440, DOI 10.1001/archgenpsychiatry.2010.6; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Niemi LT, 2003, SCHIZOPHR RES, V60, P239, DOI 10.1016/S0920-9964(02)00234-7; O'Daly O. G., 2005, J DUAL DIAGN, V1, P11; Perkonigg A, 2008, ADDICTION, V103, P439, DOI 10.1111/j.1360-0443.2007.02064.x; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rossler W, 2007, SCHIZOPHR RES, V92, P1, DOI 10.1016/j.schres.2007.01.002; Semple DM, 2005, J PSYCHOPHARMACOL, V19, P187, DOI 10.1177/0269881105049040; Spauwen J, 2006, PSYCHOL MED, V36, P407, DOI 10.1017/S0033291705006902; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Van Rossum I, 2009, SCHIZOPHR B     0930, DOI 101093/schbul/sbp101; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Wittchen HU, 2007, DRUG ALCOHOL DEPEN, V88, pS60, DOI 10.1016/j.drugalcdep.2006.12.013; Wittchen HU, 2009, DRUG ALCOHOL DEPEN, V102, P151, DOI 10.1016/j.drugalcdep.2009.02.012; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Wittchen HU, 1998, EUR ADDICT RES, V4, P18, DOI 10.1159/000018921; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Zammit S, 2002, BRIT MED J, V325, P1199, DOI 10.1136/bmj.325.7374.1199	46	183	186	0	45	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 1	2011	342								d738	10.1136/bmj.d738	http://dx.doi.org/10.1136/bmj.d738			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732ED	21363868	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000288166600010
J	Rabeharisoa, V				Rabeharisoa, Vololona			Socializing Genetic Diseases	SCIENCE			English	Editorial Material									MINES ParisTech, Ctr Sociol Innovat, Paris, France	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Rabeharisoa, V (corresponding author), MINES ParisTech, Ctr Sociol Innovat, Paris, France.								0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1027		10.1126/science.1203631	http://dx.doi.org/10.1126/science.1203631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350165				2022-12-01	WOS:000287699000050
J	Gardy, JL; Johnston, JC; Sui, SJH; Cook, VJ; Shah, LN; Brodkin, E; Rempel, S; Moore, R; Zhao, YJ; Holt, R; Varhol, R; Birol, I; Lem, M; Sharma, MK; Elwood, K; Jones, SJM; Brinkman, FSL; Brunham, RC; Tang, P				Gardy, Jennifer L.; Johnston, James C.; Sui, Shannan J. Ho; Cook, Victoria J.; Shah, Lena; Brodkin, Elizabeth; Rempel, Shirley; Moore, Richard; Zhao, Yongjun; Holt, Robert; Varhol, Richard; Birol, Inanc; Lem, Marcus; Sharma, Meenu K.; Elwood, Kevin; Jones, Steven J. M.; Brinkman, Fiona S. L.; Brunham, Robert C.; Tang, Patrick			Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR EPIDEMIOLOGY; CONTACT INVESTIGATIONS; CRACK COCAINE; RISK-FACTORS; DRUG-USERS; TRANSMISSION	BACKGROUND An outbreak of tuberculosis occurred over a 3-year period in a medium-size community in British Columbia, Canada. The results of mycobacterial interspersed repetitive unit-variable-number tandem-repeat (MIRU-VNTR) genotyping suggested the outbreak was clonal. Traditional contact tracing did not identify a source. We used whole-genome sequencing and social-network analysis in an effort to describe the outbreak dynamics at a higher resolution. METHODS We sequenced the complete genomes of 32 Mycobacterium tuberculosis outbreak isolates and 4 historical isolates (from the same region but sampled before the outbreak) with matching genotypes, using short-read sequencing. Epidemiologic and genomic data were overlaid on a social network constructed by means of interviews with patients to determine the origins and transmission dynamics of the outbreak. RESULTS Whole-genome data revealed two genetically distinct lineages of M. tuberculosis with identical MIRU-VNTR genotypes, suggesting two concomitant outbreaks. Integration of social-network and phylogenetic analyses revealed several transmission events, including those involving "superspreaders." Both lineages descended from a common ancestor and had been detected in the community before the outbreak, suggesting a social, rather than genetic, trigger. Further epidemiologic investigation revealed that the onset of the outbreak coincided with a recorded increase in crack cocaine use in the community. CONCLUSIONS Through integration of large-scale bacterial whole-genome sequencing and social-network analysis, we show that a socioenvironmental factor - most likely increased crack cocaine use - triggered the simultaneous expansion of two extant lineages of M. tuberculosis that was sustained by key members of a high-risk social network. Genotyping and contact tracing alone did not capture the true dynamics of the outbreak. (Funded by Genome British Columbia and others.)	[Gardy, Jennifer L.; Johnston, James C.; Cook, Victoria J.; Shah, Lena; Rempel, Shirley; Elwood, Kevin; Brunham, Robert C.; Tang, Patrick] British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; [Gardy, Jennifer L.; Cook, Victoria J.; Elwood, Kevin; Brunham, Robert C.; Tang, Patrick] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Moore, Richard; Zhao, Yongjun; Holt, Robert; Varhol, Richard; Birol, Inanc; Jones, Steven J. M.] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Shah, Lena] Publ Hlth Agcy Canada, Canadian Field Epidemiol Program, Vancouver, BC, Canada; [Lem, Marcus] Hlth Canada, Vancouver, BC, Canada; [Sui, Shannan J. Ho; Jones, Steven J. M.; Brinkman, Fiona S. L.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Brodkin, Elizabeth] Fraser Hlth Author, Surrey, BC, Canada; [Sharma, Meenu K.] Natl Microbiol Lab, Winnipeg, MB, Canada	University of British Columbia; Public Health Agency of Canada; Health Canada; Simon Fraser University	Tang, P (corresponding author), British Columbia Ctr Dis Control, 655 W 12th Ave, Vancouver, BC V5Z 4R4, Canada.	patrick.tang@bccdc.ca	Sharma, Meenu/AAE-2536-2022; Sharma, Meenu/GWM-5030-2022; Holt, Robert A/C-3303-2009; Brinkman, Fiona/N-3195-2013; Jones, Steven J/C-3621-2009; Birol, Inanc/G-5440-2011	Sharma, Meenu/0000-0002-6020-9995; Holt, Robert A/0000-0002-7259-1247; Brinkman, Fiona/0000-0002-0584-4099; Jones, Steven J/0000-0003-3394-2208; Birol, Inanc/0000-0003-0950-7839; Tang, Patrick/0000-0003-1583-5484; /0000-0002-6191-4709	Genome British Columbia, Health Canada; Simon Fraser University Community Trust; British Columbia Lung Association; Canadian Cystic Fibrosis Foundation; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research	Genome British Columbia, Health Canada; Simon Fraser University Community Trust; British Columbia Lung Association; Canadian Cystic Fibrosis Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by grants from Genome British Columbia, Health Canada, and the Simon Fraser University Community Trust, as well as from the British Columbia Lung Association (to Dr. Johnston), the Canadian Cystic Fibrosis Foundation (to Dr. Ho Sui), and the Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research (to Dr. Brinkman).	[Anonymous], 2007, CAN TUB STAND; [Anonymous], 2009, TUB CAN 2007; Asghar RJ, 2009, J URBAN HEALTH, V86, P776, DOI 10.1007/s11524-009-9378-z; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P485; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Cook VJ, 2007, J INFECT DIS, V196, P1517, DOI 10.1086/523109; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Fenner L, 2009, INT J EPIDEMIOL, V38, P1425, DOI 10.1093/ije/dyp367; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Grimes CZ, 2007, INT J TUBERC LUNG D, V11, P1183; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Howard AA, 2002, CLIN INFECT DIS, V35, P1183, DOI 10.1086/343827; Malakmadze N, 2005, CLIN INFECT DIS, V40, P366, DOI 10.1086/427112; McElroy RD, 2003, INT J TUBERC LUNG D, V7, pS486; Nguyen LN, 2004, RESPIROLOGY, V9, P313, DOI 10.1111/j.1440-1843.2004.00603.x; Rosenquist JN, 2010, ANN INTERN MED, V152, P426, DOI 10.7326/0003-4819-152-7-201004060-00007; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Story A, 2008, EMERG INFECT DIS, V14, P1466, DOI 10.3201/eid1409.070654; World Health Organization, 2002, WHOCDSTB2002297; World Health Organization (WHO), 2009, WHOHTMTB2009420	20	520	532	3	127	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					730	739		10.1056/NEJMoa1003176	http://dx.doi.org/10.1056/NEJMoa1003176			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345102	Green Published			2022-12-01	WOS:000287652500007
J	Pall, P; Aina, T; Stone, DA; Stott, PA; Nozawa, T; Hilberts, AGJ; Lohmann, D; Allen, MR				Pall, Pardeep; Aina, Tolu; Stone, Daithi A.; Stott, Peter A.; Nozawa, Toru; Hilberts, Arno G. J.; Lohmann, Dag; Allen, Myles R.			Anthropogenic greenhouse gas contribution to flood risk in England and Wales in autumn 2000	NATURE			English	Article							CLIMATE-CHANGE; PRECIPITATION EXTREMES; UK; ATTRIBUTION; EMISSIONS; RAINFALL; TRENDS; MODEL	Interest in attributing the risk of damaging weather-related events to anthropogenic climate change is increasing(1). Yet climate models used to study the attribution problem typically do not resolve the weather systems associated with damaging events(2) such as the UK floods of October and November 2000. Occurring during the wettest autumn in England and Wales since records began in 1766(3,4), these floods damaged nearly 10,000 properties across that region, disrupted services severely, and caused insured losses estimated at 1.3 pound billion (refs 5, 6). Although the flooding was deemed a 'wakeup call' to the impacts of climate change at the time(7), such claims are typically supported only by general thermodynamic arguments that suggest increased extreme precipitation under global warming, but fail(8,9) to account fully for the complex hydrometeorology(4,10) associated with flooding. Here we present a multi-step, physically based 'probabilistic event attribution' framework showing that it is very likely that global anthropogenic greenhouse gas emissions substantially increased the risk of flood occurrence in England and Wales in autumn 2000. Using publicly volunteered distributed computing(11,12), we generate several thousand seasonal-forecast-resolution climate model simulations of autumn 2000 weather, both under realistic conditions, and under conditions as they might have been had these greenhouse gas emissions and the resulting large-scale warming never occurred. Results are fed into a precipitation-runoff model that is used to simulate severe daily river runoff events in England and Wales (proxy indicators of flood events). The precise magnitude of the anthropogenic contribution remains uncertain, but in nine out of ten cases our model results indicate that twentieth-century anthropogenic greenhouse gas emissions increased the risk of floods occurring in England and Wales in autumn 2000 by more than 20%, and in two out of three cases by more than 90%.	[Pall, Pardeep] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Pall, Pardeep; Stone, Daithi A.; Allen, Myles R.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Aina, Tolu] Univ Oxford, Oxford E Res Ctr, Oxford OX1 3QG, England; [Stone, Daithi A.; Allen, Myles R.] Oxford Univ Ctr Environm, Tyndall Ctr Oxford, Oxford OX1 3QY, England; [Stott, Peter A.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Nozawa, Toru] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Hilberts, Arno G. J.; Lohmann, Dag] Risk Management Solut Ltd, London EC3R 8NB, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; University of Oxford; University of Oxford; Met Office - UK; Hadley Centre; National Institute for Environmental Studies - Japan	Pall, P (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland.	pardeep.pall@env.ethz.ch	Stott, Peter/N-1228-2016; Allen, Myles R/A-5172-2012; Scott, Peter/GYA-5335-2022	Stott, Peter/0000-0003-4853-7686; Stone, Daithi/0000-0002-2518-100X	NERC; Risk Management Solutions Ltd; WWF International; UK Department for Environment, Food, and Rural Affairs; Joint DECC and Defra Integrated Climate Programme-DECC/Defra [GA01101]; Japanese Ministry of Education, Culture, Sports, Science and Technology; US National Oceanic and Atmospheric Administration's Office; US Department of Energy; European Union [036946]; Smith School of Enterprise and the Environment	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Risk Management Solutions Ltd; WWF International; UK Department for Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Joint DECC and Defra Integrated Climate Programme-DECC/Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Oceanic and Atmospheric Administration's Office; US Department of Energy(United States Department of Energy (DOE)); European Union(European Commission); Smith School of Enterprise and the Environment	We thank all members of the public who ran HadAM3-N144 climate model simulations using the BOINC open source computing platform, and the climateprediction. net team for their technical support; M. Collins, N. Rayner, A. Jones and C. Johnson for originally supplying the HadAM3-N144 model, observed SSTs and sea ice, sulphate fields, and ozone fields, respectively; G. Meehl and T. Knutson for permission to use NCARPCM1 and GFDLR30 temperature data, respectively; S. Hay and I. Tracey for assistance with beta tests; C. Lee for technical advice; and W. Ingram and D. Rowlands for scientific advice. P.P. was supported by a NERC CASE studentship with Risk Management Solutions Ltd, by WWF International, and by NCCR climate. D.A.S. and P.P. received partial support from the UK Department for Environment, Food, and Rural Affairs. P.A.S. was supported by the Joint DECC and Defra Integrated Climate Programme-DECC/Defra (GA01101). T.N. was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology. D.A.S. and M.R.A. received additional support from the Climate Change Detection and Attribution Project jointly funded by the US National Oceanic and Atmospheric Administration's Office of Global Programs and the US Department of Energy. This research was also supported by the European Union (FP6) funded Integrated Project WATCH (contract number 036946) and the Smith School of Enterprise and the Environment.	Alexander LV, 2000, ATMOS SCI LETT, V1, P142, DOI 10.1006/asle.2001.0025; Allen M, 2003, NATURE, V421, P891, DOI 10.1038/421891a; Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; Association of British Insurers, 2001, FLOOD PARTN APPR PRO; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Blackburn M., 2001, ATMOSPHERIC VARIABIL; Department for Environment Food and Rural Affairs, 2001, FD2304 DEFRA; Environment Agency, 2001, LESS LEARN AUT 2000; Fowler HJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017327; Fowler HJ, 2003, INT J CLIMATOL, V23, P1313, DOI 10.1002/joc.943; Hannaford J, 2008, INT J CLIMATOL, V28, P1325, DOI 10.1002/joc.1643; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Keeling C.D., 2005, TRENDS COMPENDIUM DA; Lenderink G, 2008, NAT GEOSCI, V1, P511, DOI 10.1038/ngeo262; Lohmann D, 1996, TELLUS A, V48, P708, DOI 10.1034/j.1600-0870.1996.t01-3-00009.x; Maraun D, 2008, INT J CLIMATOL, V28, P833, DOI 10.1002/joc.1672; Marsh TJ, 2002, J CHART INST WATER E, V16, P180; Massacand A. C., 2003, 415 ECMWF; Massey N., 2006, ADV GEOSCI, V8, P49, DOI DOI 10.5194/ADGE0-8-49-2006); Meehl GA, 2004, J CLIMATE, V17, P3721, DOI 10.1175/1520-0442(2004)017<3721:CONAAF>2.0.CO;2; Natural Environmental Research Council - Centre for Ecology & Hydrology, 2010, NAT RIV FLOW ARCH; Nozawa T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023540; O'Gorman PA, 2009, P NATL ACAD SCI USA, V106, P14773, DOI 10.1073/pnas.0907610106; Pitt M., 2008, PITT REV LESSONS LEA; Pope VD, 2002, CLIM DYNAM, V19, P211, DOI 10.1007/s00382-001-0222-8; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Robson AJ, 2002, PHILOS T ROY SOC A, V360, P1327, DOI 10.1098/rsta.2002.1003; Sexton DMH, 2001, CLIM DYNAM, V17, P669, DOI 10.1007/s003820000141; Stone DA, 2005, CLIMATIC CHANGE, V71, P303, DOI 10.1007/s10584-005-6778-2; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Stott PA, 2006, J CLIMATE, V19, P3055, DOI 10.1175/JCLI3802.1; Stott PA, 2010, WIRES CLIM CHANGE, V1, P192, DOI 10.1002/wcc.34; United Nations Framework Convention on Climate Change (UNFCCC), 2007, FCCCKPCMP200610; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Wilby RL, 2008, HYDROL PROCESS, V22, P2511, DOI 10.1002/hyp.6847	37	588	603	12	359	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					382	385		10.1038/nature09762	http://dx.doi.org/10.1038/nature09762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331040				2022-12-01	WOS:000287409100039
J	Stanescu, HC; Arcos-Burgos, M; Medlar, A; Bockenhauer, D; Kottgen, A; Dragomirescu, L; Voinescu, C; Patel, N; Pearce, K; Hubank, M; Stephens, HAF; Laundy, V; Padmanabhan, S; Zawadzka, A; Hofstra, JM; Coenen, MJH; den Heijer, M; Kiemeney, LALM; Bacq-Daian, D; Stengel, B; Powis, SH; Brenchley, P; Feehally, J; Rees, AJ; Debiec, H; Wetzels, JFM; Ronco, P; Mathieson, PW; Kleta, R				Stanescu, Horia C.; Arcos-Burgos, Mauricio; Medlar, Alan; Bockenhauer, Detlef; Kottgen, Anna; Dragomirescu, Liviu; Voinescu, Catalin; Patel, Naina; Pearce, Kerra; Hubank, Mike; Stephens, Henry A. F.; Laundy, Valerie; Padmanabhan, Sandosh; Zawadzka, Anna; Hofstra, Julia M.; Coenen, Marieke J. H.; den Heijer, Martin; Kiemeney, Lambertus A. L. M.; Bacq-Daian, Delphine; Stengel, Benedicte; Powis, Stephen H.; Brenchley, Paul; Feehally, John; Rees, Andrew J.; Debiec, Hanna; Wetzels, Jack F. M.; Ronco, Pierre; Mathieson, Peter W.; Kleta, Robert			Risk HLA-DQA1 and PLA(sub 2)R1 Alleles in Idiopathic Membranous Nephropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLASS-II GENES; GLOMERULONEPHRITIS; RECEPTOR; ANTIGEN; SUSCEPTIBILITY; DETERMINANTS; AUTOIMMUNITY; LOCI	Background: Idiopathic membranous nephropathy is a major cause of the nephrotic syndrome in adults, but its etiologic basis is not fully understood. We investigated the genetic basis of biopsy-proven cases of idiopathic membranous nephropathy in a white population. Methods: We performed independent genomewide association studies of single-nucleotide polymorphisms (SNPs) in patients with idiopathic membranous nephropathy from three populations of white ancestry (75 French, 146 Dutch, and 335 British patients). The patients were compared with racially matched control subjects; population stratification and quality controls were carried out according to standard criteria. Associations were calculated by means of a chi-square basic allele test; the threshold for significance was adjusted for multiple comparisons (with the Bonferroni method). Results: In a joint analysis of data from the 556 patients studied (398 men), we identified significant alleles at two genomic loci associated with idiopathic membranous nephropathy. Chromosome 2q24 contains the gene encoding M-type phospholipase A(sub 2) receptor (PLA(sub 2)R1) (SNP rs4664308, P=8.6 x 10(sup -29)), previously shown to be the target of an autoimmune response. Chromosome 6p21 contains the gene encoding HLA complex class II HLA-DQ alpha chain 1 (HLA-DQA1) (SNP rs2187668, P=8.0 x 10(sup -93)). The association with HLA-DQA1 was significant in all three populations (P=1.8 x 10(sup -9), P=5.6 x 10(sup -27), and P=5.2 x 10(sup -36) in the French, Dutch, and British groups, respectively). The odds ratio for idiopathic membranous nephropathy with homozygosity for both risk alleles was 78.5 (95% confidence interval, 34.6 to 178.2). Conclusions: An HLA-DQA1 allele on chromosome 6p21 is most closely associated with idiopathic membranous nephropathy in persons of white ancestry. This allele may facilitate an autoimmune response against targets such as variants of PLA2R1. Our findings suggest a basis for understanding this disease and illuminate how adaptive immunity is regulated by HLA. N Engl J Med 2011;364:616-26.	[Stanescu, Horia C.; Medlar, Alan; Bockenhauer, Detlef; Voinescu, Catalin; Patel, Naina; Stephens, Henry A. F.; Powis, Stephen H.; Kleta, Robert] UCL, Royal Free Hosp, Ctr Nephrol, London NW3 2PF, England; [Stanescu, Horia C.; Bockenhauer, Detlef; Patel, Naina; Pearce, Kerra; Hubank, Mike; Kleta, Robert] UCL, Inst Child Hlth, London NW3 2PF, England; [Kleta, Robert] UCL, Dept Physiol, London NW3 2PF, England; [Kleta, Robert] UCL, Genet Inst, London NW3 2PF, England; [Bockenhauer, Detlef; Kleta, Robert] Great Ormond St Hosp Sick Children, London, England; [Stephens, Henry A. F.] Anthony Nolan Trust, London, England; [Laundy, Valerie; Mathieson, Peter W.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Padmanabhan, Sandosh] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Zawadzka, Anna] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Brenchley, Paul] Univ Manchester, Sch Biomed, Manchester, Lancs, England; [Feehally, John] Univ Leicester, John Walls Renal Unit, Leicester, Leics, England; [Feehally, John] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Arcos-Burgos, Mauricio] NHGRI, NIH, Bethesda, MD 20892 USA; [Kottgen, Anna] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Kottgen, Anna] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Dragomirescu, Liviu] Univ Bucharest, Dept Syst Ecol, Bucharest, Romania; [Hofstra, Julia M.; Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Hubank, Mike; Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Bacq-Daian, Delphine] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Stengel, Benedicte] Univ Paris Sud, INSERM, UMR S 1018, Villejuif, France; [Debiec, Hanna; Ronco, Pierre] Univ Paris 06, Tenon Hosp, AP HP, INSERM,UMR S 702, Paris, France; [Rees, Andrew J.] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Bristol; University of Glasgow; University of Oxford; Wellcome Centre for Human Genetics; University of Manchester; University of Leicester; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Freiburg; Johns Hopkins University; University of Bucharest; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Medical University of Vienna	Kleta, R (corresponding author), UCL, Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	r.kleta@ucl.ac.uk	Coenen, Marieke/A-2159-2010; Hofstra, Julia/A-4171-2015; Bockenhauer, Detlef/C-5951-2008; Bockenhauer, Detlef/AAF-6495-2020; Kiemeney, Lambertus A./D-3357-2009; Kottgen, Anna/D-2920-2012; Ronco, Pierre/AAC-8390-2022; Vargas Alfonso, Alba Lucia/E-1581-2015; Hubank, Michael JF/C-1837-2008; Stengel, Benedicte/G-5730-2015; Debiec, Hanna/AAL-8144-2021; Padmanabhan, Sandosh/S-3963-2016; Wetzels, Jack F.M./A-1720-2014; Arcos-Burgos, Mauricio/H-1326-2017; den Heijer, Martin/J-8036-2015	Coenen, Marieke/0000-0001-8796-2031; Bockenhauer, Detlef/0000-0001-5878-941X; Bockenhauer, Detlef/0000-0001-5878-941X; Kiemeney, Lambertus A./0000-0002-2368-1326; Vargas Alfonso, Alba Lucia/0000-0001-7984-0560; Hubank, Michael JF/0000-0002-2901-0742; Stengel, Benedicte/0000-0001-9469-0804; Debiec, Hanna/0000-0002-8946-8245; Wetzels, Jack F.M./0000-0002-0650-6921; Padmanabhan, Sandosh/0000-0003-3869-5808; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Voinescu, Catalin/0000-0002-3636-8689; Brenchley, Paul/0000-0003-1290-9919; den Heijer, Martin/0000-0003-3620-5617	David and Elaine Potter Charitable Foundation; St Peter's Trust for Kidney, Bladder and Prostate Research; Special Trustees of Great Ormond Street Hospital; Kids Kidney Research UK; Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester; MRC [G0000934]; Wellcome Trust [068545/Z/02]; National Institute for Health Research Manchester Biomedical Research Centre; Kidney Research UK; Dutch Kidney Foundation; French Ministry of Health [PHRC AOM 00022]; Ministry of Environment [EN00D08]; Ministry of Research [01P0513]; Biomedecine Agency; Agence Nationale pour la Recherche [ANR-07-Physio-016-01]; European Community [HEALTH-F2-2007-201590]; Fondation pour la Recherche Medicale; Association pour l'Utilisation du Rein Artificiel; Assistance Publique-Hopitaux de Paris; Medical Research Council [G0000934, G9721265] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V0901] Funding Source: researchfish; MRC [G9721265] Funding Source: UKRI	David and Elaine Potter Charitable Foundation; St Peter's Trust for Kidney, Bladder and Prostate Research; Special Trustees of Great Ormond Street Hospital; Kids Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Kidney Research UK(Kidney Research UK (KRUK)); Dutch Kidney Foundation; French Ministry of Health; Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Biomedecine Agency; Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Community(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour l'Utilisation du Rein Artificiel; Assistance Publique-Hopitaux de Paris; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the David and Elaine Potter Charitable Foundation (to Drs. Powis and Kleta), St Peter's Trust for Kidney, Bladder and Prostate Research (to Drs. Bockenhauer, Powis, and Kleta), the Special Trustees of Great Ormond Street Hospital (to Dr. Bockenhauer), Kids Kidney Research UK (to Drs. Bockenhauer and Kleta), Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester; grants from the MRC (G0000934) and the Wellcome Trust (068545/Z/02); the National Institute for Health Research Manchester Biomedical Research Centre (to Dr. Brenchley); and the MRC and Kidney Research UK, as part of the MRC/Kidney Research UK National DNA Bank for Glomerulonephritis, for the collection of the British idiopathic membranous nephropathy DNA samples; grants from the Dutch Kidney Foundation (Nierstichting Nederland OW 08, to Drs. Wetzels and Hofstra); grants from the French Ministry of Health (PHRC AOM 00022), the Ministry of Environment (Decision d'aide EN00D08), the Ministry of Research (Decision d'aide 01P0513), and the Biomedecine Agency (AO Recherche et Greffes 2005); grants from the Agence Nationale pour la Recherche (ANR-07-Physio-016-01), Coordination Theme 1 (Health) of the European Community's 7th Framework Program (HEALTH-F2-2007-201590), Fondation pour la Recherche Medicale, and Association pour l'Utilisation du Rein Artificiel (to Drs. Ronco and Debiec), and a Contrat d'Interface from Assistance Publique-Hopitaux de Paris (to Dr. Debiec).	ABE S, 1986, J CLIN PATHOL, V39, P1193, DOI 10.1136/jcp.39.11.1193; AUSTIN HA, 1992, ANN INTERN MED, V116, P672, DOI 10.7326/0003-4819-116-8-672; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; BERTHOUX FC, 1990, PRESSE MED, V19, P990; Bockenhauer D, 2008, NEPHRON CLIN PRACT, V108, pC10, DOI 10.1159/000112466; Boilard E, 2003, FASEB J, V17, P1068, DOI 10.1096/fj.02-0938com; CAMERON J S, 1965, Guys Hosp Rep, V114, P101; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DYER PA, 1992, NEPHROL DIAL TRANSPL, V7, P42; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Glassock RJ, 2009, NEW ENGL J MED, V361, P81, DOI 10.1056/NEJMe0903343; Hofstra JM, 2010, NEPHROL DIAL TRANSPL, V25, P1760, DOI 10.1093/ndt/gfq017; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kalluri R, 1997, J CLIN INVEST, V100, P2263, DOI 10.1172/JCI119764; KLOUDA PT, 1979, LANCET, V2, P770, DOI 10.1016/S0140-6736(79)92118-4; Lefaucheur C, 2006, KIDNEY INT, V70, P1510, DOI 10.1038/sj.ki.5001790; Li SJ, 2010, CLIN J AM SOC NEPHRO, V5, P439, DOI 10.2215/CJN.07571009; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Llorca O, 2008, CELL MOL LIFE SCI, V65, P1302, DOI 10.1007/s00018-007-7497-9; Moranne O, 2008, QJM-INT J MED, V101, P215, DOI 10.1093/qjmed/hcm142; OGAHARA S, 1992, KIDNEY INT, V41, P175, DOI 10.1038/ki.1992.24; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; PELLETIER L, 1987, SPRINGER SEMIN IMMUN, V9, P359; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Ponticelli C, 2007, J NEPHROL, V20, P268; Powis SH, 2003, OX MG MED G, V48, P417; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Rees A, 2009, NAT REV NEPHROL, V5, P617, DOI 10.1038/nrneph.2009.167; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Salant DJ, 2009, NEPHRON PHYSIOL, V112, pP11, DOI 10.1159/000212068; SHORT CD, 1984, BRIT MED J, V289, P1500, DOI 10.1136/bmj.289.6457.1500; SOLLID LM, 2002, COELIAC DIS DISSECTI; VAUGHAN RW, 1989, TISSUE ANTIGENS, V34, P261, DOI 10.1111/j.1399-0039.1989.tb01741.x; Waldman M, 2009, NAT REV NEPHROL, V5, P469, DOI 10.1038/nrneph.2009.101; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374	40	335	373	3	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					616	626		10.1056/NEJMoa1009742	http://dx.doi.org/10.1056/NEJMoa1009742			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323541	Bronze, Green Published			2022-12-01	WOS:000287406000007
J	Arie, S				Arie, Sophie			Vaccines Global HPV vaccination	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk						[Anonymous], 2008, HUM PAP HPV VACC BAC; Center for Disease Control, 2011, VACC IMM; World Health Organization/Information Commissioner's Office Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, HUM PAP REL CANC SUM	3	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d1042	10.1136/bmj.d1042	http://dx.doi.org/10.1136/bmj.d1042			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325382				2022-12-01	WOS:000287656500013
J	Sen Gupta, P; Green, AN; Chowdhury, TA				Sen Gupta, Piya; Green, Andrea N.; Chowdhury, Tahseen A.			Practice 10-Minute Consultation Hypoglycaemia	BRITISH MEDICAL JOURNAL			English	Editorial Material												psengupta79@doctors.net.uk		Sen Gupta, Piya/0000-0002-2800-7365					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d567	10.1136/bmj.d567	http://dx.doi.org/10.1136/bmj.d567			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325388				2022-12-01	WOS:000287656500017
J	Glick, S				Glick, Shimon			Personal View Withholding versus withdrawal of life support: is there an ethical difference?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ASSISTED SUICIDE; EUTHANASIA; END; ATTITUDES		Ben Gurion Univ Negev, Joyce & Irving Goldman Sch Med, Lord Rabbi Immanuel Jakobovits Ctr Jewish Med Eth, IL-84105 Beer Sheva, Israel	Ben Gurion University	Glick, S (corresponding author), Ben Gurion Univ Negev, Joyce & Irving Goldman Sch Med, Lord Rabbi Immanuel Jakobovits Ctr Jewish Med Eth, IL-84105 Beer Sheva, Israel.	gshimon@bgu.ac.il						Abramson N, 1998, SOUTHERN MED J, V91, P637, DOI 10.1097/00007611-199807000-00006; Dickenson DL, 2000, J MED ETHICS, V26, P254, DOI 10.1136/jme.26.4.254; Elliott C, 1996, BRIT MED J, V313, P1088; Grossman D., 2000, PSYCHOL EFFECTS COMB; Hopkins PD, 1997, HASTINGS CENT REP, V27, P29, DOI 10.2307/3528666; Meisel A, 2000, JAMA-J AM MED ASSOC, V284, P2495, DOI 10.1001/jama.284.19.2495; Ravitsky V, 2005, BRIT MED J, V330, P415, DOI 10.1136/bmj.330.7488.415; RAVITSKY V, 2008, J JEWISH MED ETHICS, V6, P13; Rebagliato M, 2000, JAMA-J AM MED ASSOC, V284, P2451, DOI 10.1001/jama.284.19.2451	9	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2011	342								d728	10.1136/bmj.d728	http://dx.doi.org/10.1136/bmj.d728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307111				2022-12-01	WOS:000287402900017
J	Hudson, T				Hudson, Tom			Genomics and Clinical Relevance	SCIENCE			English	Editorial Material									Ontario Inst Canc Res, Toronto, ON, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Hudson, T (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.								0	2	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					547	547		10.1126/science.1202572	http://dx.doi.org/10.1126/science.1202572			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292965				2022-12-01	WOS:000286933600040
J	Shin, K; Lee, J; Guo, N; Kim, J; Lim, A; Qu, LS; Mysorekar, IU; Beachy, PA				Shin, Kunyoo; Lee, John; Guo, Nini; Kim, James; Lim, Agnes; Qu, Lishu; Mysorekar, Indira U.; Beachy, Philip A.			Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder	NATURE			English	Article							URINARY-TRACT-INFECTION; ESCHERICHIA-COLI; CANCER; DIFFERENTIATION; METASTASIS; NEOPLASIA; PATTERNS; AUTOPSY; RENEWAL; ORGAN	Epithelial integrity in metazoan organs is maintained through the regulated proliferation and differentiation of organ-specific stem and progenitor cells. Although the epithelia of organs such as the intestine regenerate constantly and thus remain continuously proliferative(1), other organs, such as the mammalian urinary bladder, shift from near-quiescence to a highly proliferative state in response to epithelial injury(2-4). The cellular and molecular mechanisms underlying this injury-induced mode of regenerative response are poorly defined. Here we show in mice that the proliferative response to bacterial infection or chemical injury within the bladder is regulated by signal feedback between basal cells of the urothelium and the stromal cells that underlie them. We demonstrate that these basal cells include stem cells capable of regenerating all cell types within the urothelium, and are marked by expression of the secreted protein signal Sonic hedgehog (Shh). On injury, Shh expression in these basal cells increases and elicits increased stromal expression of Wnt protein signals, which in turn stimulate the proliferation of both urothelial and stromal cells. The heightened activity of this signal feedback circuit and the associated increase in cell proliferation appear to be required for restoration of urothelial function and, in the case of bacterial injury, may help clear and prevent further spread of infection. Our findings provide a conceptual framework for injury-induced epithelial regeneration in endodermal organs, and may provide a basis for understanding the roles of signalling pathways in cancer growth and metastasis.	[Shin, Kunyoo; Lee, John; Kim, James; Lim, Agnes; Qu, Lishu; Beachy, Philip A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA; [Guo, Nini] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Stanford University; Johns Hopkins University; Washington University (WUSTL)	Beachy, PA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA.	kunyoos@stanford.edu; pbeachy@stanford.edu	Mysorekar, Indira U./GRS-4574-2022	Mysorekar, Indira U./0000-0003-3917-8677; Lim, Agnes/0000-0002-6618-2500; Shin, Kunyoo/0000-0002-1519-9839	Department of Defense; National Institutes of Health; Pathway to Independence Award [K99/R00]	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Oro and J. Brooks for their critical reading of the manuscript, and the Stanford Center for Digestive Diseases for help with laser capture microdissection. This research was supported in part by grants from the Department of Defense and from the National Institutes of Health (P.A.B.) and a Pathway to Independence Award (K99/R00) to I.U.M. P.A.B. is an investigator of the Howard Hughes Medical Institute.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Ibla JC, 2006, METH MOL B, V341, P111; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Klumpp DJ, 2006, INFECT IMMUN, V74, P5106, DOI 10.1128/IAI.00376-06; Kurzrock EA, 2005, J UROLOGY, V173, P281, DOI 10.1097/01.ju.0000141585.17953.fa; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Nicolle LE, 2008, UROL CLIN N AM, V35, P1, DOI 10.1016/j.ucl.2007.09.004; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wallmeroth A, 1999, UROL INT, V62, P69, DOI 10.1159/000030361; WU XR, 1993, J CELL SCI, V106, P31; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	32	320	333	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					110	U145		10.1038/nature09851	http://dx.doi.org/10.1038/nature09851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21389986	Green Accepted			2022-12-01	WOS:000289199400047
J	Tirosh, A; Shai, I; Afek, A; Dubnov-Raz, G; Ayalon, N; Gordon, B; Derazne, E; Tzur, D; Shamis, A; Vinker, S; Rudich, A				Tirosh, Amir; Shai, Iris; Afek, Arnon; Dubnov-Raz, Gal; Ayalon, Nir; Gordon, Barak; Derazne, Estela; Tzur, Dorit; Shamis, Ari; Vinker, Shlomo; Rudich, Assaf			Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE SYNDROME; HEART-DISEASE; YOUNG ADULTHOOD; FOLLOW-UP; CARDIOVASCULAR-DISEASE; TRIGLYCERIDE LEVELS; METABOLIC SYNDROME; CHILDHOOD; CHILDREN	BACKGROUND The association of body-mass index (BMI) from adolescence to adulthood with obesity-related diseases in young adults has not been completely delineated. METHODS We conducted a prospective study in which we followed 37,674 apparently healthy young men for incident angiography-proven coronary heart disease and diabetes through the Staff Periodic Examination Center of the Israeli Army Medical Corps. The height and weight of participants were measured at regular intervals, with the first measurements taken when they were 17 years of age. RESULTS During approximately 650,000 person-years of follow-up (mean follow-up, 17.4 years), we documented 1173 incident cases of type 2 diabetes and 327 of coronary heart disease. In multivariate models adjusted for age, family history, blood pressure, lifestyle factors, and biomarkers in blood, elevated adolescent BMI (the weight in kilograms divided by the square of the height in meters; mean range for the first through last deciles, 17.3 to 27.6) was a significant predictor of both diabetes (hazard ratio for the highest vs. the lowest decile, 2.76; 95% confidence interval [CI], 2.11 to 3.58) and angiography-proven coronary heart disease (hazard ratio, 5.43; 95% CI, 2.77 to 10.62). Further adjustment for BMI at adulthood completely ablated the association of adolescent BMI with diabetes (hazard ratio, 1.01; 95% CI, 0.75 to 1.37) but not the association with coronary heart disease (hazard ratio, 6.85; 95% CI, 3.30 to 14.21). After adjustment of the BMI values as continuous variables in multivariate models, only elevated BMI in adulthood was significantly associated with diabetes (beta = 1.115, P = 0.003; P = 0.89 for interaction). In contrast, elevated BMI in both adolescence (beta = 1.355, P = 0.004) and adulthood (beta = 1.207, P = 0.03) were independently associated with angiography-proven coronary heart disease (P = 0.048 for interaction). CONCLUSIONS An elevated BMI in adolescence - one that is well within the range currently considered to be normal - constitutes a substantial risk factor for obesity-related disorders in midlife. Although the risk of diabetes is mainly associated with increased BMI close to the time of diagnosis, the risk of coronary heart disease is associated with an elevated BMI both in adolescence and in adulthood, supporting the hypothesis that the processes causing incident coronary heart disease, particularly atherosclerosis, are more gradual than those resulting in incident diabetes.	[Tirosh, Amir] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Tirosh, Amir] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Afek, Arnon] Boston Univ, Med Ctr, Cardiovasc Med Sect, Boston, MA USA; [Tirosh, Amir] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel; [Afek, Arnon; Shamis, Ari] Chaim Sheba Med Ctr, Chaim Sheba Med Ctr Management, IL-52621 Tel Hashomer, Israel; [Dubnov-Raz, Gal] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Exercise Nutr & Lifestyle Clin, Tel Hashomer, Israel; [Shai, Iris; Rudich, Assaf] Ben Gurion Univ Negev, S Daniel Abraham Ctr Hlth & Nutr, IL-84105 Beer Sheva, Israel; [Shai, Iris] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel; [Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; [Rudich, Assaf] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Afek, Arnon; Shamis, Ari] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Gordon, Barak; Derazne, Estela; Tzur, Dorit; Vinker, Shlomo] Israel Def Forces Med Corps, Jerusalem, Israel	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine	Tirosh, A (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	atirosh@partners.org	Gordon, Barak/L-6139-2018; Dubnov-Raz, Gal/L-3297-2016	Gordon, Barak/0000-0002-5283-722X; Dubnov-Raz, Gal/0000-0003-1469-8043; Ayalon, Nir/0000-0002-0480-1249; Tirosh, Amir/0000-0003-2210-5906; Rudich, Assaf/0000-0002-1366-1444	Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant from the Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel (to Dr. Tirosh), and by the Israel Defense Forces Medical Corps.	ABRAHAM S, 1971, HEALTH SERV REP, V86, P273, DOI 10.2307/4594149; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Deshmukh-Taskar P, 2006, EUR J CLIN NUTR, V60, P48, DOI 10.1038/sj.ejcn.1602266; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Lawlor DA, 2005, CIRCULATION, V111, P1891, DOI 10.1161/01.CIR.0000161798.45728.4D; Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; MOSSBERG HO, 1989, LANCET, V2, P491; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Oren A, 2003, INT J OBESITY, V27, P1383, DOI 10.1038/sj.ijo.0802404; Osler M, 2009, EUR J EPIDEMIOL, V24, P57, DOI 10.1007/s10654-008-9301-z; POPKIN BM, 2006, OBESITY SILVER SPRIN, V14, P846; Rodriguez G, 2004, INT J OBESITY, V28, pS54, DOI 10.1038/sj.ijo.0802805; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Shai I, 2010, CIRCULATION, V121, P1200, DOI 10.1161/CIRCULATIONAHA.109.879254; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; Tirosh A, 2006, NEW ENGL J MED, V354, P2401; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; Tirosh A, 2010, HYPERTENSION, V56, P203, DOI 10.1161/HYPERTENSIONAHA.109.146415; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Viner RM, 2005, ARCH DIS CHILD, V90, P10, DOI 10.1136/adc.2003.036467; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049	31	437	446	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1315	1325		10.1056/NEJMoa1006992	http://dx.doi.org/10.1056/NEJMoa1006992			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470009	Green Accepted, Bronze			2022-12-01	WOS:000289202800007
J	Ludwig, DS				Ludwig, David S.			Technology, Diet, and the Burden of Chronic Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; PREVENTION		Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Optimal Weight Life Program, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CNN Health, WE AR WHAT WE EAT AM; Cohen M.N., 1984, PALEOPATHOLOGY ORIGI; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pollan M., 2006, OMNIVORES DILEMMA NA; Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011; Rolls BJ, 2000, J AM DIET ASSOC, V100, P232, DOI 10.1016/S0002-8223(00)00070-5; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103	10	104	108	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1352	1353		10.1001/jama.2011.380	http://dx.doi.org/10.1001/jama.2011.380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467290				2022-12-01	WOS:000289162400027
J	Gerlach, B; Cordier, SM; Schmukle, AC; Emmerich, CH; Rieser, E; Haas, TL; Webb, AI; Rickard, JA; Anderton, H; Wong, WWL; Nachbur, U; Gangoda, L; Warnken, U; Purcell, AW; Silke, J; Walczak, H				Gerlach, Bjoern; Cordier, Stefanie M.; Schmukle, Anna C.; Emmerich, Christoph H.; Rieser, Eva; Haas, Tobias L.; Webb, Andrew I.; Rickard, James A.; Anderton, Holly; Wong, Wendy W-L.; Nachbur, Ueli; Gangoda, Lahiru; Warnken, Uwe; Purcell, Anthony W.; Silke, John; Walczak, Henning			Linear ubiquitination prevents inflammation and regulates immune signalling	NATURE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; K11-LINKED POLYUBIQUITINATION; MEDIATED REGULATION; STRUCTURAL BASIS; TNF; ACTIVATION; NEMO; RECOGNITION; MECHANISMS; CHAINS	Members of the tumour necrosis factor (TNF) receptor superfamily have important functions in immunity and inflammation. Recently linear ubiquitin chains assembled by a complex containing HOIL-1 and HOIP (also known as RBCK1 and RNF31, respectively) were implicated in TNF signalling, yet their relevance in vivo remained uncertain. Here we identify SHARPIN as a third component of the linear ubiquitin chain assembly complex, recruited to the CD40 and TNF receptor signalling complexes together with its other constituents, HOIL-1 and HOIP. Mass spectrometry of TNF signalling complexes revealed RIP1 (also known as RIPK1) and NEMO (also known as IKK gamma or IKBKG) to be linearly ubiquitinated. Mutation of the Sharpin gene (Sharpin(cpdm/cpdm)) causes chronic proliferative dermatitis (cpdm) characterized by inflammatory skin lesions and defective lymphoid organogenesis. Gene induction by TNF, CD40 ligand and interleukin-1 beta was attenuated in cpdm-derived cells which were rendered sensitive to TNF-induced death. Importantly, Tnf gene deficiency prevented skin lesions in cpdm mice. We conclude that by enabling linear ubiquitination in the TNF receptor signalling complex, SHARPIN interferes with TNF-induced cell death and, thereby, prevents inflammation. Our results provide evidence for the relevance of linear ubiquitination in vivo in preventing inflammation and regulating immune signalling.	[Gerlach, Bjoern; Cordier, Stefanie M.; Schmukle, Anna C.; Emmerich, Christoph H.; Rieser, Eva; Walczak, Henning] Univ London Imperial Coll Sci Technol & Med, Dept Med, Tumour Immunol Unit, London W12 0NN, England; [Gerlach, Bjoern; Emmerich, Christoph H.; Haas, Tobias L.; Walczak, Henning] German Canc Res Ctr, Div Apoptosis Regulat, D-69120 Heidelberg, Germany; [Haas, Tobias L.] Mediterranean Inst Oncol, Dept Expt Oncol, I-95029 Viagrande, Italy; [Webb, Andrew I.; Purcell, Anthony W.] Bio21 Melbourne Univ, Dept Biochem, Melbourne, Vic 3010, Australia; [Rickard, James A.; Anderton, Holly; Wong, Wendy W-L.; Nachbur, Ueli; Gangoda, Lahiru; Silke, John] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Warnken, Uwe] German Canc Res Ctr, Prot Anal Core Facil, D-69120 Heidelberg, Germany	Imperial College London; Helmholtz Association; German Cancer Research Center (DKFZ); Mediterranean Institute of Oncology; University of Melbourne; La Trobe University; Helmholtz Association; German Cancer Research Center (DKFZ)	Walczak, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Tumour Immunol Unit, London W12 0NN, England.	h.walczak@imperial.ac.uk	Silke, John/B-7622-2008; Purcell, Anthony/AAH-1942-2019; Wong, W. Wei-Lynn/A-6851-2015; Walczak, Henning/AAV-2214-2020	Silke, John/0000-0002-7611-5774; Purcell, Anthony/0000-0003-0532-8331; Wong, W. Wei-Lynn/0000-0003-3155-1211; Walczak, Henning/0000-0002-6312-4591; Nachbur, Ueli/0000-0001-5968-2235; Gangoda, Lahiru/0000-0003-1931-6809; Haas, Tobias/0000-0003-2336-0263; Anderton, Holly/0000-0003-3913-9686; Gerlach, Bjorn/0000-0002-4900-6302	Cancer Research UK; AICR; BBSRC (ERASysBio PLUS); Ovarian Cancer Action; EU; NHMRC [541901, 541902, 602516]; HGF/SBCancer; Schweizer Nationalfonds (SNF); BBSRC [BB/I004580/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004580/1] Funding Source: researchfish; Cancer Research UK [10950] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AICR; BBSRC (ERASysBio PLUS)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ovarian Cancer Action(Ovarian Cancer Action); EU(European Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); HGF/SBCancer; Schweizer Nationalfonds (SNF); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank M. Miasari for developing the cIAP2 antibody, M. Leverkus for advice on skin histology, J. Lokan for advice on liver histology, C. Rappl, N. Barboza, S. Kupka, D. Heinze, J. Zipprich, J. Corbin, S. Wiegelmann and A. Bankovacki for excellent technical assistance, M. Bolognesi and P. Seneci for SM-164, H. Koerner for Tnf<SUP>-/-</SUP> mice, and all past and present members of the Walczak and Silke laboratories for continuous stimulating scientific discussions and support. Research in the Walczak lab is supported by grants from Cancer Research UK, AICR, BBSRC (ERASysBio PLUS), Ovarian Cancer Action and the EU Marie Curie Research Training Network ApopTRAIN. Work in the Silke lab is supported by NHMRC grants 541901, 541902 and 602516. Work in the Purcell lab is supported by the NHMRC (Senior Research Fellowships for A.W.P. and a C.J. Martin Overseas Biomedical Fellowship to A.I.W.), and by grants from the NHMRC and ARC. U.W. is funded by HGF/SBCancer. E.R. and T.L.H. are ApopTRAIN fellows and U.N. is supported by the Schweizer Nationalfonds (SNF).	Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Cossu F, 2009, J MOL BIOL, V392, P630, DOI 10.1016/j.jmb.2009.04.033; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; GIJBELS MJJ, 1995, J INVEST DERMATOL, V105, P769, DOI 10.1111/1523-1747.ep12325599; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sacre Sandra M., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009488; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002	37	653	669	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					591	+		10.1038/nature09816	http://dx.doi.org/10.1038/nature09816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455173				2022-12-01	WOS:000288951200033
J	Wakim, LM; Bevan, MJ				Wakim, Linda M.; Bevan, Michael J.			Cross-dressed dendritic cells drive memory CD8(+) T-cell activation after viral infection	NATURE			English	Article							IMMUNE-RESPONSES; LIVE CELLS; IN-VIVO; COMPLEXES; ANTIGENS	After an infection, cytotoxic T lymphocyte precursors proliferate and become effector cells by recognizing foreign peptides in the groove of major histocompatibility complex (MHC) class I molecules expressed by antigen-presenting cells (APCs)(1). Professional APCs specialized for T-cell activation acquire viral antigen either by becoming infected themselves (direct presentation) or by phagocytosis of infected cells, followed by transfer of antigen to the cytosol, processing and MHC class I loading in a process referred to as cross-presentation(2). An alternative way, referred to as 'cross-dressing', by which an uninfected APC could present antigen was postulated to be by the transfer of preformed peptide-MHC complexes from the surface of an infected cell to the APC without the need of further processing(3). Here we show that this mechanism exists and boosts the antiviral response of mouse memory CD8(+) T cells. A number of publications have demonstrated sharing of peptide-loaded MHC molecules in vitro(4-7). Our in vitro experiments demonstrate that cross-dressing APCs do not acquire peptide-MHC complexes in the form of exosomes released by donor cells. Rather, the APCs and donor cells have to contact each other for the transfer to occur. After a viral infection, we could isolate cross-dressed APCs able to present viral antigen in vitro. Furthermore, using the diphtheria toxin system to selectively eliminate APCs that could only acquire viral peptide-MHC complexes by cross-dressing, we show that such presentation can promote the expansion of resting memory T cells. Notably, naive T cells were excluded from taking part in the response. Cross-dressing is a mechanism of antigen presentation used by dendritic cells that may have a significant role in activating previously primed CD8(+) T cells.	[Wakim, Linda M.; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Box 357370, Seattle, WA 98195 USA.	mbevan@u.washington.edu		Wakim, Linda/0000-0003-1752-9579	Howard Hughes Medical Institute; National Institutes of Health; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute and National Institutes of Health. L.M.W is supported by an Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia.	Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Dolan BP, 2006, J IMMUNOL, V176, P1447, DOI 10.4049/jimmunol.176.3.1447; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Qu CF, 2009, J IMMUNOL, V182, P3650, DOI 10.4049/jimmunol.0801532; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Smyth LA, 2008, J IMMUNOL, V181, P3212, DOI 10.4049/jimmunol.181.5.3212; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702	18	197	199	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					629	632		10.1038/nature09863	http://dx.doi.org/10.1038/nature09863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455179	Green Accepted			2022-12-01	WOS:000288951200041
J	Willyard, C				Willyard, Cassandra			LIFESTYLE Breaking the cancer habit	NATURE			English	Editorial Material							PHYSICAL-ACTIVITY; INTERVENTION; PREVENTION; MORTALITY; SURGERY; TRIAL											Adams TD, 2009, OBESITY, V17, P796, DOI 10.1038/oby.2008.610; Ashrafian H, 2010, CANCER          1129; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Friedenreich CM, 2010, EUR J CANCER, V46, P2593, DOI 10.1016/j.ejca.2010.07.028; Friedenreich CM, 2010, J CLIN ONCOL, V28, P1458, DOI 10.1200/JCO.2009.24.9557; Katz DL, 2010, AM J CLIN NUTR, V91, p1102S, DOI 10.3945/ajcn.2010.28450E; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7	9	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S16	S17		10.1038/471S16a	http://dx.doi.org/10.1038/471S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430713	Bronze			2022-12-01	WOS:000288702200014
J	Harrop, T; Aird, J; Thwaites, G				Harrop, Tara; Aird, James; Thwaites, Guy			Practice Pointer How to minimise risk of acquiring tuberculosis when working in a high prevalence setting: a guide for healthcare workers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANT TUBERCULOSIS; N95 RESPIRATORS; TRANSMISSION; TB		[Harrop, Tara] Sandground Cottage, Bristol BS39 4BZ, Avon, England		Harrop, T (corresponding author), Sandground Cottage, Bristol BS39 4BZ, Avon, England.	taraharrop@hotmail.com	Thwaites, Guy E/R-4993-2019	Thwaites, Guy E/0000-0002-2858-2087				Al-Orainey IO, 2009, ANN THORAC MED, V4, P5, DOI 10.4103/1817-1737.44778; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; [Anonymous], 2009, GLOB TUB CONTR; [Anonymous], 2007, GUIDELINE ISOLATION; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Bonifacio N, 2002, EMERG INFECT DIS, P8; Centers for Disease Control and Prevention, 2010, BCG VACC FACTSH; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; European Centre for Disease Prevention and Control, 2008, ECDC SUMM GUID XDR T; Fraser A, 2006, INT J TUBERC LUNG D, V10, P19; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Grant A, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1110; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; National Institute of Health and Clinical Excellence, 2006, CG33 NAT I HLTH CLIN; Qian YG, 1998, AM IND HYG ASSOC J, V59, P128, DOI 10.1080/15428119891010389; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Smieja M J, 2000, Cochrane Database Syst Rev, pCD001363; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; Yassi A, 2004, PROTECTING FACES HLT	25	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2011	342								d1544	10.1136/bmj.d1544	http://dx.doi.org/10.1136/bmj.d1544			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FK	21411488				2022-12-01	WOS:000288699200003
J	Casarett, DJ				Casarett, David J.			Rethinking Hospice Eligibility Criteria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PALLIATIVE CARE; CANCER		[Casarett, David J.] Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA; [Casarett, David J.] Univ Penn, Sch Med, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Casarett, DJ (corresponding author), Univ Penn, Sch Med, Ctr Bioeth, 3615 Chestnut St, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu						Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Casarett DJ, 2009, J CLIN ONCOL, V27, P953, DOI 10.1200/JCO.2008.17.8079; Fishman J, 2009, CANCER-AM CANCER SOC, V115, P689, DOI 10.1002/cncr.24046; Johnson KS, 2008, ARCH INTERN MED, V168, P218, DOI 10.1001/archinternmed.2007.36; National Hospice and Palliative Care Organization Facts and Figures, 2010, HOSP CAR AM; Rickerson E, 2005, J AM GERIATR SOC, V53, P819, DOI 10.1111/j.1532-5415.2005.53259.x; Schockett ER, 2005, J PAIN SYMPTOM MANAG, V30, P400, DOI 10.1016/j.jpainsymman.2005.04.013; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	9	27	27	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1031	1032		10.1001/jama.2011.271	http://dx.doi.org/10.1001/jama.2011.271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	731SM	21386081				2022-12-01	WOS:000288129600024
J	Hyman, SE				Hyman, Steven E.			The Meaning of the Human Genome Project for Neuropsychiatric Disorders	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Hyman, SE (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.								0	6	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1026		10.1126/science.1203544	http://dx.doi.org/10.1126/science.1203544			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350167				2022-12-01	WOS:000287699000048
J	Lal, A; Goldrich, ML; Haines, DA; Azimi, M; Singer, ST; Vichinsky, EP				Lal, Ashutosh; Goldrich, Michael L.; Haines, Drucilla A.; Azimi, Mahin; Singer, Sylvia T.; Vichinsky, Elliott P.			Heterogeneity of Hemoglobin H Disease in Childhood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTHEAST-ASIAN POPULATIONS; ALPHA-THALASSEMIA; CLINICAL-FEATURES; NORTH-AMERICA; SEVERE FORM; GENE; CALIFORNIA; BLACKS	BACKGROUND Early diagnosis during newborn screening or infancy has enabled the observation of the natural history of hemoglobin H disease, a subtype of alpha-thalassemia. METHODS We analyzed longitudinal clinical data for patients with hemoglobin H disease arising from the deletion of three of four a-globin genes (HbH) and from hemoglobin H Constant Spring (HCS), caused by the deletion of two a-globin genes and the Constant Spring mutation. RESULTS We identified 86 patients with hemoglobin H disease (48 through newborn screening). Of these patients, 60 (70%) had HbH, 23 (27%) had HCS, and 3 (3%) had other, nondeletional forms of hemoglobin H disease. The parental ethnic background was Asian in 81% of patients, Hispanic in 5%, and African American in 3%, whereas mixed ancestry was observed in 10% of patients. Among the patients with deletional hemoglobin H disease, 15% had one or both parents with African-American ancestry. Growth was normal in patients with HbH during the first decade, but growth deficits began during infancy in those with HCS. Anemia was more severe in patients with HCS at all ages (P<0.001). Acute worsening of anemia with infections requiring urgent blood transfusion was observed in patients with HCS but not in those with HbH. The probability of receiving at least one transfusion by the age of 20 years was 3% for patients with HbH and 80% for those with HCS (P<0.001). Among patients with HCS, transfusions occurred in 13% of infants and 50% of children under the age of 6 years; splenectomy was associated with a significant improvement in hemoglobin levels (P = 0.01) and a reduction in the number of transfusions. CONCLUSIONS HCS should be recognized as a distinct thalassemia syndrome with a high risk of life-threatening anemia during febrile illnesses. HbH was not associated with an increased rate of severe anemia with infections and was managed without blood transfusions. Many patients with these disorders had mixed ethnic backgrounds, which highlights the need for extended newborn screening in populations that are traditionally considered to be at low risk for hemoglobin H disease.	[Lal, Ashutosh; Azimi, Mahin] Childrens Hosp & Res Ctr Oakland, Hemoglobinopathy Reference Lab, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Lal, A (corresponding author), Childrens Hosp & Res Ctr Oakland, Hemoglobinopathy Reference Lab, 747 52nd St, Oakland, CA 94609 USA.	alal@mail.cho.org	Vichinsky, Elliott P/F-8541-2011	Vichinsky, Elliott P/0000-0002-0500-9579	Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services [57480]	Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Supported in part by Project no. 57480 from the Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services.	Census Bureau, AM COMM SURV 2006 AS; Charoenkwan P, 2005, HEMOGLOBIN, V29, P133, DOI 10.1081/HEM-200058583; Chen FE, 2000, NEW ENGL J MED, V343, P544, DOI 10.1056/NEJM200008243430804; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; DOZY AM, 1979, NATURE, V280, P605, DOI 10.1038/280605a0; Fucharoen Suthat, 2009, Hematology Am Soc Hematol Educ Program, P26, DOI 10.1182/asheducation-2009.1.26; GALANELLO R, 1983, ACTA HAEMATOL-BASEL, V69, P56, DOI 10.1159/000206840; Higgs DR, 2009, CELL MOL LIFE SCI, V66, P1154, DOI 10.1007/s00018-008-8529-9; Knapp A, 2010, EVIDENCE REV HEMOGLO; LAIG M, 1990, HUM GENET, V84, P188; Laosombat V, 2009, ANN HEMATOL, V88, P1185, DOI 10.1007/s00277-009-0743-5; Lorey F, 2001, GENET TEST, V5, P93, DOI 10.1089/109065701753145538; Michlitsch J, 2009, PEDIATR BLOOD CANCER, V52, P486, DOI 10.1002/pbc.21883; Origa R, 2007, BRIT J HAEMATOL, V136, P326, DOI 10.1111/j.1365-2141.2006.06423.x; Pakbaz Z, 2007, PEDIATR BLOOD CANCER, V49, P329, DOI 10.1002/pbc.21275; Savongsy O, 2008, ANN HEMATOL, V87, P647, DOI 10.1007/s00277-008-0490-z; Schrier SL, 1997, BLOOD, V89, P1762, DOI 10.1182/blood.V89.5.1762.1762_1762_1769; Singer ST, 2009, AM J HEMATOL, V84, P759, DOI 10.1002/ajh.21523; Singsanan S, 2007, ANN HEMATOL, V86, P665, DOI 10.1007/s00277-007-0310-x; Sobota A, 2011, AM J HEMATOL, V86, P92, DOI 10.1002/ajh.21896; STEINBERG MH, 1986, BLOOD, V68, P985; Styles LA, 1997, INT J PEDIAT HEM ONC, V4, P69; Vichinsky EP, 2005, PEDIATRICS, V116, pE818, DOI 10.1542/peds.2005-0843	23	102	114	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					710	718		10.1056/NEJMoa1010174	http://dx.doi.org/10.1056/NEJMoa1010174			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345100				2022-12-01	WOS:000287652500005
J	Evans-Brown, M; Bellis, MA; McVeigh, J				Evans-Brown, Michael; Bellis, Mark A.; McVeigh, Jim			Should "legal highs" be regulated as medicinal products?	BRITISH MEDICAL JOURNAL			English	Editorial Material							UK					m.j.evans-brown@ljmu.ac.uk	Bellis, Mark A./HGA-2019-2022; McVeigh, Jim/O-7851-2019	Evans-Brown, Michael/0000-0002-2695-5740; McVeigh, Jim/0000-0001-5319-6885				Ben-Yehudah Nahman., 2009, SOCIAL CONSTRUCTION; BIRCH R, 2010, NEW LAW J, V160; BIRCH R, 2009, NEW LAW J, V159; Brandt SD, 2010, DRUG TEST ANAL, V2, P377, DOI 10.1002/dta.155; Csizmadi I, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P791; *EUR UN, 2004, OFFICIAL J EUROPEAN, V47, P34; European Monitoring Centre for Drugs and Drug Addiction, 2009, UND SPIC PHEN; European Monitoring Centre for Drugs and Drug Addiction, 2010, RISK ASS REP NEW PSY; European Parliament, 2001, OFF J EUR COMMUNITIE, V311, P67; Gunningham N., 2010, OXFORD HDB REGULATIO, P120; *HOUS COMM, 2010, HOUS COMM OFF REP HA, pC149; *HOUS LORD, 1984, HOUS LORDS OFF REP H; House of Commons Science and Technology Committee, 2006, DRUG CLASS MAK HASH; *MED HEALTHC PROD, 2007, 8 MHRA; MONAGHAN M, 2010, EVIDENCE VERSUS POLI; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; STEPHENS M, 2004, STEPHENS DETECTION N, P63; Tyler Tom R., 1990, WHY PEOPLE OBEY LAW, DOI 10.1515/9781400828609	18	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d1101	10.1136/bmj.d1101	http://dx.doi.org/10.1136/bmj.d1101			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345907				2022-12-01	WOS:000287920100020
J	Kelley, AS; Ettner, SL; Morrison, RS; Du, QL; Wenger, NS; Sarkisian, CA				Kelley, Amy S.; Ettner, Susan L.; Morrison, R. Sean; Du, Qingling; Wenger, Neil S.; Sarkisian, Catherine A.			Determinants of Medical Expenditures in the Last 6 Months of Life	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; REGIONAL-VARIATIONS; PATIENT PREFERENCES; TREATMENT INTENSITY; END; DISABILITY; CANCER; DEATH; AGE; HOSPITALIZATION	Background: End-of-life medical expenditures exceed costs of care during other years, vary across regions, and are likely to be unsustainable. Identifying determinants of expenditure variation may reveal opportunities for reducing costs. Objective: To identify patient-level determinants of Medicare expenditures at the end of life and to determine the contributions of these factors to expenditure variation while accounting for regional characteristics. It was hypothesized that race or ethnicity, social support, and functional status are independently associated with treatment intensity and controlling for regional characteristics, and that individual characteristics account for a substantial proportion of expenditure variation. Design: Using data from the Health and Retirement Study, Medicare claims, and The Dartmouth Atlas of Health Care, relationships were modeled between expenditures and patient and regional characteristics. Setting: United States, 2000 to 2006. Participants: 2394 Health and Retirement Study decedents aged 65.5 years or older. Measurements: Medicare expenditures in the last 6 months of life were estimated in a series of 2-level multivariable regression models that included patient, regional, and patient and regional characteristics. Results: Decline in function (rate ratio [RR], 1.64 [95% CI, 1.46 to 1.83]); Hispanic ethnicity (RR, 1.50 [CI, 1.22 to 1.85]); black race (RR, 1.43 [CI, 1.25 to 1.64]); and certain chronic diseases, including diabetes (RR, 1.16 [CI, 1.06 to 1.27]), were associated with higher expenditures. Nearby family (RR, 0.90 [CI, 0.82 to 0.98]) and dementia (RR, 0.78 CI, 0.71 to 0.87]) were associated with lower expenditures, and advance care planning had no association. Regional characteristics, including end-of-life practice patterns (RR, 1.09 [CI, 1.06 to 1.14]) and hospital beds per capita (RR, 1.01 [CI, 1.00 to 1.02]), were associated with higher expenditures. Patient characteristics explained 10% of overall variance and retained statistically significant relationships with expenditures after regional characteristics were controlled for. Limitation: The study limitations include the decedent sample, proxy informants, and a large proportion of unexplained variation. Conclusion: Patient characteristics, such as functional decline, race or ethnicity, chronic disease, and nearby family, are important determinants of expenditures at the end of life, independent of regional characteristics.	[Kelley, Amy S.] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY 10029 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; James J Peters Vet Affairs Med Ctr, Bronx, NY USA; Vet Affairs Greater Los Angeles Healthcare Syst, Geriatr Res Educ Clin Ctr, Los Angeles, CA USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Kelley, AS (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Palliat Med, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	amy.kelley@mssm.edu			Brookdale Foundation; National Institute on Aging [K24 AG022345]; National Palliative Care Research Center; Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center; NATIONAL INSTITUTE ON AGING [K24AG022345] Funding Source: NIH RePORTER	Brookdale Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Palliative Care Research Center; Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By the Brookdale Foundation. Dr. Kelley is a Brookdale Leadership in Aging Fellow. Dr. Morrison is the recipient of a MidCareer Investigator Award in Patient-Oriented Research (K24 AG022345) from the National Institute on Aging and is supported by the National Palliative Care Research Center. Dr. Sarkisian is supported by the Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center.	[Anonymous], HLTH RETIREMENT STUD; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Boyd CM, 2005, AM J MED, V118, P1225, DOI 10.1016/j.amjmed.2005.01.062; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Buccaneer Computer Systems and Services, 2009, CHRON COND DAT WAR U; Cortese D, 2007, HEALTH AFFAIR, V26, pW68, DOI 10.1377/hlthaff.26.1.w68; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hoover DR, 2002, HEALTH SERV RES, V37, P1625, DOI 10.1111/1475-6773.01113; Kelley AS, 2010, J PALLIAT MED, V13, P807, DOI 10.1089/jpm.2010.0007; Kelley AS, 2010, J AM GERIATR SOC, V58, P1109, DOI 10.1111/j.1532-5415.2010.02853.x; Levinsky NG, 2001, JAMA-J AM MED ASSOC, V286, P1349, DOI 10.1001/jama.286.11.1349; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Raudenbush S.W., 2002, HIERARCHICAL LINEAR; REUBEN DB, 1992, AM J MED, V93, P663, DOI 10.1016/0002-9343(92)90200-U; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Shugarman LR, 2007, J WOMENS HEALTH, V16, P214, DOI 10.1089/jwh.2006.0012; Shugarman LR, 2004, J GEN INTERN MED, V19, P127, DOI 10.1111/j.1525-1497.2004.30223.x; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Skinner J, 2009, HEALTH AFFAIR, V28, pW119, DOI 10.1377/hlthaff.28.1.w119; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Virnig B A, 1999, J Palliat Med, V2, P23, DOI 10.1089/jpm.1999.2.23; Virnig BA, 2000, J AM GERIATR SOC, V48, P1117, DOI 10.1111/j.1532-5415.2000.tb04789.x; Welch LC, 2005, J AM GERIATR SOC, V53, P1145, DOI 10.1111/j.1532-5415.2005.53357.x; Wenger NS, 2000, J AM GERIATR SOC, V48, pS44, DOI 10.1111/j.1532-5415.2000.tb03140.x; Wennberg JE., DARTMOUTH ATLAS HLTH; Wennberg JE, 2009, HEALTH AFFAIR, V28, P103, DOI 10.1377/hlthaff.28.1.103; Werner RM, 2007, J GEN INTERN MED, V22, P1206, DOI 10.1007/s11606-007-0230-4; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	49	124	124	2	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					235	W78		10.7326/0003-4819-154-4-201102150-00004	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	720VF	21320939	Green Accepted			2022-12-01	WOS:000287310000015
J	Wang, J				Wang, Jun			Personal Genomes: For One and for All	SCIENCE			English	Editorial Material									Beijing Genome Inst, Beijing, Peoples R China	Beijing Genomics Institute (BGI)	Wang, J (corresponding author), Beijing Genome Inst, Beijing, Peoples R China.		Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931					0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	690		10.1126/science.1202811	http://dx.doi.org/10.1126/science.1202811			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310998				2022-12-01	WOS:000287205700040
J	Wu, L; Pan, LF; Wei, ZY; Zhang, MJ				Wu, Lin; Pan, Lifeng; Wei, Zhiyi; Zhang, Mingjie			Structure of MyTH4-FERM Domains in Myosin VIIa Tail Bound to Cargo	SCIENCE			English	Article							USHER-SYNDROME; UNCONVENTIONAL MYOSIN; HAIR BUNDLE; MUTATIONS; HARMONIN; DEAFNESS; PROTEIN; CELLS; CADHERIN-23; COHESION	The unconventional myosin VIIa (MYO7A) is one of the five proteins that form a network of complexes involved in formation of stereocilia. Defects in these proteins cause syndromic deaf-blindness in humans [Usher syndrome I (USH1)]. Many disease-causing mutations occur in myosin tail homology 4-protein 4.1, ezrin, radixin, moesin (MyTH4-FERM) domains in the myosin tail that binds to another USH1 protein, Sans. We report the crystal structure of MYO7A MyTH4-FERM domains in complex with the central domain (CEN) of Sans at 2.8 angstrom resolution. The MyTH4 and FERM domains form an integral structural and functional supramodule binding to two highly conserved segments (CEN1 and 2) of Sans. The MyTH4-FERM/CEN complex structure provides mechanistic explanations for known deafness-causing mutations in MYO7A MyTH4-FERM. The structure will also facilitate mechanistic and functional studies of MyTH4-FERM domains in other myosins.	[Wu, Lin; Pan, Lifeng; Wei, Zhiyi; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/C-4315-2014; Wei, Zhiyi/B-5001-2010	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Zhang, Mingjie/0000-0001-9404-0190	Research Grant Council of Hong Kong [663808, 664009, 663610, CA07/08.SC01, SEG_HKUST06, AoE/B-15/01-II]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	We thank T. Friediman for providing the mouse MYO7A cDNA construct, J. Yu and Y. Shang for the help in crystallography, Y. Zhao for the in-house x-ray diffractor, the BL17U1 of the Shanghai Synchrotron Radiation Facility for the beamline time, and A. Zhang for reading the manuscript. This work was supported by grants from the Research Grant Council of Hong Kong to M.Z. (663808, 664009, 663610, CA07/08.SC01, SEG_HKUST06, and AoE/B-15/01-II). The atomic coordinates and structure factors of the complex structure have been deposited in the Protein Data Bank under the accession code 3PVL. The superimposed final 10 NMR structures of the CEN2 peptide have been deposited in the Protein Data Bank under the accession code 2L7T.	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Reiners J, 2006, ADV EXP MED BIOL, V572, P349; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Self T, 1998, DEVELOPMENT, V125, P557; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Tepass U, 2009, CURR OPIN GENET DEV, V19, P357, DOI 10.1016/j.gde.2009.05.006; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	19	78	81	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					757	760		10.1126/science.1198848	http://dx.doi.org/10.1126/science.1198848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311020				2022-12-01	WOS:000287205700067
J	Collins, FS				Collins, Francis S.			Faces of the Genome	SCIENCE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	14	15	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					546	546		10.1126/science.1202894	http://dx.doi.org/10.1126/science.1202894			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292963	Green Published			2022-12-01	WOS:000286933600037
J	Przeworski, M				Przeworski, Molly			The Golden Age of Human Population Genetics	SCIENCE			English	Editorial Material									[Przeworski, Molly] Univ Chicago, Chicago, IL 60637 USA; [Przeworski, Molly] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Chicago; Howard Hughes Medical Institute	Przeworski, M (corresponding author), Univ Chicago, Chicago, IL 60637 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)			0	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					547	547		10.1126/science.1202571	http://dx.doi.org/10.1126/science.1202571			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292966				2022-12-01	WOS:000286933600039
J	Lipitz-Snyderman, A; Steinwachs, D; Needham, D; Colantuoni, E; Morlock, LL; Pronovos, PJ				Lipitz-Snyderman, Allison; Steinwachs, Donald; Needham, Dale M.; Colantuoni, Elizabeth; Morlock, Laura L; Pronovos, Peter J			Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay: retrospective comparative analysis	BRITISH MEDICAL JOURNAL			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; ADVERSE EVENTS; PREVENTION; INTERVENTION; COST	Objective To evaluate whether implementation of the Michigan Keystone ICU project, a comprehensive statewide quality improvement initiative focused on reduction of infections, was associated with reductions in hospital mortality and length of stay for adults aged 65 or more admitted to intensive care units. Design Retrospective comparative study, using data from Medicare claims. Setting Michigan and Midwest region, United States. Population The study period (October 2001 to December 2006) spanned two years before the project was initiated to 22 months after its implementation. The study sample included hospital admissions for patients treated in 95 study hospitals in Michigan (238 937 total admissions)compared with 364 hospitals in the surrounding Midwest region (1 091 547 total admissions). Main outcome measures Hospital mortality and length of hospital stay. Results The overall trajectory of mortality outcomes differed significantly between the two groups upon implementation of the project (Wald test chi(2)=8.73,P=0.033). Reductions in mortality were significantly greater for the study group than for the comparison group 1-12 months (odds ratio 0.83, 95% confidence interval 0.79 to 0.87 v 0.88, 0.85 to 0.90, P=0.041) and 13-22 months (0.76, 0.72 to 0.81 v 0.84, 0.81 to 0.86, P=0.007) after implementation of the project. The overall trajectory of length of stay did not differ significantly between the groups upon implementation of the project (Wald test chi 2=2.05, P=0.560). Group differences in adjusted length of stay compared with baseline did not reach significance during implementation of the project(.0.45 days, 95% confidence interval -0.62 to -0.28 v -0.35, -0.52 to -0.19) or during post-implementation months 1-12 (-0.59, -0.80 to -0.37 v -0.42, -0.59 to -0.25) and 13-22 (-0.67, -0.91 to -0.43 v -0.54, -0.72 to -0.37). Conclusions Implementation of the Keystone ICU project was associated with a significant decrease in hospital mortality in Michigan compared with the surroundingarea. The project was not, however, sufficiently powered to show a significant difference in length of stay.	[Lipitz-Snyderman, Allison; Steinwachs, Donald; Morlock, Laura L] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Needham, Dale M.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Outcomes After Crit Illness & Surg Grp, Baltimore, MD USA; [Colantuoni, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Pronovos, Peter J] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Lipitz-Snyderman, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.	alipitz@jhsph.edu						Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; BERENHOLTZ S, 2010, INFECT CONTROL HOSP; Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elixhauser A, 1996, CLIN CLASSIFICATIONS; KHAUS WA, 1993, ANN INTERN MED, V118, P753; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; KOHN LT, 1999, ERR HUMAN BUILDING S; Melsen WG, 2009, CRIT CARE MED, V37, P2709, DOI 10.1097/CCM.0b013e3181ab8655; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; POTTER L, 1997, P 5 ANN WESTERN USER; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; PRONOVOST PJ, 2010, BRIT MED J, P340; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Shorr AF, 2001, CHEST, V119, P228, DOI 10.1378/chest.119.1.228; Soufir L, 1999, INFECT CONT HOSP EP, V20, P396, DOI 10.1086/501639; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; Warren DK, 2006, INFECT CONT HOSP EP, V27, P662, DOI 10.1086/506184; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D	24	83	83	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 31	2011	342								d219	10.1136/bmj.d219	http://dx.doi.org/10.1136/bmj.d219			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PN	21282262	Green Published, hybrid			2022-12-01	WOS:000287137500014
J	O'Neill, JS; Reddy, AB				O'Neill, John S.; Reddy, Akhilesh B.			Circadian clocks in human red blood cells	NATURE			English	Article							GENE-EXPRESSION; PEROXIREDOXINS; OSCILLATIONS; FEEDBACK; NADH; MECHANISMS; HEALTH; STATES; RHYTHM; DIMER	Circadian (similar to 24 hour) clocks are fundamentally important for coordinated physiology in organisms as diverse as cyanobacteria and humans. All current models of the molecular circadian clockwork in eukaryotic cells are based on transcription-translation feedback loops. Non-transcriptional mechanisms in the clockwork have been difficult to study in mammalian systems. We circumvented these problems by developing novel assays using human red blood cells, which have no nucleus (or DNA) and therefore cannot perform transcription. Our results show that transcription is not required for circadian oscillations in humans, and that non-transcriptional events seem to be sufficient to sustain cellular circadian rhythms. Using red blood cells, we found that peroxiredoxins, highly conserved antioxidant proteins, undergo similar to 24-hour redox cycles, which persist for many days under constant conditions (that is, in the absence of external cues). Moreover, these rhythms are entrainable (that is, tunable by environmental stimuli) and temperature-compensated, both key features of circadian rhythms. We anticipate that our findings will facilitate more sophisticated cellular clock models, highlighting the interdependency of transcriptional and non-transcriptional oscillations in potentially all eukaryotic cells.	[O'Neill, John S.; Reddy, Akhilesh B.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Reddy, AB (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	areddy@cantab.net		O'Neill, John Stuart/0000-0003-2204-6096	Wellcome Trust [083643/Z/07/Z]; MRC Centre for Obesity and Related metabolic Disorders (MRC CORD); NIHR Cambridge Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Obesity and Related metabolic Disorders (MRC CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust (083643/Z/07/Z), the MRC Centre for Obesity and Related metabolic Disorders (MRC CORD) and the NIHR Cambridge Biomedical Research Centre. We thank M. Jain and R. Edgar for discussions about the manuscript, A. Coles and J. Jones for providing access to samples, and G. van der Horst and F. Tamanini for providing access to Cry1 Cry2 knockout (and wild-type) mouse embryonic fibroblasts.	Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; Griffon N, 1998, PROTEIN SCI, V7, P673, DOI 10.1002/pro.5560070316; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HESS B, 1966, BIOCHEM BIOPH RES CO, V23, P102, DOI 10.1016/0006-291X(66)90276-2; HEWITT JA, 1972, P NATL ACAD SCI USA, V69, P203, DOI 10.1073/pnas.69.1.203; Hu T, 2009, BIOCHEMISTRY-US, V48, P608, DOI 10.1021/bi801880y; JACOBSEN MP, 1995, BBA-PROTEIN STRUCT M, V1246, P17, DOI 10.1016/0167-4838(94)00174-F; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kennett EC, 2005, INT J BIOCHEM CELL B, V37, P1438, DOI 10.1016/j.biocel.2005.02.001; Kippert F, 2002, CURR BIOL, V12, pR47, DOI 10.1016/S0960-9822(01)00670-4; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; LATENKOV V P, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V101, P614; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; OGO S, 1989, J BIOL CHEM, V264, P11302; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; WOOLUM JC, 1991, J BIOL RHYTHM, V6, P129, DOI 10.1177/074873049100600203; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	45	540	557	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					498	U70		10.1038/nature09702	http://dx.doi.org/10.1038/nature09702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270888	Green Accepted			2022-12-01	WOS:000286596500025
J	Smagulova, F; Gregoretti, IV; Brick, K; Khil, P; Camerini-Otero, RD; Petukhova, GV				Smagulova, Fatima; Gregoretti, Ivan V.; Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel; Petukhova, Galina V.			Genome-wide analysis reveals novel molecular features of mouse recombination hotspots	NATURE			English	Article							MEIOTIC RECOMBINATION; HOT-SPOT; PRDM9; GENE; MAP; INSTABILITY	Meiotic recombination predominantly occurs at discrete genomic loci called recombination hotspots, but the features defining these areas are still largely unknown (reviewed in refs 1-5). To allow a comprehensive analysis of hotspot-associated DNA and chromatin characteristics, we developed a direct molecular approach for mapping meiotic DNA double-strand breaks that initiate recombination. Here we present the genome-wide distribution of recombination initiation sites in the mouse genome. Hotspot centres are mapped with approximately 200-nucleotide precision, which allows analysis of the fine structural details of the preferred recombination sites. We determine that hotspots share a centrally distributed consensus motif, possess a nucleotide skew that changes polarity at the centres of hotspots and have an intrinsic preference to be occupied by a nucleosome. Furthermore, we find that the vast majority of recombination initiation sites in mouse males are associated with testis-specific trimethylation of lysine 4 on histone H3 that is distinct from histone H3 lysine 4 trimethylation marks associated with transcription. The recombination map presented here has been derived from a homogeneous mouse population with a defined genetic background and therefore lends itself to extensive future experimental exploration. We note that the mapping technique developed here does not depend on the availability of genetic markers and hence can be easily adapted to other species with complex genomes. Our findings uncover several fundamental features of mammalian recombination hotspots and underline the power of the new recombination map for future studies of genetic recombination, genome stability and evolution.	[Smagulova, Fatima; Petukhova, Galina V.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Gregoretti, Ivan V.; Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel] NIDDKD, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Petukhova, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	rdcamerini@mail.nih.gov; gpetukhova@usuhs.mil	Brick, Kevin/N-1156-2019; Smagulova, Fatima/K-5459-2015	Brick, Kevin/0000-0002-9596-6400; Smagulova, Fatima/0000-0001-6883-1968; Mott, Richard/0000-0002-1022-9330; Khil, Pavel/0000-0002-4903-8777	March of Dimes Foundation [5-FY07-667]; NIGMS, NIH [1R01GM084104-01A1]; USUHS [FS71HU, R071HU, CS71HU]; NIDDK (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084104] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USUHS; NIDDK (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Lichten (NCI, NIH) and P. Hsieh (NIDDK, NIH) for comments and discussion. We are grateful to S. Sharmeen for her help with high-throughput sequencing. This work was supported in part by Basil O'Connor Starter Scholar Research Award Grant No. 5-FY07-667 from the March of Dimes Foundation (G. V. P.); NIH grant 1R01GM084104-01A1 from NIGMS (G. V. P.); New Investigator Start-up Grants FS71HU, R071HU and CS71HU from USUHS (G. V. P.); and the NIDDK (NIH) Intramural Research Program (R.D.C.-O.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Clark AG, 2010, ANNU REV GENOM HUM G, V11, P45, DOI 10.1146/annurev-genom-082908-150031; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kauppi L, 2009, METHODS MOL BIOL, V557, P323, DOI 10.1007/978-1-59745-527-5_20; Khambata S, 1996, GENOME RES, V6, P195, DOI 10.1101/gr.6.3.195; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Qin J, 2004, MOL CELL BIOL, V24, P1655, DOI 10.1128/MCB.24.4.1655-1666.2004; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001	30	235	237	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					375	378		10.1038/nature09869	http://dx.doi.org/10.1038/nature09869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460839	Green Accepted			2022-12-01	WOS:000289724600045
J	Liu, GH; Barkho, BZ; Ruiz, S; Diep, D; Qu, J; Yang, SL; Panopoulos, AD; Suzuki, K; Kurian, L; Walsh, C; Thompson, J; Boue, S; Fung, HL; Sancho-Martinez, I; Zhang, K; Yates, J; Belmonte, JCI				Liu, Guang-Hui; Barkho, Basam Z.; Ruiz, Sergio; Diep, Dinh; Qu, Jing; Yang, Sheng-Lian; Panopoulos, Athanasia D.; Suzuki, Keiichiro; Kurian, Leo; Walsh, Christopher; Thompson, James; Boue, Stephanie; Fung, Ho Lim; Sancho-Martinez, Ignacio; Zhang, Kun; Yates, John, III; Izpisua Belmonte, Juan Carlos			Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome	NATURE			English	Article							MUSCLE-CELL SENESCENCE; HUMAN SOMATIC-CELLS; TUMOR-SUPPRESSOR; YEAST PROTEOME; LAMIN; PRELAMIN; DEFECTS; ATHEROSCLEROSIS; DIFFERENTIATION; PHENOTYPE	Hutchinson-Gilford progeria syndrome (HGPS) is a rare and fatal human premature ageing disease(1-5), characterized by premature arteriosclerosis and degeneration of vascular smooth muscle cells (SMCs)(6-8). HGPS is caused by a single point mutation in the lamin A (LMNA) gene, resulting in the generation of progerin, a truncated splicing mutant of lamin A. Accumulation of progerin leads to various ageing-associated nuclear defects including disorganization of nuclear lamina and loss of heterochromatin(9-12). Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts obtained from patients with HGPS. HGPS-iPSCs show absence of progerin, and more importantly, lack the nuclear envelope and epigenetic alterations normally associated with premature ageing. Upon differentiation of HGPS-iPSCs, progerin and its ageing-associated phenotypic consequences are restored. Specifically, directed differentiation of HGPS-iPSCs to SMCs leads to the appearance of premature senescence phenotypes associated with vascular ageing. Additionally, our studies identify DNA-dependent protein kinase catalytic subunit (DNAPKcs, also known as PRKDC) as a downstream target of progerin. The absence of nuclear DNAPK holoenzyme correlates with premature as well as physiological ageing. Because progerin also accumulates during physiological ageing(6,12,13), our results provide an in vitro iPSC-based model to study the pathogenesis of human premature and physiological vascular ageing.	[Liu, Guang-Hui; Barkho, Basam Z.; Ruiz, Sergio; Qu, Jing; Yang, Sheng-Lian; Panopoulos, Athanasia D.; Suzuki, Keiichiro; Kurian, Leo; Walsh, Christopher; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Diep, Dinh; Fung, Ho Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Thompson, James; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Boue, Stephanie; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Zhang, Kun/ABE-6349-2020; Kurian, Leo/M-1598-2014; Ruiz, Sergio/G-1561-2016; Qu, Jing/ABB-9088-2020	Zhang, Kun/0000-0002-7596-5224; Kurian, Leo/0000-0001-7466-5169; Ruiz, Sergio/0000-0002-0177-6965; qu, jing/0000-0002-3988-5067; Suzuki, Keiichiro/0000-0001-5603-9105; Panopoulos, Athanasia/0000-0002-9610-2604; Liu, Guang-Hui/0000-0001-9289-8177; Boue, Stephanie/0000-0003-0680-4168; Sancho-Martinez, Ignacio/0000-0003-4348-1038	CIRM [TG2-01158]; AFAR/Ellison Medical Foundation; NIH [T32 CA009370, R01-DA025779, P41 RR011823]; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Ellison Medical Foundation; MICINN; Fundacion Cellex (JCIB); NATIONAL CANCER INSTITUTE [T32CA009370] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Ellison Medical Foundation(Lawrence Ellison Foundation); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Cellex (JCIB); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Comai for providing experimental material, M. Hetzer, J. Karlseder, J.-F. Deleuze, M. J. Barrero, C. Rodriguez Esteban and L. Gerace for helpful discussions, M. Marti for teratoma analysis, M. C. Llach for karyotyping, T. Berggren, M. Lutz, I. Dubova, S. Stewart, R. Dev, M. Li, L. Laricchia-Robbio, A. M. Goebl and J. Kim for technical help, and M. Schwarz for administrative help. G.-H.L. and L.K. were partially supported by a CIRM grant (TG2-01158), J.Q. was partially supported by an AFAR/Ellison Medical Foundation postdoctoral fellowship; A.D.P. was partially supported by a NIH training grant T32 CA009370. This study was supported by grants from NIH R01-DA025779 (K.Z.), and NIH P41 RR011823 (J.Y.); the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Ellison Medical Foundation, MICINN and Fundacion Cellex (JCIB).	Bern M, 2004, BIOINFORMATICS, V20, P49, DOI 10.1093/bioinformatics/bth947; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Candelario J, 2011, EXP CELL RES, V317, P319, DOI 10.1016/j.yexcr.2010.10.014; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SR, 2005, HUM GENET, V118, P444, DOI 10.1007/s00439-005-0051-7; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Liu GH, 2009, MOL CELL BIOL, V29, P5800, DOI 10.1128/MCB.00684-09; Lu SJ, 2009, REGEN MED, V4, P37, DOI 10.2217/17460751.4.1.37; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	41	398	416	0	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					221	225		10.1038/nature09879	http://dx.doi.org/10.1038/nature09879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21346760	Green Accepted			2022-12-01	WOS:000289469100043
J	Wu, D; Molofsky, AB; Liang, HE; Ricardo-Gonzalez, RR; Jouihan, HA; Bando, JK; Chawla, A; Locksley, RM				Wu, Davina; Molofsky, Ari B.; Liang, Hong-Erh; Ricardo-Gonzalez, Roberto R.; Jouihan, Hani A.; Bando, Jennifer K.; Chawla, Ajay; Locksley, Richard M.			Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis	SCIENCE			English	Article							T-CELLS; IN-VIVO; INSULIN-RESISTANCE; TISSUE; INFLAMMATION; OBESITY; POLARIZATION; EXPRESSION; CYTOKINES; DISEASE	Eosinophils are associated with helminth immunity and allergy, often in conjunction with alternatively activated macrophages (AAMs). Adipose tissue AAMs are necessary to maintain glucose homeostasis and are induced by the cytokine interleukin-4 (IL-4). Here, we show that eosinophils are the major IL-4-expressing cells in white adipose tissues of mice, and, in their absence, AAMs are greatly attenuated. Eosinophils migrate into adipose tissue by an integrin-dependent process and reconstitute AAMs through an IL-4- or IL-13-dependent process. Mice fed a high-fat diet develop increased body fat, impaired glucose tolerance, and insulin resistance in the absence of eosinophils, and helminth-induced adipose tissue eosinophilia enhances glucose tolerance. Our results suggest that eosinophils play an unexpected role in metabolic homeostasis through maintenance of adipose AAMs.	[Wu, Davina; Liang, Hong-Erh; Bando, Jennifer K.; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ricardo-Gonzalez, Roberto R.; Jouihan, Hani A.] Stanford Univ, Sch Med, Dept Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA; [Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94107 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94107 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94107 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu		Ricardo-Gonzalez, Roberto/0000-0002-6135-4035; Molofsky, Ari/0000-0003-0764-3175; Bando, Jennifer/0000-0002-1331-7424	Howard Hughes Medical Institute; NIH [AI026918, 5F30DK083194-02]; Juvenile Diabetes Research Foundation; Larry L. Hillblom Foundation; Sandler Asthma Basic Research Center; Diabetes Endocrinology Research Center [DK063720]; UCSF; UCSF Department of Laboratory Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663, R37AI026918, R01AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081405, F30DK083194, R01DK076760, P30DK063720] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Larry L. Hillblom Foundation; Sandler Asthma Basic Research Center; Diabetes Endocrinology Research Center; UCSF; UCSF Department of Laboratory Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Cyster, D. Erle, C. Gerard, J. Lee, and A. McKenzie for reagents and mice; N. Flores for animal husbandry; Z. Wang for technical assistance; and M. Anderson and C. Lowell for constructive review of the manuscript. This work was supported by the Howard Hughes Medical Institute and grants from the NIH (AI026918), Juvenile Diabetes Research Foundation Innovative Grant, Larry L. Hillblom Foundation Network Grant and the Sandler Asthma Basic Research Center. Support was provided by the Diabetes Endocrinology Research Center grant DK063720, UCSF Medical Scientist Training Program (D. W.), UCSF Department of Laboratory Medicine (A. B. M.), and 5F30DK083194-02 from the National Institutes of Health (D. W.). Animal care was in accordance with UCSF Laboratory Animal Resource Center committee guidelines. Mouse strains described are available upon completion of standard institutional Material Transfer Agreements.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Jeninga EH, 2009, TRENDS ENDOCRIN MET, V20, P380, DOI 10.1016/j.tem.2009.04.005; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Lee NA, 1997, J IMMUNOL, V158, P1332; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	25	921	941	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					243	247		10.1126/science.1201475	http://dx.doi.org/10.1126/science.1201475			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21436399	Green Accepted			2022-12-01	WOS:000289251100054
J	Navin, N; Kendall, J; Troge, J; Andrews, P; Rodgers, L; McIndoo, J; Cook, K; Stepansky, A; Levy, D; Esposito, D; Muthuswamy, L; Krasnitz, A; McCombie, WR; Hicks, J; Wigler, M				Navin, Nicholas; Kendall, Jude; Troge, Jennifer; Andrews, Peter; Rodgers, Linda; McIndoo, Jeanne; Cook, Kerry; Stepansky, Asya; Levy, Dan; Esposito, Diane; Muthuswamy, Lakshmi; Krasnitz, Alex; McCombie, W. Richard; Hicks, James; Wigler, Michael			Tumour evolution inferred by single-cell sequencing	NATURE			English	Article							WHOLE GENOME AMPLIFICATION; COPY-NUMBER ALTERATIONS; BREAST-CANCER; CARCINOMAS; HETEROGENEITY; PROGRESSION; METASTASIS; PHENOTYPE; VARIANTS	Genomic analysis provides insights into the role of copy number variation in disease, but most methods are not designed to resolve mixed populations of cells. In tumours, where genetic heterogeneity is common(1-3), very important information may be lost that would be useful for reconstructing evolutionary history. Here we show that with flow-sorted nuclei, whole genome amplification and next generation sequencing we can accurately quantify genomic copy number within an individual nucleus. We apply single-nucleus sequencing to investigate tumour population structure and evolution in two human breast cancer cases. Analysis of 100 single cells from a polygenomic tumour revealed three distinct clonal subpopulations that probably represent sequential clonal expansions. Additional analysis of 100 single cells from a monogenomic primary tumour and its liver metastasis indicated that a single clonal expansion formed the primary tumour and seeded the metastasis. In both primary tumours, we also identified an unexpectedly abundant subpopulation of genetically diverse 'pseudodiploid' cells that do not travel to the metastatic site. In contrast to gradual models of tumour progression, our data indicate that tumours grow by punctuated clonal expansions with few persistent intermediates.	[Navin, Nicholas; Kendall, Jude; Troge, Jennifer; Andrews, Peter; Rodgers, Linda; McIndoo, Jeanne; Cook, Kerry; Stepansky, Asya; Levy, Dan; Esposito, Diane; Krasnitz, Alex; McCombie, W. Richard; Hicks, James; Wigler, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Navin, Nicholas] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Muthuswamy, Lakshmi] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada	Cold Spring Harbor Laboratory; University of Texas System; UTMD Anderson Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Wigler, M (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	wigler@cshl.edu	Yang, Chen/G-1379-2010	McCombie, W. Richard/0000-0003-1899-0682; Wigler, Michael/0000-0003-4396-1971	NCI; Department of the Army [W81XWH04-1-0477]; Breast Cancer Research Foundation; Simons Foundation; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of the Army; Breast Cancer Research Foundation; Simons Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Ronemus, T. Spencer, A. Leotta, J. Meth, M. Kramer, L. Gelley, E. Ghiban. We also thank P. Blake and N. Navin at Sophic Systems Alliance. This work was supported by the NCI T32 Fellowship to N.N., and grants to M.W. and J.H. from the Department of the Army (W81XWH04-1-0477), the Breast Cancer Research Foundation, and the Simons Foundation. M.W. is an American Cancer Society Research Professor.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Farabegoli F, 2001, CYTOMETRY, V46, P50, DOI 10.1002/1097-0320(20010215)46:1<50::AID-CYTO1037>3.0.CO;2-T; Fuhrmann C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn101; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Huang J, 2009, J MOL DIAGN, V11, P109, DOI 10.2353/jmoldx.2009.080143; Hughes S, 2004, CYTOGENET GENOME RES, V105, P18, DOI 10.1159/000078004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; LOEB LA, 1974, CANCER RES, V34, P2311; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Pugh TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn378; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Talseth-Palmer Bente A, 2008, BMC Res Notes, V1, P56, DOI 10.1186/1756-0500-1-56; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	25	1704	1791	7	483	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					90	U119		10.1038/nature09807	http://dx.doi.org/10.1038/nature09807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21399628	Green Accepted			2022-12-01	WOS:000289199400043
J	Douglas, I; Evans, S; Smeeth, L				Douglas, Ian; Evans, Stephen; Smeeth, Liam			Effect of statin treatment on short term mortality after pneumonia episode: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; THERAPY	Objective To determine whether statins protect against all cause mortality after a diagnosis of pneumonia. Design Cohort study using propensity score based method to control for differences between people prescribed and not prescribed statins. Setting United Kingdom Health Improvement Network database, which contains electronic primary care medical records of more than six million patients. Participants Every patient starting a statin between 1995 and 2006 (129 288) matched with up to five non-statin users (n=600 241); 9073 patients had a recorded diagnosis of pneumonia, of whom 1398 were using a statin. Main outcome measure All cause mortality within six months of diagnosis of pneumonia. Results Among users and non-users of statins with comparable propensity scores, 95/942 users and 686/ 3615 non-users died on the day that pneumonia was diagnosed. In the following six month period, 109/847 statin users died compared with 578/2927 non-users, giving an adjusted hazard ratio of 0.67 (0.49 to 0.91). If these observed benefits translated into clinical practice, 15 patients would need to be treated with a statin for six months after pneumonia to prevent one death. Conclusions Compared with people who were not taking statins, the risk of dying in the six month period after pneumonia was substantially lower among people who were already established on long term statin treatment when the pneumonia occurred. Whether some or all of this protective effect would be obtained if statin treatment begins when a patient first develops pneumonia is not known. However, given that statins are cheap, safe, and well tolerated, a clinical trial in which people with pneumonia are randomised to a short period of statin treatment is warranted.	[Douglas, Ian; Evans, Stephen; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Douglas, I (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	ian.douglas@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Evans, Stephen/0000-0002-1474-2596; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust; Medical Research Council; MRC [G0802403] Funding Source: UKRI; Medical Research Council [G0802403] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	During this work, ID was funded by grants from the Wellcome Trust and the Medical Research Council paid to the London School of Hygiene and Tropical Medicine. LS was funded by a grant from the Wellcome Trust. Sponsors played no role in the study design; the collection, analysis, and interpretation of data; the writing of the article; or the decision to submit it for publication	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Bourke Alison, 2004, Inform Prim Care, V12, P171; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laufs U, 2001, AM J CARDIOL, V88, P1306, DOI 10.1016/S0002-9149(01)02095-1; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P1195, DOI 10.1002/pds.1441; Li JJ, 2006, ANGIOLOGY, V57, P1, DOI 10.1177/000331970605700101; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Lodi S, 2010, BRIT J CLIN PHARMACO, V69, P85, DOI 10.1111/j.1365-2125.2009.03560.x; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P697, DOI 10.1002/pds.1769; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Office for National Statistics, 2008, GUID DOCT COMPL MED; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286	22	60	60	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2011	342								d1642	10.1136/bmj.d1642	http://dx.doi.org/10.1136/bmj.d1642			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JR	21471172	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000289462100001
J	Kim, S; Grant, RA; Sauer, RT				Kim, Seokhee; Grant, Robert A.; Sauer, Robert T.			Covalent Linkage of Distinct Substrate Degrons Controls Assembly and Disassembly of DegP Proteolytic Cages	CELL			English	Article							ESCHERICHIA-COLI; SERINE-PROTEASE; HTRA GENE; CHAPERONE; PDZ; TRANSCRIPTION; ACTIVATION; PROTEINS; ENVELOPE; TEMPERATURES	Protein quality control requires careful regulation of intracellular proteolysis. For DegP, a periplasmic protease, substrates promote assembly of inactive hexamers into proteolytically active cages with 12, 18, 24, or 30 subunits. Here, we show that sensitive activation and cage assembly require covalent linkage of distinct substrate sequences that affect degradation (degrons). One degron binds the DegP active site, and another degron binds a separate tethering site in PDZ1 in the crystal structure of a substrate-bound DegP dodecamer. FRET experiments demonstrate that active cages assemble rapidly in a reaction that is positively cooperative in substrate concentration, remain stably assembled while uncleaved substrate is present, and dissociate once degradation is complete. Thus, the energy of binding of linked substrate degrons drives assembly of the proteolytic machine responsible for subsequent degradation. Substrate cleavage and depletion results in disassembly, ensuring that DegP is proteolytically active only when sufficient quantities of protein substrates are present.	[Kim, Seokhee; Grant, Robert A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu	Kim, Seokhee/C-2303-2018	Kim, Seokhee/0000-0003-0806-583X; Sauer, Robert/0000-0002-1719-5399	NIH [AI-16892]; NIH-NCRR [RR-15301]; DOE Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Cezairliyan, A. de Regt, S. Glynn, D. Kahne, H. Kim, I. Levchenko, S. Lima, A. Olivares, I. Papayannopoulos, D. Pheasant, K. Schmitz, T. Schwartz, J. Sohn, and S. F. Sui for help, information, and discussions. Supported by NIH-grant AI-16892. Studies at the NE-CAT beamlines of the Advanced Photon Source were supported by NIH-NCRR award RR-15301 and by the DOE Office of Basic Energy Sciences under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee ME, 2010, J MOL BIOL, V399, P707, DOI 10.1016/j.jmb.2010.04.027; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; SWAMY KHS, 1983, ARCH BIOCHEM BIOPHYS, V224, P543, DOI 10.1016/0003-9861(83)90242-4; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4	35	60	63	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					67	78		10.1016/j.cell.2011.02.024	http://dx.doi.org/10.1016/j.cell.2011.02.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458668	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000289053900010
J	Flynn, RL; Centore, RC; O'Sullivan, RJ; Rai, R; Tse, A; Zhou, SY; Chang, S; Karlseder, J; Zou, L				Flynn, Rachel Litman; Centore, Richard C.; O'Sullivan, Roderick J.; Rai, Rekha; Tse, Alice; Zhou Songyang; Chang, Sandy; Karlseder, Jan; Zou, Lee			TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA	NATURE			English	Article							REPLICATION PROTEIN-A; REPEAT-CONTAINING RNA; FISSION YEAST; CHROMOSOME ENDS; BINDING PROTEIN; ATR; DAMAGE; POT1; RPA; ELONGATION	Maintenance of telomeres requires both DNA replication and telomere 'capping' by shelterin. These two processes use two single-stranded DNA (ssDNA)-binding proteins, replication protein A (RPA) and protection of telomeres 1 (POT1). Although RPA and POT1 each have a critical role at telomeres, how they function in concert is not clear. POT1 ablation leads to activation of the ataxia telangiectasia and Rad3-related (ATR) checkpoint kinase at telomeres(1,2), suggesting that POT1 antagonizes RPA binding to telomeric ssDNA. Unexpectedly, we found that purified POT1 and its functional partner TPP1 are unable to prevent RPA binding to telomeric ssDNA efficiently. In cell extracts, we identified a novel activity that specifically displaces RPA, but not POT1, from telomeric ssDNA. Using purified protein, here we show that the heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) recapitulates the RPA displacing activity. The RPA displacing activity is inhibited by the telomeric repeat-containing RNA (TERRA) in early S phase, but is then unleashed in late S phase when TERRA levels decline at telomeres(3). Interestingly, TERRA also promotes POT1 binding to telomeric ssDNA by removing hnRNPA1, suggesting that the reaccumulation of TERRA after S phase helps to complete the RPA-to-POT1 switch on telomeric ssDNA. Together, our data suggest that hnRNPA1, TERRA and POT1 act in concert to displace RPA from telomeric ssDNA after DNA replication, and promote telomere capping to preserve genomic integrity.	[Flynn, Rachel Litman; Centore, Richard C.; Tse, Alice; Zou, Lee] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Zou, Lee] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [O'Sullivan, Roderick J.; Karlseder, Jan] Salk Inst Biol Studies, Mol & Cellular Lab, La Jolla, CA 92037 USA; [Rai, Rekha; Chang, Sandy] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Zhou Songyang] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Salk Institute; Yale University; Baylor College of Medicine	Zou, L (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA.	zou.lee@mgh.harvard.edu	rai, rekha/A-3680-2012		National Institutes of Health (NIH) [5T32CA009216-28, F32-GM089150, CA133249, CA129037, GM06525, AG025837, GM076388]; American Cancer Society [0902501]; George E. Hewitt Foundation for Medical Research; Welch Foundation [Q-1673]; ACS [RSG-08-297]; NATIONAL CANCER INSTITUTE [R01CA129037, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076388, F32GM089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); George E. Hewitt Foundation for Medical Research; Welch Foundation(The Welch Foundation); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. de Lange, A. Krainer, B. Chabot and M. Wold for reagents, and members of the Zou laboratory for discussion. L.Z. is an Ellison New Scholar on Aging. R.L.F. is supported by National Institutes of Health (NIH) fellowship 5T32CA009216-28 and American Cancer Society fellowship 0902501. R.C.C. is supported by NIH fellowship F32-GM089150. R.J.O. is supported by the George E. Hewitt Foundation for Medical Research. This work is supported by a Welch Foundation grant (Q-1673) to Z.S., an ACS grant (RSG-08-297) to L.Z., and NIH grants CA133249 to Z.S., CA129037 to S.C., GM06525 and AG025837 to J.K. and GM076388 to L.Z.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Kibe T, 2007, MOL BIOL CELL, V18, P2378, DOI 10.1091/mbc.E06-12-1084; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; McGee JS, 2010, NAT STRUCT MOL BIOL, V17, P1438, DOI 10.1038/nsmb.1947; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P6461, DOI 10.1093/nar/20.24.6461; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Redon S, 2010, NUCLEIC ACIDS RES, V38, P5797, DOI 10.1093/nar/gkq296; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	30	239	246	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					532	+		10.1038/nature09772	http://dx.doi.org/10.1038/nature09772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21399625	Green Accepted			2022-12-01	WOS:000288702200066
J	Jackevicius, CA; Tu, JV; Ross, JS; Ko, DT; Carreon, D; Krumholz, HM				Jackevicius, Cynthia A.; Tu, Jack V.; Ross, Joseph S.; Ko, Dennis T.; Carreon, Daniel; Krumholz, Harlan M.			Use of Fibrates in the United States and Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR OUTCOMES; GEMFIBROZIL; RHABDOMYOLYSIS; PREVENTION; EVENTS; TRENDS; TRIAL; RISK; MEN	Context Interest in the role of fibrates intensified after the publication of the negative results from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, which assessed therapy with fenofibrate plus statins. The evidence for clinical benefit in outcomes with the use of fibrates is heavily weighted on the use of the older fibrates such as gemfibrozil and clofibrate. Objectives To examine trends in the current use of fibrates and to examine the relationship between differences in the availability and use of brand-name vs generic formulations of fenofibrate and the economic implications in the United States compared with Canada. Design, Setting, and Patients Population-level, observational cohort study using IMS Health data from the United States and Canada of patients prescribed fibrates between January 2002 and December 2009. Main Outcome Measures Fibrate prescriptions dispensed and expenditures. Results In the United States, fibrate prescriptions dispensed increased from 336 prescriptions/100 000 population in January 2002 to 730 prescriptions/100 000 population in December 2009, an increase of 117.1% (95% confidence interval [CI], 116.0%-117.9%), whereas in Canada, fibrate prescriptions increased from 402 prescriptions/100 000 population in January 2002 to 474 prescriptions/100 000 population in December 2009, an increase of 18.1% (95% CI, 17.9%-18.3%) (P<.001). In the United States, fenofibrate prescriptions dispensed increased from 150 prescriptions/100 000 population in January 2002 to 440 prescriptions/100 000 population in December 2009, an increase of 159.3% (95% CI, 157.7%-161.0%), comprising 47.9% of total fibrate prescriptions in 2002 and 65.2% in 2009. In Canada, fenofibrate prescriptions increased from 321 prescriptions/100 000 population in January 2002 to 429 prescriptions/100 000 population in December 2009. The annual ratio of generic to brand-name fenofibrate use in the United States ranged from 0:1 to 0.09:1 between 2002 and 2008, while the ratio in Canada steadily increased from 0.51:1 to 1.89:1 between 2005 and 2008. In the United States, crude fenofibrate expenditures increased from $11 535/100 000 population/month in 2002 to $44 975/100 000 population/month in 2009, while the rates in Canada declined from $17 695/100 000 population/month in 2002 to $16 112/100 000 population/month in 2009. Fibrate expenditures per 100 000 population were 3-fold higher in 2009 in the United States compared with Canada. Conclusion During the past decade, prescriptions for fibrates (particularly fenofibrate) increased in the United States, while prescriptions for fibrates in Canada remained stable. JAMA. 2011; 305(12): 1217-1224	[Jackevicius, Cynthia A.; Carreon, Daniel] Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, Pomona, CA 91766 USA; [Jackevicius, Cynthia A.; Tu, Jack V.; Ko, Dennis T.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jackevicius, Cynthia A.; Tu, Jack V.] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Tu, Jack V.; Ko, Dennis T.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med,Sect Gen Internal Med, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth,Sect Hlth Policy & Adm, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT USA; [Krumholz, Harlan M.] Robert Wood Johnson Clin Scholars Program, New Haven, CT USA	Western University of Health Sciences; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Yale University; Yale University; Yale University	Jackevicius, CA (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, 309 E 2nd St, Pomona, CA 91766 USA.	cjackevicius@westernu.edu	, Harlan/AAI-2875-2020	Ko, Dennis/0000-0001-6840-8051; Tu, Jack/0000-0003-0111-722X; Ross, Joseph/0000-0002-9218-3320	College of Pharmacy of Western University of Health Sciences, Pomona, California; Canadian Institutes of Health Research; Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario, Toronto; National Institute on Aging [K08 AG032886]; American Federation of Aging Research; National Heart, Lung, and Blood Institute [U01-HL105270]; Ontario Ministry of Health and Long-Term Care, Toronto; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	College of Pharmacy of Western University of Health Sciences, Pomona, California; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research(Canada Research Chairs); Heart and Stroke Foundation of Ontario, Toronto(Heart & Stroke Foundation of Ontario); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ontario Ministry of Health and Long-Term Care, Toronto(Ministry of Health and Long-Term Care, Ontario); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded in part by the College of Pharmacy of Western University of Health Sciences, Pomona, California, and in part by a Canadian Institutes of Health Research team grant in cardiovascular outcomes research awarded to the Canadian Cardiovascular Outcomes Research Team. Dr Tu is supported by a Canada Research Chair in Health Services Research and by a Career Investigator award of the Heart and Stroke Foundation of Ontario, Toronto. Dr Ross is currently supported by the National Institute on Aging grant K08 AG032886 and by the American Federation of Aging Research through the Paul B. Beeson Career Development Award Program. Dr Ko is supported by a new investigator award from the Canadian Institutes of Health Research. Dr Krumholz is supported by grant U01-HL105270 (awarded to the Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The Institute for Clinical Evaluative Sciences is supported by an operating grant from the Ontario Ministry of Health and Long-Term Care, Toronto.	Abourbih S, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.03.030; Alsheikh-Ali AA, 2004, AM J CARDIOL, V94, P935, DOI 10.1016/j.amjcard.2004.06.033; [Anonymous], ABB SUES LUP AMD APP; [Anonymous], WALL STREET J; Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Danzon PM, 2008, HEALTH AFFAIR, V27, P221, DOI 10.1377/hlthaff.27.1.221; Drugs@FDA, APPR DRUG PROD; Fischer MA, 2003, HEALTH SERV RES, V38, P1051, DOI 10.1111/1475-6773.00162; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Health Canada, NOT COMPL; IMS Health Inc, IMS DAT ASS DAT INF; Institute of Medicine, 2010, EV BIOM SURR ENDP CH; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Jackevicius CA, 2009, CAN MED ASSOC J, V181, pE19, DOI 10.1503/cmaj.081913; Jones PH, 2005, AM J CARDIOL, V95, P120, DOI 10.1016/j.amjcard.2004.08.076; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Office of the Attorney General State of California, TRICOR SETTL AGR; Office of the Attorney General State of New York, ATT GEN CUOM ANN SET; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Orange Book Blog, ANT CAS ABB MOV FORW; Redberg RF, 2010, ARCH INTERN MED, V170, P384, DOI 10.1001/archinternmed.2010.48; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stafford RS, 2004, JAMA-J AM MED ASSOC, V291, P54, DOI 10.1001/jama.291.1.54; *STAT CAN, 2001 CENS CAN; US Census Bureau, TABL 1 POP EST; Vachris MA, 1999, MON LABOR REV, V122, P3; VHA Pharmacy Benefits Management, STAT REP	35	63	64	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1217	1224		10.1001/jama.2011.353	http://dx.doi.org/10.1001/jama.2011.353			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427374	Green Accepted, Bronze			2022-12-01	WOS:000288652100017
J	Baxter, J; Sen, N; Martinez, VL; De Carandini, MEM; Schvartzman, JB; Diffley, JFX; Aragon, L				Baxter, J.; Sen, N.; Lopez Martinez, V.; Monturus De Carandini, M. E.; Schvartzman, J. B.; Diffley, J. F. X.; Aragon, L.			Positive Supercoiling of Mitotic DNA Drives Decatenation by Topoisomerase II in Eukaryotes	SCIENCE			English	Article							INTERTWINED CATENATED DIMERS; CHROMOSOME CONDENSATION; REPLICATION; YEAST; SEGREGATION; SEPARATION; CLEAVAGE; COHESIN	DNA topoisomerase II completely removes DNA intertwining, or catenation, between sister chromatids before they are segregated during cell division. How this occurs throughout the genome is poorly understood. We demonstrate that in yeast, centromeric plasmids undergo a dramatic change in their topology as the cells pass through mitosis. This change is characterized by positive supercoiling of the DNA and requires mitotic spindles and the condensin factor Smc2. When mitotic positive supercoiling occurs on decatenated DNA, it is rapidly relaxed by topoisomerase II. However, when positive supercoiling takes place in catenated plasmid, topoisomerase II activity is directed toward decatenation of the molecules before relaxation. Thus, a topological change on DNA drives topoisomerase II to decatenate molecules during mitosis, potentially driving the full decatenation of the genome.	[Baxter, J.; Sen, N.; Aragon, L.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Cell Cycle Grp, Med Res Council MRC Clin Sci Ctr, London W12 0NN, England; [Lopez Martinez, V.; Monturus De Carandini, M. E.; Schvartzman, J. B.] CSIC, Ctr Invest Biol, Dept Cell Proliferat & Dev, E-28040 Madrid, Spain; [Baxter, J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Diffley, J. F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Sussex; Cancer Research UK	Baxter, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Cell Cycle Grp, Med Res Council MRC Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	Jon.Baxter@sussex.ac.uk; luis.aragon@csc.mrc.ac.uk	Lopez, Virginia/AAC-1321-2021; Schvartzman, Jorge B/J-9171-2014	Lopez, Virginia/0000-0002-0065-7999; Baxter, Jonathan/0000-0002-4455-9717; Diffley, John/0000-0001-5184-7680	European Research Council [202337]; Royal Society; Spanish government [BFU2008-00408/BMC]; Cancer Research UK; MRC UK; Medical Research Council [MC_U120074328, G0801130B] Funding Source: researchfish; MRC [MC_U120074328] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Spanish government(Spanish GovernmentEuropean Commission); Cancer Research UK(Cancer Research UK); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Aragon laboratory, M. Merkenschlager, A. Carr, and J. Murray for discussions and critical reading of the manuscript. We also thank K. Nasmyth and S. Henikoff for helpful discussions, as well as anonymous referees for useful suggestions. This work was funded by European Research Council starting grant 202337 (L. A. and J. B.), the Royal Society (J. B.), the Spanish government grant BFU2008-00408/BMC (J. B. S.), Cancer Research UK (J. F. X. D.), and the MRC UK (L. A.). Extended figure legends are available in the supporting online material.	Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Hardy CD, 2004, PHILOS T R SOC B, V359, P39, DOI 10.1098/rstb.2003.1363; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Martinez-Robles ML, 2009, NUCLEIC ACIDS RES, V37, P5126, DOI 10.1093/nar/gkp530; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Zechiedrich EL, 1997, GENE DEV, V11, P2580, DOI 10.1101/gad.11.19.2580	15	106	106	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1328	1332		10.1126/science.1201538	http://dx.doi.org/10.1126/science.1201538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393545				2022-12-01	WOS:000288215200048
J	Shah, SM; Carey, IM; Harris, T; DeWilde, S; Cook, DG				Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Cook, Derek G.			Quality of chronic disease care for older people in care homes and the community in a primary care pay for performance system: retrospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-FAILURE; NURSING-HOMES; OF-CARE; RESIDENTS; MANAGEMENT; HEALTH	Objective To describe the quality of care for chronic diseases among older people in care homes (nursing and residential) compared with the community in a pay for performance system. Design Retrospective analysis of The Health Improvement Network (THIN), a large primary care database. Setting 326 English and Welsh general practices, 2008-9. Participants 10 387 residents of care homes and 403 259 residents in the community aged 65 to 104 and registered for 90 or more days with their general practitioner. Main outcome measure 16 process quality indicators for chronic disease management appropriate for vulnerable older people for conditions included in the UK Quality and Outcomes Framework. Results After adjustment for age, sex, dementia, and length of registration, attainment of quality indicators was significantly lower for residents of care homes than for those in the community for 14 of 16 indicators. The largest differences were for prescribing in heart disease (beta blockers in coronary heart disease, relative risk 0.70, 95% confidence interval 0.65 to 0.75) and monitoring of diabetes (retinal screening, 0.75, 0.71 to 0.80). Monitoring hypothyroidism (0.93, 0.90 to 0.95), blood pressure in people with stroke (0.92, 0.90 to 0.95), and electrolytes for those receiving loop diuretics (0.89, 0.87 to 0.92) showed smaller differences. Attainment was lower in nursing homes than in residential homes. Residents of care homes were more likely to be identified by their doctor as unsuitable or non-consenting for all Quality and Outcomes Framework indicators for a condition allowing their exclusion from targets; 33.7% for stroke and 34.5% for diabetes. Conclusion There is scope for improving the management of chronic diseases in care homes, but high attainment of some indicators shows that pay for performance systems do not invariably disadvantage residents of care homes compared with those living in the community. High use of exception reporting may compromise care for vulnerable patient groups. The Quality and Outcomes Framework, and other pay for performance systems, should monitor attainment and exception reporting in vulnerable populations such as residents of care homes and consider measures that deal with the specific needs of older people.	[Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Cook, Derek G.] Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England	University of London	Shah, SM (corresponding author), Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England.	sushah@sgul.ac.uk	Carey, Iain/O-6973-2014	Carey, Iain/0000-0003-1099-8460; DeWilde, Stephen/0000-0002-4238-4474; Harris, Tess/0000-0002-8671-1553; Cook, Derek/0000-0002-9723-5759	BUPA Foundation	BUPA Foundation	This study was funded by a grant from the BUPA Foundation, an independent medical research charity. The funder had no involvement in the study design; collection, analysis, and interpretation of the data; writing of the article; or decision to submit the article for publication.	[Anonymous], 2007, J AM GERIATR SOC, V55, pS464; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bourke Alison, 2004, Inform Prim Care, V12, P171; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Fahey T, 2003, BRIT MED J, V326, P580, DOI 10.1136/bmj.326.7389.580; Feldman SM, 2009, J AM MED DIR ASSOC, V10, P354, DOI 10.1016/j.jamda.2009.02.010; Heckman GA, 2004, CAN J CARDIOL, V20, P963; Lester Helen, 2010, Qual Prim Care, V18, P103; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Litaker JR, 2003, CLIN THER, V25, P1918, DOI 10.1016/S0149-2918(03)80196-0; McMurdo MET, 2007, BRIT MED J, V334, P913, DOI 10.1136/bmj.39191.405833.80; NHS Employers, 2006, GUID EXC REC; Petrovic M, 2010, BRIT J CLIN PHARMACO, V69, P713; Resnick HE, 2008, DIABETES CARE, V31, P287, DOI 10.2337/dc07-1425; Rochon PA, 1999, JAMA-J AM MED ASSOC, V282, P113, DOI 10.1001/jama.282.2.113; Saliba Debra, 2004, J Am Med Dir Assoc, V5, P297, DOI 10.1016/S1525-8610(04)70019-5; Shah SM, 2010, AGE AGEING, V39, P617, DOI 10.1093/ageing/afq086; Shah SM, 2008, BRIT J GEN PRACT, V58, P862, DOI 10.3399/bjgp08X376195; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Steel N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a957; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Wenger NS, 2007, J AM GERIATR SOC, V55, pS457, DOI 10.1111/j.1532-5415.2007.01375.x; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Zingmond DS, 2009, MED CARE, V47, P536, DOI 10.1097/MLR.0b013e318190cd8b	25	39	39	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d912	10.1136/bmj.d912	http://dx.doi.org/10.1136/bmj.d912			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385803	hybrid, Green Published, Green Accepted			2022-12-01	WOS:000288446800007
J	Maxmen, A				Maxmen, Amy			Exome Sequencing Deciphers Rare Diseases	CELL			English	News Item																			0	26	29	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					635	637		10.1016/j.cell.2011.02.033	http://dx.doi.org/10.1016/j.cell.2011.02.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376225	Bronze			2022-12-01	WOS:000288007100002
J	Selvin, E; Steffes, MW; Ballantyne, CM; Hoogeveen, RC; Coresh, J; Brancati, FL				Selvin, Elizabeth; Steffes, Michael W.; Ballantyne, Christie M.; Hoogeveen, Ron C.; Coresh, Josef; Brancati, Frederick L.			Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data	ANNALS OF INTERNAL MEDICINE			English	Article							3RD NATIONAL-HEALTH; HISPANIC WHITE ADULTS; HEMOGLOBIN A(1C); ATHEROSCLEROSIS RISK; CARDIOVASCULAR RISK; AFRICAN-AMERICAN; HBA(1C) LEVELS; BLOOD-GLUCOSE; A1C; 1,5-ANHYDROGLUCITOL	Background: Although differences between black and white persons in hemoglobin A(1c) (HbA(1c)) values are well established, recent studies suggest that this might not reflect differences in glycemia. Objective: To investigate racial disparities in glycemic markers, including those that reflect biological processes independent of hemoglobin glycation and erythrocyte turnover. Design: Cross-sectional. Setting: Community-based. Participants: 1376 nondiabetic and 343 diabetic adults in a sub-study of the Atherosclerosis Risk in Communities Study. Measurements: Hemoglobin A1c, fasting glucose, glycated albumin, fructosamine, and 1,5-anhydroglucitol levels. Results: Among persons with and without diabetes, black persons had significantly higher HbA1c, glycated albumin, and fructosamine levels than white persons before and after adjustment for covariates and fasting glucose concentration. Serum 1,5-anhydroglucitol levels, which are reduced in the setting of hyperglycemia-induced glycosuria, were lower in black persons than in white persons, although this difference was statistically significant only in nondiabetic adults. Limitation: The design was cross-sectional, a limited number of participants with a history of diabetes was included, and the study did not include integrated measures of circulating nonfasting glycemia. Conclusion: Differences between black and white persons in glycated albumin, fructosamine, and 1,5-anhydroglucitol levels parallel differences between these groups in HbA(1c) values. Racial differences in hemoglobin glycation and erythrocyte turnover cannot explain racial disparities in these serum markers. The possibility that black persons have systematically higher levels of nonfasting glycemia warrants further study.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Minnesota, Minneapolis, MN USA; Baylor Coll Med, Houston, TX 77030 USA; Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Brancati, FL (corresponding author), Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21287 USA.	lselvin@jhsph.edu	Ballantyne, Christie/A-6599-2008	Hoogeveen, Ron/0000-0003-2399-4653; Ballantyne, Christie/0000-0002-6432-1730	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) [R21 DK080294, K01 DK076595, K24 DK62222]; Johns Hopkins Diabetes Research and Training Center (NIDDK) [P60 DK079637]; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055018, N01HC055016, N01HC055020, N01HC055022, N01HC055019, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055019, R42HL055018, R41HL055018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080294, R01DK089174, K24DK062222, K01DK076595, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Johns Hopkins Diabetes Research and Training Center (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) (grants R21 DK080294 and K01 DK076595 [Dr. Selvin] and K24 DK62222 [Dr. Brancati]) and by the Johns Hopkins Diabetes Research and Training Center (NIDDK grant P60 DK079637 [Dr. Brancati]). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe141, DOI 10.2337/dc09-zb12; Borg R, 2010, DIABETES, V59, P1585, DOI [10.2337/db09-1774, 10.2337/db10-0777]; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Fagot-Campagna A, 2001, DIABETES CARE, V24, P834, DOI 10.2337/diacare.24.5.834; Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2010, ANN INTERN MED, V152, P815, DOI 10.7326/0003-4819-152-12-201006150-00011; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Hu YQ, 2009, J AM COLL NUTR, V28, P636, DOI 10.1080/07315724.2009.10719796; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Kamps JL, 2010, DIABETES CARE, V33, P1025, DOI 10.2337/dc09-1440; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Kirk JK, 2008, DIABETES CARE, V31, P240, DOI 10.2337/dc07-0382; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nguyen QM, 2008, METABOLISM, V57, P1487, DOI 10.1016/j.metabol.2008.04.011; Olabi B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4354; Pal A, 2010, DIABETES CARE, V33, P252, DOI 10.2337/dc09-1246; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Selvin E, 2009, DIABETES CARE, V32, P828, DOI 10.2337/dc08-1699; SIMON D, 1989, DIABETOLOGIA, V32, P864, DOI 10.1007/BF00297451; Stettler C, 2008, DIABETES CARE, V31, P1534, DOI 10.2337/dc08-0385; Steven J, 2002, DIABETES CARE, V25, P1715, DOI 10.2337/diacare.25.10.1715; Suwa T, 2010, ENDOCR J, V57, P135, DOI 10.1507/endocrj.K09E-234; True Mark W, 2009, J Diabetes Sci Technol, V3, P743; Viberti G, 2006, DIABETIC MED, V23, P1289, DOI 10.1111/j.1464-5491.2006.02022.x; Wagenknecht L, 2009, CIRC-CARDIOVASC IMAG, V2, P314, DOI 10.1161/CIRCIMAGING.108.823922; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Won JC, 2009, DIABETES RES CLIN PR, V84, P51, DOI 10.1016/j.diabres.2009.01.002; YAMANOUCHI T, 1989, DIABETES, V38, P723, DOI 10.2337/diabetes.38.6.723; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	39	140	142	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5								10.7326/0003-4819-154-5-201103010-00004	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357907	Green Accepted			2022-12-01	WOS:000287799900002
J	George, PM; Banya, W; Pareek, N; Bilton, D; Cullinan, P; Hodson, ME; Simmonds, NJ				George, P. M.; Banya, W.; Pareek, N.; Bilton, D.; Cullinan, P.; Hodson, M. E.; Simmonds, N. J.			Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECOMBINANT HUMAN DNASE; PSEUDOMONAS-AERUGINOSA; CONTROLLED-TRIAL; DORNASE-ALPHA; MORTALITY; TRANSPLANTATION; CF	Objectives To evaluate the survival of patients with cystic fibrosis whose lung function has deteriorated to a forced expiratory volume in one second (FEV1) below 30% predicted in the recent treatment era and to explore factors associated with any change in survival. Design Cohort study. Setting Adult cystic fibrosis unit in London. Participants 276 patients (147 (53%) male) whose FEV1 was first observed to be less than 30% predicted between 1 January 1990 and 31 December 2003. Main outcome measure Survival during follow-up to 31 December 2007 in two year sub-cohorts. Results Median survival improved from 1.2 years in the 1990-1 group to 5.3 years in the 2002-3 group, with a marked improvement in survival from 1994. The use of nebulised recombinant human DNase was significantly associated with a reduced risk of death (hazard ratio 0.59, 95% confidence interval 0.44 to 0.79). Significantly increased risks were associated with a body mass index under 19 (hazard ratio 1.52, 1.10 to 2.10), long term oxygen therapy (3.52, 2.49 to 4.99), and nebulised antibiotics (1.84, 1.05 to 3.22). Conclusion A marked improvement has occurred in the survival of patients with cystic fibrosis with an FEV1 less than 30% predicted. Secondary analyses suggest that some of this improvement may be due to use of recombinant human DNase.	[George, P. M.; Pareek, N.; Bilton, D.; Hodson, M. E.; Simmonds, N. J.] Royal Brompton Hosp, Dept Cyst Fibrosis, London SW3 6NP, England; [Banya, W.] Royal Brompton Hosp, Dept Res & Dev, London SW3 6NP, England; [Bilton, D.; Cullinan, P.; Hodson, M. E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London	Simmonds, NJ (corresponding author), Royal Brompton Hosp, Dept Cyst Fibrosis, London SW3 6NP, England.	n.simmonds@rbht.nhs.uk		Bilton, Diana/0000-0002-1913-9171	Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; National Institute for Health Research [CL-2008-16-001] Funding Source: researchfish	Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; MEH, DB, and NJS are part of the Chronic Suppurative Lung Disease (CSLD) research consortium of the Respiratory BRU. We acknowledge the input of Khin Gyi for supporting the data collection process that proved invaluable to the study.	Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Doershuk CF, 1999, CHEST, V115, P782, DOI 10.1378/chest.115.3.782; ELBORN JS, 1991, THORAX, V46, P881, DOI 10.1136/thx.46.12.881; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; FINKELSTEIN SM, 1988, J PEDIATR-US, V112, P373, DOI 10.1016/S0022-3476(88)80315-9; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; GIBSON GJ, 1993, EUR RESPIR J, V6, P155; Hodson ME, 2008, J CYST FIBROS, V7, P537, DOI 10.1016/j.jcf.2008.06.003; Jones AP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001127.pub2; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; Madden BP, 2002, EUR RESPIR J, V19, P310, DOI 10.1183/09031936.02.00218502; Mahadeva R, 1998, BMJ-BRIT MED J, V316, P1771, DOI 10.1136/bmj.316.7147.1771; Milla CE, 2005, DIABETES CARE, V28, P2141, DOI 10.2337/diacare.28.9.2141; Milla CE, 1998, CHEST, V113, P1230, DOI 10.1378/chest.113.5.1230; MISCHLER EH, 1982, AM J DIS CHILD, V136, P1060, DOI 10.1001/archpedi.1982.03970480026006; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; RAMSEY BW, 1993, NEW ENGL J MED, V328, P1740, DOI 10.1056/NEJM199306173282403; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; SHAH PL, 1995, THORAX, V50, P333, DOI 10.1136/thx.50.4.333; Steinkamp G, 2002, THORAX, V57, P596, DOI 10.1136/thorax.57.7.596; UK Cystic Fibrosis Trust Nutrition Working Group, 2002, NUTR MAN CYST FIBR; Wark P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001506.pub3	28	77	81	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2011	342								d1008	10.1136/bmj.d1008	http://dx.doi.org/10.1136/bmj.d1008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732DK	21357627	hybrid, Green Published			2022-12-01	WOS:000288164200003
J	Nadeau, JH; Dudley, AM				Nadeau, Joseph H.; Dudley, Aimee M.			Systems Genetics	SCIENCE			English	Editorial Material									[Nadeau, Joseph H.; Dudley, Aimee M.] Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Nadeau, JH (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	jnadeau@systemsbiology.org; adudley@systemsbiology.org	Dudley, Aimee/K-3163-2019	Dudley, Aimee/0000-0003-3644-0625	NCRR NIH HHS [P40 RR012305, RR12305] Funding Source: Medline; NICHD NIH HHS [DP1 HD075624] Funding Source: Medline; NIGMS NIH HHS [P50 GM076547, P50GM076547, R01 GM089978, R01GM089978] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075624] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089978, P50GM076547] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Nadeau JH, 2003, GENOME RES, V13, P2082, DOI 10.1101/gr.1186603; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Newman MEJ., 2010, NETWORKS INTRO OXFOR; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shipley B., 2002, CAUSE CORRELATION US	12	58	61	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1015	1016		10.1126/science.1203869	http://dx.doi.org/10.1126/science.1203869			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350153	Green Accepted			2022-12-01	WOS:000287699000037
J	Su, CC; Long, F; Zimmermann, MT; Rajashankar, KR; Jernigan, RL; Yu, EW				Su, Chih-Chia; Long, Feng; Zimmermann, Michael T.; Rajashankar, Kanagalaghatta R.; Jernigan, Robert L.; Yu, Edward W.			Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli	NATURE			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; PSEUDOMONAS-AERUGINOSA; PERIPLASMIC COMPONENT; PUMP; ACRB; SYSTEM; TRANSPORTER; SOFTWARE; CRYSTALLOGRAPHY	Gram-negative bacteria, such as Escherichia coli, expel toxic chemicals through tripartite efflux pumps that span both the inner and outer membrane. The three parts are an inner membrane, substrate-binding transporter; a membrane fusion protein; and an outer-membrane-anchored channel. The fusion protein connects the transporter to the channel within the periplasmic space. A crystallographic model of this tripartite efflux complex has been unavailable because co-crystallization of the various components of the system has proven to be extremely difficult. We previously described the crystal structures of both the inner membrane transporter CusA(1) and the membrane fusion protein CusB(2) of the CusCBA efflux system(3,4) of E. coli. Here we report the co-crystal structure of the CusBA efflux complex, showing that the transporter (or pump) CusA, which is present as a trimer, interacts with six CusB protomers and that the periplasmic domain of CusA is involved in these interactions. The six CusB molecules seem to form a continuous channel. The affinity of the CusA and CusB interaction was found to be in the micromolar range. Finally, we have predicted a three-dimensional structure for the trimeric CusC outer membrane channel and developed a model of the tripartite efflux assemblage. This CusC(3)-CusB(6)-CusA(3) model shows a 750-kilodalton efflux complex that spans the entire bacterial cell envelope and exports Cu I and Ag I ions.	[Su, Chih-Chia; Long, Feng; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Zimmermann, Michael T.; Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA 50011 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA	Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Iowa State University; Iowa State University	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	Jernigan, Robert L/A-5421-2012; Long, Feng/F-5475-2011	Jernigan, Robert L/0000-0003-0996-8360; Long, Feng/0000-0001-6313-8558; Zimmermann, Michael/0000-0001-7073-0525	National Institutes of Health [R01GM074027, R01GM086431, R01GM081680, R01GM072014]; National Center for Research Resources at the National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086431, R01GM074027, R01GM081680, R01GM072014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants R01GM074027 (E.W.Y.), R01GM086431 (E.W.Y.), R01GM081680 (R.L.J.) and R01GM072014 (R.L.J.). This work is based on research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57	33	160	161	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					558	U153		10.1038/nature09743	http://dx.doi.org/10.1038/nature09743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350490	Green Accepted, Green Submitted			2022-12-01	WOS:000287652900047
J	Park-Wyllie, LY; Mamdani, MM; Juurlink, DN; Hawker, GA; Gunraj, N; Austin, PC; Whelan, DB; Weiler, PJ; Laupacis, A				Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Gunraj, Nadia; Austin, Peter C.; Whelan, Daniel B.; Weiler, Peter J.; Laupacis, Andreas			Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION ATTRIBUTABLE FRACTION; HIP FRACTURE; RANDOMIZED-TRIAL; DIAPHYSEAL FEMUR; ALENDRONATE; OSTEOPOROSIS; PERSISTENCE; MORTALITY; THERAPY; TRENDS	Context Osteoporosis is associated with significant morbidity and mortality. Oral bisphosphonates have become a mainstay of treatment, but concerns have emerged that long-term use of these drugs may suppress bone remodeling, leading to unusual fractures. Objective To determine whether prolonged bisphosphonate therapy is associated with an increased risk of subtrochanteric or femoral shaft fracture. Design, Setting, and Patients A population-based, nested case-control study to explore the association between bisphosphonate use and fractures in a cohort of women aged 68 years or older from Ontario, Canada, who initiated therapy with an oral bisphosphonate between April 1, 2002, and March 31, 2008. Cases were those hospitalized with a subtrochanteric or femoral shaft fracture and were matched to up to 5 controls with no such fracture. Study participants were followed up until March 31, 2009. Main Outcome Measures The primary analysis examined the association between hospitalization for a subtrochanteric or femoral shaft fracture and duration of bisphosphonate exposure. To test the specificity of the findings, the association between bisphosphonate use and fractures of the femoral neck or intertrochanteric region, which are characteristic of osteoporotic fractures, was also examined. Results We identified 716 women who sustained a subtrochanteric or femoral shaft fracture following initiation of bisphosphonate therapy and 9723 women who sustained a typical osteoporotic fracture of the intertrochanteric region or femoral neck. Compared with transient bisphosphonate use, treatment for 5 years or longer was associated with an increased risk of subtrochanteric or femoral shaft fracture (adjusted odds ratio, 2.74; 95% confidence interval, 1.25-6.02). A reduced risk of typical osteoporotic fractures occurred among women with more than 5 years of bisphosphonate therapy (adjusted odds ratio, 0.76; 95% confidence interval, 0.63-0.93). Among 52 595 women with at least 5 years of bisphosphonate therapy, a subtrochanteric or femoral shaft fracture occurred in 71 (0.13%) during the subsequent year and 117 (0.22%) within 2 years. Conclusion Among older women, treatment with a bisphosphonate for more than 5 years was associated with an increased risk of subtrochanteric or femoral shaft fractures; however, the absolute risk of these fractures is low. JAMA. 2011; 305(8): 783-789	[Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Laupacis, Andreas] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Gunraj, Nadia; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.; Hawker, Gillian A.; Laupacis, Andreas] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Whelan, Daniel B.; Weiler, Peter J.] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON M5B 1W8, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Mamdani, Muhammad M.; Laupacis, Andreas] King Saud Univ, Dept Med, Riyadh, Saudi Arabia	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; King Saud University	Park-Wyllie, LY (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	parkwylliel@smh.ca	Walter, Henrik/O-2612-2013	Austin, Peter/0000-0003-3337-233X	Novartis; Janssen-Ortho; Pfizer; Boehringer Ingelheim; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario	Novartis(Novartis); Janssen-Ortho; Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. Dr Mamdani reported that he has has participated in paid advisory board meetings and received consulting fees from Novartis, Janssen-Ortho, Pfizer, and Boehringer Ingelheim. No other disclosures were reported.; This study was funded by the Ontario Ministry of Health and Long-Term Care. Dr Park-Wyllie was supported by a Fellowship Award from the Canadian Institutes of Health Research. Dr Austin was supported by a Career Investigator Award from the Heart and Stroke Foundation of Ontario.	Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Canadian Institute for Health Information, 2003, INT STAT CLASS DIS R; Colon-Emeric CS, 2006, JAMA-J AM MED ASSOC, V296, P2968, DOI 10.1001/jama.296.24.2968; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Curtis JR, 2008, OSTEOPOROSIS INT, V19, P1613, DOI 10.1007/s00198-008-0604-4; Evans JG, 1997, J EPIDEMIOL COMMUN H, V51, P424, DOI 10.1136/jech.51.4.424; Geusens Piet, 2009, Curr Osteoporos Rep, V7, P12; Glazier RH, 2003, CAN J PUBLIC HEALTH, V94, P140, DOI 10.1007/BF03404588; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Kelsey J., 1996, METHODS OBSERVATIONA; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lofthus CM, 2005, J CLIN EPIDEMIOL, V58, P280, DOI 10.1016/j.jclinepi.2004.07.003; Mamdani M, 2007, OSTEOPOROSIS INT, V18, P1595, DOI 10.1007/s00198-007-0446-5; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Melo M, 2006, J AM GERIATR SOC, V54, P1015, DOI 10.1111/j.1532-5415.2006.00758.x; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Office of the Surgeon General, 2004, BON HLTH OST REP SUR; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P703, DOI 10.1007/s00198-008-0743-7; Park-Wyllie LY, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000157; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Rizzoli R, 2011, OSTEOPOROSIS INT, V22, P373, DOI 10.1007/s00198-010-1453-5; ROBINS JM, 1986, BIOMETRICS, V42, P293, DOI 10.2307/2531050; Rockhill B, 1998, AM J EPIDEMIOL, V147, P826, DOI 10.1093/oxfordjournals.aje.a009535; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider JP, 2009, GERIATRICS-US, V64, P18; Seeman E, 2009, OSTEOPOROSIS INT, V20, P187, DOI 10.1007/s00198-008-0813-x; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Shane Elizabeth, 2010, NEW ENGL J MED, V362, P1761; US Food and Drug Administration, 2010, ONG SAF REV OR BISPH; Wang MH, 2009, CANCER EPIDEM BIOMAR, V18, P706, DOI 10.1158/1055-9965.EPI-08-0839; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2	41	313	331	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					783	789		10.1001/jama.2011.190	http://dx.doi.org/10.1001/jama.2011.190			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343577	Bronze			2022-12-01	WOS:000287594300021
J	Raby, AM				Raby, Adrian M.			Practice A Patient's Journey Alcoholism	BRITISH MEDICAL JOURNAL			English	Editorial Material												a.raby@imperial.ac.uk						Kaner EFS, 1999, ALCOHOL ALCOHOLISM, V34, P559, DOI 10.1093/alcalc/34.4.559; National Audit Office, 2008, RED ALC HARM HLTH SE	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d956	10.1136/bmj.d956	http://dx.doi.org/10.1136/bmj.d956			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345906				2022-12-01	WOS:000287920100002
J	Hoal, E				Hoal, Eileen			Famine in the Presence of the Genomic Data Feast	SCIENCE			English	Editorial Material									Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, ZA-7505 Tygerberg, South Africa	Stellenbosch University	Hoal, E (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, ZA-7505 Tygerberg, South Africa.								0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					874	874		10.1126/science.1203261	http://dx.doi.org/10.1126/science.1203261			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330533				2022-12-01	WOS:000287455100045
J	Smith, DM; Fraga, H; Reis, C; Kafri, G; Goldberg, AL				Smith, David M.; Fraga, Hugo; Reis, Christian; Kafri, Galit; Goldberg, Alfred L.			ATP Binds to Proteasomal ATPases in Pairs with Distinct Functional Effects, Implying an Ordered Reaction Cycle	CELL			English	Article							20S PROTEASOME; REGULATORY PARTICLE; CRYSTAL-STRUCTURE; 26S PROTEASOME; PROTEIN; HYDROLYSIS; MECHANISM; PAN; UBIQUITIN; GATE	In the eukaryotic 26S proteasome, the 20S particle is regulated by six AAA ATPase subunits and, in archaea, by a homologous ring complex, PAN. To clarify the role of ATP in proteolysis, we studied how nucleotides bind to PAN. Although PAN has six identical subunits, it binds ATPs in pairs, and its subunits exhibit three conformational states with high, low, or no affinity for ATP. When PAN binds two ATP gamma S molecules or two ATP gamma S plus two ADP molecules, it is maximally active in binding protein substrates, associating with the 20S particle, and promoting 20S gate opening. However, binding of four ATP gamma S molecules reduces these functions. The 26S proteasome shows similar nucleotide dependence. These findings imply an ordered cyclical mechanism in which two ATPase subunits bind ATP simultaneously and dock into the 20S. These results can explain how these hexameric ATPases interact with and "wobble'' on top of the heptameric 20S proteasome.	[Smith, David M.; Fraga, Hugo; Reis, Christian; Kafri, Galit; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Smith, DM (corresponding author), W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA.	dsmith2@hsc.wvu.edu; alfred_goldberg@hms.harvard.edu	Smith, David/AAL-7662-2020; Fraga, Hugo/X-4850-2019	Smith, David/0000-0002-1502-676X; Fraga, Hugo/0000-0001-7677-4086	NIH [GM051923-09]; Multiple Myeloma Foundation; Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal [SFRH/26490/2006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Foundation; Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by a grant from the NIH (GM051923-09) to A. L. G., by the Multiple Myeloma Foundation to A. L. G., and by a fellowship (SFRH/26490/2006) from Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal to H.F.	Ames BN, 1966, METHOD ENZYMOL, VVIII, P115; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Fontes R, 1998, FEBS LETT, V438, P190, DOI 10.1016/S0014-5793(98)01301-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goldberg AL, 2005, NEURON, V45, P339, DOI 10.1016/j.neuron.2005.01.019; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hersch GL, 2005, CELL, V121, P1017, DOI 10.1016/j.cell.2005.05.024; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; MENON AS, 1987, J BIOL CHEM, V262, P14921; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P161; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schumacher J, 2008, J MOL BIOL, V381, P1, DOI 10.1016/j.jmb.2008.05.075; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	43	151	153	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					526	538		10.1016/j.cell.2011.02.005	http://dx.doi.org/10.1016/j.cell.2011.02.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335235	Bronze, Green Accepted			2022-12-01	WOS:000287473100008
J	Vaccarella, M				Vaccarella, Maria			The art of medicine Narrative epileptology	LANCET			English	Editorial Material									Kings Coll London, Sch Arts & Humanities, Ctr Humanities & Hlth, London WC2R 2LS, England	University of London; King's College London; University College London	Vaccarella, M (corresponding author), Kings Coll London, Sch Arts & Humanities, Ctr Humanities & Hlth, London WC2R 2LS, England.	maria.vaccarella@kcl.ac.uk						Alcauskas M, 2008, NEUROLOGY, V70, P891, DOI 10.1212/01.wnl.0000304945.48551.13; Charon Rita, 2006, NARRATIVE MED HONORI; de Toffol B, 2008, PROUST IMPROVE YOUR; Frank AW., 2013, WOUNDED STORYTELLER; Gastaut H, 1978, EPILEPSIA, V78, P198; Heritage J, 2006, STUD INTERACT SOCIO, P1, DOI 10.1017/CBO9780511607172; Stirling J., 2010, REPRESENTING EPILEPS	7	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					460	461		10.1016/S0140-6736(11)60150-5	http://dx.doi.org/10.1016/S0140-6736(11)60150-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	721TX	21300595				2022-12-01	WOS:000287381800015
J	Lewis, SL; Brando, PM; Phillips, OL; van der Heijden, GMF; Nepstad, D				Lewis, Simon L.; Brando, Paulo M.; Phillips, Oliver L.; van der Heijden, Geertje M. F.; Nepstad, Daniel			The 2010 Amazon Drought	SCIENCE			English	Article							DEFORESTATION		[Lewis, Simon L.; Phillips, Oliver L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Brando, Paulo M.; Nepstad, Daniel] Inst Pesquisa Ambiental Amazonia, BR-66035170 Belem, Para, Brazil; [Brando, Paulo M.] Woods Hole Res Ctr, Falmouth, MA 02450 USA; [van der Heijden, Geertje M. F.] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Leeds; Woods Hole Research Center; University of Sheffield	Lewis, SL (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	s.l.lewis@leeds.ac.uk	Brando, Paulo/AAC-9396-2019; van der Heijden, Geertje/AAB-4102-2019; Phillips, Oliver L/A-1523-2011; Brando, Paulo M/C-4302-2012	Brando, Paulo/0000-0001-8952-7025; van der Heijden, Geertje/0000-0002-2110-5173; Phillips, Oliver L/0000-0002-8993-6168; Brando, Paulo M/0000-0001-8952-7025; Lewis, Simon/0000-0002-8066-6851	Natural Environment Research Council [NE/B504630/1, NE/I02982X/1, NE/D010306/1, NE/D01025X/1] Funding Source: researchfish; NERC [NE/D01025X/1, NE/I02982X/1, NE/D010306/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946, 10.1029/2006GL028946.]; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Nogueira EM, 2008, FOREST ECOL MANAG, V255, P2963, DOI 10.1016/j.foreco.2008.02.002; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rammig A, 2010, NEW PHYTOL, V187, P694, DOI 10.1111/j.1469-8137.2010.03318.x	7	774	803	8	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					554	554		10.1126/science.1200807	http://dx.doi.org/10.1126/science.1200807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292971				2022-12-01	WOS:000286933600045
J	Sillesen, H; Falk, E				Sillesen, Henrik; Falk, Erling			Why not screen for subclinical atherosclerosis?	LANCET			English	Editorial Material							PRIMARY PREVENTION; TASK-FORCE; DISEASE; RISK; INTERVENTIONS; ASSOCIATION		[Sillesen, Henrik] Rigshosp, Dept Vasc Surg, DK-2100 Copenhagen, Denmark; [Sillesen, Henrik] Univ Copenhagen, DK-2100 Copenhagen, Denmark; [Falk, Erling] Aarhus Univ Hosp, Dept Cardiol, Skejby, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University	Sillesen, H (corresponding author), Rigshosp, Dept Vasc Surg, DK-2100 Copenhagen, Denmark.	sillesen@mac.com	Sillesen, Henrik/ABB-5668-2020					Fuster V, 2009, NAT REV CARDIOL, V6, P669, DOI 10.1038/nrcardio.2009.187; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Hecht HS, 2008, AM J CARDIOL, V101, P1805, DOI 10.1016/j.amjcard.2008.02.086; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Muntendam P, 2010, AM HEART J, V160, P49, DOI 10.1016/j.ahj.2010.02.021; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; WISLOFF T, 2008, COSTS LIFE YEAR GAIN	12	44	44	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					645	646		10.1016/S0140-6736(11)60059-7	http://dx.doi.org/10.1016/S0140-6736(11)60059-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21440933				2022-12-01	WOS:000294509900007
J	Ferguson, CD				Ferguson, Charles D.			Do not phase out nuclear power - yet	NATURE			English	Editorial Material									Federat Amer Scientists, Washington, DC 20036 USA		Ferguson, CD (corresponding author), Federat Amer Scientists, Washington, DC 20036 USA.	cferguson@fas.org							0	8	8	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					411	411		10.1038/471411a	http://dx.doi.org/10.1038/471411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430730				2022-12-01	WOS:000288702200022
J	Kegel, A; Betts-Lindroos, H; Kanno, T; Jeppsson, K; Strom, L; Katou, Y; Itoh, T; Shirahige, K; Sjogren, C				Kegel, Andreas; Betts-Lindroos, Hanna; Kanno, Takaharu; Jeppsson, Kristian; Strom, Lena; Katou, Yuki; Itoh, Takehiko; Shirahige, Katsuhiko; Sjogren, Camilla			Chromosome length influences replication-induced topological stress	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; TOPOISOMERASE-I; RECQ HELICASE; BUDDING YEAST; REPAIR; PROTEINS; COMPLEX; FORKS; DAMAGE	During chromosome duplication the parental DNA molecule becomes overwound, or positively supercoiled, in the region ahead of the advancing replication fork. To allow fork progression, this superhelical tension has to be removed by topoisomerases, which operate by introducing transient DNA breaks(1). Positive supercoiling can also be diminished if the advancing fork rotates along the DNA helix, but then sister chromatid intertwinings form in its wake(1,2). Despite these insights it remains largely unknown how replication-induced superhelical stress is dealt with on linear, eukaryotic chromosomes. Here we show that this stress increases with the length of Saccharomyces cerevisiae chromosomes. This highlights the possibility that superhelical tension is handled on a chromosome scale and not only within topologically closed chromosomal domains as the current view predicts. We found that inhibition of type I topoisomerases leads to a late replication delay of longer, but not shorter, chromosomes. This phenotype is also displayed by cells expressing mutated versions of the cohesin-and condensin-related Smc5/6 complex. The frequency of chromosomal association sites of the Smc5/6 complex increases in response to chromosome lengthening, chromosome circularization, or inactivation of topoisomerase 2, all having the potential to increase the number of sister chromatid intertwinings(3). Furthermore, nonfunctional Smc6 reduces the accumulation of intertwined sister plasmids after one round of replication in the absence of topoisomerase 2 function. Our results demonstrate that the length of a chromosome influences the need of superhelical tension release in Saccharomyces cerevisiae, and allow us to propose a model where the Smc5/6 complex facilitates fork rotation by sequestering nascent chromatid intertwinings that form behind the replication machinery.	[Kegel, Andreas; Betts-Lindroos, Hanna; Kanno, Takaharu; Jeppsson, Kristian; Strom, Lena; Sjogren, Camilla] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Katou, Yuki; Itoh, Takehiko] Tokyo Inst Technol, Grad Sch Biosci, Lab Silico Funct Genom, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Bunkyo Ku, Tokyo 1130032, Japan	Karolinska Institutet; Tokyo Institute of Technology; University of Tokyo	Sjogren, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Eulersvag 3, S-17177 Stockholm, Sweden.	camilla.sjogren@ki.se	Ström, Lena/AAJ-9025-2020; Itoh, Takehiko/E-8873-2014	Itoh, Takehiko/0000-0002-6113-557X; Lindroos, Hanna/0000-0002-8455-8452; Strom, Lena/0000-0002-8898-3675; Bjorkegren, Camilla/0000-0001-7354-9270; Shirahige, Katsuhiko/0000-0002-7862-1144	JST; SSF; Vinnova	JST(Japan Science & Technology Agency (JST)); SSF(Swedish Foundation for Strategic Research); Vinnova(Vinnova)	We thank K. Nasmyth, J. Haber, E. Green and X. Zhao for yeast strains and the BEA core facility at Karolinska Institutet for help with ChIP on chip. Financial support: Strategic Japanese-Swedish Cooperative Program from JST, SSF and Vinnova (C. S. and K. S.); please see Supplementary Information for additional support.	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; HAMER L, 1995, P NATL ACAD SCI USA, V92, P11706, DOI 10.1073/pnas.92.25.11706; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HIASA H, 1994, J BIOL CHEM, V269, P2093; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; KIM RA, 1989, J MOL BIOL, V208, P257, DOI 10.1016/0022-2836(89)90387-2; KJELDSEN E, 1992, J MOL BIOL, V228, P1025, DOI 10.1016/0022-2836(92)90310-G; KOSHLAND D, 1987, SCIENCE, V238, P1713, DOI 10.1126/science.3317838; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Outwin EA, 2009, MOL CELL BIOL, V29, P4363, DOI 10.1128/MCB.00377-09; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rosenfeld S, 2009, GENE REGUL SYST BIO, V3, P159; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; SPELL RM, 1994, MOL CELL BIOL, V14, P1465, DOI 10.1128/MCB.14.2.1465; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	36	79	79	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					392	+		10.1038/nature09791	http://dx.doi.org/10.1038/nature09791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368764				2022-12-01	WOS:000288444000048
J	DePaolo, RW; Abadie, V; Tang, F; Fehlner-Peach, H; Hall, JA; Wang, W; Marietta, EV; Kasarda, DD; Waldmann, TA; Murray, JA; Semrad, C; Kupfer, SS; Belkaid, Y; Guandalini, S; Jabri, B				DePaolo, R. W.; Abadie, V.; Tang, F.; Fehlner-Peach, H.; Hall, J. A.; Wang, W.; Marietta, E. V.; Kasarda, D. D.; Waldmann, T. A.; Murray, J. A.; Semrad, C.; Kupfer, S. S.; Belkaid, Y.; Guandalini, S.; Jabri, B.			Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; REGULATORY T-CELLS; GLUTEN SENSITIVITY; TRANSGENIC MICE; TGF-BETA; CLASS-I; DIFFERENTIATION; DISEASE; CYTOKINE; INTERLEUKIN-15	Under physiological conditions the gut-associated lymphoid tissues not only prevent the induction of a local inflammatory immune response, but also induce systemic tolerance to fed antigens(1,2). A notable exception is coeliac disease, where genetically susceptible individuals expressing human leukocyte antigen (HLA) HLA-DQ2 or HLA-DQ8 molecules develop inflammatory T-cell and antibody responses against dietary gluten, a protein present in wheat(3). The mechanisms underlying this dysregulated mucosal immune response to a soluble antigen have not been identified. Retinoic acid, a metabolite of vitamin A, has been shown to have a critical role in the induction of intestinal regulatory responses(4-6). Here we find in mice that in conjunction with IL-15, a cytokine greatly upregulated in the gut of coeliac disease patients(3,7), retinoic acid rapidly activates dendritic cells to induce JNK (also known as MAPK8) phosphorylation and release the proinflammatory cytokines IL-12p70 and IL-23. As a result, in a stressed intestinal environment, retinoic acid acted as an adjuvant that promoted rather than prevented inflammatory cellular and humoral responses to fed antigen. Altogether, these findings reveal an unexpected role for retinoic acid and IL-15 in the abrogation of tolerance to dietary antigens.	[DePaolo, R. W.; Abadie, V.; Tang, F.; Fehlner-Peach, H.; Wang, W.; Semrad, C.; Kupfer, S. S.; Jabri, B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hall, J. A.; Belkaid, Y.] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Hall, J. A.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Marietta, E. V.] Mayo Clin, Dept Dermatol, Coll Med, Rochester, MN 55905 USA; [Marietta, E. V.] Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA; [Kasarda, D. D.] ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA; [Waldmann, T. A.] NCI, Metab Branch, Bethesda, MD 20892 USA; [Murray, J. A.] Mayo Clin, Div Gastroenterol & Hepatol, Dept Med, Coll Med, Rochester, MN 55905 USA; [Guandalini, S.; Jabri, B.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Jabri, B.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Mayo Clinic; Mayo Clinic; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; University of Chicago; University of Chicago	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Waldmann, Thomas/AAT-5972-2021; Kupfer, Sonia S/ABD-9416-2021; Guandalini, Stefano/G-8084-2011	Waldmann, Thomas/0000-0003-4500-6660; DePaolo, William/0000-0002-3880-4544; Belkaid, Yasmine/0000-0001-9962-3571; murray, joseph/0000-0003-1941-9090	Digestive Disease Research Core Center at the University of Chicago [DK42086, R01 DK67180, R01DK71003]; Crohn's and Colitis Foundation; University of Chicago Celiac Disease Center; NATIONAL CANCER INSTITUTE [ZIASC004002, K08CA142892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067180, R01DK071003, P30DK042086, R56DK071003] Funding Source: NIH RePORTER	Digestive Disease Research Core Center at the University of Chicago; Crohn's and Colitis Foundation; University of Chicago Celiac Disease Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank coeliac disease patients and their family members as well as the University of Chicago Celiac Disease Center for supporting our research. We thank B. Sally, L. M. Sollid and M. Musch for critical reading of the manuscript. We thank C. Ciszewski, B. Uzunparmak, and N. Grandison for their help with the collection and analysis of human biopsies. We thank M. Constantinides for technical assistance with mice breeding. We also thank the University of Chicago flow cytometry facility for technical assistance. D<SUP>d</SUP>-IL-15 transgenic mice were a gift from M. Caligiuri. RAR alpha-deficient mice were provided by P. Chambon and C. Benoist. This work was supported by the Digestive Disease Research Core Center at the University of Chicago (DK42086), R01 DK67180 (for B.J.), R01DK71003 (for J.A.M.), and the Crohn's and Colitis Foundation (for V.A.).	BERNARDI.JE, 1967, J BIOL CHEM, V242, P445; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gao Y, 2007, LEUKEMIA RES, V31, P455, DOI 10.1016/j.leukres.2006.07.004; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kraus TA, 2004, GASTROENTEROLOGY, V126, P1771, DOI 10.1053/j.gastro.2004.03.076; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Liu ZJ, 2000, J IMMUNOL, V164, P3608, DOI 10.4049/jimmunol.164.7.3608; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mazzarella G, 2008, GASTROENTEROLOGY, V134, P1017, DOI 10.1053/j.gastro.2008.01.008; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Mohty M, 2003, BRIT J HAEMATOL, V122, P829, DOI 10.1046/j.1365-2141.2003.04489.x; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; Reddy D, 2006, AM J GASTROENTEROL, V101, P1569, DOI 10.1111/j.1572-0241.2006.00632.x; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Stephensen CB, 2009, AM J CLIN NUTR, V90, P457, DOI 10.3945/ajcn.2009.28343; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yokoyama S, 2009, P NATL ACAD SCI USA, V106, P15849, DOI 10.1073/pnas.0908834106	37	270	284	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					220	U110		10.1038/nature09849	http://dx.doi.org/10.1038/nature09849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21307853	Green Accepted			2022-12-01	WOS:000288170200038
J	Watts, G				Watts, Geoff			Genetics The hunt for the mystery genes	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Riksen NP, 2011, NEW ENGL J MED, V364, P1579, DOI 10.1056/NEJMc1102515	1	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2011	342								d1463	10.1136/bmj.d1463	http://dx.doi.org/10.1136/bmj.d1463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735VA	21393321				2022-12-01	WOS:000288447000009
J	Cardenas, ML; Gosling, WD; Sherlock, SC; Poole, I; Pennington, RT; Mothes, P				Cardenas, Macarena L.; Gosling, William D.; Sherlock, Sarah C.; Poole, Imogen; Pennington, R. Toby; Mothes, Patricia			The Response of Vegetation on the Andean Flank in Western Amazonia to Pleistocene Climate Change	SCIENCE			English	Article								A reconstruction of past environmental change from Ecuador reveals the response of lower montane forest on the Andean flank in western Amazonia to glacial-interglacial global climate change. Radiometric dating of volcanic ash indicates that deposition occurred similar to 324,000 to 193,000 years ago during parts of Marine Isotope Stages 9, 7, and 6. Fossil pollen and wood preserved within organic sediments suggest that the composition of the forest altered radically in response to glacial-interglacial climate change. The presence of Podocarpus macrofossils similar to 1000 meters below the lower limit of their modern distribution indicates a relative cooling of at least 5 degrees C during glacials and persistence of wet conditions. Interglacial deposits contain thermophilic palms suggesting warm and wet climates. Hence, global temperature change can radically alter vegetation communities and biodiversity in this region.	[Cardenas, Macarena L.; Gosling, William D.; Sherlock, Sarah C.] Open Univ, Dept Earth & Environm Sci, CEPSAR, Milton Keynes MK7 6AA, Bucks, England; [Poole, Imogen] Univ Aberdeen, Dept Geol & Petr Geol, Kings Coll, Aberdeen AB24 3UE, Scotland; [Pennington, R. Toby] Royal Bot Garden Edinburgh, Trop Biol Grp, Edinburgh EH3 5LR, Midlothian, Scotland; [Mothes, Patricia] Escuela Politec Nacl, Inst Geofis, Quito, Ecuador	Open University - UK; University of Aberdeen; Escuela Politecnica Nacional Ecuador	Cardenas, ML (corresponding author), Open Univ, Dept Earth & Environm Sci, CEPSAR, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	m.l.cardenas@open.ac.uk	Gosling, William/AAB-2761-2020; Gosling, William/D-2459-2009	Gosling, William/0000-0001-9903-8401; Gosling, William/0000-0001-9903-8401; Cardenas, Macarena/0000-0002-6500-2352; Pennington, Toby/0000-0002-8196-288X; Sherlock, Sarah/0000-0003-0494-6760	Open University; Royal Botanical Garden Edinburgh; Santander; British Ecological Society; University Utrecht	Open University; Royal Botanical Garden Edinburgh; Santander; British Ecological Society; University Utrecht	We thank M. Hall (Instituto Geofisico, Quito, Ecuador), A. Correa-Metrio and M. Bush (Florida Institute of Technology), and Erazo residents. We also thank the reviewers for their valuable comments. This work was supported by funding from The Open University, Royal Botanical Garden Edinburgh, Santander, British Ecological Society, and University Utrecht.	BUSH MB, 1990, QUATERNARY RES, V34, P330, DOI 10.1016/0033-5894(90)90045-M; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Faegri K., 1989, TXB POLLEN ANAL, V4th ed.; Gosling WD, 2008, PALAEOGEOGR PALAEOCL, V259, P35, DOI 10.1016/j.palaeo.2007.02.050; Gosling WD, 2009, J VEG SCI, V20, P1041, DOI 10.1111/j.1654-1103.2009.01102.x; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hooghiemstra H., 1984, VEGETATIONAL CLIMATI; Jorgensen P.M., 1999, CATALOGUE VASCULAR P; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kelley S. P., 2002, NOBLE GASES GEOCHEMI; Long CJ, 1998, CAN J FOREST RES, V28, P774, DOI 10.1139/cjfr-28-5-774; Moraes M, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P473; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niemann H, 2008, J QUATERNARY SCI, V23, P203, DOI 10.1002/jqs.1134; Pennington T. D., 2004, ILLUSTRATED GUIDE TR; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Schwerdtfeger W., 1976, CLIMATES CENTRAL S A; Torres-Romero J. H., 1988, FLORA COLOMBIA; Weng CY, 2004, J TROP ECOL, V20, P113, DOI 10.1017/S0266467403001068	20	45	49	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1055	1058		10.1126/science.1197947	http://dx.doi.org/10.1126/science.1197947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350174				2022-12-01	WOS:000287699000060
J	Sackeyfio, A; Senthinathan, A; Kandaswamy, P; Barry, PW; Shaw, B; Baker, M				Sackeyfio, A.; Senthinathan, A.; Kandaswamy, P.; Barry, P. W.; Shaw, B.; Baker, M.		Guideline Dev Grp	Practice Guidelines Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Cianferoni Antonella, 2009, Allergology International, V58, P457, DOI 10.2332/allergolint.09-RAI-0138; *NAT I HLTH CLIN E, 2011, CLIN GUID, V116	2	22	22	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d747	10.1136/bmj.d747	http://dx.doi.org/10.1136/bmj.d747			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345912				2022-12-01	WOS:000287920100005
J	Hernandez, RD; Kelley, JL; Elyashiv, E; Melton, SC; Auton, A; McVean, G; Sella, G; Przeworski, M				Hernandez, Ryan D.; Kelley, Joanna L.; Elyashiv, Eyal; Melton, S. Cord; Auton, Adam; McVean, Gilean; Sella, Guy; Przeworski, Molly		1000 Genomes Project	Classic Selective Sweeps Were Rare in Recent Human Evolution	SCIENCE			English	Article							POSITIVE SELECTION; NATURAL-SELECTION; DELETERIOUS MUTATIONS; SOFT SWEEPS; ADAPTATION; POLYMORPHISM; DIVERSITY; SIGNATURE; GENETICS; SIZE	Efforts to identify the genetic basis of human adaptations from polymorphism data have sought footprints of "classic selective sweeps" (in which a beneficial mutation arises and rapidly fixes in the population). Yet it remains unknown whether this form of natural selection was common in our evolution. We examined the evidence for classic sweeps in resequencing data from 179 human genomes. As expected under a recurrent-sweep model, we found that diversity levels decrease near exons and conserved noncoding regions. In contrast to expectation, however, the trough in diversity around human-specific amino acid substitutions is no more pronounced than around synonymous substitutions. Moreover, relative to the genome background, amino acid and putative regulatory sites are not significantly enriched in alleles that are highly differentiated between populations. These findings indicate that classic sweeps were not a dominant mode of human adaptation over the past similar to 250,000 years.	[Hernandez, Ryan D.; Kelley, Joanna L.; Melton, S. Cord; Przeworski, Molly] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Elyashiv, Eyal; Sella, Guy] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, IL-91904 Jerusalem, Israel; [Auton, Adam; McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McVean, Gilean] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Przeworski, Molly] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Przeworski, Molly] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; Hebrew University of Jerusalem; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Przeworski, M (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	mfp@uchicago.edu	Wang, Jun/A-7261-2013; Kelley, Joanna L/H-1693-2012	Kelley, Joanna L/0000-0002-7731-605X	NSF; National Research Service [GM087069]; Wellcome Trust [WT086084MA]; Israeli Science Foundation [1492/10]; NIH [GM083228, GM20373, GM72861]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, R01HG007644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072861, F32GM087069, R01GM083228] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Research Service; Wellcome Trust(Wellcome TrustEuropean Commission); Israeli Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Coop, T. Long, G. McVicker, J. Pickrell, J. Pritchard, and K. Thornton for helpful discussions, and G. Coop, A. Di Rienzo, and J. Pritchard for comments. Supported by an NSF minority postdoctoral fellowship (R.D.H.), National Research Service Award postdoctoral fellowship GM087069 (J.L.K.), Wellcome Trust grant WT086084MA (G.M.), Israeli Science Foundation grant 1492/10 and NIH grant GM083228 (G.S.), and NIH grants GM20373 and GM72861 (M.P.). M.P. is a Howard Hughes Medical Institute Early Career Scientist.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Cai JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000336; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Innan H, 2008, GENETICS, V179, P1713, DOI 10.1534/genetics.108.086835; Keinan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000886; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Orr HA, 1998, GENETICS, V149, P2099; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Przeworski M, 2002, GENETICS, V160, P1179; Ralph P, 2010, GENETICS, V186, P647, DOI 10.1534/genetics.110.119594; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Santiago E, 2005, GENETICS, V169, P475, DOI 10.1534/genetics.104.032813; SANTIAGO E, 1995, GENETICS, V139, P1013; Sattath S., 2010, PLOS GENET, P1001302; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	33	293	299	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					920	924		10.1126/science.1198878	http://dx.doi.org/10.1126/science.1198878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330547	Green Accepted			2022-12-01	WOS:000287455100060
J	Kauppi, L; Barchi, M; Baudat, F; Romanienko, PJ; Keeney, S; Jasin, M				Kauppi, Liisa; Barchi, Marco; Baudat, Frederic; Romanienko, Peter J.; Keeney, Scott; Jasin, Maria			Distinct Properties of the XY Pseudoautosomal Region Crucial for Male Meiosis	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; CHROMOSOME SYNAPSIS; MOUSE; RECOMBINATION; SPO11; SPERMATOCYTES; MICE; PROTEINS; PROPHASE; OOCYTES	Meiosis requires that each chromosome find its homologous partner and undergo at least one crossover. X-Y chromosome segregation hinges on efficient crossing-over in a very small region of homology, the pseudoautosomal region (PAR). We find that mouse PAR DNA occupies unusually long chromosome axes, potentially as shorter chromatin loops, predicted to promote double-strand break (DSB) formation. Most PARs show delayed appearance of RAD51/DMC1 foci, which mark DSB ends, and all PARs undergo delayed DSB-mediated homologous pairing. Analysis of Spo11 beta isoform-specific transgenic mice revealed that late RAD51/DMC1 foci in the PAR are genetically distinct from both early PAR foci and global foci and that late PAR foci promote efficient X-Y pairing, recombination, and male fertility. Our findings uncover specific mechanisms that surmount the unique challenges of X-Y recombination.	[Kauppi, Liisa; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Barchi, Marco; Baudat, Frederic; Romanienko, Peter J.; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Barchi, Marco] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Sect Anat, I-00133 Rome, Italy; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Rome Tor Vergata; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	s-keeney@ski.mskcc.org; m-jasin@ski.mskcc.org	Barchi, Marco/Q-9378-2019; Kauppi, Liisa/H-5845-2012; Keeney, Scott/GVR-8515-2022	Barchi, Marco/0000-0003-1104-6234; Baudat, Frederic/0000-0003-2415-8366; Keeney, Scott/0000-0002-1283-6417; Romanienko, Peter/0000-0001-6586-3841; Kauppi, Liisa/0000-0002-6759-8997	NIH [R01 HD040916]; International Grants in Cancer Research (AIRC) [4765]; Italian Ministry for Education, University and Research (MIUR); Lalor Foundation; American-Italian Cancer Foundation (AICF); Charles H. Revson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Grants in Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Lalor Foundation; American-Italian Cancer Foundation (AICF); Charles H. Revson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant R01 HD040916 (M.J. and S.K); International Grants in Cancer Research (AIRC) [My First AIRC Grant (MFAG) grant 4765], Italian Ministry for Education, University and Research (MIUR), the Lalor Foundation, and the American-Italian Cancer Foundation (AICF) (M.B.); and the Charles H. Revson Foundation (F.B.). We thank M. Leversha [Memorial Sloan-Kettering Cancer Center (MSKCC)], P. Bois (Scripps Florida), and K. Manova (MSKCC) for valuable advice and protocols. We are grateful to Keeney and Jasin lab members, especially I. Roig, E. de Boer, and F. Cole, and to N. Hunter (University of California, Davis) for insightful comments.	Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Hall H, 2006, CURR OPIN GENET DEV, V16, P323, DOI 10.1016/j.gde.2006.04.011; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Romanienko P. J., 1997, THESIS CORNELL U ITH; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; Shi QH, 2001, AM J MED GENET, V99, P34, DOI 10.1002/1096-8628(20010215)99:1<34::AID-AJMG1106>3.0.CO;2-D; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	27	168	172	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					916	920		10.1126/science.1195774	http://dx.doi.org/10.1126/science.1195774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330546	Green Accepted			2022-12-01	WOS:000287455100059
J	McCartney, M				McCartney, Margaret			Medicine and the Media How useful are lifetime risks of disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, COMP MATH MATH PHYS, V342, pD808, DOI DOI 10.1136/BMJ.D808	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d1046	10.1136/bmj.d1046	http://dx.doi.org/10.1136/bmj.d1046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325383				2022-12-01	WOS:000287656500016
J	Popow, J; Englert, M; Weitzer, S; Schleiffer, A; Mierzwa, B; Mechtler, K; Trowitzsch, S; Will, CL; Luhrmann, R; Soll, D; Martinez, J				Popow, Johannes; Englert, Markus; Weitzer, Stefan; Schleiffer, Alexander; Mierzwa, Beata; Mechtler, Karl; Trowitzsch, Simon; Will, Cindy L.; Luehrmann, Reinhard; Soell, Dieter; Martinez, Javier			HSPC117 Is the Essential Subunit of a Human tRNA Splicing Ligase Complex	SCIENCE			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; HELA-CELL EXTRACT; JUNCTION PHOSPHATE; FUNCTIONAL DOMAINS; LIGATION; PROTEIN; REVEALS; IDENTIFICATION; ENDONUCLEASE; PURIFICATION	Splicing of mammalian precursor transfer RNA (tRNA) molecules involves two enzymatic steps. First, intron removal by the tRNA splicing endonuclease generates separate 5' and 3' exons. In animals, the second step predominantly entails direct exon ligation by an elusive RNA ligase. Using activity-guided purification of tRNA ligase from HeLa cell extracts, we identified HSPC117, a member of the UPF0027 (RtcB) family, as the essential subunit of a tRNA ligase complex. RNA interference-mediated depletion of HSPC117 inhibited maturation of intron-containing pre-tRNA both in vitro and in living cells. The high sequence conservation of HSPC117/RtcB proteins is suggestive of RNA ligase roles of this protein family in various organisms.	[Englert, Markus; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Popow, Johannes; Weitzer, Stefan; Mierzwa, Beata; Martinez, Javier] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Schleiffer, Alexander] Res Inst Mol Pathol IMP IMBA, Bioinformat Dept, A-1030 Vienna, Austria; [Mechtler, Karl] Res Inst Mol Pathol IMP IMBA, Dept Prot Chem, A-1030 Vienna, Austria; [Trowitzsch, Simon; Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; javier.martinez@imba.oeaw.ac.at	Trowitzsch, Simon/O-4957-2016; Mechtler, Karl/AAF-2717-2019; Mierzwa, Beata/A-6382-2016	Trowitzsch, Simon/0000-0001-9143-766X; Mechtler, Karl/0000-0002-3392-9946; Mierzwa, Beata/0000-0002-2146-4352; Martinez, Javier/0000-0001-9152-7323; Schleiffer, Alexander/0000-0001-6251-2747	European Commission [EURASNET-518238]; Fonds zur Forderung der wissenschaftlichen Forschung [W1207 RNA Biologie]; National Institute of General Medical Sciences; S.D. Prinz Max von und zu Liechtenstein	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); S.D. Prinz Max von und zu Liechtenstein	We thank H. Beier, T. Biederer, T. Clausen, A. Meinhart, A. F. Nielsen, R. Schroeder, K. Sheppard, T. Tuschl, and S. Westermann for reagents and helpful discussions; and G. Heyne, O. Kuzyk, G. Schmauss, and G. Stengl for technical assistance; and H. Urlaub for MS analysis of HSPC117 complexes. M.E. was a Feodor-Lynen Postdoctoral Fellow of the Alexander von Humboldt Stiftung (Bonn, Germany). Supported by grants from the European Commission (EURASNET-518238) (R.L.), the Fonds zur Forderung der wissenschaftlichen Forschung (W1207 RNA Biologie) (J.P.), and the National Institute of General Medical Sciences (D.S.). J.M. would like to especially acknowledge the generous financial contribution and support by S.D. Prinz Max von und zu Liechtenstein.	Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; APOSTOL BL, 1991, J BIOL CHEM, V266, P7445; Cao D, 2009, RNA, V15, P1971, DOI 10.1261/rna.1782209; Drewett V, 2001, NUCLEIC ACIDS RES, V29, P479, DOI 10.1093/nar/29.2.479; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, pD3, DOI 10.1093/nar/gkh143; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Goyal K, 2008, PROTEINS, V70, P1206, DOI 10.1002/prot.21601; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Okada C, 2006, PROTEINS, V63, P1119, DOI 10.1002/prot.20912; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Reid CE, 2000, P NATL ACAD SCI USA, V97, P424, DOI 10.1073/pnas.97.1.424; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; VICENTE O, 1988, EUR J BIOCHEM, V176, P431, DOI 10.1111/j.1432-1033.1988.tb14300.x; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	28	153	164	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					760	764		10.1126/science.1197847	http://dx.doi.org/10.1126/science.1197847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311021	Green Submitted			2022-12-01	WOS:000287205700068
J	Stefansson, K				Stefansson, Kari			An Anniversary Party	SCIENCE			English	Editorial Material									deCode Genet, Reykjavik, Iceland		Stefansson, K (corresponding author), deCode Genet, Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019						0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					691	691		10.1126/science.1203016	http://dx.doi.org/10.1126/science.1203016			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311000				2022-12-01	WOS:000287205700043
J	Minc, N; Burgess, D; Chang, F				Minc, Nicolas; Burgess, David; Chang, Fred			Influence of Cell Geometry on Division-Plane Positioning	CELL			English	Article							CAENORHABDITIS-ELEGANS EMBRYO; MITOTIC SPINDLE ORIENTATION; FISSION YEAST; DYNAMIC MICROTUBULES; PRONUCLEAR MIGRATION; SHAPE; MECHANISM; CLEAVAGE; FORCES; LENGTH	The spatial organization of cells depends on their ability to sense their own shape and size. Here, we investigate how cell shape affects the positioning of the nucleus, spindle and subsequent cell division plane. To manipulate geometrical parameters in a systematic manner, we place individual sea urchin eggs into microfabricated chambers of defined geometry (e. g., triangles, rectangles, and ellipses). In each shape, the nucleus is positioned at the center of mass and is stretched by microtubules along an axis maintained through mitosis and predictive of the future division plane. We develop a simple computational model that posits that microtubules sense cell geometry by probing cellular space and orient the nucleus by exerting pulling forces that scale to microtubule length. This model quantitatively predicts division-axis orientation probability for a wide variety of cell shapes, even in multicellular contexts, and estimates scaling exponents for length-dependent microtubule forces.	[Burgess, David] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Minc, Nicolas; Burgess, David; Chang, Fred] Marine Biol Lab, Woods Hole, MA 02543 USA; [Minc, Nicolas; Chang, Fred] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Boston College; Marine Biological Laboratory - Woods Hole; Columbia University	Minc, N (corresponding author), Inst Curie, UMR 144 CNRS IC, 26 Rue Ulm, F-75248 Paris 05, France.	nicolas.minc@curie.fr		Minc, Nicolas/0000-0002-5543-7950	National Institutes of Health (NIH) [GM069670, GM056836]; Ellison Senior Scholar award; CNRS; ANR [ANR-10PDOC-003-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069670, R01GM056836] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Senior Scholar award(Lawrence Ellison Foundation); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge all members of the Chang and Burgess laboratories for discussions and technical assistance. We thank A. Boudaoud for careful reading of the manuscript and J. Brill for discussions. Microfabrication was made in the Columbia CEPSR clean room. Part of the microscopy was performed in the Microbiology Department confocal microscopy facility. This work, which was initiated at the Marine Biological Laboratory, was supported by National Institutes of Health (NIH) RO1 grants GM069670 and GM056836 and an Ellison Senior Scholar award to F. C. N.M. acknowledges support from the CNRS and an ANR "retour post-doctorants'' grant ANR-10PDOC-003-01. The authors dedicate this manuscript to the memory of Ray Rappaport.	Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; BJERKNES M, 1986, SCIENCE, V234, P1413, DOI 10.1126/science.3787253; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Concha ML, 1998, DEVELOPMENT, V125, P983; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; GOLDSTEIN B, 1995, J CELL BIOL, V129, P1071, DOI 10.1083/jcb.129.4.1071; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Guyer M.F., 1900, THESIS U CHICAGO CHI; HAMAGUCHI MS, 1986, DEV GROWTH DIFFER, V28, P143, DOI 10.1111/j.1440-169x.1986.00143.x; Hara Y, 2009, CURR BIOL, V19, P1549, DOI 10.1016/j.cub.2009.07.050; HAYS TS, 1982, J CELL BIOL, V93, P374, DOI 10.1083/jcb.93.2.374; Hertwig O., 1884, PROBLEM BEFRUCHTUNG; Holy J, 1997, CELL TISSUE RES, V289, P285, DOI 10.1007/s004410050875; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jenkinson J.W., 1909, EXPT EMBRYOLOGY; Kimura A, 2005, DEV CELL, V8, P765, DOI 10.1016/j.devcel.2005.03.007; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Minc N, 2010, CURR BIOL, V20, P710, DOI 10.1016/j.cub.2010.02.047; Minc N, 2009, CURR BIOL, V19, P1096, DOI 10.1016/j.cub.2009.05.031; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Reinsch S, 1998, J CELL SCI, V111, P2283; SCHATTEN G, 1986, EXP CELL RES, V166, P191, DOI 10.1016/0014-4827(86)90519-7; Schierenberg Einhard, 2006, WormBook, P1; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Seetapun D, 2010, CURR BIOL, V20, P979, DOI 10.1016/j.cub.2010.04.040; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Strickland L, 2004, METHOD CELL BIOL, V74, P371; Strickland LI, 2005, CURR BIOL, V15, P2249, DOI 10.1016/j.cub.2005.10.073; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Vaziri A, 2007, J BIOMECH, V40, P2053, DOI 10.1016/j.jbiomech.2006.09.023; Velve-Casquillas G, 2010, NANO TODAY, V5, P28, DOI 10.1016/j.nantod.2009.12.001; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; von Dassow G, 2009, J CELL BIOL, V187, P831, DOI 10.1083/jcb.200907090; Wang SW, 1997, DEVELOPMENT, V124, P773; Wong GK, 1997, CELL MOTIL CYTOSKEL, V36, P30, DOI 10.1002/(SICI)1097-0169(1997)36:1<30::AID-CM3>3.0.CO;2-L; Wuhr M, 2009, CELL CYCLE, V8, P1115; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024	56	248	248	0	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					414	426		10.1016/j.cell.2011.01.016	http://dx.doi.org/10.1016/j.cell.2011.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295701	Green Accepted, Bronze			2022-12-01	WOS:000286973100013
J	Riehle, MM; Guelbeogo, WM; Gneme, A; Eiglmeier, K; Holm, I; Bischoff, E; Garnier, T; Snyder, GM; Li, XZ; Markianos, K; Sagnon, N; Vernick, KD				Riehle, Michelle M.; Guelbeogo, Wamdaogo M.; Gneme, Awa; Eiglmeier, Karin; Holm, Inge; Bischoff, Emmanuel; Garnier, Thierry; Snyder, Gregory M.; Li, Xuanzhong; Markianos, Kyriacos; Sagnon, N'Fale; Vernick, Kenneth D.			A Cryptic Subgroup of Anopheles gambiae Is Highly Susceptible to Human Malaria Parasites	SCIENCE			English	Article							MULTILOCUS GENOTYPE DATA; DISEASE TRANSMISSION; MOLECULAR-FORMS; HOST SELECTION; MOSQUITOS; COMPLEX; INFERENCE; AFRICA; SPECIATION; CULICIDAE	Population subgroups of the African malaria vector Anopheles gambiae have not been comprehensively characterized owing to the lack of unbiased sampling methods. In the arid savanna zone of West Africa, where potential oviposition sites are scarce, widespread collection from larval pools in the peridomestic human habitat yielded a comprehensive genetic survey of local A. gambiae population subgroups, independent of adult resting behavior and ecological preference. A previously unknown subgroup of exophilic A. gambiae is sympatric with the known endophilic A. gambiae in this region. The exophilic subgroup is abundant, lacks differentiation into M and S molecular forms, and is highly susceptible to infection with wild Plasmodium falciparum. These findings might have implications for the epidemiology of malaria transmission and control.	[Riehle, Michelle M.; Eiglmeier, Karin; Holm, Inge; Bischoff, Emmanuel; Garnier, Thierry; Vernick, Kenneth D.] Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol,Dept Environm & Sustainabl, Unit Hosts Vectors & Pathogens URA 3012,CNRS, F-75015 Paris, France; [Riehle, Michelle M.; Snyder, Gregory M.; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; [Guelbeogo, Wamdaogo M.; Gneme, Awa; Sagnon, N'Fale] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Li, Xuanzhong; Markianos, Kyriacos] Harvard Univ, Childrens Hosp Boston, Sch Med, Program Genom, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Boston Children's Hospital; Harvard Medical School	Vernick, KD (corresponding author), Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol,Dept Environm & Sustainabl, Unit Hosts Vectors & Pathogens URA 3012,CNRS, 28 Rue Docteur Roux, F-75015 Paris, France.	kenneth.vernick@pasteur.fr	Bischoff, Emmanuel/F-1197-2011; GNEME, Awa/M-3299-2015	Bischoff, Emmanuel/0000-0003-4655-4247; GNEME, Awa/0000-0003-2514-5313; Markianos, Kyriacos/0000-0003-0214-6014	National Institute of Allergy and Infectious Diseases, NIH [AI073685, AI042361]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042361, R01AI073685] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge support from National Institute of Allergy and Infectious Diseases, NIH, to K.D.V., AI073685 and AI042361.	BOCKARIE MJ, 1994, ANN TROP MED PARASIT, V88, P251, DOI 10.1080/00034983.1994.11812865; BRUCECHWATT LJ, 1966, B WORLD HEALTH ORGAN, V35, P405; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; COLUZZI M, 1977, NATURE, V266, P832, DOI 10.1038/266832a0; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M., 1967, Parassitologia, V9, P73; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; MOLINEAUX L, 1979, B WORLD HEALTH ORGAN, V57, P265; Odiere M, 2007, J MED ENTOMOL, V44, P14, DOI 10.1603/0022-2585(2007)44[14:SORAGA]2.0.CO;2; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pritchard JK, 2000, GENETICS, V155, P945; REISEN WK, 1979, AM J TROP MED HYG, V28, P408, DOI 10.4269/ajtmh.1979.28.408; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Service MW, 1993, MOSQUITO ECOLOGY FIE, V2; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Smits A, 1996, J MED ENTOMOL, V33, P545, DOI 10.1093/jmedent/33.4.545; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2	27	102	104	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					596	598		10.1126/science.1196759	http://dx.doi.org/10.1126/science.1196759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292978	Green Accepted			2022-12-01	WOS:000286933600057
J	Worsdorfer, B; Woycechowsky, KJ; Hilvert, D				Woersdoerfer, Bigna; Woycechowsky, Kenneth J.; Hilvert, Donald			Directed Evolution of a Protein Container	SCIENCE			English	Article							LUMAZINE SYNTHASE; CONSTRAINED SYNTHESIS; CONTRAST AGENTS; IRON-OXIDE; NANOPARTICLES; CAGE; ENCAPSULATION; DELIVERY; INTERIOR; RELEASE	Confinement of enzymes in protein nanocompartments represents a potentially powerful strategy for controlling catalytic activity in cells. By using a simple electrostatically based tagging system for protein encapsulation, we successfully sequestered HIV protease, a toxic enzyme when produced cytoplasmically, within an engineered lumazine synthase capsid. The growth advantage resulting from protecting the Escherichia coli host from the protease enabled directed evolution of improved capsids. After four rounds of mutagenesis and selection, we obtained a variant with a 5- to 10-fold higher loading capacity than the starting capsid, which permitted efficient growth even at high intracellular concentrations of HIV protease. The superior properties of the evolved capsid can be ascribed to multiple mutations that increase the net negative charge on its luminal surface and thereby enhance engineered Coulombic interactions between host and guest. Such structures could be used for diverse biotechnological applications in living cells.	[Woersdoerfer, Bigna; Woycechowsky, Kenneth J.; Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hilvert, D (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch	Woycechowsky, Kenneth/K-5833-2015		Schweizerischer Nationalfond; ETH Zurich	Schweizerischer Nationalfond; ETH Zurich(ETH Zurich)	We thank B. Roschitzki at the Functional Genomics Center Zurich for collection of mass spectrometic data and assistance with data analysis; T. Ishikawa and M. Lucas at the Electron Microscopy Center of the ETH Zurich (EMEZ) for collecting the EM images and assistance with EM data analysis; H.-M. Fischer, F. Narberhaus, M. Neuenschwander, and F. Seebeck for contributive discussions; and P. Kast for careful reading of the manuscript. This work was supported in part by the Schweizerischer Nationalfond and the ETH Zurich. The supercharged GFP described in fig. S8 was obtained under a materials transfer agreement (MTA) with D. R. Liu at Harvard. An MTA would be required for sharing of materials used in the reported research.	Abbing A, 2004, J BIOL CHEM, V279, P27410, DOI 10.1074/jbc.M313612200; Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; Allen M, 2002, ADV MATER, V14, P1562, DOI 10.1002/1521-4095(20021104)14:21<1562::AID-ADMA1562>3.0.CO;2-D; de la Escosura A, 2009, J MATER CHEM, V19, P2274, DOI 10.1039/b815274h; DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54; Flenniken ML, 2005, CHEM COMMUN, P447, DOI 10.1039/b413435d; Flint SJ, 2009, PRINCIPLES VIROLOGY; Hooker JM, 2007, NANO LETT, V7, P2207, DOI 10.1021/nl070512c; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.biochem.63.1.133; KIS K, 1995, J BIOL CHEM, V270, P16788, DOI 10.1074/jbc.270.28.16788; Klem MT, 2007, J AM CHEM SOC, V129, P197, DOI 10.1021/ja0667561; Knez M, 2003, NANO LETT, V3, P1079, DOI 10.1021/nl0342545; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; McMillan RA, 2005, J AM CHEM SOC, V127, P2800, DOI 10.1021/ja043827s; Neuenschwander M, 2007, NAT BIOTECHNOL, V25, P1145, DOI [10.1038/nbt1341, 10.1038/nbtl341]; Rebek J, 2005, ANGEW CHEM INT EDIT, V44, P2068, DOI 10.1002/anie.200462839; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Schaffer DV, 2008, ANNU REV BIOMED ENG, V10, P169, DOI 10.1146/annurev.bioeng.10.061807.160514; Seebeck FP, 2006, J AM CHEM SOC, V128, P4516, DOI 10.1021/ja058363s; Shenton W, 2001, ANGEW CHEM INT EDIT, V40, P442, DOI 10.1002/1521-3773(20010119)40:2<442::AID-ANIE442>3.0.CO;2-2; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; Yamada T, 2003, NAT BIOTECHNOL, V21, P885, DOI 10.1038/nbt843; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang XF, 2001, J MOL BIOL, V306, P1099, DOI 10.1006/jmbi.2000.4435; Zhang XF, 2006, J MOL BIOL, V362, P753, DOI 10.1016/j.jmb.2006.07.037; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698	31	243	247	5	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					589	592		10.1126/science.1199081	http://dx.doi.org/10.1126/science.1199081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292977				2022-12-01	WOS:000286933600055
J	Ashworth, A; Lord, CJ; Reis, JS				Ashworth, Alan; Lord, Christopher J.; Reis-Filho, Jorge S.			Genetic Interactions in Cancer Progression and Treatment	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; BREAST-CANCER; EXPRESSION PROFILES; STEM-CELLS; GENOME; TUMORS; RESISTANCE; MUTATIONS; THERAPY; INHIBITORS	As cancer cell genomes are unveiled at a breathtaking pace, the genetic principles at play in cancer are emerging in all their complexity, prompting the assessment of classical genetic interaction models. Here, we discuss the implications of these findings for cancer progression and heterogeneity and for the development of new therapeutic approaches.	[Ashworth, Alan; Lord, Christopher J.; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Ashworth, A (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Fulham Rd, London SW3 6JB, England.	alan.ashworth@icr.ac.uk; chris.lord@icr.ac.uk; jorge.reis-filho@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012	Lord, Christopher J/0000-0002-3226-0515	NHS; CRUK	NHS; CRUK(Cancer Research UK)	We thank Breakthrough Breast Cancer, Cancer Research UK, The Breast Cancer Campaign, The Breast Cancer Research Foundation, AACR, and The Komen Foundation for their continued support. We acknowledge NHS funding to the NIHR Royal Marsden Hospital Biomedical Research Centre. J.S.R.-F. is the recipient of the 2010 CRUK Future Leaders Prize.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Ashworth A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003327; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI [10.1038/nmeth.1534, 10.1038/NMETH.1534]; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Davies M, 2006, EXPERT OPIN PHARMACO, V7, P2243, DOI 10.1517/14656566.7.16.2243; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; DOBZHANSKY T, 1946, GENETICS, V31, P269; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.3.CO;2-A; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lord CJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-38; LUCCHESI JC, 1968, GENETICS, V59, P37; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	61	292	299	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					30	38		10.1016/j.cell.2011.03.020	http://dx.doi.org/10.1016/j.cell.2011.03.020			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458666	Bronze			2022-12-01	WOS:000289053900007
J	Wechsler, T; Newman, S; West, SC				Wechsler, Thomas; Newman, Scott; West, Stephen C.			Aberrant chromosome morphology in human cells defective for Holliday junction resolution	NATURE			English	Article							STRUCTURE-SPECIFIC NUCLEASES; MUS81-EME1; MECHANISM; BLM; HELICASE; REPAIR; IDENTIFICATION; REPLICATION; RESOLVASE; COMPLEX	In somatic cells, Holliday junctions can be formed between sister chromatids during the recombinational repair of DNA breaks or after replication fork demise. A variety of processes act upon Holliday junctions to remove them from DNA, in events that are critical for proper chromosome segregation. In human cells, the BLM protein, inactivated in individuals with Bloom's syndrome, acts in combination with topoisomerase III alpha, RMI1 and RMI2 (BTR complex) to promote the dissolution of double Holliday junctions(1,2). Cells defective for BLM exhibit elevated levels of sister chromatid exchanges (SCEs) and patients with Bloom's syndrome develop a broad spectrum of early-onset cancers caused by chromosome instability(3). MUS81-EME1 (refs 4-7), SLX1-SLX4 (refs 8-11) and GEN1 (refs 12, 13) also process Holliday junctions but, in contrast to the BTR complex, do so by endonucleolytic cleavage. Here we deplete these nucleases from Bloom's syndrome cells to analyse human cells compromised for the known Holliday junction dissolution/resolution pathways. We show that depletion of MUS81 and GEN1, or SLX4 and GEN1, from Bloom's syndrome cells results in severe chromosome abnormalities, such that sister chromatids remain interlinked in a side-by-side arrangement and the chromosomes are elongated and segmented. Our results indicate that normally replicating human cells require Holliday junction processing activities to prevent sister chromatid entanglements and thereby ensure accurate chromosome condensation. This phenotype was not apparent when both MUS81 and SLX4 were depleted from Bloom's syndrome cells, suggesting that GEN1 can compensate for their absence. Additionally, we show that depletion of MUS81 or SLX4 reduces the high frequency of SCEs in Bloom's syndrome cells, indicating that MUS81 and SLX4 promote SCE formation, in events that may ultimately drive the chromosome instabilities that underpin early-onset cancers associated with Bloom's syndrome.	[Wechsler, Thomas; West, Stephen C.] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England; [Newman, Scott] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Cancer Research UK; University of Cambridge	West, SC (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Newman, Scott/B-4843-2012	West, Stephen/0000-0001-8848-9418	Cancer Research UK; Louis-Jeantet Foundation; European Research Council; Swiss Bridge Foundation; Breast Cancer Campaign; UK Medical Research Council; Cancer Research UK [11582] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Louis-Jeantet Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss Bridge Foundation; Breast Cancer Campaign; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	We thank I. Hickson for providing the Bloom's syndrome cell lines and advice, P. Edwards for help and providing facilities for chromosome painting, S. Horswell for the statistical analysis, S. Ip for the GEN1 antibody, M.G. Blanco for assistance with SCE scoring and our laboratory colleagues for their encouragement and suggestions. We further thank K. Cimprich, the Cimprich laboratory members, and C. Wang, W. Johnson and A. Straight. This work was supported by Cancer Research UK, the Louis-Jeantet Foundation, the European Research Council, the Swiss Bridge Foundation and the Breast Cancer Campaign. S.N. was supported by a studentship from the UK Medical Research Council.	Alsop AE, 2006, CANCER GENET CYTOGEN, V164, P97, DOI 10.1016/j.cancergencyto.2005.09.011; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bayani J., 2005, CURR PROTOC CELL BIO, P7; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Breger KS, 2004, CANCER RES, V64, P8231, DOI 10.1158/0008-5472.CAN-04-0879; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Ellis NA, 1999, AM J HUM GENET, V65, P1368, DOI 10.1086/302616; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaymes TJ, 2002, ONCOGENE, V21, P2525, DOI 10.1038/sj.onc.1205331; Hearst JE, 1998, TRENDS GENET, V14, P244, DOI 10.1016/S0168-9525(98)01481-4; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	30	160	164	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					642	U126		10.1038/nature09790	http://dx.doi.org/10.1038/nature09790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21399624	Green Accepted			2022-12-01	WOS:000288951200044
J	Hecht, SS				Hecht, Stephen S.			PERSPECTIVE Tackling the real issues	NATURE			English	Editorial Material									Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hecht, SS (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	hecht002@umn.edu		Hecht, Stephen/0000-0001-7228-1356				Boyle P., 2008, World Cancer Report 2008; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI, P221	4	0	0	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S18	S18		10.1038/471S18a	http://dx.doi.org/10.1038/471S18a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430714	Bronze			2022-12-01	WOS:000288702200015
J	Rubinow, KB; Hirsch, IB				Rubinow, Katya B.; Hirsch, Irl B.			Reexamining Metrics for Glucose Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ESTIMATED AVERAGE GLUCOSE; BLOOD-GLUCOSE; 1,5-ANHYDROGLUCITOL; RISK		[Rubinow, Katya B.; Hirsch, Irl B.] Univ Washington, Dept Internal Med, Div Metab Endocrinol & Nutr, Seattle, WA 98095 USA	University of Washington; University of Washington Seattle	Hirsch, IB (corresponding author), Univ Washington, Dept Internal Med, Div Metab Endocrinol & Nutr, 4225 Roosevelt Ave NE,Ste 101, Seattle, WA 98095 USA.	ihirsch@uw.edu						Cohen RM, 2008, DIABETES CARE, V31, P151, DOI 10.2337/dc07-1465; Hempe JM, 2010, DIABETES CARE, V33, P1449, DOI 10.2337/dc09-1498; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Lachin JM, 2007, DIABETES, V56, P1913, DOI 10.2337/db07-0028; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Roohk H Vernon, 2008, J Diabetes Sci Technol, V2, P1114; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; YAMANOUCHI T, 1991, DIABETES, V40, P52, DOI 10.2337/diabetes.40.1.52	10	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1132	1133		10.1001/jama.2011.314	http://dx.doi.org/10.1001/jama.2011.314			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZF	21406652				2022-12-01	WOS:000288381900027
J	Lara-Tejero, M; Kato, J; Wagner, S; Liu, XY; Galan, JE				Lara-Tejero, Maria; Kato, Junya; Wagner, Samuel; Liu, Xiaoyun; Galan, Jorge E.			A Sorting Platform Determines the Order of Protein Secretion in Bacterial Type III Systems	SCIENCE			English	Article							CULTURED EPITHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; NEEDLE LENGTH; YERSINIA-ENTEROCOLITICA; HOST-CELLS; INVASION; APPARATUS; ATPASE; TRANSLOCATION	Bacterial type III protein secretion systems deliver effector proteins into eukaryotic cells in order to modulate cellular processes. Central to the function of these protein-delivery machines is their ability to recognize and secrete substrates in a defined order. Here, we describe a mechanism by which a type III secretion system from the bacterial enteropathogen Salmonella enterica serovar Typhimurium can sort its substrates before secretion. This mechanism involves a cytoplasmic sorting platform that is sequentially loaded with the appropriate secreted proteins. The sequential loading of this platform, facilitated by customized chaperones, ensures the hierarchy in type III protein secretion. Given the presence of these machines in many important pathogens, these findings can serve as the bases for the development of novel antimicrobial strategies.	[Lara-Tejero, Maria; Kato, Junya; Wagner, Samuel; Liu, Xiaoyun; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu		Kato, Junya/0000-0001-5432-157X	NIH [U54 AI0157158, AI30492]; International Human Frontiers Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030492, R01AI030492, R29AI030492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Galan laboratory for critical reading of this manuscript. This work was supported by NIH grant U54 AI0157158 (M.L.-T.), a long-term fellowship of the International Human Frontiers Science Program (S.W.), and NIH grant AI30492 (J.E.G.).	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x; Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Galan JE, 2005, CURR OPIN MICROBIOL, V8, P1, DOI 10.1016/j.mib.2004.12.015; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; HKANSSON S, 1996, EMBO J, V15, P5812; Johnson S, 2008, FEMS MICROBIOL LETT, V286, P274, DOI 10.1111/j.1574-6968.2008.01284.x; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; ZIERLER MK, 1995, INFECT IMMUN, V63, P4024, DOI 10.1128/IAI.63.10.4024-4028.1995	33	187	191	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1188	1191		10.1126/science.1201476	http://dx.doi.org/10.1126/science.1201476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21292939	Green Accepted			2022-12-01	WOS:000287971200041
J	Sun, TT; Aceto, N; Meerbrey, KL; Kessler, JD; Zhou, CS; Migliaccio, I; Nguyen, DX; Pavlova, NN; Botero, M; Huang, JA; Bernardi, RJ; Schmitt, E; Hu, GA; Li, MZ; Dephoure, N; Gygi, SP; Rao, M; Creighton, CJ; Hilsenbeck, SG; Shaw, CA; Muzny, D; Gibbs, RA; Wheeler, DA; Osborne, CK; Schiff, R; Bentires-Alj, M; Elledge, SJ; Westbrook, TF				Sun, Tingting; Aceto, Nicola; Meerbrey, Kristen L.; Kessler, Jessica D.; Zhou, Chunshui; Migliaccio, Ilenia; Nguyen, Don X.; Pavlova, Natalya N.; Botero, Maria; Huang, Jian; Bernardi, Ronald J.; Schmitt, Earlene; Hu, Guang; Li, Mamie Z.; Dephoure, Noah; Gygi, Steven P.; Rao, Mitchell; Creighton, Chad J.; Hilsenbeck, Susan G.; Shaw, Chad A.; Muzny, Donna; Gibbs, Richard A.; Wheeler, David A.; Osborne, C. Kent; Schiff, Rachel; Bentires-Alj, Mohamed; Elledge, Stephen J.; Westbrook, Thomas F.			Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase	CELL			English	Article							PHOSPHOTYROSINE INTERACTION DOMAIN; PROTEIN; PEST; DIFFERENTIATION; SUBSTRATE; ONCOGENE; RECEPTOR; IDENTIFICATION; ASSOCIATION; EXPRESSION	Among breast cancers, triple-negative breast cancer (TNBC) is the most poorly understood and is refractory to current targeted therapies. Using a genetic screen, we identify the PTPN12 tyrosine phosphatase as a tumor suppressor in TNBC. PTPN12 potently suppresses mammary epithelial cell proliferation and transformation. PTPN12 is frequently compromised in human TNBCs, and we identify an upstream tumor-suppressor network that posttranscriptionally controls PTPN12. PTPN12 suppresses transformation by interacting with and inhibiting multiple oncogenic tyrosine kinases, including HER2 and EGFR. The tumorigenic and metastatic potential of PTPN12-deficient TNBC cells is severely impaired upon restoration of PTPN12 function or combined inhibition of PTPN12-regulated tyrosine kinases, suggesting that TNBCs are dependent on the proto-oncogenic tyrosine kinases constrained by PTPN12. Collectively, these data identify PTPN12 as a commonly inactivated tumor suppressor and provide a rationale for combinatorially targeting proto-oncogenic tyrosine kinases in TNBC and other cancers based on their profile of tyrosine-phosphatase activity.	[Sun, Tingting; Meerbrey, Kristen L.; Kessler, Jessica D.; Schmitt, Earlene; Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Meerbrey, Kristen L.; Kessler, Jessica D.; Schmitt, Earlene; Rao, Mitchell; Shaw, Chad A.; Gibbs, Richard A.; Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bernardi, Ronald J.; Westbrook, Thomas F.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.] Baylor Coll Med, Div Biostat, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.; Gibbs, Richard A.; Wheeler, David A.; Osborne, C. Kent; Schiff, Rachel; Westbrook, Thomas F.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Migliaccio, Ilenia; Botero, Maria; Huang, Jian; Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Muzny, Donna; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Aceto, Nicola; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; [Zhou, Chunshui; Pavlova, Natalya N.; Hu, Guang; Li, Mamie Z.; Elledge, Stephen J.] Harvard Univ, Howard Hughes Med Inst, Dept Genet, Sch Med,Div Genet,Brigham & Womens Hosp, Boston, MA 02115 USA; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Nguyen, Don X.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Friedrich Miescher Institute for Biomedical Research; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Yale University	Westbrook, TF (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	thomasw@bcm.edu	Dephoure, Noah/N-7818-2014; Wheeler, David A/M-9740-2018; Mohamed, Bentires-Alj/F-4484-2015; Hu, Guang/E-7474-2016; Aceto, Nicola/O-2484-2014	Dephoure, Noah/0000-0001-5802-2657; Wheeler, David A/0000-0002-9056-6299; Mohamed, Bentires-Alj/0000-0001-6344-1127; Hu, Guang/0000-0003-0437-4723; Hartman, Jessica/0000-0003-1578-3389; Shaw, Chad/0000-0001-7267-5398; Aceto, Nicola/0000-0001-9579-6918	Susan G. Komen for the Cure [KG090355, P50 CA058183, HG3456]; U.S. Army [W81XWH0410197]; Novartis Research Foundation; European Research Council (ERC); Swiss Cancer League; Krebsliga Beider Basel; NATIONAL CANCER INSTITUTE [P50CA058183, P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); U.S. Army(United States Department of DefenseUnited States Army); Novartis Research Foundation; European Research Council (ERC)(European Research Council (ERC)); Swiss Cancer League; Krebsliga Beider Basel; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Luo, J. Rosen, and A. Lee for suggestions and critical reading of the manuscript. We are grateful to A. Lee, J. LaBaer, O. Lee, Z. Songyang, and J. Qin for providing reagents, and A. Elia for help with phosphopeptide analysis. This work was supported by a Susan G. Komen for the Cure Career Catalyst Award (KG090355) to T. F. W., S. P. O. R. E developmental grant (P50 CA058183) to T. F. W., S. P. O. R. E. grant (P50 CA058183) to R. S. and C. K. O., grant HG3456 to S. P. G., and a U.S. Army Innovator Award (W81XWH0410197) to S. J. E. Research in the laboratory of M.B.-A. is supported by the Novartis Research Foundation, the European Research Council (ERC starting grant), the Swiss Cancer League, and the Krebsliga Beider Basel. S. J. E. is an Investigator with the Howard Hughes Medical Institute. T. F. W. is a scholar of The V Foundation and Mary Kay Ash Foundation for Cancer Research.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Brandt R, 2000, ONCOGENE, V19, P2129, DOI 10.1038/sj.onc.1203520; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Hurvitz SA, 2009, FUTURE ONCOL, V5, P1015, DOI [10.2217/fon.09.68, 10.2217/FON.09.68]; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; YANG Q, 1993, J BIOL CHEM, V268, P6622; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	41	212	222	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					703	718		10.1016/j.cell.2011.02.003	http://dx.doi.org/10.1016/j.cell.2011.02.003			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376233	Green Accepted, Bronze			2022-12-01	WOS:000288007100010
J	Christiani, DC				Christiani, David C.			Combating Environmental Causes of Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Christiani, DC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009; Hiatt, Robert/AAQ-1537-2021	Colditz, Graham/0000-0002-7307-0291; 				*IARC, IARC MON EV CARC RIS; *NAT CANC I PRES C, 2010, RED ENV CANC RISK WH; THOMAS DB, 1987, CANCER RES, V47, P5771; Tomatis L, 1997, CARCINOGENESIS, V18, P97, DOI 10.1093/carcin/18.1.97; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	5	17	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					791	793		10.1056/NEJMp1006634	http://dx.doi.org/10.1056/NEJMp1006634			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366471				2022-12-01	WOS:000287928400002
J	McGilchrist, I				McGilchrist, Iain			The Art of Medicine Paying attention to the bipartite brain	LANCET			English	Editorial Material												iain.mcgilchrist@all-souls.ox.ac.uk						MCGILCHRIST I, 2010, DIALOG CLIN NEUROSCI, V12, P317; McGilchrist I., 2009, MASTER HIS EMISSARY; McNeill D., 1992, HAND MIND WHAT GESTU; Rogers L.J., 2002, COMP VERTEBRATE LATE; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303	5	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1068	1069		10.1016/S0140-6736(11)60422-4	http://dx.doi.org/10.1016/S0140-6736(11)60422-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	21449085				2022-12-01	WOS:000289035000015
J	Lerman, L				Lerman, Liz			The Genome Dances	SCIENCE			English	Editorial Material											Lerman, L (corresponding author), Liz Lerman Dance Exchange, Takoma Pk, MD USA.								0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1027	1027		10.1126/science.1203459	http://dx.doi.org/10.1126/science.1203459			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350168				2022-12-01	WOS:000287699000051
J	Evans, JP; Meslin, EM; Marteau, TM; Caulfield, T				Evans, James P.; Meslin, Eric M.; Marteau, Theresa M.; Caulfield, Timothy			Deflating the Genomic Bubble	SCIENCE			English	Editorial Material							RISK; ASSOCIATION; PERFORMANCE; VARIANTS		[Evans, James P.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Evans, James P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Meslin, Eric M.] Indiana Univ, Ctr Bioeth, Indianapolis, IN 46202 USA; [Marteau, Theresa M.] Kings Coll London, Hlth Psychol Sect, London SE1 9RT, England; [Caulfield, Timothy] Univ Alberta, Fac Law, Edmonton, AB T6G 2H5, Canada; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Sch Publ Hlth, Edmonton, AB T6G 2H5, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University-Purdue University Indianapolis; University of London; King's College London; University of Alberta; University of Alberta	Evans, JP (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu		Marteau, Theresa/0000-0003-3025-1129	MRC [G0500274] Funding Source: UKRI; Medical Research Council [G0500274] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, NATURE, V464, P649, DOI 10.1038/464649a; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Carlsson B, 2009, IND CORP CHANGE, V18, P1193, DOI 10.1093/icc/dtp043; Caulfield T, 2004, PLOS MED, V1, P178, DOI 10.1371/journal.pmed.0010038; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Garrison LP, 2008, DRUG METAB REV, V40, P377, DOI [10.1080/03602530801952500, 10.1080/03602530801952500 ]; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; GOODMAN KW, 2003, ETHICS EVIDENCE BASE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Keeney RL, 2008, OPER RES, V56, P1335, DOI 10.1287/opre.1080.0588; Kimmelman J., 2009, GENE TRANSFER ETHICS; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; McClure JB, 2002, AM J PREV MED, V22, P200, DOI 10.1016/S0749-3797(01)00425-1; Navigenics Inc, GEN HLTH; Pedersen NL, 2010, JAMA-J AM MED ASSOC, V303, P1864, DOI 10.1001/jama.2010.609; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petersen A, 2009, MONASH BIOETH REV, V28, P22, DOI 10.2104/mber0905; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pohlhaus JR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-472; Pollack Andrew, 2010, NY TIMES, pB5; Silver H. J., 2008, 33 AAAS; Tucker G, 2004, BMJ-BRIT MED J, V329, P4, DOI 10.1136/bmj.329.7456.4; Varmus H., 2009, ART POLITICS SCI; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; WHO Regional Committee for Europe, 2008, RES BEH CHANG STRAT; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	34	137	143	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					861	862		10.1126/science.1198039	http://dx.doi.org/10.1126/science.1198039			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330519				2022-12-01	WOS:000287455100031
J	Laurell, E; Beck, K; Krupina, K; Theerthagiri, G; Bodenmiller, B; Horvath, P; Aebersold, R; Antonin, W; Kutay, U				Laurell, Eva; Beck, Katja; Krupina, Ksenia; Theerthagiri, Gandhi; Bodenmiller, Bernd; Horvath, Peter; Aebersold, Ruedi; Antonin, Wolfram; Kutay, Ulrike			Phosphorylation of Nup98 by Multiple Kinases Is Crucial for NPC Disassembly during Mitotic Entry	CELL			English	Article							NUCLEAR-PORE COMPLEX; CYCLE-DEPENDENT PHOSPHORYLATION; NEK2 PROTEIN-KINASE; ENVELOPE BREAKDOWN; NIMA-FAMILY; NUCLEOPORIN; REVEALS; MITOSIS; ACTIVATION; DOMAINS	Disassembly of nuclear pore complexes (NPCs) is a decisive event during mitotic entry in cells undergoing open mitosis, yet the molecular mechanisms underlying NPC disassembly are unknown. Using chemical inhibition and depletion experiments we show that NPC disassembly is a phosphorylation-driven process, dependent on CDK1 activity and supported by members of the NIMA-related kinase (Nek) family. We identify phosphorylation of the GLFG-repeat nucleoporin Nup98 as an important step in mitotic NPC disassembly. Mitotic hyperphos-phorylation of Nup98 is accomplished by multiple kinases, including CDK1 and Neks. Nuclei carrying a phosphodeficient mutant of Nup98 undergo nuclear envelope breakdown slowly, such that both the dissociation of Nup98 from NPCs and the permeabilization of the nuclear envelope are delayed. Together, our data provide evidence for a phosphorylation-dependent mechanism underlying disintegration of NPCs during prophase. Moreover, we identify mitotic phosphorylation of Nup98 as a rate-limiting step in mitotic NPC disassembly.	[Laurell, Eva; Beck, Katja; Krupina, Ksenia; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Theerthagiri, Gandhi; Antonin, Wolfram] Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Bodenmiller, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Horvath, Peter] ETH, Light Microscopy Ctr, Dept Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eberhard Karls University of Tubingen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Kutay, U (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	ulrike.kutay@bc.biol.ethz.ch	Antonin, Wolfram/A-8656-2014; Antonin, Wolfram/P-3648-2019	Antonin, Wolfram/0000-0003-4669-379X; Antonin, Wolfram/0000-0003-4669-379X; T. K. Boopathy, Gandhi/0000-0002-1821-9540	DFG [KN 938/1-1]; SNF [3100AO-133135]	DFG(German Research Foundation (DFG)); SNF	We thank C. Ashiono for excellent technical assistance, S. Giese for help automating image analysis, J. Ellenberg, P. Lidsky, K. S. Fields, and C. R. Mena for reagents, P. Meraldi and A. Rothballer for critical reading, and P. Meraldi, H. Meyer, D. Gerlich, and M. Held for discussion. Imaging was performed on instruments of the ETH Light Microscopy Center. This work was supported by the DFG (KN 938/1-1) to K. B. and the SNF (3100AO-133135) to U.K.	Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.E03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kiseleva E, 2001, J CELL SCI, V114, P3607; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li HC, 2010, P NATL ACAD SCI USA, V107, P14633, DOI 10.1073/pnas.1006615107; LU KP, 1994, EMBO J, V13, P2103, DOI 10.1002/j.1460-2075.1994.tb06486.x; LU KP, 1993, J BIOL CHEM, V268, P8769; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Onischenko EA, 2005, MOL BIOL CELL, V16, P5152, DOI 10.1091/mbc.E05-07-0642; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schultz C, 1999, J MED CHEM, V42, P2909, DOI 10.1021/jm9900570; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Wu WJ, 2007, J BIOL CHEM, V282, P26431, DOI 10.1074/jbc.M704969200; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598	48	173	177	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					539	550		10.1016/j.cell.2011.01.012	http://dx.doi.org/10.1016/j.cell.2011.01.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335236	Bronze			2022-12-01	WOS:000287473100009
J	Ali, K; Harnden, A; Edge, JA				Ali, Keya; Harnden, Anthony; Edge, Julie A.			Practice Easily Missed? Type 1 diabetes in children	BRITISH MEDICAL JOURNAL			English	Editorial Material							MELLITUS					julie.edge@paediatrics.ox.ac.uk						Ali K, 2009, DIABETIC MED S1, V26, P34; Bui H, 2010, J PEDIATR-US, V156, P472, DOI 10.1016/j.jpeds.2009.10.001; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; PALOWICZ MM, 2008, PEDIAT ENDOCRINOL DI, V14, P7; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; PINKNEY JH, 1994, DIABETOLOGIA, V37, P70; Roche EF, 2005, PEDIATR DIABETES, V6, P75, DOI 10.1111/j.1399-543X.2005.00110.x; Royal College of Paediatrics and Child Health, 2009, GROW DIAB CHILDR YOU; Sundaram PCB, 2009, ARCH DIS CHILD, V94, P151, DOI 10.1136/adc.2007.133405; Vanelli M, 1999, DIABETES CARE, V22, P7, DOI 10.2337/diacare.22.1.7	10	12	12	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d294	10.1136/bmj.d294	http://dx.doi.org/10.1136/bmj.d294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OZ	21325386				2022-12-01	WOS:000287656500023
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			Thirty-Day Readmission Rates for Medicare Beneficiaries by Race and Site of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; CONGESTIVE-HEART-FAILURE; SAFETY-NET HOSPITALS; DUTY HOUR REFORM; BLACK PATIENTS; TRANSITIONS INTERVENTION; ADMINISTRATIVE DATA; RACIAL DISPARITIES	Context Understanding whether and why there are racial disparities in readmissions has implications for efforts to reduce readmissions. Objective To determine whether black patients have higher odds of readmission than white patients and whether these disparities are related to where black patients receive care. Design Using national Medicare data, we examined 30-day readmissions after hospitalization for acute myocardial infarction (MI), congestive heart failure (CHF), and pneumonia. We categorized hospitals in the top decile of proportion of black patients as minority-serving. We determined the odds of readmission for black patients compared with white patients at minority-serving vs non-minority-serving hospitals. Setting and Participants Medicare Provider Analysis Review files of more than 3.1 million Medicare fee-for-service recipients who were discharged from US hospitals in 2006-2008. Main Outcome Measure Risk-adjusted odds of 30-day readmission. Results Overall, black patients had higher readmission rates than white patients (24.8% vs 22.6%, odds ratio [OR], 1.13; 95% confidence interval [CI], 1.11-1.14; P<.001); patients from minority-serving hospitals had higher readmission rates than those from non-minority-serving hospitals (25.5% vs 22.0%, OR, 1.23; 95% CI, 1.20-1.27; P<.001). Among patients with acute MI and using white patients from non-minority-serving hospitals as the reference group (readmission rate 20.9%), black patients from minority-serving hospitals had the highest readmission rate (26.4%; OR, 1.35; 95% CI, 1.28-1.42), while white patients from minority-serving hospitals had a 24.6% readmission rate (OR, 1.23; 95% CI, 1.18-1.29) and black patients from non-minority-serving hospitals had a 23.3% readmission rate (OR, 1.20; 95% CI, 1.16-1.23; P<.001 for each); patterns were similar for CHF and pneumonia. The results were unchanged after adjusting for hospital characteristics including markers of caring for poor patients. Conclusion Among elderly Medicare recipients, black patients were more likely to be readmitted after hospitalization for 3 common conditions, a gap that was related to both race and to the site where care was received. JAMA. 2011;305(7):675-681 www.jama.com	[Joynt, Karen E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Institutes of Health, Brigham and Women's Hospital, Division of Cardiovascular Medicine [T32HL007604-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	National Institutes of Health, Brigham and Women's Hospital, Division of Cardiovascular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Joynt was supported by National Institutes of Health Training Grant T32HL007604-24, Brigham and Women's Hospital, Division of Cardiovascular Medicine.	Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; BAICKER K, 2004, HLTH AFF MILLWOOD S, pVAR33; Benatar D, 2003, ARCH INTERN MED, V163, P347, DOI 10.1001/archinte.163.3.347; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Breslin TM, 2009, J CLIN ONCOL, V27, P3945, DOI 10.1200/JCO.2008.20.8546; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Culler SD, 2010, MED CARE, V48, P273, DOI 10.1097/MLR.0b013e3181c161ba; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Gaskin DJ, 2008, HEALTH AFFAIR, V27, P518, DOI 10.1377/hlthaff.27.2.518; Givens JL, 2010, ARCH INTERN MED, V170, P427, DOI 10.1001/archinternmed.2009.547; Halm EA, 2009, STROKE, V40, P2493, DOI 10.1161/STROKEAHA.108.544866; Han B, 2006, MED CARE, V44, P731, DOI 10.1097/01.mlr.0000215858.37118.65; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Healthcare Cost and Utilization Project (HCUP), COM SOFTW VERS 3 6; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; *I MED, 2002, UN TREATM CONFR RAC; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Jha AK, 2007, AM HEART J, V153, P785, DOI 10.1016/j.ahj.2007.02.014; Kahn CN, 2006, HEALTH AFFAIR, V25, P148, DOI 10.1377/hlthaff.25.1.148; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Mayr FB, 2010, CRIT CARE MED, V38, P759, DOI 10.1097/CCM.0b013e3181c8fd58; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Niederman MS, 1998, CLIN THER, V20, P820, DOI 10.1016/S0149-2918(98)80144-6; Parry Carla, 2009, Home Health Care Serv Q, V28, P84, DOI 10.1080/01621420903155924; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Sisk JE, 2006, ANN INTERN MED, V145, P273, DOI 10.7326/0003-4819-145-4-200608150-00007; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Tan EJ, 2003, J AM GERIATR SOC, V51, P246, DOI 10.1046/j.1532-5415.2003.51065.x; Trivedi AN, 2006, J AM COLL CARDIOL, V47, P417, DOI 10.1016/j.jacc.2005.08.068; *US DEP HHS, 2000, HLTH PEOPL 2010 UND; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Weller WE, 2007, J AM COLL SURGEONS, V204, P383, DOI 10.1016/j.jamcollsurg.2006.12.031; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Zwanziger J, 2008, MED CARE RES REV, V65, P478, DOI 10.1177/1077558708315440	45	557	560	1	36	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					675	681		10.1001/jama.2011.123	http://dx.doi.org/10.1001/jama.2011.123			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721NH	21325183	Bronze, Green Accepted			2022-12-01	WOS:000287361100018
J	Sabeti, P				Sabeti, Pardis			The Landscape of Human Evolution	SCIENCE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Sabeti, P (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.		Sabeti, Pardis/GQH-8610-2022						0	1	1	3	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	690		10.1126/science.1202570	http://dx.doi.org/10.1126/science.1202570			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310997	Green Submitted			2022-12-01	WOS:000287205700041
J	Culyba, EK; Price, JL; Hanson, SR; Dhar, A; Wong, CH; Gruebele, M; Powers, ET; Kelly, JW				Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Dhar, Apratim; Wong, Chi-Huey; Gruebele, Martin; Powers, Evan T.; Kelly, Jeffery W.			Protein Native-State Stabilization by Placing Aromatic Side Chains in N-Glycosylated Reverse Turns	SCIENCE			English	Article							ASPARAGINE-LINKED GLYCOSYLATION; STABILITY; CARBOHYDRATE; CONFORMATION; ACYLPHOSPHATASE; GLYCANS; CONTEXT; CD2	N-glycosylation of eukaryotic proteins helps them fold and traverse the cellular secretory pathway and can increase their stability, although the molecular basis for stabilization is poorly understood. Glycosylation of proteins at naive sites (ones that normally are not glycosylated) could be useful for therapeutic and research applications but currently results in unpredictable changes to protein stability. We show that placing a phenylalanine residue two or three positions before a glycosylated asparagine in distinct reverse turns facilitates stabilizing interactions between the aromatic side chain and the first N-acetylglucosamine of the glycan. Glycosylating this portable structural module, an enhanced aromatic sequon, in three different proteins stabilizes their native states by -0.7 to -2.0 kilocalories per mole and increases cellular glycosylation efficiency.	[Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Wong, Chi-Huey; Powers, Evan T.; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Wong, Chi-Huey; Powers, Evan T.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Dhar, Apratim; Gruebele, Martin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Powers, ET (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	epowers@scripps.edu; jkelly@scripps.edu		Price, Joshua/0000-0002-0116-0968; Powers, Evan/0000-0001-8185-8487	Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NIH [GM051105, F32 GM086039, AI072155]; NSF [MCB 1019958]; Div Of Molecular and Cellular Bioscience [1019958] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086039, R01GM051105] Funding Source: NIH RePORTER	Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. A. Dwek, I. A. Wilson, J. C. Paulson, S. Deechongkit, and D. L. Powers for presubmission reviews and for helpful prepublication discussions. This work was supported in part by the Skaggs Institute for Chemical Biology, the Lita Annenberg Hazen Foundation, and by NIH grant GM051105 to J. W. K. and E. T. P. J. L. P. was supported in part by NIH postdoctoral fellowship F32 GM086039. A. D. and M. G. were supported by NSF grant MCB 1019958. S. R. H. and C.-H. W. were supported by NIH grant AI072155. The Scripps Research Institute has filed a provisional patent application covering the results described in this paper.	ANDREOTTI AH, 1993, J AM CHEM SOC, V115, P3352, DOI 10.1021/ja00061a053; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Chen MM, 2010, P NATL ACAD SCI USA, V107, P22528, DOI 10.1073/pnas.1015356107; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; Geierhaas CD, 2004, J MOL BIOL, V343, P1111, DOI 10.1016/j.jmb.2004.08.100; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KERN G, 1992, PROTEIN SCI, V1, P120; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; Laughrey ZR, 2008, J AM CHEM SOC, V130, P14625, DOI 10.1021/ja803960x; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; PASTORE A, 1992, J MOL BIOL, V224, P427, DOI 10.1016/0022-2836(92)91005-A; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Price JL, 2010, J AM CHEM SOC, V132, P15359, DOI 10.1021/ja106896t; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yamaguchi H, 1996, J BIOCHEM-TOKYO, V120, P474; Yeung RCY, 2006, ACTA CRYSTALLOGR F, V62, P80, DOI 10.1107/S174430910504145X; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	28	140	146	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					571	575		10.1126/science.1198461	http://dx.doi.org/10.1126/science.1198461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292975	Green Accepted			2022-12-01	WOS:000286933600050
J	Sundal, AV; Shepherd, A; Nienow, P; Hanna, E; Palmer, S; Huybrechts, P				Sundal, Aud Venke; Shepherd, Andrew; Nienow, Peter; Hanna, Edward; Palmer, Steven; Huybrechts, Philippe			Melt-induced speed-up of Greenland ice sheet offset by efficient subglacial drainage	NATURE			English	Article							MASS-BALANCE; SURFACE MELT; ACCELERATION; DYNAMICS; TRACKING; RUNOFF; MOTION	Fluctuations in surface melting are known to affect the speed of glaciers and ice sheets(1-7), but their impact on the Greenland ice sheet in a warming climate remains uncertain(8). Although some studies suggest that greater melting produces greater ice-sheet acceleration(7,9), others have identified a long-term decrease in Greenland's flow despite increased melting(3). Here we use satellite observations of ice motion recorded in a land-terminating sector of southwest Greenland to investigate the manner in which ice flow develops during years of markedly different melting. Although peak rates of ice speed-up are positively correlated with the degree of melting, mean summer flow rates are not, because glacier slowdown occurs, on average, when a critical run-off threshold of about 1.4 centimetres a day is exceeded. In contrast to the first half of summer, when flow is similar in all years, speed-up during the latter half is 62 +/- 16 per cent less in warmer years. Consequently, in warmer years, the period of fast ice flow is three times shorter and, overall, summer ice flow is slower. This behaviour is at odds with that expected from basal lubrication alone(7,9). Instead, it mirrors that of mountain glaciers(10-12), where melt-induced acceleration of flow ceases during years of high melting once subglacial drainage becomes efficient. A model of ice-sheet flow that captures switching between cavity and channel drainage modes(13) is consistent with the run-off threshold, fast-flow periods, and later-summer speeds we have observed. Simulations of the Greenland ice-sheet flow under climate warming scenarios should account for the dynamic evolution of subglacial drainage; a simple model of basal lubrication alone misses key aspects of the ice sheet's response to climate warming.	[Sundal, Aud Venke; Shepherd, Andrew; Palmer, Steven] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Nienow, Peter] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Hanna, Edward] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; [Huybrechts, Philippe] Vrije Univ Brussel, Dept Geog, B-1050 Brussels, Belgium	University of Leeds; University of Edinburgh; University of Sheffield; Vrije Universiteit Brussel	Shepherd, A (corresponding author), Univ Leeds, Sch Earth & Environm, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.	a.shepherd@leeds.ac.uk	Hanna, Edward/W-5927-2019; Hanna, Edward/H-2219-2016; Palmer, Steven/D-5170-2013; Huybrechts, Philippe/J-5278-2013	Hanna, Edward/0000-0002-8683-182X; Hanna, Edward/0000-0002-8683-182X; Huybrechts, Philippe/0000-0003-1406-0525; Palmer, Steven/0000-0003-3977-8509; Shepherd, Andrew/0000-0002-4914-1299	UK NERC National Centre for Earth Observation; EU [026]; NERC [cpom20001] Funding Source: UKRI; Natural Environment Research Council [cpom20001, earth010006] Funding Source: researchfish	UK NERC National Centre for Earth Observation(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the UK NERC National Centre for Earth Observation, a Philip Leverhulme Prize to A.S. and by the EU FP7 Ice2Sea project (publ. no. 026). European Remote Sensing satellite synthetic aperture radar data were provided by the European Space Agency Vectra Consortium. We thank R. van de Wal for providing positive degree-day data.	Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33983, DOI 10.1029/2001JD900181; Bartholomaus TC, 2008, NAT GEOSCI, V1, P33, DOI 10.1038/ngeo.2007.52; Bartholomew I, 2010, NAT GEOSCI, V3, P408, DOI 10.1038/NGEO863; Bingham RG, 2003, ANN GLACIOL, V37, P181, DOI 10.3189/172756403781815762; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Hanna E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005641; Hanna E, 2008, J CLIMATE, V21, P331, DOI 10.1175/2007JCLI1964.1; Janssens I, 2000, ANN GLACIOL-SER, V31, P133, DOI 10.3189/172756400781819941; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mernild SH, 2010, J HYDROMETEOROL, V11, P3, DOI 10.1175/2009JHM1140.1; Palmer S.J., EARTH PLANE IN PRESS; Parizek BR, 2004, QUATERNARY SCI REV, V23, P1013, DOI 10.1016/j.quascirev.2003.12.024; Price SF, 2008, J GLACIOL, V54, P213, DOI 10.3189/002214308784886117; Pritchard H, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000233; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rothlisberger H., 1972, J GLACIOL, V11, P177, DOI [DOI 10.1017/S0022143000022188, 10.3189/S0022143000022188, DOI 10.3189/S0022143000022188]; Schoof C, 2005, P ROY SOC A-MATH PHY, V461, P609, DOI 10.1098/rspa.2004.1350; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618; Shepherd A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035758; Steffen K, 2001, J GEOPHYS RES-ATMOS, V106, P33951, DOI 10.1029/2001JD900161; Strozzi T, 2002, IEEE T GEOSCI REMOTE, V40, P2384, DOI 10.1109/TGRS.2002.805079; Truffer M, 2005, J GLACIOL, V51, P663, DOI 10.3189/172756505781829016; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	26	233	237	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					522	U83		10.1038/nature09740	http://dx.doi.org/10.1038/nature09740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270891				2022-12-01	WOS:000286596500030
J	Tang, W; Lu, Y; Tian, QY; Zhang, Y; Guo, FJ; Liu, GY; Syed, NM; Lai, YJ; Lin, EA; Kong, L; Su, J; Yin, FF; Ding, AH; Zanin-Zhorov, A; Dustin, ML; Tao, J; Craft, J; Yin, ZN; Feng, JQ; Abramson, SB; Yu, XP; Liu, CJ				Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Su, Jeffrey; Yin, Fangfang; Ding, Ai-Hao; Zanin-Zhorov, Alexandra; Dustin, Michael L.; Tao, Jian; Craft, Joseph; Yin, Zhinan; Feng, Jian Q.; Abramson, Steven B.; Yu, Xiu-Ping; Liu, Chuan-Ju			The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice	SCIENCE			English	Article							OLIGOMERIC MATRIX PROTEIN; GRANULIN-EPITHELIN PRECURSOR; TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR; HOST-DEFENSE; ADAMTS-7; MUTATIONS; GENE; PSEUDOACHONDROPLASIA; DEGRADATION	The growth factor progranulin (PGRN) has been implicated in embryonic development, tissue repair, tumorigenesis, and inflammation, but its receptors remain unidentified. We report that PGRN bound directly to tumor necrosis factor receptors (TNFRs) and disturbed the TNF alpha-TNFR interaction. PGRN-deficient mice were susceptible to collagen-induced arthritis, and administration of PGRN reversed inflammatory arthritis. Atsttrin, an engineered protein composed of three PGRN fragments, exhibited selective TNFR binding. PGRN and Atsttrin prevented inflammation in multiple arthritis mouse models and inhibited TNF alpha-activated intracellular signaling. Collectively, these findings demonstrate that PGRN is a ligand of TNFR, an antagonist of TNF alpha signaling, and plays a critical role in the pathogenesis of inflammatory arthritis in mice. They also suggest new potential therapeutic interventions for various TNF alpha-mediated pathologies and conditions, including rheumatoid arthritis.	[Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Liu, Chuan-Ju] NYU, Dept Orthopaed Surg, Sch Med, New York, NY 10003 USA; [Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Abramson, Steven B.; Liu, Chuan-Ju] NYU, Hosp Joint Dis, New York, NY 10003 USA; [Tang, Wei; Lu, Yi; Yu, Xiu-Ping] Shandong Univ, Sch Med, Inst Pathogen Biol, Jinan 250012, Shandong, Peoples R China; [Su, Jeffrey] Cytovance Biol, Oklahoma City, OK 73104 USA; [Yin, Fangfang; Ding, Ai-Hao] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Zanin-Zhorov, Alexandra; Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Tao, Jian; Craft, Joseph] Yale Univ, Sch Med, Dept Med, Rheumatol Sect, New Haven, CT 06520 USA; [Yin, Zhinan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX 75246 USA; [Abramson, Steven B.] NYU, Sch Med, Div Rheumatol, New York, NY 10003 USA; [Liu, Chuan-Ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Shandong University; Cornell University; New York University; Yale University; Nankai University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; New York University; New York University	Liu, CJ (corresponding author), NYU, Dept Orthopaed Surg, Sch Med, New York, NY 10003 USA.	chuanju.liu@med.nyu.edu	Dustin, Michael/AAM-4611-2020; Tian, Qingyun/L-7723-2014; Liu, Chuan-ju/AAT-8165-2021; Tang, Wei/A-6254-2016	Tang, Wei/0000-0002-4573-3502; liu, chuanju/0000-0002-7181-8032; Abramson, Steven/0000-0002-0668-6344; Syed, Nabeel/0000-0001-8901-5601; Dustin, Michael/0000-0003-4983-6389	NIH [AR050620, AR053210, GM061710, AI43542, AR040072]; Arthritis National Research Foundation; National Nature Science Foundation of China [30870121]; NSFC [30725015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542, R01AI043542, R01AI030165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053210, R37AR040072, R01AR040072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061710] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Lengyel, J. Vilcek, and T. C. Caskey for critical reading and comments. We also thank G. Wisniewski for assisting with the CIA model, M. E. Dorf and A. Mukundan for reagents, and A. Martin and J. Quinn for assistance in Surface Plasmon Resonance assay. This work was funded by NIH grants AR050620 and AR053210 (to C.-J.L.), GM061710 (to A.-H. D), AI43542 (to M. L. D), and AR040072 (to J. C.); by a grant from Arthritis National Research Foundation (to C.-J.L.); by a National Nature Science Foundation of China Grant 30870121 (to X. P. Y); and by a National Outstanding Young Scientist Award of NSFC 30725015 (to Z.N.Y). Patents have been filed by NYU that claim peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods, and uses thereof [WO/2010/120374 (C.-J.L.) and PCT/US2010/001137 (C.-J.L.)]. TNFR2 (TNFRSF1B/CD120b) accession number: NM_130426. A full list of author contributions is available in the SOM.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Deng GM, 2005, NAT MED, V11, P1066, DOI 10.1038/nm1304; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Liu CJ, 2006, J BIOL CHEM, V281, P15800, DOI 10.1074/jbc.M513433200; Liu CJ, 2009, NAT CLIN PRACT RHEUM, V5, P38, DOI 10.1038/ncprheum0961; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Netterwald James, 2009, Nat Biotechnol, V27, P495, DOI 10.1038/nbt0609-495; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Taylor PC, 2009, NAT CLIN PRACT RHEUM, V5, P126, DOI 10.1038/ncprheum1022; Thwin MM, 2004, ARTHRITIS RES THER, V6, pR282, DOI 10.1186/ar1179; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	35	508	539	6	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					478	484		10.1126/science.1199214	http://dx.doi.org/10.1126/science.1199214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21393509	Green Accepted			2022-12-01	WOS:000289784900047
J	Burguillos, MA; Deierborg, T; Kavanagh, E; Persson, A; Hajji, N; Garcia-Quintanilla, A; Cano, J; Brundin, P; Englund, E; Venero, JL; Joseph, B				Burguillos, Miguel A.; Deierborg, Tomas; Kavanagh, Edel; Persson, Annette; Hajji, Nabil; Garcia-Quintanilla, Albert; Cano, Josefina; Brundin, Patrik; Englund, Elisabet; Venero, Jose L.; Joseph, Bertrand			Caspase signalling controls microglia activation and neurotoxicity	NATURE			English	Article							KINASE-C-DELTA; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; ENDOTOXIC-SHOCK; NITRIC-OXIDE; CELL-DEATH	Activation of microglia and inflammation-mediated neurotoxicity are suggested to play a decisive role in the pathogenesis of several neurodegenerative disorders. Activated microglia release pro-inflammatory factors that may be neurotoxic. Here we show that the orderly activation of caspase-8 and caspase-3/7, known executioners of apoptotic cell death, regulate microglia activation through a protein kinase C (PKC)-delta-dependent pathway. We find that stimulation of microglia with various inflammogens activates caspase-8 and caspase-3/7 in microglia without triggering cell death in vitro and in vivo. Knockdown or chemical inhibition of each of these caspases hindered microglia activation and consequently reduced neurotoxicity. We observe that these caspases are activated in microglia in the ventral mesencephalon of Parkinson's disease (PD) and the frontal cortex of individuals with Alzheimer's disease (AD). Taken together, we show that caspase-8 and caspase-3/7 are involved in regulating microglia activation. We conclude that inhibition of these caspases could be neuroprotective by targeting the microglia rather than the neurons themselves.	[Burguillos, Miguel A.; Kavanagh, Edel; Hajji, Nabil; Joseph, Bertrand] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Burguillos, Miguel A.; Cano, Josefina; Venero, Jose L.] Univ Seville, Dept Bioquim & Biol Mol, Fac Farm, E-41012 Seville, Spain; [Burguillos, Miguel A.; Cano, Josefina; Venero, Jose L.] Inst Biomed Sevilla, Seville 41012, Spain; [Burguillos, Miguel A.; Deierborg, Tomas; Brundin, Patrik] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, S-22184 Lund, Sweden; [Persson, Annette; Englund, Elisabet] Univ Lund Hosp, Div Neuropathol, Dept Pathol, S-22185 Lund, Sweden; [Garcia-Quintanilla, Albert] Univ Seville, Serv Biol, CITIUS, Ctr Invest Tecnol & Innovac, E-41012 Seville, Spain	Karolinska Institutet; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Lund University; Skane University Hospital; University of Sevilla	Joseph, B (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden.	jlvenero@us.es; bertrand.joseph@ki.se	hajji, nabil/AAV-1435-2020; Venero, Jose/E-9979-2015; IBIS, ENVEJECIMIENTO/O-9381-2015; Garcia-Quintanilla, Albert/AAE-3247-2020; Burguillos, Miguel/N-4806-2019; Deierborg, Tomas/P-6345-2015; Garcia-Quintanilla, Albert/F-1463-2015	Venero, Jose/0000-0003-1137-8706; Burguillos, Miguel/0000-0002-3165-9997; Deierborg, Tomas/0000-0002-3651-3444; Garcia-Quintanilla, Albert/0000-0001-9617-1354; Joseph, Bertrand/0000-0001-5655-9979; Englund, Elisabet/0000-0002-2708-2443	Spanish Ministerio de Ciencia y Tecnologia [SAF2006-04119, 2009-13778]; Swedish Research Council; Parkinson Foundation of Sweden; Swedish Alzheimer Foundation; Swedish Cancer Society; Medical Research Council [G0801056B] Funding Source: researchfish	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinson Foundation of Sweden; Swedish Alzheimer Foundation; Swedish Cancer Society(Swedish Cancer Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Gorman, O. Hermanson, M. Malewicz, S. Orrenius, T. Panaretakis and B. Zhivotovsky for discussion, and L. Hjortsberg, M. Reyland and S. Ceccatelli for providing us with reagents. M. Carballo, JL. Ribas, A. Fernandez and B. Haraldsson provided qualified technical support. This work has been supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (SAF2006-04119 and 2009-13778), the Swedish Research Council, the Parkinson Foundation of Sweden, the Swedish Alzheimer Foundation and the Swedish Cancer Society. M. A. B., T. D. and P. B. are members of Neurofortis and Bagadilico, both of which are research environments sponsored by the Swedish Research Council.	Aarli JA, 2003, CURR MED CHEM, V10, P1931, DOI 10.2174/0929867033456918; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Balistreri CR, 2008, CURR PHARM DESIGN, V14, P2672, DOI 10.2174/138161208786264089; Bilsland James, 2002, Curr Opin Investig Drugs, V3, P1745; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Castano A, 1998, J NEUROCHEM, V70, P1584; CHAO CC, 1992, J IMMUNOL, V149, P2736; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cutillas B, 1999, NEUROREPORT, V10, P2605, DOI 10.1097/00001756-199908200-00030; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jordan J, 2008, CURR PHARM DESIGN, V14, P3549, DOI 10.2174/138161208786848766; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schulz JB, 1998, CELL DEATH DIFFER, V5, P847, DOI 10.1038/sj.cdd.4400420; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Vancurova I, 2001, J BIOL CHEM, V276, P19746, DOI 10.1074/jbc.M100234200; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	47	410	436	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					319	U214		10.1038/nature09788	http://dx.doi.org/10.1038/nature09788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21389984				2022-12-01	WOS:000289724600033
J	Grumbine, RE; Xu, JC				Grumbine, R. Edward; Xu, Jianchu			Mekong Hydropower Development	SCIENCE			English	Editorial Material							BASIN		[Grumbine, R. Edward] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China; [Xu, Jianchu] World Agroforestry Ctr, Kunming 650204, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Grumbine, RE (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China.	ed.grumbine@gmail.com	Xu, Jianchu/Y-2890-2019					Baran E, 2009, AQUAT ECOSYST HEALTH, V12, P227, DOI 10.1080/14634980903149902; CIA, 2017, GHAN WORLD FACTB 201; Cruz RV, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P469; Dore J, 2010, ENVIRON MANAGE, V46, P60, DOI 10.1007/s00267-010-9527-x; Evans A, 2010, GLOBALIZATION SCARCI; Foran T., 2009, CONTESTED WATERSCAPE, P55; Friend Richard, 2009, CONTESTED WATERSCAPE, P307, DOI DOI 10.4324/9781849770866; Hirsch P., 2006, NATL INTERESTS TRANS; International Center for Environmental Management, 2010, MRC STRAT ENV ASS SE; Jensen JG, 2001, WATER SCI TECHNOL, V43, P157, DOI 10.2166/wst.2001.0529; Kummu M, 2010, GEOMORPHOLOGY, V119, P181, DOI 10.1016/j.geomorph.2010.03.018; Lebel L, 2010, INT ENVIRON AGREEM-P, V10, P355, DOI 10.1007/s10784-010-9141-7; Population Reference Bureau, 2010, 2010 WORLD POP DAT S; Shankleman J., 2009, GOING GLOBAL CHINESE; WANG JJ, 2009, RIVER RES APPL, V25, P33; WIPATAYOTIN A, 2011, BANGKOK POST    0217	16	160	167	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					178	179		10.1126/science.1200990	http://dx.doi.org/10.1126/science.1200990			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	746MM	21474740				2022-12-01	WOS:000289251100029
J	Bohnert, ASB; Valenstein, M; Bair, MJ; Ganoczy, D; McCarthy, JF; Ilgen, MA; Blow, FC				Bohnert, Amy S. B.; Valenstein, Marcia; Bair, Matthew J.; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.			Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAKTHROUGH PAIN; CANCER PAIN; CASE-COHORT; MORTALITY; TIME	Context The rate of prescription opioid-related overdose death increased substantially in the United States over the past decade. Patterns of opioid prescribing may be related to risk of overdose mortality. Objective To examine the association of maximum prescribed daily opioid dose and dosing schedule ("as needed," regularly scheduled, or both) with risk of opioid overdose death among patients with cancer, chronic pain, acute pain, and substance use disorders. Design Case-cohort study. Setting Veterans Health Administration (VHA), 2004 through 2008. Participants All unintentional prescription opioid overdose decedents (n=750) and a random sample of patients (n=154 684) among those individuals who used medical services in 2004 or 2005 and received opioid therapy for pain. Main Outcome Measure Associations of opioid regimens (dose and schedule) with death by unintentional prescription opioid overdose in subgroups defined by clinical diagnoses, adjusting for age group, sex, race, ethnicity, and comorbid conditions. Results The frequency of fatal overdose over the study period among individuals treated with opioids was estimated to be 0.04%. The risk of overdose death was directly related to the maximum prescribed daily dose of opioid medication. The adjusted hazard ratios (HRs) associated with a maximum prescribed dose of 100 mg/d or more, compared with the dose category 1 mg/d to less than 20 mg/d, were as follows: among those with substance use disorders, adjusted HR=4.54 (95% confidence interval [CI], 2.46-8.37; absolute risk difference approximation [ARDA]=0.14%); among those with chronic pain, adjusted HR=7.18 (95% CI, 4.85-10.65; ARDA=0.25%); among those with acute pain, adjusted HR=6.64 (95% CI, 3.31-13.31; ARDA=0.23%); and among those with cancer, adjusted HR=11.99 (95% CI, 4.42-32.56; ARDA=0.45%). Receiving both as-needed and regularly scheduled doses was not associated with overdose risk after adjustment. Conclusion Among patients receiving opioid prescriptions for pain, higher opioid doses were associated with increased risk of opioid overdose death. JAMA. 2011;305(13):1315-1321 www.jama.com	[Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; [Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Ctr Excellence, Dept Vet Affairs Hlth Serv Res & Dev HSR&D, Ann Arbor, MI USA; [Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Serious Mental Illness Treatment Resource & Evalu, Ann Arbor, MI USA; [Bair, Matthew J.] Ctr Excellence, Dept Vet Affairs HSR&D, Indianapolis, IN USA; [Bair, Matthew J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA	University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington	Bohnert, ASB (corresponding author), Univ Michigan, Sch Med, Dept Psychiat, 4250 Plymouth Rd,Box 5765, Ann Arbor, MI 48109 USA.	amybohne@med.umich.edu	Bohnert, Amy SB/C-7313-2015		Health Services Research and Development Service (HSRD) [CDA-09-204]; Department of Veterans Affairs Office of Mental Health Services, Patient Care Services	Health Services Research and Development Service (HSRD)(US Department of Veterans Affairs); Department of Veterans Affairs Office of Mental Health Services, Patient Care Services(US Department of Veterans Affairs)	This work was financially supported by the Department of Veterans Affairs Office of Mental Health Services, Patient Care Services, and a Health Services Research and Development Service (HSR&D) Career Development Award (CDA-09-204; A.S.B.B.).	[Anonymous], NAT DEATH IND; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Donaldson AE, 2006, INJURY PREV, V12, P338, DOI 10.1136/ip.2005.011171; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Gammaitoni AR, 2003, CLIN J PAIN, V19, P286, DOI 10.1097/00002508-200309000-00002; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Lash TL, 2009, J CLIN ONCOL, V27, pE55, DOI 10.1200/JCO.2009.24.1877; Lawlor PG, 1998, CANCER, V82, P1167, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; McLellan AT, 2008, JAMA-J AM MED ASSOC, V300, P2672, DOI 10.1001/jama.2008.793; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8; Portenoy RK, 2007, CURR MED RES OPIN, V23, P222, DOI 10.1185/030079906X162818; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Prommer E, 2006, SUPPORT CARE CANCER, V14, P109, DOI 10.1007/s00520-005-0917-1; Schumann H, 2008, CLIN TOXICOL, V46, P501, DOI 10.1080/15563650701877374; Simpson DM, 2007, CLIN THER, V29, P588, DOI 10.1016/j.clinthera.2007.04.007; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; The Management of Posttraumatic Stress Disorder Work Group, 2017, VA DOD CLIN PRACT GU; Valenstein M, 2004, AM J PSYCHIAT, V161, P654, DOI 10.1176/appi.ajp.161.4.654; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	27	1044	1053	2	73	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1315	1321		10.1001/jama.2011.370	http://dx.doi.org/10.1001/jama.2011.370			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467284				2022-12-01	WOS:000289162400020
J	Zhang, K; Fischer, T; Porter, RL; Dhakshnamoorthy, J; Zofall, M; Zhou, M; Veenstra, T; Grewal, SIS				Zhang, Ke; Fischer, Tamas; Porter, Rebecca L.; Dhakshnamoorthy, Jothy; Zofall, Martin; Zhou, Ming; Veenstra, Timothy; Grewal, Shiv I. S.			Clr4/Suv39 and RNA Quality Control Factors Cooperate to Trigger RNAi and Suppress Antisense RNA	SCIENCE			English	Article							FISSION YEAST; CHROMOSOME SEGREGATION; LYSINE METHYLATION; MRNP FORMATION; HETEROCHROMATIN; COMPLEX; EXPORT; TRANSCRIPTION; PROTEINS; DEGRADATION	Pervasive transcription of eukaryotic genomes generates a plethora of noncoding RNAs. In fission yeast, the heterochromatin factor Clr4/Suv39 methyltransferase facilitates RNA interference (RNAi)-mediated processing of centromeric transcripts into small interfering RNAs (siRNAs). Clr4 also mediates degradation of antisense RNAs at euchromatic loci, but the underlying mechanism has remained elusive. We show that Clr4 and the RNAi effector RITS (RNA-induced transcriptional silencing) interact with Mlo3, a protein related to mRNA quality control and export factors. Loss of Clr4 impairs RITS interaction with Mlo3, which is required for centromeric siRNA production and antisense suppression. Mlo3 also interacts with the RNA surveillance factor TRAMP, which suppresses antisense RNAs targeted by Clr4 and RNAi. These findings link Clr4 to RNA quality control machinery and suggest a pathway for processing potentially deleterious RNAs through the coordinated actions of RNAi and other RNA processing activities.	[Zhang, Ke; Fischer, Tamas; Porter, Rebecca L.; Dhakshnamoorthy, Jothy; Zofall, Martin; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy] NCI, Lab Prote & Analyt Anal, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Fischer, Tamas/A-7729-2016	Fischer, Tamas/0000-0002-7996-4042	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Dhar and R. Allshire for antibody to Mlo3 and strains, E. Chen for helpful contributions, and F. Reyes-Turcu, N. Komissarova, and M. Lichten for comments on manuscripts and discussions. Microarray data are available at the National Center for Biotechnology Information's Gene Expression Omnibus repository under accession numbers GSE26999 and GSE17271. This work is supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Javerzat JP, 1996, NUCLEIC ACIDS RES, V24, P4676, DOI 10.1093/nar/24.23.4676; Jensen TH, 2003, NAT STRUCT BIOL, V10, P10, DOI 10.1038/nsb0103-10; Kim VN, 2001, MOL CELLS, V12, P1; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Thakurta AG, 2005, EMBO J, V24, P2512, DOI 10.1038/sj.emboj.7600713; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	27	58	59	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1624	1627		10.1126/science.1198712	http://dx.doi.org/10.1126/science.1198712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436456	Green Accepted			2022-12-01	WOS:000288754500061
J	Jonietz, E				Jonietz, Erika			DESIGNING SMARTER CANCER PREVENTION TRIALS	NATURE			English	Editorial Material							PROSTATE-CANCER											Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660	2	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S20	S21		10.1038/471S20a	http://dx.doi.org/10.1038/471S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430717	Bronze			2022-12-01	WOS:000288702200017
J	Strunker, T; Goodwin, N; Brenker, C; Kashikar, ND; Weyand, I; Seifert, R; Kaupp, UB				Struenker, Timo; Goodwin, Normann; Brenker, Christoph; Kashikar, Nachiket D.; Weyand, Ingo; Seifert, Reinhard; Kaupp, U. Benjamin			The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm	NATURE			English	Article							HUMAN SPERMATOZOA; CALCIUM INFLUX; CHEMOTAXIS; ACTIVATION; RECEPTORS; MECHANISM; CELLS	In the oviduct, cumulus cells that surround the oocyte release progesterone. In human sperm, progesterone stimulates a Ca2+ increase by a non-genomic mechanism(1-3). The Ca2+ signal has been proposed to control chemotaxis, hyperactivation and acrosomal exocytosis of sperm(4-8). However, the underlying signalling mechanism has remained mysterious. Here we show that progesterone activates the sperm-specific, pH-sensitive CatSper Ca2+ channel(9-11). We found that both progesterone and alkaline pH stimulate a rapid Ca2+ influx with almost no latency, incompatible with a signalling pathway involving metabotropic receptors and second messengers. The Ca2+ signals evoked by alkaline pH and progesterone are inhibited by the Ca-v channel blockers NNC 55-0396 and mibefradil. Patch-clamp recordings from sperm reveal an alkaline-activated current carried by mono-and divalent ions that exhibits all the hallmarks of sperm-specific CatSper Ca2+ channels(10,11). Progesterone substantially enhances the CatSper current. The alkaline- and progesterone-activated CatSper current is inhibited by both drugs. Our results resolve a long-standing controversy over the non-genomic progesterone signalling. In human sperm, either the CatSper channel itself or an associated protein serves as the non-genomic progesterone receptor. The identification of CatSper channel blockers will greatly facilitate the study of Ca2+ signalling in sperm and help to define further the physiological role of progesterone and CatSper.	[Struenker, Timo; Goodwin, Normann; Brenker, Christoph; Kashikar, Nachiket D.; Seifert, Reinhard; Kaupp, U. Benjamin] Ctr Adv European Studies & Res, Abt Mol Neurosensor, D-53175 Bonn, Germany; [Weyand, Ingo] Forschungszentrum Julich, Inst Complex Syst Cellular Biophys ICS 4, D-52425 Julich, Germany	Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; Research Center Julich	Kaupp, UB (corresponding author), Ctr Adv European Studies & Res, Abt Mol Neurosensor, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	timo.struenker@caesar.de; u.b.kaupp@caesar.de	Strünker, Timo/AAE-4722-2020	Kashikar, Nachiket/0000-0002-4466-7486	German Research Foundation [SFB 645]; International Helmholtz Research School on Biophysics and Soft Matter	German Research Foundation(German Research Foundation (DFG)); International Helmholtz Research School on Biophysics and Soft Matter	This work was supported by the German Research Foundation (SFB 645) and the International Helmholtz Research School on Biophysics and Soft Matter. We thank S. Stark for technical assistance, H. Krause and B. Kayser for preparing the manuscript, and C. Bernsdorff for preparing the figures. The caged compounds were kindly provided by V. Hagen.	Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; BLACKMORE PF, 1991, J BIOL CHEM, V266, P18655; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Harper CV, 2003, BIOCHEM J, V372, P407, DOI 10.1042/BJ20021560; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kilic F, 2009, J AM CHEM SOC, V131, P4027, DOI 10.1021/ja808334f; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; Parinaud J, 1996, J CLIN ENDOCR METAB, V81, P1357, DOI 10.1210/jc.81.4.1357; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schaefer M, 1998, P NATL ACAD SCI USA, V95, P3008, DOI 10.1073/pnas.95.6.3008; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Sun F, 2003, DEV BIOL, V255, P423, DOI 10.1016/S0012-1606(02)00090-8; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; THOMAS P, 1989, BIOCHEM J, V264, P539, DOI 10.1042/bj2640539; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	30	387	411	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					382	+		10.1038/nature09769	http://dx.doi.org/10.1038/nature09769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412338				2022-12-01	WOS:000288444000046
J	Dickinson, DJ; Nelson, WJ; Weis, WI				Dickinson, Daniel J.; Nelson, W. James; Weis, William I.			A Polarized Epithelium Organized by beta- and alpha-Catenin Predates Cadherin and Metazoan Origins	SCIENCE			English	Article							CELL POLARITY; COMPLEX; DICTYOSTELIUM; ADHESION; EVOLUTION; MEMBRANE; ANCESTRY; ACTIN; GENE	A fundamental characteristic of metazoans is the formation of a simple, polarized epithelium. In higher animals, the structural integrity and functional polarization of simple epithelia require a cell-cell adhesion complex that contains a classical cadherin, the Wnt-signaling protein beta-catenin and the actin-binding protein alpha-catenin. We show that the non-metazoan Dictyostelium discoideum forms a polarized epithelium that is essential for multicellular development. Although D. discoideum lacks a cadherin homolog, we identify an alpha-catenin ortholog that binds a beta-catenin-related protein. Both proteins are essential for formation of the epithelium, polarized protein secretion, and proper multicellular morphogenesis. Thus, the organizational principles of metazoan multicellularity may be more ancient than previously recognized, and the role of the catenins in cell polarity predates the evolution of Wnt signaling and classical cadherins.	[Dickinson, Daniel J.; Nelson, W. James; Weis, William I.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Nelson, W. James; Weis, William I.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Nelson, WJ (corresponding author), Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA.	wjnelson@stanford.edu; bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Dickinson, Daniel J./0000-0003-2651-2584	Stanford Graduate Fellowship; NSF; NIH [GM035527, GM56169]; U.S. Department of Energy; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM056169, R01GM035527] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank numerous colleagues for reagents (9); T. Soldati for sharing Sec15 antibodies before publication; C. Carswell-Crumpton, N. Ghori, J. Perrino, and T. Weiss for technical assistance; and D. Ehrhardt, N. King, D. N. Robinson, T. Soldati, J. A. Spudich, M. Tsujioka, H. Warrick, and members of the Nelson and Weis laboratories for discussions. This work was supported by a Stanford Graduate Fellowship and an NSF Graduate Research Fellowship (D. J. D.), NIH GM035527 (W. J. N.), and NIH GM56169 (W. I. W.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, supported by the U.S. Department of Energy and the National Institute of General Medical Sciences.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coates JC, 2002, MECH DEVELOP, V116, P117, DOI 10.1016/S0925-4773(02)00152-1; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; MCROBBIE SJ, 1988, DEV BIOL, V125, P59, DOI 10.1016/0012-1606(88)90058-9; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Urushihara H, 2008, DEV GROWTH DIFFER, V50, pS277, DOI 10.1111/j.1440-169X.2008.01013.x; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Williams HP, 2003, CURR OPIN MICROBIOL, V6, P621, DOI 10.1016/j.mib.2003.10.008; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893	22	97	98	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1336	1339		10.1126/science.1199633	http://dx.doi.org/10.1126/science.1199633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393547	Green Accepted			2022-12-01	WOS:000288215200050
J	Mullighan, CG; Zhang, JH; Kasper, LH; Lerach, S; Payne-Turner, D; Phillips, LA; Heatley, SL; Holmfeldt, L; Collins-Underwood, JR; Ma, J; Buetow, KH; Pui, CH; Baker, SD; Brindle, PK; Downing, JR				Mullighan, Charles G.; Zhang, Jinghui; Kasper, Lawryn H.; Lerach, Stephanie; Payne-Turner, Debbie; Phillips, Letha A.; Heatley, Sue L.; Holmfeldt, Linda; Collins-Underwood, J. Racquel; Ma, Jing; Buetow, Kenneth H.; Pui, Ching-Hon; Baker, Sharyn D.; Brindle, Paul K.; Downing, James R.			CREBBP mutations in relapsed acute lymphoblastic leukaemia	NATURE			English	Article							RUBINSTEIN-TAYBI SYNDROME; GENETIC ALTERATIONS; BINDING PROTEIN; GENOMIC ANALYSIS; P300; CBP; CANCER; REVEALS; CELLS; COACTIVATOR	Relapsed acute lymphoblastic leukaemia (ALL) is a leading cause of death due to disease in young people, but the biological determinants of treatment failure remain poorly understood. Recent genome-wide profiling of structural DNA alterations in ALL have identified multiple submicroscopic somatic mutations targeting key cellular pathways(1,2), and have demonstrated substantial evolution in genetic alterations from diagnosis to relapse(3). However, DNA sequence mutations in ALL have not been analysed in detail. To identify novel mutations in relapsed ALL, we resequenced 300 genes in matched diagnosis and relapse samples from 23 patients with ALL. This identified 52 somatic non-synonymous mutations in 32 genes, many of which were novel, including the transcriptional coactivators CREBBP and NCOR1, the transcription factors ERG, SPI1, TCF4 and TCF7L2, components of the Ras signalling pathway, histone genes, genes involved in histone modification (CREBBP and CTCF), and genes previously shown(1,2) to be targets of recurring DNA copy number alteration in ALL. Analysis of an extended cohort of 71 diagnosis-relapse cases and 270 acute leukaemia cases that did not relapse found that 18.3% of relapse cases had sequence or deletion mutations of CREBBP, which encodes the transcriptional coactivator and histone acetyltransferase CREB-binding protein (CREBBP, also known as CBP)(4). The mutations were either present at diagnosis or acquired at relapse, and resulted in truncated alleles or deleterious substitutions in conserved residues of the histone acetyltransferase domain. Functionally, the mutations impaired histone acetylation and transcriptional regulation of CREBBP targets, including glucocorticoid responsive genes. Several mutations acquired at relapse were detected in subclones at diagnosis, suggesting that the mutations may confer resistance to therapy. These results extend the landscape of genetic alterations in leukaemia, and identify mutations targeting transcriptional and epigenetic regulation as a mechanism of resistance in ALL.	[Mullighan, Charles G.; Payne-Turner, Debbie; Phillips, Letha A.; Heatley, Sue L.; Holmfeldt, Linda; Collins-Underwood, J. Racquel; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhang, Jinghui] St Jude Childrens Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Kasper, Lawryn H.; Lerach, Stephanie; Brindle, Paul K.] St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Buetow, Kenneth H.] NCI, Ctr Bioinformat, Rockville, MD 20892 USA; [Buetow, Kenneth H.] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; [Pui, Ching-Hon] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Baker, Sharyn D.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Mullighan, CG (corresponding author), St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Mullighan, Charles/H-3253-2011; Kasper, Lawryn/GWV-5700-2022; Zhang, Jing/GWZ-7332-2022; Heatley, Susan/AGP-2179-2022; Downing, James R./N-8102-2018; Pui, Ching-Hon/N-8076-2018	Mullighan, Charles/0000-0002-1871-1850; Pui, Ching-Hon/0000-0003-0303-5658; Heatley, Susan/0000-0001-7497-6477; Baker, Sharyn/0000-0003-3062-3252; Holmfeldt, Linda/0000-0003-4140-3423; Brindle, Paul/0000-0001-7172-8478	ALSAC of St Jude and Cancer Center [P30 CA021765, DE018183]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018183] Funding Source: NIH RePORTER	ALSAC of St Jude and Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank T. Jeevan, S. Orwick and A. Gibson for technical assistance, B. Schulman for assistance with structural modelling, and B. Woolf and J. Hartigan of Beckman Coulter Genomics for assistance with sequencing. We thank the Tissue Resources Facility of St Jude Children's Research Hospital for providing samples, and the following St Jude core facilities: Vector Development and Production, Flow Cytometry and Cell Sorting, Cell and Tissue Imaging, the Animal Resource Center, and the DNA sequencing and Macromolecular Synthesis laboratories of the Hartwell Center for Bioinformatics and Biotechnology. This study was supported by ALSAC of St Jude and Cancer Center support grant P30 CA021765, and grant number DE018183 (P.K.B.). C.G.M. is a Pew Scholar in the Biomedical Sciences.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Drexler HG., 2001, LEUKEMIA LYMPHOMA CE, P2, DOI [10.1016/B978-012221970-2/50002-4, DOI 10.1016/B978-012221970-2/50002-4]; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Goodman RH, 2000, GENE DEV, V14, P1553; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harrison CJ, 2009, BRIT J HAEMATOL, V144, P147, DOI 10.1111/j.1365-2141.2008.07417.x; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Kung AL, 2000, GENE DEV, V14, P272; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MANABE A, 1994, BLOOD, V83, P1731, DOI 10.1182/blood.V83.7.1731.bloodjournal8371731; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Schorry EK, 2008, AM J MED GENET A, V146A, P2512, DOI 10.1002/ajmg.a.32424; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shigeno K, 2004, CANCER LETT, V213, P11, DOI 10.1016/S0304-3835(03)00442-7; Tsapis M, 2007, INT J BIOCHEM CELL B, V39, P1500, DOI 10.1016/j.biocel.2007.03.009; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhang JH, 2002, NUCLEIC ACIDS RES, V30, P5213, DOI 10.1093/nar/gkf654; Zhang J, 2007, GENOME RES, V17, P1111, DOI 10.1101/gr.5963407	42	426	444	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					235	U127		10.1038/nature09727	http://dx.doi.org/10.1038/nature09727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390130	Green Accepted			2022-12-01	WOS:000288170200041
J	Osterholm, MT				Osterholm, Michael T.			Foodborne Disease in 2011-The Rest of the Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; ILLNESS; PATHOGENS		Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA.							Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI 10.3201/eid1701.091101p2; 2010, MMWR MORB MORTAL WKL, V59, P418	4	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					889	891		10.1056/NEJMp1010907	http://dx.doi.org/10.1056/NEJMp1010907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732FL	21345094				2022-12-01	WOS:000288170300001
J	Sandberg, MK; Al-Doujaily, H; Sharps, B; Clarke, AR; Collinge, J				Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John			Prion propagation and toxicity in vivo occur in two distinct mechanistic phases	NATURE			English	Article							MOUSE SCRAPIE; MICE; DISEASE; PROTEIN; PRP; REPLICATION; PATHOGENESIS; INFECTIVITY; RESISTANT; STRAINS	Mammalian prions cause fatal neurodegenerative conditions including Creutzfeldt-Jakob disease in humans and scrapie and bovine spongiform encephalopathy in animals(1). Prion infections are typically associated with remarkably prolonged but highly consistent incubation periods followed by a rapid clinical phase. The relationship between prion propagation, generation of neurotoxic species and clinical onset has remained obscure. Prion incubation periods in experimental animals are known to vary inversely with expression level of cellular prion protein. Here we demonstrate that prion propagation in brain proceeds via two distinct phases: a clinically silent exponential phase not rate-limited by prion protein concentration which rapidly reaches a maximal prion titre, followed by a distinct switch to a plateau phase. The latter determines time to clinical onset in a manner inversely proportional to prion protein concentration. These findings demonstrate an uncoupling of infectivity and toxicity. We suggest that prions themselves are not neurotoxic but catalyse the formation of such species from PrPC. Production of neurotoxic species is triggered when prion propagation saturates, leading to a switch from autocatalytic production of infectivity (phase 1) to a toxic (phase 2) pathway.	[Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John] UCL Inst Neurol, MRC Prion Unit, London WC1N 3BG, England; [Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL Inst Neurol, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk			UK Medical Research Council; MRC [MC_U123192748, MC_U123160656] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123160656] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council. We thank J. Wadsworth for critical review of the manuscript, S. Walker for statistical advice, staff of our Biological Services Facility for animal care and technical assistance and R. Young for preparation of figures.	Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; CZUB M, 1986, J GEN VIROL, V67, P2005, DOI 10.1099/0022-1317-67-9-2005; DICKINSON AG, 1975, GENETICS, V79, P387; DICKINSON AG, 1972, NATURE-NEW BIOL, V237, P244, DOI 10.1038/newbio237244a0; DICKINSON AG, 1969, J COMP PATHOL, V79, P15, DOI 10.1016/0021-9975(69)90021-8; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Thackray AM, 2003, J VIROL, V77, P7991, DOI 10.1128/JVI.77.14.7991-7998.2003; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002	30	220	221	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					540	542		10.1038/nature09768	http://dx.doi.org/10.1038/nature09768			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350487				2022-12-01	WOS:000287652900043
J	Zheng, W; McLerran, DF; Rolland, B; Zhang, XL; Inoue, M; Matsuo, K; He, JA; Gupta, PC; Ramadas, K; Tsugane, S; Irie, F; Tamakoshi, A; Gao, YT; Wang, RW; Shu, XO; Tsuji, I; Kuriyama, S; Tanaka, H; Satoh, H; Chen, CJ; Yuan, JM; Yoo, KY; Ahsan, H; Pan, WH; Gu, DF; Pednekar, MS; Sauvaget, C; Sasazuki, S; Sairenchi, T; Yang, G; Xiang, YB; Nagai, M; Suzuki, T; Nishino, Y; You, SL; Koh, WP; Park, SK; Chen, Y; Shen, CY; Thornquist, M; Feng, ZD; Kang, DH; Boffetta, P; Potter, JD				Zheng, Wei; McLerran, Dale F.; Rolland, Betsy; Zhang, Xianglan; Inoue, Manami; Matsuo, Keitaro; He, Jiang; Gupta, Prakash Chandra; Ramadas, Kunnambath; Tsugane, Shoichiro; Irie, Fujiko; Tamakoshi, Akiko; Gao, Yu-Tang; Wang, Renwei; Shu, Xiao-Ou; Tsuji, Ichiro; Kuriyama, Shinichi; Tanaka, Hideo; Satoh, Hiroshi; Chen, Chien-Jen; Yuan, Jian-Min; Yoo, Keun-Young; Ahsan, Habibul; Pan, Wen-Harn; Gu, Dongfeng; Pednekar, Mangesh Suryakant; Sauvaget, Catherine; Sasazuki, Shizuka; Sairenchi, Toshimi; Yang, Gong; Xiang, Yong-Bing; Nagai, Masato; Suzuki, Takeshi; Nishino, Yoshikazu; You, San-Lin; Koh, Woon-Puay; Park, Sue K.; Chen, Yu; Shen, Chen-Yang; Thornquist, Mark; Feng, Ziding; Kang, Daehee; Boffetta, Paolo; Potter, John D.			Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSPECTIVE COHORT; MORTALITY; OBESITY; OVERWEIGHT; WEIGHT; WOMEN; MEN	BACKGROUND Most studies that have evaluated the association between the body-mass index (BMI) and the risks of death from any cause and from specific causes have been conducted in populations of European origin. METHODS We performed pooled analyses to evaluate the association between BMI and the risk of death among more than 1.1 million persons recruited in 19 cohorts in Asia. The analyses included approximately 120,700 deaths that occurred during a mean follow-up period of 9.2 years. Cox regression models were used to adjust for confounding factors. RESULTS In the cohorts of East Asians, including Chinese, Japanese, and Koreans, the lowest risk of death was seen among persons with a BMI (the weight in kilograms divided by the square of the height in meters) in the range of 22.6 to 27.5. The risk was elevated among persons with BMI levels either higher or lower than that range - by a factor of up to 1.5 among those with a BMI of more than 35.0 and by a factor of 2.8 among those with a BMI of 15.0 or less. A similar U-shaped association was seen between BMI and the risks of death from cancer, from cardiovascular diseases, and from other causes. In the cohorts comprising Indians and Bangladeshis, the risks of death from any cause and from causes other than cancer or cardiovascular disease were increased among persons with a BMI of 20.0 or less, as compared with those with a BMI of 22.6 to 25.0, whereas there was no excess risk of either death from any cause or cause-specific death associated with a high BMI. CONCLUSIONS Underweight was associated with a substantially increased risk of death in all Asian populations. The excess risk of death associated with a high BMI, however, was seen among East Asians but not among Indians and Bangladeshis.	[Zheng, Wei; Zhang, Xianglan; Shu, Xiao-Ou; Yang, Gong] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Med, Div Epidemiol, Nashville, TN 37203 USA; [McLerran, Dale F.; Rolland, Betsy; Thornquist, Mark; Feng, Ziding; Potter, John D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Matsuo, Keitaro; Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Suzuki, Takeshi] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan; [Irie, Fujiko] Ibaraki Prefectural Govt, Dept Hlth & Social Serv, Ibaraki, Japan; [Tamakoshi, Akiko] Aichi Med Univ, Sch Med, Dept Publ Hlth, Aichi, Japan; [Tsuji, Ichiro; Kuriyama, Shinichi; Nagai, Masato] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Nishino, Yoshikazu] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Ishinomaki, Miyagi, Japan; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Gupta, Prakash Chandra; Pednekar, Mangesh Suryakant] Healis Sekhsaria Inst Publ Hlth, Bombay, Maharashtra, India; [Ramadas, Kunnambath] Reg Canc Ctr, Div Radiat Oncol, Trivandrum 695011, Kerala, India; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Wang, Renwei; Yuan, Jian-Min] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Chen, Chien-Jen; You, San-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei 115, Taiwan; [Chen, Chien-Jen; Pan, Wen-Harn] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan; [Pan, Wen-Harn] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Shen, Chen-Yang] China Med Univ, Grad Inst Environm Sci, Taichung, Taiwan; [Yoo, Keun-Young; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Inst Hlth Policy & Management, Seoul, South Korea; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies Med & Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gu, Dongfeng] China Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Sauvaget, Catherine] Int Agcy Res Canc, Prevent & Early Detect Sect, Screening Grp, F-69372 Lyon, France; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Chen, Yu] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA	Vanderbilt University; Fred Hutchinson Cancer Center; National Cancer Center - Japan; Aichi Cancer Center; Nagoya City University; Aichi Medical University; Tohoku University; Dokkyo Medical University; Miyagi Cancer Center; Tulane University; Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; China Medical University Taiwan; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Chicago; University of Chicago; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; World Health Organization; International Agency for Research on Cancer (IARC); National University of Singapore; New York University; Icahn School of Medicine at Mount Sinai	Zheng, W (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, 2525 W End Ave,8th Fl, Nashville, TN 37203 USA.	wei.zheng@vanderbilt.edu	Park, Sue Kyung/J-2757-2012; Zheng, Wei/O-3351-2013; He, Jiang/AAF-5303-2020; Gao, Y./GWZ-3665-2022; Tsugane, Shoichiro/A-2424-2015; Kang, Dae Hee/E-8631-2012; gao, yi/HCI-8298-2022; Yoo, Keun-Young/J-5548-2012; Nagai, Masato/ABC-6862-2020; Tanaka, Hideo/A-8145-2016; Matsuo, Keitaro/H-6758-2019; Chen, Chien-Jen/C-6976-2008; Boffetta, Paolo/AAI-7767-2021; Shen, CY/F-6271-2010; Tamakoshi, Akiko/D-5105-2012; Chen, Chien-Jen/N-4723-2019; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; He, Jiang/0000-0002-8286-9652; Tsugane, Shoichiro/0000-0003-4105-2774; Nagai, Masato/0000-0003-0818-3158; Matsuo, Keitaro/0000-0003-1761-6314; Boffetta, Paolo/0000-0002-3811-2791; Chen, Yu/0000-0002-1519-4894; Pednekar, Mangesh/0000-0001-6266-5356; Sairenchi, Toshimi/0000-0001-8896-6501; Kang, Daehee/0000-0003-4031-5878; Sauvaget, Catherine/0000-0002-8053-4963; Potter, John/0000-0001-5439-1500; Yuan, Jian-Min/0000-0002-4620-3108	CDC Foundation for Global Adult Tobacco Survey; World Lung Foundation for advancing tobacco control in India; Institute for Community Research; NATIONAL CANCER INSTITUTE [R01CA082729, R37CA070867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017541] Funding Source: NIH RePORTER	CDC Foundation for Global Adult Tobacco Survey; World Lung Foundation for advancing tobacco control in India; Institute for Community Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Dr. Gupta reports receiving consulting fees from the CDC Foundation for Global Adult Tobacco Survey. His institution, Healis-Sekhsaria Institute for Public Health, has received grants from the World Lung Foundation for advancing tobacco control in India and consulting fees from the Institute for Community Research for a project on the use of smokeless tobacco in an urban slum in Mumbai, India. No other potential conflict of interest relevant to this article was reported.	Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Lopez-Jimenez F, 2009, LANCET, V373, P1055, DOI 10.1016/S0140-6736(09)60628-0; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Zhang X, 2008, INT J OBESITY, V32, P1130, DOI 10.1038/ijo.2008.63; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	21	581	616	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					719	729		10.1056/NEJMoa1010679	http://dx.doi.org/10.1056/NEJMoa1010679			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345101	Green Accepted, Green Submitted			2022-12-01	WOS:000287652500006
J	Jasanoff, S				Jasanoff, Sheila			A Living Constitution	SCIENCE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Jasanoff, S (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.								0	2	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					872	872		10.1126/science.1203467	http://dx.doi.org/10.1126/science.1203467			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330528				2022-12-01	WOS:000287455100039
J	Tang, YC; Williams, BR; Siegel, JJ; Amon, A				Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika			Identification of Aneuploidy-Selective Antiproliferation Compounds	CELL			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; AUTOPHAGY; HSP90; PROLIFERATION; TUMORIGENESIS; INSTABILITY; METABOLISM; PHENOTYPES; INHIBITORS	Aneuploidy, an incorrect chromosome number, is a hallmark of cancer. Compounds that cause lethality in aneuploid, but not euploid, cells could therefore provide new cancer therapies. We have identified the energy stress-inducing agent AICAR, the protein folding inhibitor 17-AAG, and the autophagy inhibitor chloroquine as exhibiting this property. AICAR induces p53-mediated apoptosis in primary mouse embryonic fibroblasts (MEFs) trisomic for chromosome 1, 13, 16, or 19. AICAR and 17-AAG, especially when combined, also show efficacy against aneuploid human cancer cell lines. Our results suggest that compounds that interfere with pathways that are essential for the survival of aneuploid cells could serve as a new treatment strategy against a broad spectrum of human tumors.	[Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Tang, Yun-Chi/GRE-8205-2022	Amon, Angelika/0000-0001-9837-0314; tang, yun qi/0000-0001-9385-2787	Howard Hughes Medical Institute; Curt W. and Kathy Marble Cancer Research Fund; Human Frontier Science Program Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Curt W. and Kathy Marble Cancer Research Fund; Human Frontier Science Program Fellowship(Human Frontier Science Program)	We thank H.-C. Chang and M. vander Heiden for discussions; M. Hemann for the LMS vectors and shp53.1224; D. Sabatini for torin1; J.M. van Deursen for Bub1b<SUP>H/H</SUP> mice; P. Zhang for Cdc20<SUP>AAA</SUP> MEF cells; and E. Vazile in the Koch Institute Microscopy facility for assistance. We are grateful to M. Dunham, M. Hemann, J. Lees, D. Sabatini, F. Solomon, and members of the Amon lab for their critical reading of the manuscript. This work was supported by grants from the Howard Hughes Medical Institute and the Curt W. and Kathy Marble Cancer Research Fund. Y.-C.T. is supported by the Human Frontier Science Program Fellowship.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.tb20498.x; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Georgakis GV, 2006, EXP HEMATOL, V34, P1670, DOI 10.1016/j.exphem.2006.07.002; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Larson PS, 2006, J PATHOL, V209, P307, DOI 10.1002/path.1973; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Li M, 2009, J CELL BIOL, V185, P983, DOI 10.1083/jcb.200904020; Lin HY, 2006, AM J MED GENET A, V140A, P945, DOI 10.1002/ajmg.a.31173; LINDSLEY DL, 1972, GENETICS, V71, P157; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; MOERMAN P, 1988, HUM GENET, V80, P349, DOI 10.1007/BF00273650; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Shih IM, 2001, CANCER RES, V61, P818; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	44	244	248	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					499	512		10.1016/j.cell.2011.01.017	http://dx.doi.org/10.1016/j.cell.2011.01.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21315436	Green Submitted, Bronze, Green Accepted			2022-12-01	WOS:000287473100006
J	Philippe, H; Brinkmann, H; Copley, RR; Moroz, LL; Nakano, H; Poustka, AJ; Wallberg, A; Peterson, KJ; Telford, MJ				Philippe, Herve; Brinkmann, Henner; Copley, Richard R.; Moroz, Leonid L.; Nakano, Hiroaki; Poustka, Albert J.; Wallberg, Andreas; Peterson, Kevin J.; Telford, Maximilian J.			Acoelomorph flatworms are deuterostomes related to Xenoturbella	NATURE			English	Article							PHYLOGENETIC DISTRIBUTION; BASAL POSITION; SEQUENCES; PHYLUM; NEMERTODERMATIDA; MICRORNAS; EVOLUTION; ALIGNMENT; SUPPORTS; PACKAGE	Xenoturbellida and Acoelomorpha are marine worms with contentious ancestry. Both were originally associated with the flatworms (Platyhelminthes), but molecular data have revised their phylogenetic positions, generally linking Xenoturbellida to the deuterostomes(1,2) and positioning the Acoelomorpha as the most basally branching bilaterian group(s)(3-6). Recent phylogenomic data suggested that Xenoturbellida and Acoelomorpha are sister taxa and together constitute an early branch of Bilateria(7). Here we assemble three independent data sets-mitochondrial genes, a phylogenomic data set of 38,330 amino-acid positions and new microRNA (miRNA) complements-and show that the position of Acoelomorpha is strongly affected by a long-branch attraction (LBA) artefact. When we minimize LBA we find consistent support for a position of both acoelomorphs and Xenoturbella within the deuterostomes. The most likely phylogeny links Xenoturbella and Acoelomorpha in a clade we call Xenacoelomorpha. The Xenacoelomorpha is the sister group of the Ambulacraria (hemichordates and echinoderms). We show that analyses of miRNA complements(8) have been affected by character loss in the acoels and that both groups possess one miRNA and the gene Rsb66 otherwise specific to deuterostomes. In addition, Xenoturbella shares one miRNA with the ambulacrarians, and two with the acoels. This phylogeny makes sense of the shared characteristics of Xenoturbellida and Acoelomorpha, such as ciliary ultrastructure and diffuse nervous system, and implies the loss of various deuterostome characters in the Xenacoelomorpha including coelomic cavities, through gut and gill slits.	[Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Philippe, Herve; Brinkmann, Henner] Univ Montreal, Dept Biochim, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada; [Copley, Richard R.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, St Augustine, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, Gainesville, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, Gainesville, FL 32080 USA; [Nakano, Hiroaki] Univ Gothenburg, Dept Marine Ecol Kristineberg, S-45034 Fiskebackskil, Sweden; [Poustka, Albert J.] Max Planck Inst Mol Genet, Evolut & Dev Grp, D-14195 Berlin, Germany; [Wallberg, Andreas] Uppsala Univ, Dept Systemat Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Peterson, Kevin J.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA	University of London; University College London; Universite de Montreal; University of Oxford; Wellcome Centre for Human Genetics; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Gothenburg; Max Planck Society; Uppsala University; Dartmouth College	Telford, MJ (corresponding author), UCL, Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London WC1E 6BT, England.	m.telford@ucl.ac.uk	Telford, Maximilian J/B-7178-2008	Telford, Maximilian J/0000-0002-3749-5620; Moroz, Leonid/0000-0002-1333-3176; Wallberg, Andreas/0000-0002-9081-9663	Canada Research Chairs; Natural Sciences and Engineering Research Council; Reseau Quebecois de Calcul de Haute Performance; Biotechnology and Biological Sciences Research Council; National Science Foundation; NASA Ames; Wellcome Trust [075491/Z/04]; Max-Planck Society for the Advancement of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030118] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [0821622] Funding Source: National Science Foundation	Canada Research Chairs(Canada Research ChairsCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Reseau Quebecois de Calcul de Haute Performance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); NASA Ames(National Aeronautics & Space Administration (NASA)); Wellcome Trust(Wellcome TrustEuropean Commission); Max-Planck Society for the Advancement of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank N. Lartillot for reading the manuscript, W. Sterrer for helping collect material, and E. Sperling for help with small RNA library construction. H. P. is funded by Canada Research Chairs, Natural Sciences and Engineering Research Council and Reseau Quebecois de Calcul de Haute Performance for computational resources: more than 220,000 central processing unit (CPU)-hours were used producing at least 7 tonnes of CO<INF>2</INF> excluding grey energy. R. R. C. and M.J.T. were part-funded by the Biotechnology and Biological Sciences Research Council SYNTAX scheme. K.J.P. is supported by the National Science Foundation and NASA Ames. R. R. C. was also supported by a Wellcome Trust core award, grant number 075491/Z/04. A.J.P. was supported by the Max-Planck Society for the Advancement of Sciences e. V. A. W. was funded by Inez Johanssons Stiftelse and Stiftelsen Lars Hiertas Minne.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Baguna J, 2008, PHILOS T R SOC B, V363, P1481, DOI 10.1098/rstb.2007.2238; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bourlat SJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-107; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Egger B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005502; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FRANZEN A, 1987, ZOOL SCR, V16, P9, DOI 10.1111/j.1463-6409.1987.tb00046.x; Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2008, PHILOS T R SOC B, V363, P1463, DOI 10.1098/rstb.2007.2236; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lundin K, 2001, BELG J ZOOL, V131, P153; Nielsen C, 2010, EVOL DEV, V12, P241, DOI 10.1111/j.1525-142X.2010.00408.x; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; PARDOS F, 1988, ACTA ZOOL-STOCKHOLM, V69, P1, DOI 10.1111/j.1463-6395.1988.tb00895.x; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Roure B., BMC EVOL BI IN PRESS; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sempere LF, 2007, EVOL DEV, V9, P409, DOI 10.1111/j.1525-142X.2007.00180.x; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sperling EA, 2008, ANIMAL EVOLUTION: GENOMES, FOSSILS, AND TREES, P157; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Telford MJ, 2008, GENESIS, V46, P580, DOI 10.1002/dvg.20414; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Tyler S, 2001, INTERRELATIONSHIPS P, P3; Westblad E., 1949, ARK ZOOL, V1, P3; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x	47	301	320	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					255	+		10.1038/nature09676	http://dx.doi.org/10.1038/nature09676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307940	Green Accepted			2022-12-01	WOS:000287144200043
J	Croucher, NJ; Harris, SR; Fraser, C; Quail, MA; Burton, J; van der Linden, M; Mcgee, L; von Gottberg, A; Song, JH; Ko, KS; Pichon, B; Baker, S; Parry, CM; Lambertsen, LM; Shahinas, D; Pillai, DR; Mitchell, TJ; Dougan, G; Tomasz, A; Klugman, KP; Parkhill, J; Hanage, WP; Bentley, SD				Croucher, Nicholas J.; Harris, Simon R.; Fraser, Christophe; Quail, Michael A.; Burton, John; van der Linden, Mark; McGee, Lesley; von Gottberg, Anne; Song, Jae Hoon; Ko, Kwan Soo; Pichon, Bruno; Baker, Stephen; Parry, Christopher M.; Lambertsen, Lotte M.; Shahinas, Dea; Pillai, Dylan R.; Mitchell, Timothy J.; Dougan, Gordon; Tomasz, Alexander; Klugman, Keith P.; Parkhill, Julian; Hanage, William P.; Bentley, Stephen D.			Rapid Pneumococcal Evolution in Response to Clinical Interventions	SCIENCE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; INTERCONTINENTAL SPREAD; UNITED-STATES; SEROTYPE 19A; 23F CLONE; EMERGENCE; DISEASE; TRANSFORMATION; SEQUENCE	Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus pneumoniae have previously been confounded by high rates of recombination. Sequencing 240 isolates of the PMEN1 (Spain(23F)-1) multidrug-resistant lineage enabled base substitutions to be distinguished from polymorphisms arising through horizontal sequence transfer. More than 700 recombinations were detected, with genes encoding major antigens frequently affected. Among these were 10 capsule-switching events, one of which accompanied a population shift as vaccine-escape serotype 19A isolates emerged in the USA after the introduction of the conjugate polysaccharide vaccine. The evolution of resistance to fluoroquinolones, rifampicin, and macrolides was observed to occur on multiple occasions. This study details how genomic plasticity within lineages of recombinogenic bacteria can permit adaptation to clinical interventions over remarkably short time scales.	[Croucher, Nicholas J.; Harris, Simon R.; Quail, Michael A.; Burton, John; Dougan, Gordon; Parkhill, Julian; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fraser, Christophe; Hanage, William P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [van der Linden, Mark] Rhein Westfal TH Aachen, Univ Hosp, Inst Med Microbiol, Natl Reference Ctr Streptococci, D-52074 Aachen, Germany; [McGee, Lesley; Klugman, Keith P.] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; [von Gottberg, Anne; Klugman, Keith P.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Resp & Meningeal Pathogens Res Unit, ZA-2000 Johannesburg, South Africa; [von Gottberg, Anne; Klugman, Keith P.] Univ Witwatersrand, ZA-2000 Johannesburg, South Africa; [Song, Jae Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Song, Jae Hoon] Asia Pacific Fdn Infect Dis, Seoul, South Korea; [Ko, Kwan Soo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Pichon, Bruno] Hlth Protect Agcy Ctr Infect, Resp & Syst Infect Lab, London NW9 5HT, England; [Baker, Stephen; Parry, Christopher M.] Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Lambertsen, Lotte M.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen S, Denmark; [Shahinas, Dea; Pillai, Dylan R.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1V2, Canada; [Shahinas, Dea; Pillai, Dylan R.] Ontario Agcy Hlth Protect & Promot, Toronto, ON M5G 1V2, Canada; [Mitchell, Timothy J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Hanage, William P.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; Imperial College London; RWTH Aachen University; RWTH Aachen University Hospital; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Health Protection Agency; Statens Serum Institut; University of Toronto; University of Glasgow; Rockefeller University; Emory University; Rollins School Public Health; Emory University; Harvard University; Harvard T.H. Chan School of Public Health	Bentley, SD (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	sdb@sanger.ac.uk	Tomasz, Alexander/B-9939-2011; Fraser, Christophe/A-8109-2008; Hanage, Bill/CAF-1813-2022; Harris, Simon R/K-1318-2013; Song, Jae Hoon/C-9602-2011; Parkhill, Julian/G-4703-2011; van der Linden, Mark/B-9305-2009; Quail, michael/ABE-6131-2020	Fraser, Christophe/0000-0003-2399-9657; Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; van der Linden, Mark/0000-0002-6574-4313; Tomasz, Alexander/0000-0003-1520-1983; von Gottberg, Anne/0000-0002-0243-7455; Mitchell, Timothy/0000-0002-8309-5556; Ko, Kwan Soo/0000-0002-0978-1937; Croucher, Nicholas/0000-0001-6303-8768; Lambertsen, Lotte/0000-0001-6409-6337; Baker, Stephen/0000-0003-1308-5755	Wellcome Trust; MRC [G0800596] Funding Source: UKRI; Medical Research Council [G0800596, G0600719B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the participating surveillance networks, listed in table S1, and the core informatics, library-making, and sequencing teams at the Wellcome Trust Sanger Institute. Attending authors were grateful for the opportunity to discuss this project at the Permafrost conference. Sequence accession codes are given in tables S1 and S2. This work was funded by the Wellcome Trust.	Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BUUHOI A, 1980, J BACTERIOL, V143, P313; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; Corso A, 1998, MICROB DRUG RESIST, V4, P325, DOI 10.1089/mdr.1998.4.325; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Del Grosso M, 2007, ANTIMICROB AGENTS CH, V51, P4184, DOI 10.1128/AAC.00598-07; Del Grosso M, 2006, ANTIMICROB AGENTS CH, V50, P3361, DOI 10.1128/AAC.00277-06; Feil EJ, 2000, GENETICS, V154, P1439; Ferrandiz MJ, 2005, ANTIMICROB AGENTS CH, V49, P2237, DOI 10.1128/AAC.49.6.2237-2245.2005; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; KLUGMAN KP, 1994, EUR J CLIN MICROBIOL, V13, P171, DOI 10.1007/BF01982193; McCool TL, 2003, INFECT IMMUN, V71, P5724, DOI 10.1128/IAI.71.10.5724-5732.2003; McGee L, 1997, MICROB DRUG RESIST, V3, P253, DOI 10.1089/mdr.1997.3.253; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Parry CM, 2002, ANTIMICROB AGENTS CH, V46, P3512, DOI 10.1128/AAC.46.11.3512-3517.2002; Pestova EV, 1998, J BACTERIOL, V180, P2701, DOI 10.1128/JB.180.10.2701-2710.1998; Pletz MWR, 2006, EMERG INFECT DIS, V12, P1462, DOI 10.3201/eid1209.051400; Romero P, 2007, PLASMID, V58, P51, DOI 10.1016/j.plasmid.2006.12.006; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; SHAW JH, 1985, J BACTERIOL, V164, P782, DOI 10.1128/JB.164.2.782-796.1985; Tarasi A, 1997, MICROB DRUG RESIST, V3, P105, DOI 10.1089/mdr.1997.3.105; Trzcinski K, 2004, J BACTERIOL, V186, P3447, DOI 10.1128/JB.186.11.3447-3452.2004	31	641	659	0	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					430	434		10.1126/science.1198545	http://dx.doi.org/10.1126/science.1198545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273480	Green Accepted			2022-12-01	WOS:000286635900044
J	Rosebeck, S; Madden, L; Jin, XH; Gu, SF; Apel, IJ; Appert, A; Hamoudi, RA; Noels, H; Sagaert, X; Van Loo, P; Baens, M; Du, MQ; Lucas, PC; McAllister-Lucas, LM				Rosebeck, Shaun; Madden, Lisa; Jin, Xiaohong; Gu, Shufang; Apel, Ingrid J.; Appert, Alex; Hamoudi, Rifat A.; Noels, Heidi; Sagaert, Xavier; Van Loo, Peter; Baens, Mathijs; Du, Ming-Qing; Lucas, Peter C.; McAllister-Lucas, Linda M.			Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-kappa B Activation	SCIENCE			English	Article							T-CELL-ACTIVATION; MALT LYMPHOMA; MARGINAL ZONE; CHROMOSOMAL TRANSLOCATION; UBIQUITIN LIGASE; BINDING-SITE; KINASE; PATHWAYS; TNF; TRAF2	Proper regulation of nuclear factor kappa B (NF-kappa B) transcriptional activity is required for normal lymphocyte function, and deregulated NF-kappa B signaling can facilitate lymphomagenesis. We demonstrate that the API2-MALT1 fusion oncoprotein created by the recurrent t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma induces proteolytic cleavage of NF-kappa B-inducing kinase (NIK) at arginine 325. NIK cleavage requires the concerted actions of both fusion partners and generates a C-terminal NIK fragment that retains kinase activity and is resistant to proteasomal degradation. The resulting deregulated NIK activity is associated with constitutive noncanonical NF-kappa B signaling, enhanced B cell adhesion, and apoptosis resistance. Our study reveals the gain-of-function proteolytic activity of a fusion oncoprotein and highlights the importance of the noncanonical NF-kappa B pathway in B lymphoproliferative disease.	[Jin, Xiaohong; Apel, Ingrid J.; Lucas, Peter C.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Rosebeck, Shaun; Madden, Lisa; Gu, Shufang; McAllister-Lucas, Linda M.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Appert, Alex; Hamoudi, Rifat A.; Du, Ming-Qing] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Mol Histopathol, Cambridge CB2 0QQ, England; [Noels, Heidi; Van Loo, Peter; Baens, Mathijs] Catholic Univ Louvain, Ctr Human Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Noels, Heidi; Van Loo, Peter; Baens, Mathijs] Flanders Inst Biotechnol VIB, Dept Mol & Dev Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Sagaert, Xavier] Catholic Univ Louvain, Dept Pathol, Sect Morphol & Mol Pathol, B-3000 Louvain, Belgium	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain	Lucas, PC (corresponding author), Univ Michigan, Dept Pathol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	plucas@umich.edu; lindaluc@umich.edu	Van Loo, Peter/A-3287-2012; Noels, Heidi/AAQ-2622-2020	Van Loo, Peter/0000-0003-0292-1949; Lucas, Peter/0000-0003-4880-7172; Du, Ming-Qing/0000-0002-1017-5045; Hamoudi, Rifat/0000-0002-1402-0868	Nancy Newton Loeb Pediatric Cancer Research; Helen L. Kay Pediatric Cancer Research Award; National Institute of Child Health and Human Development, NIH [T32-HD07513]; National Heart, Lung, and Blood Institute, NIH [T32-HL007622-21A2]; Research Foundation-Flanders (FWO); Belgian Foundation against Cancer; Shirley K. Schlafer Foundation; Elizabeth Caroline Crosby Fund; University of Michigan Comprehensive Cancer Center [G007839]; Leukemia and Lymphoma Research UK; National Cancer Institute NIH [R01CA124540]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007513] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA124540] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082914, T32HL007622] Funding Source: NIH RePORTER	Nancy Newton Loeb Pediatric Cancer Research; Helen L. Kay Pediatric Cancer Research Award; National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Research Foundation-Flanders (FWO)(FWO); Belgian Foundation against Cancer; Shirley K. Schlafer Foundation; Elizabeth Caroline Crosby Fund; University of Michigan Comprehensive Cancer Center; Leukemia and Lymphoma Research UK(Leukemia and Lymphoma Society); National Cancer Institute NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Dyer for the SSK41 cells, R. Renne for the BJAB Tet-On cells, and G. Nunez for several expression plasmids. A Material Transfer Agreement is required for use of the SSK41 cells expressing API2-MALT1. Microarray data from MALT lymphoma tumor collections are Minimum Information About a Microarray Experiment (MIAME) compliant and are available online at the Gene Expression Omnibus (GEO) with accession number GSE25527 for collection no. 1 and accession number GSE25550 for collection no. 2 (www.ncbi.nlm.nih.gov/projects/geo/). L. M. is a recipient of the Nancy Newton Loeb Pediatric Cancer Research and Helen L. Kay Pediatric Cancer Research Awards and received support from National Institute of Child Health and Human Development, NIH, T32-HD07513. L.M. and S.R. were both supported by National Heart, Lung, and Blood Institute, NIH, T32-HL007622-21A2. M.B. is supported by grants from the Research Foundation-Flanders (FWO) and Belgian Foundation against Cancer. H.N. was an aspirant of the FWO-Vlaanderen. X.S. is a Senior Clinical Investigator of FWO-Vlaanderen, and P.V.L. is a postdoctoral researcher of the FWO. This work was supported by the Shirley K. Schlafer Foundation, the Elizabeth Caroline Crosby Fund, and grants from the University of Michigan Comprehensive Cancer Center (G007839), Leukemia and Lymphoma Research UK, and National Cancer Institute NIH (R01CA124540).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Guo F, 2007, BLOOD, V110, P2381, DOI 10.1182/blood-2007-02-075143; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McAllister-Lucas LM, 2008, NAT IMMUNOL, V9, P231, DOI 10.1038/ni0308-231; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012	32	110	126	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					468	472		10.1126/science.1198946	http://dx.doi.org/10.1126/science.1198946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273489	Green Accepted			2022-12-01	WOS:000286635900055
J	Tarakji, KG; Sabik, JF; Bhudia, SK; Batizy, LH; Blackstone, EH				Tarakji, Khaldoun G.; Sabik, Joseph F., III; Bhudia, Sunil K.; Batizy, Lillian H.; Blackstone, Eugene H.			Temporal Onset, Risk Factors, and Outcomes Associated With Stroke After Coronary Artery Bypass Grafting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OFF-PUMP; CARDIAC-SURGERY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; AXILLARY ARTERY; ON-PUMP; PREDICTORS; MORBIDITY; CANNULATION; SURVIVAL; TERM	Context Stroke is a devastating and potentially preventable complication of coronary artery bypass graft (CABG) surgery. Better understanding of the timing and risk factors for stroke associated with CABG are needed. Objectives To investigate temporal trends in stroke after CABG and to identify stroke risk factors and association with longitudinal outcomes. Design, Setting, and Patients Prospective study conducted from 1982 through 2009 at a single US academic medical center among 45 432 consecutive patients (mean age, 63 [SD, 10] years) undergoing isolated primary or reoperative CABG surgery. Strokes occurring following CABG were recorded prospectively and classified as having occurred intraoperatively or postoperatively. Complications and survival after stroke were assessed in propensity-matched groups. Intervention CABG performed using 4 different operative strategies (off-pump, on-pump with beating heart, on-pump with arrested heart, on-pump with hypothermic circulatory arrest). Main Outcome Measures Hospital complications; late survival. Results Among 45 432 patients undergoing CABG surgery, 705 (1.6% [95% confidence interval {CI}, 1.4%-1.7%]) experienced a stroke. The prevalence of stroke peaked in 1988 at 2.6% (95% CI, 1.9%-3.4%), then declined at 4.69% (95% CI, 4.68%-4.70%) per year (P=.04), despite increasing patient comorbidity. Overall, 279 strokes (40%) occurred intraoperatively and 409 (58%) occurred postoperatively (timing indeterminate in 17 patients). Postoperative stroke peaked at 40 hours, decreasing to 0.055%/d (95% CI, 0.047%-0.065%) by day 6. Risk factors for both intraoperative and postoperative stroke included older age (odds ratio, 8.5 [95% CI, 3.2-22]) and variables representing arteriosclerotic burden. Intraoperative stroke rates were lowest in off-pump CABG (0.14% [95% CI, 0.029%-0.40%]) and on-pump beating-heart CABG (0% [95% CI, 0%-1.6%]), intermediate with on-pump arrested-heart CABG (0.50% [95% CI, 0.41%-0.61%]), and highest with on-pump CABG with hypothermic circulatory arrest (5.3% [95% CI, 2.0%-11%]). Patients with stroke had worse adjusted hospital outcomes, longer intensive care and postoperative stays, and worse downstream survival (mean, 11 [SD, 8.6] years). Conclusion Among patients undergoing CABG surgery at a single center over the past 30 years, the occurrence of stroke declined despite an increasing patient risk profile, and more than half of strokes occurred postoperatively rather than intraoperatively. JAMA. 2011;305(4):381-390 www.jama.com	[Sabik, Joseph F., III; Bhudia, Sunil K.; Blackstone, Eugene H.] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; [Tarakji, Khaldoun G.] Cleveland Clin, Dept Cardiovasc Med, Inst Heart & Vasc, Cleveland, OH 44195 USA; [Batizy, Lillian H.; Blackstone, Eugene H.] Cleveland Clin, Dept Quantitat Hlth Sci, Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sabik, JF (corresponding author), Cleveland Clin, Dept Thorac & Cardiovasc Surg, 9500 Euclid Ave,Desk J4-1, Cleveland, OH 44195 USA.	sabikj@ccf.org	Bhudia, Sunil/AAF-8325-2020; Bhudia, Sunil K/A-3150-2011	Bhudia, Sunil K/0000-0002-6660-3141	Cleveland Clinic Department of Thoracic and Cardiovascular Surgery	Cleveland Clinic Department of Thoracic and Cardiovascular Surgery	This study was funded in part by the Cleveland Clinic Department of Thoracic and Cardiovascular Surgery and the Kenneth Gee and Paula Shaw, PhD, Chair in Heart Research, held by Dr Blackstone.	BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; BLAUTH CI, 1992, J THORAC CARDIOV SUR, V103, P1104; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brown PP, 2008, ANN THORAC SURG, V85, P1980, DOI 10.1016/j.athoracsur.2008.01.053; Charlson ME, 2007, J CARDIAC SURG, V22, P465, DOI 10.1111/j.1540-8191.2007.00471.x; DavilaRoman VG, 1996, J AM COLL CARDIOL, V28, P942, DOI 10.1016/S0735-1097(96)00263-X; Filsoufi F, 2008, ANN THORAC SURG, V85, P862, DOI 10.1016/j.athoracsur.2007.10.060; Fuchs S, 2002, CIRCULATION, V106, P86, DOI 10.1161/01.CIR.0000020678.16325.E0; GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6; Hamon M, 2008, CIRCULATION, V118, P678, DOI 10.1161/CIRCULATIONAHA.108.784504; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Koch CG, 2006, ANN THORAC SURG, V82, P1747, DOI 10.1016/j.athoracsur.2006.05.045; Lim E, 2006, J THORAC CARDIOV SUR, V132, P1409, DOI 10.1016/j.jtcvs.2006.08.012; MOODY DM, 1990, ANN NEUROL, V28, P477, DOI 10.1002/ana.410280403; Myers WO, 1999, J AM COLL CARDIOL, V33, P488, DOI 10.1016/S0735-1097(98)00563-4; Newman MF, 1996, CIRCULATION, V94, P74; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishiyama K, 2009, ANN THORAC SURG, V87, P1839, DOI 10.1016/j.athoracsur.2009.02.061; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Peel GK, 2004, J AM COLL CARDIOL, V43, P752, DOI 10.1016/j.jacc.2003.09.047; Puskas JD, 2008, ANN THORAC SURG, V86, P1139, DOI 10.1016/j.athoracsur.2008.05.073; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rosenberger P, 2008, ANN THORAC SURG, V85, P548, DOI 10.1016/j.athoracsur.2007.08.061; Sabik JF, 2004, ANN THORAC SURG, V77, P1315, DOI 10.1016/j.athoracsur.2003.08.056; Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.121975; SABIK JF, 1995, J THORAC CARDIOV SUR, V109, P885, DOI 10.1016/S0022-5223(95)70312-8; Salazar JD, 2001, ANN THORAC SURG, V72, P1195, DOI 10.1016/S0003-4975(01)02929-0; Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Society of Thoracic Surgeons National Adult Cardiac Database, SOC THOR SURG NAT AD; Stamou SC, 2001, STROKE, V32, P1508, DOI 10.1161/01.STR.32.7.1508; Svensson LG, 2004, ANN THORAC SURG, V78, P1274, DOI 10.1016/j.athoracsur.2004.04.063; Wilson MJ, 2000, ANN THORAC SURG, V70, P25, DOI 10.1016/S0003-4975(00)01256-X	34	213	225	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					381	390		10.1001/jama.2011.37	http://dx.doi.org/10.1001/jama.2011.37			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266685				2022-12-01	WOS:000286595200023
J	Capewell, S; O'Flaherty, M				Capewell, Simon; O'Flaherty, Martin			Rapid mortality falls after risk-factor changes in populations	LANCET			English	Editorial Material							HEART-DISEASE		[Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Capewell, S (corresponding author), Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England.	capewell@liverpool.ac.uk		O'Flaherty, Martin/0000-0001-8944-4131				Capewell S, 2011, EUR HEART J, V32, P1187, DOI 10.1093/eurheartj/ehr049; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; STROM A, 1951, LANCET, V260, P126, DOI 10.1016/S0140-6736(51)91210-X; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; *WHO, EUR HLTH ALL DAT HFA; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	11	108	112	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					752	753		10.1016/S0140-6736(10)62302-1	http://dx.doi.org/10.1016/S0140-6736(10)62302-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21414659				2022-12-01	WOS:000294585300010
J	Coles, CH; Shen, YJ; Tenney, AP; Siebold, C; Sutton, GC; Lu, WX; Gallagher, JT; Jones, EY; Flanagan, JG; Aricescu, AR				Coles, Charlotte H.; Shen, Yingjie; Tenney, Alan P.; Siebold, Christian; Sutton, Geoffrey C.; Lu, Weixian; Gallagher, John T.; Jones, E. Yvonne; Flanagan, John G.; Aricescu, A. Radu			Proteoglycan-Specific Molecular Switch for RPTP sigma Clustering and Neuronal Extension	SCIENCE			English	Article							TYROSINE-PHOSPHATASE-SIGMA; HEPARAN-SULFATE PROTEOGLYCANS; MICE LACKING; PTP-SIGMA; RECEPTOR; REGENERATION; LAR; SYNDECAN; SYSTEM; INJURY	Heparan and chondroitin sulfate proteoglycans (HSPGs and CSPGs, respectively) regulate numerous cell surface signaling events, with typically opposite effects on cell function. CSPGs inhibit nerve regeneration through receptor protein tyrosine phosphatase sigma (RPTP sigma). Here we report that RPTPs acts bimodally in sensory neuron extension, mediating CSPG inhibition and HSPG growth promotion. Crystallographic analyses of a shared HSPG-CSPG binding site reveal a conformational plasticity that can accommodate diverse glycosaminoglycans with comparable affinities. Heparan sulfate and analogs induced RPTPs ectodomain oligomerization in solution, which was inhibited by chondroitin sulfate. RPTPs and HSPGs colocalize in puncta on sensory neurons in culture, whereas CSPGs occupy the extracellular matrix. These results lead to a model where proteoglycans can exert opposing effects on neuronal extension by competing to control the oligomerization of a common receptor.	[Coles, Charlotte H.; Siebold, Christian; Sutton, Geoffrey C.; Lu, Weixian; Jones, E. Yvonne; Aricescu, A. Radu] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Tenney, Alan P.] Columbia Univ, Motor Neuron Ctr, New York, NY 10032 USA; [Gallagher, John T.] Univ Manchester, Paterson Inst Canc Res, Fac Med & Hlth Sci, Sch Canc & Imaging Sci, Manchester M20 4BX, Lancs, England	University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Paterson Institute for Cancer Research; University of Manchester	Jones, EY (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk; flanagan@hms.harvard.edu; radu@strubi.ox.ac.uk	Flanagan, John/AAM-2995-2020; Aricescu, Alexandru/L-3891-2013; Jones, Yvonne/J-2293-2016; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Coles, Charlotte/0000-0003-4525-7144; Siebold, Christian/0000-0002-6635-3621; Aricescu, Alexandru ARadu/0000-0003-3783-1388	Wellcome Trust; European Research Community Fund [MRTN-CT-2006-035830]; NIH [EY11559, HD29417]; Cancer Research UK; UK Medical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029417, R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; Cancer Research UK [10976] Funding Source: researchfish; Medical Research Council [G0700232, G0900084] Funding Source: researchfish; MRC [G0900084, G0700232] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Community Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Coordinates and structure factors are deposited in the Protein Data Bank (see table S2). We thank K. Harlos, T. Walter, and staff of the European Synchrotron Radiation Facility and Diamond Light Source for assistance; the Harvard Medical School Nikon Imaging Center for resources and advice; C. Serra-Pages and A. W. Stoker for RPTP sigma cDNAs; M. Tremblay and N. Uetani (McGill Univ.) for the RPTP sigma<SUP>-/-</SUP> mouse; R. J. Gilbert and R. T. Aplin for analytical ultracentrifugation and mass spectrometry; and J. Silver, B. Lang, and A. W. Stoker for advice and discussions. This work was funded by the Wellcome Trust, the European Research Community Fund (MRTN-CT-2006-035830), the NIH (grants EY11559 and HD29417), Cancer Research UK, and the UK Medical Research Council. C. H. C. was the recipient of a Wellcome Trust D. Phil. studentship, C. S. is a Wellcome Trust Research Career Development Fellow, E.Y.J. is a Cancer Research UK Principal Research Fellow, and A. R. A. is a UK Medical Research Council Career Development Award Fellow. Current patent applications related to this work have been filed by Harvard Univ. A provisional patent filed by the University College London, related to the discovery of HSPGs as RPTP sigma ligands, expired in 2001. J. T. G. is the founder, director, and majority shareholder of Iduron, Paterson Institute for Cancer Research, Univ. of Manchester (Manchester, UK).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Duan YT, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe6; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Harmer NJ, 2006, BIOCHEM J, V393, P741, DOI 10.1042/BJ20050985; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Ledig MM, 1999, J CELL BIOL, V147, P375, DOI 10.1083/jcb.147.2.375; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; McLean J, 2002, J NEUROSCI, V22, P5481; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Rashid-Doubell F, 2002, J NEUROSCI, V22, P5024, DOI 10.1523/JNEUROSCI.22-12-05024.2002; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279	33	233	246	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					484	488		10.1126/science.1200840	http://dx.doi.org/10.1126/science.1200840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21454754	Green Accepted			2022-12-01	WOS:000289784900048
J	Xu, F; Wu, HX; Katritch, V; Han, GW; Jacobson, KA; Gao, ZG; Cherezov, V; Stevens, RC				Xu, Fei; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Jacobson, Kenneth A.; Gao, Zhan-Guo; Cherezov, Vadim; Stevens, Raymond C.			Structure of an Agonist-Bound Human A(2A) Adenosine Receptor	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ALLOSTERIC MODULATION; SUBTYPE-SELECTIVITY; BINDING-SITE; IDENTIFICATION; DOMAINS; GPCR	Activation of G protein-coupled receptors upon agonist binding is a critical step in the signaling cascade for this family of cell surface proteins. We report the crystal structure of the A(2A) adenosine receptor (A(2A)AR) bound to an agonist UK-432097 at 2.7 angstrom resolution. Relative to inactive, antagonist-bound A(2A)AR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes associated with the active-state opsin structure. Additionally, a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A(2A)AR and its ligand. The results define the molecule UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.	[Xu, Fei; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Jacobson, Kenneth A.; Gao, Zhan-Guo] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLQ-8673-2022; Wu, Huixian/N-6353-2014; Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Q-8357-2016; soler, martha maricel m gomez/L-6025-2014; Jacobson, Kenneth Alan/A-1530-2009; Han, Gye Won/GLT-1531-2022; Cherezov, Vadim/L-9812-2013	Wu, Huixian/0000-0003-1357-9747; Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; soler, martha maricel m gomez/0000-0002-4412-8108; Jacobson, Kenneth Alan/0000-0001-8104-1493; Cherezov, Vadim/0000-0002-5265-3914	National Institute of Diabetes and Digestive and Kidney Diseases; NIH Roadmap Initiative [P50 GM073197]; NIH [GM075915]; NSF [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104];  [U54 GM094618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM075915, U54GM094618, R01GM089857] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (K.A.J. and Z.-G.G.), PSI: Biology grant U54 GM094618 for structure production, and NIH Roadmap Initiative grant P50 GM073197 for technology development. R. C. S. thanks N. Dekker at AstraZeneca for suggesting the UK-432097 compound for biochemical and structural studies. We thank J. Velasquez for help on molecular biology; C. Cornillez-Ty, T. Trinh, and K. Allin for help on baculovirus expression; E. Chien and W. Liu for advice on protein purification and LCP crystallization; I. Wilson, M. Hanson, and A. IJzerman for careful review and scientific feedback on the manuscript; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; L. Heitman for A<INF>2A</INF>AR compounds used in thermal stability studies; Y. Zheng and M. Caffrey for use of an in meso robot (built with support from NIH grant GM075915, NSF grant IIS0308078, and Science Foundation Ireland grant 02-IN1-B266); and J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104. R. C. S. is a founder and member of the board of directors of Receptos, a GPCR structure-based drug discovery company. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3QAK.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Cristalli Gloria, 2009, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-540-89615-9_3; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gao ZG, 2003, MOL PHARMACOL, V63, P1021, DOI 10.1124/mol.63.5.1021; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Ivanov AA, 2009, J MED CHEM, V52, P3284, DOI 10.1021/jm801533x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jaakola VP, 2010, J BIOL CHEM, V285, P13032, DOI 10.1074/jbc.M109.096974; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Katritch V, 2011, NEUROPHARMACOLOGY, V60, P108, DOI 10.1016/j.neuropharm.2010.07.009; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Mantell SJ, 2009, BIOORG MED CHEM LETT, V19, P4471, DOI 10.1016/j.bmcl.2009.05.027; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rieger JM, 2001, J MED CHEM, V44, P531, DOI 10.1021/jm0003642; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Tchilibon S, 2004, BIOORGAN MED CHEM, V12, P2021, DOI 10.1016/j.bmc.2004.02.037; Vanni S, 2010, J MOL BIOL, V397, P1339, DOI 10.1016/j.jmb.2010.01.060; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	36	638	655	0	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					322	327		10.1126/science.1202793	http://dx.doi.org/10.1126/science.1202793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21393508	Green Accepted			2022-12-01	WOS:000289516600036
J	Ritter, JM				Ritter, J. M.			Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE CONTROL; HEART-FAILURE; RENIN; SYSTEM; TRIAL; BLOCKADE; DRUGS		[Ritter, J. M.] St Thomas Hosp, Dept Clin Pharmacol, London SE1 7EH, England; [Ritter, J. M.] Kings Coll London, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Ritter, JM (corresponding author), St Thomas Hosp, Dept Clin Pharmacol, London SE1 7EH, England.	james.ritter@kcl.ac.uk						*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; BROWN JJ, 1965, BMJ-BRIT MED J, V2, P144, DOI 10.1136/bmj.2.5454.144; Brown MJ, 2003, J HUM HYPERTENS, V17, P81, DOI 10.1038/sj.jhh.1001511; Coleman JJ, 2010, BRIT J CLIN PHARMACO, V70, P109, DOI 10.1111/j.1365-2125.2010.03654.x; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Hermida RC, 2009, HYPERTENSION, V54, P40, DOI 10.1161/HYPERTENSIONAHA.109.130203; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; MACGREGOR GA, 1985, J CARDIOVASC PHARM, V7, pS82, DOI 10.1097/00005344-198507001-00016; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; Medical Research Party Working Party, 1985, BMJ-BRIT MED J, V291, P99; Menard J, 1997, CIRCULATION, V96, P3072, DOI 10.1161/01.CIR.96.9.3072; Messerli FH, 2009, J AM COLL CARDIOL, V53, P468, DOI 10.1016/j.jacc.2008.10.036; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Nakao N, 2009, LANCET, V374, P1226; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; Okin PM, 2007, ANN INTERN MED, V147, P311, DOI 10.7326/0003-4819-147-5-200709040-00006; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Ritter JM, 2008, TXB CLIN PHARM, P185; Salvetti A, 1999, DRUGS, V57, P665, DOI 10.2165/00003495-199957050-00002; Sciarretta S, 2011, ARCH INTERN MED, V171, P384, DOI 10.1001/archinternmed.2010.427; The Seventh Report of the Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure, 2004, 7 JOINT NAT COMM PRE; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	26	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2011	342								d1673	10.1136/bmj.d1673	http://dx.doi.org/10.1136/bmj.d1673			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JT	21474511				2022-12-01	WOS:000289462400002
J	Gousseff, M; Arnaud, L; Lambert, M; Hot, A; Hamidou, M; Duhaut, P; Papo, T; Soubrier, M; Ruivard, M; Malizia, G; Tieulie, N; Riviere, S; Ninet, J; Hatron, PY; Amoura, Z				Gousseff, Marie; Arnaud, Laurent; Lambert, Marc; Hot, Arnaud; Hamidou, Mohamed; Duhaut, Pierre; Papo, Thomas; Soubrier, Martin; Ruivard, Marc; Malizia, Giuseppe; Tieulie, Nathalie; Riviere, Sophie; Ninet, Jacques; Hatron, Pierre-Yves; Amoura, Zahir		Capillary Leak Syndrome Registry	The Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European Registry	ANNALS OF INTERNAL MEDICINE			English	Article							HYPOVOLEMIC SHOCK; COMPARTMENT SYNDROME; MONOCLONAL GAMMOPATHY; CLARKSONS-DISEASE; MULTIPLE-MYELOMA; RECURRENT SHOCK; RARE CAUSE; PERMEABILITY; EDEMA; TERBUTALINE	Background: The systemic capillary leak syndrome (SCLS) is a rare disease characterized by life-threatening attacks of capillary hyperpermeability. Objective: To describe the clinical characteristics, laboratory findings, treatments, and outcomes of patients with SCLS who were not previously reported in the literature. Design: Case series. Setting: Patients referred to a European multicenter SCLS registry between January 1997 and July 2010. Patients: 28 patients with SCLS. Measurements: Frequency, severity of attacks, and vital status were assessed every 6 months, from diagnosis to the end of the study. Results: 13 men and 15 women referred to the registry who were not previously reported in the literature had 252 attacks. Median age at disease onset was 49.1 years (range, 5.4 to 77.7 years), and median annual frequency of attacks was 1.23 (range, 0.13 to 21.18) per patient. Monoclonal IgG gammopathy was observed in 25 patients (89%). Preventive treatment included intravenous immunoglobulin (n = 18), terbutaline (n = 9), and aminophylline (n = 10). Eight patients died (29%); 1-year survival was 89%, and 5-year survival was 73%. Death was directly related to SCLS attacks in 6 of 8 cases (75%). In 10 patients with a prediagnosis period greater than 6 months who received preventive treatment, the annual frequency of attacks after diagnosis decreased by a median of 1.55 (range, 0.14 to 8.84) per patient. Five years after diagnosis, survival was 85% in 23 patients who had received prophylactic treatment and 20% in 5 patients who had not. Limitation: The benefits of preventive treatment could not be precisely ascertained because of the small sample size and because most patients received several treatments. Conclusion: Clinical experience with these 28 patients with SCLS suggests that prophylactic treatment with beta(2)-agonists or intravenous immunoglobulin may reduce the frequency and severity of attacks and may improve survival.	Hop Bichat Claude Bernard, AP HP, Pitie Salpetriere Hosp, INSERM, F-75877 Paris 18, France; Univ Paris 06, Paris, France; Univ Nord France, Lille, France; Univ Lyon 1, Hop Edouard Herriot, F-69365 Lyon, France; CHU Nantes, Hotel Dieu, F-44035 Nantes 01, France; Hop Nord Amiens, Amiens, France; Ctr Hosp Univ Clermont Ferrand, F-63058 Clermont Ferrand 01, France; Ctr Hosp Univ Estaing, Clermont Ferrand, France; Osped Riuniti Villa Sofia Osped Cervello, Palermo, Italy; Hop Archet, F-06202 Nice 3, France; CHU Montpellier, F-34295 Montpellier 5, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Nantes Universite; CHU de Nantes; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Nice; Universite de Montpellier; CHU de Montpellier	Amoura, Z (corresponding author), Grp Hosp Pitie Salpetriere, Serv Med Interne 2, 47-83 Blvd Hop, F-75013 Paris, France.	zahir.amoura@psl.aphp.fr	lambert, marc/V-7380-2017; Amoura, Zahir/P-5325-2017; AMOURA, Zahir/P-5324-2017	lambert, marc/0000-0002-3485-8238; AMOURA, Zahir/0000-0003-0292-9043; ARNAUD, Laurent/0000-0002-8077-8394; Malizia, Giuseppe/0000-0002-0995-8755	Universite Pierre et Marie Curie, Paris, France; Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France)	Universite Pierre et Marie Curie, Paris, France; Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France)	Universite Pierre et Marie Curie, Paris, France.r Primarily by Universite Pierre et Marie Curie (Paris, France) and in part by Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France).	ALEXANIAN R, 1995, SEMIN HEMATOL, V32, P20; Amoura Z, 1997, AM J MED, V103, P514, DOI 10.1016/S0002-9343(97)00272-6; Assaly R, 2001, CHEST, V120, P1301, DOI 10.1378/chest.120.4.1301; ATKINSON JP, 1977, MEDICINE, V56, P225, DOI 10.1097/00005792-197705000-00004; BALASCH J, 1994, ANN INTERN MED, V121, P27, DOI 10.7326/0003-4819-121-1-199407010-00005; BARNADAS MA, 1995, J AM ACAD DERMATOL, V32, P364, DOI 10.1016/0190-9622(95)90405-0; Bayry J, 2006, INT IMMUNOPHARMACOL, V6, P528, DOI 10.1016/j.intimp.2005.11.013; Bonadies N, 2006, EUR J INTERN MED, V17, P363, DOI 10.1016/j.ejim.2005.12.011; BOUHAJA B, 1994, INTENS CARE MED, V20, P307, DOI 10.1007/BF01708975; CAIN JR, 1986, KIDNEY INT, V29, P181; Chihara R, 2002, INTERNAL MED, V41, P953, DOI 10.2169/internalmedicine.41.953; CICARDI M, 1990, ANN INTERN MED, V113, P475, DOI 10.7326/0003-4819-113-6-475; CLARKSON B, 1960, AM J MED, V29, P193, DOI 10.1016/0002-9343(60)90018-8; Crenier L, 1997, ACTA CLIN BELG, V52, P401, DOI 10.1080/17843286.1997.11718607; Dams K, 2007, CHEST, V132, P1393, DOI 10.1378/chest.07-0456; de Barros R T, 1983, Rev Hosp Clin Fac Med Sao Paulo, V38, P170; Deeren DH, 2005, ANN HEMATOL, V84, P89, DOI 10.1007/s00277-004-0946-8; DEREURE O, 1994, DERMATOLOGY, V188, P152, DOI 10.1159/000247123; Dhir V, 2007, INTERNAL MED, V46, P899, DOI 10.2169/internalmedicine.46.6129; DOLBERGSTOLIK OC, 1993, CHEST, V104, P123, DOI 10.1378/chest.104.1.123; DOORENBOS CJ, 1988, NETH J MED, V32, P178; DRODER RM, 1992, AM J MED, V92, P523, DOI 10.1016/0002-9343(92)90749-2; Druey KM, 2010, ANN INTERN MED, V153, P90, DOI 10.7326/0003-4819-153-2-201007200-00005; Elias AD, 2001, BONE MARROW TRANSPL, V27, P269, DOI 10.1038/sj.bmt.1702780; EWAN PW, 1988, LANCET, V2, P1496; FELLOWS IW, 1988, LANCET, V2, P1143; FISHBEIN MC, 1974, AM J SURG, V127, P740, DOI 10.1016/0002-9610(74)90361-4; FOELDVARI I, 1995, J PEDIATR-US, V127, P739, DOI 10.1016/S0022-3476(95)70163-X; GARCIABRAGADO F, 1987, MED CLIN-BARCELONA, V89, P426; Gauvin F, 2000, CRIT CARE MED, V28, P3341, DOI 10.1097/00003246-200009000-00038; GEORGE C, 1978, INTENS CARE MED, V4, P159, DOI 10.1007/BF01700259; Gleich GJ, 2009, BRIT J HAEMATOL, V145, P271, DOI 10.1111/j.1365-2141.2009.07599.x; Gousseff M, 2009, REV MED INTERNE, V30, P754, DOI 10.1016/j.revmed.2009.01.005; GUIDET B, 1990, INTENS CARE MED, V16, P332, DOI 10.1007/BF01706361; Gyger M, 2005, BONE MARROW TRANSPL, V35, P201, DOI 10.1038/sj.bmt.1704730; Hamada Yoshihiro, 2004, Asian Cardiovasc Thorac Ann, V12, P193; Hiraoka E, 1995, INTERNAL MED, V34, P1220, DOI 10.2169/internalmedicine.34.1220; HORWITH M, 1967, J AMER MED ASSOC, V200, P101, DOI 10.1001/jama.200.2.101; JANINMANIFICAT L, 1982, NOUV PRESSE MED, V11, P2716; Jillella AP, 2000, LEUKEMIA LYMPHOMA, V38, P419, DOI 10.3109/10428190009087034; KANG PM, 1995, RENAL FAILURE, V17, P615, DOI 10.3109/08860229509037627; KAO NL, 1993, CHEST, V104, P1637, DOI 10.1378/chest.104.5.1637c; Kaplan MJ, 1999, ARCH DERMATOL, V135, P553, DOI 10.1001/archderm.135.5.553; Kapoor P, 2010, MAYO CLIN PROC, V85, P905, DOI 10.4065/mcp.2010.0159; Karatzios C, 2006, PEDIATR CRIT CARE ME, V7, P377, DOI 10.1097/01.PCC.0000227120.61949.FB; Kawabe S, 2002, INTERNAL MED, V41, P211, DOI 10.2169/internalmedicine.41.211; LAGRUE G, 1986, PRESSE MED, V15, P1554; Lambert M, 2008, CRIT CARE MED, V36, P2184, DOI 10.1097/CCM.0b013e31817d7c71; LARCAN A, 1975, BIBL ANAT, P343; Lassoued K, 1998, INTENS CARE MED, V24, P981, DOI 10.1007/s001340050700; Lee Young Seok, 2007, Korean Journal of Internal Medicine, V22, P130; LOFDAHL CG, 1979, ACTA MED SCAND, V206, P405; LUQUEL L, 1989, REV MED INTERNE, V10, P359, DOI 10.1016/S0248-8663(89)80037-2; Marasini B, 1979, Bibl Anat, P41; Marx G, 2000, INTENS CARE MED, V26, P1252, DOI 10.1007/s001340000601; Matsumura M, 2007, INTERNAL MED, V46, P1585, DOI 10.2169/internalmedicine.46.0254; MCGREGOR JM, 1991, BRIT J DERMATOL, V125, P472, DOI 10.1111/j.1365-2133.1991.tb14777.x; Michiels JJ, 2006, SEMIN THROMB HEMOST, V32, P577, DOI 10.1055/s-2006-949663; Muller M, 2004, INTERNIST, V45, P587, DOI 10.1007/s00108-004-1162-2; OHTA H, 1994, ACTA PAEDIATR, V83, P1113, DOI 10.1111/j.1651-2227.1994.tb13000.x; Onal H, 2007, ANN TROP PAEDIATR, V27, P81, DOI 10.1179/146532807X170556; PURI RK, 1989, CANCER IMMUNOL IMMUN, V28, P267; RONDEAU E, 1987, EUR J CLIN INVEST, V17, P53, DOI 10.1111/j.1365-2362.1987.tb01225.x; Sabbadini D D, 2002, Minerva Anestesiol, V68, P929; SABBADINI DD, 2002, MINERVA ANESTESIOL, V68, P933; Sahnoun I, 2005, REV MED INTERNE, V26, P409, DOI 10.1016/j.revmed.2004.12.009; Sanghavi R, 2006, ANAESTH INTENS CARE, V34, P388, DOI 10.1177/0310057X0603400308; Schmidt S, 1999, NEUROLOGY, V53, P220, DOI 10.1212/WNL.53.1.220; Shimura H, 1999, EUR SURG RES, V31, P390, DOI 10.1159/000008717; Sion-Sarid R, 2010, PEDIATRICS, V125, pE687, DOI 10.1542/peds.2009-1691; Staak JO, 2003, AM J MED, V115, P332, DOI 10.1016/S0002-9343(03)00349-8; SVENSJO E, 1982, ACTA PHYSIOL SCAND, V116, P265, DOI 10.1111/j.1748-1716.1982.tb07140.x; Tahirkheli NK, 1999, ANN INTERN MED, V130, P905, DOI 10.7326/0003-4819-130-11-199906010-00015; TEELUCKSINGH S, 1990, Q J MED, V75, P515; TEELUCKSINGH S, 1989, LANCET, V1, P330; Tieulie N, 2005, REV MED INTERNE, V26, pS223, DOI 10.1016/S0248-8663(05)80032-3; Valderrey FP, 1999, AM J EMERG MED, V17, P743, DOI 10.1016/S0735-6757(99)90179-1; Vigneau U, 2002, NEPHROL DIAL TRANSPL, V17, P492, DOI 10.1093/ndt/17.3.492; Wiest GH, 2001, MED KLIN, V96, P365, DOI 10.1007/PL00002217	79	95	102	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							464	10.7326/0003-4819-154-7-201104050-00004	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464348				2022-12-01	WOS:000289078700003
J	Boyles, JG; Cryan, PM; McCracken, GF; Kunz, TH				Boyles, Justin G.; Cryan, Paul M.; McCracken, Gary F.; Kunz, Thomas H.			Economic Importance of Bats in Agriculture	SCIENCE			English	Editorial Material							WHITE-NOSE SYNDROME; FREE-TAILED BATS; POLLINATION ECOLOGY; SOUTHERN THAILAND; MYOTIS-LUCIFUGUS; WIND TURBINES; BROWN BAT; HYPOTHESES; FATALITIES; DISEASE		[Boyles, Justin G.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Cryan, Paul M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [McCracken, Gary F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	University of Pretoria; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; Boston University	Boyles, JG (corresponding author), Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	jgboyles@zoology.up.ac.za	Boyles, Justin G/A-5152-2010	Cryan, Paul/0000-0002-2915-8894; McCracken, Gary/0000-0002-2493-8103				ANTHONY ELP, 1977, ECOLOGY, V58, P775, DOI 10.2307/1936213; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Bumrungsri S, 2008, J TROP ECOL, V24, P467, DOI 10.1017/S0266467408005191; Bumrungsri S, 2009, J TROP ECOL, V25, P85, DOI 10.1017/S0266467408005531; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Elliot D. L., 1986, WIND ENERGY RESOURCE; Federico P, 2008, ECOL APPL, V18, P826, DOI 10.1890/07-0556.1; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Hallam TG, 2011, CONSERV BIOL, V25, P189, DOI 10.1111/j.1523-1739.2010.01603.x; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; *USDA, 2009, GEOGR AR SER USDA, V1; WHITAKER JO, 1995, AM MIDL NAT, V134, P346, DOI 10.2307/2426304; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944	23	426	464	6	464	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					41	42		10.1126/science.1201366	http://dx.doi.org/10.1126/science.1201366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743EJ	21454775				2022-12-01	WOS:000289000000029
J	Roostalu, J; Hentrich, C; Bieling, P; Telley, IA; Schiebel, E; Surrey, T				Roostalu, Johanna; Hentrich, Christian; Bieling, Peter; Telley, Ivo A.; Schiebel, Elmar; Surrey, Thomas			Directional Switching of the Kinesin Cin8 Through Motor Coupling	SCIENCE			English	Article							MITOTIC SPINDLE; BUDDING YEAST; EG5; PROTEINS; MOTILITY; MICROTUBULES; CONFORMATION; ORGANIZATION; SUPERFAMILY; ANAPHASE	Kinesin motor proteins are thought to move exclusively in either one or the other direction along microtubules. Proteins of the kinesin-5 family are tetrameric microtubule cross-linking motors important for cell division and differentiation in various organisms. Kinesin-5 motors are considered to be plus-end-directed. However, here we found that purified kinesin-5 Cin8 from budding yeast could behave as a bidirectional kinesin. On individual microtubules, single Cin8 motors were minus-end-directed motors, whereas they switched to plus-end-directed motility when working in a team of motors sliding antiparallel microtubules apart. This kinesin can thus change directionality of movement depending on whether it acts alone or in an ensemble.	[Roostalu, Johanna; Schiebel, Elmar] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-69120 Heidelberg, Germany; [Hentrich, Christian; Bieling, Peter; Telley, Ivo A.; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Schiebel, E (corresponding author), Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de; thomas.surrey@cancer.org.uk	Surrey, Thomas/AAC-4608-2021; Telley, Ivo Andreas/D-2063-2011	Telley, Ivo Andreas/0000-0003-4444-1046; Roostalu, Johanna/0000-0002-6757-0468; Bieling, Peter/0000-0002-7458-4358; Hentrich, Christian/0000-0001-6697-5001; Surrey, Thomas/0000-0001-9082-1870	Deutsche Forschungsgemeinschaft; European Commission; Swiss National Science Foundation; Cancer Research UK [14256] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research UK(Cancer Research UK)	We thank D. Pellman and M. Knop for plasmids; I. Hagan, J. Ellenberg, and M. Kaksonen for critically reading the manuscript; and the Deutsche Forschungsgemeinschaft, the European Commission (Marie Curie Research Training Network "Spindle Dynamics"), and the Swiss National Science Foundation for financial support.	Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Cheerambathur DK, 2008, J CELL BIOL, V182, P429, DOI 10.1083/jcb.200804100; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Guerin T, 2010, CURR OPIN CELL BIOL, V22, P14, DOI 10.1016/j.ceb.2009.12.012; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032	30	114	116	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					94	99		10.1126/science.1199945	http://dx.doi.org/10.1126/science.1199945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21350123				2022-12-01	WOS:000289000000045
J	Kir, S; Beddow, SA; Samuel, VT; Miller, P; Previs, SF; Suino-Powell, K; Xu, HE; Shulman, GI; Kliewer, SA; Mangelsdorf, DJ				Kir, Serkan; Beddow, Sara A.; Samuel, Varman T.; Miller, Paul; Previs, Stephen F.; Suino-Powell, Kelly; Xu, H. Eric; Shulman, Gerald I.; Kliewer, Steven A.; Mangelsdorf, David J.			FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis	SCIENCE			English	Article							SYNTHASE KINASE-3-BETA; GLUCOSE-HOMEOSTASIS; GROWTH; PHOSPHORYLATION; FIBROBLAST-GROWTH-FACTOR-19; INACTIVATION; KLOTHO; MTORC1; SIGNAL; RSK	Fibroblast growth factor (FGF) 19 is an enterokine synthesized and released when bile acids are taken up into the ileum. We show that FGF19 stimulates hepatic protein and glycogen synthesis but does not induce lipogenesis. The effects of FGF19 are independent of the activity of either insulin or the protein kinase Akt and, instead, are mediated through a mitogen-activated protein kinase signaling pathway that activates components of the protein translation machinery and stimulates glycogen synthase activity. Mice lacking FGF15 (the mouse FGF19 ortholog) fail to properly maintain blood concentrations of glucose and normal postprandial amounts of liver glycogen. FGF19 treatment restored the loss of glycogen in diabetic animals lacking insulin. Thus, FGF19 activates a physiologically important, insulin-independent endocrine pathway that regulates hepatic protein and glycogen metabolism.	[Kir, Serkan; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Beddow, Sara A.; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Miller, Paul; Previs, Stephen F.] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Suino-Powell, Kelly; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Case Western Reserve University; Van Andel Institute; Howard Hughes Medical Institute; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kliewer, SA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	steven.kliewer@utsouthwestern.edu; davo.mango@utsouthwestern.edu	Shulman, Gerald I./P-7176-2019; Xu, H. Eric/ABD-7487-2021	Shulman, Gerald I./0000-0003-1529-5668; Xu, H. Eric/0000-0002-6829-8144; Mangelsdorf, David/0000-0002-4355-0796	Howard Hughes Medical Institute; NIH [DK67158, DK62434, DK40936, U24 DK076169]; Robert A. Welch Foundation [I-1275, I-558]; Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, U24DK076169, R24DK085638, U19DK062434, R01DK067158, R01DK040936] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Inagaki, X. Ding, and A. Bookout for their help with animal experiments and M. Cobb and P. Scherer (University of Texas Southwestern Medical Center) for discussion and comments. This research was supported by the Howard Hughes Medical Institute (G. I. S., D.J.M.), the NIH (DK67158 and DK62434 to S. A. K. and D.J.M., DK40936 and U24 DK076169 to G. I. S.), the Robert A. Welch Foundation (I-1275 to D.J.M. and I-558 to S. A. K.), and the Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers. A Materials Transfer Agreement is required for sharing materials from the Van Andel Institute.	Anderson SR, 2008, METABOLISM, V57, P347, DOI 10.1016/j.metabol.2007.10.009; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Dufner DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE1277, DOI 10.1152/ajpendo.00580.2004; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rachdaoui N, 2009, MOL CELL PROTEOMICS, V8, P2653, DOI 10.1074/mcp.M900026-MCP200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004	26	418	445	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1621	1624		10.1126/science.1198363	http://dx.doi.org/10.1126/science.1198363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436455	Green Accepted			2022-12-01	WOS:000288754500060
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Prescription charges: a tax on the English	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1790	10.1136/bmj.d1790	http://dx.doi.org/10.1136/bmj.d1790			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21429994				2022-12-01	WOS:000288948000020
J	Ferrell, JE; Tsai, TYC; Yang, QO				Ferrell, James E., Jr.; Tsai, Tony Yu-Chen; Yang, Qiong			Modeling the Cell Cycle: Why Do Certain Circuits Oscillate?	CELL			English	Article							POSITIVE FEEDBACK; FISSION YEAST; MATHEMATICAL-MODEL; MITOTIC OSCILLATOR; DIVISION CYCLE; BUDDING YEAST; KAIC PHOSPHORYLATION; NEGATIVE FEEDBACK; RESTRICTION POINT; CIRCADIAN CLOCKS	Computational modeling and the theory of nonlinear dynamical systems allow one to not simply describe the events of the cell cycle, but also to understand why these events occur, just as the theory of gravitation allows one to understand why cannonballs fly in parabolic arcs. The simplest examples of the eukaryotic cell cycle operate like autonomous oscillators. Here, we present the basic theory of oscillatory biochemical circuits in the context of the Xenopus embryonic cell cycle. We examine Boolean models, delay differential equation models, and especially ordinary differential equation (ODE) models. For ODE models, we explore what it takes to get oscillations out of two simple types of circuits (negative feedback loops and coupled positive and negative feedback loops). Finally, we review the procedures of linear stability analysis, which allow one to determine whether a given ODE model and a particular set of kinetic parameters will produce oscillations.	[Ferrell, James E., Jr.; Tsai, Tony Yu-Chen; Yang, Qiong] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferrell, James E., Jr.; Tsai, Tony Yu-Chen] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	james.ferrell@stanford.edu	; Yang, Qiong/G-9630-2016	Tsai, Tony/0000-0003-1121-9406; Yang, Qiong/0000-0002-2442-2094	NIH [GM077544]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Markus Covert for the idea of starting this tutorial with a Boolean analysis instead of plunging right into ODEs and David Dill for helpful discussions. This work was supported by NIH GM077544.	Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Alfieri R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S16; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Borisuk MT, 1998, J THEOR BIOL, V195, P69, DOI 10.1006/jtbi.1998.0781; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; BUSENBERG S, 1994, J MATH BIOL, V32, P573, DOI 10.1007/BF00573462; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Ciliberto A, 2003, J CELL BIOL, V163, P1243, DOI 10.1083/jcb.200306139; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Ge H, 2008, MATH BIOSCI, V211, P132, DOI 10.1016/j.mbs.2007.10.003; Gilbert D A, 1974, Curr Mod Biol, V5, P197; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 1996, EXPERIENTIA, V52, P212, DOI 10.1007/BF01920708; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; KAUFFMAN S, 1975, J THEOR BIOL, V55, P47, DOI 10.1016/S0022-5193(75)80108-1; Li B, 2010, J THEOR BIOL, V264, P771, DOI 10.1016/j.jtbi.2010.03.023; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Mangla K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008906; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Mura I, 2008, J THEOR BIOL, V254, P850, DOI 10.1016/j.jtbi.2008.07.019; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NOREL R, 1991, SCIENCE, V251, P1076, DOI 10.1126/science.1825521; NOVAK B, 1993, J THEOR BIOL, V165, P101, DOI 10.1006/jtbi.1993.1179; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 1998, BIOPHYS CHEM, V72, P185, DOI 10.1016/S0301-4622(98)00133-1; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; OBEYESEKERE MN, 1992, BIOCHEM BIOPH RES CO, V184, P782, DOI 10.1016/0006-291X(92)90658-8; Okabe Y, 2007, BIOPHYS J, V93, P3451, DOI 10.1529/biophysj.107.109991; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Sel'kov E E, 1970, Biofizika, V15, P1065; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Srividhya J, 2006, J THEOR BIOL, V241, P617, DOI 10.1016/j.jtbi.2005.12.020; Steuer R, 2004, J THEOR BIOL, V228, P293, DOI 10.1016/j.jtbi.2004.01.012; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S. H, 1994, NONLINEAR DYNAMICS C, V1st; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; TYSON J, 1975, J MATH BIOL, V1, P289, DOI 10.1007/BF00279848; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang YP, 2006, PHYSICA D, V219, P35, DOI 10.1016/j.physd.2006.05.009; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	69	220	221	2	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					874	885		10.1016/j.cell.2011.03.006	http://dx.doi.org/10.1016/j.cell.2011.03.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414480	Bronze			2022-12-01	WOS:000288543500007
J	Kaneko, H; Dridi, S; Tarallo, V; Gelfand, BD; Fowler, BJ; Cho, WG; Kleinman, ME; Ponicsan, SL; Hauswirth, WW; Chiodo, VA; Kariko, K; Yoo, JW; Lee, DK; Hadziahmetovic, M; Song, Y; Misra, S; Chaudhuri, G; Buaas, FW; Braun, RE; Hinton, DR; Zhang, Q; Grossniklaus, HE; Provis, JM; Madigan, MC; Milam, AH; Justice, NL; Albuquerque, RJC; Blandford, AD; Bogdanovich, S; Hirano, Y; Witta, J; Fuchs, E; Littman, DR; Ambati, BK; Rudin, CM; Chong, MMW; Provost, P; Kugel, JF; Goodrich, JA; Dunaief, JL; Baffi, JZ; Ambati, J				Kaneko, Hiroki; Dridi, Sami; Tarallo, Valeria; Gelfand, Bradley D.; Fowler, Benjamin J.; Cho, Won Gil; Kleinman, Mark E.; Ponicsan, Steven L.; Hauswirth, William W.; Chiodo, Vince A.; Kariko, Katalin; Yoo, Jae Wook; Lee, Dong-ki; Hadziahmetovic, Majda; Song, Ying; Misra, Smita; Chaudhuri, Gautam; Buaas, Frank W.; Braun, Robert E.; Hinton, David R.; Zhang, Qing; Grossniklaus, Hans E.; Provis, Jan M.; Madigan, Michele C.; Milam, Ann H.; Justice, Nikki L.; Albuquerque, Romulo J. C.; Blandford, Alexander D.; Bogdanovich, Sasha; Hirano, Yoshio; Witta, Jassir; Fuchs, Elaine; Littman, Dan R.; Ambati, Balamurali K.; Rudin, Charles M.; Chong, Mark M. W.; Provost, Patrick; Kugel, Jennifer F.; Goodrich, James A.; Dunaief, Joshua L.; Baffi, Judit Z.; Ambati, Jayakrishna			DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration	NATURE			English	Article							EMBRYONIC STEM-CELLS; MICRORNA BIOGENESIS; MOUSE OOCYTES; LDL RECEPTOR; RECOMBINATION; ARGONAUTE2; EXPRESSION; CANCER; SIRNAS; DIFFERENTIATION	Geographic atrophy (GA), an untreatable advanced form of age-related macular degeneration, results from retinal pigmented epithelium (RPE) cell degeneration. Here we show that the microRNA (miRNA)-processing enzyme DICER1 is reduced in the RPE of humans with GA, and that conditional ablation of Dicer1, but not seven other miRNA-processing enzymes, induces RPE degeneration in mice. DICER1 knockdown induces accumulation of Alu RNA in human RPE cells and Alu-like B1 and B2 RNAs in mouse RPE. Alu RNA is increased in the RPE of humans with GA, and this pathogenic RNA induces human RPE cytotoxicity and RPE degeneration in mice. Antisense oligonucleotides targeting Alu/B1/B2 RNAs prevent DICER1 depletion-induced RPE degeneration despite global miRNA downregulation. DICER1 degrades Alu RNA, and this digested Alu RNA cannot induce RPE degeneration in mice. These findings reveal a miRNA-independent cell survival function for DICER1 involving retrotransposon transcript degradation, show that Alu RNA can directly cause human pathology, and identify new targets for a major cause of blindness.	[Kaneko, Hiroki; Dridi, Sami; Tarallo, Valeria; Gelfand, Bradley D.; Fowler, Benjamin J.; Cho, Won Gil; Kleinman, Mark E.; Justice, Nikki L.; Albuquerque, Romulo J. C.; Blandford, Alexander D.; Bogdanovich, Sasha; Hirano, Yoshio; Baffi, Judit Z.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Cho, Won Gil] Yonsei Univ, Wonju Coll Med, Dept Anat, Wonju 220701, South Korea; [Ponicsan, Steven L.; Kugel, Jennifer F.; Goodrich, James A.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Hauswirth, William W.; Chiodo, Vince A.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Kariko, Katalin] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Sch Chem Mat Sci BK21, Suwon 440746, South Korea; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Dept Chem, Suwon 440746, South Korea; [Hadziahmetovic, Majda; Song, Ying; Milam, Ann H.; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Misra, Smita; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Buaas, Frank W.; Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA; [Hinton, David R.] Univ So Calif, Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Zhang, Qing; Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Zhang, Qing; Grossniklaus, Hans E.] Emory Univ, Atlanta, GA 30322 USA; [Provis, Jan M.] Australian Natl Univ, ANU Med Sch, ARC Ctr Excellence Vis Sci, Canberra, ACT 0200, Australia; [Provis, Jan M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [Madigan, Michele C.] Univ Sydney, Save Sight Inst, Sydney, NSW 2001, Australia; [Witta, Jassir] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; [Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Littman, Dan R.; Chong, Mark M. W.] NYU, Sch Med, Howard Hughes Med Inst, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Ambati, Balamurali K.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT 84148 USA; [Rudin, Charles M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD 21231 USA; [Chong, Mark M. W.] Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Parkville, Vic 3052, Australia; [Provost, Patrick] Univ Laval, CHUL Res Ctr CHUQ, Quebec City, PQ G1K 7P4, Canada; [Provost, Patrick] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Global Res Lab RNAi Med, Suwon 440746, South Korea	University of Kentucky; Yonsei University; University of Colorado System; University of Colorado Boulder; State University System of Florida; University of Florida; University of Pennsylvania; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); University of Pennsylvania; Pennsylvania Medicine; Meharry Medical College; Jackson Laboratory; Doheny Eye Institute; University of Southern California; Emory University; Emory University; Australian National University; Australian National University; University of New South Wales Sydney; University of Sydney; University of Kentucky; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; New York University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Johns Hopkins University; Johns Hopkins Medicine; Walter & Eliza Hall Institute; Laval University; Laval University; University of Kentucky; Sungkyunkwan University (SKKU)	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Gelfand, Brad/L-3926-2019; Fuchs, Elaine/G-1565-2016; Provost, Patrick/G-2786-2010; Kaneko, Hiroki/O-7695-2015; Provis, Jan/C-9529-2009; Rudin, Charles/R-2530-2019; Kaneko, Hiroki/AHA-2461-2022; Dridi, Sami/Q-8207-2019; Chong, Mark/H-6684-2016; Fowler, Benjamin/F-4987-2012	Provost, Patrick/0000-0002-6099-6562; Kaneko, Hiroki/0000-0003-0731-6465; Provis, Jan/0000-0002-6405-2868; Rudin, Charles/0000-0001-5204-3465; Kaneko, Hiroki/0000-0003-0731-6465; Chong, Mark/0000-0002-3701-7397; Hirano, Yoshio/0000-0002-9173-0839; Tarallo, Valeria/0000-0002-6920-4402; hauswirth, william/0000-0002-3244-4947; Kleinman, Mark/0000-0001-8557-7949	National Eye Institute (NEI)/National Institutes of Health (NIH) [R01EY015422, R01EY018350, R01EY018836, R01EY020672, R21EY019778, RC1EY020442, R01EY017182, R01EY017950, R01HD027215, R21AI076757, P30EY06360, U10EY013729, R01EY011123, P30EY008571, R01GM068414, R01EY015240, P30EY003040, R01EY001545, T32HL091812]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness Senior Scientist Investigator Awards; University of Kentucky Physician Scientist Award; International Retinal Research Foundation; American Health Assistance Foundation; VA Merit Award; Department of Defense; MEST, Korea; Arnold and Mabel Beckman Foundation; Macular Vision Research Foundation and Foundation Fighting Blindness; ARC Centres of Excellence [CE0561903]; Sydney Foundation for Medical Research; National Health and Medical Research Council, Australia [637228]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011123, R01EY020672, R01EY001545, RC1EY020442, P30EY014800, R21EY019778, R01EY015422, U10EY013729, P30EY021721, R01EY018836, P30EY006360, P30EY008571, P30EY003040, R01EY017182, R01EY018350, R01EY017950, R01EY015240] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068414] Funding Source: NIH RePORTER	National Eye Institute (NEI)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness Senior Scientist Investigator Awards(Research to Prevent Blindness (RPB)); University of Kentucky Physician Scientist Award; International Retinal Research Foundation; American Health Assistance Foundation; VA Merit Award(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); MEST, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Arnold and Mabel Beckman Foundation; Macular Vision Research Foundation and Foundation Fighting Blindness; ARC Centres of Excellence(Australian Research Council); Sydney Foundation for Medical Research; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Chrenek, J. Garcia-Perez, T. Heidmann, C. Kanellopoulou, D. M. Livingston, J. V. Moran, R. F. Mullins, J. M. Nickerson, E. A. Pearce, A. Tarakhovsky, B. Vogelstein, V. E. Velculescu and D. J. Zack for providing mice, reagents or tissues; R. King, L. Xu, M. McConnell, C. Payne, G. R. Pattison, G. J. Jaffe, S. Medearis and C. Spee for technical assistance; and A. Sinai, R. Mohan, T. S. Khurana, R. A. Brekken, P. L. Deininger, S. Bondada, P. A. Pearson, A. M. Rao, G. S. Rao and K. Ambati for discussions. J. A. was supported by National Eye Institute (NEI)/National Institutes of Health (NIH) grants R01EY015422, R01EY018350, R01EY018836, R01EY020672, R21EY019778, RC1EY020442, the Doris Duke Distinguished Clinical Scientist Award, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, and the Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair. Research to Prevent Blindness Senior Scientist Investigator Awards or departmental unrestricted grants supported J. A., H. E. G. and W. W. H.; J. Z. B. was supported by University of Kentucky Physician Scientist Award, International Retinal Research Foundation, and American Health Assistance Foundation; B. K. A. by VA Merit Award and Department of Defense; D.-k. L. by Global Research Laboratory program by MEST, Korea; D. R. H. by Arnold and Mabel Beckman Foundation; W. W. H. by Macular Vision Research Foundation and Foundation Fighting Blindness; J. M. P. by ARC Centres of Excellence Grant CE0561903; M. C. M. by Sydney Foundation for Medical Research. B. K. A was supported by NIH R01EY017182 and R01EY017950; R. E. B. by NIH R01HD027215; G. C. by NIH R21AI076757; H. E. G. by NIH P30EY06360; W. W. H. by NIH U10EY013729, R01EY011123, and P30EY008571; J. F. K. and J. A. G. by NIH R01GM068414; J. L. D. by NIH R01EY015240; D. R. H. by NIH P30EY003040 and R01EY001545; M. E. K. and S. B. by NIH T32HL091812. P. P. is a Senior Scholar from the Fonds de la Recherche en Sante du Quebec (FRSQ). M. M. W. C. is a QEII Fellow of the Australian Research Council and is supported by National Health and Medical Research Council, Australia Project Grant 637228. E. F. and D. R. L. are investigators of the Howard Hughes Medical Institute.	Alexander JJ, 2008, ADV EXP MED BIOL, V613, P121, DOI 10.1007/978-0-387-74904-4_13; Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Prades C, 1996, J MOL EVOL, V42, P37, DOI 10.1007/BF00163209; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105	52	438	467	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					325	+		10.1038/nature09830	http://dx.doi.org/10.1038/nature09830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21297615	Green Accepted			2022-12-01	WOS:000288444000034
J	Oberst, A; Dillon, CP; Weinlich, R; McCormick, LL; Fitzgerald, P; Pop, C; Hakem, R; Salvesen, GS; Green, DR				Oberst, Andrew; Dillon, Christopher P.; Weinlich, Ricardo; McCormick, Laura L.; Fitzgerald, Patrick; Pop, Cristina; Hakem, Razq; Salvesen, Guy S.; Green, Douglas R.			Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis	NATURE			English	Article							CELL-DEATH; RIP1 KINASE; ACTIVATION; REQUIREMENT; APOPTOSIS; HOMEOSTASIS; EXPRESSION; RECEPTORS; REGULATOR; CLEAVAGE	Caspase-8 has two opposing biological functions-it promotes cell death by triggering the extrinsic pathway of apoptosis, but also has a survival activity, as it is required for embryonic development(1), T-lymphocyte activation(2), and resistance to necrosis induced by tumour necrosis factor-alpha (TNF-alpha) and related family ligands(3,4). Here we show that development of caspase-8-deficient mice is completely rescued by ablation of receptor interacting protein kinase-3 (RIPK3). Adult animals lacking both caspase-8 and RIPK3 display a progressive lymphoaccumulative disease resembling that seen with defects in CD95 or CD95-ligand (also known as FAS and FASLG, respectively), and resist the lethal effects of CD95 ligation in vivo. We have found that caspase-8 prevents RIPK3-dependent necrosis without inducing apoptosis by functioning in a proteolytically active complex with FLICE-like inhibitory protein long (FLIPL, also known as CFLAR), and this complex is required for the protective function.	[Oberst, Andrew; Dillon, Christopher P.; Weinlich, Ricardo; McCormick, Laura L.; Fitzgerald, Patrick; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Pop, Cristina; Salvesen, Guy S.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Hakem, Razq] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	St Jude Children's Research Hospital; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Weinlich, Ricardo/G-9028-2013; Dillon, Christopher/P-4457-2014; Green, Douglas R/N-8083-2018; Weinlich, Ricardo/AAW-3154-2020; Weinlich, Ricardo/S-7495-2016	Dillon, Christopher/0000-0002-9458-0266; Green, Douglas R/0000-0002-7332-1417; Weinlich, Ricardo/0000-0001-6822-7330; Hakem, Razqallah/0000-0001-5948-7931	NIH [AI44828, CA69381]; CIHR [MOP 36537]; Sass Foundation for Medical Research; ALSAC; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Sass Foundation for Medical Research; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank W. J. Kaiser and E. S. Mocarski for their discussions and material support. We thank Ariad Pharmaceutical for providing the homo- and heterodimerization reagents. We thank the members of the St. Jude Immunology FACS core facility, as well as M. Johnson, L. Janke and the St. Jude Veterinary Pathology Core. We also thank the St. Jude Hartwell Center. This work was supported by NIH grant AI44828 to D. R. G. and CA69381 to G. S. S., as well as CIHR grant MOP 36537 to R. H. C. P. D. was supported by a fellowship grant from the Sass Foundation for Medical Research. This work was also supported by ALSAC.	Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chang David W, 2003, Sci STKE, V2003, pPL1, DOI 10.1126/stke.2003.167.pl1; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scharner D, 2009, ARTERIOSCL THROM VAS, V29, P571, DOI 10.1161/ATVBAHA.108.182006; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	32	872	882	8	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					363	+		10.1038/nature09852	http://dx.doi.org/10.1038/nature09852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368763	Green Accepted			2022-12-01	WOS:000288444000042
J	Struijs, JN; Baan, CA				Struijs, Jeroen N.; Baan, Caroline A.			Integrating Care through Bundled Payments - Lessons from the Netherlands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Struijs, Jeroen N.; Baan, Caroline A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Struijs, JN (corresponding author), Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.		Struijs, Jeroen/AAQ-9872-2020; Struijs, Jeroen/AAA-8057-2022; Struijs, Jeroen/AAX-6827-2020	Struijs, Jeroen/0000-0002-7493-6720; 				COORDINATINGCAR.BT, 2008, NEW ENGL J MED, V358, P1064; de Brantes F, 2009, NEW ENGL J MED, V361, P1033, DOI 10.1056/NEJMp0906121; Devers K, 2009, CAN ACCOUNTABLE CARE; Luft HS, 2010, NEW ENGL J MED, V363, P1389, DOI 10.1056/NEJMp1009380; STRUIJS JN, 2010, EXPT BUNDLED PAYMENT	5	104	104	4	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					990	991		10.1056/NEJMp1011849	http://dx.doi.org/10.1056/NEJMp1011849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735SX	21410368				2022-12-01	WOS:000288439000003
J	Davidson, GH; Hamlat, CA; Rivara, FP; Koepsell, TD; Jurkovich, GJ; Arbabi, S				Davidson, Giana H.; Hamlat, Christian A.; Rivara, Frederick P.; Koepsell, Thomas D.; Jurkovich, Gregory J.; Arbabi, Saman			Long-term Survival of Adult Trauma Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE IMPUTATION; NATIONAL EVALUATION; GERIATRIC-PATIENTS; INJURED PATIENTS; LATE DEATH; OUTCOMES; CARE; MORTALITY; SYSTEMS; DISCHARGE	Context Inpatient trauma case fatality rates may provide an incomplete assessment for overall trauma care effectiveness. To date, there have been few large studies evaluating long-term mortality in trauma patients and identifying predictors that increase risk for death following hospital discharge. Objectives To determine the long-term mortality of patients following trauma admission and to evaluate survivorship in relationship with discharge disposition. Design, Setting, and Patients Retrospective cohort study of 124 421 injured adult patients during January 1995 to December 2008 using the Washington State Trauma Registry linked to death certificate data. Main Outcome Measures Kaplan-Meier and Cox proportional hazards models were used to evaluate long-term mortality following hospital admission for trauma. Results Of the 124 421 trauma patients, 7243 died before hospital discharge and 21 045 died following hospital discharge. Cumulative mortality at 3 years postinjury was 16% (95% confidence interval [CI], 15.8%-16.2%) compared with the expected population cumulative mortality of 5.9% (95% CI, 5.9%-5.9%). In-hospital mortality improved during the 14-year study period from 8% (n=362) to 4.9% (n=600), whereas long-term cumulative mortality increased from 4.7% (95% CI, 4.1%-5.4%) to 7.4% (95% CI, 6.8%-8.1%). After adjustments for confounders, patients who were older and those who were discharged to a skilled nursing facility had the highest risk of death. The adjusted hazard ratios (HRs) for death after discharge to a skilled nursing facility compared with that after discharge home were 1.41 (95% CI, 0.72-2.76) for patients aged 18 to 30 years, 1.92 (95% CI, 1.36-2.73) for patients aged 31 to 45 years, 2.02 (95% CI, 1.39-2.93) for patients aged 46 to 55 years, 1.93 (95% CI, 1.40-2.64) for patients aged 56 to 65 years, 1.49 (95% CI, 1.14-1.94) for patients aged 66 to 75 years, 1.54 (95% CI, 1.27-1.87) for patients aged 76 to 80 years, and 1.38 (95% CI, 1.09-1.74) for patients older than 80 years. Other significant predictors of mortality after discharge included maximum head injury score on Abbreviated Injury Score scale (HR, 1.20; 95% CI, 1.13-1.26), Injury Severity Score (HR, 0.98; 95% CI, 0.97-0.98), Functional Independence Measure (HR, 0.89; 95% CI, 0.88-0.91), mechanism of injury being a fall (HR, 1.43; 95% CI, 1.30-1.58), and having Medicare (HR, 1.28; 95% CI, 1.15-1.43) or other government insurance (HR, 1.65; 95% CI, 1.47-1.85). Conclusions Among adults admitted for trauma in Washington State, 3-year cumulative mortality was 16% despite a decline in in-hospital deaths. Discharge to a skilled nursing facility at any age following trauma admission was associated with a higher risk of subsequent mortality. JAMA. 2011;305(10):1001-1007 www.jama.com	[Davidson, Giana H.; Hamlat, Christian A.; Jurkovich, Gregory J.; Arbabi, Saman] Univ Washington, Dept Surg, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Rivara, Frederick P.; Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Arbabi, Saman] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Arbabi, S (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359796, Seattle, WA 98104 USA.	sarbabi@uw.edu			National Institute of Child Health and Human Development [1T32HD057822-01AZ]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057822] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Child Health and Human Development grant 1T32HD057822-01AZ that was awarded to the Pediatric Injury Research Training Program.	Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; Claridge JA, 2010, J AM COLL SURGEONS, V210, P788, DOI 10.1016/j.jamcollsurg.2009.12.035; Clark DE, 2004, J AM GERIATR SOC, V52, P2023, DOI 10.1111/j.1532-5415.2004.52560.x; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; Gubler KD, 1996, J TRAUMA, V41, P952, DOI 10.1097/00005373-199612000-00002; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Legner VJ, 2009, ANN SURG, V249, P250, DOI 10.1097/SLA.0b013e318195e12f; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mullins RJ, 1998, JAMA-J AM MED ASSOC, V279, P1727, DOI 10.1001/jama.279.21.1727; Munin MC, 2010, AM J PHYS MED REHAB, V89, P530, DOI 10.1097/PHM.0b013e3181e29f54; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Olson CJ, 2003, J TRAUMA, V55, P45, DOI 10.1097/01.TA.0000071291.17287.57; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Skaga NO, 2008, INJURY, V39, P612, DOI 10.1016/j.injury.2007.11.426; *US CDCP, MULT CAUS DEATH 2005; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I; Winzelberg GS, 2003, ARCH INTERN MED, V163, P2552, DOI 10.1001/archinte.163.21.2552; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; ZIETLOW SP, 1994, J TRAUMA, V37, P985, DOI 10.1097/00005373-199412000-00020	26	184	186	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1001	1007		10.1001/jama.2011.259	http://dx.doi.org/10.1001/jama.2011.259			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386078	Bronze			2022-12-01	WOS:000288129600019
J	Hussein, SM; Batada, NN; Vuoristo, S; Ching, RW; Autio, R; Narva, E; Ng, S; Sourour, M; Hamalainen, R; Olsson, C; Lundin, K; Mikkola, M; Trokovic, R; Peitz, M; Brustle, O; Bazett-Jones, DP; Alitalo, K; Lahesmaa, R; Nagy, A; Otonkoski, T				Hussein, Samer M.; Batada, Nizar N.; Vuoristo, Sanna; Ching, Reagan W.; Autio, Reija; Narva, Elisa; Ng, Siemon; Sourour, Michel; Hamalainen, Riikka; Olsson, Cia; Lundin, Karolina; Mikkola, Milla; Trokovic, Ras; Peitz, Michael; Bruestle, Oliver; Bazett-Jones, David P.; Alitalo, Kari; Lahesmaa, Riitta; Nagy, Andras; Otonkoski, Timo			Copy number variation and selection during reprogramming to pluripotency	NATURE			English	Article							EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; SELF-RENEWAL; FRAGILE SITES; DIFFERENTIATION; FIBROBLASTS; SUPPRESSION; ACTIVATION; INDUCTION; CULTURE	The mechanisms underlying the low efficiency of reprogramming somatic cells into induced pluripotent stem (iPS) cells are poorly understood. There is a clear need to study whether the reprogramming process itself compromises genomic integrity and, through this, the efficiency of iPS cell establishment. Using a high-resolution single nucleotide polymorphism array, we compared copy number variations (CNVs) of different passages of human iPS cells with their fibroblast cell origins and with human embryonic stem (ES) cells. Here we show that significantly more CNVs are present in early-passage human iPS cells than intermediate passage human iPS cells, fibroblasts or human ES cells. Most CNVs are formed de novo and generate genetic mosaicism in early-passage human iPS cells. Most of these novel CNVs rendered the affected cells at a selective disadvantage. Remarkably, expansion of human iPS cells in culture selects rapidly against mutated cells, driving the lines towards a genetic state resembling human ES cells.	[Hussein, Samer M.; Vuoristo, Sanna; Hamalainen, Riikka; Olsson, Cia; Lundin, Karolina; Mikkola, Milla; Trokovic, Ras; Otonkoski, Timo] Univ Helsinki, Biomedicum Stem Cell Ctr, Res Program Unit, FI-00014 Helsinki, Finland; [Hussein, Samer M.; Sourour, Michel; Hamalainen, Riikka; Nagy, Andras] Samuel Lunenfeld Res Inst, Toronto, ON M5T 3H7, Canada; [Batada, Nizar N.; Ng, Siemon] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Ching, Reagan W.; Bazett-Jones, David P.] Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Autio, Reija; Narva, Elisa; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Autio, Reija; Narva, Elisa; Lahesmaa, Riitta] Abo Akad Univ, FIN-20520 Turku, Finland; [Autio, Reija] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Peitz, Michael; Bruestle, Oliver] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [Peitz, Michael; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Alitalo, Kari] Univ Helsinki, Lab Mol Canc Biol, FI-00014 Helsinki, Finland; [Alitalo, Kari] Univ Helsinki, Cent Hosp, FI-00014 Helsinki, Finland; [Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Otonkoski, Timo] Univ Helsinki, Childrens Hosp, FI-00029 Helsinki, Finland	University of Helsinki; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Turku; Abo Akademi University; Tampere University; University of Bonn; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Toronto; University of Helsinki	Otonkoski, T (corresponding author), Univ Helsinki, Biomedicum Stem Cell Ctr, Res Program Unit, FI-00014 Helsinki, Finland.	nagy@lunenfeld.ca; timo.otonkoski@helsinki.fi	Otonkoski, Timo/F-1189-2011; Nagy, Andras/G-6465-2013; Trokovic, Ras/AAC-7309-2022; Alitalo, Kari K/J-5013-2014; Autio, Reija/D-2037-2014; Närvä, Elisa Maarit/AAA-4885-2022; Martikainen, Riikka/AAR-8397-2020; Peitz, Michael/AHB-0741-2022	Nagy, Andras/0000-0003-4311-0413; Trokovic, Ras/0000-0002-3065-6663; Alitalo, Kari K/0000-0002-7331-0902; Närvä, Elisa Maarit/0000-0003-0517-9436; Martikainen, Riikka/0000-0002-5102-0672; Batada, Nizar/0000-0002-8007-1487; Autio, Reija/0000-0002-6519-2715	EU; Academy of Finland; Finnish Cancer Organizations; Helsinki University Hospital; Sigrid Juselius Foundation; Stem Cell Network Canada; GL2; CIHR; McEwen Centre for Regenerative Medicine; Ontario Institute for Cancer Research through the Ontario Ministry of Research and Innovation	EU(European Commission); Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Helsinki University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Stem Cell Network Canada; GL2; CIHR(Canadian Institutes of Health Research (CIHR)); McEwen Centre for Regenerative Medicine; Ontario Institute for Cancer Research through the Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by funding for the ESTOOLS consortium under the Sixth RFP of the EU (S.M.H., T.O., R.L. and O.B.), the Academy of Finland (T.O. and R.A.), the Finnish Cancer Organizations (R.L.), the Research Funds of the Helsinki University Hospital (T.O.), the Sigrid Juselius Foundation (T.O.), the Stem Cell Network Canada, GL2 and CIHR (A.N.). S.M.H. is a recipient of a McEwen Post-doctoral Fellowship from the McEwen Centre for Regenerative Medicine. N.N.B. is the recipient of a New Investigator Award from the Ontario Institute for Cancer Research, through the Ontario Ministry of Research and Innovation. A.N. is Tier 1 Canada Research Chair in Stem Cells and Regeneration. We are grateful to I. Rogers, M. Faiz and K. Nagy for critically reading and editing the manuscript, and J. Ustinov, H. Sariola and J. Palgi for skilled assistance in the characterization of human iPS cells. We thank N. Rahkonen for sample processing, as well as the Finnish Microarray and Sequencing Centre (http://www.btk.fi/), and the Institute of Human Genetics, University of Bonn, for array processing.	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hagenkord JM, 2010, J MOL DIAGN, V12, P184, DOI 10.2353/jmoldx.2010.090118; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kulkarni A, 2010, MOL CELL BIOL, V30, P578, DOI 10.1128/MCB.01137-09; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Maimets T, 2008, ONCOGENE, V27, P5277, DOI 10.1038/onc.2008.166; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Riethman H, 2005, CHROMOSOME RES, V13, P505, DOI 10.1007/s10577-005-0998-1; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zschenker O, 2009, DNA REPAIR, V8, P886, DOI 10.1016/j.dnarep.2009.05.004	49	690	732	1	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					58	U67		10.1038/nature09871	http://dx.doi.org/10.1038/nature09871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368824				2022-12-01	WOS:000287924100033
J	King, MC				King, Mary-Claire			A Healthy Son	SCIENCE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	King, MC (corresponding author), Univ Washington, Seattle, WA 98195 USA.			King, Mary-Claire/0000-0001-9426-1743					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1026		10.1126/science.1204088	http://dx.doi.org/10.1126/science.1204088			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350166				2022-12-01	WOS:000287699000049
J	Addo, J; Bhalla, A; Crichton, S; Rudd, AG; McKevitt, C; Wolfe, CDA				Addo, Juliet; Bhalla, Ajay; Crichton, Siobhan; Rudd, Anthony G.; McKevitt, Christopher; Wolfe, Charles D. A.			Provision of acute stroke care and associated factors in a multiethnic population: prospective study with the South London Stroke Register	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-CARE; ISCHEMIC-STROKE; SEX-DIFFERENCES; EUROPEAN PERSPECTIVE; THROMBOLYTIC THERAPY; NORTHERN-IRELAND; RISK-FACTORS; OUTCOMES; MANAGEMENT; GUIDELINES	Objectives To investigate time trends in receipt of effective acute stroke care and to determine the factors associated with provision of care. Design Population based stroke register. Setting South London. Participants 3800 patients with first ever ischaemic stroke or primary intracerebral haemorrhage registered between January 1995 and December 2009. Main outcome measures Acute care interventions, admission to hospital, care on a stroke unit, acute drugs, and inequalities in access to care. Results Between 2007 and 2009, 5% (33/620) of patients were still not admitted to a hospital after an acute stroke, particularly those with milder strokes, and 21% (124/584) of patients admitted to hospital were not admitted to a stroke unit. Rates of admission to stroke units and brain imaging, between 1995 and 2009, and for thrombolysis, between 2005 and 2009, increased significantly (P<0.001). Black patients compared with white patients had a significantly increased odds of admission to a stroke unit (odds ratio 1.76, 95% confidence interval 1.35 to 2.29, P<0.001) and of receipt of occupational therapy or physiotherapy (1.90, 1.21 to 2.97, P=0.01), independent of age or stroke severity. Patients with motor or swallowing deficits were also more likely to be admitted to a stroke unit (1.52, 1.12 to 2.06, P=0.001 and 1.32, 1.02 to 1.72, P<0.001, respectively). Length of stay in hospital decreased significantly between 1995 and 2009 (P<0.001). The odds of brain imaging were lowest in patients aged 75 or more years (P=0.004) and those of lower socioeconomic status (P<0.001). The likelihood of those with a functional deficit receiving rehabilitation increased significantly over time (P<0.001). Patients aged 75 or more were more likely to receive occupational therapy or physiotherapy (P=0.002). Conclusion Although the receipt of effective acute stroke care improved between 1995 and 2009, inequalities in its provision were significant, and implementation of evidence based care was not optimal.				Juliet.addo@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021	Wolfe, Charles/0000-0001-8264-0981; Crichton, Siobhan/0000-0001-9962-083X; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613	Guy's and St Thomas' Hospital Charity; Stroke Association; Department of Health, UK; National Institute for Health [RP-PG-0407-10184]; Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre [PB-PG-0407-13228]; Guy's and St Thomas' NHS Trust; National Institute for Health Research [RP-PG-0407-10184] Funding Source: researchfish	Guy's and St Thomas' Hospital Charity; Stroke Association; Department of Health, UK; National Institute for Health; Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's and St Thomas' NHS Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by Guy's and St Thomas' Hospital Charity, The Stroke Association, Department of Health HQIP grants, UK, National Institute for Health Research programme grant (RP-PG-0407-10184). The authors (CW) acknowledge financial support from the Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and the NIHR research for patient benefit programme award (PB-PG-0407-13228). CDAW is a senior investigator for the NIHR. AR is funded by the Guy's and St Thomas' NHS Trust AHSC PA Scheme.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Alter DA, 2003, CAN MED ASSOC J, V168, P261; Aly N, 2000, BRIT MED J, V320, P1511, DOI 10.1136/bmj.320.7248.1511; [Anonymous], 2008, NAT CLIN GUID STROK; Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Beech R, 1996, STROKE, V27, P1958, DOI 10.1161/01.STR.27.11.1958; Bhalla A, 2004, AGE AGEING, V33, P618, DOI 10.1093/ageing/afh219; Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Bhalla A, 2001, AGE AGEING, V30, P197, DOI 10.1093/ageing/30.3.197; Bhalla A, 2010, J STROKE CEREBROVASC, V19, P357, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.005; Bray JE, 2006, INTERN MED J, V36, P483, DOI 10.1111/j.1445-5994.2006.01127.x; Carter KN, 2007, CEREBROVASC DIS, V23, P162, DOI 10.1159/000097054; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2007, NAT STROK STRAT; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Eriksson M, 2009, STROKE, V40, P909, DOI 10.1161/STROKEAHA.108.517581; Farooq MU, 2008, CEREBROVASC DIS, V25, P12, DOI 10.1159/000111494; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Govan L, 2007, COCHRANE DB SYST REV, V4; Grieve R, 2001, STROKE, V32, P1684, DOI 10.1161/01.STR.32.7.1684; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Heidrich J, 2007, EUR J NEUROL, V14, P255, DOI 10.1111/j.1468-1331.2006.01573.x; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Horner RD, 1997, STROKE, V28, P19, DOI 10.1161/01.STR.28.1.19; Irwin P, 2005, J EVAL CLIN PRACT, V11, P306, DOI 10.1111/j.1365-2753.2005.00529.x; Johnston SC, 2001, STROKE, V32, P1061, DOI 10.1161/01.STR.32.5.1061; Kapral MK, 2002, STROKE, V33, P268, DOI 10.1161/hs0102.101169; Kjellstrom T, 2007, CEREBROVASC DIS, V23, P231; Lees KR, 2008, QJM-INT J MED, V101, P863, DOI 10.1093/qjmed/hcn102; McKevitt C, 2005, STROKE, V36, P315, DOI 10.1161/01.STR.0000152332.32267.19; Meretoja A, 2010, STROKE, V41, P1102, DOI 10.1161/STROKEAHA.109.577718; *NAT STROK FDN, 2007, CLIN GUID AC STROK M; National Audit Office, 2005, RED BRAIN DAM FAST A; Quain DA, 2008, MED J AUSTRALIA, V189, P429, DOI 10.5694/j.1326-5377.2008.tb02114.x; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; *ROYAL COLL PHYS C, 2008, NAT SENT STROK AUD P; Rudd AG, 2011, J NEUROL NEUROSUR PS, V82, P14, DOI 10.1136/jnnp.2009.203174; Rudd AG, 2005, STROKE, V36, P103, DOI 10.1161/01.STR.0000149618.14922.8a; Saposnik G, 2009, STROKE, V40, P3328, DOI 10.1161/STROKEAHA.109.558759; Schwamm LH, 2010, CIRCULATION, V121, P1492, DOI 10.1161/CIRCULATIONAHA.109.881490; Stansbury JP, 2005, STROKE, V36, P374, DOI 10.1161/01.STR.0000153065.39325.fd; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c; TEASDALE G, 1974, LANCET, V2, P81; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Weir NU, 2001, STROKE, V32, P1370, DOI 10.1161/01.STR.32.6.1370; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39; Wolfe C, 2001, BRIT MED J, V323, P5, DOI 10.1136/bmj.323.7303.5	49	36	36	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2011	342								d744	10.1136/bmj.d744	http://dx.doi.org/10.1136/bmj.d744			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729BE	21349892	hybrid, Green Published, Green Accepted			2022-12-01	WOS:000287920900009
J	Dubey, GP; Ben-Yehuda, S				Dubey, Gyanendra P.; Ben-Yehuda, Sigal			Intercellular Nanotubes Mediate Bacterial Communication	CELL			English	Article							BACILLUS-SUBTILIS; MECHANISMS; PROTEIN; CYANOBACTERIA; PEPTIDES; PLASMID; SYSTEM; CELLS	Bacteria are known to communicate primarily via secreted extracellular factors. Here we identify a previously uncharacterized type of bacterial communication mediated by nanotubes that bridge neighboring cells. Using Bacillus subtilis as a model organism, we visualized transfer of cytoplasmic fluorescent molecules between adjacent cells. Additionally, by coculturing strains harboring different antibiotic resistance genes, we demonstrated that molecular exchange enables cells to transiently acquire nonhereditary resistance. Furthermore, non-conjugative plasmids could be transferred from one cell to another, thereby conferring hereditary features to recipient cells. Electron microscopy revealed the existence of variously sized tubular extensions bridging neighboring cells, serving as a route for exchange of intracellular molecules. These nanotubes also formed in an interspecies manner, between B. subtilis and Staphylococcus aureus, and even between B. subtilis and the evolutionary distant bacterium Escherichia coli. We propose that nanotubes represent a major form of bacterial communication in nature, providing a network for exchange of cellular molecules within and between species.	[Dubey, Gyanendra P.; Ben-Yehuda, Sigal] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada IMRIC, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Ben-Yehuda, S (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada IMRIC, Hadassah Med Sch, POB 12272, IL-91120 Jerusalem, Israel.	sigalb@ekmd.huji.ac.il			European Research Council [209130]; Israel Science Foundation [696/07]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	We thank I. Popov, E. Blayvas, N. Feinstein, and E. Rahamim (Hebrew University, IL) for technical support during EM studies. We are grateful to A. Rouvinski (Hebrew University, IL) for experimental advice and insightful discussions. We thank R. Losick (Harvard University, USA), M. Kassel (National Institutes of Health, USA), G. Bachrach (Hebrew University, IL), D. Kearns (Indiana University, USA), A. Taraboulos (Hebrew University, IL), and members of the Ben-Yehuda laboratory for valuable discussions and comments. We thank the National BioResource Project National Institute of Genetics, Japan (NIG, Japan) for providing B. subtilis mutant strains. This work was supported by the European Research Council Starting Grant (209130), and by the Israel Science Foundation (696/07) awarded to S. B-Y.	Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; GIDDINGS TH, 1981, ARCH MICROBIOL, V129, P295, DOI 10.1007/BF00414700; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Harwood C.R., 1990, MOL BIOL METHODS BAC; Haugland R.P., 2005, HDB A GUIDEBOOK FLUO; Heinlein M, 2004, INT REV CYTOL, V235, P93, DOI 10.1016/S0074-7696(04)35003-5; Hershey A.D., 1983, LAMBDA 2; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kaiser D, 2008, ANNU REV GENET, V42, P109, DOI 10.1146/annurev.genet.42.110807.091615; Kearns DB, 2001, TRENDS MICROBIOL, V9, P126, DOI 10.1016/S0966-842X(01)01948-5; KOEHLER TM, 1987, J BACTERIOL, V169, P5271, DOI 10.1128/jb.169.11.5271-5278.1987; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kuchma SL, 2000, CURR OPIN BIOTECH, V11, P429, DOI 10.1016/S0958-1669(00)00123-3; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; Madigan TM, 2003, BROCK BIOL MICROORGA, P620; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; Mullineaux CW, 2008, EMBO J, V27, P1299, DOI 10.1038/emboj.2008.66; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Nudleman E, 2005, SCIENCE, V309, P125, DOI 10.1126/science.1112440; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; Schara K, 2009, CELL MOL BIOL LETT, V14, P636, DOI 10.2478/s11658-009-0018-0; SCHLEPER C, 1995, J BACTERIOL, V177, P4417, DOI 10.1128/jb.177.15.4417-4426.1995; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Silverman PM, 1997, MOL MICROBIOL, V23, P423, DOI 10.1046/j.1365-2958.1997.2411604.x; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; TANAKA T, 1977, J BACTERIOL, V131, P699, DOI 10.1128/JB.131.2.699-701.1977; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	44	353	378	12	186	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					590	600		10.1016/j.cell.2011.01.015	http://dx.doi.org/10.1016/j.cell.2011.01.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335240	Bronze			2022-12-01	WOS:000287473100013
J	Munk-Olsen, T; Laursen, TM; Pedersen, CB; Lidegaard, O; Mortensen, PB				Munk-Olsen, Trine; Laursen, Thomas Munk; Pedersen, Carsten B.; Lidegaard, Ojvind; Mortensen, Preben Bo			Induced First-Trimester Abortion and Risk of Mental Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPRESSION; PREGNANCY; WOMEN; REGISTER; HOSPITALIZATION; FAMILY	BACKGROUND Concern has been expressed about potential harm to women's mental health in association with having an induced abortion, but it remains unclear whether induced abortion is associated with an increased risk of subsequent psychiatric problems. METHODS We conducted a population-based cohort study that involved linking information from the Danish Civil Registration system to the Danish Psychiatric Central Register and the Danish National Register of Patients. The information consisted of data for girls and women with no record of mental disorders during the 1995-2007 period who had a first-trimester induced abortion or a first childbirth during that period. We estimated the rates of first-time psychiatric contact (an inpatient admission or outpatient visit) for any type of mental disorder within the 12 months after the abortion or childbirth as compared with the 9-month period preceding the event. RESULTS The incidence rates of first psychiatric contact per 1000 person-years among girls and women who had a first abortion were 14.6 (95% confidence interval [CI], 13.7 to 15.6) before abortion and 15.2 (95% CI, 14.4 to 16.1) after abortion. The corresponding rates among girls and women who had a first childbirth were 3.9 (95% CI, 3.7 to 4.2) before delivery and 6.7 (95% CI, 6.4 to 7.0) post partum. The relative risk of a psychiatric contact did not differ significantly after abortion as compared with before abortion (P=0.19) but did increase after childbirth as compared with before childbirth (P<0.001). CONCLUSIONS The finding that the incidence rate of psychiatric contact was similar before and after a first-trimester abortion does not support the hypothesis that there is an increased risk of mental disorders after a first-trimester induced abortion.	[Munk-Olsen, Trine; Laursen, Thomas Munk; Pedersen, Carsten B.; Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Lidegaard, Ojvind] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Gynecol Clin, DK-2100 Copenhagen, Denmark	Aarhus University; Rigshospitalet; University of Copenhagen	Munk-Olsen, T (corresponding author), Univ Aarhus, Natl Ctr Register Based Res, Taasingegade 1, DK-8000 Aarhus C, Denmark.	tmo@ncrr.dk	Pedersen, Carsten Bøcker/B-8441-2013; Mortensen, Preben B/D-2358-2015; Munk-olsen, Trine/AAS-3546-2021; Laursen, Thomas Munk/AFQ-8066-2022	Pedersen, Carsten Bøcker/0000-0003-2077-8533; Mortensen, Preben B/0000-0002-5230-9865; Munk-olsen, Trine/0000-0002-0786-7147; Laursen, Thomas Munk/0000-0001-6934-1784	Susan Thompson Buffett Foundation; Danish Medical Research Council [09-063642/FSS]; Bayer Schering Pharma	Susan Thompson Buffett Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bayer Schering Pharma(Bayer AG)	Supported by grants from the Susan Thompson Buffett Foundation (to Dr. Munk-Olsen and Dr. Laursen) and the Danish Medical Research Council (09-063642/FSS, to Dr. Munk-Olsen).; Dr. Lidegaard reports receiving lecture fees and research funding from Bayer Schering Pharma. No other potential conflict of interest relevant to this article was reported.	Andersen PK, 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2007, LEGALT PROVOKEREDE A; Casey P, 2008, BRIT J PSYCHIAT, V193, P452, DOI 10.1192/bjp.bp.108.059550; Charles VE, 2008, CONTRACEPTION, V78, P436, DOI 10.1016/j.contraception.2008.07.005; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Coleman PK, 2009, J PSYCHIATR RES, V43, P770, DOI 10.1016/j.jpsychires.2008.10.009; DAGG PKB, 1991, AM J PSYCHIAT, V148, P578; Danish National Board of Health. Classification of Diseases, 1971, CLASS DIS EXT DAN LA; Dwyer Judith M, 2008, Aust New Zealand Health Policy, V5, P2, DOI 10.1186/1743-8462-5-2; Fergusson DM, 2009, BRIT J PSYCHIAT, V194, P377, DOI 10.1192/bjp.194.4.377b; Fergusson DM, 2008, BRIT J PSYCHIAT, V193, P444, DOI 10.1192/bjp.bp.108.056499; Fergusson DM, 2006, J CHILD PSYCHOL PSYC, V47, P16, DOI 10.1111/j.1469-7610.2005.01538.x; Gale S, 2003, J PSYCHOSOM OBST GYN, V24, P257, DOI 10.3109/01674820309074690; GILCHRIST AC, 1995, BRIT J PSYCHIAT, V167, P243, DOI 10.1192/bjp.167.2.243; Harlow BL, 2007, ARCH GEN PSYCHIAT, V64, P42, DOI 10.1001/archpsyc.64.1.42; Jakobsen KD, 2005, NORD J PSYCHIAT, V59, P209, DOI 10.1080/08039480510027698; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; Jones I, 2008, ARCH GEN PSYCHIAT, V65, P356, DOI 10.1001/archpsyc.65.3.356-a; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; KENDELL RE, 1987, BRIT J PSYCHIAT, V151, P135; KENDLER KS, 1990, PSYCHOL MED, V20, P311, DOI 10.1017/S0033291700017621; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Laursen TM, 2005, ARCH GEN PSYCHIAT, V62, P841, DOI 10.1001/archpsyc.62.8.841; Lazzarini Z, 2008, NEW ENGL J MED, V359, P2189, DOI 10.1056/NEJMp0806742; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Major B, 2009, AM PSYCHOL, V64, P863, DOI 10.1037/a0017497; Munk-Olsen T, 2007, J CLIN PSYCHIAT, V68, P1947, DOI 10.4088/JCP.v68n1217; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; Munk-Olsen T, 2009, ARCH GEN PSYCHIAT, V66, P189, DOI 10.1001/archgenpsychiatry.2008.528; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen W, 2008, SCAND J PUBLIC HEALT, V36, P424, DOI 10.1177/1403494807088449; Reardon DC, 2002, BRIT MED J, V324, P151, DOI 10.1136/bmj.324.7330.151; Rothman K. J., 2008, MODERN EPIDEMIOLOGY; Schmiege S, 2005, BMJ-BRIT MED J, V331, P1303, DOI 10.1136/bmj.38623.532384.55; Steinberg JR, 2009, CONTRACEPTION, V79, P81, DOI 10.1016/j.contraception.2008.10.011; Thorp JM, 2003, OBSTET GYNECOL SURV, V58, P67, DOI 10.1097/00006254-200301000-00023; World Health Organization, 1994, WHO ICD 10 MENT BEH	41	108	109	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					332	339		10.1056/NEJMoa0905882	http://dx.doi.org/10.1056/NEJMoa0905882			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711LH	21268725				2022-12-01	WOS:000286592600008
J	Qureshi, OS; Zheng, Y; Nakamura, K; Attridge, K; Manzotti, C; Schmidt, EM; Baker, J; Jeffery, LE; Kaur, S; Briggs, Z; Hou, TZ; Futter, CE; Anderson, G; Walker, LSK; Sansom, DM				Qureshi, Omar S.; Zheng, Yong; Nakamura, Kyoko; Attridge, Kesley; Manzotti, Claire; Schmidt, Emily M.; Baker, Jennifer; Jeffery, Louisa E.; Kaur, Satdip; Briggs, Zoe; Hou, Tie Z.; Futter, Clare E.; Anderson, Graham; Walker, Lucy S. K.; Sansom, David M.			Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4	SCIENCE			English	Article							T-CELL; DENDRITIC CELLS; SURFACE EXPRESSION; TARGET-CELLS; B-CELLS; ACTIVATION; PROTEINS; LYMPHOPROLIFERATION; TROGOCYTOSIS; SECRETION	Cytotoxic T lymphocyte antigen 4 (CTLA-4) is an essential negative regulator of T cell immune responses whose mechanism of action is the subject of debate. CTLA-4 shares two ligands (CD80 and CD86) with a stimulatory receptor, CD28. Here, we show that CTLA-4 can capture its ligands from opposing cells by a process of trans-endocytosis. After removal, these costimulatory ligands are degraded inside CTLA-4-expressing cells, resulting in impaired costimulation via CD28. Acquisition of CD86 from antigen-presenting cells is stimulated by T cell receptor engagement and observed in vitro and in vivo. These data reveal a mechanism of immune regulation in which CTLA-4 acts as an effector molecule to inhibit CD28 costimulation by the cell-extrinsic depletion of ligands, accounting for many of the known features of the CD28-CTLA-4 system.	[Qureshi, Omar S.; Zheng, Yong; Nakamura, Kyoko; Attridge, Kesley; Manzotti, Claire; Schmidt, Emily M.; Baker, Jennifer; Jeffery, Louisa E.; Kaur, Satdip; Briggs, Zoe; Hou, Tie Z.; Anderson, Graham; Walker, Lucy S. K.; Sansom, David M.] Univ Birmingham, Sch Med, Inst Biomed Res, Sch Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; [Futter, Clare E.] UCL, Dept Cell Biol, Inst Ophthalmol, London EC1V 9EL, England	University of Birmingham; University of London; University College London	Sansom, DM (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Sch Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.	d.m.sansom@bham.ac.uk	Nakamura, Kyoko/B-4184-2013; HOU, TIEZHENG/B-4848-2015; Qureshi, Omar/CAF-4545-2022	anderson, graham/0000-0002-2917-4085; Attridge, Kesley/0000-0003-4521-9009; Walker, Lucy/0000-0001-5986-5015; Sansom, David/0000-0001-6506-3115; Manzotti, Claire/0000-0001-5894-5435; Kaur, Satdip/0000-0002-0901-9141; Futter, Clare/0000-0001-5559-9389	UK Biotechnology and Biological Sciences Research Council; MRC; Wellcome Trust; Arthritis Research UK; Biotechnology and Biological Sciences Research Council [BB/H013598/1, BB/D011000/1] Funding Source: researchfish; Medical Research Council [G9818340, G0400931, G1000213, G0802382, G9818340B, G0401620] Funding Source: researchfish; BBSRC [BB/H013598/1, BB/D011000/1] Funding Source: UKRI; MRC [G9818340, G0802382, G0400931, G0401620, G1000213] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank A. Sharpe for the generous gift of Ctla4<SUP>-/-</SUP> mice, W. Heath for the rip-mOVA mice, and G. Freeman for the I-A<SUP>d</SUP>-expressing CHO cells. This work was supported by the UK Biotechnology and Biological Sciences Research Council (O.Q.), MRC (L. S. K. W., Y.Z., K. A., E. S., and K.N.), Wellcome Trust (C. M., T. H., and Z.B.), and Arthritis Research UK (L.J.). L. S. K. W. is an MRC Senior Fellow. Cell lines expressing CD80, CD86, and CTLA-4 are available under a material transfer agreement for noncommercial use.	Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Catalfamo M, 2008, IMMUNOLOGY, V125, P70, DOI 10.1111/j.1365-2567.2008.02822.x; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Chuang E, 1997, J IMMUNOL, V159, P144; Daubeuf S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008716; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Kusakari S, 2008, J CELL SCI, V121, P1213, DOI 10.1242/jcs.025015; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2008, J IMMUNOL, V181, P1683, DOI 10.4049/jimmunol.181.3.1683	31	1002	1049	5	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					600	603		10.1126/science.1202947	http://dx.doi.org/10.1126/science.1202947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21474713	Green Accepted			2022-12-01	WOS:000289991100052
J	Sheron, N; Hawkey, C; Gilmore, I				Sheron, Nick; Hawkey, Chris; Gilmore, Ian			Projections of alcohol deaths-a wake-up call	LANCET			English	Editorial Material							POLICY		[Sheron, Nick] Univ Southampton, Fac Med, Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England; [Hawkey, Chris] Univ Nottingham Hosp, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2UH, England; [Gilmore, Ian] Royal Liverpool Hosp, Liverpool L7 8XP, Merseyside, England; [Gilmore, Ian] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Southampton; University of Nottingham; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Sheron, N (corresponding author), Univ Southampton, Fac Med, Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England.	Nick.Sheron@soton.ac.uk		Sheron, Nick/0000-0002-6156-8367; Sheron, Nick/0000-0001-5232-8292				Abel EL, 2001, ALCOHOL ALCOHOLISM, V36, P401, DOI 10.1093/alcalc/36.5.401; Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; BROWN RH, 2003, FORBIDDEN SUBSTANCES, pCH6; Department of Health, 2008, SAF SENS SOC CONS FU; DUFFY JC, 2010, J R STAT SOC, V149, P44; House of Commons Health Committee, 2010, ALC 1 REP SESS 2009; Jernigan DH, 2000, B WORLD HEALTH ORGAN, V78, P491; Jewell J, 2010, CLIN MED, V10, P259, DOI 10.7861/clinmedicine.10-3-259; JOLIFFE N, 1949, Q J STUD ALCOHOL, V2, P544; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; TERRIS M, 1967, AM J PUBLIC HEALTH, V57, P2067; The NHS Information Centre, 2009, STAT ALC ENGL 2009; *WHO, 2008, HLTH STAT INF SYST G; World Health Organisation, 2004, GLOB STAT REP ALC 20; World Health Organization, 2009, WHO EUR HLTH ALL DAT	15	35	36	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1297	1299		10.1016/S0140-6736(11)60022-6	http://dx.doi.org/10.1016/S0140-6736(11)60022-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21334738				2022-12-01	WOS:000289962900008
J	Chapman, MA; Lawrence, MS; Keats, JJ; Cibulskis, K; Sougnez, C; Schinzel, AC; Harview, CL; Brunet, JP; Ahmann, GJ; Adli, M; Anderson, KC; Ardlie, KG; Auclair, D; Baker, A; Bergsagel, PL; Bernstein, BE; Drier, Y; Fonseca, R; Gabriel, SB; Hofmeister, CC; Jagannath, S; Jakubowiak, AJ; Krishnan, A; Levy, J; Liefeld, T; Lonial, S; Mahan, S; Mfuko, B; Monti, S; Perkins, LM; Onofrio, R; Pugh, TJ; Rajkumar, SV; Ramos, AH; Siegel, DS; Sivachenko, A; Stewart, AK; Trudel, S; Vij, R; Voet, D; Winckler, W; Zimmerman, T; Carpten, J; Trent, J; Hahn, WC; Garraway, LA; Meyerson, M; Lander, ES; Getz, G; Golub, TR				Chapman, Michael A.; Lawrence, Michael S.; Keats, Jonathan J.; Cibulskis, Kristian; Sougnez, Carrie; Schinzel, Anna C.; Harview, Christina L.; Brunet, Jean-Philippe; Ahmann, Gregory J.; Adli, Mazhar; Anderson, Kenneth C.; Ardlie, Kristin G.; Auclair, Daniel; Baker, Angela; Bergsagel, P. Leif; Bernstein, Bradley E.; Drier, Yotam; Fonseca, Rafael; Gabriel, Stacey B.; Hofmeister, Craig C.; Jagannath, Sundar; Jakubowiak, Andrzej J.; Krishnan, Amrita; Levy, Joan; Liefeld, Ted; Lonial, Sagar; Mahan, Scott; Mfuko, Bunmi; Monti, Stefano; Perkins, Louise M.; Onofrio, Robb; Pugh, Trevor J.; Rajkumar, S. Vincent; Ramos, Alex H.; Siegel, David S.; Sivachenko, Andrey; Stewart, A. Keith; Trudel, Suzanne; Vij, Ravi; Voet, Douglas; Winckler, Wendy; Zimmerman, Todd; Carpten, John; Trent, Jeff; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.			Initial genome sequencing and analysis of multiple myeloma	NATURE			English	Article							B-CELL LYMPHOMA; HUMAN CANCER; SOMATIC MUTATIONS; STRESS-RESPONSE; GENE; PATHOGENESIS; BLIMP-1; EXOSOME; DIFFERENTIATION; CLASSIFICATION	Multiple myeloma is an incurable malignancy of plasma cells, and its pathogenesis is poorly understood. Here we report the massively parallel sequencing of 38 tumour genomes and their comparison to matched normal DNAs. Several new and unexpected oncogenic mechanisms were suggested by the pattern of somatic mutation across the data set. These include the mutation of genes involved in protein translation (seen in nearly half of the patients), genes involved in histone methylation, and genes involved in blood coagulation. In addition, a broader than anticipated role of NF-kappa B signalling was indicated by mutations in 11 members of the NF-kappa B pathway. Of potential immediate clinical relevance, activating mutations of the kinase BRAF were observed in 4% of patients, suggesting the evaluation of BRAF inhibitors in multiple myeloma clinical trials. These results indicate that cancer genome sequencing of large collections of samples will yield new insights into cancer not anticipated by existing knowledge.	[Chapman, Michael A.; Lawrence, Michael S.; Cibulskis, Kristian; Sougnez, Carrie; Harview, Christina L.; Brunet, Jean-Philippe; Adli, Mazhar; Ardlie, Kristin G.; Bernstein, Bradley E.; Drier, Yotam; Gabriel, Stacey B.; Liefeld, Ted; Mahan, Scott; Monti, Stefano; Onofrio, Robb; Pugh, Trevor J.; Ramos, Alex H.; Sivachenko, Andrey; Voet, Douglas; Winckler, Wendy; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.] Eli & Edythe L Broad Inst, Cambridge Ctr 7, Cambridge, MA 02412 USA; [Keats, Jonathan J.; Ahmann, Gregory J.; Bergsagel, P. Leif; Fonseca, Rafael; Stewart, A. Keith] Mayo Clin Arizona, Scottsdale, AZ 85259 USA; [Keats, Jonathan J.; Ahmann, Gregory J.; Anderson, Kenneth C.; Auclair, Daniel; Bergsagel, P. Leif; Fonseca, Rafael; Hofmeister, Craig C.; Jagannath, Sundar; Jakubowiak, Andrzej J.; Krishnan, Amrita; Levy, Joan; Lonial, Sagar; Mfuko, Bunmi; Perkins, Louise M.; Rajkumar, S. Vincent; Siegel, David S.; Stewart, A. Keith; Trudel, Suzanne; Vij, Ravi; Zimmerman, Todd] Multiple Myeloma Res Consortium, Norwalk, CT 06581 USA; [Schinzel, Anna C.; Anderson, Kenneth C.; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Adli, Mazhar; Bernstein, Bradley E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Auclair, Daniel; Levy, Joan; Mfuko, Bunmi; Perkins, Louise M.] Multiple Myeloma Res Fdn, Norwalk, CT 06581 USA; [Baker, Angela; Carpten, John; Trent, Jeff] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Bernstein, Bradley E.; Hahn, William C.; Meyerson, Matthew; Lander, Eric S.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bernstein, Bradley E.; Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Hofmeister, Craig C.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Jagannath, Sundar] St Vincents Comprehens Canc Ctr, New York, NY 11001 USA; [Jakubowiak, Andrzej J.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Krishnan, Amrita] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA; [Lonial, Sagar] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Rajkumar, S. Vincent] Mayo Clin Rochester, Rochester, MN 55905 USA; [Siegel, David S.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ 07601 USA; [Trudel, Suzanne] Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada; [Vij, Ravi] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Zimmerman, Todd] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Lander, Eric S.] MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Translational Genomics Research Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Weizmann Institute of Science; University System of Ohio; Ohio State University; Saint Vincents Hospital Manhattan; University of Michigan System; University of Michigan; City of Hope; Emory University; Mayo Clinic; Hackensack University Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Washington University (WUSTL); University of Chicago; University of Chicago Medical Center; Massachusetts Institute of Technology (MIT)	Golub, TR (corresponding author), Eli & Edythe L Broad Inst, Cambridge Ctr 7, Cambridge, MA 02412 USA.	gadgetz@broadinstitute.org; golub@broadinstitute.org	Pugh, Trevor/Y-2535-2019; Rajkumar, S. Vincent/AAV-1834-2021; Hofmeister, Craig/O-4988-2019; Bergsagel, Peter Leif/A-7842-2011; Lawrence, Michael/AAC-8202-2020; Cibulskis, Kristian/AAC-7380-2019; Hofmeister, Craig/E-3256-2011; Meyerson, Matthew L/E-7123-2012; Drier, Yotam/K-5208-2012	Pugh, Trevor/0000-0002-8073-5888; Rajkumar, S. Vincent/0000-0002-5862-1833; Hofmeister, Craig/0000-0003-4816-1607; Bergsagel, Peter Leif/0000-0003-1523-7388; Hofmeister, Craig/0000-0003-4816-1607; Drier, Yotam/0000-0003-1725-2995; Monti, Stefano/0000-0002-9376-0660; Perkins, Louise/0000-0003-3945-8927; Cibulskis, Kristian/0000-0003-1343-1582; Keats, Jonathan/0000-0003-4375-7399; Harview, Christina/0000-0002-5003-8539; Meyerson, Matthew/0000-0002-9133-8108; Fonseca, Rafael/0000-0002-5938-3769	Multiple Myeloma Research Foundation; Leukaemia and Lymphoma Research (UK); NATIONAL CANCER INSTITUTE [R01CA133115, K12CA133250, R01CA133966] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020686] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; Leukaemia and Lymphoma Research (UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by a grant from the Multiple Myeloma Research Foundation. M.A.C. was supported by a Clinician Scientist Fellowship from Leukaemia and Lymphoma Research (UK). We are grateful to all members of the Broad Institute's Biological Samples Platform, Genetic Analysis Platform, and Genome Sequencing Platform, without whom this work would not have been possible.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carbone A, 2008, GENE CHROMOSOME CANC, V47, P1067, DOI 10.1002/gcc.20601; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Cenci S, 2007, FEBS LETT, V581, P3652, DOI 10.1016/j.febslet.2007.04.031; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; ESUMI N, 1991, CANCER RES, V51, P4549; Flaherty K., 2009, 2009 ASCO M AM SOC C; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim K, 2010, BRIT J HAEMATOL, V149, P537, DOI 10.1111/j.1365-2141.2010.08127.x; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lessard J, 2003, EXP HEMATOL, V31, P567, DOI 10.1016/S0301-472X(03)00081-X; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Masciarelli S, 2010, MOL IMMUNOL, V47, P1356, DOI 10.1016/j.molimm.2009.12.003; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhang W, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-332; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	47	1090	1133	1	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					467	472		10.1038/nature09837	http://dx.doi.org/10.1038/nature09837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430775	Green Accepted, hybrid, Green Submitted			2022-12-01	WOS:000288702200053
J	Parolini, O				Parolini, Ornella			In Utero Hematopoietic Stem-Cell Transplantation - A Match for Mom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY		Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy		Parolini, O (corresponding author), Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy.		PAROLINI, ORNELLA/C-7946-2013; PAROLINI, ORNELLA/ABI-7862-2020	PAROLINI, ORNELLA/0000-0002-5211-6430; PAROLINI, ORNELLA/0000-0002-5211-6430				Flake AW, 1996, NEW ENGL J MED, V335, P1806, DOI 10.1056/NEJM199612123352404; Nijagal A, 2011, J CLIN INVEST, V121, P582, DOI 10.1172/JCI44907; Peranteau WH, 2007, BLOOD, V109, P1331, DOI 10.1182/blood-2006-04-018606; Wengler GS, 1996, LANCET, V348, P1484, DOI 10.1016/S0140-6736(96)09392-0	4	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1174	1175		10.1056/NEJMcibr1100692	http://dx.doi.org/10.1056/NEJMcibr1100692			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428775				2022-12-01	WOS:000288701100015
J	Takeuchi, D; Hirabayashi, T; Tamura, K; Miyashita, Y				Takeuchi, Daigo; Hirabayashi, Toshiyuki; Tamura, Keita; Miyashita, Yasushi			Reversal of Interlaminar Signal Between Sensory and Memory Processing in Monkey Temporal Cortex	SCIENCE			English	Article							AUDITORY-CORTEX; MACAQUE MONKEY; OSCILLATIONS; NETWORK; LOBE; ORGANIZATION; RECOGNITION; INFORMATION; PERCEPTION; MECHANISMS	The primate temporal cortex implements visual long-term memory. However, how its interlaminar circuitry executes cognitive computations is poorly understood. Using linear-array multicontact electrodes, we simultaneously recorded unit activities across cortical layers in the perirhinal cortex of macaques performing a pair-association memory task. Cortical layers were estimated on the basis of current source density profiles with histological verifications, and the interlaminar signal flow was determined with cross-correlation analysis between spike trains. During the cue period, canonical "feed-forward" signals flowed from granular to supragranular layers and from supragranular to infragranular layers. During the delay period, however, the signal flow reversed to the "feed-back" direction: from infragranular to supragranular layers. This reversal of signal flow highlights how the temporal cortex differentially recruits its laminar circuits for sensory and mnemonic processing.	[Takeuchi, Daigo; Hirabayashi, Toshiyuki; Tamura, Keita; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Tamura, Keita/I-2931-2012; Miyashita, Yasushi/B-7171-2019	Tamura, Keita/0000-0003-2697-1510; Miyashita, Yasushi/0000-0003-3496-8637	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19002010, 18700378]; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) [1811234, 211438]; Grants-in-Aid for Scientific Research [19002010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to Y.M. (19002010) and Grant-in-Aid for Young Scientists from MEXT to T. H. (18700378); a grant from Takeda Science Foundation to Y.M.; and Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists to D. T. (1811234) and K. T. (211438). This work was also supported in part by Global Center of Excellence Program from MEXT. We thank M. Takeda for discussions and comments and H. Kasahara, R. Fujimichi, T. Matsui, and K. W. Koyano for advice and help with experiments.	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; Hirabayashi T, 2010, J NEUROSCI, V30, P10407, DOI 10.1523/JNEUROSCI.0135-10.2010; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Naya Y, 2003, J NEUROSCI, V23, P2861; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Saleem KS, 1996, J NEUROSCI, V16, P4757; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Suzuki WA, 2003, J COMP NEUROL, V463, P67, DOI 10.1002/cne.10744; Suzuki WA, 2009, NEURON, V61, P657, DOI 10.1016/j.neuron.2009.02.008; Tomita M, 2005, J NEUROPHYSIOL, V93, P378, DOI 10.1152/jn.00643.2004; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003	28	91	92	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1443	1447		10.1126/science.1199967	http://dx.doi.org/10.1126/science.1199967			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415353				2022-12-01	WOS:000288504000043
J	Ataide, SF; Schmitz, N; Shen, KA; Ke, AL; Shan, SO; Doudna, JA; Ban, NN				Ataide, Sandro F.; Schmitz, Nikolaus; Shen, Kuang; Ke, Ailong; Shan, Shu-ou; Doudna, Jennifer A.; Ban, Nenad			The Crystal Structure of the Signal Recognition Particle in Complex with Its Receptor	SCIENCE			English	Article							SRP GTPASES FFH; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; TRANSLATING RIBOSOME; NUCLEOTIDE SPECIFICITY; 4.5S RNA; FTSY; BINDING; DOMAIN; CORE	Cotranslational targeting of membrane and secretory proteins is mediated by the universally conserved signal recognition particle (SRP). Together with its receptor (SR), SRP mediates the guanine triphosphate (GTP)-dependent delivery of translating ribosomes bearing signal sequences to translocons on the target membrane. Here, we present the crystal structure of the SRP: SR complex at 3.9 angstrom resolution and biochemical data revealing that the activated SRP: SR guanine triphosphatase (GTPase) complex binds the distal end of the SRP hairpin RNA where GTP hydrolysis is stimulated. Combined with previous findings, these results suggest that the SRP: SR GTPase complex initially assembles at the tetraloop end of the SRP RNA and then relocalizes to the opposite end of the RNA. This rearrangement provides a mechanism for coupling GTP hydrolysis to the handover of cargo to the translocon.	[Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ataide, Sandro F.; Schmitz, Nikolaus; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Shen, Kuang; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology; Cornell University	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu; ban@mol.biol.ethz.ch	Shen, Kuang/H-9441-2016	F Ataide, Sandro/0000-0003-1807-5708; Dietz, Nikolaus/0000-0001-7300-4342	Howard Hughes Medical Institute; ETH; Boehringer Ingelheim Fonds; NIH [GM078024]; Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) of the SNSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024, R01GM086766] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); ETH(ETH Zurich); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) of the SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Zhou for excellent technical assistance and help with crystal preparation during the early stages of the project. Initial crystallographic analysis was performed at beamline 8.2.2 at the Advanced Light Source (ALS), Lawrence Berkeley National Laboratory; we acknowledge C. Ralston for outstanding technical assistance at the ALS. Crystallographic data were collected at the beamline X06SA at the Swiss Light Source (SLS). We thank A. Brunger for the prerelease version of CNS and for helpful comments on the refinement, C. Schulze-Briese and T. Tomizaki for their outstanding support at the SLS, T. Maier and S. Klinge for critical discussion and reading of the manuscript, and T. Maier and M. Leibundgut for help and assistance with data collection and solving the structure. S.F.A. was funded initially by the Howard Hughes Medical Institute and currently by an ETH postdoctoral fellowship, N.S. is funded by Boehringer Ingelheim Fonds, and K.S. is funded by NIH grant GM078024 to S.S. This work was supported in part by the Howard Hughes Medical Institute (J.A.D.) and by the Swiss National Science Foundation (SNSF) and the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF. Atomic coordinates and structure factors for the SRP:SR crystal structure have been deposited with the Protein Data Bank under accession code 2xxa.	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Batey RT, 2002, BIOCHEMISTRY-US, V41, P11703, DOI 10.1021/bi026163c; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Buskiewicz I, 2005, J MOL BIOL, V351, P417, DOI 10.1016/j.jmb.2005.06.023; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Focia PJ, 2006, J MOL BIOL, V360, P631, DOI 10.1016/j.jmb.2006.05.031; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Gawronski-Salerno J, 2007, J STRUCT BIOL, V158, P122, DOI 10.1016/j.jsb.2006.10.025; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Jagath JR, 2001, RNA, V7, P293, DOI 10.1017/S1355838201002205; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Reyes CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000607; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Schmitz U, 1996, RNA, V2, P1213; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2005, BIOCHEMISTRY-US, V44, P6214, DOI 10.1021/bi0500980; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Spanggord RJ, 2005, NAT STRUCT MOL BIOL, V12, P1116, DOI 10.1038/nsmb1025; Weiche B, 2008, J MOL BIOL, V377, P761, DOI 10.1016/j.jmb.2008.01.040; WOOD H, 1992, NUCLEIC ACIDS RES, V20, P5919, DOI 10.1093/nar/20.22.5919; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; ZWIEB C, 1992, NUCLEIC ACIDS RES, V20, P2207, DOI 10.1093/nar/20.suppl.2207	39	108	111	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					881	886		10.1126/science.1196473	http://dx.doi.org/10.1126/science.1196473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330537	Green Accepted			2022-12-01	WOS:000287455100048
J	Sims, JK; Wade, PA				Sims, Jennifer K.; Wade, Paul A.			SnapShot: Chromatin Remodeling: CHD	CELL			English	Editorial Material							COMPLEXES; MI-2/NURD; CELLS		[Sims, Jennifer K.; Wade, Paul A.] Lab Mol Carcinogenesis, NIEHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X	Intramural Research Program of the National Institute of Environmental Health Science, NIH [Z01ES101965]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101965, Z01ES101965] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Science, NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institute of Environmental Health Science, NIH (project number Z01ES101965 to PAW). We gratefully acknowledge helpful suggestions from S. Khorasanizadeh, T. Kutateladze, S. Venkatachalam, J. Wysocka, and members of the Wade laboratory.	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Benayahu D, 2007, CRIT REV EUKAR GENE, V17, P103, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.20; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108	8	23	26	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					626	627		10.1016/j.cell.2011.02.019	http://dx.doi.org/10.1016/j.cell.2011.02.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335242	Bronze			2022-12-01	WOS:000287473100016
J	Ward, CV; Kimbel, WH; Johanson, DC				Ward, Carol V.; Kimbel, William H.; Johanson, Donald C.			Complete Fourth Metatarsal and Arches in the Foot of Australopithecus afarensis	SCIENCE			English	Article							HADAR FORMATION; EVOLUTION; JOINT; FOOTPRINTS; WALKING; TARSAL; FEET	The transition to full-time terrestrial bipedality is a hallmark of human evolution. A key correlate of human bipedalism is the development of longitudinal and transverse arches of the foot that provide a rigid propulsive lever and critical shock absorption during striding bipedal gait. Evidence for arches in the earliest well-known Australopithecus species, A. afarensis, has long been debated. A complete fourth metatarsal of A. afarensis was recently discovered at Hadar, Ethiopia. It exhibits torsion of the head relative to the base, a direct correlate of a transverse arch in humans. The orientation of the proximal and distal ends of the bone reflects a longitudinal arch. Further, the deep, flat base and tarsal facets imply that its midfoot had no ape-like midtarsal break. These features show that the A. afarensis foot was functionally like that of modern humans and support the hypothesis that this species was a committed terrestrial biped.	[Ward, Carol V.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Kimbel, William H.; Johanson, Donald C.] Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, Tempe, AZ 85287 USA	University of Missouri System; University of Missouri Columbia; Arizona State University; Arizona State University-Tempe	Ward, CV (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, M263 Med Sci Bldg, Columbia, MO 65212 USA.	wardcv@missouri.edu		Ward, Carol/0000-0001-6255-9668	NSF [NSF SBR-9601025, NSF BCS-0333296]; University of Missouri Research Board and University of Missouri Research Council; Institute of Human Origins at Arizona State University	NSF(National Science Foundation (NSF)); University of Missouri Research Board and University of Missouri Research Council; Institute of Human Origins at Arizona State University	The authors thank the members of the Hadar Research Project (1990-2004) and the Hadar Paleoanthropology Field School (2007 and 2009) for their dedication and hard work, and the directors and staff of the National Museum of Ethiopia, Cleveland Museum of Natural History, and National Museums of Kenya for facilitating the analytical research reported here. Fieldwork permissions were kindly granted by the Authority for Research and Conservation of Cultural Heritage, Ethiopian Ministry of Culture and Tourism, and the Culture and Tourism Bureau of the Afar Regional State government. We thank J. DeSilva, J. M. Plavcan, and G. Schwartz for helpful comments. The analytical research was supported by NSF (grants NSF SBR-9601025 and NSF BCS-0333296), the University of Missouri Research Board and University of Missouri Research Council, and the Institute of Human Origins at Arizona State University.	Aiello L., 1990, INTRO HUMAN EVOLUTIO; ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berillon G., 2003, Human Evolution, V18, P113, DOI 10.1007/BF02436280; D'Aout K, 2002, AM J PHYS ANTHROPOL, V119, P37, DOI 10.1002/ajpa.10112; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; Deloison Yvette, 2003, Biometrie Humaine et Anthropologie, V21, P189; DeSilva J., 2009, AM J PHYS ANTHROPOL, V141, P1; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; GEBO DL, 1992, AM J PHYS ANTHROPOL, V89, P29, DOI 10.1002/ajpa.1330890105; GOMBERG DN, 1984, AM J PHYS ANTHROPOL, V63, P164; Hamrick MW, 1996, J MORPHOL, V230, P113; Harcourt-Smith W.E., 2002, THESIS U COLL LONDON; Harcourt-Smith WE, 2005, AM J PHYS ANTHROPOL, P112; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HICKS JH, 1953, J ANAT, V87, P345; Kapandji I. A., 1985, PHYSL JOINTS; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; KIDD RS, 1993, AUST PODIATR, V27, P35; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Klenerman L., 2006, HUMAN FOOT COMPANION; LAMY P, 1986, J HUM EVOL, V15, P31, DOI 10.1016/S0047-2484(86)80063-X; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; LATIMER BM, 1982, AM J PHYS ANTHROPOL, V57, P701, DOI 10.1002/ajpa.1330570412; LEWIS OJ, 1980, J ANAT, V130, P833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Morton DJ, 1924, AM J PHYS ANTHROPOL, V7, P1, DOI 10.1002/ajpa.1330070114; SAMMARCO GJ, 1989, BASIC BIOMECHANICS M, P163; SARMIENTO E, 1991, AM J PHYS ANTHR S, V12, P157; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Tuttle R.H., 1991, Human Evolution, V6, P193, DOI 10.1007/BF02438142; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Vereecke EE, 2008, J EXP BIOL, V211, P3661, DOI 10.1242/jeb.018754; WALTER RC, 1994, GEOLOGY, V22, P6, DOI 10.1130/0091-7613(1994)022<0006:AOLATF>2.3.CO;2; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; Zipfel B, 2009, AM J PHYS ANTHROPOL, V140, P532, DOI 10.1002/ajpa.21103	36	118	122	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					750	753		10.1126/science.1201463	http://dx.doi.org/10.1126/science.1201463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311018				2022-12-01	WOS:000287205700065
J	Sinha, B; Koster, D; Ruez, R; Gonnord, P; Bastiani, M; Abankwa, D; Stan, RV; Butler-Browne, G; Vedie, B; Johannes, L; Morone, N; Parton, RG; Raposo, G; Sens, P; Lamaze, C; Nassoy, P				Sinha, Bidisha; Koester, Darius; Ruez, Richard; Gonnord, Pauline; Bastiani, Michele; Abankwa, Daniel; Stan, Radu V.; Butler-Browne, Gillian; Vedie, Benoit; Johannes, Ludger; Morone, Nobuhiro; Parton, Robert G.; Raposo, Graca; Sens, Pierre; Lamaze, Christophe; Nassoy, Pierre			Cells Respond to Mechanical Stress by Rapid Disassembly of Caveolae	CELL			English	Article							SIGNAL-REGULATED KINASE; MEMBRANE TENSION; DEPENDENT ACTIVATION; ENDOTHELIAL-CELLS; IN-VITRO; PROTEIN; ENDOCYTOSIS; MUTATIONS; MUSCLE; GENE	The functions of caveolae, the characteristic plasma membrane invaginations, remain debated. Their abundance in cells experiencing mechanical stress led us to investigate their role in membrane-mediated mechanical response. Acute mechanical stress induced by osmotic swelling or by uniaxial stretching results in a rapid disappearance of caveolae, in a reduced caveolin/Cavin1 interaction, and in an increase of free caveolins at the plasma membrane. Tether-pulling force measurements in cells and in plasma membrane spheres demonstrate that caveola flattening and disassembly is the primary actin-and ATP-independent cell response that buffers membrane tension surges during mechanical stress. Conversely, stress release leads to complete caveola reassembly in an actin-and ATP-dependent process. The absence of a functional caveola reservoir in myotubes from muscular dystrophic patients enhanced membrane fragility under mechanical stress. Our findings support a new role for caveolae as a physiological membrane reservoir that quickly accommodates sudden and acute mechanical stresses.	[Ruez, Richard; Gonnord, Pauline; Johannes, Ludger; Raposo, Graca; Lamaze, Christophe] CNRS UMR144, F-75248 Paris 05, France; [Sinha, Bidisha; Koester, Darius; Nassoy, Pierre] Univ Paris 06, CNRS UMR168, F-75248 Paris 05, France; [Sinha, Bidisha; Koester, Darius; Nassoy, Pierre] Inst Curie, Ctr Rech, Chim Phys Lab, F-75248 Paris 05, France; [Ruez, Richard; Gonnord, Pauline; Johannes, Ludger; Lamaze, Christophe] Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; [Raposo, Graca] PICT IBiSA Inst Curie, F-75248 Paris 05, France; [Raposo, Graca] Inst Curie, Ctr Rech, Lab Struct & Compartiments Membranaires, F-75248 Paris 05, France; [Sens, Pierre] ESPCI, CNRS UMR 7083, F-75231 Paris 05, France; [Bastiani, Michele; Abankwa, Daniel; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Bastiani, Michele; Abankwa, Daniel; Parton, Robert G.] Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Stan, Radu V.] Dartmouth Med Sch, Lebanon, NH 03756 USA; [Butler-Browne, Gillian] UM76 UPMC, Hop La Pitie Salpetriere, Inst Myol, CNRS AIM,Inserm U974,UMR7215, F-75651 Paris 13, France; [Vedie, Benoit] Hop Europeen Georges Pompidou, Biochim Lab, F-75015 Paris, France; [Morone, Nobuhiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 1878502, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University of Queensland; University of Queensland; Dartmouth College; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; National Center for Neurology & Psychiatry - Japan	Lamaze, C (corresponding author), CNRS UMR144, F-75248 Paris 05, France.	christophe.lamaze@curie.fr; pierre.nassoy@curie.fr	Johannes, Ludger/M-9778-2017; Köster, Darius Vasco/Y-1387-2019; Mouly, Gillian/G-6595-2017; Lamaze, Christophe/M-4912-2017; Ruez, Richard/A-3479-2013; Johannes, Ludger/W-8593-2019; Stan, Radu/AAE-7574-2021; sens, pierre/C-3537-2011; Nassoy, Pierre/AAC-2606-2019; Parton, Robert G/C-5673-2009; Bastiani, Michele/J-1823-2014	Johannes, Ludger/0000-0002-2168-0004; Köster, Darius Vasco/0000-0001-8530-5476; Ruez, Richard/0000-0001-5187-2210; Johannes, Ludger/0000-0002-2168-0004; Stan, Radu/0000-0003-2969-1725; sens, pierre/0000-0003-4523-3791; Parton, Robert G/0000-0002-7494-5248; Bastiani, Michele/0000-0001-6752-4157; Nassoy, Pierre/0000-0003-4615-9431; Raposo, graca/0000-0001-9590-1298; Morone, Nobuhiro/0000-0002-7672-158X; LAMAZE, Christophe/0000-0001-5430-2707; butler-browne, gillian/0000-0002-3431-242X; Abankwa, Daniel/0000-0003-2769-0745	Institut Curie (PIC Division Cellulaire, Polarite et Cancer); Agence Nationale pour la Recherche; Fondation de France; Association Francaise contre les Myopathies; National Health and Medical Research Council of Australia; Australian Research Council; NIH [HL83249, HL92085]; Institut Curie; Association pour la Recherche sur le Cancer; Grants-in-Aid for Scientific Research [23310087] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092085, R01HL083249] Funding Source: NIH RePORTER	Institut Curie (PIC Division Cellulaire, Polarite et Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Curie; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Institut Curie (PIC Division Cellulaire, Polarite et Cancer), Agence Nationale pour la Recherche, Fondation de France (programme tumeurs), Association Francaise contre les Myopathies, the National Health and Medical Research Council of Australia and the Australian Research Council (R. G. P. and D. A.), and NIH grants HL83249 and HL92085 (R. V. S.). Microscopy (M. B.) was performed at the ACRF/IMB Dynamic Imaging Centre for Cancer Biology. D. K. was funded by a doctorate fellowship from the Institut Curie, and B. S. was funded by postdoctoral fellowships from the Institut Curie and the Association pour la Recherche sur le Cancer. D. A. is a fellow of the Swiss National Science Foundation (PA00A-111446) and is indebted to K. Alexandrov for support. The authors gratefully acknowledge the Nikon Imaging Centre at Institut Curie and the CNRS consortium CellTis. We thank F. Perez for the pDendra2-C plasmid, A. Helenius for the Cav1-EGFP plasmid and MEF cells, and F. Pinaud for Cav1-EGFP HeLa. We are also grateful to M. Piel and N. Carpi for help in micropatterning and P. Bassereau for access to the confocal microscope coupled to optical tweezers. We thank C. Viaris and C. Blouin for carefully reading the manuscript, and we are indebted to A. Bigot for providing human muscle cells. We would like to thank Eurobiobank and Pr. C. Minette for giving access to primary cells to isolate the immortalized Cav3 cell line. C. L. wishes to dedicate this work to the memory of his father, Robert Lamaze, and to all patients suffering from pancreatic cancer.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Boyd NL, 2003, AM J PHYSIOL-HEART C, V285, pH1113, DOI 10.1152/ajpheart.00302.2003; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cuvelier D, 2005, BIOPHYS J, V88, P2714, DOI 10.1529/biophysj.104.056473; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Dai J, 1995, COLD SPRING HARB SYM, V60, P567, DOI 10.1101/SQB.1995.060.01.060; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dai JW, 1998, J NEUROSCI, V18, P6681; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kozera L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008312; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Merlini L, 2002, J NEUROL NEUROSUR PS, V73, P65, DOI 10.1136/jnnp.73.1.65; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304; Park H, 2000, AM J PHYSIOL-HEART C, V278, pH1285, DOI 10.1152/ajpheart.2000.278.4.H1285; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; PRESCOTT L, 1976, TISSUE CELL, V8, P241, DOI 10.1016/0040-8166(76)90050-1; Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sens P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031918; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	51	565	566	6	96	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					402	413		10.1016/j.cell.2010.12.031	http://dx.doi.org/10.1016/j.cell.2010.12.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295700	Bronze, Green Accepted			2022-12-01	WOS:000286973100012
J	Van Dover, CL				Van Dover, Cindy Lee			Tighten regulations on deep-sea mining	NATURE			English	Editorial Material									Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA	Duke University	Van Dover, CL (corresponding author), Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA.	clv3@duke.edu		Van Dover, Cindy/0000-0001-9845-8391				Coffey Natural Systems, 2008, ENV IMP STAT SOLW 1, P226; GJERDE KM, 2008, MARINE SERIES IUCN, V1; Gleason M, 2010, OCEAN COAST MANAGE, V53, P52, DOI 10.1016/j.ocecoaman.2009.12.001; Jankowski P, 2007, INDEPENDENT TECHNICA; SPIESS FN, 1980, SCIENCE, V207, P1421, DOI 10.1126/science.207.4438.1421; VANDOVER CL, 2011, ISA TECHNICAL STUDY, V8	6	97	98	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					31	33		10.1038/470031a	http://dx.doi.org/10.1038/470031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715LQ	21293351	Bronze			2022-12-01	WOS:000286886400013
J	Kendall, T; Cape, J; Chan, M; Taylor, C				Kendall, Tim; Cape, John; Chan, Melissa; Taylor, Clare		Guideline Dev Grp	Guidelines Management of generalised anxiety disorder in adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; PREVALENCE		[Kendall, Tim; Chan, Melissa; Taylor, Clare] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim; Cape, John] UCL, London WC1E 7HB, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Cape, John] Camden & Islington NHS Fdn Trust, St Pancras Hosp, London NW1 0PE, England	University of London; University College London; University of London; University College London	Kendall, T (corresponding author), Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England.	tim.kendall@shsc.nhs.uk	John, Cape/B-9039-2009	John, Cape/0000-0003-3108-7228				Arroll B, 2009, PRIMARY CARE MENTAL, P147; Bitran S, 2009, NEW OXFORD TXB PSYCH, P729; Culpepper L, 2009, J CLIN PSYCHIAT, V70, P20, DOI 10.4088/JCP.s.7002.04; Dugas M. J., 2007, COGNITIVE BEHAV TREA, P1; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; McManus S., 2009, ADULT PSYCHIAT MORBI; National Institute for Health and Clinical Excellence, 2009, CLIN GUID; National Institute for Health and Clinical Excellence, 2011, CLIN GUID; National Institute for Health and Clinical Excellence, 2004, CLIN GUID; Rickels K, 2001, J CLIN PSYCHIAT, V62, P4; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Roy-Byrne PP, 2004, J CLIN PSYCHIAT, V65, P20; Sareen J, 2006, ARCH INTERN MED, V166, P2109, DOI 10.1001/archinte.166.19.2109; Tyrer P, 2006, LANCET, V368, P2156, DOI 10.1016/S0140-6736(06)69865-6; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24	16	8	8	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2011	342								c7460	10.1136/bmj.c7460	http://dx.doi.org/10.1136/bmj.c7460			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270081	Green Published			2022-12-01	WOS:000286887800009
J	Winslow, MM; Dayton, TL; Verhaak, RGW; Kim-Kiselak, C; Snyder, EL; Feldser, DM; Hubbard, DD; DuPage, MJ; Whittaker, CA; Hoersch, S; Yoon, S; Crowley, D; Bronson, RT; Chiang, DY; Meyerson, M; Jacks, T				Winslow, Monte M.; Dayton, Talya L.; Verhaak, Roel G. W.; Kim-Kiselak, Caroline; Snyder, Eric L.; Feldser, David M.; Hubbard, Diana D.; DuPage, Michel J.; Whittaker, Charles A.; Hoersch, Sebastian; Yoon, Stephanie; Crowley, Denise; Bronson, Roderick T.; Chiang, Derek Y.; Meyerson, Matthew; Jacks, Tyler			Suppression of lung adenocarcinoma progression by Nkx2-1	NATURE			English	Article							EMBRYONIC STEM-CELLS; CLINICAL-SIGNIFICANCE; PROTEIN EXPRESSION; BREAST-CANCER; SELF-RENEWAL; HMGI-C; K-RAS; METASTASIS; P53; ONCOGENE	Despite the high prevalence and poor outcome of patients with metastatic lung cancer the mechanisms of tumour progression and metastasis remain largely uncharacterized. Here we modelled human lung adenocarcinoma, which frequently harbours activating point mutations in KRAS(1) and inactivation of the p53 pathway(2), using conditional alleles in mice(3-5). Lentiviral-mediated somatic activation of oncogenic Kras and deletion of p53 in the lung epithelial cells of Kras(LSL-G12D/+); p53(flox/flox) mice initiates lung adenocarcinoma development(4). Although tumours are initiated synchronously by defined genetic alterations, only a subset becomes malignant, indicating that disease progression requires additional alterations. Identification of the lentiviral integration sites allowed us to distinguish metastatic from non-metastatic tumours and determine the gene expression alterations that distinguish these tumour types. Cross-species analysis identified the NK2-related homeobox transcription factor Nkx2-1 (also called Ttf-1 or Titf1) as a candidate suppressor of malignant progression. In this mouse model, Nkx2-1 negativity is pathognomonic of high-grade poorly differentiated tumours. Gain-and loss-of-function experiments in cells derived from metastatic and non-metastatic tumours demonstrated that Nkx2-1 controls tumour differentiation and limits metastatic potential in vivo. Interrogation of Nkx2-1-regulated genes, analysis of tumours at defined developmental stages, and functional complementation experiments indicate that Nkx2-1 constrains tumours in part by repressing the embryonically restricted chromatin regulator Hmga(2). Whereas focal amplification of NKX2-1 in a fraction of human lung adenocarcinomas has focused attention on its oncogenic function(6-9), our data specifically link Nkx2-1 downregulation to loss of differentiation, enhanced tumour seeding ability and increased metastatic proclivity. Thus, the oncogenic and suppressive functions of Nkx2-1 in the same tumour type substantiate its role as a dual function lineage factor.	[Winslow, Monte M.; Dayton, Talya L.; Kim-Kiselak, Caroline; Snyder, Eric L.; Feldser, David M.; DuPage, Michel J.; Whittaker, Charles A.; Hoersch, Sebastian; Yoon, Stephanie; Crowley, Denise; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Winslow, Monte M.; Kim-Kiselak, Caroline; Jacks, Tyler] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Verhaak, Roel G. W.; Hubbard, Diana D.; Chiang, Derek Y.; Meyerson, Matthew] Harvard Univ, Dana Farber Canc Inst, Cambridge, MA 02115 USA; [Verhaak, Roel G. W.; Hubbard, Diana D.; Chiang, Derek Y.; Meyerson, Matthew] Broad Inst, Cambridge, MA 02142 USA; [Bronson, Roderick T.] Tufts Univ, Sch Vet, Dept Biomed Sci, North Grafton, MA 01536 USA; [Chiang, Derek Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Verhaak, Roel/ABE-7058-2020; Meyerson, Matthew L/E-7123-2012; Chiang, Derek/L-6452-2019	Chiang, Derek/0000-0002-1131-6065; Dayton, Talya/0000-0002-7994-7963; Whittaker, Charles/0000-0002-2400-0094; Meyerson, Matthew/0000-0002-9133-8108	Genentech; Dutch Cancer Society KWF; Alfred P. Sloan Foundation; National Institutes of Health [U01-CA84306, K99-CA151968]; Howard Hughes Medical Institute; Ludwig Center for Molecular Oncology at MIT; National Cancer Institute [P30-CA14051];  [T32-HL007627]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA109038, K99CA151968, U01CA084306, K08CA154784, R00CA151968] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Dutch Cancer Society KWF(KWF Kankerbestrijding); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Center for Molecular Oncology at MIT; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Dooley, N. Dimitrova, T. Oliver and M. Ebert for providing reagents; M. Luo (Biology/Koch Institute BioMicro Core) for array processing; M. Kumar for experimental assistance; T. Staton, D. McFadden, A. Shaw and the entire T.J. laboratory for comments. M.M.W. was a Merck Fellow of the Damon Runyon Cancer Research Foundation and was funded by a Genentech Postdoctoral Fellowship. R. G. W. V. is supported by a Fellowship from the Dutch Cancer Society KWF. E.L.S. is supported by a training grant (T32-HL007627). D.Y.C. is supported by an Alfred P. Sloan Foundation Research Fellowship. D.M.F. is a Leukemia and Lymphoma Postdoctoral Fellow. This work was supported by National Institutes of Health grants U01-CA84306 (to T.J.) and K99-CA151968 (to M.M.W.), the Howard Hughes Medical Institute, the Ludwig Center for Molecular Oncology at MIT, and in part by the Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. T.J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Berghmans T, 2006, ANN ONCOL, V17, P1673, DOI 10.1093/annonc/mdl287; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Meyer B, 2007, MOL CARCINOGEN, V46, P503, DOI 10.1002/mc.20235; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; R Development Core Team, 2005, R LANG ENV STAT COMP; RODENHUIS S, 1988, CANCER RES, V48, P5738; Rogalla P, 1997, MOL CARCINOGEN, V19, P153, DOI 10.1002/(SICI)1098-2744(199707)19:3<153::AID-MC2>3.0.CO;2-F; Rommel B, 1997, LEUKEMIA LYMPHOMA, V26, P603, DOI 10.3109/10428199709050896; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	49	303	322	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					101	U120		10.1038/nature09881	http://dx.doi.org/10.1038/nature09881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471965	Green Accepted, Green Submitted			2022-12-01	WOS:000290218300039
J	Grove, TL; Benner, JS; Radle, MI; Ahlum, JH; Landgraf, BJ; Krebs, C; Booker, SJ				Grove, Tyler L.; Benner, Jack S.; Radle, Matthew I.; Ahlum, Jessica H.; Landgraf, Bradley J.; Krebs, Carsten; Booker, Squire J.			A Radically Different Mechanism for S-Adenosylmethionine-Dependent Methyltransferases	SCIENCE			English	Article							RIBOSOMAL-RNA METHYLTRANSFERASE; CONFERS ANTIBIOTIC-RESISTANCE; CATECHOL O-METHYLTRANSFERASE; BACTERIAL RIBOSOME; BIOTIN SYNTHASE; SAM; CFR; RESOLUTION; GENE; COLI	Methylation of small molecules and macromolecules is crucial in metabolism, cell signaling, and epigenetic programming and is most often achieved by S-adenosylmethionine (SAM)-dependent methyltransferases. Most employ an S(N)2 mechanism to methylate nucleophilic sites on their substrates, but recently, radical SAM enzymes have been identified that methylate carbon atoms that are not inherently nucleophilic via the intermediacy of a 5'-deoxyadenosyl 5'-radical. We have determined the mechanisms of two such reactions targeting the sp(2)-hybridized carbons at positions 2 and 8 of adenosine 2503 in 23S ribosomal RNA, catalyzed by RlmN and Cfr, respectively. In neither case is a methyl group transferred directly from SAM to the RNA; rather, both reactions proceed by a ping-pong mechanism involving intermediate methylation of a conserved cysteine residue.	[Grove, Tyler L.; Radle, Matthew I.; Ahlum, Jessica H.; Landgraf, Bradley J.; Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Benner, Jack S.] New England Biolabs Inc, Div Chem Biol, Ipswich, MA 01938 USA; [Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; New England Biolabs; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	squire@psu.edu	Krebs, Carsten/D-4773-2009; Squire, Jeremy A/A-9352-2012	Krebs, Carsten/0000-0002-3302-7053; Squire, Jeremy A/0000-0002-9863-468X	NIH [GM-63847]; American Chemical Society [46065-AC4]; Dreyfus Foundation; Beckman Foundation; New England Biolabs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063847, R01GM101957] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society(American Chemical Society); Dreyfus Foundation; Beckman Foundation; New England Biolabs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Martin Bollinger Jr. for a critical reading of the manuscript and helpful discussions, L. Saleh for assistance, H. Noller and L. Lancaster for plasmid pKK3535, S. Tan for E. coli strain B834(DE3)pLysS, and P. Bevilacqua for a plasmid-encoding hexahistidine-tagged T7 RNA polymerase and his research group for sharing their expertise in RNA manipulation. This work was supported by NIH grant GM-63847 and American Chemical Society-Petroleum Research Fund grant 46065-AC4 (S. J. B.), the Dreyfus Foundation (Teacher Scholar Award to C. K.), the Beckman Foundation (Young Investigator Award to C. K.), and New England Biolabs (J.S.B).	Atta M, 2010, CURR OPIN STRUC BIOL, V20, P684, DOI 10.1016/j.sbi.2010.09.009; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Booth MPS, 2010, PROTEIN EXPRES PURIF, V74, P204, DOI 10.1016/j.pep.2010.07.010; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Frey P. A., 2007, ENZYMATIC REACTION M; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; Guianvarc'h D, 1997, BIOCHEM BIOPH RES CO, V236, P402, DOI 10.1006/bbrc.1997.6952; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; Kudo F, 2007, J ANTIBIOT, V60, P492, DOI 10.1038/ja.2007.63; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Steitz TA, 2010, ANGEW CHEM INT EDIT, V49, P4381, DOI 10.1002/anie.201000708; Taylor AM, 2008, BIOCHEMISTRY-US, V47, P9309, DOI 10.1021/bi801035b; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; van der Donk WA, 2006, J ORG CHEM, V71, P9561, DOI 10.1021/jo0614240; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; WU WM, 1995, BIOCHEMISTRY-US, V34, P10532, DOI 10.1021/bi00033a027; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	38	164	171	5	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					604	607		10.1126/science.1200877	http://dx.doi.org/10.1126/science.1200877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21415317				2022-12-01	WOS:000289991100053
J	Ito, H; Gaubert, H; Bucher, E; Mirouze, M; Vaillant, I; Paszkowski, J				Ito, Hidetaka; Gaubert, Herve; Bucher, Etienne; Mirouze, Marie; Vaillant, Isabelle; Paszkowski, Jerzy			An siRNA pathway prevents transgenerational retrotransposition in plants subjected to stress	NATURE			English	Article							DNA-METHYLATION; TRANSPOSABLE ELEMENTS; EPIGENETIC REGULATION; REPETITIVE ELEMENTS; GENOME SIZE; ARABIDOPSIS; DEMETHYLATION; EXPRESSION; DYNAMICS	Eukaryotic genomes consist to a significant extent of retrotransposons that are suppressed by host epigenetic mechanisms, preventing their uncontrolled propagation(1,2). However, it is not clear how this is achieved. Here we show that in Arabidopsis seedlings subjected to heat stress, a copia-type retrotransposon named ONSEN (Japanese 'hot spring') not only became transcriptionally active but also synthesized extrachromosomal DNA copies. Heat-induced ONSEN accumulation was stimulated in mutants impaired in the biogenesis of small interfering RNAs (siRNAs); however, there was no evidence of transposition occurring in vegetative tissues. After stress, both ONSEN transcripts and extrachromosomal DNA gradually decayed and were no longer detected after 20-30 days. Surprisingly, a high frequency of new ONSEN insertions was observed in the progeny of stressed plants deficient in siRNAs. Insertion patterns revealed that this transgenerational retrotransposition occurred during flower development and before gametogenesis. Therefore in plants with compromised siRNA biogenesis, memory of stress was maintained throughout development, priming ONSEN to transpose during differentiation of generative organs. Retrotransposition was not observed in the progeny of wild-type plants subjected to stress or in non-stressed mutant controls, pointing to a crucial role of the siRNA pathway in restricting retrotransposition triggered by environmental stress. Finally, we found that natural and experimentally induced variants in ONSEN insertions confer heat responsiveness to nearby genes, and therefore mobility bursts may generate novel, stress-responsive regulatory gene networks.	[Ito, Hidetaka; Gaubert, Herve; Bucher, Etienne; Mirouze, Marie; Vaillant, Isabelle; Paszkowski, Jerzy] Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Paszkowski, J (corresponding author), Univ Geneva, Dept Plant Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jerzy.paszkowski@unige.ch	Mirouze, Marie/AFL-9387-2022; Mirouze, Marie/AAG-8128-2022; Bucher, Etienne/E-7681-2013; Ito, Hidetaka/Y-2865-2018; Mirouze, Marie/AFL-8165-2022	Mirouze, Marie/0000-0002-0514-1270; Bucher, Etienne/0000-0002-3114-3763; Mirouze, Marie/0000-0002-0514-1270	Swiss National Science Foundation [31003A-125005]; European Commission [FP7 226477]; RECBREED consortium [FP7 227190]; Epigenome Network of Excellence [FP6 503433]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); RECBREED consortium; Epigenome Network of Excellence	We thank all members of the J.P. laboratory and R. L. Fisher for discussions, L. Broger, M. Freyre, J. Nicolet, C. Megies for technical assistance and P. King and J. Reinders for editing of the manuscript. This work was supported by grants from the Swiss National Science Foundation (31003A-125005) and the European Commission through the AENEAS collaborative project (FP7 226477), the RECBREED consortium (FP7 227190) and The Epigenome Network of Excellence (FP6 503433).	Ammiraju JSS, 2007, PLANT J, V52, P342, DOI 10.1111/j.1365-313X.2007.03242.x; Feuerbach F, 1997, J VIROL, V71, P4005, DOI 10.1128/JVI.71.5.4005-4015.1997; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; HIROCHIKA H, 1995, GENE, V165, P229, DOI 10.1016/0378-1119(95)00581-P; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnson LM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000280; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lim CJ, 2006, J PLANT RES, V119, P373, DOI 10.1007/s10265-006-0285-z; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tittel-Elmer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001175; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	30	391	403	1	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					115	U151		10.1038/nature09861	http://dx.doi.org/10.1038/nature09861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21399627				2022-12-01	WOS:000289199400048
J	Kim, KY; Levin, DE				Kim, Ki-Young; Levin, David E.			Mpk1 MAPK Association with the Paf1 Complex Blocks Sen1-Mediated Premature Transcription Termination	CELL			English	Article							RNA-POLYMERASE-II; ACTIVATED PROTEIN-KINASE; CELL-CYCLE REGULATOR; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NONCATALYTIC MECHANISM; HISTONE METHYLATION; ELONGATION-FACTORS; 3'-END FORMATION; BINDING PROTEIN	The Mpk1 MAPK of the yeast cell wall integrity pathway uses a noncatalytic mechanism to activate transcription of stress-induced genes by recruitment of initiation factors to target promoters. We show here that Mpk1 additionally serves a function in transcription elongation that is also independent of its catalytic activity. This function is mediated by an interaction between Mpk1 and the Paf1 subunit of the Paf1C elongation complex. A mutation in Paf1 that blocks this interaction causes a specific defect in transcription elongation of an Mpk1-induced gene, which results from Sen1-dependent premature termination through a Nab3-binding site within the promoter-proximal region of the gene. Our findings reveal a regulatory mechanism in which Mpk1 overcomes transcriptional attenuation by blocking recruitment of the Sen1-Nrd1-Nab3 termination complex to the elongating polymerase. Finally, we demonstrate that this mechanism is conserved in an interaction between the human ERK5 MAPK and human Paf1.	[Kim, Ki-Young; Levin, David E.] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Levin, David E.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Boston University; Boston University	Levin, DE (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA.	delevin@bu.edu	Kim, Ki-Young/AAK-7142-2020	Levin, David/0000-0003-0696-2860	NIH [GM48533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048533, R01GM102136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Judith Jaehning for comments on the manuscript; Steve Buratowski for helpful discussions; David Brow for the ACT1-CUP1 reporter system; Michael Culbertson for the sen1-1 mutant; Peter Piper for two-hybrid fusions; Elizabeth Yranski for assistance with strain construction; and two anonymous reviewers for insightful comments. This work was supported by a grant from the NIH (GM48533) to D.E.L.	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; ANDREWS BJ, 1992, P NATL ACAD SCI USA, V89, P11852, DOI 10.1073/pnas.89.24.11852; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Costa PJ, 2000, GENETICS, V156, P535; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; Dodou E, 1997, MOL CELL BIOL, V17, P1848, DOI 10.1128/MCB.17.4.1848; Finkel JS, 2010, GENETICS, V184, P107, DOI 10.1534/genetics.109.110031; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Kim KY, 2010, YEAST, V27, P541, DOI 10.1002/yea.1782; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; Koch C, 1999, NUCLEIC ACIDS RES, V27, P2126, DOI 10.1093/nar/27.10.2126; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sedgwick SG, 1998, J MOL BIOL, V281, P763, DOI 10.1006/jmbi.1998.1996; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; SIDOROVA J, 1993, MOL CELL BIOL, V13, P1069, DOI 10.1128/MCB.13.2.1069; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Truman AW, 2009, MOL CELL BIOL, V29, P6449, DOI 10.1128/MCB.00794-09; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013	59	73	74	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					745	756		10.1016/j.cell.2011.01.034	http://dx.doi.org/10.1016/j.cell.2011.01.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376235	Green Accepted, Bronze			2022-12-01	WOS:000288007100013
J	Thuiller, W; Lavergne, S; Roquet, C; Boulangeat, I; Lafourcade, B; Araujo, MB				Thuiller, Wilfried; Lavergne, Sebastien; Roquet, Cristina; Boulangeat, Isabelle; Lafourcade, Bruno; Araujo, Miguel. B.			Consequences of climate change on the tree of life in Europe	NATURE			English	Article							PHYLOGENETIC SIGNAL; EXTINCTION RISK; BIODIVERSITY; PREDICTORS; TRAITS; NICHE	Many species are projected to become vulnerable to twenty-first-century climate changes(1,2), with consequent effects on the tree of life. If losses were not randomly distributed across the tree of life, climate change could lead to a disproportionate loss of evolutionary history(3-5). Here we estimate the consequences of climate change on the phylogenetic diversities of plant, bird and mammal assemblages across Europe. Using a consensus across ensembles of forecasts for 2020, 2050 and 2080 and high-resolution phylogenetic trees, we show that species vulnerability to climate change clusters weakly across phylogenies. Such phylogenetic signal in species vulnerabilities does not lead to higher loss of evolutionary history than expected with a model of random extinctions. This is because vulnerable species have neither fewer nor closer relatives than the remaining clades. Reductions in phylogenetic diversity will be greater in southern Europe, and gains are expected in regions of high latitude or altitude. However, losses will not be offset by gains and the tree of life faces a trend towards homogenization across the continent.	[Thuiller, Wilfried; Lavergne, Sebastien; Roquet, Cristina; Boulangeat, Isabelle; Lafourcade, Bruno] Univ Grenoble 1, Lab Ecol Alpine, CNRS, UMR 5553, FR-38041 Grenoble 9, France; [Araujo, Miguel. B.] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain; [Araujo, Miguel. B.] Univ Evora, CIBIO, Rui Nabeiro Biodivers Chair, P-7000 Evora, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora	Thuiller, W (corresponding author), Univ Grenoble 1, Lab Ecol Alpine, CNRS, UMR 5553, BP 53, FR-38041 Grenoble 9, France.	wilfried.thuiller@ujf-grenoble.fr	Thuiller, Wilfried/G-3283-2010; Roquet, Cristina/AAB-4031-2019; Araújo, Miguel B/B-6117-2008	Thuiller, Wilfried/0000-0002-5388-5274; Araújo, Miguel B/0000-0002-5107-7265; Roquet, Cristina/0000-0001-8748-3743	EU [GOCE-CT-2007-036866, ANR-2007-BDIV-014]; Fundacion Ramon Areces; Rhone-Alpes region [CPER07-13 CIRA]	EU(European Commission); Fundacion Ramon Areces; Rhone-Alpes region(Region Auvergne-Rhone-Alpes)	This research was funded by the EU ECOCHANGE (GOCE-CT-2007-036866) and DIVERSITALP (ANR-2007-BDIV-014) projects. C. R. was supported by a grant from Fundacion Ramon Areces. We thank P. Pearman and A. Mooers for comments on earlier drafts. Computations were performed using the CIMENT infrastructure (https://ciment.ujf-grenoble.fr), supported by the Rhone-Alpes region (GRANT CPER07-13 CIRA).	[Anonymous], 2000, SPECIAL REPORT EMISS; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Nee S., 1997, SCIENCE, V288, P328; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	26	374	394	8	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					531	534		10.1038/nature09705	http://dx.doi.org/10.1038/nature09705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326204				2022-12-01	WOS:000287652900041
J	Gallio, M; Ofstad, TA; Macpherson, LJ; Wang, JW; Zuker, CS				Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.			The Coding of Temperature in the Drosophila Brain	CELL			English	Article							MICE LACKING; TRP CHANNEL; CAPSAICIN-RECEPTOR; ION-CHANNEL; EXPRESSION; HEAT; MECHANISMS; NEURONS; THERMOSENSATION; HYGROSENSATION	Thermosensation is an indispensable sensory modality. Here, we study temperature coding in Drosophila, and show that temperature is represented by a spatial map of activity in the brain. First, we identify TRP channels that function in the fly antenna to mediate the detection of cold stimuli. Next, we identify the hot-sensing neurons and show that hot and cold antennal receptors project onto distinct, but adjacent glomeruli in the Proximal-Antennal-Protocerebrum (PAP) forming a thermotopic map in the brain. We use two-photon imaging to reveal the functional segregation of hot and cold responses in the PAP, and show that silencing the hot-or cold-sensing neurons produces animals with distinct and discrete deficits in their behavioral responses to thermal stimuli. Together, these results demonstrate that dedicated populations of cells orchestrate behavioral responses to different temperature stimuli, and reveal a labeled-line logic for the coding of temperature information in the brain.	[Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Zuker, Charles S.] Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, Columbia Coll Phys & Surg, New York, NY 10032 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Zuker, Charles S.] Columbia Univ, Dept Neurosci, Howard Hughes Med Inst, Columbia Coll Phys & Surg, New York, NY 10032 USA; [Ofstad, Tyler A.; Zuker, Charles S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Zuker, CS (corresponding author), Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA.	cz2195@columbia.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Gallio, Marco/0000-0003-2132-0639; Macpherson, Lindsey/0000-0002-1089-3733	Wenner-Grens Stiftelse; Human Frontiers Science Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009597] Funding Source: NIH RePORTER	Wenner-Grens Stiftelse; Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Cahir O'Kane for UAS-TeNT flies; Paul Garrity for dTRPA1<SUP>KO</SUP> flies; and especially Michael Reiser for invaluable help with designing and implementing the behavioral arenas and assays. We also thank David Julius and Avi Priel for their help and kindness hosting us (M. G.) in our efforts to express Brv channels in Xenopus oocytes. Wilson Kwan, George Gallardo, and Lisa Ha provided expert help with fly husbandry. We are grateful to Hojoon Lee, Dimitri Trankner, and Robert Barretto for help with experiments and data analysis; and Nick Ryba, Michael Reiser, and members of the Zuker lab for critical comments on the manuscript. We also thank Kevin Moses, Gerry Rubin, and the Janelia Farm Visitor Program. M. G. was supported by a Wenner-Grens Stiftelse and a Human Frontiers Science Program long term fellowship. L.J.M. is a fellow of the Jane Coffin Childs Foundation. C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at Janelia Farm Research Campus. Author contributions: M. G. and C.S.Z. conceived all the experiments and wrote the paper. M. G. performed all the experiments presented in this paper, except the in situ hybridizations (T.A.O.). T.A.O. also helped with the set up for 2-choice behavioral assays, and J.W.W. helped design and setup the custom imaging system. L.J.M., M. G., and T.A.O. carried out extensive efforts to heterologously express Brv channels (data not shown).	ALTNER H, 1985, ANNU REV ENTOMOL, V30, P273, DOI 10.1146/annurev.en.30.010185.001421; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Darian-Smith I.D.R.W., 1971, PERIPHERAL NEURAL ME; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; FOELIX RF, 1989, CELL TISSUE RES, V258, P277, DOI 10.1007/BF00239448; Guler AD, 2002, J NEUROSCI, V22, P6408; Ha TS, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.010.2009; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hensel H, 1981, THERMORECEPTION TEMP; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; McKemy D.D., 2007, TEMPERATURE SENSING; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Plant T. D., 2007, V179, P189; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Till BJ, 2003, METH MOL B, V236, P205; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	58	160	162	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					614	624		10.1016/j.cell.2011.01.028	http://dx.doi.org/10.1016/j.cell.2011.01.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335241	Green Accepted, Bronze			2022-12-01	WOS:000287473100015
J	Pellegrini, M; Calzascia, T; Toe, JG; Preston, SP; Lin, AE; Elford, AR; Shahinian, A; Lang, PA; Lang, KS; Morre, M; Assouline, B; Lahl, K; Sparwasser, T; Tedder, TF; Paik, JH; DePinho, RA; Basta, S; Ohashi, PS; Mak, TW				Pellegrini, Marc; Calzascia, Thomas; Toe, Jesse G.; Preston, Simon P.; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Morre, Michel; Assouline, Brigitte; Lahl, Katharina; Sparwasser, Tim; Tedder, Thomas F.; Paik, Ji-hye; DePinho, Ronald A.; Basta, Sameh; Ohashi, Pamela S.; Mak, Tak W.			IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology	CELL			English	Article							CD4(+) T-CELLS; IN-VIVO; LYMPHOID-TISSUE; HOST-DEFENSE; INTERLEUKIN-22; ACTIVATION; EXPANSION; INFLAMMATION; PERSISTENCE; HEPATOCYTES	Understanding the factors that impede immune responses to persistent viruses is essential in designing therapies for HIV infection. Mice infected with LCMV clone-13 have persistent high-level viremia and a dysfunctional immune response. Interleukin-7, a cytokine that is critical for immune development and homeostasis, was used here to promote immunity toward clone-13, enabling elucidation of the inhibitory pathways underlying impaired antiviral immune response. Mechanistically, IL-7 down-regulated a critical repressor of cytokine signaling, Socs3, resulting in amplified cytokine production, increased T cell effector function and numbers, and viral clearance. IL-7 enhanced thymic output to expand the naive T cell pool, including T cells that were not LCMV specific. Additionally, IL-7 promoted production of cytoprotective IL-22 that abrogated liver pathology. The IL-7-mediated effects were dependent on endogenous IL-6. These attributes of IL-7 have profound implications for its use as a therapeutic in the treatment of chronic viral diseases.	[Pellegrini, Marc; Calzascia, Thomas; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Dept Med Biophys, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Pellegrini, Marc; Calzascia, Thomas; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Dept Immunol, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Pellegrini, Marc; Toe, Jesse G.; Preston, Simon P.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Pellegrini, Marc] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Morre, Michel; Assouline, Brigitte] Cytheris Inc, F-92130 Issy Les Moulineaux, France; [Lahl, Katharina] Stanford Univ, Lab Immunol & Vasc Biol, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, D-30625 Hannover, Germany; [Tedder, Thomas F.] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27708 USA; [Paik, Ji-hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol,Dept Med,Dana Farber Canc Inst, Boston, MA 02115 USA; [Paik, Ji-hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Dana Farber Canc Inst, Boston, MA 02115 USA; [Basta, Sameh] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 396, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Walter & Eliza Hall Institute; University of Melbourne; Stanford University; Duke University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Queens University - Canada	Ohashi, PS (corresponding author), Univ Hlth Network, Dept Med Biophys, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada.	pohashi@uhnres.utoronto.ca	Pellegrini, Marc/F-7670-2014; Lin, Amy Erica/ABG-4745-2020; Sparwasser, Tim D/AAA-4306-2022; Yang, Chen/G-1379-2010; Sparwasser, Tim/AAF-7085-2019; Lahl, Katharina/AAA-1909-2021; Lang, Karl S/R-2505-2016	Lin, Amy Erica/0000-0002-0554-2832; Sparwasser, Tim/0000-0001-5645-902X; Lahl, Katharina/0000-0003-4919-331X; Ohashi, Pamela S./0000-0003-2915-9317; Lang, Karl/0000-0001-9783-7605; Pellegrini, Marc/0000-0003-3627-3126; Preston, Simon/0000-0001-8969-8297; DePinho, Ronald/0000-0002-5625-577X; Calzascia, Thomas/0000-0001-8225-6744	Canadian Institute for Health Research [CIHR-MOP-106529]; Terry Fox Cancer Foundation National Cancer Institute of Canada; Boninchi Foundation (Geneva, Switzerland); National Cancer Institute of Canada; Irvington Institute with the Cancer Research Institute (New York, NY); Australian National Health and Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Cancer Foundation National Cancer Institute of Canada; Boninchi Foundation (Geneva, Switzerland); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Irvington Institute with the Cancer Research Institute (New York, NY); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	Dr. Mandana Nikpour assisted with statistical analyses. Marina Zaitseva contributed to the analysis of thymic emigrants; Alain Lamarre, Paul Jolicoeur, and Michel Nussenzweig provided reagents and mice. This work was supported by a Canadian Institute for Health Research grant to T. W. M. and P.S.O. (CIHR-MOP-106529) and a Terry Fox Cancer Foundation National Cancer Institute of Canada grant to T. W. M. T. C. was supported by the Boninchi Foundation (Geneva, Switzerland) and The Terry Fox Foundation through an award from the National Cancer Institute of Canada. M. P. was supported through an Irvington Institute Fellowship with the Cancer Research Institute (New York, NY) and an Australian National Health and Medical Research Council Fellowship. S. B receives support from the Natural Sciences and Engineering Research Council of Canada. P.S.O. holds a Canada Research Chair in autoimmunity and tumor immunity. This research was also funded, in part, by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Beq S, 2006, J IMMUNOL, V176, P914, DOI 10.4049/jimmunol.176.2.914; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brender C, 2007, BLOOD, V110, P2528, DOI 10.1182/blood-2006-08-041541; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; Kittipatarin C, 2007, CYTOKINE, V39, P75, DOI 10.1016/j.cyto.2007.07.183; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Nugeyre MT, 2003, J IMMUNOL, V171, P4447, DOI 10.4049/jimmunol.171.8.4447; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson EB, 2010, IMMUNOL RES, V48, P3, DOI 10.1007/s12026-010-8162-1; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	48	239	253	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					601	613		10.1016/j.cell.2011.01.011	http://dx.doi.org/10.1016/j.cell.2011.01.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21295337	Bronze			2022-12-01	WOS:000287473100014
J	Losina, E; Walensky, RP; Reichmann, WM; Holt, HL; Gerlovin, H; Solomon, DH; Jordan, JM; Hunter, DJ; Suter, LG; Weinstein, AM; Paltiel, AD; Katz, JN				Losina, Elena; Walensky, Rochelle P.; Reichmann, William M.; Holt, Holly L.; Gerlovin, Hanna; Solomon, Daniel H.; Jordan, Joanne M.; Hunter, David J.; Suter, Lisa G.; Weinstein, Alexander M.; Paltiel, A. David; Katz, Jeffrey N.			Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; NUTRITION EXAMINATION SURVEY; HEALTH-STATE UTILITIES; BODY-MASS INDEX; NATIONAL-HEALTH; METABOLIC SYNDROME; PROSPECTIVE COHORT; UNITED-STATES; RISK-FACTORS; OVERWEIGHT	Background: Obesity and knee osteoarthritis are among the most frequent chronic conditions affecting Americans aged 50 to 84 years. Objective: To estimate quality-adjusted life-years lost due to obesity and knee osteoarthritis and health benefits of reducing obesity prevalence to levels observed a decade ago. Design: The U.S. Census and obesity data from national data sources were combined with estimated prevalence of symptomatic knee osteoarthritis to assign persons aged 50 to 84 years to 4 subpopulations: nonobese without knee osteoarthritis (reference group), nonobese with knee osteoarthritis, obese without knee osteoarthritis, and obese with knee osteoarthritis. The Osteoarthritis Policy Model, a computer simulation model of knee osteoarthritis and obesity, was used to estimate quality-adjusted life-year losses due to knee osteoarthritis and obesity in comparison with the reference group. Setting: United States. Participants: U.S. population aged 50 to 84 years. Measurements: Quality-adjusted life-years lost owing to knee osteoarthritis and obesity. Results: Estimated total losses of per-person quality-adjusted life-years ranged from 1.857 in nonobese persons with knee osteoarthritis to 3.501 for persons affected by both conditions, resulting in a total of 86.0 million quality-adjusted life-years lost due to obesity, knee osteoarthritis, or both. Quality-adjusted life-years lost due to knee osteoarthritis and/or obesity represent 10% to 25% of the remaining quality-adjusted survival of persons aged 50 to 84 years. Hispanic and black women had disproportionately high losses. Model findings suggested that reversing obesity prevalence to levels seen 10 years ago would avert 178 071 cases of coronary heart disease, 889 872 cases of diabetes, and 111 206 total knee replacements. Such a reduction in obesity would increase the quantity of life by 6 318 030 years and improve life expectancy by 7 812 120 quality-adjusted years in U. S. adults aged 50 to 84 years. Limitations: Comorbidity incidences were derived from prevalence estimates on the basis of life expectancy of the general population, potentially resulting in conservative underestimates. Calibration analyses were conducted to ensure comparability of model-based projections and data from external sources. Conclusion: The number of quality-adjusted life-years lost owing to knee osteoarthritis and obesity seems to be substantial, with black and Hispanic women experiencing disproportionate losses. Reducing mean body mass index to the levels observed a decade ago in this population would yield substantial health benefits.	[Losina, Elena] Boston Univ, Sch Publ Hlth, Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res,Dept Orthopa, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Sydney, Sydney, NSW 2006, Australia; Yale Univ, Sch Med, New Haven, CT USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of Sydney; Yale University	Losina, E (corresponding author), Boston Univ, Sch Publ Hlth, Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res,Dept Orthopa, 75 Francis St,BC-4, Boston, MA 02115 USA.	Elosina@partners.org	Hunter, David J/A-4622-2010	Hunter, David J/0000-0003-3197-752X; Gerlovin, Hanna/0000-0002-6700-2129; Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle P./0000-0002-8795-379X; /0000-0002-1283-6329	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR053112, K24 AR057827, K23 AR054095, P60 AR47782, T32 AR 055885, K24 AR 02123]; Arthritis Foundation; Arthritis Investigator Award; National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047782, R01AR053112, K24AR057827, T32AR055885, K24AR002123, K23AR054095] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; Arthritis Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	By the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR053112, K24 AR057827, K23 AR054095, P60 AR47782, T32 AR 055885, and K24 AR 02123); an Arthritis Foundation Innovative Research grant (Dr. Losina); and an Arthritis Investigator Award (Dr. Suter).; Primary Funding Source: The National Institutes of Health and the Arthritis Foundation.	Abbate LM, 2006, OBESITY, V14, P1274, DOI 10.1038/oby.2006.145; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ammar KA, 2008, AM HEART J, V156, P975, DOI 10.1016/j.ahj.2008.06.018; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; BOULT C, 1994, J GERONTOL, V49, pM28, DOI 10.1093/geronj/49.1.M28; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1997, HLTH DAT INT CHRON C; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2006, NAT HLTH NUTR EX SUR; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Das UN, 2007, EUR HEART J, V28, P2953, DOI 10.1093/eurheartj/ehm472; DAVIS MA, 1988, AM J EPIDEMIOL, V127, P1019, DOI 10.1093/oxfordjournals.aje.a114878; Diehr P, 2001, MED CARE, V39, P670, DOI 10.1097/00005650-200107000-00004; Dieppe P, 1999, RHEUMATOLOGY, V38, P73, DOI 10.1093/rheumatology/38.1.73; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Harvey E L, 2002, Obes Rev, V3, P45, DOI 10.1046/j.1467-789X.2002.00053.x; Heo M, 2003, OBES RES, V11, P209, DOI 10.1038/oby.2003.33; Jordan JM, 2007, J RHEUMATOL, V34, P172; KEYFITZ N, 1975, BIOMETRICS, V31, P889, DOI 10.2307/2529814; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lean MEJ, 1999, ARCH INTERN MED, V159, P837, DOI 10.1001/archinte.159.8.837; Lloyd A, 2006, BRIT J CANCER, V95, P683, DOI 10.1038/sj.bjc.6603326; Mann DM, 2006, PREV MED, V42, P66, DOI 10.1016/j.ypmed.2005.09.011; Mathers CD, 2002, GLOBAL BURDEN DIS 20; Mathias SD, 1997, QUAL LIFE RES, V6, P311, DOI 10.1023/A:1018475108460; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Niu J, 2009, ARTHRIT RHEUM-ARTHR, V61, P329, DOI 10.1002/art.24337; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Parmet Sharon, 2003, JAMA, V289, P1068; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Quintana JM, 2006, ARCH INTERN MED, V166, P220, DOI 10.1001/archinte.166.2.220; Reichmann WM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1046, DOI 10.1002/art.24839; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; Shirai K, 2004, CURR MED RES OPIN, V20, P295, DOI 10.1185/030079903125003008; Sowers M, 2000, OSTEOARTHR CARTILAGE, V8, P69, DOI 10.1053/joca.1999.0273; Todd Miller M, 2008, J Cardiometab Syndr, V3, P162, DOI 10.1111/j.1559-4572.2008.00004.x; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; *US BUR CENS, 2010, NCEST200904HISPWANHB; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Winkelmayer WC, 2006, MED DECIS MAKING, V26, P247, DOI 10.1177/0272989X06288685; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	60	174	179	2	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					217	W74		10.7326/0003-4819-154-4-201102150-00001	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00001			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320937	Green Accepted, Green Published			2022-12-01	WOS:000287310000013
J	Benning, A; Dixon-Woods, M; Nwulu, U; Ghaleb, M; Dawson, J; Barber, N; Franklin, BD; Girling, A; Hemming, K; Carmalt, M; Rudge, G; Naicker, T; Kotecha, A; Derrington, MC; Lilford, R				Benning, Amirta; Dixon-Woods, Mary; Nwulu, Ugochi; Ghaleb, Maisoon; Dawson, Jeremy; Barber, Nick; Franklin, Bryony Dean; Girling, Alan; Hemming, Karla; Carmalt, Martin; Rudge, Gavin; Naicker, Thirumalai; Kotecha, Amit; Derrington, M. Clare; Lilford, Richard			Multiple component patient safety intervention in English hospitals: controlled evaluation of second phase	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE-NATIONAL-AUDIT; FRAMEWORK; ADMISSIONS; MORTALITY; ADULT; UNITS; WORK	Objective To independently evaluate the impact of the second phase of the Health Foundation's Safer Patients Initiative (SPI2) on a range of patient safety measures. Design A controlled before and after design. Five substudies: survey of staff attitudes; review of case notes from high risk (respiratory) patients in medical wards; review of case notes from surgical patients; indirect evaluation of hand hygiene by measuring hospital use of handwashing materials; measurement of outcomes (adverse events, mortality among high risk patients admitted to medical wards, patients' satisfaction, mortality in intensive care, rates of hospital acquired infection). Setting NHS hospitals in England. Participants Nine hospitals participating in SPI2 and nine matched control hospitals. Intervention The SPI2 intervention was similar to the SPI1, with somewhat modified goals, a slightly longer intervention period, and a smaller budget per hospital. Results One of the scores (organisational climate) showed a significant (P=0.009) difference in rate of change over time, which favoured the control hospitals, though the difference was only 0.07 points on a five point scale. Results of the explicit case note reviews of high risk medical patients showed that certain practices improved over time in both control and SPI2 hospitals (and none deteriorated), but there were no significant differences between control and SPI2 hospitals. Monitoring of vital signs improved across control and SPI2 sites. This temporal effect was significant for monitoring the respiratory rate at both the six hour (adjusted odds ratio 2.1, 99% confidence interval 1.0 to 4.3; P=0.010) and 12 hour (2.4, 1.1 to 5.0; P=0.002) periods after admission. There was no significant effect of SPI for any of the measures of vital signs. Use of a recommended system for scoring the severity of pneumonia improved from 1.9% (1/52) to 21.4% (12/56) of control and from 2.0% (1/50) to 41.7% (25/60) of SPI2 patients. This temporal change was significant (7.3, 1.4 to 37.7; P=0.002), but the difference in difference was not significant (2.1, 0.4 to 11.1; P=0.236). There were no notable or significant changes in the pattern of prescribing errors, either over time or between control and SPI2 hospitals. Two items of medical history taking (exercise tolerance and occupation) showed significant improvement over time, across both control and SPI2 hospitals, but no additional SPI2 effect. The holistic review showed no significant changes in error rates either over time or between control and SPI2 hospitals. The explicit case note review of perioperative care showed that adherence rates for two of the four perioperative standards targeted by SPI2 were already good at baseline, exceeding 94% for antibiotic prophylaxis and 98% for deep vein thrombosis prophylaxis. Intraoperative monitoring of temperature improved over time in both groups, but this was not significant (1.8, 0.4 to 7.6; P=0.279), and there were no additional effects of SPI2. A dramatic rise in consumption of soap and alcohol hand rub was similar in control and SPI2 hospitals (P=0.760 and P=0.889, respectively), as was the corresponding decrease in rates of Clostridium difficile and meticillin resistant Staphylococcus aureus infection (P=0.652 and P=0.693, respectively). Mortality rates of medical patients included in the case note reviews in control hospitals increased from 17.3% (42/ 243) to 21.4% (24/112), while in SPI2 hospitals they fell from 10.3% (24/233) to 6.1% (7/114) (P=0.043). Fewer than 8% of deaths were classed as avoidable; changes in proportions could not explain the divergence of overall death rates between control and SPI2 hospitals. There was no significant difference in the rate of change in mortality in intensive care. Patients' satisfaction improved in both control and SPI2 hospitals on all dimensions, but again there were no significant changes between the two groups of hospitals. Conclusions Many aspects of care are already good or improving across the NHS in England, suggesting considerable improvements in quality across the board. These improvements are probably due to contemporaneous policy activities relating to patient safety, including those with features similar to the SPI, and the emergence of professional consensus on some clinical processes. This phenomenon might have attenuated the incremental effect of the SPI, making it difficult to detect. Alternatively, the full impact of the SPI might be observable only in the longer term. The conclusion of this study could have been different if concurrent controls had not been used.	[Benning, Amirta; Girling, Alan; Hemming, Karla; Rudge, Gavin; Naicker, Thirumalai; Lilford, Richard] Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston B15 2TT, W Midlands, England; [Dixon-Woods, Mary] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Nwulu, Ugochi] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Clin Invest Unit, Birmingham B15 2TH, W Midlands, England; [Franklin, Bryony Dean] Univ London, Sch Pharm, Dept Practice & Policy, Ctr Medicat Safety & Serv Qual, London WC1N 1AX, England; [Ghaleb, Maisoon] Univ Hertfordshire, Sch Pharm, Hatfield AL10 9AB, Herts, England; [Dawson, Jeremy] Aston Univ, Aston Business Sch, Work & Org Psychol Grp, Birmingham B4 7ET, W Midlands, England; [Franklin, Bryony Dean] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Ctr Medicat Safety & Serv Qual, London W2 1NY, England; [Carmalt, Martin; Kotecha, Amit] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England	University of Birmingham; University of Leicester; University of Birmingham; University of London; University College London; University of London School of Pharmacy; University of Hertfordshire; Aston University; Imperial College London; Royal Orthopaedic Hospital	Lilford, R (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston B15 2TT, W Midlands, England.	r.j.lilford@bham.ac.uk	Girling, Alan J/A-7843-2012; Nwulu, Ugochi/G-9245-2011; Hemming, karla/AAB-3391-2021	Nwulu, Ugochi/0000-0002-4720-4751; Hemming, karla/0000-0002-2226-6550; Dixon-Woods, Mary/0000-0002-5915-0041; Nwulu, Ugochi/0000-0001-6372-176X; Franklin, Bryony/0000-0002-2892-1245; Girling, Alan/0000-0003-2022-045X	Health Foundation; National Patient Safety Agency; National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare; National Institute of Health Research; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI	Health Foundation; National Patient Safety Agency; National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Health Foundation and the National Patient Safety Agency. KH was funded by the National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country, and AG by the Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare programme. The Centre for Medication Safety and Service Quality is affiliated with the Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust, which is funded by the National Institute of Health Research. The evaluation was sponsored for research governance purposes by the University of Birmingham. The study was designed independently by the researchers. The researchers acted independently but worked collaboratively with the funder. The researchers independently collected, analysed and interpreted the data. The researchers wrote this article independently. The funders were given the opportunity to provide comments before submission. All researchers (apart from CD) had the opportunity to access participant anonymised data.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bate P., 2008, ORG QUALITY IMPROVEM; Benning A, 2010, CONTROLLED EVALUATIO; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d195; Borrill C, 2000, BRIT J HLTH CARE, V6, P364, DOI DOI 10.12968/BJHC.2000.6.8.19300; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; British Orthopaedic Association, 2006, PRIM TOT HIP REPL GU; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P163, DOI 10.1136/qshc.2007.023648; Campbell SE, 2001, INT J QUAL HEALTH C, V13, P309, DOI 10.1093/intqhc/13.4.309; Davidoff F, 2009, JAMA-J AM MED ASSOC, V302, P2580, DOI 10.1001/jama.2009.1845; Department of Health, 2010, BEDS OP OV ENGL; Department of Health, 2007, SAV LIV RED INF DEL; Dixon-Woods M, 2010, QUAL SAF HEALTH CARE, V19, P74, DOI 10.1136/qshc.2008.029504; EPSTEIN S, 1995, SCI TECHNOL HUM VAL, V20, P408, DOI 10.1177/016224399502000402; Gallivan S, 2008, DRUG SAFETY, V31, P637, DOI 10.2165/00002018-200831080-00001; GUZZO RA, 1985, PERS PSYCHOL, V38, P275, DOI 10.1111/j.1744-6570.1985.tb00547.x; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Healthcare Commission, 2006, MAK SENS YOUR STAFF; Hillman K, 2005, LANCET, V365, P2091; House of Commons Health Committee, 2009, 6 HOUS COMM HLTH COM; Institute for Healthcare Improvement, 2007, GUID PREV SURG SIT I; Keogh-Brown M, 2007, HEALTH TECHNOL ASSES, V11, P1; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Lilford Richard, 2007, J Health Serv Res Policy, V12, P173, DOI 10.1258/135581907781543012; LILFORD RJ, 2010, BMJ-BRIT MED J, V341, pC4413, DOI DOI 10.1136/BMJ.C4413; Michie S, 2004, INT J MANAG REV, V5-6, P91, DOI 10.1111/j.1460-8545.2004.00098.x; National Institute for Health and Clinical Excellence, 2008, 65 NAT I HLTH CLIN E; National Institute for Health and Clinical Excellence, 2010, 74 NAT I HLTH CLIN E; National Institute for Health and Clinical Excellence, 2007, CG50  NAT I HLTH CLI; National Patient Safety Agency, 2010, CLEAN CAMP; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Slaughter MJ, 2001, J INT ECON, V55, P203, DOI 10.1016/S0022-1996(00)00087-8; Stone S, 2007, J HOSP INFECT, V66, P293, DOI 10.1016/j.jhin.2007.04.011; West MA, 2006, J ORGAN BEHAV, V27, P983, DOI 10.1002/job.396	36	75	78	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2011	342								d199	10.1136/bmj.d199	http://dx.doi.org/10.1136/bmj.d199			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PW	21292720	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-01	WOS:000287138500003
J	Fukuda, S; Toh, H; Hase, K; Oshima, K; Nakanishi, Y; Yoshimura, K; Tobe, T; Clarke, JM; Topping, DL; Suzuki, T; Taylor, TD; Itoh, K; Kikuchi, J; Morita, H; Hattori, M; Ohno, H				Fukuda, Shinji; Toh, Hidehiro; Hase, Koji; Oshima, Kenshiro; Nakanishi, Yumiko; Yoshimura, Kazutoshi; Tobe, Toru; Clarke, Julie M.; Topping, David L.; Suzuki, Tohru; Taylor, Todd D.; Itoh, Kikuji; Kikuchi, Jun; Morita, Hidetoshi; Hattori, Masahira; Ohno, Hiroshi			Bifidobacteria can protect from enteropathogenic infection through production of acetate	NATURE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; SMOOTH-MUSCLE-CELLS; SHIGA-TOXIN; ARABIDOPSIS-THALIANA; GENOME SEQUENCE; GENE-EXPRESSION; LONGUM NCC2705; GUT MICROBIOTA; PPAR-ALPHA; MICE	The human gut is colonized with a wide variety of microorganisms, including species, such as those belonging to the bacterial genus Bifidobacterium, that have beneficial effects on human physiology and pathology(1-3). Among the most distinctive benefits of bifidobacteria are modulation of host defence responses and protection against infectious diseases(4-6). Nevertheless, the molecular mechanisms underlying these effects have barely been elucidated. To investigate these mechanisms, we used mice associated with certain bifidobacterial strains and a simplified model of lethal infection with enterohaemorrhagic Escherichia coli O157:H7, together with an integrated 'omics' approach. Here we show that genes encoding an ATP-binding-cassette-type carbohydrate transporter present in certain bifidobacteria contribute to protecting mice against death induced by E. coli O157:H7. We found that this effect can be attributed, at least in part, to increased production of acetate and that translocation of the E. coli O157:H7 Shiga toxin from the gut lumen to the blood was inhibited. We propose that acetate produced by protective bifidobacteria improves intestinal defence mediated by epithelial cells and thereby protects the host against lethal infection.	[Fukuda, Shinji; Hase, Koji; Nakanishi, Yumiko; Ohno, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Fukuda, Shinji; Nakanishi, Yumiko; Kikuchi, Jun; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Toh, Hidehiro; Taylor, Todd D.] RIKEN Adv Sci Inst, MetaSyst Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; [Nakanishi, Yumiko; Kikuchi, Jun] RIKEN Plant Sci Ctr, Adv NMR Metab Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Yoshimura, Kazutoshi; Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Tobe, Toru] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Clarke, Julie M.; Topping, David L.] CSIRO Food & Nutr Sci, Adelaide, SA 5000, Australia; [Suzuki, Tohru] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Kanagawa 2298501, Japan; [Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan	RIKEN; Yokohama City University; RIKEN; University of Tokyo; RIKEN; University of Tokyo; Osaka University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Gifu University; Nagoya University; Azabu University; Chiba University	Ohno, H (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hattori@k.u-tokyo.ac.jp; ohno@rcai.riken.jp	Ohno, Hiroshi/L-7899-2014; Taylor, Todd/A-7121-2009; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Kikuchi, Jun/O-4725-2019; Clarke, Julie M/H-6762-2013; topping, david l/H-7969-2013; Kikuchi, Jun/M-5512-2015	Ohno, Hiroshi/0000-0001-8776-9661; Taylor, Todd/0000-0003-4247-6253; Hattori, Masahira/0000-0001-9467-0344; Kikuchi, Jun/0000-0002-6809-394X; Clarke, Julie M/0000-0003-4676-0366; topping, david l/0000-0002-8481-9384; Kikuchi, Jun/0000-0002-6809-394X; Fukuda, Shinji/0000-0001-5161-9880; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Danone Institute of Japan; Institute for Fermentation, Osaka; Kieikai Research Foundation; Naito Foundation; Nestle Nutrition Council, Japan; Japan Science Society; Yakult Bio-Science Foundation; Academic Frontier Project for Private Universities (Matching Fund Subsidy); Private University Scientific Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Danone Institute of Japan(Danone Nutricia); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Kieikai Research Foundation(Kieikai Research Foundation); Naito Foundation(Naito Memorial Foundation); Nestle Nutrition Council, Japan; Japan Science Society; Yakult Bio-Science Foundation; Academic Frontier Project for Private Universities (Matching Fund Subsidy)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Private University Scientific Foundation	We thank H. Kitamura and M. E. Mariotti-Ferrandiz for discussions and for reading the manuscript; T. Morita for suggestions; and C. Nishigaki, M. Ohmae, Y. Chiba, T. Kato, H. Shima, A. Nakano, K. Sakaguchi, K. Furuya, C. Yoshino, H. Inaba, E. Iioka, K. Motomura and Y. Hattori for technical support. This research was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan: a Grant-in-Aid for Scientific Research on Priority Areas 'Comprehensive Genomics' (M.H.), 'Membrane Traffic' (H.O.) and 'Matrix of Infectious Phenomena' (K.H.); Young Scientists (S.F., K.H. and J.K.); Challenging Exploratory Research (J.K.); Scientific Research (H.O.); and Scientific Research on Innovative Areas 'Intracellular Logistics' (H.O.). This work was also supported in part by a RIKEN President's Special Research Grant (J.K.); a RIKEN DRI Research Grant (S.F.); a CREST grant from the Japan Science and Technology Agency (J.K.); the Danone Institute of Japan (H.O.); the Institute for Fermentation, Osaka (S.F.); the Kieikai Research Foundation (S.F.); the Naito Foundation (S.F.); the Nestle Nutrition Council, Japan (S.F.); the Sasakawa Scientific Research Grant from the Japan Science Society (S.F. and Y.N.); the Yakult Bio-Science Foundation (S.F.); the Academic Frontier Project for Private Universities (Matching Fund Subsidy (H.M.)); and the Private University Scientific Foundation (H.M.).	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Annison G, 2003, J NUTR, V133, P3523, DOI 10.1093/jn/133.11.3523; Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Eaton KA, 2008, INFECT IMMUN, V76, P3054, DOI 10.1128/IAI.01626-07; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Gagnon M, 2006, INT J FOOD MICROBIOL, V111, P26, DOI 10.1016/j.ijfoodmicro.2006.04.041; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hase K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003033; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kitajima H, 2002, ARCH DIS CHILD, V87, P335, DOI 10.1136/adc.87.4.335; Kles KA, 2006, GASTROENTEROLOGY, V130, pS100, DOI 10.1053/j.gastro.2005.11.048; KONGMUANG U, 1987, J CLIN MICROBIOL, V25, P115, DOI 10.1128/JCM.25.1.115-118.1987; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Li JL, 2005, J BIOL CHEM, V280, P7427, DOI 10.1074/jbc.M411473200; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Morita T, 2004, J GASTROEN HEPATOL, V19, P303, DOI 10.1111/j.1440-1746.2003.03208.x; Nakamura T, 2002, BIOSCI BIOTECH BIOCH, V66, P2362, DOI 10.1271/bbb.66.2362; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Saulnier DMA, 2009, CURR OPIN BIOTECH, V20, P135, DOI 10.1016/j.copbio.2009.01.002; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schuller S, 2004, CELL MICROBIOL, V6, P289, DOI 10.1046/j.1462-5822.2004.00370.x; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884; Yoshimura K, 2010, ANTON LEEUW INT J G, V97, P107, DOI 10.1007/s10482-009-9391-y; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	47	1387	1685	24	432	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					543	U791		10.1038/nature09646	http://dx.doi.org/10.1038/nature09646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270894				2022-12-01	WOS:000286596500035
J	Xian, Y; Holloway, RG; Chan, PS; Noyes, K; Shah, MN; Ting, HH; Chappel, AR; Peterson, ED; Friedman, B				Xian, Ying; Holloway, Robert G.; Chan, Paul S.; Noyes, Katia; Shah, Manish N.; Ting, Henry H.; Chappel, Andre R.; Peterson, Eric D.; Friedman, Bruce			Association Between Stroke Center Hospitalization for Acute Ischemic Stroke and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; REDUCE MORTALITY; TRAUMA CENTERS; CARE; OUTCOMES; QUALITY; COMPARE; DISEASE; BIAS	Context Although stroke centers are widely accepted and supported, little is known about their effect on patient outcomes. Objective To examine the association between admission to stroke centers for acute ischemic stroke and mortality. Design, Setting, and Participants Observational study using data from the New York Statewide Planning and Research Cooperative System. We compared mortality for patients admitted with acute ischemic stroke (n = 30 947) between 2005 and 2006 at designated stroke centers and nondesignated hospitals using differential distance to hospitals as an instrumental variable to adjust for potential prehospital selection bias. Patients were followed up for mortality for 1 year after the index hospitalization through 2007. To assess whether our findings were specific to stroke, we also compared mortality for patients admitted with gastrointestinal hemorrhage (n = 39 409) or acute myocardial infarction (n = 40 024) at designated stroke centers and nondesignated hospitals. Main Outcome Measure Thirty-day all-cause mortality. Results Among 30 947 patients with acute ischemic stroke, 15 297 (49.4%) were admitted to designated stroke centers. Using the instrumental variable analysis, admission to designated stroke centers was associated with lower 30-day all-cause mortality (10.1% vs 12.5%; adjusted mortality difference, -2.5%; 95% confidence interval [CI], -3.6% to -1.4%; P<.001) and greater use of thrombolytic therapy (4.8% vs 1.7%; adjusted difference, 2.2%; 95% CI, 1.6% to 2.8%; P<.001). Differences in mortality also were observed at 1-day, 7-day, and 1-year follow-up. The outcome differences were specific for stroke, as stroke centers and nondesignated hospitals had similar 30-day all-cause mortality rates among those with gastrointestinal hemorrhage (5.0% vs 5.8%; adjusted mortality difference, +0.3%; 95% CI, -0.5% to 1.0%; P=.50) or acute myocardial infarction (10.5% vs 12.7%; adjusted mortality difference, +0.1%; 95% CI, -0.9% to 1.1%; P=.83). Conclusion Among patients with acute ischemic stroke, admission to a designated stroke center was associated with modestly lower mortality and more frequent use of thrombolytic therapy. JAMA. 2011;305(4):373-380 www.jama.com	[Xian, Ying; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27705 USA; [Holloway, Robert G.; Noyes, Katia; Shah, Manish N.; Chappel, Andre R.; Friedman, Bruce] Univ Rochester, Rochester, NY USA; [Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Ting, Henry H.] Mayo Clin, Rochester, MN USA	Duke University; University of Rochester; Saint Luke's Mid America Heart Institute; Mayo Clinic	Xian, Y (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	ying.xian@duke.edu	Peterson, Eric David/ABF-5033-2021; Xian, Ying/O-1956-2019	Xian, Ying/0000-0002-1237-1162; Shah, Manish/0000-0001-6331-1074	Schering Plough; Bristol-Myers Squibb; Merck/Schering Plough; Sanofi Aventis; Saint Judes; American Heart Association (AHA) [0815772D]; Agency for Healthcare Research and Quality (AHRQ) [U18HS016964]; National Heart, Lung, and Blood Institute [K23HL102224]; National Institute on Aging [1K23AG028942]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028942] Funding Source: NIH RePORTER	Schering Plough(Merck & CompanySchering Plough Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck/Schering Plough(Merck & CompanySchering Plough Corporation); Sanofi Aventis(Sanofi-Aventis); Saint Judes; American Heart Association (AHA)(American Heart Association); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Holloway reported being a consultant for Milliman Guidelines, reviewing neurology guidelines. Dr Peterson reported receiving research grants from Schering Plough, Bristol-Myers Squibb, Merck/Schering Plough, Sanofi Aventis, and Saint Judes and being a consultant/advisory board member to Pfizer and Bayer Corp. No other disclosures were reported.; This study was funded in part by a predoctoral fellowship 0815772D from the American Heart Association (AHA) Founders Affiliate (Dr Xian). This study received infrastructure support from the Agency for Healthcare Research and Quality (AHRQ) (U18HS016964). Dr Chan is supported by a Career Development Grant Award (K23HL102224) from the National Heart, Lung, and Blood Institute. Dr Shah is supported by the Paul B. Beeson Career Development Award (National Institute on Aging 1K23AG028942).	Agency for Healthcare Research and Quality, 2006, INP QUAL IND OV; Alberts MJ, 2010, STROKE, V41, P1100, DOI 10.1161/STROKEAHA.110.582148; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; [Anonymous], NEW YORK STATE EMT A; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Beck CA, 2003, HEALTH SERV RES, V38, P1423, DOI 10.1111/j.1475-6773.2003.00186.x; Bhattacharya J, 2006, STAT MED, V25, P389, DOI 10.1002/sim.2226; Bravata DM, 2010, ARCH INTERN MED, V170, P804, DOI 10.1001/archinternmed.2010.92; Douglas VC, 2005, NEUROLOGY, V64, P422, DOI 10.1212/01.WNL.0000150903.38639.E1; Fonarow GC, 2010, CIRCULATION, V122, P2459, DOI 10.1161/CIR.0b013e3182011a81; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Goldstein LB, 2003, NEUROLOGY, V61, P792, DOI 10.1212/01.WNL.0000082724.77447.3A; Greene W.H., 2003, ECONOMETRIC ANAL, V5th edition; Gropen TI, 2006, NEUROLOGY, V67, P88, DOI 10.1212/01.wnl.0000223622.13641.6d; Holloway RG, 2007, JAMA-J AM MED ASSOC, V298, P802, DOI 10.1001/jama.298.7.802; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lattimore SU, 2003, STROKE, V34, pE55, DOI 10.1161/01.STR.0000073789.12120.F3; Lichtman JH, 2009, STROKE, V40, pE127; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Meretoja A, 2010, STROKE, V41, pE361; Mitchell JB, 1996, STROKE, V27, P1937, DOI 10.1161/01.STR.27.11.1937; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Pracht EE, 2007, MED CARE RES REV, V64, P83, DOI 10.1177/1077558706296241; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Stradling D, 2007, NEUROLOGY, V68, P469, DOI 10.1212/01.wnl.0000252930.82140.65; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; U.S. Department of Agriculture, MEAS RUR RUR URB COM; US Department of Health & Human Services, HOSP COMP	31	234	235	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					373	380		10.1001/jama.2011.22	http://dx.doi.org/10.1001/jama.2011.22			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711MH	21266684	Bronze, Green Accepted			2022-12-01	WOS:000286595200022
J	Ficz, G; Branco, MR; Seisenberger, S; Santos, F; Krueger, F; Hore, TA; Marques, CJ; Andrews, S; Reik, W				Ficz, Gabriella; Branco, Miguel R.; Seisenberger, Stefanie; Santos, Fatima; Krueger, Felix; Hore, Timothy A.; Marques, C. Joana; Andrews, Simon; Reik, Wolf			Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation	NATURE			English	Article							DNA METHYLATION; SELF-RENEWAL; STEM-CELLS; GENOME; WIDE; PLURIPOTENT; CONVERSION; PROTEINS	Methylation at the 59 position of cytosine in DNA has important roles in genome function and is dynamically reprogrammed during early embryonic and germ cell development(1). The mammalian genome also contains 5-hydroxymethylcytosine (5hmC), which seems to be generated by oxidation of 5-methylcytosine (5mC) by the TET family of enzymes that are highly expressed in embryonic stem(ES) cells(2-4). Here we use antibodies against 5hmC and 5mC together with high throughput sequencing to determine genome-wide patterns of methylation and hydroxymethylation in mouse wild-type and mutant ES cells and differentiating embryoid bodies. We find that 5hmC is mostly associated with euchromatin and that whereas 5mC is under-represented at gene promoters and CpG islands, 5hmC is enriched and is associated with increased transcriptional levels. Most, if not all, 5hmC in the genome depends on pre-existing 5mC and the balance between these two modifications is different between genomic regions. Knockdown of Tet1 and Tet2 causes downregulation of a group of genes that includes pluripotency-related genes (including Esrrb, Prdm14, Dppa3, Klf2, Tcl1 and Zfp42) and a concomitant increase in methylation of their promoters, together with an increased propensity of ES cells for extraembryonic lineage differentiation. Declining levels of TETs during differentiation are associated with decreased hydroxymethylation levels at the promoters of ES cell-specific genes together with increased methylation and gene silencing. We propose that the balance between hydroxymethylation and methylation in the genome is inextricably linked with the balance between pluripotency and lineage commitment.	[Ficz, Gabriella; Branco, Miguel R.; Seisenberger, Stefanie; Santos, Fatima; Hore, Timothy A.; Marques, C. Joana; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Krueger, Felix; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	wolf.reik@bbsrc.ac.uk	Branco, Miguel/H-9509-2019; Ficz, Gabriella/HCH-3771-2022; Marques, Joana/B-5564-2008; Reik, Wolf/I-6794-2012; Krueger, Felix/J-3340-2019	Branco, Miguel/0000-0001-9447-1548; Marques, Joana/0000-0002-5658-3773; Ficz, Gabriella/0000-0001-9313-9578; Santos, Fatima/0000-0002-3854-4084; Reik, Wolf/0000-0003-0216-9881; Hore, Timothy/0000-0002-6735-225X; Krueger, Felix/0000-0002-5513-3324	BBSRC; MRC; EU NoE The Epigenome; BBSRC [BBS/E/B/0000M236] Funding Source: UKRI; MRC [G0801727, G0801156] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M236] Funding Source: researchfish; Medical Research Council [G0801156, G0801727] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE The Epigenome; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank A. Bird for discussions and input, K. Tabbada for help with epigenomics and transcriptomics sequencing, and M. Okano for providing the TKO ES cells. We would like to thank H. Stuart for her dedicated contribution to gene expression analyses, and all Reik lab members for advice and discussion. This work was funded by the BBSRC, MRC and the EU NoE The Epigenome.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Ting DT, 2004, METH MOLEC MED, V105, P23; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	37	846	905	5	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					398	U589		10.1038/nature10008	http://dx.doi.org/10.1038/nature10008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21460836				2022-12-01	WOS:000290722400054
J	Neurohr, G; Naegeli, A; Titos, I; Theler, D; Greber, B; Diez, J; Gabaldon, T; Mendoza, M; Barral, Y				Neurohr, Gabriel; Naegeli, Andreas; Titos, Iris; Theler, Dominik; Greber, Basil; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel; Barral, Yves			A Midzone-Based Ruler Adjusts Chromosome Compaction to Anaphase Spindle Length	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CONDENSATION; SEPARASE; PROTEIN; KINASE; ANEUPLOIDY; CANCER; CDC14; GENE	Partitioning of chromatids during mitosis requires that chromosome compaction and spindle length scale appropriately with each other. However, it is not clear whether chromosome condensation and spindle elongation are linked. Here, we find that yeast cells could cope with a 45% increase in the length of their longest chromosome arm by increasing its condensation. The spindle midzone, aurora/Ipl1 activity, and Ser10 of histone H3 mediated this response. Thus, the anaphase spindle may function as a ruler to adapt the condensation of chromatids, promoting their segregation regardless of chromosome or spindle length.	[Neurohr, Gabriel; Titos, Iris; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel] Ctr Genom Regulat, Barcelona, Spain; [Neurohr, Gabriel; Titos, Iris; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel] Univ Pompeu Fabra, Barcelona, Spain; [Neurohr, Gabriel; Naegeli, Andreas; Theler, Dominik; Greber, Basil; Mendoza, Manuel; Barral, Yves] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mendoza, M (corresponding author), Ctr Genom Regulat, Barcelona, Spain.	manuel.mendoza@crg.es; yves.barral@bc.biol.ethz.ch	Gabaldón, Toni/A-7336-2008; Mendoza, Manuel/AAE-8987-2021; Mendoza, Manuel/M-9679-2015	Gabaldón, Toni/0000-0003-0019-1735; Mendoza, Manuel/0000-0001-5522-4878; Titos, Iris/0000-0002-5542-3794; Diez Perez, Javier/0000-0001-5032-4976; Naegeli, Andreas/0000-0002-5938-9124; Barral, Yves/0000-0002-0989-3373; Greber, Basil/0000-0001-9379-7159; Neurohr, Gabriel/0000-0003-1728-5498	La Caixa; Spanish Ministry of Science [BFU09-09168, BFU09-08213]; Swiss National Science Foundation	La Caixa(La Caixa Foundation); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank P. Meraldi, Z. Shcheprova, C. Weirich, and S. Buvelot for helpful comments and critical reading of the manuscript; D. Clarke (University of Minnesota) for reagents; C. Iannone and R. Tejedor for help with qPCR; F. Campelo for help with statistical analysis; the ETH Light Microscopy Center; the CRG Advanced Light Microscopy Unit; and the CRG Ultrasequencing Unit. This project was supported by grants from La Caixa to G. N., the Spanish Ministry of Science to T. G. (BFU09-09168) and M. M. (BFU09-08213), and the Swiss National Science Foundation to Y.B.	Bouck DC, 2008, ANNU REV GENET, V42, P335, DOI 10.1146/annurev.genet.42.110807.091620; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Harrison BD, 2009, CHROMOSOMA, V118, P633, DOI 10.1007/s00412-009-0224-6; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Nash RS, 2001, GENETICS, V157, P1469; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; SULLIVAN W, 1993, MOL BIOL CELL, V4, P885, DOI 10.1091/mbc.4.9.885; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Vas ACJ, 2007, MOL BIOL CELL, V18, P557, DOI 10.1091/mbc.E06-05-0454	20	68	69	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					465	468		10.1126/science.1201578	http://dx.doi.org/10.1126/science.1201578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21393511				2022-12-01	WOS:000289784900043
J	Misra, S; Hancock, M; Meeran, K; Dornhorst, A; Oliver, NS				Misra, Shivani; Hancock, Maggie; Meeran, Karim; Dornhorst, Anne; Oliver, Nick S.			HbA(1c): an old friend in new clothes	LANCET			English	Editorial Material							HEMOGLOBIN		[Misra, Shivani; Meeran, Karim; Dornhorst, Anne; Oliver, Nick S.] Imperial Healthcare NHS Trust, Dept Metab Med, London W6 8RF, England; [Misra, Shivani; Hancock, Maggie] Imperial Healthcare NHS Trust, Dept Clin Biochem, London W6 8RF, England		Misra, S (corresponding author), Imperial Healthcare NHS Trust, Dept Metab Med, London W6 8RF, England.	smisra@imperial.ac.uk	Oliver, Nick S/G-9109-2016	Oliver, Nick S/0000-0003-3525-3633; Misra, Shivani/0000-0003-2886-0726				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; *ASS CLIN BIOCH, HBA1C STAND LAB PROF; Barth JH, 2008, ANN CLIN BIOCHEM, V45, P343, DOI 10.1258/acb.2008.200815; Berg AH, 2008, J CLIN PATHOL, V61, P983, DOI 10.1136/jcp.2007.049205; Davidson MB, 2010, DIABETES RES CLIN PR, V87, P415, DOI 10.1016/j.diabres.2009.12.013; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Kilpatrick ES, 2009, BMJ-BRIT MED J, V339, P1288; Little Randie R, 2003, Diabetes Technol Ther, V5, P979, DOI 10.1089/152091503322641024; Little RR, 2009, CURR OPIN ENDOCRINOL, V16, P113, DOI 10.1097/MED.0b013e328327728d; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Glycohemoglobin Standardization Program (NGSP), FACT INT HBA1C TEST; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weykamp C, 2008, CLIN CHEM, V54, P240, DOI 10.1373/clinchem.2007.097402; WHO, 2011, USE GLYCATED HAEMOGL	16	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2011	377	9776					1476	1477		10.1016/S0140-6736(10)61858-2	http://dx.doi.org/10.1016/S0140-6736(10)61858-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21354611				2022-12-01	WOS:000290419400010
J	Sun, G; Dilcher, DL; Wang, HS; Chen, ZD				Sun, Ge; Dilcher, David L.; Wang, Hongshan; Chen, Zhiduan			A eudicot from the Early Cretaceous of China	NATURE			English	Article							JURASSIC ANGIOSPERM; YIXIAN FORMATION; FOSSIL EVIDENCE; AGE; FLOWER; NOV.	The current molecular systematics of angiosperms(1) recognizes the basal angiosperms and five major angiosperm lineages: the Chloranthaceae, the magnoliids, the monocots, Ceratophyllum and the eudicots, which consist of the basal eudicots and the core eudicots(2). The eudicots form the majority of the angiosperms in the world today. The flowering plants are of exceptional evolutionary interest because of their diversity of over 250,000 species and their abundance as the dominant vegetation in most terrestrial ecosystems, but little is known of their very early history. In this report we document an early presence of eudicots during the Early Cretaceous Period. Diagnostic characters of the eudicot fossil Leefructus gen. nov. include simple and deeply trilobate leaves clustered at the nodes in threes or fours, basal palinactinodromous primary venation, pinnate secondary venation, and a long axillary reproductive axis terminating in a flattened receptacle bearing five long, narrow pseudo-syncarpous carpels. These morphological characters suggest that its affinities are with the Ranunculaceae, a basal eudicot family. The fossil co-occurs with Archaefructus sinensis(3) and Hyrcantha decussata(4) whereas Archaefructus liaoningensis(5) comes from more ancient sediments. Multiple radiometric dates of the Lower Cretaceous Yixian Formation place the bed yielding this fossil at 122.6-125.8 million years old(6-8). The earliest fossil records of eudicots are 127 to 125 million years old, on the basis of pollen(9,10). Thus, Leefructus gen. nov. suggests that the basal eudicots were already present and diverse by the latest Barremian and earliest Aptian.	[Sun, Ge; Dilcher, David L.; Wang, Hongshan] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Sun, Ge; Dilcher, David L.] Jilin Univ, Res Ctr Paleontol, Changchun 130026, Peoples R China; [Dilcher, David L.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Wang, Hongshan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Chen, Zhiduan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China	Shenyang Normal University; Jilin University; Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Botany, CAS	Sun, G (corresponding author), Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China.	sunge@synu.edu.cn; dilcher@indiana.edu			Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China; Project "111'' of China; NSFC [40842002]	Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China(Ministry of Education, China); Project "111'' of China(Ministry of Education, China - 111 Project); NSFC(National Natural Science Foundation of China (NSFC))	We acknowledge the support of the Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China, and Project "111'' of China, NSFC project number 40842002, and the President Special Fund of Shenyang Normal University to carry out this research project during 2008-2009. Many thanks to S. M. Li and L. X. Wang for their help in collecting the fossil specimen. We thank Y. Duan, C. T. Li, Y. S. Liu, D. M. Jarzen, T. Lott, S. Trammel and W. Wang for their assistance in analysis, computer work, photography and artwork. We also thank P. and D. Soltis, K. Nixon, M. Moore and J. Doyle for suggestions.	Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; [Anonymous], 1991, POLLEN SPORES PATTER; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Chang M.M., 2001, JEHOL BIOTA; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Dilcher DL, 2007, P NATL ACAD SCI USA, V104, P9370, DOI 10.1073/pnas.0703497104; Doyle J., 1977, B CTR RECH EXPLOR PR, V1, P451; DOYLE JA, 1969, J ARNOLD ARBORETUM, V50, P1; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hughes NF., 1994, ENIGMA ANGIOSPERM OR; Leng Q, 2003, PLANT SYST EVOL, V241, P77, DOI 10.1007/s00606-003-0028-8; [孟凡雪 MENG Fanxue], 2008, [地质通报, Geological Bulletin of China], V27, P364; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Peng Y. D., 2003, GEOCHIMICA, V32, P427, DOI DOI 10.3321/J.ISSN:0379-1726.2003.05.003; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Ren D, 1998, SCIENCE, V280, P85, DOI 10.1126/science.280.5360.85; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Taylor T.N., 2008, PALEOBOTANY BIOL EVO; Wang SS, 2001, ACTA PETROL SIN, V17, P663; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; [张宏 Zhang Hong], 2006, [地质论评, Geological Review], V52, P63; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	30	92	105	3	83	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					625	628		10.1038/nature09811	http://dx.doi.org/10.1038/nature09811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455178				2022-12-01	WOS:000288951200040
J	Eisenstein, M				Eisenstein, Michael			VACCINES Know your enemy	NATURE			English	Editorial Material							CARCINOMA											Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; De Giovanni C, 2004, CANCER RES, V64, P4001, DOI 10.1158/0008-5472.CAN-03-2984; Gray A, 2009, VACCINE, V27, pG52, DOI 10.1016/j.vaccine.2009.09.106; Jaini R, 2010, NAT MED, V16, P799, DOI 10.1038/nm.2161; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054	5	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S8	S9		10.1038/471S8a	http://dx.doi.org/10.1038/471S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430720	hybrid			2022-12-01	WOS:000288702200010
J	Seebacher, J; Gavin, AC				Seebacher, Jan; Gavin, Anne-Claude			SnapShot: Protein-Protein Interaction Networks	CELL			English	Editorial Material							ORGANIZATION; MAP		[Seebacher, Jan; Gavin, Anne-Claude] EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Seebacher, J (corresponding author), EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.			Gavin, Anne-Claude/0000-0003-4917-2340				Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Orchard S, 2007, NAT BIOTECHNOL, V25, P894, DOI 10.1038/nbt1324; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	8	47	49	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					1000	U1		10.1016/j.cell.2011.02.025	http://dx.doi.org/10.1016/j.cell.2011.02.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414489	Bronze, Green Published			2022-12-01	WOS:000288543500016
J	Soutourina, J; Wydau, S; Ambroise, Y; Boschiero, C; Werner, M				Soutourina, Julie; Wydau, Sandra; Ambroise, Yves; Boschiero, Claire; Werner, Michel			Direct Interaction of RNA Polymerase II and Mediator Required for Transcription in Vivo	SCIENCE			English	Article							REPEAT DOMAIN; ACTIVATION; PROTEIN; YEAST; COMPLEX; RESOLUTION; GENOME; HOLOENZYME; INITIATION; MECHANISM	Gene transcription is highly regulated. Altered transcription can lead to cancer or developmental diseases. Mediator, a multisubunit complex conserved among eukaryotes, is generally required for RNA polymerase II (Pol II) transcription. An interaction between the two complexes is known, but its molecular nature and physiological role are unclear. We identify a direct physical interaction between the Rpb3 Pol II subunit of Saccharomyces cerevisiae and the essential Mediator subunit, Med17. Furthermore, we demonstrate a functional element in the Mediator-Pol II interface that is important for genome-wide Pol II recruitment in vivo. Our findings suggest that a direct interaction between Mediator and Pol II is generally required for transcription of class II genes in eukaryotes.	[Soutourina, Julie; Wydau, Sandra; Boschiero, Claire; Werner, Michel] Commissariat Energie Atom & Energies Alternat CEA, IBiTec S, Serv Biol Integrat & Genet Mol, F-91191 Gif Sur Yvette, France; [Ambroise, Yves] CEA, IBiTec S, Serv Chim Bioorgan & Marquage, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Soutourina, J (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, IBiTec S, Serv Biol Integrat & Genet Mol, F-91191 Gif Sur Yvette, France.	julie.soutourina@cea.fr; michel.werner@cea.fr	Soutourina, Julie/F-8305-2014; Werner, Michel/B-7316-2009	Soutourina, Julie/0000-0001-5218-2350; Werner, Michel/0000-0002-2965-5858; Ambroise, Yves/0000-0001-7174-9914; Wydau-Dematteis, Sandra/0000-0003-2023-3656	Agence Nationale de la Recherche [ANR-08-BLAN-0229]; Association pour la Recherche sur le Cancer [5118]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank N. Woychik, P. Thuriaux, O. Gadal, and B. Guglielmi for strains or plasmids; S. Hahn and M. Ptashne for antibodies; the Service de Pharmacologie et d'Immuno Analyse (CEA/Saclay) for monoclonal antibodies; A. Sentenac, A. W. Rutherford, and P. Thuriaux for discussions and critical reading of the manuscript; P. Thuriaux for help with crystal-structures visualization; Y. Ghavi-Helm and M. Pinskaya for help with ChIP-chip data analyses; and B. Guglielmi for initial interest in Mediator-Pol II interaction. This work was supported by the Agence Nationale de la Recherche (ANR-08-BLAN-0229) and Association pour la Recherche sur le Cancer (subvention fixe 5118). J.S. and S. W. performed the experimental work and analyzed the results, Y. A. participated in photo-cross-linking experiments and C. B. in yeast-strain constructions, and J.S. and M. W. designed the research and wrote the manuscript. Raw ChIP-chip data are available at Array Express under accession number E-MEXP-3043 (www.ebi.ac.uk/arrayexpress).	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Mehta S, 2009, FEBS LETT, V583, P3115, DOI 10.1016/j.febslet.2009.08.036; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; NONET ML, 1989, GENETICS, V123, P715; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Tan Q, 2000, GENE DEV, V14, P339; Tardiff DF, 2007, P NATL ACAD SCI USA, V104, P19948, DOI 10.1073/pnas.0710179104; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	24	104	107	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1451	1454		10.1126/science.1200188	http://dx.doi.org/10.1126/science.1200188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415355				2022-12-01	WOS:000288504000045
J	Wakil, A; Ng, JM; Atkin, SL				Wakil, Ammar; Ng, Jen Min; Atkin, Stephen L.			Rational Testing Investigating hyponatraemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERNATREMIA; WATER					ammar.wakil@gmail.com	Atkin, stephen/ABE-7047-2020; atkin, stephen/D-7400-2014	atkin, stephen/0000-0002-5887-7257				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Clayton JA, 2006, QJM-INT J MED, V99, P505, DOI 10.1093/qjmed/hcl071; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Milionis HJ, 2002, CAN MED ASSOC J, V166, P1056; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; Verbalis JG, 2007, AM J MED, V120, pS1, DOI 10.1016/j.amjmed.2007.09.001; Yeates KE, 2004, CAN MED ASSOC J, V170, P365; Zenenberg Robert D, 2010, Hosp Pract (1995), V38, P89	9	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2011	342								d1118	10.1136/bmj.d1118	http://dx.doi.org/10.1136/bmj.d1118			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UV	21382929				2022-12-01	WOS:000288446500005
J	Mihlbachler, MC; Rivals, F; Solounias, N; Semprebon, GM				Mihlbachler, Matthew C.; Rivals, Florent; Solounias, Nikos; Semprebon, Gina M.			Dietary Change and Evolution of Horses in North America	SCIENCE			English	Article							FOSSIL HORSES; STABLE-ISOTOPES; GREAT-PLAINS; OPEN-HABITAT; HYPSODONTY; MAMMALS; CARBON; COEVOLUTION; ADAPTATION; GRASSES	The evolution of high-crowned molars among horses (Family Equidae) is thought to be an adaptation for abrasive diets associated with the spread of grasslands. The sharpness and relief of the worn cusp apices of teeth (mesowear) are a measure of dietary abrasion. We collected mesowear data for North American Equidae for the past 55.5 million years to test the association of molar height and dietary abrasion. Mesowear trends in horses are reflective of global cooling and associated vegetation changes. There is a strong correlation between mesowear and crown height in horses; however, most horse paleopopulations had highly variable amounts of dietary abrasion, suggesting that selective pressures for crown height may have been weak much of the time. However, instances of higher abrasion were observed in some paleopopulations, suggesting intervals of stronger selection for the evolution of dentitions, including the early Miocene shortly before the first appearance of Equinae, the horse subfamily in which high-crowned dentitions evolved.	[Mihlbachler, Matthew C.; Solounias, Nikos] New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Mihlbachler, Matthew C.; Solounias, Nikos] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Rivals, Florent] Univ Rovira & Virgili, ICREA, Inst Catala Paleoecol Humana & Evolucio Social, Tarragona 43002, Spain; [Semprebon, Gina M.] Bay Path Coll, Dept Biol, Longmeadow, MA 01106 USA	New York Institute Technology; American Museum of Natural History (AMNH); ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES)	Mihlbachler, MC (corresponding author), New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.	mmihlbac@nyit.edu	Rivals, Florent/B-7962-2014	Rivals, Florent/0000-0001-8074-9254	NSF [EAR-0824657]; ICREA Funding Source: Custom	NSF(National Science Foundation (NSF)); ICREA(ICREA)	We thank B. Beatty, C. Norris, R. O'Leary, and H. Galiano for assistance. We thank NSF (grant EAR-0824657) for support to M.C.M. and N.S.	DeMiguel D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-13; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Eronen JT, 2010, EVOL ECOL RES, V12, P217; Eronen JT, 2010, EVOLUTION, V64, P398, DOI 10.1111/j.1558-5646.2009.00830.x; Feranec RS, 2003, PALEOBIOLOGY, V29, P230, DOI 10.1666/0094-8373(2003)029<0230:SIHATP>2.0.CO;2; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Fox DL, 2004, PALAEOGEOGR PALAEOCL, V207, P305, DOI 10.1016/j.palaeo.2003.09.030; Janis Christine, 2008, V195, P21, DOI 10.1007/978-3-540-72422-3_2; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; Matthew WD, 1926, Q REV BIOL, V1, P139, DOI 10.1086/394242; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Mihlbachler Matthew C., 2006, Journal of Mammalian Evolution, V13, P11, DOI 10.1007/s10914-005-9001-3; Passey BH, 2002, J GEOL, V110, P123, DOI 10.1086/338280; Retallack GJ, 1992, EOCENE OLIGOCENE CLI, P382; Rivals F, 2007, QUATERNARY RES, V68, P338, DOI 10.1016/j.yqres.2007.07.012; Secord R, 2008, PALEOBIOLOGY, V34, P282, DOI 10.1666/0094-8373(2008)034[0282:SIIEEM]2.0.CO;2; Simpson, 1951, HORSES STORY HORSE F; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; STEBBINS GL, 1981, ANN MO BOT GARD, V68, P75, DOI 10.2307/2398811; STIRTON RA, 1947, EVOLUTION, V1, P32, DOI 10.2307/2405401; Stromberg CAE, 2006, PALEOBIOLOGY, V32, P236, DOI 10.1666/0094-8373(2006)32[236:EOHIET]2.0.CO;2; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P269, DOI 10.1016/0031-0182(94)90099-X; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	28	196	202	3	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1178	1181		10.1126/science.1196166	http://dx.doi.org/10.1126/science.1196166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385712				2022-12-01	WOS:000287971200038
J	Oury, F; Sumara, G; Sumara, O; Ferron, M; Chang, HX; Smith, CE; Hermo, L; Suarez, S; Roth, BL; Ducy, P; Karsenty, G				Oury, Franck; Sumara, Grzegorz; Sumara, Olga; Ferron, Mathieu; Chang, Haixin; Smith, Charles E.; Hermo, Louis; Suarez, Susan; Roth, Bryan L.; Ducy, Patricia; Karsenty, Gerard			Endocrine Regulation of Male Fertility by the Skeleton	CELL			English	Article							MOUSE LEYDIG-CELLS; PROTEIN-COUPLED RECEPTOR; RAT SEMINIFEROUS TUBULES; RNA HELICASE GRTH/DDX25; BONE MASS; METABOLIC SYNDROME; ENERGY-METABOLISM; GENETIC-CONTROL; EXPRESSION; SERUM	Interactions between bone and the reproductive system have until now been thought to be limited to the regulation of bone remodeling by the gonads. We now show that, in males, bone acts as a regulator of fertility. Using coculture assays, we demonstrate that osteoblasts are able to induce testosterone production by the testes, though they fail to influence estrogen production by the ovaries. Analyses of cell-specific loss- and gain-of-function models reveal that the osteoblast-derived hormone osteocalcin performs this endocrine function. By binding to a G protein-coupled receptor expressed in the Leydig cells of the testes, osteocalcin regulates in a CREB-dependent manner the expression of enzymes that is required for testosterone synthesis, promoting germ cell survival. This study expands the physiological repertoire of osteocalcin and provides the first evidence that the skeleton is an endocrine regulator of reproduction.	[Oury, Franck; Sumara, Grzegorz; Sumara, Olga; Ferron, Mathieu; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Ducy, Patricia] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Chang, Haixin; Suarez, Susan] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Smith, Charles E.; Hermo, Louis] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Roth, Bryan L.] Univ N Carolina, Dept Pharmacol Med Chem & Nat Prod, Sch Med, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Pharm, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Pharm, Dept Pharmacol Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	Columbia University; Columbia University; Cornell University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Karsenty, G (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020; Ferron, Mathieu/M-7794-2013	Roth, Bryan/0000-0002-0561-6520; Sumara, Grzegorz/0000-0003-1502-6265; OURY, FRANCK/0000-0003-0562-9900; Sumara, Olga/0000-0002-0845-3720	NIH; Fond de la recherche en sante du Quebec; HFSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065439] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fond de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); HFSP(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Drs. Behringer and Ko for generously providing the Amh-mis-Cre and Cyp17-iCre mice; Dr. Hampson for generously providing us Gprc6a antibody; Dr. A. F. Parlow for measurements of LH in serum (National Hormone and Peptide Program); Drs. Przedborski and Jackson-Lewis for gracious help with stereological analysis; Drs. Mark, Yadav, Yoshizawa, Allen, and Setola for critical experimental advice; and G. Ren for mouse genotyping. This work was supported by grants from the NIH (G. K.), Fond de la recherche en sante du Quebec (M. F.), and HFSP (G. S. and F. O.).	Basura GJ, 2008, HEARING RES, V244, P45, DOI 10.1016/j.heares.2008.07.009; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Dacquin R, 2004, DEV DYNAM, V229, P826, DOI 10.1002/dvdy.20003; Dakhova O, 2009, ENDOCRINOLOGY, V150, P404, DOI 10.1210/en.2008-0673; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fukumoto S, 2007, BONE, V40, P1190, DOI 10.1016/j.bone.2006.12.062; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; GRAY A, 1991, J CLIN EPIDEMIOL, V44, P671, DOI 10.1016/0895-4356(91)90028-8; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HENRIKSEN K, 1995, ENDOCRINOLOGY, V136, P3285, DOI 10.1210/en.136.8.3285; Hikim APS, 1999, REV REPROD, V4, P38; HUNTER MG, 1982, MOL CELL ENDOCRINOL, V25, P35, DOI 10.1016/0303-7207(82)90167-8; Jamin SP, 2003, MOL CELL ENDOCRINOL, V211, P15, DOI 10.1016/j.mce.2003.09.006; KANAZAWA I, 2010, BONE IN PRESS, DOI DOI 10.1016/J.BONE.2010.12.020; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Powlin SS, 1998, TOXICOL SCI, V46, P61, DOI 10.1093/toxsci/46.1.61; Quigley CA, 2002, J CLIN ENDOCR METAB, V87, P24, DOI 10.1210/jc.87.1.24; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Russell L, 1990, HISTOLOGICAL HISTOPA; Saleem U, 2010, ARTERIOSCL THROM VAS, V30, P1474, DOI 10.1161/ATVBAHA.110.204859; SCHUMACHER M, 1978, FEBS LETT, V91, P333, DOI 10.1016/0014-5793(78)81204-6; SHARPE RM, 1992, J ANDROL, V13, P172; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Simpson E, 2000, TRENDS ENDOCRIN MET, V11, P184, DOI 10.1016/S1043-2760(00)00254-X; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; SUAREZ SS, 1987, BIOL REPROD, V36, P1191, DOI 10.1095/biolreprod36.5.1191; Tsai-Morris CH, 2007, MOL HUM REPROD, V13, P887, DOI 10.1093/molehr/gam065; Tsai-Morris CH, 2010, J CELL BIOCHEM, V109, P1142, DOI 10.1002/jcb.22493; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Wang GM, 2003, ENDOCRINOLOGY, V144, P5058, DOI 10.1210/en.2003-0563; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Yeap BB, 2010, EUR J ENDOCRINOL, V163, P265, DOI 10.1530/EJE-10-0414; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	52	419	451	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					796	809		10.1016/j.cell.2011.02.004	http://dx.doi.org/10.1016/j.cell.2011.02.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21333348	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000288007100017
J	Shin, JH; Ko, HS; Kang, H; Lee, Y; Lee, YI; Pletinkova, O; Troconso, JC; Dawson, VL; Dawson, TM				Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Pletinkova, Olga; Troconso, Juan C.; Dawson, Valina L.; Dawson, Ted M.			PARIS (ZNF746) Repression of PGC-1 alpha Contributes to Neurodegeneration in Parkinson's Disease	CELL			English	Article							ZINC-FINGER PROTEINS; MITOCHONDRIAL BIOGENESIS; UBIQUITIN; BINDING; IDENTIFICATION; SUBSTRATE; INTERACTS; INSULIN; LIGASE; DOMAIN	A hallmark of Parkinson's disease (PD) is the preferential loss of substantia nigra dopamine neurons. Here, we identify a new parkin interacting substrate, PARIS (ZNF746), whose levels are regulated by the ubiquitin proteasome system via binding to and ubiquitination by the E3 ubiquitin ligase, parkin. PARIS is a KRAB and zinc finger protein that accumulates in models of parkin inactivation and in human PD brain. PARIS represses the expression of the transcriptional coactivator, PGC-1 alpha and the PGC-1 alpha target gene, NRF-1 by binding to insulin response sequences in the PGC-1 alpha promoter. Conditional knockout of parkin in adult animals leads to progressive loss of dopamine (DA) neurons in a PARIS-dependent manner. Moreover, overexpression of PARIS leads to the selective loss of DA neurons in the substantia nigra, and this is reversed by either parkin or PGC-1 alpha coexpression. The identification of PARIS provides a molecular mechanism for neurodegeneration due to parkin inactivation.	[Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yun-Il; Troconso, Juan C.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lee, Yunjong; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Pletinkova, Olga; Troconso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Shin, Joo-Ho/P-1417-2018	Dawson, Valina/0000-0002-2915-3970; Lee, Yunjong/0000-0003-0182-2279	Bachmann Strauss Dystonia and Parkinson's Disease Foundation; Samsung Scholarship Foundation;  [NS38377];  [NS048206];  [NS051764]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051764, R01NS048206, P50NS038377] Funding Source: NIH RePORTER	Bachmann Strauss Dystonia and Parkinson's Disease Foundation; Samsung Scholarship Foundation(Samsung); ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NS38377, NS048206, NS051764, and the Bachmann Strauss Dystonia and Parkinson's Disease Foundation. Y. L. is supported by Samsung Scholarship Foundation. T. M. D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The authors thank Drs. Xin Guo, Sathya Siram, and members of the Dawson laboratory for assistance and contributions to the manuscript. We also thank Drs. Alex Kolodkin, David Ginty, and Solomon H. Snyder for helpful suggestions.	Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; FUNK WD, 1992, P NATL ACAD SCI USA, V89, P9484, DOI 10.1073/pnas.89.20.9484; Gasser T, 2007, MOVEMENT DISORD, V22, pS343, DOI 10.1002/mds.21676; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Vives-Bauza C, 2010, AUTOPHAGY, V6, P315, DOI 10.4161/auto.6.2.11199; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Voz ML, 2000, CANCER RES, V60, P106; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	38	666	689	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					689	702		10.1016/j.cell.2011.02.010	http://dx.doi.org/10.1016/j.cell.2011.02.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376232	Bronze, Green Accepted			2022-12-01	WOS:000288007100009
J	Ege, MJ; Mayer, M; Normand, AC; Genuneit, J; Cookson, WOCM; Braun-Fahrlander, C; Heederik, D; Piarroux, R; von Mutius, E				Ege, Markus J.; Mayer, Melanie; Normand, Anne-Cecile; Genuneit, Jon; Cookson, William O. C. M.; Braun-Fahrlaender, Charlotte; Heederik, Dick; Piarroux, Renaud; von Mutius, Erika		GABRIELA Transregio 22 Study Grp	Exposure to Environmental Microorganisms and Childhood Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SCHOOL-AGE-CHILDREN; IN-HOUSE DUST; ATOPIC SENSITIZATION; ALLERGIC DISEASES; FARM CHILDREN; MATTRESS DUST; ENDOTOXIN; BACTERIAL; INFLAMMATION; ASSOCIATION	BACKGROUND Children who grow up in environments that afford them a wide range of microbial exposures, such as traditional farms, are protected from childhood asthma and atopy. In previous studies, markers of microbial exposure have been inversely related to these conditions. METHODS In two cross-sectional studies, we compared children living on farms with those in a reference group with respect to the prevalence of asthma and atopy and to the diversity of microbial exposure. In one study - PARSIFAL (Prevention of Allergy - Risk Factors for Sensitization in Children Related to Farming and Anthroposophic Lifestyle) - samples of mattress dust were screened for bacterial DNA with the use of single-strand conformation polymorphism (SSCP) analyses to detect environmental bacteria that cannot be measured by means of culture techniques. In the other study - GABRIELA (Multidisciplinary Study to Identify the Genetic and Environmental Causes of Asthma in the European Community [GABRIEL] Advanced Study) - samples of settled dust from children's rooms were evaluated for bacterial and fungal taxa with the use of culture techniques. RESULTS In both studies, children who lived on farms had lower prevalences of asthma and atopy and were exposed to a greater variety of environmental microorganisms than the children in the reference group. In turn, diversity of microbial exposure was inversely related to the risk of asthma (odds ratio for PARSIFAL, 0.62; 95% confidence interval [CI], 0.44 to 0.89; odds ratio for GABRIELA, 0.86; 95% CI, 0.75 to 0.99). In addition, the presence of certain more circumscribed exposures was also inversely related to the risk of asthma; this included exposure to species in the fungal taxon eurotium (adjusted odds ratio, 0.37; 95% CI, 0.18 to 0.76) and to a variety of bacterial species, including Listeria monocytogenes, bacillus species, corynebacterium species, and others (adjusted odds ratio, 0.57; 95% CI, 0.38 to 0.86). CONCLUSIONS Children living on farms were exposed to a wider range of microbes than were children in the reference group, and this exposure explains a substantial fraction of the inverse relation between asthma and growing up on a farm. (Funded by the Deutsche Forschungsgemeinschaft and the European Commission.)	[Ege, Markus J.; von Mutius, Erika] Univ Childrens Hosp Munich, Munich, Germany; [Mayer, Melanie] Tech Univ Munich, Inst Anim Hyg, D-8050 Freising Weihenstephan, Germany; [Genuneit, Jon] Univ Ulm, Inst Epidemiol, Ulm, Germany; [Normand, Anne-Cecile] Univ Franche Comte, Chronoenvironm Lab, F-25030 Besancon, France; [Piarroux, Renaud] Assistance Publ Hop Marseille, Dept Parasitol & Mycol, Marseille, France; [Piarroux, Renaud] Univ Aix Marseille 2, Marseille, France; [Cookson, William O. C. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Braun-Fahrlaender, Charlotte] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Braun-Fahrlaender, Charlotte] Univ Basel, Basel, Switzerland; [Heederik, Dick] Univ Utrecht, Inst Risk Assessment, Div Environm Epidemiol, Utrecht, Netherlands	University of Munich; Technical University of Munich; Ulm University; Universite de Franche-Comte; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Utrecht University	Ege, MJ (corresponding author), Univ Munich, Childrens Hosp, Lindwurmstr 4, D-80337 Munich, Germany.	markus.ege@med.uni-muenchen.de	Loss, Georg/F-1557-2013; Genuneit, Jon/I-9323-2012; Fahimifar, Sepideh/M-5303-2019; Normand, Anne-Cécile/V-4271-2018; Ege, Markus/C-1962-2012; Latzin, Philipp/F-2206-2017	Genuneit, Jon/0000-0001-5764-1528; Normand, Anne-Cécile/0000-0002-9589-4603; Ege, Markus/0000-0001-6643-3923; Loss, Georg/0000-0003-1090-812X; Wouters, Inge M./0000-0001-7834-9390; von Mutius, Erika/0000-0002-8893-4515; piarroux, renaud/0000-0002-4151-4134; Heederik, Dick/0000-0002-4550-1437; Latzin, Philipp/0000-0002-5239-1571; Pershagen, Goran/0000-0002-9701-1130	Deutsche Forschungsgemeinschaft [SFB Transregio 22, A1]; European Commission [LSH-2004-1.2.5-1, QLRT 1999-01391]; Medical Research Council [G1000758, G0801056B, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by grants from Deutsche Forschungsgemeinschaft (SFB Transregio 22 Pulmonary Allergies, Project A1) and the European Commission (LSH-2004-1.2.5-1 and QLRT 1999-01391).	Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Hansen G, 2000, J IMMUNOL, V164, P223, DOI 10.4049/jimmunol.164.1.223; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kalliomaki M, 2008, ADV EXP MED BIOL, V635, P57, DOI 10.1007/978-0-387-09550-9_5; Korthals M, 2008, ENVIRON RES, V107, P299, DOI 10.1016/j.envres.2008.02.007; Korthals M, 2008, J MICROBIOL METH, V73, P49, DOI 10.1016/j.mimet.2008.01.010; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Normand AC, 2009, APPL ENVIRON MICROB, V75, P7617, DOI 10.1128/AEM.01414-09; Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08; Pakarinen J, 2008, ENVIRON MICROBIOL, V10, P3317, DOI 10.1111/j.1462-2920.2008.01723.x; Sahakian NM, 2008, IMMUNOL ALLERGY CLIN, V28, P485, DOI 10.1016/j.iac.2008.03.009; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schram-Bijkerk D, 2005, CLIN EXP ALLERGY, V35, P1272, DOI 10.1111/j.1365-2222.2005.02339.x; Sordillo JE, 2010, CLIN EXP ALLERGY, V40, P902, DOI 10.1111/j.1365-2222.2010.03509.x; van Strien RT, 2004, J ALLERGY CLIN IMMUN, V113, P860, DOI [10.1016/j.jaci.2004.01.078, 10.1016/j.jaci.2004.01.783]; Vartiainen E, 2002, J ALLERGY CLIN IMMUN, V109, P643, DOI 10.1067/mai.2002.123307; Vogel K, 2008, J ALLERGY CLIN IMMUN, V122, P307, DOI 10.1016/j.jaci.2008.05.016; von Mutius E, 2008, IMMUNOL ALLERGY CLIN, V28, P631, DOI 10.1016/j.iac.2008.03.010; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0	27	1007	1048	6	227	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					701	709		10.1056/NEJMoa1007302	http://dx.doi.org/10.1056/NEJMoa1007302			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345099	Green Published			2022-12-01	WOS:000287652500004
J	Tan, W; Zhang, WZ; Strasner, A; Grivennikov, S; Cheng, JQ; Hoffman, RM; Karin, M				Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Cheng, Jin Q.; Hoffman, Robert M.; Karin, Michael			Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling	NATURE			English	Article							BREAST-CANCER; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN-LIGAND; GLAND DEVELOPMENT; BONE METASTASES; PROSTATE-CANCER; EXPRESSION; ACTIVATION; DENOSUMAB; RECEPTOR	Inflammatory mechanisms influence tumorigenesis and metastatic progression even in cancers whose aetiology does not involve pre-existing inflammation or infection, such as breast and prostate cancers(1). For instance, prostate cancer metastasis is associated with the infiltration of lymphocytes into advanced tumours and the upregulation of two tumour-necrosis-factor family members: receptor activator of nuclear factor-kappa B (RANK) ligand (RANKL) and lymphotoxin(2). But the source of RANKL and its role in metastasis have not been established. RANKL and its receptor RANK control the proliferation of mammary lobuloalveolar cells during pregnancy(3) through inhibitor of nuclear factor-kappa B (I kappa B) kinase-alpha (IKK-alpha)(4), a protein kinase that is needed for the self-renewal of mammary cancer progenitors(5) and for prostate cancer metastasis(2). We therefore examined whether RANKL, RANK and IKK-alpha are also involved in mammary/breast cancer metastasis. Indeed, RANK signalling in mammary carcinoma cells that overexpress the proto-oncogene Erbb2 (also known as Neu)(6), which is frequently amplified in metastatic human breast cancers(7,8), was important for pulmonary metastasis. Metastatic spread of Erbb2-transformed carcinoma cells also required CD4(+)CD25(+) T cells, whose major pro-metastatic function was RANKL production. Most RANKL-producing T cells expressed forkhead box P3 (FOXP3), a transcription factor produced by regulatory T cells, and were located next to smooth muscle actin (SMA)(+) stromal cells in mouse and human breast cancers. The dependence of pulmonary metastasis on T cells was replaceable by exogenous RANKL, which also stimulated pulmonary metastasis of RANK(+) human breast cancer cells. These results are consistent with the adverse impact of tumour-infiltrating CD4(+) or FOXP3(+) T cells on human breast cancer prognosis(9,10) and suggest that the targeting of RANKL-RANK can be used in conjunction with the therapeutic elimination of primary breast tumours to prevent recurrent metastatic disease.	[Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA; [Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California San Diego; Anti Cancer Inc	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr,Mail Code 0723, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019	Grivennikov, Sergei/0000-0003-2987-0555	National Institutes of Health (NIH); Susan G. Komen for the Cure; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA132586, R01CA127923, T32CA121938] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Coussens for discussions and suggestions, V. Temkin and G. He for advice, and H. Herschman for critical reading. Work was supported by the National Institutes of Health (NIH). W. T. and W.Z. were supported by postdoctoral fellowships from the Susan G. Komen for the Cure. A. S. was supported by NIH Asthma Research and Cancer Therapeutic training grants, and S. G. was supported by a research fellowship from the Crohn's and Colitis Foundation of America. M. K. is an American Cancer Society research professor.	Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Body JJ, 2010, J BONE MINER RES, V25, P440, DOI 10.1359/jbmr.090810; Bohling SD, 2008, MODERN PATHOL, V21, P1527, DOI 10.1038/modpathol.2008.160; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fizazi K, 2009, J CLIN ONCOL, V27, P1564, DOI 10.1200/JCO.2008.19.2146; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Luboshits G, 1999, CANCER RES, V59, P4681; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; TIWARI RK, 1992, ANTICANCER RES, V12, P419	27	472	492	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					548	553		10.1038/nature09707	http://dx.doi.org/10.1038/nature09707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326202	Green Accepted			2022-12-01	WOS:000287652900045
J	Mattick, JS				Mattick, John S.			The Genomic Foundation Is Shifting	SCIENCE			English	Editorial Material									Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.		Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012	Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527					0	9	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					874	874		10.1126/science.1203703	http://dx.doi.org/10.1126/science.1203703			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330534				2022-12-01	WOS:000287455100044
J	Berry, JG; Hall, DE; Kuo, DZ; Cohen, E; Agrawal, R; Feudtner, C; Hall, M; Kueser, J; Kaplan, W; Neff, J				Berry, Jay G.; Hall, David E.; Kuo, Dennis Z.; Cohen, Eyal; Agrawal, Rishi; Feudtner, Chris; Hall, Matt; Kueser, Jacqueline; Kaplan, William; Neff, John			Hospital Utilization and Characteristics of Patients Experiencing Recurrent Readmissions Within Children's Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLEX CHRONIC CONDITIONS; DURABLE MEDICAL EQUIPMENT; WASHINGTON-STATE; CARE; PREVALENCE; EMERGENCY; PATTERNS	Context Early hospital readmission is emerging as an indicator of care quality. Some children with chronic illnesses may be readmitted on a recurrent basis, but there are limited data describing their rehospitalization patterns and impact. Objectives To describe the inpatient resource utilization, clinical characteristics, and admission reasons of patients recurrently readmitted to children's hospitals. Design, Setting, and Patients Retrospective cohort analysis of 317 643 patients (n=579 504 admissions) admitted to 37 US children's hospitals in 2003 with follow-up through 2008. Main Outcome Measure Maximum number of readmissions experienced by each child within any 365-day interval during the 5-year follow-up period. Results In the sample, 69 294 patients (21.8%) experienced at least 1 readmission within 365 days of a prior admission. Within a 365-day interval, 9237 patients (2.9%) experienced 4 or more readmissions; time between admissions was a median 37 days (interquartile range [IQR], 21-63). These patients accounted for 18.8% (109 155 admissions) of all admissions and 23.2% ($3.4 billion) of total inpatient charges for the study cohort during the entire follow-up period. Tests for trend indicated that as the number of readmissions increased from 0 to 4 or more, the prevalences increased for a complex chronic condition (from 22.3% [n=55 382/248 349] to 89.0% [n=8225/9237]; P<.001), technology assistance (from 5.3% [n=13 163] to 52.6% [n=4859]; P<.001), public insurance use (from 40.9% [n=101 575] to 56.3% [n=5202]; P<.001), and non-Hispanic black race (from 21.8% [n=54 140] to 34.4% [n=3181]; P<.001); and the prevalence decreased for readmissions associated with an ambulatory care-sensitive condition (from 23.1% [62 847/272 065] to 14.0% [15 282/109 155], P<.001). Of patients readmitted 4 or more times in a 365-day interval, 2633 (28.5%) were rehospitalized for a problem in the same organ system across all admissions during the interval. Conclusions Among a group of pediatric hospitals, 18.8% of admissions and 23.2% of inpatient charges were accounted for by the 2.9% of patients with frequent recurrent admissions. Many of these patients were rehospitalized recurrently for a problem in the same organ system. JAMA. 2011;305(7):682-690 www.jama.com	[Berry, Jay G.; Kaplan, William] Harvard Univ, Sch Med, Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Hall, David E.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Kuo, Dennis Z.] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72205 USA; [Cohen, Eyal] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Agrawal, Rishi] Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, Chicago, IL 60611 USA; [Feudtner, Chris] Childrens Hosp Philadelphia, Div Gen Pediat, PolicyLab, Philadelphia, PA 19104 USA; [Feudtner, Chris] Childrens Hosp Philadelphia, Dept Med Eth, Philadelphia, PA 19104 USA; [Hall, David E.; Kueser, Jacqueline] Child Hlth Corp Amer, Shawnee Mission, KS USA; [Neff, John] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Berry, JG (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	jay.berry@childrens.harvard.edu	Hall, Matt/AAT-1349-2021; Dalla Zuanna, Teresa/G-3133-2015; Feudtner, Chris/AAI-1126-2019; Cohen, Eyal/K-2575-2014	Hall, Matt/0000-0001-7778-5887; Feudtner, Chris/0000-0002-5879-0434; Cohen, Eyal/0000-0003-0112-7188	Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23 HD058092]; Arkansas Biosciences Institute National Health Center for Research Resources [KL2RR029883]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD058092] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029883] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Arkansas Biosciences Institute National Health Center for Research Resources; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Berry was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development career development award (K23 HD058092). Dr Kuo was supported by grant KL2RR029883 from the Arkansas Biosciences Institute National Health Center for Research Resources.	[Anonymous], CHILD HLTH CORPORATI; [Anonymous], PREV HOSP WIND PRIM; Beck Carolyn E, 2006, Paediatr Child Health, V11, P409; Berry JG, 2007, ARCH PEDIAT ADOL MED, V161, P38, DOI 10.1001/archpedi.161.1.38; Berry JG, 2009, PEDIATRICS, V124, P563, DOI 10.1542/peds.2008-3491; Berry SA, 2009, QUAL SAF HEALTH CARE, V18, P360, DOI 10.1136/qshc.2007.025056; Bhogal S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005306.pub2; Bowles EJA, 2009, MED CARE, V47, P1091, DOI 10.1097/MLR.0b013e3181a7e569; Buescher PA, 2006, MATERN CHILD HLTH J, V10, P461, DOI 10.1007/s10995-006-0081-3; Carrns Ann, 2010, US News World Rep, V147, P22; Consumer Price Index, CONS PRIC IND; COYE MJ, 2008, HOSP HEALTH NETWORK, V82, pA10; Curtis P, GUARDIAN; Czaja AS, 2009, PEDIATRICS, V123, P849, DOI 10.1542/peds.2008-0856; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2002, PEDIATRICS, V109, P656, DOI 10.1542/peds.109.4.656; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Feudtner C, 2009, PEDIATRICS, V123, P286, DOI 10.1542/peds.2007-3395; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V53, P401, DOI 10.1002/pbc.22048; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V52, P481, DOI 10.1002/pbc.21854; Goodman DM, 2002, PEDIATRICS, V110, P583, DOI 10.1542/peds.110.3.583; Guterman S, 2010, HEALTH AFFAIR, V29, P1188, DOI 10.1377/hlthaff.2010.0442; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kne T, 1998, AM J EMERG MED, V16, P648, DOI 10.1016/S0735-6757(98)90166-8; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Lubell Jennifer, 2007, Mod Healthc, V37, P37; Lye PS, 2010, PEDIATRICS, V126, P829, DOI 10.1542/peds.2010-1535; Mackie AS, 2008, AM HEART J, V155, P577, DOI 10.1016/j.ahj.2007.11.003; Massin MM, 2006, ACTA PAEDIATR, V95, P208, DOI 10.1080/08035250500346443; Medicare Payment Advisory Commission, REP C PROM GREAT EFF; Millman M, 1993, ACCESS HLTH CARE AM; Moore Keith D, 2010, Healthc Financ Manage, V64, P57; Palfrey JS, 2004, PEDIATRICS, V113, P1507; PALFREY JS, 1994, PUBLIC HEALTH REP, V109, P226; Reynolds S, 1996, PEDIATR EMERG CARE, V12, P166, DOI 10.1097/00006565-199606000-00005; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Shah SS, 2008, NEUROSURGERY, V62, P1095, DOI 10.1227/01.neu.0000325871.60129.23; Simon TD, 2010, PEDIATRICS, V126, P647, DOI 10.1542/peds.2009-3266; Sneed RC, 2004, PEDIATRICS, V114, pE612, DOI 10.1542/peds.2004-1063; Sneed RC, 2001, PEDIATRICS, V107, P1283, DOI 10.1542/peds.107.6.1283; Srivastava R, 2005, PEDIATR CLIN N AM, V52, P1165, DOI 10.1016/j.pcl.2005.03.007; Srivastava R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4411; Stone BL, 2008, J PEDIATR REHAB MED, V1, P237; Turnock AC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005074.pub2; Young NL, 2009, PHYS OCCUP THER PEDI, V29, P345, DOI 10.3109/01942630903245994	46	350	352	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					682	690		10.1001/jama.2011.122	http://dx.doi.org/10.1001/jama.2011.122			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325184	Green Accepted, Bronze			2022-12-01	WOS:000287361100019
J	Orchard, PJ; Wagner, JE				Orchard, Paul J.; Wagner, John E.			Leukodystrophy and Gene Therapy with a Dimmer Switch.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION; CELL		[Orchard, Paul J.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Bone & Marrow Transplant Program, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Orchard, PJ (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.							Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; KRIVIT W, 1995, CELL TRANSPLANT, V4, P385, DOI 10.1016/0963-6897(95)00021-O; Krivit W, 1998, NEW ENGL J MED, V338, P1119, DOI 10.1056/NEJM199804163381605	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					572	573		10.1056/NEJMcibr1013082	http://dx.doi.org/10.1056/NEJMcibr1013082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306246				2022-12-01	WOS:000287139900015
J	Cortada, X				Cortada, Xavier			Painting the Genome for the Public	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203069	http://dx.doi.org/10.1126/science.1203069			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292969				2022-12-01	WOS:000286933600042
J	Wu, XY; Shen, QT; Oristian, DS; Lu, CP; Zheng, QS; Wang, HW; Fuchs, E				Wu, Xiaoyang; Shen, Qing-Tao; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Wang, Hong-Wei; Fuchs, Elaine			Skin Stem Cells Orchestrate Directional Migration by Regulating Microtubule-ACF7 Connections through GSK3 beta	CELL			English	Article							ACTIN; HOMEOSTASIS; NETWORKS; PLAKIN; CDC42; ACF7	Homeostasis and wound healing rely on stem cells (SCs) whose activity and directed migration are often governed by Wnt signaling. In dissecting how this pathway integrates with the necessary downstream cytoskeletal dynamics, we discovered that GSK3 beta, a kinase inhibited by Wnt signaling, directly phosphorylates ACF7, a > 500 kDa microtubule-actin crosslinking protein abundant in hair follicle stem cells (HF-SCs). We map ACF7's GSK3 beta sites to the microtubule-binding domain and show that phosphorylation uncouples ACF7 from microtubules. Phosphorylation-refractile ACF7 rescues overall microtubule architecture, but phosphorylation-constitutive mutants do not. Neither mutant rescues polarized movement, revealing that phospho-regulation must be dynamic. This circuitry is physiologically relevant and depends upon polarized GSK3 beta inhibition at the migrating front of SCs/progeny streaming from HFs during wound repair. Moreover, only ACF7 and not GSK beta-refractile-ACF7 restore polarized microtubule-growth and SC-migration to ACF7 null skin. Our findings provide insights into how this conserved spectraplakin integrates signaling, cytoskeletal dynamics, and polarized locomotion of somatic SCs.	[Wu, Xiaoyang; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Wu, Xiaoyang; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Shen, Qing-Tao; Wang, Hong-Wei] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Zheng, Qinsi] Weill Cornell Med Coll, Triinst Training Program Chem Biol, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Yale University; Cornell University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	ZHENG, Qin/T-2925-2019; Fuchs, Elaine/G-1565-2016	Lu, Catherine/0000-0003-4593-327X	National Institutes of Health [R01-AR27883]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883, R01AR050452, R37AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to M. Schober, Y.C. Hsu, E. Ezratty, and T. Chen for discussions and helpful comments and to J. Fernandez and H. Deng (Proteomics Center) for their technical assistance in mass spectrometry analysis. Valuable technical assistance was provided by N. Stokes, L. Polak, E. Wong, M Nikolova, J. Racelis, A. North, and S. Bhuvanendran. All mice used in this study were bred and maintained at the Rockefeller University Association for Assessment and Accreditation of Laboratory Animal Care International-accredited Comparative Biology Center (CBC) in accordance with institutional and National Institutes of Health guidelines. This work was supported by Grant R01-AR27883 from the National Institutes of Health. E. F. is an investigator of the Howard Hughes Medical Institute. X. W. was an American Association for Cancer Research Anna D. Barker Fellow in Basic Cancer Research and the recipient of a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Schiller Martin R, 2007, Curr Protoc Protein Sci, VChapter 2, DOI 10.1002/0471140864.ps0212s48; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sun DM, 2001, J CELL SCI, V114, P161; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	35	139	146	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					341	352		10.1016/j.cell.2010.12.033	http://dx.doi.org/10.1016/j.cell.2010.12.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295697	Green Accepted, Bronze			2022-12-01	WOS:000286973100007
J	Bajoghli, B; Guo, P; Aghaallaei, N; Hirano, M; Strohmeier, C; McCurley, N; Bockman, DE; Schorpp, M; Cooper, MD; Boehm, T				Bajoghli, Baubak; Guo, Peng; Aghaallaei, Narges; Hirano, Masayuki; Strohmeier, Christine; McCurley, Nathanael; Bockman, Dale E.; Schorpp, Michael; Cooper, Max D.; Boehm, Thomas			A thymus candidate in lampreys	NATURE			English	Article							VARIABLE LYMPHOCYTE RECEPTORS; EVOLUTION; DIVERSIFICATION; EPITHELIUM; RESPONSES; HAGFISH	Immunologists and evolutionary biologists have been debating the nature of the immune system of jawless vertebrates-lampreys and hagfish-since the nineteenth century. In the past 50 years, these fish were shown to have antibody-like responses and the capacity to reject allografts(1) but were found to lack the immunoglobulin-based adaptive immune system of jawed vertebrates(2). Recent work has shown that lampreys have lymphocytes that instead express somatically diversified antigen receptors that contain leucine-rich-repeats, termed variable lymphocyte receptors (VLRs)(3,4), and that the type of VLR expressed is specific to the lymphocyte lineage: T-like lymphocytes express type A VLR (VLRA) genes, and B-like lymphocytes express VLRB genes(5). These clonally diverse anticipatory antigen receptors are assembled from incomplete genomic fragments by gene conversion(6-9), which is thought to be initiated by either of two genes encoding cytosine deaminase(9), cytosine deaminase 1 (CDA1) in T-like cells and CDA2 in B-like cells(5). It is unknown whether jawless fish, like jawed vertebrates, have dedicated primary lymphoid organs, such as the thymus, where the development and selection of lymphocytes takes place(10,11). Here we identify discrete thymus-like lympho-epithelial structures, termed thymoids, in the tips of the gill filaments and the neighbouring secondary lamellae (both within the gill basket) of lamprey larvae. Only in the thymoids was expression of the orthologue of the gene encoding forkhead box N1 (FOXN1)(10), a marker of the thymopoietic microenvironment in jawed vertebrates(12), accompanied by expression of CDA1 and VLRA. This expression pattern was unaffected by immunization of lampreys or by stimulation with a T-cell mitogen. Non-functional VLRA gene assemblies were found frequently in the thymoids but not elsewhere, further implicating the thymoid as the site of development of T-like cells in lampreys. These findings suggest that the similarities underlying the dual nature of the adaptive immune systems in the two sister groups of vertebrates extend to primary lymphoid organs.	[Bajoghli, Baubak; Aghaallaei, Narges; Strohmeier, Christine; Schorpp, Michael; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany; [Guo, Peng; Hirano, Masayuki; McCurley, Nathanael; Cooper, Max D.] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Guo, Peng; Hirano, Masayuki; McCurley, Nathanael; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Bockman, Dale E.] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	Max Planck Society; Emory University; Emory University; University System of Georgia; Augusta University	Boehm, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de	Bajoghli, Baubak/AAF-8388-2020	Bajoghli, Baubak/0000-0002-7368-7523; Aghaallaei, Narges/0000-0002-9890-3229; Bajoghli, Baubak/0000-0003-1395-6362	Max Planck Society; Deutsche Forschungsgemeinschaft; National Institutes of Health; Georgia Research Alliance	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance	We thank C. Happe and M. Held for technical help, C. L. Turnbough Jr for providing B. anthracis spores and exosporia, and the Emory University School of Medicine core facility for flow cytometry for cell-sorting services. This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft, the National Institutes of Health and the Georgia Research Alliance.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; BOCKMAN DE, 1973, AM J ANAT, V136, P455, DOI 10.1002/aja.1001360406; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; FINSTAD J, 1964, J EXP MED, V120, P1151, DOI 10.1084/jem.120.6.1151; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Kasamatsu J, 2010, P NATL ACAD SCI USA, V107, P14304, DOI 10.1073/pnas.1001910107; Kishishita N, 2010, EMBO REP, V11, P126, DOI 10.1038/embor.2009.274; Mayer WE, 2002, P NATL ACAD SCI USA, V99, P14350, DOI 10.1073/pnas.212527499; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Schaffer J., 1894, SBER K AKAD WISS, V103, P149; Wallin IE, 1917, AM J ANAT, V22, P127, DOI 10.1002/aja.1000220106	19	142	149	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					90	U101		10.1038/nature09655	http://dx.doi.org/10.1038/nature09655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293377				2022-12-01	WOS:000286886400040
J	Chou, R; Qaseem, A; Owens, DK; Shekelle, P				Chou, Roger; Qaseem, Amir; Owens, Douglas K.; Shekelle, Paul		Clinical Guidelines Comm Amer Coll	Diagnostic Imaging for Low Back Pain: Advice for High-Value Health Care From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LUMBAR SPINE; PATIENT EXPECTATIONS; CLINICAL-EVALUATION; PRACTICE PATTERNS; US; PREVALENCE; GUIDELINES; CANCER; COSTS	Diagnostic imaging is indicated for patients with low back pain only if they have severe progressive neurologic deficits or signs or symptoms that suggest a serious or specific underlying condition. In other patients, evidence indicates that routine imaging is not associated with clinically meaningful benefits but can lead to harms. Addressing inefficiencies in diagnostic testing could minimize potential harms to patients and have a large effect on use of resources by reducing both direct and downstream costs. In this area, more testing does not equate to better care. Implementing a selective approach to low back imaging, as suggested by the American College of Physicians and American Pain Society guideline on low back pain, would provide better care to patients, improve outcomes, and reduce costs.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA; Stanford Univ, Palo Alto, CA 94304 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	American College of Physicians; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Chou, Roger/0000-0001-9889-8610	Wellpoint; Palladian Health; Consumers Union; Blue Cross Blue Shield Association; American Pain Society; Agency for Healthcare Research and Quality	Wellpoint; Palladian Health; Consumers Union; Blue Cross Blue Shield Association; American Pain Society; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. Chou: Consulting fee or honorarium: Wellpoint, Palladian Health, Consumers Union, Blue Cross Blue Shield Association; Grants/grants pending: American Pain Society; Payment for manuscript preparation: American College of Physicians. Dr. Owens: Support for travel to meetings for the study or other purposes: American College of Physicians; Consultancy: Anthem/Wellpoint. Dr. Shekelle: Grants/grants pending: Agency for Healthcare Research and Quality; Royalties: UptoDate; Other: Unpaid advisor for a Wellpoint project that seeks to identify and certify high-quality back pain centers of excellence. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOflnterestForms.do?msNum=M10-1394. Any conflict of interest of the Clinical Guidelines Committee members was declared, discussed, and resolved.	American College of Physicians Foundation, 2011, HLTH TIPS LOW BACK P; American College of Radiology, 2008, ACR APPR CRIT LOW BA; [Anonymous], 1984, Can Med Assoc J, V130, P1542; [Anonymous], 2011, ANN INTERN MED, V154, P1; [Anonymous], 2009, 2009 MED REIMB FEE S; [Anonymous], 2009, BACKLETTER, V24, P50; Anthem Health Care Advisor, 2008, EST TOT COSTS INS BE; Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; Baras JD, 2009, HEALTH AFFAIR, V28, pW1133, DOI 10.1377/hlthaff.28.6.w1133; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Buchbinder R, 2008, SPINE, V33, P74, DOI 10.1097/BRS.0b013e31815e39c8; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Carey TS, 2009, SPINE, V34, P718, DOI 10.1097/BRS.0b013e31819792b0; Carman KL, 2010, HEALTH AFFAIR, V29, P1400, DOI 10.1377/hlthaff.2009.0296; Carragee Eugene, 2006, Spine J, V6, P624, DOI 10.1016/j.spinee.2006.03.005; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; CHOU R, 2009, EVALUATION MANAGEMEN; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; DEYO RA, 1987, ARCH INTERN MED, V147, P141, DOI 10.1001/archinte.147.1.141; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Deyo RA, 2002, ANNU REV PUBL HEALTH, V23, P23, DOI 10.1146/annurev.publhealth.23.092101.134534; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; French SD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006094.pub2; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Gillan MGC, 2001, RADIOLOGY, V220, P393, DOI 10.1148/radiology.220.2.r01au06393; Gray DT, 2003, RADIOLOGY, V227, P669, DOI 10.1148/radiol.2273012213; Grimshaw JM, 2001, MED CARE, V39, pII2; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; HALL FM, 1976, RADIOLOGY, V120, P443, DOI 10.1148/120.2.443; HALPIN SFS, 1991, BRIT MED J, V303, P813, DOI 10.1136/bmj.303.6806.813; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Henschke N, 2007, EUR SPINE J, V16, P1673, DOI 10.1007/s00586-007-0412-0; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Joines JD, 2001, J GEN INTERN MED, V16, P14, DOI 10.1111/j.1525-1497.2001.00249.x; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; McPhillips-Tangum CA, 1998, J GEN INTERN MED, V13, P289, DOI 10.1046/j.1525-1497.1998.00093.x; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P; NACHEMSON A L, 1976, Spine, V1, P59, DOI 10.1097/00007632-197603000-00009; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Pham HH, 2009, ARCH INTERN MED, V169, P972, DOI 10.1001/archinternmed.2009.78; Rhodes LA, 1999, SOC SCI MED, V48, P1189, DOI 10.1016/S0277-9536(98)00418-3; ROCKEY PH, 1978, J FAM PRACTICE, V7, P455; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Schectman JM, 2003, J GEN INTERN MED, V18, P773, DOI 10.1046/j.1525-1497.2003.10205.x; Schers H, 2001, Spine (Phila Pa 1976), V26, pE348, DOI 10.1097/00007632-200108010-00013; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Snowbeck C, 2005, PITTSBURGH POST 0611; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; SuarezAlmazor ME, 1997, JAMA-J AM MED ASSOC, V277, P1782, DOI 10.1001/jama.277.22.1782; SWEDLOW A, 1992, NEW ENGL J MED, V327, P1502, DOI 10.1056/NEJM199211193272107; Underwood MR, 1995, BRIT J RHEUMATOL, V34, P1074; United States Government Accountability Office, 2008, GAO08452; vanTulder MW, 1997, SPINE, V22, P427, DOI 10.1097/00007632-199702150-00015; Verbeek J, 2004, SPINE, V29, P2309, DOI 10.1097/01.brs.0000142007.38256.7f; Verrilli D, 1996, JAMA-J AM MED ASSOC, V275, P1189, DOI 10.1001/jama.275.15.1189; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; Webster BS, 2010, J OCCUP ENVIRON MED, V52, P900, DOI 10.1097/JOM.0b013e3181ef7e53; Webster BS, 2005, J GEN INTERN MED, V20, P1132, DOI 10.1111/j.1525-1497.2005.0230.x; Weiner DK, 2006, PAIN MED, V7, P143, DOI 10.1111/j.1526-4637.2006.00112.x; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003; Williams CM, 2010, ARCH INTERN MED, V170, P271, DOI 10.1001/archinternmed.2009.507; Wilson IB, 2001, ARCH INTERN MED, V161, P256, DOI 10.1001/archinte.161.2.256	82	301	307	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					181	+		10.7326/0003-4819-154-3-201102010-00008	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	713HY	21282698				2022-12-01	WOS:000286729200006
J	Chambers, JD; Neumann, PJ				Chambers, James D.; Neumann, Peter J.			Listening to Provenge - What a Costly Cancer Treatment Says about Future Medicare Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chambers, James D.; Neumann, Peter J.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Chambers, James D.] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England	Tufts Medical Center; Brunel University	Chambers, JD (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA.							[Anonymous], 2010, FED REG, V75, P57045; *CTR MED MED SERV, 2010, CAG00422N CTR MED ME; Food and Drug Administration, 2010, SUMM REV SUMM BAS RE; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294	4	48	49	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1687	1689		10.1056/NEJMp1103057	http://dx.doi.org/10.1056/NEJMp1103057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21470004				2022-12-01	WOS:000290219800002
J	Senturk, A; Pfennig, S; Weiss, A; Burk, K; Acker-Palmer, A				Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo			Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration	NATURE			English	Article							TYROSINE KINASES; PHOSPHORYLATION; SPECIFICATION; DISABLED-1; MECHANISMS; EXPRESSION; MUTATIONS; CASPASE-3; PREPLATE; RECEPTOR	Coordinated migration of neurons in the developing and adult brain is essential for its proper function. The secreted glycoprotein Reelin (also known as RELN) guides migration of neurons by binding to two lipoprotein receptors, the very-low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2, also known as LRP8)(1). Loss of Reelin function in humans results in the severe developmental disorder lissencephaly(2) and it has also been associated with other neurological disorders such as epilepsy, schizophrenia and Alzheimer's disease(3). The molecular mechanisms by which Reelin activates its receptors and controls cellular functions are largely unknown. Here we show that the neuronal guidance cues ephrin B proteins are essential for Reelin signalling during the development of laminated structures in the brain. We show that ephrin Bs genetically interact with Reelin. Notably, compound mouse mutants (Reln(+/-); Efnb3(-/-) or Reln(+/-); Efnb2(-/-)) and triple ephrin B1, B2, B3 knockouts show neuronal migration defects that recapitulate the ones observed in the neocortex, hippocampus and cerebellum of the reeler mouse. Mechanistically, we show that Reelin binds to the extracellular domain of ephrin Bs, which associate at the membrane with VLDLR and ApoER2 in neurons. Clustering of ephrin Bs leads to the recruitment and phosphorylation of Dab1 which is necessary for Reelin signalling. Conversely, loss of function of ephrin Bs severely impairs Reelin-induced Dab1 phosphorylation. Importantly, activation of ephrin Bs can rescue the reeler neuronal migration defects in the absence of Reelin protein. Together, our results identify ephrin Bs as essential components of the Reelin receptor/signalling pathway to control neuronal migration during the development of the nervous system.	[Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Acker-Palmer, A (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Acker-Palmer@bio.uni-frankfurt.de		Burk, Katja/0000-0001-6083-4152	Max Planck Institute of Neurobiology in Martinsried (Germany); Deutsche Forschungsgemeinschaft [AC180/2-1, 2-2]; University Frankfurt [EXC115, EXC147]	Max Planck Institute of Neurobiology in Martinsried (Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Frankfurt	We would like to thank R. Klein for the ephrin B2<SUP>lox/lox</SUP> and ephrin B1<SUP>lox/lox</SUP> mice, N. Gale for the ephrin B3<SUP>-/-</SUP> mouse, J. Herz for the ApoER2<SUP>-/-</SUP> mouse, M. Goetz for 293-cells expressing Reelin or GFP, I. Segura for help with the ephrin B triple mutants, U. Bauer, O. Yildiz, C. Saygi, F. Kasikci, F. Voss and K. Happich for technical support, K. Hong and A. Griciuc for early contributions to this project, M. Frotscher for helpful discussions and I. Dikic and T. Acker for critically reading the manuscript. We acknowledge the Max Planck Institute of Neurobiology in Martinsried (Germany) for support and the use of equipment and animal facilities in the early stages of this project. This work was supported by grants from the Deutsche Forschungsgemeinschaft (AC180/2-1, 2-2 to A. A.-P.) and the Clusters of Excellence "Macromolecular Complexes (CEF)'' (EXC115) and ECCPS (EXC147) at the University Frankfurt.	Alifragis P, 2002, EXP NEUROL, V174, P259, DOI 10.1006/exnr.2002.7870; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13	34	112	118	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					356	U123		10.1038/nature09874	http://dx.doi.org/10.1038/nature09874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460838				2022-12-01	WOS:000289724600041
J	Lozano, AM				Lozano, Andres M.			Harnessing Plasticity to Reset Dysfunctional Neurons	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Toronto Western Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lozano, AM (corresponding author), Toronto Western Res Inst, Toronto, ON, Canada.		Lozano, Andres M/A-5058-2012	Lozano, Andres M./0000-0001-8257-3694				Davis KD, 1998, NATURE, V391, P385, DOI 10.1038/34905; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Moller AR, 2009, NEUROL RES, V31, P1023, DOI 10.1179/174313209X383303	5	17	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1367	1368		10.1056/NEJMcibr1100496	http://dx.doi.org/10.1056/NEJMcibr1100496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470016				2022-12-01	WOS:000289202800015
J	Ikeda, F; Deribe, YL; Skanland, SS; Stieglitz, B; Grabbe, C; Franz-Wachtel, M; van Wijk, SJL; Goswami, P; Nagy, V; Terzic, J; Tokunaga, F; Androulidaki, A; Nakagawa, T; Pasparakis, M; Iwai, K; Sundberg, JP; Schaefer, L; Rittinger, K; Macek, B; Dikic, I				Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Stieglitz, Benjamin; Grabbe, Caroline; Franz-Wachtel, Mirita; van Wijk, Sjoerd J. L.; Goswami, Panchali; Nagy, Vanja; Terzic, Janos; Tokunaga, Fuminori; Androulidaki, Ariadne; Nakagawa, Tomoko; Pasparakis, Manolis; Iwai, Kazuhiro; Sundberg, John P.; Schaefer, Liliana; Rittinger, Katrin; Macek, Boris; Dikic, Ivan			SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappa B activity and apoptosis	NATURE			English	Article							POLYUBIQUITIN CHAINS; IMMUNE-SYSTEM; PROTEINS; ACTIVATION; FRACTIONATION; DERMATITIS; PROTEOMICS; INDUCTION; NEMO	SHARPIN is a ubiquitin-binding and ubiquitin-like-domain-containing protein which, when mutated in mice, results in immune system disorders and multi-organ inflammation(1,2). Here we report that SHARPIN functions as a novel component of the linear ubiquitin chain assembly complex (LUBAC) and that the absence of SHARPIN causes dysregulation of NF-kappa B and apoptotic signalling pathways, explaining the severe phenotypes displayed by chronic proliferative dermatitis (cpdm) in SHARPIN-deficient mice. Upon binding to the LUBAC subunit HOIP (also known as RNF31), SHARPIN stimulates the formation of linear ubiquitin chains in vitro and in vivo. Coexpression of SHARPIN and HOIP promotes linear ubiquitination of NEMO (also known as IKBKG), an adaptor of the I kappa B kinases (IKKs) and subsequent activation of NF-kappa B signalling, whereas SHARPIN deficiency in mice causes an impaired activation of the IKK complex and NF-kappa B in B cells, macrophages and mouse embryonic fibroblasts (MEFs). This effect is further enhanced upon concurrent downregulation of HOIL-1L (also known as RBCK1), another HOIP-binding component of LUBAC. In addition, SHARPIN deficiency leads to rapid cell death upon tumour-necrosis factor alpha (TNF-alpha) stimulation via FADD- and caspase-8-dependent pathways. SHARPIN thus activates NF kappa B and inhibits apoptosis via distinct pathways in vivo.	[Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Grabbe, Caroline; van Wijk, Sjoerd J. L.; Goswami, Panchali; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Grabbe, Caroline; van Wijk, Sjoerd J. L.; Goswami, Panchali; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Stieglitz, Benjamin; Rittinger, Katrin] Natl Inst Med Res, MRC, London NW7 1AA, England; [Grabbe, Caroline] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Franz-Wachtel, Mirita; Macek, Boris] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr Tubingen, D-72076 Tubingen, Germany; [Nagy, Vanja] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Terzic, Janos; Dikic, Ivan] Univ Split, Sch Med, HR-21000 Split, Croatia; [Tokunaga, Fuminori; Nakagawa, Tomoko; Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Suita, Osaka 5650871, Japan; [Androulidaki, Ariadne; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50674 Cologne, Germany; [Androulidaki, Ariadne; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Suita, Osaka 5650871, Japan; [Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Schaefer, Liliana] Klinikum Goethe Univ, Div Nephropharmakol, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; MRC National Institute for Medical Research; Umea University; Eberhard Karls University of Tubingen; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Split; Osaka University; University of Cologne; University of Cologne; Osaka University; Jackson Laboratory; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Ivan.Dikic@biochem2.de	Skånland, Sigrid S/AAW-4817-2021; Dikic, Ivan/O-4650-2015; Macek, Boris/N-1442-2015; Pasparakis, Manolis/N-4350-2019; Rittinger, Katrin/N-3344-2019; Pasparakis, Manolis/H-9292-2017; Stieglitz, Benjamin/AAY-4140-2020; Ikeda, Fumiyo/AAD-3770-2020; van Wijk, Sjoerd/AAL-6680-2021; Rittinger, Katrin/D-2586-2014; IWAI, KAZUHIRO/GSN-7385-2022	Dikic, Ivan/0000-0001-8156-9511; Macek, Boris/0000-0002-1206-2458; Pasparakis, Manolis/0000-0002-9870-0966; Rittinger, Katrin/0000-0002-7698-4435; Pasparakis, Manolis/0000-0002-9870-0966; Stieglitz, Benjamin/0000-0003-3634-6997; Ikeda, Fumiyo/0000-0003-0407-2768; van Wijk, Sjoerd/0000-0001-6532-7651; Rittinger, Katrin/0000-0002-7698-4435; Skanland, Sigrid S./0000-0003-1630-356X; Iwai, Kazuhiro/0000-0001-5620-5951; Tokunaga, Fuminori/0000-0003-3626-9119; Schaefer, Liliana/0000-0002-3318-3005; Nagy, Vanja/0000-0002-9521-4794; Terzic, Janos/0000-0003-3228-2076	Deutsche Forschungsgemeinschaft [DI 931/3-1]; Goethe University Frankfurt [EXC115]; Landesstiftung Baden-Wurttemberg; Medical Research Council UK; JSPS; EMBO; National Institutes of Health [AR049288]; Unity Through Knowledge Fund; International Human Frontier Science Program Organization; MRC [MC_U117565398] Funding Source: UKRI; Medical Research Council [MC_U117565398] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22117006] Funding Source: KAKEN	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Goethe University Frankfurt; Landesstiftung Baden-Wurttemberg; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unity Through Knowledge Fund; International Human Frontier Science Program Organization(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank E. Kim, K. Rajalingham and H.-J. Kreienkampfor reagents used in this study, I. Matic for initial MS analysis of HOIP/HOIL-1L samples, S. Wahl for sample preparation, and V. Dotsch and members of the Dikic lab for discussions and comments. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DI 931/3-1), the Cluster of Excellence "Macromolecular Complexes'' of the Goethe University Frankfurt (EXC115) to I.D., Landesstiftung Baden-Wurttemberg to B.M., the Medical Research Council UK to K.R. and B.S., JSPS Postdoctoral Fellowships for Research Abroad to F.I., EMBO long-term fellowship to S.S.S. and The National Institutes of Health (AR049288 to J.P.S.). V.N. was supported by the Unity Through Knowledge Fund, 3B Grant. C.G. acknowledges support from The International Human Frontier Science Program Organization.	Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; GIJBELS MJJ, 1995, ULTRASTRUCT PATHOL, V19, P107, DOI 10.3109/01913129509014610; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	27	534	551	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					637	U120		10.1038/nature09814	http://dx.doi.org/10.1038/nature09814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455181	Green Accepted			2022-12-01	WOS:000288951200043
J	Guizetti, J; Schermelleh, L; Mantler, J; Maar, S; Poser, I; Leonhardt, H; Muller-Reichert, T; Gerlich, DW				Guizetti, Julien; Schermelleh, Lothar; Maentler, Jana; Maar, Sandra; Poser, Ina; Leonhardt, Heinrich; Mueller-Reichert, Thomas; Gerlich, Daniel W.			Cortical Constriction During Abscission Involves Helices of ESCRT-III-Dependent Filaments	SCIENCE			English	Article							MEDIATED ABSCISSION; CYTOKINESIS; MIDBODY; MACHINERY; ALIX; SCISSION; SPASTIN; CELLS	After partitioning of cytoplasmic contents by cleavage furrow ingression, animal cells remain connected by an intercellular bridge, which subsequently splits by abscission. Here, we examined intermediate stages of abscission in human cells by using live imaging, three-dimensional structured illumination microscopy, and electron tomography. We identified helices of 17-nanometer-diameter filaments, which narrowed the cortex of the intercellular bridge to a single stalk. The endosomal sorting complex required for transport (ESCRT)-III co-localized with constriction zones and was required for assembly of 17-nanometer-diameter filaments. Simultaneous spastin-mediated removal of underlying microtubules enabled full constriction at the abscission site. The identification of contractile filament helices at the intercellular bridge has broad implications for the understanding of cell division and of ESCRT-III-mediated fission of large membrane structures.	[Mueller-Reichert, Thomas] Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Theoret Ctr, D-01307 Dresden, Germany; [Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.] Swiss Fed Inst Technol Zurich ETHZ, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Guizetti, Julien; Mueller-Reichert, Thomas; Gerlich, Daniel W.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biol, D-82152 Planegg Martinsried, Germany; [Maentler, Jana; Poser, Ina] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Marine Biological Laboratory - Woods Hole; University of Munich; Max Planck Society	Muller-Reichert, T (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Theoret Ctr, Fetscherstr 74, D-01307 Dresden, Germany.	mueller-reichert@tu-dresden.de; daniel.gerlich@bc.biol.ethz.ch	Leonhardt, Heinrich/B-2791-2014; Guizetti, Julien/AAF-3793-2020; Gerlich, Daniel Wolfram W/A-6991-2016; Schermelleh, Lothar/H-4588-2019	Guizetti, Julien/0000-0002-8762-4259; Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Schermelleh, Lothar/0000-0002-1612-9699; Guizetti, Julien/0000-0002-7735-4689	Swiss National Science Foundation [3100A0-114120]; ETH-TH; European Science Foundation; Evelyn and Melvin Spiegel Fund; Human Frontier Science Program [RGP 0034/2010]; Deutsche Forschungsgemeinschaft [MU 1423/2-1, MU 1423/3-1, SFB TR5]; BioImaging Network; Nanosystems Initiative Munich; European Commission [241548]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH-TH; European Science Foundation(European Science Foundation (ESF)European Commission); Evelyn and Melvin Spiegel Fund; Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioImaging Network; Nanosystems Initiative Munich; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. E. Smith, M. Petronczki, P. Steigemann, M. Glotzer, and Y. Barral for comments on the manuscript; S. Prugnaller, A. Boden, G. Fabig, E. Seemann, A. Maiser, J. Neumann, L. Kerr, G. Csucs, and the ETHZ Light Microscopy and RNAi Screening Centres for technical support; U. Rothbauer, J. Gertsch, I. Mellman, B. Pfeiffer, and K. H. Altmann for providing reagents; and A. A. Hyman for support and reagents. This work was supported by Swiss National Science Foundation research grant 3100A0-114120, an ETH-TH grant, a European Young Investigators award of the European Science Foundation to D. W. G., MBL Research Fellowships by the Evelyn and Melvin Spiegel Fund to D. W. G. and T. M. R., a Human Frontier Science Program grant (RGP 0034/2010) to T. M. R., and grants from the Deutsche Forschungsgemeinschaft (MU 1423/2-1 and MU 1423/3-1 to T. M. R. and SFB TR5 to H. L. and L. S.) and from the BioImaging Network and the Nanosystems Initiative Munich to L. S. and H. L. Work in the Hyman and Gerlich laboratories is supported by European Commission grant agreement 241548 (MitoSys).	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Burton K, 1997, NATURE, V385, P450, DOI 10.1038/385450a0; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Darenfed H, 2005, BIOCHEM CELL BIOL, V83, P711, DOI 10.1139/O05-164; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	26	321	329	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1616	1620		10.1126/science.1201847	http://dx.doi.org/10.1126/science.1201847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21310966				2022-12-01	WOS:000288754500059
J	Thomson, MC; Connor, SJ; Zebiak, SE; Jancloes, M; Mihretie, A				Thomson, Madeleine C.; Connor, Stephen J.; Zebiak, Stephen E.; Jancloes, Michel; Mihretie, Abere			Africa needs climate data to fight disease	NATURE			English	Editorial Material									[Thomson, Madeleine C.; Connor, Stephen J.; Zebiak, Stephen E.] Columbia Univ, Int Res Inst Climate & Soc, Earth Inst, Palisades, NY 10964 USA; [Jancloes, Michel] Hlth & Climate Fdn, Washington, DC 20005 USA; [Mihretie, Abere] Antimalaria Assoc, Addis Ababa, Ethiopia	Columbia University	Thomson, MC (corresponding author), Columbia Univ, Int Res Inst Climate & Soc, Earth Inst, Palisades, NY 10964 USA.	mthomson@iri.columbia.edu						Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; Cibrelus L., 2010, 163 ITI; Connor SJ, 2010, PROCEDIA ENVIRON SCI, V1, P27, DOI 10.1016/j.proenv.2010.09.004; Dinku T, 2010, CLIM DEV, V2, P9, DOI 10.3763/cdev.2010.0029; Ghebreyesus T.A., 2008, WMO B, V57, P256; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Parry M., 2007, CLIMATE CHANGE 2007; Reiter P, 2008, REV SCI TECH OIE, V27, P383, DOI 10.20506/rst.27.2.1804; Williams AP, 2011, CLIM DYNAM, V37, P2417, DOI 10.1007/s00382-010-0984-y	10	25	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					440	442		10.1038/471440a	http://dx.doi.org/10.1038/471440a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430752	Bronze, Green Submitted			2022-12-01	WOS:000288702200033
J	Bock, DD; Lee, WCA; Kerlin, AM; Andermann, ML; Hood, G; Wetzel, AW; Yurgenson, S; Soucy, ER; Kim, HS; Reid, RC				Bock, Davi D.; Lee, Wei-Chung Allen; Kerlin, Aaron M.; Andermann, Mark L.; Hood, Greg; Wetzel, Arthur W.; Yurgenson, Sergey; Soucy, Edward R.; Kim, Hyon Suk; Reid, R. Clay			Network anatomy and in vivo physiology of visual cortical neurons	NATURE			English	Article							INHIBITORY NEURONS; SYNAPTIC CONNECTIONS; ELECTRON-MICROSCOPY; PYRAMIDAL NEURONS; TRANSGENIC MICE; RAT NEOCORTEX; CORTEX; CAT; CELLS; MAP	In the cerebral cortex, local circuits consist of tens of thousands of neurons, each of which makes thousands of synaptic connections. Perhaps the biggest impediment to understanding these networks is that we have no wiring diagrams of their interconnections. Even if we had a partial or complete wiring diagram, however, understanding the network would also require information about each neuron's function. Here we show that the relationship between structure and function can be studied in the cortex with a combination of in vivo physiology and network anatomy. We used two-photon calcium imaging to characterize a functional property-the preferred stimulus orientation-of a group of neurons in the mouse primary visual cortex. Large-scale electron microscopy of serial thin sections was then used to trace a portion of these neurons' local network. Consistent with a prediction from recent physiological experiments, inhibitory interneurons received convergent anatomical input from nearby excitatory neurons with a broad range of preferred orientations, although weak biases could not be rejected.	[Bock, Davi D.; Lee, Wei-Chung Allen; Kerlin, Aaron M.; Andermann, Mark L.; Yurgenson, Sergey; Kim, Hyon Suk; Reid, R. Clay] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bock, Davi D.; Lee, Wei-Chung Allen; Soucy, Edward R.; Kim, Hyon Suk; Reid, R. Clay] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Hood, Greg; Wetzel, Arthur W.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA	Harvard University; Harvard Medical School; Harvard University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu		Lee, Wei-Chung/0000-0002-4618-295X	Center for Brain Science; Center for Brain Science at Harvard University; Microsoft Research; NIH though the NEI [EY10115, EY18742]; NIH though NRBSC [P41 RR06009]; Harvard Center of Neurodegeneration and Repair; NEI [EY18532]; Pittsburgh Supercomputing Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY018532, R01EY010115, R01EY018742] Funding Source: NIH RePORTER	Center for Brain Science; Center for Brain Science at Harvard University; Microsoft Research(Microsoft); NIH though the NEI; NIH though NRBSC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Center of Neurodegeneration and Repair; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pittsburgh Supercomputing Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Raviola for discussions and technical advice on all aspects of EM; J. Stiles for support and advice concerning the alignment and stitching effort at The Pittsburgh Supercomputing Center; J. Lichtman for discussions and, along with K. Blum and J. Sanes, support from the Center for Brain Science; A. Cardona for help with TrakeEM2, and many modifications of it; and H. Pfister and S. Warfield for discussions and help with computational issues. We also thank S. Butterfield for programming, and L. Benecchi and Harvard Medical School EM Core Facility for technical support. For technical help with EM and its interpretation, we thank K. Harris, M. Bickford, M. Ellisman, K. Martin and T. Reese. We thank J. Assad, R. Born, J. Maunsell, J. Stiles, E. Raviola, and members of the Reid laboratory for critical reading of the manuscript. This work was supported by the Center for Brain Science at Harvard University, Microsoft Research, and the NIH though the NEI to R.C.R. (EY10115 and EY18742) and through resources provided by the NRBSC (P41 RR06009), which is part of The Pittsburgh Supercomputing Center; and by fellowships from Harvard Center of Neurodegeneration and Repair to D.D.B. and the NEI to W.-C.A.L. (EY18532).	Ahmed B, 1997, J COMP NEUROL, V380, P230; Alitto HJ, 2010, CURR OPIN NEUROBIOL, V20, P340, DOI 10.1016/j.conb.2010.02.012; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg VB, 1998, CORTEX STAT GEOMETRY, DOI 10.1007/978-3-662-03733-1; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Ellisman M, 2005, MICROSC MICROANAL, V11, P610; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [DOI 10.1017/S1431927606066268, 10.1017/s1431927606066268]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; MASON A, 1991, J NEUROSCI, V11, P72; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; Peters A., 1978, FINE STRUCTURE NERVO, V4, P588; Ramon y Cajal S, 1904, TEXTURA SISTEMA NERV; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Ringach DL, 2002, J NEUROSCI, V22, P5639; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sorra KE, 1998, J NEUROSCI, V18, P658; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; White E.L., 1989, CORTICAL CIRCUITS SY; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	57	550	556	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					177	U59		10.1038/nature09802	http://dx.doi.org/10.1038/nature09802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390124	Green Accepted			2022-12-01	WOS:000288170200029
J	Brooks, MA; Tarini, BA				Brooks, M. Alison; Tarini, Beth A.			Genetic Testing and Youth Sports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; FITNESS		[Brooks, M. Alison] Univ Wisconsin, Dept Orthoped & Pediat, Madison, WI 53706 USA; [Tarini, Beth A.] Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Brooks, MA (corresponding author), 1685 Highland Ave, Madison, WI 53705 USA.	brooks@ortho.wisc.edu		Tarini, Beth/0000-0003-4272-8668	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057994, K12HD055894] Funding Source: NIH RePORTER; NICHD NIH HHS [K23 HD057994, K12 HD055894, K23HD057994, K12HD055894] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*ATL SPORTS GEN, ATL 1; Burdette HL, 2005, ARCH PEDIAT ADOL MED, V159, P46, DOI 10.1001/archpedi.159.1.46; Ciske DJ, 2001, PEDIATRICS, V107, P699, DOI 10.1542/peds.107.4.699; *CYGENE, OPT ATHL PERF DNA AN; National Collegiate Athletic Association, EST PROB COMP ATHL H; Rankinen T, 2010, MED SCI SPORT EXER, V42, P835, DOI 10.1249/MSS.0b013e3181d86cec; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Williams AG, 2009, MED SPORT SCI, V54, P176, DOI 10.1159/000235704; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698	10	8	9	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1033	1034		10.1001/jama.2011.286	http://dx.doi.org/10.1001/jama.2011.286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386082				2022-12-01	WOS:000288129600025
J	Nikolova, EN; Kim, E; Wise, AA; O'Brien, PJ; Andricioaei, I; Al-Hashimi, HM				Nikolova, Evgenia N.; Kim, Eunae; Wise, Abigail A.; O'Brien, Patrick J.; Andricioaei, Ioan; Al-Hashimi, Hashim M.			Transient Hoogsteen base pairs in canonical duplex DNA	NATURE			English	Article							DOUBLE-HELICAL DNA; NUCLEIC-ACIDS; TATA BOX; MOLECULAR-STRUCTURE; GENERALIZED BORN; SPIN RELAXATION; PROTEIN; NMR; DYNAMICS; PROTON	Sequence-directed variations in the canonical DNA double helix structure that retain Watson-Crick base-pairing have important roles in DNA recognition, topology and nucleosome positioning. By using nuclear magnetic resonance relaxation dispersion spectroscopy in concert with steered molecular dynamics simulations, we have observed transient sequence-specific excursions away from Watson-Crick base-pairing at CA and TA steps inside canonical duplex DNA towards low-populated and short-lived A.T and G.C Hoogsteen base pairs. The observation of Hoogsteen base pairs in DNA duplexes specifically bound to transcription factors and in damaged DNA sites implies that the DNA double helix intrinsically codes for excited state Hoogsteen base pairs as a means of expanding its structural complexity beyond that which can be achieved based on Watson-Crick base-pairing. The methods presented here provide a new route for characterizing transient low-populated nucleic acid structures, which we predict will be abundant in the genome and constitute a second transient layer of the genetic code.	[Nikolova, Evgenia N.; Wise, Abigail A.; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Kim, Eunae; Andricioaei, Ioan] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	andricio@uci.edu; hashimi@umich.edu		Nikolova, Evgenia/0000-0003-0365-2939	NSF [MCB 0644278, CHE-0918817]; NIH [R01GM089846]; Rackham International; University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089846] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rackham International; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. L. Hansen, S. Horowitz and J. Feigon for valuable discussions and suggestions, A. V. Kurochkin for NMR expertise, and C. L. Brooks III for access to a supercomputing cluster. We gratefully acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for support in the purchase of a 600 MHz spectrometer. This work was supported by NSF CAREER awards (MCB 0644278 to HMA and CHE-0918817 to I. A.) and an NIH grant (R01GM089846). E.N.N. acknowledges support by a Rackham International and Predoctoral Fellowship awarded by the University of Michigan.	Abrescia NGA, 2004, BIOCHEMISTRY-US, V43, P4092, DOI 10.1021/bi0355140; Abrescia NGA, 2002, P NATL ACAD SCI USA, V99, P2806, DOI 10.1073/pnas.052675499; Aishima J, 2002, NUCLEIC ACIDS RES, V30, P5244, DOI 10.1093/nar/gkf661; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chocholousova J, 2006, J PHYS CHEM B, V110, P17240, DOI 10.1021/jp0627675; Coman D, 2005, BIOPHYS J, V89, P3285, DOI 10.1529/biophysj.105.065763; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov VP, 1996, NAT STRUCT BIOL, V3, P505, DOI 10.1038/nsb0696-505; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; FERRY JD, 1953, J APPL PHYS, V24, P911, DOI 10.1063/1.1721401; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Frisch M., 2016, GAUSSIAN16; Ghosal G, 2006, BIOCHEM BIOPH RES CO, V343, P1, DOI 10.1016/j.bbrc.2006.02.148; GILBERT DE, 1989, P NATL ACAD SCI USA, V86, P3006, DOI 10.1073/pnas.86.9.3006; GREENE KL, 1995, J BIOMOL NMR, V5, P333; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoopes BC, 1998, J MOL BIOL, V277, P1015, DOI 10.1006/jmbi.1998.1651; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; IZATT RM, 1971, CHEM REV, V71, P439, DOI 10.1021/cr60273a002; Johnson JE, 2008, J AM CHEM SOC, V130, P16757, DOI 10.1021/ja805759z; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Koudelka GB, 2006, PROG NUCLEIC ACID RE, V81, P143, DOI 10.1016/S0079-6603(06)81004-4; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lu LH, 2010, NUCLEIC ACIDS RES, V38, P4415, DOI 10.1093/nar/gkq129; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Meyer T, 1997, J BIOL CHEM, V272, P30709, DOI 10.1074/jbc.272.49.30709; Miloushev VZ, 2005, J MAGN RESON, V177, P221, DOI 10.1016/j.jmr.2005.07.023; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; PARDI A, 1982, BIOCHEMISTRY-US, V21, P6567, DOI 10.1021/bi00268a038; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell SW, 2001, BIOCHEMISTRY-US, V40, P11065, DOI 10.1021/bi010890a; RECORD MT, 1981, ANNU REV BIOCHEM, V50, P997, DOI 10.1146/annurev.bi.50.070181.005025; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; Sau AK, 1995, FEBS LETT, V377, P301, DOI 10.1016/0014-5793(95)01362-8; SEAMAN FC, 1993, BIOCHEMISTRY-US, V32, P12577, DOI 10.1021/bi00210a005; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SegersNolten GMJ, 1997, BIOCHEMISTRY-US, V36, P13241, DOI 10.1021/bi971326w; Shajani Z, 2008, BIOCHEMISTRY-US, V47, P7617, DOI 10.1021/bi7020469; Shanmugam G, 2008, CHEM RES TOXICOL, V21, P1795, DOI 10.1021/tx8001466; Song K, 2009, J CHEM THEORY COMPUT, V5, P3105, DOI 10.1021/ct9001575; Travers AA, 2004, PHILOS T R SOC A, V362, P1423, DOI 10.1098/rsta.2004.1390; UGHETTO G, 1985, NUCLEIC ACIDS RES, V13, P2305, DOI 10.1093/nar/13.7.2305; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Xu XP, 2000, J PHYS CHEM B, V104, P5641, DOI 10.1021/jp0007538; Yang H, 2008, FEBS LETT, V582, P1629, DOI 10.1016/j.febslet.2008.04.013	58	224	228	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					498	U84		10.1038/nature09775	http://dx.doi.org/10.1038/nature09775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21270796	Green Submitted, Green Accepted			2022-12-01	WOS:000287652900034
J	McKee, M; Cole, K; Hurst, L; Aldridge, RW; Horton, R				McKee, Martin; Cole, Katie; Hurst, Louise; Aldridge, Robert W.; Horton, Richard			Observations Medicine and the Media The other Twitter revolution: how social media are helping to monitor the NHS reforms	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin; Cole, Katie] London Sch Hyg & Trop Med, London, England; [Hurst, Louise] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Aldridge, Robert W.] UCL, Dept Infect & Populat Hlth, Ctr Infect Dis Epidemiol, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Aldridge, Robert/0000-0003-0542-0816	National Institute for Health Research [ACF-2009-18-028] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Appleby J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d566; COWPER A, 2010, SUPER WEDNESDAY POLI; COWPER A, 2011, ACCOUNTABILITY MATTE; Goldacre B., 2011, GUARDIAN; Organisation for Economic Co-operation and Development, 2010, IMPR VAL HLTH CAR ME; PEEDELL C, 2011, O LETWIN NEW POLL TA; 2011, HLTH IND LOBBYING TO	7	9	9	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d948	10.1136/bmj.d948	http://dx.doi.org/10.1136/bmj.d948			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325389	Green Accepted			2022-12-01	WOS:000287656500022
J	Yadon, AN; Tsukiyama, T				Yadon, Adam N.; Tsukiyama, Toshio			SnapShot: Chromatin Remodeling: ISWI	CELL			English	Editorial Material							TRANSCRIPTION		[Yadon, Adam N.; Tsukiyama, Toshio] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Yadon, AN (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058465] Funding Source: NIH RePORTER; NICHD NIH HHS [T32HD007183] Funding Source: Medline; NIGMS NIH HHS [R01 GM058465] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10	6	46	47	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					454	U154	454.e1	10.1016/j.cell.2011.01.019	http://dx.doi.org/10.1016/j.cell.2011.01.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295704	Bronze			2022-12-01	WOS:000286973100016
J	Pei, HD; Zhang, L; Luo, KT; Qin, YX; Chesi, M; Fei, F; Bergsagel, PL; Wang, LW; You, ZS; Lou, ZK				Pei, Huadong; Zhang, Lindsey; Luo, Kuntian; Qin, Yuxin; Chesi, Marta; Fei, Frances; Bergsagel, P. Leif; Wang, Liewei; You, Zhongsheng; Lou, Zhenkun			MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites	NATURE			English	Article							WOLF-HIRSCHHORN-SYNDROME; DOUBLE-STRAND BREAKS; MULTIPLE-MYELOMA; PROTEIN; METHYLTRANSFERASE; CHECKPOINT; MDC1; RECRUITMENT; REPAIR; DOMAIN	p53-binding protein 1 (53BP1) is known to be an important mediator of the DNA damage response(1), with dimethylation of histone H4 lysine 20 (H4K20me2) critical to the recruitment of 53BP1 to double-strand breaks (DSBs)(2,3). However, it is not clear how 53BP1 is specifically targeted to the sites of DNA damage, as the overall level of H4K20me2 does not seem to increase following DNA damage. It has been proposed that DNA breaks may cause exposure of methylated H4K20 previously buried within the chromosome; however, experimental evidence for such a model is lacking. Here we found that H4K20 methylation actually increases locally upon the induction of DSBs and that methylation of H4K20 at DSBs is mediated by the histone methyltransferase MMSET (also known as NSD2 or WHSC1) in mammals. Downregulation of MMSET significantly decreases H4K20 methylation at DSBs and the subsequent accumulation of 53BP1. Furthermore, we found that the recruitment of MMSET to DSBs requires the gamma H2AX-MDC1 pathway; specifically, the interaction between the MDC1 BRCT domain and phosphorylated Ser 102 of MMSET. Thus, we propose that a pathway involving gamma H2AX-MDC1-MMSET regulates the induction of H4K20 methylation on histones around DSBs, which, in turn, facilitates 53BP1 recruitment.	[Pei, Huadong; Luo, Kuntian; Lou, Zhenkun] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Zhang, Lindsey; Fei, Frances; You, Zhongsheng] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Qin, Yuxin; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Chesi, Marta; Bergsagel, P. Leif] Mayo Clin Arizona, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA	Mayo Clinic; Washington University (WUSTL); Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Lou, ZK (corresponding author), Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA.	lou.zhenkun@mayo.edu	Bergsagel, Peter Leif/A-7842-2011; You, Zhongsheng/F-5404-2012; Pei, Huadong/C-9625-2013	Bergsagel, Peter Leif/0000-0003-1523-7388; Fei, Yueyang/0000-0001-9439-9136; You, Zhongsheng/0000-0002-9719-8791	Richard Schulze Family Foundation; NIH [CA130996, CA151329]; American Cancer Society [IRG-58-010-52]; Siteman Career Award in Breast Cancer Research; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA151329, R01CA136671, R01CA133966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG020686, R01AG020686] Funding Source: NIH RePORTER	Richard Schulze Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Siteman Career Award in Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Jasin for providing HeLa DR-GFP cells, and S. Baylin for providing MDA-MB-231 cells with inducible I-SceI expression. We thank M. Goldberg, X. Yu and M. Stucki for providing MDC1 and BRCA1 constructs. We thank M. Huen for providing 53BP1 expression constructs. We thank J. D. Licht for providing MMSET antibodies and B. Ho Park for providing MMSET shRNAs. This work was supported by the Richard Schulze Family Foundation and the NIH (CA130996 and CA151329; Z.L.), a grant from the American Cancer Society (IRG-58-010-52; Z.Y.) and a Siteman Career Award in Breast Cancer Research (Z.Y.).	Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	30	308	319	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					124	U144		10.1038/nature09658	http://dx.doi.org/10.1038/nature09658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293379	Green Accepted			2022-12-01	WOS:000286886400047
J	Berkman, MB; Plutzer, E				Berkman, Michael B.; Plutzer, Eric			Defeating Creationism in the Courtroom, But Not in the Classroom	SCIENCE			English	Editorial Material							EVOLUTION; STANDARDS		[Berkman, Michael B.; Plutzer, Eric] Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Plutzer, E (corresponding author), Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA.	Plutzer@psu.edu		Plutzer, Eric/0000-0002-5456-7227				Berkman M., 2010, EVOLUTION CREATIONIS; Berkman MB, 2009, PERSPECT POLIT, V7, P485, DOI 10.1017/S153759270999082X; Berkman MB, 2008, PLOS BIOL, V6, P920, DOI 10.1371/journal.pbio.0060124; Branch G, 2010, ANNU REV GENOM HUM G, V11, P317, DOI 10.1146/annurev-genom-082509-141815; Donnelly LA, 2007, J RES SCI TEACH, V44, P236, DOI 10.1002/tea.20150; Moore R, 2002, BIOSCIENCE, V52, P378, DOI 10.1641/0006-3568(2002)052[0378:TEDSSM]2.0.CO;2; National Center for Education Statistics, 2005, NAT ASS ED PROGR 200; National Research Council (NRC), 1996, NAT SCI ED STAND; Plutzer E, 2008, PUBLIC OPIN QUART, V72, P540, DOI 10.1093/poq/nfn034; Rutledge ML, 2002, AM BIOL TEACH, V64, P21, DOI 10.1662/0002-7685(2002)064[0021:HSBTKS]2.0.CO;2	10	72	75	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					404	405		10.1126/science.1198902	http://dx.doi.org/10.1126/science.1198902			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BB	21273472				2022-12-01	WOS:000286635900035
J	Ernst, J; Kheradpour, P; Mikkelsen, TS; Shoresh, N; Ward, LD; Epstein, CB; Zhang, XL; Wang, L; Issner, R; Coyne, M; Ku, MC; Durham, T; Kellis, M; Bernstein, BE				Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Shoresh, Noam; Ward, Lucas D.; Epstein, Charles B.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael; Ku, Manching; Durham, Timothy; Kellis, Manolis; Bernstein, Bradley E.			Mapping and analysis of chromatin state dynamics in nine human cell types	NATURE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION-FACTOR-BINDING; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; HISTONE MODIFICATIONS; SUSCEPTIBILITY LOCI; ENHANCERS; POPULATION; METAANALYSIS; PROMOTERS	Chromatin profiling has emerged as a powerful means of genome annotation and detection of regulatory activity. The approach is especially well suited to the characterization of non-coding portions of the genome, which critically contribute to cellular phenotypes yet remain largely uncharted. Here we map nine chromatin marks across nine cell types to systematically characterize regulatory elements, their cell-type specificities and their functional interactions. Focusing on cell-type-specific patterns of promoters and enhancers, we define multicell activity profiles for chromatin state, gene expression, regulatory motif enrichment and regulator expression. We use correlations between these profiles to link enhancers to putative target genes, and predict the cell-type-specific activators and repressors that modulate them. The resulting annotations and regulatory predictions have implications for the interpretation of genome-wide association studies. Top-scoring disease single nucleotide polymorphisms are frequently positioned within enhancer elements specifically active in relevant cell types, and in some cases affect a motif instance for a predicted regulator, thus suggesting a mechanism for the association. Our study presents a general framework for deciphering cis-regulatory connections and their roles in disease.	[Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Shoresh, Noam; Ward, Lucas D.; Epstein, Charles B.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael; Ku, Manching; Durham, Timothy; Kellis, Manolis; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ernst, Jason; Kheradpour, Pouya; Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kellis, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020; Mikkelsen, Tarjei S/A-1306-2007	Kellis, Manolis/0000-0001-7113-9630; Mikkelsen, Tarjei S/0000-0002-8133-3135; Ward, Lucas/0000-0002-8017-809X; Epstein, Charles B./0000-0001-8358-8345; Issner, Robbyn/0000-0003-4132-9219	National Human Genome Research Institute [U54 HG004570, R01 HG004037, RC1 HG005334]; Howard Hughes Medical Institute; National Science Foundation [0644282, 0905968]; Sloan Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005334, U54HG004570, R01HG004037] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the epigenomics community at the Broad Institute and the Bernstein and Kellis laboratories, and M. Daly, D. Altshuler and E. Lander for discussions and criticisms. We also thank M. Suva, E. Mendenhall and S. Gillespie for assistance with experiments, and L. Goff and A. Chess for critical reading of the manuscript. We acknowledge the Broad Institute Genome Sequencing Platform for their expertise and assistance with data production. This research was supported by the National Human Genome Research Institute under an ENCODE grant (U54 HG004570; B.E.B.), R01 HG004037 (M. Kellis), RC1 HG005334 (M. Kellis), the Howard Hughes Medical Institute (B.E.B.), the National Science Foundation (awards 0644282 (M. Kellis) and 0905968 (J.E.)) and the Sloan Foundation (M. Kellis).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Forte E, 2009, J VIROL, V83, P2491, DOI 10.1128/JVI.01681-08; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hoshino H, 2007, J BIOCHEM, V141, P719, DOI 10.1093/jb/mvm073; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Naumova N, 2010, J CELL SCI, V123, P1979, DOI 10.1242/jcs.051631; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Touzet H, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-15; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	65	1990	2040	5	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					43	U52		10.1038/nature09906	http://dx.doi.org/10.1038/nature09906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21441907	Green Accepted, Green Submitted			2022-12-01	WOS:000290218300027
J	Fischer, MG; Suttle, CA				Fischer, Matthias G.; Suttle, Curtis A.			A Virophage at the Origin of Large DNA Transposons	SCIENCE			English	Article							EUKARYOTES; EVOLUTION; ELEMENTS; INTEGRASES; MIMIVIRUS; VIRUSES; PRD1	DNA transposons are mobile genetic elements that have shaped the genomes of eukaryotes for millions of years, yet their origins remain obscure. We discovered a virophage that, on the basis of genetic homology, likely represents an evolutionary link between double-stranded DNA viruses and Maverick/Polinton eukaryotic DNA transposons. The Mavirus virophage parasitizes the giant Cafeteria roenbergensis virus and encodes 20 predicted proteins, including a retroviral integrase and a protein-primed DNA polymerase B. On the basis of our data, we conclude that Maverick/Polinton transposons may have originated from ancient relatives of Mavirus, and thereby influenced the evolution of eukaryotic genomes, although we cannot rule out alternative evolutionary scenarios.	[Fischer, Matthias G.; Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Suttle, CA (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 1365-2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	csuttle@eos.ubc.ca	Suttle, Curtis A/C-3150-2008; suttle, c/N-1144-2019; Fischer, Matthias G/Q-2738-2017	Suttle, Curtis A/0000-0002-0372-0033; suttle, c/0000-0002-0372-0033; Fischer, Matthias G/0000-0002-4014-3626	Natural Science and Engineering Research Council of Canada (NSERC); Tula Foundation through the Centre for Microbial Diversity and Evolution; Gottlieb Daimler- and Karl Benz-Foundation, Germany; University of British Columbia	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tula Foundation through the Centre for Microbial Diversity and Evolution; Gottlieb Daimler- and Karl Benz-Foundation, Germany; University of British Columbia	We thank B.N. Ross and G. D. Martens of the UBC Bioimaging Facility and A. M. Chan for assistance with electron microscopy; E. Zaikova for qPCR assistance; and E. J. Pritham, J. Davies, and E. Nomis for constructive comments. Supported by the Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grants Program, the Tula Foundation through the Centre for Microbial Diversity and Evolution, and fellowships awarded to M. G. F. by the Gottlieb Daimler- and Karl Benz-Foundation, Germany, and the University of British Columbia. The genome sequence of Mavirus has been deposited in GenBank under the accession number HQ712116.	Bao WD, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-3; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; Feschotte C, 2005, TRENDS GENET, V21, P551, DOI 10.1016/j.tig.2005.07.007; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Gao X, 2005, TRENDS GENET, V21, P133, DOI 10.1016/j.tig.2005.01.006; Johnson WE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001210; Kapitonov VV, 2006, P NATL ACAD SCI USA, V103, P4540, DOI 10.1073/pnas.0600833103; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Krupovic M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/nrmicro2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Pritham EJ, 2009, J HERED, V100, P648, DOI 10.1093/jhered/esp065; Stromsten NJ, 2005, J MOL BIOL, V348, P617, DOI 10.1016/j.jmb.2005.03.002	18	184	194	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					231	234		10.1126/science.1199412	http://dx.doi.org/10.1126/science.1199412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21385722				2022-12-01	WOS:000289251100050
J	Sims, RJ; Rojas, LA; Beck, D; Bonasio, R; Schuller, R; Drury, WJ; Eick, D; Reinberg, D				Sims, Robert J., III; Rojas, Luis Alejandro; Beck, David; Bonasio, Roberto; Schueller, Roland; Drury, William J., III; Eick, Dirk; Reinberg, Danny			The C-Terminal Domain of RNA Polymerase II Is Modified by Site-Specific Methylation	SCIENCE			English	Article							TRANSCRIPTION; CARM1; INTEGRATOR; EXPRESSION; IICTD	The carboxy-terminal domain (CTD) of RNA polymerase II (RNAPII) in mammals undergoes extensive posttranslational modification, which is essential for transcriptional initiation and elongation. Here, we show that the CTD of RNAPII is methylated at a single arginine (R1810) by the coactivator-associated arginine methyltransferase 1 (CARM1). Although methylation at R1810 is present on the hyperphosphorylated form of RNAPII in vivo, Ser2 or Ser5 phosphorylation inhibits CARM1 activity toward this site in vitro, suggesting that methylation occurs before transcription initiation. Mutation of R1810 results in the misexpression of a variety of small nuclear RNAs and small nucleolar RNAs, an effect that is also observed in Carm1(-/-) mouse embryo fibroblasts. These results demonstrate that CTD methylation facilitates the expression of select RNAs, perhaps serving to discriminate the RNAPII-associated machinery recruited to distinct gene types.	[Sims, Robert J., III; Rojas, Luis Alejandro; Beck, David; Bonasio, Roberto; Drury, William J., III; Reinberg, Danny] NYU, Sch Med, HHMI, Dept Biochem, New York, NY 10016 USA; [Schueller, Roland; Eick, Dirk] CIPSM, Dept Mol Epigenet, Helmholtz Ctr Munich, D-81377 Munich, Germany	Howard Hughes Medical Institute; New York University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Reinberg, D (corresponding author), NYU, Sch Med, HHMI, Dept Biochem, 522 1st Ave,Smilow 211, New York, NY 10016 USA.	danny.reinberg@nyumc.org	Bonasio, Roberto/P-1356-2014; Rojas, Luis/C-2204-2011	Bonasio, Roberto/0000-0002-0767-0889; Rojas, Luis Alejandro/0000-0001-6445-1562; Reinberg, Danny/0000-0003-4288-2016	HHMI; NIH [GM-37120, GM-71166]; Deutsche Forschungsgemeinschaft [SFB/Transregio-5, SFB684]; Jose Carreras Leukmiestiftung eV; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037120, R37GM037120, F32GM071166] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jose Carreras Leukmiestiftung eV; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by the HHMI (to D. R.) and grants from NIH (GM-37120 to D. R. and GM-71166 to R.J.S.). R. B. is a fellow of the Helen Hay Whitney foundation. D. E. was supported by Deutsche Forschungsgemeinschaft (SFB/Transregio-5, SFB684) and Jose Carreras Leukmiestiftung eV. We thank L. Vales, E. Lecona, and P. Voigt for careful reading of the manuscript; R. D. Chapman and K. Burger for technical support; and members of the Reinberg lab for critical commentaries during the development of this project. RNA-seq data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus as GEO series GSE27315.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2010, J BIOL CHEM, V285, P20564, DOI 10.1074/jbc.M110.132530; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Ryan K, 2002, MOL CELL BIOL, V22, P1684, DOI 10.1128/MCB.22.6.1684-1692.2002; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024	16	149	151	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					99	103		10.1126/science.1202663	http://dx.doi.org/10.1126/science.1202663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454787	Green Accepted			2022-12-01	WOS:000289000000046
J	Sousa-Nunes, R; Yee, LL; Gould, AP				Sousa-Nunes, Rita; Yee, Lih Ling; Gould, Alex P.			Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila	NATURE			English	Article							NEURAL STEM-CELLS; PHOSPHOINOSITIDE 3-KINASE; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; TEMPORAL IDENTITY; NERVOUS-SYSTEM; GROWTH; PROLIFERATION; RECEPTOR; SIZE	Many stem, progenitor and cancer cells undergo periods of mitotic quiescence from which they can be reactivated(1-5). The signals triggering entry into and exit from this reversible dormant state are not well understood. In the developing Drosophila central nervous system, multipotent self-renewing progenitors called neuroblasts(6-9) undergo quiescence in a stereotypical spatiotemporal pattern(10). Entry into quiescence is regulated by Hox proteins and an internal neuroblast timer(11-13). Exit from quiescence (reactivation) is subject to a nutritional checkpoint requiring dietary amino acids(14). Organ co-cultures also implicate an unidentified signal from an adipose/hepatic-like tissue called the fat body(14). Here we provide in vivo evidence that Slimfast amino-acid sensing and Target of rapamycin (TOR) signalling(15) activate a fat-body-derived signal (FDS) required for neuroblast reactivation. Downstream of this signal, Insulin-like receptor signalling and the Phosphatidylinositol 3-kinase (PI3K)/TOR network are required in neuroblasts for exit from quiescence. We demonstrate that nutritionally regulated glial cells provide the source of Insulin-like peptides (ILPs) relevant for timely neuroblast reactivation but not for overall larval growth. Conversely, ILPs secreted into the haemolymph by median neurosecretory cells systemically control organismal size(16-18) but do not reactivate neuroblasts. Drosophila thus contains two segregated ILP pools, one regulating proliferation within the central nervous system and the other controlling tissue growth systemically. Our findings support a model in which amino acids trigger the cell cycle re-entry of neural progenitors via a fat-body-glia-neuroblasts relay. This mechanism indicates that dietary nutrients and remote organs, as well as local niches, are key regulators of transitions in stem-cell behaviour.	[Sousa-Nunes, Rita; Yee, Lih Ling; Gould, Alex P.] Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Gould, Alex/M-5353-2019; Gould, Alex/A-7479-2010; Sousa-Nunes, Rita/AAE-4628-2020	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Sousa-Nunes, Rita/0000-0002-7401-8081	Medical Research Council [U117584237]; MRC [MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to A. Brand, S. Cohen, B. Edgar, U. Gaul, E. Hafen, C. Klambt, T. Lee, S. Leevers, P. Leopold, F. Matsuzaki, I. Miguel-Aliaga, T. Neufeld, R. Palmer, L. Partridge, L. Pick, E. Sanchez-Herrero, H. Stocker, N. Tapon and T. Xu, and also to the Bloomington stock centre and Kyoto National Institute of Genetics (NIG) for Drosophila stocks, antibodies and plasmids. We also acknowledge I. Salecker, J.-P. Vincent, A. Bailey, E. Cinnamon, L. Cheng, R. Makki, A. Matheu, P. Pachnis, P. Serpente and I. Stefana for providing advice, reagents and critical reading of the manuscript. The authors were supported by the Medical Research Council (U117584237).	Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Chen E, 2009, CELL STEM CELL, V5, P451, DOI 10.1016/j.stem.2009.10.011; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Huang H, 1999, DEVELOPMENT, V126, P5365; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Miguel-Aliaga I, 2008, PLOS BIOL, V6, P538, DOI 10.1371/journal.pbio.0060058; Moline MM, 1999, DEVELOPMENT, V126, P4375; Neufeld TP, 2003, MECH DEVELOP, V120, P1283, DOI 10.1016/j.mod.2003.07.003; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sanchez-Garcia I, 2007, BIOESSAYS, V29, P1269, DOI 10.1002/bies.20679; Scholz H, 1997, MECH DEVELOP, V64, P137; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	54	264	267	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					508	+		10.1038/nature09867	http://dx.doi.org/10.1038/nature09867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21346761	Green Accepted			2022-12-01	WOS:000288702200061
J	Tye, KM; Prakash, R; Kim, SY; Fenno, LE; Grosenick, L; Zarabi, H; Thompson, KR; Gradinaru, V; Ramakrishnan, C; Deisseroth, K				Tye, Kay M.; Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Zarabi, Hosniya; Thompson, Kimberly R.; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl			Amygdala circuitry mediating reversible and bidirectional control of anxiety	NATURE			English	Article							CONDITIONED FEAR; CENTRAL NUCLEUS; RAT; DISORDERS; BEHAVIOR; BRAIN; CAT; PROJECTIONS; COMPLEX; MICE	Anxiety-a sustained state of heightened apprehension in the absence of immediate threat-becomes severely debilitating in disease states(1). Anxiety disorders represent the most common of psychiatric diseases (28% lifetime prevalence) 2 and contribute to the aetiology of major depression and substance abuse(3,4). Although it has been proposed that the amygdala, a brain region important for emotional processing(5-8), has a role in anxiety(9-13), the neural mechanisms that control anxiety remain unclear. Here we explore the neural circuits underlying anxiety-related behaviours by using optogenetics with two-photon microscopy, anxiety assays in freely moving mice, and electrophysiology. With the capability of optogenetics(14-16) to control not only cell types but also specific connections between cells, we observed that temporally precise optogenetic stimulation of basolateral amygdala (BLA) terminals in the central nucleus of the amygdala (CeA)-achieved by viral transduction of the BLA with a codon-optimized channelrhodopsin followed by restricted illumination in the downstream CeA-exerted an acute, reversible anxiolytic effect. Conversely, selective optogenetic inhibition of the same projection with a third-generation halorhodopsin(15) (eNpHR3.0) increased anxiety-related behaviours. Importantly, these effects were not observed with direct optogenetic control of BLA somata, possibly owing to recruitment of antagonistic downstream structures. Together, these results implicate specific BLACeA projections as critical circuit elements for acute anxiety control in the mammalian brain, and demonstrate the importance of optogenetically targeting defined projections, beyond simply targeting cell types, in the study of circuit function relevant to neuropsychiatric disease.	[Tye, Kay M.; Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Zarabi, Hosniya; Thompson, Kimberly R.; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Gradinaru, Viviana; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Core, Vector/CAF-4832-2022; Fenno, Lief/AAF-9638-2019; Tye, Kay/J-6158-2013; Kim, Sung-Yon/AAO-8405-2020; Fenno, Lief/AAK-2924-2020	Tye, Kay/0000-0002-2435-0182; Kim, Sung-Yon/0000-0003-0791-7308; Ramakrishnan, Charu/0000-0002-3474-6332	NIMH [1F32MH088010-01]; NARSAD; Samsung; NSF [0801700]; Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery [N66001-10-C-2010]; Alice Woo Foundation; Albert Yu Foundation; Snyder Foundation; McKnight Foundation; NIDA; NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH088010, R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); Samsung(Samsung); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery; Alice Woo Foundation; Albert Yu Foundation; Snyder Foundation; McKnight Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank P. Janak, H. Fields, G. Stuber, E. Thomas, F. Zhang, I. Witten, V. Sohal, T. Davidson and M. Warden as well as J. Mattis, R. Durand, M. Mogri, J. Mirzabekov and E. Steinberg for discussions, and the entire K. D. laboratory for their support. All viruses were packaged at University of North Carolina (UNC) Vector Core. Supported by NIMH (1F32MH088010-01, K. M. T.), NARSAD (K. R. T.), Samsung Scholarship (S.-Y.K.), NSF IGERT Award 0801700 (L. G.) and the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery (N66001-10-C-2010), the Alice Woo, Albert Yu, Snyder, and McKnight Foundations, as well as NIDA, NIMH and the NIH Pioneer Award (K. D.)	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CARLSEN J, 1988, J COMP NEUROL, V273, P513, DOI 10.1002/cne.902730407; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis M., 2000, AMYGDALA, P213; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Deisseroth K, 2010, SCI AM, V303, P48, DOI 10.1038/scientificamerican1110-48; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gray J A, 1996, Nebr Symp Motiv, V43, P61; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koob GF, 2009, BRAIN RES, V1293, P61, DOI 10.1016/j.brainres.2009.03.038; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lesscher HMB, 2008, GENES BRAIN BEHAV, V7, P323, DOI 10.1111/j.1601-183X.2007.00356.x; Lieb R, 2005, HANDB EXP PHARM, V169, P405; Lyons AM, 2010, PEPTIDES, V31, P2193, DOI 10.1016/j.peptides.2010.09.009; MCDONALD AJ, 1982, J COMP NEUROL, V208, P401, DOI 10.1002/cne.902080409; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; WOODS JH, 1992, PHARMACOL REV, V44, P151	30	781	839	6	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					358	362		10.1038/nature09820	http://dx.doi.org/10.1038/nature09820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21389985	Green Accepted			2022-12-01	WOS:000288444000041
J	Fang, WG; Vega-Rodriguez, J; Ghosh, AK; Jacobs-Lorena, M; Kang, A; St Leger, RJ				Fang, Weiguo; Vega-Rodriguez, Joel; Ghosh, Anil K.; Jacobs-Lorena, Marcelo; Kang, Angray; St Leger, Raymond J.			Development of Transgenic Fungi That Kill Human Malaria Parasites in Mosquitoes	SCIENCE			English	Article							ENTOMOPATHOGENIC FUNGUS; METARHIZIUM-ANISOPLIAE; ANOPHELINE MOSQUITOS; TRANSMISSION; SPOROZOITES; STRATEGIES; SCORPINE; DISEASE; VECTOR	Metarhizium anisopliae infects mosquitoes through the cuticle and proliferates in the hemolymph. To allow M. anisopliae to combat malaria in mosquitoes with advanced malaria infections, we produced recombinant strains expressing molecules that target sporozoites as they travel through the hemolymph to the salivary glands. Eleven days after a Plasmodium-infected blood meal, mosquitoes were treated with M. anisopliae expressing salivary gland and midgut peptide 1 (SM1), which blocks attachment of sporozoites to salivary glands; a single-chain antibody that agglutinates sporozoites; or scorpine, which is an antimicrobial toxin. These reduced sporozoite counts by 71%, 85%, and 90%, respectively. M. anisopliae expressing scorpine and an [SM1](8):scorpine fusion protein reduced sporozoite counts by 98%, suggesting that Metarhizium-mediated inhibition of Plasmodium development could be a powerful weapon for combating malaria.	[Fang, Weiguo; St Leger, Raymond J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Vega-Rodriguez, Joel; Ghosh, Anil K.; Jacobs-Lorena, Marcelo] Johns Hopkins Sch Publ Hlth, Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD 21205 USA; [Kang, Angray] Univ Westminster, Sch Life Sci, Dept Mol & Appl Biosci, Antibody Technol Grp, London W1W 6UW, England	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Roehampton University; University of Westminster	St Leger, RJ (corresponding author), Univ Maryland, Dept Entomol, 4112 Plant Sci Bldg, College Pk, MD 20742 USA.	stleger@umd.edu	weiguo, fang/F-5933-2010; St. Leger, Raymond/N-3219-2013; hongbo, yi/G-9615-2011; Fang, Weiguo/G-6680-2012	Fang, Weiguo/0000-0002-8431-8256; Kang, Angray/0000-0002-4672-4114	NIH [5R21A1079429-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079429, R21AI088033, R01AI031478] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 5R21A1079429-02. The GenBank accession numbers of the sequences used in the study are P56972 (scorpine) and HQ833020 (PfNPNA-1).	Alves SB, 2002, J APPL ENTOMOL, V126, P504, DOI 10.1046/j.1439-0418.2002.00674.x; BEIER JC, 1991, MED VET ENTOMOL, V5, P71, DOI 10.1111/j.1365-2915.1991.tb00523.x; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Boyd MF, 1933, AM J HYG, V17, P666, DOI 10.1093/oxfordjournals.aje.a117932; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Chappel JA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-28; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Hancock PA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000525; Howard AFV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-168; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; James AA, 2003, J EXP BIOL, V206, P3817, DOI 10.1242/jeb.00616; James S. P., 1936, Proceedings of the Royal Society of Medicine London, V29; Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI 10.2217/FMB.10.11; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Maniania NK, 2002, BIOCONTROL SCI TECHN, V12, P59, DOI 10.1080/09583150120110662; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008; Rio RVM, 2004, TRENDS MICROBIOL, V12, P325, DOI 10.1016/j.tim.2004.05.001; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Thomson R, 2009, P NATL ACAD SCI USA, V106, P19509, DOI 10.1073/pnas.0905669106; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; *WHO, 2009, WORLD MAL REP; Zhioua E, 1997, J PARASITOL, V83, P815, DOI 10.2307/3284273	30	183	196	8	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1074	1077		10.1126/science.1199115	http://dx.doi.org/10.1126/science.1199115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350178	Green Accepted			2022-12-01	WOS:000287699000066
J	Nevo-Dinur, K; Nussbaum-Shochat, A; Ben-Yehuda, S; Amster-Choder, O				Nevo-Dinur, Keren; Nussbaum-Shochat, Anat; Ben-Yehuda, Sigal; Amster-Choder, Orna			Translation-Independent Localization of mRNA in E. coli	SCIENCE			English	Article							ESCHERICHIA-COLI; INTRACELLULAR-LOCALIZATION; BACILLUS-SUBTILIS; GLOBAL ANALYSIS; MEMBRANE; TRANSCRIPTION; PROTEINS; BINDING; CELLS; CHLORAMPHENICOL	Understanding the organization of a bacterial cell requires the elucidation of the mechanisms by which proteins localize to particular subcellular sites. Thus far, such mechanisms have been suggested to rely on embedded features of the localized proteins. Here, we report that certain messenger RNAs (mRNAs) in Escherichia coli are targeted to the future destination of their encoded proteins, cytoplasm, poles, or inner membrane in a translation-independent manner. Cis-acting sequences within the transmembrane-coding sequence of the membrane proteins are necessary and sufficient for mRNA targeting to the membrane. In contrast to the view that transcription and translation are coupled in bacteria, our results show that, subsequent to their synthesis, certain mRNAs are capable of migrating to particular domains in the cell where their future protein products are required.	[Nevo-Dinur, Keren; Nussbaum-Shochat, Anat; Ben-Yehuda, Sigal; Amster-Choder, Orna] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Amster-Choder, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, POB 12272, IL-91120 Jerusalem, Israel.	amster@cc.huji.ac.il			Israel Science Foundation; European Research Council [209130]	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission)	We acknowledge members of S.B.-Y.'s group for help with fluorescence microscopy, members of O.A.-C.'s group for stimulating discussions, and E. Bibi and E.S. Bochkareva for technical advice on cell fractionation. We thank the following individuals for their gifts: I. Golding for pIG-K33, R. H. Singer for pSL-MS2 6, and Z. Livneh for purified single-stranded DNA binding protein (SSB) and anti-SSB serum. We are grateful to A. Wright, E. Bibi, and R. Losick for critically reading our manuscript. This research was supported by a research grant (awarded to O.A.-C.) by the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities. S.B.-Y. is supported by the European Research Council starting grant (209130).	Amster-Choder O, 2005, CURR OPIN MICROBIOL, V8, P127, DOI 10.1016/j.mib.2005.02.014; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; CHEN MW, 1993, J BACTERIOL, V175, P5697, DOI 10.1128/JB.175.17.5697-5700.1993; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Ebersbach G, 2007, TRENDS MICROBIOL, V15, P101, DOI 10.1016/j.tim.2007.01.004; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; Janakiraman A, 2004, TRENDS MICROBIOL, V12, P518, DOI 10.1016/j.tim.2004.09.003; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Lopian L, 2003, P NATL ACAD SCI USA, V100, P7099, DOI 10.1073/pnas.1037608100; Lopian L, 2010, EMBO J, V29, P3630, DOI 10.1038/emboj.2010.240; LUNDBERG U, 1988, GENE, V72, P141, DOI 10.1016/0378-1119(88)90136-9; Palacios IM, 2007, SEMIN CELL DEV BIOL, V18, P163, DOI 10.1016/j.semcdb.2007.01.008; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Sorg JA, 2005, CELL MICROBIOL, V7, P1217, DOI 10.1111/j.1462-5822.2005.00563.x; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Valencia-Burton M, 2009, P NATL ACAD SCI USA, V106, P16399, DOI 10.1073/pnas.0907495106; WEISBERGER AS, 1967, ANNU REV MED, V18, P483, DOI 10.1146/annurev.me.18.020167.002411	29	185	189	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1081	1084		10.1126/science.1195691	http://dx.doi.org/10.1126/science.1195691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350180				2022-12-01	WOS:000287699000068
J	Liu, JN; Steiner, M; Dunlop, JA; Keupp, H; Shu, DG; Ou, QA; Han, JA; Zhang, ZF; Zhang, XL				Liu, Jianni; Steiner, Michael; Dunlop, Jason A.; Keupp, Helmut; Shu, Degan; Ou, Qiang; Han, Jian; Zhang, Zhifei; Zhang, Xingliang			An armoured Cambrian lobopodian from China with arthropod-like appendages	NATURE			English	Article							CHENGJIANG LAGERSTATTE; ANOMALOCARIS; EVOLUTION; ORIGIN; FAUNA	Cambrian fossil Lagerstatten preserving soft-bodied organisms have contributed much towards our understanding of metazoan origins(1-3). Lobopodians are a particularly interesting group that diversified and flourished in the Cambrian seas. Resembling 'worms with legs', they have long attracted much attention in that they may have given rise to both Onychophora (velvet worms)(4-6) and Tardigrada (water bears)(7,8), as well as to arthropods in general(9-12). Here we describe Diania cactiformis gen. et sp. nov. as an 'armoured' lobopodian from the Chengjiang fossil Lagerstatte (Cambrian Stage 3), Yunnan, southwestern China. Although sharing features with other typical lobopodians, it is remarkable for possessing robust and probably sclerotized appendages, with what appear to be articulated elements. In terms of limb morphology it is therefore closer to the arthropod condition, to our knowledge, than any lobopodian recorded until now. Phylogenetic analysis recovers it in a derived position, close to Arthropoda; thus, it seems to belong to a grade of organization close to the point of becoming a true arthropod. Further, D. cactiformis could imply that arthropodization (sclerotization of the limbs) preceded arthrodization (sclerotization of the body). Comparing our fossils with other lobopodian appendage morphologies-see Kerygmachela(9,10), Jianshanopodia(13) and Megadictyon(12)-reinforces the hypothesis that the group as a whole is paraphyletic, with different taxa expressing different grades of arthropodization.	[Liu, Jianni; Shu, Degan; Han, Jian; Zhang, Zhifei; Zhang, Xingliang] NW Univ Xian, Dept Geol, State Key Lab Continental Dynam, Early Life Inst, Xian 710069, Peoples R China; [Liu, Jianni; Steiner, Michael; Keupp, Helmut] Free Univ Berlin, Dept Earth Sci, D-12249 Berlin, Germany; [Dunlop, Jason A.] Humboldt Univ, Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, D-10115 Berlin, Germany; [Shu, Degan; Ou, Qiang] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China	Northwest University Xi'an; Free University of Berlin; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; China University of Geosciences	Liu, JN (corresponding author), NW Univ Xian, Dept Geol, State Key Lab Continental Dynam, Early Life Inst, Xian 710069, Peoples R China.	liujianni@126.com	Dunlop, Jason A./AAC-8042-2019; Han, Jian/AAU-4500-2021	Han, Jian/0000-0002-2134-4078; Ou, Qiang/0000-0002-1142-5114; Dunlop, Jason/0000-0002-0179-6640	Alexander von Humboldt Foundation at the Freie Universitat Berlin; National Science Foundation of China [40802011, 40830208]; State Key Laboratory of Continental Dynamics, Northwest University; DFG [Forschergruppe 736]	Alexander von Humboldt Foundation at the Freie Universitat Berlin(Alexander von Humboldt Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Continental Dynamics, Northwest University; DFG(German Research Foundation (DFG))	This work was supported by a Research Scholarship from the Alexander von Humboldt Foundation at the Freie Universitat Berlin, the National Science Foundation of China (grants 40802011 and 40830208) and the MOST Special Fund from the State Key Laboratory of Continental Dynamics, Northwest University (to J.L.), and a DFG grant within the Forschergruppe 736 (to H. K. and M. S.). We thank M. G. Chi for the reconstruction, J. Evers and M. Y. Sun for photography and table, and local workers for their strenuous field work.	Bergstrom J, 2008, GFF, V130, P189; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2001, ZOOL ANZ, V240, P265, DOI 10.1078/0044-5231-00034; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Delle Cave L., 1975, Monitore Zoologico Italiano (NS), V9, P67; DZIK J, 1989, LETHAIA, V22, P169, DOI 10.1111/j.1502-3931.1989.tb01679.x; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; HOU XG, 1995, ZOOL J LINN SOC-LOND, V114, P3, DOI 10.1006/zjls.1995.0014; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; HOU XG, 1991, ZOOL SCR, V20, P395; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Liu JN, 2007, ACTA ZOOL-STOCKHOLM, V88, P279, DOI 10.1111/j.1463-6395.2007.00281.x; Liu JN, 2006, ACTA PALAEONTOL POL, V51, P215; Liu JN, 2004, CHINESE SCI BULL, V49, P1063, DOI 10.1360/04wd0052; Ma XY, 2009, ARTHROPOD STRUCT DEV, V38, P271, DOI 10.1016/j.asd.2009.03.001; Maas A, 2007, CHINESE SCI BULL, V52, P3385, DOI 10.1007/s11434-007-0515-3; Ramskold L, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P107; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Wang XQ, 2004, CHINESE SCI BULL, V49, P49, DOI 10.1360/03wd0329; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Willmer P., 1991, INVERTEBRATE RELATIO, P273	24	50	59	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					526	530		10.1038/nature09704	http://dx.doi.org/10.1038/nature09704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350485				2022-12-01	WOS:000287652900040
J	Encalada, SE; Szpankowski, L; Xia, CH; Goldstein, LSB				Encalada, Sandra E.; Szpankowski, Lukasz; Xia, Chun-hong; Goldstein, Lawrence S. B.			Stable Kinesin and Dynein Assemblies Drive the Axonal Transport of Mammalian Prion Protein Vesicles	CELL			English	Article							TUG-OF-WAR; HEAVY-CHAIN; CYTOPLASMIC DYNEIN; MOLECULAR MOTORS; TARGETED DISRUPTION; IN-VITRO; DYNACTIN; GENES; MITOCHONDRIA; REQUIRES	Kinesin and dynein are opposite-polarity microtubule motors that drive the tightly regulated transport of a variety of cargoes. Both motors can bind to cargo, but their overall composition on axonal vesicles and whether this composition directly modulates transport activity are unknown. Here we characterize the intracellular transport and steady-state motor subunit composition of mammalian prion protein (PrPC) vesicles. We identify Kinesin-1 and cytoplasmic dynein as major PrPC vesicle motor complexes and show that their activities are tightly coupled. Regulation of normal retrograde transport by Kinesin-1 is independent of dynein-vesicle attachment and requires the vesicle association of a complete Kinesin-1 heavy and light chain holoenzyme. Furthermore, motor subunits remain stably associated with stationary as well as with moving vesicles. Our data suggest a coordination model wherein PrPC vesicles maintain a stable population of associated motors whose activity is modulated by regulatory factors instead of by structural changes to motor-cargo associations.	[Encalada, Sandra E.; Szpankowski, Lukasz; Xia, Chun-hong; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Szpankowski, Lukasz] Univ Calif San Diego, Sch Med, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Szpankowski, Lukasz; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Encalada, SE (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sencalada@ucsd.edu; lgoldstein@ucsd.edu			UCSD [P30 NS047101]; NIH-NIA [AG032180]; Investigator of the Howard Hughes Medical Institute; NIH [T32 GM008806, AG000216]; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032180, T32AG000216] Funding Source: NIH RePORTER	UCSD; NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ge Yang, Gaudenz Danuser, Khuloud Jaqaman, and Daniel Whisler for assistance with the development of software; Liz Roberts and Eileen Westerman for technical assistance; Jennifer Meerloo for assistance with imaging (UCSD Neuroscience Microscopy Shared Facility Grant P30 NS047101); Anne-Marie Craig (University of British Columbia) for the synaptophysin-mCherry construct; Anthony Williamson and Laura Solforosi (The Scripps Research Institute) for the HuM-D13 anti-PrP<SUP>C</SUP> antibody; Scott T. Brady for the KLC1/2 (63-90) antibody; Nancy Jenkins (Institute of Molecular and Cell Biology, Singapore) and Jiandong Huang (University of Hong Kong) for the Kinesin-1B mice; Tony Orth at the Genomics Institute of the Novartis Foundation for help with design and construction of shRNA lentiviral constructs; and Jeff W. Kelly (The Scripps Research Institute) for critical feedback on the manuscript. This work was supported in part by NIH-NIA grant AG032180 to L. S. B. G., who is an Investigator of the Howard Hughes Medical Institute. L. S. was supported by NIH Bioinformatics Training Grant T32 GM008806, and S. E. E. was supported by a Damon Runyon Cancer Research Foundation Postdoctoral Fellowship and NIH Neuroplasticity Training Grant AG000216.	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; [Anonymous], 2005, INTRO PRACTICE STAT; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BORCHELT DR, 1994, J BIOL CHEM, V269, P14711; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Butowt R, 2006, MOL CELL NEUROSCI, V31, P97, DOI 10.1016/j.mcn.2005.09.004; Butowt R, 2007, J NEUROSCI RES, V85, P2567, DOI 10.1002/jnr.21229; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cui J, 2011, DIABETES, V60, P320, DOI 10.2337/db09-1078; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; HENDRICKS AG, 2010, CURR BIOL; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Howard J., 2001, MECH MOTOR PROTEINS; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Mazumdar M, 1996, P NATL ACAD SCI USA, V93, P6552, DOI 10.1073/pnas.93.13.6552; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Moya KL, 2004, J NEUROCHEM, V88, P155, DOI 10.1046/j.1471-4159.2003.02150.x; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Plitz T, 2001, MOL CELL BIOL, V21, P6044, DOI 10.1128/MCB.21.17.6044-6055.2001; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rodolfo K, 1999, NEUROREPORT, V10, P3639, DOI 10.1097/00001756-199911260-00032; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026	55	127	128	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					551	565		10.1016/j.cell.2011.01.021	http://dx.doi.org/10.1016/j.cell.2011.01.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335237	Bronze, Green Accepted			2022-12-01	WOS:000287473100010
J	Gagne, JJ; Choudhry, NK				Gagne, Joshua J.; Choudhry, Niteesh K.			How Many "Me-Too" Drugs Is Too Many?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BRAND-NAME DRUGS		[Gagne, Joshua J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	nchoudhry@partners.org	Mendoza, Elvia/A-9361-2012					Avorn J., 2005, POWERFUL MED BENEFIT; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Choudhry NK, 2009, CIRCULATION, V119, P365, DOI 10.1161/CIRCULATIONAHA.108.829655; Congressional Budget Office, 1998, INCR COMP GEN DRUGS; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Moran DW, 2000, HEALTH AFFAIR, V19, P63, DOI 10.1377/hlthaff.19.2.63; REDELMEIER DA, 1995, JAMA-J AM MED ASSOC, V273, P302, DOI 10.1001/jama.273.4.302; US Food and Drug Administration, 2010, FY 2009 PDUFA FIN RE	9	54	55	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					711	712		10.1001/jama.2011.152	http://dx.doi.org/10.1001/jama.2011.152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325189				2022-12-01	WOS:000287361100024
J	Sabatino, CP				Sabatino, Charles P.			Damage Prevention and Control for Financial Incapacity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Amer Bar Assoc, Commiss Law & Aging, Washington, DC 20005 USA		Sabatino, CP (corresponding author), Amer Bar Assoc, Commiss Law & Aging, 740 15th St NW, Washington, DC 20005 USA.	charles.sabatino@americanbar.org						American Bar Association American Psychological Association, ASS OLD AD DIM CAP H; *CA BANK ASS, SPOT ELD FIN AB; *FIN IND REG AUTH, ELELC158 FIN IND REG; STIEGEL LA, 2008, POWER ATTORNEY ABUSE, P8; *VA POL I STAT U C, 2009, BROK TRUST ELD FAM F	5	7	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					707	708		10.1001/jama.2011.187	http://dx.doi.org/10.1001/jama.2011.187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325187				2022-12-01	WOS:000287361100022
J	Royal, CDM				Royal, Charmaine D. M.			My Genome, My Identity, My Health	SCIENCE			English	Editorial Material									[Royal, Charmaine D. M.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Royal, Charmaine D. M.] Duke Univ, Dept African & African Amer Studies, Durham, NC USA	Duke University; Duke University	Royal, CDM (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	691		10.1126/science.1203123	http://dx.doi.org/10.1126/science.1203123			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310996				2022-12-01	WOS:000287205700042
J	Berger, MF; Lawrence, MS; Demichelis, F; Drier, Y; Cibulskis, K; Sivachenko, AY; Sboner, A; Esgueva, R; Pflueger, D; Sougnez, C; Onofrio, R; Carter, SL; Park, K; Habegger, L; Ambrogio, L; Fennell, T; Parkin, M; Saksena, G; Voet, D; Ramos, AH; Pugh, TJ; Wilkinson, J; Fisher, S; Winckler, W; Mahan, S; Ardlie, K; Baldwin, J; Simons, JW; Kitabayashi, N; MacDonald, TY; Kantoff, PW; Chin, L; Gabriel, SB; Gerstein, MB; Golub, TR; Meyerson, M; Tewari, A; Lander, ES; Getz, G; Rubin, MA; Garraway, LA				Berger, Michael F.; Lawrence, Michael S.; Demichelis, Francesca; Drier, Yotam; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sboner, Andrea; Esgueva, Raquel; Pflueger, Dorothee; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Park, Kyung; Habegger, Lukas; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Simons, Jonathan W.; Kitabayashi, Naoki; MacDonald, Theresa Y.; Kantoff, Philip W.; Chin, Lynda; Gabriel, Stacey B.; Gerstein, Mark B.; Golub, Todd R.; Meyerson, Matthew; Tewari, Ashutosh; Lander, Eric S.; Getz, Gad; Rubin, Mark A.; Garraway, Levi A.			The genomic complexity of primary human prostate cancer	NATURE			English	Article							GENE FUSIONS; ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; HUMAN BREAST; PTEN; MUTATION; PATHWAY; REARRANGEMENTS; IMMUNOTHERAPY; TMPRSS2-ERG	Prostate cancer is the second most common cause of male cancer deaths in the United States. However, the full range of prostate cancer genomic alterations is incompletely characterized. Here we present the complete sequence of seven primary human prostate cancers and their paired normal counterparts. Several tumours contained complex chains of balanced (that is, 'copy-neutral') rearrangements that occurred within or adjacent to known cancer genes. Rearrangement breakpoints were enriched near open chromatin, androgen receptor and ERG DNA binding sites in the setting of the ETS gene fusion TMPRSS2-ERG, but inversely correlated with these regions in tumours lacking ETS fusions. This observation suggests a link between chromatin or transcriptional regulation and the genesis of genomic aberrations. Three tumours contained rearrangements that disrupted CADM2, and four harboured events disrupting either PTEN (unbalanced events), a prostate tumour suppressor, or MAGI2 (balanced events), a PTEN interacting protein not previously implicated in prostate tumorigenesis. Thus, genomic rearrangements may arise from transcriptional or chromatin aberrancies and engage prostate tumorigenic mechanisms.	[Demichelis, Francesca; Esgueva, Raquel; Pflueger, Dorothee; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Berger, Michael F.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Chin, Lynda; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Berger, Michael F.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Chin, Lynda; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] MIT, Cambridge, MA 02142 USA; [Demichelis, Francesca] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Sboner, Andrea; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Sboner, Andrea; Habegger, Lukas; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Ramos, Alex H.; Pugh, Trevor J.; Kantoff, Philip W.; Chin, Lynda; Meyerson, Matthew; Lander, Eric S.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pugh, Trevor J.; Kantoff, Philip W.; Chin, Lynda; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Simons, Jonathan W.] Prostate Canc Fdn, Santa Monica, CA 90401 USA; [Chin, Lynda] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Golub, Todd R.; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Inst Prostate Canc, Dept Urol, New York, NY 10065 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Lefrak Ctr Robot Surg, New York, NY 10065 USA; [Tewari, Ashutosh] New York Presbyterian Hosp, New York, NY 10065 USA; [Lander, Eric S.] 9 Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Cornell University; Weizmann Institute of Science; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Yale University; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Rubin, MA (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA.	rubinma@med.cornell.edu; levi_garraway@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Drier, Yotam/K-5208-2012; Cibulskis, Kristian/AAC-7380-2019; Pugh, Trevor/Y-2535-2019; Sboner, Andrea/C-6487-2008; Lawrence, Michael/AAC-8202-2020; Demichelis, Francesca/J-9829-2016	Drier, Yotam/0000-0003-1725-2995; Pugh, Trevor/0000-0002-8073-5888; Sboner, Andrea/0000-0001-6915-3070; Demichelis, Francesca/0000-0002-8266-8631; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108; Rubin, Mark/0000-0002-8321-9950; Simons, Jonathan/0000-0001-7660-0748; Kantoff, Philip/0000-0001-7275-0597	Prostate Cancer Foundation/Movember; Howard Hughes Medical Institute; National Human Genome Research Institute; Kohlberg Foundation; National Cancer Institute (NCI); NCI Early Detection Research Network; National Institutes of Health; Department of Defense; Dana-Farber/Harvard Cancer Center [2 P50 CA090381-11]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [P50CA090381, R33CA126674] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	Prostate Cancer Foundation/Movember; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Kohlberg Foundation; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Dana-Farber/Harvard Cancer Center; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Leung and all members of the Broad Institute Sequencing Platform. This work was supported by the Prostate Cancer Foundation/Movember (T. R. G., M. A. R., L. A. G.), the Howard Hughes Medical Institute (T. R. G.), the National Human Genome Research Institute (S. B. G., E. S. L.), the Kohlberg Foundation (P. W. K., L. A. G.), the National Cancer Institute (NCI; F. D., M. A. R., M. M.), the NCI Early Detection Research Network (M. A. R.), the National Institutes of Health (L. A. G.), the Department of Defense (F. D.), the Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE grant 2 P50 CA090381-11 (P. W. K.), and the Starr Cancer Consortium (M. F. B., F. D., M. A. R., L.A.G.).	Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006589; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	50	920	953	4	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					214	220		10.1038/nature09744	http://dx.doi.org/10.1038/nature09744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307934	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-01	WOS:000287144200035
J	Frey, BS				Frey, Bruno S.			Happy People Live Longer	SCIENCE			English	Editorial Material									[Frey, Bruno S.] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England; [Frey, Bruno S.] Univ Zurich, Dept Econ, CH-8032 Zurich, Switzerland	University of Warwick; University of Zurich	Frey, BS (corresponding author), Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England.	bruno.frey@econ.uzh.ch	Frey, Bruno/AAW-9103-2021	Holland, Sherri/0000-0003-2860-0668; tester22, sciencv/0000-0002-2791-7842				Danner DD, 2001, J PERS SOC PSYCHOL, V80, P804, DOI 10.1037/0022-3514.80.5.804; DIENER E, 2010, SSRN WORKING PAPER; Frey BrunoS., 2002, HAPPINESS EC; HOWELL RT, 2007, PSYCHOL REV, V1, P83; Layard R., 2005, HAPPINESS LESSONS NE; McQuinn A., 2008, MY FRIEND JAMAL; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Veenhoven R, 2008, J HAPPINESS STUD, V9, P449, DOI 10.1007/s10902-006-9042-1	8	33	36	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					542	543		10.1126/science.1201060	http://dx.doi.org/10.1126/science.1201060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292959				2022-12-01	WOS:000286933600033
J	Venter, JC				Venter, J. Craig			The Human Genome at 10: Successes and Challenges	SCIENCE			English	Editorial Material									[Venter, J. Craig] J Craig Venter Inst, Rockville, MD USA; [Venter, J. Craig] J Craig Venter Inst, San Diego, CA USA; [Venter, J. Craig] Synthet Genom Inc, La Jolla, CA USA	J. Craig Venter Institute; J. Craig Venter Institute	Venter, JC (corresponding author), J Craig Venter Inst, Rockville, MD USA.								0	18	19	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					546	547		10.1126/science.1202812	http://dx.doi.org/10.1126/science.1202812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292962				2022-12-01	WOS:000286933600038
J	Sosulski, DL; Bloom, ML; Cutforth, T; Axel, R; Datta, SR				Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert			Distinct representations of olfactory information in different cortical centres	NATURE			English	Article							TUFTED CELLS; BULB; PROJECTIONS; CORTEX; ODOR; ORGANIZATION; PATTERNS; SYSTEM; GENES; AXONS	Sensory information is transmitted to the brain where it must be processed to translate stimulus features into appropriate behavioural output. In the olfactory system, distributed neural activity in the nose is converted into a segregated map in the olfactory bulb(1-3). Here we investigate how this ordered representation is transformed in higher olfactory centres in mice. We have developed a tracing strategy to define the neural circuits that convey information from individual glomeruli in the olfactory bulb to the piriform cortex and the cortical amygdala. The spatial order in the bulb is discarded in the piriform cortex; axons from individual glomeruli project diffusely to the piriform without apparent spatial preference. In the cortical amygdala, we observe broad patches of projections that are spatially stereotyped for individual glomeruli. These projections to the amygdala are overlapping and afford the opportunity for spatially localized integration of information from multiple glomeruli. The identification of a distributive pattern of projections to the piriform and stereotyped projections to the amygdala provides an anatomical context for the generation of learned and innate behaviours.	[Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		Datta, Sandeep/0000-0002-8068-3862; Axel, Richard/0000-0002-3141-4076	Burroughs Wellcome Fund; National Institutes of Health [DP2-OD-007109]; Howard Hughes Medical Institute; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007109] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the R.A. and S.R.D. laboratories for comments and advice, B. Shykind for mice with GFP-labelled olfactory receptor neurons, S. X. Luo for image alignment advice, D. M. Bear for cross-correlation analysis advice, D. Padfield for Matlab code, R. Wilson for comments on the manuscript and P. Kisloff for manuscript preparation assistance. Financial support was provided by a Helen Hay Whitney Foundation Fellowship, a Career Award in the Medical Sciences grant from the Burroughs Wellcome Fund, and funding from the National Institutes of Health through the NIH Director's New Innovator Award Program (DP2-OD-007109) (S.R.D.), a Ruth L. Kirschstein National Research Service Award predoctoral fellowship from the National Institutes of Health (D.L.S.), and the Howard Hughes Medical Institute and a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative (R.A.).	BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; DEOLMOS J, 1978, J COMP NEUROL, V181, P213, DOI 10.1002/cne.901810202; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Niimura Y, 2005, GENE, V346, P23, DOI 10.1016/j.gene.2004.09.027; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1981, J NEUROPHYSIOL, V46, P918, DOI 10.1152/jn.1981.46.5.918; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; SKEEN LC, 1977, J COMP NEUROL, V172, P1, DOI 10.1002/cne.901720102; SLOTNICK BM, 1985, BEHAV NEUROSCI, V99, P956, DOI 10.1037/0735-7044.99.5.956; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306	31	301	308	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					213	216		10.1038/nature09868	http://dx.doi.org/10.1038/nature09868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451525	Green Accepted			2022-12-01	WOS:000289469100041
J	Andrews, JR; Basu, S				Andrews, Jason R.; Basu, Sanjay			Transmission dynamics and control of cholera in Haiti: an epidemic model	LANCET			English	Article							ENDEMIC CHOLERA; BANGLADESH; OUTBREAK; EXPERTS; SCALE	Background Official projections of the cholera epidemic in Haiti have not incorporated existing disease trends or patterns of transmission, and proposed interventions have been debated without comparative estimates of their effect. We used a mathematical model of the epidemic to provide projections of future morbidity and mortality, and to Produce comparative estimates of the effects of proposed interventions. Methods We designed mathematical models of cholera transmission based on existing models and fitted them to incidence data reported in Haiti for each province from Oct 31, 2010, to Jan 24, 2011. We then simulated future epidemic trajectories from March 1 to Nov 30, 2011, to estimate the effect of clean water, vaccination, and enhanced antibiotic distribution programmes. Findings We project 779 000 cases of cholera in Haiti (95% CI 599 000-914 000) and 11 100 deaths (7300-17 400) between March 1 and Nov 30, 2011. We expect that a 1% per week reduction in consumption of contaminated water would avert 105 000 cases (88 000-116 000) and 1500 deaths (1100-2300). We predict that the vaccination of 10% of the population, from March 1, will avert 63 000 cases (48 000-78 000) and 900 deaths (600-1500). The proposed extension of the use of antibiotics to all patients with severe dehydration and half of patients with moderate dehydration is expected to avert 9000 cases (8000-10 000) and 1300 deaths (900-2000). Interpretation A decline in cholera prevalence in early 2011 is part of the natural course of the epidemic, and should not be interpreted as indicative of successful intervention. Substantially more cases of cholera are expected than official estimates used for resource allocation. Combined, clean water provision, vaccination, and expanded access to antibiotics might avert thousands of deaths.	[Andrews, Jason R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Andrews, Jason R.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02114 USA; [Basu, Sanjay] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Andrews, JR (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Cox 5, Boston, MA 02114 USA.	jandrews6@partners.org		Andrews, Jason/0000-0002-5967-251X	National Institutes of Health (NIGMS) [U54 GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JRA is supported by the National Institutes of Health (NIGMS grant number U54 GM088558). This report is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank Marc Lipsitch for his helpful comments.	Alam A, 2005, INFECT IMMUN, V73, P6674, DOI 10.1128/IAI.73.10.6674-6679.2005; Anh Dang Duc, 2011, PLoS Negl Trop Dis, V5, pe1006, DOI 10.1371/journal.pntd.0001006; CLAYTON E, 2011, HAITI PROGR REPORT 2; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; Cyranoski D, 2011, NATURE, V469, P273, DOI 10.1038/469273a; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; FOX B, 2011, CHOLERA TAKES BREATH; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; International Federation of Red Cross and Red Crescent Societies, 2011, HAIT DOM REP CHOL OU; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Lawoyin TO, 1999, EUR J EPIDEMIOL, V15, P367, DOI 10.1023/A:1007547117763; Longini IM, 2002, J INFECT DIS, V186, P246, DOI 10.1086/341206; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Luby SP, 2008, AM J TROP MED HYG, V78, P382, DOI 10.4269/ajtmh.2008.78.382; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Neilan RLM, 2010, B MATH BIOL, V72, P2004, DOI 10.1007/s11538-010-9521-8; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Sullivan CA, 2003, NAT RESOUR FORUM, V27, P189, DOI 10.1111/1477-8947.00054; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Thiem VD, 2006, VACCINE, V24, P4297, DOI 10.1016/j.vaccine.2006.03.008; United Nations Office for the Coordination of Humanitarian Affairs, 2010, CHOL INT RESP STRAT; Walton DA, 2011, NEW ENGL J MED, V364, P3, DOI 10.1056/NEJMp1012997; WHO/UNICEF-Joint Monitoring Program, 2010, PROGR SAN DRINK WAT; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117; World Health Organization, 2010, 107 WHO; Zarocostas J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d23	34	131	137	3	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1248	1255		10.1016/S0140-6736(11)60273-0	http://dx.doi.org/10.1016/S0140-6736(11)60273-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21414658	Green Accepted			2022-12-01	WOS:000289597300031
J	Colson, JW; Woll, AR; Mukherjee, A; Levendorf, MP; Spitler, EL; Shields, VB; Spencer, MG; Park, J; Dichtel, WR				Colson, John W.; Woll, Arthur R.; Mukherjee, Arnab; Levendorf, Mark P.; Spitler, Eric L.; Shields, Virgil B.; Spencer, Michael G.; Park, Jiwoong; Dichtel, William R.			Oriented 2D Covalent Organic Framework Thin Films on Single-Layer Graphene	SCIENCE			English	Article							LARGE-AREA; CRYSTALLINE	Covalent organic frameworks (COFs), in which molecular building blocks form robust microporous networks, are usually synthesized as insoluble and unprocessable powders. We have grown two-dimensional (2D) COF films on single-layer graphene (SLG) under operationally simple solvothermal conditions. The layered films stack normal to the SLG surface and show improved crystallinity compared with COF powders. We used SLG surfaces supported on copper, silicon carbide, and transparent fused silica (SiO2) substrates, enabling optical spectroscopy of COFs in transmission mode. Three chemically distinct COF films grown on SLG exhibit similar vertical alignment and long-range order, and two of these are of interest for organic electronic devices for which thin-film formation is a prerequisite for characterizing their optoelectronic properties.	[Colson, John W.; Mukherjee, Arnab; Levendorf, Mark P.; Spitler, Eric L.; Park, Jiwoong; Dichtel, William R.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Shields, Virgil B.; Spencer, Michael G.] Cornell Univ, Dept Elect Engn, Ithaca, NY 14853 USA; [Woll, Arthur R.] Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; [Park, Jiwoong] Cornell Univ, Kavli Inst Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Dichtel, WR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA.	wdichtel@cornell.edu	Park, Jiwoong/C-2327-2013; Spencer, Michael/AAV-5283-2020; Dichtel, William R/A-5503-2009	Spencer, Michael/0000-0003-0914-9218; Dichtel, William R/0000-0002-3635-6119; Woll, Arthur/0000-0001-8925-2199	Cornell University; NSF [CHE-0847926, CHE-0936988]; NIH/National Institute of General Medical Sciences under NSF [DMR-0936384]; NSF Materials Research Science and Engineering Centers [DMR-0520404]	Cornell University; NSF(National Science Foundation (NSF)); NIH/National Institute of General Medical Sciences under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF Materials Research Science and Engineering Centers(National Science Foundation (NSF))	This research was supported by startup funds provided by Cornell University and the NSF-funded CCI-I Center for Molecular Interfacing (CHE-0847926). This work is based on research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the NSF and the NIH/National Institute of General Medical Sciences under NSF award DMR-0936384. We also made use of the Cornell Center for Materials Research facilities with support from the NSF Materials Research Science and Engineering Centers program (DMR-0520404). J.W.C. thanks the NSF for the award of a Graduate Research Fellowship; E. L. S. thanks the NSF for the award of the American Competitiveness in Chemistry postdoctoral fellowship (CHE-0936988); and M. G. S. (FA9550-07-1-0332) and J.P. (FA9550-09-1-0691) thank the Air Force Office of Scientific Research. We thank D. Smilgies for helpful discussions and K. Cox for technical illustration assistance. A provisional patent application based on this work has been filed by Cornell University (USA 61/382,093).	Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/NNANO.2010.132, 10.1038/nnano.2010.132]; Baker JL, 2010, LANGMUIR, V26, P9146, DOI 10.1021/la904840q; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Cote AP, 2007, J AM CHEM SOC, V129, P12914, DOI 10.1021/ja0751781; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Ding XS, 2011, ANGEW CHEM INT EDIT, V50, P1289, DOI 10.1002/anie.201005919; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Gourdon A, 2008, ANGEW CHEM INT EDIT, V47, P6950, DOI 10.1002/anie.200802229; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Kumar A, 2010, ACS NANO, V4, P11, DOI 10.1021/nn901903b; Levendorf MP, 2009, NANO LETT, V9, P4479, DOI 10.1021/nl902790r; Li XS, 2009, NANO LETT, V9, P4359, DOI 10.1021/nl902623y; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lukose B, 2011, CHEM-EUR J, V17, P2388, DOI 10.1002/chem.201001290; Mayer AC, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(07)70276-6; Perepichka DF, 2009, SCIENCE, V323, P216, DOI 10.1126/science.1165429; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Smilgies DM, 2007, J APPL CRYSTALLOGR, V40, P716, DOI 10.1107/S0021889807023382; Smilgies DM, 2009, J APPL CRYSTALLOGR, V42, P1030, DOI [10.1107/S0021889809040126, 10.1107/S00218898090401]; Spitler EL, 2010, NAT CHEM, V2, P672, DOI [10.1038/nchem.695, 10.1038/NCHEM.695]; Tilford RW, 2006, CHEM MATER, V18, P5296, DOI 10.1021/cm061177g; Veld MI, 2008, CHEM COMMUN, P1536, DOI 10.1039/b718865j; Wan S, 2008, ANGEW CHEM INT EDIT, V47, P8826, DOI 10.1002/anie.200803826; Wan S, 2009, ANGEW CHEM INT EDIT, V48, P5439, DOI 10.1002/anie.200900881; Zwaneveld NAA, 2008, J AM CHEM SOC, V130, P6678, DOI 10.1021/ja800906f	27	823	845	79	1917	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					228	231		10.1126/science.1202747	http://dx.doi.org/10.1126/science.1202747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474758				2022-12-01	WOS:000289251100049
J	Kaiser, WJ; Upton, JW; Long, AB; Livingston-Rosanoff, D; Daley-Bauer, LP; Hakem, R; Caspary, T; Mocarski, ES				Kaiser, William J.; Upton, Jason W.; Long, Alyssa B.; Livingston-Rosanoff, Devon; Daley-Bauer, Lisa P.; Hakem, Razqallah; Caspary, Tamara; Mocarski, Edward S.			RIP3 mediates the embryonic lethality of caspase-8-deficient mice	NATURE			English	Article							RECEPTOR-INTERACTING PROTEIN; HOMOTYPIC INTERACTION MOTIF; CELL-DEATH; PROGRAMMED NECROSIS; IMMUNE-SYSTEM; TNF-ALPHA; T-CELLS; IN-VIVO; CASPASE-8; EXPRESSION	Apoptosis and necroptosis are complementary pathways controlled by common signalling adaptors, kinases and proteases; among these, caspase-8 (Casp8) is critical for death receptor-induced apoptosis. This caspase has also been implicated in non-apoptotic pathways that regulate Fas-associated via death domain (FADD)dependent signalling and other less defined biological processes as diverse as innate immune signalling and myeloid or lymphoid differentiation patterns(1). Casp8 suppresses RIP3-RIP1 (also known as RIPK3-RIPK1) kinase complex-dependent(2-4) necroptosis(5) that follows death receptor activation as well as a RIP3-dependent, RIP(1)-independent necrotic pathway that has emerged as a host defence mechanism against murine cytomegalovirus(6). Disruption of Casp8 expression leads to embryonic lethality in mice between embryonic days 10.5 and 11.5 (ref. 7). Thus, Casp8 may naturally hold alternative RIP3-dependent death pathways in check in addition to promoting apoptosis. We find that RIP3 is responsible for the mid-gestational death of Casp8-deficient embryos. Remarkably, Casp8(-/-)Rip3(-/-) double mutant mice are viable and mature into fertile adults with a full immune complement of myeloid and lymphoid cell types. These mice seem immunocompetent but develop lymphadenopathy by four months of age marked by accumulation of abnormal T cells in the periphery, a phenotype reminiscent of mice with Fas-deficiency (lpr/lpr; also known as Fas). Thus, Casp8 contributes to homeostatic control in the adult immune system; however, RIP3 and Casp8 are together completely dispensable for mammalian development.	[Kaiser, William J.; Upton, Jason W.; Livingston-Rosanoff, Devon; Daley-Bauer, Lisa P.; Mocarski, Edward S.] Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Long, Alyssa B.; Caspary, Tamara] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Hakem, Razqallah] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Hakem, Razqallah] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Emory University; Emory University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kaiser, WJ (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	wkaiser@emory.edu	Mocarski, Edward/ABC-2893-2020; Caspary, Tamara/AAH-5625-2020; Long, Alyssa/AAN-8497-2020; Kaiser, William/A-3079-2012	Caspary, Tamara/0000-0002-6579-7589; Long, Alyssa/0000-0002-4467-4213; Daley-Bauer, Lisa/0000-0002-3377-7989; Upton, Jason/0000-0002-4218-4026; Hakem, Razqallah/0000-0001-5948-7931	Georgia Cancer Coalition; NIH [R01 AI20211, AI30363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030363, R21AI030363, R01AI020211, R56AI030363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER	Georgia Cancer Coalition; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge D. Green, A. Oberst and C. Dillon for their discussions and material support. We thank V. Dixit and K. Newton for RIP32/2 mice, A. Kowalczyk, R. Oas, S. Speck and R. Ahmed for providing reagents, T. Kaufmann for technical advice, C. Strauss for editing, and A. L. McCormick for discussion and comments on the manuscript. Additionally, we appreciate M. Dowdy and J. Perry for mouse colony maintenance. This work was supported by the Georgia Cancer Coalition and the NIH (PHS grants R01 AI20211 and AI30363 to E. S. M.).	Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; LAOUAR Y, 1994, J IMMUNOL, V153, P3948; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; McCormick AL, 2003, VIROLOGY, V316, P221, DOI 10.1016/j.virol.2003.07.003; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	30	739	762	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					368	+		10.1038/nature09857	http://dx.doi.org/10.1038/nature09857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368762	Green Accepted			2022-12-01	WOS:000288444000043
J	Wang, F; Mei, ZQ; Qi, YT; Yan, CY; Hu, Q; Wang, JW; Shi, YG				Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong			Structure and mechanism of the hexameric MecA-ClpC molecular machine	NATURE			English	Article							RAY-DIFFRACTION DATA; CRYSTAL-STRUCTURE; HSP100 CHAPERONE; PROTEIN; ADAPTER; DOMAIN; RECOGNITION; COMPETENCE; COMPLEX; DISAGGREGATION	Regulated proteolysis by ATP-dependent proteases is universal in all living cells. Bacterial ClpC, a member of the Clp/Hsp100 family of AAA1 proteins (ATPases associated with diverse cellular activities) with two nucleotide-binding domains (D1 and D2), requires the adaptor protein MecA for activation and substrate targeting. The activated, hexameric MecA-ClpC molecular machine harnesses the energy of ATP binding and hydrolysis to unfold specific substrate proteins and translocate the unfolded polypeptide to the ClpP protease for degradation. Here we report three relatedcrystal structures: a heterodimer between MecA and the amino domain of ClpC, a heterododecamer between MecA and D2-deleted ClpC, and a hexameric complex between MecA and full-length ClpC. In conjunction with biochemical analyses, these structures reveal the organizational principles behind the hexameric MecA-ClpC complex, explain the molecular mechanisms for MecA-mediated ClpC activation and provide mechanistic insights into the function of the MecA-ClpC molecular machine. These findings have implications for related Clp/Hsp100 molecular machines.	[Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wang, JW (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China.	jwwang@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Mei, Ziqing/AHD-6788-2022; Yan, Chuangye/AAJ-5832-2021; Wang, Feng/AAC-6221-2022	Wang, Jiawei/0000-0001-9893-8539; Mei, Ziqing/0000-0001-8554-6309; Wang, Feng/0000-0002-9403-4337; Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048	National Natural Science Foundation of China [30888001]; China Postdoctoral Science Foundation [023201058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank J. He and S. Huang at Shanghai Synchrotron Radiation Source and staff at the SPring-8 beamline BL41XU for help. This work was supported by Project 30888001 of the National Natural Science Foundation of China (Y.S.) and Postdoctoral Fellowship # 023201058 from the China Postdoctoral Science Foundation (Z.M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Bruker, 2003, SAINT SADABS XPREP S; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLano W.L., 2002, PYMOL MOL VIEWER; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lee S, 2004, J STRUCT BIOL, V146, P99, DOI 10.1016/j.jsb.2003.11.016; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; Wang F, 2009, J BIOL CHEM, V284, P34376, DOI 10.1074/jbc.M109.053033; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2010, BIOCHEM CELL BIOL, V88, P89, DOI [10.1139/O09-164, 10.1139/o09-164]; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	49	102	105	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					331	+		10.1038/nature09780	http://dx.doi.org/10.1038/nature09780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368759				2022-12-01	WOS:000288444000035
J	Shen, WL; Kwon, Y; Adegbola, AA; Luo, JJ; Chess, A; Montell, C				Shen, Wei L.; Kwon, Young; Adegbola, Abidemi A.; Luo, Junjie; Chess, Andrew; Montell, Craig			Function of Rhodopsin in Temperature Discrimination in Drosophila	SCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; PHOSPHOLIPASE-C; G-PROTEIN; THERMOSENSATION; PHOTOTRANSDUCTION; RECEPTOR	Many animals, including the fruit fly, are sensitive to small differences in ambient temperature. The ability of Drosophila larvae to choose their ideal temperature (18 degrees C) over other comfortable temperatures (19 degrees to 24 degrees C) depends on a thermosensory signaling pathway that includes a heterotrimeric guanine nucleotide-binding protein (G protein), a phospholipase C, and the transient receptor potential TRPA1 channel. We report that mutation of the gene (ninaE) encoding a classical G protein-coupled receptor (GPCR), Drosophila rhodopsin, eliminates thermotactic discrimination in the comfortable temperature range. This role for rhodopsin in thermotaxis toward 18 degrees C was light-independent. Introduction of mouse melanopsin restored normal thermotactic behavior in ninaE mutant larvae. We propose that rhodopsins represent a class of evolutionarily conserved GPCRs that are required for initiating thermosensory signaling cascades.	[Shen, Wei L.; Kwon, Young; Luo, Junjie; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Shen, Wei L.; Kwon, Young; Luo, Junjie; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Adegbola, Abidemi A.; Chess, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Adegbola, Abidemi A.; Chess, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; [Chess, Andrew] Broad Inst, Cambridge, MA 02142 USA; [Chess, Andrew] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Chess, Andrew] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	shen, wei/C-2311-2013; Luo, Junjie/L-3285-2019; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Kwon, Young/0000-0002-8937-3182	National Institute of General Medical Sciences, NIH [GM085335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085335] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Liu for advice with the statistical analyses, the Bloomington Stock Center, FlyBase, and the Harvard TRiP. A. A. A. received support from a NARSAD Young Investigator Award. This study was supported by a grant to C. M. from the National Institute of General Medical Sciences, NIH (GM085335).	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Kwon Y, 2010, J NEUROSCI, V30, P10465, DOI 10.1523/JNEUROSCI.1631-10.2010; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; STRANGE PH, 1961, J EXP BIOL, V38, P237; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081	21	147	152	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1333	1336		10.1126/science.1198904	http://dx.doi.org/10.1126/science.1198904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393546				2022-12-01	WOS:000288215200049
J	Cheung, ACM; Cramer, P				Cheung, Alan C. M.; Cramer, Patrick			Structural basis of RNA polymerase II backtracking, arrest and reactivation	NATURE			English	Article							CLEAVAGE FACTOR TFIIS; TRANSCRIPT-CLEAVAGE; ELONGATION COMPLEX; DNA HYBRID; ANGSTROM RESOLUTION; TRIGGER LOOP; MECHANISM; SITE; TRANSLOCATION; ARCHITECTURE	During gene transcription, RNA polymerase (Pol) II moves forwards along DNA and synthesizes messenger RNA. However, at certain DNA sequences, Pol II moves backwards, and such backtracking can arrest transcription. Arrested Pol II is reactivated by transcription factor IIS (TFIIS), which induces RNA cleavage that is required for cell viability(1). Pol II arrest and reactivation are involved in transcription through nucleosomes(2,3) and in promoter-proximal gene regulation(4-6). Here we present X-ray structures at 3.3 angstrom resolution of an arrested Saccharomyces cerevisiae Pol II complex with DNA and RNA, and of a reactivation intermediate that additionally contains TFIIS. In the arrested complex, eight nucleotides of backtracked RNA bind a conserved 'backtrack site' in the Pol II pore and funnel, trapping the active centre trigger loop and inhibiting mRNA elongation. In the reactivation intermediate, TFIIS locks the trigger loop away from backtracked RNA, displaces RNA from the backtrack site, and complements the polymerase active site with a basic and two acidic residues that may catalyse proton transfers during RNA cleavage. The active site is demarcated from the backtrack site by a 'gating tyrosine' residue that probably delimits backtracking. These results establish the structural basis of Pol II backtracking, arrest and reactivation, and provide a framework for analysing gene regulation during transcription elongation.	[Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Gene Ctr, D-81377 Munich, Germany; [Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de		Cheung, Alan/0000-0001-6430-5127	Deutsche Forschungsgemeinschaft [SFB646, TR5, FOR1068]; NIM; Bioimaging Network BIN; Jung-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIM; Bioimaging Network BIN; Jung-Stiftung	We thank F. Brueckner, G. Damsma, K. Kinkelin, D. Kostrewa, L. Lariviere, E. Lehmann, F. Martinez, S. Sainsbury and J. Sydow. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland. P.C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, FOR1068, NIM, Bioimaging Network BIN, and the Jung-Stiftung.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GU WG, 1993, J BIOL CHEM, V268, P25604; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; SLUDER AE, 1988, J BIOL CHEM, V263, P9917; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	30	239	241	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					249	253		10.1038/nature09785	http://dx.doi.org/10.1038/nature09785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21346759				2022-12-01	WOS:000288170200044
J	Schraidt, O; Marlovits, TC				Schraidt, Oliver; Marlovits, Thomas C.			Three-Dimensional Model of Salmonella's Needle Complex at Subnanometer Resolution	SCIENCE			English	Article							III SECRETION SYSTEM; TRANSMISSION ELECTRON-MICROSCOPY; PHAGE PIV MULTIMER; STRUCTURAL INSIGHTS; SHIGELLA-FLEXNERI; APPARATUS; ORGANIZATION; TYPHIMURIUM; COMPONENT; REVEALS	Type III secretion systems (T3SSs) are essential virulence factors used by many Gram-negative bacteria to inject proteins that make eukaryotic host cells accessible to invasion. The T3SS core structure, the needle complex (NC), is a similar to 3.5 megadalton-sized, oligomeric, membrane-embedded complex. Analyzing cryo-electron microscopy images of top views of NCs or NC substructures from Salmonella typhimurium revealed a 24-fold symmetry for the inner rings and a 15-fold symmetry for the outer rings, giving an overall C3 symmetry. Local refinement and averaging showed the organization of the central core and allowed us to reconstruct a subnanometer composite structure of the NC, which together with confident docking of atomic structures reveal insights into its overall organization and structural requirements during assembly.	[Schraidt, Oliver; Marlovits, Thomas C.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Schraidt, Oliver; Marlovits, Thomas C.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Marlovits, TC (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	marlovits@imp.ac.at	Schraidt, Oliver/ABE-3650-2020; Marlovits, Thomas/A-3568-2019	Marlovits, Thomas/0000-0001-8106-4038; Schraidt, Oliver/0000-0001-8114-3713	Boehringer Ingelheim Fonds; Zentrum fur Innovation und Technologie (ZIT); Center for Molecular and Cellular Nanostructure Vienna (CMCN)	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Zentrum fur Innovation und Technologie (ZIT); Center for Molecular and Cellular Nanostructure Vienna (CMCN)	We would like to thank G. Resch for collaborating on the development of a semi-automated image acquisition software, the Institute of Molecular Pathology/Institute of Molecular Biotechnology/Gregor Mendel Institute (IMP/IMBA/GMI) EM and bioinformatics facility for technical support, W. Weber for generating and analyzing the mutational analysis, and all members of the Marlovits laboratory for critically reading the manuscript. We furthermore would like to thank J. E. Galan (Yale University) and members of his laboratory for continuous discussion, generous support, and materials. This work was supported by a Ph.D. fellowship from Boehringer Ingelheim Fonds (to O.S.) and a research grant from the Zentrum fur Innovation und Technologie (ZIT), Center for Molecular and Cellular Nanostructure Vienna (CMCN) (to T.C.M.). Accession numbers are EMD-1871, EMD-1874, EMD-1875, and PDB ID code 2Y9K and 2Y9J.	Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554	24	162	164	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1192	1195		10.1126/science.1199358	http://dx.doi.org/10.1126/science.1199358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385715				2022-12-01	WOS:000287971200042
J	Zinzalla, V; Stracka, D; Oppliger, W; Hall, MN				Zinzalla, Vittoria; Stracka, Daniele; Oppliger, Wolfgang; Hall, Michael N.			Activation of mTORC2 by Association with the Ribosome	CELL			English	Article							ENDOPLASMIC-RETICULUM; MAMMALIAN TARGET; CELL-GROWTH; COMPLEX 2; TRANSLATION INITIATION; MOTIF PHOSPHORYLATION; AKT PHOSPHORYLATION; BINDING PARTNER; KINASE-B; RAPAMYCIN	The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of growth. Mammalian TOR complex 2 (mTORC2) regulates AGC kinase family members and is implicated in various disorders, including cancer and diabetes. Here, we investigated the upstream regulation of mTORC2. A genetic screen in yeast and subsequent studies in mammalian cells revealed that ribosomes, but not protein synthesis, are required for mTORC2 signaling. Active mTORC2 was physically associated with the ribosome, and insulin-stimulated PI3K signaling promoted mTORC2-ribosome binding, suggesting that ribosomes activate mTORC2 directly. Findings with melanoma and colon cancer cells suggest that mTORC2-ribosome association is important in oncogenic PI3K signaling. Thus, TORC2-ribosome interaction is a likely conserved mechanism of TORC2 activation that is physiologically relevant in both normal and cancer cells. As ribosome content determines growth capacity of a cell, this mechanism of TORC2 regulation ensures that TORC2 is active only in growing cells.	[Zinzalla, Vittoria; Stracka, Daniele; Oppliger, Wolfgang; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch		Hall, Michael N/0000-0002-2998-0757	Swiss National Science Foundation, SystemsX.ch; Swiss Cancer League; Louis Jeantet Foundation; Canton of Basel	Swiss National Science Foundation, SystemsX.ch(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Louis Jeantet Foundation; Canton of Basel	We thank Rachel Idol and Stefano Grosso for valuable discussions and technical assistance and Giulio Spagnoli for the melanoma cell lines. We acknowledge support from the Swiss National Science Foundation, SystemsX.ch, the Swiss Cancer League, the Louis Jeantet Foundation, and the Canton of Basel. We declare that no competing interests exist.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Certa U, 2001, BRIT J CANCER, V85, P107, DOI 10.1054/bjoc.2001.1865; Chiocchetti A, 2005, HAEMATOLOGICA, V90, P1453; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DESCHODTLANCKMAN M, 1990, INT J CANCER, V46, P1124, DOI 10.1002/ijc.2910460629; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gervois N, 1996, J EXP MED, V183, P2403, DOI 10.1084/jem.183.5.2403; Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463; Grossso S, 2008, BIOCHEM BIOPH RES CO, V376, P65, DOI 10.1016/j.bbrc.2008.08.118; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He HN, 2010, CANCER LETT, V295, P38, DOI 10.1016/j.canlet.2010.02.011; Helliwell SB, 1998, GENETICS, V148, P99; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stahl JM, 2003, CANCER RES, V63, P2881; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001	71	481	508	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					757	768		10.1016/j.cell.2011.02.014	http://dx.doi.org/10.1016/j.cell.2011.02.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376236	Bronze			2022-12-01	WOS:000288007100014
J	Seshasai, SRK; Kaptoge, S; Thompson, A; Di Angelantonio, E; Gao, P; Sarwar, N; Whincup, PH; Mukamal, KJ; Gillum, RF; Holme, I; Njolstad, I; Fletcher, A; Nilsson, P; Lewington, S; Collins, R; Gudnason, V; Thompson, SG; Sattar, N; Selvin, E; Hu, FB; Danesh, J				Seshasai, Sreenivasa Rao Kondapally; Kaptoge, Stephen; Thompson, Alexander; Di Angelantonio, Emanuele; Gao, Pei; Sarwar, Nadeem; Whincup, Peter H.; Mukamal, Kenneth J.; Gillum, Richard F.; Holme, Ingar; Njolstad, Inger; Fletcher, Astrid; Nilsson, Peter; Lewington, Sarah; Collins, Rory; Gudnason, Vilmundur; Thompson, Simon G.; Sattar, Naveed; Selvin, Elizabeth; Hu, Frank B.; Danesh, John		Emerging Risk Factors Collabora	Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANCER-MORTALITY; ASSOCIATION; METAANALYSIS; INSULIN	BACKGROUND The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.)	[Whincup, Peter H.] St Georges Univ London, London, England; [Gillum, Richard F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Holme, Ingar] Ullevaal Univ Hosp, Oslo, Norway; [Njolstad, Inger] Univ Tromso, Tromso, Norway; [Fletcher, Astrid] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Nilsson, Peter] Lund Univ, Lund, Sweden; [Lewington, Sarah; Collins, Rory] Univ Oxford, F Med Sci, Oxford, England; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Gudnason, Vilmundur] Iceland Heart Assoc, Reykjavik, Iceland; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Sattar, Naveed] Univ Glasgow, Glasgow, Lanark, Scotland; [Selvin, Elizabeth] Johns Hopkins Univ, Baltimore, MD USA; [Hu, Frank B.] Harvard Univ, Boston, MA 02115 USA	St Georges University London; Centers for Disease Control & Prevention - USA; University of Oslo; UiT The Arctic University of Tromso; University of London; London School of Hygiene & Tropical Medicine; Lund University; University of Oxford; University of Iceland; Icelandic Heart Association; MRC Biostatistics Unit; University of Glasgow; Johns Hopkins University; Harvard University			Mukamal, Kenneth/GVR-7978-2022; Marmot, M G/Y-3920-2019; vhmpp, aks/F-9756-2012; Gao, Pei/AAF-3065-2019; Brunner, Eric/H-2114-2011; Dankner, Rachel/Q-5245-2019; Gudnason, Vilmundur/AAE-7126-2019; Tanne, David/F-2560-2010; Bakker, Stephan J. L./J-4023-2015; Gao, Pei/R-4794-2018; Rubio, Miguel Angel/GRJ-0134-2022; Benn, Marianne/O-4164-2019; Gudnason, Vilmundur/K-6885-2015; Ulmer, Hanno/S-6615-2019; de la Camara, Agustin Gomez/S-7123-2018; Shaffer, Jonathan A/B-2783-2013; Lennon, Lucy/ABB-9433-2020; Njolstad, Inger/X-3784-2019; Meisinger, Christine/B-5358-2014; DiAngelantonio, Emanuele/ABE-6852-2020; Stefanadis, Christodoulos/ABH-2232-2020	Marmot, M G/0000-0002-2431-6419; Gao, Pei/0000-0001-8649-1290; Brunner, Eric/0000-0002-0595-4474; Dankner, Rachel/0000-0001-6454-6000; Gudnason, Vilmundur/0000-0001-5696-0084; Tanne, David/0000-0002-6699-2220; Bakker, Stephan J. L./0000-0003-3356-6791; Gao, Pei/0000-0001-8649-1290; Rubio, Miguel Angel/0000-0002-0495-6240; Benn, Marianne/0000-0002-1701-595X; Gudnason, Vilmundur/0000-0001-5696-0084; Ulmer, Hanno/0000-0001-5911-1002; Lennon, Lucy/0000-0002-1738-1351; Woodward, Mark/0000-0001-9800-5296; Stefanadis, Christodoulos/0000-0001-5974-6454; Pennells, Lisa Anne/0000-0002-8594-3061; Stehouwer, Coen/0000-0001-8752-3223; Rothenbacher, Dietrich/0000-0002-3563-2791; Ramachandran, Vasan/0000-0001-7357-5970; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Engstrom, Gunnar/0000-0002-8618-9152; Whincup, Peter/0000-0002-5589-4107; Di Angelantonio, Emanuele/0000-0001-8776-6719; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Nordestgaard, Borge/0000-0002-1954-7220; Lawlor, Debbie A/0000-0002-6793-2262; Tiemeier, Henning/0000-0002-4395-1397; Jorgensen, Torben/0000-0001-9453-2830; Bladbjerg, Else Marie/0000-0003-0912-2437; Amouyel, Philippe/0000-0001-9088-234X; Lewington, Sarah/0000-0002-4496-4771; Jespersen, Jorgen/0000-0002-3059-2356	British Heart Foundation [RG/08/014]; U.K. Medical Research Council; Pfizer; Gates Cambridge Trust; Overseas Research Studentship Award; Addenbrooke's Charitable Trust; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0902037, MC_U105260792, G0600705] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674, PG/09/002/26056, RG/08/014/24067, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G0100222, G0600705, MC_U137686857, G0401527, G1000143, MC_U105260792, G0902037, G8802774, G19/35] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Gates Cambridge Trust; Overseas Research Studentship Award; Addenbrooke's Charitable Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the British Heart Foundation (RG/08/014), the U.K. Medical Research Council, and Pfizer (to the ERFC Coordinating Centre), as well as the Gates Cambridge Trust Scholarship, an Overseas Research Studentship Award, and an Addenbrooke's Charitable Trust Clinical Research Fellowship (to Dr. Kondapally Seshasai). Various sources have supported recruitment, follow-up, and laboratory measurements in the cohorts contributing to the ERFC. Investigators of several of these studies have contributed to a list (http://ceu.phpc.cam.ac.uk/research/erfc/studies) naming relevant funding sources.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z; Chen SL, 2009, J UROLOGY, V182, pS51, DOI 10.1016/j.juro.2009.07.090; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dormandy J, 2009, DRUG SAFETY, V32, P187, DOI 10.2165/00002018-200932030-00002; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Emerging Risk Factors Collaboration, 2007, EUR J EPIDEMIOL, V22, P839, DOI DOI 10.1007/SL0654-007-9165-7; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gulliford MC, 2009, AM J EPIDEMIOL, V169, P455, DOI 10.1093/aje/kwn342; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jawa A, 2004, MED CLIN N AM, V88, P1001, DOI 10.1016/j.mcna.2004.04.012; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Pannala R, 2009, AM J GASTROENTEROL, V104, P2318, DOI 10.1038/ajg.2009.253; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; UN Population Division, 2005, WORLD POP PROSP; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Waters KM, 2009, AM J EPIDEMIOL, V169, P937, DOI 10.1093/aje/kwp003; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; World Health Organization, 2007, WHO STAT INF SYST WH; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	37	1751	1808	7	222	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					829	841		10.1056/NEJMoa1008862	http://dx.doi.org/10.1056/NEJMoa1008862			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366474	Green Accepted, Bronze			2022-12-01	WOS:000287928400008
J	Ioannou, GN				Ioannou, George N.			Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM IMMUNOGENICITY; VACCINATION; PREVENTION; DISEASES; BOOSTER; HEALTH	Background: Up-to-date estimates of the prevalence of hepatitis B virus (HBV) infection, exposure, and immunity are necessary to assess the effectiveness of ongoing programs aimed at preventing HBV transmission. Objective: To determine the prevalence and associations of chronic HBV infection, past exposure, and immunity in the United States from 1999 to 2008. Design: Nationally representative, cross-sectional household survey. Setting: U.S. civilian, noninstitutionalized population. Participants: 39 787 participants in the National Health and Nutrition Examination Survey (1999 to 2008) aged 2 years or older. Measurements: Chronic HBV infection was defined by presence of serum HBV surface antigen and past exposure by serum antibody to hepatitis B core antigen among persons aged 6 years or older. Infant immunity was defined by presence of serum antibody to hepatitis B surface antigen among children aged 2 years. Results: Among persons aged 6 years or older, 0.27% (95% CI, 0.20% to 0.34%) had chronic HBV infection (corresponding to approximately 704 000 persons nationwide), and 4.6% (CI, 4.1% to 5.0%) had been exposed to HBV (approximately 11 993 000 persons). These estimates are lower (P < 0.001) than estimates of HBV infection (0.42%) and exposure (5.1%) in the United States reported from 1988 to 1994. Infection and past exposure were very uncommon among persons aged 6 to 19 years. Children aged 2 years have high rates of immunity (68.6% [CI, 64.1% to 73.2%]). Adults, including those at high risk for infection, have much lower rates of immunity. Limitations: Incarcerated and homeless persons were not sampled. Categorization of race or ethnicity did not identify high-risk groups, such as persons of Asian and Pacific Islander descent. Conclusion: A cohort of children and adolescents is growing up in the United States with high rates of immunity against HBV and very low rates of infection. Vaccination of high-risk adults should continue to be emphasized.	[Ioannou, George N.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Ioannou, George N.] Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Ioannou, GN (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, S-111 Gastro,1660 S Columbian Way, Seattle, WA 98108 USA.	georgei@medicine.washington.edu			Veterans Affairs Research Enhancement Award Program	Veterans Affairs Research Enhancement Award Program	Grant Support: By the Veterans Affairs Research Enhancement Award Program.	Alter MJ, 2003, SEMIN LIVER DIS, V23, P39, DOI 10.1055/s-2003-37583; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P574; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P997; Cheung RC, 2002, J CLIN GASTROENTEROL, V34, P476, DOI 10.1097/00004836-200204000-00021; Dorell C., 2010, Morbidity and Mortality Weekly Report, V59, P1018; Gabbuti A, 2007, VACCINE, V25, P3129, DOI 10.1016/j.vaccine.2007.01.045; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goldstein ST, 2002, J INFECT DIS, V185, P713, DOI 10.1086/339192; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall AJ, 2010, HEPATOLOGY, V51, P1485, DOI 10.1002/hep.23674; Ioannou GN, 2007, CLIN GASTROENTEROL H, V5, P938, DOI 10.1016/j.cgh.2007.02.039; Kao JH, 2005, LANCET, V366, P1337, DOI 10.1016/S0140-6736(05)67544-7; Kaplan JE, 2009, MMWR RECOMM REP, V58, pCE1; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Lin YC, 2003, J INFECT DIS, V187, P134, DOI 10.1086/345871; Lu CY, 2008, J INFECT DIS, V197, P1419, DOI 10.1086/587695; McMahon BJ, 2005, ANN INTERN MED, V142, P333, DOI 10.7326/0003-4819-142-5-200503010-00008; McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14; Molinari N. A., 2009, Morbidity and Mortality Weekly Report, V58, P921; *NHANES, LAB PROC MAN ANT HEP; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; The National Health and Nutrition Examination Survey (NHANES), AN REP GUID; Urbani S, 2010, CLIN CHEM LAB MED, V48, P23, DOI 10.1515/CCLM.2010.002; US Census Bureau, US CENS 2000; Van Damme P, 2009, J MED VIROL, V81, P1710, DOI 10.1002/jmv.21568; Van Damme Pierre, 2007, Travel Med Infect Dis, V5, P79, DOI 10.1016/j.tmaid.2006.04.004; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171; Zanetti AR, 2005, LANCET, V366, P1379, DOI 10.1016/S0140-6736(05)67568-X	32	122	124	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					319	328		10.7326/0003-4819-154-5-201103010-00006	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357909				2022-12-01	WOS:000287799900004
J	Scepaniak, JJ; Vogel, CS; Khusniyarov, MM; Heinemann, FW; Meyer, K; Smith, JM				Scepaniak, Jeremiah J.; Vogel, Carola S.; Khusniyarov, Marat M.; Heinemann, Frank W.; Meyer, Karsten; Smith, Jeremy M.			Synthesis, Structure, and Reactivity of an Iron(V) Nitride	SCIENCE			English	Article							SPECTROSCOPIC CHARACTERIZATION; INTERSTITIAL ATOM; FEMO-COFACTOR; COMPLEX; NITROGENASE; MOSSBAUER; CATALYSIS; FIXATION; LIGAND; ENDOR	Despite being implicated as important intermediates, iron(V) compounds have proven very challenging to isolate and characterize. Here, we report the preparation of the iron(V) nitrido complex, [PhB((t)BuIm)(3)Fe-V N]BArF24 (PhB((t)BuIm)(3)(-) = phenyltris(3-tert-butylimidazol-2-ylidene)borato, BArF24 = B(3,5-(CF3)(2)C6H3)(4)(-)), by one electron oxidation of the iron(IV) nitrido precursor. Single-crystal x-ray diffraction of the iron(V) complex reveals a four-coordinate metal ion with a terminal nitrido ligand. Mossbauer and electron paramagnetic resonance spectroscopic characterization, supported by electronic structure calculations, provide evidence for a d(3) iron(V) metal center in a low spin (S = 1/2) electron configuration. Low-temperature reaction of the iron(V) nitrido complex with water under reducing conditions leads to high yields of ammonia with concomitant formation of an iron(II) species.	[Vogel, Carola S.; Khusniyarov, Marat M.; Heinemann, Frank W.; Meyer, Karsten] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany; [Scepaniak, Jeremiah J.; Smith, Jeremy M.] New Mexico State Univ, Dept Chem & Biochem, MSC 3C, Las Cruces, NM 88003 USA	University of Erlangen Nuremberg; New Mexico State University	Meyer, K (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Egerlandstr 1, D-91058 Erlangen, Germany.	KMeyer@chemie.uni-erlangen.de; jesmith@nmsu.edu	Smith, Jeremy M/H-5043-2012; Heinemann, Frank Wilhelm/AAC-3062-2022; Khusniyarov, Marat/O-7723-2016; Meyer, Karsten/G-2570-2012; Scepaniak, Jeremiah/I-5920-2015	Heinemann, Frank Wilhelm/0000-0002-9007-8404; Khusniyarov, Marat/0000-0002-2034-421X; Meyer, Karsten/0000-0002-7844-2998; Scepaniak, Jeremiah/0000-0002-0135-3954	Friedrich-Alexander-University Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; Department of Energy Office of Basic Energy Sciences [DE-FG02-08ER15996]; Camille and Henry Dreyfus Foundation	Friedrich-Alexander-University Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Camille and Henry Dreyfus Foundation	We acknowledge funding from Friedrich-Alexander-University Erlangen-Nuremberg and the Deutsche Forschungsgemeinschaft (K.M.); Fonds der Chemischen Industrie (M.M.K.); and the Department of Energy Office of Basic Energy Sciences (DE-FG02-08ER15996) and the Camille and Henry Dreyfus Foundation (J.M.S.). J. Sutter is gratefully acknowledged for collecting the spectroscopic data, and K. Wieghardt and E. Bill (Max-Planck-Institut for Bioinorganic Chemistry, Mulheim/Ruhr, Germany) for helpful discussions. The crystallographic data CCDC-786059 (2 at 35 K) and CCDC-786060 (2 at 100 K) can be obtained free at www.ccdc.cam.ac.uk/data_request/cif (or from Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK; fax: ++44-1223-336-033; e-mail: deposit@ccdc.cam.ac.uk).	Aliaga-Alcalde N, 2005, ANGEW CHEM INT EDIT, V44, P2908, DOI 10.1002/anie.200462368; Berry JF, 2006, SCIENCE, V312, P1937, DOI 10.1126/science.1128506; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Betley TA, 2004, J AM CHEM SOC, V126, P6252, DOI 10.1021/ja048713v; Chen K, 2002, J AM CHEM SOC, V124, P3026, DOI 10.1021/ja0120025; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Ertl G, 2001, CHEM REC, V1, P33; ERTL G, 1990, ANGEW CHEM INT EDIT, V29, P1219, DOI 10.1002/anie.199012191; Hendrich MP, 2006, P NATL ACAD SCI USA, V103, P17107, DOI 10.1073/pnas.0604402103; Herber R. H., 1984, CHEM MOSSBAUER SPECT; Hoffman BM, 2009, ACCOUNTS CHEM RES, V42, P609, DOI 10.1021/ar8002128; Jackson TA, 2008, J AM CHEM SOC, V130, P12394, DOI 10.1021/ja8022576; Lukoyanov D, 2007, INORG CHEM, V46, P11437, DOI 10.1021/ic7018814; Meyer K, 1999, J AM CHEM SOC, V121, P4859, DOI 10.1021/ja983454t; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Scepaniak JJ, 2008, J AM CHEM SOC, V130, P10515, DOI 10.1021/ja8027372; SCHULZ CE, 1987, J CHEM PHYS, V87, P5077, DOI 10.1063/1.453675; de Oliveira FT, 2007, SCIENCE, V315, P835, DOI 10.1126/science.1133417; Vogel C, 2008, ANGEW CHEM INT EDIT, V47, P2681, DOI 10.1002/anie.200800600; Yang TC, 2005, J AM CHEM SOC, V127, P12804, DOI 10.1021/ja0552489; YOUSIF AA, 1989, J PHYS-CONDENS MAT, V1, P7103, DOI 10.1088/0953-8984/1/39/022	22	227	229	7	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1049	1052		10.1126/science.1198315	http://dx.doi.org/10.1126/science.1198315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350172				2022-12-01	WOS:000287699000058
J	Wilding, JPH; Hardy, K				Wilding, John P. H.; Hardy, Kevin			Therapeutics Glucagon-like peptide-1 analogues for type 2 diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material							METFORMIN-TREATED PATIENTS; TWICE-DAILY EXENATIDE; OPEN-LABEL TRIAL; GLYCEMIC CONTROL; RANDOMIZED-TRIAL; INSULIN GLARGINE; PARALLEL-GROUP; LIRAGLUTIDE; SULFONYLUREA; EXENDIN-4					j.p.h.wilding@liv.ac.uk	Wilding, John/ABB-6443-2020; Wilding, John PH/A-7106-2008	Wilding, John/0000-0003-2839-8404; Wilding, John PH/0000-0003-2839-8404				Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; BUSE JB, 2002, TECHN APPR NAT I HLT, V203; Buse JB, 2010, DIABETES CARE, V33, P1300, DOI 10.2337/dc09-2260; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; *MED HEALTHC PROD, 2009, DRUG SAF UPD, V2; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HLTH, V87; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Ratner RE, 2006, DIABETES OBES METAB, V8, P419, DOI 10.1111/j.1463-1326.2006.00589.x; Ray JA, 2007, CURR MED RES OPIN, V23, P609, DOI 10.1185/030079907X178685; Riddle MC, 2006, DIABETES-METAB RES, V22, P483, DOI 10.1002/dmrr.646; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Yoon NM, 2009, CLIN THER, V31, P1511, DOI 10.1016/j.clinthera.2009.07.021; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	23	17	22	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d410	10.1136/bmj.d410	http://dx.doi.org/10.1136/bmj.d410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OZ	21325387				2022-12-01	WOS:000287656500015
J	Farzadfar, F; Finucane, MM; Danaei, G; Pelizzari, PM; Cowan, MJ; Paciorek, CJ; Singh, GM; Lin, JK; Stevens, GA; Riley, LM; Ezzati, M				Farzadfar, Farshad; Finucane, Mariel M.; Danaei, Goodarz; Pelizzari, Pamela M.; Cowan, Melanie J.; Paciorek, Christopher J.; Singh, Gitanjali M.; Lin, John K.; Stevens, Gretchen A.; Riley, Leanne M.; Ezzati, Majid		Global Burden Metab Risk Factors C	National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants	LANCET			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR RISK; 20-YEAR TRENDS; SECULAR TRENDS; PRIMARY-CARE; HYPERCHOLESTEROLEMIA; PREVALENCE	Background Data for trends in serum cholesterol are needed to understand the effects of its dietary, lifestyle, and pharmacological determinants; set intervention priorities; and evaluate national programmes. Previous analyses of trends in serum cholesterol were limited to a few countries, with no consistent and comparable global analysis. We estimated worldwide trends in population mean serum total cholesterol. Methods We estimated trends and their uncertainties in mean serum total cholesterol for adults 25 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (321 country-years and 3.0 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean total cholesterol by age, country, and year, accounting for whether a study was nationally representative. Findings In 2008, age-standardised mean total cholesterol worldwide was 4.64 mmol/L (95% uncertainty interval 4.51-4.76) for men and 4.76 mmol/L (4.62-4.91) for women. Globally, mean total cholesterol changed little between 1980 and 2008, falling by less than 0.1 mmol/L per decade in men and women. Total cholesterol fell in the high-income region consisting of Australasia, North America, and western Europe, and in central and eastern Europe; the regional declines were about 0.2 mmol/L per decade for both sexes, with posterior probabilities of these being true declines 0.99 or greater. Mean total cholesterol increased in east and southeast Asia and Pacific by 0.08 mmol/L per decade (-0.06 to 0.22, posterior probability=0.86) in men and 0.09 mmol/L per decade (-0.07 to 0.26, posterior probability=0.86) in women. Despite converging trends, serum total cholesterol in 2008 was highest in the high. income region consisting of Australasia, North America, and western Europe; the regional mean was 5.24 mmol/L (5.08-5.39) for men and 5.23 mmol/L (5.03-5.43) for women. It was lowest in sub-Saharan Africa at 4.08 mmol/L (3.82-4.34) for men and 4.27 mmol/L (3.99-4.56) for women. Interpretation Nutritional policies and pharmacological interventions should be used to accelerate improvements in total cholesterol in regions with decline and to curb or prevent the rise in Asian populations and elsewhere. Population-based surveillance of cholesterol needs to be improved in low-income and middle-income countries.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Farzadfar, Farshad; Singh, Gitanjali M.; Lin, John K.; Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Finucane, Mariel M.; Paciorek, Christopher J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Pelizzari, Pamela M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Cowan, Melanie J.; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; World Health Organization; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Bjerregaard, Peter/ABD-8894-2020; Danaei, Goodarz/B-6085-2008; Nsour, Mohannad Al/ABE-8741-2020; Colaus, PsyColaus/K-6607-2013; Miranda, J. Jaime/A-8482-2008; Panza, Francesco/Y-2539-2019; Cífková, Renata/O-5731-2017; Chen, Chien-Jen/N-4723-2019; Lim, Stephen S/B-4055-2012; Bovet, Pascal/F-4477-2011; Rampal, Sanjay/B-9691-2010; VOLPATO, STEFANO/H-2977-2014; Castetbon, Katia/F-2686-2017; Thomas, G. Neil/A-1879-2013; You, Qisheng/AAG-7153-2020; Panza, Francesco/M-6804-2017; Marques-Vidal, Pedro/C-9449-2009	Bjerregaard, Peter/0000-0001-7153-8447; Nsour, Mohannad Al/0000-0003-1212-1611; Miranda, J. Jaime/0000-0002-4738-5468; Panza, Francesco/0000-0002-7220-0656; Cífková, Renata/0000-0003-2765-3821; Bovet, Pascal/0000-0002-0242-4259; Rampal, Sanjay/0000-0002-0105-6407; VOLPATO, STEFANO/0000-0003-4335-6034; Thomas, G. Neil/0000-0002-2777-1847; You, Qisheng/0000-0003-0743-7320; Panza, Francesco/0000-0002-7220-0656; Lin, John/0000-0003-2490-4453; LIN, HSIEN-HO/0000-0002-7481-6016; Woodward, Mark/0000-0001-9800-5296; Eggertsen, Robert/0000-0003-3807-3769; Marques-Vidal, Pedro/0000-0002-4548-8500; Farzadfar, Farshad/0000-0001-8288-4046; Pelizzari, Pamela/0000-0002-6992-9462	Harvard University; Bill & Melinda Gates Foundation; WHO; Medical Research Council [G0801056B] Funding Source: researchfish	Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO(World Health Organization); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JKL holds stock in Johnson & Johnson. CJP holds stock in Pfizer. GAS has received funding from Harvard University for travel purposes. ME has chaired a session at the World Cardiology Congress, which was sponsored by the organiser. All other authors declare that they have no conflicts of interest.; Funding Bill & Melinda Gates Foundation and WHO.	Ahmad OB, 2014, AGE STANDARDIZATION; Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; awes CMM, 2003, COMP QUANTIFICATION, P391; Ben Romdhane Habiba, 2005, Tunis Med, V83 Suppl 5, P8; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Bowden RG, 2006, PUBLIC HEALTH, V120, P572, DOI 10.1016/j.puhe.2006.03.005; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; COHN JS, 1988, CLIN CHEM, V34, P2456; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2010, INT J CARDIOL, V140, P226, DOI 10.1016/j.ijcard.2008.11.033; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HOFFMEISTER H, 1994, PREV MED, V23, P197, DOI 10.1006/pmed.1994.1027; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; JOOSSENS JV, 1977, LANCET, V1, P1069; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; KEYS A, 1975, ATHEROSCLEROSIS, V22, P149, DOI 10.1016/0021-9150(75)90001-5; Khoo KL, 2003, ATHEROSCLEROSIS, V169, P1, DOI 10.1016/S0021-9150(03)00009-1; KNUIMAN JT, 1982, AM J EPIDEMIOL, V116, P631, DOI 10.1093/oxfordjournals.aje.a113446; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Kuklina EV, 2009, JAMA-J AM MED ASSOC, V302, P2104, DOI 10.1001/jama.2009.1672; LABARTHE DR, 1991, ANN NY ACAD SCI, V623, P108, DOI 10.1111/j.1749-6632.1991.tb43722.x; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Law M, 2000, AM J CLIN NUTR, V72, p1291S, DOI 10.1093/ajcn/72.5.1291s; LAW MR, 1994, EUR J CLIN NUTR, V48, P305; Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Lyratzopoulos G, 2006, HEART, V92, P1198, DOI 10.1136/hrt.2005.081042; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; OKAYAMA A, 1995, J CLIN EPIDEMIOL, V48, P329, DOI 10.1016/0895-4356(94)00146-H; OKAYAMA A, 1993, INT J EPIDEMIOL, V22, P1038, DOI 10.1093/ije/22.6.1038; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; SJOL A, 1991, INT J EPIDEMIOL, V20, P105, DOI 10.1093/ije/20.1.105; Steinhagen-Thiessen E, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-31; Sun Jia-yi, 2006, Zhonghua Nei Ke Za Zhi, V45, P980; Tolonen H, 2005, INT J EPIDEMIOL, V34, P181, DOI 10.1093/ije/dyi056; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; WILSON PWF, 1989, AM J MED, V87, pS5, DOI 10.1016/S0002-9343(89)80593-5; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	47	416	431	1	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					578	586		10.1016/S0140-6736(10)62038-7	http://dx.doi.org/10.1016/S0140-6736(10)62038-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724DQ	21295847				2022-12-01	WOS:000287556700028
J	Ives, A; Ronet, C; Prevel, F; Ruzzante, G; Fuertes-Marraco, S; Schutz, F; Zangger, H; Revaz-Breton, M; Lye, LF; Hickerson, SM; Beverley, SM; Acha-Orbea, H; Launois, P; Fasel, N; Masina, S				Ives, Annette; Ronet, Catherine; Prevel, Florence; Ruzzante, Giulia; Fuertes-Marraco, Silvia; Schutz, Frederic; Zangger, Haroun; Revaz-Breton, Melanie; Lye, Lon-Fye; Hickerson, Suzanne M.; Beverley, Stephen M.; Acha-Orbea, Hans; Launois, Pascal; Fasel, Nicolas; Masina, Slavica			Leishmania RNA Virus Controls the Severity of Mucocutaneous Leishmaniasis	SCIENCE			English	Article							MUCOSAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; INNATE IMMUNITY; BRAZILIENSIS; PATHOGENESIS; EXPRESSION; RESISTANCE; EVOLUTION; INFECTION; PARASITES	Mucocutaneous leishmaniasis is caused by infections with intracellular parasites of the Leishmania Viannia subgenus, including Leishmania guyanensis. The pathology develops after parasite dissemination to nasopharyngeal tissues, where destructive metastatic lesions form with chronic inflammation. Currently, the mechanisms involved in lesion development are poorly understood. Here we show that metastasizing parasites have a high Leishmania RNA virus-1 (LRV1) burden that is recognized by the host Toll-like receptor 3 (TLR3) to induce proinflammatory cytokines and chemokines. Paradoxically, these TLR3-mediated immune responses rendered mice more susceptible to infection, and the animals developed an increased footpad swelling and parasitemia. Thus, LRV1 in the metastasizing parasites subverted the host immune response to Leishmania and promoted parasite persistence.	[Ives, Annette; Ronet, Catherine; Prevel, Florence; Ruzzante, Giulia; Fuertes-Marraco, Silvia; Zangger, Haroun; Revaz-Breton, Melanie; Acha-Orbea, Hans; Fasel, Nicolas; Masina, Slavica] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Schutz, Frederic] Univ Lausanne, Swiss Inst Bioinformat, CH-1015 Dorigny, Switzerland; [Lye, Lon-Fye; Hickerson, Suzanne M.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Launois, Pascal] WHO Immunol Res & Training Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Washington University (WUSTL)	Fasel, N (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	nicolas.fasel@unil.ch	Fasel, Nicolas/O-4253-2016; Marraco, Silvia A Fuertes/I-2481-2014; Ronet, Catherine/O-6866-2017	Fasel, Nicolas/0000-0003-0136-7245; Ronet, Catherine/0000-0003-1479-2873; Ives, Annette/0000-0002-7407-960X; Beverley, Stephen/0000-0001-5319-0811; Fuertes Marraco, Silvia A/0000-0002-3456-3317	FNRS [3100A0-116665/1, 310030-120325]; Foundation Pierre Mercier; NIH [A129646]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029646] Funding Source: NIH RePORTER	FNRS(Fonds de la Recherche Scientifique - FNRS); Foundation Pierre Mercier; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to N. Saravia (CIDEIM, Colombia) and Instituto Oswaldo Cruz, for L. guyanensis strains; S. Akira (Frontier Research center, Osaka University), P. Romero (LICR, Lausanne), and B. Ryffel (CNRS, Orleans) for knockout and mutant mice; M. Delorenzi (SIB, Lausanne) for bioinformatics expertise; F. Morgenthaler (Cellular Imaging Facility, Lausanne), S. Cawsey, and M.-A. Hartley for technical assistance; and J. Patterson and Y. T. Ro for the L.g. M4147 strains. This work was funded by FNRS grants 3100A0-116665/1 (N.F.) and 310030-120325 (P.L.), Foundation Pierre Mercier (S.M.), and NIH A129646 (S.M.B.). Microarray data are available within the Gene Expression Omnibus database (GSE21418) and at http://people.unil.ch/nicolasfasel/data-from-fasels-lab/.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; Acestor N, 2006, J INFECT DIS, V194, P1160, DOI 10.1086/507646; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; BARRAL A, 1995, AM J TROP MED HYG, V53, P256, DOI 10.4269/ajtmh.1995.53.256; BARRAL A, 1995, AM J PATHOL, V147, P947; Ben-Othman R, 2008, MOL IMMUNOL, V45, P3222, DOI 10.1016/j.molimm.2008.02.019; Blackwell JM, 1999, PARASITOL TODAY, V15, P73, DOI 10.1016/S0169-4758(98)01355-6; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; CADD TL, 1993, J VIROL, V67, P5647, DOI 10.1128/JVI.67.9.5647-5650.1993; Castellucci L, 2006, J INFECT DIS, V194, P519, DOI 10.1086/505504; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Gaze ST, 2006, SCAND J IMMUNOL, V63, P70, DOI 10.1111/j.1365-3083.2005.01707.x; GUILBRIDE L, 1992, MOL BIOCHEM PARASIT, V54, P101, DOI 10.1016/0166-6851(92)90099-6; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; MARTINEZ JE, 1992, T ROY SOC TROP MED H, V86, P392, DOI 10.1016/0035-9203(92)90233-3; Martinez JE, 2000, J PARASITOL, V86, P792, DOI 10.1645/0022-3395(2000)086[0792:CDITEA]2.0.CO;2; Ogg MM, 2003, AM J TROP MED HYG, V69, P309, DOI 10.4269/ajtmh.2003.69.309; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; REY JA, 1990, AM J TROP MED HYG, V43, P623, DOI 10.4269/ajtmh.1990.43.623; Ro YT, 1997, J VIROL, V71, P8991, DOI 10.1128/JVI.71.12.8991-8998.1997; Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425; TRAVI B, 1988, J PARASITOL, V74, P1059, DOI 10.2307/3282237; Vargas-Inchaustegui DA, 2010, INFECT IMMUN, V78, P301, DOI 10.1128/IAI.00959-09; Vergel C, 2006, J INFECT DIS, V194, P503, DOI 10.1086/505583; Weigle K, 1996, CLIN DERMATOL, V14, P433, DOI 10.1016/0738-081X(96)00036-3; WIDMER G, 1989, P NATL ACAD SCI USA, V86, P5979, DOI 10.1073/pnas.86.15.5979	30	247	255	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					775	778		10.1126/science.1199326	http://dx.doi.org/10.1126/science.1199326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311023	Green Accepted, Green Submitted			2022-12-01	WOS:000287205700072
J	Bjorndal, KA; Bowen, BW; Chaloupka, M; Crowder, LB; Heppell, SS; Jones, CM; Lutcavage, ME; Policansky, D; Solow, AR; Witherington, BE				Bjorndal, Karen A.; Bowen, Brian W.; Chaloupka, Milani; Crowder, Larry B.; Heppell, Selina S.; Jones, Cynthia M.; Lutcavage, Molly E.; Policansky, David; Solow, Andrew R.; Witherington, Blair E.			Better Science Needed for Restoration in the Gulf of Mexico	SCIENCE			English	Editorial Material							LOGGERHEAD SEA-TURTLE; CLIMATE-CHANGE; POPULATION; ECOSYSTEMS; MARINE; ECOLOGISTS		[Bjorndal, Karen A.] Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA; [Bjorndal, Karen A.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Bowen, Brian W.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Chaloupka, Milani] Univ Queensland, Ecol Modelling Serv Pty Ltd, St Lucia, Qld 4067, Australia; [Crowder, Larry B.] Duke Univ, Marine Lab, Ctr Marine Conservat, Beaufort, NC 28516 USA; [Heppell, Selina S.] Oregon State Univ, Dept Wildlife & Fisheries, Corvallis, OR 97331 USA; [Jones, Cynthia M.] Old Dominion Univ, Ctr Quantitat Fisheries Ecol, Norfolk, VA 23529 USA; [Lutcavage, Molly E.] Univ Massachusetts, Dept Environm Conservat, Large Pelag Res Ctr, Gloucester, MA 01930 USA; [Policansky, David] CNR, Washington, DC 20001 USA; [Witherington, Blair E.] Florida Fish & Wildlife Conservat Commiss, Melbourne Beach, FL 32951 USA; [Solow, Andrew R.] Woods Hole Oceanog Inst, Marine Policy Ctr, Woods Hole, MA 02543 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Hawaii System; University of Queensland; Duke University; Oregon State University; Old Dominion University; University of Massachusetts System; Florida Fish & Wildlife Conservation Commission; Woods Hole Oceanographic Institution	Bjorndal, KA (corresponding author), Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA.	bjorndal@ufl.edu		Bjorndal, Karen/0000-0002-6286-1901				Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 2011, FRONT ECOL ENVIRON, V9, P295, DOI 10.1890/090126; BOWEN BW, 1994, SCIENCE, V266, P713, DOI 10.1126/science.7973619; BOWEN BW, 1996, NOAA TECH MEMO NMFS, V396, P1; *BP, FUNDS BP INCLUDE  50; Carr MH, 2003, ECOL APPL, V13, pS90; Chaloupka M, 2003, LOGGERHEAD SEA TURTL, P274; Chaloupka M, 2008, J EXP MAR BIOL ECOL, V356, P136, DOI 10.1016/j.jembe.2007.12.009; Contreras JL, 2010, SCIENCE, V329, P393, DOI 10.1126/science.1189253; Ellison AM, 2010, FRONT ECOL ENVIRON, V8, P362, DOI 10.1890/080209; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Graham B., 2011, NATL COMMISSION BP D; Harrison A., 2006, CONNECTIVITY CONSERV, V14, P213; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.2307/177367; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoekstra JM, 2002, ECOL APPL, V12, P630, DOI 10.1890/1051-0761(2002)012[0630:ACROES]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lehodey P, 2010, PROG OCEANOGR, V84, P69, DOI 10.1016/j.pocean.2009.09.008; LIMPUS CJ, 2010, CHALOUPKA LED DATA C; Lutcavage Molly E., 1997, P387; *NAT RES COUNC, 2010, ASS SEA IURTL STAT T; Nielsen J.L., 2009, TAGGING TRACKING MAR, V9; *OC POL TASK FORC, 2010, FIN REC INT OC POL T; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1	27	56	61	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					537	538		10.1126/science.1199935	http://dx.doi.org/10.1126/science.1199935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292956				2022-12-01	WOS:000286933600030
J	Cole-Turner, R				Cole-Turner, Ronald			What Defines Us?	SCIENCE			English	Editorial Material									Pittsburgh Theol Seminary, Pittsburgh, PA USA		Cole-Turner, R (corresponding author), Pittsburgh Theol Seminary, Pittsburgh, PA USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203070	http://dx.doi.org/10.1126/science.1203070			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292967				2022-12-01	WOS:000286933600041
J	Gibbs, RA				Gibbs, Richard A.			Bringing Genomics and Genetics Back Together	SCIENCE			English	Editorial Material									[Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Gibbs, RA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG003273] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203017	http://dx.doi.org/10.1126/science.1203017			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292968	Green Accepted			2022-12-01	WOS:000286933600043
J	Axon, RN; Williams, MV				Axon, R. Neal; Williams, Mark V.			Hospital Readmission as an Accountability Measure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INPATIENT CARE; QUALITY; ASSOCIATION		[Axon, R. Neal] Ralph H Johnson VAMC, Ctr Dis Prevent & Hlth Intervent Diverse Populat, Charleston, SC USA; [Axon, R. Neal] Med Univ S Carolina, Div Gen Internal Med & Geriatr, Charleston, SC USA; [Williams, Mark V.] Northwestern Univ, Feinberg Sch Med, Div Hosp Med, Chicago, IL 60611 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Northwestern University; Feinberg School of Medicine	Axon, RN (corresponding author), 135 Rutledge Ave,MSC 591, Charleston, SC 29425 USA.	axon@musc.edu		Williams, Mark V/0000-0001-6107-0457				[Anonymous], HOSP CAR OUTC EFF ME; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; *MED PAYM ADV COMM, 2007, MED PAYM POL	10	297	298	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					504	505		10.1001/jama.2011.72	http://dx.doi.org/10.1001/jama.2011.72			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285430				2022-12-01	WOS:000286810700026
J	Avinoam, O; Fridman, K; Valansi, C; Abutbul, I; Zeev-Ben-Mordehai, T; Maurer, UE; Sapir, A; Danino, D; Grunewald, K; White, JM; Podbilewicz, B				Avinoam, Ori; Fridman, Karen; Valansi, Clari; Abutbul, Inbal; Zeev-Ben-Mordehai, Tzviya; Maurer, Ulrike E.; Sapir, Amir; Danino, Dganit; Gruenewald, Kay; White, Judith M.; Podbilewicz, Benjamin			Conserved Eukaryotic Fusogens Can Fuse Viral Envelopes to Cells	SCIENCE			English	Article							VESICULAR STOMATITIS-VIRUS; MEMBRANE-FUSION; C-ELEGANS; GLYCOPROTEIN; MECHANISMS; EFF-1; PROTEINS	Caenorhabditis elegans proteins AFF-1 and EFF-1 [C. elegans fusion family (CeFF) proteins] are essential for developmental cell-to-cell fusion and can merge insect cells. To study the structure and function of AFF-1, we constructed vesicular stomatitis virus (VSV) displaying AFF-1 on the viral envelope, substituting the native fusogen VSV glycoprotein. Electron microscopy and tomography revealed that AFF-1 formed distinct supercomplexes resembling pentameric and hexameric "flowers" on pseudoviruses. Viruses carrying AFF-1 infected mammalian cells only when CeFFs were on the target cell surface. Furthermore, we identified fusion family (FF) proteins within and beyond nematodes, and divergent members from the human parasitic nematode Trichinella spiralis and the chordate Branchiostoma floridae could also fuse mammalian cells. Thus, FF proteins are part of an ancient family of cellular fusogens that can promote fusion when expressed on a viral particle.	[Avinoam, Ori; Fridman, Karen; Valansi, Clari; Sapir, Amir; Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Abutbul, Inbal; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Abutbul, Inbal; Danino, Dganit] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Zeev-Ben-Mordehai, Tzviya; Gruenewald, Kay] Univ Oxford, Oxford Particle Imaging Ctr, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Maurer, Ulrike E.; Gruenewald, Kay] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society; University of Virginia	Podbilewicz, B (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	podbilew@technion.ac.il	Podbilewicz, Benjamin/N-4825-2014; Grünewald, Kay/AAW-3652-2020; Danino, Dganit/D-6832-2016; Sapir, Amir/C-5758-2015; Zeev-Ben-Mordehai, Tzviya/D-7112-2014; Avinoam, Ori/AAX-7382-2020; Zeev-Ben-Mordehai, Tzviya/AAD-3270-2021	Grünewald, Kay/0000-0002-4788-2691; Danino, Dganit/0000-0002-9782-4940; Sapir, Amir/0000-0001-9888-1800; Zeev-Ben-Mordehai, Tzviya/0000-0002-2571-550X; Avinoam, Ori/0000-0003-3543-168X; Zeev-Ben-Mordehai, Tzviya/0000-0002-2571-550X; Podbilewicz, Benjamin/0000-0002-0411-4182	Israel Science Foundation [ISF 1542/07]; Human Frontier Science Program [RG0079/2009-C]; NIH [AI22470]; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022470] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Nagano, M. Whitt, A. Fire, C. Giraudo, and J. Rothman for reagents; F. Glaser, M. Glickman, A. Harel, O. Kleifeld, T. Schwartz, I. Sharon, E. Spooner, R. Sommer, and members of the White and Podbilewicz labs for discussions; the Smoler Proteomics Center at the Technion and the Whitehead Institute for Biomedical Research for mass spectrometry; T. Ziv for proteomics analysis; the Caenorhabditis Genetics Center for nematode strains; and I. Yanai and A. de Silva for critically reading the manuscript. This work was supported by grants from the FIRST Program of the Israel Science Foundation (ISF 1542/07 to B.P.), the Human Frontier Science Program (RG0079/2009-C to K.G.), and the NIH (AI22470 to J.M.W.), as well as a Wellcome Trust Senior Research Fellowship to K. G. The Technion Research and Development Foundation has filed a patent relating to methods and compositions useful in cell-cell fusion using FF proteins of nematode origin and to antinematodal methods and compositions, using proteins of the nematode fusion family.	Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Matsuura Y, 2001, VIROLOGY, V286, P263, DOI 10.1006/viro.2001.0971; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Shemer G, 2004, CURR BIOL, V14, P1587, DOI 10.1016/j.cub.2004.07.059; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; ZAVADA J, 1972, J GEN VIROL, V15, P183, DOI 10.1099/0022-1317-15-3-183	17	51	55	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					589	592		10.1126/science.1202333	http://dx.doi.org/10.1126/science.1202333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21436398	Green Accepted			2022-12-01	WOS:000289991100049
J	Beardmore, RE; Gudelj, I; Lipson, DA; Hurst, LD				Beardmore, Robert E.; Gudelj, Ivana; Lipson, David A.; Hurst, Laurence D.			Metabolic trade-offs and the maintenance of the fittest and the flattest	NATURE			English	Article							LETHAL MUTAGENESIS; ESCHERICHIA-COLI; PERIODIC SELECTION; GROWTH-RATE; EVOLUTION; YIELD; POPULATIONS; MECHANISMS; TRANSPORT; DIVERSITY	How is diversity maintained? Environmental heterogeneity is considered to be important(1), yet diversity in seemingly homogeneous environments is nonetheless observed(2). This, it is assumed, must either be owing to weak selection, mutational input or a fitness advantage to genotypes when rare(1). Here we demonstrate the possibility of a new general mechanism of stable diversity maintenance, one that stems from metabolic and physiological trade-offs(3). The model requires that such trade-offs translate into a fitness landscape in which the most fit has unfit near-mutational neighbours, and a lower fitness peak also exists that is more mutationally robust. The 'survival of the fittest' applies at low mutation rates, giving way to 'survival of the flattest'(4-6) at high mutation rates. However, as a consequence of quasispecies-level negative frequency-dependent selection and differences in mutational robustness we observe a transition zone in which both fittest and flattest coexist. Although diversity maintenance is possible for simple organisms in simple environments, the more trade-offs there are, the wider the maintenance zone becomes. The principle may be applied to lineages within a species or species within a community, potentially explaining why competitive exclusion need not be observed in homogeneous environments. This principle predicts the enigmatic richness of metabolic strategies in clonal bacteria(7) and questions the safety of lethal mutagenesis(8,9) as an antimicrobial treatment.	[Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Beardmore, Robert E.; Gudelj, Ivana] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2A7, England; [Lipson, David A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of Bath; Imperial College London; California State University System; San Diego State University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054	Royal Society; EPSRC; NERC; EPSRC [EP/F037856/1, EP/I018263/1] Funding Source: UKRI; MRC [G0802611] Funding Source: UKRI; NERC [NE/E013007/3, NE/E013007/2, NE/E013007/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I018263/1, EP/F037856/1] Funding Source: researchfish; Medical Research Council [G0802611] Funding Source: researchfish; Natural Environment Research Council [NE/E013007/3, NE/E013007/1, NE/E013007/2] Funding Source: researchfish	Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Burch, M. Doebeli and T. Ferenci for discussions. L. D. H. is a Royal Society Wolfson Research Merit Award Holder, R. E. B. holds an EPSRC Leadership Fellowship, and I. G. holds a NERC Advanced Research Fellowship.	Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Bull JJ, 2008, GENETICS, V180, P1061, DOI 10.1534/genetics.108.091413; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; Doebeli M, 2010, SCIENCE, V328, P494, DOI 10.1126/science.1187468; Gillies RJ, 2007, J BIOENERG BIOMEMBR, V39, P251, DOI 10.1007/s10863-007-9085-y; Gudelj I, 2007, J EVOLUTION BIOL, V20, P1882, DOI 10.1111/j.1420-9101.2007.01376.x; Keller H.B., 1977, APPL BIFURCATION THE; KOCH AL, 1974, GENETICS, V77, P127; Krak N, 2008, MOL IMAGING BIOL, V10, P356, DOI 10.1007/s11307-008-0163-2; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; LEVIN BR, 1981, GENETICS, V99, P1; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Maharjan RP, 2007, J BACTERIOL, V189, P2350, DOI 10.1128/JB.01414-06; Martin G, 2010, PHILOS T R SOC B, V365, P1953, DOI 10.1098/rstb.2010.0058; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEUSTHUIS RA, 1994, MICROBIOL REV, V58, P616, DOI 10.1128/MMBR.58.4.616-630.1994; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569	27	72	75	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					342	346		10.1038/nature09905	http://dx.doi.org/10.1038/nature09905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21441905	Green Submitted			2022-12-01	WOS:000289724600038
J	Weiss, J; Pyrski, M; Jacobi, E; Bufe, B; Willnecker, V; Schick, B; Zizzari, P; Gossage, SJ; Greer, CA; Leinders-Zufall, T; Woods, CG; Wood, JN; Zufall, F				Weiss, Jan; Pyrski, Martina; Jacobi, Eric; Bufe, Bernd; Willnecker, Vivienne; Schick, Bernhard; Zizzari, Philippe; Gossage, Samuel J.; Greer, Charles A.; Leinders-Zufall, Trese; Woods, C. Geoffrey; Wood, John N.; Zufall, Frank			Loss-of-function mutations in sodium channel Na(v)1.7 cause anosmia	NATURE			English	Article							MOUSE OLFACTORY-BULB; PAIN; EXPRESSION; SYSTEM; RAT; RECEPTOR; ORGANIZATION; DELETION; SUBUNIT; REVEALS	Loss of function of the gene SCN9A, encoding the voltage-gated sodium channel Na(v)1.7, causes a congenital inability to experience pain in humans. Here we show that Na(v)1.7 is not only necessary for pain sensation but is also an essential requirement for odour perception in both mice and humans. We examined human patients with loss-of-function mutations in SCN9A and show that they are unable to sense odours. To establish the essential role of Na(v)1.7 in odour perception, we generated conditional null mice in which Na(v)1.7 was removed from all olfactory sensory neurons. In the absence of Na(v)1.7, these neurons still produce odour-evoked action potentials but fail to initiate synaptic signalling from their axon terminals at the first synapse in the olfactory system. The mutant mice no longer display vital, odour-guided behaviours such as innate odour recognition and avoidance, short-term odour learning, and maternal pup retrieval. Our study creates a mouse model of congenital general anosmia and provides new strategies to explore the genetic basis of the human sense of smell.	[Weiss, Jan; Pyrski, Martina; Jacobi, Eric; Bufe, Bernd; Leinders-Zufall, Trese; Zufall, Frank] Univ Saarland, Dept Physiol, Sch Med, D-66421 Homburg, Germany; [Willnecker, Vivienne; Schick, Bernhard] Univ Saarland, Dept Otolaryngol, Sch Med, D-66421 Homburg, Germany; [Zizzari, Philippe] Univ Paris 05, Fac Med, INSERM, Ctr Psychiat & Neurosci,UMR 894, F-75014 Paris, France; [Gossage, Samuel J.; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London WC1E 6BT, England; [Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Woods, C. Geoffrey] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Wood, John N.] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea	Saarland University; Saarland University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; University of London; University College London; Yale University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Seoul National University (SNU)	Zufall, F (corresponding author), Univ Saarland, Dept Physiol, Sch Med, D-66421 Homburg, Germany.	frank.zufall@uks.eu	Leinders-Zufall, Trese/S-3664-2019; Leinders-Zufall, Trese/B-4103-2009; Zufall, Frank/AAE-5290-2021; Bufe, Bernd/N-6685-2018	Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Zizzari, Philippe/0000-0001-8838-0762; Pyrski, Martina/0000-0002-5751-178X; Jacobi, Eric/0000-0003-0055-3476; Bufe, Bernd/0000-0003-1610-0658	Deutsche Forschungsgemeinschaft (DFG) [SFB 530, SFB 894, GK 1326]; Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust; Korean Ministry of Education, Science and Technology [R31-2008-000-10103-0]; National Research Foundation of Korea; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000210] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the individuals who participated in this study, P. Mombaerts for supplying OMP-Cre and OMP-GFP mice, F. Margolis for anti-OMP antibodies, J. Epelbaum for supporting the IGF-1 measurements, P. Hammes for assistance with the immunohistochemistry and C. Kaliszewski for assistance with the electron microscopy. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to F.Z. (SFB 530 and SFB 894) and T.L.-Z. (SFB 894). E.J. was supportedby the DFG-funded International Graduate School GK 1326. T.L.-Z. is a Lichtenberg Professor of the Volkswagen Foundation. J.N.W. was supported by the Biotechnology and Biological Sciences Research Council, Medical Research Council, Wellcome Trust and grant number R31-2008-000-10103-0 from the World Class University project of the Korean Ministry of Education, Science and Technology and the National Research Foundation of Korea.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Au WW, 2002, J COMP NEUROL, V446, P68, DOI 10.1002/cne.10182; BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; Baker H, 1999, J NEUROSCI, V19, P9313; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cho JY, 1996, J COMP NEUROL, V369, P264; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Feldmesser E, 2007, CHEM SENSES, V32, P21, DOI 10.1093/chemse/bjl032; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Keller A, 2008, CURR OPIN NEUROBIOL, V18, P364, DOI 10.1016/j.conb.2008.09.020; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Morinville A, 2007, J COMP NEUROL, V504, P680, DOI 10.1002/cne.21484; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; Nilsen KB, 2009, PAIN, V145, P264, DOI 10.1016/j.pain.2009.06.025; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Puche AC, 1999, J NEUROSCI, V19, P1359; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; Richard MB, 2010, P NATL ACAD SCI USA, V107, P15613, DOI 10.1073/pnas.1007931107; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Ukhanov K, 2007, J NEUROPHYSIOL, V98, P2357, DOI 10.1152/jn.00642.2007; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	37	208	216	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					186	190		10.1038/nature09975	http://dx.doi.org/10.1038/nature09975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21441906	Green Accepted			2022-12-01	WOS:000289469100035
J	Lee, SJ; Eng, C				Lee, Sei J.; Eng, Catherine			Goals of Glycemic Control in Frail Older Patients With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISABILITY; CARE		[Lee, Sei J.] San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; [Lee, Sei J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Eng, Catherine] On Lok Lifeways, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Lee, SJ (corresponding author), San Francisco VA Med Ctr, Div Geriatr, 4150 Clement St,Bldg 1,Room 211A, San Francisco, CA 94121 USA.	sei.lee@ucsf.edu			NCRR NIH HHS [KL2 RR024130] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Araki A, 2009, GERIATR GERONTOL INT, V9, P105, DOI 10.1111/j.1447-0594.2008.00495.x; Berlie HD, 2010, ANN PHARMACOTHER, V44, P712, DOI 10.1345/aph.1M551; Centers for Disease Control and Prevention, 2011, ED SERV UDOHAH; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Guralnik JM, 1996, ANNU REV PUBL HEALTH, V17, P25, DOI 10.1146/annurev.pu.17.050196.000325; Hobbs C, 2010, VA DOD CLIN PRACTICE; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; MANTON KG, 1993, J GERONTOL, V48, pS153, DOI 10.1093/geronj/48.4.S153; Resnick HE, 2008, DIABETES CARE, V31, P287, DOI 10.2337/dc07-1425	10	35	44	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1350	1351		10.1001/jama.2011.404	http://dx.doi.org/10.1001/jama.2011.404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745JT	21467289	Green Accepted			2022-12-01	WOS:000289162400026
J	Raya-Rivera, A; Esquiliano, DR; Yoo, JJ; Lopez-Bayghen, E; Soker, S; Atala, A				Raya-Rivera, Atlantida; Esquiliano, Diego R.; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony			Tissue-engineered autologous urethras for patients who need reconstruction: an observational study	LANCET			English	Article							COLLAGEN MATRIX; BUCCAL MUCOSAL; GRAFTS; VASCULARIZATION; REPLACEMENT; MANAGEMENT; ANTERIOR; STENOSIS; BLADDER	Background Complex urethral problems can occur as a result of injury, disease, or congenital defects and treatment options are often limited. Urethras, similar to other long tubularised tissues, can stricture after reconstruction. We aimed to assess the effectiveness of tissue-engineered urethras using patients' own cells in patients who needed urethral reconstruction. Methods Five boys who had urethral defects were included in the study. A tissue biopsy was taken from each patient, and the muscle and epithelial cells were expanded and seeded onto tubularised polyglycolic acid:poly(lactide-co-glycolide acid) scaffolds. Patients then underwent urethral reconstruction with the tissue-engineered tubularised urethras. We took patient history, asked patients to complete questionnaires from the International Continence Society (ICS), and did urine analyses, cystourethroscopy, cystourethrography, and flow measurements at 3, 6, 12, 24, 36, 48, 60, and 72 months after surgery. We did serial endoscopic cup biopsies at 3, 12, and 36 months, each time in a different area of the engineered urethras. Findings Patients had surgery between March 19, 2004, and July 20, 2007. Follow-up was completed by July 31, 2010. Median age was 11 years (range 10-14) at time of surgery and median follow-up was 71 months (range 36-76 months). AE1/AE3, alpha actin, desmin, and myosin antibodies confirmed the presence of cells of epithelial and muscle lineages on all cultures. The median end maximum urinary flow rate was 27.1 mL/s (range 16-28), and serial radiographic and endoscopic studies showed the maintenance of wide urethral calibres without strictures. Urethral biopsies showed that the engineered grafts had developed a normal appearing architecture by 3 months after implantation. Interpretation Tubularised urethras can be engineered and remain functional in a clinical setting for up to 6 years. These engineered urethras can be used in patients who need complex urethral reconstruction.	[Raya-Rivera, Atlantida; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA; [Raya-Rivera, Atlantida; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony] Wake Forest Univ, Sch Med, Dept Urol, Winston Salem, NC 27157 USA; [Raya-Rivera, Atlantida; Esquiliano, Diego R.; Lopez-Bayghen, Esther] Metropolitan Autonomous Univ, HIMFG Tissue Engn Lab, Mexico City, DF, Mexico; [Raya-Rivera, Atlantida; Esquiliano, Diego R.; Lopez-Bayghen, Esther] IPN, CINVESTAV, Mexico City 07738, DF, Mexico	Wake Forest University; Wake Forest University; Universidad Autonoma Metropolitana - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Atala, A (corresponding author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.	aatala@wfubmc.edu	Yoo, James J./L-4850-2017; Lopez-Bayghen, Esther/A-8006-2008	Lopez-Bayghen, Esther/0000-0002-2849-7587; Atala, Anthony/0000-0001-8186-2160	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [AA- P50DKO65289]; Conacyt; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065298] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (AA- P50DKO65289). ARR and DE were recipients of a Conacyt Doctoral Fellowship. We thank R Fierro-Pastrana and P Valencia for their scientific expertise and contributions, and J Olson for editorial assistance.	Al-Qudah Hosam S., 2005, Int. braz j urol., V31, P459, DOI 10.1590/S1677-55382005000500007; Asif A, 2005, KIDNEY INT, V67, P1986, DOI 10.1111/j.1523-1755.2005.00299.x; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061; Brandes S, 2006, UROL CLIN N AM, V33, P87, DOI 10.1016/j.ucl.2005.10.001; Caldamone AA, 1998, UROLOGY, V51, P15, DOI 10.1016/S0090-4295(98)00088-0; Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X; De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1016/S0022-5347(05)64414-X; Dorin RP, 2008, WORLD J UROL, V26, P323, DOI 10.1007/s00345-008-0316-6; El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101; El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8; Joseph D., 2009, AM UR ASS ANN M CHIC; Kajbafzadeh Abdol-Mohammad, 2005, BMC Urol, V5, P3, DOI 10.1186/1471-2490-5-3; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; KANTERMAN RY, 1995, RADIOLOGY, V195, P135, DOI 10.1148/radiology.195.1.7892454; Koraitim MM, 2004, UROLOGY, V64, P228, DOI 10.1016/j.urology.2004.03.019; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundy AR, 2006, POSTGRAD MED J, V82, P489, DOI 10.1136/pgmj.2005.042945; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Pansadoro Vito, 2002, Curr Opin Urol, V12, P223, DOI 10.1097/00042307-200205000-00008; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Sander EA, 2004, J BIOMED MATER RES A, V70A, P506, DOI 10.1002/jbm.a.30109; Sarkar S, 2007, MED BIOL ENG COMPUT, V45, P327, DOI 10.1007/s11517-007-0176-z; Zinman L, 2000, Curr Urol Rep, V1, P180, DOI 10.1007/s11934-000-0017-1	26	319	346	0	86	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1175	1182		10.1016/S0140-6736(10)62354-9	http://dx.doi.org/10.1016/S0140-6736(10)62354-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21388673	Green Accepted			2022-12-01	WOS:000289539300033
J	Sarafoglou, K; Rodgers, J; Hietala, A; Matern, D; Bentler, K				Sarafoglou, Kyriakie; Rodgers, John; Hietala, Amy; Matern, Dietrich; Bentler, Kristi			Expanded Newborn Screening for Detection of Vitamin B-12 Deficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							METHYLMALONIC ACID; TOTAL HOMOCYSTEINE; COBALAMIN		[Sarafoglou, Kyriakie; Rodgers, John; Bentler, Kristi] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Hietala, Amy] Minnesota Dept Hlth, St Paul, MN USA; [Matern, Dietrich] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD); Mayo Clinic	Sarafoglou, K (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.	saraf010@umn.edu		Sarafoglou, Kyriakie/0000-0002-5741-3629				Campbell C D, 2005, Haematologica, V90, pECR45; Hinton CF, 2010, J PEDIATR-US, V157, P162, DOI 10.1016/j.jpeds.2010.03.006; Monsen ALB, 2001, PEDIATRICS, V108, P624, DOI 10.1542/peds.108.3.624; Rasmussen SA, 2001, J PEDIATR-US, V138, P10, DOI 10.1067/mpd.2001.112160; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Turgeon CT, 2010, CLIN CHEM, V56, P1686, DOI 10.1373/clinchem.2010.148957	6	36	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1198	1200		10.1001/jama.2011.310	http://dx.doi.org/10.1001/jama.2011.310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427371	Bronze			2022-12-01	WOS:000288652100013
J	Conde, DA; Flesness, N; Colchero, F; Jones, OR; Scheuerlein, A				Conde, D. A.; Flesness, N.; Colchero, F.; Jones, O. R.; Scheuerlein, A.			An Emerging Role of Zoos to Conserve Biodiversity	SCIENCE			English	Editorial Material							POPULATION VIABILITY ANALYSIS; VERTEBRATES		[Conde, D. A.; Colchero, F.; Jones, O. R.; Scheuerlein, A.] Max Planck Inst Demog Res, D-18057 Rostock, Germany; [Flesness, N.] Int Species Informat Syst, Eagan, MN 55121 USA	Max Planck Society	Conde, DA (corresponding author), Max Planck Inst Demog Res, D-18057 Rostock, Germany.	conde@demogr.mpg.de	Scheuerlein, Alexander/AAK-1111-2021; Jones, Owen/B-8439-2008; Colchero, Fernando/A-9368-2015	Jones, Owen/0000-0001-5720-4686; Colchero, Fernando/0000-0001-8613-4568; Conde, Dalia A./0000-0002-7923-8163				Barnett R, 2006, CONSERV GENET, V7, P507, DOI 10.1007/s10592-005-9062-0; BELANT J, 2010, IUCN RED LIST THREAT; BISBY FA, ISIS IUCN INFORM WER; Conway WG, 2011, ZOO BIOL, V30, P1, DOI 10.1002/zoo.20352; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; GUSSET M, 2010, ZOO BIOL        1206; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; *IUCN, 2002, IUCN TECHN GUID MAN, P4; IUCN, 2009, IUCN RED LIST THREAT; Meretsky VJ, 2000, CONSERV BIOL, V14, P957, DOI 10.1046/j.1523-1739.2000.99113.x; Morell V, 2008, SCIENCE, V320, P742, DOI 10.1126/science.320.5877.742; NORMILE D, 2010, SCI INSIDER     1029; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spalton JA, 1999, ORYX, V33, P168, DOI 10.1046/j.1365-3008.1999.00062.x; Thibault JC, 2001, ORYX, V35, P73, DOI 10.1017/S0030605300031550; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; WAZA (World Association of Zoos and Aquariums), 2005, BUILD FUT WILDL WORL; White TH, 2005, CONDOR, V107, P424, DOI 10.1650/7672	20	187	195	10	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1390	1391		10.1126/science.1200674	http://dx.doi.org/10.1126/science.1200674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736OM	21415339				2022-12-01	WOS:000288504000023
J	Janssens, ACJW; Ioannidis, JPA; van Duijn, CM; Little, J; Khoury, MJ				Janssens, A. Cecile J. W.; Ioannidis, John P. A.; van Duijn, Cornelia M.; Little, Julian; Khoury, Muin J.		GRIPS Grp	Research Methods & Reporting Strengthening the reporting of genetic risk prediction studies: the GRIPS statement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; ASSOCIATION; MODELS; MARKER; CURVE					a.janssens@erasmusmc.nl	Ioannidis, John P. A./G-9836-2011; Little, Julian/AAR-6117-2020	Little, Julian/0000-0001-5026-5531; Van Duijn, Cornelia/0000-0002-2374-9204; Dolan, Siobhan/0000-0001-8890-8045; Janssens, A Cecile/0000-0002-6153-4976	Centers for Disease Control and Prevention on behalf of Human Genome Epidemiology Network; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention on behalf of Human Genome Epidemiology Network; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The workshop was sponsored by the Centers for Disease Control and Prevention on behalf of the Human Genome Epidemiology Network. Opinions in this paper do not necessarily represent the official position or policies of the authors' employers, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Janssens ACJW, 2010, CIRC-CARDIOVASC GENE, V3, P3, DOI 10.1161/CIRCGENETICS.110.938092; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Kyzas PA, 2007, JNCI-J NATL CANCER I, V99, P236, DOI 10.1093/jnci/djk032; Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136, 10.1136/bmj.b2700]; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Vandenbrouke JP, 2009, J CLIN EPIDEMIOL, V62, P594, DOI 10.1016/j.jclinepi.2008.12.003; von Elm E, 2004, BMJ-BRIT MED J, V329, P868, DOI 10.1136/bmj.329.7471.868; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	26	15	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2011	342								d631	10.1136/bmj.d631	http://dx.doi.org/10.1136/bmj.d631			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KW	21411493	Green Submitted, Green Published			2022-12-01	WOS:000209546100001
J	Mackin, P; Thomas, SHL				Mackin, Paul; Thomas, Simon H. L.			Therapeutics Atypical antipsychotic drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; 2ND-GENERATION; SCHIZOPHRENIA					paul.mackin@ncl.ac.uk	Thomas, Simon/AAK-9674-2021					Agid O, 2007, NEUROPSYCHOPHARMACOL, V32, P1209, DOI 10.1038/sj.npp.1301242; Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Bushe Chris, 2008, J Psychopharmacol, V22, P46, DOI 10.1177/0269881107088435; Citrome L, 2006, INT J CLIN PRACT, V60, P933, DOI 10.1111/j.1742-1241.2006.01044.x; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; FARAH A, 2005, J CLIN PSYCHIAT, V7, P268, DOI DOI 10.4088/PCC.V07N0602; Grunder G, 2009, NAT REV DRUG DISCOV, V8, P197, DOI 10.1038/nrd2806; Hedges D, 2003, DRUG TODAY, V39, P551, DOI 10.1358/dot.2003.39.7.799445; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; Kesselheim AS, 2007, JAMA-J AM MED ASSOC, V297, P308, DOI 10.1001/jama.297.3.308; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mackin P, 2008, HUM PSYCHOPHARM CLIN, V23, P3, DOI 10.1002/hup.915; *NAT HLTH SERV BUS, PRESCR REV APR JUN 2; Newham JJ, 2008, BRIT J PSYCHIAT, V192, P333, DOI 10.1192/bjp.bp.107.041541; *NIH CLIN EXC, 2009, 82 NIH CLIN EXC; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Stanniland C, 2000, DRUG SAFETY, V22, P195, DOI 10.2165/00002018-200022030-00004; Tanne JH, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4422; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x	21	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2011	342								d1126	10.1136/bmj.d1126	http://dx.doi.org/10.1136/bmj.d1126			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732EU	21378070				2022-12-01	WOS:000288168600002
J	Deriano, L; Chaumeil, J; Coussens, M; Multani, A; Chou, YF; Alekseyenko, AV; Chang, S; Skok, JA; Roth, DB				Deriano, Ludovic; Chaumeil, Julie; Coussens, Marc; Multani, Asha; Chou, Yifan; Alekseyenko, Alexander V.; Chang, Sandy; Skok, Jane A.; Roth, David B.			The RAG2 C terminus suppresses genomic instability and lymphomagenesis	NATURE			English	Article							DOUBLE-STRAND BREAKS; ATM-DEFICIENT MICE; V(D)J RECOMBINATION; LYMPHOCYTE DEVELOPMENT; GENE AMPLIFICATION; THYMIC LYMPHOMA; B-CELL; REPAIR; ROLES; TRANSLOCATIONS	Misrepair of DNA double-strand breaks produced by the V(D)J recombinase (the RAG1/RAG2 proteins) at immunoglobulin (Ig) and T cell receptor (Tcr) loci has been implicated in pathogenesis of lymphoid malignancies in humans(1) and in mice(2-7). Defects in DNA damage response factors such as ataxia telangiectasia mutated (ATM) protein and combined deficiencies in classical non-homologous end joining and p53 predispose to RAG-initiated genomic rearrangements and lymphomagenesis(2-11). Although we showed previously that RAG1/RAG2 shepherd the broken DNA ends to classical non-homologous end joining for proper repair(12,13), roles for the RAG proteins in preserving genomic stability remain poorly defined. Here we show that the RAG2 carboxy (C) terminus, although dispensable for recombination(14,15), is critical for maintaining genomic stability. Thymocytes from 'core' Rag2 homozygotes (Rag2(c/c) mice) show dramatic disruption of Tcr alpha/delta locus integrity. Furthermore, all Rag2(c/c) p53(-/-) mice, unlike Rag1(c/c) p53(-/-) and p53(-/-) animals, rapidly develop thymic lymphomas bearing complex chromosomal translocations, amplifications and deletions involving the Tcra/delta and Igh loci. We also find these features in lymphomas from Atm(-/-) mice. We show that, like ATM-deficiency(3), core RAG2 severely destabilizes the RAG post-cleavage complex. These results reveal a novel genome guardian role for RAG2 and suggest that similar 'end release/end persistence' mechanisms underlie genomic instability and lymphomagenesis in Rag2(c/c) p53(-/-) and Atm(-/-) mice.	[Deriano, Ludovic; Chaumeil, Julie; Coussens, Marc; Chou, Yifan; Skok, Jane A.; Roth, David B.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Multani, Asha] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, Div Clin Pharmacol,Dept Med, New York, NY 10016 USA; [Chang, Sandy] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Skok, Jane A.] UCL, Div Infect & Immun, Dept Immunol & Mol Pathol, London W1T 4JF, England	New York University; University of Texas System; UTMD Anderson Cancer Center; New York University; Yale University; University of London; University College London	Roth, DB (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	david.roth@nyumc.org	Skok, Jane/ABF-7249-2020; Deriano, Ludovic/D-2048-2019	Skok, Jane/0000-0002-4145-1516; Deriano, Ludovic/0000-0002-9673-9525; CHAUMEIL, Julie/0000-0002-8976-2890; Alekseyenko, Alexander/0000-0002-5748-2085	National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center [1PN2EY018244]; National Institutes of Health [CA104588, R01GM086852]; Irene Diamond Fund; National Center for Research Resources, National Institutes of Health [1UL1RR029893]; NCI [R01CA145746-01]; Leukemia and Lymphoma Scholar Award; Wellcome trust [085096]; NATIONAL CANCER INSTITUTE [RC1CA145746, R01CA104588] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852] Funding Source: NIH RePORTER	National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Fund; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); Wellcome trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schlissel for the gift of core Rag2 mice, F. Alt for the gift of core Rag1 mice and S. Hewitt for the Igh BAC probes. D.B.R. was supported by National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center award (1PN2EY018244), a National Institutes of Health grant CA104588 and the Irene Diamond Fund. L.D. is a Fellow of The Leukemia and Lymphoma Society. A.V.A. was supported in part by grant 1UL1RR029893 from the National Center for Research Resources, National Institutes of Health. J.A.S. was supported by a National Institutes of Health grant R01GM086852, a National Institutes of Health Challenge grant NCI R01CA145746-01, a Leukemia and Lymphoma Scholar Award and a Wellcome trust project grant 085096.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Arnal SM, 2010, NUCLEIC ACIDS RES, V38, P2944, DOI 10.1093/nar/gkp1252; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Callen E, 2009, CELL CYCLE, V8, P2408, DOI 10.4161/cc.8.15.9085; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Curry JD, 2008, NUCLEIC ACIDS RES, V36, P5750, DOI 10.1093/nar/gkn553; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; FORSTER A, 1980, NATURE, V286, P897, DOI 10.1038/286897a0; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; Multani AS, 2000, NEOPLASIA, V2, P339, DOI 10.1038/sj.neo.7900105; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; PATHAK S, 1976, J REPROD MED, V17, P25; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; R_Development_Core_Team, 2006, R LANG ENV STAT COMP; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Steen SB, 1999, MOL CELL BIOL, V19, P3010; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zha S, 2010, J EXP MED, V207, P1369, DOI 10.1084/jem.20100285; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	39	78	80	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					119	U145		10.1038/nature09755	http://dx.doi.org/10.1038/nature09755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368836	Green Accepted			2022-12-01	WOS:000287924100046
J	Liang, XF; Li, L; Liu, DW; Li, KL; Wu, WD; Zhu, BP; Wang, HQ; Luo, HM; Cao, LS; Zheng, JS; Yin, DP; Cao, L; Wu, BB; Bao, HH; Xu, DS; Yang, WZ; Wang, Y				Liang, Xiao-Feng; Li, Li; Liu, Da-Wei; Li, Ke-Li; Wu, Wen-Di; Zhu, Bao-Ping; Wang, Hua-Qing; Luo, Hui-Ming; Cao, Ling-Sheng; Zheng, Jing-Shan; Yin, Da-Peng; Cao, Lei; Wu, Bing-Bing; Bao, Hong-Hong; Xu, Di-Sha; Yang, Wei-Zhong; Wang, Yu			Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUILLAIN-BARRE-SYNDROME; UNITED-STATES	Background: On September 21, 2009, China began administering vaccines, obtained from 10 different manufacturers, against 2009 pandemic influenza A (H1N1) virus infection in priority populations. We aimed to assess the safety of this vaccination program. Methods: We designed a plan for passive surveillance for adverse events after immunization with the influenza A (H1N1) vaccine. Physicians or vaccination providers were required to report the numbers of vaccinees and all adverse events to their local Center for Disease Control and Prevention (CDC), which then reported the data to the Chinese CDC through the online National Immunization Information System's National Adverse Event Following Immunization Surveillance System. Data were collected through March 21, 2010, and were verified and analyzed by the Chinese CDC. Results: A total of 89.6 million doses of vaccine were administered from September 21, 2009, through March 21, 2010, and 8067 vaccinees reported having an adverse event, for a rate of 90.0 per 1 million doses. The age-specific rates of adverse events ranged from 31.4 per 1 million doses among persons 60 years of age or older to 130.6 per 1 million doses among persons 9 years of age or younger, and the manufacturer-specific rates ranged from 4.6 to 185.4 per 1 million doses. A total of 6552 of the 8067 adverse events (81.2%; rate, 73.1 per 1 million doses) were verified as vaccine reactions; 1083 of the 8067 (13.4%; rate, 12.1 per 1 million doses) were rare and more serious (vs. common, minor events), most of which (1050) were allergic reactions. Eleven cases of the Guillain-Barre syndrome were reported, for a rate of 0.1 per 1 million doses, which is lower than the background rate in China. Conclusions: No pattern of adverse events that would be of concern was observed after the administration of influenza A (H1N1) vaccine, nor was there evidence of an increased risk of the Guillain-Barre syndrome. N Engl J Med 2011;364:638-47.	[Liang, Xiao-Feng; Li, Li; Liu, Da-Wei; Li, Ke-Li; Wu, Wen-Di; Wang, Hua-Qing; Luo, Hui-Ming; Cao, Ling-Sheng; Zheng, Jing-Shan; Yin, Da-Peng; Cao, Lei; Wu, Bing-Bing; Bao, Hong-Hong; Xu, Di-Sha; Yang, Wei-Zhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 100050, Peoples R China; [Zhu, Bao-Ping] Chinese Field Epidemiol Training Program, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 100050, Peoples R China.	wangyu@chinacdc.cn		Zhu, Baoping/0000-0003-0065-0153				[Anonymous], PRELIMINARY REPORT A; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; *EUR MED AG, EUR MED AG REAFF EFF; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005; Izurieta HS, 2005, JAMA-J AM MED ASSOC, V294, P2720, DOI 10.1001/jama.294.21.2720; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Liu D., 2007, CHIN J VACCINES IMMU, V13, P505; *MIN HLTH PEOPL RE, 2009, GUID VACC PAND H1N1; Ministry of Health of the People's Republic of China, 2008, GUID ID ADV REACT IM; Ministry of Health of the People's Republic of China, 2005, CHIN STAND PROC VACC; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; *STAT FOOD DRUG AD, 2009, LIC PAND H1N1 VACC P; Vellozzi C, 2010, VACCINE, V28, P7248, DOI 10.1016/j.vaccine.2010.09.021; *WHO, 1999, WPROEPI9901; *WHO, 2000, SUPPL INF VACC SAF 2; WHO, 2009, 16 WHO; WU WD, 2009, CHIN J VACC IMNMUNIZ, V15, P481; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	22	91	98	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					638	647		10.1056/NEJMoa1008553	http://dx.doi.org/10.1056/NEJMoa1008553			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21288090	Bronze			2022-12-01	WOS:000287406000009
J	Danaei, G; Finucane, MM; Lin, JK; Singh, GM; Paciorek, CJ; Cowan, MJ; Farzadfar, F; Stevens, GA; Lim, SS; Riley, LM; Ezzati, M; Abdeen, Z; Agyemang, C; Al Nsour, M; Ali, MM; Ambady, R; Babu, BV; Barbagallo, CM; Barcelo, A; Barreto, SM; Barros, H; Bautista, LE; Bjerregaard, P; Bjorkelund, C; Bo, S; Bobak, M; Bonora, E; Botana, MA; Bovet, P; Breckenkamp, J; Breteler, MM; Broda, G; Brown, IJ; Bursztyn, M; de Leon, AC; Casiglia, E; Castetbon, K; Chatterji, S; Chen, ZM; Chen, CJ; Chua, L; Cifkova, R; Cobiac, LJ; Cooper, RS; Dankner, RS; Dong, GH; Elliott, P; Erem, C; Esteghamati, A; Fan, JG; Ferreccio, C; Firmo, JO; Fornes, NS; Fuchs, FD; Getz, L; Giampaoli, S; Gomez, LF; Graff-Iversen, S; Carvajal, RG; Gulliford, MC; Gupta, PC; Gureje, O; Hansen, TW; He, J; Heinrich, J; Hennis, A; Herrera, VM; Ho, SC; Ibrahim, MM; Ikeda, N; Jafar, TH; Joffres, MR; Jonas, JB; Kamadjeu, RM; Karalis, I; Kastarinen, MJ; Katz, J; Kelly, P; Khalilzadeh, O; Khang, YH; Kiechl, S; Kim, KW; Kobayashi, J; Kubinova, R; Kusuma, YS; Lam, TH; Lawes, CMM; Le, C; Lee, J; Lin, X; Lin, HH; Lin, CC; Liu, XQ; Lorbeer, R; Ma, S; Ma, GS; Magliano, DJ; Makdisse, M; Mancia, G; Mbanya, JCN; Miettola, J; Minh, HV; Miranda, JJ; Mohamed, MK; Mohan, V; Mokdad, AH; Morales, DD; Morgan, K; Muiesan, LM; Muntoni, S; Nabipour, I; Nangia, V; Neuhauser, H; Ninomiya, T; Olivieri, O; Onal, AE; Onat, A; Orostegui, M; Panagiotakos, DB; Panza, F; Pednekar, MS; Perez, C; Perez-Fernandez, R; Pichardo, R; Phua, HP; Plans, P; Poulter, N; Raitakari, OT; Rampal, S; Rampal, L; Redon, J; Revilla, L; Roaeid, RB; Rojas-Martinez, R; Sanisoglu, SY; Sans, S; Schelleman, H; Schneider, IJC; Silva, DAS; Silva, E; Simons, LA; Smith, M; Soebardi, S; Solfrizzi, V; Stein, AD; Stergiou, GS; Stessman, J; Suka, M; Tambs, K; Tesfaye, F; Thorogood, M; Tilvis, RS; Trenkwalder, P; Tuomilehto, JO; Tzourio, C; Vander Hoorn, S; Vanderpump, MP; Verschuren, M; Vioque, J; Waspadji, S; Wilhelmsen, L; Willeit, J; Woodward, M; Xavier, AJ; Xu, L; Yang, GH; Yeh, LC; Yoon, JS; You, QS; Zhou, M				Danaei, Goodarz; Finucane, Mariel M.; Lin, John K.; Singh, Gitanjali M.; Paciorek, Christopher J.; Cowan, Melanie J.; Farzadfar, Farshad; Stevens, Gretchen A.; Lim, Stephen S.; Riley, Leanne M.; Ezzati, Majid; Abdeen, Ziad; Agyemang, Charles; Al Nsour, Mohannad; Ali, Mohamed M.; Ambady, Ramachandran; Babu, Bontha V.; Barbagallo, Carlo M.; Barcelo, Alberto; Barreto, Sandhi M.; Barros, Henrique; Bautista, Leonelo E.; Bjerregaard, Peter; Bjoerkelund, Cecilia; Bo, Simona; Bobak, Martin; Bonora, Enzo; Botana, Manuel A.; Bovet, Pascal; Breckenkamp, Juergen; Breteler, Monique M.; Broda, Grazyna; Brown, Ian J.; Bursztyn, Michael; de Leon, Antonio Cabrera; Casiglia, Edoardo; Castetbon, Katia; Chatterji, Somnath; Chen, Zhengming; Chen, Chien-Jen; Chua, Lily; Cifkova, Renata; Cobiac, Linda J.; Cooper, Richard S.; Dankner, Rachel S.; Dong, Guang-Hui; Elliott, Paul; Erem, Cihangir; Esteghamati, Alireza; Fan, Jian-Gao; Ferreccio, Catterina; Firmo, Joselia O.; Fornes, Nelida S.; Fuchs, Flavio D.; Getz, Linn; Giampaoli, Simona; Gomez, Luis F.; Graff-Iversen, Sidsel; Carvajal, Ramiro Guerrero; Gulliford, Martin C.; Gupta, Prakash C.; Gureje, Oye; Hansen, Tine W.; He, Jiang; Heinrich, Joachim; Hennis, Anselm; Herrera, Victor M.; Ho, Suzanne C.; Ibrahim, M. Mohsen; Ikeda, Nayu; Jafar, Tazeen H.; Joffres, Michel R.; Jonas, Jost B.; Kamadjeu, Raoul M.; Karalis, Ioannis; Kastarinen, Mika J.; Katz, Joanne; Kelly, Paul; Khalilzadeh, Omid; Khang, Young-Ho; Kiechl, Stefan; Kim, Ki Woong; Kobayashi, Junji; Kubinova, Ruzena; Kusuma, Yadlapalli S.; Lam, Tai H.; Lawes, Carlene M. M.; Le, Cai; Lee, Jeannette; Lin, Xu; Lin, Hsien-Ho; Lin, Cheng-Chieh; Liu, Xiaoqing; Lorbeer, Roberto; Ma, Stefan; Ma, Guansheng; Magliano, Dianna J.; Makdisse, Marcia; Mancia, Giuseppe; Mbanya, Jean Claude N.; Miettola, Juhani; Minh, Hoang V.; Miranda, J. Jaime; Mohamed, Mostafa K.; Mohan, V.; Mokdad, Ali H.; Morales, Dante D.; Morgan, Karen; Muiesan, Lorenza M.; Muntoni, Sergio; Nabipour, Iraj; Nangia, Vinay; Neuhauser, Hannelore; Ninomiya, Toshiharu; Olivieri, Oliviero; Oenal, Ayse Emel; Onat, Altan; Orostegui, Myriam; Panagiotakos, Demosthenes B.; Panza, Francesco; Pednekar, Mangesh S.; Perez, Cynthia; Perez-Fernandez, Roman; Pichardo, Rafael; Phua, Hwee Pin; Plans, Pedro; Poulter, Neil; Raitakari, Olli T.; Rampal, Sanjay; Rampal, Lekhraj; Redon, Josep; Revilla, Luis; Roaeid, Ragab B.; Rojas-Martinez, Rosalba; Sanisoglu, Selim Y.; Sans, Susana; Schelleman, Hedi; Schneider, Ione J. C.; Silva, Diego Augusto Santos; Silva, Egle; Simons, Leon A.; Smith, Margaret; Soebardi, Suharko; Solfrizzi, Vincenzo; Stein, Aryeh D.; Stergiou, George S.; Stessman, Jochanan; Suka, Machi; Tambs, Kristian; Tesfaye, Fikru; Thorogood, Margaret; Tilvis, Reijo S.; Trenkwalder, Peter; Tuomilehto, Jaakko O.; Tzourio, Christophe; Vander Hoorn, Stephen; Vanderpump, Mark P.; Verschuren, Monique; Vioque, Jesus; Waspadji, Sarwono; Wilhelmsen, Lars; Willeit, Johann; Woodward, Mark; Xavier, Andre J.; Xu, Liang; Yang, Gonghuan; Yeh, Li-Chia; Yoon, Jin-Sang; You, Qisheng; Zhou, Maigeng		Global Burden Metab Risk Factors C	National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS; HYPERTENSION CONTROL; EUROPEAN COUNTRIES; UNITED-STATES; PREVALENCE; AWARENESS; DISEASE; POPULATION; MONICA; GUIDELINES	Background Data for trends in blood pressure are needed to understand the effects of its dietary, lifestyle, and pharmacological determinants; set intervention priorities; and evaluate national programmes. However, few worldwide analyses of trends in blood pressure have been done. We estimated worldwide trends in population mean systolic blood pressure (SBP). Methods We estimated trends and their uncertainties in mean SBP for adults 25 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (786 country-years and 5.4 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean SBP by age, country, and year, accounting for whether a study was nationally representative. Findings In 2008, age-standardised mean SBP worldwide was 128.1 mm Hg (95% uncertainty interval 126.7-129.4) in men and 124.4 mm Hg (123.0-125.9) in women. Globally, between 1980 and 2008, S BP decreased by 0.8 mm Hg per decade (-0.4 to 2.2, posterior probability of being a true decline=0.90) in men and 1.0 mm Hg per decade (-0.3 to 2.3, posterior probability=0.93) in women. Female SBP decreased by 3.5 mm Hg or more per decade in western Europe and Australasia (posterior probabilities >= 0.999). Male SBP fell most in high-income North America, by 2.8 mm Hg per decade (1.3-4.5, posterior probability >0.999), followed by Australasia and western Europe where it decreased by more than 2.0 mm Hg per decade (posterior probabilities >0.98). SBP rose in Oceania, east Africa, and south and southeast Asia for both sexes, and in west Africa for women, with the increases ranging 0.8-1.6 mm Hg per decade in men (posterior probabilities 0.72-0.91) and 1.0-2.7 mm Hg per decade for women (posterior probabilities 0.75-0.98). Female SBP was highest in some east and west African countries, with means of 135 mm Hg or greater. Male SBP was highest in Baltic and east and west African countries, where mean SBP reached 138 mm Hg or more. Men and women in western Europe had the highest SBP in high-income regions. Interpretation On average, global population SBP decreased slightly since 1980, but trends varied significantly across regions and countries. SBP is currently highest in low-income and middle-income countries. Effective population-based and personal interventions should be targeted towards low-income and middle-income countries.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Finucane, Mariel M.; Paciorek, Christopher J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lin, John K.; Singh, Gitanjali M.; Farzadfar, Farshad; Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cowan, Melanie J.; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Lim, Stephen S.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; World Health Organization; World Health Organization; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Dong, Guanghui/AAN-4630-2020; Ma, Guansheng/AAD-6767-2020; You, Qisheng/A-3619-2014; Heinrich, Joachim/N-1720-2013; Adewuya, Abiodun/N-4997-2017; Tzourio, christophe/B-4015-2009; Miranda, J. Jaime/A-8482-2008; Fuchs, Flávio D/L-5078-2016; Raitakari, Olli/AAQ-7389-2021; You, Qisheng/AAG-7153-2020; He, Jiang/AAF-5303-2020; Gulliford, Martin C/I-8606-2018; Kim, Ki Woong/D-5801-2012; Vioque, Jesus/A-1066-2008; Rampal, Lekhraj/G-6117-2010; Cífková, Renata/O-5731-2017; Tzourio, christophe/L-6344-2019; Chen, Chien-Jen/N-4723-2019; Silva, Diego Augusto Santos/AAB-9249-2020; Mokdad, Ali H./AAD-1232-2022; solfrizzi, vincenzo/AAL-3222-2020; Herrera, Víctor/ABB-4480-2020; Iats, Inct/K-2300-2013; Panagiotakos, Demosthenes/C-9776-2013; Barreto, Sandhi M/D-2855-2014; Stergiou, George/J-3083-2019; Gureje, Oye/J-1183-2014; Van Hoang, Minh/AET-0962-2022; Barros, Henrique/A-5488-2008; Bjerregaard, Peter/ABD-8894-2020; Nsour, Mohannad Al/ABE-8741-2020; Rampal, Sanjay/B-9691-2010; Breteler, Monique M.B./J-5058-2014; Önal, Ayşe Emel/AAC-8984-2020; Schneider, Ione J.C./J-8762-2013; Abdeen, Ziad/AAC-7889-2019; BABU, BONTHA VEERRAJU/X-2096-2019; Barros, Henrique/Q-8609-2019; Dankner, Rachel/Q-5245-2019; Xavier, André J/D-3287-2015; Perez-Fernandez, Roman/L-6342-2014; Danaei, Goodarz/B-6085-2008; Silva, Diego/GRF-5446-2022; Panza, Francesco/Y-2539-2019; Firmo, Josélia Oliveira Araújo/AAD-6553-2022; Panza, Francesco/M-6804-2017; Lim, Stephen S/B-4055-2012; REDON, JOSEP/E-1719-2019; CHATTERJI, Somnath/ABE-6832-2020; Castetbon, Katia/F-2686-2017; Ikeda, Nayu/J-9890-2019; Panagiotakos, Demosthenes/M-9167-2019; mohamed, mostafa/AFE-7371-2022; Panagiotakos, Demosthenes/K-8294-2019; Makdisse, Marcia/AAY-9814-2020; Sans, Susana/ABD-5378-2021; Bo, Simona/AAC-1110-2019; Bonora, Enzo/AAA-5300-2022; Redon, Josep/L-5997-2019; morgan, karen/C-3846-2012; Woodward, Mark/L-6817-2017; Bovet, Pascal/F-4477-2011; Mbanya, Jean Claude N/T-5147-2018	You, Qisheng/0000-0003-0743-7320; Heinrich, Joachim/0000-0002-9620-1629; Adewuya, Abiodun/0000-0002-7611-6953; Tzourio, christophe/0000-0002-6517-2984; Miranda, J. Jaime/0000-0002-4738-5468; You, Qisheng/0000-0003-0743-7320; He, Jiang/0000-0002-8286-9652; Gulliford, Martin C/0000-0003-1898-9075; Kim, Ki Woong/0000-0002-1103-3858; Vioque, Jesus/0000-0002-2284-148X; Cífková, Renata/0000-0003-2765-3821; Tzourio, christophe/0000-0002-6517-2984; Silva, Diego Augusto Santos/0000-0002-0489-7906; Mokdad, Ali H./0000-0002-4994-3339; solfrizzi, vincenzo/0000-0002-8524-0315; Herrera, Víctor/0000-0002-6295-1640; Panagiotakos, Demosthenes/0000-0001-8583-153X; Barreto, Sandhi M/0000-0001-7383-7811; Stergiou, George/0000-0002-6132-0038; Gureje, Oye/0000-0003-0094-5947; Bjerregaard, Peter/0000-0001-7153-8447; Nsour, Mohannad Al/0000-0003-1212-1611; Rampal, Sanjay/0000-0002-0105-6407; Breteler, Monique M.B./0000-0002-0626-9305; Schneider, Ione J.C./0000-0001-6339-7832; BABU, BONTHA VEERRAJU/0000-0001-5096-2222; Barros, Henrique/0000-0003-4699-6571; Dankner, Rachel/0000-0001-6454-6000; Xavier, André J/0000-0002-8282-0939; Perez-Fernandez, Roman/0000-0002-5894-0615; Panza, Francesco/0000-0002-7220-0656; Firmo, Josélia Oliveira Araújo/0000-0001-5330-476X; Panza, Francesco/0000-0002-7220-0656; Ikeda, Nayu/0000-0002-3424-1991; Panagiotakos, Demosthenes/0000-0001-8583-153X; mohamed, mostafa/0000-0002-1421-2667; Sans, Susana/0000-0002-0400-5197; Redon, Josep/0000-0001-8777-6773; morgan, karen/0000-0001-6193-1747; Bovet, Pascal/0000-0002-0242-4259; CASTETBON, Katia/0000-0002-1207-6729; Dong, Guang-Hui/0000-0002-2578-3369; Woodward, Mark/0000-0001-9800-5296; Pednekar, Mangesh/0000-0001-6266-5356; Mbanya, Jean Claude N/0000-0001-9651-8653; Lin, John/0000-0003-2490-4453; Farzadfar, Farshad/0000-0001-8288-4046; Hoang Van, Minh/0000-0002-4749-5536; Elliott, Paul/0000-0002-7511-5684; LIN, HSIEN-HO/0000-0002-7481-6016	Harvard University; Bill & Melinda Gates Foundation; WHO; Medical Research Council [G0801056, G0801056B] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI	Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO(World Health Organization); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JKL holds stock in Johnson & Johnson. CJP holds stock in Pfizer. GAS has received funding from Harvard University for travel purposes. ME has chaired a session at the World Cardiology Congress, which was sponsored by the organiser. All other authors declare that they have no conflicts of interest.; Funding Bill & Melinda Gates Foundation and WHO.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ahmad O.B., 2001, GENEVA WORLD HEAL OR; Andersen UO, 2010, J HYPERTENS, V28, P1091, DOI 10.1097/HJH.0b013e328335fa81; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Antikainen RL, 2010, J HUM HYPERTENS, V24, P439, DOI 10.1038/jhh.2009.85; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Campbell NRC, 2009, HYPERTENSION, V53, P128, DOI 10.1161/HYPERTENSIONAHA.108.119784; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Fasce E, 2007, J HYPERTENS, V25, P1807, DOI 10.1097/HJH.0b013e328244e481; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; HOFFMEISTER H, 1994, PREV MED, V23, P197, DOI 10.1006/pmed.1994.1027; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; Kastarinen M, 2009, J HYPERTENS, V27, P1552, DOI 10.1097/HJH.0b013e32832c41cd; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lanti M, 2005, AGING CLIN EXP RES, V17, P306; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CM, 2004, COMP QUANTIFICATION, P497; Lee K, 2010, ASIA PAC J CLIN NUTR, V19, P261; Lenfant C, 2002, ARCH INTERN MED, V162, P131, DOI 10.1001/archinte.162.2.131; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Opie LH, 2009, CARDIOVASC J AFR, V20, P52; Osler M, 2000, J EPIDEMIOL COMMUN H, V54, P108, DOI 10.1136/jech.54.2.108; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Sheffer R, 2008, EUR J PUBLIC HEALTH, V18, P121, DOI 10.1093/eurpub/ckm083; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Venketasubramanian N, 1998, INT J EPIDEMIOL, V27, P15, DOI 10.1093/ije/27.1.15; Vlasoff T, 2008, EUR J PUBLIC HEALTH, V18, P666, DOI 10.1093/eurpub/ckn063; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	44	698	722	1	132	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					568	577		10.1016/S0140-6736(10)62036-3	http://dx.doi.org/10.1016/S0140-6736(10)62036-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21295844				2022-12-01	WOS:000287556700027
J	Akil, H; Martone, ME; Van Essen, DC				Akil, Huda; Martone, Maryann E.; Van Essen, David C.			Challenges and Opportunities in Mining Neuroscience Data	SCIENCE			English	Editorial Material							MICROSCOPY; BRAIN	Understanding the brain requires a broad range of approaches and methods from the domains of biology, psychology, chemistry, physics, and mathematics. The fundamental challenge is to decipher the "neural choreography" associated with complex behaviors and functions, including thoughts, memories, actions, and emotions. This demands the acquisition and integration of vast amounts of data of many types, at multiple scales in time and in space. Here we discuss the need for neuroinformatics approaches to accelerate progress, using several illustrative examples. The nascent field of "connectomics" aims to comprehensively describe neuronal connectivity at either a macroscopic level (in long-distance pathways for the entire brain) or a microscopic level (among axons, dendrites, and synapses in a small brain region). The Neuroscience Information Framework (NIF) encompasses all of neuroscience and facilitates the integration of existing knowledge and databases of many types. These examples illustrate the opportunities and challenges of data mining across multiple tiers of neuroscience information and underscore the need for cultural and infrastructure changes if neuroinformatics is to fulfill its potential to advance our understanding of the brain.	[Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Martone, Maryann E.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Van Essen, David C.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego; Washington University (WUSTL)	Akil, H (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	akil@umich.edu	Van Essen, David/ABA-8888-2020	Martone, Maryann/0000-0002-8406-3871	NIDA NIH HHS [P01 DA021633-01A2, 5P01-DA021633-02, P01 DA021633] Funding Source: Medline; NIMH NIH HHS [U54 MH091657, R01 MH060974, 1U54MH091657-01] Funding Source: Medline; NINDS NIH HHS [HHSN271200800035C] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060974, U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA021633] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bernard R, 2010, MOL PSYCHIAT    0413; Bjorklund A., 1983, HDB CHEM NEUROANATOM, VI; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Bug WJ, 2008, NEUROINFORMATICS, V6, P175, DOI 10.1007/s12021-008-9032-z; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; CRICK F, 1993, NATURE, V361, P109, DOI 10.1038/361109a0; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI [10.1038/nmeth.f.324, 10.1038/NMETH.F.324]; Gardner D, 2008, NEUROINFORMATICS, V6, P149, DOI 10.1007/s12021-008-9024-z; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; Gupta A, 2008, NEUROINFORMATICS, V6, P205, DOI 10.1007/s12021-008-9033-y; Hey T, 2009, 4 PARADIGM DATA INTE; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Marcus DS, 2007, NEUROINFORMATICS, V5, P11, DOI 10.1385/NI:5:1:11; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Martone ME, 2004, NAT NEUROSCI, V7, P467, DOI 10.1038/nn1229; Nicolson N., 1982, LETT V WOOLF; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Watson BO, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00029; WHO, 2010, MENT HLTH DEV TARG P; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	27	115	117	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					708	712		10.1126/science.1199305	http://dx.doi.org/10.1126/science.1199305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311009	Green Accepted			2022-12-01	WOS:000287205700052
J	Gong, CG; Maquat, LE				Gong, Chenguang; Maquat, Lynne E.			lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3 ' UTRs via Alu elements	NATURE			English	Article							THERMODYNAMIC PARAMETERS; NONCODING RNAS; EXPRESSION; PREDICTION; DATABASE; REPEATS; BINDING; PROTEIN; IMPACT	Staufen 1 (STAU1)-mediated messenger RNA decay (SMD) involves the degradation of translationally active mRNAs whose 3'-untranslated regions (39 UTRs) bind to STAU1, a protein that binds to double-stranded RNA(1,2). Earlier studies defined the STAU1-binding site within ADP-ribosylation factor 1 (ARF1) mRNA as a 19-base-pair stem with a 100-nucleotide apex(2). However, we were unable to identify comparable structures in the 3' UTRs of other targets of SMD. Here we show that STAU1-binding sites can be formed by imperfect base-pairing between an Alu element in the 3' UTR of an SMD target and another Alu element in a cytoplasmic, polyadenylated long non-coding RNA (lncRNA). An individual lncRNA can downregulate a subset of SMD targets, and distinct lncRNAs can downregulate the same SMD target. These are previously unappreciated functions of non-coding RNAs and Alu elements(3-5). Not all mRNAs that contain an Alu element in the 3' UTR are targeted for SMD even in the presence of a complementary lncRNA that targets other mRNAs for SMD. Most known trans-acting RNA effectors consist of fewer than 200 nucleotides, and these include small nucleolar RNAs and microRNAs. Our finding that the binding of STAU1 to mRNAs can be transactivated by lncRNAs uncovers an unexpected strategy that cells use to recruit proteins to mRNAs and mediate the decay of these mRNAs. We name these lncRNAs half-STAU1-binding site RNAs (1/2-sbsRNAs).	[Gong, Chenguang; Maquat, Lynne E.] Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA; [Gong, Chenguang; Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Maquat, LE (corresponding author), Univ Rochester, Ctr RNA Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu	Gong, Chenguang/F-5791-2014	Maquat, Lynne/0000-0002-2789-2075	National Institutes of Health [GM074593]; Elon Huntington Hooker Graduate Student Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074593, R37GM074593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elon Huntington Hooker Graduate Student Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Mathews and A. Grossfield for the use of computer clusters, D. Matthews for access to the program Structure 5.0, K. Nerhrke for fluorescence microscope time, S. de Lucas and J. Ortiz for anti-STAU1 antibodies, M. Gorospe for pcDNA3-MS2bsX12, S. Higgins and P. Higgins for HaCaT cells and advice on the scrape-injury repair assay, J. Wang for the initial BAG5 mRNA assays, and O. Isken, M. Gleghorn and D. Matthews for comments on the manuscript. This work was supported by the National Institutes of Health (GM074593 to L. E. M.) and an Elon Huntington Hooker Graduate Student Fellowship (C.G.).	ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Pang KC, 2007, NUCLEIC ACIDS RES, V35, pD178, DOI 10.1093/nar/gkl926; Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; YULUG IG, 1995, GENOMICS, V27, P544, DOI 10.1006/geno.1995.1090; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	897	966	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					284	+		10.1038/nature09701	http://dx.doi.org/10.1038/nature09701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307942	Green Accepted			2022-12-01	WOS:000287144200049
J	Gibson, WT; Veldhuis, JH; Rubinstein, B; Cartwright, HN; Perrimon, N; Brodland, GW; Nagpal, R; Gibson, MC				Gibson, William T.; Veldhuis, James H.; Rubinstein, Boris; Cartwright, Heather N.; Perrimon, Norbert; Brodland, G. Wayne; Nagpal, Radhika; Gibson, Matthew C.			Control of the Mitotic Cleavage Plane by Local Epithelial Topology	CELL			English	Article							REGULATES SPINDLE ORIENTATION; ORIENTED CELL-DIVISION; MECHANICAL SIGNALS; 1ST CLEAVAGE; DROSOPHILA; SHAPE; POLARITY; NUCLEUS; MITOSIS; MICROTUBULES	For nearly 150 years, it has been recognized that cell shape strongly influences the orientation of the mitotic cleavage plane (e. g., Hofmeister, 1863). However, we still understand little about the complex interplay between cell shape and cleavage-plane orientation in epithelia, where polygonal cell geometries emerge from multiple factors, including cell packing, cell growth, and cell division itself. Here, using mechanical simulations, we show that the polygonal shapes of individual cells can systematically bias the long-axis orientations of their adjacent mitotic neighbors. Strikingly, analyses of both animal epithelia and plant epidermis confirm a robust and nearly identical correlation between local cell topology and cleavage-plane orientation in vivo. Using simple mathematics, we show that this effect derives from fundamental packing constraints. Our results suggest that local epithelial topology is a key determinant of cleavage-plane orientation, and that cleavage-plane bias may be a widespread property of polygonal cell sheets in plants and animals.	[Gibson, William T.; Rubinstein, Boris; Cartwright, Heather N.; Gibson, Matthew C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gibson, William T.; Nagpal, Radhika] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Gibson, William T.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Veldhuis, James H.; Brodland, G. Wayne] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Gibson, William T.; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Gibson, Matthew C.] Kansas Univ Med Ctr, Dept Anat & Cell Biol, Kansas City, MO 64110 USA	Stowers Institute for Medical Research; Harvard University; Harvard University; University of Waterloo; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Gibson, MC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	mg2@stowers.org		Gibson, Matthew/0000-0001-5588-8842; Cartwright, Heather/0000-0001-6639-5808; Perrimon, Norbert/0000-0001-7542-472X	Stowers Institute for Medical Research; Burroughs Wellcome Fund; National Science Foundation; Natural Sciences and Engineering Research Council of Canada; Howard Hughes Medical Institute; NIH/NIGMS [T32 GM008313, 1029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support for this research from the Stowers Institute for Medical Research and the Burroughs Wellcome Fund (to M. C. G.), from the National Science Foundation (to R.N.), from the Natural Sciences and Engineering Research Council of Canada (to G. W. B.), and from the Howard Hughes Medical Institute (to N.P.). W. T. G. was supported in part by NIH/NIGMS Molecular Biophysics Training Grant #T32 GM008313 and CTC grant 1029 to M.C.G.	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; BLACK SD, 1988, DEV BIOL, V128, P65, DOI 10.1016/0012-1606(88)90267-9; Brodland GW, 2002, J BIOMECH, V35, P673, DOI 10.1016/S0021-9290(02)00006-4; Buschmann H, 2006, CURR BIOL, V16, P1938, DOI 10.1016/j.cub.2006.08.028; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; COWAN R, 1988, J THEOR BIOL, V131, P33, DOI 10.1016/S0022-5193(88)80118-8; Dubertret B, 1998, PHYS REV E, V58, P6368, DOI 10.1103/PhysRevE.58.6368; Dubertret B, 1997, BIOPHYS J, V73, P38, DOI 10.1016/S0006-3495(97)78045-7; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; FLANDERS DJ, 1990, J CELL BIOL, V110, P1111, DOI 10.1083/jcb.110.4.1111; Gallagher K, 1999, DEVELOPMENT, V126, P4623; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; GOODBODY KC, 1991, DEVELOPMENT, V113, P931; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hofmeister W., 1863, JB WISSENSCHAFT BOT, V3, P259; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; KATSUTA J, 1990, J CELL SCI, V95, P413; KORN RW, 1973, NEW PHYTOL, V72, P1357, DOI 10.1111/j.1469-8137.1973.tb02114.x; Kost B, 2002, CELL, V108, P9, DOI 10.1016/S0092-8674(01)00634-1; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; Li W, 2009, CURR BIOL, V19, P1821, DOI 10.1016/j.cub.2009.09.023; LINTILHAC PM, 1984, NATURE, V307, P363, DOI 10.1038/307363a0; LLOYD CW, 1991, DEVELOPMENT, P55; Lynch TM, 1997, DEV BIOL, V181, P246, DOI 10.1006/dbio.1996.8462; Miri MF, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031101; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; PALEVITZ BA, 1987, J CELL BIOL, V104, P1515, DOI 10.1083/jcb.104.6.1515; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; PESHKIN MA, 1991, PHYS REV LETT, V67, P1803, DOI 10.1103/PhysRevLett.67.1803; PICKETTHEAPS JD, 1966, J CELL SCI, V1, P109; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rivier N, 1995, ACTA BIOTHEOR, V43, P403, DOI 10.1007/BF00713562; RIVIER N, 1982, J PHYS A-MATH GEN, V15, pL143, DOI 10.1088/0305-4470/15/3/012; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sinnott EW, 1940, P NATL ACAD SCI USA, V26, P223, DOI 10.1073/pnas.26.4.223; Speicher S, 2008, CURR BIOL, V18, P831, DOI 10.1016/j.cub.2008.04.072; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; TRAAS J, 1995, NATURE, V375, P676, DOI 10.1038/375676a0; Vanstraelen M, 2006, CURR BIOL, V16, P308, DOI 10.1016/j.cub.2005.12.035; Walker KL, 2007, CURR BIOL, V17, P1827, DOI 10.1016/j.cub.2007.09.063; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019; Wright AJ, 2009, PLANT CELL, V21, P234, DOI 10.1105/tpc.108.062810	56	142	143	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					427	438		10.1016/j.cell.2010.12.035	http://dx.doi.org/10.1016/j.cell.2010.12.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295702	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000286973100014
J	Ampollini, L; Carbognani, P				Ampollini, Luca; Carbognani, Paolo			Madelung's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ampollini, Luca; Carbognani, Paolo] Univ Parma, I-43100 Parma, Italy	University of Parma	Ampollini, L (corresponding author), Univ Parma, I-43100 Parma, Italy.	lampollini@ao.pr.it		Ampollini, Luca/0000-0003-2225-299X					0	12	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					465	465		10.1056/NEJMicm1003531	http://dx.doi.org/10.1056/NEJMicm1003531			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288098				2022-12-01	WOS:000286885900012
J	Chapman, HN; Fromme, P; Barty, A; White, TA; Kirian, RA; Aquila, A; Hunter, MS; Schulz, J; DePonte, DP; Weierstall, U; Doak, RB; Maia, FRNC; Martin, AV; Schlichting, I; Lomb, L; Coppola, N; Shoeman, RL; Epp, SW; Hartmann, R; Rolles, D; Rudenko, A; Foucar, L; Kimmel, N; Weidenspointner, G; Holl, P; Liang, MN; Barthelmess, M; Caleman, C; Boutet, S; Bogan, MJ; Krzywinski, J; Bostedt, C; Bajt, S; Gumprecht, L; Rudek, B; Erk, B; Schmidt, C; Homke, A; Reich, C; Pietschner, D; Struder, L; Hauser, G; Gorke, H; Ullrich, J; Herrmann, S; Schaller, G; Schopper, F; Soltau, H; Kuhnel, KU; Messerschmidt, M; Bozek, JD; Hau-Riege, SP; Frank, M; Hampton, CY; Sierra, RG; Starodub, D; Williams, GJ; Hajdu, J; Timneanu, N; Seibert, MM; Andreasson, J; Rocker, A; Jonsson, O; Svenda, M; Stern, S; Nass, K; Andritschke, R; Schroter, CD; Krasniqi, F; Bott, M; Schmidt, KE; Wang, XY; Grotjohann, I; Holton, JM; Barends, TRM; Neutze, R; Marchesini, S; Fromme, R; Schorb, S; Rupp, D; Adolph, M; Gorkhover, T; Andersson, I; Hirsemann, H; Potdevin, G; Graafsma, H; Nilsson, B; Spence, JCH				Chapman, Henry N.; Fromme, Petra; Barty, Anton; White, Thomas A.; Kirian, Richard A.; Aquila, Andrew; Hunter, Mark S.; Schulz, Joachim; DePonte, Daniel P.; Weierstall, Uwe; Doak, R. Bruce; Maia, Filipe R. N. C.; Martin, Andrew V.; Schlichting, Ilme; Lomb, Lukas; Coppola, Nicola; Shoeman, Robert L.; Epp, Sascha W.; Hartmann, Robert; Rolles, Daniel; Rudenko, Artem; Foucar, Lutz; Kimmel, Nils; Weidenspointner, Georg; Holl, Peter; Liang, Mengning; Barthelmess, Miriam; Caleman, Carl; Boutet, Sebastien; Bogan, Michael J.; Krzywinski, Jacek; Bostedt, Christoph; Bajt, Sasa; Gumprecht, Lars; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Reich, Christian; Pietschner, Daniel; Strueder, Lothar; Hauser, Guenter; Gorke, Hubert; Ullrich, Joachim; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Soltau, Heike; Kuehnel, Kai-Uwe; Messerschmidt, Marc; Bozek, John D.; Hau-Riege, Stefan P.; Frank, Matthias; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri; Williams, Garth J.; Hajdu, Janos; Timneanu, Nicusor; Seibert, M. Marvin; Andreasson, Jakob; Rocker, Andrea; Joensson, Olof; Svenda, Martin; Stern, Stephan; Nass, Karol; Andritschke, Robert; Schroeter, Claus-Dieter; Krasniqi, Faton; Bott, Mario; Schmidt, Kevin E.; Wang, Xiaoyu; Grotjohann, Ingo; Holton, James M.; Barends, Thomas R. M.; Neutze, Richard; Marchesini, Stefano; Fromme, Raimund; Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais; Andersson, Inger; Hirsemann, Helmut; Potdevin, Guillaume; Graafsma, Heinz; Nilsson, Bjoern; Spence, John C. H.			Femtosecond X-ray protein nanocrystallography	NATURE			English	Article							REFINEMENT	X-ray crystallography provides the vast majority of macromolecular structures, but the success of the method relies on growing crystals of sufficient size. In conventional measurements, the necessary increase in X-ray dose to record data from crystals that are too small leads to extensive damage before a diffraction signal can be recorded(1-3). It is particularly challenging to obtain large, well-diffracting crystals of membrane proteins, for which fewer than 300 unique structures have been determined despite their importance in all living cells. Here we present a method for structure determination where single-crystal X-ray diffraction 'snapshots' are collected from a fully hydrated stream of nanocrystals using femtosecond pulses from a hard-X-ray free-electron laser, the Linac Coherent Light Source(4). We prove this concept with nanocrystals of photosystem I, one of the largest membrane protein complexes(5). More than 3,000,000 diffraction patterns were collected in this study, and a three-dimensional data set was assembled from individual photosystem I nanocrystals (similar to 200 nm to 2 mm in size). We mitigate the problem of radiation damage in crystallography by using pulses briefer than the timescale of most damage processes(6). This offers a new approach to structure determination of macromolecules that do not yield crystals of sufficient size for studies using conventional radiation sources or are particularly sensitive to radiation damage.	[Chapman, Henry N.; Barty, Anton; White, Thomas A.; Aquila, Andrew; Schulz, Joachim; DePonte, Daniel P.; Martin, Andrew V.; Coppola, Nicola; Liang, Mengning; Caleman, Carl; Gumprecht, Lars; Stern, Stephan] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Chapman, Henry N.; Nass, Karol] Univ Hamburg, D-22761 Hamburg, Germany; [Fromme, Petra; Hunter, Mark S.; Grotjohann, Ingo; Fromme, Raimund] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Kirian, Richard A.; Weierstall, Uwe; Doak, R. Bruce; Schmidt, Kevin E.; Wang, Xiaoyu; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Maia, Filipe R. N. C.; Hajdu, Janos; Timneanu, Nicusor; Seibert, M. Marvin; Andreasson, Jakob; Rocker, Andrea; Joensson, Olof; Svenda, Martin] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [Schlichting, Ilme; Epp, Sascha W.; Rolles, Daniel; Rudenko, Artem; Foucar, Lutz; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Strueder, Lothar; Ullrich, Joachim; Krasniqi, Faton] Max Planck Adv Study Grp, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Schlichting, Ilme; Lomb, Lukas; Shoeman, Robert L.; Rolles, Daniel; Foucar, Lutz; Krasniqi, Faton; Bott, Mario; Barends, Thomas R. M.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Epp, Sascha W.; Rudenko, Artem; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Ullrich, Joachim; Kuehnel, Kai-Uwe; Schroeter, Claus-Dieter] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hartmann, Robert; Holl, Peter; Reich, Christian; Soltau, Heike] PNSensor GmbH, D-81739 Munich, Germany; [Kimmel, Nils; Weidenspointner, Georg; Pietschner, Daniel; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Halbleiterlab, D-81739 Munich, Germany; [Weidenspointner, Georg] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Boutet, Sebastien; Krzywinski, Jacek; Bostedt, Christoph; Messerschmidt, Marc; Bozek, John D.; Williams, Garth J.] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Gorke, Hubert] Forschungszentrum Julich, Inst ZEL, D-52425 Julich, Germany; [Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Holton, James M.; Marchesini, Stefano] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Neutze, Richard] Univ Gothenburg, Dept Chem Biochem & Biophys, SE-40530 Gothenburg, Sweden; [Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais] Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany; [Andersson, Inger] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Uppsala University; Max Planck Society; Max Planck Society; Max Planck Society; PNSensor GmbH; Max Planck Society; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Research Center Julich; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Gothenburg; Technical University of Berlin; Swedish University of Agricultural Sciences	Chapman, HN (corresponding author), DESY, Ctr Free Electron Laser Sci, Notkestr 85, D-22607 Hamburg, Germany.	henry.chapman@desy.de	Barty, Anton/K-5137-2014; Rudek, Benedikt/AAX-1278-2021; Marchesini, Stefano/GYR-1409-2022; Bajt, Sasa/G-2228-2010; Rupp, Daniela/AAD-7978-2021; Gorkhover, Tais/K-8468-2012; Nass, Karol/K-1970-2012; Messerschmidt, Marc/F-3796-2010; Schlichting, Ilme/I-1339-2013; Maia, Filipe R.N.C./C-3146-2014; Marchesini, Stefano/A-6795-2009; Messerschmidt, Marc/Y-8929-2019; Fromme, Raimund/AAG-6578-2019; Weierstall, Uwe/B-3568-2011; Fromme, Raimund/C-8885-2012; Rudek, Benedikt/A-5100-2017; Fromme, Raimund/W-5838-2019; Bozek, John D/E-9260-2010; Neutze, Richard/A-7573-2010; FRS, Henry N Chapman/G-2153-2010; Bajt, Sasa/O-4695-2019; Kirian, Richard/M-3750-2013; Williams, Garth/H-1606-2012; Jönsson, H Olof/O-8664-2017; Rupp, Daniela/P-7590-2016; Frank, Matthias/O-9055-2014; Timneanu, Nicusor/C-7691-2012; Bogan, Mike/I-6962-2012; Rudenko, Artem/C-7412-2009	Barty, Anton/0000-0003-4751-2727; Rudek, Benedikt/0000-0002-6404-4294; Rupp, Daniela/0000-0002-6504-7956; Nass, Karol/0000-0001-8843-1566; Messerschmidt, Marc/0000-0002-8641-3302; Maia, Filipe R.N.C./0000-0002-2141-438X; Marchesini, Stefano/0000-0002-6798-2913; Messerschmidt, Marc/0000-0002-8641-3302; Fromme, Raimund/0000-0003-4835-1080; Fromme, Raimund/0000-0003-4835-1080; Bozek, John D/0000-0001-7486-7238; Neutze, Richard/0000-0003-0986-6153; FRS, Henry N Chapman/0000-0002-4655-1743; Bajt, Sasa/0000-0002-7163-7602; Jönsson, H Olof/0000-0002-2076-0918; Timneanu, Nicusor/0000-0001-7328-0400; Bogan, Mike/0000-0001-9318-3333; Rudenko, Artem/0000-0002-9154-8463; MARTIN, ANDREW/0000-0003-3704-1829; Schulz, Joachim/0000-0002-9310-8832; Fromme, Petra/0000-0003-0953-4909; Andreasson, Jakob/0000-0002-3202-2330; graafsma, heinz/0000-0003-2304-667X; Epp, Sascha/0000-0001-6366-9113; Aquila, Andrew/0000-0003-0358-2774; Stern, Stephan/0000-0001-9786-7513; Schmidt, Kevin/0000-0002-1597-9835; Kirian, Richard/0000-0001-7197-3086; Seibert, Mark Marvin/0000-0003-0251-0744; Frank, Matthias/0000-0002-5244-0791; Erk, Benjamin/0000-0001-8413-3588; RUDENKO, Artem/0000-0001-6771-2510	DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Center for Bio-Inspired Solar Fuel Production; DOE, Office of Basic Energy Sciences [DE-SC0001016]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung; Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics; Max Planck Society; US National Science Foundation [0417142, MCB-1021557]; US National Institutes of Health [1R01GM095583-01, 1U54GM094625-01]; Swedish Research Council; Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; CBST at the University of California [PHY 0120999]; Div Of Molecular and Cellular Bioscience [1021557] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583, U54GM094599, U54GM094625] Funding Source: NIH RePORTER	DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Center for Bio-Inspired Solar Fuel Production; DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Hamburg Ministry of Science and Research; Joachim Herz Stiftung; Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics; Max Planck Society(Max Planck SocietyFoundation CELLEX); US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); DFG Cluster of Excellence at the Munich Centre for Advanced Photonics(German Research Foundation (DFG)); CBST at the University of California; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Experiments were carried out at the Linac Coherent Light Source and the Advanced Light Source, both National User Facilities operated respectively by Stanford University and the University of California on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences. We acknowledge support from the DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; the Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344; the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the DOE, Office of Basic Energy Sciences (award DE-SC0001016); the Hamburg Ministry of Science and Research and the Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); the Hamburg School for Structure and Dynamics; the Max Planck Society, for funding the development and operation of the CAMP instrument within the ASG at CFEL; the US National Science Foundation (awards 0417142 and MCB-1021557); the US National Institutes of Health (awards 1R01GM095583-01 (ROADMAP) and 1U54GM094625-01 (PSI: Biology)); the Swedish Research Council; the Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; the DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; and the CBST at the University of California under cooperative agreement no. PHY 0120999. We acknowledge discussions with M. Rossmann, E. Snell, R. Stroud and A. Brunger, thank B. Hedman, E. Gullikson, F. Filsinger, A. Berg, H. Mahn and C. Kaiser for technical help and thank the staff of the LCLS for their support in carrying out these experiments.	Bergh M, 2008, Q REV BIOPHYS, V41, P181, DOI 10.1017/S003358350800471X; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Chapman HN, 2007, NATURE, V448, P676, DOI 10.1038/nature06049; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; DePonte DP, 2009, MICRON, V40, P507, DOI 10.1016/j.micron.2008.12.009; Ding Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.254801; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Emma P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074801; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Fromme P., 2009, CURR TOP MEMBR, V63, P192; Fung R, 2009, NAT PHYS, V5, P64, DOI [10.1038/nphys1129, 10.1038/NPHYS1129]; Hau-Riege SP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051906; HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Hunter M. S., BIOPHYS J IN PRESS; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Loh NTD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026705; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Riekel C, 2004, J SYNCHROTRON RADIAT, V11, P4, DOI 10.1107/S090904950302541X; Robinson I, 2009, NAT MATER, V8, P291, DOI [10.1038/nmat2400, 10.1038/NMAT2400]; ROSSMANN MG, 1979, J APPL CRYSTALLOGR, V12, P570, DOI 10.1107/S0021889879013273; SAYRE D, 1952, ACTA CRYSTALLOGR, V5, P843, DOI 10.1107/S0365110X52002276; Spence JCH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198102; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; WANG DN, 1991, J MOL BIOL, V217, P691, DOI 10.1016/0022-2836(91)90526-C; Willis B., 1975, THERMAL VIBRATIONS C, V92; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177; Zaefferer S, 2000, J APPL CRYSTALLOGR, V33, P10, DOI 10.1107/S0021889899010894	35	1473	1510	7	584	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					73	U81		10.1038/nature09750	http://dx.doi.org/10.1038/nature09750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293373	Green Accepted, Green Published			2022-12-01	WOS:000286886400036
J	Spence, D				Spence, Des			From the Frontline Bad medicine: cardiology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Hingorani AD, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c6244; NHS Information Centre, PRESCR DISP COMM ENG; Office for National Statistics, MORT CIRC DIS LEAD C; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2011	342								d670	10.1136/bmj.d670	http://dx.doi.org/10.1136/bmj.d670			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PR	21285189				2022-12-01	WOS:000287138000005
J	Chen, DY; Stern, SA; Garcia-Osta, A; Saunier-Rebori, B; Pollonini, G; Bambah-Mukku, D; Blitzer, RD; Alberini, CM				Chen, Dillon Y.; Stern, Sarah A.; Garcia-Osta, Ana; Saunier-Rebori, Bernadette; Pollonini, Gabriella; Bambah-Mukku, Dhananjay; Blitzer, Robert D.; Alberini, Cristina M.			A critical role for IGF-II in memory consolidation and enhancement	NATURE			English	Article							GROWTH-FACTOR-II; LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; BINDING-PROTEIN; PERSISTENT DISRUPTION; RAT HIPPOCAMPUS; RECONSOLIDATION; RECEPTOR; GENE; MECHANISMS	We report that, in the rat, administering insulin-like growth factor II (IGF-II, also known as IGF2) significantly enhances memory retention and prevents forgetting. Inhibitory avoidance learning leads to an increase in hippocampal expression of IGF-II, which requires the transcription factor CCAAT enhancer binding protein beta and is essential for memory consolidation. Furthermore, injections of recombinant IGF-II into the hippocampus after either training or memory retrieval significantly enhance memory retention and prevent forgetting. To be effective, IGF-II needs to be administered within a sensitive period of memory consolidation. IGF-II-dependent memory enhancement requires IGF-II receptors, new protein synthesis, the function of activity-regulated cytoskeletal-associated protein and glycogen-synthase kinase 3 (GSK3). Moreover, it correlates with a significant activation of synaptic GSK3 beta and increased expression of GluR1 (also known as GRIA1) alpha-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid receptor subunits. In hippocampal slices, IGF-II promotes IGF-II receptor-dependent, persistent long-term potentiation after weak synaptic stimulation. Thus, IGF-II may represent a novel target for cognitive enhancement therapies.	[Chen, Dillon Y.; Stern, Sarah A.; Garcia-Osta, Ana; Pollonini, Gabriella; Bambah-Mukku, Dhananjay; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Saunier-Rebori, Bernadette; Blitzer, Robert D.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Blitzer, Robert D.; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Alberini, CM (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	Cristina.Alberini@mssm.edu	Stern, Sarah/AAV-6019-2021; Garcia-Osta, Ana/H-1139-2017	Stern, Sarah/0000-0002-3033-8251; Garcia-Osta, Ana/0000-0001-6326-9064; Bambah-Mukku, Dhananjay/0000-0001-5822-6326	NARSAD [R01-MH065635, R01-MH074736]; Hirschl Foundation; Philoctetes Foundation [F31-MH816213, T32-MH087004, R21-DA29298, R01-GM054508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087004, R01MH074736, R01MH065635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029298] Funding Source: NIH RePORTER	NARSAD(NARSAD); Hirschl Foundation; Philoctetes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants R01-MH065635, R01-MH074736, NARSAD, the Hirschl Foundation and Philoctetes Foundation awarded to C.M.A., F31-MH816213 to D.Y.C., and T32-MH087004 to S.A.S.; R21-DA29298 and R01-GM054508 to R.D.B. We thank M. Baxter for assistance with statistical analyses. We thank J. Feng, J.-W. Koo and C.-Y. Lu for technical assistance. We thank A. Suzuki and A. Arguello for comments on the manuscript. We thank R. Miller and the Center for Comparative Medicine and Surgery Facility at Mount Sinai School of Medicine for technical support.	Alberini CM, 2006, CELL MOL LIFE SCI, V63, P999, DOI 10.1007/s00018-006-6025-7; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Elizalde PV, 1998, J STEROID BIOCHEM, V67, P305, DOI 10.1016/S0960-0760(98)00123-X; Elkobi A, 2008, NAT NEUROSCI, V11, P1149, DOI 10.1038/nn.2190; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; KAR S, 1993, J COMP NEUROL, V333, P375, DOI 10.1002/cne.903330306; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; KITRAKI E, 1993, INT J DEV NEUROSCI, V11, P1, DOI 10.1016/0736-5748(93)90029-D; LIANG KC, 1982, BEHAV BRAIN RES, V4, P237, DOI 10.1016/0166-4328(82)90002-X; Litvin O O, 2000, Neurosci Behav Physiol, V30, P671, DOI 10.1023/A:1026698700139; Lo JH, 2010, ENDOCRINOLOGY, V151, P2128, DOI 10.1210/en.2009-0960; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2007, LEARN MEMORY, V14, P504, DOI 10.1101/lm.598307; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Nadel L, 2000, NAT REV NEUROSCI, V1, P209, DOI 10.1038/35044572; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; NISSLEY SP, 1984, CLIN ENDOCRINOL META, V13, P43; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Quesada A, 2004, J NEUROSCI RES, V75, P107, DOI 10.1002/jnr.10833; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Scalia P, 2001, J CELL BIOCHEM, V82, P610, DOI 10.1002/jcb.1196; Shamblott MJ, 1998, MOL MAR BIOL BIOTECH, V7, P181; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; VANDIJK MA, 1992, NUCLEIC ACIDS RES, V20, P3099, DOI 10.1093/nar/20.12.3099; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xu CM, 2009, J NEUROCHEM, V111, P1357, DOI 10.1111/j.1471-4159.2009.06414.x	50	289	297	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					491	U63		10.1038/nature09667	http://dx.doi.org/10.1038/nature09667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270887	Green Accepted			2022-12-01	WOS:000286596500024
J	Pinnock, H; Kendall, M; Murray, SA; Worth, A; Levack, P; Porter, M; MacNee, W; Sheikh, A				Pinnock, Hilary; Kendall, Marilyn; Murray, Scott A.; Worth, Allison; Levack, Pamela; Porter, Mike; MacNee, William; Sheikh, Aziz			Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							END-STAGE COPD; PALLIATIVE CARE; CHRONIC ILLNESS; BIOGRAPHICAL DISRUPTION; LUNG-CANCER; OLDER AGE; OF-LIFE; COMMUNITY	Objectives To understand the perspectives of people with severe chronic obstructive pulmonary disease (COPD) as their illness progresses, and of their informal and professional carers, to inform provision of care for people living and dying with COPD. Design Up to four serial qualitative interviews were conducted with each patient and nominated carer over 18 months. Interviews were transcribed and analysed both thematically and as narratives. Participants 21 patients, and 13 informal carers (a family member, friend, or neighbour) and 18 professional carers (a key health or social care professional) nominated by the patients. Setting Primary and secondary care in Lothian, Tayside, and Forth Valley, Scotland, during 2007-9. Results Eleven patients died during the study period. Our final dataset comprised 92 interviews (23 conducted with patient and informal carer together). Severe symptoms that caused major disruption to normal life were described, often in terms implying acceptance of the situation as a "way of life" rather than an "illness." Patients and their informal carers adapted to and accepted the debilitating symptoms of a lifelong condition. Professional carers' familiarity with the patients' condition, typically over many years, and prognostic uncertainty contributed to the difficulty of recognising and actively managing end stage disease. Overall, patients told a "chaos narrative" of their illness that was indistinguishable from their life story, with no clear beginning and an unanticipated end described in terms comparable with attitudes to death in a normal elderly population. Conclusions Our findings challenge current assumptions underpinning provision of end of life care for people with COPD. The policy focus on identifying a time point for transition to palliative care has little resonance for people with COPD or their clinicians and is counter productive if it distracts from early phased introduction of supportive care. Careful assessment of possible supportive and palliative care needs should be triggered at key disease milestones along a lifetime journey with COPD, in particular after hospital admission for an exacerbation.	[Pinnock, Hilary] Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, GP Sect,Med Sch, Edinburgh EH8 9AG, Midlothian, Scotland; [Kendall, Marilyn; Murray, Scott A.] Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, GP Sect, Edinburgh EH8 9AG, Midlothian, Scotland; [Levack, Pamela] Ninewells Hosp, NHS Tayside, Dundee DD1 9SY, Scotland; [MacNee, William] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Pinnock, H (corresponding author), Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, GP Sect,Med Sch, Doorway 3,Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; MacNee, William/0000-0002-3692-1448	Chief Scientist's Office of the Scottish Government	Chief Scientist's Office of the Scottish Government	This study was supported by the Chief Scientist's Office of the Scottish Government. HP is supported by a primary care research career award from the Chief Scientist's Office of the Scottish Government.	Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; [Anonymous], 2004, SOL FACTS PALL CAR; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Centers for Medicare & Medicaid Services, 2008, PUBL US DEP HLTH HUM; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Cornwell Jocelyn, 1984, HARD EARNED LIVES AC; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Department of Health, 2008, NHS END LIF CAR STRA; Department of Health, 2010, CONS STRAT SERV CHRO; Diffen E, 2010, BBC NEWS        0322; Elofsson LC, 2004, PALLIATIVE MED, V18, P611, DOI 10.1191/0269216304pm922oa; Exley C, 2005, PALLIATIVE MED, V19, P76, DOI 10.1191/0269216305pm973oa; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Frank AW., 2013, WOUNDED STORYTELLER; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Habraken JM, 2007, PATIENT EDUC COUNS, V68, P121, DOI 10.1016/j.pec.2007.05.011; Habraken JM, 2008, BRIT J GEN PRACT, V58, P844, DOI 10.3399/bjgp08X376186; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; Lynn J, 2000, J AM GERIATR SOC, V48, pS91, DOI 10.1111/j.1532-5415.2000.tb03147.x; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; NHS End of Life Care Program, 2010, GOLD STAND FRAM; NHS Quality Improvement Scotland, 2010, CLIN STAND CHRON OBS; Pound P, 1998, SOCIOL HEALTH ILL, V20, P489, DOI 10.1111/1467-9566.00112; Reissman CK, 1993, NARRATIVE ANAL; Rocker GM, 2007, J PALLIAT MED, V10, P783, DOI 10.1089/jpm.2007.9951; Sanders C, 2002, SOCIOL HEALTH ILL, V24, P227, DOI 10.1111/1467-9566.00292; Seamark DA, 2007, J ROY SOC MED, V100, P225, DOI 10.1258/jrsm.100.5.225; Seymour JE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4860; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Williams B, 2009, QUAL HEALTH RES, V19, P1443, DOI 10.1177/1049732309348363; WILLIAMS G, 1984, SOCIOL HEALTH ILL, V6, P175, DOI 10.1111/1467-9566.ep10778250; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191	41	203	205	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2011	342								d142	10.1136/bmj.d142	http://dx.doi.org/10.1136/bmj.d142			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LP	21262897	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000286886300001
J	Hirnschall, G; Schwartlander, B				Hirnschall, Gottfried; Schwartlaender, Bernhard			Treatment 2.0: catalysing the next phase of scale-up	LANCET			English	Editorial Material									[Schwartlaender, Bernhard] Joint United Nations Programme HIV AIDS, Evidence Strategy & Results Dept, CH-1211 Geneva, Switzerland; [Hirnschall, Gottfried] WHO, HIV Dept, CH-1211 Geneva, Switzerland	World Health Organization	Schwartlander, B (corresponding author), Joint United Nations Programme HIV AIDS, Evidence Strategy & Results Dept, CH-1211 Geneva, Switzerland.	schwartlanderb@unaids.org						[Anonymous], 2010, ANTIRETROVIRAL THERA; GRUBB I, 2003, PUBLIC HLTH APPROACH; Kates J, 2010, FINANCING RESPONSE A; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; MIDDELKOOP K, 2009, 5 IAS C HIV PATH TRE; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; *UN GEN ASS, 2006, 2006 HIGH LEV M AIDS; *UNAIDS, 2007, RES NEEDS AIDS LOW M; UNAIDS, 2010, TREATM 2 0 IS THIS F; UNAIDS, 2010, GLOB REP UNAIDS REP; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; World Health Organization, 2010, ANT THER HIV INF INF	12	34	34	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					209	211		10.1016/S0140-6736(11)60247-X	http://dx.doi.org/10.1016/S0140-6736(11)60247-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21353697				2022-12-01	WOS:000293201100009
J	Ishizuka, K; Kamiya, A; Oh, EC; Kanki, H; Seshadri, S; Robinson, JF; Murdoch, H; Dunlop, AJ; Kubo, K; Furukori, K; Huang, B; Zeledon, M; Hayashi-Takagi, A; Okano, H; Nakajima, K; Houslay, MD; Katsanis, N; Sawa, A				Ishizuka, Koko; Kamiya, Atsushi; Oh, Edwin C.; Kanki, Hiroaki; Seshadri, Saurav; Robinson, Jon F.; Murdoch, Hannah; Dunlop, Allan J.; Kubo, Ken-ichiro; Furukori, Keiko; Huang, Beverly; Zeledon, Mariela; Hayashi-Takagi, Akiko; Okano, Hideyuki; Nakajima, Kazunori; Houslay, Miles D.; Katsanis, Nicholas; Sawa, Akira			DISC1-dependent switch from progenitor proliferation to migration in the developing cortex	NATURE			English	Article							DEVELOPING MOUSE-BRAIN; NEURONAL MIGRATION; DISC1; PROTEIN; ADULT; GENE; MICE; DIFFERENTIATION; VISUALIZATION; DEFECTS	Regulatory mechanisms governing the sequence from progenitor cell proliferation to neuronal migration during corticogenesis are poorly understood(1-10). Here we report that phosphorylation of DISC1, a major susceptibility factor for several mental disorders, acts as a molecular switch from maintaining proliferation of mitotic progenitor cells to activating migration of postmitotic neurons in mice. Unphosphorylated DISC1 regulates canonical Wnt signalling via an interaction with GSK3 beta, whereas specific phosphorylation at serine 710 (S710) triggers the recruitment of Bardet-Biedl syndrome (BBS) proteins to the centrosome. In support of this model, loss of BBS1 leads to defects in migration, but not proliferation, whereas DISC1 knockdown leads to deficits in both. A phospho-dead mutant can only rescue proliferation, whereas a phospho-mimic mutant rescues exclusively migration defects. These data highlight a dual role for DISC1 in corticogenesis and indicate that phosphorylation of this protein at S710 activates a key developmental switch.	[Ishizuka, Koko; Kamiya, Atsushi; Seshadri, Saurav; Furukori, Keiko; Huang, Beverly; Zeledon, Mariela; Hayashi-Takagi, Akiko; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27710 USA; [Kanki, Hiroaki; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Kubo, Ken-ichiro; Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan; [Murdoch, Hannah; Dunlop, Allan J.; Houslay, Miles D.] Univ Glasgow, CMVLS, Inst Neurosci & Psychol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Duke University; Duke University; Duke University; Keio University; Keio University; University of Glasgow; Johns Hopkins University	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA.	katsanis@cellbio.duke.edu; asawa1@jhmi.edu	Kubo, Ken-ichiro/B-2520-2015; kamiya, atsushi/L-8550-2016; Houslay, Miles D/A-6825-2011; Katsanis, Nicholas/E-1837-2012; Okano, Hideyuki/I-7584-2019; Houslay, Miles/AAM-5281-2020; Nakajima, Kazunori/L-3396-2013	Kubo, Ken-ichiro/0000-0003-4023-5069; kamiya, atsushi/0000-0002-4274-5567; Nakajima, Kazunori/0000-0003-1864-9425; Houslay, Miles/0000-0002-3826-8091; Katsanis, Nicholas/0000-0002-2480-0171	USPHS [MH-084018, MH-069853, MH-085226, MH-088753, MH-091230, HD-04260, DK-072301, DK-075972]; Stanley foundation; RUSK foundation; Maryland Stem Cell Research Fund; NARSAD; Macular Vision Research Foundation; Foundation for Fighting Blindness; Health Labor Sciences; MEXT; Takeda; PMAC-PSJ; Fight for Sight Postdoctoral Fellowship; Medical Research Council, UK [G0600765]; Strategic Research Program for Brain Sciences; Medical Research Council [G0600765] Funding Source: researchfish; MRC [G0600765] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301, R01DK075972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092443, R01MH091230, R01MH069853, P20MH084018, RC1MH088753, R21MH085226] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Stanley foundation; RUSK foundation; Maryland Stem Cell Research Fund; NARSAD(NARSAD); Macular Vision Research Foundation; Foundation for Fighting Blindness; Health Labor Sciences; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda(Takeda Pharmaceutical Company Ltd); PMAC-PSJ; Fight for Sight Postdoctoral Fellowship; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Y. Y. Lema for preparing figures and organizing the manuscript and P. Talalay for critical reading of this manuscript. We appreciate J. M. Gerdes, A. K. Mustafa, N. Shahani, T. Boronina, D. Chen and R. N. Cole for scientific discussions and technical support. We thank T. Tomoda, N. Sugiyama, M. Hasegawa, Q. Lu, E. S. Anton and A. Chenn for providing us with constructs. This work was supported by USPHS grants of MH-084018 Silvo O. Conte center (A. S.), MH-069853 (A.S.), MH-085226 (A.S.), MH-088753 (A.S.), MH-091230 (A.K.), HD-04260 (N.K.), DK-072301 (N.K.), and DK-075972 (N.K.); grants from Stanley and RUSK foundations and from Maryland Stem Cell Research Fund (A.S.); grants from NARSAD and S-R foundations (A.S. and A.K.); grants from the Macular Vision Research Foundation and the Foundation for Fighting Blindness as well as the Distinguished George W. Brumley Professorship (N.K.); a grant from Health Labor Sciences (K.-i.K.); grants from Strategic Research Program for Brain Sciences (K.N.), MEXT (K.N.), Takeda (K.N.) and PMAC-PSJ (K.N.); Fight for Sight Postdoctoral Fellowship (E.O.); grant from the Medical Research Council, UK (G0600765; M.D.H.).	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Greengard P, 1998, BRAIN RES REV, V26, P274, DOI 10.1016/S0165-0173(97)00057-X; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kanki H, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-5; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mochida GH, 2004, ARCH NEUROL-CHICAGO, V61, P637, DOI 10.1001/archneur.61.5.637; Moudjou M, 1996, J CELL SCI, V109, P875; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tan PL, 2007, P NATL ACAD SCI USA, V104, P17524, DOI 10.1073/pnas.0706618104; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang X, 2007, J NEUROSCI RES, V85, P3567, DOI 10.1002/jnr.21440; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	38	145	157	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					92	U107		10.1038/nature09859	http://dx.doi.org/10.1038/nature09859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471969	Green Accepted			2022-12-01	WOS:000290218300037
J	Biton, S; Ashkenazi, A				Biton, Sharon; Ashkenazi, Avi			NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-alpha Feedforward Signaling	CELL			English	Article							NF-KAPPA-B; DOMAIN KINASE RIP; IONIZING-RADIATION; IKK ACTIVATION; DEATH; CANCER; ATM; EXPRESSION; APOPTOSIS; NECROSIS	Upon DNA damage, ataxia telangiectasia mutated (ATM) kinase triggers multiple events to promote cell survival and facilitate repair. If damage is excessive, ATM stimulates cytokine secretion to alert neighboring cells and apoptosis to eliminate the afflicted cell. ATM augments cell survival by activating nuclear factor (NF)-kappa B; however, how ATM induces cytokine production and apoptosis remains elusive. Here we uncover a p53-independent mechanism that transmits ATM-driven cytokine and caspase signals upon strong genotoxic damage. Extensive DNA lesions stimulated two sequential NF-kappa B activation phases, requiring ATM and NEMO/IKK-gamma: The first phase induced TNF-alpha-TNFR1 feedforward signaling, promoting the second phase and driving RIP1 phosphorylation. In turn, RIP1 kinase triggered JNK3/MAPK10-dependent interleukin-8 secretion and FADD-mediated proapoptotic caspase-8 activation. Thus, in the context of excessive DNA damage, ATM employs NEMO and RIP1 kinase through autocrine TNF-alpha signaling to switch on cytokine production and caspase activation. These results shed light on cell-fate regulation by ATM.	[Biton, Sharon; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bartek J, 2006, SCIENCE, V311, P1110, DOI 10.1126/science.1124540; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; HANDE KR, 1984, CANCER RES, V44, P379; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jones DT, 2001, BLOOD, V98, P2800, DOI 10.1182/blood.V98.9.2800; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Zhou DH, 2001, INT J RADIAT BIOL, V77, P763, DOI 10.1080/09553000110050047	61	210	214	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					92	103		10.1016/j.cell.2011.02.023	http://dx.doi.org/10.1016/j.cell.2011.02.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458669	Bronze			2022-12-01	WOS:000289053900012
J	Arkin, AP; Schaffer, DV				Arkin, Adam P.; Schaffer, David V.			Network News: Innovations in 21st Century Systems Biology	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; MOTIFS; GENOME; CELLS; STRATEGIES; DIVERSITY; PATHWAY; MODULE; MODEL; YEAST	A decade ago, seminal perspectives and papers set a strong vision for the field of systems biology, and a number of these themes have flourished. Here, we describe key technologies and insights that have elucidated the evolution, architecture, and function of cellular networks, ultimately leading to the first predictive genome-scale regulatory and metabolic models of organisms. Can systems approaches bridge the gap between correlative analysis and mechanistic insights?	[Arkin, Adam P.; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Arkin, Adam P.; Schaffer, David V.] EO Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Arkin, AP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931	National Institutes of Health [R01 GM073010-01]; Office of Science, Office of Biological and Environmental Research of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank our colleagues for suggesting a number of the papers that we reference in this work, and we apologize for not being able to include all of them. The authors would like to acknowledge the National Institutes of Health (R01 GM073010-01), and work conducted by ENIGMA was supported by the Office of Science, Office of Biological and Environmental Research of the US Department of Energy under contract number DE-AC02-05CH11231.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; Arkin A, 1998, GENETICS, V149, P1633; BEKEY GA, 1978, AUTOMATICA, V14, P41, DOI 10.1016/0005-1098(78)90075-4; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; CANON W, 1939, WISDOM BODY; Carlson Robert, 2003, Biosecur Bioterror, V1, P203, DOI 10.1089/153871303769201851; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cheng Y., 2000, P 8 INT C INT SYST M, P93; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; El Samad H, 2005, P 16 IFAC WORLD C; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hartemink A J, 2001, Pac Symp Biocomput, P422; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moore G. E., 1965, ELECT MAG, V38, P114, DOI DOI 10.1109/N-SSC.2006.4785860; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Rosenblueth A., 1943, PHILOS SCI, V10, P18, DOI [10.1086/286788, DOI 10.1086/286788]; Rzhetsky A, 2001, BIOINFORMATICS, V17, P988, DOI 10.1093/bioinformatics/17.10.988; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Singh AH, 2008, P NATL ACAD SCI USA, V105, P7500, DOI 10.1073/pnas.0709764105; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; WADDINGTON CH, 1954, P 9 INT C GEN, V9, P232; Waddington CH, 1977, TOOLS THOUGHT UNDERS; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10	54	35	38	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					844	849		10.1016/j.cell.2011.03.008	http://dx.doi.org/10.1016/j.cell.2011.03.008			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414475	Bronze			2022-12-01	WOS:000288543500002
J	Hoskins, AA; Friedman, LJ; Gallagher, SS; Crawford, DJ; Anderson, EG; Wombacher, R; Ramirez, N; Cornish, VW; Gelles, J; Moore, MJ				Hoskins, Aaron A.; Friedman, Larry J.; Gallagher, Sarah S.; Crawford, Daniel J.; Anderson, Eric G.; Wombacher, Richard; Ramirez, Nicholas; Cornish, Virginia W.; Gelles, Jeff; Moore, Melissa J.			Ordered and Dynamic Assembly of Single Spliceosomes	SCIENCE			English	Article							PRE-MESSENGER-RNA; MOLECULE FLUORESCENCE; YEAST SPLICEOSOME; CATALYTIC STEPS; EXON DEFINITION; IN-VIVO; COMPLEX; SNRNP; U1; MACHINE	The spliceosome is the complex macromolecular machine responsible for removing introns from precursors to messenger RNAs (pre-mRNAs). We combined yeast genetic engineering, chemical biology, and multiwavelength fluorescence microscopy to follow assembly of single spliceosomes in real time in whole-cell extracts. We find that individual spliceosomal subcomplexes associate with pre-mRNA sequentially via an ordered pathway to yield functional spliceosomes and that association of every subcomplex is reversible. Further, early subcomplex binding events do not fully commit a pre-mRNA to splicing; rather, commitment increases as assembly proceeds. These findings have important implications for the regulation of alternative splicing. This experimental strategy should prove widely useful for mechanistic analysis of other macromolecular machines in environments approaching the complexity of living cells.	[Hoskins, Aaron A.; Friedman, Larry J.; Crawford, Daniel J.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Gallagher, Sarah S.; Wombacher, Richard; Cornish, Virginia W.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Hoskins, Aaron A.; Crawford, Daniel J.; Anderson, Eric G.; Ramirez, Nicholas; Moore, Melissa J.] Univ Massachusetts, Howard Hughes Med Inst, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA	Brandeis University; Columbia University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Gelles, J (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	gelles@brandeis.edu; melissa.moore@umassmed.edu	Wombacher, Richard/M-7117-2016; Wombacher, Richard/AAP-7591-2021	Wombacher, Richard/0000-0002-3027-7778; Wombacher, Richard/0000-0002-3027-7778; Friedman, Larry/0000-0003-4946-8731	NIH [RO1s GM043369, GM81648, GM053007, GM54469, RC1 GM091804, GM759628]; National Research Service Award fellowship [GM079971, K99/R00 GM086471]; National Defense Science and Engineering Graduate fellowship; Deutscher Akademischer Austausch Dienst fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM079971, R37GM043369, R01GM053007, T32GM007596, K99GM086471, R01GM081648, R01GM043369, R01GM054469, RC1GM091804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate fellowship; Deutscher Akademischer Austausch Dienst fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Chung, A. Okonechnikov, J. Yan, J. Haber, S. Lovett, I. Correa, M.-Q. Xu, Z. Chen, and B. Smith for helpful discussions and assistance. This work was supported by NIH RO1s GM043369 (J. G.), GM81648 (J. G.), GM053007 (M. J. M), GM54469 (V. W. C.), RC1 GM091804 (V. W. C), National Research Service Award fellowship GM079971 (A. A. H.), and K99/R00 GM086471 (A. A. H.). D. J. C., S. S. G., and R. W were supported by NIH training grant GM759628, a National Defense Science and Engineering Graduate fellowship, and a Deutscher Akademischer Austausch Dienst fellowship, respectively. M. J. M. is a Howard Hughes Medical Institute investigator. V. W. C. holds patents on the TMP-tag technology, and the technology is licensed and commercialized by Active Motif.	Abelson J, 2010, NAT STRUCT MOL BIOL, V17, P504, DOI 10.1038/nsmb.1767; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Crawford DJ, 2008, RNA, V14, P170, DOI 10.1261/rna.794808; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; DUNN SMJ, 1980, BIOCHEMISTRY-US, V19, P766, DOI 10.1021/bi00545a024; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; LEGRAIN P, 1988, MOL CELL BIOL, V8, P3755, DOI 10.1128/MCB.8.9.3755; Liu L, 2007, NAT STRUCT MOL BIOL, V14, P519, DOI 10.1038/nsmb1240; Miller LW, 2005, NAT METHODS, V2, P255, DOI 10.1038/NMETH749; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Ruby SW, 1997, J BIOL CHEM, V272, P17333, DOI 10.1074/jbc.272.28.17333; Schneider M, 2010, MOL CELL, V38, P223, DOI 10.1016/j.molcel.2010.02.027; SERAPHIN B, 1991, EMBO J, V10, P1209, DOI 10.1002/j.1460-2075.1991.tb08062.x; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Xu YZ, 2004, EMBO J, V23, P376, DOI 10.1038/sj.emboj.7600050	23	200	204	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1289	1295		10.1126/science.1198830	http://dx.doi.org/10.1126/science.1198830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393538	Green Accepted			2022-12-01	WOS:000288215200037
J	Septimus, EJ; Perlin, JB; Cormier, SB; Moody, JA; Hickok, JD				Septimus, Edward J.; Perlin, Jonathan B.; Cormier, Scott B.; Moody, Julia A.; Hickok, Jason D.			A Multifaceted Mandatory Patient Safety Program and Seasonal Influenza Vaccination of Health Care Workers in Community Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Septimus, Edward J.; Perlin, Jonathan B.; Cormier, Scott B.; Moody, Julia A.; Hickok, Jason D.] HCA Inc, Clin Serv Grp, Nashville, TN USA	Hospital Corporation of America	Septimus, EJ (corresponding author), HCA Inc, Clin Serv Grp, Nashville, TN USA.	jonathan.perlin@hcahealthcare.com						Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; *CDCP, SEAS INFL FREE RES; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210	5	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					999	1000		10.1001/jama.2011.244	http://dx.doi.org/10.1001/jama.2011.244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386077				2022-12-01	WOS:000288129600018
J	Arpaia, N; Godec, J; Lau, L; Sivick, KE; McLaughlin, LM; Jones, MB; Dracheva, T; Peterson, SN; Monack, DM; Barton, GM				Arpaia, Nicholas; Godec, Jernej; Lau, Laura; Sivick, Kelsey E.; McLaughlin, Laura M.; Jones, Marcus B.; Dracheva, Tatiana; Peterson, Scott N.; Monack, Denise M.; Barton, Gregory M.			TLR Signaling Is Required for Salmonella typhimurium Virulence	CELL			English	Article							TOLL-LIKE RECEPTORS; III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; PHAGOSOME MATURATION; SEROVAR TYPHIMURIUM; NATURAL-RESISTANCE; DENDRITIC CELLS; INTRACELLULAR PARASITES; ANTIMICROBIAL PEPTIDES; MACROPHAGE APOPTOSIS	Toll-like receptors (TLRs) contribute to host resistance to microbial pathogens and can drive the evolution of virulence mechanisms. We have examined the relationship between host resistance and pathogen virulence using mice with a functional allele of the nramp-1 gene and lacking combinations of TLRs. Mice deficient in both TLR2 and TLR4 were highly susceptible to the intracellular bacterial pathogen Salmonella typhimurium, consistent with reduced innate immune function. However, mice lacking additional TLRs involved in S. typhimurium recognition were less susceptible to infection. In these TLR-deficient cells, bacteria failed to upregulate Salmonella pathogenicity island 2 (SPI-2) genes and did not form a replicative compartment. We demonstrate that TLR signaling enhances the rate of acidification of the Salmonella-containing phagosome, and inhibition of this acidification prevents SPI-2 induction. Our results indicate that S. typhimurium requires cues from the innate immune system to regulate virulence genes necessary for intracellular survival, growth, and systemic infection.	[Arpaia, Nicholas; Godec, Jernej; Lau, Laura; Sivick, Kelsey E.; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [McLaughlin, Laura M.; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Jones, Marcus B.; Dracheva, Tatiana; Peterson, Scott N.] J Craig Venter Inst, Pathogen Funct Genom Resource Ctr, Rockville, MD 20850 USA	University of California System; University of California Berkeley; Stanford University; J. Craig Venter Institute	Barton, GM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	barton@berkeley.edu	hongbo, yi/G-9615-2011; Arpaia, Nicholas/R-2549-2018	Barton, Gregory/0000-0002-3793-0100; Monack, Denise/0000-0003-3804-2209; Arpaia, Nicholas/0000-0002-0657-0528	NIH [P01-AI063302, Y1-AI-8401, T32-GM007232]; Burroughs Wellcome Fund; University of California Cancer Research Coordinating Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI008401, R22AI008401, R01AI072429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); University of California Cancer Research Coordinating Committee(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Machen, P. Herzmark, J. Ross, and E. Peled for assistance with ratiometric imaging; members of the Barton lab, J. Ayres, and R. Vance for critical reading of this manuscript; C. Rae and N. Meyer-Morse for assistance with L. monocytogenes; M. Fontana and K. Monroe for assistance with L. pneumophila; R. Zalpuri and K. McDonald for assistance with EM; and H. Nolla for assistance with flow cytometry. This work was supported in part by grants from the NIH (P01-AI063302 to D. M. M. and G. M. B.; Y1-AI-8401 to S. N. P.), the Burroughs Wellcome Fund (D. M. M.), and the University of California Cancer Research Coordinating Committee (G. M. B.) and an NIH NRSA Trainee appointment on grant T32-GM007232 (N. A.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cook P, 2007, IMMUNOLOGY, V122, P222, DOI 10.1111/j.1365-2567.2007.02631.x; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kim CC, 2004, J BACTERIOL, V186, P4694, DOI 10.1128/JB.186.14.4694-4704.2004; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pfeifer CG, 1999, INFECT IMMUN, V67, P5690, DOI 10.1128/IAI.67.11.5690-5698.1999; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Royle MCJ, 2003, J IMMUNOL, V170, P5445, DOI 10.4049/jimmunol.170.11.5445; Russell DG, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217a; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vidal SM, 1996, J IMMUNOL, V157, P3559; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wong CE, 2009, INFECT IMMUN, V77, P4750, DOI 10.1128/IAI.00545-09; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599	72	167	171	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					675	688		10.1016/j.cell.2011.01.031	http://dx.doi.org/10.1016/j.cell.2011.01.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376231	Green Accepted, Bronze			2022-12-01	WOS:000288007100008
J	Wartlick, O; Mumcu, P; Kicheva, A; Bittig, T; Seum, C; Julicher, F; Gonzalez-Gaitan, M				Wartlick, O.; Mumcu, P.; Kicheva, A.; Bittig, T.; Seum, C.; Juelicher, F.; Gonzalez-Gaitan, M.			Dynamics of Dpp Signaling and Proliferation Control	SCIENCE			English	Article							WING IMAGINAL DISC; CELL-PROLIFERATION; MORPHOGEN GRADIENT; DROSOPHILA; SIZE; GROWTH; HEDGEHOG; ROBUSTNESS; EXPRESSION; DIFFUSION	Morphogens, such as Decapentaplegic (Dpp) in the fly imaginal discs, form graded concentration profiles that control patterning and growth of developing organs. In the imaginal discs, proliferative growth is homogeneous in space, posing the conundrum of how morphogen concentration gradients could control position-independent growth. To understand the mechanism of proliferation control by the Dpp gradient, we quantified Dpp concentration and signaling levels during wing disc growth. Both Dpp concentration and signaling gradients scale with tissue size during development. On average, cells divide when Dpp signaling levels have increased by 50%. Our observations are consistent with a growth control mechanism based on temporal changes of cellular morphogen signaling levels. For a scaling gradient, this mechanism generates position-independent growth rates.	[Mumcu, P.; Bittig, T.; Juelicher, F.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Wartlick, O.; Kicheva, A.; Seum, C.; Gonzalez-Gaitan, M.] Univ Geneva, Fac Sci, Dept Biochem, CH-1211 Geneva, Switzerland; [Wartlick, O.; Kicheva, A.; Seum, C.; Gonzalez-Gaitan, M.] Univ Geneva, Fac Sci, Dept Mol Biol, CH-1211 Geneva, Switzerland	Max Planck Society; University of Geneva; University of Geneva	Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	julicher@pks.mpg.de; marcos.gonzalez@unige.ch	Julicher, Frank/B-1828-2009	Julicher, Frank/0000-0003-4731-9185; Kicheva, Anna/0000-0003-4509-4998; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321	Max-Planck-Gesellschaft; Geneva University; European Research Council; SystemsX (LipidX); Swiss National Science Foundation (SNF); National Centre of Competence in Research (NCCR)	Max-Planck-Gesellschaft(Max Planck Society); Geneva University; European Research Council(European Research Council (ERC)European Commission); SystemsX (LipidX); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	We thank E. Sanchez-Herrero, S. Cohen, G. Campbell, and K. Irvine for reagents, and M. Milinkovitch, A. Martinez-Arias, T. Ferraro, and F. Naef for discussions. A.K. developed and performed the FRAP and P-Mad assays. O.W. generated all other experimental data and had a leading role to develop the quantitative methods to analyze it. P.M. had a leading role to develop the theoretical description of growth control, and he performed computer simulations. P.M. and T.B. developed a continuum theory of the Dpp gradient during growth and studied possible growth rules. C.S. generated reagents. O.W., P.M., A.K., T.B., F.J., and M.G.-G. developed the whole project synergistically and equally and wrote the paper together. P.M., T.B., and F.J. were supported by the Max-Planck-Gesellschaft. O.W., A.K., C.S., and M.G.-G. were supported by Geneva University and by European Research Council advanced investigator grant (SARA), SystemsX (LipidX), Swiss National Science Foundation (SNF), National Centre of Competence in Research (NCCR) chemical biology and Frontiers in Genetics and R'equip grants.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Bargmann C.I., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barkai N, 2009, FEBS J, V276, P1196, DOI 10.1111/j.1742-4658.2008.06854.x; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Ben-Zvi D, 2010, P NATL ACAD SCI USA, V107, P6924, DOI 10.1073/pnas.0912734107; Burke R, 1996, DEVELOPMENT, V122, P2261; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Day SJ, 2000, DEVELOPMENT, V127, P2977; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FAIN MJ, 1982, DEV BIOL, V92, P247, DOI 10.1016/0012-1606(82)90169-5; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; OTHMER HG, 1980, P NATL ACAD SCI-BIOL, V77, P4180, DOI 10.1073/pnas.77.7.4180; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Strigini M, 1997, DEVELOPMENT, V124, P4697; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; Yao LC, 2008, DEVELOPMENT, V135, P2183, DOI 10.1242/dev.015826; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	39	232	235	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1154	1159		10.1126/science.1200037	http://dx.doi.org/10.1126/science.1200037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385708				2022-12-01	WOS:000287971200032
J	Porrello, ER; Mahmoud, AI; Simpson, E; Hill, JA; Richardson, JA; Olson, EN; Sadek, HA				Porrello, Enzo R.; Mahmoud, Ahmed I.; Simpson, Emma; Hill, Joseph A.; Richardson, James A.; Olson, Eric N.; Sadek, Hesham A.			Transient Regenerative Potential of the Neonatal Mouse Heart	SCIENCE			English	Article							CELL-CYCLE CONTROL; MAMMALIAN CARDIOMYOCYTES; ZEBRAFISH; INJURY; PROLIFERATION; GROWTH	Certain fish and amphibians retain a robust capacity for cardiac regeneration throughout life, but the same is not true of the adult mammalian heart. Whether the capacity for cardiac regeneration is absent in mammals or whether it exists and is switched off early after birth has been unclear. We found that the hearts of 1-day-old neonatal mice can regenerate after partial surgical resection, but this capacity is lost by 7 days of age. This regenerative response in 1-day-old mice was characterized by cardiomyocyte proliferation with minimal hypertrophy or fibrosis, thereby distinguishing it from repair processes. Genetic fate mapping indicated that the majority of cardiomyocytes within the regenerated tissue originated from preexisting cardiomyocytes. Echocardiography performed 2 months after surgery revealed that the regenerated ventricular apex had normal systolic function. Thus, for a brief period after birth, the mammalian heart appears to have the capacity to regenerate.	[Porrello, Enzo R.; Hill, Joseph A.; Richardson, James A.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mahmoud, Ahmed I.; Hill, Joseph A.; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Simpson, Emma; Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu; hesham.sadek@utsouthwestern.edu	Porrello, Enzo/G-9934-2012	Porrello, Enzo/0000-0001-6105-7463; Mahmoud, Ahmed/0000-0003-1528-7393	National Health and Medical Research Council; National Heart Foundation of Australia; American Heart Association; NIH [HL100401-01]; Donald W. Reynolds Center for Clinical Cardiovascular Research; Jon Holden DeHaan Foundation; Leducq Foundation; Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115275, R01HL077439, R37HL053351, R01HL093039, U01HL100401] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Jon Holden DeHaan Foundation; Leducq Foundation(Leducq Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Simsek, J. Shelton, and the UT Southwestern Histology Core for help with histology and immunostaining, and J. Cabrera for graphical assistance. Supported by an overseas postdoctoral fellowship from the National Health and Medical Research Council and National Heart Foundation of Australia (E.R.P.), a cardiovascular research scholar award from Gilead Sciences and a fellow-to-faculty award from the American Heart Association (H.A.S.), and NIH grant HL100401-01, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the American Heart Association, the Jon Holden DeHaan Foundation, the Leducq Foundation, and the Robert A. Welch Foundation (E.N.O.).	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	15	1544	1616	13	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1078	1080		10.1126/science.1200708	http://dx.doi.org/10.1126/science.1200708			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350179	Green Accepted			2022-12-01	WOS:000287699000067
J	Merrikh, H; Machon, C; Grainger, WH; Grossman, AD; Soultanas, P				Merrikh, Houra; Machon, Cristina; Grainger, William H.; Grossman, Alan D.; Soultanas, Panos			Co-directional replication-transcription conflicts lead to replication restart	NATURE			English	Article							BACILLUS-SUBTILIS; DNA-REPLICATION; PROTEINS; PRIA; LOCALIZATION; INITIATION; REPLISOME; REP; RNA; RECOMBINATION	Head-on encounters between the replication and transcription machineries on the lagging DNA strand can lead to replication fork arrest and genomic instability(1,2). To avoid head-on encounters, most genes, especially essential and highly transcribed genes, are encoded on the leading strand such that transcription and replication are co-directional. Virtually all bacteria have the highly expressed ribosomal RNA genes co-directional with replication(3). In bacteria, co-directional encounters seem inevitable because the rate of replication is about 10-20-fold greater than the rate of transcription. However, these encounters are generally thought to be benign(2,4-9). Biochemical analyses indicate that head-on encounters(10) are more deleterious than co-directional encounters(8) and that in both situations, replication resumes without the need for any auxiliary restart proteins, at least in vitro. Here we show that in vivo, co-directional transcription can disrupt replication, leading to the involvement of replication restart proteins. We found that highly transcribed rRNA genes are hotspots for co-directional conflicts between replication and transcription in rapidly growing Bacillus subtilis cells. We observed a transcription-dependent increase in association of the replicative helicase and replication restart proteins where head-on and co-directional conflicts occur. Our results indicate that there are co-directional conflicts between replication and transcription in vivo. Furthermore, in contrast to the findings in vitro, the replication restart machinery is involved in vivo in resolving potentially deleterious encounters due to head-on and co-directional conflicts. These conflicts probably occur in many organisms and at many chromosomal locations and help to explain the presence of important auxiliary proteins involved in replication restart and in helping to clear a path along the DNA for the replisome.	[Merrikh, Houra; Grossman, Alan D.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Machon, Cristina; Grainger, William H.; Soultanas, Panos] Univ Nottingham, Sch Chem, Ctr Biomol Sci, Nottingham NG7 2RD, England	Massachusetts Institute of Technology (MIT); University of Nottingham	Grossman, AD (corresponding author), MIT, Dept Biol, Bldg 68-530, Cambridge, MA 02139 USA.	adg@mit.edu; Panos.Soultanas@nottingham.ac.uk	Sobrado, Cristina Machón/K-1634-2014	Sobrado, Cristina Machón/0000-0001-5363-2958; Soultanas, Panos/0000-0003-3578-5699	Biotechnology and Biological Sciences Research Council [BB/E006450/1]; Wellcome Trust [091968/Z/10/Z]; NIH [GM41934, GM093408]; Royal Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041934, R01GM041934, F32GM093408] Funding Source: NIH RePORTER; BBSRC [BB/E006450/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Grainger, C. Lee, T. Baker, and W. K. Smits for discussions, W. K. Smits for constructing the priA-ssrA* mutant, and C. Lee, C. Bonilla, S. P. Bell, and J. D. Wang for comments on the manuscript. Work in the P. S. laboratory was supported by Biotechnology and Biological Sciences Research Council grant BB/E006450/1 and a Wellcome Trust grant 091968/Z/10/Z. Work in the A. D. G. laboratory was supported by NIH grant GM41934 and H. M. was supported in part by NIH postdoctoral fellowship GM093408. The Biotechnology and Biological Sciences Research Council and the Royal Society provided funds for a sabbatical visit of P. S. in the A. D. G. laboratory.	Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Grainger WH, 2010, NUCLEIC ACIDS RES, V38, P2851, DOI 10.1093/nar/gkp1236; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Harwood C.R., 1990, MOL BIOL METHODS BAC; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Imai Y, 2000, MOL MICROBIOL, V36, P1037, DOI 10.1046/j.1365-2958.2000.01928.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Mahdi AA, 2006, GENE DEV, V20, P2135, DOI 10.1101/gad.382306; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Olavarrieta L, 2002, J MOL BIOL, V322, P1, DOI 10.1016/S0022-2836(02)00740-4; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Pomerantz RT, 2010, CELL CYCLE, V9, P2537, DOI 10.4161/cc.9.13.12122; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104	34	122	122	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					554	U147		10.1038/nature09758	http://dx.doi.org/10.1038/nature09758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350489	Green Accepted, Green Submitted			2022-12-01	WOS:000287652900046
J	Jiang, H; Shukla, A; Wang, XL; Chen, WY; Bernstein, BE; Roeder, RG				Jiang, Hao; Shukla, Abhijit; Wang, Xiaoling; Chen, Wei-yi; Bernstein, Bradley E.; Roeder, Robert G.			Role for Dpy-30 in ES Cell-Fate Specification by Regulation of H3K4 Methylation within Bivalent Domains	CELL			English	Article							EMBRYONIC STEM-CELLS; ELEGANS DOSAGE COMPENSATION; HISTONE H3; DEVELOPMENTAL REGULATORS; CHROMATIN SIGNATURES; GROUP PROTEINS; POLYCOMB; PLURIPOTENT; DIFFERENTIATION; TRITHORAX	Histone H3K4 methylation is associated with active genes and, along with H3K27 methylation, is part of a bivalent chromatin mark that typifies poised developmental genes in embryonic stem cells (ESCs). However, its functional roles in ESC maintenance and differentiation are not established. Here we show that mammalian Dpy-30, a core subunit of the SET1/MLL histone methyltransferase complexes, modulates H3K4 methylation in vitro, and directly regulates chromosomal H3K4 trimethylation (H3K4me3) throughout the mammalian genome. Depletion of Dpy-30 does not affect ESC self-renewal, but significantly alters the differentiation potential of ESCs, particularly along the neural lineage. The differentiation defect is accompanied by defects in gene induction and in H3K4 methylation at key developmental loci. Our results strongly indicate an essential functional role for Dpy-30 and SET1/MLL complex-mediated H3K4 methylation, as a component of the bivalent mark, at developmental genes during the ESC fate transitions.	[Jiang, Hao; Wang, Xiaoling; Chen, Wei-yi; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Rockefeller University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Wang, Xiaoling/D-4208-2013	Chen, Wei-Yi/0000-0002-0661-6899	Tri-Institutional Starr Stem Cell Scholars fellowship; NIH [DK071900]; Starr Cancer Consortium [I2-A88]; Leukemia and Lymphoma Society [7132-08]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	Tri-Institutional Starr Stem Cell Scholars fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Yali Dou for baculoviruses encoding RbBP5, WDR5 and Ash2L, Cristina Hughes (David Allis lab), and Eric McIntush (Bethyl Laboratories) for Dpy-30 antibody, Joanna Wysocka for WDR5 antibody, Aaron Goldberg (David Allis lab) for LIF, Shannon Lauberth and Zhanyun Tang for providing supporting data, Zheng-Yuan Fu for technical assistance, Esther Rheinbay, Jing Wang and Xiaojian Sun for data analyses, and Bing Ren (UCSD) and Xiangdong Lu for insightful discussions of the project. H.J. and W.-Y.C. are Leukemia and Lymphoma Society Fellows. X. W. is a recipient of a Tri-Institutional Starr Stem Cell Scholars fellowship. This work was supported by NIH (DK071900), Starr Cancer Consortium (I2-A88), and Leukemia and Lymphoma Society (7132-08) grants to R.G.R.	Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; HSU DR, 1995, DEVELOPMENT, V121, P3323; HSU DR, 1994, GENETICS, V137, P999; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wang X, 2008, J VIS EXP; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	44	206	223	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					513	525		10.1016/j.cell.2011.01.020	http://dx.doi.org/10.1016/j.cell.2011.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335234	Green Accepted, Bronze			2022-12-01	WOS:000287473100007
J	Elyada, E; Pribluda, A; Goldstein, RE; Morgenstern, Y; Brachya, G; Cojocaru, G; Snir-Alkalay, I; Burstain, I; Haffner-Krausz, R; Jung, S; Wiener, Z; Alitalo, K; Oren, M; Pikarsky, E; Ben-Neriah, Y				Elyada, Ela; Pribluda, Ariel; Goldstein, Robert E.; Morgenstern, Yael; Brachya, Guy; Cojocaru, Gady; Snir-Alkalay, Irit; Burstain, Ido; Haffner-Krausz, Rebecca; Jung, Steffen; Wiener, Zoltan; Alitalo, Kari; Oren, Moshe; Pikarsky, Eli; Ben-Neriah, Yinon			CKI alpha ablation highlights a critical role for p53 in invasiveness control	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; INTESTINAL EPITHELIUM; MOUSE MODEL; EXPRESSION; INVASION; TUMORIGENESIS; TRANSGENE; MUTATIONS; APOPTOSIS; BIOLOGY	The mature gut renews continuously and rapidly throughout adult life, often in a damage-inflicting micro-environment. The major driving force for self-renewal of the intestinal epithelium is the Wnt-mediated signalling pathway, and Wnt signalling is frequently hyperactivated in colorectal cancer(1). Here we show that casein kinase I alpha (CKI alpha), a component of the beta-catenin-destruction complex(1), is a critical regulator of the Wnt signalling pathway. Inducing the ablation of Csnk1a1 (the gene encoding CKI alpha) in the gut triggers massive Wnt activation, surprisingly without causing tumorigenesis. CKI alpha-deficient epithelium shows many of the features of human colorectal tumours in addition to Wnt activation, in particular the induction of the DNA damage response and cellular senescence, both of which are thought to provide a barrier against malignant transformation(2). The epithelial DNA damage response in mice is accompanied by substantial activation of p53, suggesting that the p53 pathway may counteract the pro-tumorigenic effects of Wnt hyperactivation. Notably, the transition from benign adenomas to invasive colorectal cancer in humans is typically linked to p53 inactivation, underscoring the importance of p53 as a safeguard against malignant progression(3); however, the mechanism of p53-mediated tumour suppression is unknown. We show that the maintenance of intestinal homeostasis inCKI alpha-deficient gut requires p53-mediated growth control, because the combined ablation of Csnk1a1 and either p53 or its target gene p21 (also known as Waf1, Cip1, Sdi1 and Cdkn1a) triggered high-grade dysplasia with extensive proliferation. Unexpectedly, these ablations also induced non-proliferating cells to invade the villous lamina propria rapidly, producing invasive carcinomas throughout the small bowel. Furthermore, in p53-deficient gut, loss of heterozygosity of the gene encoding CKI alpha caused a highly invasive carcinoma, indicating that CKI alpha functions as a tumour suppressor when p53 is inactivated. We identified a set of genes (the p53-suppressed invasiveness signature, PSIS) that is activated by the loss of both p53 and CKI alpha and which probably accounts for the brisk induction of invasiveness. PSIS transcription and tumour invasion were suppressed by p21, independently of cell cycle control. Restraining tissue invasion through suppressing PSIS expression is thus a novel tumour-suppressor function of wild-type p53.	[Elyada, Ela; Pribluda, Ariel; Goldstein, Robert E.; Morgenstern, Yael; Brachya, Guy; Cojocaru, Gady; Snir-Alkalay, Irit; Burstain, Ido; Pikarsky, Eli; Ben-Neriah, Yinon] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel; [Haffner-Krausz, Rebecca] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Wiener, Zoltan; Alitalo, Kari] Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Program, FIN-00014 Helsinki, Finland; [Wiener, Zoltan; Alitalo, Kari] Univ Helsinki, Biomedicum Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Pathol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science; Weizmann Institute of Science; University of Helsinki; University of Helsinki; Weizmann Institute of Science; Hebrew University of Jerusalem	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel.	peli@hadassah.org.il; yinon@cc.huji.ac.il	Jung, Steffen/K-1409-2012; Ben-Neriah, Yinon/L-6285-2019; Alitalo, Kari K/J-5013-2014; pikarsky, eli/GXV-7099-2022	Jung, Steffen/0000-0003-4290-5716; Alitalo, Kari K/0000-0002-7331-0902; Oren, Moshe/0000-0003-4311-7172; pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation; RUBICON EC Network of Excellence; Israel Cancer Research Fund; Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST); Marie-Curie Intra-European Fellowship	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation(Israel Science Foundation); RUBICON EC Network of Excellence; Israel Cancer Research Fund; Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST); Marie-Curie Intra-European Fellowship(European Commission)	We thank S. Robine for the Vil1-Cre-ER<SUP>T2</SUP> mice, O. Sansom and B. Romagnolo for intestinal sections of Apc<SUP>Delta gut</SUP> mice, K. Rajewsky for the pGEM-loxP-Neo-loxP and pCA-NLS-Cre vectors; and E. Horwitz, M. Farago, D. Naor, N. Asherie and D. Knigin for providing expertise and reagents. We are grateful to A. Yaron for critical reading of the manuscript. This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF), the Israel Science Foundation, the RUBICON EC Network of Excellence, the Israel Cancer Research Fund and Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST). Z.W. is supported by a Marie-Curie Intra-European Fellowship.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; DAVALLI AM, 1995, TRANSPLANTATION, V59, P817, DOI 10.1097/00007890-199503270-00003; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1994, COLD SPRING HARB SYM, V59, P67, DOI 10.1101/SQB.1994.059.01.010; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fazeli A, 1997, P NATL ACAD SCI USA, V94, P10199, DOI 10.1073/pnas.94.19.10199; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Ko CH, 2005, MOL CANCER THER, V4, P281; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Valentin-Vega YA, 2009, DIFFERENTIATION, V77, P442, DOI 10.1016/j.diff.2009.03.001; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; YIN J, 1993, GASTROENTEROLOGY, V104, pA464	42	143	160	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					409	U208		10.1038/nature09673	http://dx.doi.org/10.1038/nature09673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331045				2022-12-01	WOS:000287409100045
J	Iglehart, JK				Iglehart, John K.			Bundled Payment for ESRD - Including ESAs in Medicare's Dialysis Package	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P49029; FIELDS R, 2010, PROPUBLICA      1109; *MED PAYM ADV COMM, 2001, REP C MED PAYM POL; ZHANG Y, 2010, HLTH SERV RES   1209, DOI DOI 10.1111/J.1475-6773.2010.01219.X	5	24	25	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					593	595		10.1056/NEJMp1014187	http://dx.doi.org/10.1056/NEJMp1014187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722BW	21323538	Bronze			2022-12-01	WOS:000287406000001
J	Baker, M				Baker, Monya			GENOMES IN THREE DIMENSIONS	NATURE			English	Editorial Material							CHROMATIN; ORGANIZATION											Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2009, J CELL BIOL, V187, P801, DOI 10.1083/jcb.200909127; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	20	17	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					289	294		10.1038/470289a	http://dx.doi.org/10.1038/470289a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307943	Bronze			2022-12-01	WOS:000287144200050
J	Colbourne, JK; Pfrender, ME; Gilbert, D; Thomas, WK; Tucker, A; Oakley, TH; Tokishita, S; Aerts, A; Arnold, GJ; Basu, MK; Bauer, DJ; Caceres, CE; Carmel, L; Casola, C; Choi, JH; Detter, JC; Dong, QF; Dusheyko, S; Eads, BD; Frohlich, T; Geiler-Samerotte, KA; Gerlach, D; Hatcher, P; Jogdeo, S; Krijgsveld, J; Kriventseva, EV; Kultz, D; Laforsch, C; Lindquist, E; Lopez, J; Manak, JR; Muller, J; Pangilinan, J; Patwardhan, RP; Pitluck, S; Pritham, EJ; Rechtsteiner, A; Rho, M; Rogozin, IB; Sakarya, O; Salamov, A; Schaack, S; Shapiro, H; Shiga, Y; Skalitzky, C; Smith, Z; Souvorov, A; Sung, W; Tang, ZJ; Tsuchiya, D; Tu, H; Vos, H; Wang, M; Wolf, YI; Yamagata, H; Yamada, T; Ye, YZ; Shaw, JR; Andrews, J; Crease, TJ; Tang, HX; Lucas, SM; Robertson, HM; Bork, P; Koonin, EV; Zdobnov, EM; Grigoriev, IV; Lynch, M; Boore, JL				Colbourne, John K.; Pfrender, Michael E.; Gilbert, Donald; Thomas, W. Kelley; Tucker, Abraham; Oakley, Todd H.; Tokishita, Shinichi; Aerts, Andrea; Arnold, Georg J.; Basu, Malay Kumar; Bauer, Darren J.; Caceres, Carla E.; Carmel, Liran; Casola, Claudio; Choi, Jeong-Hyeon; Detter, John C.; Dong, Qunfeng; Dusheyko, Serge; Eads, Brian D.; Froehlich, Thomas; Geiler-Samerotte, Kerry A.; Gerlach, Daniel; Hatcher, Phil; Jogdeo, Sanjuro; Krijgsveld, Jeroen; Kriventseva, Evgenia V.; Kueltz, Dietmar; Laforsch, Christian; Lindquist, Erika; Lopez, Jacqueline; Manak, J. Robert; Muller, Jean; Pangilinan, Jasmyn; Patwardhan, Rupali P.; Pitluck, Samuel; Pritham, Ellen J.; Rechtsteiner, Andreas; Rho, Mina; Rogozin, Igor B.; Sakarya, Onur; Salamov, Asaf; Schaack, Sarah; Shapiro, Harris; Shiga, Yasuhiro; Skalitzky, Courtney; Smith, Zachary; Souvorov, Alexander; Sung, Way; Tang, Zuojian; Tsuchiya, Dai; Tu, Hank; Vos, Harmjan; Wang, Mei; Wolf, Yuri I.; Yamagata, Hideo; Yamada, Takuji; Ye, Yuzhen; Shaw, Joseph R.; Andrews, Justen; Crease, Teresa J.; Tang, Haixu; Lucas, Susan M.; Robertson, Hugh M.; Bork, Peer; Koonin, Eugene V.; Zdobnov, Evgeny M.; Grigoriev, Igor V.; Lynch, Michael; Boore, Jeffrey L.			The Ecoresponsive Genome of Daphnia pulex	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENES; EXPRESSION; DUPLICATIONS; EVOLUTION; MAGNA	We describe the draft genome of the microcrustacean Daphnia pulex, which is only 200 megabases and contains at least 30,907 genes. The high gene count is a consequence of an elevated rate of gene duplication resulting in tandem gene clusters. More than a third of Daphnia's genes have no detectable homologs in any other available proteome, and the most amplified gene families are specific to the Daphnia lineage. The coexpansion of gene families interacting within metabolic pathways suggests that the maintenance of duplicated genes is not random, and the analysis of gene expression under different environmental conditions reveals that numerous paralogs acquire divergent expression patterns soon after duplication. Daphnia-specific genes, including many additional loci within sequenced regions that are otherwise devoid of annotations, are the most responsive genes to ecological challenges.	[Colbourne, John K.; Gilbert, Donald; Choi, Jeong-Hyeon; Dong, Qunfeng; Eads, Brian D.; Lopez, Jacqueline; Patwardhan, Rupali P.; Rechtsteiner, Andreas; Smith, Zachary; Tang, Zuojian; Tsuchiya, Dai; Shaw, Joseph R.; Andrews, Justen; Tang, Haixu] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Pfrender, Michael E.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Gilbert, Donald; Tucker, Abraham; Casola, Claudio; Eads, Brian D.; Schaack, Sarah; Andrews, Justen; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Thomas, W. Kelley; Tucker, Abraham; Bauer, Darren J.; Hatcher, Phil; Jogdeo, Sanjuro; Sung, Way] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; [Oakley, Todd H.; Geiler-Samerotte, Kerry A.; Sakarya, Onur] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Tokishita, Shinichi; Shiga, Yasuhiro; Yamagata, Hideo] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Div Environm Sci, Lab Environm & Mol Biol, Tokyo 1920392, Japan; [Aerts, Andrea; Detter, John C.; Dusheyko, Serge; Lindquist, Erika; Pangilinan, Jasmyn; Pitluck, Samuel; Salamov, Asaf; Shapiro, Harris; Tu, Hank; Wang, Mei; Lucas, Susan M.; Grigoriev, Igor V.; Boore, Jeffrey L.] JGI, Dept Energy, Walnut Creek, CA 94598 USA; [Arnold, Georg J.; Froehlich, Thomas] Univ Munich, Gene Ctr, Lab Funct Genome Anal LAFUGA, D-82152 Planegg Martinsried, Germany; [Basu, Malay Kumar; Carmel, Liran; Rogozin, Igor B.; Souvorov, Alexander; Wolf, Yuri I.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Caceres, Carla E.] Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; [Gerlach, Daniel; Kriventseva, Evgenia V.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Gerlach, Daniel; Kriventseva, Evgenia V.; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, NL-3584 CA Utrecht, Netherlands; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Netherlands Prote Ctr, NL-3584 CA Utrecht, Netherlands; [Kueltz, Dietmar] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Laforsch, Christian] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Laforsch, Christian] Univ Munich, GeoBio Ctr Munich, D-82152 Planegg Martinsried, Germany; [Manak, J. Robert; Skalitzky, Courtney] Roche NimbleGen Inc, Gene Express, Madison, WI 53719 USA; [Muller, Jean; Yamada, Takuji; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Pritham, Ellen J.; Schaack, Sarah] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Rho, Mina; Ye, Yuzhen; Tang, Haixu] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47408 USA; [Shaw, Joseph R.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Crease, Teresa J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Zdobnov, Evgeny M.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Boore, Jeffrey L.] Genome Project Solut, Hercules, CA 94547 USA; [Boore, Jeffrey L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Indiana University System; Indiana University Bloomington; Utah System of Higher Education; Utah State University; Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire; University of California System; University of California Santa Barbara; Tokyo University of Pharmacy & Life Sciences; United States Department of Energy (DOE); Joint Genome Institute - JGI; University of Munich; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Illinois System; University of Illinois Urbana-Champaign; University of Geneva; Swiss Institute of Bioinformatics; Utrecht University; Utrecht University; Utrecht University; University of California System; University of California Davis; University of Munich; University of Munich; Roche Holding; European Molecular Biology Laboratory (EMBL); University of Texas System; University of Texas Arlington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Guelph; University of Illinois System; University of Illinois Urbana-Champaign; Imperial College London; University of California System; University of California Berkeley	Colbourne, JK (corresponding author), Indiana Univ, Ctr Genom & Bioinformat, 915 E 3rd St, Bloomington, IN 47405 USA.	jcolbour@indiana.edu	Crease, Teresa/E-2932-2015; Choi, Justin/F-8792-2014; Muller, Jean/L-7412-2018; Krijgsveld, Jeroen/F-5974-2011; , DK/AAU-3163-2021; Pfrender, Micheal E./C-5065-2019; Zdobnov, Evgeny/AAB-2745-2022; Colbourne, John K/L-7748-2014; Bork, Peer/F-1813-2013; Fröhlich, Thomas/C-6735-2011; Zdobnov, Evgeny M/K-1133-2012; Choi, Jeong-Hyeon/E-3084-2010	Crease, Teresa/0000-0001-8074-8024; Muller, Jean/0000-0002-7682-559X; Zdobnov, Evgeny/0000-0002-5178-1498; Colbourne, John K/0000-0002-6966-2972; Bork, Peer/0000-0002-2627-833X; Fröhlich, Thomas/0000-0002-4709-3211; Manak, John/0000-0002-6562-7694; Grigoriev, Igor/0000-0002-3136-8903; Krijgsveld, Jeroen/0000-0001-7549-9326; Oakley, Todd/0000-0002-4478-915X; Vos, Harmjan/0000-0002-4696-6068; Rogozin, Igor/0000-0003-0802-4851; Wolf, Yuri/0000-0002-0247-8708; Casola, Claudio/0000-0003-4853-1866; Rechtsteiner, Andreas/0000-0001-6031-1087; Gerlach, Daniel/0000-0001-9338-3765	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Daphnia Genomics Consortium (DGC); NSF [0221837, 0328516]; NIH [R24GM07827401]; METACyt Initiative of Indiana University; Lilly Endowment, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019324, P42ES004699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078274] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000073] Funding Source: NIH RePORTER	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Daphnia Genomics Consortium (DGC); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); METACyt Initiative of Indiana University; Lilly Endowment, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M. Frazer (JGI), P. Cherbas (CGB), R. Green, and T. Takova (Roche NimbleGen, Inc.). The work conducted by the U.S. Department of Energy Joint Genome Institute (JGI) was supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231 and in collaboration with the Daphnia Genomics Consortium (DGC). This project was also supported by NSF grants 0221837 and 0328516 and NIH grant R24GM07827401. Coordination infrastructure for the DGC is provided by the Center for Genomics and Bioinformatics (CGB) at Indiana University, which is supported in part by the METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. Additional contributions and acknowledgments are provided in the SOM. Our work benefits from and contributes to the Daphnia Genomics Consortium. Daphnia pulex genome assembly version 1.1 and annotations are deposited at DNA Data Bank of Japan, European Molecular Biology Laboratory, and GenBank databases under accession ACJG00000000. ESTs (FE274839 to FE425949) are in GenBank. Microarray platforms GPL11200 to GPL11201 and data GSE25823 are deposited at National Center for Biotechnology Information Gene Expression Omnibus database.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Colbourne John K., 1997, P163; Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Hebert P.D.N., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P439; Hoffmann FG, 2008, MOL BIOL EVOL, V25, P591, DOI 10.1093/molbev/msn004; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Kimura S, 1999, J BIOL CHEM, V274, P10649, DOI 10.1074/jbc.274.15.10649; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lynch Michael, 1994, P109; Martins J, 2007, ENVIRON INT, V33, P414, DOI 10.1016/j.envint.2006.12.006; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Shaw JR, 2008, ADV EXP BIOL, V2, P165, DOI 10.1016/S1872-2423(08)00005-7; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; Taylor DJ, 1999, P ROY SOC B-BIOL SCI, V266, P791, DOI 10.1098/rspb.1999.0707; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P177; Wang FY, 2009, VISION RES, V49, P1860, DOI 10.1016/j.visres.2009.04.023; Zeis B, 2008, COMP BIOCHEM PHYS A, V151, pS38, DOI 10.1016/j.cbpa.2008.05.141; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	24	898	949	12	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					555	561		10.1126/science.1197761	http://dx.doi.org/10.1126/science.1197761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292972	Green Submitted, Green Accepted			2022-12-01	WOS:000286933600046
J	Howell, P				Howell, Peter			Listen to the lessons of The King's Speech	NATURE			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Howell, P (corresponding author), UCL, London WC1E 6BT, England.	p.howell@ucl.ac.uk							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					7	7		10.1038/470007a	http://dx.doi.org/10.1038/470007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715LQ	21293331				2022-12-01	WOS:000286886400004
J	Seibert, MM; Ekeberg, T; Maia, FRNC; Svenda, M; Andreasson, J; Jonsson, O; Odic, D; Iwan, B; Rocker, A; Westphal, D; Hantke, M; DePonte, DP; Barty, A; Schulz, J; Gumprecht, L; Coppola, N; Aquila, A; Liang, MN; White, TA; Martin, A; Caleman, C; Stern, S; Abergel, C; Seltzer, V; Claverie, JM; Bostedt, C; Bozek, JD; Boutet, S; Miahnahri, AA; Messerschmidt, M; Krzywinski, J; Williams, G; Hodgson, KO; Bogan, MJ; Hampton, CY; Sierra, RG; Starodub, D; Andersson, I; Bajt, S; Barthelmess, M; Spence, JCH; Fromme, P; Weierstall, U; Kirian, R; Hunter, M; Doak, RB; Marchesini, S; Hau-Riege, SP; Frank, M; Shoeman, RL; Lomb, L; Epp, SW; Hartmann, R; Rolles, D; Rudenko, A; Schmidt, C; Foucar, L; Kimmel, N; Holl, P; Rudek, B; Erk, B; Homke, A; Reich, C; Pietschner, D; Weidenspointner, G; Struder, L; Hauser, G; Gorke, H; Ullrich, J; Schlichting, I; Herrmann, S; Schaller, G; Schopper, F; Soltau, H; Kuhnel, KU; Andritschke, R; Schroter, CD; Krasniqi, F; Bott, M; Schorb, S; Rupp, D; Adolph, M; Gorkhover, T; Hirsemann, H; Potdevin, G; Graafsma, H; Nilsson, B; Chapman, HN; Hajdu, J				Seibert, M. Marvin; Ekeberg, Tomas; Maia, Filipe R. N. C.; Svenda, Martin; Andreasson, Jakob; Joensson, Olof; Odic, Dusko; Iwan, Bianca; Rocker, Andrea; Westphal, Daniel; Hantke, Max; DePonte, Daniel P.; Barty, Anton; Schulz, Joachim; Gumprecht, Lars; Coppola, Nicola; Aquila, Andrew; Liang, Mengning; White, Thomas A.; Martin, Andrew; Caleman, Carl; Stern, Stephan; Abergel, Chantal; Seltzer, Virginie; Claverie, Jean-Michel; Bostedt, Christoph; Bozek, John D.; Boutet, Sebastien; Miahnahri, A. Alan; Messerschmidt, Marc; Krzywinski, Jacek; Williams, Garth; Hodgson, Keith O.; Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri; Andersson, Inger; Bajt, Sasa; Barthelmess, Miriam; Spence, John C. H.; Fromme, Petra; Weierstall, Uwe; Kirian, Richard; Hunter, Mark; Doak, R. Bruce; Marchesini, Stefano; Hau-Riege, Stefan P.; Frank, Matthias; Shoeman, Robert L.; Lomb, Lukas; Epp, Sascha W.; Hartmann, Robert; Rolles, Daniel; Rudenko, Artem; Schmidt, Carlo; Foucar, Lutz; Kimmel, Nils; Holl, Peter; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Reich, Christian; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Gorke, Hubert; Ullrich, Joachim; Schlichting, Ilme; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Soltau, Heike; Kuehnel, Kai-Uwe; Andritschke, Robert; Schroeter, Claus-Dieter; Krasniqi, Faton; Bott, Mario; Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais; Hirsemann, Helmut; Potdevin, Guillaume; Graafsma, Heinz; Nilsson, Bjoern; Chapman, Henry N.; Hajdu, Janos			Single mimivirus particles intercepted and imaged with an X-ray laser	NATURE			English	Article							FREE-ELECTRON LASER; DIFFRACTION MICROSCOPY; VIROPHAGE	X-ray lasers offer new capabilities in understanding the structure of biological systems, complex materials and matter under extreme conditions(1-4). Very short and extremely bright, coherent X-ray pulses can be used to outrun key damage processes and obtain a single diffraction pattern from a large macromolecule, a virus or a cell before the sample explodes and turns into plasma(1). The continuous diffraction pattern of non-crystalline objects permits oversampling and direct phase retrieval(2). Here we show that high-quality diffraction data can be obtained with a single X-ray pulse from a noncrystalline biological sample, a single mimivirus particle, which was injected into the pulsed beam of a hard-X-ray free-electron laser, the Linac Coherent Light Source(5). Calculations indicate that the energy deposited into the virus by the pulse heated the particle to over 100,000 K after the pulse had left the sample. The reconstructed exit wavefront (image) yielded 32-nm full-period resolution in a single exposure and showed no measurable damage. The reconstruction indicates inhomogeneous arrangement of dense material inside the virion. We expect that significantly higher resolutions will be achieved in such experiments with shorter and brighter photon pulses focused to a smaller area. The resolution in such experiments can be further extended for samples available in multiple identical copies.	[Seibert, M. Marvin; Ekeberg, Tomas; Maia, Filipe R. N. C.; Svenda, Martin; Andreasson, Jakob; Joensson, Olof; Odic, Dusko; Iwan, Bianca; Rocker, Andrea; Westphal, Daniel; Hantke, Max; Caleman, Carl; Hajdu, Janos] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [DePonte, Daniel P.; Barty, Anton; Schulz, Joachim; Gumprecht, Lars; Coppola, Nicola; Aquila, Andrew; Liang, Mengning; White, Thomas A.; Martin, Andrew; Caleman, Carl; Stern, Stephan; Chapman, Henry N.] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Stern, Stephan; Chapman, Henry N.] Univ Hamburg, D-22607 Hamburg, Germany; [Abergel, Chantal; Seltzer, Virginie; Claverie, Jean-Michel] Aix Marseille Univ, CNRS, UPR2589, Inst Microbiol & Mediterranee, F-13288 Marseille 9, France; [Bostedt, Christoph; Bozek, John D.; Boutet, Sebastien; Miahnahri, A. Alan; Messerschmidt, Marc; Krzywinski, Jacek; Williams, Garth] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Hodgson, Keith O.; Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Andersson, Inger] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden; [Spence, John C. H.; Weierstall, Uwe; Kirian, Richard; Doak, R. Bruce] Arizona State Univ, Dept Phys, PSF470, Tempe, AZ 85287 USA; [Fromme, Petra; Hunter, Mark] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Marchesini, Stefano] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Shoeman, Robert L.; Lomb, Lukas; Rolles, Daniel; Foucar, Lutz; Schlichting, Ilme; Krasniqi, Faton; Bott, Mario] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Epp, Sascha W.; Rolles, Daniel; Rudenko, Artem; Schmidt, Carlo; Foucar, Lutz; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Strueder, Lothar; Ullrich, Joachim; Schlichting, Ilme; Krasniqi, Faton] Max Planck Adv Study Grp, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Epp, Sascha W.; Rudenko, Artem; Schmidt, Carlo; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Ullrich, Joachim; Kuehnel, Kai-Uwe; Schroeter, Claus-Dieter] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hartmann, Robert; Holl, Peter; Reich, Christian; Soltau, Heike] PNSensor GmbH, D-80803 Munich, Germany; [Kimmel, Nils; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Halbleiterlab, D-81739 Munich, Germany; [Kimmel, Nils; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Strueder, Lothar] Univ Siegen, D-57068 Siegen, Germany; [Gorke, Hubert] Forschungszentrum Julich, Inst ZEL, D-52425 Julich, Germany; [Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais] Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany	Uppsala University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Swedish University of Agricultural Sciences; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Max Planck Society; Max Planck Society; Max Planck Society; PNSensor GmbH; Max Planck Society; Max Planck Society; Universitat Siegen; Helmholtz Association; Research Center Julich; Technical University of Berlin	Hajdu, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, Husargatan 3,Box 596, SE-75124 Uppsala, Sweden.	chantal.abergel@igs.cnrs-mrs.fr; janos.hajdu@xray.bmc.uu.se	Bogan, Mike/I-6962-2012; Marchesini, Stefano/GYR-1409-2022; Barty, Anton/K-5137-2014; Bajt, Sasa/G-2228-2010; Rudek, Benedikt/AAX-1278-2021; Marchesini, Stefano/A-6795-2009; Frank, Matthias/O-9055-2014; Bajt, Sasa/O-4695-2019; Williams, Garth/H-1606-2012; Messerschmidt, Marc/Y-8929-2019; Messerschmidt, Marc/F-3796-2010; Schlichting, Ilme/I-1339-2013; Maia, Filipe R.N.C./C-3146-2014; Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019; Rupp, Daniela/P-7590-2016; Bozek, John D/E-9260-2010; Rudek, Benedikt/A-5100-2017; Gorkhover, Tais/K-8468-2012; Weierstall, Uwe/B-3568-2011; Rupp, Daniela/AAD-7978-2021; Rudenko, Artem/C-7412-2009; Jönsson, H Olof/O-8664-2017; FRS, Henry N Chapman/G-2153-2010; Kirian, Richard/M-3750-2013	Bogan, Mike/0000-0001-9318-3333; Barty, Anton/0000-0003-4751-2727; Rudek, Benedikt/0000-0002-6404-4294; Marchesini, Stefano/0000-0002-6798-2913; Bajt, Sasa/0000-0002-7163-7602; Messerschmidt, Marc/0000-0002-8641-3302; Messerschmidt, Marc/0000-0002-8641-3302; Maia, Filipe R.N.C./0000-0002-2141-438X; Claverie, Jean-Michel/0000-0003-1424-0315; Bozek, John D/0000-0001-7486-7238; Rupp, Daniela/0000-0002-6504-7956; Rudenko, Artem/0000-0002-9154-8463; Jönsson, H Olof/0000-0002-2076-0918; FRS, Henry N Chapman/0000-0002-4655-1743; Frank, Matthias/0000-0002-5244-0791; Erk, Benjamin/0000-0001-8413-3588; Andreasson, Jakob/0000-0002-3202-2330; Kirian, Richard/0000-0001-7197-3086; Schulz, Joachim/0000-0002-9310-8832; MARTIN, ANDREW/0000-0003-3704-1829; Epp, Sascha/0000-0001-6366-9113; RUDENKO, Artem/0000-0001-6771-2510; graafsma, heinz/0000-0003-2304-667X; Seibert, Mark Marvin/0000-0003-0251-0744; Abergel, Chantal/0000-0003-1875-4049; Stern, Stephan/0000-0001-9786-7513; Aquila, Andrew/0000-0003-0358-2774	Swedish Research Councils; Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; Swedish University of Agricultural Sciences; Helmholtz Association [VH-VI-302]; DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-BLAN08-0089]; Hamburg Ministry of Science and Research; Hamburg School for Structure and Dynamics; Max Planck Society; US National Science Foundation [MCB 0919195, MCB-1021557]; US Department of Energy through the PULSE Institute; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research (LEXI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER; Direct For Biological Sciences [1021557] Funding Source: National Science Foundation	Swedish Research Councils(Swedish Research Council); Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Swedish University of Agricultural Sciences; Helmholtz Association(Helmholtz Association); DFG Cluster of Excellence at the Munich Centre for Advanced Photonics(German Research Foundation (DFG)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Hamburg Ministry of Science and Research; Hamburg School for Structure and Dynamics; Max Planck Society(Max Planck SocietyFoundation CELLEX); US National Science Foundation(National Science Foundation (NSF)); US Department of Energy through the PULSE Institute(United States Department of Energy (DOE)); Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research (LEXI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the following agencies: the Swedish Research Councils; the Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; the Swedish University of Agricultural Sciences; the Helmholtz Association (VH-VI-302); the DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; the Centre National de la Recherche Scientifique; Agence Nationale de la Recherche (ANR-BLAN08-0089); the Hamburg Ministry of Science and Research and Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); the Hamburg School for Structure and Dynamics; the Max Planck Society, the US National Science Foundation (grants MCB 0919195 and MCB-1021557); and the US Department of Energy, through the PULSE Institute. Portions of this research were carried out at the Linac Coherent Light Source, a National User Facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. We are grateful to B. Hedman and N. Timneanu for their help and to the scientific and technical staff of the LCLS for their outstanding facility and support.	Bergh M, 2008, Q REV BIOPHYS, V41, P181, DOI 10.1017/S003358350800471X; Bogan MJ, 2008, NANO LETT, V8, P310, DOI 10.1021/nl072728k; Bortel G, 2009, J STRUCT BIOL, V166, P226, DOI 10.1016/j.jsb.2009.01.005; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Ding Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.254801; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Fung R, 2009, NAT PHYS, V5, P64, DOI [10.1038/nphys1129, 10.1038/NPHYS1129]; Hau-Riege SP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.064801; Huldt G, 2003, J STRUCT BIOL, V144, P219, DOI 10.1016/j.jsb.2003.09.025; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Loh NTD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026705; Luke DR, 2005, INVERSE PROBL, V21, P37, DOI 10.1088/0266-5611/21/1/004; Maia FRNC, 2010, J APPL CRYSTALLOGR, V43, P1535, DOI 10.1107/S0021889810036083; Maia FRNC, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031905; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Nagler B, 2009, NAT PHYS, V5, P693, DOI 10.1038/NPHYS1341; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Seibert MM, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/19/194015; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Song CY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.158101; Steinbrener J, 2010, OPT EXPRESS, V18, P18598, DOI 10.1364/OE.18.018598; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; Thibault P, 2006, ACTA CRYSTALLOGR A, V62, P248, DOI 10.1107/S0108767306016515; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177	33	646	663	6	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					78	U86		10.1038/nature09748	http://dx.doi.org/10.1038/nature09748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293374	Green Published, Green Accepted			2022-12-01	WOS:000286886400037
J	St Hilaire, C; Ziegler, SG; Markello, TC; Brusco, A; Groden, C; Gill, F; Carlson-Donohoe, H; Lederman, RJ; Chen, MY; Yang, D; Siegenthaler, MP; Arduino, C; Mancini, C; Freudenthal, B; Stanescu, HC; Zdebik, AA; Chaganti, RK; Nussbaum, RL; Kleta, R; Gahl, WA; Boehm, M				St Hilaire, Cynthia; Ziegler, Shira G.; Markello, Thomas C.; Brusco, Alfredo; Groden, Catherine; Gill, Fred; Carlson-Donohoe, Hannah; Lederman, Robert J.; Chen, Marcus Y.; Yang, Dan; Siegenthaler, Michael P.; Arduino, Carlo; Mancini, Cecilia; Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Chaganti, R. Krishna; Nussbaum, Robert L.; Kleta, Robert; Gahl, William A.; Boehm, Manfred			NT5E Mutations and Arterial Calcifications	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; VASCULAR CALCIFICATION; MINERALIZATION; ADENOSINE; INFANCY; ENPP1; CELLS	BACKGROUND Arterial calcifications are associated with increased cardiovascular risk, but the genetic basis of this association is unclear. METHODS We performed clinical, radiographic, and genetic studies in three families with symptomatic arterial calcifications. Single-nucleotide-polymorphism analysis, targeted gene sequencing, quantitative polymerase-chain-reaction assays, Western blotting, enzyme measurements, transduction rescue experiments, and in vitro calcification assays were performed. RESULTS We identified nine persons with calcifications of the lower-extremity arteries and hand and foot joint capsules: all five siblings in one family, three siblings in another, and one patient in a third family. Serum calcium, phosphate, and vitamin D levels were normal. Affected members of Family 1 shared a single 22.4-Mb region of homozygosity on chromosome 6 and had a homozygous nonsense mutation (c.662C -> A, p.S221X) in NT5E, encoding CD73, which converts AMP to adenosine. Affected members of Family 2 had a homozygous missense mutation (c.1073G -> A, p.C358Y) in NT5E. The proband of Family 3 was a compound heterozygote for c.662C -> A and c.1609dupA (p.V537fsX7). All mutations found in the three families result in nonfunctional CD73. Cultured fibroblasts from affected members of Family 1 showed markedly reduced expression of NT5E messenger RNA, CD73 protein, and enzyme activity, as well as increased alkaline phosphatase levels and accumulated calcium phosphate crystals. Genetic rescue experiments normalized the CD73 and alkaline phosphatase activity in patients' cells, and adenosine treatment reduced the levels of alkaline phosphatase and calcification. CONCLUSIONS We identified mutations in NT5E in members of three families with symptomatic arterial and joint calcifications. This gene encodes CD73, which converts AMP to adenosine, supporting a role for this metabolic pathway in inhibiting ectopic tissue calcification.	[Markello, Thomas C.; Groden, Catherine; Gahl, William A.] NHGRI, NIH Undiagnosed Dis Program, NIH, Bethesda, MD 20892 USA; [St Hilaire, Cynthia; Lederman, Robert J.; Chen, Marcus Y.; Yang, Dan; Siegenthaler, Michael P.; Boehm, Manfred] NHLBI, NIH, Bethesda, MD 20892 USA; [Gill, Fred] NIH, Off Rare Dis Res, Ctr Clin, Bethesda, MD 20892 USA; [Brusco, Alfredo; Arduino, Carlo; Mancini, Cecilia] Direz Univ Med Genet, Azienda Osped Univ San Giovanni Battista, Turin, Italy; [Brusco, Alfredo; Arduino, Carlo; Mancini, Cecilia] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Kleta, Robert] UCL, Dept Med, London WC1E 6BT, England; [Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Kleta, Robert] UCL, Dept Physiol, London WC1E 6BT, England; [Chaganti, R. Krishna] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Nussbaum, Robert L.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Center for Advancing Translational Sciences (NCATS); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Turin; University of London; University College London; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gahl, WA (corresponding author), NHGRI, NIH Undiagnosed Dis Program, NIH, 10 Ctr Dr,Bldg 10,Rm 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	Hofbauer, Lorenz C/G-2490-2010; Mancini, Cecilia/AAB-7442-2019; lederman, robert j/C-6305-2009; Riksen, Niels P/G-8260-2015; Rongen, Gerard A/C-1578-2018; Brusco, Alfredo/A-1811-2013; St. Hilaire, Cynthia/R-8205-2017; Rongen, Gerard/AAJ-9694-2021; St. Hilaire, Cynthia/I-4713-2014	Hofbauer, Lorenz C/0000-0002-8691-8423; lederman, robert j/0000-0003-1202-6673; Riksen, Niels P/0000-0001-9197-8124; Brusco, Alfredo/0000-0002-8318-7231; St. Hilaire, Cynthia/0000-0003-1871-6915; Mancini, Cecilia/0000-0003-1282-0404; Freudenthal, Bernard/0000-0003-4669-918X	National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL006077, ZIAHL005062, ZIDHL006061, ZIAHL006079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309, T32GM007814] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Intramural Research Programs of the National Human Genome Research Institute (NHGRI) and the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.	Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delomenede M, 2009, ACTA BIOCHIM POL, V56, P301; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; HAYASHI E, 1985, BRIT J PHARMACOL, V84, P765, DOI 10.1111/j.1476-5381.1985.tb16159.x; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; LEVITIN J, 1945, RADIOLOGY, V44, P489, DOI 10.1148/44.5.489; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Magnus-Levy A, 1914, DEUT MED WOCHENSCHR, V40, P1305, DOI 10.1055/s-0029-1190517; Mori Hideki, 1992, Heart and Vessels, V7, P211, DOI 10.1007/BF01744607; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; NOSAKA H, 1974, YONAGO ACTA MED, V18, P191; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2008, CIRC-CARDIOVASC GENE, V1, P133, DOI 10.1161/CIRCGENETICS.108.797704; SHARP J, 1954, ANN RHEUM DIS, V13, P15, DOI 10.1136/ard.13.1.15; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933	29	303	314	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					432	442		10.1056/NEJMoa0912923	http://dx.doi.org/10.1056/NEJMoa0912923			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21506749	Green Accepted, Green Published			2022-12-01	WOS:000286885900008
J	Riksen, NP; Rongen, GA				Riksen, Niels P.; Rongen, Gerard A.			NT5E Mutations and Arterial Calcifications	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							ECTO-5'-NUCLEOTIDASE		[Riksen, Niels P.; Rongen, Gerard A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Riksen, NP (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	n.riksen@aig.umcn.nl	Hofbauer, Lorenz C/G-2490-2010; Mancini, Cecilia/AAB-7442-2019; lederman, robert j/C-6305-2009; Riksen, Niels P/G-8260-2015; Rongen, Gerard A/C-1578-2018; Brusco, Alfredo/A-1811-2013; St. Hilaire, Cynthia/R-8205-2017; Rongen, Gerard/AAJ-9694-2021; St. Hilaire, Cynthia/I-4713-2014	Hofbauer, Lorenz C/0000-0002-8691-8423; lederman, robert j/0000-0003-1202-6673; Riksen, Niels P/0000-0001-9197-8124; Brusco, Alfredo/0000-0002-8318-7231; St. Hilaire, Cynthia/0000-0003-1871-6915; Mancini, Cecilia/0000-0003-1282-0404; Freudenthal, Bernard/0000-0003-4669-918X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL006077, ZIAHL005062, ZIDHL006061, ZIAHL006079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309, T32GM007814] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Meijer P, 2010, HYPERTENSION, V56, P722, DOI 10.1161/HYPERTENSIONAHA.110.155689; Sanada S, 2004, CIRCULATION, V110, P2143, DOI 10.1161/01.CIR.0000143830.59419.73; Zernecke A, 2006, CIRCULATION, V113, P2120, DOI 10.1161/CIRCULATIONAHA.105.595249	4	303	314	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1579	1579		10.1056/NEJMoa0912923	http://dx.doi.org/10.1056/NEJMoa0912923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21506749	Green Accepted, Green Published			2022-12-01	WOS:000289722700025
